{
    "pages": [
        {
            "index": 0,
            "markdown": "$\\sqrt{ }$ heterogeneous texture $\\leftarrow$ necrosis (common)\n4. Osteosarcoma\n(c) secondary bladder tumor\n\n1. Metastases\n$1.5 \\%$ of all bladder malignancies\nOrigin: melanoma $>$ stomach $>$ breast $>$ kidney $>$ lung\n$\\sqrt{ }$ solitary / multiple nodules\n2. Lymphoma\nautoptic bladder involvement in $15 \\%$ of NHL, in 5\\% of Hodgkin disease\n3. Leukemia\nmicroscopic involvement in $22 \\%$ at autopsy\n4. Direct extension (common)\n$\\leftarrow$ prostate, rectum, sigmoid, cervix, ovary\n5. Endometriosis\n\nLocation: on posterior wall\n\n- urinary symptoms in $80 \\%$\n\n\n# Bladder Calcification \n\n## Bladder Calculus\n\n1. Stasis calculus $(70 \\%)$\nin bladder outflow obstruction, bladder diverticula, cystocele, neuropathic bladder dysfunction\nAssociated with: gram-negative lower urinary tract infection (in 30\\%), esp. Proteus\n2. Migrant calculus\n$=$ renal calculi spontaneously passing into bladder\n3. Foreign body nidus calculus\n$\\leftarrow$ self-introduced objects, urinary stent, chronic catheterization, bladder wallpenetrating bone fragments, prostatic chips, nonabsorbable suture material, fragments of Foley balloon catheter, pubic hair, presence of intestinal mucosa (in bladder augmentation, ileal conduit, repaired bladder exstrophy)\n4. Idiopathic / primary / ende mic calculus\n\nCountries: North Africa, India, Indonesia\nAge: in young boys of low socioeconomic class (nutritional deficiency?)\nPrevalence: India ( $13 \\div 100,000$ ); less common in western hemisphere\nNumber of stones: solitary ( $86 \\%$ ); multiple (in up to $25 \\%$ )\nComposition: magnesium ammonium phosphate ( $50 \\%$ ), calcium salts ( $31 \\%$ ), uric acid origin $(5 \\%)$\n\n- hematuria, recurrent UTIs, pelvic pain, irritative / obstructive voiding symptoms\n$R x$ : surgical extraction, lithotripsy, alkalinization of urine\nRate of recurrence: $41 \\%$\n\n\n## Bladder Wall Calcification\n\nA. INFLAMMATION\n\n1. Schistosomiasis (50\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 1,
            "markdown": "$\\checkmark$ relatively normal distensibility of bladder\n$\\checkmark$ thin arcuate pattern of calcification\n2. Tuberculosis\n$\\checkmark$ bladder markedly contracted\n3. Cystitis: postirradiation cystitis, alkaline incrusted cystitis and pyelitis, cytotoxin cystitis\n4. Bacillary UTI (extremely uncommon)\n5. Encrusted foreign material\nB. NEOPLASM\n\n1. Primary neoplasm of bladder: TCC, squamous cell carcinoma, leiomyosarcoma, hemangioma, neuroblastoma, osteogenic sarcoma\n2. Urachal carcinoma\nmnemonic: SCRITT\nSchistosomiasis\nCytoxan\nRadiation\nInterstitial cystitis\nTuberculosis\nTransitional cell carcinoma\n\n# Mass Extrinsic to Urinary Bladder \n\nA. NORMAL / ENLARGED ORGAN\n\n1. Uterus: leiomyomatous uterus, pregnant uterus\n2. Distended rectosigmoid\n3. Ectopic pelvic kidney\n4. Prostate cancer / BPH\nB. SOLID PELVIC TUMOR\n5. Lymphadenopathy\n6. Bone tumor $\\leftarrow$ sacrum / coccyx\n7. Rectosigmoid mass\n8. Hip arthroplasty\n9. Neurogenic neoplasm, meningomyelocele\n10. Pelvic lipomatosis / liposarcoma\nC. CYSTIC PELVIC LESION\n(a) congenital / developmental\n11. Urachal cyst\n12. MÃ¼llerian duct cyst\n13. Gartner duct cyst\n14. Anterior meningocele\n15. Hydrometrocolpos\n(b) related to trauma\n16. Hematoma: eg, rectus sheath hematoma\n17. Urinoma\n18. Lymphocele\n19. Abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 2,
            "markdown": "5. Aneurysm\n6. Mesenteric cyst\n(c) cyst of genitalia\n7. Prostatic cyst\n8. Cyst of seminal vesicle\n9. Cyst of vas deferens\n10. Ovarian cyst\n11. Hydrosalpinx\n12. Vaginal cyst\n(d) cyst of urinary bladder\n13. Bladder diverticulum\n(e) cyst of GI tract\n14. Peritoneal inclusion cyst\n15. Fluid-filled bowel\n\n# Bladder Perforation \n\nA. Trauma\n\n1. Blunt trauma\n2. Penetrating trauma\n3. Iatrogenic: pelvic surgery, cystoscopy, suprapubic or transurethral placement of a Foley catheter (especially a long-term indwelling catheter), bladder biopsy, ureteral stent manipulation\nB. Spontaneous\n\nPathophysiology: increase in bladder pressure + weakening of mucosa\n\n1. Urinary tract infection\n2. Urinary retention\n3. Vaginal delivery\n4. Alcoholism\n5. Bladder calculi\n6. Radiation therapy\n7. Foley catheter malposition\n\n## VOIDING DYSFUNCTION\n\nA. FAILURE TO STORE URINE\n\n- urinary frequency, urgency, incontinence\n(a) bladder causes\n\n1. Involuntary detrusor contractions\n> detrusor instability: idiopathic / neurogenic\n> detrusor hyperreflexia $\\leftarrow$ upper cord lesion\n2. Poor bladder compliance\n> detrusor hyperreflexia\n> bladder wall fibrosis\n3. Sensory urgency\n> infection, inflammation, irritation\n> neoplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 3,
            "markdown": "4. Vesicovaginal fistula\n5. Psychogenic condition\n(b) sphincter causes\n6. Stress incontinence\n7. Sphincteric incontinence\n(c) extravesical ectopic insertion of ureter in females\nB. FAILURE TO EMPTY BLADDER\n\n- poor flow, straining, hesitancy\n- inability to completely empty bladder\n(a) bladder causes\n\n1. Detrusor areflexia $\\leftarrow$ sacral arc lesion\n2. Impaired detrusor contractility $\\leftarrow$ myogenic\n3. Psychogenic condition\n(b) bladder outlet obstruction\n4. Bladder neck contracture\n5. Prostatic enlargement\n6. Detrusor-external sphincter dyssynergia\n7. Scarring from surgery / radiation therapy\n8. Ectopic ureterocele\n9. Urethral stenosis\n10. Urethral kinking: eg, $\\leftarrow$ cystocele\n\n# Urinary Incontinence \n\n1. Stress incontinence\n2. Vesicovaginal / ureterovaginal fistula\n3. Urge incontinence\n4. Psychogenic incontinence\n5. Overflow incontinence\n$\\leftarrow$ lesions of sacral spinal cord / sacral reflex arc or severe outlet obstruction\n6. Reflex voiding\n(a) hyperreflexive lesion $\\leftarrow$ lesion of upper spinal cord\n(b) uninhibited / unstable bladder\n7. Continual dribbling\n$=$ extravesical ectopic termination of ureter\nAssociated with pelvic floor dysfunction:\n8. Stress urinary incontinence\n9. Overactive bladder $=$ urge incontinence\n10. Bladder outlet obstruction\n\n## Stress Incontinence\n\n$=$ SPHINCTER WEAKNESS INCONTINENCE $=$ URETHRAL INCOMPETENCE\n$=$ involuntary loss of urine during physical activity such as coughing, sneezing, laughing, exercise\nCause:\n(a) male: S/P prostatectomy with damage to distal sphincter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 4,
            "markdown": "(b) female: congenital bladder neck weakness, pregnancy, childbirth, aging $\\leftarrow$ changes in anatomic relationship of urethra + bladder base\n\n- frequency, urgency (involuntary filling of bladder neck)\n$\\checkmark$ opening of bladder neck during coughing\n$\\checkmark$ impairment of milk-back mechanism (= retrograde emptying of urethra during interruption of voiding phase does not occur)\n$\\checkmark$ urethrovesical descent (in types I + II)\nChain cystography:\n$\\checkmark$ posterior urethrovesical angle (= angle between posterior urethra + bladder base) increased $>100^{\\circ}$\n$\\checkmark$ upper urethral axis (= angle between upper urethra + vertical line) increased $>35^{\\circ}$\nMR:\n$\\checkmark$ urethral hypermobility $(80-90 \\%) \\leftarrow$ laxity of urethral supporting structures:\n$\\checkmark$ rotational descent during straining = rotation of urethral axis from vertical to horizontal to a position $>30^{\\circ}$ from its resting axis\n$\\checkmark$ funneling = bladder neck + proximal urethra pushed low + appearing widely patent (SAG view)\n\n\n# Detrusor Instability \n\n$=$ MOTOR URGE INCONTINENCE $=$ UNSTABLE BLADDER\n$=$ sudden contraction of detrusor muscle often related to inflammation / infection / nervous system diseases\n$\\diamond$ Condition resembles that of immature bladder before toilet training\nPathophysiology: likely induced by bladder outlet obstruction\nPatient groups:\n(1) Symptoms of nocturnal enuresis + frequency / incontinence dating back to childhood\n(2) Idiopathic instability occurring in middle age\n(3) Outflow obstruction commonly in men with BPH / women with pelvic floor dysfunction\n(4) Degenerative instability $\\leftarrow$ cardiovascular + neurologic disease later in life\n\n- frequency, urgency, urge incontinence, occasionally nocturia\n- hesitancy + difficulty in voiding may occur in men without significant prostatic hypertrophy\n$\\checkmark$ involuntary bladder contractions with NO relationship to bladder distension\n$\\checkmark$ progressively vigorous contractions during bladder filling\n$\\checkmark$ postural instability limited to upright position\n$\\checkmark$ impaired milk-back mechanism $\\leftarrow$ high bladder pressure\n$\\checkmark$ strong contractions following bladder emptying\n$C x$ : thickening of bladder wall, bladder diverticula\n$R x$ : treatment of obstruction, anticholinergic drug (oxybutynin), operative increase in bladder capacity\n\n\n## Sensitive Bladder (Sensory Urgency)\n\nCause: cystitis (reduced compliance), some cases of stress incontinence (filling of bladder neck induces urgency)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 5,
            "markdown": "- frequency, urgency, sometimes nocturia\n$\\sqrt{ }$ patient uncomfortable with low bladder filling\n$\\sqrt{ }$ no abnormal rise in bladder pressure\n$\\sqrt{ }$ normal voiding function\n\n\n# Detrusor-Sphincter Dyssynergia \n\n$=$ overactivity of bladder neck muscle with failure to relax at beginning of voiding\nCause: spinal cord lesion / trauma above level of sacral outflow\n\n- difficulty in voiding $\\pm$ frequency\n- lifelong history of poor stream\n$\\sqrt{ }$ collarlike indentation of bladder neck during voiding (= persistent / intermittent narrowing of membranous urethra)\n$\\sqrt{ }$ may have high voiding pressure + reduced flow\n$\\sqrt{ }$ trapping of contrast in urethra during interruption of flow\n$\\sqrt{ }$ massive reflux into prostatic ducts during voiding $\\leftarrow$ high pressure within prostatic urethra\n$\\sqrt{ }$ severely trabeculated \"Christmas-tree\" bladder + bilateral hydroureteronephrosis\n$R x$ : bladder neck incision\n\n\n## Hinman Syndrome\n\n$=$ NONNEUROGENIC NEUROGENIC BLADDER [NNNB] = DETRUSOR-SPHINCTER DYSSYNERGIA\nCause: no neurologic / anatomic obstructive disease; distinctly abnormal family dynamics (in 50\\%)\nAge: some time after toilet training with onset during early / late childhood / puberty\n\n- clinical criteria:\n(1) Intact perineal sensation + anal tone\n(2) Normal anatomy + function of lower extremities\n(3) Absence of skin lesions overlying sacrum\n(4) Normal lumbosacral spine at plain radiography\n(5) Normal spinal cord at MR imaging\n$\\sqrt{ }$ high-pressure uninhibited detrusor contractions\n$\\sqrt{ }$ lack of coordination between detrusor contraction + periurethral striated sphincter relaxation\n$\\sqrt{ }$ inability to suppress bladder contractions\n$\\sqrt{ }$ normal response of detrusor muscle to reflex stimulation\n$\\sqrt{ }$ increased bladder capacity + pressure\n$\\sqrt{ }$ sphincter activity may increase paradoxically during detrusor contraction\nUS:\n$\\sqrt{ }$ trabeculated bladder\n$\\sqrt{ }$ dilatation of upper urinary tracts\n$\\sqrt{ }$ renal damage\nVCUG:\n$\\sqrt{ }$ urethra normal during early voiding\n$\\sqrt{ }$ urethral distension after contraction of external sphincter as voiding progresses\n$\\sqrt{ }$ ureterovesical obstruction / reflux",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 6,
            "markdown": "$R x$ : suggestion therapy + hypnosis, bladder retraining, biofeedback, anticholinergic drugs\n\n# Wetting \n\n1. Enuresis\n$=$ manifestation of neuromuscular vesicourethral immaturity; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 2$\n\n- intermittent wetting, usually at night during sleep\n- often positive history of enuresis from one parent\n- normal physical examination\n$\\sqrt{ }$ no structural abnormality; urography NOT indicated\n\n2. Epispadia\n3. Sacral agenesis\n$=$ segmental defect (below S2) with deficiency of nerves that innervate bladder, urethra, rectum, feet\n$\\diamond$ Children of diabetic mothers are affected in $17 \\%$ !\n4. Extravesical infrasphincteric ectopic ureter only affects girls, as boys do NOT have infrasphincteric ureteral orifices\n(a) ureter draining upper pole of duplex system $\\rightarrow$ exits below urethral sphincter ( $90 \\%$ )\n(b) ureter draining single system $\\rightarrow$ ectopic extravesical orifice ( $10 \\%$ )\n5. Synechia vulvae\n$=$ adhesive fusion of minor labia $\\rightarrow$ directs urine primarily into vagina, from where it dribbles out post micturition\n6. Vaginal reflux\nin obese older girls with fat thighs and fat labia\n7. Miscellaneous\nposterior urethral valves, urethral stricture, urethral diverticula\n\n## Prostatic Obstruction\n\n$=$ urethral compression by hypertrophic prostatic tissue\n\n- difficulty in voiding, reduction in flow rate\n$\\sqrt{ }$ high-pressure bladder\n$\\sqrt{ }$ slow + prolonged flow\n$\\sqrt{ }$ increase in bladder capacity with reduced contractility (late)\n\n\n## SCROTUM\n\n## Acutely Symptomatic Scrotum\n\n$=$ acute unilateral scrotal swelling $\\pm$ pain\nCause:\nepididymitis + torsion $=3 \\div 2<20$ years of age\nepididymitis + torsion $=9 \\div 1>20$ years of age\nA. ISCHEMIA\n\n1. Acute testicular torsion (20\\%)\n2. Torsion of appendix testis\n3. Testicular infarction\nB. INFECTION / INFLAMMATION (75-80\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 7,
            "markdown": "1. Acute epididymitis\n2. Orchitis\n3. Intrascrotal abscess\n4. Henoch-SchÃ¶nlein purpura\n5. Kawasaki syndrome\n6. Insect bite\n7. Acute hydrocele\n8. Fournier gangrene\nC. HEMORRHAGE\n9. Testicular trauma\n10. Hemorrhage into testicular tumor\nD. HERNIA\n11. Scrotal fat necrosis\n12. Strangulated hernia\n\n# Scrotal Wall Thickening \n\n1. Acute idiopathic scrotal edema\n\nFrequency: $20-30 \\%$ of all acute scrotal disorders\nAge: 5-11 years (range, 18 months to 14 years)\n\n- subcutaneous scrotal edema, erythema\n- minimal pain, afebrile, peripheral eosinophilia\n\nPrognosis: spontaneous resolution in 72 hours to 4 days\n2. Epididymo-orchitis\n3. Testicular torsion\n4. Torsion of testicular / epididymal appendage\n5. Trauma\n6. Henoch-SchÃ¶nlein purpura\n7. Cx of ventriculoperitoneal shunt\n8. Cx of peritoneal dialysis $\\leftarrow$ ? leakage of fluid into the anterior abdominal wall with dissection into scrotum\n9. Acute hemorrhagic edema of infancy\n$=$ similar to Henoch-SchÃ¶nlein purpura\nAge: 5 months -2 years\n\n## Testicular Blood Flow\n\n## Increased Testicular Blood Flow\n\n1. Orchitis\n2. Torsion-detorsion sequence\n3. Torsion of appendix testis / epididymis\n4. Abscess\n5. Tumor\n\n## Decreased Testicular Blood Flow\n\n1. Torsion\n2. Infarct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 8,
            "markdown": "# Scrotal Gas \n\n1. Fournier gangrene\n2. Scrotal abscess\n3. Scrotal hernia with gas-containing bowel\n4. Scrotal emphysema from bowel perforation\n5. Extension of subcutaneous emphysema\n6. Air leakage + dissection $\\leftarrow$ faulty chest tube positioning\n\n## Groin Mass\n\nA. CONGENITAL\n\n1. Encysted hydrocele\n= peritoneal fluid remnant of processus vaginalis\n(a) of spermatic cord (male)\n(b) of canal of Nuck (female equivalent)\n2. Retractile testis\nB. HERNIA\n3. Inguinal-scrotal hernia\n4. Femoral hernia\nC. VASCULAR\n5. Hematoma\n6. Pseudoaneurysm\n7. Varicocele\n8. Varices of greater saphenous vein\nD. INFECTIOUS / INFLAMMATORY\n9. Inflammation of ileopectineal bursa\n10. Synovial osteochondromatosis of hip joint\n11. Groin abscess\nE. NEOPLASM\n12. Lipoma (most common benign tumor)\n13. Inguinal lymph node metastases $\\leftarrow$ cancer of lower vagina, vulva, penis, lower rectum, anus, lower extremity\n\n## Scrotal mass\n\nUS is used to distinguish between\n(a) intratesticular masses (more commonly malignant) and extratesticular masses (more commonly benign)\n(b) intratesticular solid masses (often malignant) and cystic lesions (usually benign).\n\nMost frequent conditions:\n\n1. Inflammation $48 \\%$\n2. Hydrocele $24 \\%$\n3. Torsion $9 \\%$\n4. Varicocele $7 \\%$\n5. Spermatocele $4 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 9,
            "markdown": "6. Cysts $4 \\%$\n7. Malignant tumor $2 \\%$\n8. Benign tumor $0.7 \\%$\n$\\diamond$ Sonographic differentiation of intra- from extratesticular masses is $80-95 \\%$ accurate!\nMRI's ability to characterize soft tissue helps to differentiate benign from malignant neoplasms or predict the presence of malignant disease.\n\n# Benign Tumors and Tumorlike Conditions \n\n$=$ benign mesenchymal tumors\n\n1. Lipoma\n2. Hemangioma\n3. Lymphangioma\n4. Leiomyoma\n5. Nerve sheath tumor\n6. Angiomyofibroblastoma (AMF)-like tumor\n7. Fibrous pseudotumor\n\n## Intratesticular Mass\n\n$\\diamond 90-95 \\%$ of testicular tumors are malignant!\n(a) benign\n\n1. Leydig cell hyperplasia\n2. Intratesticular lipoma\n3. Adrenal rest tumor\n(b) potentially malignant\n4. Leydig cell tumor\n5. Sertoli cell tumor\n(c) malignant\n6. Germ cell tumor\n7. Lymphoma\n(d) pseudotumor\n8. Orchitis\n9. Abscess\n10. Testicular infarction\n11. Testicular hematoma\n12. Postbiopsy defect\n\n## Multiple Intratesticular Masses\n\n1. Lymphoma / leukemia\n2. Primary testicular tumor\n3. Chronic infection: epididymo-orchitis\n4. Metastases: $\\leftarrow$ prostate, kidney, melanoma\n5. Granulomatous disease: sarcoidosis, TB\n6. Leydig cell hyperplasia\n$\\diamond$ The prevalence of synchronous / metachronous bilateral testicular neoplasms is $1-$ $3 \\%$ !",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 10,
            "markdown": "# Prepubertal Testicular Mass \n\n$\\diamond$ Only $0.5-5.0 \\%$ of all intratesticular tumors occur in patients $<15$ years of age\nA. Primary tumor\n(a) Germ cell tumors ( $70-90 \\%$ ):\n\n1. Yolk sac tumor $\\leq 2$ years\n2. Teratoma $\\leq 5$ years\n(b) Sex cord-stromal tumors ( $10-30 \\%$ ):\n3. Leydig cell tumor $3-9$ years\n4. Sertoli cell tumor commonly $<1$ year\n5. Gonadoblastoma after puberty\n6. Fibroma, lipoma, hemangioma, sarcoma, adrenal rest\nB. Secondary tumor\n7. Lymphoproliferative tumor: leukemia, lymphoma\n8. Solid tumor: Wilms, neuroblastoma, rhabdomyosarcoma, retinoblastoma\n9. Others: sinus histiocytosis, Langerhans cell histiocytosis, tuberculous orchitis\n\n## Paratesticular Mass\n\n$\\diamond$ Only $4 \\%$ of all scrotal tumors!\nparatesticular $=$ group of extratesticular lesions not readily identified as originating from a particular tissue\n\n## PARATESTICULAR INFLAMMATORY MASS\n\n1. Sarcoidosis of epididymis\n2. Inflammatory nodule of epididymitis\n3. Sperm granuloma\n$=$ foreign body giant cell reaction to extravasated sperm\nAutopsy: in $42 \\%$ of postvasectomy patients\nLocation: cut end of vas deferens\n$\\sqrt{ }$ well-defined hypoechoic solid mass / masses\n4. Scrotal calculi = \"scrotal pearls\"\n$=$ freely mobile calcified bodies between layers of tunica vaginalis\nCause: fibrinous debris in long-standing hydrocele / following torsion of appendix testis or epididymis / dislodged fibrous pseudotumor\n$\\sqrt{ }$ central nidus of discrete acoustic shadow / \"comet-tail\" artifact (= calcium hydroxyapatite) surrounded by fibrous tissue\n5. Sclerosing lipogranuloma\n(a) primary sclerosing lipogranuloma\n(b) secondary sclerosing lipogranuloma\n\nCause: injection of liquid paraffin, vegetable oil, silicon into scrotal sac\n$\\sqrt{ }$ gradually increasing hypoechoic mass\n$\\sqrt{ }$ heterogeneous mass with intravoxel fat SI on MRI\n$\\sqrt{ }$ avid heterogeneous enhancement\n6. Spermatic cord hematoma\n\n## PARATESTICULAR TUMOR\n\n$\\diamond$ The majority of paratesticular tumors are derived from the spermatic cord!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 11,
            "markdown": "$\\diamond$ Sarcomas are the most common spermatic cord tumor!\nA. EPIDIDYMAL TUMOR\nB. SPERMATIC CORD TUMOR\n(a) benign: lipoma $>$ fibroma $>$ dermoid cyst $>$ lymphangioma\n(b) malignant: sarcoma\nC. SCROTAL TUNICA TUMOR\n\n# Benign Paratesticular Tumor (75-97\\%) \n\n1. Spermatic cord lipoma (most common)\n2. Adenomatoid tumor ( $2^{\\text {nd }}$ most common)\n3. Fibrous pseudotumor of scrotum $\\left(3^{\\text {rd }}\\right)$\n4. Epidermoid inclusion cyst\n5. Polyorchidism\n6. Leiomyoma\n7. Cord fibroma\n$=$ reactive nodular proliferation of paratesticular tissue\n8. Papillary epididymal cystadenoma\n\nFrequency: in up to $60 \\%$ of patients with Von Hippel-Lindau disease\n$\\sqrt{ }$ solid mass with a few cystic spaces\n$\\sqrt{ }$ multiloculated cystic lesion with small papillary projections\n9. Others: herniated omentum, adrenal rest, carcinoid, cholesteatoma\n\nLipomas are the most common extratesticular neoplasm of the scrotum, discovered in $22 \\%$ of hernia repairs.\n\n## Malignant Paratesticular Tumor (3-25\\%)\n\nThe majority of malignant tumors in the nonepididymal extratesticular soft tissues are sarcomas that arise from the spermatic cord.\n\n1. Sarcomas:\n(a) primarily in adults: undifferentiated sarcoma (30\\%), leiomyo-, lipo-, fibro-, myxochondro-sarcoma, malignant fibrous histiocytoma\n(b) children: rhabdomyosarcoma (20\\%), embryonal sarcoma\n\nWell-differentiated liposarcoma tends to have large amounts of macroscopic fat relative to enhancing soft tissue, while dedifferentiated liposarcomas may have only small amounts of macroscopic fat within a mostly soft-tissue mass.\n2. Mesothelioma of tunica (in $15 \\%$ malignant)\n3. Metastases ( $8 \\%$ ): $\\leftarrow$ prostate $>$ kidney $>$ stomach $>$ colon $>$ ileal carcinoid tumor $>$ pancreas\n\n## Primary Tumor of Tunica Vaginalis\n\n1. Adenomatoid tumor\n2. Scrotal tunica cyst\n3. Mesothelioma\n4. Lipoma\n5. Leiomyoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 12,
            "markdown": "6. Sarcoma: rhabdo-, lipo-, leiomyo-\n\n# Extratesticular Fluid Collection \n\n1. Hydrocele, pyocele, hematocele $\\leftarrow$ surgery, trauma, neoplasm\n2. Spermatic cord hydrocele: encysted / funicular\n$\\sqrt{ }$ fluid collection superior to testis\n$\\sqrt{ }$ NO communication with scrotal sac\n3. Varicocele\n4. Spermatocele (exclusively after puberty)\n$=$ single / multiple retention cysts filled with fluid + spermatozoa + cellular debris\nCause: obstruction + dilatation of efferent ductal system\n\n- frequently following vasectomy\n\nLocation: commonly in head of epididymis\n$\\sqrt{ }$ up to a few cm in size $\\pm$ septations\n5. Epididymal cyst\n$=$ cyst without spermatozoa of lymphatic origin (less common than spermatoceles)\n\n- status post vasectomy\n\nLocation: anywhere within epididymis\n$\\sqrt{ }$ wide range of sizes\n6. Lymphangioma, hemangioma\n7. Lymphocele\n8. Abscess\n9. Scrotal hernia $=$ bowel in inguinal hernia\n$\\sqrt{ }$ peristalsing hypoechoic bowel musculature\n\n## Congenital Anomalies of Processus Vaginalis\n\n1. Patent processus vaginalis\n\n- may remain asymptomatic\n- patent at birth ( $20 \\%$ ), usually closes in $1^{\\text {st }}$ year\n\nConditions for delayed / nonclosure:\npremature birth, cystic fibrosis, Ehlers-Danlos syndrome, hip dysplasia, peritoneal dialysis, ventriculoperitoneal shunt\n$C x$ : failure of testis to descend into scrotum, gliding testis, communicating hydrocele, indirect inguinoscrotal hernia\n2. Hydrocele of spermatic cord\n(a) communicating = fluid collection extending from pelvis through deep inguinal ring to scrotum\n(b) funicular = fluid collection communicating with peritoneum at deep inguinal ring ( $=$ peritoneal diverticulum) as potential indirect hernia\n$\\sqrt{ }$ become larger with $\\uparrow$ intraperitoneal pressure\nRx: herniotomy\n(c) encysted = isolated fluid collection between deep inguinal ring and superior pole of testis\nLocation: anywhere along spermatic cord\n$\\sqrt{ }$ ovoid / round cyst in the groin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 13,
            "markdown": "3. Inguinoscrotal hernia\n\n# Cystic Lesion of Testis \n\nPrevalence: $4-10 \\%$ (increasing with age)\n\n- asymptomatic\nA. NONNEOPLASTIC\n\n1. Intratesticular cyst\n\nPrevalence: $8-10 \\%$\nCause: ? trauma, prior inflammation, surgery\nAge: $>40$ years\n\n- nonpalpable\n\nOften associated with: spermatocele, dilated rete testis\nLocation: related to rete testis (in 92\\%)\n$\\checkmark$ usually solitary $2-20-\\mathrm{mm}$ simple cyst\n$D D x:$ cystic neoplasm\n2. Tunica albuginea cyst / scrotal tunica cyst\n\nCause: fluid within mesothelial rests; fluid from blind-ending efferent ductules\nHisto: cyst lined by nonciliated cuboidal cells; contains serous fluid + cellular debris\nMean age: 40 years\n\n- palpable firm nodule\n\nLocation: upper anterior / lateral aspect of testis\nSite: subcapsular / tunica vaginalis\n$\\checkmark$ solitary uni- / multilocular $2-5-\\mathrm{mm}$ marginally located cyst\n3. Intratesticular tubular ectasia\n$=$ DILATATION OF RETE TESTIS = CYSTIC TRANSFORMATION OF THE RETE TESTIS\nCause: partial / complete obliteration of efferent ductules\nAge: $>55$ years\nOften associated with: spermatocele\n\n- nonpalpable\n\nLocation: mediastinum testis, frequently asymmetrically bilateral\n$\\checkmark$ elliptical hypoechoic branching tubular structures $\\pm$ cysts\n$\\checkmark \\pm$ epididymal cysts / spermatoceles\nMR:\n$\\checkmark$ hypointense on T1WI\n$\\checkmark$ iso- to hyperintense on T2WI\n$D D x:$ teratoma\n4. Intratesticular spermatocele\n$=$ cyst containing mature spermatozoa\nLocation: attached to mediastinum testis\n5. Intratesticular varicocele\n\n- $\\pm$ pain $\\leftarrow$ related to passive congestion\n$\\checkmark$ multiple anechoic serpiginous tubules\n$\\checkmark$ characteristic venous flow pattern increasing with Valsalva on Doppler\nInfrequently associated with: extratesticular varicocele\n\n6. Intratesticular abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 14,
            "markdown": "Cause: epididymoorchitis, trauma, testicular infarction, mumps $\\sqrt{ }$ collection with low-level echoes, shaggy irregular wall, occasionally hypervascular margin\n7. Intratesticular infarction\n$\\checkmark$ avascular hypoechoic mass\n8. Congenital cystic dysplasia of testis (extremely rare)\nB. BENIGN TUMOR\n\n1. Epidermoid inclusion cyst / keratin cyst of testis\nC. MALIGNANCY\n$\\diamond 24 \\%$ of all testicular tumors have a cystic component!\n\n- palpable\n$\\checkmark$ in combination with solid elements\n$D D x$ : hematoma, inflammation, seminoma, Leydig cell tumor\n\n\n# Infiltrative Process of Testis and Epididymis \n\n1. Epididymoorchitis\n2. Sarcoidosis\n3. Lymphoma\n4. Tuberculosis\n5. Leukemia\n\n## Epididymal Enlargement with Hypoechoic Foci\n\n1. Epididymitis\n2. Sperm granulomas\n3. Tuberculosis\n4. Lymphogranuloma venereum\n5. Granuloma inguinale\n6. Filarial granuloma\n7. Fungal disease\n8. Lymphoproliferative disease\n9. Metastases\n\n## Enlargement and Hyperemia of Epididymis\n\n1. Epididymoorchitis\n2. Trauma\n\n## Cystic Lesions of Epididymis\n\n1. Epididymal cyst\n\nPrevalence: in up to $40 \\%$\nMay be associated with: intratesticular tubular ectasia\n$\\checkmark$ single / multiple / bilateral\n$D D x$ : loculated hydrocele\n2. Spermatocele\n$\\checkmark$ may contain low-level echoes\n3. Cystic degeneration of epididymis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 15,
            "markdown": "# PROSTATE \n\n## Large Utricle\n\n1. Prune belly syndrome\n2. Imperforate anus of high type\n3. Down syndrome\n4. Hypospadia\n5. Posterior urethral valves\n\n## Extraprostatic Cyst\n\n1. Seminal Vesicle Cyst\n\nCause: congenital / acquired\nAge: $10-40$ years\nMay be associated with: ipsilateral renal agenesis, autosomal dominant polycystic kidney disease\n\n- asymptomatic, chronic recurrent prostatitis / epididymitis\n- painful ejaculation, perineal / testicular pain\n- urgency, hesitancy, tenesmus, pain upon defecation\n- hematuria, hematospermia, infertility; urethral discharge\n- acute urinary retention, constipation $\\leftarrow$ bladder / bowel obstruction\n\nSize: usually $<5 \\mathrm{~cm}$\n$\\sqrt{ }$ well-defined intraseminal unilocular round / oval cyst\n2. Vas Deferens Cyst\n$\\sqrt{ }$ cyst superior to prostate along course of vas deferens\n3. Cowper Duct Cyst\n\nCause: congenital / acquired\nLocation: posterior / posterolateral to posterior urethra\n\n- mostly asymptomatic, hematuria, urinary obstruction\n$D D x$ : ureterocele, TURP defect, bladder diverticulum, hydroureter, ectopic insertion of ureter\n\n\n## Prostatic Cyst\n\nA. MEDIAN CYST\n\n1. Utricle cyst\n2. MÃ¼llerian duct cyst\nB. PARAMEDIAN CYST\n3. Ejaculatory duct cyst\nC. LATERAL CYST\n4. Prostatic retention cyst\n5. Cystic degeneration of BPH\n6. Cystic carcinoma of prostate / multilocular prostatic cystadenoma, papillary adenocarcinoma\n\n- hemorrhagic aspirate!\n$\\checkmark$ solid tissue invaginating into cyst\n\n4. Cyst associated with infection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 16,
            "markdown": "(a) Cavitary / diverticular prostatitis\n(b) Prostatic abscess\n(c) Parasitic cyst (Echinococcus, bilharziasis)\n\n# Hypoechoic Lesion of Prostate \n\n1. Adenocarcinoma $35 \\%$\n2. Benign prostatic hyperplasia $18 \\%$\n$\\checkmark$ rarely originating in peripheral zone\n3. \"Normal\" prostatic tissue $18 \\%$\n(a) cluster of prostate retention cysts\n(b) prominent ejaculatory / other dilated duct\n(c) external sphincter veins\n(d) neurovascular bundle\n(e) seminal vesicle\n(f) sonographic artifact\n4. Acute / chronic prostatitis $14 \\%$\n5. Granulomatous prostatitis $1 \\%$\nmost frequently $\\leftarrow$ intravesical Calmette-GuÃ©rin bacillus (BCG) therapy for bladder cancer\n6. Atrophy $10 \\%$\n\n- occurs in $70 \\%$ of young healthy men\n$\\diamond$ May be confused with carcinoma histologically!\n\n7. Prostatic dysplasia $6 \\%$\n\n## Hypointense T2 Signal of Prostate\n\n1. Adenocarcinoma\n2. Post-biopsy hemorrhage\n$\\diamond$ Wait 6-8 weeks after biopsy before MR imaging\n3. Bacterial prostatitis, fibrosis, scarring\n4. Hyperplastic nodules\n5. Hormonal / radiation treatment\n6. Anterior fibromuscular stroma\n\nDDx: The normal central zone appears homogeneously hypointense on T2WI and dark on ADC map of 42-84-year old men mimicking prostate cancer. Location and symmetry of the central zone help to differentiate it from prostate cancer, although it is asymmetric in $20 \\%$.\n\n## PENIS\n\n## Painful Penile Induration\n\nA. INFLAMMATION / INFECTION\n\n1. Peyronie disease\n2. Cavernositis\n\nCause: self-administration of intracavernosal drug, prosthesis implantation\n3. Spongiositis\n\nCause: improper catheterization, endoscopic manipulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 17,
            "markdown": "4. Cellulitis\n5. Balanitis\nB. VASCULAR\n6. Dorsal vein thrombosis\n7. Corporal thrombosis\n8. Low-flow priapism\n9. Calciphylaxis\n$=$ life-threatening disorder characterized by progressive vascular calcification + ischemic tissue loss in patients with end-stage renal disease\n10. Penile Mondor disease\n$=$ thrombosis / thrombophlebitis in superficial dorsal vein of penis of poorly understood cause\nC. TRAUMA\n11. Penile fracture\nD. TUMOR\n\n# URETHRA \n\n## Congenital Urethral Anomalies\n\nA. Anomaly of number\n\n1. Duplication of urethra\nB. Anomaly of form\n2. Posterior urethral valves\n3. Congenital stricture\n4. Congenital polyp\n5. Congenital diverticulum\nC. Malformation of urethral groove\n6. Epispadia\n$=$ absent roof of urethra with opening anywhere between base of bladder and glans penis\nAssociated with: bladder exstrophy\n\n- urinary incontinence from incompetent bladder neck / urethral sphincter\n$\\sqrt{ }$ abnormally wide symphysis pubis $(>1 \\mathrm{~cm}$ )\n\n2. Hypospadia\n$=$ congenital defect of anterior urethra with opening anywhere along ventral aspect of penile shaft\n\n## Urethral Stricture\n\n$=$ fibrous scarring of anterior urethra $\\leftarrow$ collagen + fibroblast proliferation; $\\pm$ spongiofibrosis\n$=$ scar in surrounding corpus spongiosum\nA. Inflammation\n\n1. Infectious urethritis: $\\leftarrow$ eg, gonococcal urethritis\n2. Balanitis xerotica obliterans\nB. Trauma\n3. Straddle injury",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 18,
            "markdown": "2. Instrumentation: pressure necrosis $\\leftarrow$ indwelling catheter\n3. Surgery: TURP, open radical prostatectomy $\\rightarrow$ \"bladder neck contracture\"\nC. Congenital\n\n# Cowper (Bulbourethral) Gland Lesions \n\nAnalogous to Bartholin glands in females\nPrevalence: $2.3 \\%$ (autopsy)\nLocation: within urogenital diaphragm\n\n1. Retention cyst\n$C x$ : prenatal death from urinary obstruction\n2. Infectious / traumatic cyst\n\n- asymptomatic (most)\n- hematuria, bloody urethral discharge, postvoid dribbling\n\n\n## Periurethral Cyst\n\n$\\diamond$ NO communication with urethra\nA. Vaginal cyst\n\n1. Gartner duct cyst\n2. Bartholin gland cyst\n3. MÃ¼llerian cyst\n\nSite: anterolateral vaginal wall\n5. Vaginal (epidermal) inclusion cyst\n\nSite: lower posterior / lateral vaginal wall\nB. Paraurethral cyst\n\n1. Skene duct cyst\n2. Urethral diverticulum\n3. Urethral caruncle\n\nCause: distal urethral prolapse in hypoestrogenic postmenopausal woman\nHisto: hyperplastic squamous epithelium with submucosal vascularity, fibrosis, inflammation\nLocation: posterior margin of external urethral meatus\n\n- asymptomatic, pain, hematuria\n- soft exophytic lesion of the meatus\nC. Other periurethral lesions\n\n1. Perineal-vulvovaginal endometrioma\n\nSite: distal urethra\n2. Injected collagen\n\nCause: treatment of stress incontinence\n$\\checkmark$ hyperintense nodules in urethral wall on T2WI\n$C x$ : infection, hemorrhage, rupture\n$D D x$ : ectopic ureter, ureterocele\n\n## Urethral Tumor\n\nA. MALIGNANT\n\n1. Urethral carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 19,
            "markdown": "2. Metastasis: $\\leftarrow$ bladder, prostate, rectum, spermatic cord, testis, melanoma\nB. BENIGN\n3. Fibroepithelial polyp\n4. Transitional cell papilloma\n\nAge: older patient\nLocation: in prostatic / bulbomembranous urethra\n$\\diamond$ Frequently associated with concomitant bladder papillomas\n3. Adenomatous polyp\n\nAge: young men\nHisto: columnar epithelium $\\leftarrow$ aberrant prostatic epithelium\nLocation: adjacent to verumontanum\n\n- hematuria\n\n4. Penile squamous papilloma\n5. Urethral leiomyoma (female)\n$\\checkmark$ well-defined homogeneous tumor with increased vascularity\n$\\checkmark$ T1-hypointense + T2-hyperintense relative to muscle + uniform enhancement\n6. Others: caruncle, urethral mucosal prolapse, inflammatory tags (in female)\n\n# CALCIFICATIONS OF MALE GENITAL TRACT \n\nA. VAS DEFERENS\n\n1. Diabetes mellitus: in muscular outer layer\n2. Degenerative changes\n3. TB, syphilis, nonspecific UTI: intraluminal\nB. SEMINAL VESICLES\ngonorrhea, TB, schistosomiasis, bilharziasis\nC. PROSTATE\ncalcified corpora amylacea, TB\n\n## AMBIGUOUS GENITALIA\n\n$=$ INTERSEX\n$=$ external genitalia that are not clearly of either sex\nPrevalence: $1 \\div 1,000$ live births\n$\\diamond$ Only $4-7 \\%$ of infants with disorders of sex development (DSD) have ambiguous genitalia\nIndication for postnatal evaluation:\n\n- cryptorchidism = neither testis palpable\n- epi- / hypospadia combined with unilateral undescended / nonpalpable testis\n- clitoromegaly = clitoral hypertrophy\n- foreshortened vulva; labial fusion\n- single urogenital tract opening = urogenital sinus\n- inguinal hernia containing gonad in phenotypic female\n\nIndication for evaluation of older patients:\n\n- unrecognized genital ambiguity\n- female inguinal hernia; delayed / incomplete puberty",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 20,
            "markdown": "- female virilization; primary amenorrhea\n- phenotypic male breast development\n- cyclical gross hematuria in phenotypic male\n\nCause:\nA. Abnormal hormone levels\n\n1. Congenital adrenal hyperplasia (most commonly)\n2. Transplacental passage of hormones\n3. True hermaphroditism\nB. Anomalies of external genitalia not hormonally mediated (eg, micropenis)\n\nLaboratory tests:\n\n1. Karyotype analysis for sex chromosome determination\n2. 17-hydroxyprogesterone level: elevation suggests CAH\n3. 11-deoxycortisol, 11-deoxycorticosterone levels:\n> elevated in 11-b-hydroxylase deficiency in CAH\n> depressed in 21-hydroxylase deficiency in CAH\n4. Testosterone-to-dihydrotestosterone ratio: $>20 \\div 1$ indicates 5a-reductase deficiency\n5. hCG-stimulation test: nonresponse indicates nonfunctioning Leydig cells / anorchia / luteinizing hormone receptor defect\n6. AntimÃ¼llerian hormone + inhibin B levels: normal values suggest normal Sertoli cell function with presence of at least one testis\nImaging Evaluation:\n7. Ultrasound of kidneys, adrenals, pelvis, inguinal, perineal, anal regions\n8. Voiding cystourethrogram, genitography\n9. MRI: greater sensitivity for intraabdominal gonads\n\nTerminology:\nSex $=$ what a person is biologically; sex assignment based on\n(1) Karyotype\n(2) Gonadal biopsy\n(3) Genital anatomy\n\nGender $=$ what a person becomes socially\n\n# Female Pseudohermaphroditism \n\n$=$ FEMALE INTERSEX $=46$, XX DISORDER OF SEX DEVELOPMENT\nCause: exposure to excessive androgens in $1^{\\text {st }}$ trimester $\\leftarrow$\n(a) congenital adrenogenital syndrome\n(b) maternal drug ingestion (progestational agents, androgens)\n(c) masculinizing ovarian tumor\n\nKaryotype: 46,XX\n\n- masculinized external genitalia:\n- penislike clitoris $\\leftarrow$ prominent corpora cavernosa + corpus spongiosum\n- rugose labioscrotum\n- uterus + vagina may be filled with urine via urogenital sinus\n$\\checkmark$ normal ovaries, fallopian tubes, uterus, vagina\n$\\checkmark$ enlarged adrenal glands $\\leftarrow$ adrenal hyperplasia\n$\\checkmark$ no testicular tissue / internal wolffian duct derivatives",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 21,
            "markdown": "# Male Pseudohermaphroditism \n\n$=46, X Y$ DISORDER OF SEX DEVELOPMENT\nCause: fetal testis with\n(a) $\\downarrow$ testosterone synthesis\n(b) $\\downarrow$ dihydrotestosterone production (= substance responsible for masculinization of external genitalia) $\\leftarrow 5 \\alpha$ - reductase deficiency\n(b) no testosterone production $\\leftarrow$ early destruction / dysgenesis of testes\n(c) complete / incomplete androgen insensitivity $\\leftarrow$ androgen receptor defect ( $=$ testicular feminization)\nKaryotype: 46,XY\n\n- undermasculinized / ambiguous external genitalia\n[^0]\n## Gonadal Dysgenesis\n\ncharacterized by abnormal gonadal organization and function with gonads often partially / completely replaced by fibrous stroma ( $=$ streak gonad)\n(1) Mixed gonadal dysgenesis\n$=$ testis on one side + gonadal streak on other side\nKaryotype: 45,XO / 46,XY karyotype or other mosaics with a Y chromosome\n\n- ambiguous external genitalia\n$\\checkmark$ small / rudimentary uterus + vagina\n$\\checkmark$ fallopian tube present on side of streak gonad\n$\\checkmark$ urogenital sinus commonly empties at base of phallus\n$\\checkmark$ dysgenetic gonads $\\leftarrow$ inability to secrete mÃ¼llerian regression factor\n$C x$ : gonadal neoplasia\n(2) Pure XY gonadal dysgenesis\n\nKaryotype: 46, XY\n$\\checkmark$ bilateral streak gonads / dysgenetic testes\n$\\checkmark$ mÃ¼llerian + wolffian duct derivatives both absent / partially developed\n(3) XY gonadal agenesis\n$=$ vanishing testes syndrome $=$ testicular resorption in early fetal life of unknown cause\nKaryotype: 46,XY\n\n- ambiguous external genitalia / female phenotype\n$\\checkmark$ absent testes\n$\\checkmark$ mÃ¼llerian + wolffian duct derivatives both absent / partially developed\n\n\n## True Hermaphroditism\n\n$=$ TRUE INTERSEX $=$ OVOTESTICULAR DISORDER OF SEX DEVELOPMENT\n$=$ condition characterized by presence of ovarian + testicular tissue either separate or in same\n\n\n[^0]:    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    $\\sqrt{ }$\n    3022",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 22,
            "markdown": "gonad (= ovotestis in 64\\%)\nGonads:\n(a) ovary on one + testis on other side ( $30 \\%$ )\n(b) ovary / testis on one + ovotestis on other side ( $50 \\%$ )\n(c) bilateral ovotestes $(20 \\%)$\n\nLocation: in pelvis predominantly ovarian tissue; in scrotum / inguinal region predominantly testicular tissue\nPrevalence: rare ( 500 cases in world literature); $<10 \\%$ of all intersex conditions\nAge: diagnosed within first 2 decades ( $75 \\%$ )\nKaryotype: 46,XX (80\\%) / 46,XY (10\\%) / mosaicism (10\\%)\nClassification:\nClass I : normal female genitalia ( $80 \\%$ )\nClass II : enlarged clitoris\nClass III : partially fused labioscrotal folds\nClass IV : fused labioscrotal folds\nClass V : hypoplastic scrotum + penoscrotal hypospadia\nClass VI : normal male genitalia\n\n- ambiguous external + internal genitalia, inguinal hernia\n- lower abdominal pain $\\leftarrow$ endometriosis\n- lower abdominal tumor (dysgerminoma, myomatous uterus)\n\nReared as boy:\n\n- cryptorchidism\n- short penis\n- slight degree of hypospadia\n- urogenital sinus at base of penis\n- penile urethra (extremely rare)\n- effective spermatogenesis (rare)\n\nReared as girl:\n\n- development of breasts\n- hematuria ( $=$ menstruation via urogenital sinus opening) in $50 \\%$\n- internal female organs + female fertility\n- amenorrhea\n- separate urethral + vaginal openings (uncommon)\n$\\checkmark$ hypoplastic uterus (in virtually $100 \\%$ )\n$\\checkmark$ ovotestis with heterogeneous appearance $\\leftarrow$ combination of testicular tissue + ovarian follicles\n$\\checkmark$ internal gonadal duct fits the gonad:\n$\\checkmark$ deferent duct on side of testis\n$\\checkmark$ fallopian tube on side of ovary\n$\\checkmark$ ipsilateral fallopian tube absent $\\leftarrow$ suppression of development by fetal testis\n$\\checkmark$ testis / testicular portion of ovotestis usually dysgenetic\n\n\n# MALE INFERTILITY \n\nA. CONGENITAL",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 23,
            "markdown": "(a) Wolffian duct anomalies\n\n1. Renal agenesis / atrophy\n2. Vas deferens agenesis / cyst\n3. Seminal vesicle agenesis / cyst\n4. Ejaculatory duct cyst\n(b) MÃ¼llerian duct anomalies\n5. MÃ¼llerian duct cyst\n6. Utricle cyst\nB. ACQUIRED\n7. Cowper duct cyst\n8. Prostatic cyst in peripheral zone\nC. INFECTIOUS\n9. Prostatitis\nD. HORMONAL\n\n- semen low in volume, acid pH , without fructose\n\n1. Seminal vesicle atrophy\n$=$ seminal vesicles $<7 \\mathrm{~mm}$ in width\n2. Seminal vesicle hypoplasia\n$=$ seminal vesicles $<11 \\mathrm{~mm}++>7 \\mathrm{~mm}$ in width",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 24,
            "markdown": "# ANATOMY AND FUNCTION OF UROGENITAL TRACT \n\n![img-0.jpeg](img-0.jpeg)\n\n## UROGENITAL EMBRYOLOGY\n\n## Pronephros = forekidney\n\ndevelops from mesoderm during $3^{\\text {rd }}$ week of gestation; involutes during $4^{\\text {th }}$ week of gestation $\\rightarrow$ vestigial remnant / complete absence\n\n## Mesonephros = midkidney\n\ndevelops during $4^{\\text {th }}$ week of gestation immediately caudal to pronephros, functions as interim kidney; degenerates around 8 weeks of gestation\n(a) mesonephric tubules\n$\\rightarrow$ paradidymis, epididymis, efferent ductules (M); epinephron (F)",
            "images": [
                {
                    "id": "img-0.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 393,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1507,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 25,
            "markdown": "(b) mesonephric (wolffian) duct\n$\\rightarrow$ appendix epididymis, vas deferens, ejaculatory duct, seminal vesicles (M); vanishes (F)\n[Caspar Friedrich Wolff (1733-1794), German anatomist, biologist, and embryologist in Berlin and St. Petersburg, cofounder of embryology, established doctrine of germ layers]\nmnemonic: Gardener's SEED\nÂ» female: Gartner duct, cyst\nÂ» male: Seminal vesicle\nEpididymis\nEjaculatory duct\nDuctus deferens\n\n# Paramesonephric (MÃ¼llerian) Duct \n\n(grows alongside mesonephric duct)\n[Johannes Peter MÃ¼ller (1801-1858), German physiologist and comparative anatomist in Bonn and Berlin]\nMale: degenerates $\\leftarrow$ production of mÃ¼llerian inhibiting factor (MIF) by Sertoli cells of testis at about 6 weeks GA\n$\\rightarrow$ prostatic utricle + appendix testis\nFemale: induced by wolffian duct at 5 weeks GA; grows caudally $\\rightarrow$ joins in midline $\\rightarrow$ fuses with outgrowth of urogenital sinus\n$\\rightarrow$ uterus, fallopian tubes\n\n## Metanephros = hindkidney = permanent kidney\n\n(1) metanephric diverticulum (ureteric bud) buds from mesonephric duct near its entry into the cloaca at $4^{\\text {th }}$ week; it lengthens + grows toward nephrogenic cord which becomes the metanephric blastema that divides and forms\n$\\rightarrow$ ureter (mesonephric duct)\n$\\rightarrow$ renal pelvis (first 4 dividing generations of duct)\n$\\rightarrow$ calices (second 4 dividing generations of duct)\n$\\rightarrow$ collecting tubules ( $10-12$ generations of duct)\n(2) metanephric blastema ( $=$ nephrogenic mesoderm) forms nephrons under the influence of ureteral bud $\\rightarrow$ the end of collecting tubules induce clusters of metanephric blastema cells located at the periphery and along the sides of the medullary ray ( $=$ pyramid) except around the papilla\n(3) metanephric vesicles form within clusters of metanephric blastema cells + elongate into S -shaped tubules which, by $12^{\\text {th }}$ week of gestation, result in\n$\\rightarrow$ glomerulus\n$\\rightarrow$ proximal convoluted tubule\n$\\rightarrow$ loop of Henle\n[Friedrich Gustav Jakob Henle (1809-1885), German pathologist and anatomist in Berlin, ZÃ¼rich, GÃ¶ttingen]\n$\\rightarrow$ distal convoluted tubule\n$\\rightarrow$ connective tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 26,
            "markdown": "$\\diamond$ Polycystic kidney disease is believed to be a failure of linkage!\n\n# Urogenital Sinus \n\nforms from cloaca\n$\\rightarrow$ develops into bladder + urethra (+ prostate)\n\n## Bladder\n\ndevelops in $2^{\\text {nd }}-4^{\\text {th }}$ embryonal month\n\n## Urachus\n\n$=$ narrowed apex of fetal bladder continuous with allantoic stalk at the umbilicus\n$\\rightarrow$ forms median umbilical ligament\n(a) supravesical portion\n(b) intramural portion\n(c) intramucosal portion\n\n## SEX DEVELOPMENT\n\n## Indifferent Stage of Sexual Differentiation\n\nPeriod: until $7^{\\text {th }}$ week of GA\nComposition of undifferentiated gonad:\n(1) Mesenchyme\ncondensation of mesenchyme forms genital ridges on both sides of midline between $6^{\\text {th }}$ thoracic and $2^{\\text {nd }}$ sacral segments; differentiates into interstitial (Leydig) cells within seminiferous tubules ( $=$ supporting stromal cells of testicular interstitium, including endothelial cells and vascular smooth muscle cells)\n(2) Mesothelium\ngenital ridges are covered by proliferating mesothelium (coelomic epithelium);\ndifferentiates into Sertoli / supporting cells of the seminiferous tubules; forms tunica\nalbuginea (vaginalis) as the serous covering of the testes\n(3) Germ cells\nform in wall of yolk sac and migrate along hindgut into genital ridge; differentiate into spermatogonia within seminiferous tubules; give rise to most testicular tumors\n\n## Chromosomes\n\n$>$ determine genotypic sex\n> issue complex signaling pathways + hormones $\\rightarrow$ modify primordial mesodermal cells $\\rightarrow$ phenotypic sex\n\n## Formation of Testis\n\nPeriod: around 8-12 weeks GA\n\n- sex-determining factor localized on short arm of Y chromosome (SRY gene) $\\rightarrow$ initiates male sex differentiation $=$ seminiferous tubules\n- Leydig cells secrete testosterone $\\rightarrow$ stimulating growth of mesonephric (wolffian) structures\n- Sertoli cells secrete mÃ¼llerian-inhibiting factor $\\rightarrow$ leading to regression of paramesonephric (mÃ¼llerian) duct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 27,
            "markdown": "# Testicular Migration \n\n@ inguinal canal:\n@ scrotum:\nby 21 weeks\nby 30 weeks at birth (in $97 \\%$ of full-term infants) during first 3 months of life (most)\n\n## Prenatal Evaluation of Sex\n\n$\\diamond$ Imaging of genitalia recommended only when\n(a) medically indicated\n(b) in twin gestation\n\nSuccessful imaging of genitalia:\n$>$ in $60 \\%$ by $14-18$ weeks GA\n$>$ in $80-100 \\%>20$ weeks GA\nErrors in imaging of genitalia:\n$\\checkmark$ adducted fetal legs\n$\\checkmark$ US beam at wrong angle\nFemale:\n$\\checkmark 3$ parallel lines between legs on transverse US\n$\\checkmark 3$ bumps with clitoris in midline directed caudally\nMale:\n$\\checkmark$ small semicircular structure ( $=$ scrotal sac $)$\n$\\checkmark$ penis in midline directed anteriorly and superiorly\n$\\checkmark$ visualization of testes in scrotum in late $2^{\\text {nd }}$ trimester\nAmbiguous genitalia:\n$\\checkmark$ thorough fetal survey to detect associated anomalies\n$\\checkmark$ repeated US examinations with early GA\n$\\checkmark$ MRI with present oligohydramnios / multiple anomalies\n\n## RENAL ANATOMY\n\n## Adult Kidney\n\n> forms by fusion of superior + inferior subkidneys ( $=$ metanephric lobes); the line of fusion runs obliquely forward and upward\n$\\checkmark$ separation of upper + lower groups of calices\n$\\checkmark$ indentation of cortical contour + echogenic line ( $=$ interrenicular septum $=$ junctional parenchymal defect) delineates junctional parenchyma (often referred to as hypertrophic column of Bertin)\n> consists of 20,000 lobules within 14 lobes (reniculi)\n> initially located in pelvic region ventral to sacrum, ascending cranially at 9 weeks of gestation $\\leftarrow$ body growth caudal to kidneys + straightening of body curvature\n> renal hilum at first ventrally located, eventually rotating medially by 90 degrees with renal ascent\n\n## Reniculus $=$ renal lobe\n\n$=$ central core of medullary tissue enveloped by\n(a) centrilobar cortex ( $=$ cortical arch) that covers the base of the pyramid $\\rightarrow$ subsequently",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 28,
            "markdown": "forming the renal cortex with loss of grooves\n(b) mural cortex that wraps around sides of pyramid $\\rightarrow$ and fuses with the mural cortex of adjacent lobe $\\rightarrow$ to form renal septum ( $=$ column of Bertin)\n> renal lobes completed by 28 weeks GA\n$\\checkmark$ ren lobatus (= interlobar surface grooves) present in fetus and infant, rare in adulthood\n$\\checkmark$ assimilation of independent lobes $>28$ weeks GA makes renal surface smoother\n> nephrogenesis completed by 36 weeks GA\n![img-1.jpeg](img-1.jpeg)\n\n# Renal Size (in cm) \n\n$>1$ year of age: $4.98+0.155 \\mathrm{x}$ age (in months)\n$>1$ year of age: $6.79+0.22 \\mathrm{x}$ age (in years)\n> adulthood: R kidney $10.74 \\pm 1.35$ (SD); L kidney $11.10 \\pm 1.15$ (SD)\n> ratio of renal length (RL) to distance between first 4 lumbar transverse processes (4 TP)\n\n$$\n=1.04 \\pm 0.22\n$$\n\n## Renal Echogenicity\n\nA. ADULTHOOD\nliver $\\geq$ spleen $\\geq$ renal cortex $>$ renal medulla\nB. INFANCY (in neonate up to 6 months of age)\n$\\checkmark$ cortex may be more echogenic than adjacent normal liver / spleen\nCause: glomeruli occupy $18 \\%$ of cortex in neonate compared with $9 \\%$ in adult\n$\\checkmark$ increase in corticomedullary differentiation\nCause: ratio of cortex to medulla $1.64 \\div 1$ in neonate compared with $2.59 \\div 1$ in adult\n$\\checkmark$ hypoechoic pyramids appear relatively large\nCause: thin immature cortex in neonate\nN.B.: may be misinterpreted as dilated calices / renal cystic disease\n$\\checkmark$ renal sinus echogenicity less prominent\nCause: paucity of fat",
            "images": [
                {
                    "id": "img-1.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 501,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1106,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 29,
            "markdown": "# Renal Vascular Anatomy \n\n## Hilar Arteries\n\nEntry: renal hilum\n$1^{\\text {st }}$ order: main renal arteries at level of L1 / upper margin of L2\n$2^{\\text {nd }}$ order: 5 segmental branches = apical, anterior superior, anterior inferior, posterior, basilar\nExtrahilar branching:\n$=$ branching of main renal artery prior to reaching hilum\nEntry: renal hilum / direct as polar arteries\n> early branching: within 1.5 cm from aorta\nResistive index: $<0.701 \\mathrm{SD}$ of several measurements $=0.04$\n\n## Renal Polar Artery\n\nEntry: without going through renal hilum directly into renal parenchyma at the poles\nTypes: superior polar artery; inferior polar artery (with supply of upper urinary tract)\nOrigin: main renal a., contralateral main renal a., aorta, iliac a., superior mesenteric a., inferior mesenteric a., celiac a., middle colic a., lumbar a., gonadal a., middle sacral a.\n![img-2.jpeg](img-2.jpeg)\n\n## Capsular artery\n\n$=$ tiny vessels perfusing the renal capsule coursing tangentially to renal margin\nOrigin: main renal a., branch renal a., other retroperitoneal aa. (lumbar a.)\n\n## Anatomic Renal Artery Variants\n\nMultiple renal arteries (25-30\\%):\nunilaterally (32\\%); bilaterally (12\\%)\nNumber of renal arteries per kidney:",
            "images": [
                {
                    "id": "img-2.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 957,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1650,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 30,
            "markdown": "(a) one $71 \\%$\n(b) two $24 \\%$\n> 2 hilar arteries $12 \\%$\n> 1 hilar +1 superior polar artery $7 \\%$\n$>1$ hilar +1 inferior polar artery $5 \\%$\n(b) three $4 \\%$\n(c) more than three $1 \\%$\n$\\diamond$ More than 2 renal arteries per kidney is a contraindication for donation! A small superior polar artery $<2 \\mathrm{~mm}$ in diameter may be sacrificed.\n\nSeparate aortic ostium:\nMain renal artery\n$=$ vessel with the greatest diameter\nAccessory renal artery\n$=$ vessel with smaller diameter\n$=$ segmental artery originating from aorta / iliac a.\nSupplementary artery:\nEntry: renal hilum\nOrigin: aorta, iliac a., internal spermatic a., SMA, IMA, celiac trunk, middle colic a., lumbar a., middle sacral a., contralateral renal a.\nSupply: lower pole $(72 \\%)>$ upper pole\nAberrant renal artery:\n$=$ segmental artery arising from superior mesenteric artery / internal spermatic artery\n\n# Renal Veins \n\n## Single right renal vein\n\nwithout major extrarenal tributaries ( $85 \\%$ )\nwith major extrarenal tributaries:\n(a) right adrenal vein $(30 \\%)$\n(b) right gonadal vein $(7 \\%)$\n(c) lumbar + hemiazygos veins (3\\%)\n\n## Single preaortic left renal vein\n\nwithout major extrarenal tributaries ( $86 \\%$ )\nwith major extrarenal tributaries:\n(a) left adrenal vein\n(b) hemiazygos vein\n(c) lumbar vein\n(d) ascending lumbar vein\n(e) left gonadal vein",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 31,
            "markdown": "![img-3.jpeg](img-3.jpeg)\n\n# Anatomic Renal Vein Variants \n\n## MULTIPLE RIGHT RENAL VEINS (15-30\\%)\n\n(a) single right renal vein divides just before union with IVC 4\\%\n(b) right gonadal vein joins the renal vein $6 \\%$\n(c) accessory branch of adrenal vein enters right renal vein $31 \\%$\n(d) lumbar / azygos vv. enter right renal vein $3 \\%$\n\n## CIRCUMAORTIC LEFT RENAL VEIN (5-6-17\\%)\n\n## SINGLE RETROAORTIC LEFT RENAL VEIN (2-3\\%)\n\nLUMBAR VEINS JOINING LEFT RENAL VEIN (75\\%)\n\n## URETER\n\n$=$ retroperitoneal muscular conduit that carries urine from renal pelvis to urinary bladder\nHisto: (a) inner cell layer of watertight urothelium surrounded by\n(b) outer layer of smooth muscle $\\rightarrow$ coordinated contraction\n\nOrigin: ureteropelvic junction at intra / extrarenal pelvis\nTerminus: ureterovesical junction\nLength: $\\sim 25 \\mathrm{~cm}$\nDiameter: $<3 \\mathrm{~mm}$\n\n## Congenital Ureteral Abnormalities\n\nA. URETERAL DUPLICATION\n\n1. Complete ureteral duplication\n2. Partial ureteral duplication\nB. SMOOTH MUSCLE DYSFUNCTION\n3. UPJ obstruction\n4. Primary congenital megaureter",
            "images": [
                {
                    "id": "img-3.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1496,
                    "bottom_right_y": 805,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 32,
            "markdown": "# C. ABNORMAL TERMINATION OF SINGLE URETER \n\n1. Ectopic ureter\n2. Ureterocele\n3. Vesicoureteral reflux\n\n## Extrarenal Pelvis\n\n$=$ normal anatomic variant in which the renal pelvis lies predominantly outside of the renal sinus\n$\\sqrt{ }$ may be dilated under normal circumstances\n$D D x:$ UPJ obstruction, distal obstruction\n$\\sqrt{ }$ NO associated caliectasis\n$\\sqrt{ }$ normal size of ureter\n\n## RETROPERITONEUM\n\n$=$ space posterior to peritoneal cavity extending from diaphragm to pelvic brim; separated from peritoneum anteriorly by posterior peritoneal fascia; bounded posteriorly by transversalis fascia\n(a) anterior border: posterior peritoneal fascia (posterior to peritoneum)\n(b) posterior border: transversalis fascia (attaches to psoas muscle)\n\n## Retroperitoneal Compartments\n\n## A. Anterior pararenal space\n\nBoundaries: posterior parietal peritoneum (anteriorly), anterior renal fascia (posteriorly), lateroconal fascia (laterally)\n$\\rightarrow$ superiorly joins with posterior renal fascia and attaches to crux of diaphragm\n$\\rightarrow$ in the middle blends with connective tissues of central prevertebral space around great vessels\n$\\rightarrow$ inferiorly joins with posterior renal fascia and attaches to great vessels\n(a) pancreaticoduodenal space\n\nContents: pancreas, duodenum, root of small bowel mesentery\n(b) pericolonic space\n\nContents: ascending colon + descending colon\nB. Perirenal / perinephric space $=$ capsula adiposa\n\nBoundaries: fascia renalis $=$ Gerota fascia $=$ anterior (membrane of Toldt) + posterior (Zuckerkandl) renal fasciae\n[Carl Toldt (1840-1920), Austrian anatomist, professor of anatomy in Prague and Vienna] subdivided into multiple compartments by thin fibrous lamellae + incomplete bridging septa (Kunin septa) that attach to anterior + posterior renal fascia\n$\\rightarrow$ forms superiorly closed inverted cone around adrenal gland + perirenal fat + upper half of kidney; fixed to diaphragmatic fascia above; abuts bare area of liver (R) + subphrenic space (L)\n$\\rightarrow$ inferiorly forms cone around perirenal fat + lower pole of kidney blending with iliac fascia below\n$\\rightarrow$ laterally closed by fusion of anterior + posterior sheath\n$\\rightarrow$ medially open communicating with central prevertebral space",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 33,
            "markdown": "Contents: kidneys, adrenal glands, proximal renal collecting system, proximal ureters, perirenal fat, renal hilar vessels, lymphatic vessels\nThe perirenal fascia is not made up of distinct unilaminated fascia; rather, it is composed of multiple layers of variably fused embryonic mesentery, creating potential spaces between the retroperitoneal spaces.\nC. Posterior pararenal space\n\nBoundaries: posterior renal fascia, transversalis fascia, fascia over psoas muscle continuous with transversalis fascia\nContents: fat, no organs\nD. Great vessel space\n\nInterfascial spread is the spread of fluid within the layers of the retroperitoneal fascia and is a common route of disease across the midline within the retroperitoneum and from the abdomen to the pelvis along the retromesenteric, retrorenal, and interfascial planes.\n\n# Potential Routes of Interfascial Communication \n\nCause: laminar + variably fused + expandable fasciae\nA. Retromesenteric plane\nB. Retrorenal space\nC. Lateroconal space\n\n## Organ of Zuckerkandl\n\n$=$ PARAAORTIC BODIES (DDx to aortic bodies which are chemoreceptors near thoracic aorta regulating circulation)\n[Emil Zuckerkandl (1849-1910], Hungarian-Austrian anatomist at the universities of Utrecht, Graz, and Vienna, colleague of Carl Freiherr von Rokitansky]\n$=$ diffuse group of neuroendocrine sympathetic fibers constituting the chromaffin body $\\rightarrow$ possible source of pheochromocytoma\nOrigin: neural crest\nLocation: at aortic bifurcation / at origin of IMA\nFunction: homeostatic regulator of blood pressure $\\rightarrow$ by secretion of catecholamines into fetal circulation $\\rightarrow$ involuting during $3^{\\text {rd }}$ trimester",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 34,
            "markdown": "![img-4.jpeg](img-4.jpeg)\n\n# RENAL HORMONES \n\n## Antidiuretic Hormone (ADH)\n\nProduction site: supraoptic nuclei of hypothalamus, transported to neurohypophysis\nStimulus: fluid loss $\\rightarrow$ increase in osmolality\nEffects: (1) 10 x increase in permeability of collecting ducts (= concentrated urine)\n(2) decreased blood flow through vasa recta leads to increased hypertonicity of interstitium (= countercurrent multiplier mechanism)\n\n## Renin-Aldosterone Mechanism\n\n> receptors in juxtaglomerular apparatus register intraglomerular capillary hydraulic pressure, one of the main determinants of the glomerular filtration rate (GFR);\n> receptors regulate the release of renin as an autoregulatory feedback mechanism $\\rightarrow$ to maintain intraglomerular hydraulic pressure;\n> renin mediates conversion of angiotensin to angiotensin-I $\\rightarrow$ which is then cleaved by angiotensin converting enzyme (ACE) into angiotensin-II\n\n## Angiotensin-II Effect\n\n> constriction of efferent postglomerular arterioles $\\rightarrow$ n intraglomerular capillary hydraulic pressure + GFR\n> systemic arteriolar constriction (= most potent vasoconstrictor of biologic systems) $\\rightarrow$ causes systemic hypertension\n> release of aldosterone $\\rightarrow$ which increases sodium retention by renal tubules $\\rightarrow$ leads to an increase in blood volume + blood pressure if both kidneys are affected",
            "images": [
                {
                    "id": "img-4.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 996,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 35,
            "markdown": "$\\rightarrow$ leads to compensatory natriuresis if only one kidney is affected\n$\\diamond$ ACE inhibitors (eg, captopril) produce a dramatic decrease in blood pressure!\n\n# RENAL PHYSIOLOGY \n\nPerfusion: 1.2-1.3 L of blood per minute ( $=20-25 \\%$ of total cardiac output)\nUrine output: $1 \\mathrm{~L} / \\mathrm{d}$\nFiltration: substances of up to 4 nm (excluding substances $>8 \\mathrm{~nm}$ ), threshold at molecular weight of $=40,000$\n\n## Glomerular Filtration Rate (GFR)\n\n$[\\mathrm{P}] \\times \\mathrm{GFR}=[\\mathrm{U}] \\times \\mathrm{U}_{\\text {vol }}$\nGFR $=\\left\\{[\\mathbf{U}] \\times \\mathbf{U}_{\\text {vol }}\\right\\} /[\\mathrm{P}]=125 \\mathrm{~mL} / \\mathrm{min}=20 \\%$ of RPF\nSubstrate: inulin; ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA\n\n## Tubular Secretion (Tm)\n\n$[\\mathrm{U}] \\times \\mathrm{U}_{\\text {vol }}=[\\mathrm{P}] \\times \\mathrm{GFR}+\\mathrm{Tm}$\n$\\mathbf{T m}=\\left\\{[\\mathbf{U}] \\times \\mathbf{U}_{\\text {vol }}\\right\\}-\\{[\\mathbf{P}] \\times \\mathbf{G F R}\\}$\nSubstrate: p-aminohippurate (PAH); ${ }^{131}$ I-Hippuran\n\n## Renal Plasma Flow (RPF)\n\n$[\\mathrm{P}] \\times \\mathrm{RPF}=[\\mathrm{U}] \\times \\mathrm{U}_{\\text {vol }}$\nRPF $=\\left\\{[\\mathbf{U}] \\times \\mathbf{U} \\mathbf{~ v o l}\\right\\} /[\\mathbf{P}]$\nSubstrate: p-aminohippurate\n$[\\mathrm{P}]=$ concentration in plasma\nGFR $=$ glomerular filtration rate\n$[\\mathrm{U}]=$ concentration in urine\nU vol $=$ urine volume\nTm = transport maximum (across tubular cells)\nRPF = renal plasma flow",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 36,
            "markdown": "![img-5.jpeg](img-5.jpeg)\n\n# Renal Acidification Mechanism \n\nProximal tubule:\nreabsorption of $90 \\%$ of filtered bicarbonate by luminal $\\mathrm{Na}+/ \\mathrm{H}+$ exchange and $\\mathrm{Na}+/ \\mathrm{HCO} 3$\n\n- cotransport at basolateral membrane\nregulated by: luminal carbonic anhydrase\ninfluenced by: luminal HCO3- concentration, extracellular fluid volume, parathormone, $\\mathrm{K}+$, aldosterone\nDistal nephron:\nactive secretion of $\\mathrm{H}+$ against a steep urine-to-blood gradient across luminal cell membrane by $\\mathrm{H}+$-ATPase pump $\\rightarrow$ facilitated by $\\mathrm{Na}+$ reabsorption $\\rightarrow$ resulting in reabsorption of $10 \\%$ of filtered bicarbonate, formation of ammonium $(\\mathrm{NH} 4+)$ and titratable acidity\nAmmonium excretion:\nAmmonia (NH3) is formed in proximal tubule as a product of\ncatabolism of glutamine + other amino acids; combination with secreted $\\mathrm{H}+$ to $\\mathrm{NH} 4+$ takes place in distal nephron\nTitratable acidity: divalent basic phosphate is converted into monovalent acid form in distal tubule\n\n\n## Renal Imaging in Newborn Infant\n\n$\\diamond$ Low glomerular filtration rate (GFR):",
            "images": [
                {
                    "id": "img-5.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 189,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 976,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 37,
            "markdown": "![img-6.jpeg](img-6.jpeg)\non first day of life: $21 \\%$ of adult values\nby 2 weeks of age: $44 \\%$ of adult values\nat end of $1^{\\text {st }}$ year: close to adult values\n$\\diamond$ Limited capacity to concentrate urine\nIVP:\n$\\checkmark$ occasional failure of renal visualization\nNUC:\n$\\sqrt{ }$ improved visualization on radionuclide studies\n\n# Normal Nephrographic Phases / Progression \n\n1. Vascular phase\n$=$ CORTICAL ARTERIOGRAM\n$=$ contrast material in interlobular arteries + glomeruli\nTiming after IV injection: 10-15-25 seconds (arm-to-kidney circulation time)\nDuration: transient vascular phase of $<0.5$ seconds\n2. Cortical phase\n$=$ CORTICAL NEPHROGRAM\n$=$ contrast medium in cortical capillaries + peritubular spaces + cortical tubular lumina\nTiming after IV injection: 25-45-70 seconds\nTiming after intraarterial injection: $2-3$ seconds\nCT:\n$\\checkmark$ exclusive renal cortical enhancement with minimally enhancing renal medulla (= corticomedullary differentiation)\n3. Parenchymal phase\n$=$ GENERALIZED / DIFFUSE / TUBULAR NEPHROGRAM\n$=$ contrast material in loops of Henle + collecting tubules\nTiming after IV injection: 60-85-120 seconds (max)\n$\\sqrt{ }$ enhancement of both cortex and medulla\nN.B.: most valuable phase for detecting renal masses\n4. Excretory phase",
            "images": [
                {
                    "id": "img-6.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 193,
                    "bottom_right_x": 1319,
                    "bottom_right_y": 719,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 38,
            "markdown": "$=$ contrast material in collecting system\nTiming after IV injection: beginning at $2-3-5$ minutes\n\n# Contrast Excretion \n\nUROGRAPHIC DENSITY depends on $[\\mathrm{U}]=\\{\\mathrm{P} \\mid \\mathrm{x} \\mathrm{GFR}\\} / \\mathrm{Uvol}$\n\n1. Concentration of contrast material in plasma $[\\mathrm{P}]$ is a function of\n(a) total iodine dose\n(b) contrast injection rate\n(c) volume distribution\n\nRapid decline of concentration of contrast material in vessels due to:\n(1) rapid mixing within vascular compartment\n(2) diffusion into extravascular extracellular fluid space (capillary permeation)\n(3) renal excretion\n2. Glomerular filtration rate (GFR): $99 \\%$ filtered\n3. Urine volume (Uvol):\n(a) in dehydrated state $\\rightarrow$ increased ADH activity $\\rightarrow$ higher concentrations of contrast material\n$\\diamond$ Dehydration is considered a risk-potentiating factor for nephrotoxicity!\n(b) in volume-expanded state $\\rightarrow$ decreased ADH activity $\\rightarrow$ lower concentrations of contrast material\n$\\diamond$ Patients with CHF require higher doses of contrast material!\nA. MEGLUMINE\nno metabolization, excreted by glomerular filtration alone\nMeglumine effect of osmotic diuresis:\n(a) lower concentration of urinary iodine per mL urine\n(b) greater distension of collecting system\nN.B.: Avoid meglumine in \"at risk\" patients (higher incidence of contrast reactions than sodium!)\nB. SODIUM\nextensive reabsorption by tubules with delayed excretion\nSodium effect of reabsorption:\n(a) increased concentration of urinary iodine (improved visualization)\n(b) less distension of collecting system (ureteral compression necessary)\n\n## ADRENAL GLAND\n\nFunction: regulation of metabolism, salt and water balance, response to stress, sexual function\nFrom periphery to centrum:\n(a) renin-angiotensin-dependent outer adrenal cortex zona glomerulosa $=$ mineralocorticoid (aldosterone)\n(b) corticotropin-dependent inner adrenal cortex:\nzona fasciculata $=$ glucocorticoids (cortisol)\nzona reticularis $=$ sex steroids (androgen, estrogen) + gonadocorticoids\n(c) medulla $=$ catecholamines (epinephrine, norepinephrine)\nmnemonic: Glomerular Filtration Rate May Give Answers",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 39,
            "markdown": "Glomerulosa\nFasciculata\nReticularis\nMineralocorticoids\nGlucocorticoids\nAndrogens\n@ IN FETUS\nresponsible for masculinization of external genitalia\n@ IN NEONATAL PERIOD\nNormal weight: $5-10 \\mathrm{~g}$ at birth\n$\\diamond$ Rapid regression of fetal cortex during first 6 weeks of life!\n$\\checkmark$ central echogenic stripe (= medulla) surrounded by thick hypoechoic region (= adrenal cortex)\n@ IN ADULTHOOD\nNormal size: $3-5(\\mathrm{~L}) \\times 3(\\mathrm{~W}) \\times 1 \\mathrm{~cm}$ (thick)\nNormal thickness: $2-6 \\mathrm{~mm}$\n$\\diamond$ Each limb of the adrenal gland should not be thicker than the crus of the diaphragm\nNormal weight: $3-5 \\mathrm{~g}(5-10 \\mathrm{~g}$ at birth)\nVisualization by CT : left side $100 \\%$, right side $99 \\%$\nby US : left side $45 \\%$, right side $80 \\%$\n\n# Adrenal Vascular Anatomy \n\n## Adrenal Arteries\n\n(1) superior suprarenal artery $\\leftarrow$ inferior phrenic artery\n(2) middle suprarenal artery $\\leftarrow$ abdominal aorta\n(3) inferior suprarenal artery $\\leftarrow$ renal artery\n\n50-60 small adrenal branches from 3 main adrenal arteries form a subcapsular plexus $\\rightarrow$ drains into medullary sinusoids\nSupply: inferior phrenic a., directly from aorta, renal artery\n(a) all 3 sources in $34 \\%$\n(b) two sources in $61 \\%$\n(c) single source in $5 \\%$ (renal a. only in $2 \\%$ )\nforming superior, middle, inferior adrenal arteries\n$\\diamond$ The renal artery contributes in $71 \\%$ !\n$\\diamond$ Gonadal artery contributes in $60 \\%$ in fetal circulation!\n\n## Adrenal Veins\n\n\"Vascular dam\" = gland is drained by an intrinsically vulnerable network of relatively few venules\n(1) Single right adrenal vein drains into IVC (69\\%)\n(2) Accessory right adrenal vein drains into renal v. (31\\%)\n(3) Left adrenal vein enters left renal vein (almost always) / inferior phrenic vein\n\n## BLADDER",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 40,
            "markdown": "Bladder capacity $[\\mathrm{mL}]=$ (age in years +2$) \\times 30$\n\n# Layers of Bladder Wall (from inner to outer) \n\n(1) Uroepithelium $=3-7$ layers of stratified flat cells; able to change shape from cuboidal to flattened as the bladder distends (= transitional epithelium)\n(2) Lamina propria: very vascular\n(3) Muscularis propria $=$ complex network of interlacing bundles of smooth detrusor muscle; fibers merge with prostate capsule / anterior vagina + pelvic floor muscles\n(4) Adventitia $=$ connective tissue + serosal covering formed by peritoneum at bladder dome\n\n## SCROTUM\n\n$=$ cutaneous fibromuscular sac containing testes + extratesticular tissues\n\n## Scrotal Sac\n\nScrotal wall thickness: $2-8 \\mathrm{~mm}(3-6 \\mathrm{~mm}$ in $89 \\%$ )\nLayers of scrotal sac:\n\n1. Pigmented Skin\n2. Dartos muscle and fascia\n3. External spermatic fascia $\\leftarrow$ external oblique muscle\n4. Cremaster muscle and fascia $\\leftarrow$ internal oblique muscle\n5. Internal spermatic fascia $\\leftarrow$ transversalis fascia\n6. Tunica vaginalis\n\n## Processus Vaginalis\n\n$=$ socklike evagination (outpouching) of the parietal peritoneum at 13 weeks EGA\n> forms anterior to developing testis + ligamentous cord\n> elongates caudally through abdominal wall into scrotal folds\n> becomes ensheathed by fascial extensions of abdominal wall (from inner to outer layer):\n\n- fascia transversalis $\\rightarrow$ internal spermatic fascia\n- internal oblique muscle $\\rightarrow$ cremaster muscle\n- external oblique muscle $\\rightarrow$ external spermatic fascia\n\nWITHOUT contribution by transversus abdominis m.\nFunction: guides testicular descent from abdomen to scrotum at $7^{\\text {th }}-9^{\\text {th }}$ months of fetal life",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 41,
            "markdown": "![img-7.jpeg](img-7.jpeg)\n(a) superior portion: becomes obliterated in 3 steps\n(1) closure of deep inguinal ring\n(2) closure of area above testis\n(3) atresia between these constrictions\n(b) scrotal portion:\nperitoneum-lined cavity surrounding anterior surface of the testis = tunica vaginalis\n(1) parietal layer envelops all but the posterior aspect of testis\n(2) visceral layer closely adherent to the tunica albuginea\n\nContent: $1-2 \\mathrm{~mL}$ of serous fluid\n\n# Testis \n\nEmbryology: descent from abdomen to scrotum between $7^{\\text {th }}$ and $9^{\\text {th }}$ months of gestation\nAverage size of testis: $\\mathbf{3 . 0} \\times 2.0-3.0 \\times 3.8-5.0 \\mathrm{~cm}$ (decreasing with age)\nLength of testis: $3-5.5 \\mathrm{~cm}$ (mature); $1-1.5 \\mathrm{~cm}$ (newborn)\nTesticular cysts: in $8 \\%$ of normals (average size $2-3 \\mathrm{~mm}$ ), numbers increasing with age\nAnatomy: 200-300 lobules each containing 400-600 seminiferous tubules; each tubule is $30-80 \\mathrm{~cm}$ long with a total length of $300-980 \\mathrm{~m}$\nHisto: (1) spermatogonia (adjacent to basement membrane) $\\rightarrow$ spermatocytes $\\rightarrow$ spermatids $\\rightarrow$ spermatozoa\n(2) nondividing Sertoli cells provide the support structure; their tight cell junctions are responsible for the blood-testis barrier",
            "images": [
                {
                    "id": "img-7.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 191,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1084,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 42,
            "markdown": "(3) interstitium (= space between seminiferous tubules) contains connective tissue, lymphatics, blood vessels, mast cells, Leydig cells (= principal source of testosterone production)\n\n# Appendix Testis \n\n$=$ HYDATID OF MORGAGNI\n$=$ small stalked appendage at upper pole of testis\nFrequency: $92 \\%$ of testes\nOrigin: remnant of paramesonephric duct\nAppendix testis+appendix epididymis $=9 \\div 1$\n\n## Tunica Albuginea\n\n$=$ tough fibrous capsule of testis with great tensile strength (sustaining forces of up to 50 kg without rupturing)\n> posterior surface invaginates into testicular parenchyma at mediastinum testis $\\rightarrow$ divides testis into lobules\n> externally covered by visceral layer of tunica vaginalis (= flattened layer of mesothelium)\n$\\sqrt{ }$ echogenic rim surrounding the testis\n\n## Tunica VASCULOSA\n\n$=$ composed of capsular arteries, applied internally to tunica albuginea\n\n## Tunica Vaginalis\n\n= 2-layered serous membrane as inferior extension of processus vaginalis of peritoneum forming a mesothelium-lined sac that covers entire testis except for the posterior border\n(a) inner visceral layer: envelopes most of testis and epididymis\n(b) outer parietal layer: lines internal spermatic fascia\n\nHydrocele: fluid accumulation in potential space between layers of tunica vaginalis (small to moderate in $14 \\%$ of normals)\n\n## Mediastinum Testis\n\n$=$ converging point of $\\sim 400$ cone-shaped lobules separated by fibrous septa + seminiferous tubules forming larger tubuli recti and draining into the rete testis ( $=15-20$ efferent ductules)\n$=$ incomplete septum acting as entry and exit point for ducts, nerves, vessels (= hilum of testis)\n$\\sqrt{ }$ posteriorly located linear echogenic region extending longitudinally $5-8 \\mathrm{~mm}$ from the edge\n\n## Epididymis\n\n$=$ tortuous tightly folded canal forming the efferent route from testis; consists of head ( $=$ globus major), body, tail (= globus minor)\nLocation : superolateral aspect of testis\nLength : 7 cm\nGlobus major : $11 \\times 7 \\times 6 \\mathrm{~mm}$ (decreasing with age); located atop superior pole of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 43,
            "markdown": "| Epididymal body | $: 2-4 \\mathrm{~mm}$ thick |\n| :-- | :-- |\n| Epididymal tail | $:$ continues as vas deferens |\n| Epididymal cysts | $:$ occur in $30 \\%$ of normals (average size of 4 mm ) |\n| Epididymal | $:$ in $3 \\%$ |\n| calcification |  |\n\n# Appendix epididymis \n\n$=$ small stalked appendage of globus major near upper pole of testes; occasionally duplicated\nFrequency: $20-33 \\%$ of epididymes\nOrigin: remnant of mesonephric (wolffian) duct; regarded as detached efferent duct\n\n## Spermatic Cord\n\nCourse: originates in scrotum $\\rightarrow$ leaves scrotum via superficial inguinal ring $\\rightarrow$ passes through inguinal canal $\\rightarrow$ and through deep inguinal ring\nComponents: testicular + deferential + cremasteric aa., pampiniform plexus of veins, vas deferens, nerves, lymphatics\nCover: (from superficial to deep) external spermatic fascia, cremasteric m. + fascia, internal spermatic fascia\n\n## Gonadal Vascular Anatomy\n\n## Gonadal Artery\n\nOrigin: ventral surface of aorta ( $83 \\%$ ) a few cm below the origin of renal arteries / from renal artery or arteries $(17 \\%)$ :\n![img-8.jpeg](img-8.jpeg)\n(a) R from renal a. +L from aorta $(6 \\%)$",
            "images": [
                {
                    "id": "img-8.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1247,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1903,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 44,
            "markdown": "(b) R from aorta +L from renal a. (4\\%)\n(c) $\\mathrm{R}+\\mathrm{L}$ from both renal arteries (4\\%)\n\nCourse: L anterior to left renal vein ( $20 \\%$ );\nR behind IVC + anterior to right renal vein\n\n# Gonadal Vein \n\nR: drains into IVC (93\\%) / right renal vein (7\\%)\nL: drains into left renal vein\nMultiple gonadal veins ( $15 \\%$ )\nLymphatic drainage follows venous drainage: testes drain into paraaortic and paracaval lymph nodes.\n\n## Blood Flow To Textis\n\nPeak systolic velocity: $4-10-19 \\mathrm{~cm} / \\mathrm{sec}$\nEnd-diastolic velocity: $2-5-8 \\mathrm{~cm} / \\mathrm{sec}$\nResistive index: 0.60 (range, $0.44-0.75$ )\n\n## ZONAL ANATOMY OF PROSTATE\n\nNormal weight : $20 \\pm 6 \\mathrm{~g}$\nNormal size $\\quad: 2.8 \\mathrm{~cm}$ (craniocaudad), 2.8 cm (anteroposterior), 4.8 cm (width)\nA. OUTER / PERIPHERAL GLAND\n\n1. Central zone ( $25 \\%$ of glandular tissue):\nsurrounds ejaculatory ducts from their entrance at prostatic base to verumontanum\n2. Peripheral zone ( $70 \\%$ of glandular tissue):\nextends from base of prostate to apex along rectal surface\n$\\sqrt{ }$ outer gland is hyperintense on T2WI\n$\\sqrt{ }$ surrounded by thin hypointense rim on T2WI $\\leftarrow$ anatomic / true capsule\nB. INNER / CENTRAL GLAND\n3. Transition zone ( $5 \\%$ of glandular tissue):\non each side of internal sphincter; enlarges with BPH\n4. Periurethral zone ( $1 \\%$ of glandular tissue):\nsurrounding urethra\n$\\sqrt{ }$ inner gland is hypointense on T2WI\nC. ANTERIOR FIBROMUSCULAR STROMA\n$\\sqrt{ }$ hypointense on T2WI\n$\\diamond$ Zonal anatomy is best depicted on high-resolution T2WI\n\n## SEMINAL VESICLES (SV)\n\nOrigin: separate symmetric buds extend from distal mesonephric duct (vas deferens) just proximal to ejaculatory duct\nConnection: SV join distal part of vas deferens forming ejaculatory duct which drains into prostatic urethra through verumontanum\n$\\checkmark$ symmetric and of smooth saccular appearance\n$\\checkmark 1-2 \\mathrm{~mm}$ thin wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 45,
            "markdown": "Size: 3 cm in length, 1.5 cm in diameter\nVolume: 13.7 mL\n![img-9.jpeg](img-9.jpeg)\n\n# VAS DEFERENS \n\nOrigin: mesonephric duct\nAmpulla: $4 \\pm 1 \\mathrm{~mm}$ (distal segment of vas deferens just before junction with seminal vesicle)\n\n## EJACULATORY DUCT\n\nOrigin: mesonephric duct\nDiameter: $4-8 \\mathrm{~mm}$\n\n## URETHRA\n\n## Male Urethra\n\nLength: $17.5-20.0 \\mathrm{~cm}$\nA. POSTERIOR URETHRA\n\n1. Prostatic urethra\n$=3.5-\\mathrm{cm}$ long segment from vesical neck to triangular ligament at urogenital diaphragm\n> urethral crest $=$ posteriorly located longitudinal ridge of smooth muscle with overlying prominent fold from bladder neck to membranous urethra\n> verumontanum $=$ colliculus seminalis\n$=1 \\mathrm{~cm}$ long ovoid mound at posterior wall of prostatic urethra with a small saccular depression centrally ( $=$ prostatic utricle representing the fused end of vestigial mÃ¼llerian ducts)\n> multiple small orifices of ducts from prostate gland acini exit at floor of prostatic urethra around verumontanum",
            "images": [
                {
                    "id": "img-9.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 301,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 961,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 46,
            "markdown": "orifices of the paired ejaculatory ducts just distal + lateral to utricle\n> contains involuntary internal urethral sphincter (composed of smooth muscle) for primary passive continence\n2. Membranous urethra\n$=1.0-1.5 \\mathrm{~cm}$ long portion traversing urogenital diaphragm; anchored to anterior pubic arch by paired puboprostatic ligaments\n> contains 2 muscles:\n(a) voluntary external urethral sphincter (composed of striated muscle with contributions from levator ani complex) for active continence\n(b) involuntary intrinsic urethral sphincter (composed of smooth muscle) for secondary passive continence\n![img-10.jpeg](img-10.jpeg)\n\nAssociated with:\n2 cm long pea-sized bulbourethral glands of Cowper that lie laterally + posteriorly between fasciae and sphincter urethrae in urogenital diaphragm $\\rightarrow$ empty into bulbous urethral sump\n[William Cowper FRS (1666-1709), English surgeon and anatomist in London]\nB. ANTERIOR $=$ CAVERNOUS URETHRA\n$=$ segment from external meatus to inferior edge of urogenital diaphragm through corpus spongiosum\n\n1. Bulbous urethra\n\n- entirely internal\n> located in crura of corpus spongiosum\n(a) \"sump\" = proximal dilated portion of urethra\n(b) \"cone\" = conical shape of urethra at bulbomembranous junction\n\n2. Penile (= pendulous) urethra",
            "images": [
                {
                    "id": "img-10.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 666,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1405,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 47,
            "markdown": "- entirely external\n> beginning at penoscrotal junction + terminating in glans penis\n\n3. Fossa navicularis: $1.0-1.5 \\mathrm{~cm}$ in length\n4. External meatus\n\nAssociated with:\nmany small branched tubular periurethral glands of LittrÃ© that terminate in recesses (lacunae of Morgagni) and are most numerous at dorsal aspect of penile urethra + in bulbous urethral sump\n$C x$ : recurring urethral discharge following chronic urethritis; latent gonorrheal urethritis; stricture formation\n\n# Female Urethra \n\nSize: $3-5 \\mathrm{~cm}$ in length, 6 mm in diameter\nCourse: from bladder neck at urethrovesical junction obliquely forward + downward to vestibule forming external meatus between labia minora\nEpithelium: transitional cell epithelium (proximal $1 / 3$ ), stratified squamous epithelium (distal $2 / 3$ )\nTwo sets of glands:\n(a) periurethral glands\nterminate in 6-30 paraurethral ducts that drain into distal urethra\n(b) paraurethral glands $=$ glands of Skene\n[Alexander Johnston Chalmers Skene (1837-1900), Scottish gynecologist, Professor of Disease of Women at Long Island College Hospital]\n( $=$ derivatives of urogenital sinus + homologues of prostatic ducts)\nFunction: urethral lubrication during sexual intercourse\n> formed by an interdependent conducting system\n> exit on either side of external meatus of the urethra anteriorly draining into vaginal vestibule\n$C x$ : chronic gonorrheal urethritis\n\n1. Intrapelvic urethra\n$=$ upper $2 / 7$ of urethra that lies behind symphysis pubis\nMuscles: > inner layer: longitudinal smooth muscle > outer layer: circular smooth muscle; thinner\n2. Membranous urethra\nsurrounded by sphincter membranacea urethrae (weaker less important structure than in male)\nMuscle: compressor urethrae muscle (formerly known as deep transverse perineal muscle)\nFunction: compresses + elongates urethra $\\rightarrow$ improving continence\n3. Perineal urethra\nlower $1 / 3$ extending from superior fascia of urogenital diaphragm to external meatus between labia minora\nMuscle: striated urethrovaginal sphincter reinforcing the 2 concentric layers of smooth muscle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 48,
            "markdown": "MR:\n$\\sqrt{ }$ targetlike urethral sphincters on AXIAL plane:\n$\\sqrt{ }$ average thickness of 4 mm\n$\\sqrt{ }$ hypointense striated-muscle of outer sphincter\n$\\sqrt{ }$ surrounding smooth-muscle of inner sphincter\n$\\sqrt{ }$ innermost mucosa-submucosa\n$\\sqrt{ }$ hypointense tubular retropubic structure on SAG view\n\n# PENIS \n\n## Layers of Penile Shaft\n\n1. Dartos fascia separates skin from loose layer of subcutaneous connective tissue\n2. Buck fascia\n$=$ fascia penis profunda surrounding corpora cavernosa only\n[Gurdon Buck (1807-1877), pioneer military plastic surgeon during the Civil War, Columbia University + New York Hospital]\n3. Tunica albuginea: surrounding corpora cavernosa (thick) and corpus spongiosum (thin)\n\n## Corpora cavernosa\n\n$=$ dorsally located paired structures consisting of venous sinusoids surrounded by strong fascial sheath ( $=$ tunica albuginea)\nFunction: erection\n\n## Corpus spongiosum\n\n$=$ ventrally located midline structure surrounding urethra terminating in glans penis + surrounded by tunica albuginea\nAttached to: ischial tuberosity via crura\n\n## Perfusion of Penis\n\nA. ARTERIAL INFLOW:\n\n1. Dorsal artery: lateral to deep dorsal vein Supply for: glans penis, skin\n2. Cavernosal artery: located in center of corpus callosum; terminal branch of internal pudendal artery\nSupply for: corpus cavernosum during erection\n3. Bulbourethral artery Supply for: urethral bulb + posterior corpus spongiosum\nB. VENOUS DRAINAGE:\n4. Superficial dorsal vein = superficial to Buck fascia\n5. Deep dorsal vein = deep to Buck fascia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 49,
            "markdown": "# RENAL, ADRENAL, URETERAL, VESICAL, AND SCROTAL DISORDERS \n\n## ABORTIVE CALYX\n\n$=$ developmental anomaly with short blind-ending outpouching of pyramid without papillary invagination\nLocation: (a) renal pelvis\n(b) infundibulum (mostly upper pole)\n\n## ACQUIRED CYSTIC KIDNEY DISEASE\n\n$=$ ACQUIRED CYSTIC DISEASE OF UREMIA\n$=$ development of numerous fluid-filled renal cysts in end-stage kidney disease without hereditary causes\n$\\diamond$ Successful transplant probably stops development of additional cysts, but does not affect malignant potential!\nPrevalence: in $8-13 \\%$ before dialysis\nin $13 \\%$ after 2 years of hemodialysis,\nin $50 \\%$ after 6 years of hemodialysis,\nin $87 \\%$ after 9 years of hemodialysis,\nin $100 \\%$ after 10 years of hemodialysis;\nin $25 \\%$ of renal allograft recipients\nProposed etiologies:\ncompensatory hypertrophy of functional nephrons $\\leftarrow$ tissue destruction\n(a) renal tubular obstruction $\\leftarrow$ interstitial fibrosis\n(b) renal tubular expansion $\\leftarrow$ epithelial hyperplasia\n(c) cyst development $\\leftarrow$ increased fluid secretion\n\nNot correlated with: race, cause of renal failure, method of dialysis (hemodialysis / peritoneal)\nAt increased risk: older men; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nHisto: cysts lined by flattened cuboidal epithelium with papillary proliferations within renal cortex + medulla\nAssociated with:\n(a) small papillary / tubular / solid clear-cell adenomas (in 13-20\\%): $\\sim 1 \\mathrm{~cm}$ in diameter\n(b) renal cell carcinoma (in 3-7\\%): 7-year interval between transplantation + detection of renal cell carcinoma\n$\\checkmark$ small hypoplastic end-stage kidneys $(<280 \\mathrm{~g})$\n$\\checkmark$ multiple $1 / 2-3-\\mathrm{cm}$ cysts bilaterally (early = small, late = large): must have at least 3 cysts in each kidney\n$\\checkmark$ occasionally progressive renal enlargement due to cysts\nUS:\n$\\checkmark$ atrophic echogenic kidneys",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 50,
            "markdown": "$\\sqrt{ }$ cysts of varying size and complexity\n$D x:>3$ cysts + NO history of hereditary cystic disease\n$C x$ : spontaneous hemorrhage into cyst (macrohematuria / retroperitoneal hemorrhage from cyst rupture); cyst infection; ureteral stones; malignancy (risk factors are male sex + increased length of time on dialysis)\n\nRenal malignancy develops in 3-7\\% of patients with acquired cystic kidney disease\n\n# AIDS \n\n- azotemia, proteinuria, hematuria, pyuria (in 38-68\\% sometime during illness); progressive renal failure $(10 \\%)$\n\n1. HIV-associated nephropathy (up to $40 \\%$ )\n$=$ characterized by nephrotic-range proteinuria + rapidly progressive renal failure, primarily occurring in African-Americans\nHisto: focal + segmental glomerulosclerosis with collapsed glomerular tufts (= collapsing glomerulopathy), sparse interstitial infiltrates, severe tubular atrophy and dilatation containing protein casts\n\n- nephrotic range proteinuria\n- early + rapidly progressive renal failure\n$\\sqrt{ }$ normal-sized (majority) / globally enlarged kidneys:\n$\\sqrt{ }$ bulbous shape with loss of reniform appearance\nUS (best screening test):\n$\\sqrt{ }$ increased cortical echogenicity (33-89\\%) greater than liver and approaching that of renal sinus\n$\\sqrt{ }$ thickening of pelvicaliceal system\n$\\sqrt{ }$ \"decreased renal sinus fat\" sign (in up to $49 \\%$ ) $\\leftarrow$ renal edema invading renal sinus fat\n$\\sqrt{ }$ decreased corticomedullary differentiation\nCT:\n$\\sqrt{ }$ medullary hyperattenuation ( $14 \\%$ )\n$\\sqrt{ }$ striated nephrogram on $\\mathrm{CECT} \\leftarrow$ dilated protein-filled tubules\nMR:\n$\\sqrt{ }$ loss of corticomedullary differentiation\nPrognosis: $100 \\%$ mortality within 6 months\n$D D x$ : infection, acute tubular necrosis\n\n## 2. Renal infection with Pneumocystis jirovecii (8\\%)\n\n$\\diamond$ More frequent since introduction of prophylactic aerosolized pentamidine therapy encouraging extrapulmonic spread ( $<1 \\%$ ) due to inadequate systemic distribution of drug!\n$\\sqrt{ }$ punctate renal calcifications confined to cortex $\\leftarrow$ areas of infiltrate + subsequent destruction of renal tubules (DDx: CMV, Mycobacterium avium-intracellulare)\n$\\sqrt{ }$ associated areas of increased echogenicity in spleen, liver, lymph nodes, adrenal glands $\\leftarrow$ calcifications / protein\n3. Other renal infections\n\nCandida albicans, Aspergillus, disseminated pulmonary tuberculosis, M. aviumintracellulare",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 51,
            "markdown": "$\\sqrt{ }$ focal microabscesses + hydronephrosis\n4. Renal lymphoma (3-12\\%)\n$=$ AIDS-RELATED LYMPHOMA\n$=$ highly aggressive often extranodal B-cell lymphomas (centroblastic, lymphoblastic, immunoblastic);\nNHL $>$ Burkitt lymphoma, Hodgkin disease\n$\\sqrt{ }$ bilateral multiple renal masses:\n$\\checkmark$ slightly hyperattenuating relative to renal parenchyma on NECT\n$\\checkmark$ hypoattenuating homogeneous masses during nephrographic phase on CECT\n$\\checkmark$ direct extension of retroperitoneal lymphadenopathy engulfing kidney, renal sinus, ureter\n5. Kaposi sarcoma (27\\%)\n$=$ AIDS-defining illness usually in patients with CD4 lymphocyte count $<150-200$ cells $/ \\mathrm{mm} 3$\nHisto: renal tissue replaced + infiltrated by proliferation of spindle cells with characteristic small vascular spaces + demonstrable nuclear staining for $\\mathrm{HHV}_{8}$\n$\\checkmark$ renal enlargement + irregular hypoattenuating areas in renal cortex\n6. HAART-related nephropathy\n[highly active antiretroviral therapy]\n\n- acute renal failure $\\leftarrow$ renal tubular damage from nucleotide reverse-transcriptase inhibitors (tenofovir, adefovir, cidofovir)\n- dyslipidemia, insulin resistance, fat redistribution\n- hypertension\n$\\checkmark$ renal calculi (in up to $20 \\%$ ) $\\leftarrow$ indinavir and nelfinavir\n$\\checkmark$ renal artery stenosis\n\n7. Cystitis ( $22 \\%$ )\n\nOrganism: routine gram-negative species, Candida, beta-hemolytic streptococci, Salmonella, CMV\n$\\checkmark$ bladder wall thickening\n\n# ACUTE CORTICAL NECROSIS \n\n$=$ rare form of acute renal failure\nEtiology:\n(a) ischemia $\\leftarrow$ vasospasm of small vessels\n(b) toxic damage to glomerular capillary endothelium\n(c) primary intravascular thrombosis\n\nAt risk:\n(a) Obstetric patient (most often): abruptio placentae = premature separation of placenta with concealed hemorrhage ( $50 \\%$ ), septic abortion, placenta previa\n(b) Children: severe dehydration + fever, infection, hemolytic uremic syndrome, transfusion reaction\n(c) Adults: sepsis, severe dehydration, acute prolonged shock, myocardial failure, burns, venomous snakebite, abdominal aortic surgery, hyperacute renal transplant rejection\nHisto: patchy / universal necrosis of renal cortex + proximal convoluted structures $\\leftarrow$ distension of glomerular capillaries with dehemoglobulinized RBCs; medulla and 1-2",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 52,
            "markdown": "mm of peripheral cortex are spared\n\n- protracted + severe oliguria / anuria\n\nDistribution: diffuse / multifocal; mostly bilateral\nA. EARLY SIGNS\n$\\sqrt{ }$ diffusely enlarged smooth kidneys\n$\\sqrt{ }$ absent / faint nephrogram\nCT:\n$\\sqrt{ }$ enhancing interlobar and arcuate arteries adjacent to nonenhancing cortex (arterial phase)\n$\\sqrt{ }$ \"reversed rim\" sign = enhancement of medulla + nonenhancement of hypoattenuating cortex (parenchymal phase)\nCause: sustained hypotension for 1 hour\n$\\sqrt{ }$ rim of subcapsular cortical enhancement $\\leftarrow$ collateral blood flow from cortical vessels\n$\\sqrt{ }$ enhancement of juxtamedullary zone of cortex\nUS:\n$\\sqrt{ }$ loss of normal corticomedullary region with hypoechoic outer rim of cortex\nNUC:\n$\\sqrt{ }$ severely impaired renal perfusion\nB. LATE SIGNS\n$\\sqrt{ }$ small kidney (after a few months)\n$\\sqrt{ }$ \"tramline\" / punctate calcifications along margins of viable and necrotic tissue (as early as $1-2$ months)\nUS:\n$\\sqrt{ }$ hyperechoic cortex with acoustic shadowing\nPrognosis: poor chance of recovery\n\n# ACUTE INTERSTITIAL NEPHRITIS \n\n$=$ infiltration of interstitium by lymphocytes, plasma cells, eosinophils, few PMNs + edema\nCause: allergic / idiosyncratic reaction to drug exposure (penicillin, methicillin, sulfonamides, ampicillin, cephalotin, anticoagulants, phenindione, diphenylhydantoin)\n\n- eosinophilia (develops 5 days to 5 weeks after exposure)\n$\\sqrt{ }$ large smooth kidneys with thick parenchyma\n$\\sqrt{ }$ normal / diminished contrast density\nUS:\n$\\sqrt{ }$ normal / increased echogenicity\n\n\n## ACUTE TUBULAR NECROSIS\n\n$=$ ACUTE VASOMOTOR NEPHROPATHY\n$=$ temporary reversible marked reduction in tubular flow rate\nEtiology:\n(a) DRUGS: bichloride of mercury, ethylene glycol (antifreeze), carbon tetrachloride, bismuth, arsenic, uranium, urographic contrast material (esp. when associated with glomerulosclerosis in diabetes mellitus), aminoglycosides (gentamicin, kanamycin)\n(b) ISCHEMIA: major trauma, massive hemorrhage, postpartum hemorrhage, crush injury,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 53,
            "markdown": "myoglobulinuria, compartmental syndrome, septic shock, cardiogenic shock, burns, transfusion reaction, severe dehydration, pancreatitis, gastroenteritis, renal transplantation, cardiac surgery, biliary surgery, aortic resection\nPathophysiology: profound reduction in renal blood flow $\\leftarrow$ elevated arteriolar resistance\n$\\sqrt{ }$ smooth large kidneys, especially increase in AP diameter $>4.63 \\mathrm{~cm} \\leftarrow$ interstitial edema\n$\\sqrt{ }$ diminished / absent opacification of collecting system\n$\\sqrt{ }$ immediate persistent dense nephrogram ( $75 \\%$ )\n$\\sqrt{ }$ increasingly dense persistent nephrogram ( $25 \\%$ )\n$\\sqrt{ }$ diffuse calcifications (rare)\nUS:\n$\\sqrt{ }$ normal to diminished echogenicity of medulla\n$\\sqrt{ }$ sharp delineation of swollen pyramids\n$\\sqrt{ }$ normal ( $89 \\%$ ) / increased ( $11 \\%$ ) echogenicity of cortex\n$\\sqrt{ }$ elevated resistive index $\\geq 0.75$ (in $91 \\%$ excluding patients with hepatorenal syndrome); unusual in prerenal azotemia\nAngio:\n$\\sqrt{ }$ normal arterial tree with delayed emptying of intrarenal vessels\n$\\sqrt{ }$ slightly delayed / normal venous opacification\nNUC:\n$\\sqrt{ }$ well-maintained renal perfusion\n$\\sqrt{ }$ poor concentration of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-glucoheptonate / ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA\n$\\sqrt{ }$ better renal visualization on immediate postinjection images than on delayed images\n$\\sqrt{ }$ progressive parenchymal accumulation of ${ }^{131} \\mathrm{I}$-Hippuran / ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$\n$\\sqrt{ }$ no excretion\n\n# ADDISON DISEASE \n\n$=$ PRIMARY ADRENAL INSUFFICIENCY\n$\\diamond 90 \\%$ of adrenal cortex must be destroyed!\nCourse: acute (adrenal apoplexy), subacute (disease present for $<2$ years), chronic\n\n## Acute Primary Adrenal Insufficiency\n\n$=$ ADDISONIAN CRISIS $=$ ADRENAL APOPLEXY\nCause: bilateral adrenal hemorrhage most commonly due to stress from surgery / sepsis / hypotension with shock / hemorrhagic diathesis, anticoagulation therapy\n\n- abdominal / back pain\n- fever ( $70 \\%$ ), hyperpyrexia, lethargy, nausea, vomiting\n$\\sqrt{ }$ bilateral adrenal enlargement with areas of increased attenuation\nCx: catastrophic hypotension + shock\n\n\n## Chronic Primary Adrenal Insufficiency\n\nCause:\n\n1. Idiopathic adrenal atrophy ( $60-70 \\%$ ): likely autoimmune disorder\n2. Fungal infection: histoplasmosis, blastomycosis, coccidioidomycosis\n3. Granulomatous disease: tuberculosis, sarcoidosis\n4. Bilateral metastatic disease (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 54,
            "markdown": "- hyponatremia, hyperkalemia, azotemia, hypercalcemia\n$\\sqrt{ }$ diminutive glands $\\leftarrow$ idiopathic atrophy + chronic inflammation\n$\\sqrt{ }$ calcifications (in $25 \\%$ of chronic course)\n\n\n# ADENOMATOID TUMOR OF SCROTUM \n\n$=$ benign slow-growing mesothelial neoplasm\nFrequency: $30 \\%$ of all extratesticular masses;\n$2^{\\text {nd }}$ most common extratesticular mass (after lipoma)\nAge: $2^{\\text {nd }}-4^{\\text {th }}$ decade\nHisto: epithelial-like cells + stroma of hyalinized / loose collagen with varying amounts of smooth muscle + elastic fibers\nOrigin: epididymal tail\nLocation: epididymis $>$ tunica vaginalis, spermatic cord (rare)\nSite: $\\mathrm{L}>\\mathrm{R}$; lower pole + upper pole $=4 \\div 1$\nSize: $0.4-5.0 \\mathrm{~cm}$ (usually $<2 \\mathrm{~cm}$ )\n\n- hard painless scrotal mass\n$\\checkmark$ smooth round paratesticular mass at periphery of testis:\n$\\checkmark$ well-marginated solid hypoechoic mass with echogenicity equal to / greater than testis\n$\\checkmark$ indentation of the testicular contour\nMR:\n$\\checkmark$ isointense relative to testis on T1WI\n$\\checkmark$ slightly hypointense relative to testis on T2WI\n$\\checkmark$ enhancement similar to testicular enhancement\n$D D x$ : germ cell tumor, granulomatous epididymitis (painful, avascular), metastasis from B-cell ALL/ NHL\n\n\n## ADRENAL CYST\n\nFrequency: $0.06-0.18 \\%$ (at autopsy)\nAge: $3^{\\text {rd }}-5^{\\text {th }}$ decades (most commonly); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$ to $1 \\div 2$\nPath: (a) vascular / endothelial cyst (45-48\\%)\n(b) pseudocyst (39-42\\%)\n(c) epithelial lining $=$ true simple cyst $(9-10 \\%)$\n(d) parasitic cyst $(7 \\%)$\n\nLocation: mostly solitary; $\\mathrm{R} \\div \\mathrm{L}=1 \\div 1$; bilateral in $8-15 \\%$\nMean size: $5.3 \\mathrm{~cm} ;<5 \\mathrm{~cm}$ in diameter in $50 \\%$ (up to 20 cm )\n\n- asymptomatic, unless very large / infected / ruptured / bled into\n$\\checkmark$ well-circumscribed encapsulated uni- / multilocular lesion with internal septa\n$\\checkmark$ thin wall of $<3 \\mathrm{~mm}$ in thickness (unless pseudocyst)\n$\\checkmark$ lack of central enhancement $\\pm$ wall and septal enhancement\n$\\checkmark$ calcifications:\n(a) peripheral / mural: rimlike / nodular (51-69\\%)\n(b) central (rarely): in intracystic septation (19\\%) / punctate within intracystic hemorrhage $(5 \\%)$\n(c) scattered throughout the lesion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 55,
            "markdown": "Radiography:\n$\\sqrt{ }$ inferior displacement of ipsilateral kidney US:\n$\\checkmark$ well-circumscribed hypo- to anechoic lesion\nCT:\n$\\checkmark$ well-circumscribed nonenhancing hypoattenuating lesion of $<20 \\mathrm{HU}$ (near-water density); higher attenuation with hemorrhage / intracystic debris / crystals\nMR:\n$\\checkmark$ uniformly hypointense on T1WI + hyperintense on T2WI\n$\\sqrt{ }$ NO enhancement\n$\\sqrt{ }$ T1 hyperintense signal $\\leftarrow$ hemorrhage\n$\\sqrt{ } \\pm$ septations / soft-tissue component $\\leftarrow$ hemorrhage / hyalinized thrombus\nCx: hypertension; hemorrhage; infection; rupture with retroperitoneal hemorrhage\nPrognosis: interval increase in cyst size in $60 \\%$\nRx: (1) Resection of cyst $>5 \\mathrm{~cm} \\leftarrow$ risk of hemorrhage\n(2) Functional symptomatic cyst\n(3) Cyst worrisome for malignancy\n\nDDx: (a) benign\n\n1. Cystic pheochromocytoma\n2. Cystic adenomatoid tumor\n3. Schwannoma\n4. Adrenocortical adenoma (contrast enhancement, no wall, no peripheral calcification)\n5. Hemangioma\n(b) benign\n6. Cystic adrenocortical carcinoma (thick-walled lesion $>7 \\mathrm{~cm}$ in size; extremely rare)\n7. Metastatic disease\n\nVascular / Endothelial Adrenal Cyst (45-48\\%)\nCause: 1. Simple cyst without soft-tissue component\n2. Lymphangioma\n3. Hemangioma\n\nHisto: lined by cells resembling normal endothelium\n$\\sqrt{ }$ multilocular thin-walled cyst containing serous / serosanguinous / clear fluid\n$\\sqrt{ }$ scattered / central septal calcifications in $15-30 \\%$\nAdrenal Pseudocyst (39-42\\%)\nCause:\n\n1. Previous hemorrhage / infarction\n2. Hemorrhagic complication of benign vascular neoplasm / malformation\n3. Cystic degeneration / hemorrhage of primary adrenal mass\n\nHisto: wall consists of dense hyalinized material + occasional calcification / osseous metaplasia; adrenal cortical cells can be found in wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 56,
            "markdown": "- amorphous material + blood products as content\n$\\sqrt{ }$ typically unilocular thick-walled cyst $>3.5 \\mathrm{~mm}$\n$\\sqrt{ }$ internal scattered echogenicity $\\leftarrow$ debris / fluid-fluid levels from recent hemorrhage\n$\\sqrt{ }$ peripheral calcifications\n\n\n# True Simple / Epithelial Adrenal Cyst (9-10\\%) \n\nCause: 1. Glandular / retention cyst\n2. Embryonal cyst\n3. Cystic adenoma\n4. Mesothelial inclusion cyst\n\nHisto: simple epithelial lining\n$\\sqrt{ }$ unilocular thin-walled cyst\n\n## Parasitic Adrenal Cyst (7\\%)\n\nCause: usually Echinococcus granulosus\nPath: purely cystic to more complex contents depending on stage of infection\n$\\sqrt{ }$ variable internal complexity $\\leftarrow$ daughter vesicles, freed scolices, brood capsules\n$\\sqrt{ }$ septal / mural calcifications\n$\\sqrt{ }$ \"water lily\" sign\n$\\sqrt{ }$ extra-adrenal foci of hydatid disease\n\n## ADRENAL HEMORRHAGE\n\nSite: medulla with variable degree of cortical involvement\n\n- sudden / gradual onset of lower chest / upper abdominal / flank / back pain; shocklike symptoms $=$ signs of massive blood loss\n- acute adrenal insufficiency (rare): manifesting as hypotension + hyponatremia + hyperkalemia\n$\\sqrt{ }$ round / oval mass displacing kidney inferiorly + IVC anteriorly\n$\\sqrt{ }$ uniform adrenal enlargement gradually decreasing in size over 6-8 weeks (follow-up for 2-3 months)\n$\\sqrt{ }$ complete resolution with time:\n$\\sqrt{ } \\pm$ rimlike curvilinear / eggshell calcifications $>1$ year\n$\\sqrt{ }$ no enhancement\nNECT:\n@ acute stage ( $<7$ days):\n$\\sqrt{ }$ round / oval mass (in $83 \\%$ ) located in medulla + stretching cortex around hematoma:\n$\\sqrt{ }$ hyperattenuating ( $50-90 \\mathrm{HU})$ similar to most neoplasms in acute stage $\\rightarrow$ slowly decreasing over time\nN.B.: Follow-up required to confirm regression!\n$\\sqrt{ }$ obliteration of gland by diffuse irregular hemorrhage (in 9\\%)\n$\\sqrt{ }$ periadrenal fat stranding\n$\\sqrt{ }$ asymmetric thickening of diaphragmatic crus $\\leftarrow$ periadrenal hemorrhage\n@ chronic stage ( $>7$ weeks):\n$\\sqrt{ }$ mass with hypoattenuating center $\\pm$ calcifications $=$ adrenal pseudocyst (DDx: adrenal adenoma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 57,
            "markdown": "US (modality of choice for neonate):\n$\\sqrt{ }$ complex solid heterogeneously hyperechoic mass during early stage\n$\\sqrt{ }$ mixed echogenicity with centrally hypoechoic region (as liquefaction occurs)\n$\\sqrt{ }$ peripheral curvilinear hyperechoic calcifications appearing within 1-2 weeks\n$\\sqrt{ }$ completely anechoic / cystlike in chronic stage\n$\\sqrt{ }$ avascularity on color Doppler / power Doppler\nMR:\n@ acute stage ( $<7$ days):\n$=$ high concentration of intracellular deoxyhemoglobin with preferential T2 proton relaxation enhancement\n$\\sqrt{ }$ isointense / slightly hypointense on T1WI\n$\\sqrt{ }$ markedly hypointense on T2WI\n@ subacute stage ( 7 days -7 weeks):\n$=\\mathrm{T} 1$ shortening $\\leftarrow$ paramagnetic effect of free methemoglobin $(\\mathrm{Fe} 3+) \\leftarrow$ produced by oxidation of hemoglobin $(\\mathrm{Fe} 2+)$\n$\\sqrt{ }$ hyperintensity on T1WI and T2WI appearing in periphery with filling in (over several weeks)\n$\\sqrt{ }$ hematoma may be multilocular, each locule with its own different signal intensity\n@ chronic stage ( $>7$ weeks):\n$=\\mathrm{T} 2$ proton relaxation enhancement $\\leftarrow$ hemosiderin deposition + presence of a fibrous capsule\n$\\sqrt{ }$ hypointense rim on T1WI + T2WI\n$\\sqrt{ }$ \"blooming effect\" (= magnetic susceptibility) of hemosiderin in gradient-echo imaging\n$R x$ : supportive; prompt glucocorticoid administration with concomitant intravenous saline therapy for acute adrenal insufficiency\n\n# Nontraumatic Adrenal Hemorrhage (20\\%) \n\nIncidence: in $1.8 \\%$ (autopsy study)\nCause: (1) Stress: severe burn, sepsis, surgery, hypotension\n(2) Hemorrhagic diathesis: anticoagulant therapy\n(3) Coagulopathy\n(4) Underlying adrenal mass: adrenocortical adenoma / carcinoma, myelolipoma, pheochromocytoma, metastasis, neuroblastoma\nLocation: typically bilateral\n$D D x$ : neuroblastoma (stippled calcifications, increase in vanillylmandelic acid, no decrease on follow-up)\n\n## Blunt Trauma to Adrenal Gland (80\\%)\n\nIncidence: in $28 \\%$ of autopsies; in $2 \\%$ of trauma CTs\n$\\diamond$ Adrenal injury means exposure to major force!\nMechanism:\n(a) direct crush injury between spine and liver / spleen\n(b) acutely increased adrenal venous pressure $\\leftarrow$ transmitted from compressed IVC / adrenal venous sampling",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 58,
            "markdown": "(c) IVC-adrenal vein thrombosis\n(d) shear injury to small adrenal vessels (from rotational / deceleration forces)\n\nOften associated with: injury to liver + kidney\nLocation: $\\mathrm{R} \\div \\mathrm{L} \\div$ bilateral $=75 \\div 15 \\div 10$\nPrognosis: (1) unilateral hematoma: spontaneous resolution without sequelae\n(2) bilateral hemorrhage: acute primary adrenal insufficiency (rare) is lifethreatening\n$D D x$ : preexisting adrenal mass $\\rightarrow$ repeat imaging after $8-10$ weeks!\n\n# ADRENOCORTICAL ADENOMA \n\n$\\diamond$ Most common tumor of adrenal gland!\nPrevalence: $1-2 \\%$ in general population; age-dependent $6.6-8.7 \\%$ at autopsies (small tumors in $50 \\%$ of autopsies)\n$\\diamond$ In a patient with lung carcinoma a solitary small adrenal mass is more likely an adenoma than a metastasis!\nPath: atypical intralesional cystic degeneration / less often hemorrhage\nHisto: clear cells arranged in cords with abundant intracellular (= intracytoplasmic) palestaining lipid; rich delicate vascular network\n$\\diamond$ Detection of lipid by CT / MRI is NOT $100 \\%$ specific!\n$D D x$ : metastatic clear cell renal cell carcinoma, pheochromocytoma, adrenocortical carcinoma\n$\\diamond$ No lipid may mean a benign lipid-free adenoma!\n$\\diamond$ Fat cell aggregates (macroscopic fat) may be present!\n$D D x$ : lipomatous / myelolipomatous metaplasia\n\n- usually nonfunctioning\n\nAverage size: $2.0-2.5 \\mathrm{~cm}$ : usually $<5 \\mathrm{~cm}$ in size\n$\\sqrt{ }$ well-defined homogeneous ( $87 \\%$ ) sharply marginated mass\n$\\sqrt{ }$ small adenomas $<1 \\mathrm{~cm}$ often go undetected\n$\\sqrt{ }$ contralateral gland often normal / atrophic\nNECT:\nCategories:\n(a) lipid-rich adenoma $<10 \\mathrm{HU}(60-90 \\%$ of all adenomas)\n(b) lipid-poor adenoma $>10 \\mathrm{HU}$ (up to $40 \\%$ )\n$\\sqrt{ }$ soft-tissue density / cystic density (mimicked by high cholesterol content) with poor\ncorrelation between functional status and HU number:\n$\\sqrt{ }<0 \\mathrm{HU}$ on NECT ( $47 \\%$ sensitive, $100 \\%$ specific)\n$\\sqrt{ } \\leq 10 \\mathrm{HU}$ on NECT ( $79 \\%$ sensitive, $96 \\%$ specific)\n$\\sqrt{ }<18 \\mathrm{HU}$ on NECT ( $85 \\%$ sensitive, $100 \\%$ specific)\n$\\sqrt{ }>10 \\%$ negative pixels on histogram ( $100 \\%$ specific)\n$\\sqrt{ }$ homogeneous attenuation ( $87 \\%$ )\nCECT:\n$\\sqrt{ }$ homogeneous ( $58 \\%$ ) enhancement\n$\\sqrt{ }<37 \\mathrm{HU}$ on 5-15-min delayed CECT is DIAGNOSTIC of adenoma\nWashout Technique:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 59,
            "markdown": "Rationale: adenomas show significantly more initial enhancement than nonadenomas\n(1) Attenuation before contrast administration $=$ ANECT\n(2) Early attenuation at $60 \\mathrm{sec}=$ Aearly\n(3) Delayed attenuation at $10-15 \\mathrm{~min}=$ Adelayed\n(4) Absolute percentage washout (Wabs / APW)\n$\\mathrm{W}_{\\text {abs }}=\\left[1-\\left(\\mathrm{A}_{\\text {delayed }}-\\mathrm{A}_{\\mathrm{NECT}}\\right) /\\left(\\mathrm{A}_{\\text {early }}-\\mathrm{A}_{\\mathrm{NECT}}\\right)\\right] \\cdot 100$\n$\\sqrt{ }$ washout $>40 \\%=$ adenoma\n$\\sqrt{ }$ washout $\\leq 40 \\%=$ indeterminate mass\n(5) Relative percentage washout ( $\\mathrm{W}_{\\text {rel }} / \\mathrm{RPW}$ ) useful when the NECT value is not known\n$\\mathrm{W}_{\\text {rel }}=\\left[\\left(\\mathrm{A}_{\\text {early }}-\\mathrm{A}_{\\text {delayed }}\\right) / \\mathrm{A}_{\\text {early }}\\right] \\cdot 100$\n$\\sqrt{ }$ washout $>60 \\%=$ adenoma\n$\\sqrt{ }$ washout $\\leq 60 \\%=$ indeterminate mass\nAngio:\n$\\sqrt{ }$ tumor blush + neovascularity; occasionally hypovascular\n$\\sqrt{ }$ pooling of contrast material\n$\\sqrt{ }$ enlarged central vein with high flow\n$\\sqrt{ }$ arcuate displacement of intraadrenal veins\n$\\sqrt{ }$ bilateral adrenal venous sampling $\\rightarrow$ in up to $40 \\%$ unsuccessful in localizing\nMR:\n$\\sqrt{ }$ isointense mass relative to liver + hyperintense relative to spleen on T1WI $\\leftarrow$ short T1 time of lipid\n$\\sqrt{ }$ iso- / hypointense mass (rarely hyperintense) to spleen on T2WI\n$\\sqrt{ }$ marked hypointensity compared with spleen / skeletal muscle on opposed-phase GRE images $\\leftarrow$ destructive interference of lipid and water signals $=$ phase cancellation of fat + water protons in same voxel in $95 \\%$ of adenomas ( $>90 \\%$ accurate)\n$\\sqrt{ }$ signal loss of $\\geq 20 \\%$ on opposed-phase image\n$\\sqrt{ }$ India ink effect $=$ characteristic black lines outlining interface between organ + adjacent fat (chemical shift artifact)\n$\\sqrt{ }$ small round foci of altered SI $\\leftarrow$ cystic changes / hemorrhage / variation in vascularity\nCEMR:\n$\\sqrt{ }$ uniform enhancement on immediate early imaging\n$\\sqrt{ }$ adenomas tend to enhance less rapidly + less intensely than metastases on timeenhancement curves\n$\\sqrt{ }$ relatively rapid washout of contrast material compared with metastases with return to baseline at 15 minutes $\\leftarrow$ lack of large interstitial spaces of edema + necrosis (DDx: metastases tend to have higher signal intensities [however 20-30\\% overlap])\nUS:\n$\\sqrt{ }$ well-circumscribed round or oval lesion of slightly heterogeneous mixed echogenicity Atypical appearance:\n$\\diamond$ Occasional intralesional cystic degeneration / hemorrhage make an accurate diagnosis more challenging!\n$\\sqrt{ }$ adenoma may calcify $\\rightarrow$ often in areas of old hemorrhage\n$D D x$ : pheochromocytoma, adrenocortical carcinoma, metastasis, functioning adenoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 60,
            "markdown": "# Nonhyperfunctioning Adrenocortical Adenoma \n\ncharacterized by\n(a) normal lab values of adrenal hormones\n(b) NO pituitary shutdown of the contralateral gland\n(c) activity on NP-59 radionuclide scans\n\nPrevalence: incidental finding in $0.6-1.5 \\%$ of CT examinations, in $3-9 \\%$ at autopsy\n$\\sqrt{ }$ surveillance CT to confirm lack of growth\n$R x$ : surgical removal for masses $3-5 \\mathrm{~cm}$ as indeterminate potentially malignant neoplasms\n$D D x$ : metastasis\n\n## Hyperfunctioning Adrenocortical Adenoma\n\n$\\sqrt{ }$ contralateral adrenal atrophy $\\leftarrow$ suppression of pituitary ACTH by elevated cortisol levels\n\n1. Primary hyperaldosteronism $=$ Conn syndrome $(80 \\%)$\n\nPathophysiology: secretion of aldosterone by an adenoma is pulsatile\n$\\sqrt{ }$ ACTH infusion incites a dramatic increase in levels of cortisol + aldosterone for venous sampling\n2. Cushing syndrome $(10 \\%)$\n3. Virilization\n(a) hirsutism + clitoromegaly in girls\n(b) pseudopuberty in boys\n$\\diamond$ Most common type of hormone elevation in children!\n\n- elevated testosterone levels $>0.55 \\mathrm{ng} / \\mathrm{mL}$\n\n4. Feminization (estrogen production)\n$\\sqrt{ }$ contralateral atrophic gland $\\leftarrow$ ACTH suppression with autonomous adenoma\n$\\sqrt{ }$ unilateral focus of ${ }^{131}$ I NP-59 radioactivity + contralateral absence of iodocholesterol accumulation (DDx: hyperplasia [bilateral activity])\n\n## ADRENOCORTICAL CARCINOMA\n\nPrevalence: $1-2 \\div 1,000,000$ people; $0.3-0.4 \\%$ of all pediatric neoplasms ( 3 x more likely than adrenal adenoma)\nAge: biphasic distribution $\\left(1^{\\text {st }}+4^{\\text {th }}-5^{\\text {th }}\\right.$ decade $) ; \\mathrm{M}+\\mathrm{F}=1 \\div 1.5$\nMay be associated with:\nhemihypertrophy, Li-Fraumeni syndrome, Beckwith-Wiedemann syndrome, Carney complex, congenital adrenal hyperplasia, MEN 1, astrocytomas\nPath: large lobulated tumor, often with cystic / necrotic / hemorrhagic center\nHisto: differentiation of benign from malignant solely on the basis of histologic features may be difficult\n\n- abdominal / back pain, palpable abdominal mass\n- weight loss, early satiety\n- $20 \\%$ nonfunctioning\n- $50 \\%$ hyperfunctioning (in $10-15 \\%$ Cushing syndrome, occasionally Conn syndrome, feminization, adrenogenital syndrome with virilization) inversely related to size\n- hypertension (common in all syndrome types)\n\nLocation: left+right adrenal $=53 \\div 47$; bilateral in $10 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 61,
            "markdown": "Median size: $10-12 \\mathrm{~cm}$ (range, $4-25 \\mathrm{~cm}$ ); usually $>5 \\mathrm{~cm}$; in $70 \\%>6 \\mathrm{~cm}$ in diameter\nA heterogeneous enhancing adrenal mass $>4 \\mathrm{~cm}$ in diameter has a high likelihood of malignancy!\n$\\sqrt{ }$ frequently heterogeneous mass with irregular margins + displacement of regional structures\n$\\sqrt{ }$ occasionally calcified (in 19-33\\%)\n$\\checkmark$ invasion of IVC, liver, kidney, diaphragm (multiplanar imaging helpful)\n$\\checkmark$ metastases to liver, regional lymph nodes, lung, bone, brain\n$\\diamond$ Metastases are the only reliable sign of malignancy!\n$\\diamond$ Large size + calcifications suggest malignancy!\nCT:\n$\\checkmark$ tumor attenuation typically $>10 \\mathrm{HU}$\n$\\checkmark$ central areas of low attenuation $\\leftarrow$ tumor necrosis\n$\\checkmark$ heterogeneous enhancement ( $=$ foci of hemorrhage + central necrosis) + thin peripheral rim of enhancement\nCECT:\n$\\checkmark$ peripheral nodular enhancement (in 88\\%)\n$\\checkmark$ venous tumor thrombus\n$\\checkmark$ relative percentage washout (RPW) of $<40 \\%$ at 15 min\n$\\checkmark$ slow absolute washout of $<60 \\%$ at 15 min\nUS:\n$\\checkmark$ well-defined round / oblong mass with lobulated contours\n$\\checkmark$ homogeneous echotexture in small tumor\n$\\checkmark$ complex echo pattern in large tumor with hyperechoic + hypoechoic regions $\\leftarrow$ hemorrhage + necrosis\nMR:\n$\\checkmark$ tumor of low T1 signal + heterogeneously high T2 signal\n$\\checkmark$ heterogeneous areas hyperintense to liver on T1WI + T2WI $\\leftarrow$ internal hemorrhage + necrosis frequent:\n$\\checkmark$ high SI on T1WI $\\leftarrow$ methemoglobin\n$\\checkmark$ high SI on T2WI $\\leftarrow$ necrosis\n$\\checkmark$ loss of SI on out-of-phase imaging $\\leftarrow$ intracytoplasmic lipid\nCEMR:\n$\\checkmark$ heterogeneous enhancement pattern with slow washout\n$\\checkmark$ nodular enhancement + central hypoperfusion\nAngio:\n$\\checkmark$ enlarged adrenal arteries\n$\\checkmark$ neovascularity, occasionally with parasitization\n$\\checkmark$ AV shunting; multiple draining veins\nNUC:\n$\\checkmark$ usually bilateral nonvisualization with ${ }^{131}$ I NP-59 (= carcinomatous side does not visualize because amount of uptake is small for size of lesion; contralateral side does not visualize because carcinoma is releasing sufficient hormone to cause pituitary feedback shutdown of contralateral gland)\nPET:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 62,
            "markdown": "$\\sqrt{ }$ hypermetabolic tumor on 18F-FDG with adrenal-to-liver max SUV ratio of $>1.45$ ( $100 \\%$ sensitive, $88 \\%$ specific)\nBiopsy: may appear histologically benign in well-differentiated adenocarcinoma\n$\\diamond$ Sampling error with fine-needle aspiration possible; use core biopsy instead\nPrognosis: $0 \\% 5$-year survival rate\n$D D x$ : metastasis (similar signal intensities on MR); adrenocortical adenoma (mass of $<10$ $\\mathrm{HU},>40 \\%$ relative washout, $>60 \\%$ absolute washout); myelolipoma (intralesional bulk fat)\n\n# Adrenocortical Neoplasm in Children \n\nIncidence: $3 \\div 1,000,000$ annually; less common than neuro- blastoma but more common than pheochromocytoma\nMean age: 8 years (range, 6 months to 19 years); $2 / 3$ younger than 5 years of age; $\\mathrm{M} \\div \\mathrm{F}=$ $2.2 \\div 1.0$\nPath: adenoma $=$ solitary spherical well-demarcated unencapsulated tumor of $<50 \\mathrm{~g}$ carcinoma $=$ multinodular tumor with areas of hemorrhage + necrosis of $>100-500 \\mathrm{~g}$\nHisto: NO reliable features to distinguish between adenoma and carcinoma!\nAssociated with:\n(1) Beckwith-Wiedemann syndrome (3\\%)\n\n2nd most common abdominal tumor after Wilms tumor\n(2) Li-Fraumeni syndrome $=$ SBLA (sarcoma, breast and brain tumors, laryngeal carcinoma, adrenocortical carcinoma)\n[Frederick Pei Li (1940-), American epidemiologist at Harvard School of Public Health and Harvard Medical School in Boston]\n[Joseph F. Fraumeni, Jr. (1933-), American epidemiologist at Harvard School of Public Health in Boston]\n\n- alteration of p53 tumor suppressor gene located on short arm of chromosome 17, band 13\n(3) Familial Carney complex $=$ cardiac myxoma + Sertoli cell tumor + adrenocortical neoplasm\n(4) MEN $1=$ pituitary prolactinoma + pancreatic islet cell tumor + parathyroid hyperplasia + adrenocortical neoplasm\n- palpable abdominal mass $(57 \\%)$\n- gonadotropin-independent production of endogenous androgens + cortisol (92\\%):\n- virilization in female\n$=$ herculean habitus (increased muscle mass), clitoromegaly, facial hair, advanced pubic + axillary hair development, advanced bone age\n- isosexual precocious puberty in male\n$=$ early development of acne, pubic hair, penile enlargement\n- mixed endocrine syndrome with cushingoid features (less frequent)\n- other endocrine abnormalities (unusual):\n- pure Cushing syndrome\n- feminization in boys $\\leftarrow$ secretion of estrogen\n- Conn syndrome (primary hyperaldosteronism)\n- increase in 24-hour urinary ketosteroid excretion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 63,
            "markdown": "- increased levels of serum cortisol, testosterone, androstenedione, estradiol\n\nMetastases: lung $>$ liver $>$ tumor invasion of IVC $(35 \\%)>$ peritoneum $(29 \\%)>$ pleura + diaphragm $(24 \\%)>$ abdominal lymph nodes $(24 \\%)>$ kidney $(18 \\%)$\nUS:\n$\\checkmark$ 3-22-cm round / ovoid well-circumscribed mass\n$\\checkmark$ lobulated border (common)\n$\\checkmark$ thin echogenic capsule-like rim (27\\%)\n$\\checkmark$ homogeneous mass hypo- / isoechoic to kidney\n$\\checkmark$ heterogeneous mass with centrally hypoechoic regions (= tumor necrosis) if large\n$\\checkmark$ tumor calcification (19\\%)\nCECT:\n$\\checkmark$ well-circumscribed mass with thin rim\n$\\checkmark$ heterogeneous predominantly peripheral enhancement if lesion large\n$\\checkmark$ fine / coarse calcification (24\\%)\nMR:\n$\\checkmark$ iso- / slightly hypointense to liver on T1WI\n$\\checkmark$ hyperintense to liver on T2WI\n$\\checkmark$ uniform signal loss at chemical shift imaging $\\leftarrow$ intracytoplasmic lipid\nPET/CT:\n$\\checkmark$ hypermetabolic primary tumor + metastases\n$\\checkmark$ secondary findings $\\leftarrow$ excess serum cortisol of Cushing syndrome:\n$\\checkmark$ hyperattenuating / hyperechoic renal pyramids $\\leftarrow$ hypercalcemia\n$\\checkmark$ increase in retroperitoneal fatty tissue $\\leftarrow$ obesity\nRx: surgery\nPrognosis of adrenocortical carcinoma:\nsurvival rate of $70 \\%$ [13\\%] for children $<5$ years [ $>5$ years] of age; death within 1-2 years after diagnosis\n$D D x$ : (1) Neuroblastoma (encasing vascular structures, punctate calcifications, crosses midline, extradural extension through neural foramina, ill child, often already metastatic, increase in catecholamines)\n(2) Pheochromocytoma (older child, headaches)\n(3) Adrenal hemorrhage (neonate, temporal evolution)\n(4) Metastasis (extremely rare)\n\n# ADRENOCORTICAL HYPERPLASIA \n\n$=$ ADRENALCORTICALHYPERPLASIA\n$\\diamond$ Responsible for $8 \\%$ of Cushing syndrome and $10-20 \\%$ of hyperaldosteronism! Cause:\n\n1. Corticotropin-dependent ( $85 \\%$ ): pituitary causes, ectopic ACTH production, CRF (corticotropin-releasing factor)production\n2. Primary pigmented nodular adrenocortical hyperplasia\n3. Primary aldosteronism (rare)\n\nPrevalence: $0.51 \\%$ increasing with age (autopsy); 4 x increased in patients with malignancy Age: $70-80 \\%$ in adults; $19 \\%$ in children",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 64,
            "markdown": "Location: typically bilateral\nTypes:\n(1) Smooth diffuse hyperplasia (common)\n$\\sqrt{ }$ smooth to slightly lobular thickening of entire adrenal gland while maintaining its overall normal inverted-V or inverted-Y appearance\n$\\diamond$ In $45 \\%$ of patients with Cushing syndrome\n(2) Cortical nodular hyperplasia (less common)\n\nPrevalence: increasing with age (autopsy)\nHisto: mild nodularity (50\\%), distinct nodularity (15\\%)\nAge: 65 years\nSite: multifocal\n$\\sqrt{ }$ focal hypo- to isoattenuating micro- / macronodules ( $=$ nodules up to 2.5 cm )\n$\\checkmark$ background of normal adrenal tissue / atrophic intervening cortex\n$\\diamond$ In $3 \\%$ of patients with Cushing syndrome\nAngio:\n$\\checkmark$ minimally increased hypervascularity\n$\\checkmark$ focal accumulation of contrast medium\n$\\checkmark$ normal venogram / may show enlarged gland\n$\\checkmark$ adrenal venous sampling to direct therapy in symptomatic patients $\\leftarrow$ results NOT ALWAYS CONCORDANT with imaging findings\nNUC:\n$\\checkmark$ asymmetric bilateral NP-59 uptake (related to urinary cortisol excretion) WITHOUT dexamethasone suppression in Cushing syndrome\n$\\checkmark$ bilateral foci of NP-59 uptake WITH dexamethasone suppression (nondiagnostic $\\geq 5$ days)\n$R x$ : no treatment in the absence of clinical / biochemical evidence of adrenocortical hyperfunction\n\n# ACTH-independent Macronodular Hyperplasia \n\n= MACRONODULAR HYPERPLASIA WITH MARKED ADRENAL ENLARGEMENT\nEtiology: unknown\n\n- clinical features of hyperaldosteronism / Cushing syndrome\n- suppressed ACTH $\\leftarrow$ active production of hormones\n$\\checkmark$ bilateral enlarged adrenal glands (often $>5 \\mathrm{~cm}$ ) with macronodules\n\n\n## Primary Pigmented Nodular Adrenocortical Disease\n\n$\\checkmark$ normal to slightly enlarged adrenals + small nodules + atrophy of intervening cortex\nAssociated with: Carney complex\n\n## ADRENAL REST TUMOR\n\n$=$ ADRENOCORTICAL REST\nPrevalence: $7-15 \\%$ of newborns; $1.6 \\%$ of adults\n$\\diamond$ Adrenal rests only form masses after exposure to elevated levels of adrenocorticotropic hormone\nAssociated with conditions of $\\uparrow$ circulating ACTH:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 65,
            "markdown": "(1) Congenital adrenal hyperplasia\n(2) Cushing syndrome\n(3) Addison disease\n\n- increase in cortisol levels (testicular vein sampling is DIAGNOSTIC)\n\nLocation: near testicular hilum; usually bilateral\nUS:\n$\\sqrt{ }$ multiple hypoechoic nodules\n$\\sqrt{ }$ may become hyperechoic with acoustic shadowing\nMR:\n$\\sqrt{ }$ nodules isointense relative to normal testis on T1WI\n$\\sqrt{ }$ nodules hypointense relative to normal testis on T2WI\n$\\sqrt{ }$ diffuse enhancement after contrast administration\n\n# ADRENOGENITAL SYNDROMES \n\n## A. CONGENITAL TYPE $=$ Congenital Adrenal Hyperplasia\n\n$=$ autosomal recessive enzyme defect\nIncidence: $1 \\div 15,000$ in most white populations\nCause: mutation of CYP21A2 (in 90\\%)\nPathophysiology (in 90-95\\%):\n21-hydroxylase deficiency $\\rightarrow$ impaired cortisol + aldosterone synthesis $\\rightarrow$ hyponatremia + hypokalemia + hypotension $\\rightarrow \\uparrow$ ACTH stimulation by pituitary gland (negative\nfeedback mechanism) $\\rightarrow \\uparrow$ production of steroid precursors $\\rightarrow$ diverted to production of androgens\nAge: manifestation most often in neonatal period; $\\mathrm{M}<\\mathrm{F}$\nPath: cerebriform appearance of cortical hyperplasia (weight increase to $2-4 \\mathrm{x}$ of normal); multilobular bilateral masses near rete testis (adrenocortical rests)\n\n- excess of androgenic steroids:\n> F: virilization of female fetus:\n- pseudohermaphroditism (= clitoral hypertrophy, ambiguous external genitalia, urogenital sinus)\n> M: precocious puberty in male $\\rightarrow$ rapid growth at 3-7 years of age\n- salt wasting $\\leftarrow$ diminished aldosterone production (in 75\\%):\n- life-threatening hypovolemic salt-wasting adrenal crisis (during first 2 weeks of life)\n@ Adrenal glands\n$\\sqrt{ } \\pm$ symmetrically enlarged + thickened adrenal glands:\n$\\sqrt{ }$ adrenal limb $>4 \\mathrm{~mm}$ thick\n$\\sqrt{ }$ coiled / cerebriform appearance\n$\\sqrt{ }$ central echogenic stripe replaced by diffusely stippled echoes\n$\\sqrt{ }$ massive bilateral myelolipomas $\\leftarrow$ long-standing / poorly treated congenital adrenal hyperplasia\n@ Gonads (55\\%)\n(a) females\n$\\sqrt{ }$ typically normal gonads in females\n$\\sqrt{ }$ cystic ovaries mimicking polycystic ovaries ( $76 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 66,
            "markdown": "(b) males\n$\\sqrt{ }$ bilateral multinodular adrenocortical rests in rete testis (= mediastinum testis) in postpubertal boys (in $25 \\%$ ):\n$\\sqrt{ }$ growth of adrenocortical rests $\\leftarrow$ effect of ACTH\n$\\checkmark$ usually hypoechoic $<5 \\mathrm{~mm}$ masses\n$\\checkmark$ occasionally heterogeneously hyperechoic adrenals $\\pm$ acoustic shadowing\n$\\checkmark$ iso- / slightly hyperintense on T1WI + hypointense on T2WI compared to adjacent testicular parenchyma\n$R x$ : cortisone $\\pm$ mineralocorticoids\nB. ACQUIRED TYPE\n$\\mathrm{M}<\\mathrm{F}$\n(a) adrenal hyperplasia / adenoma / carcinoma: occasionally bilateral myelolipomas\n(b) ovarian / testicular tumor\n(c) gonadotropin-producing tumor: pineal, hypothalamic tumor, choriocarcinoma\n\n- virilization; Cushing syndrome\n\n\n# ALKALINE-ENCRUSTED CYSTITIS AND PYELITIS \n\n$=$ chronic severe urinary tract infection affecting urothelial lining\nCause: nosocomial infection with urease-producing bacterium, most commonly\nCorynebacterium $\\rightarrow$ producing alkaline urine\nPredisposed: immunocompromised patient (esp. renal transplant patient), after invasive urologic procedure\nPath: mucosal inflammation + encrustation of urothelial lining with struvite + calcium phosphate\n\n- fever, hematuria, dysuria, suprapubic pain\n- ammonia-like smell of urine\n\nNECT:\n$\\sqrt{ }$ diffuse thin / coarse superficial linear urothelial calcifications\nSite: collecting system, ureter, bladder; often bilateral\n$D x$ : culture positive $>48 \\mathrm{hr}$ for urea-splitting micro-organism\n$C x$ : septic shock, graft failure\n$R x$ : antibiotics, oral acidification of urine\n\n## AMYLOIDOSIS\n\n$=$ accumulation of extracellular eosinophilic amyloid protein\n\n- gross hematuria ( $60 \\%$ ), urethral bleeding\n- dysuria, frequency, cystitis, acute renal failure\n\nGU location: bladder (50\\%), ureter (25\\%), urethra (20\\%), renal pelvis (6\\%)\n@ Urinary bladder (50\\%)\nCause: ? chronic cystitis\nHisto: stromal + muscle deposits of amyloid\n\n- painless gross hematuria $\\leftarrow$ mucosal ulceration\n- irritative symptoms\n\nSite: posterior + posterolateral wall of bladder (68\\%) > multiple areas (65\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 67,
            "markdown": "$\\sqrt{ }$ nonspecific filling defects + distortion of bladder outline\n$\\sqrt{ }$ CHARACTERISTIC linear submucosal / intramural calcifications\n$D D x$ : schistosomiasis mansoni, TB, urothelial carcinoma, other neoplasm\n$\\sqrt{ }$ variable degrees of decreased contrast enhancement\n$\\sqrt{ }$ decreased SI in bladder wall on T2WI\n$D D x$ : desmoplastic metastasis + bladder wall lymphoma ( $\\downarrow$ T2-SI); urothelial carcinoma $(\\uparrow$ T2-SI)\n@ Renal involvement\nFrequency: $1^{\\circ}$ amyloidosis ( $35 \\%$ ),\n$2^{\\circ}$ amyloidosis (in $>80 \\%$ )\n\n- nephrotic-range proteinuria, renal insufficiency\n$\\sqrt{ }$ smooth normal to large kidneys with increase in parenchymal thickness (acute stage)\n$\\sqrt{ }$ small kidneys = cortical atrophy (in $50 \\%$ of late stage)\n$\\sqrt{ }$ occasionally attenuated collecting system\n$\\sqrt{ }$ nephrographic density normal to diminished\n$\\sqrt{ }$ amorphous renal calcifications\n$\\sqrt{ }$ focal renal parenchymal mass lesions\nUS:\n$\\sqrt{ }$ diffusely increased cortical echogenicity $\\leftarrow$ deposition of amyloid in glomeruli and interstitium\n$\\sqrt{ }$ obscuration of arcuate arteries\n$\\sqrt{ }$ preservation of corticomedullary differentiation\n$C x$ : renal vein thrombosis $\\rightarrow$ renal failure\n@ Renal pelvis (6\\%)\n$\\sqrt{ }$ calcification in submucosal deposit\n$\\sqrt{ }$ irregular filling defect on excretory urography\n$\\sqrt{ }$ hypointense amyloid deposit on T2WI (DDx: lymphoma, desmoplastic metastasis)\n$\\sqrt{ }$ variable to NO enhancement\n@ Ureter (25\\%)\nSite: distal ureter; rarely bilateral\n$\\sqrt{ }$ focal / diffuse areas of wall thickening + filling defects\n$\\sqrt{ }$ irregular ureteral narrowing + stricture $\\rightarrow$ hydronephrosis\n$\\sqrt{ }$ linear submucosal / intramural calcifications\n@ Urethra (rare)\n- hematuria, dysuria, urethral obstruction\n$\\sqrt{ }$ narrowing of urethra with filling defects\n$\\sqrt{ }$ foci of increased echogenicity + posterior shadowing within corpus spongiosum\n$\\sqrt{ }$ hypointense urethral + periurethral lesions on T2WI\n$D x$ : urethroscopy + transurethral biopsy\n$D D x$ : urethral neoplasm\n@ Seminal vesicles\n$=$ senile localized amyloidosis of seminal vesicles\nFrequency: in $21 \\%$ of men $>75$ years of age (autopsy)\nSite: symmetric involvement of both SV",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 68,
            "markdown": "$D D x:$ invasion of SV by prostate cancer\n$D x$ : transrectal biopsy\n@ Retroperitoneum\n$\\sqrt{ }$ diffuse infiltration encasing kidneys, aorta, IVC, pancreas\n$\\sqrt{ }$ replacement of retroperitoneal fat with soft-tissue\n$\\sqrt{ }$ focal retroperitoneal mass\nMR:\n$\\checkmark$ intermediate T1 signal intensity\n$\\checkmark$ decreased T2 signal intensity\n\n# ANALGESIC NEPHROPATHY \n\n$=$ renal damage from ingestion of salicylates in combination with phenacetin / acetaminophen in a cumulative dose of 1 kg\nPrevalence: USA (2-10\\%), Australia (20\\%)\nAge: middle-aged; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 4$\n\n- gross hematuria, hypertension\n- renal colic (passage of renal tissue)\n- renal insufficiency ( $2-10 \\%$ of all end-stage renal failures)\n- Analgesic syndrome: history of psychiatric therapy, abuse of alcohol + laxatives, headaches, pain in cervical + lumbar spine, peptic ulcer, anemia, splenomegaly, arteriosclerosis, premature aging\n$\\checkmark$ papillary necrosis\n$\\checkmark$ scarring of renal parenchyma (\"wavy outline\"); bilateral in $66 \\%$, unilateral in $5 \\%$\n$\\checkmark$ renal atrophy\n$\\checkmark$ papillary urothelial tumors in calices / pelvis (mostly TCC / squamous cell carcinoma), in 5\\% bilateral\n\n\n## ANGIOMYOLIPOMA\n\n$=\\mathrm{AML}=$ Renal choristoma ( $=$ benign tumor composed of tissues not normally occurring within the organ of origin)\nN.B.: normal cells / tissues in an abnormal location!\n[= Renal Hamartoma (improper name since fat and smooth muscle do normally occur within renal parenchyma]\n$=$ most common benign mesenchymal tumor of kidney composed of varying admixtures of thickwalled blood vessels, smooth muscle cells and mature fat ( $\\rightarrow$ hence name!)\nPrevalence: $\\quad 0.3-2.0 \\%$ of all renal tumors; $1 \\%$ of all surgically removed renal tumors\nGenetics: (a) sporadic ( $50-70 \\%$ )\n(b) inherited with tuberous sclerosis ( $30-50 \\%$ ), neurofibromatosis, vHL syndrome\n\nPath: large infiltrating necrotic tumor without true capsule, $88 \\%$ extending through renal capsule, hemorrhage (characteristic lack of complete elastic layer of vessels predisposes to aneurysm formation); tumor continues to grow during childhood + early adulthood\nHisto:\n(a) classic triphasic ( $92 \\%$ ): tumor composed of mature fat, aggregates of dysmorphic / thick-",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 69,
            "markdown": "walled blood vessels, epitheloid immature smooth muscle; coexpresses melanocytic markers (HMB-45, melan-A) and smooth muscle markers (smooth muscle actin, calponin), negative for epithelial markers\n(b) monophasic epitheloid ( $8 \\%$ ): high degree of association with tuberous sclerosis + aggressive behavior\nAverage age: 41 years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n\n- small lesions are asymptomatic $(60 \\%)$\n- acute flank / abdominal pain in $87 \\%$\n$\\diamond$ Angiomyolipomas $>4 \\mathrm{~cm}$ are symptomatic in $82-94 \\% \\leftarrow$ spontaneous bleeding in $50-60 \\%$ !\n- gross hematuria, anemia, hypertension\n- Wunderlich syndrome $=$ hemorrhagic shock $\\leftarrow$ massive bleeding into angiomyolipoma or into retroperitoneum $(10 \\%)$\nLocation: renal parenchyma; renal hilum; may be exophytic perirenal / completely extrarenal (retroperitoneum, solid + hollow organs, skin, gynecologic region)\nMean size: 9 cm (range, few mm to 30 cm ) in diameter\n$\\sqrt{ }$ hypervascular mass with large feeding arteries, multiple aneurysms, laking without shunting, tortuous circumferential vessels, whorled parenchymal + venous phase\nUS:\n$\\sqrt{ }$ homogeneously echogenic mass similar to sinus fat (DDx to renal cell carcinoma)\nCT:\n(a) ordinary AML (in 95\\%):\n$\\sqrt{ }$ negative attenuation values\n$\\diamond$ Even a small amount of fat within a solid mass on NECT secures the diagnosis!\n(b) minimal-fat AML (in 5\\%)\n$=$ angiomyolipoma with microscopic fat only mimicks RCC\n$\\sqrt{ }$ hyperattenuating (53\\%) / isoattenuating (26\\%) / hypoattenuating (21\\%) mass (DDx: RCC)\n$\\sqrt{ }$ homogeneous prolonged tumor enhancement\nMR:\n$\\sqrt{ }$ markedly hyperintense adipose tissue relative to renal parenchyma + isointense relative to fat on T1WI\n$\\sqrt{ }$ demonstration of fat on selective fat-suppression sequence\n$\\sqrt{ }$ prominent signal loss relative to other tissues on fat-suppressed / opposed-phase images with respect to in-phase images $\\leftarrow$ intravoxel coexistence of fat and water:\n$\\sqrt{ }$ characteristic India ink artifact at interface between mass and normal renal parenchyma on opposed-phase T1WI\n$\\sqrt{ }$ central portions of lesion do not demonstrate changes in signal intensity compared with in-phase images\n$\\sqrt{ }$ variable SI on T2WI:\n$\\sqrt{ }$ homogeneously high SI at single-shot T2WI with large fatty mass\n$\\sqrt{ }$ homogeneously low SI relative to renal parenchyma in lipid-poor angiomyolipomas on T2WI\n$\\sqrt{ }$ decreased signal intensity on Gd-enhanced images (DDx: RCC enhances)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 70,
            "markdown": "Cx: (1) Hemorrhage with spontaneous rupture $(25 \\%) \\leftarrow$ tumor $>4 \\mathrm{~cm} /$ intratumoral aneurysm $>5 \\mathrm{~mm}$\n(2) Growth into renal vein / IVC\n$\\diamond$ Not necessarily implying malignant transformation\n(3) Renal failure\n\nRx: (1) Annual follow-up of lesions $<4 \\mathrm{~cm}$\n(2) Semiannual follow-up of lesions $\\geq 4 \\mathrm{~cm}$\n(3) Emergency laparotomy (in 25\\%): nephrectomy, tumor resection\n(4) Selective arterial embolization with hemorrhage\n(5) Prophylactic surgery in pregnant women\n(6) Screening for tuberous sclerosis\n\nDDx: renal / perirenal lipoma or liposarcoma; Wilms tumor / renal cell carcinoma (occasionally contains fat if large, but also calcium); clear cell RCC with small amount of intracellular fat\n\nIsolated Angiomyolipoma (50-70\\%)\n= SPORADIC ANGIOMYOLIPOMA\nMean age: 43 (range, 27-72) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\n\n- flank pain, hematuria, palpable mass\n$\\sqrt{ }$ solitary + unilateral (in $80 \\%$ on R side) AML, NO stigmata of tuberous sclerosis\n$\\checkmark$ stable over long periods of time\nAngiomyolipoma Associated with TS (30-50\\%)\nMean age: 17 years; usually present by 10 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\n$\\diamond$ In $70-80-95 \\%$ of patients with tuberous sclerosis\n$\\diamond$ May be the only evidence of tuberous sclerosis\n$\\checkmark$ commonly large + bilateral + multifocal AMLs with macroscopic fat\n$\\checkmark$ tendency for growth + hemorrhage\n\n\n# ARTERIOVENOUS RENAL CONNECTION \n\n$\\sqrt{ }$ early enhancement of draining vein + renal vein + IVC\n$\\checkmark$ intraparenchymal / subcapsular / perirenal hematoma (as a result of bleeding)\nRx: transcatheter intraarterial occlusion, surgery\nArteriovenous Malformation (20-30\\%)\nCause: (1) Congenital AVM\n\n- asymptomatic; $\\mathrm{M}<\\mathrm{F}$\n(2) Acquired AVM: trauma, spontaneous rupture of aneurysm, very vascular malignant neoplasm\nHisto:\n(a) cirsoid AVM = multiple coiled vascular channels grouped in cluster\n(b) cavernous AVM = single well-defined artery feeding into a single vein (rare)\n- gross hematuria",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 71,
            "markdown": "Location: adjacent to collecting system\n$\\sqrt{ }$ large unifocal mass:\n$\\checkmark$ focally attenuated and displaced collecting system\n$\\checkmark$ homogeneously enhancing mass\n$\\checkmark$ curvilinear calcification\n$\\checkmark$ supplied by multiple segmental / interlobar arteries of normal caliber\n$\\checkmark$ draining into one / more veins\nUS:\n$\\checkmark$ tubular anechoic structure (DDx: hydronephrosis, hydrocalyx)\nCx: subcapsular / perinephric hematoma (rare)\n\n# Arteriovenous Fistula (70-80\\%) \n\n$\\mathrm{M}>\\mathrm{F}$\nCause: (1) Acquired: trauma (stab wound, percutaneous needle biopsy, percutaneous nephrostomy, nephrolithotripsy), surgery, tumor, inflammation, erosion of aneurysm into vein\n(2) Idiopathic\n\nPath: single dilated feeding artery + single draining vein\n\n- asymptomatic with abdominal bruit / abdominal pain\n- persistent / delayed gross hematuria (common)\n$\\checkmark$ tortuous varices over time\n$\\checkmark$ enlargement of renal vein\nUS:\n$\\checkmark$ focal area of aliasing / color saturation $\\leftarrow$ high flow rate + vessel tortuosity\n$\\checkmark \\quad \\square$ flow velocity $+\\Downarrow$ resistance in feeding artery\n$\\checkmark$ arterial pulsations in draining vein\nAngio:\n$\\checkmark$ detailed vascular anatomy for planning embolic occlusion\n$\\checkmark$ diminished nephrogram $\\pm$ cortical atrophy distal to fistula $\\leftarrow$ reduced flow to renal segment\nCx: (1) Cardiomegaly + high-output cardiac failure (50\\%)\n(2) Renin-mediated hypertension\n(3) Hydronephrosis\n\nPrognosis: spontaneous closure within a few months\n\n## BENIGN PROSTATIC HYPERTROPHY\n\n$=$ BENIGN PROSTATIC HYPERPLASIA\nPrevalence: $50 \\%$ between ages $51+60$ years; $75-80 \\%$ of all men $>80$ years of age\nHisto: fibromyoadenomatous nodule (most common), muscular + fibromuscular + fibroadenomatous + stromal nodules\nAge: initial growth onset $<30$ years of age; onset of clinical symptoms at $60 \\pm 9$ years\n\n- sensation of full bladder, nocturia, trouble initiating micturition\n- decreased urine caliber + force",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 72,
            "markdown": "- dribbling at termination of micturition\n\nLocation: transition + periurethral zone proximal to verumontanum forming \"lateral lobes\" $(82 \\%)$, \"median lobe\" $(12 \\%)$\n$\\sqrt{ }$ oval $(61 \\%) /$ round $(22 \\%) /$ pear-shaped $(17 \\%)$ enlargement of central gland\n$\\sqrt{ }$ posterior + lateral displacement of outer gland (= prostate proper) creating cleavage plane of fibrous tissue between hyperplastic tissue + compressed prostatic tissue (= surgical capsule) often demarcated by displaced intraductal calcifications\n$C x$ : bladder outflow obstruction\nRx: (1) Surgery: open prostatectomy (glands $>80 \\mathrm{~g}$ ), trans-urethral resection of prostate $=$ TURP (glands $<80 \\mathrm{~g}$ )\n$\\diamond$ Only $4-5 \\%$ of patients need surgical treatment!\n(2) Drugs: $\\alpha$-blockers (for stromal hyperplasia); androgen deprivation (suppression of LHRH / inhibition of Leydig cell synthesis of testosterone / competition for androgen receptor binding sites) $+\\alpha$-blockers (for glandular hyperplasia)\n\n# Prostatic Retention Cyst \n\n$=$ dilatation of glandular acini in BPH\nCause: acquired obstruction of glandular ductule\nAge: $\\quad 5^{\\text {th }}-6^{\\text {th }}$ decade\nLocation: transition / central / peripheral zone\n$\\sqrt{ } 1-2-\\mathrm{cm}$ smooth-walled unilocular cyst\n\n## Cystic Degeneration of BPH\n\n$\\diamond$ Most common cystic lesion of prostate!\nLocation: transition zone\n$\\sqrt{ }$ usually small cyst within nodules of benign prostatic hyperplasia\n\n## BLADDER CANCER\n\nPrevalence: 76,960 new cases annually $+16,390$ deaths (2016) $4^{\\text {th }}$ (10th) most common cancer in males (females); $5 \\%$ of all new malignant neoplasms; most common tumor of genitourinary tract\nHisto: (a) urothelial: transitional cell carcinoma ( $90 \\%$ )\n(b) squamous cell carcinoma $(6-8 \\%)$\n(c) adenocarcinoma (rare): resembling serous papillary cancer of ovary\n(d) mixed histology: small cell neuroendocrine, micropapillary, sarcomatoid, plasmacytoid\nAge: $\\quad 3.1 \\%[8 \\%]$ in patients $<44$ [45-54] years; usually in patients $>65$ years; twice as frequent $>80$ years; $\\mathrm{M} \\div \\mathrm{F}=3-5 \\div 1$\nT-Staging: primary question \"Is there muscle invasion (T2)?\"\n$N$-Staging: obturator node (most common), nodes above aortic bifurcation (17\\%), presacral adenopathy ( $8 \\%$ ); accuracy of CT $(70-90 \\%)>$ MR $(64-92 \\%)$\nStaging accuracy: $50 \\%$ clinically; $32-80 \\%$ for CT; $72-96 \\%$ for MR\nOverstaging due to: edema following endoscopy / endoscopic resection, fibrosis from radiation therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 73,
            "markdown": "- painless gross hematuria / microhematuria (80-90\\%)\n- frequency, dysuria, pelvic pain / pressure\n\nPresentation:\n(1) Superficial papillary lesion (70\\%): papilloma, inverted papilloma, papillary urothelial neoplasm of low malignant potential (PUNLMP), low-grade and high-grade papillary urothelial carcinoma; in $20 \\%$ progressing to invasive cancer\n(2) Aggressive invasive de novo tumor (20\\%)\n(3) Metastatic tumor (10\\%)\n\nLocation: bladder base ( $80 \\%$ ); lateral wall of bladder, bladder diverticulum (in $0.8-10.8 \\%$ ); single (in $60 \\%$ )\n\n| Staging of Bladder Cancer |  |  |\n| :--: | :--: | :--: |\n| Jewett- <br> Strong | TNM | Histopathologic Findings |\n| $O$ | T0 | no primary tumor |\n|  | Ta | papillary tumor confined to mucosa $=$ noninvasive |\n|  | Tis | carcinoma in situ |\n| A | T1 | invasion of lamina propria |\n| $B$ | T2 | invasion of muscle |\n| $B 1$ | T2a | of inner half of muscle |\n| $B 2$ | T2b | of outer half of muscle |\n| C | T3 | of perivesical fat |\n|  | T3a | microscopic |\n|  | T3b | macroscopic |\n| $D$ | T4 | invasion of surrounding organs |\n| $D 1$ | T4a | seminal vesicles, prostate, vagina, rectum |\n|  | T4b | pelvic / abdominal wall |\n|  | N1 | metastasis to single node $\\leq 2 \\mathrm{~cm}$ |\n|  | N2 | metastasis to single node of $2-5 \\mathrm{~cm} / \\mathrm{in}$ multiple nodes $\\leq 5 \\mathrm{~cm}$ |\n|  | N3 | metastasis to single node $>5 \\mathrm{~cm}$ |\n| $D 2$ | N4 | lymph node metastasis above bifurcation of common iliac arteries |\n|  | M1 | distant metastasis (lung, liver, bone) |\n\nSize: $<2.5 \\mathrm{~cm}(\\text { in }>50 \\%)$\n$\\sqrt{ }$ intraluminal papillary / nodular mass\n$\\sqrt{ }$ focal / diffuse wall thickening\n$\\sqrt{ }$ ureteral obstruction $\\leftarrow$ muscle invasion\nIVP ( $70 \\%$ accuracy rate):\n$\\sqrt{ }$ irregular filling defect with broad base and fronds (DDx: rectal gas marginated by Simpson's white line)\n$\\sqrt{ }<1 \\%$ calcified\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 74,
            "markdown": "$\\checkmark$ papillary hypoechoic mass protruding into lumen\n$\\checkmark$ vascularity on Doppler imaging\nCT urography ( $90 \\%$ sensitive + specific):\n$\\diamond$ Cystoscopy always required to detect small flat lesions!\n$\\diamond$ Delay CT for $>7$ days after instrumentation!\n$\\checkmark$ nodular / arched tumoral calcifications ( $<5 \\%$ ) typically encrusting the surface\n$\\checkmark$ early tumor enhancement\n$\\checkmark$ increased attenuation of perivesical fat with invasion\nMR (staging modality of choice, $52-93 \\%$ accuracy):\n$\\checkmark$ tumor isointense to bladder muscle on T1WI + hyperintense on T2WI\n$\\checkmark$ T1WI optimal to detect invasion of perivesical fat + metastases to lymph nodes + bone\n$\\checkmark$ T2WI optimal to differentiate tumor from fibrosis and to evaluate tumor depth (SI differences between inner + outer layers of muscularis propria)\n$\\checkmark$ enhancement differentiates between early enhancing mucosa, submucosa, tumor, nonenhancing muscle, edema + fibrosis\nPrognosis: $40-70 \\%$ recurrence rate\n\n# Transitional Cell Carcinoma of Bladder \n\nClassification:\n(a) noninvasive / superficial flat / papillary (80-85\\%)\n(b) muscle-invasive / nonpapillary (20-25\\%)\n$\\diamond$ Synchronous upper tract TCC in $2 \\%$\n$\\diamond$ Metachronous upper tract TCC in $6 \\%$\nMetachronous bladder TCC:\n$>$ in $23-40 \\%$ of primary renal TCC after $15-48$ months\n$>$ in $20-50 \\%$ of primary ureteral TCC after $10-24$ months\n$>$ in $4 \\%$ of bladder primaries up to 20 years later ( $2 / 3$ within 2 years)\nSynchronous bladder TCC:\n$>$ in $24 \\%$ of primary renal pelvic involvement\n$>$ in $39 \\%$ of primary ureteral involvement\n$>$ in $2 \\%$ of primary bladder involvement\nPrognosis: overall $82 \\%$ 5-year survival rate; after cystectomy $55-80 \\% 5$-year survival with tumor confined to lamina propria, $40 \\%$ with invasion of muscularis propria, $20 \\%$ with invasion of perivesical fat, $6 \\%$ for metastatic cancer\n$R x$ : cystoscopic resection, intravesical mitomycin C , radical cystectomy with urinary diversion\n\n## Noninvasive / Superficial / Papillary TCC (80-85\\%)\n\nGrade: low-grade lesion, usually multifocal\nOrigin: hyperplastic epithelium\nPrognosis: good; $50 \\%$ rate of recurrence; evolve into muscle-invasive cancer if untreated\nGenetics: activate mutation of HRAS gene and fibroblast growth factor\nMuscle-invasive / Nonpapillary TCC (20-25\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 75,
            "markdown": "Grade: higher histologic grade\nOrigin: severe dysplasia / carcinoma in situ\nGenetics: structural + functional defects in p53 and retinoblastoma tumor suppressor pathways\n\n# Squamous Cell Carcinoma of Urinary Bladder \n\nRisk factors: long-term catheterization, nonfunctioning bladder, urinary tract calculi, bladder diverticulum ( $2-10 \\%$ risk), chronic infection by Schistosoma hematobium\nPrognosis: worse than urothelial cancer\n\n## BLADDER DIVERTICULUM\n\n$=$ cavity formed by herniation of bladder mucosa through muscular wall, joined to bladder cavity by constricted neck\nPrevalence: $1.7 \\%$ in children\nAverage age: 57 years; $\\mathrm{M}+\\mathrm{F}=9 \\div 1$\nSite: areas of congenital weakness of muscular wall at\n(a) urethral meatus\n(b) posterolateral wall (Hutch diverticulum = paraureteral)\n$\\sqrt{ }$ hypoechoic fluid-filled structure continuous with bladder wall\n$\\sqrt{ }$ may appear complex $\\leftarrow$ thickened wall / debris / soft-tissue component\n$\\sqrt{ }$ may contain calculi\nCx: (1) Bladder cancer in $0.8-10 \\% \\leftarrow$ urinary stasis $\\leftarrow$ chronic mucosal irritation $\\leftarrow$ prolonged exposure to urinary carcinogens (average age of 66 years)\n(2) Ureteral obstruction\n(3) Ureteral reflux\n\nDDx: pelvic cyst\n\n## Primary Diverticulum (40\\%)\n\n$=$ CONGENITAL / IDIOPATHIC DIVERTICULUM\n$\\sqrt{ }$ in $3 \\%$ single diverticulum\n(a) WITH vesicoureteral reflux\n\n1. Hutch diverticulum in paraureteral region\n(b) WITHOUT vesicoureteral reflux\n\n## Secondary Diverticulum (60\\%)\n\n$\\sqrt{ }$ in $50 \\%$ multiple diverticula\n(a) postoperative state\n(b) associated with bladder outlet obstruction\n\n1. Posterior urethral valves\n2. Urethral stricture\n3. Large ureterocele\n4. Neurogenic dysfunction\n5. Enlarged prostate\n6. Bladder neck stenosis\n(c) associated with congenital syndromes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 76,
            "markdown": "1. Prune belly syndrome\n2. Menkes kinky-hair syndrome\n3. Williams syndrome\n4. Ehlers-Danlos type 9 syndrome\n5. Diamond-Blackfan syndrome\n\n# Multiple Diverticula in Children \n\n1. Neurogenic dysfunction\n2. Posterior urethral valves\n3. Prune belly syndrome\n\n## BLADDER EXSTROPHY\n\n$=$ EPISPADIA-EXSTROPHY COMPLEX\n$=$ failure of lower abdominal wall + anterior bladder wall to close normally\nPrevalence: $1 \\div 30,000$ to $1 \\div 40,000$ live births; $\\mathrm{M}>\\mathrm{F}$\nEtiology: incomplete retraction of cloacal membrane prevents normal midline migration of mesoderm $\\rightarrow$ resulting in incomplete midline closure of infraumbilical abdominal wall; size of persistent cloacal membrane at time of rupture accounts for different degrees of severity\n\n- urinary bladder exposed + open anteriorly\n- mucosa everted through abdominal wall defect\n- bladder margins continuous with margins of abdominal wall\n- epispadia + short / split penis (male); bifid clitoris (female)\n- maldescended testes\n\nMay be associated with:\nwide linea alba, omphalocele, limb defects (eg, club feet), renal malformation (horseshoe kidney, renal agenesis), incomplete testicular descent, GI obstruction, bilateral inguinal hernias, imperforate anus, cardiac anomalies, hydrocephalus, meningomyelocele male: epispadia, short or split penis (common);\nfemale: bifid clitoris, uterine and vaginal anomalies\n$\\sqrt{ }$ persistently \"absent\" urinary bladder (HALLMARK) $\\rightarrow$ urine is released immediately into amniotic cavity through opening between bladder and abdominal wall.\n$\\sqrt{ }$ irregular thickening of everted posterior bladder wall $\\leftarrow$ inflammation of exposed mucosa\n$\\sqrt{ }$ ventral defect of infraumbilical abdominal wall\n$\\sqrt{ }$ low position of umbilicus\n$\\sqrt{ }$ pubic diastasis $=$ widening of pubic symphysis\n$D D x$ : cloacal exstrophy (NO extruded bowel loops, abnormal rectum)\n$C x$ : urinary incontinence, infertility, pyelonephritis, bladder carcinoma (4\\%)\n$R x$ : primary closure, bladder excision with urinary diversion\n\n## Closed Exstrophy = Pseudoexstrophy\n\n$=$ persistent large cloacal membrane without rupture\n\n- anterior wall of bladder covered by thin bilaminar epithelial membrane\n$\\sqrt{ }$ infraumbilical musculoskeletal defect",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 77,
            "markdown": "$\\sqrt{ }$ subcutaneous position of bladder\n\n# CHOLESTEATOMA \n\n$=$ KERATIN BALL\n$=$ keratinized squamous epithelium shed into lumen\nPathogenesis: long-standing urinary infection may result in squamous metaplasia of transitional epithelium\n\n- history of UTIs; repeated episodes of renal colic with passage of \"white tissue flakes\"\n\nLocation: renal pelvis $>$ upper ureter\n$\\sqrt{ }$ mottled / stringy \"onion-skin\" filling defect in calices / renal pelvis\n$\\sqrt{ }$ dilatation of pelvicaliceal system (with obstruction)\n$\\sqrt{ }$ calcification of keratinized material possible\n$\\diamond$ Not a premalignant condition!\n\n## CHRONIC GLOMERULONEPHRITIS\n\nCause: acute poststreptococcal glomerulonephritis\n\n- late presentation without prior clinically apparent acute phase\n- hypertension, renal failure\n$\\checkmark$ small smooth kidneys with wasted parenchyma\n$\\checkmark$ normal papillae + calices\n$\\checkmark$ patchy nephrogram with diminished density of contrast medium\n$\\checkmark$ cortical calcification (uncommon)\nUS:\n$\\checkmark$ increased echogenicity\n$\\checkmark$ small kidneys with vicarious sinus lipomatosis\nAngio:\n$\\checkmark$ marked reduction in renal blood flow\n$\\checkmark$ reflux of contrast material into aorta\n$\\checkmark$ severely pruned + tortuous interlobar and arcuate arteries\n$\\checkmark$ nonvisualization of interlobular arteries\n$\\checkmark$ delayed contrast clearance from interlobar arteries\n\n\n## CLEAR CELL SARCOMA OF KIDNEY\n\n$=$ BONE-METASTASIZING RENAL TUMOR OF CHILDHOOD\n$=$ rare highly malignant mesenchymal renal neoplasm of childhood with propensity for bone metastasis (rare for Wilms)\nIncidence: 20 cases annually in USA; 4-5\\% of primary renal neoplasms in childhood; $2^{\\text {nd }}$ most common renal malignancy after Wilms\nMean age: 3 (range, 1-6) years; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$\nPath: always unilateral unicentric soft well-circumscribed mass replacing most of the kidney / centered in renal medulla; hemorrhage + necrosis (in 70\\%); hilar lymphovascular infiltration ( $30 \\%$ ); extension into renal vein (5\\%)\nHisto: composed of well-defined polygonal to stellate cells with vacuolization, ovoid to rounded nuclei, prominent capillary pattern + tendency toward cyst formation separated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 78,
            "markdown": "by slightly thickened septa\n\n- increasing abdominal girth + palpable abdominal mass\n- lethargy, weight loss, hematuria, bone pain (infrequent)\n$\\sqrt{ }$ expansile well-demarcated mass $(8-16 \\mathrm{~cm})$ with dominant soft-tissue component\n$\\sqrt{ }$ cystic component of varying size (few mm to 5 cm ) + multiplicity (58\\%)\n$\\sqrt{ }$ amorphous / linear calcifications (25\\%)\n$\\sqrt{ }$ renal mass crossing midline (58\\%)\n$\\sqrt{ }$ NO intravascular extension\n$\\sqrt{ }$ lytic / sclerotic / mixed metastatic bone lesions\nMetastases to: lymph nodes (30\\%), bone (13-20\\%), lung, brain, liver; in 5-18\\% metastatic at presentation\nUS:\n$\\sqrt{ }$ inhomogeneous renal mass of soft-tissue density\n$\\sqrt{ }$ well-defined hypoechoic central area (= necrosis)\n$\\sqrt{ }$ mass with fluid-filled anechoic cystic spaces\n$\\sqrt{ }$ large fluid-filled spaces + echogenic septa may predominate\nCT:\n$\\sqrt{ }$ heterogeneous enhancement less than that of normal renal parenchyma\n$\\sqrt{ }$ low-attenuation areas $\\leftarrow$ hemorrhage / necrosis\n$\\sqrt{ }$ water-density areas $\\leftarrow$ cysts\nMR:\n$\\sqrt{ }$ low to intermediate signal intensity on T1WI\n$\\sqrt{ }$ high signal intensity on T2WI\nNUC:\n$\\sqrt{ }$ bone scan recommended after diagnosis is established\nPrognosis: 60-70\\% long-term survival rate; aggressive behavior (worse than Wilms tumor) with higher rate of relapse + mortality\n$D D x$ : cystic form of Wilms tumor (vascular invasion), multilocular cystic nephroma, cystic dysplasia\n\n\n# CONDYLOMA ACUMINATA \n\n$=$ VENEREAL WART $=$ PENILE SQUAMOUS PAPILLOMA\nCause: viral infection\nHisto: squamous papilloma\n@ Skin\n\n- soft sessile verucca of penile glans / shaft / prepuce\n@ Urethra\nPrevalence: $0.5-5 \\%$ of male patients with cutaneous disease\nN.B.: retrograde urethrography NOT recommended as it may cause retrograde seeding!\n\nVoiding cystourethrography:\n$\\sqrt{ }$ multiple papillary filling defects in anterior urethra\n$\\sqrt{ } \\pm$ extension into bladder (rare)\n$R x$ : instillation of podophyllin, thiotepa, 5-fluorouracil into urethra",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 79,
            "markdown": "# CONGENITAL RENAL HYPOPLASIA \n\n$=$ miniaturization with reduction in number of renal lobes, number of calices and papillae, amount of nephrons\n$(+$ smallness of cells)\nVARIANT: Ask-Upmark kidney = aglomerular focal hypoplasia\n$\\sqrt{ }$ unilateral small kidney\n$\\sqrt{ }$ decreased number of papillae + calices (5 or less)\n$\\sqrt{ }$ hypertrophied contralateral kidney\n$\\sqrt{ }$ absent renal artery\n$\\sqrt{ }$ hypoplastic disorganized renal veins\n\n## CONN SYNDROME\n\n$=$ PRIMARY HYPERALDOSTERONISM $=$ PRIMARY ALDOSTERONISM\n$=$ autonomous excess secretion of the mineralocorticoid aldosterone with hypertension + spontaneous hypokalemia\nPrevalence: $2-15 \\%$ of hypertensive population\nAge: $3^{\\text {rd }}-5^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$\nCause of aldosteronism:\n(a) responsive to corticotropin\n> aldosterone-producing adenoma\n> primary adrenal hyperplasia\n(b) responsive to renin-angiotensin system\n> aldosterone-producing renin-responsive adenoma\n> bilateral adrenal glomerulosa hyperplasia\n> familial form of aldosteronism\n\n- hypertension $\\leftarrow$ hypernatremia\n- hypokalemia ( $80-90 \\%$, induced by administering large amounts of sodium chloride for 3-5 days):\n- muscle weakness, cardiac arrhythmia\n- carbohydrate intolerance, nephrogenic diabetes insipidus\n- depletion of magnesium, metabolic alkalosis\n- increased urinary excretion of aldosterone + metabolites\n- plasma aldosterone-to-renin ratio (test of choice):\n- nonsuppressible elevation in plasma aldosterone concentration\n- suppressed plasma renin levels\n\nPath:\n(a) bilateral idiopathic adrenal hyperplasia ( $60 \\%$ ):\n= idiopathic hyperaldosteronism = focal / diffuse hyperplasia of glomerulosa zone accompanied by micro- / macroscopic nodules\n(b) adrenocortical adenoma (40\\%): solitary aldosteronoma (65-70\\%); multiple (13\\%); microadenomatosis (6\\%)\n(c) adrenocortical carcinoma $(<1 \\%)$\n\nAverage size: 1.7 (range, $0.5-3.5$ ) cm\nLocation: $\\mathrm{L}>\\mathrm{R}$; bilateral in $6 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 80,
            "markdown": "Adrenal venography : $76 \\%$ accurate\nAdrenal venous blood sampling : $95 \\%$ accurate, $75 \\%$ sensitive\nCT ( $60-80 \\%$ sensitive):\n$\\sqrt{ }$ mass of soft-tissue density / low attenuation\n$\\diamond$ Among hyperfunctioning adrenal adenomas aldosteronomas have the lowest attenuation!\n$\\checkmark$ usually hypervascular, rarely hypovascular\n$\\checkmark$ both glands normal in size $\\leftarrow$ micronodules\n$\\checkmark$ nodular / multinodular adrenal gland(s) $\\leftarrow$ hyperplasia\nNUC:\n$\\sqrt{ }^{131}$ I NP-59 uptake following dexamethasone suppression:\n$\\checkmark$ bilateral early visualization ( $<5$ days) implies adrenal hyperplasia\n$\\checkmark$ unilateral early visualization implies adenoma\n$\\checkmark$ late bilateral visualization ( $>5$ days) may be normal\n$D x$ : elevated plasma aldosterone concentration + suppressed plasma renin activity Diagnostic endocrine tests: postural stimulation test, short saline infusion test, 18-hydroxycorticosterone concentration\nCave:\n$\\diamond$ Adenoma in one gland + nonhyperfunctioning adenoma in other gland can suggest bilateral adrenal hyperplasia\n$\\diamond$ Dominant macronodule of one gland in bilateral adrenal hyperplasia can simulate adenoma\nSolution: Adrenal venous blood sampling to determine appropriate therapy\n$R x$ : adrenalectomy for neoplasms ( $75 \\%$ long-term cure rate for hypertension); medical treatment for hyperplasia\n\n# CONTRAST NEPHROPATHY \n\n$=$ CONTRAST-INDUCED RENAL FAILURE\n$=$ increase in serum creatinine of $\\geq 1 \\mathrm{mg} / \\mathrm{dL} \\pm 25-50 \\%$ of baseline creatinine level after intravascular contrast administration\nPatients at risk:\n\n1. Preexisting renal insufficiency\n2. Insulin-dependent diabetes mellitus\n3. Large volume of contrast media\n4. Concomitant administration of other nephrotoxic drugs: aminoglycosides, nonsteroidal anti-inflammatory agents\n5. American Heart Association class IV congestive heart failure\n6. Hyperuricemia\n\n| Contrast Medium-induced Risk of Nephropathy |  |\n| :--: | :--: |\n| Test | Threshold |\n| Serum creatinine level | $>1.6 \\mathrm{mg} / \\mathrm{dL}$ |\n| Estimated glomerular filtration rate* | $<45 \\mathrm{~mL} / \\mathrm{min}$ |\n| * Online Calculator using age, race, gender, body weight and plasma creatinine: http://www.medcalc.com/gfr.html; http://www.mcw.edu/calculators/creatinine.htm |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 81,
            "markdown": "$\\diamond$ A serum creatinine level of $>4.5 \\mathrm{mg} / \\mathrm{dL}$ causes acute renal failure in $60 \\%$ of nondiabetics + $100 \\%$ of diabetics!\n$\\diamond$ IV LOCM is an independent risk factor for acute kidney injury post CECT for a serum creatinine $\\geq 1.6 \\mathrm{mg} / \\mathrm{dL}$\nPreviously considered but no longer accepted risk factors:\ndehydration, hypertension, proteinuria, peripheral vascular disease, age $>65$ years, multiple myeloma\n$\\diamond$ IV LOCM is NOT a risk factor for acute kidney injury post CECT with a stable serum creatinine $<1.5 \\mathrm{mg} / \\mathrm{dL}$\nMechanism:\nincrease in renal perfusion by vasodilatation (via prostaglandin $\\mathrm{I} 2 \\pm \\mathrm{E} 2$ ) $\\rightarrow$ followed by vasoconstriction (via angiotensin II, norepinephrine, vasopressin)\nTime course:\n(a) rise in serum creatinine within $1-2$ days\n(b) peak at $4-7$ days\n(c) return to normal by $10-14$ days\n$\\checkmark$ persistent nephrogram on plain film\n$\\checkmark$ cortical attenuation $>140 \\mathrm{HU}$ on CT after 24-hour delay\nRecommendation:\n$\\diamond$ Employ nonionic contrast media (LOCM appears safe in patients without renal dysfunction / underlying risk factors in doses as large as 800 mL [ 300 mg iodine per mL$]$ )\n$\\diamond$ Do NOT exceed maximum allowed dose (Cigarroa formula for HOCM): 5 mL x body weight $(\\mathrm{kg})$\nContrast limit (mL) $60 \\%$ by weight $=$ serum creatinine $(\\mathrm{mg} / 100 \\mathrm{~mL})$\n\n# CUSHING SYNDROME \n\n$=$ HYPERCORTISOLISM\n$=$ excessive glucocorticoid from either exogenous / endogenous sources\nEtiology:\nA. ACTH-(PITUITARY)-DEPENDENT (70\\%)\n$=$ overproduction of corticotropin\n\n1. Cushing disease ( $68-90 \\%$ of endogenous causes)\n$=$ overproduction of pituitary $\\mathrm{ACTH} \\rightarrow$ non-autonomous adrenal hyperplasia\nCause:\n(a) basophilic / chromophobe adenoma\n(b) overactive pituitary\n(c) ACTH-producing primary elsewhere\n$\\checkmark$ normal adrenal glands\n$\\checkmark$ diffuse adrenal enlargement\n$\\checkmark$ macronodular adrenal hyperplasia (in up to $85 \\%$ )\n$\\diamond$ Micronodular hyperplasia is NOT seen on imaging\n2. Paraneoplastic ectopic ACTH production (12-20\\%): bronchial / thymic carcinoid $>$ pheochromocytoma, pancreatic islet cell tumor ( $10 \\%$ ), oat cell carcinoma of lung ( $8 \\%$ ), liver cancer, prostate cancer, ovarian cancer, breast cancer, bronchial adenoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 82,
            "markdown": "medullary carcinoma of thyroid, thymoma\n$\\diamond$ Bronchial + thymic carcinoids are often $<1 \\mathrm{~cm}$ at the time they produce Cushing syndrome!\n$\\diamond$ Islet cell tumors are large + often metastatic by the time they produce Cushing syndrome!\nRecommendation: thin-section CT of chest\n3. Exogenous ACTH\n4. Hypothalamic dysfunction\n5. Production of corticotropin-releasing factor (rare)\nB. ACTH-(PITUITARY)-INDEPENDENT (30\\%)\n(a) primary adrenal abnormality ( $18 \\%$ ):\n$=$ autonomous cortisol production by adrenal gland\n\n1. Adrenocortical adenoma\n( $10-20 \\%$ of cases; $10 \\%$ in adults, $15 \\%$ in children)\n$\\checkmark$ often $>2 \\mathrm{~cm}$ in size\n$\\rightarrow$ readily visualized by CT / MRI\n$\\checkmark$ atrophy of remaining adrenal tissue $\\leftarrow$ adenoma suppresses ACTH levels\n$\\diamond$ A hyperfunctioning adenoma does NOT always cause atrophy of the adrenal glands, but normal / thickened adrenal limbs should raise concern for ACTHdependency!\n2. Adrenocortical carcinoma\n( $5-10 \\%$ of cases; $10 \\%$ in adults, $66 \\%$ in children)\n3. Ectopic ACTH production / ectopic corticotropic-releasing factor (CRF) secretion\n4. Primary pigmented nodular adrenocortical ( $<1 \\%$ )hyperplasia (rare; in children + young adults)\n$\\checkmark$ multiple small bilateral nodules / normal adrenal\n5. Massive macronodular hyperplasia with marked adrenal enlargement ( $<1 \\%$ )\n$\\checkmark$ multiple bilateral macronodules\n(b) exogenous cortisol ( $12 \\%$ )\n\nPrevalence: $1 \\div 1,000$ autopsies; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 4$\nAge: 30-40 years (highest incidence); more often following pregnancy\n\n- central / truncal obesity, buffalo hump, moon face, facial plethora\n- purple abdominal striae, acne, hirsutism, amenorrhea\n- fatigue, mood changes, proximal muscle weakness\n- hypertension, atherosclerosis, edema\n- impaired glucose tolerance = glycosuria / diabetes\n- elevated plasma cortisol levels\n- hypokalemia $\\leftarrow$ excess cortisol binding $\\mathrm{Na}+/ \\mathrm{K}+$ pump acting like aldosterone\n- excessive excretion of urinary 17-hydroxy-corticosteroids\n- elevated peripheral ACTH level\n- dexamethasone suppression test / metyrapone test\n$\\checkmark$ retarded bone maturation\n$\\checkmark$ most often axial osteoporosis\n$\\checkmark$ stippled calvarium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 83,
            "markdown": "$\\sqrt{ }$ demineralized dorsum sellae\n$\\sqrt{ }$ excess callus formation\nCx: (1) Pathologic fractures of vertebrae + ribs with excessive callus formation\n(2) Aseptic necrosis of hips\n(3) Bone infarcts\n(4) Delayed skeletal maturation in children\n\nDDx of Cushing syndrome:\n(a) focal unilateral adrenal mass\n$\\sqrt{ } 2-4-\\mathrm{cm}$ focal mass in one adrenal gland + atrophy of contralateral gland $=$ adrenal adenoma\n$\\sqrt{ }>4-\\mathrm{cm}$ large focal mass with central necrosis in one adrenal gland + atrophy of contralateral gland $=$ adrenal adenocarcinoma\n(b) bilateral adrenal enlargement\n$\\sqrt{ }$ diffuse uniform thickening $=$ Cushing disease\n(c) Multiple bilateral adrenal nodules\n$\\sqrt{ }$ macronodules $=$ multinodular hyperplasia of long-standing Cushing disease\n$\\sqrt{ }$ large nodules (autonomous ACTH-independent) $=$ massive macronodular hyperplasia\n$\\sqrt{ }$ small nodules $=$ primary pigmented nodular adrenocortical disease\n\n# CYSTITIS \n\n$=$ bacterial infection; $\\mathrm{M}<\\mathrm{F}$\n\n- frequency, dysuria, hematuria, reduced bladder capacity\n$\\sqrt{ }$ cystogram insensitive\nUS:\n$\\sqrt{ }$ focal / multifocal / circumferential isoechoic bladder wall thickening\n$\\sqrt{ }$ decrease in bladder wall thickening during bladder distension (eg, instillation of sterile saline via a urethral catheter)\n$\\sqrt{ }$ bullous lesions\n$\\sqrt{ }$ intact mucosa\n$D D x$ : bladder neoplasm, ureterocele, pseudoureterocele, neurofibromatosis, pseudosarcomatous myofibroblastic proliferations\n\n\n## Cystitis Cystica\n\n$=$ CYSTITIS FOLLICULARIS $=$ CYSTITIS GLANDULARIS $=$ BULLOUS CYSTITIS\n$=$ nonspecific chronic reactive inflammatory process of bladder wall\nAge: any; $\\mathrm{M}>\\mathrm{F}$\nHisto: metaplasia of urothelium $\\rightarrow$ proliferation into buds (nests of von Brunn) $\\rightarrow$ growth into lamina propria $\\rightarrow$ differentiation into cystic deposits (cystitis cystica) or intestinal columnar mucin-secreting glands formed of goblets cells (cystitis glandularis)\n\n- frequency, dysuria, urgency, hematuria\n- cystoscopy: cobblestone mucosa; papillary / polypoid mass\n$\\sqrt{ }$ multiple small round cystlike mucosal elevations\n$\\sqrt{ }$ filling defects\n$\\sqrt{ }$ intact muscle layer",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 84,
            "markdown": "May be associated with: pelvic lipomatosis $\\rightarrow$ bladder obstruction and chronic infection\nPrognosis: potentially malignant in adults\n\n# Emphysematous Cystitis \n\n$=$ uncommon complication of urinary tract infection by gas-forming organism almost\nPATHOGNOMONIC of poorly controlled diabetes (= bacterial fermentation of glucose)\nAge: $\\quad>50$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\nPredisposed: diabetes mellitus, neurogenic bladder, bladder outlet obstruction, chronic UTI\nOrganism: E. coli, E. aerogenes, P. mirabilis, S. aureus, streptococci, Clostridium perfringens, Nocardia, Candida\nMay be associated with: emphysematous pyelitis / pyelonephritis\n\n- pneumaturia (rare)\n\nPlain film:\n$\\sqrt{ }$ translucent streaky irregular area / ring of air bubbles in bladder wall\n$\\sqrt{ }$ intraluminal air-fluid level\nUS:\n$\\sqrt{ }$ shadowing echogenic foci within area of bladder wall thickening\nCT (most specific modality)\n$D D x$ : (a) Gas within bladder:\ntrauma, urinary tract instrumentation, enterovesical fistula\n(b) Gas external to bladder:\nrectal gas, emphysematous vaginitis, pneumatosis cystoides intestinalis, gas gangrene of uterus\n\n## Eosinophilic Cystitis\n\n$=$ rare chronic inflammatory disease\nPrevalence: 83 adult cases in literature\nMean age: 42-48 years; $\\mathrm{M} \\div \\mathrm{F}=1.3 \\div 1.0$\nCause: idiopathic (29\\%); atopy; after bladder surgery; adverse reaction to drugs + food; parasitic / nonparasitic urinary tract infections; autoimmune disorder; eosinophilic enteritis\nHisto: transmural infiltrate of eosinophils with variable degree of fibrosis + muscle necrosis of detrusor\n\n- hematuria, frequency, dysuria, pain\n- peripheral eosinophilia ( $0-43 \\%$ )\n$\\sqrt{ }$ single / multiple bladder masses $\\pm$ cystic component\n$\\sqrt{ }$ normal / thickened bladder wall\n$\\sqrt{ }$ small contracted bladder (in fibrotic stage)\n$\\sqrt{ }$ isointense mass relative to muscle on T2WI\n$\\sqrt{ }$ hyperintense mass relative to muscle on T1WI with enhancement\nPrognosis: usually benign self-limiting course, if cause removed\n\n\n## Granulomatous Cystitis = Tuberculous Cystitis\n\n$\\sqrt{ }$ irritable hypertonic bladder with decreased capacity\n$\\sqrt{ }$ disease process usually starts at trigone spreading upward and laterally",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 85,
            "markdown": "$\\sqrt{ }$ calcification of bladder wall (rare)\n\n# Hemorrhagic Cystitis \n\nCause: unclear\n(a) nonspecific: negative culture\n(b) bacterial: E. coli (in $17 \\%$ )\n(c) viral (adenovirus in 19\\%): negative culture, viral exanthem\n(d) cytotoxic: cyclophosphamide (Cytoxan ${ }^{\\circledR}$ ), in $15 \\%$ of patients within 1 st year of treatment\n$\\sqrt{ }$ echogenic mobile clumps of solid material (= intraluminal blood clot)\n\n## Interstitial Cystitis\n\nAge: postmenopausal female\n\n- pink pseudoulceration of bladder mucosa characteristically at vertex of bladder (= Hunner ulcer)\n\n\n## Bullous Edema of Bladder Wall\n\nCause: continuous internal contact with Foley catheter, involvement of bladder wall by external contact in pelvic inflammatory conditions (eg, Crohn disease, appendicitis, diverticulitis)\n$\\sqrt{ }$ smoothly thickened / polypoid redundant hypoechoic mucosa\n\n## ECTOPIC URETER\n\n$=$ abnormal distal insertion outside bladder trigone\nAssociated with: duplication of ureter\nSite of insertion of ectopic ureter:\n> in female infrasphincteric insertion: bladder neck, upper urethra, uterus, cervix, vaginal vestibule, vagina, fallopian tube, rectum\n\n- incontinence after toilet training $\\leftarrow$ ureteral insertion below level of external urethral sphincter\n- WETTING in upright females $=$ intermittent / constant dribbling\n- urinary tract infection\n> in male always suprasphincteric insertion: posterior urethra, seminal vesicle (seminal vesical cyst), vas deferens, low in bladder, bladder neck, prostatic urethra, ejaculatory duct\n- NO enuresis in males after toilet training $\\leftarrow$ ureteral insertion above level of external urethral sphincter\n- epididymitis / orchitis in preadolescent male\n- urge incontinence (insertion into posterior urethra)\n$\\sqrt{ }$ often associated with ureteral obstruction\n\n\n## EJACULATORY DUCT CYST\n\nCause: congenital / acquired obstruction of ejaculatory duct\n\n- perineal pain, dysuria, ejaculatory pain, hematospermia\n- major cause of male infertility (= low-volume oligospermia / azoospermia)\n\nLocation: along expected course of ejaculatory duct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 86,
            "markdown": "$\\sqrt{ }$ intraprostatic cyst within central zone\n$\\sqrt{ }$ aspirate contains spermatozoa / fructose with normal testicular function\n$\\sqrt{ }$ cyst commonly contains calculi\n$\\sqrt{ }$ cystic dilatation of ipsilateral seminal vesicle\n$\\sqrt{ }$ contrast injection into cyst outlines seminal vesicle\n\n# EPIDIDYMITIS \n\n## Acute Epididymitis\n\n$\\diamond$ Most common acute pathologic process in postpubertal age\nCause: retrograde ascending urinary tract infection; instrumentation + prostatitis (in older men); chemical (Amiodarone); posttraumatic; vasculitis (Henoch-SchÃ¶nlein Purpura); idiopathic\nIncidence: 634,000 cases annually\nAge: , child $<2$ years ( $23 \\%$ of children):\nimperforate anus, ureteral ectopia to seminal vesicle, bladder exstrophy, neurogenic bladder, posterior urethral valves, dysfunctional voiding\n> child $>6$ years ( $77 \\%$ of children)\n$>18$ years (common)\n> 19-25 years (very common)\n$>25$ years (extremely common)\n$>30$ years (almost all cases of scrotal pain)\nOrganism: E. coli + S. aureus (85\\%), Gonococcus (12\\%), TB (2\\%); nonspecific (? chemical) epididymitis in $20 \\%$\n(a) child $+>35$ years of age: Escherichia coli + Proteus mirabilis, CMV with AIDS\n(b) $<35$ years of age: Chlamydia trachomatis, Neisseria gonorrhoeae\n\n- fever, increasing scrotal pain over 1-2 days\n- hemiscrotal swelling + tenderness + erythema\n- pyuria ( $95 \\%$ ), positive urine culture, leukocytosis ( $50 \\%$ )\n- dysuria + frequency ( $25 \\%$ ), prostatic tenderness (infrequent)\n\nSite: may begin with focal epididymitis ( $25 \\%$ ) often in epididymal tail $\\rightarrow$ body $\\rightarrow$ head (most common)\n$\\diamond$ Subsequent spread to testis (common): global orchitis (frequent), focal orchitis $(10 \\%)$\nUS:\n$\\sqrt{ }$ enlarged heterogeneous epididymis:\n$\\sqrt{ }$ enlarged head suggests hematogenous spread\n$\\sqrt{ }$ enlarged tail suggests retrograde reflux from prostate / urine\n$\\sqrt{ }$ hypoechoic epididymis relative to testis $\\leftarrow$ edema\n$\\sqrt{ }$ reactive hydrocele $\\pm$ thickening of scrotal wall\n$\\sqrt{ }$ enlarged spermatic cord containing hyperechoic fat\n$\\sqrt{ }$ thickening of tunica albuginea (in severe infection)\nColor Duplex ( $91 \\%$ sensitive, $100 \\%$ specific):\n$\\sqrt{ }$ increased number + concentration of identifiable vessels in affected region (=",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 87,
            "markdown": "hyperemia)\n$\\sqrt{ }$ peak systolic velocity (PSV) $>15 \\mathrm{~cm} / \\mathrm{sec}$ with PSV ratio $>1.9$ compared with normal side\n$\\checkmark$ detection of venous flow\n$\\checkmark$ diastolic flow reversal in testicular artery $\\leftarrow$ epididymal edema with obstruction of venous outflow\nNUC (true positive rate of $99 \\%$ ):\n$\\checkmark$ symmetric perfusion of iliac + femoral vessels\n$\\checkmark$ markedly increased perfusion through spermatic cord vessels ( $=$ testicular + deferential arteries)\n$\\checkmark$ curvilinear increased activity laterally in hemiscrotum on static images (also centrally if testis involved)\n$\\checkmark$ increased activity of scrotal contents on static images $\\leftarrow$ hyperemia + increased capillary permeability\n$R x$ : antimicrobial therapy, scrotal elevation, bed rest, analgesics, ice packs\nCx: (1) Epididymo-orchitis (20-40\\%) (see below)\n(2) Epididymal abscess (6\\%)\n$\\checkmark$ central hypoechoic region of liquefaction with absence of color Doppler signals\n(3) Testicular abscess (6\\%)\n(4) Testicular infarction (3\\%) $\\leftarrow$ extrinsic compression of testicular blood flow\n(5) Late testicular atrophy ( $21 \\%$ )\n(6) Hydro- / pyocele\n(7) Fournier gangrene\n\nDDx: (1) Testicular abscess ( $\\rightarrow$ increased perfusion with centrally decreased uptake)\n(2) Hydrocele ( $\\rightarrow$ normal perfusion, no uptake)\n(3) Testicular tumor ( $\\rightarrow$ slightly increased perfusion; in- / decreased uptake; no associated epididymal hyperemia on CFI; positive tumor markers: hCG, AFP)\n\n# Acute Epididymo-orchitis \n\n$=$ progression of epididymal infection $\\rightarrow$ focal / diffuse involvement of testis\nFrequency: $20-40 \\%$\nAge: two peaks at $>15$ years (sexually active) and $>50$ years (with BPH)\n\n- Prhen sign = pain associated with epididymo-orchitis improves with elevation of testes above level of pubic symphysis\n$C x$ : testicular necrosis $\\leftarrow$ infarction $\\leftarrow$ compromised testicular venous outflow $\\leftarrow$ edema\n\n\n## Chronic Epididymitis\n\n$=$ GRANULOMATOUS ORCHITIS\n$=$ granulomatous reaction to sperm / microorganisms\n\n- painful mass\n\nSite: mostly tail",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 88,
            "markdown": "US:\n$\\sqrt{ }$ enlarged heterogeneous hyperechoic epididymis\n$\\sqrt{ }$ NO increased blood flow\n$D D x$ : epididymal adenomatoid tumor (painless)\n\n# ERECTILE DYSFUNCTION \n\n$=$ IMPOTENCE (term replaced due to negative connotation)\n$=$ inability to have / maintain a penile erection sufficient for vaginal penetration in $50 \\%$ or more attempts during intercourse\nPrevalence: 10 million Americans\nPhysiology:\n(a) psychogenic phase:\n\n- stimuli from thalamic nuclei, rhinencephalon, limbic system converge in medial preoptic anterior hypothalamic area\n(b) neurologic phase:\n- sacral nerve roots (S2-S4) contribute fibers to pelvic sympathetic plexus\n- stimulation of cavernous nerve (parasympathetic nerve) $\\rightarrow$ changes in blood flow $\\rightarrow$ full erection\n- stimulation of pudendal nerve (motor nerve) $\\rightarrow$ contraction of bulbocavernosus + ischiocavernosus muscle $\\rightarrow$ occlusion of veins $\\rightarrow$ rigid erection\nRisk factors: hypertension, diabetes, smoking, CAD, peripheral vascular disease, pelvic trauma / surgery, blood lipid abnormalities\nCause:\nA. ORGANIC (majority)\n\n1. Endocrine disorder reducing serum testosterone / increasing serum prolactin\n2. Vascular disease ( $10-20 \\%$ ): increasing with age\n(a) failure to fill (arteriogenic)\n(b) failure to store (venogenic)\n3. Neurogenic disease $(10 \\%)=$ failure to initiate:\n(a) neurologic disorder: multiple sclerosis, spinal cord injury, cervical spondylosis, spinal arachnoiditis, pelvic trauma, temporal lobe / idiopathic epilepsy, Alzheimer disease, Parkinson disease, tabes dorsalis, amyloidosis, primary autonomic insufficiency, cerebrovascular accidents, primary / metastatic tumor\n(b) surgical injury to nerves: damage to pelvic sympathetic nerves / cavernous nerve during radical prostatectomy / cystectomy\n4. Chronic disease: diabetes mellitus (2 million); drugs (antihypertensives, anticonvulsants, alcohol, narcotics, psychotropic agents)\n5. Endorgan disease: priapism\nB. PSYCHOGENIC\n\nPenile-brachial index (normal $>1.0$ ):\n$=$ highest penile artery pressure over mean brachial pressure\n$\\sqrt{ }<0.70$ suggests large vessel disease\nRx: (1) Surgery:\n(a) vascular reconstructive surgery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 89,
            "markdown": "(b) penile prosthesis placement\n> nonhydraulic: semirigid, malleable, positionable\n> hydraulic\n(2) Oral / intracavernosal injection of vasoactive agents\n(3) Nonsurgical external devices: vacuum erection devices\n(4) Sex therapy\n\n# EXTRAGONADAL GERM CELL TUMOR \n\n$=$ PRIMARY EXTRAGONADAL GERM CELL TUMOR\nFrequency: $1.0-2.5 \\%$ of germ cell tumors; $\\mathrm{M}>\\mathrm{F}$\nOrigin: aberrant primordial germ cell rests $\\leftarrow$\n(a) faulty migration from yolk sac / endoderm to urogenital ridge\n(b) physiologic germ cell distribution to liver, bone marrow, brain\n\nHisto: seminoma (rare in retroperitoneum) / nonseminomatous germ cell tumor (embryonal carcinoma, yolk sac tumor, choriocarcinoma, teratoma, mixed germ cell tumor)\n$\\diamond 80 \\%$ of mediastinal germ cell tumors are benign!\n\n- elevated $\\alpha$-fetoprotein: embryonal carcinoma, yolk sac tumor\n- elevated $\\beta$-hCG: choriocarcinoma\n\nLocation: along midline from pineal to sacrococcygeal region, mediastinum $>$ retroperitoneum\n$\\diamond$ The anterior mediastinum is the most common site of extragonadal germ cell tumors!\nSite: near midline between T6 and S2\n$\\diamond$ A midline mass is more suggestive of a primary tumor than metastasis!\nCT/MR:\n$>$ seminoma:\n$\\sqrt{ }$ large lobulated well-defined homogeneous solid mass with ringlike / speckled calcifications\n$\\sqrt{ }$ hypointense fibrous septa on T2WI\n$\\sqrt{ }$ contrast enhancement of septa\n$>$ nonseminoma:\n$\\sqrt{ }$ heterogeneous tumor with areas of hemorrhage + necrosis\n$\\sqrt{ }$ heterogeneous contrast enhancement\n$\\sqrt{ } \\pm$ flow voids $\\leftarrow$ hypervascularity\n$\\sqrt{ } \\pm$ invasion of adjacent structures\n$D x$ : after exclusion of primary gonadal source\nPrognosis: worse compared to gonadal location\n$D D x$ : metastasis from gonadal primary (in 30\\%)\n\n## FIBROEPITHELIAL POLYP\n\n$=$ FIBROUS POLYP $=$ FIBROEPITHELIOMA $=$ VASCULAR FIBROUS POLYP $=$ POLYPOID FIBROMA\nOrigin: embryonic\nHisto: mesodermal tumor with fibrovascular stroma covered by normal transitional cell epithelium\nAge: in child / young adult 20-40 years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 90,
            "markdown": "Multiplicity: usually solitary\n$\\sqrt{ }$ mobile elongated cylindrical filling defect on a thin stalk\n$\\checkmark$ multilocular wormlike appearance with smooth margins\n$\\checkmark$ (occasionally) frondlike appearance\n@ Ureter\n$\\diamond$ Most common nonepithelial tumor of ureter!\nSite: proximal ureter\n\n- intermittent abdominal / flank pain\n- gross hematuria (rare)\n@ Urethra\n- hematuria at birth, obstructive voiding symptoms\n\nSite: verumontanum\n$\\sqrt{ }$ polyp may extend through bladder neck into bladder\n$\\checkmark$ extension into midpoint of bulbar urethra during voiding phase of cystourethrography\nCx: bladder outlet obstruction\n\n# FIBROUS PSEUDOTUMOR OF SCROTUM \n\n$=$ NODULAR PERIORCHITIS $=$ NODULAR FIBROSIS\n$=$ uncommon benign reactive fibrous proliferation\nFrequency: 3rd most common paratesticular mass (after lipoma and epididymal adenomatoid tumor)\nCause: often related to prior inflammation / infection / trauma\nOrigin: tunica vaginalis (most common)\nHisto: dense fibrous tissue with interspersed fibroblasts and mixed inflammatory cells\nAssociated with: hydrocele (50\\%)\n\n- history of trauma, surgery, infection, inflammation\n- mimicks malignancy at physical examination\n\nSize: up to 8 cm in diameter\n$\\checkmark$ hypoechoic mass(es) arising from tunica vaginalis (76\\%):\n$\\checkmark$ shadowing $\\leftarrow$ dense fibrosis / internal calcifications\n$\\checkmark$ uniformly low signal intensity on T1WI + T2WI like fibroma\n$\\checkmark$ slow persistent variable enhancement\n$\\checkmark$ may dislodge (as \"scrotal pearl\")\n$\\checkmark$ single / multiple hypoechoic / hyperechoic nodules arising from epididymis / spermatic cord / tunica albuginea\n$\\checkmark$ diffuse fibrous pseudotumor ( $=$ fibromatous periorchitis):\n$\\checkmark$ thickening of inner surface of tunica vaginalis $\\leftarrow$ diffuse proliferative encasement of testis\n$\\checkmark$ focal linear calcification + ossification\n$\\checkmark$ inflammatory pseudotumor of paratesticular lymph node\n$=$ predominantly hypoechoic lymph node $\\leftarrow$ spindle cell proliferation in connective tissue framework of hilum and capsule\n\n## FOURNIER GANGRENE\n\n$=$ FULMINANT NECROTIZING FASCIITIS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 91,
            "markdown": "[Jean Alfred Fournier (1832-1914), venereologist in Paris, France]\n$=$ uncommon potentially lethal polymicrobial necrotizing fasciitis of the perineal, perianal or genital areas\nPrevalence: 500 cases in literature\nPredisposed: diabetes mellitus (present in 40-60\\%), alcoholism, HIV, neutropenia\nOrganism: (a) aerobes: E. coli, S. aureus, Proteus species, enterococci\n(b) anaerobes: Bacteroides fragilis, anaerobic streptococci, clostridia\n$\\diamond$ Synergistic action between aerobes + anaerobes!\nSource of infection:\n$\\diamond$ In $90 \\%$ primary focus of infection is recognizable!\n(a) colorectal: colorectal cancer, inflammatory bowel disease, perirectal abscess, perianal / perirectal / ischiorectal abscess, anal fissure, colonic perforation\n(b) urologic: epididymitis, orchitis, urethral stricture with extravasation, urethral instrumentation, chronic urinary tract infection, circumcision\n(c) cutaneous: pressure ulcer of skin, IM injection, hidradenitis, insect bite, burn\n(d) female: septic abortion, vulvar / Bartholin gland abscess, hysterectomy, episiotomy\n(e) occult $(10 \\%)$\n\nPath: obliterative endarteritis with ensuing cutaneous + subcutaneous necrosis and gangrene, cellulitis, myositis, fasciitis (rate of fascial destruction as high as $2-3 \\mathrm{~cm} / \\mathrm{hr}$ )\nAge: newborn to elderly; $\\mathrm{M}+\\mathrm{F}=10 \\div 1$\n$\\diamond$ SURGICALEMERGENCY!\n\n- pain, fever, leukocytosis\n- scrotal tenderness, erythema, swelling, crepitation\n\nCT (modality of choice):\n$\\sqrt{ }$ gas in scrotal wall + perineum\n$\\sqrt{ }$ scrotal skin thickening + normal testes\n$\\diamond$ Scan entire abdomen + pelvis to find source of infection!\nMortality: $7-75 \\%=$ UROLOGIC EMERGENCY\n$R x$ : antibiotic therapy + debridement + hyperbaric oxygen\n$D D x$ : epididymoorchitis, gas-containing scrotal abscess, scrotal hernia with gas-containing bowel, scrotal emphysema from bowel perforation, extension of subcutaneous emphysema, air leakage + dissection due to faulty chest tube positioning\n\n# GANGLIONEUROBLASTOMA \n\n$=$ pediatric tumor of sympathetic nervous system of intermediate grade (cellular maturity between malignant neuroblastoma and benign ganglioneuroma); metastatic potential\nFrequency: less common than neuroblastoma / ganglioneuroma\nAge: $2-4$ years; rare in adults; $\\mathrm{M}+\\mathrm{F}=1 \\div 1$\nLocation: posterior mediastinum, abdomen\n$\\sqrt{ }$ extension through neural foramen into epidural space\n$\\sqrt{ }$ nerve root / spinal cord compression\n\n## GANGLIONEUROMA\n\n$=$ rare benign neoplastic growth of sympathetic ganglia evolving from a spontaneously regressed",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 92,
            "markdown": "(1\\%) neuroblastoma or induced by chemotherapy / occurring spontaneously de novo\nPath: usually larger than nerve sheath tumor\nHisto: mixture of Schwann cells + mature ganglion cells (predominating over glial cells)\nAge: older than for neuroblastoma; $<20$ years (42-60\\%), 20-39 years (39\\%), 40-80 years $(19 \\%) ; \\mathrm{M}+\\mathrm{F}=1 \\div 1$\nLocation: anywhere along paravertebral sympathetic plexus\n(a) extraadrenal posterior mediastinum (25-43\\%); retroperitoneum (32-52\\%); pelvis (9\\%); neck (8-9\\%); GI tract (rare)associated with MEN 2b\n(b) adrenal medulla ( $20-30 \\%$ )\n\nElaborated hormones: catecholamines, vasoactive intestinal polypeptides, androgenic hormones\n\n- usually asymptomatic / pain\n- respiratory symptoms, local pressure (40\\%)\n- rarely hormone-active: diarrhea, sweating, hypertension, virilization, myasthenia gravis\n\nAverage size: 8 cm (up to 20 cm )\n$\\sqrt{ }$ spherical / elliptical large lobulated well-defined encapsulated slow-growing mass\n$\\sqrt{ }$ tendency to surround blood vessels without compromising the lumen\n$\\sqrt{ }$ dumbbell-shaped mass extending from paraspinous region through neural foramen into epidural space\n$\\checkmark$ discrete punctate calcifications ( $8-27 \\%$ )\n$\\checkmark$ unusually homogeneous / mildly heterogeneous mass for its large size\n$\\checkmark$ variable contrast enhancement\nCT:\n$\\checkmark$ homogeneous / mildly heterogeneous hypoattenuating mass with a density of $<40 \\mathrm{HU}$ (less than that of muscle)\nCECT:\n$\\checkmark$ homogeneously hypoattenuating mass compared to muscle\n$\\checkmark$ surrounds vessels without vascular narrowing / occlusion\nMR:\n$\\checkmark$ homogeneous + isointense with muscle on T1WI\n$\\checkmark$ hyperintense to muscle on T2WI with varying signal intensities $\\leftarrow$ depending on composition of myxoid / cellular / collagen components):\n$\\checkmark \\pm$ whorled appearance $\\leftarrow$ interlacing bundles of longitudinal + transverse Schwann cells / collagen fibers\n$\\checkmark$ gradual delayed enhancement\nPrognosis: good after surgical resection\n$D D x$ : neurofibroma (no calcification), schwannoma (no calcification), ganglioneuroblastoma, neuroblastoma (coarse calcifications)\n\n# Gastrointestinal Ganglioneuroma \n\n## Manifestation:\n\n1. Focal polypoid lesions $=$ ganglioneuromas\n\n- asymptomatic\n$\\sqrt{ }$ well-circumscribed round / oval lobulated hypoattenuating masses",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 93,
            "markdown": "2. Multifocal polyps $=$ ganglioneuromatous polyposis\n\nLocation in NF1: colon, rectum\n3. Diffuse infiltrating lesions = ganglioneuromatosis\n\n- disturbance in gastrointestinal motility (HirschsprÃ¼ng-like condition, chronic colonic pseudo-obstruction, megacolon)\nLocation in NF1: colon, rectum\n$\\sqrt{ }$ diffuse / focal mural thickening\n$\\sqrt{ }$ diffuse high-attenuation mural thickening\n\n\n# GENITOURINARY DIABETES MELLITUS \n\nA. CHRONIC GU EFFECTS\n\n1. Papillary necrosis\n2. Renal artery stenosis\n3. Vas deferens calcification\nB. URINARY TRACT INFECTIONS\n4. Renal and perirenal abscess\n5. Emphysematous pyelonephritis\n6. Emphysematous cystitis\n7. Fungal infection: Candida, Aspergillus\n8. Xanthogranulomatous pyelonephritis\nC. GENITAL INFECTION\n9. Fournier gangrene\n10. Postmenopausal tuboovarian abscess\n\n## Diabetic Nephropathy\n\n$=$ defined as persistent proteinuria ( $>500 \\mathrm{mg}$ of albumin $/ 24$ hours) + retinopathy + elevated blood pressure\n$\\diamond$ Most common cause of end-stage renal disease!\nPrevalence: $35-45 \\%$ of IDDM; $<20 \\%$ of NIDDM; M $>$ F\nHisto: diffuse intercapillary glomerulosclerosis\nEarly:\n$\\checkmark$ renal enlargement (= renal hypertrophy with glomerular expansion)\nLate:\n$\\checkmark$ progressive decrease in size\n$\\checkmark$ diffuse cortical hyperechogenicity with gradual loss of corticomedullary differentiation\n$\\checkmark$ resistive index $>0.7$ (very late)\nIVP:\n$\\checkmark$ contrast material may induce renal failure (= rise in serum creatinine level $1-5$ days after exposure)\n$\\diamond$ Keep patient well hydrated with $0.45 \\%$ saline!\nMortality: $90 \\%$ after 40 years of age\n\n## Diabetic Cystopathy\n\nCause: autonomous peripheral neuropathy\nHisto: vacuolation of ganglion cells in bladder wall, giant sympathetic neurons,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 94,
            "markdown": "hypochromatic ganglion cells, demyelination\n\n- insidious impairment of bladder sensation\n- decreased reflex detrusor activity\n$\\sqrt{ }$ enlarged postvoid residual urine volume\nCx: vesicoureteral reflux, recurrent pyelonephritis, pyohydronephrosis, overflow incontinence\n\n\n# GLOMERULOCYSTIC KIDNEY DISEASE \n\n$=\\mathrm{GCKD}=$ rare form of cystic renal disease characterized by cystic dilatation of Bowman capsule\nGenetics: often inherited autosomal-dominant disease in families with ADPKD / component of hereditary syndromes (tuberous sclerosis, orofacialdigital syndrome, short rib polydactyly group of skeletal dysplasias); also sporadic cases\nAge: neonate, young child\nHisto: uniform cystic dilatation of Bowman capsule around glomerulus\n\n- symptoms of renal failure\n- accompanying infantile congenital malformations\n\nSite: primarily in cortical subcapsular distribution sparing tubular portions of nephron\n$\\sqrt{ }$ normal-sized / hypoplastic kidneys\nUS:\n$\\sqrt{ }$ small round cysts in renal cortex\n$\\sqrt{ }$ cortical hyperechogenicity $\\leftarrow$ if cysts difficult to define\nNEMR (preferred imaging modality):\n$\\sqrt{ }$ numerous T2-hyperintense lesions predominantly in subcapsular portion of renal cortex\n$D D x:$ ADPKD (much larger diffusely distributed renal cysts)\n\n## HEMANGIOMA OF ADRENAL GLAND\n\n$=$ rare benign vasoformative stromal tumor of adrenal gland\nPrevalence: $1 \\div 10,000$ autopsies\nHisto: cavernous > capillary type\n\n- typically asymptomatic for hemangiomas $<2 \\mathrm{~cm}$\n$\\sqrt{ }$ often large mass (usually $>10 \\mathrm{~cm}$ in diameter, up to 22 cm ) owing to their indolent nature\n$\\sqrt{ }$ highly vascular mass with multiple peripheral nodular areas of marked enhancement after contrast bolus injection:\n$\\sqrt{ }$ NO complete fill in of contrast material\n$\\sqrt{ }$ calcifications ( $28-87 \\%$ ) from previous hemorrhage / multiple CHARACTERISTIC phleboliths\n$\\sqrt{ }$ persistent enhancement on delayed imaging\nCT:\n$\\sqrt{ }$ central low attenuation (necrosis / fibrosis)\nMR:\n$\\sqrt{ }$ mass hypointense relative to liver on T1WI + central hyperintensity $\\leftarrow$ hemorrhage / necrosis\n$\\sqrt{ }$ usually markedly hyperintense on T2WI, especially in central portion\n$\\sqrt{ }$ variable appearance after hemorrhage, thrombosis, necrosis, fibrosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 95,
            "markdown": "# HEMANGIOMA OF KIDNEY \n\n$=$ uncommon benign vascular tumor\nOrigin: embryonic rest of unipotent angioblastic cells\nPrevalence: $1 \\div 2,000$ to $1 \\div 30,000 ; \\mathrm{M}=\\mathrm{F}$\nPeak age: young to middle-aged adults\nMay be associated with: Klippel-TrÃ©naunay syndrome, Sturge-Weber syndrome\nPath: unencapsulated tumor\nHisto: cavernous variant (widely dilated vessels) > capillary variant (slit-like vascular spaces)\nLocation: medulla ( $90 \\%$ ), renal pelvis\nSize: mostly $<2 \\mathrm{~cm}$\n\n- mostly asymptomatic\n- recurrent episodes of hematuria, colicky abdominal pain\n$\\sqrt{ }$ intense arterial enhancement persisting into venous phase\nCT:\n$\\checkmark$ lobulated hypo- to isoattenuating soft-tissue mass\n$\\checkmark$ multiple phleboliths (uncommon)\nMR:\n$\\checkmark$ homogeneously hypointense mass on T1WI\n$\\checkmark$ hyperintense on T2WI\n\n\n## HEMANGIOMA OF URINARY BLADDER\n\nFrequency: $\\quad 0.6 \\%$ of primary bladder neoplasms; $0.3 \\%$ of all bladder tumors\nAge: $<20$ years (in $>50 \\%$ ); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nMay be associated with:\n(a) additional hemangiomas in $30 \\%$\n(b) Klippel-TrÃ©naunay syndrome\n(c) Sturge-Weber syndrome\n\nHisto: capillary / venous / cavernous / hemangiolymphomatous form\n\n- recurrent gross painless hematuria\n- cutaneous hemangiomas over abdomen, perineum, thighs in $25-30 \\%$\n\nLocation: dome, posterolateral wall\nSite: limited to submucosa ( $33 \\%$ ), muscular wall, perivesical tissue\n$\\checkmark$ compressible solitary $\\left(2 / 3\\right.$ ) / multiple ( $1 / 3$ ) masses:\n$\\checkmark$ rounded well-marginated intraluminal mass\n$\\checkmark$ diffuse bladder wall thickening + punctate calcifications ( $=$ phleboliths)\nIVP:\n$\\checkmark$ rounded / lobulated filling defect\nUS:\n$\\checkmark$ solid predominantly hyperechoic mass\n$\\checkmark$ hypoechoic spaces within thickened bladder wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 96,
            "markdown": "# CAVE: high risk of intractable hemorrhage at biopsy! \n\n## HEMOLYTIC-UREMIC SYNDROME\n\n$=$ characterized by microangiopathic hemolytic anemia with typical features of DIC\n$\\diamond$ Most common cause of acute renal failure in children requiring dialysis!\nCause: ? triggered by an autoimmune response to infection\n(1) Infection: enterotoxic E. coli, > Shigella dysenteriae I, Streptococcus pneumoniae, Salmonella typhi, Coxsackie virus, ECHO virus, adenovirus\n(2) Associated medical condition: pregnancy, SLE + other collagen vascular disease, malignancy, malignant hypertension\n(3) Drugs: oral contraceptives, cyclosporine, mitomycin, 5-fluorouracil\n\nPathogenesis: capillary and endothelial injury to kidney $\\rightarrow$ mechanical damage of RBCs + formation of hyaline microthrombi within renal vasculature + focal infarction\nAge: usually children $<2$ years\nHisto: microangiopathy including endothelial swelling + thrombus formation in glomerulus + renal arterioles\nCLASSIC TRIAD:\n(1) Microangiopathic hemolytic anemia\n(2) Thrombocytopenia\n(3) Acute oliguric / anuric renal failure $\\rightarrow$ uremia\n\n- recent bout of gastroenteritis (commonly with E. coli)\n- sudden pallor, irritability, bloody diarrhea, convulsions\n- dyspnea $\\leftarrow$ fluid retention, heart failure, pleural effusion\n- rapid rise in blood urea nitrogen level out of proportion to plasma creatinine level $\\leftarrow$ cell lysis\n@ Kidney (sometimes only organ involved):\n$\\checkmark$ kidneys of normal / slightly increased size\n$\\checkmark$ hyperechoic cortex\nDoppler-US:\n$\\checkmark$ diastolic flow absent / reversed / reduced (= increase in resistance to flow)\n$\\checkmark$ return to normal waveforms predates return of urine output\nScintigraphy:\n$\\checkmark$ lack of renal perfusion\n@ Liver: hepatomegaly, hepatitis\n@ Pancreas: diabetes mellitus\n@ Heart: myocarditis\n@ Muscle: rhabdomyolysis\n@ Intestines:\n$\\checkmark$ mural stratification + narrowing of bowel lumen\n$\\checkmark$ pericolonic fat stranding\nCx: perforation, intussusception, infectious colitis\n@ Brain (20-50\\%): drowsiness, personality changes, coma, hemiparesis, seizures (up to $40 \\%)$\nPrognosis: complete spontaneous recovery (in 85\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 97,
            "markdown": "# HEREDITARY CHRONIC NEPHRITIS \n\n$=$ ALPORT SYNDROME\n$=$ probably autosomal dominant trait with presence of fat-filled macrophages (\"foam cells\") in corticomedullary junction and medulla\n(a) males: progressive renal insufficiency, death usually before age 50\n(b) females: nonprogressive\n\n- polyuria, salt wasting, hyposthenuria, NO hypertension\n- anemia, nerve deafness\n- ocular abnormalities: congenital cataracts, nystagmus, myopia, spherophakia\n$\\checkmark$ small smooth kidneys\n$\\checkmark$ diminished density of contrast material\n$\\checkmark$ cortical calcifications\n\n\n## HORSESHOE KIDNEY\n\n$=$ two kidneys joined at poles by parenchymal / fibrous isthmus\nPrevalence: $1-4 \\div 1,000$ births; $0.2-1.0 \\%$ (autopsy series); $\\mathrm{M} \\div \\mathrm{F}=2-3 \\div 1$\n$\\diamond$ Most common fusion anomaly!\nAssociated with:\ncardiovascular anomaly, skeletal anomaly, CNS anomaly, anorectal malformation, genitourinary anomaly (hypospadia, undescended testis, bicornuate uterus, ureteral duplication), trisomy 18, Turner syndrome (60\\%)\nIn $50 \\%$ associated with:\n(1) Caudal ectopia\n(2) Vesicoureteral reflux\n(3) Hydronephrosis $\\leftarrow$ UPJ obstruction\n$\\checkmark$ fusion of $\\mathrm{R}+\\mathrm{L}$ kidney at lower $(90 \\%)$ / upper $(10 \\%)$ pole\n$\\checkmark$ renal long axis medially oriented\n$\\checkmark$ isthmus at L4-5 between aorta + inferior mesenteric artery\n$\\checkmark$ renal pelves and ureters situated anteriorly\n$\\checkmark$ multiple renal arteries including isthmus artery\n$C x$ : infection, renal calculi\n\n## HYDROCELE\n\n$=$ abnormal collection of fluid between parietal and visceral layers of tunica vaginalis\n$\\diamond$ Most common cause of painless scrotal swelling\n$\\diamond$ Most common type of fluid collection in scrotum\nUS:\n$\\checkmark$ anechoic, good back wall, through-transmission\n$\\checkmark$ COMPLICATED HYDROCELE $=$ hydrocele with low-level echoes $\\pm$ septations $=$ hematocele / pyocele / cholesterol crystals / protein aggregates\n\n## Primary = Idiopathic Hydrocele\n\nwithout predisposing lesion as congenital defect of lymphatic drainage $=$ failure of mesothelial lining to reabsorb fluid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 98,
            "markdown": "# Secondary = Acquired Hydrocele \n\nAge: $\\quad>$ older child to adulthood\n(a) inflammation: epididymitis, epididymoorchitis\n(b) testicular tumor (in $10-40 \\%$ of malignancies)\n(c) trauma / postsurgical\n$\\diamond 50 \\%$ of acquired hydroceles are due to trauma!\n(d) torsion, infarction\n\n## Congenital Encysted Hydrocele\n\n$=$ ascites trapped in scrotum through communication with peritoneal cavity (= open processus vaginalis)\nMay be associated with: inguinal hernia\n\n- resolves within 2 years (in $80 \\%$ )\n\n\n## Infantile Hydrocele\n\n$=$ hydrocele with fingerlike extension into funicular process but WITHOUT communication with peritoneal cavity\n\n## HYDRONEPHROSIS\n\nA. OBSTRUCTIVE UROPATHY $=$ HYDRONEPHROSIS\n$=$ dilatation of collecting structures without functional deficit\nB. OBSTRUCTIVE NEPHROPATHY = dilatation of collecting system with renal functional impairment\nGrading system of hydronephrosis by US:\nGrade $0=$ homogeneous central renal sinus complex without separation of central sinus echoes\nGrade $1=$ separation of central sinus echoes of ovoid configuration; continuous echogenic sinus periphery; $52 \\%$ predictive value for obstruction\nGrade $2=$ separation of central sinus echoes of rounded configuration; dilated calices connecting with renal pelvis; continuity of echogenic sinus periphery\nGrade $3=$ replacement of major portions of renal sinus; discontinuity of echogenic sinus periphery\nAmount of collecting system dilatation depends on:\n(a) duration of obstruction\n(b) renal output\n(c) presence of spontaneous decompression\n$\\diamond$ Amount of residual renal cortex is of prognostic significance!\n\n## Acute Hydronephrosis\n\nCause:\n(1) Passage of calculus\n(2) Sulfonamide crystallization in nonalkalinized urine\n(3) Passage of blood clot $\\leftarrow$ carcinoma, AV malformation, trauma, anticoagulant therapy\n(4) Sloughed necrotic papilla\n(5) Ureteral edema following instrumentation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 99,
            "markdown": "(6) Suture on ureter\n(7) Normal pregnancy\n\n- pain (50\\%), UTI (36\\%), nausea + vomiting (33\\%)\n$\\checkmark$ normal-sized kidney with normal parenchymal thickness\n$\\checkmark$ increasingly dense nephrogram\n$\\checkmark$ delayed opacification of collecting system $\\leftarrow$ decreased glomerular filtration\n$\\checkmark$ increasingly dense nephrogram over time (= \"obstructed nephrogram\")\n$\\checkmark$ dilated collecting system + ureter\n$\\checkmark$ widening of forniceal angles\n$\\checkmark$ delayed images demonstrate site of obstruction at the end of a persistent column of contrast material in a dilated urinary collecting system\n$\\checkmark$ vicarious contrast excretion through gallbladder (uncommon)\nUS:\n$\\checkmark$ separation of renal sinus echoes\nFalse-negatives:\nstaghorn calculus filling entire collecting system, hyperacute renal obstruction (system not yet dilated), spontaneous decompression of obstruction, fluid-depleted patient with partial obstruction, dehydrated neonate\nFalse-positives:\nfull bladder, increased urine flow (overhydration, medications, following urography, diabetes insipidus, diuresis in nonoliguric azotemia), acute pyelonephritis, postobstructive / postsurgical dilatation, vesicoureteral reflux\nImposters:\nparapelvic cysts, sinus vessels, prominent extrarenal pelvis\n$\\checkmark$ ureteral jet not detectable / trickling flow:\nCAVE: in $25 \\%$ ureteral jets NOT detectable $\\leftarrow$ insufficient differences in specific gravity between ureteral urine and urine in urinary bladder in normals\n$\\checkmark$ ureteral jet absent in $13 \\%$ of pregnant patients without ureteral obstruction\nN.B.: turning pregnant patient into contralateral decubitus position will make jet visible\nDuplex US:\n$\\checkmark$ mean RI of $0.77 \\pm 0.05$ versus $0.63 \\pm 0.06$ in nonobstructed kidney\nCaution: RI often normal in chronic obstruction; nonobstructive renal disease may elevate RIs\n$\\checkmark \\geq 0.08$ difference in RI in right-to-left comparison with unilateral obstruction\n$C x$ : spontaneous urinary extravasation ( $10-18 \\%$ ) from forniceal / pelvic tear ( $=$ pyelosinus reflux)\n\n\n# Chronic Hydronephrosis \n\n$=$ most frequent cause of abdominal mass in first 6 months of life ( $=25 \\%$ of all neonatal abdominal masses)\nCause:\n(a) acquired: benign + malignant tumors of the ureter; ureteral strictures; retroperitoneal tumor / fibrosis; neurogenic bladder; benign prostatic hyperplasia; cervical / prostatic carcinoma; pelvic mass (lymphoma, abscess, ovarian); urethral polyps; urethral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 100,
            "markdown": "neoplasm; acquired urethral strictures\n(b) congenital: ureteropelvic junction obstruction (most common); posterior urethral valves; ectopic ureterocele; congenital ureterovesical obstruction; prune-belly syndrome; primary megaureter\n\n- insidious course\n$\\checkmark$ large kidney with wasted parenchyma\n$\\checkmark$ diminished nephrographic density $\\leftarrow$ decreased clearance\n$\\checkmark$ early \"rim\" sign ( $=$ thin band of radiodensity surrounding calices)\n$\\checkmark$ \"crescent\" sign = concentrated contrast material in collecting tubules arranged parallel to margin of dilated calices $\\leftarrow$ reversible incomplete prolonged obstruction\n$\\checkmark$ delayed opacification of collecting system\n$\\checkmark$ moderate to marked widening of collecting system\n$\\checkmark$ tortuous dilated ureter\nCT:\n$\\checkmark$ hypoenhancement of renal parenchyma during corticomedullary + nephrographic phases\n$\\checkmark$ delayed persistent nephrogram sign\nNUC:\n$\\checkmark$ photopenic area during vascular phase\n$\\checkmark$ accumulation of radionuclide tracer within hydronephrotic collecting system on delayed images\nCx: superimposed infection (= pyonephrosis)\n\n\n# Congenital Hydronephrosis \n\nMostly isolated malformation\nPrevalence: $1 \\div 100-300$ births\nRisk of recurrence: $2-3 \\%$ for siblings\nAge at presentation: $25 \\%$ by age 1 year, $55 \\%$ by age 5 years\n\n## Cause:\n\n1. UPJ obstruction $22-40-67 \\%$\n2. Posterior urethral valves $18 \\%$\n3. Ectopic ureterocele $14 \\%$\n4. Prune belly syndrome $12 \\%$\n5. Ureteral + UVJ obstruction $8 \\%$\n6. Others: severe vesicoureteral reflux, bladder neck obstruction, hypertrophy of verumontanum, urethral diverticulum, congenital urethral strictures, anterior urethral valves, meatal stenosis\nMay be associated with: Down syndrome (in 17-25\\%)\n\n- palpable abdominal mass\n- intermittent flank + periumbilical pain\n- failure to thrive, vomiting, hematuria, infection\n\nLocation: $70 \\%$ unilateral\nOB-US:\n$\\sqrt{ }$ AP diameter of renal pelvis $\\geq 5 \\mathrm{~mm}$ between $15-20$ weeks, $\\geq 8 \\mathrm{~mm}$ at $20-30$ weeks, $\\geq$ 10 mm after 30 weeks MA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 101,
            "markdown": "$\\diamond$ Pyelectasis $<7.0 \\mathrm{~mm}$ after 32 weeks EGA is highly predictive of a normal postnatal outcome\n$\\sqrt{ }$ ratio of AP diameter of renal pelvis to kidney $>50 \\%$\n$\\sqrt{ }$ caliceal distension communicating with renal pelvis\n$\\diamond$ Postnatal evaluation after 4-7 days of age (because of $\\downarrow$ GFR + relative dehydration in first days of life)!\nPrognosis: parenchymal atrophy + renal impairment (dependent on severity + duration)\n\n# Focal Hydronephrosis \n\n$=$ HYDROCALICOSIS $=$ HYDROCALYX\n$=$ obstructed drainage of one portion of kidney\nCause: (1) Congenital: partial / complete duplication\n(2) Infectious stricture: eg, TB\n(3) Infundibular calculus\n(4) Tumor\n(5) Trauma\n$\\sqrt{ }$ unifocal mass, commonly in upper pole\n$\\checkmark$ absent polar group of calices (early)\n$\\checkmark$ dilated polar group (late) with displacement of adjacent calices\n$\\checkmark$ delayed opacification in obstructed group\n$\\checkmark$ focally replaced nephrogram\nUS:\n$\\checkmark$ anechoic cystic lesion with smooth margins\nCT:\n$\\checkmark$ focal area of water density with smooth margin + thick wall\n\n## Hydronephrosis in Pregnancy\n\n1. Physiologic hydronephrosis / dilatation\n\nPrevalence: $80 \\%$; in up to $90 \\%$ by $3^{\\text {rd }}$ trimester\nCause:\n(a) hormonal: relaxation of ureteric smooth muscle in response to progesterone\n(b) mechanical: gravid uterus compresses ureter at pelvic brim near crossing of iliac vessels with right ureter taking a more acute angle\n\n- asymptomatic / may manifest as abdominal pain\n\nTime of onset: as early as 6-10 weeks of gestation\nLocation: right (85-90\\%), left (15-67\\%)\nNot associated with: renal enlargement / perinephric fluid\n$\\sqrt{ }$ gradual smooth tapering of mid to distal ureter $\\leftarrow$ extrinsic compression between gravid uterus + iliopsoas\n$\\sqrt{ }$ ureter widened only to level of sacral promontory\nPrognosis: resolution within a few weeks to 6 months after delivery\n2. \"Overdistension syndrome\"\n\nCause: obstruction by gravid uterus\n\n- pain mimicking renal colic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 102,
            "markdown": "# 3. Acute (obstructive) hydronephrosis \n\nCause: change in position of fetus, diuresis, passage of stone into ureter\n\n- constant pain $\\pm$ nausea and vomiting\n$\\sqrt{ }$ renal enlargement\n$\\sqrt{ }$ increased perirenal fluid $\\leftarrow$ lymphatic congestion / forniceal rupture\n$\\sqrt{ }$ ureterovesical stone $\\rightarrow$ ureter dilated distal to sacral promontory\n\n\n## IgG4-RELATED RENAL DISEASE\n\nRenal lesions in patients with pancreatic disease have been used to differentiate autoimmune pancreatitis from pancreatic cancer.\nHisto: tubulointerstitial nephritis with fibrosis + abundant IgG4-positive plasma cell infiltration\n$\\sqrt{ }$ bilateral round / wedge-shaped peripheral cortical lesions (most common)\n$\\sqrt{ }$ diffuse patchy renal involvement\n$\\sqrt{ }$ rim of soft tissue around kidney\n$\\sqrt{ }$ bilateral nodules in renal sinus\n$\\sqrt{ }$ diffuse wall thickening of renal pelvis\n\n## INFLAMMATORY PSEUDOTUMOR OF BLADDER\n\n$=$ PSEUDOSARCOMATOUS FIBROMYXOID TUMOR\nCause: ? response to infection, inflammation or malignancy\nAge: 38 (range, 15-74) years; $\\mathrm{M}+\\mathrm{F}=11 \\div 6$\nPath: ulcerating bleeding mass\nHisto: loosely packed spindle cells within myxoid matrix\n\n- hematuria, voiding symptoms, fever, iron deficiency anemia\n\nLocation: reported in every organ of body\nSite: spares trigone\n$\\sqrt{ }$ locally aggressive single exophytic / polypoid $2-8 \\mathrm{~cm}$ bladder mass $\\pm$ ulceration\n$\\sqrt{ }$ may invade through bladder wall with extravesical component\n$\\sqrt{ }$ ringlike peripheral enhancement + poor central enhancement $\\leftarrow$ necrosis\nMR:\n$\\sqrt{ }$ heterogeneous mass with central hyperintense component surrounded by hypointense periphery on T2WI\n$R x$ : surgery, high-dose steroids, radiation therapy\n$D D x$ : rhabdomyosarcoma, myxoid leiomyosarcoma\n\n## JUXTAGLOMERULAR CELL TUMOR\n\n$=$ RENINOMA\n$=$ very rare benign renin-secreting tumor\nOrigin: juxtaglomerular cells of adult kidney\nPrevalence: $<30$ cases reported\nOrigin: myoendocrine cell arising from afferent arterioles of glomeruli\nPath: small foci of hemorrhage + pseudocapsule\nHisto: tumor resembles hemangiopericytoma composed of sheets / trabeculae of round to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 103,
            "markdown": "polygonal cells;\nCHARACTERISTIC renin granules on electron microscopy\nMean age: 24 (range, $7-58$ ) years; $50 \\%<21$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$\n\n- typical features of primary reninism:\n- marked + sustained hypertension, often accelerated and poorly controlled\n- secondary hyperaldosteronism with hypokalemia\n- hyperreninemia $\\rightarrow$ in the absence of renal artery stenosis\n- moderate to severe headaches + muscle aches\n- hypertensive retinopathy, polydipsia, polyuria, enuresis\n\nLocation: just beneath renal capsule\nSize: usually $2-3$ (range, $0.8-6.5$ ) cm\n$\\sqrt{ }$ well-circumscribed renal mass\nUS:\n$\\checkmark$ echogenic mass $\\pm$ areas of necrosis / hemorrhage\nNECT (thin overlapping cuts):\n$\\checkmark$ hypo- to isodense tumor\nCECT:\n$\\checkmark$ hypovascular mass on arterial phase $\\leftarrow$ renin-induced vascoconstriction\n$\\checkmark$ moderate enhancement during delayed phase\nMR:\n$\\checkmark$ hypointense mass relative to renal parenchyma on precontrast T1WI + T2WI\n$\\checkmark$ early low-level peripheral enhancement on T1WI\n$\\checkmark$ washout of contrast material from periphery + filling in of central tumor portion on delayed T1WI\nAngio:\n$\\checkmark$ (easily overlooked) hypo- / avascular tumor (in 43\\%)\n$\\checkmark$ renal vein sampling yields high renin level on affected side\n$D x$ : combination of elevated renin without renal arterial lesion + hypovascular solid renal mass\n$R x$ : surgical excision\n\n# LEIOMYOMA OF KIDNEY \n\n$=$ CAPSULOMA\n$=$ rare benign mesenchymal neoplasms that mostly occurs in asymptomatic adults\nPrevalence: $5 \\%$ at autopsy (average size of 5 mm )\nOrigin: smooth muscle cells of renal capsule, muscularis of renal pelvis, wall of cortical vessels\nPath: well-encapsulated solid mass containing hemorrhage (17\\%) / cystic degeneration (27\\%) / irregular calcifications\nHisto: interlacing bundles of smooth muscle cells in a whorled arrangement without nuclear pleomorphism; immunoreactivity to smooth muscle markers (actin, desmin)\nAssociated with: tuberous sclerosis\nMedian age: 42 years; $\\mathrm{M}<\\mathrm{F}$; Whites $>$ Blacks\nLocation: $53 \\%$ subcapsular, $37 \\%$ capsular, $10 \\%$ at renal pelvis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 104,
            "markdown": "Mean size: 12 cm\n\n- palpable mass if large ( $50 \\%$ ), hematuria ( $20 \\%$ )\n$\\sqrt{ }$ well-circumscribed exophytic solid lesion $\\pm$ cleavage plane between tumor and cortex\n$\\sqrt{ }$ areas of hemorrhage + cystic / myxoid degeneration + dense calcifications in larger tumor\nCT:\n$\\sqrt{ }$ relatively homogeneous peripherally located hyperattenuating solid mass causing cortical buckling\n$\\checkmark$ relatively homogeneous enhancement\nMR:\n$\\checkmark$ homogeneously low SI on T1WI + T2WI\nAngio:\n$\\checkmark$ hypo- to hypervascular nonspecific mass\n$D D x$ : renal leiomyosarcoma, renal cell carcinoma\n\n\n# LEIOMYOSARCOMA OF KIDNEY \n\n$\\diamond$ Most common sarcoma of adult kidney ( $50-60 \\%$ of all renal sarcomas)!\nAge: $40-70$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nPath: large well-circumscribed encapsulated tumor with focal areas of necrosis\nHisto: spindle cells in fascicular / plexiform / haphazard growth pattern interspersed with variable amount of connective tissue; positive for $\\alpha$-smooth muscle actin, desmin, calponin\n\n- flank pain, abdominal mass, hematuria\n\nLocation: renal capsule, parenchyma, smooth muscle fibers of renal pelvis / main renal vein\n$\\checkmark$ expansile well-defined solid mass\n$\\checkmark$ heterogeneous enhancement + delayed enhancing fibrous stroma\n$\\checkmark$ central necrosis / multiloculated cystic mass for large tumors\nMR:\n$\\checkmark$ soft-tissue mass of heterogeneous SI on T1WI + T2WI\nPrognosis: aggressive + rapidly progressive; 29-36\\% 5-year survival rate\n\n## LEUKEMIA\n\n$=$ clonal proliferation of lymphoblasts (acute leukemia) or small lymphocytes (chronic leukemia)\n$\\diamond$ Most common malignant cause of bilateral global renal enlargement!\nPrevalence: renal involvement in $50 \\%$ of children + in $65 \\%$ of adults at autopsy\nA. DIFFUSE INVOLVEMENT (most common)\n> leukemic cells infiltrate the interstitial tissue + renal sinus; tubules are replaced (more common in lymphocytic than in granulocytic forms); no relationship to peripheral white blood cell count\n\n- hypertension; renal impairment $\\leftarrow$ leukemic infiltrate, hyperuricemia, septicemia, hemorrhage\n$\\checkmark$ moderate to massive nephromegaly bilaterally with smooth contours\n$\\checkmark$ normal or diminished density on nephrogram\n$\\checkmark$ occasionally attenuated collecting system (DDx: renal sinus lipomatosis)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 105,
            "markdown": "$\\sqrt{ }$ nonopaque filling defects on IVP $\\leftarrow$ clot, uric acid\n$\\sqrt{ }$ renal / subcapsular / perinephric hemorrhage frequent\n$\\sqrt{ }$ retroperitoneal lymphadenopathy\nUS:\n$\\sqrt{ }$ loss of definition + distortion of central sinus complex\n$\\sqrt{ }$ normal to increased coarse echoes throughout renal cortex with preservation of renal medulla\n$\\sqrt{ }$ single / multiple focal anechoic masses\nB. FOCAL ACCUMULATION OF LEUKEMIC CELLS (rare)\nchloroma (= granulocytic sarcoma) of acute myeloblastic leukemia, myeloblastoma, myeloblastic sarcoma\n\n- may antedate other manifestations of leukemia\n$\\sqrt{ }$ unifocal mass in renal cortex / renal sinus\n$D D x$ : Hodgkin disease, malignant lymphoma, multiple myeloma\n\n\n# LEUKOPLAKIA \n\n$=$ KERATINIZING SQUAMOUS METAPLASIA / DYSPLASIA = DYSKERATOSIS\nCause: chronic infection ( $80 \\%$ ) / stones ( $40 \\%$ )\nHisto: large confluent areas / scattered patches of squamous metaplasia of transitional cell epithelium with keratinization + cellular atypia in deeper layers\nPeak age: $4^{\\text {th }}-5^{\\text {th }}$ decade;\n$\\mathrm{M}+\\mathrm{F}=1 \\div 1$ (with involvement of renal pelvis)\n$\\mathrm{M}+\\mathrm{F}=4 \\div 1$ (with involvement of bladder)\n\n- hematuria ( $30 \\%$ ), recurrent UTIs\n- PATHOGNOMONIC passage of gritty flakes, soft-tissue stones, white chunks of tissue (= desquamated keratinized epithelial layers) $\\rightarrow$ leading to colic, fever, chills\nLocation: bladder $>$ renal pelvis $>$ ureter; bilateral in $10 \\%$\n$\\sqrt{ }$ corrugated / striated irregularities of pelvicaliceal walls; localized / generalized\n$\\sqrt{ }$ plaquelike intraluminal mass with \"onion skin\" pattern of contrast material in interstices\n$\\sqrt{ }$ caliectasis + pyelectasis common (with obstruction)\n$\\sqrt{ }$ ridging / filling defects of ureter\n$\\sqrt{ }$ associated with calculi in $25-50 \\%$\n$C x$ : premalignant condition for epidermoid carcinoma in $12 \\%$ (controversial!)\n\n\n## LEYDIG CELL HYPERPLASIA\n\n$=$ rare benign condition characterized by an increased number of Leydig cells\n\n- asymptomatic (in adults)\n- precocious puberty (in childhood) $\\leftarrow$ hormone secretion\n\nLocation: frequently bilateral; multifocal\nSize: $1-6 \\mathrm{~mm}$\n$\\sqrt{ }$ hypo- / hyperechoic, T2-hypointense intratesticular nodule(s)\n$\\sqrt{ }$ variable vascularity $\\pm$ avid enhancement\n\n## LIPOMA OF SPERMATIC CORD",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 106,
            "markdown": "$=$ EXTRATESTICULAR / PARATESTICULAR LIPOMA\nFrequency: most common extratesticular tumor\nUS:\n$\\checkmark$ well-defined homogeneous scrotal mass\n$\\sqrt{ }$ NO internal flow on color Doppler\nMR:\n$\\checkmark$ homogeneous high SI on T1WI (DDx: hematoma, proteinaceous cyst)\n$\\checkmark$ hyperintense paratesticular mass on T2WI\n$\\checkmark$ india-ink = black boundary artifact and signal suppression on out-of-phase imaging\n$\\checkmark$ signal suppression on fat-suppressed images\n\n# LIPOMA OF SCROTUM \n\n$=$ INTRATESTICULAR LIPOMA\n$=$ rare benign fat-containing tumor\nLocation: epididymis, spermatic cord, tunica vaginalis\nUS:\n$\\checkmark$ well-defined homogeneous hyperechoic nonshadowing lesion\n$\\sqrt{ }$ NO color Doppler flow signals (frequent)\nCT:\n$\\checkmark$ homogeneous attenuation similar to subcutaneous fat\nMR:\n$\\checkmark$ high signal intensity on T1WI and T2WI\n$\\checkmark$ loss of signal intensity on frequency-selective fat-saturated images\n$\\sqrt{ }$ NO enhancement\nLipoma can be differentiated from liposarcoma by the lack of any enhancing soft tissue within a lipoma.\n\n## Testicular Lipomatosis\n\nCause: exclusively in Cowden disease\nUS:\n$\\checkmark$ multiple nonshadowing hyperechoic small round foci of varying sizes\nMR:\n$\\checkmark$ multiple high SI foci on T1WI\n\n## LITHIUM-INDUCED NEPHROTOXICITY\n\n- clinical and laboratory data typically sufficient for diagnosis\n\nClinical categories:\n\n1. Acute intoxication\n2. Nephrogenic diabetes insipidus (most common)\n$R x$ : reversible with drug cessation\n3. Chronic focal interstitial nephritis\n$=$ progressive nonreversible chronic renal insufficiency\nHisto: tubular atrophy, glomerulosclerosis, interstitial fibrosis, distal tubular dilatation with microcyst formation\n$\\checkmark$ typically normal-sized kidneys",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 107,
            "markdown": "$\\sqrt{ }$ abundant uniformly distributed renal microcysts\n$\\sqrt{ } 1-2 \\mathrm{~mm}$ microcysts (in 33-62\\%)\nSite: cortex and medulla\nCT:\n$\\sqrt{ }$ multiple tiny hypoattenuating lesions\nMR (best depiction of number + size of cysts):\n$\\sqrt{ }$ multiple T2-hyperintense foci\nCT and MR findings typically include normal-sized kidneys with abundant and uniformly distributed renal microcysts.\n$D D x$ : autosomal dominant polycystic kidney disease, glomerulocystic kidney disease, medullary cystic kidney disease, acquired cystic kidney disease\n\n# LOCALIZED CYSTIC DISEASE OF KIDNEY \n\n$=$ SEGMENTAL RENAL CYSTIC DISEASE\n$=$ rare nonprogressive condition characterized by replacement of portion / entire renal parenchyma of one kidney with cysts\n\n- mostly asymptomatic, NO impairment of renal function\n- abdominal pain, hematuria, hypertension\n\nGenetics: nonhereditary\nPathogenesis: ? acquired maldevelopment\nPath: multicystic lesion composed of cysts of varying sizes separated by normal / atrophic renal parenchyma without surrounding capsule\nHisto: dilated ducts and tubules varying in size from mm to several cm lined by single layer of flattened epithelium\nLocation: unilateral in one kidney\n$\\sqrt{ }$ conglomerate mass of cluster of variably sized + tightly spaced cysts separated by enhancing / atrophic renal tissue:\n$\\sqrt{ }$ intervening parenchyma may be stretched + attenuated (DDx: thick septations, impossible to distinguish)\n$\\sqrt{ }$ NO surrounding capsule\n$\\sqrt{ }$ remaining renal parenchyma of affected / contralateral kidney may contain a few scattered cysts\n$\\sqrt{ }$ normal excretion of uninvolved segments\nPrognosis: not progressive\n$D D x$ : (1) Autosomal dominant polycystic kidney disease (bilateral, positive family history, cysts in other visceral organs)\n(2) Multicystic dysplastic kidney (absent pelvicaliceal system + absent / hypoplastic renal vessels)\n(3) Cystic neoplasm (capsule, coronal plane helpful)\n\nIntervening normally enhancing renal parenchyma + absence of a surrounding capsule distinguishes localized cystic renal disease from cystic nephroma and multiloculated cystic renal cell carcinoma.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 108,
            "markdown": "# LYMPHOCELE \n\n$=$ fluid-filled cyst without epithelial lining\nFrequency: in 12-30\\% after radical lymphadenectomy / renal transplantation (within 4-8 weeks after surgery)\nCause:\n\n1. Complication of radical lymphadenectomy to assess lymph node status in malignancy\n2. Lymphatic leakage from allograft / allograft bed\n\nLocation: at sites of lymph node dissection; frequently in pelvic / abdominal retroperitoneum, axilla, groin\nTime to discovery: 3-8 weeks after surgery\n\n- mostly asymptomatic, edema of abdominal wall / scrotum / labia\n- lower limb edema $\\leftarrow$ pressure effect on veins\n- hydronephrosis $\\leftarrow$ pressure effect on ureter\n$\\checkmark$ unilocular thin-walled fluid-filled structure\n$\\checkmark$ photopenic region with displacement / impression on renal transplant / urinary bladder\n$\\checkmark$ rarely calcification of wall\n$D x$ : aspiration / drainage with biochemical analysis (creatinine + urea nitrogen + protein + electrolyte components similar to serum)\n- predominantly lymphocytes, few leukocytes\n$C x$ : hemorrhage; superinfection; compression of adjacent structures if large\n$R x$ : sclerotherapy with povidone-iodine / doxycycline / ethanol / bleomycin; long-term catheter drainage / surgical marsupialization\n$D D x$ : hematoma; seroma; abscess; cystic tumor recurrence (enhancing soft-tissue component)\n\n\n## Cystic Degeneration of Lymph Node\n\nCause: squamous cell carcinoma (from uterine cervix, vagina, vulva, urinary bladder)\n$\\checkmark$ thin-walled cystic lymph node\n$D D x$ : lymphocele; lymphangioleiomyomatosis\n\n## LYMPHOMA OF KIDNEY\n\nPrevalence: in 3-8\\% (by CT), 30-60\\% (by autopsy); occurs usually late in disease\n$\\diamond$ The kidneys are the $2^{\\text {nd }}$ most commonly affected anatomic entity aside from hematopoietic and reticuloendothelial organs!\nPath: initially lymphomatous cells grow in interstitium; nephrons, collecting ducts, blood vessels serve as framework for tumor expansion; with continued growth $\\rightarrow$ parenchymal compression + destruction\nTypes:\nA. NON-HODGKIN LYMPHOMA (more common)\n(a) SECONDARY $\\leftarrow$ systemic disease\n\nType: typically intermediate + high-grade B-cell type\nAt risk: immunocompromised patients with uncontrolled Epstein-Barr virus proliferation in patients with HIV infection / organ transplantation (esp. after cyclosporine therapy), ataxia-telangiectasia\n(b) PRIMARY renal lymphoma $(<1 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 109,
            "markdown": "arising in renal hilar nodes / renal parenchyma\nB. HODGKIN DISEASE $(<1 \\%)$\n\nPrevalence: renal involvement in $13 \\%$ of autopsies\nPatterns of involvement:\n(1) Hematogenous dissemination (bilateral in 75\\%):\n> multiple foci (50-65\\%):\n$\\sqrt{ }$ multiple hypoenhancing $1-3 \\mathrm{~cm}$ usually bilateral renal masses\n> single mass ( $10-25 \\%$ ):\n$\\sqrt{ }$ solitary homogeneous hypovascular renal mass (in 10-20\\%) with minimal enhancement mimicking a primary renal neoplasm:\n$\\checkmark$ distortion of renal contour with larger mass\n$\\checkmark \\pm$ invasion of perirenal space / renal hilum\n> diffuse infiltration (in 20\\%) along scaffolding of normal interstitial tissue, almost always bilateral:\n$\\checkmark$ nephromegaly with preservation of renal contour $\\leftarrow$ primarily interstitial lymphomatous infiltration\n$\\checkmark$ poorly enhancing areas in kidneys\n> rindlike perinephric soft-tissue mass\n$\\checkmark$ invasion / compression of kidney without significant effect on renal function\n(2) Direct extension from retroperitoneal mass / adenopathy (25-30\\%):\n$\\checkmark$ cloaking of renal vessels without obstruction\n$\\checkmark$ occasionally displacement of involved kidney\nCx: hydronephrosis\n(3) Isolated perinephric lymphoma $(<10 \\%)$\n\n- clinically silent ( $50 \\%$ ), palpable mass, hematuria\n- flank pain, weight loss, fever, night sweats\n- compromised renal function: urinary tract obstruction, renal vein compression, diffuse infiltration of kidney, superimposed infarct, amyloidosis, hypercalcemia\nAssociated with: splenomegaly, lymphadenopathy\n$\\diamond$ Look for other sites of multisystemic involvement in bone marrow, liver, GI tract, lung, heart, CNS!\n$\\checkmark$ unilateral $\\div$ bilateral $=1 \\div 3$\n$\\checkmark$ multiple nodular masses (29-61\\%): $1.0-4.5 \\mathrm{~cm}$ in size\n$\\checkmark$ solitary tumor ( $10-25 \\%$ ): bulky up to 15 cm in size ( $7 \\%$ ) / small ( $7-48 \\%$ )\n$\\checkmark$ spread from retroperitoneal disease with involvement via transcapsular / hilar invasion (25$30 \\%)$\n$\\checkmark$ perinephric lymphoma $(<10 \\%)$ :\n(a) direct extension from retroperitoneal disease\n(b) transcapsular growth of renal parenchymal disease\n$\\diamond$ A tumor surrounding kidney without parenchymal compression or compromise in function is virtually PATHOGNOMONIC of lymphoma\n$\\checkmark$ renal sinus infiltration\n$\\checkmark$ small curvilinear areas of high attenuation\n$\\checkmark$ thickening of fascia of Gerota",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 110,
            "markdown": "$\\sqrt{ }$ perirenal nodules / plaques of soft-tissue density\n$\\sqrt{ }$ mass contiguous with retroperitoneal disease\n$\\sqrt{ }$ nephromegaly $\\leftarrow$ diffuse infiltration of interstitium (6-19\\%) sparing glomeruli and tubules):\n$\\sqrt{ }$ preservation of renal contour\n$\\sqrt{ }$ almost always bilateral\n$\\sqrt{ }$ encasement / deformation of pelvicaliceal system\n\n- clinically silent $\\rightarrow$ presenting with $\\Downarrow$ renal function\n$\\sqrt{ }$ patency of renal vessels despite tumor encasement is CHARACTERISTIC\n$\\sqrt{ }$ wall thickening + enhancement of renal pelvis and ureter\nNECT:\n$\\sqrt{ }$ mass with slightly higher attenuation than normal surrounding parenchyma\nCT (nephrographic phase most sensitive for detection):\n$\\sqrt{ }$ usually homogeneous poorly marginated masses less dense than renal parenchyma + decreased enhancement compared with renal parenchyma\nMR:\n$\\sqrt{ }$ iso- to hypointense SI on T1WI relative to normal cortex\n$\\sqrt{ }$ hypointense on T2WI relative to normal cortex\n$\\sqrt{ }$ lymphomatous deposits enhance less than normal parenchyma $\\pm$ progressive delayed enhancement\nUS:\n$\\sqrt{ }$ single / multiple anechoic / hypoechoic masses:\n$\\sqrt{ }$ may show increased through transmission\n$\\sqrt{ }$ renal enlargement + decreased parenchymal echoes\n$\\sqrt{ }$ loss of renal sinus echoes\n$\\sqrt{ }$ little lesion vascularity + displacement of renal vessels\nPET:\n$\\sqrt{ }$ hypermetabolic activity\nAngio:\n$\\sqrt{ }$ neovascularity, encasement, vascular displacement (occasionally palisade-like configuration)\n$D D x$ of nodular mass:\n(1) RCC (more heterogeneous, vascular invasion)\n(2) Metastases $\\leftarrow$ lung, breast, stomach, melanoma, synchronous renal cell cancer\n(3) Acute pyelonephritis, septic emboli, renal infarct, abscess\n\nDDx of perinephric lymphoma:\nsarcoma arising from renal capsule, perinephric metastases, perinephric hematoma, retroperitoneal fibrosis, amyloidosis, extramedullary hematopoiesis\n$D D x$ of infiltrative tumor:\nTCC, acute / xanthogranulomatous pyelonephritis\n\n# MALAKOPLAKIA \n\n[ malaka, Greek = soft; plakos, Greek = flat surface]\n= uncommon chronic granulomatous inflammatory response to gram-negative infection that can affect any organ",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 111,
            "markdown": "Frequency: $<200$ cases reported\nOrganism: E. coli (in 94\\%)\nPredisposed: diabetes mellitus, immunocompromised\nPathogenesis: altered host response to infection at the macrophage level = engulfed organisms remain viable + become a source for recurring infection\nHisto: submucosal histiocytic granulomas containing large foamy mononuclear cells (Hansemann macrophages) with calcified intracytoplasmic basophilic PAS-positive inclusion bodies (Michaelis-Gutmann bodies = calculospherules) consisting of incompletely destroyed E. coli bacterium surrounded by lipoprotein membranes\nPeak age: $5^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\n\n- recurrent urinary tract infections: hesitancy, dysuria, frequency\n- variable proteinuria, leukocytes + erythrocytes in urine\n- gross hematuria\n- cystoscopy: raised soft yellow-brown lesion $<3 \\mathrm{~cm}$ in diameter, nodules, papillary lesions, hemorrhagic masses, necrotic ulcerations\nLocation:\n> bladder $>$ lower $2 / 3$ of ureter $>$ upper ureter $>$ renal pelvis; multifocal in $75 \\%$; bilateral in $50 \\%$\n> outside urinary tract\n@ Bladder ( $40 \\%$ ) / ureter\n$\\checkmark$ multiple nodular dome-shaped smooth mural filling defects of collecting system\n$\\checkmark$ scalloped appearance if lesions confluent\n$\\checkmark$ generalized pelviureteral dilatation (if obstructive)\n$\\checkmark$ vesicoureteral reflux\n$\\checkmark$ circumferential bladder wall thickening\n$\\checkmark$ invasion of perivesical space\n$D D x$ : pyeloureteritis cystica\n@ Kidney ( $16 \\%$ )\n$\\checkmark$ diffuse renal enlargement (bilateral involvement unusual)\n$\\checkmark$ displacement of pelvicaliceal system + distortion of central sinus complex\n$\\checkmark$ multifocal parenchymal masses $\\rightarrow \\pm$ diminished / absent nephrogram\n$\\checkmark$ urinary tract calcification rare\nUS:\n$\\checkmark$ lesions of variable echogenicity\nCT:\n$\\checkmark$ ill-defined low-attenuation lesions\n$\\checkmark \\pm$ perinephric extension\n$D D x$ : infiltrative neoplasm; XGP (unilateral, urinary tract calcification)\n$R x$ : antibiotics, ascorbic acid, cholinergic agonist\n\n\n# MALPOSITIONED TESTIS \n\n$=$ MALDESCENDED TESTIS\nTesticles are normally within scrotum by 28-32 weeks MA\nPrevalence: early $3^{\\text {rd }}$ trimester in $10 \\%$; at birth in $3.7-6.0 \\%$ (in babies $>2,500 \\mathrm{~g}$ in $3.4 \\%$; in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 112,
            "markdown": "premature babies in $30 \\%$ ); beyond 3 months of age in $1 \\%$\nTest sensitivity:\nMR modality of choice; $84-96 \\%$ sensitive; $100 \\%$ specific\nUS: $\\quad 20-45-88 \\%$ (very sensitive in inguinal canal); $78 \\%$ specific, $88 \\%$ accurate\nCT: $\\quad 95 \\%$ (testis $<1 \\mathrm{~cm}$ cannot be detected)\n$\\checkmark$ no spermatic cord in inguinal canal\nVenography: $50-90 \\%$\nLaparoscopy: most reliable method\nCx: (1) Sterility\n(2) Malignancy: most commonly seminoma, $30-50 \\mathrm{x}$ risk increase $=1 \\div 1,000 \\mathrm{men}$ annually; $4-11 \\%$ of all testicular tumors found in cryptorchidism; risk remains increased even after orchiopexy\n$\\diamond$ Annual screening until at least age 35 !\n(3) Torsion: 10 x risk in cryptorchidism\n\nRx: surgery / orchiopexy at $9-12$ months of age\n$D D x$ : (1) Rudimentary testis\n(2) Pars intravaginalis gubernaculum $=$ nonatrophied bulbous termination\n(3) Congenital absence $=$ monorchia $/$ anorchia (in $3-5 \\%$ )\n$\\diamond$ Nonpalpable testes are agenetic in $15-63 \\%$ of term infants!\n\n# Cryptorchidism (20-29\\%) \n\n$=$ arrested migration of testis along its normal course through internal inguinal ring, inguinal canal, external inguinal ring into scrotal sac\nPrevalence: $9-30 \\%$ in premature infants;\n$3.4-5.8 \\%$ in full-term infants\nPathophysiologic theory:\ngeneralized defect in embryogenesis results in bilateral dysgenetic gonads\nTheory supported by:\n> cancer risk extends to contralateral testis\n> orchiopexy does not decrease cancer risk\n> cancer risk increases with degree of ectopy\nAssociated with: prune belly syndrome (bilateral cryptorchidism), Prader-Willi syndrome, Beckwith-Wiedemann syndrome, Noonan syndrome, Laurence-Moon-Biedl syndrome, trisomies 13, 18, 21\n\n- nonpalpable testis means:\n> in $41 \\%$ testis atrophic / absent\n> in $39 \\%$ testis distal to external inguinal ring / in inguinal canal\n$>$ in $20 \\%$ testis intraabdominal\nLocation: bilateral in $10 \\%$\n(a) canalicular $=$ between internal + external inguinal ring $(70 \\%)$\n(b) prescrotal region = high scrotal position below external inguinal ring (20\\%)\n(c) abdominal $(10 \\%)$\n$\\diamond$ The most craniad possible point of an undescended testis is the lower pole of the",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 113,
            "markdown": "ipsilateral kidney!\n$\\sqrt{ }$ failure to visualize testis within scrotum\n$\\sqrt{ }$ empty ipsilateral scrotal sac + intra-abdominal mass\nUS:\n$\\sqrt{ }$ often small atrophic testis with generalized decreased / similar echogenicity compared to contralateral testis\n$\\sqrt{ }$ identification of mediastinum testis is necessary\n$\\sqrt{ } \\pm$ testicular microlithiasis\nMR (key tool in localization of undescended testis; $62 \\%$ sensitive):\n$\\sqrt{ }$ signal characteristics similar to contralateral / normal testis\n$\\sqrt{ }$ usually homogeneously hypointense on T1WI\n$\\sqrt{ }$ homogeneously hyperintense on T2WI\n$\\sqrt{ }$ markedly hyperintense on DWI\n$D D x:$ lymph node\n\n# Ectopia Testis (1\\%) \n\n$=$ deviation from the usual pathway\nLocation:\n(a) interstitial = groin (on external oblique muscle)\n(b) pubopenile $=$ root of penis, perineal, femoral triangle, on opposite side\n\n## Pseudocryptorchidism (70\\%)\n\n$=$ RETRACTILE TESTIS\n$=$ unusually spastic cremasteric muscle\n\n## Undescended Testis\n\n$=$ retractile testis + cryptorchidism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 114,
            "markdown": "# MECKEL-GRUBER SYNDROME \n\n$=$ autosomal-recessive perinatally lethal disease characterized by occipital encephalocele, polycystic kidneys, polydactyly\nPrevalence: $1 \\div 12,000$ to $1 \\div 50,000$; more common among Yemenite Jews\nRisk of recurrence: $25 \\%$; carrier frequency of $1 \\div 56$\n\n- history of affected siblings, microphthalmia\n\nOB-US:\n$\\checkmark$ large polycystic kidneys containing $2-10-\\mathrm{mm}$ cysts\n$\\checkmark$ occipital encephalocele\n$\\checkmark$ postaxial polydactyly\n$\\checkmark$ other intracranial abnormalities: microcephaly, Dandy-Walker malformation\n$\\checkmark$ cleft lip and palate\n$\\checkmark$ cardiac anomalies\n$\\checkmark$ ductal plate malformation of liver\n$\\checkmark$ ambiguous genitalia in males\n$\\checkmark$ moderate-to-severe oligohydramnios (onset midtrimester)\n$\\checkmark$ inability to visualize urine in fetal bladder\nOB management:\n\n1. Chromosomal analysis to exclude trisomy 13 (if no prior family history)\n2. Option of pregnancy termination $<24$ weeks GA\n3. Nonintervention for fetal distress $>24$ weeks GA\n\nPrognosis: invariably fatal at birth $\\leftarrow$ pulmonary hypoplasia with renal failure\n$D D x:$ trisomy 13\n\n## MEDULLARY CYSTIC DISEASE\n\n$=$ NEPHRONOPHTHISIS\n$=$ autosomal dominant salt-wasting nephropathy characterized by multiple medullary cysts + tubulointerstitial nephropathy\nGenetics: mutations in $>13$ different recessive genes $\\rightarrow$ ciliary dysfunction\n(a) MCKD1 gene located on chromosome 1 p12 encoding an as of yet unidentified protein product\n(b) MCKD2 gene located on chromosome 16p12 encoding protein uromodulin (TammHorsfall glycoprotein)\n(c) NPHP1, NPHP2, NPHP3 (nephronophthisis) mutations\n\nPath: tubulointerstitial fibrosis $\\rightarrow$ small kidneys with $1.0-1.5 \\mathrm{~cm}$ corticomedullary cysts (in $70 \\%)$\nHisto: variable number of medullary cysts ( $100 \\mu \\mathrm{~m}$ to 2 cm$)+$ progressive periglomerular and interstitial fibrosis + tubular atrophy with dilatation of proximal tubules\nTypes:\n(1) Medullary Cystic Disease $=$ ADULT ONSETautosomal dominant, in young adults, rapidly progressive course with uremia + death in 2 years\nMedian age at uremia: $62(50-70)$ years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 115,
            "markdown": "(2) Juvenile Nephronophthisis $=$ JUVENILE ONSET $=$ UREMIC MEDULLARY CYSTIC DISEASE autosomal recessive, in children 3-6 years, average duration of 10 years before uremia and death occurs\nMedian age at uremia: 32 (20-60) years\n(3) Infantile nephronophthisis\n\nMay be associated with: retinal degeneration\n\n- urinary concentration defect $\\rightarrow$ hyposthenuria + salt-wasting\n- polyuria, polydipsia $\\rightarrow$ dehydration\n- failure to thrive, growth retardation (in early teens)\n- uremia, severe anemia, normal sediment\n- hypertension (only in late phase)\n- adult-onset hyperuricemia + gout\n\nSize of kidneys: small to normal\nSize of cysts: $<3 \\mathrm{~cm}$\n$\\sqrt{ }$ smoothly contoured kidneys with thin cortex\nIVP:\n$\\checkmark$ poor opacification of renal collecting system\n$\\checkmark$ \"medullary nephrogram\" = medullary striations persistent for up to 2 hours; occasionally replaced by sharply defined multiple thin-walled lucencies\nRetrograde pyelogram:\n$\\checkmark$ communication between collecting system + cysts\nUS / CT / MR:\n$\\checkmark$ increased parenchymal echogenicity + poor corticomedullary differentiation\n$\\checkmark$ multiple small medullary / corticomedullary cysts ( $70 \\%$ ) (secondary feature NOT essential for diagnosis)\n$D D x$ : medullary sponge kidney, multicystic dysplastic kidney, lithium-induced renal disease\n\n# MEDULLARY RENAL TUMOR \n\nFrequency: $1-2 \\%$ of all renal cancers\n\n## Collecting Duct Carcinoma\n\n$=$ BELLINI DUCT CARCINOMA\nFrequency: $\\sim 100$ cases reported in literature\nMean age: 55 (range, 13-80) years\nHisto: mostly high-grade tumor\n\n- abdominal pain, flank mass, hematuria\n$\\diamond$ In $40 \\%$ metastasized at presentation\n$\\checkmark$ infiltrative neoplasm centered in medulla:\n$\\checkmark$ renal sinus invasion\n$\\checkmark$ extension into cortex (frequent)\n$\\checkmark \\pm$ coexisting expansile component\n$\\checkmark$ large tumor at presentation\nUS: Vhyperechoic mass\nAngio: Vhypovascular mass",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 116,
            "markdown": "MR: Vhypointense mass on T2WI\nPrognosis: aggressive clinical course with $33 \\%$ surviving $>2$ years\n\n# Renal Medullary Carcinoma \n\n$=$ highly aggressive malignant tumor of epithelial origin occurring almost exclusively in adolescent / young adult blacks with sickle cell trait / hemoglobin SC disease (termed \"7th sickle cell nephropathy\") but NOT with hemoglobin SS (sickle cell) disease\nOrigin: distal collecting duct / epithelium of papilla; ? aggressive form of collecting duct carcinoma\nMean age: 20 (range, 11-39) years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$ (if $<24$ years of age) and $1 \\div 1$ (if $>24$ years of age)\nHisto: poorly differentiated tumor cells within a desmoplastic stroma + mixed with reticular, yolk saclike, adenoid cystic components\n\n- abdominal / flank pain, gross hematuria\n- palpable mass, weight loss, fever\n- metastases at presentation common: regional lymph nodes, liver, lung, bone\n$\\sqrt{ }$ large ill-defined mass centered in renal medulla:\n$\\checkmark$ heterogeneous $\\leftarrow$ varying amounts of hemorrhage and necrosis\n$\\checkmark$ extension into renal sinus and cortex\n$\\checkmark \\pm$ peripheral caliectasis\n$\\checkmark$ heterogeneous enhancement\n$\\checkmark$ reniform enlargement with shape of kidney preserved\n$\\checkmark$ small peripheral satellite nodules\nPrognosis: mean survival rate of 15 weeks from diagnosis\n$D D x$ : transitional cell carcinoma, rhabdoid tumor\n\n\n## MEDULLARY SPONGE KIDNEY\n\n$=$ congenital developmental abnormality characterized by ectasia + cystic dilatation of intrapyramidal / intrapapillary portions of medullary collecting ducts (= first few generations of metanephric duct branchings)\nPrevalence: $1 \\div 5,000$ persons; in $0.5 \\%$ of IVPs; in $12-20 \\%$ of patients with calcified kidney stones\nAge: $3^{\\text {rd }}-4^{\\text {th }}$ decade\nGenetics: mostly sporadic, occasionally autosomal dominant\nPathogenesis: ? disruption in ureteric bud-metanephros interface during embryogenesis $\\rightarrow$ abnormal formation of medullary collecting ducts\nHisto: ectasia of medullary + papillary collecting ducts with small $<1 \\mathrm{~cm}$ cysts in medulla which are lined by columnar / transitional cell epithelium\nMay be associated with:\ncongenital hemihypertrophy, Beckwith-Wiedemann syndrome, Caroli syndrome, Wilms tumor, horseshoe kidney, Ehlers-Danlos syndrome, parathyroid adenoma\n\n- mostly asymptomatic; hematuria, renal colic, fever, dysuria\n\nLocation: usually both kidneys + all pyramids; may be unilateral (in up to $25 \\%$ ); may be segmental + involve only one pyramid (up to $25 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 117,
            "markdown": "$\\sqrt{ }$ persistent thick dense paintbrushlike streaks of contrast material (\"bunch of flowers\") extending from surface of papilla into medulla $\\leftarrow$ pooling of contrast material in dilated medullary collecting ducts\n$\\sqrt{ }$ striated / beaded appearance of medullary collecting ducts $\\rightarrow$ distortion of calices (in severe cases)\n$\\sqrt{ }$ medullary nephrocalcinosis ( $40-80 \\%$ ) with one / more calculi of up to 5 mm clustered in papillary region $\\leftarrow$ urinary stasis + hypercalciuria / acidification defects / distal renal tubular acidosis\nUS:\n$\\checkmark$ echogenic medulla (in absence of stones)\nCx: (1) Nephrolithiasis\n(2) Renal calculi $=$ urolithiasis\n(3) Hematuria\n(4) Urinary tract infection\n(5) Progressive renal failure (in severe cases)\n$D x$ : (1) Opacification of stone-free papillary cysts\n(2) Accumulation of contrast material around calculi within ectatic tubules / cysts\n$D D x$ :\n(1) Normal variant (\"papillary blush\" without distinct streaks / nephrocalcinosis / pyramidal enlargement)\n(2) Renal tuberculosis (larger more irregular calcifications + cavitations + strictures + ulcerations)\n(3) Papillary necrosis (\"sloughed papilla + caliceal ring\" sign)\n(4) Medullary nephrocalcinosis (no ectatic ducts / cysts, calcifications beyond pyramids)\n(5) Juvenile polycystic kidney disease (bilateral renal enlargement + hepatic periportal fibrosis)\n(6) Caliceal diverticulum (small, solitary, located between pyramids)\n\n# MEGACALICOSIS \n\n$=$ CONGENITAL MEGACALICES\n$=$ nonprogressive caliceal dilatation caused by hypoplastic medullary pyramids\nAge: any age; $\\mathrm{M}>>\\mathrm{F}$\nMay be associated with: primary megaureter\n\n- normal glomerular filtration rate\n\nSite: entire kidney / part of kidney; unilateral $>>$ bilateral\n$\\checkmark$ kidney usually enlarged with prominent fetal lobation\n$\\checkmark$ reduced parenchymal thickness (medulla affected, NOT cortex):\n$\\checkmark$ normal DMSA scintigram\n$\\checkmark$ mosaic-like arrangement of dilated calices (polygonal faceted appearance, NOT globular as in obstruction)\n$\\checkmark$ increased number of calices $(>15)$\n$\\checkmark$ ABSENT caliceal cupping (semilunar instead of pyramidal configuration of papillae)\n$\\checkmark$ NO dilatation of pelvis / ureters, NORMAL contrast excretion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 118,
            "markdown": "Cx: (1) Hematuria\n(2) Stone formation\n\n# MEGACYSTIS-MICROCOLON SYNDROME \n\n$=$ MEGALOCYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME (MMIH)\n$=$ functional obstruction of bladder + colon characterized by\n(a) enlarged urinary bladder\n(b) small colon\n(c) strikingly short small intestine suspended on a primitive dorsal mesentery\n(d) markedly enlarged hydronephrotic kidneys with little remaining parenchyma\n\nPrevalence: 26 cases reported; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 7$\nMay be associated with: diaphragmatic hernia, PDA, teeth at birth\n\n- distended abdomen (large bladder + dilated small bowel loops)\n- intestinal pseudoobstruction (poor emptying of stomach, NO peristaltic activity of small bowel); overflow incontinence\nOB-US:\n$\\checkmark$ normal amount of amniotic fluid / polyhydramnios (in spite of dilated bladder $=$ \"nonobstructive obstruction\")\n$\\checkmark$ massive + progressive bladder distension with poor emptying\n$\\checkmark$ bilateral megaloureters\n$\\checkmark \\pm$ hydronephrosis\n$\\checkmark$ female sex\nBE:\n$\\checkmark$ microcolon (= transient feature of \"unused colon\") with narrow rectum + sigmoid\n$\\checkmark$ malrotation / malfixation or foreshortening of small bowel\nVCUG\n$\\checkmark$ distended unobstructed bladder with poor / absent muscular function\nPrognosis: lethal in most cases (at a few months of age)\n\n\n## MEGALOURETER\n\n$=$ CONGENITAL PRIMARY MEGAURETER $=$ TERMINALURETERECTASIS $=$ ACHALASIA OF URETER $=$ URETEROVESICALJUNCTION OBSTRUCTION\n$=$ intrinsic congenital dilatation of lower juxtavesical orthotopic ureter $\\geq 7 \\mathrm{~mm} \\leftarrow$ intrinsic smooth muscle dysfunction and abnormal peristalsis\nCause: aperistaltic juxtavesical ( 1.5 cm long) segment $\\leftarrow$ faulty development of muscle layers of ureter with too much collagen / too much muscle (functional, NOT mechanical obstruction) = \"Hirschsprung disease of ureter\"\nFrequency: $2^{\\text {nd }}$ most common cause of hydronephrosis in fetus and newborn\nAge: any; $\\mathrm{M} \\div \\mathrm{F}=2-5 \\div 1$\nAssociated disorders (in 40\\%):\n(a) contralateral: UPJ obstruction, reflux, ureterocele, ureteral duplication, renal ectopia, renal agenesis\n(b) ipsilateral: caliceal diverticulum, megacalycosis, papillary necrosis\n\n- asymptomatic (mostly), abdominal mass, pain",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 119,
            "markdown": "- hematuria, infection\n\nLocation: $\\mathrm{L}+\\mathrm{R}=3 \\div 1$, bilateral in $15-40 \\%$\nGrading system:\nI (mild) = distal $1 / 3$ of ureter involved\nII (moderate) = entire ureter involved $\\pm$ caliectasis\nIII (severe) = entire ureter + moderate to marked caliectasis\n$\\sqrt{ }$ prominent localized dilatation of pelvic ureter (up to 5 cm in diameter) usually not progressive, but may involve entire ureter + collecting system\n$\\checkmark$ vigorous nonpropulsive to-and-fro motion in dilated segment\n$\\checkmark$ functional \"beaking\" / gradual tapering (= smoothly tapered narrowing) of abnormal distal ureter without peristalsis\n$\\sqrt{ }$ NO reflux, NO stenosis\n\n# Secondary Megaureter \n\n$=$ ureteral dilatation $\\leftarrow$ any other cause than primary megaureter\nCause: neurogenic bladder, bladder outlet obstruction, posterior urethral valve, obstructing calculus\n\n## MESOBLASTIC NEPHROMA\n\n$=$ FETAL RENAL HAMARTOMA $=$ LEIOMYOMATOUS HAMARTOMA $=$ BENIGN CONGENITAL WILMS TUMOR $=$ BENIGN FETAL HAMARTOMA $=$ FETAL MESENCHYMAL TUMOR $=$ FIBROMYXOMA $=$ BOLANDE TUMOR = CONGENITAL FIBROSARCOMA = CONGENITAL MESOBLASTIC NEPHROMA (CMN)\n$=$ nonfamilial benign fibromyomatoid mass arising from renal connective tissue; first described in 1967\nIncidence: most common solid renal neoplasm discovered in $2^{\\text {nd }} / 3^{\\text {rd }}$ trimester, in neonate or in infant $<1$ year; $3-6 \\%$ of all renal neoplasms in children\nPeak age: 1-3 months; $90 \\%$ within $1^{\\text {st }}$ year of life; rare after the age of 6 months; may occasionally go undetected until adulthood; $\\mathrm{M}+\\mathrm{F}=1.5 \\div 1$\nPath: solid unencapsulated mass infiltrating renal parenchyma (derived from early nephrogenic mesenchyme) $\\rightarrow$ sparing renal pelvis + vascular pedicle\nSubtypes:\n\n1. Classic benign mesoblastic nephroma $\\left(<1 / 3\\right)$\n$=$ represents infantile fibromatosis\nAge: $<3$ months\nPath: little hemorrhage + cystic / necrotic change\nHisto: monomorphic tumor composed of uniform elongated spindle cells arranged in bundles resembling leiomyoma with interspersed areas of entrapped normal embryonic glomeruli, tubules vessels, hematopoietic cells, cartilage\n$\\sqrt{ }$ often infiltrative tumor with extension into renal hilum / perinephric fat\n2. Cellular aggressive mesoblastic nephroma (42-63\\%)\n$=$ visceral form of infantile fibrosarcoma\nAge: $>3$ months\nPath: identical to infantile fibrosarcoma; much larger soft fleshy tumor; tendency to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 120,
            "markdown": "invade perinephric fat + connective tissue; multicystic areas of intratumoral hemorrhage and fluid accumulation (cysts + necrosis)\nHisto: haphazardly arranged sheets of spindle cells with limited tendency to form interlacing bundles\n$\\sqrt{ }$ fluid-filled spaces $\\leftarrow$ hemorrhage, necrosis, cyst formation\n3. Both patterns (in $10-20 \\%$ )\n\nIn $14 \\%$ associated with: prematurity, polyhydramnios, GI + GU tract malformations, neuroblastoma\n\n- large palpable abdominal / flank mass within first 6 months of life (most common); hypercalcemia, anemia, vomiting\n- hematuria (20\\%) / hypertension (4\\%) $\\leftarrow \\uparrow$ renin production\n$\\sqrt{ }$ large usually solid intrarenal mass:\n$\\checkmark$ usually replaces $60-90 \\%$ of renal parenchyma\n$\\checkmark$ typically involves renal sinus\n$\\checkmark$ may produce multiple cystic spaces $\\leftarrow$ hemorrhage, necrosis\n$\\checkmark$ infiltrative growth:\n$\\checkmark$ NO sharp cleavage plane toward normal parenchyma\n$\\checkmark$ may extend beyond capsule (common)\n$\\checkmark$ involvement of renal hilum without invasion of vessels\n$\\checkmark$ calcifications (rare)\n$\\checkmark$ NO venous extension (DDx: Wilms tumor)\n$\\checkmark$ NO invasion of collecting system\nIVP:\n$\\checkmark$ large noncalcified renal mass with distortion of collecting system\n$\\checkmark$ usually NO herniation into renal pelvis (DDx: MLCN)\nCECT:\n$\\checkmark$ minimal predominantly peripheral enhancement $\\leftarrow$ functioning entrapped renal elements at tumor periphery\n$\\checkmark$ areas of low attenuation in large lesions $\\leftarrow$ hemorrhage / necrosis\nMR:\n$\\checkmark$ iso- to hypointense on T1WI\n$\\checkmark$ variable from markedly hypo- to hyperintense on T2WI\n$\\checkmark$ restricted diffusion in solid portion $\\leftarrow$ increased cellularity\n$\\checkmark$ focal areas of T1 shortening $\\leftarrow$ hemorrhage\nUS:\n$\\checkmark$ evenly echogenic tumor resembling uterine fibroids\n$\\checkmark$ \"ring\" sign = concentric rings of alternating hyper- and hypoechogenicity surrounding tumor\n$\\leftarrow$ peripheral dilated blood vessels\n$\\checkmark$ homogeneously hypoechoic tumor\n$\\checkmark$ complex heterogeneous mass with hemorrhage + cyst formation + necrosis\nOB-US (prenatal detection often possible in $3^{\\text {rd }}$ trimester):\n- rapid unexplained increase in fundal height\n- premature delivery, increased renin levels\n$\\checkmark$ polyhydramnios, hydrops",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 121,
            "markdown": "$C x$ : pre-term labor, premature rupture of membranes\nAngio:\n$\\checkmark$ hypervascular mass with neovascularity + displacement of adjacent vessels\nCx: (1) Transformation to metastasizing spindle cell sarcoma (rare)\n(2) Metastases to lung, brain, bone (rare)\n\nDx: Cellular CMN is indistinguishable from Wilms tumor.\nWhile Wilms tumor is the most common pediatric renal tumor, congenital mesoblastic nephroma is more common in young infants. With bilateral tumors, venous invasion, or pulmonary metastases Wilms tumor is more likely.\n$R x$ : radical nephrectomy with wide surgical margin; $10 \\%$ relapse ( $\\leftarrow$ local recurrence / metastases to lung, heart, bone, brain, liver)\nPrognosis: excellent (imaging follow-up for 1 year)\n$D D x$ : (1) Wilms tumor (peaks at 3-4 years, history of nephroblastomatosis, associated congenital syndromes, bilateral, vascular invasion, pulmonary metastases)\n(2) Clear cell sarcoma (age $>1$ year; bone metastases)\n(3) Rhabdoid tumor (local + distant metastases to lung, abdominal lymph nodes, liver, bone; associated with intracranial tumor)\n(4) Multilocular cystic nephroma (boys between 3 months and 4 years; wellcircumscribed encapsulated multiloculated cystic mass + enhancing septa)\n(5) Neuroblastoma (inferior displacement of ipsilateral kidney; encasement of adjacent blood vessels, crosses midline, invasion of spinal canal, tumoral calcifications)\n(6) Ossifying renal tumor of infancy (calcified osteoid matrix)\n\n# METANEPHRIC ADENOMA \n\n$=$ NEPHROGENIC ADENOFIBROMA $=$ EMBRYONAL ADENOMA\nAge: any (range, 15 months -83 years); $\\mathrm{M}<\\mathrm{F}$\nHisto: proliferation of spindle-shaped mesenchymal cells encasing nodules of embryonal epithelium; numerous psammoma bodies\n\n- pain, hematoma, flank mass\n- hypercalcemia, polycythemia, hypertension\n\nUS:\n$\\checkmark$ well-defined solid hypovascular mass\n$\\checkmark$ hypo- / hyperechoic / cystic with mural nodule\nCT:\n$\\checkmark$ iso- / hypoattenuating mass + little enhancement\n$\\checkmark \\pm$ small calcifications\n$R x$ : local resection with sparing of kidney\n\n## METASTASIS TO ADRENAL GLAND\n\nFrequency: $4^{\\text {th }}$ most common site of metastatic disease in the body; in $3 \\%$ of all autopsy cases (in $27 \\%$ with known primary)\n$\\diamond 50 \\%$ of adrenal masses in oncologic patients represent benign nonhyperfunctioning",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 122,
            "markdown": "# adenomas! \n\n$\\diamond$ An adrenal mass in a patient with a malignancy is a metastasis in $30-40 \\%$ !\nOrigin: lung ( $40 \\%$ ), breast ( $20 \\%$ ), colon, stomach, lymphoma, malignant melanoma, renal cell carcinoma, prostate, pancreas, thyroid\nLocation: bilateral ( $49 \\%$ ); $\\mathrm{L} \\div \\mathrm{R}=1.5 \\div 1$; collision tumor $=$ rare coexistence of metastasis + adenoma\n$\\checkmark$ large heterogeneously attenuating mass with irregular contour and progressive heterogeneous enhancement\nMR:\n$\\checkmark$ lack of signal loss on out-of-phase images (DDx: adrenal adenoma)\n$\\checkmark$ low-signal intensity on T1WI $\\leftarrow$ edema, necrosis\n$\\checkmark$ heterogeneous high-signal intensity on T2WI\nCEMR:\n$\\checkmark$ strong rapid progressive enhancement\n$\\checkmark$ prolonged retention of contrast material $\\leftarrow$ large interstitial spaces of edema + necrosis PET:\n$\\checkmark 18 \\mathrm{~F}$-fluorodeoxyglucose uptake in $100 \\%$ with rare false-positive results\n$D x:$ biopsy\n$D D x$ : adenoma (intracytoplasmic lipid $\\rightarrow$ chemical shift artifact + significant decrease in SI on out-of-phase GRE)\n\n## METASTASIS TO KIDNEY\n\n$\\diamond$ Most common malignant tumor of the kidney ( $2-3$ times as frequent as primaries in autopsy studies)!\n$\\diamond 5^{\\text {th }}$ most common site of metastases (after lung, liver, bone, adrenals)!\nFrequency: $7-13 \\%$ in large autopsy series\n$\\diamond$ Renal metastases typically means advanced disease!\n\n## most common primaries:\n\nbronchus, breast, GI tract, opposite kidney, non-Hodgkin lymphoma, colon, neuroblastoma (in children)\nless common primaries:\nstomach, cervix, ovary, pancreas, prostate, chloroma, myeloblastoma, myeloblastic sarcoma, melanoma ( $45 \\%$ incidence), osteogenic sarcoma, choriocarcinoma ( $10-50 \\%$ incidence), Hodgkin lymphoma, rhabdomyosarcoma\n\n- usually asymptomatic\n$\\checkmark$ bilateral multiple small masses $\\leftarrow$ brief survival of patient\n$\\checkmark$ solitary exophytic mass (in colon cancer)\n$\\checkmark$ perinephric tumor (in melanoma)\n$\\checkmark$ infiltrative growth pattern\nDDx on CT: lymphoma, bilateral RCC, multiple renal infarcts, acute focal bacterial nephritis, infiltrating TCC\n\n\n## METASTASIS TO URETER\n\n$\\diamond$ Hematogenous metastases to the ureter are rare!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 123,
            "markdown": "most common primaries: breast, GI tract, prostate, cervix\n\n# MIXED EPITHELIAL AND STROMAL TUMOR \n\n$=$ MEST $=$ LEIOMYOMATOUS RENAL HAMARTOMA $=$ CYSTIC HAMARTOMA OF RENAL PELVIS $=$ ADULT TYPE MESOBLASTIC NEPHROMA $=$ MULTILOCULAR CYST WITH OVARIAN STROMA\nPrevalence: $<100$ cases reported in literature\nAverage age: 56 (range, 17-84) years; $\\mathrm{M}+\\mathrm{F}=1 \\div 11$\nAssociated with: oral estrogen supplements / contraceptives\nPath: benign complex solid + cystic renal tumor\nHisto: > stromal spindle cells mimicking ovarian stroma with estrogen + progesterone receptors, and\n> epithelium-lined cysts / microcysts\n\n- hematuria, flank pain, palpable mass, urinary tract infection\n- asymptomatic $(1 / 4)$\n$\\sqrt{ }$ well-circumscribed expansile multiseptate complex (= cystic and solid) mass\n$\\sqrt{ }$ may herniate into renal pelvis\n$\\checkmark$ variable contrast enhancement of intervening septa\n$\\checkmark$ delayed contrast enhancement\n$\\checkmark \\pm$ adipose tissue\n$\\checkmark \\pm$ enhancing mural nodule / mural calcifications\n$\\checkmark \\pm$ intralesional hemorrhage\nUS:\n$\\checkmark$ heterogeneous hyperechoic / partially cystic mass\nMR:\n$\\checkmark$ cystic region with T1 hypointensity + T2 hyperintensity\n$\\checkmark$ nodular component T1 hyperintense + T2 hypointense\n$R x:$ surgery (impossible DDx from cystic RRC)\n$D D x$ : (1) Multilocular cystic renal tumor - adult cystic nephroma\n(2) Cystic renal cell carcinoma\n(3) Complex renal cyst\n(4) Multicystic dysplastic kidney\n(5) Obstructed duplicated renal collecting system\n(6) Renal abscess\n\n\n## MÃLLERIAN DUCT CYST\n\n$=$ failed regression of paramesonephric (= mÃ¼llerian) duct which usually regresses by $3^{\\text {rd }}$ fetal month\nPrevalence: $4-5 \\%$ of male newborns; in $1 \\%$ of men\nPeak age: $20-40$ years\n\n- obstructive / irritative urinary tract symptoms\n- suprapubic / rectal pain, hematuria\n- infertility $\\leftarrow$ most common cause of ejaculatory duct obstruction\n\nLocation: arises from region of verumontanum slightly lateral to midline",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 124,
            "markdown": "$\\diamond$ No communication with genital tract / urethra; connected by thin stalk\nAssociated with: typically NO other congenital anomalies; renal agenesis (rare)\n$\\sqrt{ }$ large teardrop-shaped intraprostatic cyst usually with extension superolaterally above prostate\n$\\checkmark$ aspirate contains serous / mucous clear brown / green fluid (hemorrhage + debris), NOT spermatozoa\n$\\checkmark$ commonly contains calculi\nMR:\n$\\checkmark$ increased signal on T1WI $\\leftarrow$ hemorrhage, protein\nCx: infection, hemorrhage, carcinomatous transformation\n$D D x$ : posterior bladder diverticulum, urethral diverticulum, utricle cyst, vas deferens cyst, seminal vesicle cyst\n\n# MULTICYSTIC DYSPLASTIC KIDNEY \n\n$=$ MULTICYSTIC DYSGENETIC KIDNEY (MCDK) = MULTICYSTIC KIDNEY (MCK) = Potter Type II\n$=$ nonheritable developmental disorder in which kidney is replaced by nonfunctioning noncommunicating cysts\n$\\diamond 2^{\\text {nd }}$ most common cause of an abdominal mass in neonate (after hydronephrosis)!\n$\\diamond$ Most common form of cystic disease in infants!\nPrevalence: $1 \\div 4,300$ (for unilateral MCDK), $1 \\div 10,000$ (for bilateral MCDK) live births; $\\mathrm{M} \\div \\mathrm{F}$ $=2 \\div 1$ (for unilateral MCDK); more common among infants of diabetic mothers\nRisk of recurrence: $2-3 \\%$\nGenetics: sporadic NOT familial\nEtiology: obstruction / atresia of ureter during metanephric stage before $8-10$ weeks GA\nPathophysiology: interference with ureteral bud division $\\rightarrow$ inhibiting induction and maturation of nephrons and various stromal renal elements; collecting tubules enlarge into cysts\nHisto: immature glomeruli + tubules reduced in number + whirling mesenchymal tissue, cartilage ( $33 \\%$ ), cysts\n\n- abdominal mass\n- asymptomatic if unilateral (may go undetected until adulthood)\n- recurrent urinary tract infections, intermittent abdominal pain, nausea + vomiting, hematuria, failure to thrive\n- fatal $\\leftarrow$ pulmonary hypoplasia if bilateral\n\nFatal form: bilateral MCDK (4.5-21\\%), contralateral renal agenesis ( $0-11 \\%$ )\nLocation:\n\n1. UNILATERAL multicystic dysplastic kidney ( $80-90 \\%$ )\nmost common form ( $80-90 \\%$ ); $\\mathrm{L} \\div \\mathrm{R}=2 \\div 1$\nCause: pelvoinfundibular atresia\nIn 33 (range, 20-50)\\% associated with anomalies of the contralateral kidney:\n(1) Vesicoureteral reflux $15-43 \\%$\n(2) Ureteropelvic junction obstruction $7-27 \\%$\n(3) Horseshoe kidney $5-9 \\%$\n(4) Ureteral anomalies $5 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 125,
            "markdown": "(5) Renal hypoplasia $4 \\%$\n(6) Megaloureter\n(7) Malrotation\n(8) Renal agenesis\n\nAssociated with anomalies of the ipsilateral kidney:\n(1) Vesicoureteral reflux (25\\%)\n(2) Ectopic ureter\n2. SEGMENTAL / focal renal dysplasia\n$=$ \"multilocular cyst\" secondary to\n(a) high-grade obstruction of upper pole moiety in duplex kidney from ectopic ureterocele\n(b) single obstructed infundibulum\n3. BILATERAL cystic dysplasia\nin the presence of severe obstruction in utero from posterior urethral valves / urethral atresia with oligohydramnios + pulmonary hypoplasia\nPrognosis: lethal\n\n# Potter types: \n\n(1) Multicystic kidney (Potter IIa)\n$\\sqrt{ }$ large kidney with multiple large cysts + little visible renal parenchyma\n(2) Hypoplastic / diminutive form (Potter IIb)\n$\\checkmark$ echogenic small kidney\nTime of appearance:\n(A) RELATED TO SITE OF OBSTRUCTION\n@ ureteropelvic junction\n$\\checkmark$ single / several large / multiple medium-sized cysts in large kidney\n@ distal ureter / urethra\n$\\checkmark$ small / no cysts in small kidney\n(B) RELATED TO TIME OF INSULT\n(a) early onset between $8^{\\text {th }}$ and $11^{\\text {th }}$ week\n$\\checkmark$ small / atretic renal pelvis + calices\n$\\checkmark 10-20$ cysts + loss of reniform appearance\n(b) late onset $=$ HYDRONEPHROTIC FORM\n$\\checkmark$ large central cyst (= dilated pelvis) often communicating with cysts\n$\\checkmark$ some renal function may be demonstrated\n$\\checkmark$ imaging appearance of MCDK varies by age:\n$\\checkmark$ large kidney with lobulated contour in infancy\n$\\checkmark$ often incidental finding of small kidney in adult (as little as $1 \\mathrm{~g} \\leftarrow$ arrested growth)\n$\\checkmark$ calcification: curvilinear / ringlike in wall of cysts in $30 \\%$ of adults, rarely in children\n$\\checkmark$ central region of soft tissue\n$\\checkmark$ peripheral noncommunicating cysts $\\pm$ calcifications\n$\\checkmark$ absence / severe atrophy of ipsilateral ureter + renal collecting system + renal vasculature\n$\\checkmark$ contralateral renal hypertrophy\n$\\checkmark$ contralateral vesicoureteral reflux (VUR) in 5-43\\%\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MAG 3):\n$\\diamond$ NUC preferred over IVP in first month of life as concentrating ability of even normal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 126,
            "markdown": "neonatal kidneys is suboptimal!\n$\\sqrt{ }$ NO function\n$D D x$ : severe hydronephrosis (peripheral activity), UPJ obstruction (minimal uptake)\nUS:\n$\\sqrt{ }$ normal renal architecture replaced by:\n$\\sqrt{ }$ random cysts of varying shape + size (\"cluster of grapes\") with largest cyst in peripheral nonmedial location ( $100 \\%$ accurate)\n$\\sqrt{ }$ cysts separated by septa ( $100 \\%$ accurate)\n$\\sqrt{ }$ no communication between multiple cysts ( $93 \\%$ accurate)\n$\\sqrt{ }$ cysts begin to disappear in infancy\n$\\sqrt{ }$ central sinus complex absent ( $100 \\%$ accurate)\n$\\sqrt{ }$ no identification of parenchymal rim or corticomedullary differentiation ( $74 \\%$ accurate)\n$\\sqrt{ }$ oligohydramnios in bilateral MCDK / unilateral MCDK + contralateral urinary obstruction\nAngio:\n$\\sqrt{ }$ absent / hypoplastic renal artery; angiography unnecessary since a DDx to long-standing functionless kidney is not possible\nOB management:\n(1) Routine antenatal care + evaluation by pediatric urologist following delivery if unilateral\n(2) Option of pregnancy termination if $\\leq 24$ weeks GA\n(3) Nonintervention for fetal distress if $>24$ weeks GA\n\nCx: (1) Renin-dependent hypertension (rare)\n(2) Malignancy in $<1 \\div 330$\n\nRx: (1) Follow-up in 3-4-month intervals in first year (isolated reports of developing malignancy)\n(2) Nephrectomy (in hypertension / massive renal enlargement)\n(3) Assessment of contralateral kidney for VUR\n\nDDx: (1) Hydronephrosis\n(2) Renal dysplasia with cysts (associated with partial obstruction)\n\n# MULTILOCULAR CYSTIC RENAL TUMOR \n\n$=$ MCRT $=$ MULTILOCULAR CYSTIC NEPHROMA (MLCN) $=$ POLYCYSTIC NEPHROBLASTOMA $=$ WELLDIFFERENTIATED POLYCYSTIC WILMS TUMOR $=$ BENIGN CYSTIC (PARTIALLY) DIFFERENTIATED NEPHROBLASTOMA $=$ MULTILOCULAR CYSTIC NEPHROMA $=$ PERLMAN TUMOR $=$ MULTILOCULAR RENAL CYST $=$ CYSTIC ADENOMA / HAMARTOMA / LYMPHANGIOMA $=$ PARTIALLY POLYCYSTIC KIDNEY\n$=$ rare nonhereditary benign renal neoplasm originating from metanephric blastema possibly representing the benign end of a spectrum with solid Wilms tumor at the malignant end\nAge: bimodal age + sex distribution: $<4$ years in $73 \\%$ male, $>4$ years in $89 \\%$ female\n(a) 3 months to 2 years of age ( $65 \\%$ ), 5-30 years (5\\%); $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\n(b) $>30$ (mostly, $40-60$ ) years ( $30 \\%$ ); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 8$\n$\\diamond 90 \\%$ of tumors in males occur in first 2 years of life (peak 3-24 months)!\n$\\diamond$ Most of the lesions in females occur between ages 4 and 20 or 40 and 60 !\nPath: solitary large well-circumscribed multiseptated mass of noncommunicating loculi,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 127,
            "markdown": "surrounded by thick fibrous capsule + compressed renal parenchyma\nSolid tumor portion: thin fibrous septa\n$\\diamond$ Solid nodules are absent!\nContent of loculi: colorless fluid / thick myxoid material\nSize of loculi: between a few mm to 4 cm\n$\\sqrt{ }$ tumor tendency to herniate into collecting system\nHisto: (gross anatomic + radiologic features are identical)\n\n1. Adult cystic nephroma\nfibrous tissue septa of undifferentiated mesenchymal and primitive glomerulotubular elements surround cysts lined by flattened eosinophilic cuboidal epithelium partially protruding into lumen in a hobnail / teardrop appearance; NO blastemal / other embryonal elements\n\n- typically seen in adult women\n\n2. Cystic partially differentiated nephroblastoma (CPDN)\npredominantly cystic lesion with septa containing primitive metanephric blastema\n\n- primarily in young boys\n$\\diamond$ No association with Wilms tumor!\n- commonly asymptomatic painless abdominal mass\n- $\\pm$ sudden and rapid enlargement, pain, urinary tract infection\n- hematuria $\\leftarrow$ tumor herniation into renal collecting system\n\nLocation: unilateral, often replacing an entire renal pole (usually lower pole)\nSize of tumor: $5-10 \\mathrm{~cm}$ (range, few cm to 33 cm )\n$\\sqrt{ }$ contrast enhancement of capsule + septations $\\leftarrow$ tortuous fine vessels course through septa\n$\\sqrt{ }$ curvilinear to flocculent calcification of septa / capsule in $5 \\%$\n$\\sqrt{ }$ absence of intratumoral / perinephric hemorrhage\nIVP:\n$\\sqrt{ }$ distortion of calices / hydronephrosis $\\leftarrow$ nonfunctional mass\n$\\sqrt{ }$ tendency for herniation of tumor cysts into renal pelvis and proximal ureter is CHARACTERISTIC (but nonspecific as it also occurs in Wilms tumor + RCC)\nUS:\n$\\sqrt{ }$ cystic mass with claw / beak shape of adjacent normal renal parenchyma $\\leftarrow$ intrarenal origin:\n$\\sqrt{ }$ cluster of cysts separated by thick septa (SUGGESTIVE):\n$\\sqrt{ }$ NO solid / nodular elements\n$\\sqrt{ }$ occasionally solid echogenic character $\\leftarrow$ closely packed acoustic interfaces with very small cysts / jellylike contents\n$\\sqrt{ } \\pm$ associated urinary tract obstruction\nCT:\n$\\sqrt{ }$ well-circumscribed (CHARACTERISTIC) multiseptated cystic renal mass:\n$\\sqrt{ }$ tumor encapsulated by thick fibrous capsule\n$\\sqrt{ }$ attenuation of cysts equal to / higher than water $\\leftarrow$ gelatinous fluid\n$\\sqrt{ }$ multicystic $=$ cluster of noncommunicating honeycombed cysts between a few mm and 4 cm in size\n$\\sqrt{ }$ cysts separated by variably enhancing thick septa",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 128,
            "markdown": "$\\sqrt{ }$ closely packed septa may appear as solid nodules but are separated by very small cystic spaces\nMR:\n$\\sqrt{ }$ multicystic mass of low signal intensity on T1WI + hyperintense on T2WI\n$\\checkmark$ hypointense capsule and septa on all sequences\n$\\checkmark$ variable SI of cyst content on T1WI $\\leftarrow$ old hemorrhage / concentrated protein\n$\\checkmark$ enhancing septa\nCx: local recurrence / coexistent Wilms tumor (very rare)\n$R x$ : nephrectomy with excellent prognosis\n$D D x$ : (1) Cystic Wilms tumor (overlapping age, expansile solid masses of nephroblastomatous tissue)\n(2) Clear cell sarcoma (poor prognosis)\n(3) Cystic mesoblastic nephroma (most common renal tumor of infancy)\n(4) Cystic RCC (mean age of 10 years)\n(5) Segmental form of multicystic dysplastic kidney (pre- / perinatal discovery in a duplex kidney)\n(6) Complex renal cysts\n(7) Mixed epithelial and stromal tumor\n(8) Severe hydronephrosis (cysts communicating with one another and with a large central cyst)\n(9) Complicated benign cyst / polycystic kidney disease\n\n# MULTIPLE MYELOMA \n\n$\\diamond$ It is essential that dehydration be avoided!\nImpairment of renal function:\n(1) Precipitation of abnormal proteins (Bence-Jones $\\pm$ Tamm-Horsfall protein casts) within tubule lumen $(30-50 \\%)$\n(2) Toxicity of Bence-Jones proteins on tubules\n(3) Impaired renal blood flow $\\leftarrow$ increased blood viscosity\n(4) Amyloidosis\n(5) Nephrocalcinosis from hypercalcemia\n$\\diamond$ Contrast-induced renal failure in multiple myeloma is not seen with greatly increased frequency!\n\n- Tamm-Horsfall proteinuria (tubular cell secretion)\n$\\checkmark$ smooth normal to large kidneys (initially), becoming small over time\n$\\checkmark$ occasionally attenuated pelvoinfundibulocaliceal system\n$\\checkmark$ normal to diminished contrast material density; increasingly dense in acute oliguric failure US:\n$\\checkmark$ normal to increased echogenicity\nNUC in bone scintigraphy:\n$\\checkmark$ nonspecific increased parenchymal activity\n\n\n## MYCETOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 129,
            "markdown": "$=$ FUNGUS BALL\nOrganism: typically Candida, Aspergillus, Mucor, Cryptococcus, Phycomycetes, Actinomycetes mostly mycelial (M-form) or occasionally yeast cells (Y-form)\nPredisposed: diabetics, debilitating illness, prolonged antibiotic therapy, leukemia, lymphoma, thymoma, immunosuppression\n\n- flank pain, passing of tissue, hematuria (extremely rare)\n- renal candidiasis associated with candidemia\n- Candida cystitis preceded by vaginal candidiasis\n$\\checkmark$ unilateral nonvisualization of kidney (most frequent)\n$\\checkmark$ large irregular filling defect extending into dilated calices (retrograde contrast study)\n$\\checkmark$ necrotizing papillitis from Candida nephritis (common)\n$\\checkmark$ lacelike pattern (on antegrade contrast study)\n\n\n# MYELOLIPOMA \n\n$=$ uncommon benign tumor composed of hematopoietic cells + mature fat resembling bone marrow\nPrevalence: $0.08-0.20 \\%$ (autopsy series); 3-6\\% of all incidental primary adrenal tumors\nMean age: 55 years (for adrenal myelolipoma); $\\mathrm{M}+\\mathrm{F}=2 \\div 3 ; 64$ years (for extraadrenal myelolipoma)\nCause: chronic ACTH elevation $\\rightarrow$ metaplasia of adrenocortical cells precipitated by chronic stress / degeneration\nPath: mature fat $(0-100 \\%)$ interspersed with hematopoietic cells resembling bone marrow + pseudocapsule\nHisto: variable mixture of megakaryocytes, myeloid and leukocyte precursor cells, erythroid cells, lymphocytes\nAssociated with: endocrine disorders in 7\\% (Cushing syndrome, Conn syndrome, 21hydroxylase deficiency, 17-hydroxylase deficiency); nonhyperfunctioning adenoma $(15 \\%)$\n$\\diamond$ Long-standing / poorly treated congenital adrenal hyperplasia may develop massive bilateral myelolipomas!\n\n- usually clinically occult\n- pain (from spontaneous hemorrhage if large)\n\nLocation:\n(a) adrenal myelolipoma (85\\%)\n> isolated adrenal myelolipoma\n> adrenal myelolipoma with hemorrhage\n(b) extraadrenal myelolipoma ( $15 \\%$ ):\n> retroperitoneal ( $12 \\%$ ): presacral space ( $6 \\%$ ), abdomen, stomach, liver, muscle fascia\n> intrathoracic (3\\%): mediastinum, lung\nPredilection for: perirenal + presacral spaces\nSite: unilateral + bilateral $=10 \\div 1 ; \\mathrm{RT} \\div \\mathrm{LT}=3 \\div 1$\nMean size: 10 (range, $2-17$ ) cm ;\nenlargement with hemorrhage ( $11 \\%$ )\nX-ray:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 130,
            "markdown": "$\\sqrt{ }$ soft lucent mass with rim of residual normal adrenal cortex\nUS:\n$\\sqrt{ }$ heterogeneous predominantly hyperechoic ( $=$ fat + myeloid tissue) mass interspersed with hypoechoic regions ( $=$ pure fat)\n$\\sqrt{ } \\pm$ hypoechoic areas of hemorrhage\nCT:\n$\\sqrt{ }$ heterogeneous mass composed of:\n$\\sqrt{ }$ fat of -74 (range, -30 to -115 ) HU:\n$\\sqrt{ } 50-90 \\%$ fat in adrenal myelolipoma\n$\\sqrt{ }<50 \\%$ fat in extraadrenal myelolipoma\n$\\sqrt{ }$ interspersed \"smoky\" areas of higher attenuation of $+20-30 \\mathrm{HU}$ ( $=$ admixture of fat + marrowlike elements)\n$\\sqrt{ }$ occasionally tiny foci of fat ( $<10 \\%$ fat)\n$\\sqrt{ }$ small punctate calcifications from previous hemorrhage:\n$\\sqrt{ }$ calcifications in up to $24 \\%$ of adrenal myelolipomas\n$\\sqrt{ }$ calcifications in $10 \\%$ of extraadrenal myelolipomas\n$\\sqrt{ } \\pm$ enhancement of soft-tissue component\nIn general, macroscopic fat-containing adrenal lesions are myelolipomas characteristically identified at CT!\n\nMR:\n$\\sqrt{ }$ intermediate SI on T2WI similar to spleen / heterogeneous high signal (admixture with hematopoietic tissue + myeloid tissue + hemorrhage)\nN.B.: pure fat may demonstrate no SI decrease on opposed-phase images dependent on proportion of fat to water in an image voxel\n(a) for lesion with predominantly mature adipose tissue\n$\\sqrt{ }$ homogeneously hyperintense mass on T1WI\n$\\sqrt{ }$ intermediate SI on T2WI\n$\\sqrt{ }$ signal dropout on fat-suppressed images\n(b) for lesion with mixture of fatty + myeloid elements\n$\\sqrt{ }$ heterogeneous masses containing foci of fat SI intermixed with focal high SI on T2WI + contrast enhancement on T1WI\n(c) for lesion with predominantly myeloid elements\n$\\sqrt{ }$ nodules hypointense relative to liver on T1WI\n$\\sqrt{ }$ hyperintense relative to liver on T2WI\n$\\sqrt{ }$ contrast enhancement on T1WI\nNUC:\n$\\sqrt{ }$ uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid in erythropoietic elements\n$C x$ : acute retroperitoneal hemorrhage $\\leftarrow$ myeloid elements with increase in size $>5 \\mathrm{~cm}(12 \\%)$\n$D x$ : percutaneous needle biopsy with demonstration of megakaryocytes\n$R x$ : surgical excision of (a) symptomatic lesion (b) enlarging lesion (c) lesion $>7 \\mathrm{~cm}$ in diameter $\\rightarrow$ increased risk of hemorrhage (d) lesion of diagnostic uncertainty\n$D D x$ : adrenocortical carcinoma with lipomatous metaplasia, adrenal lipoma, adrenal teratoma, adrenal adenoma with degenerative and myelolipomatous changes, liposarcoma (unencapsulated + less well defined + infiltrative without hemorrhage),",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 131,
            "markdown": "# NEPHROBLASTOMATOSIS \n\n$=$ multiple / diffuse NEPHROGENIC RESTS\n$=$ dysontogenetic process with persistence of embryonic renal parenchyma (= metanephric\nblastema) within the renal cortex $>36$ weeks GA\nPrevalence: in $1 \\%$ of infant kidneys (at autopsy); in $41 \\%$ with unilateral Wilms tumor, in $94 \\%$ with metachronous contralateral Wilms tumor, in $99 \\%$ with bilateral Wilms tumor $\\diamond$ Usually absent in infants $>4$ months of age\nPathogenesis: embryonal renal tissue in mature kidney after birth retains potential to form nephroblastoma / Wilms tumor\nA. Perilobar nephrogenic rest $(0.87 \\%)$\n\nPath: multiple rests forming a well-circumscribed smooth band at periphery of lobe (cortex / column of Bertin)\nHisto: predominantly blastemal tissue\nAssociated with:\n(1) Beckwith-Wiedemann syndrome (gigantism, macroglossia, omphalocele, genitourinary anomalies)\n(2) Hemihypertrophy $\\rightarrow 3 \\%$ develop Wilms tumor\n(3) Perlman syndrome (visceromegaly, gigantism, cryptorchidism, polyhydramnios, characteristic facies)\n(4) Trisomy 18 syndrome\n\n- abnormal chromosome band 11 p15 (Wilms tumor gene 2) in up to $77 \\%$ of patients with perilobar rests\n- mean age presenting with neoplasia: 36 months\nB. Intralobar nephrogenic rest $(0.10 \\%)$\n\nPath: single / few rests with irregular indistinct margins located centrally anywhere within a lobe $\\rightarrow$ higher risk of developing neoplasia\nHisto: predominantly stromal + epithelial tissue\nAssociated with:\n(1) Drash syndrome (ambiguous genitalia in genotypic males, progressive renal failure): $78 \\%$ with intralobar rests $+11 \\%$ with perilobar rests\n(2) Sporadic aniridia: $100 \\%$ with intralobar rests $+20 \\%$ with perilobar rests $\\rightarrow 33 \\%$ likelihood of Wilms tumor\n(3) WAGR syndrome (Wilms tumor, aniridia, genital abnormalities, mental retardation)\n\n- abnormal chromosome band 11 p13 (Wilms tumor gene 1)\n- mean age presenting with neoplasia: 16 months\n\nAge: $<2$ years of age; neonatal period, infancy, childhood\nHistologic subtypes:\n(a) dormant (nascent): nephrogenic rests the size of a glomerulus primarily composed of blastemal + epithelial elements; no malignant potential\n(b) sclerotic (regressing / obsolescent): microscopic rests primarily composed of stromal elements; nonmalignant\n(c) hyperplastic: spherical / irregular / oval proliferation of most or all cell elements",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 132,
            "markdown": "(d) neoplastic: expansile mass $\\leftarrow$ proliferation of a single cell line\n\n- clinically occult in vast majority / renal enlargement\n$\\checkmark$ peripheral rind of nephrogenic rests that compress normal renal tissue toward the center of the kidney\nUS (least sensitive technique):\n$\\checkmark$ hypo-, iso-, or hyperechoic nodules distorting renal shape\n$\\checkmark \\pm$ enlargement of kidney causing diffuse hyperechogenicity and poor corticomedullary differentiation\nCT (modality of choice):\n$\\checkmark$ hypo- to isoattenuating nodules\n$\\checkmark$ striated enhancement pattern / no enhancement\nMR ( $43 \\%$ sensitivity, $58 \\%$ sensitivity with enhancement):\n$\\checkmark$ renal enlargement\n$\\checkmark$ absent corticomedullary differentiation\n$\\checkmark$ homogeneously hypo- to isointense foci on T1WI\n$\\checkmark$ homogeneously T1-hypointense lesions after enhancement\n$\\checkmark$ iso- to slightly hyperintense on T2WI\n$C x$ : malignant transformation (in 1\\%) into Wilms tumor / cystic partially differentiated nephroblastoma\n$\\checkmark$ increase in size of nephrogenic rest\n$\\checkmark$ increasing tissue heterogeneity\n$\\checkmark$ developing a spherical masslike configuration\nScreening: for children with associated syndromes baseline CT at diagnosis at 6 months of age + follow-up sonograms every 3 months until age 8 years\n$R x$ : radiologic follow-up / chemotherapy (for biopsy-proved hyperplastic nephrogenic rests similar to stage I Wilms tumor)\n\n\n# Multifocal (Juvenile) Nephroblastomatosis \n\nmost common form\n$=$ isolated macroscopic nephrogenic rests\n$\\checkmark$ may escape detection with imaging\n$\\checkmark \\pm$ nodular mass effect on pelvicaliceal structures\n$\\checkmark$ kidneys may be enlarged\n$\\checkmark$ lobulated contour of kidney\nUS:\n$\\checkmark$ hypoechoic / isoechoic / hyperechoic nodules\nCECT (preferred study):\n$\\checkmark$ nodules with less enhancement than renal parenchyma\n\n## Superficial Diffuse Nephroblastomatosis\n\n$=$ LATE INFANTILE NEPHROBLASTOMATOSIS\n$=$ superficial continuous rind of rests around medulla (= perilobar type)\nAge: $\\quad<2$ years\n$\\checkmark$ nephromegaly\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 133,
            "markdown": "$\\sqrt{ }$ loss of corticomedullary differentiation\n$\\sqrt{ }$ kidneys diffusely echogenic / of normal echogenicity\n$\\sqrt{ }$ cysts of variable size\nCECT:\n$\\sqrt{ }$ thick rind at periphery of kidney with poor / striated enhancement\n$D D x$ : autosomal recessive polycystic kidney disease, leukemia, lymphoma\n$\\diamond$ Strong association with Wilms tumor!\n\n# Universal / Panlobar (Infantile) Nephroblastomatosis \n\nrare form\n$=$ entire renal parenchyma diffusely involved\n\n- may develop renal failure\n$\\sqrt{ }$ bilateral renal enlargement (infiltrative growth)\n\n\n## NEPHROGENIC ADENOMA\n\n$=$ uncommon benign metaplastic response to urothelial injury / prolonged irritation\nCause: (a) trauma: pelvic trauma, surgery in lower urinary tract, endoscopic procedure, renal transplantation (after a mean of 50 months)\n(b) irritation: calculi, chronic bacterial infection, irradiation, intravesical chemotherapy, immunosuppressive therapy\nAge: 3 weeks to 83 years; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$ (more common in females if $<20$ years of age)\nPath: discrete raised papillary / polypoid / cystic areas projecting from epithelial surface\nHisto: variable number of small tubules (resembling loops of Henle and collecting ducts) + cysts + papillae lined with a single layer of cuboidal / low columnar cells\n\n- asymptomatic; hematuria, dysuria, bladder instability\n\nLocation: bladder ( $72 \\%$ ), renal pelvis, ureter, urethra; strong correlation between location + site of insult to urothelium\nSize: usually 1 mm , up to 7 cm in diameter\n$\\sqrt{ }$ papillary / polypoid filling defect\nPrognosis: high likelihood of recurrence; rarely malignant transformation\n$R x$ : resection / fulguration\n$D D x$ : inflammatory / malignant urothelial lesions\n\n## NEUROBLASTOMA\n\nMost common solid abdominal mass of infancy ( $12.3 \\%$ of all perinatal neoplasms), $4^{\\text {th }}$ most common malignant tumor in infancy (after leukemia, lymphoma, CNS tumor); $2^{\\text {nd }}$ most common tumor in childhood (Wilms tumor more common in older children), $8 \\%$ of all childhood cancers; $15 \\%$ of cancer deaths in children; $30 \\%$ of all fetal (congenital) tumors\nIncidence: $9.5 \\div 1,000,000$ live births; 650 new cases annually in USA; $20 \\%$ hereditary\nOrigin: neural crest in adrenal medulla / along sympathetic chain\nPath: round irregular lobulated mass of $50-150 \\mathrm{~g}$ with areas of hemorrhage + necrosis\nHisto: small round cells slightly larger than lymphocytes with scant cytoplasm; Horner-\nWright rosettes $=$ one / two layers of primitive neuroblasts surrounding a central zone of tangled neurofibrillary processes ( $=$ neuropils)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 134,
            "markdown": "Median age: 22 months; $25 \\%(50 \\%)[79 \\%$ ] \\{97\\%\\} in $1^{\\text {st }}$ year ( $<2$ years) $[<4$ years $]$ ã $<10$ years $\\} ; \\mathrm{M}+\\mathrm{F}=1 \\div 1$ occasionally present at birth or $1^{\\text {st }}$ seen in adults;\nMay be associated with: aganglionosis of bowel, CHD\n\n- constitutional symptoms:\n- fever ( $30 \\%$ ), weight loss, malaise, failure to thrive\n- symptoms of mass effect:\n- pain, urinary retention, frequency of evacuation, constipation\n- bone pain, limp, inability to walk ( $20 \\%$ )\n- palpable abdominal mass $(45-54 \\%)$\n- cerebellar ataxia:\n- myoclonus of trunk + extremities\n- opsomyoclonus $(20 \\%)=$ spontaneous conjugate + chaotic eye movements (sign of cerebellar disease)\n- \"raccoon\" sign = orbital ecchymosis / proptosis (12\\%)\n- increased catecholamine production ( $75-90 \\%$ ):\n- in $95 \\%$ excreted in urine as vanillylmandelic acid (VMA) / homovanillic acid (HVA)\n- paroxysmal episodes of:\n- flushing, tachycardia, headaches, hyperglycemia\n- hypertension (in up to $30 \\%$ )\n- intractable diarrhea $(9 \\%) \\leftarrow$ increase in vasoactive intestinal polypeptides (VIP)\n- acute cerebellar encephalopathy\n- rise in body temperature / sweating\n- positive bone marrow aspiration ( $70 \\%$ )\n\nStage:\nI confined to organ of origin\nII local extension not crossing midline\nIII extension across midline\nIV metastatic to distant lymph nodes, liver, bone, brain, lung\nIVs stages I + II with disease confined to liver $(25 \\%)>$ skin $>$ bone marrow $(<10 \\%)$\nWITHOUT radiographic evidence of skeletal metastases\nMetastases:\nbone ( $60 \\%$ ), regional lymph nodes ( $42 \\%$ ), orbit ( $20 \\%$ ), liver ( $15 \\%$ ), intracranial ( $14 \\%$ ), lung $(10 \\%)$\n$\\diamond$ Metastases are the $1^{\\text {st }}$ manifestation in up to $60-70 \\%$ !\n) Hutchinson syndrome\n(1) Primary adrenal neuroblastoma\n(2) Extensive skeletal metastases, esp. skull\n$\\sqrt{ }$ widened cranial sutures $=$ sutural diastasis $\\leftarrow$ subjacent dural metastases\n$\\sqrt{ }$ hair-on-end appearance of skull\n(3) Proptosis\n(4) Bone pain\n> Pepper syndrome\n(1) Primary adrenal neuroblastoma\n(2) Massive hepatomegaly from metastases\n> Blueberry muffin syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 135,
            "markdown": "(1) Primary adrenal neuroblastoma\n(2) Multiple metastatic skin lesions\n$\\diamond$ Bone marrow aspirate is positive in $50-70 \\%$ at time of initial diagnosis!\n$\\diamond 2 / 3$ of patients $>2$ years have disseminated disease!\nMR (modality of choice):\n$\\checkmark$ focal T2-hyperintense areas\n$\\checkmark$ enhancing lesions on fat-suppressed T1WI\n@) Skeletal metastases:\n\n- paraplegia / extremity weakness $\\leftarrow$ spinal canal extension\n$\\checkmark$ periosteal new-bone formation\n$\\checkmark$ osteolytic focus / multicentric lytic lesions\n$\\checkmark$ \"black eyes / raccoon\" sign $\\leftarrow$ metastasis to both lateral orbital walls (common)\n$\\checkmark$ lucent horizontal metaphyseal line\n$\\checkmark$ vertical linear radiolucent streaks in metadiaphysis of long bones\n$\\checkmark$ pathologic fracture\n$\\checkmark$ vertebral collapse\n$\\checkmark$ sclerotic lesions $\\leftarrow$ healing\n$D D x$ : Ewing sarcoma, rhabdomyosarcoma, leukemia, lymphoma\n@) Intracranial + maxillofacial metastases:\nSite: dura, brain substance\n@) Orbital metastasis (20-55\\%):\n- periorbital ecchymosis (\"raccoon eyes\"); bilateral in $1 / 2$\n- periorbital swelling, subconjunctival hemorrhage, ocular mobility disturbance, strabismus\n- atrophy of the optic head\n$\\checkmark$ uni- / bilateral proptosis\n$\\checkmark$ soft-tissue mass originating in diploic space of bony orbit with extension beyond inner + outer tables\n$\\checkmark$ high attenuation relative to muscle with small calcific foci\n$\\checkmark$ tumor hypointense to muscle on T1WI\n$\\checkmark$ slightly hyperintense to muscle on T2WI\n$\\checkmark$ avid heterogeneous contrast enhancement\n$\\checkmark$ no tumor extension into preseptal soft tissues\n$D D x$ : rhabdomyosarcoma\n@) Pulmonary metastases:\n$\\checkmark$ nodular infiltrates\n$\\checkmark$ rib erosion\n$\\checkmark$ mediastinal + retrocrural lymphadenopathy (common)\n@) Mesenteric / peritoneal metastases:\n$\\checkmark$ spread through subperitoneal space (common)\n$\\checkmark$ peritoneal metastases typically not calcified\nLocation: anywhere within sympathetic neural chain\n@) Abdomen ( $70 \\%$ ):\n(a) adrenal (36-67\\%): almost always unilateral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 136,
            "markdown": "(b) both adrenals ( $7-10 \\%$ )\n(c) extraadrenal in sympathetic chain (18\\%)\n@ Thorax + posterior mediastinum (20\\%): aortic bodies\n@ Neck (5\\%): carotid ganglia\n@ Pelvis (2-3\\%): organ of Zuckerkandl\n@ Skull, olfactory bulb, cerebellum, cerebrum (2\\%)\n@ Other sites (10\\%): eg, intrarenal (very rare)\n@ Unknown (10\\%)\nClue: large calcified retroperitoneal mass encircling the aorta with extension into neural foramina\n$\\sqrt{ }$ large suprarenal mass with irregular shape + margins ( $82 \\%$ ):\n$\\checkmark$ displacement of kidney\n$\\checkmark$ inseparable from kidney $\\pm$ invasion of kidney ( $10-32 \\%$ ) along the vascular pathways\n$\\checkmark$ propensity for extension into spinal canal through neural foramen with erosion of pedicles $(15 \\%)$\n$\\checkmark$ extension across midline (55\\%) (DDx: Wilms tumor)\n$\\checkmark$ stippled / coarse amorphous calcifications (frequent)\n$\\checkmark$ retroperitoneal adenopathy / contiguous extension (73\\%)\n$\\checkmark$ retrocrural adenopathy (27\\%)\n$\\checkmark$ encasement of IVC + aorta, celiac axis, SMA (32\\%):\nN.B.: $\\quad$ caval involvement $=$ indicator of unresectability\n$\\checkmark$ liver metastases ( $18-66 \\%$ ); invasion of liver (5\\%)\nIVP:\n$\\checkmark$ \"drooping lily\" sign = displacement of kidney inferolaterally without distortion of collecting system\n$\\checkmark$ hydronephrosis (24\\%)\n$\\checkmark$ calcifications in $36-50 \\%$ on KUB\nCT:\n$\\checkmark$ heterogeneous texture with low-density areas $\\leftarrow$ hemorrhage + necrosis (55\\%)\n$\\checkmark$ calcifications in up to $85 \\%$\n$\\checkmark$ variable contrast enhancement\nMR (most sensitive modality $\\leftarrow$ high soft-tissue contrast):\n$\\checkmark$ hyperintense heterogeneous mass on T2WI\n$\\checkmark$ enhancing heterogeneous low SI on T1WI\n$\\checkmark$ areas of high SI on T1WI $\\leftarrow$ intratumoral hemorrhage\n$\\checkmark$ areas of high SI on T2WI $\\leftarrow$ cystic changes\nAngio:\n$\\checkmark$ hypo- / hypervascular mass\nUS:\n$\\checkmark$ hyperechoic poorly defined mass with acoustic shadowing (calcifications):\n$\\checkmark$ hypoechoic areas of heterogeneous texture $\\leftarrow$ hemorrhage / necrosis\nOB-US:\nTime of $D x: 1^{\\text {st }}$ identified in $3^{\\text {rd }}$ trimester (earliest at 20 weeks GA); usually at 36 weeks GA\n\n- (occasionally) maternal hypertension + preeclampsia $\\leftarrow$ fetal catecholamines reaching maternal circulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 137,
            "markdown": "Location: right suprarenal; adrenal $\\div$ extraadrenal $=9 \\div 1$ (compared to $3.5 \\div 6.5$ in pediatric age group)\n$\\sqrt{ }$ cystic $(50 \\%) /$ mixed cystic + solid / solid adrenal mass\n$\\sqrt{ }$ may exhibit acoustic shadowing (calcifications)\n$\\sqrt{ }$ displacement of adjacent kidney inferiorly + laterally\n$\\sqrt{ }$ hydrops fetalis $\\leftarrow$ severe anemia $\\leftarrow$ metastases to bone marrow, mechanical compression of IVC, hypersecretion of aldosterone\n$\\sqrt{ }$ polyhydramnios\nPrognosis: 90-96\\% survival rate (better than for neonates)\nNUC (bone scan sensitivity better than radiography):\n$\\sqrt{ }$ increased radiotracer uptake on bone scan ( $60 \\%$ ):\n$\\sqrt{ }$ purely lytic lesions may present as photopenic areas\nCAVE: symmetric lytic neuroblastoma metastases occur frequently in metaphyseal areas where normal epiphyseal activity obscures lesions\n$\\sqrt{ }$ soft-tissue uptake of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-phosphate in $60 \\%$\n$\\sqrt{ }$ frequently 67 Ga uptake in primary site of neuroblastoma\n$\\sqrt{ }$ focal uptake of ${ }^{131} \\mathrm{I}-/ 123 \\mathrm{I}$-MIBG radioactivity ( $82 \\%$ sensitive; $88 \\%$ specific) $\\rightarrow$ method of choice\nPET-CT (sensitive + specific)\nPrognosis:\n> 2-year survival rate versus age at presentation:\n$60 \\%$ if patient's age $<1$ year\n$20 \\%$ if patient's age $1-2$ years\n$10 \\%$ if patient's age $>2$ years\n$\\diamond$ May revert to benign ganglioneuroma in $0.2 \\%$ !\n> Survival rate versus stage:\n\n| $80 \\%$ | for stage I |\n| :-- | :-- |\n| $60 \\%$ | for stage II |\n| $30 \\%$ | for stage III |\n| $7 \\%$ | for stage IV |\n| $75-87 \\%$ | for stage IVs |\n\n$D D x$ : adrenal hemorrhage, exophytic Wilms tumor, mesoblastic nephroma, multicystic kidney, retroperitoneal teratoma, infradiaphragmatic extralobar sequestration, hepatic hamartoma / hemangioma, splenic cyst\n\n# NEUROGENIC BLADDER \n\nNeuroanatomy: bladder innervation of detrusor muscle by parasympathetic nerves S2-S4\nEtiology: congenital (myelomeningocele); trauma; neoplasm (spinal, CNS); infection (herpes, polio); inflammation (multiple sclerosis, syrinx); systemic disorder (diabetes, pernicious anemia)\nA. SPASTIC BLADDER\n\"upper motor neuron\" lesion above conus\nB. ATONIC BLADDER",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 138,
            "markdown": "\"lower motor neuron lesion\" below conus\n\n# ORCHITIS \n\nEtiology:\n(a) bacterial infection ascending from bladder associated with epididymitis\n(b) viral infection\n> complication of mumps in $20-35 \\%$ :\nAge: adolescents + young adults\nTime of onset: usually within 3-5 days of infection\n$\\checkmark$ unilateral (bilateral) orchitis in $90 \\%(10 \\%)$;\n$\\checkmark$ parotitis precedes orchitis in $84 \\%$, simultaneous in $3 \\%$, later in $4 \\%$; without parotitis in $10 \\%$\n> Coxsackie virus\nLocation: diffuse / focal\n$\\checkmark$ increased testicular blood flow\n$\\checkmark \\pm$ diffuse enlargement of testis\n$\\checkmark \\pm$ reactive hydrocele + thickening of scrotal wall\n$\\checkmark$ decreased testicular echogenicity\nMR:\n$\\checkmark$ heterogeneously decreased SI on T1WI\n$\\checkmark$ increased SI on T2WI\n$\\checkmark$ avid homogeneous enhancement\n$C x$ : ischemia $\\leftarrow$ increased intratesticular pressure; pyocele; testicular rupture\n\n## Focal Orchitis\n\nCause: usually epididymitis\n$\\checkmark$ ill-defined hypoechoic lesion of crescent / amorphous shape\n$\\checkmark$ peripheral adjacent to abnormal epididymis\n$\\checkmark$ increased / no color Doppler flow\n$D D x$ : neoplasm (mimicked by focal orchitis)\n\n## Granulomatous Orchitis\n\n(a) TB, syphilis, fungi, parasites\n$\\checkmark$ tendency to involve epididymis first\n(b) sarcoidosis (genital tract affected in 5\\%)\n$\\checkmark$ multiple hypo- / hyperechoic masses within testis / epididymis\n\n## Diffuse Orchitis\n\n$D D x$ : leukemia, lymphoma\n\n## OSSIFYING RENAL TUMOR OF INFANCY\n\n$=$ extremely rare benign renal mass originating from urothelium\nPrevalence: only 11 cases in literature\nAge: 6 days -14 months; $\\mathrm{M}>\\mathrm{F}$\nHisto: osteoid core, osteoblasts, spindle cells",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 139,
            "markdown": "- hematuria\n\nLocation: $\\mathrm{L}>\\mathrm{R}$ kidney; attached to renal papilla\nSite: upper pole\n$\\checkmark$ 2-3-cm polypoid mass:\n$\\checkmark$ calcified (in $80 \\%$ ) resembling a staghorn calculus\n$\\checkmark$ filling defect of collecting system\n$\\checkmark$ partial obstruction of collecting system\n$\\checkmark$ echogenic mass + shadowing\n$\\checkmark$ poor enhancement on CT\n$R x$ : nephron-sparing resection curative\n$D D x$ : staghorn calculus\n\n# PAGE KIDNEY \n\n$=$ renin-angiotensin-mediated hypertension $\\leftarrow$ constrictive ischemic nephropathy ( $=$ reduction of blood flow to kidney) $\\leftarrow$ renal compression in a perinephric / subcapsular location\nEtiology: (1) Spontaneous hematoma (most common)\n(2) Blunt trauma with chronic contained subcapsular hematoma / perirenal scarring\n(3) Cyst\n(4) Tumor\n$\\checkmark$ (compressive) subcapsular fluid collection:\n$\\checkmark$ indentation / flattening of renal margin\n$\\checkmark$ distortion of renal contour + thinning of renal parenchyma\n$\\checkmark$ kidney surrounded by fibrotic band $\\pm$ calcification\n$\\checkmark$ stretching + splaying of intrarenal vessels\n$\\checkmark$ enlarged + displaced capsular artery\n$\\checkmark$ delayed nephrogram\n![img-11.jpeg](img-11.jpeg)\n$\\checkmark$ slow arterial washout\n$\\checkmark$ elevated resistive index at spectral Doppler\n$\\checkmark$ globally decreased renal function at perfusion scintigraphy\n\n## PAPILLARY NECROSIS\n\n$=$ NECROTIZING PAPILLITIS",
            "images": [
                {
                    "id": "img-11.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1335,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1705,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 140,
            "markdown": "$=$ ischemic coagulative necrosis of renal papilla (loops of Henle + vasa recta) $\\leftarrow$ interstitial nephritis (interstitial edema) or intrinsic vascular obstruction\nCause:\nmnemonic: POSTCARD\nPyelonephritis\nObstructive uropathy\nSickle cell disease\nTuberculosis, Trauma\nCirrhosis = alcoholism, Coagulopathy\nAnalgesic nephropathy\nRenal vein thrombosis\nDiabetes mellitus ( $50 \\%$ )\nalso: nonsteroidal anti-inflammatory drugs (NSAID), dehydration, severe infantile diarrhea, hemophilia, Christmas disease, acute tubular necrosis, transplant rejection, postpartum state, high-dose urography, intravesical instillation of formalin, thyroid cancer\n\n# Types: \n\n1. Necrosis in situ $=$ necrotic papilla detaches but remains unextruded within its bed\n2. Medullary type (partial papillary slough) = single irregular cavity located concentric / eccentric in papilla with long axis paralleling the long axis of the papilla + communicating with calyx\n$\\sqrt{ }$ central necrosis at tip of pyramid\n3. Papillary type (total papillary slough)\n$\\sqrt{ }$ detachment of papilla begins in caliceal fornix\n\n## Phases:\n\n(1) Enlargement of papilla (papillary swelling)\n(2) Fine projections of contrast material alongside papilla (tract formation)\n(3) Medullary cavitation / complete slough of papilla\n\n- flank pain, dysuria, fever, chills, ureteral colic, hypertension\n- acute oliguric renal failure\n- proteinuria, pyuria, hematuria, leukocytosis\n\nLocation: (a) localized / diffuse\n(b) bilateral distribution: systemic cause\n(c) unilateral: obstruction, renal vein thrombosis, acute bacterial nephritis\n$\\sqrt{ }$ normal or small kidney $\\leftarrow$ analgesic nephropathy\n$\\sqrt{ }$ large kidney $\\leftarrow$ acute fulminant disease\n$\\sqrt{ }$ smooth / wavy renal contour $\\leftarrow$ analgesic nephropathy)\n$\\sqrt{ }$ calcification of necrotic papilla: papillary / curvilinear / ringlike\nIVP:\n$\\sqrt{ }$ multiple small collections of contrast material in papilla:\n$\\sqrt{ }$ \"lobster claw\" sign = subtle streak of contrast material extending from fornix parallel to long axis of papilla\n$\\sqrt{ }$ centric / eccentric, thin and short / bulbous cavitation of papilla\n$\\sqrt{ }$ displaced collecting system $\\leftarrow$ enlarged septal cortex $\\leftarrow$ edema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 141,
            "markdown": "$\\sqrt{ }$ necrosis of entire papilla:\n$\\sqrt{ }$ widened fornix $\\leftarrow$ necrotic shrinkage of papilla\n$\\sqrt{ }$ \"signet ring\" sign = ring shadow of papilla $\\rightarrow$ outlining detached papilla within contrast material-filled cavity\n$\\sqrt{ }$ club-shaped / saccular calyx $\\leftarrow$ sloughed papilla\n$\\sqrt{ }$ intraluminal nonopaque filling defect in calyx / pelvis / ureter $\\leftarrow$ expelled sloughed papilla\n$\\sqrt{ }$ loss of renal function:\n$\\sqrt{ }$ diminished density of contrast material in nephrogram; rarely increasingly dense\n$\\sqrt{ }$ wasted parenchymal thickness\nUS:\n$\\sqrt{ }$ multiple round / triangular cystic spaces in medulla with echo reflections of arcuate arteries at periphery of cystic spaces\n$C x$ : acute ureteral obstruction after sloughing of papilla; higher incidence of transitional cell carcinoma in analgesic abusers ( 8 x ); higher incidence of squamous cell carcinoma\n$D D x$ : (1) Postobstructive renal atrophy\n(2) Congenital megacalices (normal renal function)\n(3) Hydronephrosis (dilated infundibula, blunting of all calices)\n(4) Parapelvic cyst\n(5) Caliceal diverticulum (adjacent to fornix / infundibulum)\n\n# PAROXYSMAL NOCTURNAL HEMOGLOBINURIA \n\n$=$ rare acquired disorder of nonmalignant hematopoietic stem cells\nCause: infection, transfusion, radiographic contrast material, exercise, drugs, immunization, surgery\nPathophysiology:\ndestruction of abnormally sensitive RBCs + granulocytes + platelets by activated\ncomplement; complement activation of abnormal platelets + release of thrombogenic material from lysed RBCs\n\n- increased susceptibility to infections\n- intravascular hemolysis:\n- hemoglobinuria, pancytopenia / aplasia\n- chronic iron deficiency anemia\n- venous thrombosis in uncommon sites:\n- acute (tubulointerstitial nephritis) / chronic renal failure (small vessel thrombosis)\n- cerebral vein thrombosis\n- thrombosis of mesenteric vein + splenic vein + portal vein\n- hepatic vein thrombosis (= Budd-Chiari syndrome) involving tertiary + secondary venous radicles\nMR:\n$\\sqrt{ }$ low SI of renal cortex on T1WI + T2WI $\\leftarrow$ hemosiderin deposition $\\leftarrow$ free hemoglobin is filtered across renal glomeruli + reabsorbed by proximal convoluted tubular cells $\\leftarrow$ intravascular hemolysis\n$\\sqrt{ }$ usually decreased iron concentration in liver + spleen unless transfusions were given (DDx",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 142,
            "markdown": "to other hemolytic anemias)\nPrognosis: venous thrombosis is a major cause of death\n\n# PELVIC LIPOMATOSIS \\& FIBROLIPOMATOSIS \n\n$=$ nonmalignant overgrowth of adipose tissue with minimal fibrotic + inflammatory components compressing soft-tissue structures within pelvis\nPrevalence: $0.6 \\div 100,000$ to $1.7 \\div 100,000$\nCause: unknown; ? UTIs, obesity, endocrine dysfunction\nMean age: 48 (range, $9-80$ ) years; $\\mathrm{M} \\div \\mathrm{F}=10 \\div 1$ to $18 \\div 1$; racial predilection for blacks ( $67 \\%$ ); obesity NOT contributing factor\nPath: unencapsulated mature homogeneous white fat separated by thin fibrous septa\n\n- often incidental finding\n- urinary tract symptoms ( $50 \\%$ ): frequency, dysuria, nocturia, urgency, hematuria, sensation of incomplete emptying, suprapubic tenderness, recurrent urinary tract infections\n- GI symptoms ( $20 \\%$ ): constipation, nausea, vomiting, tenesmus, rectal bleeding, ribbonlike stools with mucus\n- generalized symptoms: lower abdominal pain, low back pain, flank pain, fever\n- edema of lower extremities\n@ GU tract\n$\\checkmark$ elongation + elevation of urinary bladder with symmetric inverted pear shape / teardrop\n$\\checkmark$ elongation of posterior urethra\n$\\checkmark$ medial / lateral displacement of lower ureters\n$\\checkmark$ pelvic lucency (CT confirmatory)\n@ GI tract\n$\\checkmark$ straightening + elongation + narrowing of rectum\n$\\checkmark$ stretching + elevation of rectosigmoid and sigmoid colon out of pelvis\n$\\checkmark$ increase in sacrorectal space $>10 \\mathrm{~mm}$\n@ Vessels\n$\\checkmark$ stretching + thinning of femoral veins\nCx of fibrolipomatosis:\n(1) Ureteral obstruction with hydroureteronephrosis ( $40 \\%$ within 5 years)\n(2) IVC obstruction + deep vein thrombosis\n(3) Ureteral calculi\n(4) Hypertension\n\nRx: urinary diversion ( $39 \\%$ ) to prevent end stage renal disease; screening for proliferative bladder lesions\n\n## PENILE CARCINOMA\n\nPrevalence: $0.4 \\%$ of all male malignancies in US; $1 \\%$ in Western countries; $10-20 \\%$ of all malignancies in Asian, African, South American males\nCause: uncircumcised men (smegma $\\leftarrow$ poor hygiene $\\leftarrow$ presence of foreskin / phimosis); chronic inflammation (balano-posthitis, lichen sclerosus et atrophicus); human papilloma virus $16 \\& 18$; psoralen / ultraviolet A photochemotherapy for psoriasis treatment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 143,
            "markdown": "Histo: squamous cell carcinoma (95\\%), sarcoma (epitheloid $\\sim$, Kaposi $\\sim$, leiomyo $\\sim$, rhabdomyo ), melanoma, basal cell carcinoma, lymphoma\nAge: $6^{\\text {th }}$ and $7^{\\text {th }}$ decade; $<25 \\%$ are less than 40 years of age\n\n- palpable inguinal nodes ( $30-60 \\%$ of SCC): $1 / 2$ reactive, $1 / 2$ metastatic\n\nLocation: glans $(48 \\%)>$ prepuce $(21 \\%)>$ glans + prepuce $(9 \\%)>$ coronal sulcus $(6 \\%)>$ shaft $(2 \\%)$\nSpread: (a) superficial inguinal nodes $\\leftarrow$ skin + prepuce\n(b) deep inguinal + external iliac nodes $\\leftarrow$ glans\n(c) internal iliac nodes $\\leftarrow$ erectile tissue + penile urethra\n> Nodal disease in $20 \\%$ of T1 + in $47-66 \\%$ of T2-T4 tumors\n> Nodal disease in $42 \\%$ of superficial spreading SCC\n> Nodal disease in $82 \\%$ of deep vertical growth\nMR:\n$\\checkmark$ solitary ill-defined infiltrating tumor:\n$\\checkmark$ hypointense relative to corpora on T1WI + T2WI\n$\\checkmark$ enhancement with Gd (less than corpora)\nMRI can assess (1) extent of penile cancer, (2) depth of invasion into corpora cavernosa $\\pm$ urethra, (3) involvement of inguinal + pelvic lymph nodes.\n\nRx: circumcision, partial / total penectomy $\\pm$ inguinal lymphadenectomy; radiation therapy\n\n# PENILE FIBROMATOSIS \n\n$=$ PEYRONIE DISEASE $=$ INDURATIO PENIS PLASTICA\n[FranÃ§ois Gigot de La Peyronie (1678-1747), chief of surgery at the HÃ´tel-Dieu in Paris and Montpellier, surgeon to King Louis XI]\n$=$ benign acquired condition characterized by chronic inflammation $\\rightarrow$ fibrosis + focal thickening of tunica albuginea\nPrevalence: 3\\%\nAge: $40-60$ years\nCause: ? aberrant healing response to minor penile trauma\nAssociated with: palmar fibromatosis (Dupuytren contracture) in 16-20\\%, plantar fibromatosis, Paget disease of bone, diabetes mellitus, gout\n\n- abnormal penile curvature during erection $\\rightarrow$ erectile dysfunction; painful penile induration\n- palpable albugineal plaques along corpora cavernosa\n\nSite: dorsal $>$ ventral $>$ lateral aspect of penis, intercorporeal septum\nUS ( $68 \\%$ sensitive):\n$\\checkmark$ focal hyperechoic thickening of tunica albuginea with shadowing $\\leftarrow$ calcification\n$\\checkmark$ focal nonshadowing echogenic thickening of tunica\n$\\checkmark$ nodular echogenic thickening of intercorporeal septum\n$\\checkmark$ iso- / hypoechoic plaques (rare)\nMR ( $61 \\%$ sensitive):\n$\\checkmark$ hypointense focal thickening of tunica on T1WI + T2WI\n$\\checkmark$ enhancement during active inflammation\n$D D x$ : (1) Congenital penile curvature",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 144,
            "markdown": "(2) Dorsal vein thrombosis\n(3) Penile calciphylaxis = acute life-threatening condition in end-stage renal disease with occlusion of arterial flow to penis\n(4) Penile fibrosis $\\leftarrow$ prolonged priapism, trauma, removal of penile prosthesis, intracavernosal injections for erectile dysfunction\n(5) Penile malignancy\n\n# PENILE FRACTURE \n\n$=$ tear in tunica albuginea $\\rightarrow$ rupture of corpus cavernosum\nAssociated with: urethral injury (in 10-20\\%)\n\n- blood at urethral meatus\n\nCause: blunt / penetrating (rare) trauma; powerful lateral motions of the erect penis (frequently during sexual intercourse)\nAge: younger man; often related to sports\n\n- excruciating pain, bruising, rapid detumescence\n\nUS (difficult in identifying site + extent of tunica albuginea involvement)\n\n| Hereditary Syndromes Associated with Pheochromocytoma |  |  |\n| :--: | :--: | :--: |\n| Syndrome | Risk of <br> Tumor [\\%] | Mutated Gene |\n| Multiple endocrine neoplasia | 50 | RET |\n| Neurofibromatosis 1 | 1 | NF1 |\n| von Hippel-Lindau disease | $10-20$ | VHL |\n| Familial paraganglioma syndrome | $-20$ | SDHB, SDHC, SDHD* |\n| * SDH = succinate dehydrogenase (SDH) subunits B, C, or D |  |  |\n\nMR:\n$\\sqrt{ }$ focal disruption of T1- and T2-hypointense tunica albuginea\n$\\sqrt{ }$ adjacent T2-hyperintense hematoma\n$\\diamond$ With a scrotal hematoma / hematocele the radiologist should be vigilant in looking for associated penile / testicular injury.\n$D D x$ : penile contusion (focal area of hypointensity in a normally T2-bright corpus cavernosum)\n\n## PHEOCHROMOCYTOMA\n\n$=$ ADRENAL MEDULLARY PARAGANGLIOMA\n$=$ rare catecholamine-secreting tumor of chromaffin tissue; responsible for $0.1-0.9 \\%$ of hypertensive individuals\nPrevalence: $0.13 \\%$ in autopsy series; increasing occurrence of incidentalomas by crosssectional imaging\nIncidence: $2-8 \\div 1,000,000$ annually\nOrigin: neuroectodermal tissue\nPath: well-circumscribed $3-5 \\mathrm{~cm}$ mass with central degenerative changes of fibrosis / cystic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 145,
            "markdown": "change; larger lesions are often hemorrhagic / cystic\nHisto: chromaffin tumor cells contain chromogranin within secretory granule forming CHARACTERISTIC clusters of tumor cells = \"Zellballen\"; architectural patterns are\n(a) combination of alveolar + trabecular ( $36 \\%$ )\n(b) predominantly alveolar = nesting ( $35 \\%$ )\n(c) predominantly trabecular ( $27 \\%$ )\n\nAge: $5 \\%$ in childhood\nN.B.: Any physical contact can precipitate cardiac arrhythmia + malignant hypertension\n\n- symptomatology $\\leftarrow$ excess catecholamine production (norepinephrine $>$ epinephrine):\n- asymptomatic $(9-10 \\%)$\n- headaches, sweating, flushing, palpitations, tachycardia, anxiety, tremor, nausea, vomiting, abdominal pain, chest pain\n- paroxysmal (47-53\\%) / sustained (37\\%) hypertension\n(a) elevated catecholamine\n(b) functional renal vasoconstriction\n(c) renal artery stenosis: fibrosis, intimal proliferation, tumor encasement\n- hypoglycemia during hypertensive crisis\n\nDx (biochemical confirmation):\n\n- plasma metanephrine level $>1.1 \\mathrm{nmol} / \\mathrm{L}$\n- plasma normetanephrine concentration $>2.2 \\mathrm{nmol} / \\mathrm{L}$\n- elevated urine vanillylmandelic acid (VMA) in $54 \\%$; in up to $22 \\%$ false-negative result because VMA is not excreted\nAssociated heritable conditions (in 10-25\\%):\n$\\sqrt{ }$ usually with bilateral pheochromocytomas + extraadrenal sympathetic and parasympathetic paragangliomas\n(1) Multiple endocrine neoplasia (MEN):\n$\\diamond$ malignant transformation in $5-10 \\%$\n$\\checkmark$ pheochromocytoma small + asymptomatic in $50 \\%$\n(2) Neuroectermalod disorder\n(a) neurofibromatosis type 1 (in $0.1-5.7 \\%$ )\n(b) Von Hippel-Lindau disease\n(c) tuberous sclerosis\n(d) Sturge-Weber syndrome\n$\\diamond 10 \\%$ of patients with neurofibromatosis (NF1) / von Hippel-Lindau disease have pheochromocytoma!\n(3) Familial paraganglioma syndrome / pheochromocytosis\n(4) Carney syndrome\nmnemonic: VEIN\nVon Hippel-Lindau\nEndocrine neoplasia (MEN 2)\nInherited (congenital) pheochromocytoma\nNeurofibromatosis (von Recklinghausen disease)\nRULE OF TENS (\"ten-percent tumor\"):\n$10 \\%$ bilateral $10 \\%$ extraadrenal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 146,
            "markdown": "$10 \\%$ multiple $\\quad 10 \\%$ familial / syndromic\n$10 \\%$ malignant $\\quad 10 \\%$ nonfunctioning\nLocation: (a) intraabdominal ( $98 \\%$ ), medulla of adrenal gland ( $>90 \\%$ )\n(b) extraadrenal paragangliomas of sympathetic nervous system (from base of brain to urinary bladder) including organ of Zuckerkandl, bladder wall, retroperitoneum, heart, mediastinum, glomus jugulare body\nSize: mean diameter 5.3 (range, $2.6-11.2$ ) cm\n\n- clinically silent lesions tend to be large\n- large lesions are often nonfunctioning\n$\\sqrt{ }$ discrete round / oval mass:\n$\\sqrt{ }$ marked heterogeneity $\\leftarrow$ degeneration, necrosis, fibrosis, cystic change, intracellular lipid degeneration, calcification\n$\\sqrt{ }$ small / large necrotic areas in $90 \\% \\pm$ fluid-fluid level\n$\\sqrt{ }$ scattered punctate ( $=$ speckled) calcifications in $10-29 \\%$\nThe \"imaging chameleon\" pheochromocytoma should be considered in any adrenal lesion of lowattenuation / avid washout / dominant cystic component!\nCT ( $93-100 \\%$ sensitive):\nLocalization: accurate in $91 \\%$ with tumor $>2 \\mathrm{~cm}$ in size; up to $40 \\%$ in extraadrenal location are missed by CT\n$\\sqrt{ }$ solid / cystic / complex mass with low-density areas $\\leftarrow$ hemorrhage / cystic degeneration / necrosis\n$\\sqrt{ }$ tumor attenuation of similar density as surrounding soft tissue with a mean of $36 \\pm 10 \\mathrm{HU}$\n$\\sqrt{ }$ may rarely have abundant intracellular fat of $<10 \\mathrm{HU}$\n$\\sqrt{ }$ may have macroscopic fat of $<30 \\mathrm{HU} \\leftarrow$ lipid degeneration (DDx: myelolipoma)\n$\\sqrt{ } \\pm$ calcifications\nCECT:\nCave: IV injection of iodinated contrast material MAY precipitate a hypertensive crisis in patients not on $\\alpha$-adrenergic blockers! Nonionic low-osmolar IV contrast media are SAFE!\n$\\sqrt{ }$ usually avid contrast enhancement $\\leftarrow$ capillary-rich framework\n$\\diamond$ Absolute enhancement of $>110-120 \\mathrm{HU}$ is INDICATIVE of a pheochromocytoma!\n$\\sqrt{ }$ variable contrast wash-out patterns, occasionally similar to adrenocortical adenoma:\n$\\sqrt{ }$ relative washout $>40 \\%$ (in $25 \\%$ of pheochromocytomas)\n$\\sqrt{ }$ absolute washout $>60 \\%$ (in $29 \\%$ of pheochromocytomas)\nNUC:\n$\\sqrt{ }$ increased uptake with ${ }^{131} \\mathrm{I}-/ 123 \\mathrm{I}$-metaiodobenzylguanidine (MIBG $=80-90 \\%$ sensitive; $98 \\%$ specific)\nUseful:\n(a) with clear clinical / laboratory evidence of tumor but no adrenal abnormality on CT / MR\n(b) in detecting extraadrenal pheochromocytomas / bilaterality / metastases by whole-body scintigraphy\n(c) in diagnosing postoperative recurrence\n\nPET ( $72-98 \\%$ sensitive):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 147,
            "markdown": "$\\sqrt{ }$ increased uptake (DDx: metastasis)\nUS:\n$\\sqrt{ }$ well-marginated ovoid purely solid (68\\%) / complex (16\\%) / cystic tumor (16\\%)\n$\\sqrt{ }$ homo- (46\\%) / heterogeneously (54\\%) solid tumor: isoechoic + hypoechoic (77\\%) / hyperechoic $(23 \\%)$ to renal parenchyma\n$\\sqrt{ }$ heterogeneity introduced by hemorrhage / necrosis\nMR (method of choice):\n$\\sqrt{ }$ iso- / slightly hypointense to liver on T1WI\n$\\sqrt{ }$ may contain areas of high SI on T1WI $\\leftarrow$ hemorrhage (20\\%) / fat\n$\\sqrt{ }$ hyperintense compared with spleen on T2WI (in 11\\%) $\\leftarrow$ intratumoral cystic regions N.B.: $30 \\%$ are hypointense + may be confused with malignancy / benign adenoma\n$\\sqrt{ }$ contains central heterogeneous areas of decreased SI in $35 \\%$ on T2WI $\\leftarrow$ necrosis / hemorrhage / calcifications\n$\\sqrt{ }$ no change in SI between in-phase + opposed-phase T1WI images $\\leftarrow$ no substantial amount of cytoplasmic lipid\nCEMR:\n$\\sqrt{ }$ rapid marked homo- / inhomogeneous enhancement (not routinely used as it does not increase sensitivity)\n$\\sqrt{ }$ extremely hyperintense (\"light bulb\" sign) $\\leftarrow$ avid enhancement\nAngio:\nN.B.: intraarterial injection CONTRAINDICATED $\\rightarrow$ may induce hypertensive crisis\n$\\sqrt{ }$ localization by aortography in $>91 \\%$\n$\\sqrt{ }$ usually hypervascular lesion with intense tumor blush\n$\\sqrt{ }$ slow washout of contrast material\n$\\sqrt{ }$ enlarged feeding arteries + neovascularity (= \"spoke-wheel\" pattern)\n$\\sqrt{ }$ parasitization from intrarenal perforating branches\n$\\sqrt{ }$ venous blood sampling (at different levels in IVC)\nCave: indiscriminate biopsy may trigger a catastrophic crisis and must be avoided requiring consultation with endocrine + anesthesia services and appropriate endocrine blockade\n$C x$ : (1) Malignancy in $2-14 \\%$ with ( $\\pm$ hormonally active) metastases to bone, lymph nodes, liver, lung\n(2) Spontaneous retroperitoneal hemorrhage $\\rightarrow$ lethal in $50 \\%$ if tumor previously undiagnosed\n$\\diamond$ Most common cause of spontaneous retroperitoneal hemorrhage from a primary adrenal tumor!\nRx: (1) Surgical removal curative\n(2) Alpha-adrenergic blocker (phenoxybenzamine / phentolamine)\n(3) Beta-adrenergic blocker (propranolol)\n(4) ${ }^{131} \\mathrm{I}$-MIBG used to treat metastases\n\nDDx: nonfunctioning adrenal adenoma, adrenocortical carcinoma, adrenal cyst, metastatic disease\n\n# PLASMACYTOMA OF KIDNEY \n\n= group of malignant disorders involving differentiated B lymphocytes or plasma cells",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 148,
            "markdown": "# Classification: \n\nA. SOLITARY $=$ PLASMACYTOMA $(5 \\%)$\nB. MULTIPLE $=$ MULTIPLE MYELOMA $(95 \\%)$ : autoptically involves kidney in $17 \\%$\nDistribution of primary extramedullary plasmacytoma:\n(a) skeleton $(95 \\%)$\n(b) nonskeletal sites (5\\%): upper respiratory tract\n\n- monoclonal immunoglobulin / Bence-Jones proteinuria\n$\\sqrt{ }$ well-circumscribed mass / infiltrative lesion\n$D D x$ : indistinguishable from other renal primaries\n\n\n## POLYCYSTIC KIDNEY DISEASE\n\n## Autosomal Dominant Polycystic Kidney Disease\n\n$=$ ADPKD $=$ ADULT POLYCYSTIC KIDNEY DISEASE $=$ Potter type III\n[Edith Louise Potter(1901-1993], American pathologist in Chicago]\n$=$ characterized by bilaterally enlarged kidneys with multiple expansile cysts along nephron\nPrevalence: $1 \\div 500-1,000$ live births; affects $300,000-600,000$ Americans; $5-10 \\%$ of dialysis patients\n$\\diamond$ Most common heritable renal disorder!\n$\\diamond 3^{\\text {rd }}$ most common cause of end-stage renal disease!\nGenetics:\nhereditary ( $90 \\%$ ) or spontaneous mutation ( $10 \\%$ ) of\n(a) PKD1 gene located on short arm of chromosome 16p13.3 encoding protein polycystin$1(85 \\%)$\n(b) PKD2 gene located on long arm of chromosome 4q13-23 encoding protein polycystin$2(15 \\%)=$ milder form of disease with later age of onset\nlocalized in cell membrane of primary cilia of renal tubular epithelial cells $\\rightarrow$ both polycystin proteins interact to form a calcium $2+$-channel receptor\n$\\diamond$ Genetic testing identifies only $70 \\%$ of individuals with ADPKD\nPathophysiology:\nderanged function of polycystin proteins $\\rightarrow$ ciliary dysfunction $\\rightarrow$ overproliferation of tubular epithelial cells with $\\uparrow$ tubular fluid secretion $\\rightarrow$ tubular ectasia + cyst formation\nPath: cysts form as outpouchings of nephron $\\rightarrow$ become disconnected from nephron early on $\\rightarrow$ continued growth into round (rather than tubular) shape of up to several cm in diameter $\\rightarrow$ compression of tubules and glomeruli\nHisto: abnormal rate of tubule divisions (Potter type III) with hypoplasia of portions of tubules left behind as the ureteral bud advances; cystic dilatation of Bowman capsule / loop of Henle / proximal convoluted tubule coexisting with normal tissue\nMean age at diagnosis:\n43 years; early clinical manifestations $<15$ years of age in $2 \\%$ (with rare neonatal / infantile onset); $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nOnset of cyst formation:\n$54 \\%(72 \\%)[86 \\%]$ in $1^{\\text {st }}$ decade ( $2^{\\text {nd }}$ decade) [3rd decade]; morphologic evidence in all",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 149,
            "markdown": "patients by age 80\nMinimum diagnostic criteria in screening exam for cysts to confirm diagnosis of ADPKD:\n$15-39$ years $\\geq 3$ uni- / bilateral cysts\n$40-59$ years $\\geq 2$ cysts in each kidney\n$>60$ years $\\geq 4$ cysts in each kidney\nAssociated with:\n(1) Cysts in: liver ( $40 \\%$ ), pancreas ( $9 \\%$ ); rare in spleen, arachnoid membrane, lung, thyroid, ovary, uterus, testis, seminal vesicle, epididymis, bladder\n(2) Saccular \"berry\" aneurysm of cerebral arteries (3-15\\%)\n\n- Screening recommended to start at age 20 years\n(3) Aortic aneurysm, aortic dissection\n(4) Mitral valve abnormalities ( $26 \\%$ )\n(4) Abdominal wall hernia\n(5) Colonic diverticulosis\n- usually asymptomatic $\\rightarrow$ symptomatic at mean age of 35 years $\\leftarrow$ cysts grow with age; disease is slowly progressive with nearly $100 \\%$ penetrance and great variation in expressivity\n- hypertension (50-70\\%), hematuria, proteinuria\n- azotemia $\\leftarrow$ replacement of renal parenchyma by cysts\n- lumbar / abdominal pain\n\nSize of kidney: up to 40 cm in length; up to 8 kg in weight\nRenal volume: mean of $>1,000 \\mathrm{~mL}$ (normal mean $=150 \\mathrm{~mL}$ ) with mean annual increase of 63 mL\n$\\diamond$ Volume measurements by MR may be used to monitor disease progression!\n$\\sqrt{ }$ enlargement of both kidneys with innumerable cysts of varied size + diffuse distribution\n$\\sqrt{ }$ cysts may calcify in curvilinear rim- / ringlike irregular amorphous fashion\n$\\sqrt{ }$ elongated + distorted + attenuated collecting system\n$\\sqrt{ }$ nodular puddling of contrast material on delayed images\n$\\sqrt{ }$ \"Swiss cheese\" nephrogram = multiple lesions of varying size with smooth margins\n$\\sqrt{ }$ polycystic kidneys shrink after beginning of renal failure, after renal transplantation, or on chronic hemodialysis\n$\\sqrt{ }$ liver cysts (may be identified without renal involvement):\n$\\sqrt{ }$ isolated from bile ducts (DDx ARPKD)\n$\\sqrt{ }$ liver cyst size + number increase with advancing age $\\rightarrow$ liver function preserved\n$C x$ : mass effect, intracyst hemorrhage / infection\nNUC: poor renal function on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA scan\n$\\sqrt{ }$ multiple areas of diminished activity, cortical activity only in areas of functioning cortex US:\n$\\sqrt{ }$ multiple cysts in cortical region (usually seen in $50 \\%$ by 10 years of age)\n$\\sqrt{ }$ diffusely echogenic when cysts small (children)\n$\\sqrt{ }$ renal contour poorly demarcated\nN.B.: A normal US examination cannot exclude ADPKD until after age 35 years!\n\nIn a child with known PKD1 mutation $\\geq 3$ renal cysts / cyst in liver establishes the",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 150,
            "markdown": "# diagnosis! \n\nOB-US:\n$\\sqrt{ }$ kidneys normal in size / mildly enlarged\n$\\sqrt{ }$ echogenic kidneys similar to infantile PCKD (usually in $3^{\\text {rd }}$ trimester, may be unilateral (earliest sonographic diagnosis at 14 weeks GA):\n$\\sqrt{ }$ hyperechoic cortex + relatively hypoechoic medulla $\\rightarrow$ increased corticomedullary differentiation\n$\\sqrt{ } \\pm$ few macroscopic small round cysts in cortex and medulla (rare)\n$\\sqrt{ }$ normal amount of amniotic fluid / oligohydramnios $\\leftarrow$ renal function usually not impaired Atypical rare presentation:\n(a) unilateral adult PCKD\n(b) segmental adult PCKD\n(c) adult PCKD in utero / neonatal period\n\nCx:\n(1) Death from uremia in late adulthood (59\\%) / cerebral hemorrhage $\\leftarrow$ hypertension / ruptured aneurysm ( $13 \\%$ ) / cardiac complications (mean age 50 years)\n$\\diamond$ NO increased risk of renal cell carcinoma!\nAbout $50 \\%$ of ADPKD patients will develop end-stage renal disease.\n(2) Renal calculi ( $20 \\%$ ): mostly urate\n(3) Cyst infection\n(4) Cyst rupture\n(5) Cyst hemorrhage ( $66 \\%$ ):\n\n- common cause of acute flank pain\n$\\sqrt{ }$ hyperattenuated cyst content on CT\n$\\sqrt{ }$ calcifications frequent, which may take years\n(6) Liver dysfunction (sporadically): hepatomegaly, liver failure, Budd-Chiari syndrome\n$\\diamond$ NO increased risk for renal cell carcinoma unless on prolonged dialysis\n$D D x$ :\n(1) Multiple simple cysts (less diffuse, no family history)\n(2) Glomerulocystic disease\n(3) Von Hippel-Lindau disease (cerebellar hemangioblastoma, retinal hemangiomas, occasionally pheochromocytomas)\n(4) Acquired uremic cystic disease (kidneys small, no renal function, transplant)\n(5) Infantile PCKD (usually microscopic cysts)\n\n\n## Autosomal Recessive Polycystic Kidney Disease\n\n$=$ ARPKD $=$ INFANTILE POLYCYSTIC KIDNEY DISEASE $=$ POLY-CYSTIC DISEASE OF CHILDHOOD $=$ Potter Type I\n$=$ most common ciliopathy affecting kidney + liver to varying degrees\nPrevalence: $1 \\div 22,000$ live births; $\\mathrm{F}=\\mathrm{M}$; carrier frequency of $1 \\div 70$\nMean age: 2.5 years (at presentation)\nGenetics: mutations in PKHD1 (polycystic kidney hepatic disease 1) gene located on chromosome $6 \\mathrm{p} 12 \\rightarrow$ encodes protein fibrocystin-polyductin localizing to primary cilia of epithelial cells that line renal tubules (collecting ducts) + intrahepatic bile",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 151,
            "markdown": "ducts\nPathogenesis:\nsymmetric circumferential epithelial proliferation results in tubular lengthening + fusiform dilatation of collecting ducts; abnormal epithelium becomes secretory instead of resorptive; secreted fluid is rich in epithelial growth factors stimulating further epithelial proliferation\nPath:\n@ Kidney:\nnumerous nonobstructive fusiform dilated + elongated collecting tubules with radial orientation extending from enlarged medulla into compressed cortex; associated renal interstitial edema + fibrosis; increased separation of a normal number of glomeruli $\\rightarrow$ progressive cystic degeneration into peripheral cortical microcysts of $1-3 \\mathrm{~mm}$ in diameter with occasional macrocyst\n$\\sqrt{ }$ spongelike texture of renal parenchyma\n\n- diminished concentrating ability of kidneys, azotemia\n@ Liver:\nmalformation of ductal plate $\\rightarrow$ congenital hepatic fibrosis = irregularly formed ectatic nonobstructive intrahepatic bile ducts increased in number with atypical branching pattern + septa of fibrosed portal tracts $\\rightarrow$ disproportionate enlargement of left lobe\n@ Pancreas: pancreatic fibrosis\n$\\diamond$ The greater the percentage of abnormal collecting tubules, the more severe the renal compromise and the earlier the clinical presentation!\n$\\diamond$ The less severe the renal findings, the more severe the hepatic findings!\nBlythe \\& Ockenden classification:\nA. PERINATAL FORM (most common)\n\n90\\% of tubules show cystic changes\n\n- onset of renal failure in utero, Potter sequence\n- large palpable flank masses, small thorax, respiratory distress, oliguria in neonate\n$\\sqrt{ }$ both kidneys enlarged\n$\\sqrt{ }$ oligohydramnios + dystocia $\\leftarrow$ large abdominal mass\nPrognosis: death from renal failure / respiratory insufficiency (pulmonary hypoplasia) within 24 hours in $75 \\%$, within 1 year in $93 \\%$; uniformly fatal\nB. NEONATAL FORM\n\n60\\% of tubules show ectasia + minimal hepatic fibrosis + bile duct proliferation\n\n- onset of renal failure within $1^{\\text {st }}$ month of life\n\nPrognosis: death from renal failure / hypertension / left ventricular failure within $1^{\\text {st }}$ year of life\nC. INFANTILE FORM\n\n25\\% of renal tubules involved + mild / moderate periportal fibrosis\n\n- disease appears by 3-6 months of age\n\nPrognosis: death from chronic renal failure / systemic arterial hypertension / portal hypertension\nD. JUVENILE FORM\n\n10\\% of tubules involved + gross hepatic fibrosis + bile duct proliferation\n\n- disease appears at 6 months to 5 years of age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 152,
            "markdown": "$\\checkmark$ portal hypertension:\n\n- thrombocytopenia $\\leftarrow$ hypersplenism\n- gastroesophageal variceal bleeding\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ ascites\nPrognosis: death from portal hypertension\nRadiography\n$\\checkmark$ abdominal distension\n$\\checkmark$ gas-filled bowel loops deviated centrally\n$\\checkmark$ small bell-shaped thorax $\\rightarrow$ severe pulmonary hypoplasia\n$\\checkmark$ pneumothorax / pneumomediastinum\nIVP:\n$\\checkmark$ bilateral gross smooth renal enlargement\n$\\checkmark$ faint nephrogram + blotchy opacification on initial images\n$\\checkmark$ increasingly dense nephrogram\n$\\checkmark$ poor visualization of collecting system\n$\\checkmark$ \"sunburst nephrogram\" = striated nephrogram with persistent radiating opaque streaks (= collecting ducts) on delayed images\n$\\checkmark$ prominent fetal lobation\n$\\checkmark$ poor opacification + contrast excretion $\\leftarrow$ impaired renal function\nCT:\n$\\checkmark$ kidneys of low attenuation $\\leftarrow$ stagnant urine in dilated collecting ducts\n$\\checkmark$ prolonged corticomedullary phase\n$\\checkmark$ striated nephrogram $\\leftarrow$ contrast material accumulating in dilated collecting ducts MR:\n$\\checkmark$ enlarged kidneys darker than normal on T1WI\n$\\checkmark$ hyperintense renal parenchyma on T2WI:\n$\\checkmark$ homogeneously T2-bright kidneys\n$\\checkmark$ multiple rounded $1-2-\\mathrm{mm}$ discrete tubular cystic foci\n$\\checkmark$ large $1-2-\\mathrm{cm}$ macrocysts\nGU-US:\n$\\checkmark$ hyperechoic enlarged kidneys $\\leftarrow$ increased number of acoustic interfaces $\\leftarrow$ unresolved $1-2-\\mathrm{mm}$ cystic / ectatic dilatation of renal tubules\n$\\checkmark$ increased renal through-transmission $\\leftarrow$ fluid content of cysts:\n$\\checkmark$ high-spatial-resolution US may resolve tiny dilated tubular cysts:\n$\\checkmark$ isolated medullary disease (in $37 \\%$ )\n$\\checkmark$ corticomedullary involvement (in 63\\%)\n$\\checkmark$ normal renal cortex $\\rightarrow \\sim$ normal renal function\n$\\checkmark$ loss of corticomedullary differentiation $\\rightarrow$ poor visualization of renal sinus + renal borders\n$\\checkmark$ thin rim of hypoechoic cortex\n$\\checkmark$ occasionally discrete macrocysts $<1 \\mathrm{~cm}$ with tendency to become larger + more numerous over time (in older children) resembling adult medullary sponge kidney\n$\\checkmark$ small bladder\nLiver-US:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 153,
            "markdown": "- portal venous hypertension (5-13 years of age)\n$\\checkmark$ disproportionate enlargement of left hepatic lobe\n$\\checkmark$ patchy / diffuse heterogeneously coarse liver echogenicity:\n$\\checkmark$ increased echogenicity of portal tracts $=$ echogenic periportal thickening $\\leftarrow$ fibrosis\n$\\checkmark$ tubular cystic dilatation of small intrahepatic bile ducts:\n$\\checkmark$ \"central dot\" sign = portal vein + hepatic artery branches completely surrounded by dilated intrahepatic bile duct\n$\\checkmark$ cysts in continuity with bile ducts\n$\\checkmark$ dilated extrahepatic bile ducts + elongated hydropic gallbladder (in up to 55\\%)\n$\\checkmark$ splenomegaly\n$\\checkmark$ ascites\n$\\checkmark$ enlarged splenic v., portal v. + splanchnic collateral veins (gastroesophageal varices, \"recanalized\" paraumbilical veins, spontaneous splenorenal shunts)\n$\\checkmark$ increased stiffness on liver elastography $\\leftarrow$ fibrosis\nOB-US (diagnostic as early as $15-17$ weeks GA):\n\n- decreased fetal urine output\n- Potter facies: low-set + flattened ears, short + snubbed nose, deep eye creases, micrognathia\n$\\checkmark$ progressive massive renal enlargement ( $10-20 \\mathrm{x}$ larger than normal):\n$\\checkmark$ renal +abdominal circumference ratio $>0.30$\n$\\checkmark$ hyperechoic renal parenchyma $=$ echogenic medulla with relative sparing of cortex\n$\\checkmark$ nonvisualization of urine in fetal bladder (in severe cases)\n$\\checkmark$ severe oligohydramnios ( $33 \\%$ ) by 20 weeks GA $\\rightarrow$ oligohydramnios / Potter sequence mnemonic: POTTER\n\nPulmonary hypoplasia\nOligohydramnios\nTwisted wrinkly skin\nTwisted Potter face\nExtremity defects\nRenal agenesis, bilateral\n$\\checkmark$ small / absent urinary bladder\n$\\checkmark$ small fetal thorax with pulmonary hypoplasia\n$\\checkmark$ club foot\n$\\checkmark$ congenital dislocation of hips\nOB management:\n(1) Chromosome studies to determine if other malformations present (eg, trisomy 13 / 18)\n(2) Option of pregnancy termination $<24$ weeks\n(3) Nonintervention for fetal distress $>24$ weeks if severe oligohydramnios present\n\nRisk of recurrence: $25 \\%$\nDDx: Meckel-Gruber syndrome, adult polycystic kidney disease (absence of tiny tubular cysts, cysts in parents), nephronophthisis, cystic renal dysplasia (round cysts), tuberous sclerosis (cortical rather than medullary cysts, angiomyolipomas)\n\n# POLYORCHIDISM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 154,
            "markdown": "$=$ SUPERNUMERARY TESTIS\n$=$ rare congenital anomaly, in which $>2$ testes are present\nCause: developmental accident in union / division of genital ridge + mesonephric ducts $\\leftarrow$ peritoneal bands\nAssociated with: maldescent of one supernumerary testis (15-50\\%), inguinal hernia (30\\%), hydrocele, epididymitis, varicocele, infertility, cryptorchidism (40\\%), malignancy\n\n- painless extratesticular scrotal mass\n\nLocation: left $>$ right\n$\\sqrt{ }$ duplication of testis + single epididymis (most common)\n$\\checkmark$ bridging vessels between supernumerary + normal testis\n$C x:$ torsion $(13-15 \\%) \\leftarrow \\uparrow$ mobility of supernumerary testis\n$R x:$ orchiopexy\n$D D x:$ splenogonadal fusion\n\n# POSTERIOR URETHRAL VALVES \n\n$=$ congenital thick folds of mucous membrane located in posterior urethra (prostatic + membranous) distal to verumontanum\nType I: (most common) mucosal folds (vestiges of wolffian duct) extend anteroinferiorly from the caudal aspect of the verumontanum, often fusing anteriorly at a lower level\nType II: (rare) mucosal folds extend anterosuperiorly from verumontanum toward bladder neck (nonobstructive normal variant, probably a consequence of bladder outlet obstruction)\nType III: diaphragm-like membrane located below the verumontanum = abnormal canalization of urogenital membrane\nPrevalence: $1 \\div 5,000$ to $1 \\div 8,000$ boys; most common cause of urinary tract obstruction + leading cause of end-stage renal disease among boys\nTime of discovery: prenatal ( $8 \\%$ ), neonatal ( $34 \\%$ ), 1st year ( $32 \\%$ ), $2^{\\text {nd }}-16^{\\text {th }}$ year ( $23 \\%$ ), adult $(3 \\%)$\n\n- urinary tract infection (fever, vomiting) in $36 \\%$\n- obstructive symptoms in $32 \\%$ (hesitancy, straining, dribbling [20%], enuresis [20%]); failure to thrive $(13 \\%)$\n- palpable kidneys / bladder in neonate ( $21 \\%$ ), hematuria (5\\%)\n\nVCUG:\n$\\checkmark$ vesicoureteral reflux, mainly on left side (in 33\\%)\n$\\checkmark$ fusiform distension + elongation of proximal posterior urethra persisting throughout voiding\n$\\checkmark$ transverse / curvilinear filling defect in posterior urethra\n$\\checkmark$ diminution of urethral caliber distal to severe obstruction\n$\\checkmark$ hypertrophy of bladder neck\n$\\checkmark$ trabeculation + sacculation of bladder wall\n$\\checkmark$ large postvoid bladder residual\nUS:\n$\\checkmark$ male gender\n$\\checkmark$ oligohydramnios (related to severity + duration of obstruction)\n$\\checkmark$ hypoplastic / multicystic dysplastic kidney (if early occurrence)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 155,
            "markdown": "$\\sqrt{ }$ bilateral hydroureteronephrosis $\\rightarrow$ pulmonary hypoplasia\n$\\sqrt{ }$ dilated renal pelvis may be absent in renal dysplasia / rupture of bladder / pelviureteral atresia\n$\\checkmark$ overdistended urinary bladder ( $=$ megacystis) in $30 \\%$\n$\\checkmark$ thick-walled urinary bladder + trabeculations (best seen after decompression)\n$\\checkmark$ urine leak: urinoma, urine ascites, urothorax\n$\\checkmark$ \"pear / keyhole\" bladder = thick-walled bladder + dilated posterior urethra (on perineal scan)\n$\\checkmark$ dilated utricle (perineal scan)\nOB management:\n(1) Induction of labor as soon as fetal lung maturity established (if diagnosed during last 10 weeks of pregnancy)\n(2) Vesicoamniotic shunting may be contemplated if diagnosed remote from term ( $68 \\%$ survivors) with good prognostic parameters of fetal urinary sodium $<100 \\mathrm{mEq} / \\mathrm{dL}+$ chloride $<90 \\mathrm{mEq} / \\mathrm{dL}+$ osmolality $<210 \\mathrm{mOsm} / \\mathrm{dL}$\n$C x$ : (1) Neonatal urine leak: ascites, urothorax, urinoma (13\\%)\n(2) Neonatal pneumothorax / pneumomediastinum (in 9\\%)\n(3) Prune belly syndrome\n(4) Renal dysplasia (if obstruction occurs early during gestation)\n\nPrognosis: depends upon duration of obstruction prior to corrective surgery; poor prognosis if associated with vesicoureteral reflux; nephrectomy for irreversible damage (13\\%)\n$D D x$ : (1) UPJ obstruction\n(2) UVJ obstruction\n(3) Primary megaureter\n(4) Massive vesicoureteral reflux\n(5) Megacystis-microcolon-intestinal hypoperistalsis syndrome\n\n# POSTINFLAMMATORY RENAL ATROPHY \n\n$=$ acute bacterial nephritis with irreversible ischemia as unusual form of severe gram-negative bacterial infection in patients with altered host resistance in spite of proper antibiotic treatment\nHisto: occlusion of interlobar arteries / vasospasm\n$\\checkmark$ small smooth kidney\n$\\checkmark$ papillary necrosis in acute phase\n\n## POSTOBSTRUCTIVE RENAL ATROPHY\n\n$=$ generalized papillary atrophy usually following successful surgical correction of urinary tract and obstruction progressing in spite of relief of obstruction\n$\\checkmark$ small smooth kidney, usually unilateral\n$\\checkmark$ dilated calices with effaced papillae\n$\\checkmark$ thinned cortex\n\n## PRIAPISM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 156,
            "markdown": "$=$ prolonged penile erection not associated with sexual arousal\n[ Priapus, Greek mythology = god of fertility]\nTypes:\n(1) LOW-FLOW / ischemic / venoocclusive form (common): characterized by ischemia, venous stasis, pooling of blood within corpora cavernosa\nCause: intracavernosal injection of vasoactive agent (papaverine, prostaglandin), sickle cell disease, hematopoietic malignancy, hypercoagulable state\n$\\diamond$ SURGICAL EMERGENCY!\n\n- painful erection\n- corporeal aspiration of nonoxygenated blood (with low oxygen tension in blood gas analysis)\n$\\checkmark$ sluggish flow / blood stasis in corpora cavernosa:\n$\\checkmark$ sedimentation of blood with fluid-fluid level\n$\\checkmark$ decreased venous outflow\n$\\checkmark$ decreased arterial inflow\n$\\checkmark$ intracavernosal thrombosis\n$R x$ : cavernosal aspiration + irrigation, cavernosal injection of $\\alpha$-adrenergic receptor agonists (phenylephrine), anticoagulation, shunt procedure\n$C x$ : cavernosal tissue fibrosis $\\rightarrow$ permanent erectile dysfunction (in $50 \\%$ in spite of Rx)\n(2) HIGH-FLOW / arterial / nonischemic form (rare):\ncharacterized by unregulated arterial inflow of blood into corpora cavernosa $\\leftarrow$ usually arterial injury\nCause: perineal / penile trauma\n- subsequent persistent painless erection\n- corporeal aspiration of oxygenated blood (with high oxygen tension in blood gas analysis)\nColor Doppler US:\n$\\checkmark$ high blood flow in cavernosal artery\n$\\checkmark$ focal blush of abnormal intracavernosal flow adjacent to cavernosal artery from arterial-sinusoidal fistula / pseudoaneurysm\n$R x$ : percutaneous transcatheter embolization; arterial ligation\n\n\n# PROSTATE CANCER \n\nIncidence:\ndoubles with each decade after age 50;129 100,000 new cases annually in USA (2012); 3rd most common new malignancy in USA in 2016 (after female breast cancer + lung cancer); in $35 \\%$ of men $>45$ years of age (autopsies)\n$\\diamond 14 \\%$ of males will develop prostate cancer (= lifetime risk)!\nRacial factors: White $>$ Black $>$ Hispanic $>$ Asian\nRisk factors: advancing age, presence of testes, cadmium exposure, animal fat intake; $\\geq 1$ firstdegree relative\nHisto: adenocarcinoma (common); rare cancers: transitional cell cancer, adenoid cystic cancer, endometrioid neoplasm of verumontanum, carcinosarcoma, sarcoma, lymphoma\nHisto for adenocarcinoma:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 157,
            "markdown": "nuclear anaplasia + large nucleoli in secretory cells, disturbed architecture, invasive growth Premalignant change:\n(1) Prostatic intraepithelial neoplasia (PIN)\n$=$ premalignant lesion frequently associated with invasive carcinoma next to it / elsewhere in the gland\n(2) Atypical adenomatous hyperplasia $=$ proliferation of newly formed small acini Grading (Gleason score $2-10$ ):\n1,2,3 glands surrounded by 1 row of epithelial cells\n4 absence of complete gland formation\n5 sheets of malignant cells\nlow numbers refer to well-differentiated, high numbers to anaplastic tumors; primary predominant grade ( $1-5$ ) is added to secondary less representative area with highest degree of dedifferentiation (1-5)\n$\\diamond$ Gleason grading is in only $80 \\%$ reproducible!\n$\\diamond$ Gleason grade $\\geq 7$ has worse prognosis\n\n- Clinical categories:\n\n1. Latent carcinoma $=$ usually discovered at autopsy of a patient without signs or symptoms referable to the prostate $(26-73 \\%)$\n2. Incidental carcinoma $=$ discovered in $6-20 \\%$ of specimens obtained during transurethral resection for clinically benign prostatic hyperplasia\n3. Occult carcinoma $=$ found at biopsy of metastatically involved bone lesion / lymph node in a patient without symptoms of prostatic disease\n4. Clinical carcinoma $=$ cancer detected by digital rectal examination based on induration / irregularity / nodule\n\n- digital rectal exam is $30-60 \\%$ accurate for differentiating stage B from stage C disease\n- elevated Prostate-Specific Antigen (PSA)\n( $=$ glycoprotein produced by prostatic epithelium) is measured by a monoclonal\nradioimmunoassay (Hybritech ${ }^{\\circledR}$, most commonly used: normal value of $0.1-4 \\mathrm{ng} / \\mathrm{mL}$ )\n$\\diamond 19-30 \\%$ of prostate cancers have normal PSA!\n$\\diamond$ Cancers of $<1 \\mathrm{~mL}$ usually do not elevate PSA!\nConfined disease (stage B and less) \\& PSA level:\n$75 \\%$ of patients with PSA of $<4 \\mathrm{ng} / \\mathrm{mL}$\n$53 \\%$ of patients with PSA of $4-10 \\mathrm{ng} / \\mathrm{mL}$\n$2 \\%$ of patients with PSA of $>30 \\mathrm{ng} / \\mathrm{mL}$\n$\\diamond 16 \\%$ of normal men have PSA $>4 \\mathrm{ng} / \\mathrm{mL}$\n$\\diamond$ Benign conditions with PSA elevation: benign prostatic hypertrophy, acute urinary retention, acute prostatitis, prostatic intraepithelial neoplasia (PIN)\n\n- $\\downarrow$ free-to-total PSA ratio:\n$<15 \\%$ is highly suggestive of cancer,\n$<25 \\%$ detects $95 \\%$ of detectable cancers\n- $\\uparrow$ PSA density\n$=$ volume corrected PSA level [= prostate volume (height x width x length x 0.523 ) / PSA value]:\n$>0.12(90 \\%$ sensitive, $51 \\%$ specific for cancer $)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 158,
            "markdown": "$\\diamond$ Each gram of malignant prostate tissue produces $3.5 \\mathrm{ng} / \\mathrm{mL}$ PSA versus $0.3 \\mathrm{ng} / \\mathrm{mL}$ PSA for BPH!\n\n- $\\uparrow$ PSA velocity $=$ serial PSA evaluation $>0.75 \\mathrm{ng} \\times \\mathrm{mL}-1 \\times \\mathrm{yr}-1$\n\n| Staging of Prostate Cancer American Joint Committee on Cancer |  |\n| :--: | :--: |\n| T0 | No evidence of primary tumor |\n| T1 | Clinically inapparent nonpalpable nonvisible tumor $<3$ microscopic foci of cancer / $\\leq 5 \\%$ of resected tissue |\n| T1a | $>3$ microscopic foci of cancer / $>5 \\%$ of resected tissue |\n| T1b | tumor diagnosed by needle biopsy |\n| T2 | Tumor clinically present + confined to prostate |\n| T2a | tumor $\\leq 1.5 \\mathrm{~cm},<1 / 2$ of one lobe |\n| T2b | tumor $>1.5 \\mathrm{~cm} />1 / 2$ of one lobe (unilateral) |\n| T2c | tumor involves both lobes (bilateral) |\n| T3 | Extension through prostatic capsule |\n| T3a | unilateral |\n| T3b | bilateral |\n| T3c | invasion of seminal vesicles |\n| T4 | Tumor fixed / invading adjacent structures other than seminal vesicles |\n| T4a | invasion of bladder neck, external sphincter, rectum |\n| T4b | invasion of levator ani muscle and/or fixed to pelvic wall |\n| N | Involvement of regional lymph nodes |\n| N1 | metastasis in a single node $\\leq 2 \\mathrm{~cm}$ |\n| N2 | metastasis in a single node $>2$ and $<5 \\mathrm{~cm} /$ multiple lymph nodes affected |\n| N3 | metastasis in a lymph node $\\geq 5 \\mathrm{~cm}$ |\n| M | Distant metastasis |\n| M1a | nonregional lymph nodes |\n| M1b | bone |\n| M1c | other site $\\pm$ bone |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 159,
            "markdown": "| Staging of Prostate Cancer <br> American Urological Association System <br> (modified Jewitt-Whitmore Staging System) |  |\n| :-- | :-- |\n| A | No palpable lesion |\n| $\\mathrm{A}_{1}$ | focal well-differentiated tumor $<1.5 \\mathrm{~cm}$ |\n| $\\mathrm{~A}_{2}$ | diffuse poorly differentiated tumor; |\n|  | $>5 \\%$ of chips from TURP contain cancer |\n| B | Palpable tumor confined to prostate |\n| $\\mathrm{B}_{1}$ | lesion $<1.5 \\mathrm{~cm}$ in diameter confined to one lobe |\n| $\\mathrm{B}_{2}$ | tumor $\\geq 1.5 \\mathrm{~cm} /$ involving more than one lobe |\n| C | Localized tumor with capsular involvement |\n| $\\mathrm{C}_{1}$ | capsular invasion |\n| $\\mathrm{C}_{2}$ | capsular penetration |\n| $\\mathrm{C}_{3}$ | seminal vesicle involvement |\n| D | Distant metastasis |\n| $\\mathrm{D}_{1}$ | involvement of pelvic lymph nodes |\n| $\\mathrm{D}_{2}$ | distant nodes involved |\n| $\\mathrm{D}_{3}$ | metastases to bone / soft tissues / organs |\n\nStaging:\n$\\diamond$ At initial presentation $>75 \\%$ have stage $\\mathrm{C}+\\mathrm{D}$ !\n$\\diamond 40 \\%$ of patient believed to have organ-confined disease have extraprostatic disease at radical prostatectomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 160,
            "markdown": "| Benign Conditions Mimicking Prostate Cancer at MRI |  |\n| :--: | :--: |\n| Condition | Histologic \\& Anatomic Features |\n| Normal anatomy |  |\n| Anterior fibromuscular stroma | dense fibromuscular band anterior to transition zone |\n| Surgical capsule | band of fibromuscular + compressed glandular tissue between transition + peripheral zone |\n| Central zone | complex crowded glands + dense stroma surrounding ejaculatory ducts |\n| Periprostatic vein | venous plexus closely associated with pseudocapsule |\n| Periprostatic lymph nodes | Lnn adjacent to lateral / posterolateral prostate |\n| Benign pathology |  |\n| Stroma-rich BPH | stromal fibromuscular proliferation in transition zone (rarely in peripheral zone) |\n| Bacterial prostatitis | inflammatory infiltrate (neutrophils + lymphocytes) $\\pm$ glandular atrophy |\n| Mycobacterial granulomatous prostatitis | granulomatous inflammation $\\pm$ central caseation |\n| Malakoplakia | granulomatous inflammation + MichaelisGutman bodies |\n| Atrophy | crowded glands with scan cytoplasm + nuclear crowding |\n| Necrosis | coagulative necrosis + surrounding inflammatory infiltrate |\n| Calcification | concreted prostatic secretions / calcified corpora amylacea |\n\nEscape routes through prostatic capsule are:\n(1) Capsular margin at neurovascular bundle posterolaterally $(80 \\%) \\leftarrow$ intrinsic weakness of capsule at this location\n(2) Apex\n(3) Seminal vesicles!\n\nStaging accuracy for local [advanced] disease:\n$46[66 \\%$ ] for US, $57[77 \\%$ ] for MR\n$\\diamond$ Extracapsular disease is common at $>3.8 \\mathrm{~cm}^{3}$ tumor volume!\nMetastases to lymph nodes:\n$0 \\%(3-7 \\%)[5 \\%]\\{10-12 \\%\\}$ in stage A1 (A2) [B1] \\{B2\\}; 54-57\\% in stage C; 10\\% [70$93 \\%$ ] with Gleason grade $\\leq 5[9 / 10]$\n$\\sqrt{ }$ size $>10 \\mathrm{~mm}(25-78 \\%$ sensitive, $77-98 \\%$ specific $)$\n$\\sqrt{ }$ MR-enhancement with ultrasmall superparamagnetic iron oxide particles (USPIO) for nodal mapping is superior\nPredictors for bone metastases:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 161,
            "markdown": "- PSA $>20$; Gleason score of $8-10$\n- clinical stage of $>$ T3; bone symptoms\n\nLocation of cancer: peripheral zone (70\\%), transition zone (20\\%), central zone (10\\%); multifocal in $40 \\%$\n\nMR imaging findings suggestive of transition zone cancer:\n$\\checkmark$ homogeneous low T2 signal intensity (\"erased charcoal sign\") + ill-defined margins + lack of capsule + lenticular shape + invasion of anterior fibromuscular stroma\nUS ( $21 \\%$ positive predictive value):\n$\\checkmark$ hypoechoic ( $61 \\%$ ) / mixed (2\\%) / hyperechoic (2\\%) lesion; undetectable isoechoic lesion $(35 \\%)$\n$\\checkmark$ asymmetric enlargement of gland\n$\\checkmark$ deformed contour of prostate $=$ \"irregular bulge\" sign ( $75 \\%$ PPV)\n$\\checkmark$ heterogeneous texture\nSize versus rate of detection:\n$\\leq 5 \\mathrm{~mm}(36 \\%), 6-10 \\mathrm{~mm}(65 \\%), 11-15 \\mathrm{~mm}(53 \\%), 16-20 \\mathrm{~mm}(84 \\%), 21-25 \\mathrm{~mm}(92 \\%)$, $\\geq 26 \\mathrm{~mm}(75 \\%)$\nMR (useful for targeted biopsy):\n$\\checkmark$ low-signal abnormality within the normally high-signal glandular tissue of the peripheral zone on T2WI\n$\\checkmark$ tumor isointense relative to surrounding gland on T1WI\n$\\checkmark$ extracapsular extension ( $90 \\%$ specific, $15 \\%$ sensitive):\n$\\checkmark$ direct tumor extension beyond prostate\n$\\checkmark$ decreased SI in periprostatic fat adjacent to capsule near tumor on T1WI + T2WI (capsule optimally depicted on T1WI $\\leftarrow$ demarcation by periprostatic fat of high SI)\n$\\checkmark$ capsular thickening\n$\\checkmark$ irregular focal bulge in contour of capsule near tumor ( $24-38 \\%$ sensitive, $77-88 \\%$ specific)\n$\\checkmark$ angulated glandular contour\n$\\checkmark$ irregular spiculated margin\n$\\checkmark$ flattening / obliteration of rectoprostatic angle ( $24-50 \\%$ sensitive, $81-95 \\%$ specific)\n$\\checkmark$ asymmetry of neurovascular bundle ( $21-38 \\%$ sensitive, $81-95 \\%$ specific)\n$\\checkmark$ tumor enveloping neurovascular bundle\n$\\checkmark$ low-signal lesion on T2WI within seminal vesicles that are normally of high-SI (43-71\\% sensitive, $99 \\%$ specific)\nCEMR:\n$\\checkmark$ enhancement of cancer relative to surrounding tissue:\n$\\checkmark$ calculation of peak enhancement parameters\n$\\checkmark$ area enhancing within $30-60 \\mathrm{sec}$\nMR spectroscopy (metabolic mapping of entire gland):\n$\\checkmark \\uparrow$ choline-citrate ratio $>2$ SD:\n$\\checkmark \\downarrow$ citrate levels $\\leftarrow$ conversion from citrate-producing to citrate-oxidating metabolism\n$\\checkmark \\uparrow$ cholin levels $\\leftarrow$ increased turnover of phospholipid cell membrane in proliferating malignant tissue\nN.B.: creatinine peak may be inseparable from cholin peak",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 162,
            "markdown": "$D D x$ : post-biopsy hemorrhage $\\rightarrow$ low signal on T2WI + high signal on T1WI; inflammation; fibrosis; scarring\nPrognosis: increase in tumor volume increases probability of capsular penetration, metastasis, histologic dedifferentiation; $100 \\%$ (28\\%) 5-year survival for localized disease (metastatic cancer)\nMortality: $20.7 \\div 100,000$ (2013); 26,120 deaths annually (2016)\nScreening recommendation (American Urological Association, American Cancer Society):\nPSA level measurements + digital rectal exam annually\n$D x$ : transrectal biopsy\nSextant biopsy: $83 \\%$ PPV, $37 \\%$ NPV, $30 \\%$ of cancers are missed, localization inaccurate\n$\\diamond 40 \\%$ accuracy of biopsy for Gleason grade\nRx: (1) Watchful waiting\n(2) Radical prostatectomy for disease confined to capsule $\\rightarrow$ life expectancy $>15$ years\n(3) Radiation therapy for\n(a) disease confined to capsule $\\rightarrow$ life expectancy $<15$ years\n(b) disease outside capsule, no spread\n(4) Hormonal therapy: orchiectomy, diethylstilbestrol, leuprolide acetate (for widely metastatic disease)\n(5) Cryosurgery\n(6) Chemotherapy\n\n# PROSTATIC ABSCESS \n\nAge: $5^{\\text {th }}-6^{\\text {th }}$ decade\nAgent: E. coli (main cause)\n\n- urinary frequency, urgency, dysuria, hematuria\n- perineal / lower back pain, fever, chills\n- focally enlarged tender prostate\n$\\checkmark$ hypo- / anechoic mass with irregular wall + septations\n\n\n## PROSTATITIS\n\n## Bacterial Prostatitis\n\nPrevalence: $9.7 \\%$\nConsider prostatitis with a clinical history of urinary $\\pm$ sexual symptoms, fluctuating PSA levels, or PSA response to antibiotics.\nDistribution: diffuse / focal\nLocation: peripheral zone (common); transition zone mimicking \"erased charcoal\" appearance of prostate carcinoma\nMR:\n$\\checkmark$ low T2 signal intensity $\\leftarrow$ increased inflammatory cellular infiltrates\n$\\checkmark$ mildly to moderately restricted diffusion (less than in prostate cancer)\nCEMR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 163,
            "markdown": "$\\sqrt{ }$ increased early enhancement (similar to prostate cancer)\nAcute Bacterial Prostatitis (uncommon)\nCause: intraprostatic reflux of infected urine, prostatic Bx\nOrganisms: Escherichia coli, Enterococcus, Proteus\nAge: young men\nHisto: influx of neutrophils\n\n- local and systemic symptoms\n$\\sqrt{ }$ enlarged reactive lymph nodes\n\n\n# Chronic Bacterial Prostatitis \n\nCause: undertreated acute prostatitis, recurrent infection, lower urinary tract obstruction in older men\nHisto: influx of lymphocytes, often with glandular atrophy\n\n- indolent (without systemic symptoms)\n- lower GU tract symptoms\n\n\n## CAUTARY / DivERTICULAR PROSTAtitis\n\nCause: fibrosis of chronic prostatitis constricts ducts leading to stagnation of exudate + breakdown of intraacinar septa with cavity formation\n\n- history of long-standing inflammatory condition\n$\\sqrt{ }$ \"Swiss cheese\" appearance of prostate\n\n\n## Granulomatous Prostatitis\n\n- clinically often mistaken for prostate cancer\n\nTypes:\n(1) Idiopathic: nonspecific and nonnecrotic\n(2) Infective: specific, nonnecrotic / necrotic\n(3) Iatrogenic: postsurgical\n(4) Malakoplakia\n(5) Systemic granulomatous disease\n\nFlorid granulomatous prostatitis may demonstrate extraprostatic extension like prostate cancer, both entities of a similar appearance at MRI.\n$D D x$ : clinically often mistaken for prostate cancer\nIdiopathic Granulomatous Prostatitis (60-78\\%)\n$=$ nonspecific nonnecrotic prostatitis\nCause: not clear\n\n- often self-limiting\n\nNo association with: systemic diseases\n\n## Sarcoid Prostatitis (rare)\n\n= idiopathic multisystem noncaseating granulomatous disease\nPredilection for: African-Americans\nHisto: nonspecific histology\n\n- mostly asymptomatic; elevated PSA level",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 164,
            "markdown": "$D x$ : based on clinical-radiologic correlation + exclusion of other granulomatous disease entities\n\n# Iatrogenic Granulomatous Prostatitis \n\nIncidence: $2^{\\text {nd }}$ most common type\nCause: transurethral resection of prostate / bladder $\\leftarrow$ reaction to altered epithelium + stroma from intervention\nHisto: palisaded histiocytoid granulomas with central necrotizing / fibrinoid necrosis surrounded by infiltrative eosinophils\n\n## Infective Granulomatous Prostatitis\n\nCause: mycobacterium tuberculosis ( $\\leftarrow$ hematogenous spread / direct extension from adjacent organs); development after intravesical bacillus Calmette-GuÃ©rin therapy for bladder cancer; Treponema pallidum; viruses (herpes zoster); fungi (Cryptococcus, Candida, Aspergillus)\nHisto: well-formed granulomas with epithelioid cell + multinucleated giant cell infiltration $+/-$ central necrosis (caseation)\nPredisposing risk factors: Hx of tuberculosis infection, bacillus Calmette-GuÃ©rin therapy, immunosuppressive state\n\n- mostly asymptomatic, elevated PSA level\n- indurated prostate at digital rectal examination\n$\\checkmark$ area of hypointensity on T2WI associated with diffusion restriction\n$\\sqrt{ }$ moderate / marked enhancement on dynamic images\n\n\n## Nonnecrotic Granulomatous Prostatitis\n\nHisto: highly cellular simulating prostate cancer\nMR:\n$\\sqrt{ }$ area of hypointensity on T2WI associated with restricted diffusion in the peripheral zone\n$\\sqrt{ }$ moderate / marked enhancement\n$D D x$ : prostate cancer\n\n## Necrotic Granulomatous Prostatitis\n\nHisto: central necrosis (caseation)\nMR:\n$\\sqrt{ }$ area of central hyperintensity on T2WI\n$\\sqrt{ }$ focal hyperintensity on high-b-value images\n$\\sqrt{ }$ marked diffusion restriction\n$\\sqrt{ }$ NO enhancement\n\n## Malakoplakia\n\n= rare granulomatous inflammatory condition associated with recurrent infection\nPath: granulomatous infiltration with Michaelis-Gutmann bodies, which may represent abnormality of intraphagosomal digestion of macrophages\n\n- bulging and irregularity of prostatic capsule\n\nMR:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 165,
            "markdown": "$\\sqrt{ }$ diffuse low T2 signal intensity, diffusion restriction\n$\\sqrt{ }$ hyperenhancement\n$D D x$ : prostate cancer\n\n# PRUNE BELLY SYNDROME \n\n$=$ EAGLE-BARRETT SYNDROME\n$=$ congenital nonhereditary multisystem disorder; almost exclusively in males\nTRIAD: 1. Abdominal wall muscle deficiency (wrinkled \"prune belly\" appearance of abdominal wall)\n2. Nonobstructed markedly distended redundant ureters $\\pm$ hydronephrosis and variable degree of renal dysplasia\n3. Bilateral undescended testes (cryptorchidism)\n\nEtiology:\n(1) Primary mesodermal arrest at 6-10 weeks GA:\nabundance of fibrous tissue with sparsely placed smooth muscle throughout urinary tract\n(2) Massive abdominal distension with pressure effects on abdominal wall musculature: $\\leftarrow$ bladder outlet obstruction ( $10-20 \\%$ ) / urine ascites / intestinal perforation with ascites / cystic abdominal masses / megacystis-microcolon-intestinal hypoperistalsis syndrome causing pressure atrophy of abdominal wall muscles; bladder distension interfering with descent of testes\n(3) Dysgenesis of yolk sac\n\nPrevalence: $1 \\div 29,000$ to $1 \\div 50,000$ live births; $\\mathrm{M} \\div \\mathrm{F}=19 \\div 1$; increased prevalence in Nigeria + Saskatchewan, Canada\nGroups:\n(1) Severe urethral obstruction $\\leftarrow$ urethral atresia [most commonly] / valves\n\nAssociated with:\nmalrotation (most common anomaly), intestinal atresia, imperforate anus, skeletal abnormalities (meningo-myelocele, scoliosis, pectus carinatum/excavatum, arthrogryposis, clubfoot, dislocation of hip, lower limb hemimelia, sacral agenesis, polydactyly), CHD (VSD, pulmonary artery stenosis), Hirschsprung disease, congenital cystic adenomatoid malformation of lung\n$\\sqrt{ }$ bladder wall hypertrophy\n$\\sqrt{ }$ bilateral cystic renal dysplasia\nPrognosis: in $20 \\%$ [50\\%] death within 1 month [2 years] $\\leftarrow$ renal failure $\\pm$ pulmonary insufficiency\n(2) Functional abnormality of bladder emptying (more common) with no associated abnormalities\n$\\sqrt{ }$ large floppy urinary bladder\n$\\sqrt{ }$ large urachal remnant\n$\\sqrt{ }$ dilated posterior urethra (without obstruction)\n$\\sqrt{ }$ utricle\n$\\sqrt{ }$ vesicoureteral reflux\n$\\sqrt{ }$ dilated tortuous ureters + focal areas of narrowing\n$\\sqrt{ }$ lobulated kidneys with dilated collecting system of bizarre shape",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 166,
            "markdown": "Prognosis: chronic urinary tract problems\n\n- wrinkled flaccid appearance of hypotonic abdominal wall with bulging flanks $\\leftarrow$ agenesis / hypoplasia of muscles in lower parts of abdominal wall ventrally + laterally:\ntransverse muscle $>$ rectus abdominis muscle below umbilicus $>$ internal + external oblique muscle $>$ rectus abdominis muscle above umbilicus\n- bilateral cryptorchidism (ESSENTIAL COMPONENT) with increased risk for malignant degeneration\n- $\\pm$ impaired renal function\n\nOB-US:\n$\\sqrt{ }$ enlarged bladder, dilated ureters\n$\\sqrt{ }$ abnormal abdominal wall\n$\\sqrt{ }$ normal / decreased AFI\n$D D x$ : posterior urethral valves\n@ Bladder\n$\\sqrt{ }$ thickened bladder wall without trabeculations $\\leftarrow$ replacement by fibrocytes + collagen\n$\\sqrt{ }$ large distended urinary bladder with a capacity of $600-800 \\mathrm{~mL}$\n$\\sqrt{ }$ intramural bladder calcifications\n$\\sqrt{ }$ persistence of patent urachus $\\pm$ calcification\n$\\sqrt{ }$ widely patent bladder neck\n$\\sqrt{ }$ laterally placed ureteric orifices\n@ Urethra\n$\\sqrt{ }$ elongated + dilated prostatic urethra with tapering of membranous urethra\n$\\sqrt{ }$ small / absent verumontanum\n$\\sqrt{ }$ absent / markedly hypoplastic prostate $\\rightarrow$ infertility and enlarged prostatic urethra\n$\\sqrt{ }$ enlarged pro utrstaticicle ( $=$ small epithelium-lined diverticulum representing the remnant of the fused caudal ends of the mÃ¼llerian ducts)\n$\\sqrt{ }$ urethral obstruction: stenosis / atresia / dorsal chordae / posterior urethral valves (in $20 \\%)$\n$\\sqrt{ }$ scaphoid megalourethra ( $70 \\%$ )\n(a) complete / fusiform megalourethra (rare)\n$=$ complete absence / marked deficiency of corpora cavernosa + corpus spongiosum\n(b) incomplete / scaphoid megalourethra (common)\n$=$ congenital absence / deficiency of corpus spongiosum with a normal glans + navicular fossa\n@ Ureters\nHisto: diffuse increase in connective tissue with replacement of smooth muscle\n$\\sqrt{ }$ massively dilated tortuous elongated ureters affecting the lower $1 / 3$ more profoundly (HALLMARK)\n$\\sqrt{ }$ poor ureteral peristalsis $\\leftarrow$ decrease in number of nerves + degeneration of nonmyelinated Schwann fibers\n$\\sqrt{ }$ alternating narrowed + dilated ureteral segments\n$\\sqrt{ }$ vesicoureteral reflux ( $>70 \\%$ )\n@ Kidneys\n$\\sqrt{ }$ asymmetry of renal size + lobulated contours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 167,
            "markdown": "$\\sqrt{ }$ no / mild ( $>50 \\%$ ) hydronephrosis\n$\\sqrt{ }$ caliceal dilatation $\\pm$ diverticula\n$\\sqrt{ }$ renal calcifications\n$\\sqrt{ }$ renal dysplasia with cystic dysplastic changes, oligohydramnios, pulmonary hypoplasia (in severe cases due to a combination defect of ureteric bud + metanephron)\n@ Lung (55\\%)\n$\\sqrt{ }$ pulmonary hypoplasia\n$\\sqrt{ }$ cystic adenomatoid malformation\n$C x$ : respiratory infections $\\leftarrow$ ineffective cough\n@ Musculoskeletal ( $50 \\%$ ):\nscoliosis, pectus deformity, arthrogryposis, clubfoot, valgus foot, hemimelia, dislocation of hip, sacral agenesis, polydactyly\n@ Gastrointestinal anomalies ( $30 \\%$ ):\nmalrotation, atresia, stenosis, volvulus, imperforate anus, Hirschsprung disease, gastroschisis\n@ Cardiovascular ( $10 \\%$ ): VSD, PDA, tetralogy of Fallot\n$C x$ : chronic renal failure / urosepsis / respiratory failure ( $30 \\%$ die within first 2 years of life)\n$R x$ : internal urethrotomy, cutaneous vesicostomy, reduction cystoplasty, ureteral reimplantation, orchiopexy at 1-2 years of age, renal transplantation after bilateral nephroureterectomy, abdominoplasty\n\n# PYELOCALICEAL DIVERTICULUM \n\n$=$ PYELOGENIC CYST $=$ PERICALICEAL CYST $=$ CALICEAL DIVERTICULUM\n$=$ uroepithelium-lined urine-filled cavity within renal cortex communicating with renal collecting system\nTYPE I (connecting with minor calyx):\nmore common; connected to caliceal cup, usually at fornix; bulbous shape; narrow connecting infundibulum of varying length; few millimeters in diameter; in polar region especially upper pole\nTYPE II (connecting with major calyx / renal pelvis):\ninterpolar region; communicates directly with pelvis; usually larger and rounder; neck short and not easily identified\nPrevalence: $2.1-4.5 \\div 1000$ intravenous urograms\nCause:\n(1) Congenital: developmental origin from ureteral bud remnant $\\leftarrow$ obstruction of peripheral aberrant \"minicalyx\" / failure of regression of $3^{\\text {rd }}-4^{\\text {th }}$-generation ureteric bud\n(2) Acquired (less common): reflux, obstructing stone, infection, rupture of simple cyst / abscess, infundibular achalasia / spasm, hydrocalyx $\\leftarrow$ inflammatory fibrosis of an infundibulum\n$\\checkmark$ appearance of simple cyst\n$\\checkmark$ opacification during excretory phase may be delayed and remain so for prolonged period $\\rightarrow$ layering of contrast medium\n$\\checkmark$ mass effect on adjacent pelvicaliceal system if large enough\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 168,
            "markdown": "$\\sqrt{ }$ anechoic cyst\n$\\sqrt{ } \\pm$ layering mobile echogenic material $\\leftarrow$ formation of single / multiple stones ( $50 \\%$ ) / milk of calcium (fluid-calcium level)\n$C x$ : hemorrhage, recurrent infection, cyst rupture, malignancy (exceedingly rare)\n$D D x$ : ruptured simple nephrogenic cyst, evacuated abscess / hematoma, renal papillary necrosis, medullary sponge kidney, hydrocalyx $\\leftarrow$ infundibular narrowing from TB / crossing vessel / stone / infiltrating carcinoma\n\n# PYELONEPHRITIS \n\n$=$ upper urinary tract infection with pelvic + caliceal + parenchymal inflammation\n$\\diamond$ The Society of Uroradiology recommends eliminating the terms (acute focal) bacterial nephritis, lobar nephritis, lobar nephronia, preabscess, renal cellulitis, renal phlegmon, renal carbuncle!\n\n## Acute Pyelonephritis\n\n$=$ episodic bacterial infection of kidney with acute inflammation, usually involving pyelocaliceal lining + renal parenchyma centrifugally along medullary rays\nRisk factors:\n\n1. Vesicoureteral reflux in children\n2. Obstruction, stasis, stone in adults (5\\%)\n\nPathway of infection:\n(a) ascending bacterial infection $\\leftarrow$ (usually) P-fimbriated E. coli (fimbriae facilitate adherence to mucosal surface): initial colonization of ureter in areas of turbulent flow $\\rightarrow$ paralysis of ureteral smooth muscle $\\rightarrow$ dilatation + functional obstruction of collecting system\n(b) vesicoureteral reflux + pyelotubular backflow: P-fimbriated E. coli NOT necessary for infection\n(c) hematoge nous spread ( $12-20 \\%$ ) with gram-positive cocci\n\nPath: thickened urothelium with multifocally / globally edematous kidney; radiating yellowwhite stripes / wedges extending from papillary tip to cortical surface in a patchy distribution + sharply demarcated from adjacent spared parenchyma by 48-72 hours\nHisto: tubulointerstitial nephritis = leukocytic migration from interstitium into lumen of tubules $\\rightarrow$ destruction of tubule cells by released enzymes $\\rightarrow$ bacterial invasion of interstitium by $48-72$ hours\nOrganism: E. coli $>$ Proteus $>$ Klebsiella, Enterobacter, Pseudomonas\nAge: most commonly 15-30 years; $\\mathrm{M}<<\\mathrm{F}$\nPrevalence: $1-2 \\%$ of all pregnant women\n\n- fever, chills, flank pain + tenderness\n- pyuria, bacteriuria, positive urine culture\n- $\\pm$ microscopic hematuria / bacteremia; leukocytosis\n\nIndication for imaging in adults:\n(1) Diabetes\n(2) Analgesic abuse\n(3) Neuropathic bladder",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 169,
            "markdown": "(4) History of urinary tract stones\n(5) Atypical organism: eg, proteus\n(6) Poor response to antibiotics\n(7) Frequent recurrences\n(8) Immunocompromise\n\nIVP (abnormal in 25\\%):\n$\\sqrt{ }$ smooth normal / enlarged kidney(s), focal $>>$ diffuse involvement of kidney\n$\\sqrt{ }$ diminished nephrographic density (global / wedge-shaped / patchy)\n$\\sqrt{ }$ immediate persistent dense nephrogram, rarely striated\n$\\sqrt{ }$ nonvisualization of kidney $\\leftarrow$ severe pyelonephritis (rare)\n$\\sqrt{ }$ \"tree-barking\" = mucosal striations (rare)\n$\\sqrt{ }$ compression of collecting system $\\leftarrow$ edema\n$\\sqrt{ }$ delayed opacification of collecting system\n$\\sqrt{ }$ nonobstructive ureteral dilatation $\\leftarrow$ effect of endotoxins (rare)\nCT:\n$\\sqrt{ }$ thickening of Gerota fascia + thickened bridging septa / stranding $\\leftarrow$ perinephric inflammation\n$\\sqrt{ }$ generalized renal enlargement / focal swelling\n$\\sqrt{ }$ obliteration of renal sinus\n$\\sqrt{ }$ thickening of walls of renal pelvis + calices\n$\\sqrt{ }$ mild dilatation of renal pelvis + ureter\n$\\sqrt{ }$ area of high attenuation on unenhanced $\\operatorname{sca}(=$ hemorrhagic bacterial nephritis $)$\nCECT (abnormal in 65-90\\%):\n$\\sqrt{ }$ hypoattenuating ( $80-90 \\mathrm{HU}$ ) wedge-shaped area of cortex extending from papilla to renal capsule during nephrographic phase ( $=$ lobar segments of hypoperfusion + edema)\n$\\sqrt{ }$ striated nephrogram\n$\\sqrt{ }$ poor corticomedullary differentiation\n$\\sqrt{ }$ dense parenchymal staining on scan delayed by 3-6 hours in area of earlier diminished enhancement $\\leftarrow$ functioning renal parenchyma\n$\\sqrt{ }$ soft-tissue filling defect in collecting system $\\leftarrow$ papillary necrosis, inflammatory debris, blood clot\n$\\sqrt{ }$ caliceal effacement\nUS (abnormal in $<50 \\%$ ):\n$\\diamond$ Pyelonephritis is difficult to detect sonographically!\n$\\sqrt{ }$ swollen kidney of decreased echogenicity\n$\\sqrt{ }$ loss of central sinus complex\n$\\sqrt{ }$ wedge-shaped hypo- / isoechoic zones, rarely hyperechoic $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ thickened sonolucent corticomedullary bands\n$\\sqrt{ }$ blurred corticomedullary junctions\n$\\sqrt{ }$ localized increase in size + echogenicity of perinephric fat $\\pm$ fat within renal sinus\n$\\sqrt{ }$ localized perinephric exudate\n$\\sqrt{ }$ thickening of wall of renal pelvis\n$\\sqrt{ }$ focally decreased blood flow on power Doppler\nMR:\n$\\sqrt{ }$ perinephric edema surrounding enlarged kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 170,
            "markdown": "$\\sqrt{ }$ wedge-shaped foci of persistent increased SI on contrast-enhanced fast inversion recovery / T2WI\nRenal cortical scintigraphy $\\left({ }^{99 \\mathrm{~m}} \\mathrm{Tc}\\right.$-DMSA $):$\n$\\sqrt{ }$ focal areas of diminished uptake (in $90 \\%$ )\nPrognosis:\n(1) Quick response to antibiotic treatment will leave no scars\n(2) Delayed treatment of acute pyelonephritis during first 3 years of life can severely affect renal function later in life $\\rightarrow$ decreased renal function, hypertension ( $33 \\%$ ), end-stage renal disease $(10 \\%)$\nCx: (1) Renal abscess (near-water density lesion without enhancement)\n(2) Scarring of affected renal lobes often in children + in up to $43 \\%$ in adults\n(3) Maternal septic shock (3\\%)\n(4) Premature labor $(17 \\%)$\n\n# Acute Focal Pyelonephritis \n\n$=$ LOBAR NEPHRONIA $=$ ACUTE FOCAL BACTERIAL NEPHRITIS $=$ CARBUNCLE $=$ RENAL CELLULITIS $=$ RENAL PHLEGMON\n$=$ focal variant of acute pyelonephritis with single / multiple areas of suppuration + necrosis\nOrganism: E. coli $>$ Proteus $>$ Klebsiella\nPredisposed: patients with altered host resistance (diabetes [60\\%], immunosuppression), trauma, chronic catheterization, mechanical / functional obstruction\n\n- fever, flank pain, pyuria\n\nSite: usually involves entire renal lobe\n$\\sqrt{ }^{67} \\mathrm{Ga}$ uptake\n$\\sqrt{ }$ vesicoureteral reflux often present\nIVP:\n$\\sqrt{ }$ focal area of absent nephrogram / distorted pyelogram\nUS:\n$\\sqrt{ }$ hypoechoic mass with ill-defined margins and disruption of corticomedullary border\n$\\sqrt{ }$ NOT a fluid collection\nCT:\n$\\sqrt{ }$ hypoattenuating zone with poorly defined transition to surrounding parenchyma\n$\\sqrt{ }$ less than normal parenchymal enhancement\nMR:\n$\\sqrt{ }$ area of low signal intensity on T1WI\n$\\sqrt{ }$ hyperintense center on T2WI $\\leftarrow$ fluid, necrosis\nAngio:\n$\\sqrt{ }$ renal arteries displaced, renal veins compressed\n$D D x$ : abscess (no enhancement on CT)\nCx: scarring, abscess\n\n## Acute Suppurative Pyelonephritis\n\n$=$ ACUTE DIFFUSE BACTERIAL NEPHRITIS\n$=$ more severe and extensive form of acute pyelonephritis $\\rightarrow$ may lead to diffuse necrosis $(=$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 171,
            "markdown": "phlegmon)\nOrganism: Proteus, Klebsiella $>$ E. coli\nPredisposed: diabetics (60\\%)\n\n# Emphysematous Pyelitis \n\n$=$ gas confined to renal pelvis + calices\nOrganism: E. coli\nPredisposed: diabetes mellitus (50\\%); $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nMay be associated with: emphysematous cystitis (rare)\n\n- pyuria\n$\\sqrt{ }$ gas pyelogram outlining pelvicaliceal system\n$\\sqrt{ }$ dilated renal collecting system (frequent)\n$\\sqrt{ } \\pm$ gas in ureters\n$D D x$ : reflux of gas / air from bladder or urinary diversion\n\n\n## Emphysematous Pyelonephritis\n\n$=$ life-threatening acute fulminant necrotizing infection of kidney and perirenal tissues associated with gas formation\nOrganism: E. coli (68\\%), Klebsiella pneumoniae (9\\%), Proteus mirabilis, Pseudomonas, Enterobacter, Candida, Clostridia (exceptionally rare)\nPath: acute and chronic necrotizing pyelonephritis with multiple cortical abscesses\nMechanism: pyelonephritis $\\rightarrow$ ischemia + low O 2 tension with anaerobic metabolism; facultative anaerobe organisms form $\\mathrm{CO}_{2}$ with fermentation of necrotic tissue / tissue glucose\nPredisposed: immunocompromised patients, esp. diabetics (in 87-97\\% of cases); ureteral obstruction (in $20-40 \\%$ )\nAverage age: 54 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$\nMay be associated with: XGP\n\n- features of acute severe pyelonephritis (chills, fever, flank pain, lethargy, confusion) not responding to Rx\n- positive blood + urine cultures (in majority), urosepsis, shock\n- fever of unknown origin + no localizing signs in $18 \\%$\n- multiple associated medical problems: uncontrolled hyperglycemia, acidosis, dehydration, electrolyte imbalance\nLocation: in 5-7\\% bilateral\n$\\sqrt{ }$ parenchymal destruction\n$\\sqrt{ }$ absent / decreased contrast excretion $\\leftarrow$ compromised renal function\nType I $(33 \\%)$ :\n$\\sqrt{ }$ streaky / mottled gas in interstitium of renal parenchyma radiating from medulla to cortex\n$\\sqrt{ }$ crescent of subcapsular / perinephric gas\n$\\sqrt{ }$ no fluid collection $\\leftarrow$ no effective immune response\nPrognosis: $69 \\%$ mortality\nType II $(66 \\%)$ :\n$\\sqrt{ }$ bubbly / loculated intrarenal gas (infers presence of abscess)\n$\\sqrt{ }$ renal / perirenal fluid collection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 172,
            "markdown": "$\\sqrt{ }$ gas within collecting system ( $85 \\%$ )\nPrognosis: $18 \\%$ mortality\nUS:\n$\\sqrt{ }$ high-amplitude echoes within renal sinus / renal parenchyma associated with \"dirty\" shadowing / \"comet tail\" reverberations\nCAVE: (1) Kidney may be completely obscured by large amount of gas in perinephric space (DDx: surrounding bowel gas)\n(2) Gas may be confused with renal calculi\n\nCT (most reliable + sensitive modality):\n$\\sqrt{ }$ mottled areas of low attenuation extending radially along pyramids\n$\\sqrt{ }$ extensive involvement of kidney + perinephric space\n$\\sqrt{ }$ air extending through Gerota fascia into retroperitoneal space\n$\\sqrt{ }$ occasionally gas in renal veins\nMR:\n$\\sqrt{ }$ signal void on T1WI + T2WI (DDx: renal calculi, rapidly flowing blood)\nMortality: $60-75 \\%$ under antibiotic Rx; $21-29 \\%$ after antibiotic Rx + nephrectomy; $80 \\%$ with extension into perirenal space\n$R x$ : antibiotic therapy + nephrectomy; drainage procedure for coexisting obstruction\n$D D x$ : emphysematous pyelitis (gas in collecting system but not in parenchyma, diabetes in $50 \\%$, less grave prognosis)\n\n# Fungal Pyelonephritis \n\nOrganism: Candida, Aspergillus, Mucor, Coccidioides, Cryptococcus, Actinomyces, Nocardia, Torulopsis\nAt risk: diabetes, drug addiction, leukemia, debilitation, immunosuppression\n$\\sqrt{ }$ pyelonephritis, papillary necrosis, renal abscess\n$\\sqrt{ }$ fungus ball\n\n## Xanthogranulomatous Pyelonephritis\n\n$=$ rare chronic suppurative granulomatous infection characterized by progressive parenchymal destruction $\\leftarrow$ chronic renal obstruction $\\leftarrow$ calculus, stricture, carcinoma\nCause: abnormal host response to bacterial infection\nPrevalence: 681,000 surgically proven cases of chronic pyelonephritis\nOrganism: Proteus mirabilis, E. coli, S. aureus\nRisk factors: female gender, diabetes\nAssociated with: nephrolithiasis (staghorn calculus in 50\\%)\nPath: replacement of corticomedullary junction with soft yellow nodules; calices filled with pus and debris\nHisto: diffuse infiltration by plasma cells + histiocytes + lipid-laden macrophages (xanthoma cells)\nPathophysiology:\ninfection of renal pelvis, which the host is unable to eradicate; macrophages become enlarged with undigested bacteria gradually replacing the renal parenchyma + perinephric space\nPeak age: 45-65 years; all ages affected, may occur in infants; $\\mathrm{M} \\pm \\mathrm{F}=1 \\pm 3-1: 4$; typically in",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 173,
            "markdown": "perimenopausal woman\n\n- pyuria $95 \\%$\n- flank pain $80 \\%$\n- fever $70 \\%$\n- palpable mass $50 \\%$\n- weight loss $50 \\%$\n- microscopic hematuria $50 \\%$\n- elevated ESR; reversible elevated liver function tests $(50 \\%) \\leftarrow$ inflammation of portal triads\n$\\diamond$ Symptomatic for 6 months prior to diagnosis in $40 \\%$ !\nA. DIFFUSE XGP $(83-90 \\%)$\n$=$ massive renal enlargement, lithiasis, peripelvic fibrosis, hydronephrosis, lobulated masses replacing parenchyma\nB. SEGMENTAL / FOCAL XGP (10-17\\%)\n$=$ tumefactive form $\\leftarrow$ obstructed single infundibulum / one moiety of duplex system\n$D D x$ : renal cell carcinoma\nIVP:\n$\\checkmark$ global enlargement of kidney (smooth contour uncommon) / focal renal mass (less frequent)\n$\\checkmark$ contracted pelvis with dilated calices\n$\\checkmark$ focally absent / totally absent nephrogram ( $80 \\%$ )\n$\\checkmark$ centrally obstructing calculus:\n$\\checkmark$ staghorn calculus in $75 \\%$\n$\\checkmark$ extension of inflammation into perirenal space, pararenal space, ipsilateral psoas muscle, colon, spleen, diaphragm, posterior abdominal wall, skin\nRetrograde:\n$\\checkmark$ complete obstruction at ureteropelvic junction / infundibulum / proximal ureter\n$\\checkmark$ contracted renal pelvis, dilated deformed calices + nodular filling defects\n$\\checkmark$ irregular parenchymal masses with cavitation\nCT:\n$\\checkmark$ enlargement of kidney\n$\\checkmark$ obstructive staghorn-like calculus\n$\\checkmark$ hydronephrosis + abscesses:\n$\\checkmark$ \"bear paw\" sign = low-attenuation fatty masses arranged in a \"hydronephrotic\" pattern replacing renal parenchyma ( $=$ replacement fibrolipomatosis with attenuation values of less than water)\n$\\checkmark$ extension into perinephric space + retroperitoneum (simulating an infiltrative malignancy)\n$\\checkmark$ heterogeneous parenchymal / NO enhancement\nUS:\n$\\checkmark$ hypoechoic dilated calices with echogenic rim\n$\\checkmark$ hypoechoic masses frequently with low-level internal echoes replacing renal parenchyma\n$\\checkmark$ loss of corticomedullary junction\n$\\checkmark$ parenchymal calcifications (uncommon)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 174,
            "markdown": "MR:\n$\\sqrt{ }$ renal parenchyma replaced by dilated calices + abscess cavities of intermediate SI on T1WI and high SI on T2WI\n$\\sqrt{ } \\pm$ marked enhancement of cavity walls\n$\\sqrt{ }$ signal void of calculus within collecting system\nAngio:\n$\\sqrt{ }$ stretching of segmental / interlobar arteries around large avascular masses\n$\\sqrt{ }$ hypervascularity / blush around periphery of masses in late arterial phase (= granulation tissue)\n$\\sqrt{ }$ venous encasement + occlusion\n$D D x$ : pyonephrosis, long-standing hydronephrosis, avascular tumor\n$R x$ : nephrectomy\n\n# PYELOURETERITIS CYSTICA \n\n$=$ POLYURETERITIS CYSTICA\n$=$ hyperplastic noncommunicating cystic transitional epithelial cell collections projecting into ureteral lumen\n$\\diamond$ Indicative of past / present urinary tract infection!\nCause: chronic urinary tract irritant $\\leftarrow$ stone / infection\nHisto: numerous small submucosal epithelial-lined cysts representing cystic degeneration of epithelial cell nests within lamina propria (cell nests of von Brunn) formed by downward proliferation of buds of surface epithelium that have become detached from the mucosa\nOrganism: E. coli > M. tuberculosis, Enterococcus, Proteus, schistosomiasis\nPredisposed: diabetics\nAge: $6^{\\text {th }}$ decade; more prevalent in women\n\n- no specific symptoms; $\\pm$ hematuria\n\nLocation: bladder $>>$ proximal $1 / 3$ of ureter $>$ ureteropelvic junction; unilateral $>>$ bilateral\n$\\sqrt{ }$ multiple small round smooth lucent filling defects of $2-3 \\mathrm{~mm}$ in size; scattered discrete /\nclustered\n$\\sqrt{ }$ persist unchanged for years in spite of antibiotic therapy\n$C x$ : increased incidence of transitional cell carcinoma\n$D x$ : biopsy to exclude malignancy\n$D D x$ : (1) Spreading / multifocal TCC\n(2) Vascular ureteral notching\n(3) Multiple blood clots\n(4) Multiple polyps\n(5) Allergic urticaria of mucosa\n(6) Submucosal hemorrhage (eg, anticoagulation)\n\n## PYONEPHROSIS\n\n$=$ presence of pus in dilated collecting system (= infected hydronephrosis)\nPath: purulent exudate composed of sloughed urothelium + inflammatory cells from early",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 175,
            "markdown": "formation of microabscesses + necrotizing papillitis\nOrganism: most commonly E. coli\nUS:\n$\\sqrt{ }$ dispersed / dependent internal echoes within dilated pelvicaliceal system\n$\\sqrt{ }$ shifting urine-debris level\n$\\sqrt{ }$ dense peripheral echoes in nondependent location + shadowing (gas from infection)\nCx: (1) Renal microabscesses + necrotizing papillitis\n(2) XGP\n(3) Renal / perinephric abscess\n(4) Fistula to duodenum, colon, pleura\n\n# RADIATION NEPHRITIS \n\nHisto: interstitial fibrosis, tubule atrophy, glomerular sclerosis, sclerosis of arteries of all sizes, hyalinization of afferent arterioles, thickening of renal capsule\nThreshold dose: 2,300 rad over 5 weeks\n\n- clinically resembling chronic glomerulonephritis\n$\\sqrt{ }$ normal / small smooth kidney consistent with radiation field\n$\\sqrt{ }$ parenchymal thickness diminished (globally / focally; related to radiation field)\n$\\sqrt{ }$ diminished nephrographic density\n\n\n## REFLUX ATROPHY\n\nCause: increased hydrostatic pressure of pelvicaliceal urine with atrophy of nephrons $\\leftarrow$ longstanding vesicoureteral reflux\n$\\sqrt{ }$ small smooth kidney with loss of parenchymal thickness\n$\\sqrt{ }$ widened collecting system with effaced papillae\n$\\sqrt{ }$ longitudinal striations $\\leftarrow$ redundant mucosa when collecting system is collapsed\n$\\diamond$ Do NOT confuse with reflux nephropathy!\n\n## REFLUX NEPHROPATHY\n\n$=$ CHRONIC ATROPHIC PYELONEPHRITIS\n$=$ ascending bacterial urinary tract infection $\\leftarrow$ reflux of infected urine from lower tract + tubulointerstitial inflammation in childhood (hardly ever endangers adult kidney)\n$\\diamond$ Most common cause of a small scarred kidney!\nEtiology: 3 essential elements:\n(1) Infected urine\n(2) Vesicoureteral reflux\n(3) Intrarenal reflux\n\nAge: usually young adultssub (clinical diagnosis starting in childhood); $\\mathrm{M}<\\mathrm{F}$\n\n- fever, flank pain, frequency, dysuria, hypertension, renal failure\n- may have no history of significant symptoms\n\nSite: predominantly affecting poles of kidneys $\\leftarrow$ presence of compound calices having distorted papillary ducts of Bellini ( $=$ papillae with gaping openings instead of slitlike openings of interpolar papillae)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 176,
            "markdown": "$\\sqrt{ }$ normal / small kidney; uni- / bilateral; uni- / multifocal\n$\\sqrt{ }$ focal parenchymal thinning with contour depression in upper / lower pole (more compound papillae in upper pole), scar formation only up to age 4\n$\\sqrt{ }$ retracted papilla with clubbed calyx subjacent to scar\n$\\sqrt{ }$ contralateral / focal compensatory hypertrophy (= renal pseudotumor)\n$\\sqrt{ }$ dilated ureters $\\leftarrow$ reflux, sometimes with linear striations (= redundant / edematous mucosa)\nUS:\n$\\sqrt{ }$ focally increased echogenicity within cortex $\\leftarrow$ scar\nAngio:\n$\\sqrt{ }$ small tortuous intrarenal arteries, pruning of intrarenal vessels\n$\\sqrt{ }$ vascular stenoses, occlusion, aneurysms\n$\\sqrt{ }$ inhomogeneous nephrographic phase\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-glucoheptonate / DMSA with SPECT most sensitive method):\n$\\sqrt{ }$ focal / multifocal photon-deficient areas\nCx: (1) Hypertension\n(2) Obstetric complications\n(3) Renal failure\n\n# RENAL ABSCESS \n\n= PYOGENIC RENAL ABSCESS = KIDNEY ABSCESS\n$=$ usually complication of renal inflammation with liquefactive necrosis; $2 \\%$ of all renal masses\nCause: typically complication of acute untreated / incompletely treated pyelonephritis / ascending UTI; hematogenous seeding via bacteremia\nPathway of infection:\n(a) ascending ( $80 \\%$ ): associated with obstruction (UPJ, ureter, calculus)\n\nOrganism: E. coli, Proteus\n(b) hematogenous ( $20 \\%$ ): infection from skin, teeth, lung, tonsils, endocarditis, intravenous drug abuse\nOrganism: staphylococcus aureus\nPredisposed: diabetic (twice as frequent compared with nondiabetic); immunocompromised; pregnancy\n\n- positive urine (blood) culture in $33 \\%(50 \\%)$\n- may have negative urine analysis / culture (in up to $20 \\%$ )\n- pyuria, hematuria (absent if abscess isolated within parenchyma)\n\nIVP:\n$\\sqrt{ }$ focal mass displacing collecting system\nCECT:\n$\\sqrt{ }$ well-defined hypoattenuating irregular focal round renal mass:\n$\\sqrt{ }$ thick rim / halo of enhancing wall / pseudocapsule\n$\\sqrt{ }$ no enhancement of center of abscess\n$\\sqrt{ } \\pm$ presence of gas\n$\\sqrt{ }$ thickened septa + Gerota fascia\n$\\sqrt{ }$ perinephric fat obliteration $\\leftarrow$ perinephric extension\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 177,
            "markdown": "$\\sqrt{ }$ slightly hypoechoic (early), hypo- to anechoic (late) mass\n$\\checkmark$ irregular margins + increased through-transmission\n$\\checkmark \\pm$ septations $\\pm$ microbubbles of gas\nMR:\n$\\checkmark$ heterogeneous thick-rimmed complex T1-hypointense and T2-hyperintense lesion replacing renal parenchyma\n$\\checkmark$ restricted diffusion\n$\\checkmark$ surrounding thick hypointense rim on T2WI\n$\\checkmark$ elevated perinephric SI on T2WI\n$\\checkmark$ blooming artifact on GRE $\\leftarrow$ gas\nNUC ( ${ }^{67} \\mathrm{Ga}$-citrate / ${ }^{111}$ In leukocytes):\n$\\checkmark$ hot spot\n$D D x$ : renal cyst; cystic renal cell carcinoma\n\n# Perinephric / Perirenal Abscess \n\n## Cause:\n\n(1) Acute pyelonephritis with extension of renal abscess through capsule\n(2) Adjacent retroperitoneal infection: eg, perforation of colon cancer, psoas abscess\n(3) Deep penetrating subcutaneous abscess\n(4) Hematogenous spread\n\nPredisposed: diabetics (in 30\\%), urolithiasis, septic emboli\n$\\diamond 14-75 \\%$ of patients with perinephric abscess have diabetes mellitus!\nOrganism: in up to $30 \\%$ different from abscess\n$\\checkmark$ loss of psoas margin / obscuration of renal contour\n$\\checkmark$ renal displacement\n$\\checkmark$ focal renal mass\n$\\checkmark$ scoliosis concave to involved side\n$\\checkmark$ respiratory immobility of kidney $=$ renal fixation\n$\\checkmark$ occasionally gas in renal fossa\n$\\checkmark$ unilateral impaired excretion\n$\\checkmark$ pleural effusion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 178,
            "markdown": "# RENAL ADENOMA \n\n$\\diamond$ Small adenoma $<3 \\mathrm{~cm}$ should be considered a renal cell carcinoma of low metastatic potential = borderline renal cell carcinoma!\nFrequency: in 7-15-23\\% of adults (autopsies); most common cortical lesion; increasing with age (in $10 \\%$ of patients $<40$ years of age, in $40 \\%$ of patients $>70$ years of age); increased frequency in tobacco users + patients on long-term dialysis\nAge: usually $>30$ years; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nTypes:\n(1) Papillary adenoma / cystadenoma (38\\%)\n(2) Tubular adenoma (38\\%)\n(3) Mixed type adenoma ( $21 \\%$ )\n(4) Alveolar adenoma ( $3 \\%$ ) = precursor of RCC\n$\\checkmark$ solitary in $75 \\%$, multiple in $25 \\%$\n$\\checkmark$ usually $<3 \\mathrm{~cm}$ in size; subcapsular cortical location\n$\\checkmark$ impossible to differentiate from renal cell carcinoma\nCx: premalignant (adenoma-carcinoma sequence)\nPrognosis: average growth rate of 0.4 (range, $0.2-3.5$ ) cm annually; tumors growing $<0.25 \\mathrm{~cm}$ annually rarely metastasize; tumors growing $>0.6 \\mathrm{~cm}$ annually frequently metastasize\n\n## RENAL AGENESIS\n\n## Mechanism:\n\n(a) formation failure\n$=$ failure of ureteral bud to form\n\n- hemitrigone $=$ absence of ipsilateral trigone + ureteral orifice\n(b) induction failure\n$=$ failure of growing ureteral bud to induce metanephric tissue\n- blind-ending ureter\n\n\n## Unilateral Renal Agenesis\n\nPrevalence: $1 \\div 600$ to $1 \\div 1,000$ pregnancies; $\\mathrm{M}+\\mathrm{F}=1.8 \\div 1$\nRisk of recurrence: $4.5 \\%$\nOften coexisting with other anomalies:\n\n1. Genital abnormalities:\n(a) in male ( $10-15 \\%$ ): Zinner syndrome\n$=$ rare congenital abnormality of the mesonephric (Wolffian) duct = TRIAD of (1) hypoplasia or agenesis of testis / vas deferens, (2) seminal vesicle cyst, (3) ipsilateral ejaculatory duct obstruction\n[Alfred Zinner (?1887-1967), urologist in Wien, Austria]\n(b) in female ( $25-50 \\%$ ): unicornuate / bicornuate / hypoplastic / absent uterus, absent / aplastic vagina\n$\\diamond 90 \\%$ of women with renal agenesis have uterine anomalies\n$\\diamond 30-40 \\%$ of women with uterine anomalies have renal agenesis\n2. Turner syndrome, trisomy, Fanconi anemia, Laurence-Moon-Biedl syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 179,
            "markdown": "Location: $\\mathrm{L}>\\mathrm{R}$\n$\\checkmark$ visualization of single kidney (DDx: additional kidney in ectopic location)\n$\\checkmark$ absent adrenal gland $(11 \\%)$\n$\\checkmark$ absent / rudimentary renal vessels\n$\\checkmark$ colon occupies renal fossa\n$\\checkmark$ compensatory contralateral renal hypertrophy ( $50 \\%$ )\n\n# Bilateral Renal Agenesis \n\n$=$ POTTER SYNDROME\nPrevalence: $1 \\div 3,000$ to $1 \\div 10,000$ pregnancies; $\\mathrm{M} \\div \\mathrm{F}=2.5 \\div 1$\nRisk of recurrence: $<1 \\%$\n\n- Potter's facies = low-set ears, redundant skin, parrot-beaked nose, receding chin\n$\\diamond$ US sensitivity is ONLY $69-73 \\% \\leftarrow$ decreased visualization from oligohydramnios + discoid-shaped adrenal glands simulating kidneys!\n$\\checkmark$ severe oligohydramnios (after 14 weeks MA)\n$\\checkmark$ bilateral absence of kidneys, ureters, renal arteries (after 12 weeks)\n$\\checkmark$ inability to visualize renal arteries by color duplex\n$\\checkmark$ inability to visualize urine in fetal bladder (after 13 weeks) $\\leftarrow$ bladder agenesis / hypoplasia; negative furosemide test (20-60 mg IV) NOT diagnostic (fetuses with severe IUGR may not be capable of diuresis)\n$\\checkmark$ flattened discoid shape of adrenals $\\leftarrow$ absence of pressure by kidney\n$\\checkmark$ bell-shaped thorax in mid to late $3^{\\text {rd }}$ trimester $\\leftarrow$ pulmonary hypoplasia\n$\\checkmark$ compression deformities of extremities $\\rightarrow$ clubfoot, flexion contractures, joint dislocations (eg, hip)\nPrognosis: stillbirths (24-38\\%); invariably fatal in the first days of life $\\leftarrow$ pulmonary hypoplasia\n$D D x$ : functional cause of in utero renal failure (eg, severe IUGR)\n\n\n## Potter Sequence\n\n$=$ hypoplasia of lungs, bowing of legs, broad hands, loose skin, growth retardation associated with long-standing severe oligohydramnios\nCause: renal agenesis, urethral obstruction, prolonged rupture of membranes, severe IUGR\n\n## RENAL ARTERY ANEURYSM\n\nIncidence: $0.01-0.10 \\% ; 22 \\%$ of visceral aneurysms\nCause: medial fibrodysplasia, penetrating trauma\nAge: $50-61$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\nLocation: $\\mathrm{R}>\\mathrm{L} ; 1^{\\text {st }}$-order branch of main renal artery (usually)\nType:\n(a) saccular ( $80 \\%$ ): near first bifurcation of main renal artery; variety of causes (congenital; associated with medial fibroplasia + atherosclerosis)\n(b) fusiform ( $20 \\%$ ): $\\leftarrow$ advanced renal artery medial fibrodysplasia; not calcified\n(c) dissecting: traumatic, spontaneous (atherosclerosis, intimal fibroplasia, perimedial fibroplasia), iatrogenic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 180,
            "markdown": "- usually asymptomatic (in $>50 \\%$ )\n\nRx: Endovascular therapy ( $>80 \\%$ success rate)\nCx: (1) Hypertension (unusual)\n(2) Perinephric / retroperitoneal hemorrhage (rare) with increased risk in peripartum women\n(3) Formation of AV fistula\n(4) Peripheral renal embolization $\\leftarrow$ mural thrombus\n(5) Thrombosis\n(6) Hematuria\n\n# Extrarenal Aneurysm ( $9 / 4$ ) \n\nA. TRUE ANEURYSM\n\n1. Atherosclerotic (most common)\n2. Fibromuscular dysplasia\n3. Pregnancy\n4. Mesenchymal disease: neurofibromatosis, Ehlers-Danlos syndrome\nB. FALSE ANEURYSM\n5. Trauma; renal artery angioplasty\n6. BehÃ§et disease\n7. Mycotic aneurysm $2.5 \\%$ of all aneurysms\n\nCause: bacteremia, SBE, perivascular extension of inflammation\nOrganism: Streptococcus, Staphylococcus, Pneumococcus, Salmonella\n$\\sqrt{ }$ incomplete / complete ring of calcification\n$\\sqrt{ }$ variable enhancement (depending on amount of thrombus)\nRx: (1) Conservative in asymptomatic patient for well-calcified aneurysm $<2 \\mathrm{~cm}$ in diameter\n(2) Surgery for (a) interval growth, (b) emboli to kidney, (c) in woman of childbearing age, (d) diminished renal function / ischemia / hypertension / dissection\n\n## Intrarenal Aneurysm ( $1 / 4$ )\n\nin interlobar and more peripheral branches\nA. CONGENITAL (most common)\n\n1. Congenital renal aneurysm\n\nAge at $D x: 30$ years or older; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- hypertension in $25 \\% \\leftarrow$ segmental renal ischemia\n$\\sqrt{ }$ saccular aneurysm close to vascular bifurcations, may calcify\n$\\sqrt{ }$ often bilateral\nRx: surgical / endovascular repair for aneurysm $>1.0 \\mathrm{~cm}$ in hypertensive patient / for aneurysm $>1.5 \\mathrm{~cm}$ in asymptomatic normotensive patient\nB. ARTERITIS\n\n1. Polyarteritis nodosa\n2. SLE\n3. Allergic vasculitis\n4. Wegener granulomatosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 181,
            "markdown": "5. Transplant rejection\n6. Drug-abuse vasculitis\n$\\diamond$ Kidney most commonly affected organ!\nCause:\n(a) immunologic injury from circulating hepatitis antigen-antibody complexes producing a necrotizing angiitis\n(b) bacterial endocarditis\n(c) drug-related\n(d) impurity-related\n\nDrugs: methamphetamine, heroin, LSD\n$\\checkmark$ multiple small aneurysms in interlobar branches near corticomedullary junction\n$\\checkmark$ inhomogeneous spotty nephrogram\nC. DEGENERATIVE: Atherosclerosis (may calcify)\nD. TUMOR\n\n1. Neoplasm (RCC in 14\\%; adult Wilms tumor)\n2. Hamartoma (angiomyolipoma in 50\\%)\n3. Metastatic arterial myxoma\n4. Vascular malformation\nE. MESENCHYMAL DISEASE\n5. Neurofibromatosis\n6. Fibroplasia\nF. TRAUMA\nG. INFECTION: syphilis, tuberculosis\n\n# RENAL ARTERY STENOSIS \n\nPrevalence: $1-2-4 \\%$ of hypertensive individuals; $4.3 \\%$ of autopsies; $10 \\%$ of hypertensive individuals with coronary artery disease; $25 \\%$ of patients with hypertension that is difficult to control; in $45 \\%$ of patients with malignant hypertension; in $45 \\%$ of patients with peripheral vascular disease\n\n## Cause:\n\n1. Atherosclerosis ( $60-90 \\%$ ): mostly in proximal 2 cm of main renal artery\n$\\diamond$ Any of multiple renal arteries (occurring in $14-28 \\%$ of the population) may be affected!\n2. Fibromuscular dysplasia $(10-30 \\%)$\n3. Others $(<10 \\%)$ : thromboembolic disease, arterial dissection, infrarenal aortic aneurysm, arteriovenous fistula, vasculitis (Buerger disease, Takayasu disease, polyarteritis nodosa, postradiation), neurofibromatosis, retroperitoneal fibrosis\nPathophysiology:\n$\\downarrow$ perfusion pressure of glomeruli $\\rightarrow$ stimulates production of renin in juxtaglomerular apparatus + angiotensin II in kidney; renin converts circulating angiotensinogen ( $\\alpha 2$-globulin) into angiotensin $\\mathrm{I} \\rightarrow$ subsequently converted by angiotensin-converting enzyme (ACE present in vascular endothelium) $\\rightarrow$ into angiotensin II releasing aldosterone; aldosterone increases salt + water retention; angiotensin II + aldosterone vasoconstrict vessels (especially intraglomerular efferent arteriole to maintain filtration pressure)\n$\\diamond$ ACE inhibition may impair overall renal function $\\leftarrow$ disruption of autoregulatory",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 182,
            "markdown": "mechanism of GFR (with renal artery stenosis in both kidneys / solitary kidney)\nRenin production stimuli:\n(a) baroreceptors in afferent glomerular arteriole sense $\\Downarrow$ stretching of arteriolar wall with diminished blood flow\n(b) chemoreceptors of macula densa located in first part of the distal tubule sense a $\\Downarrow$ amount of sodium and chloride (which have been largely reabsorbed $\\leftarrow$ low GFR)\nHisto: tubular atrophy and shrinkage of glomeruli\n\n- abdominal / flank pain, hematuria, oliguria, anuria\n- renin-mediated hypertension $\\leftarrow$ ischemia\n- low urine sodium concentration\n\nHemodynamic significance determined by:\n(a) elevated renin levels in ipsilateral renal vein $\\geq 1.5 \\div 1$\n(b) presence of collateral vessels\n(c) greater than $70 \\%$ stenosis with poststenotic dilatation\n(d) transstenotic pressure gradient $\\geq 40 \\mathrm{mmHg}$\n(e) decrease in renal size\n$\\diamond 15-20 \\%$ of patients remain hypertensive after restoration of normal renal blood flow ( $=$ renal artery stenosis without renovascular hypertension)!\nPatient selection criteria for screening test:\n$=$ clinical signs associated with moderate-to-high risk of renovascular hypertension (HTN):\n\n1. Abrupt onset or severe HTN\n2. HTN resistant to 3-drug therapy in compliant patient\n3. Abdominal / flank bruits\n4. Unexplained azotemia in elderly patient with HTN\n5. Worsening renal function during antihypertensive therapy, especially with ACEIs\n6. Grade $3 / 4$ hypertensive retinopathy\n7. Occlusive disease in other vascular beds\n8. Onset of $\\mathrm{HTN}<30$ years or $>55$ years of age\n9. Recurrent pulmonary edema in elderly patient with HTN\n10. HTN in infants with an umbilical artery catheter\n11. HTN in children\n$\\sqrt{ }$ normal / decreased renal size ( $\\mathrm{R} 2 \\mathrm{~cm}<\\mathrm{L} ; \\mathrm{L} 1.5 \\mathrm{~cm}<\\mathrm{R}$ ) with smooth contour\n$\\checkmark$ vascular calcifications (aneurysm / atherosclerosis)\nIVP ( $60 \\%$ true-positive rate, $22 \\%$ false-negative rate):\n$\\checkmark$ delayed appearance of contrast material $\\leftarrow$ decreased glomerular filtration\n$\\checkmark$ increased density of contrast material $\\leftarrow$ increased water reabsorption\n$\\checkmark$ delayed washout of contrast material $\\leftarrow$ prolonged urine transit time\n$\\checkmark$ lack of distension of collecting system\n$\\checkmark$ global attenuation of contrast density; urogram may be normal with adequate collateral circulation\n$\\checkmark$ notching of proximal ureter $\\leftarrow$ enlargement of collateral vessels\nCT:\n$\\checkmark$ prolongation of cortical nephrographic phase + persistent corticomedullary differentiation\n$\\checkmark$ CT angiography ( $2-3-\\mathrm{mm}$ collimation, pitch $\\leq 1.5-2.0$ ): specificity of real-time interactive volume rendering $>$ maximum-intensity projection $>$ shaded-surface display",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 183,
            "markdown": "MRA ( $>95 \\%$ sensitive, $>90 \\%$ specific):\n$\\sqrt{ }$ tendency to overestimate stenosis\nLimitations:\n> evaluation of branch vessels\n> presence of metallic stent\n> detection of accessory arteries\n> evaluation of small renal arteries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 184,
            "markdown": "![img-12.jpeg](img-12.jpeg)\n\nAngiography:\n(a) conventional angiography $=$ \"gold standard\" test",
            "images": [
                {
                    "id": "img-12.jpeg",
                    "top_left_x": 363,
                    "top_left_y": 191,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1887,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 185,
            "markdown": "(b) intravenous digital subtraction angiography: does not address hemodynamic significance\nACE inhibitor scintigraphy ( $51-96 \\%$ sensitive, $80-93 \\%$ specific):\n= screening test for renovascular hypertension (not renal artery stenosis) with angiotensinconverting enzyme inhibitor (ACEI) challenge\n$\\diamond$ ACE inhibition may impair overall renal function due to disruption of autoregulatory mechanism of GFR (with renal artery stenosis in both kidneys / solitary kidney)\nPharmacology:\naffected kidney responds to decreased arteriolar flow by releasing renin + angiotensin II (= extremely potent vasoconstrictor acting on the efferent renal arteriole to increase filtration pressure) in juxtaglomerular apparatus; ACE inhibitors (eg, captopril, enalapril) $\\rightarrow$ block ACE (angiotensin-converting enzyme) $\\rightarrow$ reduces GFR (51-96\\% sensitive, 80-93\\% specific)\n$\\checkmark$ unilateral parenchymal retention after ACEI: reduced GFR $\\rightarrow \\Downarrow$ urinary output $+\\uparrow$ radiotracer retention\n$=>90 \\%$ probability of renovascular hypertension\n$\\checkmark$ change in grade of differential renal function from baseline grade $0 / 1$ by $>1$ grade\n$=$ high probability for renal artery stenosis\n$\\checkmark$ abnormal baseline curve without change\n$=$ indeterminate for renovascular hypertension\n$\\checkmark$ functional improvement following ACEI challenge\n$=$ low probability for renovascular hypertension\nSemiquantitative interpretation of time-activity renograms:\n$\\checkmark$ normal ACE inhibitor scintigram ( $<10 \\%$ probability for renovascular hypertension)\n$\\checkmark$ criteria for high probability ( $>90 \\%$ ):\n$\\checkmark$ worsening of scintigraphic curve\n$\\checkmark$ reduction in relative uptake with $>10 \\%$ change after ACE inhibition\n$\\checkmark$ prolongation of parenchymal transit time with $>2 \\mathrm{~min}$ delay of excretion into renal pelvis\n$\\checkmark \\uparrow$ in 20 -minute peak uptake ratio $>0.15$ from baseline\n$\\checkmark$ prolongation of $\\mathrm{T}_{\\text {max }}$ of $>2 \\mathrm{~min} / 40 \\%$\n$\\checkmark$ asymmetry of renal uptake $<40 \\%$ of total renal uptake\n$\\checkmark$ bilateral symmetrical changes are usually due to:\n(a) hypotension\n(b) salt depletion\n(c) use of calcium channel blockers\n(d) low urine flow rate\n\nDecreased accuracy with:\n(1) Bilateral renal artery stenosis\n(2) Impaired renal function\n(3) Urinary obstruction\n(4) Chronic ACE inhibitor therapy\n\nSources of error:\n(1) Failure to administer ACEIs properly:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 186,
            "markdown": "(a) ingestion of food within 4 hours of taking captopril\n(b) paravenous infiltration\n(2) Causes of abnormal whole-kidney renograms:\n(a) renal pelvic retention\n(b) dehydration\n(c) hypotension\n(d) full bladder impairing drainage\n\nDuplex US:\n(1) direct signs $=$ visualization of renal artery stenosis\n$\\sqrt{ }$ peak systolic velocity $>150 \\mathrm{~cm} / \\mathrm{sec}$ for angles $<60^{\\circ}$ or $180 \\mathrm{~cm} / \\mathrm{sec}$ for angles $>70^{\\circ}$ (with many false positives due to suboptimal Doppler angles)\n$\\sqrt{ }$ ratio of peak renal artery velocity to peak aortic center stream velocity $>3.5$ (for $>$ $60 \\%$ stenosis; $0-91 \\%$ sensitive, $37-97 \\%$ specific)\n$\\sqrt{ }$ poststenotic spectral broadening $\\pm$ flow reversal\n$\\sqrt{ }$ absence of blood flow during diastole (for $>50 \\%$ stenosis)\n$\\sqrt{ }$ NO detectable Doppler signal with good visualization of renal artery (= arterial occlusion)\nProblems:\n(a) technically inadequate examination (gas, corpulence, respiratory motion) in 6$49 \\%$; US usually limited to children + thin adults\n(b) multiple renal arteries in $16-28 \\%$\n(c) \"false\" tracings from large collateral vessels / reconstituted segments of main renal artery\n(d) need to visualize entire length of renal artery\n(e) transmitted cardiac / aortic pulsations obscure renal artery waveform recordings\n(2) indirect signs $=$ analysis of intrarenal arterial Doppler waveforms\n(a) pattern recognition\n$\\sqrt{ }$ dampened appearance $=$ tardus-parvus pulse\n[tardus, Latin = late arrival; parvus, Latin = attenuated peak]\n$\\sqrt{ }$ loss of early systolic peak (not necessarily abnormal!)\n$\\sqrt{ }$ segmental arterial flow detectable with renal artery occlusion $\\leftarrow$ collateral circulation\n(b) quantitative criteria",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 187,
            "markdown": "![img-13.jpeg](img-13.jpeg)\n$\\sqrt{ }$ acceleration index of $<370-470 \\mathrm{~cm} / \\mathrm{s} 2=\\Delta \\mathrm{V} / \\Delta \\mathrm{T}=$ tangential inclination of Doppler waveform in early systole (single most sensitive screening parameter)\n$\\sqrt{ }$ delay in acceleration / pulse rise time of $>0.05-0.08 \\mathrm{sec}=$ gradual slope of Doppler waveform during early systole\n$\\sqrt{ } \\Delta \\mathrm{RI}>5 \\%$ between both kidneys ( $82 \\%$ sensitive $+92 \\%$ specific for stenosis $>$ $50 \\%, 100 \\%$ sensitive $+94 \\%$ specific for stenosis $\\geq 60 \\%$ )\n$\\sqrt{ }$ RI $<0.56$\n$\\sqrt{ }$ attenuated (= parvus) Doppler waveform amplitude = decrease in peak systolic",
            "images": [
                {
                    "id": "img-13.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1353,
                    "bottom_right_y": 1421,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 188,
            "markdown": "velocity to $<20-30 \\mathrm{~cm} / \\mathrm{s}$\nProblems: technically inadequate examination in $0-2 \\%$\nFalse-negative US: stenosis in accessory renal artery\nFalse-positive US: coarctation\n\n# Arteriosclerotic Renal Artery Disease \n\nFrequency: in up to $6 \\%$ of hypertensive patients; most common cause of secondary hypertension\nAge: $\\quad>50$ years; $\\mathrm{M}>\\mathrm{F}$\nPath: lesion primarily involving intima\n\n- worsening of preexistent hypertension\n- abrupt onset of severe hypertension $>180 / 110 \\mathrm{mmHg}$\n- vascular bruit in $40-50 \\%$ (present in $20 \\%$ of hypertensive patients without renal artery stenosis)\nAssociated with: severe arteriosclerosis of aorta, cerebral, coronary, peripheral arteries\nLocation: main renal artery ( $93 \\%$ ) + additional stenosis of renal artery branch ( $7 \\%$ ); bilateral in $31 \\%$\n$\\sqrt{ }$ eccentric stenosis in proximal 2 cm of renal artery, frequently involving orifice\n$\\sqrt{ }$ decrease in renal length over time ( $=$ high-grade renal artery stenosis with risk for occlusion)\nPrognosis: progression of atherosclerotic lesion (40-45\\%) to renal atrophy, arterial occlusion, ischemic renal failure\nCx: azotemia with\n(a) bilateral renal artery stenoses\n(b) unilateral renal artery stenosis + poorly functioning contralateral kidney\n$\\diamond$ Reversible azotemia may be induced by treatment with angiotensin-converting enzyme inhibitors / sodium nitroprusside!\nRx: (1) Three-step antihypertensive therapy (control of hypertension difficult)\n(2) Angiotensin-converting enzyme inhibitors (eg, captopril PO, enalaprilat IV)\n(3) Renal artery angioplasty ( $80 \\%$ success for nonostial lesion, $25-30 \\%$ for ostial lesion)\n(4) Surgical revascularization ( $80-90 \\%$ success for any lesion location)\n> hypertension improved in $66 \\%$\n> improvement / stabilization of renal function in $27-80 \\%$\n\n\n## Fibromuscular Dysplasia of Renal Artery\n\nPrevalence: $4 \\div 1000$ symptomatic patients of renal artery $+2 \\div 1000$ of extracranial carotid artery involvement (2007); $35 \\%$ of renal artery stenoses; $25 \\%$ of all cases of renovascular hypertension\nAge: most common cause of renovascular hypertension in children + young adults $<30-40$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 3$\nAssociated with: fibromuscular dysplasia of other aortic branches in 1-2\\%: celiac artery, hepatic artery, splenic artery, mesenteric artery, iliac artery, internal carotid artery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 189,
            "markdown": "- hypertension, progressive renal insufficiency\n\nSites: mid and distal main renal artery ( $79 \\%$ ), renal artery branches ( $4 \\%$ ), combination $(17 \\%)$; proximal $1 / 3$ of main renal artery spared in $98 \\%$; bilateral in ${ }^{2} / ; \\mathrm{R} \\div \\mathrm{L}=4 \\div 1$\nTypes:\n\n1. Intimal fibroplasia $=$ intimal hyperplasia\n$\\sqrt{ }$ narrow annular radiolucent band in main renal artery + major segmental branches; often bilateral\n$\\sqrt{ }$ poststenotic fusiform dilatation\n2. Medial fibroplasia with microaneurysm\n$\\sqrt{ }$ \"string-of-beads / string-of-pearls sign\" = alternating areas of stenoses + aneurysms in mid + distal renal artery + branches; usually bilateral\n3. Fibromuscular hyperplasia\n$\\sqrt{ }$ long smooth tubular narrowing of main renal artery and branches\n4. Perimedial fibroplasia\n$\\sqrt{ }$ beading without aneurysm formation of distal (mostly right) main renal artery\n5. Medial dissection\n$\\sqrt{ }$ false channel in main renal artery + branches\n6. Adventitial fibroplasia\n$\\sqrt{ }$ long segmental stenosis of main renal artery + large branches\nPrognosis: progression of lesion in $20 \\% \\rightarrow$ decline in renal function\nCx: (1) Giant aneurysm\n(2) AV fistula between renal artery + vein (in medial fibroplasia)\nRx: (1) Resection of diseased segment with end-to-end anastomosis\n(2) Replacement by autogenous vein graft, excision + repair by patch angioplasty\n(3) Transluminal balloon angioplasty ( $90 \\%$ success rate with very low restenosis rate)\n\n# Neurofibromatosis of Renal Artery \n\nHypertension in neurofibromatosis due to:\n(1) Pheochromocytoma\n(2) Renal artery stenosis\n$\\diamond$ Renal artery involvement mainly seen in children!\n\n## Types:\n\n(a) mesodermal dysplasia of arterial wall with fibrous transformation (common)\n(b) narrowing of main renal artery by periarterial neurofibroma (rare)\n$\\sqrt{ }$ saccular funnel-shaped aneurysm involving aorta / main renal artery\n$\\sqrt{ }$ smooth / nodular stenosis (mural / adventitial neurofibroma) in proximal renal artery\n$\\sqrt{ }$ intrarenal aneurysm (rare)\n$D D x$ : fibromuscular dysplasia; congenital renal artery stenosis\n\n## RENAL CELL CARCINOMA\n\n$=\\mathrm{RCC}=$ RENAL ADENOCARCINOMA $=$ HYPERNEPHROMA\nPrevalence: $2-3 \\%$ of all adult visceral cancers (frequency approximates ovarian cancer, gastric cancer, pancreatic cancer, leukemia); 65,000 new RCCs in USA annually with 13,500 deaths (2012); 85-90\\% of all renal malignant primaries in adults; $7^{\\text {th }} / 12^{\\text {th }}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 190,
            "markdown": "most common malignancy in men / women; $61 \\%$ found incidentally with imaging\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade (generally $>40$ years); median age of 55 years; $2 \\%$ occur in children in first 2 decades of life; frequency increasing with age; $\\mathrm{M} \\div \\mathrm{F}=1.6 \\div 1$\nPath: arises from proximal tubular cells\nTumor growth pattern:\npapillary ( $5-15 \\%$, best prognosis); trabecular / tubular / cystic / solid (poorer prognosis)\nAssociated with familial and hereditary syndromes:\n(1) von Hippel-Lindau syndrome\n(2) Birt-Hogg-DubÃ© syndrome: rare autosomal dominant disease characterized by hair follicle hamartomas, renal tumors, pulmonary cysts\n(3) Hereditary papillary renal cancer\n\n# Predisposed: \n\n(1) Von Hippel-Lindau syndrome ( $10-25 \\%$ ): multiple often small intracystic tumors (hemangioblastoma, retinal angioma, renal cysts) manifesting at a young age\n(2) Hemodialysis (in $1.4-2.6 \\%$ )\n(3) Acquired cystic disease of uremia (3.3-6.1\\%; 7 x increased risk)\n(4) Tobacco; phenacetin abuse\n(5) Obesity\n\nHistopathologic subtypes associated with different prognosis:\n(a) clear cell RCC ( $65-80 \\%$ )\n(b) multilocular clear cell RCC $(<1 \\%)$\n(c) papillary $\\operatorname{RCC}(15-20 \\%)=\\mathrm{pRCC}$\n(d) chromophobe RCC (4-11\\%)\n(e) collecting duct carcinoma of Bellini $(<1 \\%)$\n(f) renal medullary carcinoma\n(g) unclassified\n> Xp11 translocation carcinoma\n> carcinoma associated with neuroblastoma\n> mucinous tubular spindle cell carcinoma\nGrading (Fuhrman):\nGrade 1 tumor cells with $10-\\mu \\mathrm{m}$ small round uniform nuclei without nucleoli\nGrade 2 tumor cells with $15-\\mu \\mathrm{m}$ nuclei, subtle irregular outline and with nucleoli\nGrade 3 tumor cells with $20-\\mu \\mathrm{m}$ nuclei obvious irregular outline and prominent larger nucleoli\nGrade 4 tumor cells with bizarre multilobed nuclei and heavy clumps of chromatin Staging:\n\n| Staging of Renal Cell Carcinoma <br> American Joint Committee on Cancer (2002) |\n| :-- |\n| T1 tumor $\\leq 7 \\mathrm{~cm}$ confined to kidney |\n| T2 tumor $>7 \\mathrm{~cm}$ confined to kidney |\n| T3 invasion of perinephric fat / adrenal gland / major vein |\n| T4 extension beyond Gerota fascia / distant metastasis |\n\nStaging accuracy: $84-91 \\%$ for CT; $82-96 \\%$ for MR; poor for US",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 191,
            "markdown": "Regional extension: into lymph nodes ( $9-23 \\%$ ); into main renal vein ( $21-35 \\%$ ); into IVC $(4-10 \\%)$\nMultiple RCC: commonly in Von Hippel-Lindau syndrome; hereditary RCC; sporadic in 4$15 \\%$; bilateral in $1-3 \\%$\n\n# Metastasis: \n\n- hematuria (56\\%), flank pain (36\\%), weight loss (27\\%), fever (11-15\\%); normochromic normocytic anemia ( $28-40 \\%$ )\n- classic triad of flank pain + gross hematuria + palpable renal mass ( $4-9 \\%$ ); varicocele ( $2 \\%$ )\n- Stauffer syndrome ( $15 \\%$ ) = nephrogenic hepatopathy = hepatosplenomegaly + abnormal liver function in absence of hepatic metastases (? tumor hepatotoxin)\n- Paraneoplastic syndromes: erythrocytosis (2\\%); hypercalcemia $\\leftarrow$ parathormone, prostaglandin, vitamin D metabolites)\n$\\checkmark$ well-marginated often lobulated solitary mass:\n$\\checkmark$ focal bulge in renal contour\n$\\checkmark$ enlargement of affected part of kidney\n$\\checkmark$ calcification ( $15-20 \\%$ ): usually central + amorphous or peripheral + curvilinear in cystic RCC\n$\\checkmark$ extrinsic compression / displacement / invasion of renal pelvis + calices\n$\\checkmark$ cysts:\n(a) cystic necrotic tumor ( $40 \\%$ )\n(b) cystadenocarcinoma ( $2-5 \\%$ )\n(c) renal cell carcinoma in wall of cyst (3\\%)\n$\\checkmark$ tumor growth into renal vein ( $23 \\%$ ) / IVC (in up to $16 \\%$ ) $\\rightarrow$ conveys poor prognosis\n$\\checkmark$ infiltrative growth pattern ( $6 \\%$ ) with ill-defined margin\nIVP:\n$\\checkmark$ diminished function $\\leftarrow$ parenchymal replacement, hydronephrosis\n$\\checkmark$ absence of contrast excretion $\\leftarrow$ renal vein occlusion\n$\\checkmark$ pyelotumoral backflow = necrotic part of tumor fills with contrast material\nNECT:\n$\\checkmark$ homogeneous solid mass of $>20 \\mathrm{HU} \\leftarrow$ if $\\leq 3 \\mathrm{~cm}$ lesion\n$\\checkmark$ heterogeneous hemorrhagic / necrotic mass $\\leftarrow$ if $>3 \\mathrm{~cm}$\n$\\checkmark$ calcifications in up to $30 \\%$\n$\\checkmark$ perinephric fat stranding ( $50 \\%$ ) $\\leftarrow$ edema, vascular engorgement, previous inflammation, tumor invasion\n$\\checkmark \\pm$ subcapsular / perinephric hemorrhage\n$\\checkmark$ nodal enlargement of $>1 \\mathrm{~cm}(43 \\% \\mathrm{PPV}, 96 \\% \\mathrm{NPV}$ ) (DDx: benign inflammation as reactive immune response)\nFalsely negative in corticomedullary phase:\n(1) a small tumor may enhance to the same degree as renal parenchyma\n(2) centrally located tumor mistaken for medulla\n\n## CECT:\n\n$\\checkmark$ mostly heterogeneous enhancement $\\leftarrow$ cystic areas / necrosis:\n$\\checkmark$ enhancement of $>12 \\mathrm{HU}$ compared with NECT\n$\\checkmark$ enhancement to a similar degree as renal cortex\n$\\checkmark$ enhancement to a lesser degree than renal cortex = papillary / chromophobe RCC",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 192,
            "markdown": "$\\checkmark$ metastases show similar enhancement as primary\n$\\checkmark$ enhancing nodule in perinephric space ( $46 \\%$ sensitive for perinephric spread)\n$\\checkmark$ renal vein thrombus ( $92 \\%$ PPV, $97 \\%$ NPV):\n$\\checkmark$ low-attenuation filling defect in corticomedullary phase (MOST SPECIFIC SIGN)\n$\\checkmark$ abrupt change in caliber of vein\n$\\checkmark$ presence of collateral veins\n$\\checkmark$ heterogeneous enhancement of malignant thrombus\nUS:\n$\\checkmark$ hyperechoic mass (in $20-50 \\%$ ), mostly in small tumors $<3 \\mathrm{~cm}(78 \\%)$, occasionally in large tumors $(32 \\%)$ :\n$\\checkmark$ markedly hyperechoic, ie, isoechoic to renal sinus fat in $4-12 \\%$ of small tumors (DDx: angiomyolipoma)\n$\\checkmark$ anechoic rim (in $84 \\%$ of small hyperechoic RCCs) $\\leftarrow$ pseudocapsule of compressed renal tissue (NOT seen in angiomyolipoma)\n$\\checkmark$ isoechoic ( $30-86 \\%$ ) / hypoechoic ( $10-12 \\%$ ), mostly in larger tumors\n$\\checkmark$ cystic lesion with increase in acoustic transmission $(2-13 \\%) \\leftarrow$ extensive liquefaction necrosis (DDx: complicated cyst)\n$\\checkmark$ inhomogeneity $\\leftarrow$ hemorrhage, necrosis, cystic degeneration\nMR (best modality to assess stage III + IV disease):\n$\\checkmark$ hyper- / iso- (most) / hypointense relative to renal parenchyma:\n$\\checkmark$ often low to medium signal intensity on T1WI\n$\\checkmark$ hyperintense areas on T1WI + hypointense on T2WI $\\leftarrow$ usually from hemorrhage\n$\\checkmark$ heterogeneous hyperintensity on T2WI\n$\\checkmark$ mild decrease in SI on opposed-phase images $\\leftarrow$ diffuse microscopic intracellular lipid in cRCC\n$\\checkmark$ imaging at 2 to 5 minutes post contrast injection is critical for the detection of small renal mass ( $=$ less enhancement than in normal renal tissue)\nPET (sensitivity inferior to CT and MR):\n$\\checkmark$ inconsistent FDG uptake $\\leftarrow$ hypo- / isometabolism relative to background + lack of accessibility of FDG $\\leftarrow$ heterogeneity of glucose transporter expression\n$\\diamond$ Malignancy cannot be ruled out with a negative study!\nAngio:\n$\\checkmark$ typically hypervascular ( $95 \\%$ ) with puddling of contrast + occasional AV shunting\n$\\checkmark$ enlarged tortuous poorly tapering feeding vessels\n$\\checkmark$ coarse neovascularity + formation of small aneurysms\n$\\checkmark$ parasitization of lumbar, adrenal, subcostal, mesenteric artery branches\n$\\checkmark$ poorly defined tumor margins\n\n# Prognosis: \n\n$\\checkmark$ Tumor stage + histologic grade are the most important prognosticators!\n> 5-year survival rates for stages I, II, III, IV are $85-100 \\%, 45-65 \\%, 20-40 \\%, 0-10 \\%$;\n> 10-year survival rates for stages I, II, III, IV are $56 \\%, 28 \\%, 20 \\%, 3 \\%$\n$>4.4 \\% 3$-year survival rate if untreated\n> papillary carcinomas have a better prognosis than nonpapillary carcinomas!\n> clear cell + granular cell cancers have a better prognosis than spindle cell + anaplastic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 193,
            "markdown": "cancers\nRecurrence: in $11 \\%$ after 10 years\n$R x$ :\n(1) Radical nephrectomy ( $2-5 \\%$ operative mortality)\nN.B.: chemo- / radiation- / immunotherapy cannot cure metastatic renal cell carcinoma!\n(2) Nephron-sparing surgery (partial nephrectomy) with solitary functioning kidney, compromised renal function, multiple bilateral tumors, small RCC ( $<3 \\mathrm{~cm}$ in diameter, polar, cortical, far from renal hilum / sinus / collecting system)\n(3) $<5 \\%$ of metastatic RCCs respond to chemotherapy; only $20 \\%$ respond to interleukin-2 / interferon- $\\alpha$\n(4) Targeting tumor-angiogenesis: sunitinib and temsirolimus\n\n# Chromophobe Renal Cell Carcinoma \n\nPrevalence: $4-11 \\%$\nAssociated with: Birt-Hogg-DubÃ© syndrome\nOrigin: intercalated cells of renal cortex\n\n| Differentiation of Renal Cyst vs. Neoplasm by CT |  |  |\n| :-- | :--: | :--: |\n| CT Feature | Cyst | Neoplasm |\n| Shape | round, oval | irregular |\n| Margin | smooth | lobulated |\n| Wall | thin, not measurable | thick |\n| Interface | sharp, distinct | indistinct |\n| Density | $0-20 \\mathrm{HU}$ | $>30 \\mathrm{HU}$ |\n| Enhancement | $<10-20 \\mathrm{HU}$ | $>10-20 \\mathrm{HU}$ |\n| Portal venous phase | $<70 \\mathrm{HU}$ | $>70 \\mathrm{HU}$ |\n| Vascular invasion | none | yes |\n\nPath: solid growth, rarely necrotic even in large tumor\nHisto: round to polygonal cells with well-defined cytoplasmic border, abundant pale eosinophilic cytoplasm, fine reticular pattern, perinuclear halo\nMedian age: $6^{\\text {th }}$ decade (range, $31-75$ years)\nAverage size: 8.0 (range, $1.3-20.0) \\mathrm{cm}$\n$\\sqrt{ }$ less hypervascular than clear cell RCC\n$\\sqrt{ }$ cystic changes within solid tumor (rare)\n$\\sqrt{ }$ spokewheel enhancement (? related to oncocytoma)\nPrognosis: 5-year survival rate of $90 \\%$; better than for cRCC\n\n## Collecting Duct Renal Cell Carcinoma\n\n$=$ highly aggressive subtype of RCC\nSite: centered in pelvicaliceal system\n$\\sqrt{ }$ infiltrative growth pattern with medullary epicenter\n$\\sqrt{ }$ large lesions: heterogeneous $\\leftarrow$ areas of necrosis, hemorrhage, calcifications\nMR:\n$\\sqrt{ }$ typically low SI on T2WI with hypovascularity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 194,
            "markdown": "# Clear Cell Renal Cell Carcinoma (cRCC) \n\n$=$ CONVENTIONAL $\\mathrm{RCC}=\\mathrm{cRCC}$\nPrevalence: $60-80 \\%$ of all RCCs\nAssociated with: von Hippel-Lindau syndrome\nOrigin: derived from epithelium of proximal convoluted tubule $\\rightarrow$ cortical location and expansile growth\nPath: central necrosis (common); may be predominantly cystic with only minor solid enhancing component\nHisto: rich in cytoplasmic glycogen + lipid content that washes away (hence \"clear\") during tissue processing; extensive thin-walled sinusoid-like vessels\nGenetics: translocation of short arm of chromosome 3; mutation of von Hippel-Lindau tumor suppressor gene $\\rightarrow$ synthesizes protein that suppresses hypoxia-induced genes involved in angiogenesis\nLocation: in cortex as exophytic hypervascular solid mass\n$\\checkmark$ heterogeneous appearance $\\leftarrow$ macroscopic areas of necrosis, hemorrhage, cystic changes, calcifications\n$\\checkmark$ greater degree of enhancement than other subtypes $\\leftarrow$ CHARACTERISTIC network of small sinusoid blood vessels\nMR:\n$\\checkmark$ tumor isointense to renal parenchyma on T1WI\n$\\checkmark$ tumor hyperintense to renal parenchyma on T2WI\n$\\checkmark$ SI loss within solid portions on opposed-phase compared with in-phase images $\\leftarrow$ cytoplasmic fat (in $60 \\%$ )\n$\\checkmark \\pm$ hypointense rim on both T1- and T2-weighted images = pseudocapsule of compressed adjacent renal parenchyma:\n$\\checkmark$ interruption of pseudocapsule $\\leftarrow$ invasion of perirenal fat in advanced tumor stage\n$\\checkmark$ imaging of tumor necrosis:\n$\\checkmark$ homogeneously hypointense area in center of mass on T1WI that is hypo- to hyperintense on T2WI\n$\\checkmark$ solid rim of tumor peripherally\n$\\checkmark$ lack of enhancement in necrotic area + marked enhancement of viable tumor component\n$\\checkmark$ imaging of intratumoral hemorrhage:\n$\\checkmark$ high signal intensity on both T1- and T2WI = subacute to chronic hemorrhage\n$\\checkmark$ hypointense on both T1- and T2WI = long-standing hemorrhage predominantly containing hemosiderin\n$\\checkmark$ hypervascularity during cortical phase $\\leftarrow$ network of small sinusoid-like blood vessels\n$\\checkmark$ renal vein tumor thrombus $=$ higher-stage tumor\nPrognosis: 5-year survival rate of $55-60 \\%$; poorer than for chromophobe or pRCC\n\n## Cystic Renal Cell Carcinoma\n\nPrevalence: $4-15 \\%$ of all RCCs\nSpectrum:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 195,
            "markdown": "(a) Unilocular cystic RCC (50\\%)\n$=$ extensive necrosis of a previously solid RCC / intrinsic cystic growth of a cystadenocarcinoma / papillary RCC\n$\\sqrt{ }$ fluid-filled mass without criteria of a renal cyst\n(b) Multilocular RCC (30\\%)\n$=$ intrinsic multilocular growth; impossible to distinguish from multilocular cystic nephroma\n$\\sqrt{ }$ septated variable-sized cysts + septal calcifications\n(c) Mural nodule in cystic RCC (20\\%)\n$\\checkmark$ asymmetric cystic tumor necrosis\n$\\checkmark$ tumor arising in wall of preexisting cyst\n$\\checkmark$ tubular dilatation with secondary cyst formation from tumor obstruction\n$\\checkmark$ characteristics of a fluid-filled cystic mass:\n$\\checkmark$ calcifications\n$\\checkmark$ atypical contents:\n$\\checkmark$ high attenuation $>20 \\mathrm{HU}$ at NECT\n$\\checkmark$ signal intensity atypical for water at MRI\n$\\checkmark$ solid component with internal echoes failing to show acoustic enhancement at US\n$\\checkmark$ septations\n$\\checkmark$ multiple locules\n$\\checkmark$ contrast enhancement\n$\\checkmark$ wall thickening $>2-3 \\mathrm{~mm}$\n$\\checkmark$ nodularity\nCT (triple phase):\n$\\checkmark>15 \\mathrm{HU}$ change within solid portion (DDx: cystic angiomyolipoma, oncocytoma, infection)\n$\\checkmark$ rarely $10-15 \\mathrm{HU}$ change (DDx: papillary RCC, volume averaging, motion, streak artifact, imperfect placement of ROI)\n$D D x$ : complicated renal cyst\n\n# Metastatic Renal Cell Carcinoma \n\n$18-28 \\%$ of patients have clinically apparent multiple synchronous distant metastases at presentation\n$50 \\%$ will develop metachronous metastases during follow-up after nephrectomy (in $85 \\%$ within 3 years)\nIncidence of metastatic disease:\n(a) tumors $<3 \\mathrm{~cm}: 2.6 \\%$\n(b) tumors $3-5 \\mathrm{~cm}: 15.4 \\%$\n(c) tumors $>5 \\mathrm{~cm}: 78.6 \\%$\n\nNumber of sites: single+multiple sites $=3 \\div 2$\nSpread to:\nlung ( $45-55 \\%$ ) > bone ( $32 \\%$ ) > lymph nodes ( $22-34 \\%$ ); liver ( $20-33 \\%$ ); pancreas(1.6$11 \\%$ ); adrenals ( $4.3-19 \\%$ ); contralateral kidney ( $11 \\%$ ); brain ( $6 \\%$ ); heart ( $5 \\%$ ); spleen (5\\%); bowel (4\\%); skin (3\\%); ureter (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 196,
            "markdown": "(a) hematogenous: venous extension ( $20-35 \\%$ )\n> ascending into IVC $\\rightarrow$ right chambers $\\rightarrow$ lung $\\rightarrow$ systemic circulation\n> descending (= venous reflux) into adrenal, gonadal, second lumbar veins $\\rightarrow$ (often ipsilateral) ovary / testis / adrenal gland\n> with venous thrombosis $\\rightarrow$ retroperitoneal and paravertebral Batson plexus\n(b) lymphatic:\nÂ» regional lymph nodes (N): renal hilar and retroperitoneal (paraaortic + paracaval) nodes\n> mediastinal, pelvic, inguinal nodes (M1)\n> invasion of thoracic duct $\\rightarrow$ thoracic (mediastinal and hilar) / supraclavicular nodes\n\n- cough, bone pain, hemoptysis (as initial symptoms of metastatic disease present in 9\\%)\n\nCT:\n$\\checkmark$ tumor metastases tend to be hypervascular\n$\\checkmark$ some metastases (eg, clear cell RCC) are detected only during arterial phase\n$\\checkmark$ hypovascular metastases are best detected during the nephrographic phase\nBone scintigraphy:\n$\\checkmark$ negative uptake for bone metastases if lesion purely lytic without associated reactive bone formation\n\n# Papillary Renal Cell Carcinoma (pRCC) \n\nPrevalence: $10-15 \\%$ (2nd most common) of all RCCs\nAge: $\\quad 3 \\mathrm{rd}-8^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=2 \\div 1$ to $4 \\div 1$\nOrigin: derived from epithelium of proximal convoluted tubules\nAssociated with: end-stage renal disease\nPath: cystic necrosis + degeneration frequent; familial form associated with trisomy $7 \\& 17$\n\\& loss of Y chromosome in males (similar to papillary adenoma)\nHisto: cells surrounding fronds of delicate fibrovascular core; macrophages infiltrating papillary stalks\n(a) basophilic $=$ small cuboidal cells with uniform nuclei covering thin papillae\n(b) eosinophilic = large eosinophilic cells with pleomorphic nuclei\n\nGrowth pattern: papillary, tubular, tubulopapillary\nLocation: most common of multifocal / bilateral renal tumors!\n$\\checkmark$ typically hypovascular $\\rightarrow$ enhances to a lesser degree compared with clear cell RCC\n$\\checkmark$ homogeneous slow growing well-encapsulated tumor\n$\\checkmark$ peripheral calcifications frequent\nCECT:\n$\\checkmark$ little contrast enhancement in all phases to a lesser degree than renal cortex (DDx to hypervascular cRCC)\n$\\checkmark$ usually homogeneous enhancement if $<3 \\mathrm{~cm}$\n$\\checkmark$ heterogeneous enhancement if $>3 \\mathrm{~cm}$ (DDx to usually homogeneously enhancing chromophobe RCC)\nMR:\n$\\checkmark$ fibrous capsule (frequent)\n$\\checkmark$ hypointense on T1WI + T2WI (DDx to hyperintense cRCC on T2WI)\n$\\checkmark$ low-grade basophilic (type I) tumor:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 197,
            "markdown": "$\\sqrt{ }$ homogeneously low SI on T2WI\n$\\checkmark$ hypovascular homogeneous low-level enhancement\n$\\checkmark$ high-grade eosinophilic (type II) tumor:\n$\\checkmark$ complex tumor appearance $\\leftarrow$ hemorrhage + necrosis\n$\\checkmark$ enhancing papillary projections at periphery of cystic hemorrhagic mass\nUS:\n$\\checkmark$ frequently hypoechoic mass\nPrognosis: 5-year survival rate of $80-90 \\%$; favorable (smaller mean diameter, lower stage, later metastases than cRCC)\n$D D x$ : renal cyst (enhancement of $<10 \\mathrm{HU} /$ pseudoenhancement, cyst by US +MR )\n\n# Renal Cell Carcinoma in Childhood \n\nFrequency: $7 \\%$ of all primary renal tumors during first 2 decades of life;\nin childhood: Wilms tumor $+\\mathrm{RCC}=30 \\div 1$\nin $2^{\\text {nd }}$ decade: Wilms tumor $+\\mathrm{RCC}=1 \\div 1$\nMean age: 9 years\n\n- palpable abdominal mass ( $60 \\%$ ), abdominal pain ( $50 \\%$ )\n- hematuria ( $30-60 \\%$ ), hypertension due to renin production\n- polycythemia $\\leftarrow$ erythropoietin production\n- bone resorption $\\leftarrow$ parathyroid hormone production\n\nIncreased risk of renal cell carcinoma:\nVon Hippel-Lindau disease in 10-25\\% (cerebellar hemangioblastoma, retinal angioma, pancreatic cysts + tumors, pheochromocytoma, renal cysts + tumors)\nMetastases (20\\%): lung, bone, liver, brain\n$C x$ : intravascular extension ( $25 \\%$ )\nPrognosis: $64 \\%$ overall survival rate\n$D D x$ : Wilms tumor (younger age, larger at presentation, calcifications less frequent [ $9 \\%$ versus $25 \\%$ ], less dense / homogeneous)\n\n## RENAL CYST\n\n## Simple Cortical Renal Cyst\n\n$=$ acquired lesion possibly secondary to tubular obstruction; accounts for $62 \\%$ of all renal masses\nFrequency: in 1-2\\% (3-5\\%) of all urograms (autopsies)\nAge: peak incidence after age 30; increasing frequency with age ( $0.22 \\%$ in pediatric age group, $50 \\%$ over age 50 )\nPath: low cuboidal / flattened epithelium surrounded by 1-2-mm thick fibrous wall containing clear / slightly yellow serous fluid\nMay be associated with:\ntuberous sclerosis, Von Hippel-Lindau disease, Caroli disease, neurofibromatosis\n$\\checkmark$ large and unifocal when peripheral\n$\\checkmark$ focal attenuation + displacement of collecting system\n$\\checkmark$ focally replaced nephrogram with smooth margin\n$\\checkmark$ \"beak / claw\" sign = effaced wedge of renal parenchyma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 198,
            "markdown": "$\\sqrt{ }$ delicate filamentous often undulating septa (10-15\\%)\n$\\sqrt{ }$ curvilinear calcification ( $1-3 \\%$ ) in wall / septa\n$\\sqrt{ }$ milk of calcium in dependent portion $=$ always benign\n\n| CT / MR Features of Cystic Renal Lesions |  |  |  |\n| :--: | :--: | :--: | :--: |\n|  |  | Bosniak Classification |  |\n| Class | Description | Findings | Malignant |\n| I | simple cyst | $\\checkmark$ well-defined round mass of water attenuation <br> $\\checkmark$ hairline-thin smooth imperceptible wall <br> $\\checkmark$ no enhancement | $\\sim 0 \\%$ |\n| II | minimally <br> complicated <br> cyst | $\\checkmark$ cluster of cysts / septated cyst <br> $\\checkmark$ fine curvilinear calcification <br> $\\checkmark$ minimally irregular wall <br> $\\checkmark$ high-density content in $<3 \\mathrm{~cm}$ cyst | $\\sim 0 \\%$ |\n| IIF | Follow-up <br> lesion <br> (initially 6 <br> months, then <br> yearly) | $\\checkmark$ several hairline-thin septa <br> $\\checkmark$ wall / septa with perceived enhancement <br> $\\checkmark$ thick nodular calcium <br> $\\checkmark$ intrarenal $>3 \\mathrm{~cm}$ high-density lesion | $\\sim 5 \\%$ |\n| III | complicated <br> (surgical) <br> lesion: <br> hemorrhagic <br> / infected cyst, <br> MLCN, cystic <br> neoplasm | $\\checkmark$ irregular thickened septa <br> $\\checkmark$ measurable enhancement <br> $\\checkmark$ coarse irregular calcification <br> $\\checkmark$ irregular margin <br> $\\checkmark$ multiloculated lesion <br> $\\checkmark$ uniform wall thickening <br> $\\checkmark$ nonenhancing nodular mass | $\\sim 50 \\%$ |\n| IV | clearly <br> malignant <br> cystic lesion | $\\checkmark$ large cystic / necrotic component <br> $\\checkmark$ irregular wall thickening <br> $\\checkmark$ solid enhancing elements | $>90 \\%$ |\n\nN.B.: measurement of cyst wall thickness not accurate in a completely intrarenal cyst US ( $90-100 \\%$ accuracy of US \\& CT):\n$\\checkmark$ spherical / ovoid in shape\n$\\checkmark$ anechoic content without internal echoes\n$\\checkmark$ smooth clearly demarcated back wall\n$\\checkmark$ acoustic enhancement of tissue beyond cyst (= positive through transmission) $\\leftarrow$ unattenuated sound reflections\n$\\checkmark$ refraction along sidewalls\nCT ( $100 \\%$ accuracy):\n$\\checkmark$ near-water-density lesion ( $0-20 \\mathrm{HU}$ ) with thin wall + smooth interface with renal parenchyma\nN.B.: Accuracy of HU measurements depends on: patient size, mass size, size of region examined, CT scanner type \\& manufacturer, CT technique, image noise, partial",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 199,
            "markdown": "volume averaging, pseudoenhancement\n$\\sqrt{ }$ no enhancement $(<12 \\mathrm{HU})$\nMR:\n$\\sqrt{ }$ most sensitive modality for cysts $<10 \\mathrm{~mm}$\n$\\sqrt{ }<15 \\%$ enhancement after $0.1 \\mathrm{mmol} / \\mathrm{kg}$ gadolinium on spoiled GE T1WI without fat sat and without retuning $=\\left(\\mathrm{SI}_{\\text {post }}-\\mathrm{SI}_{\\text {pre }}\\right)+\\mathrm{SI}_{\\text {pre }} \\times 100$\nCystography:\n$\\sqrt{ }$ smooth wall, clear aspirate with low lactic dehydrogenase, no fat content\nCx: (1) Hemorrhage in $1-11.5 \\%$\n(2) Infection in $2.5 \\%$\n(3) Tumor within cyst in $<1 \\%$\n\n# PSEUDOENHANCEMENT \n\n$=$ artificial elevation of Hounsfield unit measurements of renal cyst measured on CECT images\n$\\diamond$ Most frequently occurs in intrarenal cyst of $<2 \\mathrm{~cm}$ during peak parenchymal enhancement\nCause: secondary to image reconstruction algorithm used to adjust for beam-hardening effects\n$\\sqrt{ }$ simple fluid attenuation of $<10 \\mathrm{HU}$ on NECT images\n$\\sqrt{ }$ simple renal cyst mischaracterized as solid mass\nRecommendation if suspected: US / MR\n\n## Atypical / Complicated Renal Cyst\n\nPath: calcification, hemorrhage, septations, wall-thickening, nodularity\nHisto: inflammatory cells + granulation tissue + neovascularity $\\leftarrow$ host reparative response to hemorrhage, infection, inflammation, ischemia\nUS:\n$\\sqrt{ }$ cyst content of low-level echoes / layers of echoes\n$\\sqrt{ }$ cyst septations $\\pm$ reverberation artifacts\n$\\sqrt{ } \\pm$ shadowing calcifications\nCT:\n) Bosniak II cyst\n$\\sqrt{ }$ fine calcifications $\\pm$ short segment of slightly thickened calcification in cyst wall / septa\n$\\sqrt{ } \\pm$ few hairline-thin septa\n$\\sqrt{ }$ nonenhancing homogeneously hyperattenuating ( $>20 \\mathrm{HU}$ ) lesion measuring $\\leq 3 \\mathrm{~cm}$\n) Bosniak IIF cyst ( $0.01 \\%$ chance of malignancy)\n$\\sqrt{ }$ several thin internal septations without measurable enhancement\n$\\sqrt{ }$ few nodular calcifications\n$\\sqrt{ }$ smooth thickening of cyst wall\n$\\sqrt{ }$ nonenhancing hyperattenuating ( $>20 \\mathrm{HU}$ ) cyst $>3 \\mathrm{~cm} \\pm$ completely intrarenal\n$\\diamond$ cyst content of $>70 \\mathrm{HU}$ on NECT in $>99.9 \\%$ benign\n) Bosniak III cyst ( $30-100 \\%$ chance of malignancy)\n$\\sqrt{ }$ thick irregular walls $\\pm$ numerous septa with measurable enhancement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 200,
            "markdown": "$\\sqrt{ } \\pm$ thick nodular calcifications in cyst wall and septa\n$D D x:$ RCC, cystic nephroma, mixed epithelial and stromal tumor (MEST), benign multiloculated cyst, hemorrhagic cyst, renal abscess, hematoma, renal artery aneurysm\n$R x:$ serial follow-up, surgery\n, Bosniak IV cyst (= malignant until proven otherwise)\n$\\sqrt{ }$ enhancing nodular soft-tissue component\n$R x:$ surgery\n$D x:$ cyst puncture + aspiration\n\n# Hemorrhagic Renal Cyst \n\nCause: trauma, varices, bleeding diathesis\n\n- rust-colored puttylike material\n$\\sqrt{ }$ uni- / multilocular cyst separated by thick septa\n$\\sqrt{ }$ thick fibrous $\\pm$ calcified wall\n$\\sqrt{ }$ fibrin ball inside cyst (rare)\nCT:\n$\\sqrt{ }$ increased density $\\leftarrow$ acute hemorrhage / high protein contents (= hyperattenuating cyst with $\\sim 60-90 \\mathrm{HU})$\n$\\sqrt{ }$ no contrast enhancement\nMR:\n$\\sqrt{ }$ usually iso- to hyperintense on T1WI $\\leftarrow$ methemoglobin + hyperintense on T2WI $\\leftarrow$ lysis of RBCs\n$\\sqrt{ }$ NO suppression on fat-saturated T1WI\n$\\sqrt{ }$ variable signal intensities (dependent on amount + acuity of hemorrhage, hemoglobin degradation product, degree of RBC lysis, protein content)\n$\\sqrt{ }$ hematocrit effect $\\leftarrow$ settling of RBCs at cyst bottom\n\n\n## Infected Renal Cyst\n\nCause: hematogenous dissemination of bacteria, ascending urinary tract infection\nMean age: 61 years; in $94 \\%$ females\n\n- history of no response to antibiotic Rx for acute pyelonephritis; leukocyturia\n\nUS:\n$\\sqrt{ }$ thickened irregular cyst wall ( $22 \\%$ )\n$\\sqrt{ }$ internal septations ( $11 \\%$ )\n$\\sqrt{ }$ wall calcification (occasionally)\n$\\sqrt{ }$ minute debris either diffusely / fluid-fluid level in dependent portion of cyst\n$\\sqrt{ }$ amorphous solid conglomerates\n$\\sqrt{ }$ round sharply marginated lesion\n\n## High-density Renal Cyst\n\n$=$ completely homogeneous cyst content $\\geq 20 \\mathrm{HU}$ (often $50-90 \\mathrm{HU}$ ) without enhancement\n\n1. Proteinaceous content $(20-40 \\mathrm{HU})$\n$\\sqrt{ }$ simple cyst on US\n2. Hemorrhage $(>40 \\mathrm{HU})$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 201,
            "markdown": "$\\checkmark$ complex cyst on US\n3. Infection\n4. Calcification\n5. Communication with calyx\n6. Streak artifact\n$\\checkmark$ pseudoenhancement (see above)\n$\\diamond$ Cyst wall cannot be evaluated in high-attenuation cysts!\n$\\diamond$ Considered a Bosniak Class II lesion if:\n$\\leq 3 \\mathrm{~cm}$ in size, partially exophytic, round, sharply marginated, homogeneous, nonenhancing\n$\\diamond$ A homogeneous renal mass with attenuation $>70 \\mathrm{HU}$ on NECT is benign with a $99 \\%$ probability!\n\n# Cyst of Renal Pelvis \n\n$=$ generic term for spherical fluid-filled mass intimately attached to renal pelvis without connection to pelvicaliceal system\nPrevalence: $1.5 \\%$ (autopsies); $4-6 \\%$ of all renal cysts\nAge: mostly during $5^{\\text {th }}-6^{\\text {th }}$ decade\n\n- clear straw-colored serous fluid\n$\\checkmark$ soft-tissue density in renal sinus\n$\\checkmark$ anechoic mass(es) with acoustic enhancement\n$D D x$ : hydronephrosis\n\n\n## Renal Sinus Cyst\n\n$=$ PERIPELVIC CYST $=$ PARAPELVIC LYMPHATIC CYST $=$ PARAPELVIC LYMPHANGIECTASIA\n$=$ multiple small confluent cysts arising from renal sinus\nEtiology: probably ectatic lymphatic channels from lymphatic obstruction; ?\nposttraumatic extravasation of urine / blood; ? mesonephric remnant; ? remnant of wolffian body; ? outpouchings of renal pelvis; ? duplication anomaly\n\n- almost always asymptomatic\n\nLocation: frequently bilateral\n$\\checkmark$ multiple small renal sinus cysts\n$\\checkmark$ focal displacement + smooth effacement of collecting system\n$\\checkmark$ rarely curvilinear calcification of cyst wall (4\\%)\nIVP:\n$\\checkmark$ stretching of collecting system when generalized (indistinguishable from sinus lipomatosis)\nNECT / US:\n$\\checkmark$ multiple confluent cysts (mimicking hydronephrosis)\nCECT:\n$\\checkmark$ high-attenuation contrast fills collecting system but not cyst\nPrognosis: NO change on long-term follow-up\n\n## Parapelvic Cyst\n\n$=$ protrusion of medial parenchymal cyst into sinus fat",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 202,
            "markdown": "# Histo: lined with single epithelial layer \n\n- hematuria $\\leftarrow$ cyst rupture\n- pain $\\leftarrow$ obstructive caliectasis / infection\n- renovascular hypertension $\\leftarrow$ compression of renal arteries\n\nLocation: usually single unilateral cyst, may be multiple\n$\\sqrt{ }$ simple cortical renal cyst that extends into renal sinus fat\nCx: (1) Caliectasis / localized hydronephrosis) $\\leftarrow$ compression of collecting system\n(2) hypertension $\\leftarrow$ compression of renal artery\n(3) infection, hemorrhage\n\nRx: cyst ablation with $95 \\%$ ethanol if symptomatic\n\n## RENAL DYSGENESIS\n\n$=$ undifferentiated tissue of renal anlage\n$\\diamond$ Pathologic NOT radiologic diagnosis\n$\\checkmark$ renal vessels usually absent; occasionally small vascular channels\n\n## RENAL INFARCTION\n\n## Cause:\n\n1. TRAUMA\nblunt abdominal trauma with traumatic avulsion / occlusion of renal artery, penetrating vascular injury, surgery\n2. EMBOLISM\n(a) Cardiac: rheumatic heart disease with arrhythmia (atrial fibrillation), myocardial infarction, prosthetic valve, myocardial trauma, left atrial / mural thrombus, myocardial tumor, subacute bacterial endocarditis $\\rightarrow$ septic emboli\n(b) Catheters: angiographic catheter manipulation, transcatheter embolization, umbilical artery catheter above level of renal arteries\n3. ARTERIAL THROMBOSIS\narteriosclerosis, aneurysm or dissection of aorta / renal artery, thrombangiitis obliterans, polyarteritis nodosa, syphilitic cardiovascular disease, sickle cell disease, paraneoplastic syndrome (Trousseau syndrome), hypercoagulable state\n4. VASCULITIS\npolyarteritis nodosa, SLE, drug-induced vasculitis\n5. Sudden complete renal vein thrombosis\n\n## Acute Renal Infarction\n\n- sudden onset of flank / back pain\n- $\\pm$ hematuria, proteinuria, fever, leukocytosis\n$\\checkmark$ normal / large kidney with smooth contour\n$\\checkmark$ normal / expanded parenchymal thickness\n$\\checkmark$ normal / attenuated collecting system, often only opacified by retrograde pyelography\n$\\checkmark$ absent / diminished nephrogram with cortical rim enhancement, rarely striations\nCT:\n$\\checkmark$ wedge-shaped area of absent enhancement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 203,
            "markdown": "$\\checkmark$ edematous enlargement of kidney (with large infarct)\n$\\checkmark$ \"cortical rim\" sign within several days after global infarction\nUS:\n$\\checkmark$ diminished echogenicity (within $<24$ hours)\n$\\checkmark$ normal echogenicity (echoes appear within 7 days)\nNUC (SPECT imaging with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA):\n$\\checkmark$ photon-deficient area\n$R x$ : thrombolytic therapy, supportive hemodialysis, transcatheter thrombembolectomy, surgery\n\n# Lobar Renal Infarction \n\n## Early signs:\n\n$\\checkmark$ focal attenuation of collecting system $\\leftarrow$ tissue swelling\n$\\checkmark$ focally absent nephrogram (triangular with base at cortex)\nLate signs:\n$\\checkmark$ normal / small kidney(s)\n$\\checkmark$ focally wasted parenchyma with NORMAL interpapillary line (portion of lobe / whole lobe / several adjacent lobes)\nCT:\n$\\checkmark$ nonperfused area corresponding to vascular division\n$\\checkmark$ \"cortical rim\" sign (subacute) = thin rim of preserved subcapsular perfusion $\\leftarrow$ capsular perforators\nUS:\n$\\checkmark$ focally increased echogenicity\n\n## Chronic Renal Infarction\n\nPath: all elements of kidney atrophied with replacement by interstitial fibrosis\n$\\checkmark$ normal / small kidney with smooth contour\n$\\checkmark$ globally wasted parenchyma\n$\\checkmark$ diminished / absent contrast material density\nUS:\n$\\checkmark$ increased echogenicity (by 17 days)\nAngio:\n$\\checkmark$ normal intrarenal venous architecture\n$\\checkmark$ late visualization of renal arteries on abdominal aortogram\n\n## Atheroembolic Renal Disease\n\n$=$ dislodgment of multiple atheromatous emboli from the aorta into renal circulation $\\rightarrow$ below level of arcuate arteries\n$\\checkmark$ normal / small kidneys with smooth contour or shallow depressions\n$\\checkmark$ wasted parenchymal thickness\n$\\checkmark$ diminished density of contrast material\nCT:\n$\\checkmark$ patchy nephrographic distribution\nAngio:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 204,
            "markdown": "# $\\checkmark$ embolic occlusion \n\n## Arteriosclerotic Renal Disease\n\n$=$ disseminated process involving most of the interlobar + arcuate arteries causing uniform shrinkage of kidney\nAge: generally over 60 years\nAccelerated development in: scleroderma, polyarteritis nodosa, chronic tophaceous gout\n\n- often associated with hypertension ( $=$ nephrosclerosis)\n$\\checkmark$ normal / small kidneys\n$\\checkmark$ smooth contour with random shallow contour depressions $\\leftarrow$ infarctions\n$\\checkmark$ uniform loss of cortical thickness\n$\\checkmark$ normal / effaced collecting system $\\leftarrow$ fat proliferation\n$\\checkmark$ increased pelvic radiolucency (vicarious sinus fat proliferation)\n$\\checkmark$ calcification of medium-sized intrarenal arteries\nUS:\n$\\checkmark$ increased echogenicity possible\n$\\checkmark$ increased size of renal sinus echoes $\\leftarrow$ fatty replacement\n\n\n## Nephrosclerosis\n\nHisto: thickening + hyalinization of afferent arterioles, proliferative endarteritis, necrotizing arteriolitis, necrotizing glomerulitis\n\n- arterial hypertension\n(a) benign nephrosclerosis\n(b) malignant nephrosclerosis (rapid deterioration of renal function)\n$\\checkmark$ radiographic appearance similar to arteriosclerotic kidney\n\n\n## RENAL SARCOMA\n\nFrequency: $1 \\%$ of malignant renal parenchymal tumors\nSubtypes: leiomyosarcoma ( $>50 \\%$ ), angiosarcoma, hemangiopericytoma, rhabdomyosarcoma, fibrosarcoma, osteosarcoma\n$\\checkmark$ considerable variation in growth pattern:\n$\\checkmark$ expansile mass (most commonly)\n$\\checkmark$ infiltrative growth (rhabdomyosarcoma, angiosarcoma)\n$D x:$ by exclusion of sarcomatoid renal carcinoma + primary retroperitoneal sarcoma with direct extension into kidney\n\n## RENAL TRANSPLANT\n\nFrequency: 316,493 transplants between 1988 and 2012 in US; 17,107 transplants annually in USA (2014)\nComplications in $10 \\%$ :\n\n- Problematic period between 4 days and 3 weeks after surgery!\n- hypertension in $50 \\%$ (from rejection / arterial stenosis)\n(a) immediate: ATN, acute humeral rejection, renovascular thrombosis, perinephric hematoma, graft infection + abscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 205,
            "markdown": "(b) early ( $>1-4$ weeks): acute rejection, renal vein thrombosis, urinary tract obstruction, urine leak, urinoma\n(c) late ( $>1$ month): acute + chronic rejection, ureteral stricture, VUR, renal artery stenosis, arteriovenous fistula, pseudoaneurysm, lymhocele, seroma\nPrognosis: organ survival at 1 (5) years in $89-95 \\%(67-80 \\%) ; 13-24$ years half-life for transplant from living related donor\n\n| Renal Allograft Dysfunction relative to Time since Surgery |  |\n| :--: | :--: |\n| Immediate to $1^{\\text {st }} 48 \\mathrm{hr}$ | Day 2 to 7 |\n| 1. Hyperacute rejection <br> 2. Renal vein thrombosis <br> 3. Discordant size | 1. ATN <br> 2. RVT |\n| $>1$ week postop | Delayed |\n| 1. Acute rejection <br> 2. ATN | 1. Chronic rejection <br> 2. Drug toxicity <br> 3. Obstruction <br> 4. Infection <br> 5. Extrinsic compression |\n\n\n| Renal Transplant Scintigram |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n|  | Early study (<24 hr post transplantation) |  | Late study ( $>5$ days post transplantation) |  |\n|  | Flow | Excretion | Flow | Excretion |\n| Acute tubular necrosis | normal $/ \\downarrow$ | $\\downarrow$ | normal $/ \\downarrow$ | $\\downarrow$ |\n| Hyperacute rejection | absent | absent |  |  |\n| Acute rejection | $\\downarrow$ | $\\downarrow$ | worsening | worsening |\n| Chronic rejection | $\\downarrow$ | $\\downarrow$ | $\\downarrow$ | $\\downarrow$ |\n\n# Acute Tubular Necrosis in Renal Transplant \n\n$=$ primary nonfunction within 72 hours of transplantation followed by improvement within a few days to 1 month\n$\\diamond$ Most common cause of \"delayed\" graft function\"\nCause: preservation injury $\\leftarrow$ prolonged ischemia (cold ischemia time $>24-30$ hours), reperfusion injury\n> ATN more frequent in cadaveric than living-related donor transplant $\\leftarrow$ donor hypotension\n> ATN greater in transplants with $>1$ renal artery\n> ATN related to length of ischemic interval $\\leftarrow$ prolonged organ storage\nHisto: sloughed renal tubular epithelium + surrounding edema\nPathophysiology: relative preservation of renal perfusion + minimal / absent urinary excretion\n\n- no constitutional symptoms; elevated urine sodium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 206,
            "markdown": "- oliguria may begin immediately after transplantation / may be delayed for several days US:\n$\\checkmark$ transient enlargement of transplant\n$\\checkmark$ transient increase in resistive index\nNUC ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ mertiatide preferred):\n$=1^{\\text {st }}$-line imaging modality!\n$\\diamond$ Limited diagnostic value if serum creatinine $>6 \\mathrm{mg} / \\mathrm{dL}$\n$\\checkmark$ normal / slightly decreased transplant perfusion:\n$\\checkmark$ delayed time from Tmax to one-half maximal activity\n$\\checkmark$ decreased + delayed radiopharmaceutical uptake:\n$\\checkmark$ delayed transit time + delayed Tmax\n$\\checkmark$ delayed / decreased / absent excretion of radiotracer with prolonged cortical retention:\n$\\checkmark$ high 20-minute to 3-minute ratio\n$D D x$ : acute rejection (serial studies help to differentiate)\n\n\n# Rejection of Renal Transplant \n\n$\\diamond$ Most common cause of parenchymal failure!\n$\\diamond$ Rejection occurs in all transplants to some degree!\n\n## Hyperacute Rejection of Renal Transplant (rare)\n\n$=$ humeral rejection with preformed circulating antibodies present in recipient at time of transplantation, usually following retransplantation\nPath: thrombosed arterioles + cortical necrosis\nTime of onset: within minutes after transplantation\n$\\diamond$ In practice never imaged!\n$\\checkmark$ complete absence of renal perfusion + renal function on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA scan (DDx: complete arterial / venous occlusion)\n$R x$ : requires immediate reoperation\n\n## Accelerated Acute Rejection of Renal Transplant\n\n$=$ combination of antibody + cell-mediated rejection\nTime of onset: $2-5$ days after transplantation\n\n## Acute Rejection of Renal Transplant (in up to 40\\%)\n\n$=$ cellular rejection predominantly dependent on cellular immunity\n$\\diamond$ Most common type of allograft rejection\nTime of onset: any time, typically within 5 days to 6 months; peak incidence at $2^{\\text {nd }}-5^{\\text {th }}$ week\nPrevalence: in $50 \\%$ at least 1 episode in $1^{\\text {st }}$ year\nPath:\n(a) acute interstitial rejection\n$=$ edema of interstitium with lymphocytic infiltration of capillaries + lymphatics\n(b) acute vascular rejection (rare)\n$=$ proliferative endovasculitis + vessel thrombosis\n\n- malaise, fever, weight gain; graft tenderness\n- low urine sodium, increase in serum creatinine",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 207,
            "markdown": "- hypertension, oliguria, proteinuria\n\nUS ( $30-50 \\%$ negative predictive value):\n$\\sqrt{ }$ increase in renal volume from edema:\n$\\sqrt{ } \\downarrow$ renal sinus fat $+\\uparrow$ cortical thickness (most predictive)\n$\\sqrt{ }$ loss of corticomedullary differentiation\n$\\sqrt{ }$ thickening of pelvoinfundibular wall\n$\\sqrt{ }$ diminished echogenicity of renal sinus fat\nDoppler US (higher accuracy than morphologic parameters):\n$\\sqrt{ }$ initially decrease in resistive index (? autoregulatory mechanism)\n$\\sqrt{ }$ increase in resistive index $>0.80$ (with increasing severity of rejection)\n(a) $\\leq 0.70$ without any form of rejection ( $57 \\%$ NPV)\n(b) $>0.90$ ( $100 \\%$ PPV, $26 \\%$ sensitivity)\n$\\sqrt{ }$ reversal of diastolic flow\nNUC:\n$\\sqrt{ }$ typically $\\downarrow$ renal perfusion $+\\downarrow$ graft function + high background radiotracer activity\n$\\sqrt{ }$ initially perfusion may be normal with only function decreased (DDx to ATN may not be possible on single study)\n$\\sqrt{ }$ subsequent exams (1-3-day intervals) demonstrate decreasing renal perfusion\n$\\sqrt{ }$ prolonged excretory phase\n$\\sqrt{ }$ poor and inhomogeneous nephrogram\nAngio:\n$\\sqrt{ }$ rapid tapering + pruning of interlobar arteries\n$\\sqrt{ }$ multiple stenoses + occlusions\n$\\sqrt{ }$ nonvisualization of interlobular arteries\n$\\sqrt{ }$ prolonged arterial opacification (normally $<2$ seconds)\n$D D x$ : acute tubular necrosis (develops within first few days)\n\n# Chronic Rejection of Renal Transplant \n\n$=$ slow relentless progressive process resulting in interstitial scarring\n$\\diamond$ Most common cause of late graft loss\nHisto: endothelial proliferation in small arteries + arterioles; interstitial cellular infiltration + fibrosis; tubular atrophy; glomerular lesions (? recurrence of patient's original glomerulonephritis)\nTime of onset: months to years after transplantation\n\n- progressive decline of renal function\n$\\sqrt{ }$ progressive volume loss $\\rightarrow$ small kidney with thin cortex\n$\\sqrt{ }$ diminished number of intrarenal vessels\n$\\sqrt{ }$ vascular pruning / stenoses / occlusions $\\rightarrow$ commonly focal cortical scarring\n$\\sqrt{ }$ mild hydronephrosis\nNUC:\n$\\sqrt{ }$ small graft with poor perfusion + globally decreased function\n\n\n## Drug Nephrotoxicity\n\nNephrotoxic potential of calcineurin inhibitors:\ncyclosporine (vasoconstrictive effect on afferent glomerular arterioles) $>$ OKT3 $>$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 208,
            "markdown": "tacrolimus (FK-506)\n$\\diamond$ Effects are dose-dependent and accentuated by dehydration + decreased renal perfusion Action: impedes rejection process with narrow therapeutic window\nHisto: (a) acutely: damage to tubules, microthrombosis of kidney $\\leftarrow$ activation of coagulation cascade\n(b) chronically: hyaline deposition within arterial walls\n$\\checkmark$ no change in renal size\n$\\checkmark$ no change (?) / elevation of resistive index\nNUC:\n$\\checkmark$ depressed effective renal plasma flow\n$\\checkmark$ no parenchymal retention\n\n# Urologic Problems with Renal Transplant \n\n$\\diamond$ US is $1^{\\text {st }}$-line imaging modality!\n\n## Ureteral Obstruction of Renal Transplant (2-10\\%)\n\n(a) acute: secondary to technical problems\n(b) late: secondary to ischemia / previous extravasation\n\nCause: ischemic stricture (most commonly at ureterovesical junction), ureteral kinking, (transient) edema at ureteroneocystostomy, ureteropelvic fibrosis, crossing vessels, blood clot, fungus ball, calculus, tumor, perinephric fluid collection (hematoma, lymphocele)\n\n- rising serum creatinine level, oliguria\n$\\checkmark$ pyelocaliectasis\n$\\checkmark$ normal resistive index strongly argues against obstruction unless ureteral leak is present\nNUC (only $18 \\%$ sensitive $\\leftarrow$ impaired uptake)\n$D D x$ : diminished ureteral tone $\\leftarrow$ denervation\n\n\n## Urine Extravasation of Renal Transplant (1-5\\%)\n\nCause:\n(1) Distal ureteral necrosis $\\leftarrow$ interruption of blood supply (early) / vascular insufficiency $\\leftarrow$ rejection (late)\n(2) Leakage from ureteroneocystostomy site (related to surgical technique / distal ureteral necrosis)\n(3) Leakage from anterior cystostomy closure site\n(4) Segmental renal infarction\n\n- high creatinine level in fluid collection\n\nPrognosis: high morbidity + mortality $\\leftarrow$ death from transplant infection + septicemia\nParatransplant Fluid Collection (in up to 50\\%)\n$D x$ : percutaneous fluid aspiration\nCx: Page kidney\n(1) Lymphocele ( $0.6-18 \\%$ )\n\nOnset: within 4-8 weeks after transplantation\n$\\checkmark$ mean diameter of 11 cm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 209,
            "markdown": "$\\sqrt{ }$ thick septa $(50 \\%)+$ internal debris\n$D D x$ : urinoma (radiotracer uptake)\n(2) Urinoma (rare)\n\nOnset: in early postoperative period\n(3) Hematoma, seroma, abscess\n\nOnset: in early postoperative period\n$\\sqrt{ }$ small crescentic peritransplant fluid collection (as normal sequelae of surgery)\n$\\sqrt{ }$ photopenic region with displacement / impression on renal transplant / urinary bladder\nPrognosis: small hematomas typically resolve spontaneously within a few weeks\nmnemonic: HAUL\nHematoma\nAbscess\nUrinoma\nLymphocele\n\n# Vascular Problems with Renal Transplant (10\\%) \n\n$\\diamond$ Doppler US is $1^{\\text {st }}$-line imaging modality!\nA. PRERENAL\n\n1. Renal artery stenosis $(1-4 \\%)$\n$\\diamond$ Transient elevation of velocities in immediate postop. period $\\leftarrow$ vessel wall edema / arterial spasm!\nTime of onset: late $=$ within 3 years; cadaver kidney $>$ young donor kidney $>$ livingrelated donor kidney\nLocation:\n(a) short-segment stenosis at anastomosis: technical ( $75 \\%$ )\n\nCause: use of clamp / cannula, trauma, ischemia of donor vessel\n(b) long-segment stenosis of proximal artery (close to anastomosis) > distal artery\n\nCause: trauma during allograft harvesting, faulty operative technique, chronic rejection, atherosclerosis, kinking, scar formation\n\n- recent onset of hypertension / severe hypertension refractory to multiple drug regimens\n$\\diamond 1-5 \\%$ of all causes of posttransplant hypertension (nonrenovascular hypertension in $65 \\%)$\n- unexplained graft dysfunction\n- nonspecific audible bruit over graft (occasionally)\n$\\sqrt{ }$ surrounding soft-tissue \"speckle\" $\\leftarrow$ vibration\n$\\sqrt{ }$ increase in peak systolic velocity $>180-210 \\mathrm{~cm} / \\mathrm{s}$\n$\\sqrt{ } 2 \\div 1$ ratio between peak stenotic and poststenotic velocities\n$\\sqrt{ }$ main renal artery / external iliac artery ratio $>3.5$ (normally $<2.0$ )\n$\\sqrt{ }$ marked poststenotic turbulence (supportive evidence)\n$\\sqrt{ }$ dampened signals distal to stenosis (= tardus-parvus waveform)\n$\\sqrt{ }$ increase in acceleration time (= pulse rise time) of intrarenal arteries\nNUC (low sensitivity):\n$\\sqrt{ } \\downarrow$ perfusion + cortical uptake, photopenic graft",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 210,
            "markdown": "Angio:\n$\\sqrt{ }$ standard test for detection of arterial stenosis $\\pm$ intravascular treatment\n$C x(0.5-2.3 \\%)$ : hemorrhage, intimal flap, AV fistula\n2. Renal artery thrombosis $(1-6 \\%)$\n\nCause: rejection, faulty surgical technique (torsion / kinking / angulation of anastomosis)\nTime of onset: within first 48 hours - $1^{\\text {st }}$ week\nPredisposed: allografts with disparate vessel size, multiple anastomoses, arterial dissection $\\leftarrow$ faulty handling, rejection\n\n- early sudden onset of anuria\n- graft tenderness + swelling\n(a) global\n$\\sqrt{ }$ absence of perfusion, uptake, excretion\n$\\sqrt{ }$ failure to demonstrate intrarenal arterial / venous flow\nPrognosis: graft loss\n(b) segmental (late complication)\n$\\sqrt{ }$ segmental infarction $\\leftarrow$ occlusion of polar artery\n$\\sqrt{ }$ hypo- / hyperechoic area $\\pm$ cortical thickening\n$\\sqrt{ }$ no flow in affected area\n\n3. Pseudoaneurysm (in up to $17 \\%$ )\n\nCause: percutaneous biopsy with laceration of arterial wall, faulty surgical technique, perivascular infection\nLocation:\n(a) extrarenal at anastomotic site (uncommon): $\\leftarrow$ suture rupture, anastomotic leakage, vessel wall ischemia\n(b) intrarenal, mostly of arcuate arteries: following needle biopsy, mycotic infection\n$\\sqrt{ }$ mimics renal cyst\n$\\sqrt{ }$ disorganized flow / to-and-fro waveform\nPrognosis: spontaneous regression frequent\n$C x$ : spontaneous rupture\n4. Arteriovenous fistula (in $2-18 \\%$ )\n\nCause: percutaneous biopsy with simultaneous laceration of artery and vein, faulty surgical technique, perivascular infection\n\n- hypertension, hematuria, high-output cardiac failure\n\nUS:\n$\\sqrt{ }$ high-velocity low-resistance flow in feeding artery\n$\\sqrt{ }$ pulsatile \"arterialized\" waveform in draining vein\n$\\sqrt{ }$ turbulence + high-frequency velocity shift\n$\\sqrt{ }$ exaggerated focal color around lesion (= bruit = perivascular soft-tissue vibration)\nAngio (gold standard + allows treatment):\n$\\sqrt{ }$ rapid contrast appearance in IVC\n$\\sqrt{ }$ decreased density on nephrogram\nPrognosis: $70 \\%$ resolve within 1-2 years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 211,
            "markdown": "Cx: renal ischemia (with large lesion), persistent hematuria, rupture\n\n# 5. Renal allograft necrosis / infarct \n\n$=$ total lack of perfusion in an area of renal cortex associated with variable degrees of medullary necrosis\nCause: rejection, surgical ligature, preexistent arterial lesion, severe ATN, prolonged time of warm ischemia\nPattern:\n\n1. Small focal necrosis\n2. Large isolated area of infarction $\\leftarrow$ segmental arterial occlusion)\n3. Outer cortical necrosis\n4. Cortical necrosis with large patches\n5. Diffuse cortical necrosis\n6. Cortical + medullary necrosis\n7. Necrosis of whole kidney $\\leftarrow$ occlusion of main renal artery\n\nMR:\n$\\checkmark$ slightly hyperintense $\\leftarrow$ ischemic necrosis / hypointense $\\leftarrow$ hemorrhagic necrosis / isointense area on T2WI\n$\\checkmark$ hypointense areas on Gd-DTPA images\nUS:\n$\\checkmark$ hypoechoic $\\leftarrow$ ischemic necrosis / iso- or hyperechoic areas $\\leftarrow$ hemorrhagic necrosis\n$\\checkmark$ swollen area $\\leftarrow$ probably cortical edema\n$\\checkmark$ absence of arterial perfusion by color duplex (not sensitive for small infarcts / superficial cortical necrosis)\n$\\checkmark$ elevated resistive indexes + no / reversed diastolic flow\nB. POSTRENAL\n\n1. Renal / iliac vein thrombosis (4.2-5\\%)\n\n## Cause:\n\n(a) immediately: injury to epithelium at site of renal vein anastomosis, extrinsic compression by fluid collection (hematoma, lymphocele)\n(b) after $1^{\\text {st }}$ week: acute rejection, reduced intrarenal arterial flow, hypovolemia, propagation of iliofemoral vein thrombosis\n\n- abrupt onset of oliguria, graft tenderness\n- hematuria, proteinuria\n$\\checkmark$ enlarged hypoechoic transplant\n$\\checkmark$ prolonged arterial transit time without arterial occlusions + arterial spasms\n$\\checkmark$ diminished cortical perfusion\n$\\checkmark$ absent venous flow\n$\\checkmark$ \"U-shaped\" / plateau-like reversal of diastolic arterial flow\n$\\checkmark$ decreased systolic rise time\nNUC:\n$\\checkmark$ lack of perfusion (but no graft photopenia)\n\n## 2. Renal vein stenosis\n\nCause: perivascular fibrosis, compression from adjacent perinephric fluid collection\n$\\checkmark$ color aliasing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 212,
            "markdown": "# High Vascular Impedance of Renal Transplant \n\n$=$ pulsatility index $(\\mathrm{A}-\\mathrm{B} \\div$ mean $)>1.8$ or resistive index $(\\mathrm{A}-\\mathrm{B} \\div \\mathrm{B})$ of Doppler signals of $0.75-0.80$ indicate a reduction in diastolic flow velocity\nCause:\n(a) intrinsic vascular obstruction\n\n1. Acute vascular rejection (later stage)\n2. Renal vein obstruction\n(b) increased intraparenchymal pressure\n3. Severe ATN\n4. Severe pyelonephritis:\n\nCMV, herpes, E. coli, C. albicans\n3. Extrarenal compression:\nlarge collection, hematoma, discordant size\n4. Urinary obstruction (doubted!)\n5. Excessive pressure by transducer\n\n## Gastrointestinal Problems with Renal Transplant\n\nPrevalence: $40 \\%$\n\n1. Gastrointestinal hemorrhage\n(a) upper GI tract bleeding:\ngastric erosions, gastric / duodenal ulcers\nMortality rate: $2-3 \\mathrm{x}$ of normal\n(b) lower GI tract bleeding:\nhemorrhoids, pseudomembranous colitis, cecal ulcers, colonic polyps\n2. GI tract perforation $(3 \\%)$\n\nCause: spontaneous, antacid impaction, perinephric abscess, diverticular disease\nLocation: colon $>$ small bowel $>$ gastroduodenal\nMortality rate: approaches $75 \\%$ (because of delayed Dx)\n\n## Hypertension with Renal Transplant\n\n$\\diamond$ Leading cause of death in renal transplant recipient!\nPrevalence: up to $60 \\% 1$ year after transplantation\nCause:\nA. TRANSPLANT RELATED\n\n1. Acute transplant rejection\n2. Chronic rejection\n3. Cyclosporine toxicity\n4. Ureteral obstruction\n5. Renal artery stenosis ( $1-5 \\%$ )\n(a) accelerated atherosclerosis\n(b) postsurgical fibrosis at anastomosis\nB. NOT TRANSPLANT RELATED\n6. Renin production of native kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 213,
            "markdown": "2. Original renal disease involving transplant\n3. Development of essential hypertension\n\n# Aseptic Necrosis with Renal Transplant \n\nMost common long-term disabling complication; femoral head most common site; bilateral in $59-80 \\%$\nFrequency: 6-15-29\\% within 3 years after surgery\nMean time of onset: 9-19 (range, 5-126) months after transplantation when symptoms develop\nRisk factors:\ndose + method of glucocorticoid administration, duration + quality of dialysis before transplantation, secondary hyperparathyroidism, allograft dysfunction, liver disease, previous transplantation, iron overload, increased protein catabolism during dialysis\nPathophysiology of corticosteroid therapy:\n(1) Fat embolism $\\rightarrow$ fat globules occlude subchondral end arteries\n(2) Increase in fat cell volume in closed marrow space $\\rightarrow \\uparrow$ intramedullary pressure $\\rightarrow$ diminished perfusion\n(3) Osteopenia $\\rightarrow$ increased bone fragility\n(4) Reduced sensibility to pain $\\rightarrow$ loss of protection against excessive stress\n\nHisto: fragmentation, compression, resorption of dead bone, proliferation of granulation tissue, revascularization, production of new bone\n\n- $40 \\%$ asymptomatic, joint pain, restriction of movement\n\nSites: femoral head, femoral condyles (lateral > medial condyle), humeral head\n$\\sqrt{ }$ subchondral bone resorption\n$\\sqrt{ }$ patchy osteosclerosis\n$\\sqrt{ }$ collapse / fragmentation of bone\nMR abbreviated T1WI protocol = test of choice!\n\n## RENAL TUBULAR ACIDOSIS\n\n$=$ clinical syndrome characterized by tubular insufficiency to resorb bicarbonate, excrete hydrogen ion, or both (= nonanion gap metabolic acidosis)\n\n- failure to thrive\n\n\n## Proximal Renal Tubular Acidosis\n\n$=$ TYPE 2 RTA\n$=$ impaired capacity to absorb HCO3 - in proximal tubule $\\rightarrow$ bicarbonate in urine at lower plasma levels than normal\nPathogenesis:\n? defect in $\\mathrm{Na}+/ \\mathrm{HCO} 3$ - cotransport at basolateral membrane; deficit of carbonic anhydrase; parathyroid hormone activates cyclic AMP $\\rightarrow$ inhibits carbonic anhydrase $\\rightarrow$ hypocalcemia of hyperparathyroidism + various types of Fanconi syndrome\n\n- self-limited acidosis ( $=$ bicarbonate loss stops once bicarbonate threshold of about 15 $\\mathrm{mEq} / \\mathrm{L}$ is reached)\n- unimpaired ability to lower urine $\\mathrm{pH}(\\mathrm{pH} 4.5-7.8$ depending on level of plasma bicarbonate) by normal excretion of $\\mathrm{H}+$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 214,
            "markdown": "- hypokalemia $\\leftarrow$ hyperaldosteronism $\\leftarrow$ decreased proximal resorption of NaCl\n$\\sqrt{ }$ rickets / osteomalacia\nN.B.: NEVER nephrocalcinosis / nephrolithiasis $\\leftarrow$ normal urinary citrate excretion, low urine pH , self-limited less severe acidosis with less calcium release from bone\n$D x$ : bicarbonate titration test, large requirement of alkali to sustain plasma bicarbonate level at $22 \\mathrm{mmol} / \\mathrm{L}$\n$R x$ : administration of alkali $\\pm$ potassium $\\pm$ hydrochloro-thiazide\n\n\n# Infantile Type of Primary Proximal RTA \n\nAge: diagnosed within first 18 months of life; usually male patient\n\n- excessive vomiting in early infancy\n- growth retardation ( $<3^{\\text {rd }}$ percentile)\n- metabolic hyperchloremic acidosis\n- normal quantities of net acid excretion\n\nPrognosis: transient type with spontaneous remission\n\n## Secondary Proximal RTA\n\n$=$ tubular defect of bicarbonate resorption associated with other tubular dysfunction/ generalized disease\nCause:\n) Fanconi syndrome, cystinosis, Lowe syndrome, hereditary fructose intolerance, glycogen storage disease, galactosemia, tyrosinemia, Wilson disease, Leigh syndrome\n$) 1^{\\circ}+2^{\\circ}$ hyperparathyroidism, vitamin D deficiency, mineralocorticoid deficiency, osteopetrosis\n> medullary cystic disease, renal transplantation, vascular accident to kidney in newborn period, multiple myeloma, amyloidosis, nephrotic syndrome, cyanotic CHD, SjÃ¶gren syndrome\n> intoxication with cadmium, outdated tetracycline, methylchromone, 6-mercaptopurine\n\n## Distal Renal Tubular Acidosis\n\n$=$ TYPE 1 RTA (first type discovered)\n$=$ impaired ability to secrete $\\mathrm{H}+$ in distal tubule despite low levels of plasma bicarbonate (urine cannot be acidified with pH invariably high at $>5.5-6.0$ )\nPathophysiology:\nprimary defect of nonacidification of urine followed by\n(a) hyperchloremia:\nsmall constant loss of serum sodium bicarbonate ( NaHCO 3 ) without concomitant loss of chloride ( $=\\mathrm{NaCl}$ retention) $\\rightarrow$ shrinkage of ECF volume\n(b) chronic severe + progressive acidosis ( $\\leftarrow$ inability to excrete the usual endogenously produced nonvolatile acid) leads to:\n> mobilization of calcium + phosphate from bone (osteomalacia)\n> growth retardation\n> hypercalciuria $\\rightarrow 2^{\\circ}$ hyperparathyroidism\n> loss of phosphate $\\rightarrow$ osteomalacia / rickets\n(c) nephrocalcinosis + nephrolithiasis $\\leftarrow$ combination of hypercalciuria + elevated urine",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 215,
            "markdown": "$\\mathrm{pH}+$ marked reduction in urinary citrate\n(d) potassium wastage with hyperkaliuria + hypokalemia $\\leftarrow$ constant small loss of sodium bicarbonate in urine, reduction of ECF space, $2^{\\circ}$ hyperaldosteronism, increase in sodium-potassium exchange in distal tubule\nPath: calcium deposits accompanied by chronic interstitial nephritis with cellular infiltration, tubular atrophy, glomerular sclerosis\n\n- muscle weakness, hyporeflexia, paralysis $\\leftarrow$ hypokalemia\n- bone pain $\\leftarrow$ osteomalacia\n- polyuria $\\leftarrow$ defect in urinary concentrating ability as a result of nephrocalcinosis + potassium deficiency\n- low plasma bicarbonate, hypokalemia, loss of sodium\n- hyperchloremic acidosis $\\leftarrow$ impaired ability to excrete the usual endogenous load of nonvolatile acid\n- alkaline urine $=$ urine $\\mathrm{pH}>5.0-5.5$\n- hypercalciuria $\\leftarrow$ continued mobilization of calcium + phosphate from bone $\\leftarrow$ metabolic acidosis\n- hypocitraturia $\\leftarrow$ increased proximal tubular reabsorption of citrate\n\nDx: acid load test with ammonium chloride (NH4Cl)\n$R s:$ administration of a mixture of sodium + potassium bicarbonate\nCx: interstitial nephritis, chronic renal failure (damage from nephrocalcinosis + secondary pyelonephritis), bone lesions, nephrocalcinosis, nephrolithiasis\n\n# Permanent Distal Renal Tubular Acidosis \n\n$=$ ADULT TYPE OF PRIMARY DISTAL RTA $=$ BUTLER-ALBRIGHT SYNDROME\nGenetics: mostly sporadic; may be autosomal dominant\nAge: children + adults (usually not diagnosed before age 2); $\\mathrm{F}>\\mathrm{M}$\n\n- vomiting, constipation, polyuria, dehydration\n- failure to thrive, growth retardation, anorexia\n- polyuria $\\leftarrow$ renal concentrating defect\n- potassium loss $\\rightarrow$ flaccid paralysis\n- bone pain + pathologic fractures in adolescents + adults $\\leftarrow$ osteomalacia\n- low serum pH , low bicarbonate concentration\n- elevation of chloride, urinary pH of 6.0-6.5\n$\\sqrt{ }$ rickets / osteomalacia\n$\\sqrt{ }$ moderately retarded bone age\n$\\sqrt{ }$ medullary nephrocalcinosis / nephrolithiasis (as early as 1 month of age)\n\n\n## Secondary Distal Renal Tubular Acidosis\n\n(a) systemic conditions:\n> starvation, malnutrition, sickle cell disease\n> primary hyperthyroidism + nephrocalcinosis, $1^{\\circ}$ hyperparathyroidism + nephrocalcinosis, vitamin D intoxication, idiopathic hypercalcemia, idiopathic hypercalciuria + nephrocalcinosis\n> amphotericin B nephropathy, toxicity to lithium, toluene sniffing\n> hepatic cirrhosis, fructose intolerance with nephrocalcinosis, Ehlers-Danlos",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 216,
            "markdown": "syndrome, Marfan syndrome, elliptocytosis\n(b) renal conditions: renal tubular necrosis, renal transplantation, medullary sponge kidney, obstructive uropathy\n(c) hypergammaglobulinemic states (? autoimmune process): idiopathic hypergammaglobulinemia, chronic active hepatitis, hyperglobulinemic purpura, SjÃ¶gren syndrome, cryoglobulinemia, systemic lupus erythematosus, lupoid hepatitis, fibrosing alveolitis\n\n# Transient Distal Renal Acidosis \n\n$=$ INFANTILE TYPE OF PRIMARY DISTAL RTA\n$=$ LIGHTWOOD SYNDROME $=$ SALT-LOSING NEPHRITIS\n$=$ transient self-limited form of infancy (only observed within $1^{\\text {st }}$ year of life) with unclear pathophysiology, probably due to vitamin D intoxication\n\n- NO nephrocalcinosis\n\n\n## RENAL VEIN THROMBOSIS\n\nPrevalence: $0.5 \\%$ (autopsy)\nCause:\nA. Intrinsic\n$=$ thrombotic process begins intrarenally within small intrarenal veins $\\leftarrow$ acidosis, hemoconcentration, disseminated intravascular coagulation, intrarenal arteriolar constriction reducing venous flow\n(a) antenatally: abruptio placentae\n(b) neonates (most common): advanced maternal age, glycosuria in infants of diabetic mothers, dehydration from vomiting, diarrhea, enterocolitis, sepsis, polycythemia, birth trauma, left adrenal hemorrhage, prematurity\n(c) adults: pyelonephritis, amyloidosis, polyarteritis nodosa, sickle cell anemia, thrombosis of IVC, low flow states (CHF, constrictive pericarditis), diabetic nephropathy, sarcoidosis\n> hypercoagulable state:\nÂ» nephrotic syndrome: membranous + membrano-proliferative glomerulonephritis (most common), lupoid nephrosis\nÂ» SLE\nÂ» inherited hypercoagulable state: deficiency of antithrombin III / protein C / protein S\n> mechanical process:\nÂ» trauma\nÂ» neoplasm: renal neoplasia ( $50 \\%$ : RCC, TCC, Wilms tumor), left adrenal carcinoma\nÂ» abscess\nÂ» aneurysm\n> left ovarian vein thrombosis\nB. Extrinsic umbilical vein catheterization, thrombosis of IVC with extension into renal vein, malpositioned IVC filter, carcinoma of pancreatic tail invading renal vein (in 75\\%), pancreatitis, lymphoma, retroperitoneal sarcoma, retroperitoneal fibrosis, metastases to",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 217,
            "markdown": "retroperitoneum (bronchogenic carcinoma)\nmnemonic: TEST MAN\nThrombophlebitis\nEnterocolitis (dehydration)\nSickle cell disease, Systemic lupus erythematosus\nTrauma\nMembranous glomerulonephritis\nAmyloidosis\nNeoplasm\nRadiographic appearance varies with:\n(1) Rapidity of venous occlusion\n(2) Extent of occlusion\n(3) Availability of collateral circulation\n(4) Site of occlusion in relation to collateral pathways\n\nPathophysiology: formation of collateral channels develops at 24 hours + peaks at 2 weeks after onset of occlusion\nCollaterals: ureteral vein to vesicular veins, pericapsular veins to lumbar veins, azygos vein, portal vein\non left (in addition): gonadal vein, adrenal vein, inferior phrenic veins\n\n# Acute Renal Vein Thrombosis \n\nPath: hemorrhagic renal infarction + edema from ruptured venules + capillaries without time for effective development of collaterals\n\n- gross hematuria, proteinuria, anuria, hypertension, azotemia\n- asymptomatic / painful flank mass\n- consumptive thrombocytopenia\n\nLocation: more common on left (longer left renal vein)\n$\\sqrt{ }$ focal hemorrhagic infarction + capsular rupture\n$\\sqrt{ }$ smooth enlargement of kidney $\\leftarrow$ edema + hemorrhage\nIVP:\n$\\sqrt{ }$ initially faint + delayed dense nephrogram\n$\\sqrt{ }$ range of completely normal to pyelocaliceal nonvisualization\nUS:\n$\\sqrt{ }$ focal / generalized areas of increased echogenicity $\\leftarrow$ hemorrhage / edema\n$\\sqrt{ }$ loss of corticomedullary differentiation\n$\\sqrt{ }$ thrombus within distended renal vein / IVC\nDoppler-US:\n$\\sqrt{ }$ venous flow present in segmental veins + collateral veins overlying renal hilum mimicking patency of main renal v.\n$\\sqrt{ }$ steady / less pulsatile venous flow compared with contralateral main renal vein\n$\\sqrt{ }$ main renal vein not traceable into IVC on color Doppler\n$\\sqrt{ }$ elevated resistive index $>0.70 \\pm$ reversed end-diastolic renal arterial flow in native kidney\nCT:\n$\\sqrt{ }$ prolonged cortical nephrographic phase with coarse striations + persistent",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 218,
            "markdown": "corticomedullary differentiation\n$\\checkmark$ edema in renal sinus + perinephric space\n$\\checkmark$ thickened renal fascia + perirenal stranding\n$\\checkmark$ development of collateral venous vessels\n$\\checkmark$ retroperitoneal hemorrhage\nMR:\n$\\checkmark$ high signal intensity on T1WI + T2WI\nAngio:\n$\\checkmark$ poorly filling cortical arteries\n$\\checkmark$ absent inflow from renal vein into IVC\n$\\checkmark$ thrombus extending into IVC\nNUC:\n$\\checkmark$ no characteristic pattern on sequential functional study\n$\\checkmark$ markedly decreased / absent perfusion\n$\\checkmark$ delayed radiotracer uptake + excretion\n$\\checkmark$ retention of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ mertiatide\n$D D x$ : acute renal artery occlusion; chronically nonfunctioning kidney\nCx: (1) Pulmonary emboli (50\\%)\n(2) Severe renal atrophy (may show complete recovery)\n\n# Subacute Renal Vein Thrombosis \n\n$=$ good collateral drainage; impaired function with steady state or recanalization\n$\\checkmark$ enlarged edematous boggy kidney\n$\\checkmark$ slightly diminished / normal nephrographic density (may increase over time)\n$\\checkmark$ compression of collecting system (\"spidery calices\")\n$\\checkmark$ hypoechoic large kidney\n$\\checkmark$ collateral veins allow venous efflux $\\rightarrow$ normalizing arterial waveform\n$\\checkmark$ main renal vein appears small $\\leftarrow$ recanalization\n\n## Chronic Renal Vein Thrombosis\n\n$=$ indolent stage\n\n- $80-90 \\%$ asymptomatic\n- nephrotic syndrome (= proteinuria, hypercholesterolemia, anasarca)\n$\\checkmark$ normal excretory urogram in $25 \\%$ (with good collateral circulation especially if left side affected)\n$\\checkmark$ notching of collecting system + proximal ureter\n$\\checkmark$ retroperitoneal dilated collaterals\n$\\checkmark$ lacelike intrarenal pattern of calcifications\nUS:\n$\\checkmark$ branching linear calcifications (calcified thrombus)\n$\\checkmark$ small atrophic echogenic kidney\nCT:\n$\\checkmark$ attenuated renal vein $\\leftarrow$ retraction of blood clot + IVC thrombus (24\\%)\n$\\checkmark$ collaterals along proximal + middle ureter + perirenal\n$\\checkmark$ prolonged corticomedullary differentiation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 219,
            "markdown": "$\\sqrt{ }$ delayed / absent pyelocaliceal opacification + attenuated collecting system\n$\\sqrt{ }$ thickening of Gerota fascia\nArteriography:\n$\\sqrt{ }$ enlarged venous collaterals on delayed images\n\n# RENOMEDULLARY INTERSTITIAL CELL TUMOR \n\n$=$ MEDULLARY FIBROMA\n$=$ rare benign often incidental mesenchymal neoplasm of kidney\nFrequency: $50 \\%$ of autopsies in adults\nOrigin: interstitial cells of medulla\nHisto: stellate spindle cells on basophilic stroma\nSize: $<5 \\mathrm{~mm}$ (most)\n\n- asymptomatic, (rarely) flank pain and hematuria\n\nLocation: renal pyramid\n$\\sqrt{ }$ small nonenhancing noncalcified hypoattenuating solid mass\n$\\sqrt{ }$ hypointense on T1WI + T2WI ( $\\leftarrow$ rich collagen content)\n\n## RETROCAVAL URETER\n\n$=$ CIRCUMCAVAL URETER\nEtiology: abnormality in embryogenesis of IVC with persistence of right posterior cardinal vein ventral to ureter + failure of right supracardinal system to develop\nPrevalence: $0.07 \\% ; \\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\n\n- symptoms of right ureteral obstruction\n$\\sqrt{ }$ proximal right ureter swings medially over pedicle of L3-4, passes behind IVC, and emerges to right of aorta $\\rightarrow$ returns to its normal position anterior to iliac vessels\n$\\sqrt{ }$ varying degrees of hydronephrosis + proximal hydrouretero-nephrosis\n$C x$ : recurrent urinary tract infections\n\n\n## RETROPERITONEAL FAT NECROSIS\n\nCause: fat saponification $\\leftarrow$ autodigestion of pancreatic parenchyma + peripancreatic fat $\\leftarrow$ release of lipolytic enzymes $\\leftarrow$ pancreatitis\nPathophysiology:\nphospholipases + proteases attack plasma membranes of fat cells $\\rightarrow$ release and\nhydrolyzation of triglycerides $\\rightarrow$ production of free fatty acids $\\rightarrow$ combining with serum\ncalcium $\\rightarrow$ precipitate as calcium soap\n\n- hypocalcemia (associated with severe pancreatitis)\n$\\sqrt{ }$ scattered nodules of fat necrosis throughout retroperitoneum + abdominal cavity:\n$\\sqrt{ }$ mass effect + delayed contrast enhancement\n$D D x$ : peritoneal carcinomatosis\n\n\n## RETROPERITONEAL FIBROSIS\n\n$=\\mathrm{RPF}=$ ORMOND DISEASE $=$ CHRONIC PERIAORTITIS $=$ PERIURETERITIS FIBROSA $=$ GEROTA FASCIITIS $=$ SCLEROSING RETROPERITONEAL GRANULOMA\n[John Kelso Ormond (1886-1978), surgeon-in-chief of urology division at Henry Ford Hospital,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 220,
            "markdown": "Detroit]\n$=$ uncommon collagen vascular disease of unknown cause characterized by aggressive confluent fibroproliferative masses in retroperitoneal space leading to progressive encasement of retroperitoneal structures, especially ureters\n\n# Pathogenesis: \n\n(a) probably autoimmune disease with antibodies to insoluble ceroid + oxidized low-density lipoproteins (by-products of aortic plaque, which has penetrated locally into media) leading to systemic vasculitis\n(b) systemic autoimmune / inflammatory disease frequently associated with systemic lupus erythematosus, ankylosing spondylitis, Wegener granulomatosis, antineutrophil cytoplasmic antibody (ANCA)-positive rapidly progressive glomerulonephritis, primary biliary cirrhosis\n(c) immunoglobulin G4 (IgG4)-related disease (= multifocal fibrosclerosis)\n\n## Classification:\n\nA. Primary / idiopathic retroperitoneal fibrosis ( $2 / 3$ )\n\nWith idiopathic RPF the fibroinflammatory tissue entraps both ureters in most cases causing obstructive uropathy (in $56-100 \\%$ ) and subsequent renal failure. Some patients present late with nonfunctioning kidneys.\nB. Secondary retroperitoneal fibrosis ( $1 / 3$ )\n(1) Drugs ( $12 \\%$ ): derivatives of ergot alkaloids (methysergide, ergotamine, lysergic acid diethylamide [LSD]), beta-blocker, phenacetin, hydralazine, methyldopa, amphetamines\n(2) Malignancy (in up to $8 \\%$ ): desmoplastic response to: lymphoma, Hodgkin disease, carcinoid, retroperitoneal metastases (breast, lung, thyroid, GI tract, GU organs)\n\n- positive tumor markers\n$\\checkmark$ anterior displacement of aorta + IVC\n$\\checkmark$ nodularity of retroperitoneal mass\n$\\checkmark$ hyperintense SI on T2WI\n(3) Infection = desmoplastic response to: histoplasmosis, tuberculosis, actinomycosis\n(4) Retroperitoneal fluid collection / hematoma / urine extravasation: $\\leftarrow$ major trauma, major surgery\n(5) Aneurysm of aorta / iliac arteries: desmoplastic response to chronic periaortitis\n(6) Connective tissue disease: eg, polyarteritis nodosa\n(7) Radiation therapy: fibrosis limited to radiation field\n\nPrevalence: $1.3 \\div 100,000$ to $1 \\div 200,000$\nPeak age: $40-65$ years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$ to $3 \\div 1$\nPath: hard retroperitoneal plaque with ill-defined margins enveloping abdominal aorta, iliac vessels, IVC, ureters\nHisto:\n(a) early: immature fibrotic process with capillary proliferation + diffuse perivascular infiltrate of T and B lymphocytes, plasma cells + fibroblasts in loose matrix of collagen fibers\n(b) later: mature plaque composed of relatively acellular and avascular hyalinized collagen + scattered calcifications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 221,
            "markdown": "May be associated with: asbestos exposure\n\n- weight loss, nausea, malaise, anorexia, low-grade fever\n- dull pain in costovertebral angle, back, abdomen ( $90 \\%$ )\n- obstructive uropathy $\\rightarrow$ oliguria $\\rightarrow$ anuria $\\rightarrow$ renal insufficiency ( $50-60 \\%$ )\n- renal vessel involvement ( $2-35 \\%$ ) $\\rightarrow$ hypertension $\\rightarrow$ renal insufficiency\n- lymphatic + venous obstruction $\\rightarrow$ lower extremity edema, deep vein thrombosis (6\\%), hydrocele ( $10 \\%$ ), scrotal swelling, varicocele\n- compression of arteries $\\rightarrow$ bowel ischemia, claudication (occasionally)\n- high erythrocyte sedimentation rate (ESR), anemia\n- high levels of C-reactive protein ( $80-100 \\%$ )\n- tests for antinuclear antibodies may be positive\n\nLocation: plaque typically begins around aortic bifurcation (L4-5) extending cephalad to renal hilum / surrounding kidney, duodenum, pancreas and spleen; rarely extends below pelvic rim, but may extend caudad to bladder + rectosigmoid\n\nRetroperitoneal fibrosis most commonly surrounds the infrarenal abdominal aorta and proximal common iliac arteries.\n$\\sqrt{ }$ tethering of aorta / IVC to vertebrae without anterior displacement\n$\\checkmark$ usually mild uni- / bilateral pyelocaliectasis $\\rightarrow$ hydronephrosis $\\rightarrow$ renal failure ( $56-100 \\%$ )\n$\\diamond$ Diagnostic clue: incongruity between severe degree of renal failure + mild degree of hydronephrosis!\nIVP / retrograde pyelography:\n$\\checkmark$ Classic TRIAD:\n(1) Ureterectasis above L4-5 $\\leftarrow$ interference with peristalsis\n(2) Medial deviation of ureters in middle third, typically bilateral = maiden waist deformity\n(3) Gradual tapering of ureters at lower lumbar spine / upper sacral region $\\leftarrow$ extrinsic compression\n$D D x$ : primary ureteral tumor, periureteral lymph nodes, inflammatory ureteral stricture US (poor sensitivity):\n$\\checkmark$ hypo- / isoechoic well-demarcated irregularly contoured homogeneous mass with smooth margins anterior to lower lumbar spine / sacral promontory\n$\\checkmark$ varying degrees of uni- / bilateral hydronephrosis\n$\\checkmark$ NO flow on Doppler imaging\nCT:\n$\\checkmark$ well-delimited irregular periaortic rindlike layer of soft tissue isoattenuating to muscle\n$\\checkmark$ contrast enhancement (during active inflammation of immature plaque)\n$\\checkmark$ localized reactive infracentimetric lymphadenopathy ( $25 \\%$ )\n$\\checkmark$ NO aortic displacement (!)\nCT / MR allow comprehensive evaluation of morphology, location and extent of RPF + involvement of adjacent organs and vascular structures. They may detect diseases often associated with idiopathic RPF (eg, autoimmune pancreatitis) or an underlying cause of secondary RPF (eg, malignancy).\nMR:\n$\\diamond$ In impaired renal function use HASTE + RARE urography",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 222,
            "markdown": "$\\sqrt{ }$ low to medium homogeneous signal intensity on T1WI\n$\\sqrt{ }$ T2WI:\n(a) acute phase $\\rightarrow$ inflammatory edema\n$\\sqrt{ }$ heterogeneous high SI on T2WI (DDx: malignancy)\n$\\sqrt{ }$ early soft-tissue enhancement mirrors degree of inflammatory activity\n(b) chronic phase $\\rightarrow$ dense fibrotic plaque\n$\\sqrt{ }$ low SI on T2WI\n$\\sqrt{ }$ little / NO enhancement during venous phase\n$\\sqrt{ }$ delayed enhancement\nNUC:\n$\\sqrt{ } 67 \\mathrm{Ga}$-citrate uptake during active inflammation\n$\\sqrt{ }$ little / NO gallium uptake in chronic fibrotic stage\nPET:\n$\\sqrt{ }$ increased uptake of FDG paralleling degree of activity\n$\\sqrt{ }$ may detect remote disease (multifocal fibrosclerosis, infectious / neoplastic disease, other autoimmune process)\n${ }^{18} \\mathrm{~F}$-FDG PET is the most sensitive modality for\n(a) assessing metabolic activity of residual masses,\n(b) demonstrating relapse.\n$D x$ : open surgical / laparoscopic biopsy preferred for differentiation of benign from malignant disease\n\nHistologic evaluation of biopsy tissue is mandatory to establish a definitive diagnosis if there are (a) findings suggestive of underlying malignancy or infection; (b) atypical location of the retroperitoneal mass (eg, pelvic, peripancreatic, perirenal); (c) progression of the mass or absence of response to immunosuppressive therapy.\nPrognosis: chronic relapsing course\nThe most important challenge is to differentiate benign from malignant RPF because benign forms of RPF have a good outcome, whereas RPF secondary to malignancy has a poor prognosis.\n$D D x$ : (1) Perianeurysmal fibrosis (dilated encased aorta)\n(2) Malignant retroperitoneal fibrosis / sarcoma (mass with irregular lobular / nodular margins, more cephalad location, anterior displacement of aorta, edema, Doppler flow, contrast enhancement)\n(3) Retroperitoneal lymphadenopathy, lymphoma (anterior elevation of aorta / IVC off vertebral body)\n(4) Primary amyloidosis\n(5) Subacute retroperitoneal hematoma\n$R x$ : (1) Withdrawal of possible causative agent\n(2) Interventional relief of urinary obstruction\n(3) Corticosteroids / immunotherapeutic drugs\n(4) Disease-modifying antirheumatic drugs, tamoxifen\n(5) Ureterolysis for refractory cases",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 223,
            "markdown": "# RETROPERITONEAL LEIOMYOSARCOMA \n\nFrequency: $2^{\\text {nd }}$ most common ( $28 \\%$ ) primary retroperitoneal malignancy (after liposarcoma)\nPath: necrosis + cystic degeneration + hemorrhage in large tumor; calcifications uncommon Age: $5^{\\text {th }}-6^{\\text {th }}$ decade; $\\mathrm{M} \\circ \\mathrm{F}=1 \\circ 6$\n\n- abdominal mass, pain, weight loss, nausea, vomiting\n- abdominal distension, change in defecation habits, leg edema, back / radicular pain, frequency of urination\n- hemoperitoneum, GI bleeding, dystocia, paraplegia\n\nSite:\n(a) retroperitoneal space without attachment to organs\n(b) wall of inferior vena cava (in $6 \\%$ of leiomyosarcomas)\n\nSize: average diameter $>10 \\mathrm{~cm}$\nMetastases:\nfrequently hematogenous, less commonly lymphatic dissemination\n(a) common sites: liver, lung, brain, peritoneum\n(b) rare sites: skin, soft tissue, bone, kidney, omentum\n$\\diamond$ Distant metastases present at time of diagnosis in $40 \\%$\n$D x$ : extensive necrosis in a retroperitoneal mass with contiguous involvement of a vessel!\n$D D x$ : (1) Liposarcoma (fat content)\n(2) Malignant fibrous histiocytoma (not as necrotic)\n(3) Lymphoma (nonnecrotic, tends to envelop IVC + aorta)\n(4) Primary adrenal tumor\n(5) Bland IVC thrombus (NO enhancement / luminal enlargement)\n$R x$ : (1) Complete excision (resectable in $10-75 \\%$ )\n(2) Partial resection (reduction in tumor size)\n(3) Adjuvant chemotherapy / radiotherapy\n\nPrognosis: local recurrence in $40-70 \\%$; death within 5 years in $80-87 \\%$ with extraluminal tumors\n\n## Extravascular Leiomyosarcoma (62\\%)\n\nPath: extraluminal (= completely extravascular) large tumor with extensive necrosis IVP:\n$\\sqrt{ }$ large soft-tissue mass with displacement of\n(a) kidney + ureter\n(b) gas-containing ascending / descending colon\n$\\sqrt{ }$ well-defined fat plane between mass and kidney\n$\\sqrt{ }$ obstruction of kidney (ureteral involvement)\n$\\sqrt{ }$ usually not calcified\nUS:\n$\\sqrt{ }$ solid mass isoechoic to liver / rarely hyperechoic\n$\\sqrt{ }$ complex mass with cystic spaces + irregular walls\nCT:\n$\\sqrt{ }$ lobulated mass often $>10 \\mathrm{~cm}$ in size",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 224,
            "markdown": "$\\sqrt{ }$ large cystic areas of tumor necrosis in center of mass\n$\\sqrt{ }$ areas of high attenuation $\\pm$ fluid-debris level with recent hemorrhage\n$\\sqrt{ }$ homogeneously solid with small tumor\nMR:\n$\\sqrt{ }$ intermediate intensity on T1WI with low-intensity areas of necrosis\n$\\sqrt{ }$ inhomogeneous intermediate to high SI on T2WI $\\leftarrow$ high water content of cystic areas\n$\\sqrt{ } \\pm$ fluid-debris level $\\leftarrow$ hemorrhage\nAngio:\n$\\sqrt{ }$ hypervascular tumor with blood supply from lumbar, celiac, mesenteric, renal arteries\n$\\sqrt{ }$ avascular center surrounded by thick hypervascular rind\n\n# Intravascular Leiomyosarcoma (5\\%) \n\nPath: intraluminal (= completely intravascular) polypoid mass firmly attached to vessel wall\nLocation: between diaphragm + renal veins, may extend along entire length of IVC + into heart\n$\\sqrt{ }$ small solid mass within IVC\n$\\sqrt{ }$ gradual expansion / obstruction of IVC\n$\\sqrt{ }$ intratumoral vascularity confirmed by Doppler\n$\\sqrt{ }$ irregular enhancement (CT bolus injection)\nCx: (1) Budd-Chiari syndrome (intrahepatic segment of IVC)\n(2) Nephrotic syndrome $\\leftarrow$ IVC segment involved between hepatic + renal veins\n(3) Edema of lower extremities $\\leftarrow$ IVC segment below renal veins without adequate collateralization\n(4) Tumor embolus to lung\n\nPrognosis: better for middle segment of IVC (between hepatic + renal veins) than other segments\n\n## Extra- \\& Intravascular Leiomyosarcoma (33\\%)\n\n$\\sqrt{ }$ solid / necrotic extraluminal mass not originating from a retroperitoneal organ with contiguous intravascular enhancing component (PATHOGNOMONIC)\n\n## Intramural Leiomyosarcoma (extremely rare)\n\n## RETROPERITONEAL LIPOSARCOMA\n\n$=$ slow-growing tumor that displaces rather than infiltrates surrounding tissue and rarely metastasizes\nFrequency: most common (33\\%) of primary malignant retroperitoneal sarcomas; $95 \\%$ of all fatty retroperitoneal tumors\nHisto:\n> biologically least aggressive\n(a) well-differentiated lipogenic type (most common):\n$\\sqrt{ }$ radiodensity of fat\n> biologically intermediate aggressiveness\n(b) myxoid type (more common in younger population):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 225,
            "markdown": "$\\checkmark$ radiodensity between water + muscle\n$\\checkmark$ solid appearance on US\n> biologically highly aggressive\n$\\checkmark$ radiodensity of muscle for (c), (d), (e)\n(c) round cell type\n(d) pleomorphic type (least common)\n(e) dedifferentiated $(10-15 \\%) \\leftarrow$ long latent period\n\nAge: most commonly $50-70$ years; $\\mathrm{M}=\\mathrm{F}$\n\n- abdominal pain, weight loss, anemia, palpable mass\n\nSite: anterior to spine + psoas muscle $>$ paraspinal + posterior pararenal space\nSize: average diameter $>20 \\mathrm{~cm}$\nCT:\n$\\checkmark$ solid pattern: inhomogeneous poorly marginated infiltrating mass with contrast enhancement\n$\\checkmark$ mixed pattern: focal fatty areas ( -40 to -20 HU ) + areas of higher density ( +20 HU )\n$\\checkmark$ pseudocystic pattern: water-density mass $\\leftarrow$ averaging of fatty + solid connective-tissue elements\n$\\checkmark$ calcifications in up to $12 \\%$ (= important sign of dedifferentiation of an initially welldifferentiated type)\n$\\diamond$ Recurrent tumors have higher attenuation values than fat!\nMR:\n$\\checkmark$ hyperintense on T1WI\n$\\checkmark$ intermediate SI on T2WI; more hyperintense for myxoid type $\\leftarrow$ mucopolysaccharide content\n$\\checkmark$ loss of fat signal intensity on fat-suppressed sequence\n$\\checkmark$ enhancing thick irregular nodular septa\nAngio:\n$\\checkmark$ hypovascular without vessel dilatation / capillary staining / laking\nPrognosis: local recurrence in $90 \\%$; most radiosensitive of soft-tissue sarcomas; $32 \\%$ overall 5 -year survival\n$D D x$ : malignant fibrous histiocytoma, leiomyosarcoma, desmoid tumor, encapsulated fat necrosis\n\n# RETROPERITONEAL LYMPHANGIOMA \n\n## Lymphangioma of Adrenal Gland\n\n$=$ exceedingly rare tumor usually discovered incidentally\nPrevalence: $0.06 \\%$\nAge: any; peaks during $3^{\\text {rd }}-6^{\\text {th }}$ decade of life\nCT:\n$\\checkmark$ thin-walled multilocular cystic lesion near fluid attenuation\n$\\checkmark$ thin septa WITHOUT internal enhancement\nMR:\n$\\checkmark$ decreased SI on T1WI + increased intensity on T2WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 226,
            "markdown": "$D D x$ : adrenal cyst, hemangioma, cystic pheochromocytoma, schwannoma with cystic degeneration\n\n# Lymphangioma of Kidney \n\n$=$ RENALLYMPHANGIECTASIA/LYMPHANGIOMATOSIS\nFrequency: rare benign renal tumor ( 50 cases in literature)\nOrigin: developmental anomaly of perirenal lymphatic system / true neoplasm (monosomy, trisomy 7 q , defect in vHL gene)\nPath: (a) well-encapsulated unilateral mass\n(b) bilateral multilocular cystic mass with clear fluid\n\nHisto: multiple communicating cysts lined by flattened endothelial cells; multiple septa containing entrapped renal tubules, lymphoid cells, smooth muscle elements\nAge: adulthood $\\left(2 / 3\\right) ; \\mathrm{M}+\\mathrm{F}=1 \\div 1$\n\n- mostly asymptomatic, flank pain, abdominal mass, hematuria\n\nLocation: renal sinus, perinephric region; (commonly) bilateral\n$\\sqrt{ }$ uni- / multilocular cystic mass\nMR:\n$\\checkmark$ hypointense on T1WI + uniformly hyperintense on T2WI\n$\\checkmark$ variable SI of intracystic fluid (depending on presence of hemorrhage / debris / protein content)\nPrognosis: spontaneous regression (occasionally)\n\n## Decompensated Lymphangiectasia\n\n$=$ exacerbation during pregnancy\n\n- hypertension, flank pain\n$\\checkmark$ increasing perinephric collection, ascites\n\n\n## RETROPERITONEAL LYMPHOMA\n\nFrequency: most common retroperitoneal malignancy\nHisto: Hodgkin disease / NHL\nA. PRIMARY lymphoma $=$ confined to single organ\n\n+ immediately adjacent lymph nodes\nB. SECONDARY lymphoma (more common)\n\nLocation: bilateral in $50 \\%$\nUS:\n$\\checkmark$ heterogeneous predominantly hypoechoic mass $\\leftarrow$ varying degrees of hemorrhage and necrosis\nCT:\n$\\checkmark$ well-defined homogeneous hypoattenuating mass spreading between normal structures without compressing them:\n$\\checkmark$ mass enveloping normal constituents of renal sinus\n$\\checkmark$ often contiguous spread into perinephric space\n$\\checkmark \\pm$ anterior displacement of IVC and aorta (\"floating aorta\")\n$\\checkmark$ rarely calcified + necrotic prior to therapy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 227,
            "markdown": "CECT:\n$\\checkmark$ mild to moderate homogeneous contrast enhancement\n$\\checkmark$ slow washout on delayed images\nMR:\n$\\checkmark$ isointense to muscle on T1WI\n$\\checkmark$ iso- to hyperintense on T2WI\n$\\checkmark$ moderate homogeneous / patchy enhancement\nCx: obstruction of ureters + IVC\n\n# Hodgkin Disease \n\nAge: bimodal distribution in 20s and 60s\nExtent: limited disease involving mediastinum + spleen\n$\\checkmark$ enlarged paraaortic lymph nodes in $25 \\%$\n\n## Non-Hodgkin Lymphoma\n\nAge: $\\quad 40-70$ years\nExtent: commonly extranodal disease in liver, spleen, bowel at an advanced stage\n$\\checkmark$ retroperitoneal mass in $14 \\%$\n$\\checkmark$ enlarged paraaortic lymph nodes in $55 \\%$\n$\\checkmark$ mesenteric lymphadenopathy (frequent)\n\n## Posttherapy Lymphoma\n\nPath: soft-tissue masses persist as fibrosis\nMR:\n$\\checkmark$ low signal intensity on T2WI + minimal enhancement\nFDG-PET:\n$\\checkmark$ no uptake in fibrosis\n$\\checkmark$ hypermetabolic activity in viable tumor\n\n## RETROPERITONEAL ONCOCYTOMA\n\n## Oncocytoma of Adrenal Gland\n\n$=$ ONCOCYTIC ADRENOCORTICAL ADENOMA/NEOPLASM\nMedian age: 46 years; $\\mathrm{M}+\\mathrm{F}=1 \\div 1.8$\nHisto: abundant deeply eosinophilic (mitochondria-rich) cells; positive for vimentin, melan A, inhibin- $\\alpha$, calretinin; $\\pm$ immunoreactive for synaptophysin + mitochondrial antigen $\\mathrm{MTCO}_{2}$; variably positive for CK8, CK18, CD10\nLocation: $\\mathrm{L}+\\mathrm{R}=1.5 \\div 1$\nMean size: 9 cm\n\n- asymptomatic $(70 \\%)$\n- symptomatic ( $30 \\%$ ) due to steroid production $\\rightarrow$ Cushing syndrome, virilization, feminization\n$\\checkmark$ well-marginated often large mass with heterogeneous enhancement of nonspecific appearance\nCx: malignant transformation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 228,
            "markdown": "# Oncocytoma of Kidney \n\n$=$ PROXIMAL TUBULAR ADENOMA = BENIGN OXYPHILIC ADENOMA\n$=$ rare form of a benign hypervascular adenoma\nPrevalence: $3-7 \\%$ of solid renal masses\nMedian age: 65 (range, 26-94) years; $\\mathrm{M} \\div \\mathrm{F}=1.6 \\div 1$ to $2.5 \\div 1$\nPath: well-encapsulated tan-colored tumor of well-differentiated proximal tubular cells + oncocytes\nHisto: oncocytes = large uniformly round epithelial cells with granular oxyphilic / eosinophilic cytoplasm $\\leftarrow$ large number of mitochondria; no clear cytoplasm; similar to oncocytic tumors seen in thyroid, parathyroid, salivary glands, adrenals\nLocation: rarely multicentric / bilateral / metachronous\n\n- majority asymptomatic, occasionally hypertension\n\nTumor size: $6.0-7.5$ (range, $0.1-26.0) \\mathrm{cm}$\n$\\sqrt{ }$ renal mass of homogeneously low attenuation / hypoechogenicity (in $>50 \\%$ )\n$\\checkmark$ well-demarcated with pseudocapsule\n$\\checkmark$ central stellate scar in $30 \\%$ (in lesions $>3 \\mathrm{~cm}$ in diameter $\\leftarrow$ organization of central infarction + hemorrhage after tumor growth has outstripped blood supply)\n$\\checkmark$ invasion of renal capsule / renal vein in large tumors\nMR:\n$\\checkmark$ typically spherical well-defined mass\n$\\checkmark$ hypointense relative to renal parenchyma on T1WI (70\\%)\n$\\checkmark$ hyperintense relative to renal parenchyma on T2WI (67\\%)\n$\\checkmark$ prominent enhancement of mass\n$\\checkmark$ central stellate scar:\n$\\checkmark$ hypointense on T1WI + hyperintense on T2WI\n$\\checkmark$ less enhancement than remainder of mass\n$\\checkmark$ scar may show delayed enhancement\n$\\checkmark$ nonspecific well-defined hypointense capsule (in $<50 \\%$ )\nAngio:\n$\\checkmark$ spoke-wheel configuration in $80 \\%$ (DDx: renal cell ca.)\n$\\checkmark$ homogeneously dense parenchymal phase ( $71 \\%$ )\n$\\checkmark$ NO contrast puddling / arteriovenous shunting / renal vein invasion\nNUC:\n$\\checkmark$ photopenic area on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA $\\leftarrow$ tubular cells do not function normally\n$D x$ : percutaneous needle biopsy unreliable\n$\\diamond$ Pathologic diagnosis requires entire tumor because a well-differentiated renal cell carcinoma may have oncocytic features!\n$R x$ : local resection / heminephrectomy\nPrognosis: death from malignancy following surgery (3\\%)\n\n## RETROPERITONEAL PARAGANGLIOMA\n\n$=$ EXTRAADRENAL PHEOCHROMOCYTOMA\nLocation: anywhere in sympathetic nervous system from neck to sacrum; subdiaphragmatic in $98 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 229,
            "markdown": "(a) adrenal medulla $(85-90 \\%)=$ pheochromocytoma\n(b) extraadrenal ( $10-15 \\%$ in adults, $31 \\%$ in children)\n$=$ paraganglioma:\n) diaphragm to lower poles of kidney $50 \\%$\n> lower poles of kidney to bifurcation $30 \\%$\nÂ» organ of Zuckerkandl at origin of inferior mesenteric artery 2-5\\%\n$>$ pelvis $10 \\%$\nÂ» gonads, urinary bladder $1 \\%$\n$>$ thorax $10 \\%$\nadherent to / involving LA\nMultiplicity: $10 \\%$ in nonfamilial adult cases\n$32 \\%$ in nonfamilial childhood cases\n$65 \\%$ in familial syndromes\n$\\sqrt{ }$ well-defined hypervascular mass in pelvic retroperitoneum along course of common iliac vessels\nCT ( $90 \\%$ sensitive):\n$\\checkmark$ large well-defined lobular tumor\n$\\checkmark$ fluid-fluid level $\\leftarrow$ hemorrhage + necrosis\n$\\checkmark$ punctate calcifications (in $15 \\%$ )\n$\\checkmark$ intense contrast enhancement\nMRI ( $90 \\%$ sensitive):\n$\\checkmark$ signal voids on T1WI\n$\\checkmark$ \"lightbulb\" high SI (unusual) with superimposed variable heterogeneous SI ( $\\leftarrow$ hemorrhage) on T2WI\nNUC:\n$\\checkmark$ high uptake of m-iodobenzylguanidine (MIBG) with ${ }^{123} \\mathrm{I} /{ }^{131} \\mathrm{I}$ (77-95\\% sensitive, 95$100 \\%$ specific)\n$\\sqrt{ }^{111}$ In-pentetreotide scintigraphy (up to $94 \\%$ sensitive) for lesions $>1.5 \\mathrm{~cm}$\nPET:\n$\\sqrt{ }$ 18F-fluorodihydroxyphenylalanine ( $98 \\%$ sensitive, up to $100 \\%$ specific), especially for predominantly noradrenaline-secreting and hereditary types\nCave: Percutaneous biopsy of a hypervascular retroperitoneal mass without adequate laboratory evaluation and prebiopsy preparation (like pharmacologic blockade) must be avoided, since it can result in hypertensive crisis or even death.\n$C x$ : (1) Malignancy: $30-40 \\%$ of paragangliomas\n$\\checkmark$ local invasion\n$\\checkmark$ metastases (in $22-50 \\%$ ): versus $2-10 \\%$ in pheochromocytomas\n(2) Rupture with retroperitoneal hemorrhage\n\nDDx: (1) Nerve sheath tumor\n(2) Hypervascular lymphadenopathy: metastasis / Castleman disease\n(3) Hypervascular soft-tissue sarcoma\n\n# Paraganglioma of Organ of Zuckerkandl \n\nFrequency: 135 cases in literature",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 230,
            "markdown": "Age: $\\quad 20-40$ years\nMay be associated with:\n(1) Multiple endocrine neoplasia type 2a (MEN 2a)\n(2) Neurofibromatosis\n(3) von Hippel-Lindau disease\n(4) Triad of Carney\n\n- functional ( $3 / 4$ ): associated with hypertension\n- nonfunctional ( $1 / 4$ ): abdominal pain / mass\n\n\n# RETROPERITONEAL TERATOMA \n\n$=$ germ cell tumor with somatic differentiation of cells producing mature but disorganized tissues of $>2$ embryonic layers (ectoderm, mesoderm, endoderm)\nFrequency: $1-11 \\%$ of all primary retroperitoneal tumors; $<10 \\%$ of all teratomas located in retroperitoneum; $3^{\\text {rd }}$ most common tumor of retroperitoneum in children (after neuroblastoma + Wilms tumor)\nOrigin: interruption of normal embryologic migration of pluripotent primordial germ cells from yolk sac to genital ridge\nPath: benign (mature $=$ dermoid cyst $/$ immature) or malignant\nHisto: cysts lined by epithelium of ectodermal and endodermal origin + glial tissue + mesodermal components (fat, bone, cartilage); may harbor various malignancies of germ cell (seminoma, embryonal cell carcinoma, yolk sac tumor) or somatic (rhabdomyosarcoma, chondrosarcoma, liposarcoma) origin\nAge: bimodal distribution with peaks in first 6 months + early adulthood; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 2$ to $1 \\div 3.4$\nLocation: retroperitoneum ( $<10 \\%$ ), ovary, testis, anterior mediastinum, presacral + coccygeal area\nSite: midline (common), left side, suprarenal fossa\n\n- asymptomatic (most); fixed palpable midline mass, abdominal tenderness, progressive abdominal distension\n- nausea, vomiting, pain, GU symptoms, lower extremity swelling (after growth)\n$\\sqrt{ }$ varied appearance from predominantly cystic to completely solid mass:\n$\\checkmark$ containing fat (in $61-83 \\%$ )\n$\\checkmark$ congealed / linear / shardlike / toothlike calcifications (in 83-93\\%)\n$\\checkmark$ wall nodules (= Rokitansky nodules) in cystic component\n$\\checkmark$ necrosis + hemorrhage $\\rightarrow$ suggest malignancy\n$R x$ : surgical resection\nPrognosis: excellent for benign teratoma; poor with malignant teratoma (adults + children $=$ $26 \\% \\div 7 \\%$ )\n\n\n## Immature Teratoma (< 1\\%)\n\nAge: younger age group ( $<20$ years) than mature teratomas\nHisto: $>10 \\%$ undifferentiated tissue\nLocation: near upper pole of left kidney\n$\\checkmark$ predominantly solid with scattered areas of fat and coarse + ill-defined calcifications\n$\\checkmark$ occasionally cystic component",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 231,
            "markdown": "# Mature Retroperitoneal Teratoma (99\\%) \n\n$=$ DERMOID CYST\nHisto: well-differentiated tissue from at least 2 germ cell layers: ectodermal (in 100\\%), mesodermal (in $90 \\%$ ), endodermal (in majority of lesions)\n$\\checkmark$ predominantly cystic\n$\\checkmark$ villiform solid component (= Rokitansky protuberance) in $81 \\%$\n$\\checkmark$ toothlike / well-defined calcification (56\\%)\n$\\checkmark$ fat $(93 \\%)$\n$D x$ : A fat-fluid level of sebum with chemical shift between fat and fluid are PATHOGNOMONIC .\n$C x$ : malignant degeneration $(2-3 \\%)$ : in $1 / 4$ of children and $1 / 10$ of adults\n\n## Malignant Teratoma\n\nHisto: malignant tissue of germ cell / non-germ cell origin\n\n- elevated a-fetoprotein (in 50\\%)\n$\\checkmark$ irregular mass with invasion of adjacent structures + vessels\nPrognosis: poor with germ cell lesions or lesions with rhabdomyosarcomatous / neural differentiation\n\n\n## RHABDOID TUMOR OF KIDNEY\n\n$\\diamond$ Most aggressive renal neoplasm of childhood!\nFrequency: $<2 \\%$ of pediatric renal tumors\nMean age: 11-17 months; 6-12 months of age (25\\%), $<1$ year [ $<2$ years] of age $60 \\%[80 \\%]$;\n\n$$\n\\mathrm{M} \\div \\mathrm{F}=1.5 \\div 1\n$$\n\nOrigin: renal sinus\nHisto: monomorphic noncohesive large cells with prominent nucleoli + abundant eosinophilic cytoplasm (superficial resemblance to skeletal muscle, hence name); filamentous intracytoplasmic inclusions (CHARACTERISTIC)\nAssociated with: syn- / metachronous primary brain tumor of neuroectodermal origin (medulloblastoma, ependymoma, cerebellar / brainstem astrocytoma, PNET)\nMetastatic to: lung, liver, brain\n\n- paraneoplastic hypercalcemia (occasionally)\n$\\checkmark$ centrally located heterogeneous renal mass:\n$\\checkmark$ indistinct borders with infiltration of medulla + sinus\n$\\checkmark$ PROMINENT peripheral crescent-shaped subcapsular fluid collection in $70 \\%$ (subcapsular hematoma in $47 \\%$ / necrotic cavity in $53 \\%$ )\nSubcapsular hemorrhage suggests rhabdoid tumor; however, since Wilms tumor is so much more common, a tumor with this finding is more likely to be a Wilms tumor than a rhabdoid tumor.\n$\\checkmark$ SUGGESTIVE multilobulated architecture, esp. if surrounded by low-attenuation material $\\leftarrow$ old hemorrhage / necrosis\n$\\checkmark$ curvilinear calcifications outlining tumor lobules ( $2 / 4$ )\n$\\checkmark$ may invade renal vein and IVC\n$\\checkmark$ midline mass in posterior fossa of skull\n$\\checkmark$ metastatic (in $80 \\%$ ) to lung, liver, retroperitoneal lymph nodes, abdomen, brain, bone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 232,
            "markdown": "Prognosis: 20\\% 18-month survival rate\n$D D x$ : (1) Wilms tumor\n(2) Mesoblastic nephroma (young infant, subcapsular fluid collection, no lymphadenopathy)\n\n# RHABDOMYOSARCOMA \n\n$=$ rapidly growing aggressive malignancy frequently invading adjacent bones and soft tissues\nOrigin: pluripotential mesenchymal cell with capacity to differentiate into skeletal muscle (rhabdomyoblasts resemble primitive striated muscle cells; NOT from striated muscle) Frequency:\n$4-10 \\%$ of cancers in children $<15$ years of age (ranking $4^{\\text {th }}$ after CNS neoplasm, neuroblastoma, Wilms tumor);\n$5-15 \\%$ of all adult sarcomas; $35 \\%$ of pediatric sarcomas\n$\\diamond$ Most common soft-tissue tumor in childhood ( $60 \\%$ )\nIncidence: $4.5(1.3) \\div 1,000,000$ annually in USA in white (black)\nAge: bimodal age distribution: 1-4 years (1st peak), 14-19 years (2nd smaller peak); < 11 years $(70 \\%) ; \\mathrm{M} \\div \\mathrm{F}=2 \\div 1$\nAssociated with: Li-Fraumeni syndrome, neurofibromatosis type 1, Beckwith-Wiedemann syndrome, DICER1 mutation (familial pleuropulmonary blastoma)\nHisto: arising from small undifferentiated \"blue cells\" with scant cytoplasm + primitiveappearing nuclei; perineural invasion common\n(1) embryonal type ( $70-80 \\%$ )\n\nVariant: polypoidal form = sarcoma botryoides [bÃ³try, Greek = bunch of grapes] = grapelike\nAge: newborn - 15 years\n(2) alveolar type ( $10-15-20 \\%$, worst prognosis)\n\nAge: $10-25$ years\n(3) pleomorphic type ( $10 \\%$, poor prognosis)\n\nPeak age: 45 years; rare in children\nLocation: primarily large muscles of extremities\n$\\sqrt{ }$ variable amounts of hemorrhage + necrosis\n(4) mixture of two types\n\nDDx of other small round blue cell tumors:\nneuroblastoma, Ewing sarcoma, primitive neuroecto-dermal tumor, lymphoma, desmoplastic small round cell tumor\nLocation: head + neck ( $35-40 \\%$ ), trigone and bladder neck ( $18-21 \\%$ ), extremities ( $18-23 \\%$ ), orbit ( $10 \\%$ ), trunk ( $7-8 \\%$ ), retroperitoneum ( $6-7 \\%$ ), perineum + anus ( $2 \\%$ ), other sites $(7 \\%)$; intraperitoneal involvement $(10 \\%)$\nSpread: $15-20 \\%$ have metastatic disease at presentation\n\n## Head \\& Neck Rhabdomyosarcoma (40\\%)\n\nFrequency: $10 \\%$ of all rhabdomyosarcomas; $3^{\\text {rd }}$ most common primary childhood malignancy of head and neck (following CNS neoplasm + retinoblastoma)\n$\\diamond$ Most common primary extracranial tumor invading cranial vault in childhood",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 233,
            "markdown": "Classification of head \\& neck tumors:\n(a) orbital $(25-35 \\%)$ (see below)\n(b) parameningeal ( $50 \\%$ ): middle ear, paranasal sinus, mastoid process, pterygopalatine fossa, nasopharyngeal musculature ( $1 / 2$ ) especially in masticator space\n$\\sqrt{ }$ MR to assess intracranial extension (in up to $55 \\%$ )\n$\\diamond$ Parameningeal disease carries the worst prognosis!\n(c) nonparameningeal $=$ superficial ( $25 \\%$ )\n\nMetastases: lung, cortical bone, lymph nodes (10-20\\%) > bone marrow, liver\n$\\diamond$ Metastases in $10-20 \\%$ at time of diagnosis!\n\n- cranial nerve palsy\n$\\checkmark$ bulky nasopharyngeal mass\n$\\checkmark$ extension into cranial vault through fissures + foramina (up to $35 \\%$ ) usually involving cavernous sinus\n$\\checkmark$ bone destruction by direct invasion\n$\\checkmark$ mild to moderate uniform diffuse contrast enhancement\nCT:\n$\\checkmark$ poorly defined relatively homogeneous mass isodense to brain\n$\\checkmark$ expanded foramen / fissure\nMR (imaging modality of choice):\n$\\sqrt{ }$ SI intermediate between muscle and fat on T1WI + hyperintense on T2WI\nPrognosis: $12.5 \\% 5$-year survival (better than in extremities)\n$D D x$ : fibrosarcoma, hemangioma, lymphangioma, lymphoma, mastoiditis, lymphadenopathy, Langerhans cell histiocytosis\n\n\n# Rhabdomyosarcoma of Orbit \n\n$\\diamond$ Most common primary extraocular malignancy in a child\nFrequency:\n$25 \\%-35 \\%$ of head and neck rhabdomyosarcomas; 3-4\\% of all pediatric orbital masses:\n$>10 \\%$ as primary tumor of orbit\n$>10 \\%$ as metastasis / from invasion of orbit $\\leftarrow$ nasopharynx, pterygopalatine fossa, infratemporal fossa, paranasal sinuses (= parameningeal site)\nHisto: embryonal form (most common) in young children; alveolar form (less common) generally affecting older children / adolescents; pleomorphic type extremely rare in orbit\nMean age: 6-8 (range, infancy -68 ) years; $90 \\%$ by 16 years of age; $\\mathrm{M} \\div \\mathrm{F}=5 \\div 3$\nRarely associated with: neurofibromatosis\n\n- rapidly progressive unilateral proptosis / globe displacement\n- conjunctival + palpebral swelling (DDx orbital cellulitis)\n\nStaging: I localized completely resected tumor\nII residual microscopic disease after surgery\nIII gross residual disease after biopsy\nIV distant metastases at onset\nLocation:\n(a) extraconal (37-87\\%): superonasal quadrant / superior orbit / retrobulbar (71\\%), lid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 234,
            "markdown": "$(22 \\%)$, conjunctiva $(7 \\%)$\n(b) intra- and extraconal (13-47\\%)\n$\\sqrt{ }$ TYPICALLY thickening of eyelid\n$\\sqrt{ }$ large soft-tissue density mass with ill-defined margins:\n$\\sqrt{ }$ mass often contiguous with adjacent extraocular muscle $\\leftarrow$ muscle displaced / encased (without enlargement of muscle belly)\n$\\sqrt{ }$ globe often distorted / displaced but rarely invaded\n$\\sqrt{ } \\pm$ invasion of adjacent preseptal space, paranasal sinus ( $20 \\%$ ), nasal cavity, intracranial cavity $(3 \\%)$\n$\\sqrt{ }$ moderate to marked generalized enhancement\n$\\sqrt{ }$ cavitary mass with ringlike enhancement (rare)\nCT (sensitive for bone erosion):\n$\\sqrt{ }$ extraconal well-circumscribed ovoid irregular homogeneous mass isoattenuating to muscle:\n$\\sqrt{ }$ necrosis + hemorrhage (uncommon)\n$\\sqrt{ }$ bone erosion (in $30-40 \\%$ ) at presentation\nMR (sensitive for intracranial extension):\n$\\sqrt{ }$ homogeneous mass isointense / minimally hyperintense to muscle / brain on T1WI:\n$\\sqrt{ }$ areas of high signal intensity on T1WI and T2WI $\\leftarrow$ foci of subacute hemorrhage\n$\\sqrt{ }$ hyperintense to muscle, fat and brain on T2WI\n$\\sqrt{ }$ moderate to marked uniform internal enhancement\nUS:\n$\\sqrt{ }$ heterogeneous well-defined irregular mass of low to medium echogenicity\n$\\sqrt{ }$ variable vascular flow pattern on Doppler US\nMetastases: (a) hematogenous: lung, bone marrow\n(b) lymphatic (rare): cervical lymph nodes\n\nPrognosis:\n(1) $40 \\%$ survival after exenteration\n(2) $80-90 \\% 5$-year survival after biopsy / surgical debulking followed by radiation therapy $(4,000-5,000 \\mathrm{rad})+$ chemotherapy (vincristine, cyclophosphamide, doxorubicin)\n$D D x$ : (1) Subperiosteal hemorrhage (bone erosion during resolution)\n(2) Orbital cellulitis with abscess (fever, leukocytosis)\n(3) Dermoid cyst (cystic appearance, internal fat attenuation, calcification, fluid level, bone depression near zygomaticofrontal suture)\n(4) Capillary hemangioma (growth during 1.0-1.5 year of life, ipsilateral cutaneous hemangiomas, peripheral + internal flow voids)\n(5) Venous-lymphatic malformation (multiloculated cystic with ill-defined border, fluid-fluid levels, peripheral enhancement, phleboliths)\n(6) Langerhans cell histiocytosis (pronounced bone destruction, diabetes insipidus)\n(7) Leukemia (peripheral blood smear)\n(8) Lymphoma (lacrimal gland involvement, encasement of globe, hypointense on T2WI)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 235,
            "markdown": "# Genitourinary Rhabdomyosarcoma \n\nFrequency: $4-8 \\%$ of all malignant solid tumors in children $<15$ years of age (ranking $4^{\\text {th }}$ after CNS neoplasm, neuroblastoma, Wilms tumor); 10-25\\% of all sarcomas; annual incidence of $4.5[1.3] \\div 1,000,000$ in white [black] children\nAge: bimodal distribution with peaks at 7 years + at adolescence; white + black $=3 \\div 1 ; \\mathrm{M} \\div \\mathrm{F}$ $=6 \\div 4$\nPath: firm fleshy lobulated mass with infiltrative margin / well-defined pseudocapsule; composed of smooth grapelike clusters if intraluminal (= sarcoma botryoides)\nHisto (Horn \\& Enterline):\n(a) embryonal $(56 \\%)$\n(b) botryoid $(5 \\%)=$ subtype of embryonal rhabdomyosarcoma\n(c) alveolar ( $20 \\%$ ): worst prognosis\n(d) pleomorphic ( $1 \\%$ ): mostly in adults\n\nDDx: primitive neuroectodermal tumor, extraosseous Ewing sarcoma, synovial cell sarcoma, fibrosarcoma, alveolar soft part sarcoma, hemangiopericytoma, undifferentiated sarcoma, neuroblastoma\n$\\checkmark$ nonspecific imaging features:\n$\\sqrt{ }$ homogeneous echogenicity similar to muscle $\\pm$ hypoechoic areas on US $\\leftarrow$ hemorrhage / necrosis\n$\\checkmark$ heterogeneous lesion with calcifications + necrosis\n$\\checkmark \\pm$ hyperemia with high diastolic flow component\n$\\checkmark$ bulky pelvic mass of heterogeneous attenuation\n$\\checkmark$ hypointense on T1WI + hyperintense on T2WI with heterogeneous enhancement\n$\\checkmark$ diffuse tumor vascularity on angio\nPrognosis:\n(a) $14-35 \\% 5$-year survival with radical surgery\n(b) $60-90 \\% 3$-year survival with chemotherapy added\n$\\diamond$ Local recurrence is common!\n\n## Bladder-Prostate Rhabdomyosarcoma\n\n$\\diamond 5 \\%$ of all rhabdomyosarcomas occur in genitourinary tract\n$\\diamond$ Most common bladder tumor in patients $<10$ years\nAge: in first 3 years of life; $\\mathrm{M} \\div \\mathrm{F}=3 \\div 1$\nAssociated with: congenital anomalies of the brain, neurofibromatosis, nephroblastoma\nHisto: embryonal ( $90 \\%$ ), alveolar ( $10 \\%$ )\nLocation: trigone of urinary bladder / prostate (tumor infiltrating both)\n\n- abdominal pain + distension (from bladder outlet obstruction), urinary retention, palpable bladder\n- urinary frequency + dysuria ( $\\leftarrow$ urinary tract infection)\n- hematuria (unusual late manifestation)\n- strangury (= painful urge to void without success)\n$\\checkmark$ polypoid intraluminal tumor mass\n$\\checkmark$ elevation of bladder floor with obstruction of bladder neck + large postvoid residual\n$\\checkmark \\pm$ invasion of periurethral / perivesical tissues\n$\\checkmark$ retroperitoneal lymph node enlargement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 236,
            "markdown": "MR:\n$\\sqrt{ }$ low signal intensity on T1WI + hyperintense on T2WI\n$\\checkmark$ heterogeneous enhancement\n$R x$ : chemotherapy prior to surgery\n$D D x$ : polyp, hemangioma, ectopic ureterocele, hemorrhagic cystitis\n![img-14.jpeg](img-14.jpeg)\n\n# Rhabdomyosarcoma of Female Genital Tract \n\nLocation: vulva / vagina (infancy), cervix (reproductive years), uterine corpus (postmenopausal)\n\n- vulvar / perineal / vaginal mass\n- vaginal bleeding / discharge / protruding grapelike mass\n\nDDx: polyp, urethral prolapse, hydrometrocolpos, neoplasm\nPrognosis: $91 \\% 5$-year survival rate for nonmetastatic rhabdomyosarcoma of genital tract\n\n## VAGINAL RhABDOMYOSARCOMA\n\nAge: very young children (almost exclusively)\nHisto: commonly botryoid\n$\\checkmark$ large solid heterogeneous hypoechoic mass posterior to urinary bladder\n\n## Paratesticular Rhabdomyosarcoma\n\n$\\diamond$ Most common extratesticular neoplasm in children!\nAge: childhood, $2^{\\text {nd }}$ age peak in adolescence\nHisto: embryonal subtype (majority)\nLocation: spermatic cord, testis, penis, epididymis\n\n- painless scrotal swelling\n- palpable nontransilluminating intrascrotal tumor\n- bulky abdominal (lymphadenopathy)\n$\\checkmark$ hypervascular hypo- / hyperechoic solid mass\n$\\checkmark$ displacement / compression / infiltration of adjacent epididymis + testis\nPrognosis: 73-89\\% 3-year survival rate\n$D D x$ : hydrocele, epididymitis, testicular neoplasm",
            "images": [
                {
                    "id": "img-14.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 426,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 990,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 237,
            "markdown": "# Abdominal Rhabdomyosarcoma (rare) \n\nLocation: peritoneum, mesentery, omentum\n$\\sqrt{ }$ omental caking (primary disease)\nUS:\n$\\sqrt{ }$ predominantly solid mixed-echogenicity mass\n$\\sqrt{ }$ markedly increased color flow\nCT:\n$\\sqrt{ }$ mild to moderate ascites\n$\\sqrt{ }$ hypoattenuating intraperitoneal + mesenteric nodules and masses\n$\\sqrt{ }$ variable enhancement\n\n## SCHISTOSOMIASIS\n\n$=$ BILHARZIASIS $=$ SNAIL FEVER\n[schisto, Greek = split; soma, Greek = body]\n[Theodor Maximilian Bilharz (1825-1862), German physician and parasitologist, chair of descriptive anatomy at Kasr el AÃ¯n, Cairo]\n$\\diamond$ One of the most protean diseases in humans ( $>200$ million people infected in Africa, Asia, and the Americas)!\n$\\diamond 2^{\\text {nd }}$ most common cause of mortality among parasitic infections after malaria $\\rightarrow 500,000$ deaths annually!\n$\\diamond$ The most prevalent waterborne disease!\nOrganism: S. haematobium (GU tract) $>95 \\%$;\nS. mansoni, S. japonicum (GI tract) $<5 \\%$\n\nContact: exposure of skin to water contaminated with cercariae excreted by snails as a result of unsanitary disposal of human and animal wastes combined with repeated daily contact with contaminated freshwater (eg, fishing, farming, swimming, bathing, recreation)\n\n- dermatitis $=$ swimmer's itch (common manifestation) $\\leftarrow$ juvenile worms enter circulatory system\n- \"Katayama fever\" = fever, chills, sweating, cough (occasional) $\\leftarrow$ adult female worms develop in GU and GI tracts\n$R x:$ praziquantel (destroys adult worms + incites eggs to hatch), albendazole\n\n\n## Schistosoma Hematobium\n\nPrevalence: 8\\% of world's population; 25\\% in Africa\nEndemic to: South Africa, Egypt, Nigeria, Tanzania, Zimbabwe; South America; Carribean; Middle East; Asia; Puerto Rico\nLife cycle:\nfemale parasite resides within venules of urinary bladder $\\rightarrow$ eggs erode bladder mucosa $\\rightarrow$ excreted with urine and feces $\\rightarrow$ hatch in fresh water into larval miracidia\nlarvae invade aquatic / amphibious fresh-water snails (= intermediate host) of genus\nBulinus $\\rightarrow$ miracidia develop into adult sporocytes $\\rightarrow$ in 4-6 weeks thousands of fork-\ntailed free swimming $1-\\mathrm{mm}$ long cercariae are released $\\rightarrow$ pass into surrounding body of water\n$\\rightarrow$ death within 72 hours OR",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 238,
            "markdown": "penetration of human skin (usually foot) where they lose their tail $\\rightarrow$ pass into lymphatics + thoracic duct $\\rightarrow$ travel to RT heart + lungs $\\rightarrow$ LT heart + mesenteric capillaries $\\rightarrow$ reach portal vein where they mature into adult worms + copulate (in 21 days after penetration) $\\rightarrow$ return into pelvic venous plexus where they may live for many years\nHisto: eggs incite granulomatous response + fibrosis $\\rightarrow$ polypoid lesions (acute phase) and ultimately SCC (chronic phase); large number of eggs calcify in bladder wall without viable eggs in urine\nDefinite $D x$ : eggs found at urine microscopy\n\n- frequency, urgency, dysuria\n- terminal microscopic hematuria, hemospermia\n- albuminuria in the nephrotic range (most common)\n- suprapubic pain; dull flank pain (from hydronephrosis)\n- hypertrophic, ulcerative, fistulous, wart-like lesions of vulva + perineum (can be mistaken for condylomata lata)\n- index of infectious severity = urine egg count\n\nLocation: lower ureters + bladder\n@ Urinary bladder\nPathogenesis:\nchronic irritation of mucosa $\\rightarrow$ proliferation of urothelium into buds (von Brunn nests)\n$\\rightarrow$ growth into lamina propria $\\rightarrow$\n(a) cystic deposits = cystitis cystica\n(b) intestinal mucin-secreting glands (goblet cells) = cystitis glandularis\n$\\checkmark$ polypoid filling defects + mucosal irregularities in urinary bladder (pseudotubercles, papillomas) during acute phase $\\leftarrow$ cystitis cystica\n$\\checkmark$ bladder wall calcifications (in 4-56\\%): curvilinear / coarse / floccular, beginning at base parallel to upper aspect of pubic bone, involving all wall layers:\n$\\checkmark$ calcified bladder resembling a fetal head (PATHOGNOMONIC)\n$\\diamond$ Calcifications present with an abundance of calcified dead ova in submucosa in chronic stage\n$\\checkmark$ thick-walled fibrotic \"flat-topped\" bladder with high insertion of ureters\n$\\checkmark$ reduced bladder capacity (fibrotic stage) $\\rightarrow$ significant postvoid residual\n$\\checkmark$ vesical calculi (in 39\\%), distal ureteral calcification (in 34\\%), honeycombed calcification of seminal vesicles\nCx: Squamous cell carcinoma of bladder (SCC)\nAge: 30-50 years (exposed early in childhood with 20-30-year latency period)\nLocation: posterior bladder wall, rarely trigone\n$\\checkmark$ nodular / fungating filling defect ( $80 \\%$ )\n$\\checkmark$ diffuse / focal region of wall thickening\n$\\checkmark$ multiple tumors $(25 \\%)$\n$\\checkmark$ discontinuous calcifications\n@ Ureter (in up to $65 \\%$ )\n$\\checkmark$ persistent filling defect of distal ureteral segment with ureterectasis $\\leftarrow$ peristaltic disorganization $\\leftarrow$ focal egg deposition\n$\\checkmark$ beaded appearance of ureter:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 239,
            "markdown": "$\\sqrt{ }$ air bubble-like filling defect $=$ ureteritis cystica\n$\\checkmark$ multiple inflammatory pseudopolyps in ureter $\\leftarrow$ granulomas (= bilharziomas)\n$\\checkmark$ ureteral strictures in distal third (in $8 \\%, \\mathrm{~L}>\\mathrm{R}$ ), most commonly in intravesical portion with cobra-head configuration $=$ pseudoureterocele; Makar stricture $=$ focal stricture at L3\n$\\checkmark$ linear wall calcifications $=$ ureteritis calcinosa (PATHOGNOMONIC)\n$\\checkmark$ vesicoureteral reflux (in up to $30 \\%$ )\n$\\checkmark$ striation of renal pelvis + proximal ureter in $21 \\%$ (DDx: normal in $3 \\%$, other urinary tract infection, vesicoureteric reflux\n$C x$ : hydroureteronephrosis $\\leftarrow$ cessation of peristalsis\n@ Urethra\n$\\checkmark$ polyps in fossa navicularis of urethra\n$\\checkmark$ urethral stricture with perineal and scrotal fistulas\n@ Scrotum\n$\\checkmark$ testicular + epididymal lesions simulating malignancy\n$\\checkmark$ tunica vaginalis shows septate collections, multiple calcifications, diffuse / nodular enlargement $\\leftarrow$ granulomatous inflammatory reaction\n$D D x$ : malignancy, infarction, epididymo-orchitis\n\n# Schistosoma Mansoni \\& Japonicum \n\nOrganism:\n\n## A. Schistosoma mansoni\n\nEndemic to: Africa, Saudi Arabia, Madagascar, Brazil, Surinam, Venezuela, Puerto Rico, Middle East\nPath: eggs deposited along large portal veins of liver hilum\n\n## B. Schistosoma japonicum\n\nEndemic to: east Asia, China, Philippines\nPath: eggs deposited in peripheral small portal veins\nIntermediate host: snail\nLife cycle:\n(a) within snail : miracidia mature into cercariae $\\rightarrow$ released into water + swim $\\rightarrow$ penetrate skin / intestinal wall of human host\n(b) within human: in mesenteric veins\n> migration via blood + lymph vessels into lung $\\rightarrow$ afterward liver $\\rightarrow$ eggs released into portal circulation\n> adult worm inhabits inferior mesenteric + portal veins\n> eggs excreted in human feces $\\rightarrow$ reach water $\\rightarrow$ hatching of miracidia $\\rightarrow$ infection of snails\nPath: (a) intestinal schistosomiasis:\n> exudative granulomatous response (proctocolitis) $\\rightarrow$ formation of inflammatory polyps, fibrosis, wall thickening, colonic stenosis\n(b) hepatosplenic schistosomiasis:\n> liver granulomas $\\rightarrow$ periportal (Symmers) fibrosis $\\rightarrow$ fibrosis-induced presinusoidal portal hypertension\n> chronic endothelial inflammation $\\rightarrow$ venous thrombosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 240,
            "markdown": "$D x$ : eggs identified in stool specimen / rectal biopsy\nCx: (1) Splenomegaly with siderotic nodules\n(2) Portal vein thrombosis with collateral circulation $\\rightarrow$ gastrointestinal hemorrhage\n(3) Portal cholangiopathy $\\rightarrow$ cavernous transformation of portal vein $\\rightarrow$ biliary obstruction with jaundice\n(4) Portal hypertension $\\rightarrow$ eggs shunted from portal system into pulmonary vasculature\n@ GI tract\n$\\checkmark$ esophageal varices $\\leftarrow$ portal hypertension\n$\\checkmark$ polypoid calcifying bowel lesions $\\leftarrow$ eggs of S. mansoni trapped in bowel wall + inciting granulomatous reaction)\n$D D x$ : isolated intestinal schistosomiasis may be indistinguishable from other forms of proctocolitis.\n@ Liver\n$\\checkmark$ severe splenomegaly with siderotic nodules\n$\\checkmark$ atrophy of right hepatic lobe + widening of fissures\n$\\checkmark$ portal hypertension $\\leftarrow$ fibrosing granulomatous reaction within presinusoidal portal veins $\\leftarrow$ ova migrating into portal venous system\n$\\checkmark$ periportal hyperechogenicity\n$\\checkmark$ gallbladder wall thickening\nMR:\n$\\checkmark$ high-signal-intensity bands along portal tracts on T2WI $\\leftarrow$ periportal fibrosis\n$\\checkmark$ low signal intensity bands on T1WI enhance during venous phase\nAdvanced-stage hepatosplenic schistosomiasis causes marked morphologic changes in the liver with periportal fibrosis, signs of portal hypertension and severe splenomegaly with siderotic nodules.\n@ Lung\n> early form (3-8 weeks after parasitic penetration)\n\n- shortness of breath, wheezing, dry cough\n- eosinophilia $\\leftarrow$ immunologic type 3 reaction\n- Katayama fever = pulmonary symptoms coincide with febrile illness $\\leftarrow$ immunologic reaction to parasite eggs\nAssociated with: hepatosplenomegaly, hepatitis, urticaria, arthralgia\n$\\checkmark$ diffuse small nodular granulomatous lung lesions with ill-defined borders\n$\\checkmark$ reticulonodular pattern (less common)\n$\\checkmark$ bilateral diffuse ground-glass opacities / hyperattenuation\n> late form = granulomatous type 4 reaction to eggs deposited in pulmonary vasculature $\\rightarrow$ intimal fibrosis, pulmonary hypertension, cor pulmonale\n- dyspnea, chest pain, fatigue, palpitations, cough\n- right-sided heart failure (late)\n$\\checkmark$ cardiomegaly\n$\\checkmark$ enlargement of RV + pulmonary artery + azygos vein (from portal hypertension)\n\n\n# SCHWANNOMA OF ADRENAL GLAND",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 241,
            "markdown": "$=$ benign nerve sheath tumor of neural crest origin\nLocation: retroperitoneum (3\\%), adrenal gland (rare)\nAge: $20-40$ years\nCT:\n$\\checkmark$ heterogeneously enhancing hypoattenuating mass\nMR:\n$\\checkmark$ marked variability depending on degree of degeneration\n$\\checkmark$ isointense signal to muscle on T1WI\n$\\checkmark$ hyperintensity on T2WI\n$D D x$ : pheochromocytoma, malignant tumor\n\n# SCROTAL ABSCESS \n\nEtiology:\n(1) Complication of epididymoorchitis (often in diabetics), missed testicular torsion, gangrenous tumor, infected hematoma after trauma, primary pyogenic orchitis\n(2) Systemic infection: mumps, smallpox, scarlet fever, influenza, typhoid, syphilis, TB\n(3) Septic dissemination: sinusitis, osteomyelitis, cholecystitis, appendicitis\n\nPredisposed: diabetics\nNUC:\n$\\checkmark$ marked increase in perfusion $=$ hot hemiscrotum with photon-deficient area representing the abscess on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate scan (DDx: chronic torsion)\n$\\checkmark$ increased scrotal uptake with leukocyte imaging\nUS:\n$\\checkmark$ hypoechoic / complex fluid collection (differentiation of intra- from extratesticular abscess location possible):\n$\\checkmark$ intratesticular abscess with low-level internal echoes + shaggy wall\n$\\checkmark$ focal area of absent color Doppler flow\n$\\checkmark$ hypervascular surrounding testicular parenchyma\n$\\checkmark$ skin thickening\n$\\checkmark$ hydrocele\nMR:\n$\\checkmark$ hypointense on T1WI + hyperintense on T2WI $\\leftarrow$ fluid content\n$\\checkmark$ hypointense rim on T2WI\n$\\checkmark$ nonenhancing lesion + avid enhancement of surrounding tissue\n$\\checkmark$ central hyperintensity on DWI with corresponding low signal on ADC map $\\leftarrow$ restricted diffusion of abscess cavity\nCx: (1) Pyocele\n(2) Fistulous tract to skin (T1-hypointense linearity with corresponding hyperintensity on fat-suppressed T2WI)\n\n## SEMINAL VESICLE CYST\n\n$\\checkmark$ cystic mass posterior to urinary bladder (DDx: mÃ¼llerian duct cyst)\n$\\checkmark$ dilated ejaculatory duct",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 242,
            "markdown": "# Acquired Seminal Vesicle Cyst \n\nEtiology:\n\n1. Autosomal dominant polycystic kidney disease\n$\\checkmark$ bilateral seminal vesicle cysts\n2. Invasive bladder tumor\n3. Infection\n4. Benign prostatic hypertrophy\n5. Ejaculatory duct obstruction\n\n## Congenital Seminal Vesicle Cyst\n\nAssociated with: anomalies of ipsilateral mesonephric duct:\nEtiology:\n(1) Ectopic insertion of ipsilateral ureter $92 \\%$ into bladder neck / posterior prostatic urethra / ejaculatory duct / seminal vesicle\n(2) Ipsilateral renal dysgenesis $80 \\%$\n(3) Duplication of collecting system $8 \\%$\n(4) Vas deferens agenesis\n\nSymptomatic age: 21-41 years\n\n- abdominal / flank / pelvic / perineal pain exacerbated by ejaculation, epididymitis in prepubertal boy\n- dysuria, frequent urination, recurrent urinary tract infection\n\n\n## SINUS LIPOMATOSIS\n\n$=$ PERIPELVIC LIPOMATOSIS = PELVIC FIBROLIPOMATOSIS = PERIPELVIC FAT PROLIFERATION Etiology:\n(1) Normal increase with aging and obesity\n(2) Proliferation of sinus fat\n(a) vicarious proliferation (usually unilateral) (= replacement lipomatosis) see below\n(b) metabolic proliferation (bilateral) $\\leftarrow$ increased exogenous / endogenous steroids\n(3) Extravasation of urine $\\rightarrow$ proliferation of fatty granulation tissue\n(4) Normal variant\n\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade\n\n- asymptomatic\n$\\checkmark$ kidney may be enlarged\n$\\checkmark$ elongated \"spiderlike / trumpetlike\" pelvicaliceal system\n$\\checkmark$ infundibula arranged in \"spoke-wheel\" pattern\n$\\checkmark$ parenchymal thickness diminished with underlying disease\n$\\checkmark$ occasionally focal fat deposit with localized deformity of collecting system\nPlain film:\n$\\checkmark$ diminished sinus density = radiolucent sinus\nCT:\n$\\checkmark$ unequivocal fat values\nUS:\n$\\checkmark$ echodense / patchy hypoechoic sinus complex",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 243,
            "markdown": "# Replacement Lipomatosis / Fibrolipomatosis \n\n$=$ extreme form of renal sinus lipomatosis $\\leftarrow$ renal destruction / atrophy\nAssociated with: infection, long-term hydronephrosis, calculi ( $70 \\%$ )\nPath: marked proliferation of hyperplastic sinus fat with extremely atrophied cortex + varying degrees of hydro- / pyonephrosis, acute / chronic pyelonephritis\n$\\sqrt{ }$ kidney enlarged by a fatty sinus mass and outlined by an extremely thin cortex:\n$\\sqrt{ }$ fat characteristically distributed within renal sinus + perinephric space\n$\\checkmark$ staghorn calculus inside an enlarged renal outline\n$\\checkmark$ poorly functioning / nonfunctioning kidney\n$D D x$ : xanthogranulomatous pyelonephritis, lipoma, angiomyolipoma, liposarcoma (focal mass effect on intrarenal collecting system, no calculus, no parenchymal renal atrophy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 244,
            "markdown": "# SKENE DUCT CYST \n\n$=$ paraurethral retention cyst\nOrigin: urogenital sinus\nCause: inflammatory obstruction of paraurethral ducts\nHisto: stratified squamous epithelium\nLocation: lateral to external urethral meatus\n$\\sqrt{ }$ round / oval T2-hyperintense lesion\n$D D x$ : Bartholin gland cyst (similar location)\n\n## SPERMATIC CORD TORSION\n\n$=$ TESTICULAR TORSION = TWISTING OF SPERMATIC CORD\n$\\diamond$ Most common scrotal disorder in children, $20 \\%$ of acute scrotal pathology\nIncidence: $1 \\div 4,000$ to $1 \\div 25,000$ males of $<25$ years annually; 10 -fold risk in undescended testis\nEtiology:\n(1) Intravaginal torsion (= torsion distal to attachment of tunica vaginalis) = \"bell and clapper\" deformity = high insertion of tunica vaginalis on spermatic cord in $12 \\%$ of males\nSite: in 5\\% bilateral $\\leftarrow$ anomalous suspension of contralateral testis found in $80 \\%$ Age: any, predominantly adolescence\n(2) Extravaginal torsion $(10 \\%)=$ torsion proximal to attach-ment of tunica vaginalis involving testis + tunica vaginalis $\\leftarrow$ loose attachment of testicular tunics to scrotum Age: in utero (mostly) + perinatal period; may be bilateral\n\n- testis necrotic at birth $\\rightarrow$ swollen + discolored hemiscrotum $\\sqrt{ }$ complex hydrocele + calcification of tunica albuginea\n(3) Abnormally loose mesorchium between testis + epididymis\n\nPathophysiology: blood flow compromise $\\rightarrow$ venous obstruction followed by arterial obstruction\nPeak age: newborn period + puberty (13-16 years); $<20[>21]\\{>30\\}$ years in $74-85 \\%$\n$[26 \\%]\\{9 \\%\\}$\nCx: testicular atrophy (in 33-45\\%)\n\n## Acute Testicular Torsion\n\n$=$ symptoms present for $<24$ hours\n\n- $70 \\%$ of patients present within first 6 hours from onset of pain:\n- sudden severe pain in $100 \\%$ (frequently at night)\n- negative urine analysis ( $98 \\%$ ), nausea + vomiting ( $50 \\%$ )\n- history of similar episode in same / contralateral testis ( $42 \\%$ ); history of trauma / extreme exertion $(13 \\%)$\n- scrotal swelling + tenderness ( $42 \\%$ )\n- leukocytosis ( $32 \\%$ ), low-grade fever ( $20 \\%$ )\n- Brunzel sign = elevated horizontal lie of testis\n- Ger sign = skin pitting at scrotal base",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 245,
            "markdown": "# SURGICALEMERGENCY! \n\nTesticular viability related to:\n(a) degree of torsion ( $720^{\\circ}$ necessary for complete ischemia)\n\nDegree of torsion and blood flow:\n\n- testis usually turns medially up to $1,080^{\\circ}$\n$\\sqrt{ }$ diminished blood flow in $<180^{\\circ}$-torsion at 1 hour\n$\\sqrt{ }$ absent blood flow in any degree of torsion $>4$ hours\n(b) length of ischemia\n\nSalvage rate versus time from onset of pain to surgery\n$97-100 \\%<6 \\mathrm{hrs} \\quad 57 \\% 6-12 \\mathrm{hrs}$\n$35 \\% 12-24 \\mathrm{hrs} \\quad 0-9 \\%>24 \\mathrm{hrs}$\n$\\diamond$ Irreversible ischemic damage begins at 3-6 hours after onset of torsion!\n(c) intermittent torsion\n$\\diamond$ Spontaneous detorsion in $7 \\%$\n$\\checkmark$ hyperemia after spontaneous detorsion\nUS ( $80-90 \\%$ sensitivity):\n$\\checkmark$ testicular echogenicity:\n$\\checkmark$ normal grey-scale appearance (within 1-3-6 hours)\n$\\checkmark$ diffusely hypoechoic echotexture ( $>6$ hours)\n$\\checkmark$ heterogeneous echotexture $\\leftarrow$ ischemic necrosis\n$\\checkmark$ testicular size:\n$\\checkmark$ normal size $=80 \\%$ salvage rate\n$\\checkmark$ testicular + epididymal enlargement with decreased echogenicity (within 8-24 hours)\n$\\diamond$ Torsion has no / minimal epididymal flow (DDx: acute epididymitis has increased flow)\n$\\checkmark$ extratesticular findings:\n$\\checkmark$ scrotal skin thickening\n$\\checkmark$ hydrocele (occasionally)\n$\\checkmark$ \"torsion knot\" sign = twisted enlarged spermatic cord with spiraling vessels at external inguinal orifice\n$\\checkmark$ intrascrotal portion of cord round / ovoid / curled with epididymal head wrapped around it\n$\\checkmark$ inverted orientation of testis + epididymis + cord (in 6\\%)\nPitfall: dilated cord mistaken for abnormal epididymis\nColor duplex ( $86 \\%$ sensitive, $100 \\%$ specific, $97 \\%$ accurate):\nN.B.: contralateral testis $=$ internal normal control (!)\n$\\checkmark$ loss of spermatic cord Doppler signal ( $44 \\%$ sensitive, $67 \\%$ specific)\n$\\checkmark$ absence of testicular + epididymal flow (DDx: global testicular infarction)\n$\\checkmark$ diminished flow (veins affected before arteries) $\\leftarrow$ incomplete $\\left(<360^{\\circ}\\right) /$ intermittent torsion:\n$\\checkmark$ some arterial flow persists (in $20 \\%$ of torsions)\n$\\checkmark$ high-resistance waveform $=$ decreased / reversed arterial flow in diastole\nFalse-negative: torsion-detorsion sequence, incomplete torsion $<360$ degrees\nFalse-positive: in small boys $<4$ years of age ( $=$ limitation of color Doppler sensitivity)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 246,
            "markdown": "NUC ( $98 \\%$ accuracy):\nDose: $5-15 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate\nImaging: at 2- to 5-sec intervals for 1 min (vascular phase); at 5-min intervals for 20 minutes (tissue phase)\n$\\checkmark$ decreased perfusion / occasionally normal\n$\\checkmark$ \"nubbin\" sign = bump of activity extending medially from iliac artery $\\leftarrow$ reactive increased blood flow in spermatic cord with abrupt termination\n$\\checkmark$ rounded cold area replacing testis (requires knowledge of side + location of painful testis)\nRx: (1) Detorsion (should be attempted by radiologist):\n$\\diamond$ Twist testis outward + laterally by $180^{\\circ}$ like \"opening a book\"! May have to be repeated; successful in ${ }^{2} / 3$\n(2) Orchiopexy\n\nDDx: epididymo-orchitis (more gradual onset of pain, however, in 5\\% sudden onset of pain)\n\n# Subacute Testicular Torsion \n\n$=$ MISSED TESTICULAR TORSION\n$=$ symptoms present for $>24$ hours + less than 10 days\nUS:\n$\\checkmark$ enlarged / normal-sized testis with heterogeneous punctate / diffusely increased echotexture\n$\\sqrt{ } \\pi$ peritesticular flow without parenchymal blood flow\nPitfall: increased flow in scrotal wall mistaken for intrascrotal inflammatory disease\nNUC:\n$\\checkmark$ normal NUC angiogram / \"nubbin\" sign\n$\\checkmark$ \"doughnut\" sign = decreased testicular activity with rim hyperemia of dartos perfusion MR:\n$\\checkmark$ enlarged spermatic cord without increase in vascularity\n$\\checkmark$ whirlpool pattern (twisting of spermatic cord)\n$\\checkmark$ torsion knot = low-signal-intensity focus at point of twist (= displacement of free protons from epicenter of twist)\n\n## Chronic Testicular Torsion\n\n$\\checkmark$ small atrophied homogeneously hypoechoic testis\n$\\checkmark$ enlarged echogenic epididymis\n\n## Appendix Testis Torsion\n\n$=$ TORSION OF TESTICULAR APPENDAGE\n$\\checkmark$ Most common cause of scrotal pain in pediatric population; accounts for $5 \\%$ of scrotal pathology\nPrevalence: $31-67 \\%$\nAge: prepubertal male aged $7-14$ years\n\n- gradual / sudden intense pain localized to upper pole of testis\n- \"blue dot\" sign $(21 \\%)=$ PATHOGNOMONIC nodule visible as bluish dot beneath skin in upper scrotum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 247,
            "markdown": "Location: near superior pole of testis; $\\mathrm{L}>\\mathrm{R}$\n$\\sqrt{ }$ ovoid complex hypo- to hyperechoic extratesticular 4-16 mm mass in superior aspect of scrotum\n$\\checkmark$ mass without color Doppler flow signals\n$\\checkmark$ reactive noninfectious epididymo-orchitis:\n$\\checkmark$ mildly enlarged epididymal head ( $75 \\%$ )\n$\\checkmark$ hyperemia of ipsilateral epididymis ( $60 \\%$ ) + scrotal wall ( $53 \\%$ ) + testis ( $13 \\%$ ) simulating acute epididymo-orchitis\n$\\checkmark$ reactive hydrocele + scrotal skin thickening\n$\\sqrt{ }$ NO Doppler signal within twisted appendage\n$\\checkmark$ hypervascularisation of epididymis + scrotal tunics\n$\\checkmark$ \"scrotal pearl\" = scrotolith = calcified detached remnant of twisted appendix testis on follow-up US within days\n$R x:$ bed rest, NSAID\n\n# SQUAMOUS CELL CARCINOMA OF KIDNEY \n\nFrequency: $5-10 \\%$ of all urothelial tumors; $1 \\%$ of renal neoplasms; $2^{\\text {nd }}$ most common malignancy of pelvic urothelium after TCC\nAge: $60-70$ years; $\\mathrm{M} \\circ \\mathrm{F}=2: 1$\nPath: flat ulcerating mass + extensive induration\nAssociated with: chronic irritation of urothelium by renal infection + calculi (25-60\\%)\n\n- painless hematuria\n- flank pain (with ureteropelvic junction obstruction)\n$\\checkmark$ infiltrating renal process\n$\\checkmark$ nonfunctional kidney:\n$\\checkmark$ ureteropelvic junction obstruction (common)\n$\\checkmark$ presence of faceted calculi ( $40-80 \\%$ )\nIVP:\n$\\checkmark$ stricture that may simulate extrinsic cause\nAngio:\n$\\checkmark$ arterial encasement + occlusion + neovascularity\n$\\checkmark$ enlarged pelvic + ureteric arteries\n$\\checkmark$ occlusion of renal vein / branches ( $41 \\%$ )\nCT:\n$\\checkmark$ thickening of pelvicaliceal wall (with superficial spread over large areas)\n$\\checkmark$ enlarged kidney maintaining reniform shape:\n$\\checkmark$ infiltrating growth into sinus + parenchyma\n$\\checkmark$ tumor mass infrequent\n$\\checkmark$ no contrast excretion $\\leftarrow$ obstruction\nPrognosis: worse than TCC $\\leftarrow$ early metastases; $33 \\%$ 1-year survival rate\n$D D x$ : xanthogranulomatous pyelonephritis (radiologically indistinguishable)\n\n\n## SUPERNUMERARY KIDNEY\n\n$=$ aberrant division of nephrogenic cord into two metanephric tails (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 248,
            "markdown": "Associated with: horseshoe kidney, vaginal atresia, duplicated female urethra, duplicated penis Location: most commonly on left side of abdomen caudal to normal kidney\n$\\checkmark$ supernumerary ureter may insert into ipsilateral kidney / directly into bladder / ectopic site\nCx: hydronephrosis, pyonephrosis, pyelonephritis, cysts, calculi, carcinoma, papillary cystadenoma, Wilms tumor\n\n# TESTICULAR CANCER \n\n$\\diamond$ Most common neoplasm in males between ages 15 and 35 years; $0.5 \\%$ of all cancers in males; $4-6 \\%$ of all male genitourinary tumors; $1 \\%$ of all childhood malignancies; $4^{\\text {th }}$ most common cause of death from malignancy between ages $15-34$ years ( $12 \\%$ )\nIncidence annually: $5.7 \\div 100,000$ in 2016 (4.1 100,000 in 1975); 1 263 males; 8,720 new cases in USA (2016)\nPeak age: 25-35 years; 71-90 years; infants $<3$ years: yolk sac tumor + teratoma; White $\\div$ Black $=4.5 \\div 1$\nRisk factors:\n(1) Prior testicular cancer ( $20 \\times$ risk $=2-5 \\%$ )\n(2) Maldescension = cryptorchidism (10 x risk)\n$5 \\%$ for abdominal site, $1.25 \\%$ for inguinal site\nRx: orchiopexy\n(3) Family history of testicular cancer ( 6 x risk for $1^{\\text {st }}$-degree relative $=2 \\%$ )\nmore prevalent in Caucasian race, Jewish religion\n(4) Infertility ( $0.4-1.1 \\%$ prevalence of intratubular germ cell neoplasia)\n(5) Intersex syndrome: gonadal dysgenesis, true hermaphroditism, pseudohermaphroditism\n\n- painless enlarging testis / mass ( $90 \\%$ ), however:\n- acute scrotal pain ( $10 \\%$, from intratumoral hemorrhage)\n- \"heaviness / fullness\" in lower abdomen / scrotum\n- gynecomastia, virilization\n\nLocation: mostly unilateral; contralateral tumor develops eventually in $8 \\%$\nMetastases: at presentation in $4-14 \\%$\n(a) lymphatic dissemination\ntesticular lymphatic drainage follows gonadal veins to\n> interaortocaval chain at L2 (for right testicular tumor)\n> left paraaortic nodes between renal vein, aorta, ureter and inferior mesenteric artery\nalong thoracic duct\n> left supraclavicular nodes\n> lungs\n(b) hematogenous dissemination (usually late) to lung > liver, brain, bone\n$\\diamond$ Choriocarcinoma has a proclivity for early hematogenous spread (especially to brain)!\n(c) direct extension through tunica albuginea to skin (rare and late) / epididymis $\\rightarrow$ spread to inguinal + iliac nodes\nHisto: may be different from that of primary tumor indicating totipotential nature of germ cells\nTumor markers (elevated in $80 \\%$ at time of diagnosis):\n$\\alpha$ yolk sac tumors, mixed germ cell tumors with yolk sac elements",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 249,
            "markdown": "fetoprotein:\n$\\beta$-hCG: seminoma, choriocarcinoma (tumors containing syncytiotrophoblasts)\nLDH: $\\quad$ correlates with bulk of disease (nonspecific as it is produced by multiple organs)\nUS ( $92-98 \\%$ sensitive, $95.0-99.8 \\%$ specific):\nColor duplex:\n$\\sqrt{ }$ tumor $<1.5 \\mathrm{~cm}$ is hypovascular in $86 \\%,>1.6 \\mathrm{~cm}$ hypervascular in $95 \\%$ (DDx: orchitis associated with epididymal hyperemia)\n$\\sqrt{ }$ distortion of vessels\n\n| Age Group of Testicular Tumors |  |\n| :-- | :-- |\n| Yolk sac tumor / teratoma | $1^{\\text {st }}$ decade |\n| Choriocarcinoma | $2^{\\text {nd }}+3^{\\text {rd }}$ decade |\n| Embryonal cell carcinoma | $3^{\\text {rd }}$ decade |\n| Seminoma | $4^{\\text {th }}$ decade |\n| Lymphoma | $7^{\\text {th }}$ decade |\n\n\n| Staging of Testicular Cancer <br> (American Joint Committee on Cancer) |  |\n| :-- | :-- |\n| pTX | primary tumor not available (no orchiectomy) |\n| pT0 | no primary tumor found |\n| pTis | intratubular germ cell tumor (carcinoma in situ) |\n| pT1 | limited to testis + epididymis |\n| pT2 | same as pT1 + vascular / lymphatic invasion or <br> involvement of tunica vaginalis |\n| pT3 | invasion of spermatic cord |\n| pT4 | invasion of scrotum |\n| pN0 | negative lymph nodes |\n| pN1 | node $\\leq 20 \\mathrm{~mm}$; or $\\leq 5$ nodes involved all $<20 \\mathrm{~mm}$ |\n| pN2 | node between 20 and 50 mm ; or $>5$ nodes none $>50 \\mathrm{~mm}$ |\n| pN3 | node mass $>50 \\mathrm{~mm}$ |\n| M0 | no distant metastasis |\n| M1 | distant metastasis |\n| S0 | all markers normal |\n| S1 | LDH $<1.5 \\times$ ULN + hCG $<5,000 \\mathrm{mIU} / \\mathrm{mL}$ <br> + AFP $<1,000 \\mathrm{ng} / \\mathrm{mL}$ |\n| S2 | LDH $<1.5-10 \\times$ ULN $\\pm$ hCG $5,000-50,000 \\mathrm{mIU} / \\mathrm{mL}$ <br> $\\pm$ AFP $1,000-10,000 \\mathrm{ng} / \\mathrm{mL}$ |\n| S3 | LDH $>10 \\times$ ULN $\\pm$ hCG $>50,000 \\mathrm{mIU} / \\mathrm{mL}$ <br> $\\pm$ AFP $>10,000 \\mathrm{ng} / \\mathrm{mL}$ |\n|  |  |\n|  |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 250,
            "markdown": "| Testicular Cancer Stage Grouping |  |\n| :--: | :--: |\n| I | limited to testis + spermatic cord |\n| II | metastases to lymph nodes below diaphragm |\n| II A | nonpalpable $<2 \\mathrm{~cm}$ in diameter |\n| II B | moderate mass $=2-5 \\mathrm{~cm}$ in diameter |\n| II C | bulky mass $>5 \\mathrm{~cm}$ in diameter |\n| III | metastases to lymph nodes above diaphragm |\n| III A | confined to lymphatic system |\n| III B | extranodal metastases |\n\n![img-15.jpeg](img-15.jpeg)\n\nMR:\n$\\sqrt{ }$ tumors isointense to testicular parenchyma on T1WI + T2WI\nPrognosis: $>93 \\%$ [85-90\\%] 5-year survival rate for stage I [stage II]; complete remission under chemotherapy in $65-75 \\%$; relapse in $10-20 \\%$ within 18 months\nMost cases of testicular cancer are curable as a result of advances in chemotherapy.\n$D D x$ :\nImaging overlap exists between testicular tumors and nontumorous conditions. Correlation with clinical history is critical to avoid unnecessary surgery.\n(1) Testicular infarction\n(2) Testicular hematoma\n(3) Orchitis: acute / granulomatous\n(4) Epidermoid cyst\n(5) Syndromic lesion:\n(a) adrenal rests in congenital adrenal hyperplasia\n(b) lipomatosis in Cowden disease\n$R x$ : inguinal orchiectomy (first-line treatment)\nAbout $95 \\%$ of testicular cancers are germ cell tumors, and $5 \\%$ are sex-cord-stromal tumors. Approximately $50 \\%$ of germ cell tumors are seminomas, and about $50 \\%$ are nonseminomatous germ cell tumors (NSGCTs).\n\nGerm Cell Tumor (95\\%)",
            "images": [
                {
                    "id": "img-15.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 629,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1056,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 251,
            "markdown": "Origin: primitive spermatogenic cell\n(a) one histologic type in $65 \\%$\n> from unipotential nondifferentiated gonadal line:\n\n1. Seminoma\n> along a totipotential line $\\rightarrow$ forming differentiated nonseminomatous tumors (more aggressive than seminoma):\n2. Embryonal carcinoma (slightly differentiated)\n3. Teratoma (embryonic differentiation)\n4. Yolk sac tumor (extraembryonic differentiation)\n5. Choriocarcinoma (extraembryonic differentiation)\n(b) mixed lesion\n> from totipotential cells developing along several pathways (embryonal carcinoma being the most common component of mixed lesions)\n6. Teratocarcinoma ( $=$ teratoma + embryonal cell ca.)\n$\\diamond 2^{\\text {nd }}$ most common after seminoma, may occasionally undergo spontaneous regression\n7. Embryonal cell carcinoma + seminoma\n8. Seminoma + teratoma\n(c) Growing Teratoma Syndrome:\n$=$ evolution of mixed germ cell tumor $\\rightarrow$ into mature teratoma after chemotherapy (in $40 \\%) \\rightarrow$ followed by interval growth despite maintaining a benign histology\nmnemonic: YES CT\nYolk sac tumor\nEmbryonal cell carcinoma\nSeminoma\nChoriocarcinoma\nTeratoma\nSeminoma (35-50\\%)\n$\\diamond$ Most common tumor in undescended testis!\n$\\diamond$ Most common pure germ cell tumor!\nAverage age: 40.5 years (slightly older patient compared with other germ cell tumors)\nStem cell: unipotential cell line\nHisto: uniform cellular morphology resembling primitive germ cells\n(1) Typical seminoma $85 \\%$\n(2) Anaplastic seminoma $10 \\%$\n(3) Spermatocytic seminoma $5 \\%$\n\nPresentation: in $75 \\%$ limited to testis;\nin $20 \\%$ retroperitoneal lymphadenopathy;\nin $5 \\%$ extranodal metastases\nAssociated with: testicular microlithiasis\n\n- serum $\\alpha$-fetoprotein normal in pure seminomas\n- $\\beta$-hCG elevation (in 5-25\\%) $\\leftarrow$ produced by syncytiotrophoblastic giant cells\n$\\checkmark$ usually homogeneous hypoechoic mass:\n$\\checkmark$ round / lobulated / multiple confluent nodules",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 252,
            "markdown": "$\\sqrt{ }$ entire testis replaced $(>50 \\%)$\n$\\sqrt{ }$ cystic component $(10 \\%) \\pm$ fluid-debris level\n$\\checkmark$ confined within tunica albuginea (= less aggressive)\n$\\checkmark$ calcifications / cystic spaces (infrequent)\n$\\checkmark$ may be multifocal\n$\\checkmark$ bilateral in $1-3 \\%$, almost always asynchronous\nMR:\n$\\checkmark$ homogeneously hypointense on T2WI\n$\\checkmark$ enhancing bandlike areas of low SI on T1WI + T2WI $\\leftarrow$ fibrovascular septa\n$R x$ : very sensitive to radiation $\\pm$ chemotherapy\nPrognosis: 10-year survival rate of $75-85 \\% ; 19 \\%$ develop pulmonary metastases\n\n# Nonseminomatous Tumor \n\nFrequency: $50 \\%$ of all germ cell tumors\nStem cell: totipotential embryonal cell line with varying degrees of differentiation into embryonal, teratoma, yolk sac, or choriocarcinoma cells\nAge: $20-30$ years\n\n- $\\square \\alpha$-fetoprotein level (in $50-60 \\%$ )\n$\\checkmark$ heterogeneous echotexture ( $71 \\%$ )\n$\\checkmark$ cystic spaces $(61 \\%)$\n$\\checkmark$ irregular ill-defined margins ( $45 \\%$ )\n$\\checkmark$ echogenic foci $\\leftarrow$ calcifications ( $35 \\%$ )\n\n\n## Embryonal Cell Carcinoma (20-25\\%)\n\n$\\diamond$ Second most common testicular tumor!\n$\\diamond$ Most common component of mixed germ cell tumors (embryonal cells present in $87 \\%$ ); often associated with teratoma\nHisto: primitive anaplastic epithelial cells resembling early embryonic cells; in $3 \\%$ as pure form\nAge: $25-35$ years and $<2$ years\nSpread: most aggressive testicular tumor, visceral metastases\n\n- $\\pm \\alpha$-fetoprotein elevation\n$\\checkmark$ hypoechoic mass with heterogeneous areas:\n$\\checkmark$ ill-defined borders\n$\\checkmark$ areas of increased echogenicity $\\leftarrow$ hemorrhage\n$\\checkmark$ cystic areas $\\leftarrow$ necrosis\n$\\checkmark$ may show invasion of tunica albuginea (common)\n$R x$ : less sensitive to radiation\nPrognosis: 30-35\\% 5-year survival rate\n\n\n## Mixed Germ Cell Tumor\n\n$=$ malignant neoplasm with more than 1 germ cell tumor component excluding seminoma with syncytiotropho-blastic cells\nFrequency: $69 \\%$ of all nonseminomatous $+32 \\%$ of all testicular germ cell tumors\nComponents: embryonal cell (most common, often combined with teratoma / seminoma / yolk sac tumor)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 253,
            "markdown": "Average age: 30 years\n\n- $\\uparrow \\alpha$-fetoprotein (in $60 \\%$ ), $\\uparrow \\beta$-hCG levels (in $55 \\%$ )\n$\\sqrt{ }$ unilateral mass with a mixture of solid + cystic components $\\leftarrow$ necrosis, hemorrhage, cystic degeneration\n$\\sqrt{ }$ calcifications (in $40 \\%$ )\n\n\n# Teratoma (4-10\\%) \n\nPrevalence: $1 \\div 1,000,000$;\n$\\diamond 2^{\\text {nd }}$ most common testicular tumor in young boys $\\leq 5$ years ( $75 \\%$ )\nHisto: consists of elements from $>1$ germ cell layer (keratin, muscle, bone, cartilage, hair, mucous glands, neural tissue); $2-3 \\%$ as pure form (in adult)\n(a) mature\n(b) immature\n(c) malignant areas\n\nAge: within first 4 years of life; benign in children; may transform into malignancy in adulthood\n\n- serum $\\alpha$-fetoprotein usually normal\n$\\checkmark$ well-circumscribed heterogeneous complex mass:\n$\\checkmark$ anechoic / complex cysts with variable echogenicity $\\leftarrow$ serous, mucoid, keratinous fluid\n$\\checkmark$ markedly echogenic components $\\leftarrow$ cartilage, calcification, fibrosis, scar formation\n$\\checkmark$ echogenic intratumoral fat\nPrognosis:\nvariable biologic behavior: benign in prepubertal testes BUT may metastasize in postpubertal testes with nonteratomatous germ cell elements; metastases to lymph nodes, bone, liver in $30 \\%$ within 5 years\n\n\n## Epidermoid Cyst / Keratin cyst of Testis (1\\%)\n\n$=$ \"monodermal dermoid\"\n$=$ benign teratoma with only ectodermal components / squamous metaplasia of surface mesothelium\nOrigin: ? monodermal development of a teratoma, ? meta- plasia of rete testis / seminiferous epithelium\nAge: 20-40 (range, 3-77) years; primarily in white + Asian population\nHisto: cyst contains keratin debris / other desquamated material; wall composed of fibrous tissue + lined by keratinizing stratified squamous epithelium\n\n- smooth firm painless testicular nodule\n- negative tumor marker status\n\nLocation: $\\mathrm{R}(>)$ L; solitary $>>$ multiple $>>$ bilateral\nSize: $1-3$ (range $0.5-10.5$ ) cm in diameter\n$\\checkmark$ sharply circumscribed encapsulated round lesion:\n$\\checkmark$ \"onion-skin\" / ringed appearance of alternating hypo- and hyperechogenicity (= alternating layers of compacted keratin + loosely arranged desquamated squamous cells):\n$\\checkmark$ well-defined rim = hyperechoic fibrous cyst wall $\\pm$ shadowing from",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 254,
            "markdown": "calcifications / ossification\n$\\checkmark$ hypoechoic cyst contents (= laminated keratin debris)\n$\\checkmark$ \"target / bull's eye\" appearance $\\leftarrow$ echogenic center $\\leftarrow$ compacted keratin / calcification\n$\\checkmark$ confined by tunica albuginea\n$\\checkmark$ diffuse testicular enlargement ( $10 \\%$ )\n$\\checkmark$ NO blood flow on Doppler (avascular lesion)\nMR:\n$\\checkmark$ target appearance:\n$\\checkmark$ fibrous capsule of low SI on T1WI + T2WI\n$\\checkmark$ cyst content (water and lipid) of high SI on T1WI + T2WI\n$\\checkmark$ alternating concentric rings of low + high SI\n$\\checkmark$ center of mass of low SI $\\leftarrow$ keratin debris $\\pm$ central calcification\n$\\checkmark$ NO enhancement\nPrognosis: no malignant potential\n$R x$ : enucleation + frozen section (testis-sparing surgery to avoid orchiectomy)\n\n# CHORIOCARCINOMA (1-3\\%) \n\nPrevalence: in $0.3 \\%$ in pure form; in $8-16 \\%$ of mixed germ cell tumors\nPeak age: $20-30$ years\nHisto: admixture of cytotrophoblastic + syncytiotrophoblastic cells\nSpread: may rapidly metastasize (lung, liver, GI tract, brain) without evidence of choriocarcinoma in primary lesion, pulmonary metastases develop in $81 \\%$\n\n- symptoms of metastatic disease while primary not yet palpable\n- serum $\\beta$-hCG always elevated $\\rightarrow$ gynecomastia in $10 \\%$\nN.B.: choriocarcinoma has a proclivity for hemorrhage in primary site and metastases!\n$\\checkmark$ often small tumor of mixed echotexture $\\leftarrow$ hemorrhage, necrosis, calcifications\n$\\checkmark$ indistinct margins of pulmonary metastases $\\leftarrow$ hemorrhage\nPrognosis: death usually within 1 year of diagnosis; nearly $0-48 \\% 5$-year survival rate\n\n\n## Yolk Sac Tumor = Endodermal Sinus Tumor\n\nEquivalent to endodermal sinus tumor of ovary\nPrevalence: most common germ cell tumor\n$\\diamond 80 \\%$ of childhood testicular tumors!\n$\\diamond$ Present in $44 \\%$ of mixed germ cell tumors of adults\nAge: $\\leq 2$ years $(80 \\%)$\n\n- serum $\\alpha$-fetoprotein elevated in $>90 \\%$ (exclusive to yolk sac elements)\n$\\checkmark$ nonspecific imaging findings:\n$\\checkmark$ testicular enlargement $\\pm$ identifiable mass\n$\\checkmark$ hypoechoic areas (frequent) $\\leftarrow$ necrosis\n$\\checkmark$ pulmonary metastases (most common site of recurrent disease)\n\n\n## Sex Cord-Stromal Tumor = Interstitial Cell Tumor\n\nPrevalence: $4 \\%$ of all testicular tumors; $10-30 \\%$ during childhood\nOrigin: supporting tissues of testis (sex cord + stromal cells)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 255,
            "markdown": "- precocious virilism ( $10 \\%$ in children)\n- painless testicular mass without endocrine abnormalities\n- gynecomastia (adults $>$ children)\n- loss of libido, impotence (adults)\n\nSpread: in 20\\% at initial diagnosis; metastases to lymph nodes (70\\%), liver (45\\%), lung $(40 \\%)$, bone $(25 \\%)$\n$R x$ : orchiectomy; conservative resection under ultrasound guidance\nPrognosis: malignant in $10-20 \\%$\n\n# Leydig Cell Tumor \n\nPrevalence: $1-3 \\%$ of all testicular tumors\nOrigin: interstitial cells forming the fibrovascular stroma\nAge: 3-6 years; $20 \\%$ in patients $<10$ years; $25 \\%$ between ages 30 and 50 years; $25 \\%$ in patients $>50$ years\nHisto: usually polygonal large cells with abundant cytoplasm; intracytoplasmic / intranuclear cylindric / rectangular / rhomboid structures = Reinke crystals\n\n- endocrinopathy (in $30 \\%$ ) $\\rightarrow$ secretion of androgens or estrogens (direct production of estradiol / aromatization of testosterone moiety) by the tumor:\n- precocious puberty / virilization\n- gynecomastia (in 30\\%); decreased libido\n\nLaterality: unilateral + solitary; 3\\% bilateral\nSize: $3-5 \\mathrm{~cm}$\nUS:\n$\\sqrt{ }$ usually small homogeneous hypoechoic / occasionally echogenic nodule\n$\\sqrt{ } \\pm$ cystic areas in $25 \\% \\leftarrow$ hemorrhage / necrosis\n$\\checkmark$ lacking internal vascularity + prominent circumferential blood flow on Doppler MR:\n$\\checkmark$ isointense on T1WI + hypointense on T2WI compared to surrounding normal testis\n$\\checkmark$ hyperintense capsule on T2WI\n$\\checkmark$ internal high SI on T2WI $\\leftarrow$ central scar\n$\\checkmark$ marked homogeneous enhancement\nPrognosis: benign+malignant $=9+1$\n$R x$ : enucleation to preserve fertility (if benign); radical orchiectomy + retroperitoneal lymphadenectomy\n\n## Sertoli Cell Tumor\n\nPrevalence: $0.4-1.5 \\%$ of all testicular tumors\nOrigin: sex cord (derived from Sertoli cells of seminiferous tubules)\nHisto: moderate to abundant eosinophilic cytoplasm / pale $\\leftarrow$ lipid accumulation; $\\pm$ Charcot-BÃ¶ttcher crystals (specific cytoplasmic inclusion bodies)\nSubtype: large-cell calcifying Sertoli cell tumor\nAge: most $<40$ years; $30 \\%$ in children\n\n- may secrete estrogens $\\rightarrow$ gynecomastia in $3 \\%$\n\nLaterality: unilateral; may be bilateral + multifocal\nUS:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 256,
            "markdown": "$\\sqrt{ }$ multicystic \"spoke-wheel\" appearance\n$\\sqrt{ }$ diffusely $\\uparrow$ : inhomogeneous echogenicity in enlarged testis (occasionally) $\\leftarrow$ dense collagenous matrix\n$\\sqrt{ }$ well-circumscribed round / lobulated hypoechoic nodules + surrounding thin hypoechoic rims (usually)\n$\\sqrt{ }$ dense echogenic foci $\\leftarrow$ calcified scars = \"burned-out\" tumor\n\n# Large-cell calcifying Sertoli cell tumor \n\n$=$ LCCSCT $=$ most common histologic variant in children + adolescents\n\n- precocious puberty $\\leftarrow$ testosterone production\n\nAssociated with: Peutz-Jeghers syndrome, Carney syndrome (almost exclusively)\nUS:\n$\\checkmark$ echogenic nodule with acoustic shadowing\n$\\checkmark$ multiple bilateral ( $20 \\%$ ) large areas of calcifications\nMR:\n$\\checkmark$ homogeneously isointense on T1WI + hyperintense on T2WI\n$\\checkmark$ variably homogeneous / rim enhancement\nPrognosis: benign+malignant $=9 \\div 1$\n$R x$ : radical orchiectomy (may be delayed to bank sperm)\n\n## Gonadoblastoma\n\n$=$ primitive gonadal stroma tumor (exceedingly rare) containing sex cord-stromal elements + germ cells\nHisto: dysgenetic lesion not neoplasm\n\n- abnormal karyotype in $80 \\%$ : intersex status, phenotypically female\n\n\n## Nonprimary Testicular Tumors\n\nMetastases to Testis (in $0.7 \\%$ of autopsies)\nMean age: 55 years\n(a) in adults: prostate $(35 \\%)>$ lung $(19 \\%)>$ melanoma $(9 \\%)$, colon $(9 \\%)>$ kidney $(7 \\%)$, bladder, thyroid\n$\\diamond$ More common than germ cell tumors in males $>50$ years of age!\n(b) in children: neuroblastoma, retinoblastoma, Wilms tumor, rhabdomyosarcoma\n$\\checkmark$ often multiple and bilateral (in $8-15 \\%$ )\n$\\checkmark$ mostly hypoechoic, occasionally echogenic masses\n\n## Lymphoma of Testis\n\nFrequency: $1-9 \\%$ of all testicular tumors; in $1 \\%$ of patients with NHL / ALL\nAge: most common testicular tumor in men $>$ age 60 ; median age of 37 years in immunocompromised\nPresentation:\n(a) primary testicular lymphoma (rare)\n(b) secondary involvement:\n> initial manifestation of clinically occult disease\n> site of recurrent disease in established lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 257,
            "markdown": "$\\diamond$ Metachronous involvement (in $80 \\%$ ) months to years following orchiectomy\nHisto: NHL = almost exclusively B-cell lymphoma (most commonly diffuse large cell lymphoma $>$ follicular lymphoma, mucosa-associated lymphoid tissue, plasmacytoma, granulocytic sarcoma)\nAssociated with: widespread dissemination to skin, lung, CNS (6-17\\%), Waldeyer ring $(6 \\%)$\n\n- painless testicular enlargement over weeks to months\n- weight loss, anorexia, fever, weakness (initial complaint in 25\\%)\n\nLocation: bilateral in $38 \\%$; synchronous in $20 \\%$\n$\\diamond$ The most common bilateral testicular tumor!\n$\\sqrt{ }$ enlarged diffusely hypoechoic testis $\\leftarrow$ ill-defined diffuse infiltrative process\n$\\sqrt{ }$ multiple focal hypoechoic masses\n$\\sqrt{ }$ epididymis + spermatic cord + skin commonly infiltrated\n$\\sqrt{ }$ increased blood flow on color Doppler\nMR:\n$\\sqrt{ }$ testis replaced by tissue hypointense on T1WI + T2WI\n$\\sqrt{ }$ low-level enhancement less than normal testis\n$\\sqrt{ }$ one / more focal masses\n$\\sqrt{ }$ frequent extension outside testis into epididymis\nPrognosis: poor; median survival of 12 months; 12-35\\% 5-year survival\n$D D x$ : epididymo-orchitis (tender, improvement on Rx), sarcoid (African-American), tuberculosis, leukemia (often prior history of treated leukemia)\n\n# Leukemia of Testis \n\nPrevalence: $60-92 \\%$ on autopsy; $8-16 \\%$ on clinical examination during therapy; up to $41 \\%$ on clinical examination after therapy\n$\\diamond$ Occult testicular tumor often found in patients in bone marrow remission (gonadal barrier $=$ blood-testis barrier to chemotherapy)\n$\\sqrt{ }$ uni- / bilateral tumors:\n$\\sqrt{ }$ diffuse / focal\n$\\sqrt{ }$ hypo- or hyperechoic\n\n## Burned-out Tumor of Testis\n\n$=$ AZZOPARDI TUMOR = REGRESSED GERM CELL TUMOR\n$=$ widespread metastatic disease + spontaneous regression of testicular malignancy $\\leftarrow$ teratocarcinoma\nHisto: minute amounts of residual tumor / dense deposit of collagen + scattered inflammatory cells\nPathogenesis: tumor with high metabolic rate outgrows its own blood supply\n$\\sqrt{ }$ small primary tumor:\n$\\sqrt{ }$ hypoechoic lesion\n$\\sqrt{ }$ highly echogenic focal lesion (= scarred tumor residue)\n$\\sqrt{ } \\pm$ shadowing (= focal calcification)\n$\\sqrt{ }$ metastases to retroperitoneum, mediastinum, cervical / axillary / supraclavicular lymph nodes, lung, liver",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 258,
            "markdown": "# Second Testicular Tumor \n\nPrevalence: $1-5 \\%$ of all testicular cancers\nUS: a testicular abnormality is malignant in only $50 \\%$ !\n\n## SynchRONOUS Testicular Tumor\n\n$=$ development of 2 separate primary tumors $\\leftarrow \\mathrm{NO}$ lymphatic / vascular connections between testes\nFrequency: $10 \\%$ of bilateral tumors\nHisto: identical\n$R x$ : bilateral orchiectomy; for small tumors testis-preserving surgery + radiation therapy\n\n## Metachronous Testicular Tumor\n\n$=$ subsequent development of second primary tumor\nFrequency: $90 \\%$ of bilateral tumors\nRisk for second tumor in cryptorchidism:\n$15 \\%$ for inguinal, $30 \\%$ for abdominal location\nRisk for second contralateral tumor:\nincreased by $500-1,000 \\mathrm{x}$; bilaterality in $1.1-4.4 \\%$;\nDevelopment interval between $1^{\\text {st }}+2^{\\text {nd }}$ tumor:\n4 months to 25 years\n$\\diamond$ Detected in $47 \\%[60 \\%]\\{75 \\%\\}$ by $2[5]\\{10\\}$ years\n\n## TESTICULAR INFARCTION\n\n$=$ extremely rare\nCause: torsion, trauma, acute epididymo-orchitis, leukemia, embolus (eg, bacterial endocarditis, sickle cell disease, polycythemia), vasculitis (eg, polyarteritis nodosa, Henoch-SchÃ¶nlein purpura), hernia repair (testicular atrophy in $0.5 \\%$ after first repair, in $0.8-5 \\%$ after recurrent repair)\nAge: $20-40$ years\nLocation: often in periphery with extension to capsule\n\n- painful testis, soft to palpation\n$\\checkmark$ focal hypoechoic wedge-shaped region without flow (most common)\n$\\checkmark$ hyperechoic regions $\\leftarrow$ hemorrhage / fibrosis\n$\\checkmark$ decrease in testicular size over time $\\leftarrow$ fibrosis\n$\\checkmark$ diffusely hypoechoic small testis\nMR:\n$\\checkmark$ hypo- / (typically) isointense to normal testis on T1WI:\n$\\checkmark$ may have high SI on T1WI $\\leftarrow$ hemorrhage\n$\\checkmark$ hypointense to normal testis on T2WI\n$\\checkmark$ avascular area + enhancing rim on contrast administration\n$D D x$ : malignancy (difficult differentiation)\n\n\n## TESTICULAR MICROLITHIASIS\n\nDefinition: $>5$ microliths per image; $\\leq 5$ microliths per image $=$ limited microlithiasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 259,
            "markdown": "Etiology: defect in phagocytotic activity of Sertoli cells leaving degenerated intratubular debris behind\nPrevalence: $0.6 \\% ; 5 \\%$ in asymptomatic men aged 18-35 years\nMay be associated with:\ntesticular germ cell tumor ( $40 \\%$ ), cryptorchidism, subfertility, infertility, Klinefelter syndrome, testicular infarcts, granulomas, male pseudohermaphroditism, Down syndrome, pulmonary alveolar microlithiasis, congenital urethroperineal fistula\nHisto: laminated concretions within lumen of seminiferous tubules\n\n- asymptomatic, uncommon incidental finding\n$\\sqrt{1-2-\\mathrm{mm}(>5)}$ hyperechoic nonshadowing foci scattered throughout the parenchyma of both testes (PATHOGNOMONIC):\n$\\sqrt{ }$ may be asymmetrically distributed, unilateral, clustered in periphery\n$C x:$ concurrent germ cell tumor in up to $40 \\%$ ( 21.6 x risk)\nPrognosis: the vast majority of patients with testicular microlithiasis will not develop testicular cancer\n$\\diamond$ Testicular microlithiasis is not a premalignant condition and does not cause testicular cancer!\nRecommendation: follow up in 6-12-month intervals to screen for testicular tumors (contested)\n$D D x:$ postinflammatory changes, scars, granulomatous changes, benign adenomatoid tumor, hemorrhage with infarction, large-cell calcifying Sertoli cell tumor\n\n\n# TESTICULAR TRAUMA \n\n$=$ SCROTAL TRAUMA\nFrequency: $<1 \\%$ of all traumas\nCause:\n(a) blunt force (crushing of testis against symphysis / between thighs): sporting activity ( $>$ $50 \\%$ ), motor vehicle accident ( $9-17 \\%$ )\nPathophysiology: contusion $\\rightarrow$ hematoma $\\rightarrow$ fracture $\\rightarrow$ rupture\n(b) penetrating: sharp object (knife), missile (bullet), animal bite, self mutilation\n(c) iatrogenic: complication of herniorrhaphy\n(d) degloving injury: genital skin entrapped in rotating machinery\n(e) thermal injury\n\nPeak age: $10-30$ years\nSite: $\\mathrm{R}>\\mathrm{L}$ (superior location with propensity to become trapped against pubis / inner thigh)\n$\\sqrt{ }$ hematoma in scrotal wall / between layers of tunica vaginalis (= hematocele) / in epididymis / in testis\n$\\sqrt{ }$ uriniferous hydrocele $\\leftarrow$ perforated bulbous urethra\n$C x:$ torsion in $5-8 \\% \\leftarrow$ sudden forceful cremasteric contraction on \"bell and clapper\" deformity\n\n## Testicular Dislocation\n\nCause: impact against fuel tank of motor cycle\nAt risk: patients with wide inguinal ring / indirect inguinal hernia / atrophic testis\nSite: superficial inguinal ( $50 \\%$ ), pubic ( $18 \\%$ ), canalicular ( $8 \\%$ ), penile ( $8 \\%$ ),",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 260,
            "markdown": "intraabdominal (6\\%), perineal (4\\%), crural (2\\%)\n\n# Testicular Fracture \n\n$=$ break / discontinuity in testicular parenchyma\nFrequency: $17 \\%$ of testicular trauma\n$\\sqrt{ }$ linear hypoechoic + avascular band disrupting the architecture (= fracture line)\n$\\sqrt{ }$ smooth outer contour with intact tunica albuginea\n$\\sqrt{ }$ usually preserved vascular flow\n$R x:$ conservative / debridement along fracture line\n\n## Testicular Hematoma\n\n- may be quite large $\\leftarrow$ surrounding scrotal elasticity\n\nUS:\n$\\sqrt{ }$ over time age-dependent rapid change in echo character of hematoma + decrease in size\n(a) hyperacute / acute hematoma\n$\\sqrt{ }$ initially hyperechoic acute hematoma\n$\\sqrt{ }$ later isoechoic $\\rightarrow$ reexamination after 12-24 hours\n(b) chronic hematoma\n$\\sqrt{ }$ hypoechoic / anechoic mass decreasing in size\n$\\sqrt{ }$ absence of internal vascularity (DDx: tumor)\n$\\sqrt{ }$ peripheral hyperemia in infected hematoma ( $40 \\%$ incidence)\n$\\sqrt{ }$ developing testicular cyst $\\leftarrow$ subacute / chronic liquefaction of hematoma\nMR:\n$\\sqrt{ }$ hyperintense hematoma on T1WI\n$\\sqrt{ }$ hypointense hemosiderin rim on T2WI\nNB.: Follow-up all hematomas to resolution!\n$\\diamond 40 \\%$ of hematomas become infected + lead to necrosis!\n$\\diamond$ Testicular cancer is incidentally identified in $10-15 \\%$ of patients with scrotal trauma!\n$R x:$ conservative (ice pack, NSAID)\n\n## Testicular Rupture\n\n$=$ tear / rupture of tunica albuginea with protrusion of seminiferous tubules\nPathophysiology: 50 kg of force ruptures tunica albuginea\n$\\diamond$ SURGICALEMERGENCY!\nUS ( $100 \\%$ sensitive, $65 \\%$ specific):\n$\\sqrt{ }$ disruption of tunica albuginea = discontinuity of echogenic testicular outline ( $50 \\%$ sensitive, $76 \\%$ specific)\n$\\sqrt{ }$ abnormal testicular contour = extrusion of testicular parenchyma (difficult DDx: peritesticular hematoma)\n$\\diamond$ Err on the side of overcalling!\n$\\sqrt{ }$ heterogeneous echotexture of testis with areas of $\\Downarrow / \\uparrow$ echogenicity $\\leftarrow$ hemorrhage $\\pm$ necrosis (DDx: intratesticular hematoma without rupture)\n$\\sqrt{ }$ avascular region on color duplex $\\leftarrow$ disruption of tunica vasculosa (DDx: hematoma)\n$\\sqrt{ }$ thickened scrotal wall $\\leftarrow$ hematoma of scrotal wall",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 261,
            "markdown": "$\\sqrt{ }$ hematocele, may show thickening + calcification of tunica vaginalis if chronic MR (long examination time):\n$\\sqrt{ }$ area of heterogeneously low SI on T2WI\n$\\sqrt{ }$ interruption of hypointense fibrous tunica albuginea\n$R x$ : immediate surgical repair $\\rightarrow$ preservation of fertility + hormonal function / orchiectomy\nSalvageability: $80-90 \\%$ if surgical repair occurs $<72$ hours after trauma; $30-55 \\%$ if surgical repair occurs $>72$ hours after trauma\n$D D x$ : laceration, contusion, hemorrhage\n\n# TRANSITIONAL CELL CARCINOMA \n\n$=$ UROTHELIAL CELL CARCINOMA\n$\\diamond$ Most common urinary tract cancer in USA + Europe!\nMean age: 68 years; $\\mathrm{M} \\div \\mathrm{F}=2.7 \\div 1$; Whites $>$ Blacks\nPathogenesis: chemical carcinogens act locally on epithelium (= field of change), action enhanced by length of contact time (eg, stasis / diverticulum / horseshoe kidney)\nRisk factors:\n(1) Cigarette smoking ( $2-3 \\mathrm{x}$ ): dose-response relation to pack-years; $50-60 \\%$ in M, $33 \\%$ in F\n(2) Chemical carcinogens: aniline dye, benzidine, aromatic amines, azo dyes in textile, rubber, petroleum, printing, plastic manufacturing, arsenic in drinking water (lag time of 10 years)\n(3) Antineoplastic alkylating agents: carmustine, busulfan, cyclophosphamide (lag time of 6.5 years)\n(4) Analgesic abuse ( 8 x increase): long-term use of phenacetin $\\rightarrow$ capillosclerosis + renal pelvic TCC\n(5) Balkan nephropathy ( $=$ progressive renal failure + development of bilateral and multiple tumors) $\\leftarrow$ unintentional ingestion of aristolochic acid in seeds of the Aristolochia clematitis plant (contaminating flour)\n(6) Recurrent / chronic urinary tract infection (esp. Schistosoma haematobium)\n(7) Heavy caffeine consumption (?)\n\nGrowth pattern:\n(a) papillary lesion with predominantly exophytic growth\n$=$ frondlike structure with central fibrovascular core lined by epithelial layer\n> broad based\n> pedunculated\n(b) infiltrating: usually higher grade + less common\n(c) carcinoma in situ\n\nGrade: usually correlates with stage\n$1=$ cells slightly anaplastic\n$2=$ intermediate features\n$3=$ marked cellular pleomorphism\nLocation: typically multifocal\n@ Lower urinary tract $(95 \\%)$\n\n1. Urinary bladder: $30-50 \\mathrm{x}$ more common than upper urinary tract",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 262,
            "markdown": "@ Upper urinary tract $(5 \\%)$\n2. Kidney ( $3.75 \\%$ ): calyx $>$ renal pelvis\n3. Ureter $(1.25 \\%)$ : $75 \\%$ in lower $1 / 3-25 \\%$ in upper $2 / 3$\n\nSpread: mucosal extension, regional lymph nodes (early involvement), hematogenous (liver, bone, lung)\nPrognosis: multicentricity means poor survival; frequent synchronous + metachronous tumors requires vigilant urologic + radiographic follow-up\nFollow-up: annual CT x 2 years; cystoscopy $4 \\times 3$ months for 1 st year, $2 \\times 6$ month in 2 nd year, yearly thereafter for early detection of metachronous bladder TCC\n\n# Renal TCC \n\nPrevalence: $7 \\%$ of all renal neoplasms; bilateral in $2-4 \\% ; 90 \\%$ of all tumors arising from renal pelvic urothelium\nAge: $\\quad 6^{\\text {th }} \\& 7^{\\text {th }}$ decades; $\\mathrm{M}+\\mathrm{F}=3 \\div 1$\nSite: extrarenal part of renal pelvis $>$ infundibulocaliceal region\n$\\diamond$ Synchronous bilateral renal TCC in 1-2\\%\n$\\diamond$ Metachronous renal TCC in 11-13\\%\n$\\diamond$ Metachronous bladder TCC in 23-40\\% after 15-48 months\nExcretory Urogram:\n$\\sqrt{ }$ single / multiple sessile / pedunculated mulberry-like filling defects in renal pelvis $(35 \\%)$ :\n$\\sqrt{ }$ \"stipple\" sign = contrast material trapped in interstices of papillary lesion (DDx: blood clot, fungus ball)\n$\\checkmark$ dilated calyx with filling defect $(26 \\%) \\leftarrow$ stricture / complete obstruction of infundibulum:\n$\\sqrt{ } \\pm$ focal delayed increasingly dense nephrogram\n$\\sqrt{ }$ caliceal amputation $(19 \\%)=$ \"phantom calyx\" = failure to opacify $\\leftarrow$ obstruction (DDx: TB stricture of infundibulum)\n$\\sqrt{ }$ \"oncocalyx\" = contrast outlining distended calyx completely filled with tumor\n$\\checkmark$ absent / decreased excretion with renal atrophy $(13 \\%) \\leftarrow$ long-standing obstruction of ureteropelvic junction\n$\\checkmark$ renal enlargement:\n$\\checkmark$ large bean-shaped kidney $\\leftarrow$ infiltrative tumor invasion of renal parenchyma\n$\\checkmark$ hydronephrosis $(6 \\%) \\leftarrow$ tumor obstructing ureteropelvic junction\n$\\checkmark$ tumor calcifications in $2-7 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 263,
            "markdown": "| Staging of Transitional Cell Cancer of Kidney |  |  |\n| :--: | :--: | :--: |\n| TNM | AJCC | Description |\n| Tx | ... | primary tumor cannot be assessed |\n| T0 | ... | no evidence of primary tumor |\n| Tis | 0 | in situ lesion |\n| Ta | ... | noninvasive papillary carcinoma |\n| T1 | I | invasion of subepithelial connective tissue |\n| T2 | II | confined to muscularis layer |\n| T3 | III | invasion of renal parenchyma / peripelvic soft tissues |\n| T4 | IV | extension beyond renal capsule |\n| N0 |  | negative lymph nodes |\n| N1 |  | single node $\\leq 20 \\mathrm{~mm}$ |\n| N2 |  | single node $>20-\\leq 50 \\mathrm{~mm} /$ multiple nodes $\\leq 50 \\mathrm{~mm}$ |\n| N3 |  | node $>50 \\mathrm{~mm}$ |\n| M0 |  | no distant metastasis |\n| M1 |  | distant metastasis: lung, retroperitoneum, bone |\n\nRetrograde pyelography:\n$\\sqrt{ }$ smooth / irregular / stippled intraluminal filling defect\n$\\sqrt{ }$ irregular papillary / nodular mucosa\n$\\sqrt{ }$ \"amputated\" calyx $\\pm$ focal hydronephrosis\n$\\sqrt{ }$ \"oncocalyx\" = tumor-filled distended calyx\n$\\sqrt{ }$ calculus $\\leftarrow$ urinary stasis\nUS:\n$\\sqrt{ }$ bulky hypoechoic (similar to renal parenchyma) / slightly hyperechoic mass lesion\n$\\sqrt{ }$ infiltrative without disruption of renal contour\n$\\sqrt{ }$ splitting / separation of central renal sinus complex\n$\\sqrt{ } \\pm$ caliectasis without pelviectasis\nNECT:\n$\\sqrt{ }$ tumor density of $5-30 \\mathrm{HU}$ :\n$\\sqrt{ }$ hyperattenuating relative to urine + renal parenchyma\n$\\sqrt{ }$ hypoattenuating relative to clot ( $40-80 \\mathrm{HU}$ ) / calculus ( $>100 \\mathrm{HU}$ )\n$\\sqrt{ }$ hydronephrosis / hydrocalyx (most frequent finding)\n$\\sqrt{ }$ \"faceless\" kidney on cross-sectional imaging $\\rightarrow$ coronal imaging helpful\nCECT (36-52-83\\% staging accuracy):\n$\\sqrt{ }$ focal or diffuse mural thickening of pelvicaliceal wall\n$\\sqrt{ }$ pelvicaliceal irregularity\n$\\sqrt{ }$ oncocalyx\n$\\sqrt{ }$ central sessile solid filling defect centrifugally expanding renal pelvis\n$\\sqrt{ }$ obliteration / compression of renal sinus fat\n$\\sqrt{ }$ invasion of renal parenchyma (infiltrating growth pattern) with preservation of reniform shape\n(DDx: expansile RCC distorting renal contour)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 264,
            "markdown": "$\\sqrt{ }$ coarse punctate calcific deposits $(0.7-6.7 \\%)$ may mimic urinary calculi\n$\\sqrt{ }$ variable enhancement of tumor\nMR:\n$\\sqrt{ }$ typically isointense relative to renal medulla on T1WI\n$\\sqrt{ }$ hypointense filling defect in hyperintense urine on T2WI\n$\\sqrt{ }$ hypointense soft-tissue mass infiltrating renal parenchyma of intermediate SI\n$\\sqrt{ }$ hypoenhancing tumor mass on postcontrast imaging, (rarely) avidly enhancing\n$\\sqrt{ }$ enhancing focal filling defect in collecting system\n$D x$ : cytologic analysis of urine (selective lavage, ureteral urine collection, brush biopsy, ureteroscopy\n$D D x$ : papilloma (benign lesion, fronds lined by normal epithelium), blood clot\nPrognosis: $77-80 \\%$ 5-year survival rate without invasion of muscularis mucosa; $5 \\%$ 5-year survival rate with invasion of muscularis mucosa\n$R x$ : total nephroureterectomy + excision of ipsilateral ureteric orifice with cuff of bladder\n\n# Ureteral TCC \n\nIncidence: $1 \\%$ of all upper urinary tract cancers\nSite: lower $1 / 3(70 \\%)$, mid $1 / 3(15 \\%)$, upper $1 / 3(15 \\%)$\n$\\diamond$ Synchronous TCC in both ureters in $2-9 \\%$\n$\\diamond$ Metachronous upper tract TCC in 11-13\\%\n$\\diamond$ Metachronous bladder TCC in 20-50\\% (within 2 years of surgical treatment)\nExcretory Urogram:\n$\\sqrt{ }$ nonfunctioning kidney in advanced tumor (46\\%)\n$\\sqrt{ }$ hydronephrosis $\\pm$ hydroureter (34\\%)\n$\\sqrt{ }$ single / multiple ureteral filling defects (19\\%) $\\pm$ surface stippling\n$\\sqrt{ }$ irregular nontapering narrowing of ureteral lumen\nRetrograde pyelography:\n$\\sqrt{ }$ stricture suggestive of malignancy:\n$\\sqrt{ }$ ureteric fixation + nontapering margins\n$\\sqrt{ }$ eccentric / circumferential stricture\n$\\sqrt{ }$ \"champagne glass / chalice / goblet\" sign = focal expansion of ureter around + distal to intraluminal slow growing polypoid tumor $\\leftarrow$ mechanical dilatation $\\leftarrow$ to-and-fro peristalsis of mass\n$\\sqrt{ }$ Bergman sign = \"catheter-coiling\" sign = coiling of catheter on retrograde catheterization below the mass\nCT:\n$\\sqrt{ }$ enhancing intraluminal soft-tissue mass\n$\\sqrt{ }$ eccentric / circumferential thickening of ureteral wall\n$\\sqrt{ }$ periureteric fat stranding $\\leftarrow$ extramural spread\n\n## TRAUMA TO BLADDER\n\n## Cause:\n\n1. Blunt injury (67-86\\%): often associated with pelvic fractures\n2. Penetrating injury ( $14-33 \\%$ )\n\nAssociated with: pelvic fracture in $70 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 265,
            "markdown": "Indications for urethrogram:\n\n- blood at urethral meatus, inability to pass Foley catheter\n- \"floating\" prostate\n$\\checkmark$ diastasis of symphysis\n$\\sqrt{ }$ \"pie-in-the-sky bladder\" = high position of opacified bladder within pelvis $\\leftarrow$ large pelvic hematoma with disruption of bladder moorings + associated urethral injury\nCT cystogram:\nTechnique:\nÂ» prior to IV contrast instill up to 400 mL of diluted contrast solution via Foley catheter under gravity flow $\\rightarrow$ clamp Foley to maintain bladder distension, OR\nÂ» clamp Foley $\\rightarrow$ IV contrast injection $\\rightarrow$ delayed imaging after 180-300 seconds after opacification of bladder\n$\\checkmark$ focal thickening of bladder wall = contusion\n$\\checkmark$ contrast extravasation\n\n\n# Bladder Contusion (most common injury) \n\n$=$ intramural hematoma\n$\\checkmark$ no extravasation\n$\\checkmark$ lack of normal distensibility\n$\\checkmark$ crescent-shaped filling defect in contrast-distended bladder\n\n## Interstitial Bladder Injury (uncommon)\n\n$=$ bladder tear without serosal involvement\n\n## Bladder Rupture\n\nCystography: diagnostic in $>85 \\%$; false-negatives if tear sealed by hematoma / mesentery CT:\n$\\checkmark$ unusual fluid / gas collection\n$\\checkmark$ abnormal location of Foley catheter\n$\\checkmark$ defect in enhancing bladder wall\n\n## Extraperitoneal Rupture of Bladder (80-90\\%)\n\nCause: pelvic fracture (sharp bony spicule) or avulsion tear at fixation points of puboprostatic ligaments $\\rightarrow$ separation of fascial planes between bladder + pelvis\nLocation: tear usually close to base of bladder anterolaterally\nPlain film:\n$\\checkmark$ \"pear-shaped\" bladder\n$\\checkmark$ loss of obturator fat planes\n$\\checkmark$ paralytic ileus\n$\\checkmark$ upward displacement of ileal loops\nContrast examination:\n$\\checkmark$ flame-shaped contrast extravasation into perivesical fat, best seen on postvoid films, may extend into thigh / anterior abdominal wall\nCT:\n$\\checkmark$ relatively contained extravasated fluid isoattenuating to fluid in bladder:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 266,
            "markdown": "$\\sqrt{ }$ limited to perivesical (Retzius) space $=$ simple\n$\\sqrt{ }$ extravasated contrast extends to prevesical space, thigh, scrotum, perineum $=$ complex\nUS:\n$\\sqrt{ }$ \"bladder within a bladder\" = bladder surrounded by fluid collection\n$R x$ : conservative (urinary drainage via Foley); surgery\n\n# Intraperitoneal Rupture of Bladder (10-20\\%) \n\n## Cause:\n\n(a) usually as a result of invasive procedure (cystoscopy), stab wound, surgery\n(b) blunt trauma with sudden rise in intravesical pressure (= distended bladder at time of impact)\nLocation: tear usually at dome of bladder\n$\\sqrt{ }$ contrast extravasation (requires adequate bladder filling) into paracolic gutters, rectovesical / rectouterine pouch\n$\\sqrt{ }$ contrast outlining / surrounding intraperitoneal structures (small bowel loops + mesentery)\n$\\sqrt{ }$ extravasated contrast less dense than in bladder $\\leftarrow$ contrast dilution within large intraperitoneal space\n$\\sqrt{ }$ uriniferous ascites\n$R x$ : surgery\n\n## TRAUMA TO KIDNEY\n\nFrequency: $3-10 \\%$ of injuries in emergency department\n$\\diamond 95-98 \\%$ of isolated renal injuries are considered minor injuries and managed nonsurgically!\nIndications for imaging:\n(1) Penetrating injury + gross hematuria\n(2) Blunt trauma + microscopic hematuria + hypotension $<90 \\mathrm{mmHg}$\n(3) Blunt trauma + known association with renal injuries (eg, rapid deceleration, fall from a height, direct contusion / hematoma of flank soft tissues, fracture of lower ribs / transverse processes / thoracolumbar spine)\n(4) Microscopic hematuria + positive peritoneal lavage\n$\\diamond$ Only $0.1-0.5 \\%$ of hemodynamically stable patients with microscopic hematuria have significant urinary tract injury!\n\n## Classification:\n\nI. MINOR RENAL INJURY (75-85\\%)\n$\\sqrt{ }$ no / limited perinephric hematoma\n$D D x$ : respiratory motion artifact (low-attenuation area surrounding kidney)\n$\\sqrt{ }$ no extravasation of urine (= no caliceal disruption)\n\n1. Intrarenal hemorrhage / hematoma $=$ renal contusion\n$\\sqrt{ }$ hyperattenuating area of $40-70 \\mathrm{HU}$ (= acute clotted blood) on NECT\n$\\sqrt{ }$ sharply / poorly defined round / ovoid area of decreased enhancement during CECT (DDx: renal infarction with no enhancement)\n$\\sqrt{ }$ focal area of striation on delayed nephrogram\n$\\sqrt{ }$ area of persistent contrast material staining on very delayed scan",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 267,
            "markdown": "# 2. Subcapsular hematoma \n\n$\\sqrt{ }$ round / lenticular-shaped fluid collection + flattening of subjacent parenchyma\n3. Perinephric hematoma without extension to collecting system / medulla\n$\\sqrt{ }$ defects in periphery of renal parenchyma\n$\\sqrt{ } \\pm$ limited perinephric hematoma with attenuation values of $45-90 \\mathrm{HU}$\n$\\diamond$ Subcapsular / perinephric hematoma usually proportional to extent of injury\n4. Small subsegmental cortical infarct\n\nCause: stretching + thrombotic occlusion of accessory renal artery / capsular artery / segmental artery\n$\\sqrt{ }$ sharply demarcated wedge-shaped area of decreased contrast enhancement\n$R x:$ observation\nII. MAJOR RENAL LACERATION (10\\%)\n$=$ complete cortical laceration / fracture extending to medulla $\\pm$ collecting system\n$\\sqrt{ }$ laceration connecting two cortical surfaces $=$ renal fracture $=$ separation of renal poles\n$\\sqrt{ } \\pm$ devascularization of renal parenchyma\n(a) without involvement of collecting system:\n$\\sqrt{ }$ nonenhancing deep parenchymal cleft filled with hematoma on CECT\n$\\sqrt{ }$ perirenal hematoma from capsular disruption\n\n| Kidney Injury Scale |  |  |\n| :--: | :--: | :--: |\n| American Association for the Surgery of Trauma (AAST) |  |  |\n| Grade | Injury | Description (based on surgical findings) |\n| I | contusion | hematuria + normal urologic studies |\n|  | hematoma | subcapsular nonexpanding, no laceration |\n| II | hematoma | nonexpanding perirenal, confined to renal retroperitoneum |\n|  | laceration | $<1 \\mathrm{~cm}$ parenchymal depth of renal cortex, no urinary extravasation |\n| III | laceration | $>1 \\mathrm{~cm}$ parenchymal depth of renal cortex, no collecting system rupture / urinary extravasation |\n| IV | laceration | parenchymal laceration extending through renal cortex, medulla, collecting system |\n|  | vascular | main renal artery / vein injury + contained hemorrhage |\n| V | laceration | completely shattered kidney |\n|  | vascular | avulsion of renal hilum with devascularization of kidney |\n| $\\nabla$ | Advance one grade for multiple injuries to same organ |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 268,
            "markdown": "![img-16.jpeg](img-16.jpeg)\n(b) with involvement of collecting system:\n$\\sqrt{ }$ urine extravasation of contrast material on delayed images 3-5 minutes after injection\n$\\sqrt{ }$ perinephric fluid during portal venous phase $\\rightarrow$ suspect urinoma!\n(c) active hemorrhage / pseudoaneurysm:\n$\\diamond$ Hemodynamic decompensation may be imminent in $38 \\%$ !\n$\\sqrt{ }$ intense contrast enhancement within a laceration / hematoma during early phase:\n$\\sqrt{ }$ linear / flamelike contrast extravasation of $80-370 \\mathrm{HU}$ or within $10-15 \\mathrm{HU}$ of aortic density\n$R x:$ variable (clinical judgement required)\nIII. CATASTROPHIC RENAL INJURY (5\\%)\n$\\sqrt{ }$ extravasation of contrast material with patchy areas of $85-370 \\mathrm{HU}$ (= active bleeding)\n\n1. Multiple renal lacerations $=$ shattered kidney\n$\\sqrt{ }$ multiple separate renal fragments\n$\\sqrt{ }$ lack of enhancement of part of kidney $\\leftarrow$ segmental renal arterial infarctions\n$\\sqrt{ } \\pm$ cortical rim nephrogram ( $=$ enhancement of renal periphery through intact capsular / collateral vessels)\n$R x:$ surgical exploration / nephrectomy\n2. Vascular injury of renal pedicle\n$=$ occlusion of main renal artery $\\leftarrow$ intimal flap",
            "images": [
                {
                    "id": "img-16.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1166,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 269,
            "markdown": "- hematuria may be absent\n$\\sqrt{ }$ abrupt termination of main renal artery just beyond its origin\n$\\sqrt{ }$ minimal hematoma around proximal renal artery\n$\\sqrt{ }$ absence of perinephric hematoma (HALLMARK)\n$\\sqrt{ }$ absent nephrogram on affected side\n$\\sqrt{ }$ retrograde opacification of ipsilateral renal vein\n$\\sqrt{ }$ cortical rim nephrogram (develops $>8$ hours after injury)\nPrognosis: high risk of ongoing hemorrhage\n$R x$ : revascularization procedure (in $14 \\%$ return of renal function)\n\n3. Avulsion of renal artery (rare)\n$=$ tearing of tunica muscularis + adventitia\n$\\sqrt{ }$ absent contrast enhancement ( $=$ global infarct)\n$\\sqrt{ }$ extensive medial perirenal hematoma\n$\\sqrt{ }$ active arterial bleeding\nPrognosis: life-threatening\n4. Thrombosis / laceration of renal vein (rare)\n$\\sqrt{ }$ intraluminal thrombus in dilated renal vein\n$\\sqrt{ }$ acute venous hypertension:\n$\\sqrt{ }$ nephromegaly\n$\\sqrt{ }$ diminished nephrogram\n$\\sqrt{ }$ delayed nephrographic progression\n$\\sqrt{ }$ decreased excretion\nIV. INJURY OF URETEROPELVIC JUNCTION (rare)\n$=$ laceration ( $=$ incomplete tear in $60 \\%$ ) / avulsion\n( $=$ complete transection) of ureter at UPJ\nMechanism: tension on renal pedicle by sudden deceleration\nAge: usually young boys\nAssociated with: fracture of transverse process (30\\%)\n\n- gross / microscopic hematuria (53-60\\%)\nN.B.: delayed imaging to check for urine leak!\n$\\sqrt{ }$ massive extravasation of contrast material medially in the region of UPJ\n$\\sqrt{ }$ nonfilling of affected ureter (with avulsion)\n$\\sqrt{ } \\pm$ circumferential perinephric urinoma\nEarly Cx: urinoma formation (1-7\\%), infected urinoma, perinephric abscess, sepsis, delayed bleeding $\\leftarrow$ arteriovenous fistula / pseudoaneurysm\nLate Cx: posttraumatic renovascular hypertension, hydro- nephrosis, calculus formation, chronic pyelonephritis\n\n\n# Blunt Trauma to Kidney \n\nFrequency: $80-90 \\%$ of all renal injuries\nCause: motor vehicle accident, fight, assault, contact sports, fall from a height\nMechanism: (a) crush injury $(>80 \\%)=$ direct blow with renal laceration by lower ribs\n(b) sudden deceleration $\\rightarrow$ renal artery tear\n\nAssociated with: other organ injury in $75 \\%$; fracture of lower ribs / thoracolumbar spine /",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 270,
            "markdown": "transverse processes of L-spine\n\n- contusion / hematoma of flank\n- $>95 \\%$ hematuria ( $>5$ RBCs per high-power field):\nN.B.: poor correlation between severity of hematuria + severity of renal injury\n$\\diamond$ With gross hematuria $25 \\%$ have significant injuries!\n$\\diamond$ With renal pedicle injury $24 \\%$ have no hematuria!\n$\\diamond$ Normotensive patients with microscopic hematuria ( $<35$ RBCs per high-power field) have a significant renal injury in $<0.2 \\%$ !\nLocation: simultaneous upper + lower GU tract injury in $<5 \\%$\n$R x$ : The only absolute indication for surgery is life-threatening active bleeding! Urine leaks will close spontaneously in $87 \\%$ !\n\n\n# Penetrating Renal Trauma \n\nFrequency: $10-20 \\%$ of all renal trauma\nCause: gunshot, stab wound, shrapnel, biopsy\nAssociated with: multiorgan injuries in $80 \\%$\n$C x$ : (1) infection $\\leftarrow$ \"dirty\" contaminated wound\n(2) \"bullet / buckshot colic\", \"birdshot calculus\" = ureteral obstruction $\\leftarrow$ migrating missile\n![img-17.jpeg](img-17.jpeg)",
            "images": [
                {
                    "id": "img-17.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 990,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1958,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 271,
            "markdown": "| Classification System of Urethral Injury at Urethrography (Goldman) |  |  |\n| :--: | :--: | :--: |\n| Type | Injury | Urethrographic Signs |\n| I | stretching of posterior urethra | $\\sqrt{ }$ intact stretched urethra |\n| II | disruption of urethra above urogenital diaphragm | $\\checkmark$ extravasation above urogenital diaphragm |\n| III | disruption of membranous urethra with extension below urogenital diaphragm to involve anterior urethra | $\\checkmark$ extravasation below urogenital diaphragm $\\pm$ extension to pelvis / perineum <br> $\\checkmark$ intact bladder neck |\n| IV | bladder neck injury with extension to proximal urethra | $\\checkmark$ extraperitoneal extravasation <br> $\\checkmark$ bladder neck disruption |\n| IVa | bladder base injury simulating type IV | $\\checkmark$ periurethral extravasation <br> $\\checkmark$ bladder base disruption |\n| V | isolated anterior urethral injury | $\\checkmark$ extravasation below urogenital diaphragm confined to anterior urethra |\n\n# TRAUMA TO URETHRA \n\nFrequency: in $4-14 \\%$ of pelvic fractures in males, in $<6 \\%$ of pelvic fractures in females Associated with: bladder laceration in up to $20 \\%$\nLocation:\n(a) posterior urethra (in $4-14 \\%$ of pelvic fractures)\n(b) anterior urethra (often isolated) $\\leftarrow$ straddle injury\n\n- gross hematuria, blood at meatus ( $50 \\%$ ), swelling / hematoma of perineum / penis, \"highriding\" prostate at digital exam\n- inability to void\nN.B.: blind urethral catheterization is contraindicated!\n\nCT (indirect findings):\n$\\checkmark$ pelvic diastasis / fractures\n$\\checkmark$ distortion of periprostatic structures\n$\\checkmark$ hematoma of ischiocavernosus / obturator muscle\n$\\checkmark$ excretory contrast extravasation around bladder base\nUrethrographic technique:\n(a) ascending (retrograde) urethrography\nÂ» external occlusion with Knutsson / Brodney clamp\nÂ» internal occlusion with inflatable balloon (6-8-F Foley with 5 mL balloon / HSG catheter with 3 mL balloon)\n(b) descending (antegrade) urethrography\nÂ» bladder filling with $350-400 \\mathrm{~mL}$ contrast\nÂ» imaging during micturation + after voiding\n(c) ascending pericatheter urethrography",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 272,
            "markdown": "Â» 4-6-F pediatric catheter with balloon inflated in navicular fossa alongside indwelling catheter\nÂ» gradually advance 4-6-F feeding tube $\\pm$ seal with tightly tied ribbon gauze around penis proximal to glans\n(d) descending pericatheter urethrography\n$=$ voiding around indwelling catheter\nÂ» indwelling catheter pushed deeper into bladder $\\pm$ deflation of balloon (avoid dislodging catheter!)\n$R x$ : suprapubic catheter for urethral / bladder injury\nCx: (1) Urethral stricture $(38-100 \\%)$\n(2) Impotence (in up to $40 \\%$ )\n(3) Incontinence $(30 \\%)$\n\n# TUBERCULOSIS OF GU TRACT \n\nThe urogenital tract is the $2^{\\text {nd }}$ most common site after lung; almost always affects the kidney first $=$ hematogenous focus from lung / bone / GI tract\nAge: usually before age $50 ; \\mathrm{M}>\\mathrm{F}$\nPath: organisms lodge in periglomerular capillaries; breakdown in host immunity results in extensive necrosis + fibrosis (coalescing cortical granulomas); organisms spill down the nephrons and become trapped in the narrow segment of the loop of Henle forming ulcerocavernous papillary lesions, which erode into collecting system\nSpread:\n(a) contiguous: from renal parenchyma $\\rightarrow$ along urothelium $\\rightarrow$ to infundibula, renal pelvis, ureter, bladder\n(b) hematogenous (rare): epididymis, testis\n$\\diamond$ It is unusual for genitourinary sites to be affected without involvement of kidney first!\n\n- gross / microscopic hematuria\n- \"sterile\" pyuria, frequency, urgency, dysuria\n- history of previous clinical TB $(15-20 \\%) \\rightarrow$ lag time of $2-40$ years\n\nIVP (abnormal in $85-90 \\%$ )\n\n## Adrenal Tuberculosis 6\\%\n\n$\\diamond 5^{\\text {th }}$ most common site of extrapulmonary tuberculosis\n\n- Addisonian type clinical picture\n$\\sqrt{ }$ bilaterally enlarged glands ( $91 \\%$ )\n$\\sqrt{ }$ low-attenuation center + peripheral enhancement (47\\%)\n$\\sqrt{ }$ dotlike calcifications (59\\%)\n\n\n## Renal Tuberculosis\n\n$\\diamond$ Renal TB in 5-10\\% of patients with pulmonary TB!\n$\\diamond$ Radiographic evidence of pulmonary TB in $<50 \\%$ of patients with renal TB (only $5 \\%$ have active cavitary TB)!\nLocation: unilateral (75\\%)\n$\\sqrt{ }$ renal size: enlarged (early) / small (late) / normal (most common):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 273,
            "markdown": "$\\sqrt{ }$ \"putty kidney\" = tuberculous pyonephrosis from ureteral stricture\n$\\sqrt{ }$ autonephrectomy $=$ small shrunken scarred nonfunctioning kidney $\\pm$ dystrophic calcifications\n$\\sqrt{ }$ cortical scars, often associated with parenchymal calcifications:\n$\\sqrt{ }$ distortion of collecting system $\\leftarrow$ adjacent cortical scarring\n$\\sqrt{ }$ displacement of collecting system $\\leftarrow$ tuberculoma of low attenuation (initial infection)\n$\\sqrt{ }$ \"moth-eaten calyx\" = \"smudged\" papillae = irregular feathery appearance of surface of papilla $\\leftarrow$ erosion (earliest sign) $\\rightarrow$ progression to papillary necrosis\n$\\sqrt{ }$ cavities communicating with collecting system:\n$\\sqrt{ }$ irregular tract formations from calyx into papilla\n$\\sqrt{ }$ large irregular cavities with extensive destruction\n$\\sqrt{ }$ blunted dilated calices = papillary necrosis\n$\\sqrt{ }$ strictures of infundibula / renal pelvis:\n$\\sqrt{ }$ dilated calices (hydrocalycosis) often with sharply defined circumferential narrowing (infundibular strictures) at one / several sites (most common finding)\n$\\sqrt{ }$ caliceal truncation\n$\\sqrt{ }$ \"phantom calyx\" / amputated calyx = incomplete visualization of calyx $\\leftarrow$ infundibular stenosis\n$\\sqrt{ }$ reduced capacity of renal pelvis\n$\\sqrt{ }$ Kerr kink = kinking of renal pelvis\n$\\sqrt{ }$ hydronephrosis with irregular margins + filling defects $\\leftarrow$ caseous debris\n$\\sqrt{ }$ mural thickening of collecting system\n$\\sqrt{ }$ dystrophic amorphous parenchymal calcifications (50\\%)\n$\\sqrt{ }$ in tuberculomas (in $24-44 \\%$ ): amorphous / granular / curvilinear / punctate / confluent (\"toothpaste\") / involving entire kidney (\"putty kidney\"):\n$\\sqrt{ }$ nephrolithiasis (in 10\\%)\n$\\sqrt{ }$ globally poor renal function\n$\\sqrt{ }$ infection may extend into peri- / pararenal space + psoas\nCT:\n$\\sqrt{ }$ triangular / ringlike calcifications within renal collecting system (= papillary necrosis)\n\n# Ureteral Tuberculosis \n\nFrequency: in 50\\% of genitourinary TB; always with evidence of renal involvement as it spreads from kidney\nLocation: either end of ureter (most commonly distal $1 / 3$ ), usually asymmetric, may be unilateral\n$\\sqrt{ }$ ureteral filling defects $\\leftarrow$ mucosal granulomas\n$\\sqrt{ }$ \"saw-tooth ureter\" = irregular jagged contour $\\leftarrow$ dilatation from ureterovesical junction obstruction + multiple small mucosal ulcerations + wall edema (early changes)\n$\\sqrt{ }$ strictures (late changes):\nSite: pelviureteric junction, across pelvic brim, at vesicoureteric junction\n\"beaded ureter\" = alternating areas of strictures + dilatations\n\"corkscrew ureter\" = marked tortuosity with strictures + dilatations\n\"pipestem ureter\" = rigid aperistaltic foreshortened thick and straight ureter\n$\\sqrt{ }$ vesicoureteral reflux through \"fixed\" patulous orifice",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 274,
            "markdown": "$\\sqrt{ }$ ureteral calcifications uncommon (usually in distal portion)\nCT:\n$\\sqrt{ }$ thickening of ureteral wall with periureteric inflammation\n\n# Bladder Tuberculosis \n\n$=$ infection from renal source causes interstitial cystitis\n$\\sqrt{ }$ thickened bladder wall (= muscle hypertrophy + inflammatory tuberculomas)\n$\\sqrt{ }$ filling defects $\\leftarrow$ multiple granulomas\n$\\sqrt{ }$ bladder wall ulcerations\n$\\sqrt{ }$ \"shrunken bladder\" = scarred bladder with diminished capacity\n$\\sqrt{ }$ \"thimble bladder\" = diminutive irregular bladder\n$\\sqrt{ }$ bladder wall calcifications (rare)\n$C x$ : fistula / sinus tract / vesicoureteral reflux $\\leftarrow$ fibrosis of ureteral orifice\n\n## Male Genital Tuberculosis\n\n$\\sqrt{ }$ calcifications in $10 \\%$ (diabetes more common cause)\n(1) Tuberculous prostatitis / prostatic abscess:\n$\\sqrt{ }$ hypoechoic irregular area in peripheral zone\n$\\sqrt{ }$ hypoattenuating prostatic lesion $\\leftarrow$ foci of caseous necrosis + inflammation\n$\\sqrt{ }$ hypointense diffuse radiating streaky areas on T2WI (= \"watermelon\" sign)\n$\\sqrt{ }$ peripheral enhancement\n(2) Tuberculous epididymitis\nascending / descending route of infection\n$\\sqrt{ }$ diffusely enlarged / nonspecific nodular epididymis of heterogeneous echogenicity\n$\\sqrt{ }$ hydrocele, sinus tract, calcifications\n(3) Tuberculous orchitis (rare)\ndirect extension from epididymal infection, rarely from hematogenous spread\n$D D x$ : brucellosis, fungal infections (identical picture)\n\n## Female Genital Tuberculosis\n\nPrevalence: $1.3 \\%$ involve genital tract (fallopian tube in 34\\%)\n(1) Salpingitis ( $94 \\%$ ): mostly bilateral\n$\\sqrt{ }$ thick-walled serpentine juxtauterine structure\n$\\sqrt{ }$ intense enhancement\n$\\sqrt{ }$ beaded appearance of salpinges $\\leftarrow$ multiple constrictions\n$\\sqrt{ }$ tubal obstruction is unusual\n(2) Tuboovarian abscess: $\\rightarrow$ extension into extraperitoneal compartment\n$\\sqrt{ }$ loculated ascites\n$\\sqrt{ }$ omental + mesenteric soft-tissue infiltration\n$\\sqrt{ }$ peritoneal thickening + nodularity\n$\\sqrt{ }$ enlarged necrotic lymph nodes (= lymphadenitis)\n$D D x$ : peritoneal carcinomatosis\n$C x$ : tuberculous peritonitis (in up to $50 \\%$ ): may mimic ovarian cancer $\\leftarrow$ elevated CA-125\n\n## UNICALICEAL (UNIPAPILLARY) KIDNEY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 275,
            "markdown": "Path: OLIGOMEGANEPHRONIA = reduced number of nephrons and enlargement of glomeruli Associated with: absence of contralateral kidney, other anomalies\n\n- hypertension, proteinuria, azotemia\n\n\n# URACHAL ANOMALIES \n\nurachus $=$ median umbilical ligament $=$ thick fibrous cord as the remnant of the allantois ( $=$ endodermal outgrowth from yolk sac into stalk), which regresses at $5^{\\text {th }}$ month of development; bounded by transverse fascia ventrally + parietal peritoneum dorsally (space of Retzius)\n$C x$ : infection ( $23 \\%$ ), intestinal obstruction, hemorrhage into cyst, peritonitis from rupture, malignant degeneration\n\n## Alternating Sinus = Umbilical-Urachal Fistula\n\n$=$ cystic dilatation of urachus periodically emptying into bladder / umbilicus\n\n## Patent Urachus\n\n$=$ fistula between bladder and umbilicus\nPrevalence: $1 \\div 200,000$ live births\n\n- urine draining from umbilicus\n\n\n## Urachal Cyst (30\\%)\n\n$=$ gradually enlarging cyst $\\leftarrow$ closure of both ends of urachus\nPrevalence: $1 \\div 5,000$ (at autopsy); $30 \\%$ of all urachal anomalies\n\n- asymptomatic in children unless rupture occurs\n- symptomatic in adults $\\leftarrow$ enlargement / infection\n$\\checkmark$ cystic extraperitoneal mass\n$\\checkmark$ no communication with bladder or umbilicus\n\n\n## Urachal / Vesicourachal Diverticulum (3\\%)\n\n$=$ urachus communicates only with bladder dome\n\n## Urachal Sinus\n\n$=$ urachus patent only at umbilicus\nAssociated with: urachal cyst\n\n- umbilical mass / inflammation $\\pm$ drainage\n$\\checkmark$ thickened tubular structure with echogenic center\n\n\n## URACHAL CARCINOMA\n\n$=$ rare tumor arising from the urachus ( $=$ vestigial remnant of cloaca + allantois) within space of Retzius\nFrequency: $\\quad 0.01 \\%$ of all adult cancers;\n$0.17-0.34 \\%$ of all bladder cancers;\n$20-40 \\%$ of all primary bladder adenocarcinomas\n\n## Histo:\n\n(a) adenocarcinoma ( $84-90 \\%$ ), in $75 \\%$ mucin producing\n$\\diamond 34 \\%$ of all bladder adenocarcinomas are urachal in origin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 276,
            "markdown": "Cause: columnar epithelial metaplasia of transitional cell epithelium in urachal remnant\n(b) urothelial cancer (3\\%), sarcoma, squamous cell carcinoma\n$\\diamond 75 \\%$ of urachal neoplasms in patients $<20$ years of age are sarcomas!\n\n| Stages of Urachal Carcinoma |  |\n| :--: | :-- |\n| I | cancer limited to urachus |\n| II | invasion limited to urachus |\n| III A | local invasion of bladder |\n| III B | invasion of abdominal wall |\n| III C | invasion of peritoneum |\n| III D | invasion of other viscera |\n| IV A | metastases to local lymph nodes |\n| IV B | distant metastases (liver) |\n\nAge: $40-70$ years; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 1$ to $3 \\div 1$\n\n- suprapubic mass, abdominal pain; mucous micturition (25\\%)\n- irritative voiding symptoms: dysuria, abdominal pain\n- discharge of blood, pus from umbilicus, hematuria ( $71 \\%$ )\n\nLocation: supravesical, midline, anterior ( $80 \\%$ ), extraperitoneally in space of Retzius\nSite: close to bladder ( $90 \\%$ ); along course of urachus / at umbilical end ( $10 \\%$ )\n$\\sqrt{ }$ midline mass anterosuperior to vesical dome in the space of Retzius with predominantly muscular / extravesical involvement\n$\\sqrt{ }$ tumor bulk outside bladder + invasion of bladder dome ( $88 \\%$ )\n$\\sqrt{ }$ mean tumor size of 6 cm\n$\\sqrt{ }$ often peripheral curvilinear / punctate stippled psammomatous calcifications (50-72\\%)\nPATHOGNOMONIC for mucinous adenocarcinoma\n$\\sqrt{ }$ heterogeneous enhancement\nUS:\n$\\sqrt{ }$ midline fluid-filled cavity with mixed echogenicity + calcifications adjacent to anterior abdominal wall\nCT:\n$\\sqrt{ }$ low-attenuation mass in $60 \\%$ (mucin)\nMR:\n$\\sqrt{ }$ markedly increased SI on T2WI $\\leftarrow$ mucin\n$C x$ : pseudomyxoma peritonei (in peritoneal carcinomatosis); metastasis to pelvic lymph nodes, lung, brain, liver, bone\nPrognosis: 7-61\\% 5-year survival rate\n$R x$ : radical cystectomy; often local recurrence within 2 years\n$D D x$ : infected benign urachal cyst; primary benign bladder tumor (adenoma, fibroadenoma, fibromyxoma, hamartoma); primary malignant bladder tumor (adenocarcinoma, transitional cell carcinoma); secondary bladder tumor (metastasis from colon, prostate, female genital tract); desmoid tumor\n\n# URETERAL DUPLICATION \n\n$=$ RENAL DUPLICATION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 277,
            "markdown": "# Complete Duplication of Ureter (0.2\\%) \n\nCause: second ureteral bud arising from mesonephric duct leading to complete ureteral duplication\nPrevalence: $0.2 \\%$ of live births; $\\mathrm{M}+\\mathrm{F}=1 \\div 2$; in $15-40 \\%$ bilateral\nRisk of recurrence: $12 \\%$ in 1 st-degree relatives\nIncreased risk for: UTI, obstruction, vesicoureteral reflux\nEmbryology: ureters develop from separate ureteric buds originating from a single wolffian duct\n$\\checkmark$ duplicated ureter may be orthotopic\n$\\checkmark$ renal enlargement\n$\\checkmark$ tortuous dilated lower pole ureter\nUS:\n$\\checkmark$ two separate echodense renal sinuses + pelves separated by parenchymal bridge\nIVP:\n$\\checkmark$ poor / nonvisualization of upper pole collecting system (delayed films):\n$\\checkmark$ \"drooping lily\" sign = hydronephrosis + decreased function of obstructed upper pole moiety causing downward displacement of lower pole calices\n$\\checkmark$ lateral + downward displacement of lower pole collecting system + ureter:\n$\\checkmark$ \"nubbin\" sign = scarring, atrophy, and decreased function of lower pole moiety may simulate a renal mass\n$\\checkmark$ displacement of proximal orifice upward\nVCUG:\n$\\checkmark$ ureterocele\n$\\checkmark$ reflux into lower moiety (rare)\nCx: (1) Vesicoureteral reflux (most commonly)\n(2) Ectopic ureteral insertion\n(3) Ectopic ureterocele\n(4) Ureteropelvic junction obstruction of lower pole\n\n## Weigert-Meyer Rule\n\n$=$ the upper pole ureter terminates inferior and medial to the lower pole ureter\n(a) upper moiety ureter\nremains with wolffian duct longer $\\rightarrow$ passes through bladder wall $\\rightarrow$ inserts ectopic\ninferior and medial to lower moiety ureter below the level of the trigone / into any wolffian duct derivative\n(b) lower moiety ureter\ndrains lower pole and interpolar portion; is incorporated into developing bladder first $\\rightarrow$ ascends during bladder growth $\\rightarrow$ enters bladder at trigone\n\n## UPPER MOIETY URETER\n\nThree possible distal configurations:\n\n1. Ureterocele\n2. Ectopic ureter",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 278,
            "markdown": "3. Normal insertion into bladder\n$\\diamond$ Subject to ureteral obstruction $\\leftarrow$ stenosis at ectopic ureteral insertion / ectopic ureterocele / aberrant artery crossing!\n$\\diamond$ The ectopic ureteral orifice is inferior + medial to orthotopic ureteral orifice!\nAssociated with: significant renal dysplasia\nSite of insertion of ectopic ureter\n$C x:$ upper pole obstructive hydronephrosis\n\n# LOWER MOIETY URETER \n\n$\\diamond$ Subject to vesicoureteral reflux $\\leftarrow$ abnormal UVJ valve mechanism $\\leftarrow$ shortened ureteral tunnel at bladder insertion!\nCx: lower pole of duplex kidney may atrophy (in $50 \\%$ ) $\\leftarrow$ chronic pyelonephritis $\\leftarrow$ reflux nephropathy ( $=$ reflux $\\pm$ infection)\n$\\checkmark$ clubbed calices underneath focal scars\n\n## Incomplete / Partial Duplication of Ureter (0.6\\%)\n\n$=$ initially separate upper + lower pole ureters fuse proximal to UVJ into a common ureter\nDevelopment: branching of ascending single ureteral bud ( $=$ one ureteral orifice + common distal ureter) before reaching metanephric blastema\nPrevalence: in $0.6 \\%$ of urograms\nAssociated with: ureteropelvic junction obstruction of lower renal pole\n\n- frequently clinically insignificant\n$\\checkmark$ bifid ureter (in early branching)\n$\\checkmark$ bifid pelvis (in late branching)\n$\\checkmark$ ureteroureteral reflux = \"yo-yo\" / \"saddle\" / \"seesaw\" peristalsis = urine moves down the cephalad ureter + refluxes up the lower pole ureter and vice versa\n$\\checkmark$ asymmetric dilatation of one ureteral segment\n$\\checkmark$ upper pole ureter may end blindly (seen on retrograde injection only)\nCx: urinary tract infections\n\n\n## URETEROCELE\n\n$=$ bulbous dilatation / cystic ectasia of subepithelial segment of intravesical ureter\nPrevalence: $1 \\div 5,000$ to $1 \\div 12,000$ children\nIVP:\n$\\checkmark$ early filling of bulbous terminal ureter (\"cobra head / spring onion\" sign) projecting into urinary bladder\n$\\checkmark$ surrounded by a thin radiolucent halo ( $=$ combined thickness of ureteral wall + prolapsed bladder mucosa)\nVCUG:\n$\\checkmark$ round / oval lucent defect near trigone\n$\\checkmark$ effacement with increased bladder distension\n$\\checkmark \\pm$ eversion during voiding\n\n## Simple Ureterocele\n\n$=$ ORTHOTOPIC URETEROCELE",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 279,
            "markdown": "$=$ congenital prolapse of dilated distal ureter + orifice into bladder lumen at the usual location of the trigone, typically seen with single ureter\nPresentation: incidental finding in adults; $\\mathrm{M} \\div \\mathrm{F}=2 \\div 3$; bilateral in $33 \\%$\n$C x$ :\n(1) Pyelocaliceal dilatation\n(2) Prolapse into bladder neck / urethra $\\rightarrow$ obstruction (rare)\n(3) Wall thickening $\\leftarrow$ edema from impacted stone / infection\n\n# Ectopic Ureterocele \n\n$=$ ureteral bud arising in an abnormal cephalad position from the mesonephric duct and moving caudally resulting in an ureteral orifice distal to trigone within / outside bladder Frequency: in $10 \\%$ bilateral\n(a) in single nonduplicated system $(20 \\%)$\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n\n- hypoplastic / absent ipsilateral trigone\n$\\sqrt{ }$ poorly visualized / nonvisualized kidney\n$\\sqrt{ }$ small / poorly functioning kidney\n(b) in upper moiety ureter of duplex kidney ( $80 \\%$ )\n$\\mathrm{M} \\div \\mathrm{F}=1 \\div 4$ to $1 \\div 8$\n$C x$ : (1) Bladder outlet obstruction $\\leftarrow$ ectopic ureterocele prolapsing into bladder neck / urethra\n(2) Contralateral ureteral obstruction (if ectopic ureterocele large)\n(3) Multicystic dysplastic kidney (the further the orifice from normal site of insertion, the more dysplastic the kidney!)\n\n\n## Pseudoureterocele\n\n$=$ obstruction of an otherwise normal intramural ureter mimicking simple ureterocele\nCause:\n(a) Tumor\nbladder tumor (most common in adults), invasion by cervical cancer, pheochromocytoma of intravesical ureter\n(b) Edema\nfrom impacted ureteral calculus (most common in children), radiation cystitis, following ureteral instrumentation, schistosomiasis\n$\\sqrt{ }$ NO protrusion of ureter into bladder lumen (oblique views + cystoscopy normal)\n$\\sqrt{ }$ thick irregular radiolucent halo surrounding bulbous terminal ureter\n$D x$ : cystoscopy\n\n## URETEROPELVIC JUNCTION OBSTRUCTION\n\n## Primary UPJ Obstruction\n\n$=$ congenital partial functional / anatomic obstruction at junction of renal pelvis + proximal ureter\nPrevalence: $1 \\div 20,000$ live births",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 280,
            "markdown": "# $\\diamond$ Most common cause of fetal / neonatal hydronephrosis! \n\n## Cause:\n\nA. INTRINSIC FUNCTIONAL CAUSE\n$=$ embryonic insult to smooth muscle cells $\\rightarrow$ adynamic aperistaltic proximal ureteral segment $\\rightarrow$ impaired formation of urine bolus\n(1) Replacement of UPJ muscle by excessive local collagen deposition\n(2) Abnormal arrangement of junction muscles causing dysmotility (69\\%)\n(3) Abnormal intercellular conduction\nB. EXTRINSIC MECHANICAL / ANATOMIC CAUSE\n(1) Crossing aberrant vessels (11-79\\%):\n> branch of main renal artery / vein\n> accessory branch from aorta / iliac artery / IVC\n$\\checkmark$ vessel to lower renal pole (in $25-39 \\%$ of adult patients): anterior to UPJ (90$95 \\%$ ), posterior to UPJ ( $5-10 \\%$ )\n(2) Luminal narrowing by mucosal folds (= stenosis or valve) in upper ureter\n(3) Periureteral fibrosis (= adventitial bands) $\\leftarrow$ recurrent urinary tract infections\n(4) Insertional abnormality\n> primary high ureteral insertion\n> developing over time with renal pelvic distension\n(5) Fixed kink / angulation\n\nAge at discovery: in utero; $<15$ years ( $25 \\%$ ); $>40$ years ( $50 \\%$ ); $\\mathrm{M}+\\mathrm{F}=5 \\div 1$\nAssociated anomalies $(27 \\%)$ :\nvesicoureteral reflux, bilateral ureteral duplication, bilateral obstructed megaureter, contralateral multicystic dysplastic kidney, contralateral renal agenesis, meatal stenosis, hypospadia\nLocation: left > right side; bilateral (10-20-40\\%)\n\n- abdominal mass, intermittent flank pain\n- Dietl crisis = \"beer-drinker's hydronephrosis\"\n[Jozef Dietl (1804- 1878), Polish physician, pioneer of balneology and mayor of KrakÃ³w]\n$=$ intermittent flank pain typically after a large volume of fluid intake and subsequent diuresis (classically in college freshmen after excessive alcohol intake)\n- hematuria, renal stones, UTI, pyelonephritis\n$\\checkmark$ hugely dilated largely extrarenal pelvis:\n$\\checkmark$ draped over lower pole vessel as inverted teardrop shape\n$\\checkmark$ proximal ureter hooking over lower pole vessel\n$\\checkmark$ variable degree of caliceal dilatation\n$\\sqrt{ }$ NO dilatation of ureter\nIVP:\n$\\checkmark$ sharply defined narrowing at UPJ\n$\\checkmark$ pelvicaliectasis without ureterectasis\n$\\checkmark$ anterior rotation of pelvis\n$\\checkmark$ broad tangential sharply defined extrinsic compression (in arterial crossing)\n$\\checkmark$ longitudinal striae of redundant mucosa (in dehydrated state)\n$\\checkmark$ late changes: unilateral renal enlargement, diminished opacification, wasting of kidney",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 281,
            "markdown": "substance\n$\\checkmark$ \"balloon-on-a-string\" sign:\n$\\checkmark$ caliceal crescents surrounding dilated collecting system\n$\\checkmark$ eccentric exit of ureter from dilated renal pelvis\nCT / MRI:\n$\\checkmark$ accurate detection of crossing vessels ( $100 \\%$ PPV) during late arterial phase\nNUC: confirms obstruction at UPJ + determines function\nOB-US:\n$\\checkmark$ progressive enlargement of renal pelvis + branching infundibula + calices\n$\\checkmark$ anteroposterior diameter of renal pelvis $\\geq 10 \\mathrm{~mm}$\n$\\checkmark$ large unilocular fluid collection (severely dilated collecting system)\n$D D x$ : multicystic dysplastic kidney, perinephric urinoma\nADDITIONAL TESTS:\n(1) Diuresis excretory urography (Whitfield): accurate in $85 \\%$\n(2) Diuresis renography ( ${ }^{131}$ Iodine-iodohippurate sodium / 99 mTc -DTPA)\n(3) Pressure flow urodynamic study (Whitaker test)\n$R x$ : early surgical correction (ante- / retrograde endopyelotomy, open / laparoscopic dismembered pyeloplasty) to preserve renal function\n\n# Secondary UPJ Obstruction \n\nCause:\n(1) Infection: eosinophilic ureteritis, XGP\n(2) Stones\n(3) Ischemia\n(4) Iatrogenic injury\n(5) Aortic aneurysm\n(6) Renal cyst\n\n## URETHRAL CARCINOMA\n\nPrevalence: $<1 \\%$ of all urologic cancers\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade; $\\mathrm{M}+\\mathrm{F}=1 \\div 4$\n\n## Urethral Carcinoma of Male Urethra\n\nCause: chronic urethritis from venereal disease ( $25-44 \\%$ ) + urethral strictures ( $50-88 \\%$ )\n\n- palpable mass in perineum / along shaft of urethra\n- periurethral abscess, obstructive voiding symptoms\n- urethrocutaneous fistula, serosanguinous discharge\n$\\checkmark$ urethral stricture\nSite: @ Prostatic urethra ( $10 \\%$ ):\nTCC $(90 \\%)>$ squamous cell ca. $(10 \\%)$\n@ Bulbomembranous urethra ( $60 \\%$ ):\nsquamous cell ca. $(80 \\%)>$ TCC $(10 \\%)>$ adenocarcinoma + undifferentiated carcinoma $(10 \\%)$\n@ Penile urethra ( $30 \\%$ ):\nsquamous cell ca. $(90 \\%)>$ TCC $(10 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 282,
            "markdown": "# Histo: \n\n1. Squamous cell carcinoma ( $70-80 \\%$ )\n2. Transitional cell carcinoma ( $16 \\%$ ) part of multifocal urothelial neoplasia; in $10 \\%$ after cystectomy for bladder tumor\n3. Adenocarcinoma ( $6 \\%$ ) in bulbous urethra originating in glands of Cowper / LittrÃ©\n4. Malignant melanoma, leiomyosarcoma, rhabdomyosarcoma, fibrosarcoma (rare)\n5. Metastases from bladder / prostatic carcinoma (rare)\n\nStage I: confined to subepithelial connective tissue\nStage II: invasion of corpus spongiosum / prostate / periurethral muscle\nStage III: invasion of corpus cavernosum + bladder neck beyond prostatic capsule\nStage IV: invasion of other organs\nSpread: direct extension + regional lymph nodes (superficial + deep inguinal + external iliac nodes from anterior urethra; pelvic nodes from posterior urethra)\nMR:\n$\\sqrt{ }$ mass hypointense relative to normal corpora on T1WI + T2WI\n\n## Urethral Carcinoma of Female Urethra\n\nPrevalence: $<0.02 \\%$ of all malignancies in women\nCause: chronic irritation, urinary tract infection, proliferative lesions (caruncle, papilloma, adenoma, polyp, leukoplakia)\nRisk factor: human papilloma virus infection, urethral diverticulum\nHisto:\n\n1. Squamous cell carcinoma ( $70 \\%$ ):\n\nSite: distal $2 / 3$ of urethra + meatus\n$\\sqrt{ }$ lobulated exophytic / deeply infiltrating lesion\n$\\sqrt{ }$ irregularly marginated hypo- / isoechoic mass\n$\\sqrt{ }$ T2-hypointense with heterogeneous enhancement\n2. TCC $(8-24 \\%)$ :\n\nSite: posterior $1 / 3$ of urethra\n$\\sqrt{ }$ lobulated iso- to hypointense on T1WI + T2WI\n$\\sqrt{ }$ heterogeneous contrast enhancement\n3. Adenocarcinoma ( $10-18-28 \\%$ ):\n\nSite: urethrovulvar junction from periurethral glands of Skene (40\\%), urethral diverticulum $(60 \\%)$\n$\\diamond$ similarity to nephrogenic adenoma, immunostaining for PSA + prostate acid phosphatase\n$\\checkmark$ exophytic diverticular tumor\n$\\sqrt{ }$ T2-hyperintense + peripheral rim of low SI\n$\\sqrt{ }$ variably heterogeneous contrast enhancement\n4. Secondary tumor: contiguous extension from bladder, cervix, vagina, anus\n\nAge: $\\quad>50$ years\nMR (best on SAG T2WI):\n$\\sqrt{ }$ mass hypointense on T1WI + hyperintense on T2WI\n@ Cancer of the anterior urethra ( $46 \\%$ )\nSite: distal $1 / 3$ of urethra",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 283,
            "markdown": "- urethral bleeding, urinary frequency, dysuria\n- palpable mass at urethral orifice\n\nSpread: superficial + deep inguinal nodes\n$R x$ : local surgical excision\n@ Cancer of the entire urethra\nHisto: SCC (60\\%), TCC (20\\%), adenocarcinoma (10\\%), undifferentiated ca. / sarcoma $(8 \\%)$, melanoma $(2 \\%)$\n\n- urinary retention, urethral abscess, urethrovaginal fistula\n\nSpread: (a) local extension: into bladder neck, vagina, vulva\n(b) lymphatic: external iliac, hypogastric, obturator nodes (for posterior urethra)\n$R x$ : surgery, radiation, chemotherapy\nPrognosis: poor (in $50 \\%$ metastatic at presentation); survival rate of $50 \\%$ for distal tumor, survival rate of $6 \\%$ for proximal tumor\n$D D x$ : markedly inflamed diverticulum\n\n# URETHRAL DIVERTICULUM \n\n$=$ protrusion of urethra into periurethral fascia\nPrevalence: $0.6-6 \\%$ of women\nAge: 26-74 years; 6 x more common in black women (?)\nHisto: same as urethral mucosa\n\n- asymptomatic (3-20\\%); fluid / pus may be expressed from urethra\n- tender cystic swelling protruding from anterior wall of vagina\n- classic \"triad of Ds\": dysuria (45\\%), dyspareunia, postvoid dribbling\n- vague nonspecific urinary tract symptoms mimicking chronic / interstitial cystitis, periurethral cysts / fibrosis, urethrocele, carcinoma in situ of the bladder / urethra, detrusor instability:\n- urinary frequency / urgency $(67 \\%)$\n- recurrent urinary tract infections $(40 \\%)$\n- urinary incontinence ( $9-32-70 \\%$ ), urine retention, pelvic pain\n\n\n## Congenital Urethral Diverticulum\n\nCause: ectopic cloacal epithelium\n$\\mathrm{M}>\\mathrm{F}$\n\n## Acquired Urethral Diverticulum\n\nPrevalence: in $1.4 \\%$ of women with stress incontinence; $\\mathrm{M}<\\mathrm{F}$\nCause:\n(1) Obstruction of paraurethral glands (of Skene) $\\rightarrow$ subsequent infection (E. coli, gonococci, chlamydia) of dilated periurethral gland $\\rightarrow$ rupture into urethra\n(2) Trauma: catheterization / childbirth / disruption of periurethral fascia during bladder neck suspension surgery\nMay be associated with: cloacal epithelium, wolffian / mÃ¼llerian duct remnant\nSite: posterolateral aspect of midurethra at level of pubic symphysis\nVoiding cystourethrography ( $65 \\%$ accurate):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 284,
            "markdown": "$\\sqrt{ }$ rounded / elongated sac connected to urethra\nUS:\n$\\sqrt{ }$ echogenic focus with distinct acoustic shadow $\\leftarrow$ stone\nMR:\n$\\sqrt{ }$ cystic T2-hyperintense lesion with various degrees of extensions around the circumference of urethra:\n$\\sqrt{ }$ oval / U-shaped \"saddlebag\" / circumferential\n$\\sqrt{ }$ single / multiple\n$\\sqrt{ }$ unilocular / multiseptated\n$\\sqrt{ }$ narrow / wide neck\n$\\sqrt{ }$ heterogeneous hyperintense signal compared with urine on T1WI if content is proteinaceous / hemorrhagic\n$\\sqrt{ }$ fluid-fluid level on T2WI if inflammation present\nCx: (1) Infection\n(2) Stone formation (in up to $5-10 \\%$ )\n(3) Malignant degeneration to adenocarcinoma $(60 \\%)>$ TCC $(30 \\%)>$ squamous cell carcinoma $(10 \\%)$\nRx: transvaginal / endoscopic diverticulectomy with resection of neck (to prevent recurrence)\n$D D x$ : (1) Vaginal cyst (Gartner duct cyst, paramesonephric cyst, mÃ¼llerian duct cyst, epithelial inclusion cyst)\n(2) Ectopic ureterocele\n(3) Endometrioma\n(4) Urethral tumor\n\n# URINOMA \n\n= uriniferous perirenal pseudocyst $\\leftarrow$ tear in collecting system with continued renal function Etiology:\nA. NONOBSTRUCTIVE: blunt / penetrating trauma, surgery, infection, calculus erosion\nB. OBSTRUCTIVE:\n(1) Ureteral obstruction (calculus, surgical ligature, neoplasm)\n(2) Bladder outlet obstruction (posterior urethral valves)\n$\\diamond$ Augmented by sudden diuretic load of urographic contrast material!\nPath: fibroblastic cavity (in 5-12 days), dense connective tissue encapsulation (in 3-6 weeks)\n\n- pain, malaise, nausea, fever\n- hematuria ( $10-50 \\%$ ), fluctuant tender mass\n- discharge from wound (in early postoperative period)\n\nLocation:\n$\\sqrt{ }$ cystic mass in perirenal space $=$ localized perirenal urinoma (most common)\n$\\sqrt{ }$ cystic mass filling entire perirenal space $=$ diffuse perirenal urinoma\n$\\sqrt{ }$ sickle-shaped collection $=$ subcapsular urinoma\n$\\sqrt{ }$ encapsulated expanding intrarenal cystic mass separating renal tissue fragments $=$ intrarenal urinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 285,
            "markdown": "Plain radiography:\n$\\sqrt{ }$ soft-tissue mass obliterating retroperitoneal structures\n$\\sqrt{ }$ superior + lateral displacement of kidney\nCT:\n$\\checkmark$ extravasation of contrast material\n$\\checkmark$ smooth thin-walled cavity $(-10$ to +30 HU$)$\n$\\checkmark$ frequently associated with urine ascites\n$\\checkmark$ rarely septated + smaller than lymphocele\nNUC:\n$\\checkmark$ progressive radiotracer activity within collection\n$C x$ : retroperitoneal fibrosis, stricture of upper ureter, perinephric abscess, rupture into peritoneal cavity\n$\\diamond$ Renal dysplasia of affected kidney in almost $100 \\%$ when detected in utero!\n$D x$ : aspirated fluid with high urea concentration\n$D D x$ : lymphocele, hematoma, abscess, renal cyst, pancreatic pseudocyst, ascites\n\n# UROLITHIASIS \n\n$=$ NEPHROLITHIASIS\n$\\diamond$ Most common cause of calcification within the kidney:\n$>12 \\%$ of population develop a renal stone by age 70 ;\n$\\diamond 2-3 \\%$ of population experience an attack of acute renal colic during their lifetime\n$\\diamond$ Patients with acute flank pain have ureteral calculi in $67-95 \\%$\nAnnual incidence: $1-2 \\div 1,000 ; 1,200,000$ annually in USA\nAge: $30-60$ years; $\\mathrm{M} \\div \\mathrm{F}=4 \\div 1$\nAnderson-Carr-Randall theory of renal stone formation:\nabnormally high calcium excretion exceeds lymphatic capacity, microaggregates of calcium (present in the normal kidney) occur in medulla $\\rightarrow \\uparrow$ in size $\\rightarrow$ migrate toward caliceal epithelium and $\\rightarrow$ rupture into calices to form calculi\n(a) nucleation theory\n$=$ crystal / foreign body initiates formation in urine supersaturated with crystallizing salt\n(b) stone matrix theory\n$=$ organic matrix of urinary proteins + serum serves as framework for deposition of crystals\n(c) inhibitor theory\n$=$ little / no concentration of urinary stone inhibitors (citrate, pyrophosphate, glycosaminoglycan, nephrocalcin, Tamm-Horsfall protein) $\\rightarrow$ crystal formation\nStone composition in order of frequency:\ncalcium oxalate mono- and dihydrate $40-60 \\%$\ncalcium phosphate $20-60 \\%$\nstruvite $5-15 \\%$\nuric acid $5-10 \\%$\nbrushite $2-4 \\%$\ncystine $1-3 \\%$\nCause:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 286,
            "markdown": "genetics, diet, employment, geography, history of UTI\n$\\diamond 70-80 \\%$ of patients with first-time stones have a specific metabolic disorder (idiopathic hypercalciuria, secondary hypercalciuria (sarcoidosis, hyperparathyroidism), hyperuricosuria (gout, Lesch-Nyhan syndrome, hyperoxaluria, cystinuria)\n\n| Radiographic Opacity and Frequency of Urolithiasis |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Mineral Composition | Description | Frequency | Opacity | NECT [HU] | Factors |\n| Calcium stones |  | $70-80 \\%$ | $+++$ |  |  |\n| 1. Calcium oxalate |  | $20-30 \\%$ | $+++$ |  | underlying metabolic disorder; |\n| (a) Calcium oxalate monohydrate (= whewellite) | $\\sqrt{ }$ small highly opaque |  |  | $1700-2800$ | hard to fragment |\n| (b) Calcium oxalate dihydrate (= wedellite) | $\\sqrt{ } \\pm$ spiculated / mamillated (\"mulberry stone\") |  |  |  |  |\n| (c) Calcium oxalate-phosphate (calcium oxalate plus apatite) |  | $30-40 \\%$ | $+++$ |  |  |\n| 2. Calcium hydrogen phosphate (= brushite) |  | $2-4 \\%$ | $+++$ | $1700-2800$ | hard to fragment |\n| 3. Calcium phosphate (= hydroxyapatite) | - rarely pure (= laminated), occasionally forms in infected alkaline urine | $20-60 \\%$ | $+++$ | $1200-1600$ | usually no metabolic abnormality |\n| Cystine stone |  | $1-3 \\%$ |  | $600-1100$ | renal tubular defect; hard to fragment |\n| Struvite stones | $\\sqrt{ }$ mildly opaque | $5-15 \\%$ | $++$ | $600-900$ | renal infection |\n| 1. Magnesium ammonium phosphate (= struvite) | $\\sqrt{ }$ laminated +- urea-splitting organisms (usually Proteus) | $1 \\%$ | $++$ |  | most common constituent of staghorn calculus |\n| 2. Struvite plus calcium phosphate | - associated with infection | $15-20 \\%$ | $++$ |  |  |\n| Uric acid stone | $\\sqrt{ }$ radiolucent | $5-10 \\%$ | - | $200-450$ | $\\mathrm{pH}<5.8$ |\n| Xanthine stone | $\\sqrt{ }$ nonopaque | extremely rare | - | $>200$ |  |\n| Matrix stone (mucoprotein / mucopolysaccharide) | $\\sqrt{ }$ nonopaque | rare | - | $15-200$ | pure matrix stones may not be visible |\n\n\n| Interventional Procedures for Urolithiasis |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Treatment | Location \\& Size of Stone | Advantage |  | Disadvantage |\n| Shock wave lithotripsy (SWL) | kidney $<1 \\mathrm{~cm}$; ureter $<1 \\mathrm{~cm}$ | least invasive, good success rate, under sedation / anesthetics |  | poor success for cystine stones / stones $>1000 \\mathrm{HU}$ |\n| Ureteroscopy with semirigid lithotripsy | distal ureter $<1 \\mathrm{~cm}$; proximal ureter $<1 \\mathrm{~cm}$ (in woman) | stones refractory to SWL, high stone-free rate (better than SWL) |  | invasive, general / spinalepidural anesthesia |\n| Ureteroscopy with flexible lithotripsy | proximal ureter stone $<1 \\mathrm{~cm}$ kidney stone $<1.5 \\mathrm{~cm}$ | stones refractory to SWL, high stone-free rate (better than SWL) |  | invasive, general / spinalepidural anesthesia |\n| Percutaneous nephrolithotomy (PCNL) | proximal ureter stone $<1.5 \\mathrm{~cm}$ kidney stone $<1.5 \\mathrm{~cm}$ staghorn calculus | highest stone-free rate for large kidney + upper ureter stones |  | most invasive, may require blood transfusion |\n| Ureterolithotomy: open / laparoscopic | large stone <br> in middle / distal ureter | most effective for large stones |  | rarely used |\n| Pyelolithotomy: open / laparoscopic | large stone: <br> unbranched in renal pelvis / in horseshoe kidney | most effective for very large stones |  | rarely used |\n| Anatrophic nephrolithotomy | full staghorn calculus | alternative to multiple-track PCNL |  | rarely used |\n\n# 1. Hypercalciuria \n\n- with hypercalcemia (50\\%): primary hyperparathyroidism, milk-alkali syndrome, hypervitaminosis D, malignant neoplasm, Paget disease, prolonged immobilization, sarcoidosis, adrenal insufficiency, hyper- and hypothyroidism, renal transplantation\n- with normocalcemia ( $30-60 \\%$ ): obstruction, urinary tract infection, vesical diverticulum, horseshoe kidney, medullary sponge kidney, renal tubular acidosis, malignant neoplasm, Paget disease, Cushing syndrome, prolonged immobilization,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 287,
            "markdown": "idiopathic hypercalciuria, acetazolamide therapy, sarcoidosis\n(a) ABSORPTIVE HYPERCALCIURIA\n$=$ increased intestinal absorption of calcium\nCause: increase in 1,25-dihydroxy-vitamin D levels (50\\%)\n(b) RENAL HYPERCALCIURIA\n$=$ abnormal renal calcium leak\nCause: diet high in sodium, urinary tract infection (33\\%)\n(c) RESORPTIVE HYPERCALCIURIA\n$=$ increased bone demineralization $\\leftarrow$ subtle hyper-parathyroidism\n(d) IDIOPATHIC\n$\\sqrt{ }$ attenuation of calcium stones $>1,000 \\mathrm{HU}$ similar to bone cortex\n2. Hyperoxaluria $=$ OXALOSIS\n$\\diamond$ Hyperoxaluria has a stronger correlation to severity of stone disease than hypercalciuria!\nPhysiology:\n$\\diamond 85 \\%$ of urinary oxalate is produced endogenously in liver!\n$\\diamond$ Oxalic acid is present in many foods but poorly absorbed in healthy individuals resulting in increase in urinary oxalate by only $2-3 \\%$ !\n\n1. Primary hyperoxaluria (more common)\n$=$ HEREDITARY HYPEROXALURIA\n$=$ rare autosomal recessive inherited enzyme deficiency of carboligase $\\rightarrow$ diffuse oxalate deposition in kidneys, heart, blood vessels, lung, spleen, bone marrow\nType I = deficient ketoglutarate-glyoxylate carboxylase\n\n- glycolic aciduria\n\nType II = D-glycerate dehydrogenase deficiency\n\n- D-glyceric aciduria\n\nAge: usually $<5$ years\nPrognosis: early death in childhood\n2. Secondary / enteric hyperoxaluria (rare)\n\nCause: disturbance of bile acid metabolism after excess oxalate absorption from bowel after jejunoileal bypass, ileal resection, blind loop syndrome, Crohn disease; increased ingestion (green leafy vegetables), pyridoxine deficiency, ethylene glycol poisoning, methoxyflurane anesthesia\n3. Hyperuricosuria\n\n- uric acid lithiasis ( $15-20 \\%$ ); stones form in acid urine\n- $\\mathrm{M}>\\mathrm{F}$; usually familial\n- multiple small hard smooth yellow / red-brown radiolucent stones\n(a) WITH HYPERURICEMIA:\ngout $(25-50 \\%) \\leftarrow$ excessive intake of meat, fish, poultry; myeloproliferative diseases; antimitotic drugs; chemo- / radiation therapy; uricosuric agents; Lesch-Nyhan syndrome\n(b) WITH NORMOURICEMIA:\nidiopathic; occurrence in concentrated acidic urine $\\rightarrow$ becomes supersaturated with undissociated uric acid (hot climate, ileostomy)\n$\\sqrt{ }$ bright well-defined stone of medium-high attenuation (> $150 \\mathrm{HU}[300-500 \\mathrm{HU}]$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 288,
            "markdown": "Rx: raising urinary pH (potassium citrate / sodium bicarbonate)\n4. Cystinuria (stones form in acid urine)\n$=$ autosomal recessive disorder with tubular inability to reabsorb cystine, ornithine, lysine, arginine\nAge of onset: after 10 years (usually young girls)\n\n- multiple soft / hard, pink / yellow radiopaque stones\n\nRx: (1) Decreased intake of methionine\n(2) Alkalinization of urine\n\n# 5. Xanthinuria \n\n$=$ inherited autosomal recessive deficiency of xanthine oxidase $\\leftarrow$ failure of normal oxidation of purines\n6. Urinary tract infection\n\nCause: urea-splitting organisms (Proteus mirabilis, P. vulgaris, Haemophilus influenzae, S. aureus, Ureaplasma urealyticum) + alkaline environment $(\\mathrm{pH}>7.19)$\n$\\diamond$ May lead to magnesium ammonium phosphate $=$ struvite stones\nPredisposed: women $\\left(\\mathrm{M} \\div \\mathrm{F}=1 \\div 2\\right)$, neurogenic bladder, urinary diversion, indwelling catheter, lower-urinary-tract voiding dysfunction\n$\\sqrt{ }$ often branching into staghorn calculi\n$\\sqrt{ }$ most struvite stones are radiopaque, but poorly mineralized matrix stones are not\n7. Any condition causing nephrocalcinosis\n8. Idiopathic calcium urolithiasis\n9. Indinavir (protease inhibitor for treatment of HIV type 1) $\\rightarrow$ precipitation of drug crystals in renal tubule\n\n- rectangular brown puttylike nonradiopaque stones\n$\\sqrt{ }$ detectable sonographically / IVP / CECT\nNECT:\nAll urinary tract calculi are of high attenuation measuring $>200 \\mathrm{HU}$ (except for indinavir calculi, which have soft-tissue attenuation) and may be obscured by contrast material!\n\n\n## Radiographic Shape of Kidney Stone\n\n1. Staghorn calculus (resembling antlers of a stag):\n$=$ branched calculus filling the entire bifid renal collecting system\nCause: recurrent urinary tract infections from bacterial pathogens producing alkaline urine (the only stone more common in females)\nComposition: struvite ( $=$ mixture of calcium, magnesium, ammonium, phosphate) / cystine / uric acid\n2. Fragmented staghorn\n$=$ incomplete branched calculus\nCause: infection complicated by obstruction\n(a) pyonephrosis\n(b) XGP\n3. Jack stone (resembling a child's toy jack)\n$=$ stone of spiked configuration\nComposition: calcium oxalate dihydrate",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 289,
            "markdown": "Location: urinary bladder $>$ kidney\n4. Mulberry stone $=$ mamillated contour\n\nComposition: calcium oxalate dihydrate\n5. Hemp-seed calculi\n$=$ multiple small stones of similar size with lapidary appearance (like cut gems)\n[lapis, Latin = stone; lapidarius = stonecutter]\nComposition: calcium oxalate / calcium phosphate\nLocation: caliceal diverticulum, cyst, hydronephrosis)\n6. Milk of calcium (with urine-calcium level)\n\nComposition: calcium carbonate\nLocation: any epithelium-lined structure directly communicating with the collecting system (caliceal diverticulum, hydrocalyx, renal cyst)\n\n# Nonradiopaque Stones \n\nmnemonic: SMUX\nStruvite (rarely of pure magnesium ammonium phosphate)\nMatrix stone (mucoprotein, mucopolysaccharide)\nUric acid\nXanthine\n\n## Calculi often Associated with Infection\n\nmnemonic: S and M\nStruvite (magnesium ammonium phosphate $\\pm$ calcium phosphate)\nMatrix stone (mucoprotein, mucopolysaccharide)\n\n## Acute Obstruction by Ureteric Calculi\n\n$=$ URETEROLITHIASIS\n\n- renal colic = acute severe spasmodic / steady continuous flank pain\n- frequently radiating into pelvis / groin / scrotum / labia\n- hematuria ( $85 \\%$ ): absent in completely obstructing stone\n\nSite: at points of ureteral narrowing\n(a) ureterovesical junction (UVJ)\n(b) ureteropelvic junction (UPJ)\n(c) iliac vessel crossing\n\n| Frequency of Stones | Location |\n| :--: | :-- |\n| $37 \\%$ | in proximal ureter |\n| $7 \\%$ | in midureter |\n| $33 \\%$ | in distal ureter |\n| $18 \\%$ | at ureterovesical junction |\n\nPlain radiography $=\\mathrm{KUB}(45 \\%$ sensitive, $77 \\%$ specific $)$ :\nUseful: planning ESWL, monitoring stone fragments in 1-2-week intervals\nVisualization:\n$\\diamond 90 \\%$ of urinary calculi are radiopaque\nConfounding factors: small size of calculus, overlying bowel gas / fecal matter, osseous structures (transverse process, sacrum), extrarenal calcifications (gallstone, calcific",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 290,
            "markdown": "pancreatitis, mesenteric lymph node, arterial calcification, phlebolith), obesity\n$\\diamond$ Stones may be present in $30 \\%$ of the time when KUB is negative!\n$\\diamond 60 \\%$ of calcifications along expected course of ureter on symptomatic side are ureteric stones!\nIVP (64-97\\% sensitive, 92-94\\% specific, 31-48\\% FN):\n$\\diamond$ Most common cause of ureteral filling defects at IVP!\n$\\checkmark$ delayed opacification of collecting system: degree of obstruction displayed by time delay of appearance of contrast material (physiologic information)\n$\\checkmark$ persistent delayed nephrogram increasing in intensity with time\n$\\checkmark$ hydroureteronephrosis\n$\\checkmark$ column of contrast material proximal to obstructing stone\n$\\diamond$ Nonobstructing calculi may be difficult to detect\nUS ( $37 \\%$ sensitive):\n$\\checkmark$ highly echogenic focus + acoustic shadow within dilated ureter\n$\\checkmark$ unilateral hydronephrosis ( $11-35 \\% \\mathrm{FN}$, up to $10 \\% \\mathrm{FP}$ rate)\n$D D x$ : physiologic dilatation in pregnancy\n$\\checkmark$ RI (resistive index) $>0.70$ in symptomatic kidney within 6 hours after acute obstruction (partial obstruction, antecedent IVP may alter RI)\nN.B.: normal pregnancy does NOT alter RI\n$\\checkmark$ difference in RI between kidneys of $\\geq 0.04$\n$\\checkmark$ absent ureteral jet / continuous low-level flow on affected side (jet may be present with partially obstructing calculus)\nN.B.: $15 \\%$ falsely positive during pregnancy\n$\\checkmark$ direct visualization of prevesical calculus by transabdominal / transrectal / transvaginal US\nNECT ( $95-98 \\%$ sensitive, $96-100 \\%$ specific, $97 \\%$ accurate):\n$\\diamond$ Helical NECT is the most accurate technique and gold standard for detecting urinary tract calculi!\nAdvantages:\n(a) visualization of all calculi (= stone burden)\n(b) short exam time ( $3-5$ minutes)\n(c) avoidance of IV contrast\n(d) detection of extraurinary causes of flank pain (in 16-45\\%)\n(e) information about stone composition and fragility\n$\\checkmark$ calcified stone within ureter (PATHOGNOMONIC):\n$D D x$ : phlebolith $\\rightarrow$ no continuity with the ureter\n$\\checkmark$ all stone compositions readily detectable (except unmineralized stone matrix + stones related to protease inhibitor indinavir [Crixivan ${ }^{\\circledR}$ ] for HIV treatment)\n$\\checkmark$ proximal ureteral dilatation + normal caliber distally\n$\\checkmark$ stone at ureterovesical junction\n$D D x$ : stone passed into bladder (stone falls anteriorly in prone position)\n$\\checkmark$ \"soft-tissue rim\" sign ( $50-77 \\%$ sensitive, $92 \\%$ specific):\n$=$ halo of soft-tissue attenuation around calcific focus $\\leftarrow$ thickening of ureteral wall surrounding impacted small ureteric calculus $\\leftarrow$ edema within 4-24 hours after",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 291,
            "markdown": "obstruction\n$\\sqrt{ }$ visible in $90 \\%$ of stones $<4 \\mathrm{~mm}$\n$\\sqrt{ }$ not visible in $33 \\%$ of stones $>5 \\mathrm{~mm} \\leftarrow$ thinning of ureteral wall by impaction of larger stones\n$D D x$ : gonadal vein phlebolith (in front of upper ureter, lateral to mid ureter); $2-8 \\%$ of phleboliths have a \"soft-tissue rim\" sign\n$\\checkmark$ secondary signs of urinary tract obstruction (in 96\\%):\n$\\checkmark$ asymmetric stranding of perinephric fat (in $65 \\%, 76 \\%$ sensitive, $90 \\%$ specific) with loss of well-defined fat-kidney interface due to\n(a) fluid within bridging septa of perinephric fat $\\leftarrow$ increased lymphatic pressure\n$\\diamond$ A higher degree of perinephric edema means a higher degree of obstruction!\n(b) focal nonlinear fluid collection of extravasated urine $\\leftarrow$ forniceal rupture\n$\\checkmark$ periureteral edema (in $31 \\%$ )\n$\\checkmark$ hydronephrosis (in $69 \\%, 83 \\%$ sensitive, $94 \\%$ specific) = rounded fluid-filled calices and infundibula partially obliterating the renal sinus fat; seen early\n$D D x$ : extrarenal pelvis, parapelvic cysts\n$\\checkmark$ hydroureter above stone ( $87 \\%$ sensitive, $90 \\%$ specific) continuous with renal pelvis\n$\\checkmark$ unilateral renal enlargement ( $71 \\%$ sensitive, $89 \\%$ specific)\n$\\checkmark$ thickening of lateroconal fascia\n$\\checkmark$ perinephric edema\n$\\checkmark$ unilateral absence of white pyramid ( $=$ loss of the occasional incidental finding of high-attenuation medullary pyramids in normal kidneys)\nFalse negatives $(2-7 \\%)$ :\n(a) volume averaging ( $=$ stone small relative to collimation)\n(b) patients treated with indinavir\n\nStone burden:\n$\\checkmark$ greatest dimension of stone in magnified bone window setting\n$\\checkmark$ stone volume for large / staghorn calcul $\\rightarrow$ SWL failure likely with a stone of $>700$ mm 3\nStone fragility:\n$\\checkmark$ stone heterogeneity $\\rightarrow$ susceptible to fragmentation\n$\\checkmark$ stone homogeneity $\\rightarrow$ harder to fragment\nMR:\n$\\diamond$ May be helpful when use of contrast media / radiation is undesirable (pregnancy, children)!\n$\\checkmark$ renal enlargement\n$\\checkmark$ perinephric fluid $\\leftarrow$ lymphatic congestion / forniceal rupture\n$\\checkmark$ periureteral edema associated with urinary obstruction\n$\\checkmark$ abrupt change in ureteral caliber\n$\\checkmark$ dilatation distal to sacral promontory $\\leftarrow$ suspect ureterovesical junction stone\n$\\checkmark$ dark signal void (low SI of filling defect) in ureter (DDx: flow artifact on T2 single-shot fast SE images)\n$\\diamond$ insensitive for most renal / ureteral stones of $<1 \\mathrm{~cm}$\nVisualization of stones in the urinary tract is challenging with MRI, particularly for intrarenal stones and",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 292,
            "markdown": "those at the ureterovesical junction.\nNUC (DTPA, MAG3):\n$\\sqrt{ }$ initially diminished uptake during renal perfusion phase\n$\\sqrt{ }$ prolonged nephrographic phase\n$\\sqrt{ }$ delayed excretion into collecting system\n$\\sqrt{ }$ delayed transit of radiotracer with accumulation in obstructed collecting system\n$\\sqrt{ }$ no clearing effect of IV furosemide injection\nAdvantages: quantitative assessment of renal function\n$C x$ : xanthogranulomatous pyelonephritis\nRx: (1) Medical expulsive therapy: $\\alpha$-blocker, calcium channel blocker, steroids, NSAID\n(2) Hydration (during strenuous physical activity, at bedtime, within 3 hours after meal) maintaining urine output of $2-3 \\mathrm{~L} /$ days\n(3) Diet: restrict amounts of protein, sodium, calcium\n(4) Drugs: thiazide diuretics (lowers urinary calcium), allopurinol (lowers urate + oxalate excretion)\n(5) Extracorporeal shock wave lithotripsy (ESWL)\n\nDDx: (1) Recent passage of stone\n(2) Phlebolith\n$\\sqrt{ }$ \"comet-tail\" sign = extension of curvilinear soft-tissue band from stone (in 65\\%)\n$\\sqrt{ }$ comet nucleus $\\leftarrow$ calcified phlebolith\n$\\sqrt{ }$ comet tail $\\leftarrow$ noncalcified gonadal vein\n$\\sqrt{ }$ low-attenuation center (visible in $9 \\%$, detectable with profile analysis in $21 \\%$ )\n(3) Arterial calcification\n(4) Calcified lymph node\n(5) Surgical clip\n\nPrognosis:\n(1) Spontaneous passage of ureteral calculi (in 93\\%)\n\n| Stone size | passes in |\n| :--: | :--: |\n| $<4 \\mathrm{~mm}$ | $90 \\%$ |\n| $\\leq 5 \\mathrm{~mm}$ | $68 \\%$ |\n| $4-6 \\mathrm{~mm}$ | $50 \\%$ |\n| $5-10 \\mathrm{~mm}$ | $47 \\%$ |\n\n$\\diamond$ Stones $>6 \\mathrm{~mm}$ rarely pass!\n(2) Without treatment stone recurrence is $10 \\%$ at 1 year, $33 \\%$ at 5 years, $50 \\%$ at 10 years, $75 \\%$ by 20 years\n\n# UTRICLE CYST \n\n= dilatation of prostatic utricle (sometimes believed to be a remnant of the mÃ¼llerian duct)\nPrevalence: $1-5 \\%$ of general population\nAge: $1^{\\text {st }}-2^{\\text {nd }}$ decade\n\n- postvoid dribbling, suprapubic / rectal pain, hematuria",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 293,
            "markdown": "- obstructive / irritative urinary tract symptoms\n\nOften associated with:\nhypospadia, intersex disorders, incomplete testicular descent, ipsilateral renal agenesis\nLocation: arise in midline from verumontanum\n$\\diamond$ Free communication with urethra\n$\\checkmark$ usually $8-10-\\mathrm{mm}$ long pear-shaped cyst posterior to urethra\n$\\sqrt{ }$ NO extension above base of prostate (DDx: mÃ¼llerian duct cyst, usually larger with extension above base of prostate)\n$D x$ : endoscopic catheterization with aspiration of white / brown fluid occasionally containing spermatozoa\n$C x$ : recurrent epididymitis, hematospermia, carcinomatous metaplasia\n\n# VARICOCELE \n\n$=$ abnormal dilatation + tortuosity of plexus pampiniformis $\\leftarrow$ retrograde flow into internal spermatic vein\nComponents of pampiniform plexus:\n(a) internal spermatic vein (ventral location) draining testis\n(b) vein of vas deferens (mediodorsal) draining epididymis\n(c) cremasteric vein (laterodorsal location) draining scrotal wall\n\nUS:\n$\\checkmark$ multiple hypoechoic serpiginous tubular structures, initially superior and lateral, later posterior and inferior to testis\n$\\checkmark$ containing low-level echoes if flow slow\n\n| Grading of Varicocele |  |  |\n| :--: | :--: | :--: |\n| Grade | Relaxed State | During Valsalva |\n| Normal | 2.2 mm | 2.7 mm |\n| Small varicocele | $2.5-4.0 \\mathrm{~mm}$ | $\\uparrow$ by 1.0 mm |\n| Moderate varicocele | $4.0-5.0 \\mathrm{~mm}$ | $\\uparrow$ by $1.2-1.5 \\mathrm{~mm}$ |\n| Large varicocele | $>5.0 \\mathrm{~mm}$ | $\\uparrow$ by $>1.5 \\mathrm{~mm}$ |\n\n## Idiopathic / Primary Varicocele\n\nCause: incompetent / absent valve at level of left renal vein / IVC on right side\nPrevalence:\n(a) clinical varicocele: in $8-15 \\%$ of adult males, in $21-39 \\%$ of infertile men\n(b) subclinical varicocele: in $40-75 \\%$ of infertile men\n\nTheoretical causes for infertility:\n(1) Increase in local temperature\n(2) Reflux of toxic substances from adrenal gland (countercurrent exchange of norepinephrine from refluxing renal venous blood into testicular arterial blood at the level of the pampiniform plexus)\n(3) Alteration in Leydig cell function\n(4) Hypoxia of germinative tissue $\\leftarrow$ venous reflux resulting in venous hypertension + stasis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 294,
            "markdown": "- scrotal pain, scrotal swelling with \"bag of worms\" quality\n- abnormal spermatogram: impaired motility, immature sperm, oligospermia\n\nLocation: left side ( $78 \\%$ ), bilateral ( $16 \\%$ ), right side ( $6 \\%$ )\nReasons for left-sided prevalence:\n(a) left testicular vein longer\n(b) left testicular vein enters left renal vein at right angle\n(c) compression of left renal vein by left testicular artery in some men\n(d) compression of left testicular vein by descending colon distended with feces\n\nBidirectional Doppler sonography (erect with quiet breathing):\n(1) SHUNT TYPE ( $86 \\%$ ): insufficient distal valves allow spontaneous + continuous reflux from internal spermatic vein (retrograde flow) into cremasteric vein + vein of vas deferens (where flow is orthograde) via collaterals\n\n- sperm quality diminished\n- clinically plexus type (grade II + III) = medium-sized + large varicoceles\n$\\checkmark$ continuous reflux during Valsalva maneuver\n(2) STOP TYPE / PRESSURE TYPE (14\\%): intact intrascrotal valves allow only brief period of reflux from spermatic vein into pampiniform plexus under Valsalva maneuver\n- sperm quality normal\n- clinically central type (grade $0+\\mathrm{I}$ ) = subclinical + small varicocele\n$\\checkmark$ short phase of initial retrograde flow\nUS (almost $100 \\%$ sensitive + specific):\n$\\checkmark$ diameter of dominant vein in upright position at inguinal canal\n$D x$ : documentation of venous reflux\n$C x$ : testicular atrophy (volume measurement of testes!)\n$R x$ : (1) Ivanissevitch procedure $=$ surgery\n(2) Transcatheter spermatic vein occlusion\n$\\diamond$ Treatment improves sperm quality in up to $53 \\%$\n\n\n# Secondary Varicocele \n\n$=$ compression of left renal vein by tumor, aberrant renal artery, obstructed renal vein, hydronephrosis, cirrhosis\n\n- nondecompressible varicocele\n$\\diamond$ Check left renal vein!\n\n\n## VESICOURETERIC REFLUX\n\n$=$ abnormal valve mechanism at UVJ resulting in reflux, ureteral dilatation, clubbed calices, eventual renal scarring\nA. CONGENITAL REFLUX $=$ PRIMARY REFLUX\n$=$ incompetence of ureterovesical junction $\\leftarrow$ abnormal tunneling of distal ureter through bladder wall\nPrevalence: in 9-10\\% of normal Caucasian babies; in 1.4\\% of school girls; in 30\\% of children with a first episode of UTI\n\n- short submucosal ureteral tunnel (normally has a length/width ratio of $4 \\div 1$ )\n- large laterally located ureteral orifice",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 295,
            "markdown": "Location: uni- / bilateral (frequently involves lower pole ureter in total ureteral duplication)\n![img-18.jpeg](img-18.jpeg)\n$\\sqrt{ }$ renal scars in $22-50 \\%$\nPrognosis: disappears spontaneously in $80 \\%$\nCx: reflux atrophy / nephropathy in $22-50 \\%$; end-stage renal disease in $5-15 \\%$ of adults\nB. ACQUIRED REFLUX $=$ SECONDARY REFLUX\n\n1. Paraureteric diverticulum $=$ Hutch diverticulum\n2. Duplication with ureterocele",
            "images": [
                {
                    "id": "img-18.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 299,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1713,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 296,
            "markdown": "3. Cystitis (in $29-50 \\%$ )\n4. Urethral obstruction (urethral valves)\n5. Neurogenic bladder\n6. Absence of abdominal musculature (prune belly syndrome)\n\nCx: renal scarring with UTI (30-60\\%)\nEstimated radiation dose to ovaries:\n(a) usual fluoroscopy: $\\quad 300 \\mathrm{mrad}$\n(c) tailored low-dose fluoroscopy: $\\quad 3 \\mathrm{mrad}$\n(b) radionuclide cystography: $\\quad 2 \\mathrm{mrad}$\n\nUS ( $74 \\%$ of kidneys with VUR may be normal by US):\n$\\sqrt{ }$ intermittent hydroureteronephrosis = variable size of collecting system\n$\\sqrt{ }$ redundant mucosa causing apparent thickening of renal pelvic wall\n$\\sqrt{ }$ large thin-walled bladder\n$\\sqrt{ }$ midline-to-orifice distance $>7-9 \\mathrm{~mm}$ has high probability of vesicoureteric reflux\nPrognosis:\nAll grades of reflux can be outgrown:\n$>80 \\%$ [46\\%] of grade I-II [III] outgrow reflux within 5 years\n$>50 \\%$ of grade IV continue to have reflux 9 years after initial diagnosis\nRenal scarring: $>20 \\%$ chance for grade III-V reflux; $2-3 \\%$ chance for grade I-II reflux\nRx: (1) Grade IV-V require surgery to avoid renal scarring + renal impairment + hypertension (except in infants\n(2) Periureteral diverticulum requires surgery (grade of reflux not prognostic)\n$\\diamond$ Grade I-III resolve with maturation of the UV junction\n\n# WILMS TUMOR \n\n[Carl Max Wilhelm Wilms (1867-1918), pathologist and chair of surgery at the University of Heidelberg]\n$=$ NEPHROBLASTOMA\n$\\diamond$ Most common malignant abdominal neoplasm in children 1-8 years old (10\\%)!\n$\\diamond 3^{\\text {rd }}$ most common malignancy in childhood (after leukemia + brain tumors; neuroblastoma more common in infancy)!\n$\\diamond 3^{\\text {rd }}$ most common ( $87 \\%$ ) of all renal masses in childhood (after hydronephrosis + multicystic dysplastic kidney)!\nPrevalence: $7-8 \\div 1,000,000$ children; 500 new cases annually in USA (2015, stable for years); familial in $1-2 \\%$\nPeak age: 2-3 years (range, 3 months - 11 years); rare in neonates ( $0.16 \\%$ ) and during $1^{\\text {st }}$ year; $50 \\%<3$ years; $80 \\%<5$ years; $90 \\%<8$ years; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$; more common in blacks\nHisto: arises from undifferentiated metanephric blastema ( $=$ nephrogenic rests) with variable amounts of blastema, stroma, epithelium; occasionally mesodermal derivatives of striated / smooth muscle, fat, bone, cartilage = \"teratoid Wilms tumor\"\n(a) unfavorable histologic character = presence of anaplasia in $6.2 \\%$ : localized / diffuse\n(b) favorable histologic character ( $90 \\%$ )\n$\\diamond$ Multilocular cystic nephroma, mesoblastic nephroma, nephro-blastomatosis are related to the",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 297,
            "markdown": "more favorable types of Wilms tumor!\nGenetics: multifactorial; abnormal WT1 gene on locus 11p13 with WAGR syndrome (Wilms tumor, aniridia, genitourinary abnormalities, mental retardation) or Drash syndrome; abnormal WT2 gene on locus 11 p15 with Beckwith-Wiedemann syndrome or hemihypertrophy; familial Wilms tumor in $1 \\%$\n\n| Staging of Wilms Tumor (stage each kidney separately) <br> (National Wilms Tumor Study Group) |\n| :-- |\n| I tumor limited to kidney (renal capsule intact) |\n| II extracapsular extension into perirenal tissue / renal vessels <br> outside kidney / lymph nodes |\n| III not totally resectable (peritoneal implants, other than <br> paraaortic nodes involved, invasion of vital structures) |\n| IV hematogenous metastases (lung in 85\\%, liver in 20\\%, bone <br> in 0.8\\%, brain [rare]) / lymph node metastases outside <br> abdomen or pelvis |\n| V bilateral renal involvement at diagnosis (4-13\\%) |\n\nSyndromic Wilms tumor (in 10-14\\%) associated with:\n(1) Sporadic aniridia (= severe hypoplasia of iris)\n$\\diamond 33 \\%$ of sporadic aniridia patients develop Wilms tumor!\n(2) Beckwith-Wiedemann syndrome\n$\\diamond 10-20 \\%$ of patients with Beckwith-Wiedemann syndrome develop Wilms tumor!\n(3) Hemihypertrophy: total / segmental / crossed (2.5\\%)\n$\\diamond$ Ipsilateral or contralateral kidney affected\n$\\diamond$ Increased incidence of all embryonal tumors (adrenal cortical neoplasms, hepatoblastoma)\n(4) Genitourinary disorders (4.4\\%):\n(a) Drash syndrome: male pseudohermaphroditism, progressive glomerulonephritis\n(b) Renal anomalies: horseshoe kidney, duplex / solitary / fused kidney\n(c) Genital anomalies: cryptorchidism (2.8\\%), hypospadia (1.8\\%), ambiguous genitalia\n\nScreening recommendations (up to age 7 years):\nCT at 6 months of age followed by US every 3 months\nStaging:\n> evaluate for - invasion of adjacent organs\n\n- involvement of regional lymph nodes\n- involvement of the other kidney\n- spread to the peritoneum\n- metastatic disease\n> screen contralateral kidney\n> examine renal vein + IVC\n$\\checkmark$ signs of tumor rupture:\n$\\checkmark$ poorly defined tumor margins\n$\\checkmark$ perinephric fat stranding\n$\\checkmark$ retroperitoneal fluid\n$\\checkmark$ ipsilateral pleural effusion\n$\\checkmark$ peritoneal fluid beyond cul-de-sac",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 298,
            "markdown": "- asymptomatic palpable abdominal mass ( $90 \\%$ ), often discovered by a parent\n- hypertension (in up to $25 \\%$ ) $\\leftarrow$ renin production by tumor / vascular compression by tumor\n- abdominal pain ( $25 \\%$ ), low-grade fever ( $15 \\%$ )\n- gross hematuria ( $7-15 \\%$ ) $\\leftarrow$ invasion of renal pelvis\n- microscopic hematuria ( $15-25 \\%$ )\n- hemorrhage after minor trauma\n- ascites $\\leftarrow$ venous obstruction; varicocele $\\leftarrow$ left-sided tumor\n\nRULE OF 10's:\n$>10 \\%$ unfavorable histology\n$>10 \\%$ multifocal in one kidney\n$>10 \\%$ bilateral\n$>10 \\%$ vascular invasion\n$>10 \\%$ calcifications\n$>10 \\%$ pulmonary metastases at presentation\nLocation: usually solitary lesion; multifocal within one kidney ( $12 \\%$ ); syn- / metachronous bilateral tumors ( $7 \\%$ ) with nephrogenic rests in $94-99 \\%$\n$\\checkmark$ large tumor $\\rightarrow$ average size of 12 cm in diameter\n$\\checkmark$ expansile intrarenal growth:\n$\\checkmark$ sharply marginated with compression of renal tissue\n$=$ pseudocapsule\n$\\checkmark$ distorted \"clobbered\" / dilated calices\n$\\checkmark$ displacement of major vessels, rather than encasement\n$\\checkmark$ curvilinear / phlebolithic calcifications in $5 \\%$ on plain film, in $15 \\%$ on CT (DDx: regular stippled calcifications in $85 \\%$ of neuroblastomas)\n$\\checkmark$ tumor invasion of renal vein and IVC ( $4-10 \\%$ ); extension into right atrium (in $21 \\%$ of cases with IVC invasion)\n$\\checkmark$ tumor may cross midline\n$\\checkmark$ poor / nonexcretion of IV contrast $\\leftarrow$ invasion or compression of hilar vessels + collecting system / extensive tumor infiltration of renal parenchyma\nUS:\n$\\checkmark$ predominantly solid spherical mass:\n$\\checkmark$ heterogeneous echogenicity (frequent):\n$\\checkmark$ irregular anechoic areas $\\leftarrow$ cyst formation + central necrosis + hemorrhage\n$\\checkmark$ echogenic areas $\\leftarrow$ calcium ( $9 \\%$ ) / fat\n$\\checkmark$ fairly evenly echogenic (rare)\nCT (preferred modality):\n$\\checkmark$ large well-circumscribed heterogeneous partially cystic intrarenal mass $\\leftarrow$ old hemorrhage + necrosis ( $71 \\%$ ), cyst formation, fat, calcifications ( $15 \\%$ )\n$\\checkmark$ beak / claw of renal tissue extends partially around mass\n$\\checkmark$ tumor less enhancing than renal parenchyma\nCECT (ALARA dose $\\rightarrow$ ONLY portal venous phase necessary):\n$\\checkmark$ nodal / hepatic metastases\n$\\checkmark$ tumor extension into renal vein / IVC\n$\\checkmark$ contralateral synchronous tumor/ nephrogenic rests",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 299,
            "markdown": "MR:\n$\\sqrt{ }$ typically heterogeneous lobulated hypointense compared with normal renal parenchyma on T1WI\n$\\sqrt{ }$ foci of increased T1 signal intensity $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ hyper- or isointense on T2WI\nNUC:\n$\\sqrt{ }$ nonfunctioning kidney ( $10 \\%$ )\n$\\sqrt{ }$ hypo- / iso- / hyperperfusion on radionuclide angiogram\n$\\sqrt{ }$ absent tracer accumulation on delayed static images\n$\\sqrt{ }$ displacement of kidney + distortion of collecting system\nPET:\n$\\sqrt{ }$ FDG-avid primary + metastatic Wilms tumor\n$\\sqrt{ }$ may be useful to detect active / residual disease and identify nonresponders of neoadjuvant chemotherapy\nAngio:\n$\\sqrt{ }$ hypervascular tumor: enlarged tortuous vessels, coarse neovascularity; small arterial aneurysms; vascular lakes\n$\\sqrt{ }$ parasitization of vascular supply\nSpread with rupture through renal capsule:\n$\\sqrt{ }$ broad-based subdiaphragmatic masses on surface of liver and spleen\n$\\sqrt{ }$ omental caking\nCx: tumor rupture\n$R x$ : presurgical chemotherapy + nephrectomy + adjuvant chemotherapy $\\pm$ radiation therapy\nPrognosis: survival rate $\\leftarrow$ depending on pathologic pattern, age at time of diagnosis, extent of disease; 4-year relapse-free survival: $91 \\%$ for stage I; $88 \\%$ for stage II; $79 \\%$ for stage III; $78-84 \\%$ for stage IV\n$D D x$ : Age is the most important consideration formulating a DDx\n(1) Neuroblastoma (encasement / elevation of aorta, many regular stippled calcifications, displacement of kidney, tumor crossing midline behind aorta, extension through neural foramina into spinal canal, skeletal metastases)\n(2) Congenital mesoblastic nephroma (in fetus / neonate)\n(3) $\\mathrm{RCC}\\left(2^{\\text {nd }}\\right.$ decade of life, renal vein extension)\n(4) Clear cell sarcoma (early skeletal metastases)\n(5) Rhabdoid tumor (subcapsular hemorrhage, brain tumor in posterior fossa)\n(6) Infection: acute bacterial nephritis, renal abscess\n\n# WOLMAN DISEASE \n\n[Moshe Wolman (1914-?), chairman of pathology at University of Tel-Aviv, Israel]\n= PRIMARY FAMILIAL XANTHOMATOSIS\n= rare autosomal recessive lipidosis with accumulation of cholesterol esters and triglycerides in visceral foam cells + various tissues (liver, spleen, lymph nodes, adrenal cortex, small bowel)\nEtiology: deficiency of lysosomal acid esterase / acid lipase\n\n- malabsorption in neonatal period: failure to thrive, diarrhea, steatorrhea, vomiting",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 300,
            "markdown": "- delayed growth, diminished muscle mass, abdominal distension\n$\\checkmark$ hepatosplenomegaly\n$\\checkmark$ extensive bilateral punctate calcifications (calcification of fatty-acid soaps) throughout enlarged adrenals (maintaining their normal triangular shape) are DIAGNOSTIC\n$\\checkmark$ enlarged fat-containing lymph nodes\n$\\checkmark$ small bowel wall thickening $\\leftarrow$ infiltration of mucosa of small bowel by lipid-filled histiocytes impairing absorption\n$\\checkmark$ generalized osteoporosis\nCT \\& MR: attenuation + signal intensities consistent with deposition of lipids\nDx: assay of leukocytes / cultured skin fibroblasts\nPrognosis: death occurs within first 6 months of life",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 301,
            "markdown": "# OBSTETRICS AND GYNECOLOGY \n\n## DIFFERENTIAL DIAGNOSIS OF OBSTETRIC AND GYNECOLOGIC DISORDERS\n\n## PELVIC PAIN\n\n## Chronic Pelvic Pain\n\n$=$ nonmenstrual pain of $>6$ months duration\nPrevalence: $15 \\%$ in women between 18 and 50 years; $10-40 \\%$ of all gynecologic outpatient visits; $35 \\%$ of diagnostic laparoscopies; $15 \\%$ of all hysterectomies\nAge: typically $<35$ years; Whites $>$ Blacks\n\n## Pelvic Pain in Young Woman\n\nA. Most common*\n\n1. Hemorrhagic ovarian cyst\n2. Pelvic inflammatory disease (PID)\n3. Ectopic pregnancy\nB. Less frequent*\n4. Torsion of ovary\n5. Massive ovarian edema\n6. Endometriosis\n7. Degenerating fibroid\n8. Pelvic congestion syndrome\nC. Post partum\n9. Endometritis\n10. Ovarian vein thrombosis\n\n* $\\beta$-hCG results influence options\n\n\n## Pelvic Pain in Nongynecological Condition\n\n1. Appendicitis\n2. Diverticulitis\n3. Epiploic appendagitis\n4. Crohn disease\n5. Infectious ileocolitis\n6. Colonic malignancy\n7. Ureterolithiasis\n\n## Pelvic Pain in Pediatric Age Group\n\n1. Ovarian torsion\n(a) of normal ovary",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 302,
            "markdown": "Cause: excessive mobility of ovary in childhood\n(b) with ovarian mass:\n> functional cyst $(60 \\%)$\n> neoplasm $(40 \\%)$ :\nÂ» benign mature teratoma ( $66 \\%$ )\nÂ» malignancy ( $33 \\%$ ): germ cell tumor ( $60-75 \\%$ ), epithelial tumor ( $10-20 \\%$ ), stromal tumor $(10 \\%)$\n2. Hemorrhagic ovarian cyst\n3. Pelvic inflammatory disease\n4. Ectopic pregnancy\n\n# Pelvic Pain in Pregnancy \n\nConfounding factors:\n\n1. Nonspecific leukocytosis\n2. Displacement of structures from their normal locations by gravid uterus\n3. Difficult abdominal examination\n4. Nonspecific nausea and vomiting\nA. PROBLEMS WITH THE PREGNANCY\n5. Failed pregnancy\n6. Ectopic pregnancy\n7. Placental abruption\n8. Placenta previa\nB. PROBLEMS WITH PELVIC ORGANS\n(a) Uterus\n9. Degenerating fibroid $\\leftarrow$ altered blood supply with enlargement during pregnancy\n(b) Ovary\n10. Ruptured hemorrhagic corpus luteum cyst\n11. Adnexal mass $\\leftarrow$ rupture / rapid enlargement\n12. Ovarian torsion / edema\n(c) General\n13. Endometriosis\n14. PID: pregnancy decreases risk of PID\nC. NONOBSTETRICAL PROBLEMS\n(a) GI tract\n15. Acute appendicitis\n16. Inflammatory bowel disease: peak age $15-25$ years\n17. Diverticulitis: no increase during pregnancy\n18. Small bowel obstruction / ileus\n(b) Hepatobiliary\n19. Cholelithiasis / choledocholithiasis\n20. Acute cholecystitis\n21. Pancreatitis: mostly secondary to gallstones\n22. HELLP syndrome\n23. Acute fatty liver\n(c) GU tract",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 303,
            "markdown": "1. Physiologic hydronephrosis\n2. Obstructing ureteral stone\n(d) Vascular\n3. Venous thromboembolic disease\n4. Ovarian vein enlargement / thrombosis\n\n# GENERAL OBSTETRICS \n\nParity Nomenclature (for pregnancies $<20$ weeks)\nexample: $\\mathrm{G}_{5} \\mathrm{P}_{4004}$\nGravida 5 pregnancies\nParity\nmnemonic: FPAL\nFull term 4 full term\nPreterm 0 preterm\nAbortion 0 abortion\nLiving 4 living\n\n## Level I Obstetric Ultrasound\n\nIndication: MS-AFP $\\geq 2.5$ multiples of mean (MoM) between 14 and 18 weeks MA Limited scope of examination to identify frequent causes of MS-AFP elevation in 20-50\\% of pregnancies:\n\n1. Gestational age $\\geq 2$ weeks more advanced than estimated clinically (18\\%)\n2. Multiple gestations ( $10 \\%$ )\n3. Unsuspected fetal demise (5\\%)\n4. Obvious fetal NTD / abdominal wall defect\n\nOutcome: no cause identified in $50-80 \\%$\nRecommendation if level I ultrasound is unrevealing:\n(1) Amniocentesis for AF-AFP $\\rightarrow$ normal results in $>90 \\%$\n(2) Level II obstetric ultrasound (skipping amniocentesis)\n\n## Level II Obstetric Ultrasound\n\nIndication: AF-AFP $\\geq 2 \\mathrm{MoM}$\nAccuracy: identification of abnormal fetuses in $99 \\%$\nExamination targeted for:\n\n1. Open neural tube defect: anencephaly, encephalocele, open spina bifida, amniotic band syndrome resulting in open neural tube defect\n2. Closed neural axis anomaly: hydrocephalus, Dandy-Walker malformation\n3. Abdominal wall defect: gastroschisis, omphalocele, gastropleuroschisis from amniotic band syndrome\n4. Upper GI obstruction: esophageal atresia $\\pm$ tracheoesophageal fistula, duodenal obstruction\n5. Cystic hygroma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 304,
            "markdown": "6. Teratoma: sacrococcygeal, lingual, retropharyngeal\n7. Renal anomalies: obstructive uropathy, renal agenesis, multicystic dysplastic kidney, congenital Finnish nephrosis\n$\\diamond$ Risk of fetal chromosomal anomaly is only $0.6-1.1 \\%$ with normal level II sonogram!\n\n# MATERNAL SERUM SCREENING \n\n## Alpha-fetoprotein\n\n$=$ glycoprotein as major circulatory protein of early fetus\nOrigin: formed initially by yolk sac + fetal gut (4-8 weeks), later by fetal liver\nDetectable in\n(a) fetal serum\n\n- concentration peaks at 14-15 weeks followed by progressive decline\n(b) amniotic fluid (AF-AFP) is a result of\n> fetal urination\n> fetal gastrointestinal secretions\n> transudation across fetal membranes: amnion, placenta\n> transudation across immature fetal epithelium\n- concentration peaks early in $2^{\\text {nd }}$ trimester followed by progressive decline\n(c) maternal circulation (MS-AFP) $\\leftarrow$ leakage from amniotic fluid across placenta\n- levels start to rise at $7^{\\text {th }}$ week, peak at $32^{\\text {nd }}$ week, and decline toward end of pregnancy\n$\\diamond$ Either high / low MS-AFP is associated with $34 \\%$ of all major congenital defect\nAt the end of the $1^{\\text {st }}$ trimester AFP is present:\nin fetal plasma in milligram quantities\nin amniotic fluid in microgram quantities\nin maternal serum in nanogram quantities\nReported in $\\mathrm{MoM}=$ multiples of mean to standardize interpretation among laboratories\n\n\n## Elevated Alpha-fetoprotein\n\n- screening at $16-18$ weeks GA\n$\\diamond$ Values must be corrected for dates, maternal weight, race, presence of diabetes (diabetes has depressing effect on MS-AFP so that lower levels may be associated with NTDs)\nAssociated with:\nA. LABORATORY ERROR\nB. ERRONEOUS DATES (18\\%):\n\nGA $\\geq 2$ weeks more advanced sonographically than by clinical estimate (AFP levels rise $15 \\%$ per week during $16-18$-week window)\nC. MULTIPLE GESTATIONS (14\\%)\nD. FETAL DEMISE (7\\%) / fetal distress / threatened abortion\nE. FETAL ANOMALIES (61\\%)\n\n1. Neural tube defects $(51 \\%)$ : anencephaly ( $30 \\%$ ), myelomeningocele ( $18 \\%$ ), encephalocele ( $3 \\%$ ), forebrain malformation\nPrevalence: $1.6 \\div 1,000$ births in USA; $6 \\div 1,000$ births in Great Britain",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 305,
            "markdown": "$\\diamond$ In $90 \\%$ as $1^{\\text {st }}$ time event!\nRisk of recurrence: $3 \\%$ after one affected child; $6 \\%$ after 2 affected children\n2. Ventral wall defects $(21 \\%)$ : gastroschisis, omphalocele (sensitivity of 50\\%)\n3. Proximal fetal gut obstruction: esophageal / duodenal atresia\n$\\rightarrow$ diminished AFP degradation in small bowel\n4. Cystic hygroma, teratoma: pharyngeal, sacral\n5. Amniotic band syndrome:\nasymmetric cephalocele, gastropleuroschisis\n6. Renal abnormalities:\nmulticystic dysplastic kidney, renal agenesis, pelviectasis, congenital Finnish nephrosis $\\rightarrow$ typically $\\geq 10 \\mathrm{MoM}+$ negative amniotic fluid acetylcholinesterase\n7. Oligohydramnios\nF. PLACENTAL LESION\naltering the placentomaternal barrier\n\n1. Chorioangioma\n2. Peri- and intraplacental hematoma\n$\\rightarrow$ resulting in fetomaternal hemorrhage\n3. Placental lakes, infarct, intervillous thrombosis\nG. LOW BIRTH WEIGHT\nH. Normal pregnancy + MATERNAL DISORDER\n4. Hepatitis\n5. Hepatoma\nI. Fetal-maternal blood mixing:\ncollection of MS-AFP samples after amniocentesis\nmnemonic: GEM MINER CO\nGastroschisis\nEsophageal atresia\nMultiple gestations\nMole\nIncorrect menstrual dates\nNeural tube defects\nError: laboratory\nRenal disease in fetus: autosomal recessive polycystic kidney disease, renal dysplasia, obstructive uropathy, congenital Finnish nephrosis\nChorioangioma\nOmphalocele\n\n# Elevated Maternal Serum AFP (MS-AFP) \n\n$=$ defined as $\\geq 2.5 \\mathrm{MoM} /$ equivalent to the $5^{\\text {th }}$ percentile: 4.5 MoM for multiple gestations\nPower of detection at $\\geq 2.5 \\mathrm{MoM}$ cutoff:\n$98 \\%$ for gastroschisis\n$90 \\%$ for anencephalic fetuses",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 306,
            "markdown": "$75-80 \\%$ for open spinal defects\n$70 \\%$ for omphaloceles\nPrevalence: 2-5\\% screen-positive rate (in 16\\% normal MS-AFP on retesting); 6-15\\% of fetuses have some type of major congenital defect; in $1.3 \\div 1,000$ tests fetal anomaly detected\n$\\diamond$ The higher the AFP elevation the higher the probability of fetal anomalies\n$\\diamond 20-38 \\%$ of women with unexplained high MS-AFP (ie, in the absence of fetal abnormality) suffer adverse pregnancy outcomes (premature birth, preeclampsia, 2-4 x IUGR, 10 x perinatal mortality, 10 x placental abruption)!\n\n# Elevated Amniotic Fluid AFP (AF-AFP) \n\n$=$ defined as $\\geq 2 \\mathrm{MoM}(<2 \\mathrm{MoM}$ has a $97 \\% \\mathrm{NPV})$\nPrevalence: $<10 \\%$ of women with elevated MS-AFP and \"unrevealing\" level I US exam\n\n- amniotic fluid also tested for karyotype + acetylcholinesterase ( $=$ neurotransmitter enzyme present when neural tissue is exposed)\n$\\diamond 66 \\%$ of fetuses with $\\uparrow$ maternal AF-AFP are normal!\n$\\diamond$ A targeted level II ultrasound exam will show fetal anomalies in $33 \\%$ !\n\n\n## Low Alpha-fetoprotein\n\n$=$ MS-AFP $\\leq 0.5 / \\mathrm{AF}-\\mathrm{AFP} \\leq 0.72 \\mathrm{MoM}$\nPrevalence: $3 \\%$\n\n1. Autosomal trisomy syndromes: trisomy $21,18,13$\n$\\diamond 20 \\%$ of trisomy 21 fetuses are found in women with low MS-AFP after adjustment for age!\n2. Absence of fetal tissues: eg, hydatidiform mole\n3. Fetal demise\n4. Misdated pregnancy\n5. Normal pregnancy\n6. Patient not pregnant\n\n## Use of Karyotyping\n\nFrequency: 11-35\\% of fetuses with sonographically identified abnormalities have chromosomal abnormalities\nA. FETAL ANOMALIES\n\n1. CNS anomalies: holoprosencephaly (43-59\\%), Dandy-Walker malformation (29$50 \\%$ ), cerebellar hypoplasia, agenesis of corpus callosum, myelomeningocele (33$50 \\%$ )\n2. Cystic hygroma ( $72 \\%$ ): Turner syndrome\n3. Omphalocele ( $30-40 \\%$ )\n4. Cardiac malformations\n5. Nonimmune hydrops\n6. Duodenal atresia\n7. Severe early-onset IUGR: trisomy 18, 13, triploidy\n8. Congenital diaphragmatic hernia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 307,
            "markdown": "9. Bone-echodense bowel (20\\%): trisomy 21\nB. MATERNAL RISK FACTORS\n10. Advanced age\n11. Low serum alpha-fetoprotein\n12. Abnormal triple screen of maternal serum\n13. History of previous chromosomally abnormal pregnancy ( $1 \\%$ risk of recurrence)\n\n| Aneuploid Risk of Major Anomalies |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Structural Defect | Incidence | Aneuploidy |  |\n|  |  | Risk | Most common |\n| Cystic hygroma | $1: 6,000$ | $60-75 \\%$ | 45X, 21,18,13, <br> XXY |\n| Hydrops | $1: 4,000$ | $30-80 \\%$ | 13,21,18,45X |\n| Holoprosencephaly | $1: 16,000$ | $40-60 \\%$ | 13,18,18p |\n| Cardiac defects | $1: 125$ | $5-30 \\%$ | 21,18,13,22 |\n| AV canal |  | $40-70 \\%$ | 21 |\n| Omphalocele | $1: 5,800$ | $30-40 \\%$ | 13,18 |\n| Duodenal atresia | $1: 10,000$ | $20-30 \\%$ | 21 |\n| Diaphragmatic hernia | $1: 4,000$ | $20-25 \\%$ | 13,18,21,45X |\n| Bladder outlet obstruction | $1: 1,000$ | $20-25 \\%$ | 13,18 |\n| Limb reduction | $1: 2,000$ | $8 \\%$ | 18 |\n| Clubfoot | $1: 830$ | $6 \\%$ | 18,13,4p-,18q- |\n| Hydrocephalus | $1: 1,250$ | $3-8 \\%$ | 13,18, triploidy |\n| Facial cleft | $1: 700$ | $1 \\%$ | 13,18,deletions |\n| Prune belly | $1: 40,000$ | low | 18,13,45X |\n| Single umbilical artery | $1: 100$ | minimal |  |\n| Bowel obstruction | $1: 4,000$ | minimal |  |\n| Gastroschisis | $1: 12,000$ | minimal |  |\n\n# C. PLANNED INTENSE INTRAUTERINE MANAGEMENT \n\nFetal anomalies not associated with chromosomal anomalies:\n\n1. Gastroschisis\n2. Unilateral renal anomaly\n3. Intestinal obstruction distal to duodenal bulb\n4. Off-midline unilateral cleft lip\n5. Fetal teratoma: sacrococcygeal / anterior cervical\n6. Isolated single umbilical artery\n\n## AMNIOTIC FLUID VOLUME\n\n## Production:\n\n(a) 1st trimester: dialysate of maternal + fetal serum across the noncornified fetal skin\n(b) $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ trimester: fetal urine ( $600-800 \\mathrm{~cm}^{3} / \\mathrm{d}$ near term), fetal lungs ( $600-800 \\mathrm{~cm}^{3} / \\mathrm{d}$ near term), amniotic membrane\nAbsorption:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 308,
            "markdown": "fetal swallowing + GI absorption, fetal lung absorption, clearance by placenta Assessment of amniotic fluid volume by:\n(1) Subjective assessment (\"Gestalt\" method):\nquick + efficient, accounts for GA-related variations in fluid volume, considered the most accurate if performed by experienced operator, operator + interpreter must be identical, no documentation, variations on serial scans difficult to appreciate\n(2) Depth of largest vertical pocket:\nsimple + quick (used in BPP), pockets $>2 \\mathrm{~cm}$ may be found in crevices between fetal parts with moderately severe oligohydramnios, does not account for GA-related variations\n(3) Four-quadrant Amniotic Fluid Index (AFI):\nfairly quick, probably correlates better with fluid volume than any single measurement, may not accurately reflect overall fluid volume, may be affected by fetal movement during measurements\n(4) Planimetric measurement of total intrauterine volume\n(5) Dye / para-aminohippurate dilution technique:\n$800 \\mathrm{~cm}^{3}$ at 34 weeks, $500 \\mathrm{~cm}^{3}>34$ weeks\n\n# Polyhydramnios \n\n$=$ amniotic fluid volume $>1,500-2,000 \\mathrm{~cm}^{3}$ at term\nPrevalence: $1.1-2-3.5 \\%$\n$\\sqrt{ }$ fetus does not fill the AP diameter of uterus\n$\\sqrt{ }$ single largest pocket devoid of fetal parts / cord $>8 \\mathrm{~cm}$ in vertical direction\n$\\sqrt{ }$ AFI $\\geq 20-24 \\mathrm{~cm}$\nPrognosis: $64 \\%$ perinatal mortality with severe polyhydramnios\nEtiology:\nA. IDIOPATHIC (35\\%)\n\nAssociated with: macrosomia in 19-37\\%\nSuggested cause:\n(1) Increased renal vascular flow\n(2) Bulk flow of water across surface of fetus + umbilical cord + placenta + membranes\nB. MATERNAL CAUSES (36\\%)\n\n1. Diabetes ( $25 \\%$ )\n2. Isoimmunization: Rh incompatibility (11\\%)]\n3. Placental tumors: chorioangioma\nC. FETAL ANOMALIES ( $20 \\%$ )\n(a) gastrointestinal anomalies ( $6-16 \\%$ ):\nimpairment of fetal swallowing (esophageal atresia in 3\\%); high intestinal atresias /\nobstruction of duodenum / proximal small bowel (1.2-1.8\\%), omphalocele, meconium peritonitis\n(b) nonimmune hydrops ( $16 \\%$ )\n(c) neural tube defects ( $9-16 \\%$ ):\nanencephaly, hydranencephaly, holoprosencephaly, myelomeningocele, ventriculomegaly, agenesis of corpus callosum, encephalocele, microcephaly\n(d) chest anomalies $(12 \\%)$ :",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 309,
            "markdown": "diaphragmatic hernia, cystic adenomatoid malformation, tracheal atresia, mediastinal teratoma, primary pulmonary hypoplasia, extralobar sequestration, congenital chylothorax\n(e) skeletal dysplasias ( $11 \\%$ ):\ndwarfism (thanatophoric dysplasia, achondroplasia), kyphoscoliosis, platyspondyly\n(f) chromosomal abnormalities ( $9 \\%$ ):\ntrisomy $21,18,13$\n(g) cardiac anomalies $(5 \\%)$ :\nVSD, truncus arteriosus, ectopia cordis, septal rhabdomyoma, arrhythmia\n(h) genitourinary malformations:\nunilateral UPJ obstruction, unilateral multicystic dysplastic kidney, mesoblastic\nnephroma\nCause: ? hormonally mediated polyuria\n(i) miscellaneous $(8 \\%)$ :\ncystic hygroma, facial tumors, cleft lip / palate, teratoma, amniotic band syndrome, congenital pancreatic cyst\n$\\diamond$ In polyhydramnios efforts to detect fetal anomalies should be directed at SGA fetuses!\nmnemonic: TARDI\nTwins\nAnomalies, fetal\nRh incompatibility\nDiabetes\nIdiopathic\n\n# Oligohydramnios \n\n$=$ amniotic fluid volume $<500 \\mathrm{~cm}^{3}$ at term\n$\\sqrt{ }$ single largest pocket devoid of fetal parts / cord $\\leq 1-2 \\mathrm{~cm}$ in vertical direction\n$\\sqrt{ }$ AFI $\\leq 5-7 \\mathrm{~cm}$\nEtiology:\nmnemonic: DRIPP\nDemise of fetus / Drugs (Motrin ${ }^{\\circledR}$ therapy for tocolysis of preterm labor)\nRenal anomalies, bilateral ( $=$ inadequate urine production): renal agenesis / dysgenesis, infantile polycystic kidney disease, prune belly syndrome, posterior urethral valves, urethral atresia, cloacal anomalies\n$\\diamond 20$-fold increase in incidence of fetal anomalies with oligohydramnios!\nN.B.: bilateral renal obstruction, if combined with intestinal obstruction, may be associated with polyhydramnios\nIUGR: $\\leftarrow$ reduced renal perfusion\nPremature rupture of membranes (most common)\nPostmaturity\nCx: pulmonary hypoplasia, cord compression\nPrognosis: $77-100 \\%$ perinatal mortality with $2^{\\text {nd }}$ trimester oligohydramnios\n\n## ABNORMAL FIRST TRIMESTER FINDINGS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 310,
            "markdown": "Time of onset: prior to $8-10$ weeks\n\n# First Trimester Bleeding \n\n$=$ VAGINAL BLEEDING IN FIRST TRIMESTER\nFrequency: $15-25 \\%$ of all pregnancies, of which $50 \\%$ terminate in abortion\nA. INTRAUTERINE CONCEPTUS IDENTIFIED\n\n1. Threatened abortion\n2. Embryonic demise\n3. Blighted ovum\n4. Gestational trophoblastic disease\n5. Implantation bleed: 3-4 weeks after last menstrual period\n6. Subchorionic hemorrhage\n7. Low-lying placenta previa\n8. Twin loss\nB. NORMAL ENDOMETRIAL CAVITY\n(a) with $\\beta$-hCG level $>1,800 \\mathrm{mIU} / \\mathrm{mL}$\n9. Recent spontaneous abortion\n10. Ectopic pregnancy\n(b) with $\\beta$-hCG level $<1,800 \\mathrm{mIU} / \\mathrm{mL}$\n11. Very early IUP\n12. Ectopic pregnancy\nC. SAC VULNERABILITY\n13. Leiomyoma\n14. Intrauterine contraceptive device\n\n## Hemoperitoneum during Pregnancy\n\n$=$ hemorrhage in cul-de-sac ( $=$ rectouterine pouch)\n\n1. Hemorrhagic corpus luteum cyst\n2. Placenta accreta\n3. Spontaneous abortion\n4. Ectopic pregnancy\n5. HELLP syndrome\n6. Uterine rupture\n\n| Poor Prognostic Indicators in Early Pregnancy |\n| :-- |\n| $\\sqrt{ }$ irregular contour / low-lying position of gestational sac |\n| $\\sqrt{ }$ calcified yolk sac $>7 \\mathrm{~mm}$ in diameter |\n| $\\sqrt{ }$ empty enlarged / expanded amnion |\n| $\\sqrt{ }$ amorphous shape of embryo |\n| $\\sqrt{ }$ embryonic bradycardia of $\\leq 85 \\mathrm{bpm}$ |\n| $\\sqrt{ }$ hydropic embryo |\n| $\\sqrt{ }$ large subchorionic hemorrhage encircling $>2 / 3$ of gestational sac |\n| circumference |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 311,
            "markdown": "| US Findings Diagnostic of Pregnancy Failure |\n| :-- |\n| $\\sqrt{ }$ no heartbeat with CRL of $\\geq 7 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ no embryo with mean sac diameter of $\\geq 25 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ no heartbeat $\\geq 2$ weeks after appearance of gestational sac |\n| without yolk sac |\n| $\\sqrt{ }$ no heartbeat $\\geq 11$ days after appearance of gestational sac with |\n| yolk sac |\n| US Findings Suspicious of Pregnancy Failure |\n| $\\sqrt{ }$ no heartbeat with CRL of $<7 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ no embryo with mean sac diameter of $16-25 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ no heartbeat $7-13$ days after appearance of gestational sac |\n| without yolk sac |\n| $\\sqrt{ }$ no heartbeat $7-10$ days after appearance of gestational sac with |\n| yolk sac |\n| $\\sqrt{ }$ no embryo $\\geq 6$ weeks after last menstrual period |\n| $\\sqrt{ }$ no embryo with empty amnion |\n| $\\sqrt{ }$ no embryo with yolk sac $>7 \\mathrm{~mm}$ |\n| $\\sqrt{ }$ small gestational sac relative to size of embryo with a $<5-\\mathrm{mm}$ |\n| difference between mean sac diameter and CRL |\n\n# Abnormal Sonographic Findings in 1st Trimester \n\n1. Embryonic demise $=$ abortion (clinical term)\n2. Nondevelopment $=$ blighted ovum\n3. Maldevelopment $=$ hydatidiform mole\n\n## Empty Gestational Sac\n\n1. Normal early IUP between 5 and 7 weeks MA\n2. Blighted ovum\n\nDDx: Pseudosac of ectopic pregnancy\n\n## Gestational Sac in Low Position\n\n1. Abortion in progress\n$\\sqrt{ }$ no placental blood flow\n2. Cervical ectopic pregnancy\n3. Fundal fibroid compressing sac downward\n\n## Pregnancy of Unknown Location\n\n$=$ normal pelvic US $=$ transient state of early pregnancy during which no definite IUP is visualized at US with normal adnexa\n$=$ positive $\\beta$-hCG without IUP\nmnemonic: HERE\nHCG-producing tumor (rare)\nEctopic pregnancy: occult\nRecent completed spontaneous abortion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 312,
            "markdown": "Early intrauterine pregnancy\nIn a hemodynamically stable patient with a pregnancy of unknown location, it is less harmful to wait, follow the $\\beta$-hCG levels, and repeat the US examination than to presumptively treat an ectopic pregnancy.\n\n# hCG-producing Tumor \n\n1. Gestational trophoblastic disease: hydatidiform mole, gestational choriocarcinoma\n2. Ovarian malignant germ cell tumor\n3. Nontesticular teratoma\n4. Nontrophoblastic tumor: hepatoma, neuroendocrine tumor, breast cancer, pancreatic cancer, cervical cancer, gastric cancer, malignant phyllodes tumor\n5. Spurious laboratory finding\n\n## Thickened Central Cavity Complex\n\n1. Intrauterine blood\n2. Retained products of conception following an incomplete spontaneous abortion\n3. Early intrauterine not yet visible pregnancy\n4. Decidual reaction $\\leftarrow$ ectopic pregnancy\n\n## Uterus Large for Dates\n\n1. Multiple gestation pregnancy\n2. Inaccurate menstrual history\n3. Fibroids\n4. Polyhydramnios\n5. Hydatidiform mole\n6. Fetal macrosomia\n\n## Intrauterine Membrane in Pregnancy\n\nA. MEMBRANE OF MATERNAL ORIGIN\n\n1. Uterine septum\n$=$ incomplete resorption of sagittal septum between the fused two mÃ¼llerian ducts\n2. Amniotic sheet / shelf\n$=$ folding of amniochorionic membrane around uterine synechia\n$\\sqrt{ }$ synechia often thins during uterine stretching + disappears as pregnancy progresses\n3. Wisps of umbilical cord\nB. MEMBRANE OF FETAL ORIGIN\n4. Intertwin membrane\n$=$ apposing membrane of multiple pregnancy / residual sac of blighted twin pregnancy\n5. Amniotic band\n$=$ rent within amnion\n6. Chorioamnionic separation\n$=$ incomplete fusion / hemorrhagic separation of amnion (= inner membrane) and chorion (= outer membrane)\n7. Subchorionic hemorrhage $=$ chorioamnionic elevation\n$=$ separation of chorionic membrane from decidua",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 313,
            "markdown": "- implantation bleed of early pregnancy\nC. FIBRIN STRAND\n\nCause: hemorrhage during transplacental amniocentesis\nmnemonic: STABS\nSeparation (chorioamnionic)\nTwins (intertwin membrane)\nAbruption\nBands (amniotic band syndrome)\nSynechia\n\n# Dilated Cervix \n\n1. Inevitable abortion\n2. Premature labor\n$=$ spontaneous onset of palpable, regularly occurring uterine contractions between 20 and 37 weeks MA\n3. Incompetent cervix\n\n## PLACENTA\n\n## Abnormal Placental Size\n\n$\\diamond$ Placental mass tends to reflect fetal mass!\nA. ENLARGEMENT OF PLACENTA $=$ Placentomegaly\n$=>5 \\mathrm{~cm}$ thick in sections obtained at right angles to long axis of placenta\n(a) maternal disease\n\n1. Maternal diabetes $\\leftarrow$ villous edema\n2. Chronic intrauterine infections: eg, syphilis\n3. Maternal anemia: normal histology\n4. Alpha-thalassemia\n(b) fetal disease\n5. Hemolytic disease of the newborn $\\leftarrow$ villous edema + hyperplasia $\\leftarrow$ immunologic incompatibility including Rh sensitization\n6. Umbilical vein obstruction\n7. Fetal high-output failure: large chorioangioma, arteriovenous fistula\n8. Fetal malformation:\n\nBeckwith-Wiedemann syndrome, sacrococcygeal teratoma, chromosomal abnormality, fetal hydrops\n5. Twin-twin transfusion syndrome\n(c) fetomaternal hemorrhage\n(d) placental abnormalities\n\n1. Molar pregnancy\n2. Chorioangioma\n3. Intraplacental hemorrhage\nmnemonic: HAD IT\nHydrops",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 314,
            "markdown": "Abruption\nDiabetes mellitus\nInfection\nTriploidy\nB. DECREASE IN PLACENTAL SIZE\n\n1. Preeclampsia: associated with placental infarcts in 33-60\\%\n2. IUGR\n3. Chromosomal abnormality\n4. Intrauterine infection\n\n# Vascular Spaces of the Placenta \n\n1. \"Placental cysts\"\n$=$ large fetal veins located between amnion + chorion anastomosing with umbilical vein\n$\\sqrt{ }$ sluggish blood flow (detectable by real-time observation)\n2. Basal veins\n$=$ decidual + uterine veins\n$\\sqrt{ }$ lacy appearing network of veins underneath placenta\n$D D x:$ placental abruption\n3. Intraplacental venous lakes\n$\\sqrt{ }$ intraplacental sonolucent spaces\n$\\sqrt{ }$ whirlpool motion pattern of flowing blood\n\n## Placental Causes of Antepartum Hemorrhage\n\n$=$ vaginal bleeding between 20 wks GA and delivery\n\n1. Placenta previa\n2. Placental abruption = placental hematoma\n> on fetal side\n(a) Subchorionic = preplacental hematoma\n> on maternal side\n(b) Retroplacental hematoma\n(c) Intraplacental hematoma\n\n## Macroscopic Lesion of the Placenta\n\n1. Intervillous thrombosis ( $36 \\%$ )\n$=$ intraplacental areas of hemorrhage\nEtiology: breaks in villous capillaries with bleeding from fetal vessels\n$\\sqrt{ }$ irregular sonolucent intraplacental lesions ( mm to cm range)\n$\\sqrt{ }$ blood flow may be observed within lesion\nSignificance: fetal-maternal hemorrhage (Rh sensitization, elevated AFP levels)\n2. Perivillous fibrin deposition ( $22 \\%$ )\n$=$ nonlaminated collection of fibrin deposition\nEtiology: thrombosis of intervillous space\nSignificance: none\n3. Septal cyst (19\\%)\n\nEtiology: obstruction of septal venous drainage by edematous villi",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 315,
            "markdown": "$\\sqrt{5-10-\\mathrm{mm}}$ cyst within septum\nSignificance: none\n4. Placental infarct $(25 \\%)$\n$=$ coagulation necrosis of villi\nEtiology: disorder of maternal vessels, retroplacental hemorrhage\n$\\sqrt{ }$ not visualized unless hemorrhagic\n$\\sqrt{ }$ well-circumscribed mass with hyperechoic / mixed echo pattern\nSignificance: dependent on extent + associated maternal condition\n5. Subchorionic fibrin deposition $(20 \\%)$\n$=$ laminated collection of fibrin deposition\nEtiology: thrombosis of maternal blood in subchorionic space\n$\\sqrt{ }$ subchorionic sonolucent area\nSignificance: none\n6. Massive subchorial thrombus\n$=$ BREUS MOLE $=$ PREPLACENTAL HEMORRHAGE\n\n# Placental Tumor \n\nA. TROPHOBLASTIC\n\n1. Complete hydatidiform mole\n2. Partial hydatidiform mole\n3. Invasive mole\n4. Choriocarcinoma\nB. NONTROPHOBLASTIC\n5. Chorioangioma (in up to $1 \\%$ of placentas)\n6. Teratoma (rare)\n7. Metastatic lesion (rare): melanoma, breast carcinoma, bronchial carcinoma\n\n## Unbalanced Intertwin Transfusion\n\n$=$ unbalanced intertwin transfusion through vascular anastomoses between 2 circulations of monochorionic twins\nA. ACUTE $=$ Twin-embolization syndrome\nB. CHRONIC $=$ Twin-twin transfusion syndrome\nC. REVERSE $=$ Acardiac twinning\n\n## UMBILICAL CORD\n\n## Abnormal Umbilical Cord Insertion\n\n1. Marginal cord insertion\n$=$ cord insertion $<1-2 \\mathrm{~cm}$ from placental edge\nFrequency: $5-7 \\%$ of pregnancies\n2. Battledore placenta\n[battledore $=$ flat wooden paddle in ancient form of badminton]\n$=$ cord insertion on edge of placenta $=$ extreme marginal\n\n- no clinical significance\n\n3. Velamentous cord insertion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 316,
            "markdown": "4. Vasa previa\n\n# Distortion Abnormality of Umbilical Cord \n\n1. Cord torsion\n$=$ excessive twisting of cord as rare form of cord constriction\nTiming: any time during pregnancy; more common during $2^{\\text {nd }}$ and $3^{\\text {rd }}$ trimester\n$\\sqrt{ }$ evaluation of pitch value of cord coiling\n$\\sqrt{ }$ abnormal S/D flow velocity ratio of umbilical artery\n$C x$ : critically reduced fetal blood flow and fetal hypoxia, oligohydramnios, IUGR, and fetal death\n$D x$ : difficult to diagnose prenatally; mostly detected during postnatal examination\n2. Cord entanglement\n\nCause: nearby umbilical cord insertions on single placenta in monoamniotic twin pregnancy\n$\\checkmark$ branching pattern at level of entanglement\n$\\checkmark$ end systolic notch on umbilical artery waveform $\\leftarrow$ vascular compression / narrowing\n$C x$ : vascular compromise in one / both fetuses $\\rightarrow$ fetal demise\n3. Noncoiled \"straight\" cord\ncounterclockwise $\\div$ clockwise umbilical cords $=7 \\div 1$\nright-handed $\\div$ left-handed persons $=7 \\div 1$\nPrevalence: $3.7-5 \\%$\n$\\checkmark$ absent vascular coiling for entire length of visible cord\nAt risk for: intrauterine death ( $8 \\%$ ), stillbirth, fetal anomalies ( $24 \\%$ ), prematurity, intrapartum heart rate decelerations, fetal distress, meconium staining\n4. Body cord\n$=$ loop around fetal body / any fetal body part\n5. Nuchal cord\n\n## Umbilical Cord Lesion\n\nA. DEVELOPMENTAL CORD LESION\n\n1. Umbilical hernia\n$=$ protrusion from anterior abdominal wall with normal insertion of umbilical vessels Predisposed:\n\nBlacks, low-birth-weight infants, trisomy 21, congenital hypothyroidism, BeckwithWiedemann syndrome, mucopolysaccharidoses\nPrognosis: spontaneous closure in first 3 years of life\n2. Umbilical cord cyst\nB. ACQUIRED CORD LESION\n\n1. False knot\n(a) exaggerated looping of cord vessels $\\rightarrow$ focal dilatation of cord\n(b) focal accumulation of Wharton jelly\n(c) varix of umbilical vessel\n\n- clinically insignificant\n$\\checkmark$ knoblike protrusion / bulge of cord\n\n2. True knot",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 317,
            "markdown": "Prevalence: $1 \\%$ of pregnancies\nCause: excessive fetal movements\nPredisposed: long cord, polyhydramnios, small fetus, monoamniotic twins\n$\\sqrt{ }$ \"hanging noose\" sign = segment of umbilical cord closely surrounded by another loop of cord\n$\\sqrt{ }$ local distension / thrombosis of umbilical vein near cord knot resembling an umbilical cyst\n$\\sqrt{ }$ tortuosity of cord at level of knot\n$C x$ : vascular occlusion $\\rightarrow$ fetal asphyxia $\\rightarrow$ fetal demise\nOB management: expectant (mostly loose knot with marginal impact on fetal wellbeing)\n3. Umbilical cord hematoma\n$=$ rupture of the wall of the umbilical vein $\\leftarrow$ mechanical trauma (cordocentesis, torsion, loops, knots, traction) / congenital weakness of vessel wall\nPrevalence: $0.02 \\%$ of pregnancies\nLocation: near fetal insertion of umbilical cord (most common)\n$\\sqrt{ }$ hyper- / hypoechoic mass $1-2 \\mathrm{~cm}$ in size, multiple (in $18 \\%$ )\n$C x$ : rupture into amniotic cavity $\\rightarrow$ exsanguination\nPrognosis: $52 \\%$ overall perinatal fetal mortality\n4. Neoplasm\n(a) Angiomyxoma / hemangioma of cord\n\nPrevalence: 22 cases in literature\nHisto: multiple vascular channels lined by benign endothelium surrounded by edema + myxomatous degeneration of Wharton jelly\nAssociated with: single umbilical artery\n\n- increased maternal serum $\\alpha$-fetoprotein level\n\nLocation: more frequently near placental insertion of umbilical cord\n$\\sqrt{ }$ hyperechoic / multicystic mass within cord\n$\\sqrt{ }$ may be associated with pseudocyst (= localized collection of edema)\n$\\sqrt{ }$ blood flow on Doppler\nCx: premature delivery, stillbirth, hydramnios, nonimmune hydrops, massive hemorrhage $\\leftarrow$ rupture\n(b) Other tumors: myxosarcoma, dermoid, teratoma\n\n# Umbilical Cord Cyst \n\n$\\diamond$ Umbilical cord cysts persisting into $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ trimester are frequently accompanied by fetal anomalies: angiomyxoma of cord, hernia, intestinal obstruction, urinary tract obstruction, urachal anomalies, imperforate anus, TE fistula, omphalocele, cardiac defect, trisomy 18\nLocation: toward fetal insertion of cord\nA. UMBILICAL CORD PSEUDOCYST (common)\n$=$ Mucoid degeneration of umbilical cord\n$=$ Wharton jelly cyst\nHisto: localized edema + liquefaction of Wharton jelly without epithelial lining\nCommonly associated with: omphalocele",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 318,
            "markdown": "$\\sqrt{ }$ focal thickening of Wharton jelly\nPrognosis: usually resolved by 12 weeks MA\nB. TRUE UMBILICAL CORD CYST (rare)\n\nPrevalence: $3.4 \\%$ of $1^{\\text {st }}$ trimester pregnancies; $20 \\%$ persist into $2^{\\text {nd }}$ trimester\nHisto: lined by single layer of flattened epithelium\nRarely associated with: fetal structural anomaly, aneuploidy\nSize: $4-60 \\mathrm{~mm}$ in diameter\n\n1. Omphalomesenteric duct cyst\n\nSite: eccentric in cord\n2. Allantoic cyst\n$=$ remnant of umbilical vesicle / allantois; usually degenerates by 6 weeks\nSite: in center of cord\n3. Amniotic inclusion cyst\n$=$ amniotic epithelium trapped within umbilical cord\n\n# Vascular Abnormalities of Umbilical Cord \n\n1. Single umbilical artery\n2. Persistent Right Umbilical Vein (PRUV)\n$=$ regression of left umbilical vein $\\rightarrow$ abnormal course of blood flow in fetal liver\nFrequency: $0.1-0.3 \\%$\nCause: altered development of umbilical cord during $4^{\\text {th }}-7^{\\text {th }}$ week GA\nMay be associated with: situs inversus, heterotaxy, anomalies of GU / GI tract, heart, skeletal development\nPath of blood flow:\n(a) intrahepatic PRUV = isolated right umbilical vein joins fetal portal system at sinus venosus + gives rise to ductus venosus\n(b) extrahepatic PRUV = right umbilical vein bypasses liver and drains into RA / IVC / right iliac vein + absent ductus venosus\n$\\sqrt{ }$ fetal portal vein curves toward (rather than parallel to) stomach\n$\\sqrt{ }$ fetal gallbladder between umbilical vein and stomach + medial (rather than lateral) to umbilical vein\n$\\sqrt{ }$ umbilical vein connects to right (rather than left) portal vein\n3. Umbilical vein / Cord varix\n\nFrequency: $<4 \\%$ of all umbilical cord abnormalities\nMay be associated with: aneuploidy (6\\%), other fetal anomalies (28\\%)\nSite: intraamniotic / intraabdominal, intrahepatic / extrahepatic\nNormal size of umbilical vein: 3 mm at 15 weeks GA, 8 mm at term\n$\\sqrt{ }$ fusiform dilatation of umbilical vein $>9 \\mathrm{~mm}$\n$\\sqrt{ }$ transverse diameter of extrahepatic umbilical vein $>1.5 \\mathrm{x}$ greater than intrahepatic component\n$\\sqrt{ }$ vein diameter $>2$ SD above mean diameter for GA\n$\\sqrt{ }$ fetal hydrops, anemia, IUGR\n$C x$ : (1) Thrombosis with subsequent fetal death\n(2) Partial thrombosis with IUGR",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 319,
            "markdown": "$\\diamond$ Serial US examinations are recommended from diagnosis to delivery!\nPrognosis: usually no clinical significance\n4. Umbilical artery aneurysm Often associated with single umbilical artery, aneuploidy, fetal structural abnormalities\n\n# SMALL-FOR-GESTATIONAL AGE FETUS (SGA) \n\n$=$ generic clinical term describing a group of perinates at / below $10^{\\text {th }}$ percentile for gestational age without reference to etiology\n\n1. Fetus of appropriate growth (misdiagnosed as small)\n2. Small normal fetus $=$ constitutionally small fetus ( $80-85 \\%$ )\n$\\diamond$ No indication for surveillance / intervention!\n3. Small abnormal fetus $=$ primary growth failure associated with karyotype anomaly / fetal infection $(5-10 \\%)$\n$\\diamond$ Active intervention is of no benefit!\n4. Dysmature fetus $=$ IUGR $=$ growth failure as a result of uteroplacental insufficiency (10$15 \\%)$\n$\\diamond$ Intensive management is likely of benefit!\n\n## FETAL OVERGROWTH DISORDER\n\n1. Beckwith-Wiedemann syndrome\n2. Simpson-Golabi-Behmenl syndrome\n3. Perlman syndrome\n\n## FETAL SKELETAL DYSPLASIA\n\n$=$ DWARFISM\n$=$ heterogeneous group of bone growth disorders resulting in abnormal shape + size of the skeleton\n$\\diamond$ More than 200 skeletal dysplasias are known, but only a few are frequent:\n$>$ thanatophoric dysplasia\n> osteogenesis imperfecta type II\n$>$ achondrogenesis\n> heterozygous achondroplasia\nBirth prevalence:\n$2.3 \\div 10,000-7.6 \\div 10,000$ births for all skeletal dysplasias; $1.5 \\div 10,000$ births for lethal skeletal dysplasias\nPrognosis: $51 \\%$ mortality $\\leftarrow$ hypoplastic lungs: $23 \\%$ stillbirths, $32 \\%$ death in $1^{\\text {st }}$ week of life\nTerminology:\n\n| Amelia | $=$ absence of limb |\n| :-- | :-- |\n| Hemimelia | $=$ absence of distal parts |\n| Micromelia | $=$ shortening involves entire limb (eg, humerus, radius + ulna, hand) |\n| Rhizomelia | $=$ shortening involves proximal segment (ie, humerus / femur) |\n| Mesomelia | $=$ shortening involves intermediate segment (ie, radius + ulna / tibia + |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 320,
            "markdown": "```\n            fibula)\n                [mesos, Greek= middle]\nAcromelia = shortening involves distal segment (eg, hand)\nMeromelia = partial absence of a limb\nPhocomelia = proximal reduction with distal parts attached to trunk\nPreaxial = extra digit on radial / tibial side\npolydactyly\nPostaxial = extra digit on ulnar / fibular side\npolydactyly\nClassification:\n```\n\n(1) OSTEOCHONDRODYSPLASIA\n$=$ abnormalities of cartilage / bone growth and development\n(a) identifiable at birth:\n> usually lethal: achondrogenesis, fibrochondrogenesis, thanatophoric dysplasia, short rib syndrome\n> usually nonlethal: chondrodysplasia punctata, camptomelic dysplasia, achondroplasia, diastrophic dysplasia, chondroectodermal dysplasia, Jeune syndrome, spondyloepiphyseal dysplasia congenita, mesomelic dysplasia, cleidocranial dysplasia, otopalatodigital syndrome\n(b) identifiable in later life: hypochondroplasia, dyschondrosteosis, spondylometaphyseal dysplasia, acromicric dysplasia\n(c) abnormal bone density: osteopetrosis, pyknodysostosis, Melnick-Needles syndrome\n(2) DYSOSTOSIS\n$=$ malformation of individual bones singly / in combination\n(a) with cranial + facial involvement: craniosynostosis, craniofacial dysostosis (Crouzon), acrocephalosyndactyly, acrocephalopolysyndactyly, branchial arch syndromes (Treacher-Collins, Franceschetti, acrofacial dysostosis, oculoauriculovertebral dysostosis, hemifacial microsomia, oculomandibulofacial syndrome)\n(b) with predominant axial involvement: vertebral segmentation defects (Klippel-Feil), Sprengel anomaly, spondylocostal dysostosis, oculovertebral syndrome\n(c) with predominant involvement of extremities: acheiria (= absence of hands), apodia (= absence of feet), polydactyly, syndactyly, camptodactyly, Rubinstein-Taybi syndrome, pancytopenia-dysmelia syndrome (Fanconi), Blackfan-Diamond anemia with thumb anomaly, thrombocytopenia-radial aplasia syndrome, cardiomelic syndromes (Holt-Oram), focal femoral deficiency, multiple synostoses\n(3) IDIOPATHIC OSTEOLYSIS\n$=$ disorders with multifocal resorption of bone\n(4) CHROMOSOMAL ABERRATION\n(5) PRIMARY METABOLIC DISORDER\n(a) calcium / phosphorus: hypophosphatasia\n(b) complex carbohydrates: mucopolysaccharidosis\n\nAssessment of:\n\n1. Long bones for absence, hypoplasia, malformation, curvature, degree of mineralization, fractures, premature ossification centers",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 321,
            "markdown": "$\\sqrt{ }$ shortening of long bones (common characteristic)\n$\\diamond$ Femur length $>5 \\mathrm{~mm}$ below 2 standard deviations suggests skeletal dysplasia!\n$\\sqrt{ } \\mathrm{FL}+$ foot length $<0.9=$ suggests skeletal dysplasia\n$\\sqrt{ }$ limb shortening of $40-60 \\%$ of the mean in thanatophoric dysplasia + OI type II\n$\\sqrt{ }$ limb shortening of $>30 \\%$ of the mean in achondrogenesis\n2. Thorax for shape, abnormal rib size, absence / hypoplasia of clavicles, presence of scapula\n$\\sqrt{ }$ Chest Circumference $<5^{\\text {th }}$ percentile (= lung hypoplasia)\n$\\sqrt{ }$ Chest Circumference $+\\mathrm{AC}<5^{\\text {th }}$ percentile\n$\\sqrt{ }$ heart area + chest area $<5^{\\text {th }}$ percentile\n$\\sqrt{ } \\mathrm{FL}+\\mathrm{AC}<0.16=$ suggests lung hypoplasia\n2. Hand \\& foot for clinodactyly, syndactyly, pre- or postaxial polydactyly\n$\\sqrt{ }$ \"hitchhiker's thumb\", radial ray anomaly, absence of thumb\n$\\sqrt{ }$ \"rocker-bottom\" foot, clubbed foot\n4. Skull for size, shape (brachycephaly, scaphocephaly, craniosynostosis, frontal bossing, cloverleaf skull), degree of mineralization\n$\\sqrt{ }$ HC and BPD\n$\\sqrt{ }$ binocular and interocular diameter\n$\\sqrt{ }$ micrognathia, short upper lip, abnormally shaped ears\n4. Spine for relative total length, scoliosis, mineralization of vertebral bodies, integrity of neural arches, vertebral height, absence of segments\n5. Pelvis for shape\n\nAssociated with: polyhydramnios\n$D D x$ features: mineralization, bowing, fractures, number of digits, fetal movement, thoracic measurement, associated anomalies, age of onset\n$D D x$ : constitutionally short limbs, severe IUGR\n\n# Micromelic Dwarfism \n\n$=$ disproportionate shortening of entire leg\nA. Mild micromelic dwarfism\n\n1. Jeune syndrome\n2. Chondroectodermal dysplasia\n3. Diastrophic dwarfism\nB. Mild bowed micromelic dwarfism\n4. Camptomelic dysplasia\n5. Osteogenesis imperfecta, type III\nC. Severe micromelic dwarfism\n6. Thanatophoric dysplasia\n7. Osteogenesis imperfecta, type II\n8. Homozygous achondroplasia\n9. Hypophosphatasia\n10. Short-rib polydactyly syndrome\n11. Fibrochondrogenesis\n\n## Acromelic Dwarfism",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 322,
            "markdown": "Asphyxiating thoracic dysplasia\n\n# Rhizomelic Dwarfism \n\nmnemonic: MA CAT\nMetatrophic dwarfism\nAchondrogenesis (most severe shortening)\nChondrodysplasia punctata: autosomal recessive\nAchondroplasia, heterozygous\nThanatophoric dysplasia\n\n## Osteochondrodysplasia\n\nA. Failure of\n(a) articular cartilage: spondyloepiphyseal dysplasia\n(b) ossification center: multiple epiphyseal dysplasia\n(c) proliferating cartilage: achondroplasia\n(d) spongiosa formation: hypophosphatasia\n(e) spongiosa absorption: osteopetrosis\n(f) periosteal bone: osteogenesis imperfecta\n(g) endosteal bone: idiopathic osteoporosis\nB. Excess of\n(a) articular cartilage: dysplasia epiphysealis hemimelica\n(b) hypertrophic cartilage: enchondromatosis\n(c) spongiosa: multiple exostosis\n(d) periosteal bone: progressive diaphyseal dysplasia\n(e) endosteal bone: hyperphosphatemia\n\n## Lethal Bone Dysplasia\n\nin order of frequency:\n\n1. Thanatophoric dysplasia\n2. Osteogenesis imperfecta type II\n3. Achondrogenesis type I + II\n4. Jeune syndrome (may be nonlethal)\n5. Hypophosphatasia, congenital lethal form\n6. Chondroectodermal dysplasia (usually nonlethal)\n7. Chondrodysplasia punctata, rhizomelic type\n8. Camptomelic dysplasia\n9. Short-rib polydactyly syndrome\n10. Homozygous achondroplasia\n$\\diamond$ Lethal short-limbed dysplasias typically are manifest on sonograms $<24$ weeks MA!\n\n## Nonlethal Dwarfism\n\n1. Achondroplasia (heterozygous)\n2. Asphyxiating thoracic dysplasia\n3. Chondroectodermal dysplasia\n4. Chondrodysplasia punctata",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 323,
            "markdown": "5. Spondyloepiphyseal dysplasia (congenital)\n6. Diastrophic dysplasia\n7. Metatrophic dwarfism\n8. Hypochondroplasia\n\n# Late-onset Dwarfism \n\n1. Spondyloepiphyseal dysplasia tarda\n2. Multiple epiphyseal dysplasia\n3. Pseudoachondroplasia\n4. Metaphyseal chondrodysplasia\n5. Dyschondrosteosis\n6. Cleidocranial dysostosis\n7. Progressive diaphyseal dysplasia\n\n## Hypomineralization in Fetus\n\nA. DIFFUSE\n\n1. Osteogenesis imperfecta\n2. Hypophosphatasia\nB. SPINE\n3. Achondrogenesis\n\n## Large Head in Fetus\n\n1. Achondroplasia\n2. Thanatophoric dysplasia\n\n## Narrow Hypoplastic Chest in Fetus\n\n1. Short-rib polydactyly syndrome\n2. Asphyxiating thoracic dysplasia\n3. Chondroectodermal dysplasia\n4. Camptomelic dysplasia\n5. Thanatophoric dysplasia\n6. Homozygous achondroplasia\n7. Achondrogenesis\n8. Hypophosphatasia\n9. Osteogenesis imperfecta\n\n## Platyspondyly\n\n1. Thanatophoric dysplasia\n2. Osteogenesis imperfecta type II\n3. Achondroplasia\n4. Morquio syndrome\n\n## Bowed Long Bones in Fetus\n\n1. Camptomelic syndrome\n2. Osteogenesis imperfecta\n3. Thanatophoric dysplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 324,
            "markdown": "4. Hypophosphatasia\n\n# Bone Fractures in Fetus \n\n1. Osteogenesis imperfecta\n2. Hypophosphatasia\n3. Achondrogenesis\n\n## Acrocephalosyndactyly\n\n$=$ syndrome characterized by\n(1) increased height of skull vault $\\leftarrow$ generalized craniosynostosis (= acrocephaly, oxycephaly)\n(2) syndactyly of fingers / toes\n\nType 1: Apert syndrome\nType 2: Crouzon syndrome\nType 3: Saethre-Chotzen syndrome\nType 4: Wardenburg type\nType 5: Pfeiffer syndrome\n\n## Acrocephalopolysyndactyly\n\nType 1: Noack syndrome\nType 2: Carpenter syndrome\nType 3: Sakati-Nyhan-Tisdale syndrome\nType 4: Goodman syndrome\nType 5: Pfeiffer syndrome\n\n## LIMB REDUCTION ANOMALIES\n\nPrevalence: $0.49 \\div 10,000$ births\n\n## Isolated Extremity Amputation\n\n1. Amniotic band syndrome\n2. Exposure to teratogen\n3. Vascular accident\n\n## Aplasia / Hypoplasia of Radius\n\nmnemonic: The Furry Cat Hit My Dog\nThrombocytopenia-absent radius syndrome\nFanconi anemia\nCornelia de Lange syndrome\nHolt-Oram syndrome\nMyositis ossificans progressiva (thumb only)\nDiastrophic dwarfism (\"hitchhiker's thumb\")\n\n## Pubic Bone Maldevelopment\n\nmnemonic: CHIEF\nCleidocranial dysostosis\nHypospadia, epispadia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 325,
            "markdown": "Idiopathic\nExstrophy of bladder\nF for syringomyelia\n\n# Fetal Hand Anomalies \n\nBest time for assessment:\nlate $1^{\\text {st }}$ to middle $2^{\\text {nd }}$ trimester $\\leftarrow$ ossification of metacarpals beginning at 12 weeks EGA\n\n+ frequent fetal movement\n$\\diamond$ Complete fetal work-up needed for associated anomalies!\nNormal findings:\n> unossified hypoechogenic carpus\n> 5 hyperechoic + cylindric metacarpal bones\n> 5 independent digits of different lengths with 3 ossified phalanges ( 2 for thumb)\n> normal radius, ulna, humerus\n> flexion (fist) + extension (unclenched hand)\nClassification:\n(a) abnormal alignment: clenched hand, camptodactyly, clinodactyly, akinesia deformation sequence, clubhand, phocomelia\n(b) thumb anomalies: macrodactyly, trident hand\n(c) abnormal number: polydactyly, syndactyly, ectrodactyly\n\n\n## Camptodactyly\n\n$=$ flexion contracture of PIP joint of any finger\nCause: karyotype anomaly (trisomy 18, 13, 15) or contracture syndrome; may be isolated\nLocation: often asymmetric\nPrognosis: may progress during infancy / childhood\n\n## Clenched Hand\n\n$=$ index finger overlaps clenched fist formed by other digits\nCause: trisomy 18, akinesia-hypokinesia syndromes, temporarily closed normal fist\n$\\checkmark$ proximal interphalangeal articulation of index finger flexed + ulnarly deviated\n$\\checkmark$ adducted thumb\n\n## Clinodactyly\n\n$=$ fixed abnormal deviation of 5th finger in radioulnar plane (= radial angulation of DIP joint) $\\leftarrow$ abnormally small size of middle phalanx\nCause: trisomy 21 (in up to $60 \\%$ ), triploidy; isolated familial clinodactyly; normal in $18 \\%$\n\n## Clubhand\n\n$=$ permanently deviated axis of wrist + usually closed hand\nClassification:\n(a) Radial clubhand associated with preaxial deficits (ranging from mild hypoplasia of thumb to complete absence of radius)\n(b) Ulnar clubhand $\\leftarrow$ ulnar deficiency",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 326,
            "markdown": "# Ectrodactyly \n\n$=$ SPLIT / CLEFT HAND $=$ LOBSTER CLAW HAND\n$=$ longitudinal deficiency of central digits\nCause: EEC (ectrodactyly, ectodermal dysplasia, cleft lip or palate), Roberts syndrome\nPathogenesis: failure of median apical ectodermal ridge in developing limb bud\nMay be associated with: syndactyly, aplasia, hypoplasia of residual phalanges + metacarpals\n$\\sqrt{ }$ deep V- or U-shaped central defect\n$D D x$ : oligodactyly (= reduced number of well-formed fingers), constrictive amniotic bands\n\n## Macrodactyly\n\n$=$ overgrowth of all structures of affected (commonly radial) fingers\nCause: proteus syndrome, neurofibromatosis type 1\n\n## Phocomelia\n\n$=$ missing / foreshortened arm / forearm with presence of hand\nCause:\n(1) Thalidomide\n(2) Roberts syndrome = autosomal recessive disorder associated with tetraphocomelia with more severe upper-limb deformities, facial cleft, polyhydramnios\n(3) TAR syndrome\n(4) Grebe syndrome = autosomal recessive disorder associated with marked hypomelia (more severe in lower limbs increasing in severity distally)\n\n## Polydactyly\n\n$=$ presence of supernumerary digits\nIncidence: $1 \\div 683$ pregnancies;\n$\\diamond$ Most common hand anomaly!\nCause: trisomy 13, short-rib-polydactyly syndrome, asphyxiating thoracic dystrophy (Jeune syndrome), Smith-Lemli-Opitz syndrome\n\n## Ulnar / Postaxial Polydactyly (more frequent)\n\naffecting $5^{\\text {th }}$ finger\nCause:\n(1) Trisomy 13\n(2) Meckel-Gruber syndrome\n(3) Short-rib polydactyly syndrome\n(4) Ellis-van Creveld syndrome\n(5) Smith-Lemli-Opitz syndrome ( $=$ intrauterine growth retardation + characteristic high level of 7-dehydrocholesterol)\n(6) Hydrolethalus syndrome ( $=$ heart and brain defects, cleft lip / palate, abnormally shaped nose / jaw, incomplete lung development causing stillbirth / death within a few days after birth)\n(7) Bardet-Biedl syndrome = medullary cystic kidney disease without encephalocele, progressive renal dystrophy, obesity, hypogonadism, learning",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 327,
            "markdown": "difficulties\nRadial / Preaxial PolyOAcTyly (less frequent)\naffecting thumb\nCause:\n(1) Holt-Oram syndrome\n(2) Short-rib-polydactyly syndrome\n(3) Carpenter syndrome\n(4) Trisomy 21\n(5) VACTERL association\n(6) Fanconi anemia\n(7) Orodigitofacial syndrome\n\n# PolYSYNDACTYLY \n\n= association of polydactyly with syndactyly\n\n## Syndactyly\n\n$=$ abnormal connection between adjacent digits\nIncidence: $2-3 \\div 10,000$ live births\nLocation: commonly between $2^{\\text {nd }}+3^{\\text {rd }}$ digit\nClassification: simple (between soft tissues), complex (between bones), complete (entire length of finger), incomplete (sparing of distal part)\nCause: Poland sequence, Apert syndrome and other acrocephalosyndactylies, triploidy, Roberts syndrome, familial syndactyly (autosomal dominant, with variable expressivity and incomplete penetrance), constriction band sequence\n\n## Trident Hand\n\n$=$ same length of last 4 fingers\nCause: various chondrodysplasias\n\n## Overlapping Digit\n\ntrisomy 18\n\n## Hitchhiker's Thumb\n\ndiastrophic dysplasia\n\n## Flexion Contractures\n\ntrisomy $13+18$, fetal akinesia deformation sequence\n\n## Limb Reduction\n\ncongenital varicella, hypoglossia-hyperdactyly syndrome\n\n## Amputation\n\namniotic band syndrome\n\n## Drug-induced Musculoskeletal Embryopathy\n\n## Thalidomide",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 328,
            "markdown": "$=$ sedative-hypnotic nonbarbiturate (sold 1954-1961)\nCritical period: 34-50 days after most recent menstrual period\n\n- increased miscarriage, increased stillbirth rate\n- $40 \\%$ increased infant mortality\n$\\checkmark$ narrowing, disorganization, destruction of joints\n$\\checkmark$ hemimelia $=$ absence / gross shortening of distal portion of one / more limbs (esp. radius + thumb)\n$\\checkmark$ phocomelia $=$ attachment of hands + feet to abbreviated arms and legs\n$\\checkmark$ amelia $=$ congenital absence of one / more arms / legs\n$\\checkmark$ fusion / absence of paired bones\n\n\n# Anticonvulsant Drugs \n\nPrevalence: $0.4 \\%$ of pregnancies\nDrugs: valproic acid, carbamazepine, phenytoin, phenobarbital\n$\\checkmark$ diminished bone mineral density\n$\\checkmark$ poorly developed diaphyses of long bones\n$\\checkmark$ anomalies of phalanges:\n$\\checkmark$ hypoplastic terminal phalanges associated with dysplastic nails\n$\\checkmark$ hyperphalangism\n$\\checkmark$ congenital heart disease, cleft lip + palate, urinary tract anomalies, syndromes of dysmorphism, mental retardation\n\n## Folic Acid Antagonists\n\nDrugs: aminopterin, methotrexate\nCritical period: 6-8 weeks after conception\n$\\checkmark$ growth retardation\n$\\checkmark$ osteoporosis\n$\\checkmark$ talipes equinovarus, foreshortened extremities, absent digits, syndactyly, anomalous ribs\n$\\checkmark$ CNS anomalies, cardiac abnormalities\n\n## Vitamin A and Retinoids\n\n- anomalies of external ear, facial dysmorphism\n$\\checkmark$ CNS, craniofacial, cardiovascular, thymic malformations\n$\\checkmark$ hydrocephalus, microcephalus\n\n\n## Warfarin\n\nCritical period: 6-9 weeks GA\nFrequency: $10 \\%$\n$\\checkmark$ stippled ossification centers in vertebrae, proximal femora, tarsal + carpal bones\n\n## FETAL CNS ANOMALIES\n\nPrevalence: $2 \\div 1,000$ births in USA; $90 \\%$ as 1st time occurrence\nRecurrence: $2-3 \\%$ after $1^{\\text {st }}, 6 \\%$ after $2^{\\text {nd }}$ occurrence\n$\\checkmark$ ventricular atrium + cisterna magna are two sensitive anatomic markers for normal brain development!\nA. HYDROCEPHALUS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 329,
            "markdown": "1. Aqueductal stenosis\n2. Communicating hydrocephalus\n3. Dandy-Walker malformation\n4. Choroid plexus papilloma\nB. NEURAL TUBE DEFECT\n\nPrevalence: $1 \\div 500-600$ live births\nRisk of recurrence: $3-4 \\%$\n\n1. Spina bifida\n2. Anencephaly\n3. Acrania\n4. Encephalocele ( $8-15 \\%)$\n5. Porencephaly\n6. Hydranencephaly\n7. Holoprosencephaly\n8. Iniencephaly\n9. Microcephaly\n10. Agenesis of corpus callosum\n11. Lissencephaly\n12. Arachnoid cyst\n13. Choroid plexus cyst\n14. Vein of Galen aneurysm\n15. Schizencephaly\n\nAssociated with: trisomy 13 and 18\nIncreased risk: low parity, low socioeconomic status, relative infertility, diabetes, obesity, anticonvulsants, folate deficiency\nC. INTRACRANIAL NEOPLASM\n\n1. Teratoma ( $>50 \\%$ ): benign / malignant\n\nLocation: originate from base of skull\n2. Glioblastoma\n3. Astrocytoma\n\n# Fetal Ventriculomegaly \n\n## Cause:\n\nA. MORPHOLOGIC ANOMALY (70-80\\%):\n\n1. Spina bifida ( $30-65 \\%)$\n2. Dandy-Walker malformation\n3. Encephalocele\n4. Holoprosencephaly\n5. Agenesis of corpus callosum\nB. ABNORMAL KARYOTYPE ( $10-20 \\%$ )\nC. VIRAL INFECTION\n$\\diamond 20-40 \\%$ of concurrent anomalies are missed by ultrasound!\n$\\sqrt{ }$ \"dangling\" choroid plexus\n$\\sqrt{ }$ width of ventricular atrium $>10 \\mathrm{~mm}$\nPrognosis: $21 \\%$ survival rate; $50 \\%$ with intellectual impairment",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 330,
            "markdown": "# Isolated Mild Ventriculomegaly \n\n$=$ atrial width of $10-15 \\mathrm{~mm}$\nPrevalence: $1 \\div 700$ in low-risk population\n$\\diamond$ Most common brain anomaly on prenatal sonograms\nAssociated structural anomalies ( $9 \\%$ ):\nperiventricular leukomalacia, subependymal / germinal matrix hemorrhage, partial\nagenesis of corpus callosum, heterotopia, parenchymal dysplasia\nAssociated chromosomal anomalies: in $4 \\%$\nRecommendation: MR to diagnose associated structural anomalies\nPrognosis: $80 \\%$ with isolated mild ventriculomegaly have normal motor + intellectual function at $\\geq 12$ months of age\n\n## Lemon Sign\n\n$=$ flat / inwardly scalloped contour of both frontal bones\n\n1. Spina bifida\n\nPrevalence for fetuses $\\leq 24$ weeks: $98 \\%$\n( $90-93 \\%$ sensitive, $98-99 \\%$ specific, $84 \\%$ PPV for high-risk population, $6 \\%$ PPV for low-risk population)\nPrevalence for fetuses $>24$ weeks: $13 \\%$\n(disappears in 3rd trimester)\n2. Encephalocele\n3. Agenesis of corpus callosum\n4. Thanatophoric dysplasia\n5. Cystic hygroma\n6. Congenital diaphragmatic hernia\n7. Fetal hydronephrosis\n8. Umbilical vein varix\n9. Normal fetus (in $0.7-1.3 \\%$ )\n\n## Prenatal Intracranial Calcifications\n\n1. Toxoplasmosis\n2. CMV infection\n3. Tuberous sclerosis\n4. Sturge-Weber syndrome\n5. Venous sinus thrombosis\n6. Teratoma\n\n## Cystic Intracranial Lesion\n\nmnemonic: CHAP VAN\nChoroid plexus cyst\nHydrocephalus, Holoprosencephaly, Hydranencephaly\nAgenesis of corpus callosum + cystic dilatation of $3^{\\text {rd }}$ ventricle\nPorencephaly (= schizencephaly)\nVein of Galen aneurysm\nArachnoid cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 331,
            "markdown": "Neoplasm: cystic teratoma\n\n# Abnormal Cisterna Magna \n\nNormal size between 15 and 25 weeks MA:\n$>2$ to $<10 \\mathrm{~mm}$ (usually $4-9 \\mathrm{~mm}$ ) in $94-97 \\%$ of fetuses\nA. SMALL CISTERNA MAGNA + \"banana\" sign\n\n1. Chiari II malformation (with myelomeningocele)\n2. Occipital cephalocele\n3. Severe hydrocephalus\nB. LARGE CISTERNA MAGNA\n4. Megacisterna magna\n$\\sqrt{ }$ cerebellum + vermis remain intact\n5. Arachnoid cyst\n$\\sqrt{ }$ en bloc displacement of cerebellum + vermis\n6. Cerebellar hypoplasia\n7. Dandy-Walker syndrome (with vermian agenesis)\n\n## FETAL ORBITAL ANOMALIES\n\n## Hypotelorism\n\n1. Holoprosencephaly\n2. Chromosomal abnormalities: trisomy 13\n3. Microcephaly, trigonocephaly\n4. Maternal phenylketonuria\n5. Meckel-Gruber syndrome\n6. Myotonic dystrophy\n7. Williams syndrome\n8. Oculodental dysplasia\n\n## Hypertelorism\n\n1. Median cleft syndrome: cleft lip / palate\n2. Craniosynostosis: Apert / Crouzon syndrome\n3. Pena-Shokeir syndrome\n4. Frontal / ethmoidal, sphenoidal encephalocele\n5. Dilantin / phenytoin effect\n\n## Orbital and Periorbital Masses\n\n1. Dacryocystocele\n2. Anterior encephalocele\n3. Glioma\n4. Hemangioma\n5. Teratoma\n\n## FETAL NECK ANOMALIES\n\n1. Cervical myelomeningocele",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 332,
            "markdown": "2. Occipital cephalocele\n3. Cystic hygroma / lymphangioma\n4. Teratoma\n5. Branchial cleft cyst\n6. Enlarged thyroid\n7. Sarcoma\n\n# Nuchal Skin Thickening \n\n$=$ NUCHAL SONOLUCENCY / FULLNESS / EDEMA\n$=$ skin thickening of posterior neck measured between calvarium + dorsal skin margin\n(a) $\\geq 3 \\mathrm{~mm}$ during $9-13$ weeks MA\n(b) $\\geq 5 \\mathrm{~mm}$ during $14-21$ weeks MA\n(c) $\\geq 6 \\mathrm{~mm}$ during $19-24$ weeks MA\n$\\diamond$ The smallest measurement should be used!\nImage plane: axial / transverse image (slightly craniad to that of the BPD measurement) that includes cavum septi pellucidi, cerebellar hemisphere and cisterna magna (transcerebellar diameter view)\nPrevalence: among the most common anomaly in $1^{\\text {st }}$ trimester + early $2^{\\text {nd }}$ trimester\nCause:\nA. NORMAL VARIANT $(0.06 \\%)$\nB. CHROMOSOMAL DISORDERS trisomy 21 (in 45-80\\%), Turner syndrome (45 XO), Noonan syndrome, trisomy 18, XXX syndrome, XYY syndrome, XXXX syndrome, XXXXY syndrome, 18p-syndrome, 13q-syndrome\n$\\diamond 30-40 \\%$ of fetuses with Down syndrome have nuchal skin thickening!\nC. NONCHROMOSOMAL DISORDERS\n\n1. Multiple pterygium syndrome $=$ Escobar syndrome\n2. Klippel-Feil syndrome: fusion of cervical vertebrae, CHD, deafness ( $30 \\%$ ), cleft palate\n3. Zellweger syndrome = cerebrohepatorenal syndrome: large forehead, flat facies, macrogyria, hepatomegaly, cystic kidney disease, contractures of extremities\n4. Robert syndrome\n5. Cumming syndrome\n$\\checkmark$ larger lymphangiomas with radiating septations are usually found with trisomy 18\n$\\checkmark$ nuchal fullness $\\geq 3 \\mathrm{~mm}$ during $1^{\\text {st }}$ trimester is seen in trisomy $21 / 18 / 13(30-50 \\% \\mathrm{PPV})$\n$\\checkmark$ often reverting to normal by $16-18$ weeks\n$\\checkmark$ septations within nuchal translucency carries a 20 - to 200 -fold risk for chromosomal anomalies compared with normal\nSensitivity: $2-44-75 \\%$ for detection of trisomy 21\nSpecificity: $99 \\%$ for detection of trisomy 21\nPPV: $69 \\%$\nPositive screen: $1.2-3.0 \\%$ in general population (exceeding $0.5 \\%$ risk of amniocentesis)\nFalse positives: $0.5-2-8.5 \\%$\nOB management: thorough sonographic evaluation at 18-20 weeks MA\n$D D x$ : chorioamnionic separation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 333,
            "markdown": "# Protruding Tongue \n\n1. Macroglossia\n2. Lymphangioma of the tongue\n\n## Macroglossia\n\n1. Beckwith-Wiedemann syndrome\n2. Down syndrome\n3. Hypothyroidism\n4. Mental retardation\n\n## FETAL CHEST ANOMALIES\n\n## Pulmonary Underdevelopment\n\n## Pulmonary Aplasia\n\n$=$ rudimentary bronchus ending in blind pouch + absence of parenchyma + vessels\nFrequency: $1 \\div 10,000 ; \\mathrm{R} \\div \\mathrm{L}=1 \\div 1$\nCT:\n$\\sqrt{ }$ diffuse opacification of involved hemithorax\n$\\checkmark$ ipsilateral mediastinal shift\n$\\checkmark$ absence of ipsilateral pulmonary tissue + artery\n$\\checkmark$ bronchus terminates in dilated short blind pouch\n\n## Pulmonary Hypoplasia\n\n$=$ completely formed but congenitally small bronchus with rudimentary parenchyma + small vessels\nCause:\nA. PRIMARY / idiopathic pulmonary hypoplasia (rare)\nB. SECONDARY pulmonary hypoplasia limiting space for lung development\n(a) Intrathoracic lung compression\n\n1. Intrathoracic mass\n2. Mediastinal mass\n3. Large hydrothorax\n4. Lymphatic malformation\n5. Agenesis of diaphragm\n(b) Extrathoracic lung compression (= Potter syndrome)\n6. Prolonged oligohydramnios $(20-25 \\%) \\leftarrow$ renal agenesis, bilateral cystic renal disease, obstructive uropathy, premature rupture of membranes\n7. Fetal ascites\n(c) Dysplasia of thoracic cage\n8. Jeune\n9. Thanatophoric dystrophy\n10. Ellis-van Creveld\n11. Severe achondroplasia\n(d) Others $\\leftarrow$ reduced breathing activity\n12. Muscular disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 334,
            "markdown": "2. Neurologic condition\n3. Chromosomal abnormality\n\nPath: absolute decrease in lung volume / weight for GA\n$\\sqrt{ }$ thoracic circumference (TC) $<5^{\\text {th }}$ percentile for EGA\n$\\sqrt{ } \\mathrm{TC} \\div \\mathrm{AC}$ length ratio $<0.32$\n$\\sqrt{ } \\mathrm{FL} \\div \\mathrm{AC}$ ratio $<0.16$\n$\\sqrt{ }$ small hyperlucent lung $\\leftarrow$ oligemia\n$\\sqrt{ }$ diminutive ipsilateral pulmonary artery\n$\\sqrt{ }$ hyperlucent contralateral lung $\\leftarrow$ compensatory hyperexpansion\n$\\sqrt{ }$ ipsilateral mediastinal shift\n\n# Congenital Chest Malformation \n\n1. Congenital pulmonary airway malformation\n2. Congenital diaphragmatic hernia ( CDH )\n3. Bronchopulmonary sequestration (BPS)\n4. Congenital hydrothorax\n5. Congenital lobar emphysema\n6. Congenital high airway obstruction syndrome\n\n## Intrathoracic Mass\n\nin order of frequency:\n\n1. Congenital diaphragmatic hernia / eventration\n2. Congenital pulmonary airway malformation\n3. Bronchopulmonary sequestration\n4. Bronchogenic cyst\n5. Bronchial atresia\n\n## Unilateral Chest Mass\n\n1. Congenital diaphragmatic hernia\n2. Congenital pulmonary airway malformation\n3. Bronchopulmonary sequestration\n4. Bronchogenic cyst\n5. Unilateral bronchial atresia / stenosis\n\n## Bilateral Chest Masses\n\n1. Laryngeal / tracheal atresia\n$\\sqrt{ }$ pulmonary hyperplasia\n$\\sqrt{ }$ symmetrically enlarged echogenic lungs\n$\\sqrt{ }$ dilated fluid-filled trachea + bronchi\n$\\sqrt{ }$ inverted hemidiaphragms\n$\\sqrt{ }$ diminutive heart amongst enlarged lungs\n$\\sqrt{ } \\pm$ hydrops\n2. Congenital high airway obstruction\n3. Bilateral congenital pulmonary airway malformation\n4. Bilateral congenital diaphragmatic herniae",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 335,
            "markdown": "# Mediastinal Mass \n\n1. Goiter\n2. Cystic hygroma\n3. Pericardial teratoma\n4. Neuroblastoma\n\n## Cystic Chest Mass\n\n1. Bronchogenic cyst\n2. Enteric cyst\n3. Neurenteric cyst\n4. Cystic adenomatoid malformation type I\n5. Congenital diaphragmatic hernia\n6. Pericardial cyst\n7. Mediastinal meningocele\n\n## Complex Chest Mass\n\n1. Congenital diaphragmatic hernia\n2. Congenital pulmonary airway malformation\n3. Bronchopulmonary sequestration\n4. Complex enteric cyst\n5. Pericardial teratoma\n\n## Solid Chest Mass\n\n1. Congenital diaphragmatic hernia: bowel $\\pm$ liver\n2. Cystic adenomatoid malformation type III\n3. Pulmonary sequestration\n4. Obstructed lung $\\leftarrow$ bronchial atresia, laryngeal atresia, bronchogenic cyst\n5. Bronchopulmonary foregut malformation\n6. Pericardial tumor\n7. Heterotopic brain tissue\n\n## Regressing Fetal Chest Mass\n\n1. Cystic adenomatoid malformation\n2. Bronchopulmonary sequestration\n\n## Chest Wall Mass\n\n1. Hemangioma\n2. Cystic hygroma\n3. Teratoma\n4. Hamartoma\n5. Thoracic myelomeningocele\n\n## Pleural Effusion\n\n1. Primary idiopathic chylothorax (most common)\n2. Hydrops fetalis (multiple causes)\n3. Chromosome anomaly: trisomy 21, 45 XO (mostly)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 336,
            "markdown": "4. Pulmonary lymphangiectasia / cystic hygroma\n5. Lung mass: cystic adenomatoid malformation, bronchopulmonary sequestration, congenital diaphragmatic hernia, chest wall hamartoma (uncommon)\n6. Pulmonary vein atresia\n7. Idiopathic\n\n# FETAL CARDIAC ANOMALIES \n\nPrevalence: $1 \\div 125$ births $=0.8 \\%$ of population; most common of all congenital malformations $(40 \\%)$\n$\\diamond 90 \\%$ occur as isolated multifactorial traits with a recurrence risk of $2-4 \\%$\n$\\diamond 10 \\%$ are associated with multiple birth defects\n$\\diamond$ responsible for $50 \\%$ of childhood deaths from congenital malformations\nAntenatal sonographic diagnosis to prompt cardiac evaluation:\nA. ABNORMALITIES IN CARDIAC POSITION\nB. CNS\n\n1. Hydrocephalus\n2. Microcephaly\n3. Agenesis of corpus callosum\n4. Encephalocele: Meckel-Gruber syndrome\nC. GASTROINTESTINAL\n5. Esophageal atresia\n6. Duodenal atresia\n7. Situs abnormalities\n8. Diaphragmatic hernia\nD. VENTRAL WALL DEFECT\n9. Omphalocele\n10. Ectopia cordis\nE. RENAL\n11. Bilateral renal agenesis\n12. Dysplastic kidneys\nF. TWINS\n13. Conjoined twins\n\n## Prenatal Risk Factors for Congenital Heart Disease\n\nA. FETAL RISK FACTORS\n\n1. Symmetric IUGR\n2. Arrhythmias\n(a) fixed fetal bradycardia $(50 \\%) \\leq 110 \\mathrm{bpm}$\n(b) tachycardia (low risk)\n(c) irregular: PACs, PVCs (low risk)\n3. Abnormal fetal karyotype: CHD in Down syndrome ( $40 \\%$ ); in trisomy 18 / 13 ( $>90 \\%$ ); in Turner syndrome ( $35 \\%$ )\n4. Extracardiac somatic anomalies by US: omphaloceles (20\\%), duodenal atresia, hydrocephaly, spina bifida, VACTERL\n5. Nonimmune hydrops ( $30-35 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 337,
            "markdown": "6. Oligo- / polyhydramnios\nB. MATERNAL RISK FACTORS\n7. Maternal heart disease $(10 \\%)$\n8. Insulin-dependent diabetes mellitus (4-5\\%)\n9. Phenylketonuria (in $15 \\%$ if maternal phenylalanine $>15 \\%$ )\n10. Collagen vascular disease: SLE\n11. Viral infection: rubella\n12. Drugs\n(a) phenytoin: in $2 \\%$ PS, AS, coarctation, PDA\n(b) trimethadione: in $20 \\%$ transposition, tetralogy, hypoplastic left heart\n(c) sex hormones (in 3\\%)\n(d) lithium ( $7 \\%$ ): Ebstein anomaly, tricuspid atresia\n(e) alcohol ( $25 \\%$ of fetal alcohol syndrome): VSD, ASD\n(f) retinoic acid $=$ isotretinoin $(? 15 \\%)$\n13. Paternal CHD (risk uncertain)\nC. MENDELIAN SYNDROMES\n14. Tuberous sclerosis\n15. Ellis-van Creveld syndrome\n16. Noonan syndrome\nD. FAMILIAL RISK FACTORS FOR RECURRENCE OF HEART DISEASE\n> overall incidence : $6-8 \\div 1,000$ live births\n> affected sibling : $1-4 \\%$ (risk doubled)\n> affected parent : $2.5-4 \\%$\n$\\diamond$ In $50 \\%$ of neonates with CHD there is no identifiable risk factor!\nPoor prognostic features:\n(1) Intrauterine cardiac failure $\\rightarrow$ hydrops\n(2) Severe trisomy: 18,13\n(3) Hypoplastic left heart + endocardial fibroelastosis\n(4) Delivery in center without pediatric cardiology\n\n# In Utero Detection of Cardiac Anomalies \n\nA. ABNORMAL HEART POSITION\n\n1. Diaphragmatic hernia\n2. Lung anomaly\n3. Pleural effusion\n4. Cardiac defect\nB. CHAMBER ENLARGEMENT",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 338,
            "markdown": "|  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| 1. Tricuspid regurgitation | 1. Mitral stenosis |  |  |  |\n| 2. Tricuspid valve dysplasia | 2. Aortic stenosis |  |  |  |\n| 3. Ebstein anomaly |  |  |  |  |\n|  |  |  |  |  |\n|  |  |  |  |  |\n| 1. Coarctation | 1 | Aortic stenosis |  |  |\n| 2. Normal in $3^{\\text {rd }}$ trimester | 2 | Cardiomyopathy |  |  |\n\nC. ABNORMALFOUR-CHAMBER VIEW\n\n1. Septal rhabdomyoma\n2. Endocardial cushion defect\n3. Ventricular septal defect\n4. Ebstein anomaly\n5. Single ventricle\nD. VENTRICULAR DISPROPORTION\n6. Hypoplastic right / left ventricle\n7. Hypoplastic aortic arch\n8. Aortic / subaortic stenosis\n9. Coarctation of aorta\n10. Ostium primum defect\nE. INCREASED AORTIC ROOT DIMENSION\n11. Tetralogy of Fallot\n12. Truncus arteriosus\n13. Hypoplastic left ventricle with transposition\nF. DECREASED AORTIC ROOT DIMENSION\n14. Coarctation of aorta\n15. Hypoplastic left ventricle\n$\\diamond 26-80 \\%$ of serious cardiac anomalies can be detected on four-chamber view!\n$\\diamond$ Increased sensitivity $>20$ weeks + by including outflow views!\n\n# Structural Cardiac Abnormalities \\& Fetal Hydrops \n\n1. Atrioventricular septal defect + complete heart block\n2. Hypoplastic left heart\n3. Critical aortic stenosis\n4. Cardiac tumor\n5. Ectopia cordis\n6. Dilated cardiomyopathy\n7. Ebstein anomaly\n8. Pulmonary atresia\n\n## Fetal Echocardiographic Views\n\nIdentification of fetal $R V$ :\n$\\sqrt{ } \\mathrm{RV}$ lies closest to anterior chest wall\n$\\sqrt{ }$ foramen ovale flap seen within LA\n$\\sqrt{ }$ prominent moderator band + papillary muscles in RV",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 339,
            "markdown": "# A. FOUR-CHAMBER VIEW \n\n1. Position of heart within thorax\n2. Number of cardiac chambers\n3. Ventricular proportion\n4. Integrity of atrial + ventricular septa\n5. Position + size + excursion of AV valves\nB. LONG-AXIS VIEW OF LV OUTFLOW TRACT\n$=$ PARASTERNAL LONG-AXIS VIEW\n6. Continuity between ventricular septum + anterior aortic wall\n7. Caliber of aortic outflow tract\n8. Excursion of aortic valve leaflets\nC. SHORT-AXIS VIEW OF OUTFLOW TRACTS\n9. Spatial relationship between aorta + pulmonary artery\n10. Caliber of aortic + pulmonary outflow tracts\nD. AORTIC ARCH VIEW\n\n## Echogenic Intracardiac Focus\n\nCause: mineralization of a papillary muscle\n$\\diamond$ Isolated anomaly in $90 \\%$ !\n\n1. Trisomy 21 (in $30 \\%$ of affected fetuses)\n2. Trisomy 13 (in $50 \\%$ of affected fetuses)\n3. Normal pregnancy ( $4 \\%$ in a population at high risk for fetal anomalies)\n\n## FETAL GASTROINTESTINAL ANOMALIES\n\n1. Esophageal atresia $\\pm$ tracheoesophageal fistula\n2. Duodenal atresia\n3. Meconium peritonitis\n4. Hirschsprung disease\n5. Choledochal cyst\n6. Mesenteric cyst\n\n## Fetal Abdominal Wall Defect\n\nPrevalence: $6 \\div 2,000$ pregnancies; $6 \\div 10,000$ births\nThe American Institute of Ultrasound in Medicine mandates demonstration of the umbilical cord insertion on the fetal abdomen during $2^{\\text {nd }}+3^{\\text {rd }}$ trimester US exams.\n(a) normal cord insertion (CI)\n> defect to right of CI: gastroschisis\n> defect below CI: bladder exstrophy\n(b) abnormal cord insertion\n> low defect + absent bladder: cloacal exstrophy\n> CI on membrane: omphalocele\n> high defect: pentalogy of Cantrell\n> no defined distribution: abdominoschisis, limb-body wall complex",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 340,
            "markdown": "# Fetal Hepatomegaly \n\nA. CONGENITAL INFECTIONS\n\n1. CMV\nB. SEVERE HEMOLYTIC DISEASE\nC. SYNDROMES\n2. Beckwith-Wiedemann syndrome\n3. Zellweger syndrome\n\n## Intraabdominal Echogenic Mass in Fetus\n\nA. ABDOMEN\n\n1. Echogenic bowel\n2. Enteric duplication cyst (rarely echogenic)\n3. Subdiaphragmatic extralobar pulmonary sequestration ( $4 \\div 1$ left-sided predominance)\nB. LIVER\n4. Hepatic hemangioma\n5. Hepatic mesenchymal hamartoma composed of multiple microcysts\nC. ADRENAL/ RENAL\n6. Neuroblastoma\n7. Adrenal hemorrhage\n8. Mesoblastic nephroma\n\n## Nonvisualization of Fetal Stomach\n\n$\\diamond$ Fetal swallowing begins at 11 weeks MA\nNormal: stomach is visualized in almost all normal fetuses by 13-14 weeks (definitely by 19 weeks)\nPrevalence: $2 \\%$\nCause:\n\n1. Physiologic gastric emptying / intermittent swallowing\n$\\diamond$ Repeat scan after 30 min !\n2. Oligohydramnios\n3. CNS depression / abnormalities impairing swallowing\n4. Abnormal position of stomach:\n$\\checkmark$ stomach on contralateral side (situs inversus)\n$\\checkmark$ congenital diaphragmatic hernia\n5. Esophageal atresia $\\pm$ tracheoesophageal fistula\n$\\diamond$ Nonvisualization of fetal stomach and polyhydramnios in $33 \\%$ fetuses with esophageal atresia after 24 weeks MA!\n6. Cleft lip / palate $\\rightarrow$ impairing normal swallowing\n\nRx: repeat ultrasound scan\n\n## Double Bubble Sign\n\n$=$ fluid-filled stomach + proximal duodenum\n$\\diamond$ A persistently fluid-filled duodenum is always abnormal!\nA. DUODENAL OBSTRUCTION\n\n1. Duodenal atresia (usually not seen $<24$ weeks MA)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 341,
            "markdown": "Cause: in 30\\% due to Down syndrome\n2. Severe duodenal stenosis\n3. Duodenal web\n4. Duodenal duplication cyst\nB. PERIDUODENAL ANOMALY\n\n1. Ladd bands\n2. Annular pancreas\n3. Preduodenal portal vein\nC. DISTAL OBSTRUCTION\n4. Midgut volvulus\n5. Malrotation\nmnemonic: LADS\nLadd bands / malrotation\nAnnular pancreas\nDuodenal atresia\nStenosis (duodenal)\n\n# Dilated Bowel in Fetus \n\n1. Meconium ileus\n$\\diamond$ All newborns with meconium ileus have cystic fibrosis!\n$\\diamond 10-15 \\%$ of newborns with cystic fibrosis present with meconium ileus!\n2. \"Apple peel\" atresia of small bowel\n3. Jejunal atresia\n4. Megacystis-microcolon-intestinal hypoperistalsis syndrome\n5. Colonic aganglionosis $=$ Hirschsprung disease\n(may be associated with Down syndrome)\n6. Anorectal atresia: associated with CNS abnormalities, part of VACTERL complex\n\n## Bowel Obstruction in Fetus\n\nEtiology: intestinal atresia / stenosis secondary to vascular accident, volvulus, meconium ileus, intussusception after organogenesis\nPrevalence: imperforate anus $1 \\div 3,000$; small bowel $1 \\div 5,000$; colon $1 \\div 20,000$\nPathologic types:\nI one / more transverse diaphragms\nII blind-ending loops connected by fibrous string\nIII complete separation of blind-ending loops\nIV apple-peel atresia of small bowel $\\leftarrow$ occlusion of SMA branch\nAssociated with: GI anomalies in 45\\% (malrotation, duplication, microcolon, esophageal atresia)\n$\\sqrt{ }$ multiple distended bowel loops $>7 \\mathrm{~mm}$ in diameter\n$\\sqrt{ }$ increased peristalsis\n$\\sqrt{ }$ polyhydramnios (if obstruction above level of mid jejunum; exceptions are esophageal atresia + tracheoesophageal fistula) $\\leftarrow$ fetal inability to cycle amniotic fluid through gut\nCx: Meconium peritonitis ( $50 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 342,
            "markdown": "$D D x$ : (1) Other cystic masses: duodenal atresia, hydronephrosis, ovarian cyst, mesenteric cyst\n(2) Chronic chloride diarrhea\n\n# Hyperechoic Fetal Bowel \n\n$\\diamond$ Most common echogenic mass in fetal abdomen\nDefinition: bowel echogenicity $\\geq$ bone\nPrevalence: $0.2-1.0 \\%$ of $2^{\\text {nd }}$ trimester fetuses\nCause: (?) \"constipation\" in utero $\\leftarrow$ decreased swallowing, hypoperistalsis, bowel obstruction + increased fluid absorption, ingestion of blood\n\n1. Normal small bowel variant (especially $<20$ weeks MA) with resolution on follow-up sonogram toward end of $2^{\\text {nd }}$ trimester (in $50-70 \\%$ )\n2. Normal colon variant in $3^{\\text {rd }}$ trimester $\\leftarrow$ echogenic meconium\n3. Meconium ileus\n$\\diamond$ Increased abdominal echogenicity is seen in $60-70 \\%$ of fetuses with cystic fibrosis!\n4. Chromosomal abnormality (3-25\\%)\n(a) Down syndrome (5-14\\%)\n(b) Trisomy 13, 18\n(c) Turner syndrome\n5. Severe IUGR ( $16 \\%$ )\n6. Intraamniotic bleeding\nwith subsequent swallowing of blood by fetus\nPrognosis:\n5 -fold increase in risk for adverse fetal outcome (due to chromosomal abnormality, other anomalies, placental abruption, perinatal death [8-16\\%], IUGR [67-23\\%])\n$\\diamond 30-50 \\%$ of fetuses with echogenic bowel in $2^{\\text {nd }}$ trimester will have poor outcome!\nManagement: parental testing for cystic fibrosis, careful fetal anatomic survey, follow-up for growth assessment\n\n## Hyperechoic Adrenal Gland in Fetus\n\nseen routinely on US $>30-32$ weeks GA\n\n1. Acute adrenal hemorrhage\n2. Exophytic renal tumor: mesoblastic nephroma\n3. Neuroblastoma\n4. Subdiaphragmatic extralobar sequestration\n\n## Intraabdominal Calcifications in Fetus\n\n$\\diamond$ Isolated liver calcifications are relatively frequent ( $1 \\div 1,750$ pregnancies) and of no clinical significance!\n\n## Scattered Calcifications\n\nA. PERITONEAL\n\n1. Meconium peritonitis\n2. Plastic peritonitis associated with hydrometrocolpos\nB. CONGENITAL INFECTION",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 343,
            "markdown": "1. Toxoplasmosis\n2. Cytomegalovirus\n\n# Focal Calcification \n\nA. TUMOR\n\n1. Hepatoblastoma\n2. Metastatic neuroblastoma\n3. Hemangioma / hemangioendothelioma\n4. Teratoma\n5. Ovarian dermoid\nB. OTHERS\n6. Fetal gallstones ( $>28$ weeks EGA)\n\nCause: hemolytic disease, cholestasis, maternal drug use\nPrognosis: resolution before / after delivery\n\n## Cystic Mass in Fetal Abdomen\n\nIncidence: abdominal cyst in $1 \\div 500-1 \\div 1,000$ live births; $1 \\div 2,625$ pregnancies\nA. POSTERIOR MID ABDOMEN\n\n1. Simple renal cyst\n2. Hydroureteronephrosis\n3. Multicystic dysplastic kidney\n4. Paranephric collection $=$ urinoma\n5. Lymphangioma\n6. Cystic neuroblastoma\nB. RIGHT UPPER QUADRANT\n7. Liver cyst\n8. Choledochal cyst\nC. LEFT UPPER QUADRANT\n9. Splenic cyst\nD. ANTERIOR MID ABDOMEN\n10. Gastrointestinal duplication cyst\n11. Mesenteric cyst\n12. Meconium pseudocyst\n13. Dilated bowel\n14. Urachal cyst\nE. LOWER ABDOMEN\n15. Fetal ovarian cyst (see below)\n16. Hydrometrocolpos\n17. Meningocele\n18. Sacrococcygeal teratoma\n19. Ureterocele\n\n## Fetal Ovarian Cyst\n\n$\\diamond$ Most common intraabdominal mass in female fetus\nIncidence: clinically significant ovarian cyst in $1 \\div 2500$ live births",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 344,
            "markdown": "Time of development: $3^{\\text {rd }}$ trimester\nCause: elevated hormone levels $\\leftarrow$ fetal pituitary gonadotropins, placental human chorionic gonadotropins, maternal estrogens\n\n1. Simple ovarian cyst\n2. Complex ovarian cyst\n\nPrognosis: $<5 \\mathrm{~cm}$ cyst: spontaneous resolution ( $69 \\%$ ), $>5 \\mathrm{~cm}$ cyst: spontaneous resolution $(15 \\%)$\n$R x$ : The most conservative postpartum approach is a period of observation because many cysts will regress spontaneously.\n\n# Fetal Ascites \n\nA. ASCITES + FETAL HYDROPS\n\n1. Immune hydrops\n2. Nonimmune hydrops\nB. ISOLATED ASCITES\n3. Urinary ascites\n4. Meconium peritonitis\n5. Bowel rupture\n6. Ruptured ovarian cyst\n7. Hydrometrocolpos\n8. Glycogen storage disease\n\n## Solid-appearing Fetal Abdominal Mass\n\n1. Neoplasm: neuroblastoma, mesoblastic nephroma, liver tumor (eg, hemangioendothelioma)\n2. Abdominal bronchopulmonary sequestration\n3. Fetus in fetu\n\n## FETAL URINARY TRACT ANOMALIES\n\nPrevalence: $0.25 \\%-1.00 \\%$ liveborn infants (OB-US); $1 \\div 100$ to $1 \\div 200$ neonates (pediatrics) Types:\n\n1. Bilateral renal agenesis\n2. Infantile polycystic kidney disease\n3. Adult polycystic kidney disease\n4. Multicystic dysplastic kidney\n5. Ureteropelvic junction obstruction\n6. Megaureter\n7. Posterior urethral valves\n8. Prune belly syndrome\n9. Megacystis-microcolon-intestinal hypoperistalsis syndrome\n10. Mesoblastic nephroma\n11. Wilms tumor\n12. Neuroblastoma\n\nAssociated with: chromosome abnormalities in $12 \\%$ ( $74 \\%$ trisomy, $10 \\%$ deletion, $9 \\%$ sex chromosome aneuploidy, $6 \\%$ triploidy)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 345,
            "markdown": "- fetal urine production: $5 \\mathrm{~mL} /$ hour at 20 weeks MA; $56 \\mathrm{~mL} /$ hour at 40 weeks MA\n$\\checkmark$ bladder volume: 1 mL at 20 weeks MA; 36 mL at 40 weeks MA\n$\\checkmark$ filling + emptying of fetal urinary bladder occurs every 10-30 (range 7-43) minutes\n$\\checkmark$ increased renal parenchymal echogenicity indicates renal abnormality in $80 \\%$\n$\\checkmark$ fetal hydronephrosis\n$=$ AP diameter of renal pelvis $>5 \\mathrm{~mm}$ at $15-20$ weeks, $\\geq 8 \\mathrm{~mm}$ at $20-30$ weeks, $\\geq 10 \\mathrm{~mm}$ at $>$ 30 weeks\n\n\n# FETAL TUMOR \n\n$=$ CONGENTTAL TUMOR\n$=$ mass in fetus + newborn manifesting in first 3 months of life\nPrevalence: $1.7-13.5 \\div 100,000$ live births\nCommon features: polyhydramnios ( $1 / 3$ ), associated congenital anomalies ( $20 \\%$ ), hydrops $(17 \\%)$\nA. EXTRACRANIAL TERATOMA (most common)\n\nLocation: typically along midline of body\nOrigin: during amoeba-like migration from yolk sac wall to genital ridges a few pluripotential primordial germ cells become isolated in aberrant locations and grow\nPath: all 3 germ cell layers:\n(a) ectoderm (dominant): neural tissue\n(b) mesoderm (common): fat, bone, smooth muscle, cartilage\n(c) endoderm (least common): respiratory epithelium, gastrointestinal tissue\n\nHisto: (a) mature\n(b) immature: primitive neuroglial tissue + neuroepithelial rosettes; (occasionally) malignant: yolk sac tumor / embryonal carcinoma\n\n1. Sacrococcygeal teratoma ( $70-80 \\%$ )\n2. Teratoma of head \\& neck $(10-20 \\%)$\n3. Chest \\& abdomen teratoma $(<10 \\%)$\n4. Fetus in fetu\n$=$ highly differentiated \"fetiform\" teratoma / parasitic monochorionic diamniotic twin embedded in retroperitoneal location of host\nB. NEUROBLASTOMA ( $30 \\%$ )\nC. SOFT-TISSUE TUMOR (12-22\\%)\n(a) benign: fibromatosis, digital fibromatosis, myofibromatosis, fibrous hamartoma\n(b) malignant: infantile fibrosarcoma, rhabdosarcoma, primitive neuroectodermal tumor, rhabdoid tumor, hemangiopericytoma\n(b) developmental vascular: hemangioma, lymphangioma, AV malformation\nD. INTRACRANIAL TUMOR ( $10 \\%$ )\n\nLocation: pineal region, suprasellar area, cerebral hemispheres\nSite: supratentorial > infratentorial (unlike pediatric age)\n$\\sqrt{ }$ macrocephaly, hydrocephalus, polyhydramnios $\\leftarrow$ depressed swallowing $\\leftarrow$ hypothalamic dysfunction\nMortality: $97 \\%$ (except for lipoma)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 346,
            "markdown": "$D D x$ : intracranial hemorrhage\n\n1. Intracranial teratoma ( $50 \\%$ of all fetal CNS tumors)\n2. Astrocytoma\n3. Lipoma ( $10 \\%$ )\n4. Choroid plexus papilloma (5-9\\%)\n5. Craniopharyngioma\n6. Primitive neuroectodermal tumor (3.4-13.2\\%)\nE. RENAL TUMOR (5\\%)\n7. Mesoblastic nephroma\n8. Wilms tumor\n9. Rhabdoid tumor\nF. LIVER TUMOR (5\\%)\n10. Hemangioendothelioma\n11. Mesenchymal hamartoma\n12. Hepatoblastoma\n13. Metastases: $\\leftarrow$ neuroblastoma + leukemia\nG. Congenital leukemia\n\nPrevalence: $4.7 \\div 1,000,000$ live births\nPrognosis: poor $\\leftarrow$ rapidly progressive course\nAge: first 4-6 weeks of infancy\nAssociated with: congenital leukemia of Down syndrome (15-fold increase of leukemia)\nOB-US:\n$\\sqrt{ }$ hepatosplenomegaly $\\rightarrow \\uparrow$ abdominal circumference\n$\\sqrt{ }$ hydrops $\\leftarrow$ fetal anemia / leukemic infiltrate of myocardium / visceral fibrosis with $\\uparrow$ vascular resistance\n$D D x$ : infection, metastatic neuroblastoma\n\n# GENERAL GYNECOLOGY \n\n## Pelvic Features of Estrogen Stimulation\n\n$\\sqrt{ }$ increased thickness + volume of uterus\n$\\sqrt{ }$ fundocervical ratio $>2$\n$\\sqrt{ }$ echogenic endometrium\n$\\sqrt{ }$ appearance of ovaries NOT USEFUL (because of widely varying ovarian volumes + normal visualization of follicles at all ages)\n\n## Precocious Puberty\n\n$=$ development of secondary sex characteristics $<8$ years of age in girls $/<9$ years of age in boys\n\n- premature thelarche / adrenarche / menarche\n$\\sqrt{ }$ significantly advanced bone age (may limit adult height potential)\nTerminology:\n(a) isosexual precocity $=$ secondary sex characteristics appropriate for patient's gender\n(b) heterosexual precocity $=$ secondary sex characteristics inappropriate for patient's gender",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 347,
            "markdown": "> virilization in girls\n> feminization in boys\n(c) gonadotropin-dependent $=$ true precocious puberty\n(d) gonadotropin-independent $=$ pseudoprecocious puberty\n\nSource: pituitary - adrenal - gonad\n\n# Central Precocious Puberty \n\n$=$ TRUE PRECOCIOUS PUBERTY $=$ TRUE ISOSEXUAL PRECOCITY $=$ COMPLETE PRECOCIOUS PUBERTY\n$=$ isosexual gonadotropin-dependent early development of gonads + secondary sex characteristics with ovulation before 8 years of age\nCause:\nA. IDIOPATHIC $(66-80 \\%) \\mathrm{F}>\\mathrm{M}$ activation of hypothalamic-pituitary-gonadal axis\n$=$ hypothalamic release of GnRH $\\rightarrow$ pituitary gonadotropin secretion $\\rightarrow$ ovulation / spermatogenesis\nB. ORGANIC $(13-42 \\%) \\mathrm{M}>>\\mathrm{F}$\n(1) Lesion of pituitary gland / hypothalamus: eg, tuber cinereum hamartoma, cyst\n(2) Increased intracranial pressure: eg, postmeningitic hydrocephalus\n(3) Traumatic brain injury\n(4) Empty sella\n(5) Congenital toxoplasmosis\n(6) Septo-optic dysplasia, pituitary duplication\n\n- increased levels of estrogen, advanced bone age\n- increased gonadotropin levels after LHRH stimulation\n$\\sqrt{ }$ bilateral adult-sized ovaries $\\left(1.2-12 \\mathrm{~cm}^{3}\\right)$ with bilateral cysts of $<9 \\mathrm{~mm}$\n$\\checkmark$ dominance of corpus over cervix length\n$\\diamond$ Uterine size + shape are more reliable indicators of estrogen stimulation!\n$R x$ : long-acting gonadotropin-releasing hormone analogue\nRadiologic workup:\n(1) Bone age assessment\n(2) Pelvic ultrasound for evidence of maturation of uterus + ovaries\n(3) Search for estrogen-producing lesion: functioning ovarian cysts, juvenile granulosa cell tumor of ovary, feminizing adrenal cortical tumor\n\n\n## Peripheral Precocious Puberty\n\n$=$ PSEUDOPRECOCIOUS PUBERTY = PSEUDOSEXUAL PRECOCITY = INCOMPLETE PRECOCIOUS PUBERTY\n$=$ iso- / heterosexual pubertal changes independent of secretion of pituitary gonadotropins =early development of secondary sex characteristics without ovulation\nCause:\nA. ISOSEXUAL PPP IN FEMALES\n\n1. Autonomously functioning ovarian follicular cyst (most common cause)\n$\\checkmark$ asymmetric ovarian enlargement (one ovary $2.4-7 \\mathrm{~cm}^{3}$ ) with macrocysts ( $>9$ mm )\n$\\checkmark$ pubertal morphology + size of uterus $\\leftarrow$ estrogen stimulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 348,
            "markdown": "2. Estrogen-secreting ovarian tumor: eg, granulosa cell tumor, gonadoblastoma, thecoma, choriocarcinoma\n3. Feminizing adrenocortical neoplasm\nrare others: McCune-Albright syndrome, untreated hypothyroidism, neurofibromatosis (NF1), hepatoblastoma, estrogen ingestion (food, topical cream)\nB. HETEROSEXUAL PPP IN FEMALES\n4. Virilizing adrenocortical neoplasm (ACN)\n5. Congenital adrenal hyperplasia (CAH)\nC. ISOSEXUAL PPP IN BOYS\n6. Sex cord-stromal tumor of testis\n7. hCG-secreting tumors stimulating Leydig cells: hepatoblastoma, mediastinal teratoma, some testicular germ cell tumors, suprasellar germinoma\n\n- low gonadotropin levels after LHRH stimulation\n- high serum estradiol level, low serum levels of FSH +LH\n- normal bone age; uterine bleeding $\\leftarrow$ withdrawal of estrogen stimulation upon cyst rupture\n$\\checkmark$ prepubertal small uterus + ovaries\n$\\checkmark$ asymmetric ovarian enlargement (one ovary $2.4-7 \\mathrm{~cm}^{3}$ ) with macrocysts ( $>9 \\mathrm{~mm}$ )\n$\\checkmark \\pm$ unilateral follicular ovarian cyst characterized by internal daughter cyst\n\n\n# Isolated Premature Adrenarche \n\n$=$ axillary and pubic hair development $\\leftarrow$ action of adrenal androgens in girls $1-3$ years of age\n\n- increased levels of adrenal androgens independent of stimulation by adrenocorticotropic hormone (ACTH)\n$\\checkmark$ prepubertal uterus + ovaries $\\left(0.1-1.0 \\mathrm{~cm}^{3}\\right)$\n$\\checkmark$ normal / slightly advanced bone age\n\n\n## Isolated Premature Thelarche\n\n$=$ breast enlargement in girls $1-3$ years of age\n$\\diamond$ May occur without endocrine abnormalities\n$\\checkmark$ prepubertal uterus + ovaries\n$\\checkmark$ normal / slightly advanced bone age\n\n## Infertility\n\n$=$ failure to conceive after 1 year of unprotected intercourse\nIncidence: affects $10-15 \\%$ of couples $=7.4$ million women in 2010\nEtiology:\nA. FEMALE FACTORS (55\\%):\n\n> Tubal disease ( $10-20-40 \\%$ ): congenital anomalies, DES exposure, pelvic inflammatory disease, salpingitis isthmica nodosa, endometriosis, postoperative factors, polyp, neoplasm, ectopic pregnancy\n> Uterine factors ( $2-5 \\%$ ): bicornuate uterus, septate uterus, DES exposure, intrauterine adhesions, endometrial inflammation / infection, uterine neoplasm, complications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 349,
            "markdown": "after pregnancy, leiomyoma\n> Ovulatory disorder (10-20\\%): premature ovarian failure, gonadal dysgenesis, polycystic ovary syndrome\n> Pelvic factors ( $20-25 \\%)$\n> Cervical factors (5-10\\%)\nB. MALE FACTORS (40\\%)\nC. COMBINATION OF FACTORS (15-25\\%)\nD. UNKNOWN CAUSE (5-10\\%)\n\nTests:\n\n- history + physical examination\n- laboratory tests (mainly hormonal), postcoital test\n- basal body temperature measurement, cervical culture\n- endometrial biopsy, sonographic monitoring of ovaries\n- in vitro mucus penetration test, sperm agglutination studies\n- laparoscopy + hysteroscopy, hysterosalpingography\n\n\n# Fallopian Tube Occlusion, Irregularity and Adhesions \n\nFrequency: $30-40 \\%$\n\n1. Pelvic inflammatory disease\n(a) granulomatous salpingitis: TB\n(b) parasitic infection\n2. Congenital anomaly\n3. Postsurgical anomaly\n4. Tubal spasm\n5. Intraluminal endometriosis\n6. Salpingitis isthmica nodosa\n\n## Intrauterine Filling Defect on HSG\n\n1. Intrauterine synechiae\n2. Submucosal leiomyoma\n3. Endometrial polyps\n4. Blood clot\n5. Air bubbles\n\n## Uterine Contour Irregularities\n\n1. Adenomyosis\n2. Leiomyoma\n3. MÃ¼llerian duct anomalies (up to 25\\%)\n\n## Cervical Anomalies\n\n1. Cervical factor infertility ( $10 \\%$ )\n$=$ inadequate quality / volume of cervical mucus\n2. Cervical stenosis\n\n## Ovarian Abnormalities\n\nA. PRIMARY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 350,
            "markdown": "1. Nonfunctioning ovaries\n2. Premature ovarian failure\n3. Gonadal dysgenesis\nB. SECONDARY\n4. Polycystic ovary syndrome\n5. Endometriosis\n6. Ovarian cancer\n\n# Amenorrhea \n\n## Primary Amenorrhea\n\nDefinition:\n(a) no menarche by 16 years of age\n(b) no thelarche / adrenarche by 14 years of age\n(c) no menarche $>3$ years after adrenarche + thelarche\n\n## Cause:\n\nA. FEMALE ANATOMIC ANOMALIES\n$=$ MÃ¼llerian (uterovaginal) anomalies (20\\%)\nB. CONGENITAL DISORDERS OF SEXUAL DIFFERENTIATION\n(a) pure gonadal dysgenesis $=$ Turner syndrome ( $33 \\%$ )\n$\\checkmark$ bilateral dysfunctional / streak gonads\n(b) mixed gonadal dysgenesis\n$\\checkmark$ testis + streak gonad\nRisk: in 25\\% development of dysgerminoma / gonadoblastoma in dysgenetic gonads with Y chromosome\nC. OVARIAN FAILURE / DYSFUNCTION\nD. HYPOTHALAMIC / PITUITARY CAUSES (15\\%)\nE. CONSTITUTIONAL DELAY (10\\%)\nF. OTHERS: eg, systemic, psychiatric illness (22\\%)\n$\\checkmark$ absent / streak gonads + infantile uterus:\n\n1. Hypogonadotropic hypogonadism\n\n- low / normal LH + FSH levels\n(a) hypothalamic dysfunction: hypothalamic tumor, Kallmann disease (= lack of pulsatile GnRH release), systemic illness, constitutional growth delay, extreme physical / psychological / nutritional stress (cystic fibrosis, sickle cell disease, Crohn disease), irradiation\n(b) pituitary dysfunction: disruption of pituitary stalk from child abuse, head trauma\n\n2. Hypergonadotropic hypogonadism\n$=$ ovarian tissue fails to respond to endogenous gonadotropins\n\n- high LH + FSH levels\n(a) abnormal karyotype: Turner syndrome, XY gonadal dysgenesis\n(b) irradiation, chemotherapy, autoimmune disease (eg, autoimmune oophoritis)\n$\\checkmark$ absent uterus:\n\n1. Testicular feminization $=$ male intersex $=$ male pseudohermaphroditism $\\leftarrow$ endorgan insensitivity to testosterone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 351,
            "markdown": "2. MÃ¼llerian dysgenesis (= Mayer-Rokitansky-KÃ¼ster-Hauser syndrome)\n$\\sqrt{ }$ normal fallopian tubes + ovaries\nAssociated with: unilateral renal abnormality (50\\%), skeletal abnormality (12\\%)\n$\\sqrt{ }$ small infantile uterus:\n3. Androgen-producing virilizing tumor of adolescent ovary $\\leftarrow$ usually Sertoli-Leydig cell tumor\n$\\sqrt{ }$ unilateral adnexal mass\n4. Turner syndrome\n5. In utero exposure to diethylstilbestrol\n$\\sqrt{ }$ normal uterus + unilateral ovarian tumor:\n6. Estrogen-producing ovarian tumor with disruption of menstrual cycle: granulosa cell tumor, thecoma\n$\\sqrt{ }$ hematometrocolpos:\n(a) neonate $=$ congenital uterovaginal obstruction\n7. Urogenital sinus / cloacal malformation\n$\\sqrt{ }$ pelviabdominal cystic mass with fluid-debris level in fetal US during $3^{\\text {rd }}$ trimester\n$\\sqrt{ }$ renal dysplasia / obstruction\n(b) teenager\n8. Imperforate hymen\n9. Transverse vaginal septum\n> in upper vagina ( $45 \\%$ )\n> in mid vagina ( $40 \\%$ )\n> in lower vagina ( $15 \\%$ )\n$\\sqrt{ }$ hematometra\n10. Cervical dysgenesis\n$\\sqrt{ }$ bilateral ovarian enlargement:\n11. Polycystic ovary syndrome\n(= Stein-Leventhal syndrome): most common cause of secondary amenorrhea\n\n# Secondary Amenorrhea \n\n1. Pregnancy: most common cause in girls $>9$ years of age\n2. Polycystic ovary syndrome (main pathologic cause)\n3. Asherman syndrome\n4. All causes of primary amenorrhea\n\n## Oligomenorrhea\n\nDefinition: $<9$ menstrual cycles per year\n\n## Calcifications of Female Genital Tract\n\nA. UTERUS\n\n1. Uterine fibroid\n2. Arcuate arteries\nB. OVARIES\n3. Dermoid cyst $(50 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 352,
            "markdown": "2. Papillary cystadenoma (psammomatous bodies)\n3. Cystadenocarcinoma\n4. Hemangiopericytoma\n5. Gonadoblastoma\n6. Chronic ovarian torsion\n7. Pseudomyxoma peritonei\nC. FALLOPIAN TUBES\n8. Tuberculous salpingitis\nD. PLACENTA\nE. LITHOPEDION\n\n# Psammoma Bodies in Tumor \n\n1. Papillary serous cystadenoma / cystadenocarcinoma\n2. Mucinous carcinoma of colon\n3. Papillary thyroid cancer\n4. Meningioma\n\n## Free Fluid in Cul-de-sac\n\n1. Follicular rupture\n2. Ovulation\n3. Ectopic pregnancy\n4. S/P culdocentesis\n5. Ovarian neoplasm\n6. Pelvic inflammatory disease\n\n## PELVIC MASS\n\n## Frequency of Pelvic Masses\n\n1. Benign adnexal cyst $34 \\%$\n2. Leiomyoma $14 \\%$\n3. Cancer $14 \\%$\n4. Dermoid $13 \\%$\n5. Endometriosis $10 \\%$\n6. Pelvic inflammatory disease $8 \\%$\n\n## Cystic Pelvic Mass\n\nA. CYSTIC ADNEXALMASS\nB. EXTRAADNEXAL CYSTIC MASS\n(a) intraperitoneal\n@ Peritoneum\n\n1. Peritoneal inclusion cyst\n2. Paraovarian cyst\n@) Bowel\n3. Mucocele of the appendix\n4. Mesenteric cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 353,
            "markdown": "3. Fluid-distended bowel\n@ Fallopian tube\n4. Hydro-, pyo-, hematosalpinx\n5. Ectopic gestation\n@ Uterus\n6. Pedunculated / parasitized leiomyoma with cystic degeneration\n7. Cystic adenomyosis\n8. Unicornuate uterus with obstructed rudimentary horn\n(b) extraperitoneal\n@ Presacral space\n9. Spinal meningeal cyst\n10. Retrorectal developmental cyst: dermoid, epidermoid, enteric tailgut / duplication cyst\n@ Lymphatics\n11. Lymphocele\n12. Cystic degeneration of lymph node\n13. Lymphangioleiomyomatosis\n14. Lymphangioma\n(c) intra- and extraperitoneal\n15. Loculated pelvic abscess: appendiceal, diverticular, postoperative, Crohn disease, tuberculous, pelvic actinomycosis\n16. Hematoma\n17. Bladder diverticulum\n\n# Complex Pelvic Mass \n\nmnemonic: CHEETAH\nCystadenoma / Cystadenocarcinoma\nHemorrhagic cyst\nEndometrioma\nEctopic pregnancy\nTeratoma: dermoid\nAbscess $\\leftarrow$ adjacent appendicitis, etc.\nHematoma in pelvis\n\n## Solid Pelvic Mass\n\n1. Pedunculated myoma (most common)\n2. Fibroma\n3. Adenofibroma\n4. Thecoma\n5. Brenner tumor\n\n## Fatty Pelvic Mass\n\nA. UTERUS\n\n1. Lipoleiomyoma\n2. Fibromyolipoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 354,
            "markdown": "# B. OVARY \n\n1. Benign cystic ovarian teratoma\n2. Malignant degeneration of cystic teratoma\n3. Nonteratomatous lipomatous ovarian tumor\nC. PELVIS\n4. Benign pelvic lipoma\n5. Liposarcoma\n6. Lipoblastic lymphadenopathy\n\n## Extrauterine Pelvic Mass\n\n1. Solid adnexal mass\n2. Metastatic disease\n3. Lymphoma\n4. Pelvic kidney\n5. Rectosigmoid carcinoma\n6. Bladder carcinoma\n7. Retroperitoneal tumor / fibrosis\n8. Intraperitoneal fat\n9. Vascular mass / malformation\n10. Hematoma\n11. Bowel\n\n## ADNEXA\n\n## Adnexal Mass\n\nA. CYSTIC OVARIAN MASS\n\n1. Physiologic ovarian cyst:\n> Graafian follicle: at midcycle $<25 \\mathrm{~mm}$\n> Corpus luteum: after midcycle $<15 \\mathrm{~mm}$\n2. Functional / retention cyst\n3. Endometrioma\n4. Tuboovarian abscess\n5. Dermoid cyst\n6. Ectopic pregnancy\n7. Serous / mucinous ovarian tumor\n8. Ovarian hyperstimulation cysts\n9. Massive ovarian edema\nB. EXTRAOVARIAN CYSTIC LESION\n10. Hydrosalpinx\n11. Paraovarian cyst / cystadenoma\n12. Peritoneal inclusion cyst\nC. SOLID OVARIAN\n13. Ovarian tumor\n14. Torsion of ovary\n15. Oophoritis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 355,
            "markdown": "4. Stein-Leventhal syndrome\n5. Ovarian fibromatosis\nD. SOLID EXTRA-OVARIAN\n6. Fallopian tube carcinoma\n7. Pedunculated fibroid\n\n# Ovarian Mass with Low Resistive Flow \n\nLow resistance flow $=\\mathrm{RI}<0.5$ or $\\mathrm{PI} \\leq 1.0$\n\n1. Physiologic corpus luteum\n2. Inflammatory mass\n3. Endometrioma\n4. Mesothelial cyst\n5. Benign tumor: serous / mucinous cystadenoma, mature cystic teratoma, cystadenofibroma\n6. Malignant ovarian tumor\n$\\diamond$ Some malignancies have high resistive blood flow!\n\n## Hemorrhagic Adnexal Lesion\n\n1. Endometriosis\n2. Hemorrhagic ovarian cyst\n3. Hemorrhagic foci of adenomyosis\n4. Hematosalpinx\n\n## Low-intensity Adnexal Lesion on T1WI\n\n1. Fibroma\n2. Fibrothecoma\n3. Cystadenofibroma\n4. Brenner tumor\n5. Ovarian fibromatosis\n6. Krukenberg tumor\n7. Wall of chronic pelvic abscess\n8. Pedunculated leiomyoma\n\n## High-intensity Adnexal Lesion on T1WI\n\n$=$ T1-shortening $\\leftarrow$ fat, hemorrhage, high protein\n\n1. Endometrioma\n$\\sqrt{ }$ frequently multilocular + bilateral\n$\\sqrt{ }$ shading (= signal loss) on T2WI\n2. Hemorrhagic ovarian cyst\n$\\checkmark$ unilocular\n$\\checkmark$ no shading\n$\\checkmark$ resolution with time\n3. Dermoid\n$\\checkmark$ chemical shift artifact\n$\\checkmark$ signal drop-out after fat suppression\n4. Mucinous cystic neoplasm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 356,
            "markdown": "$\\checkmark$ signal intensity less than fat / blood\n5. Ovarian carcinoma\n$\\checkmark$ solid components, septations\n$\\checkmark$ large size\n\n# LOW SI OF T1-HyPERINTENSE ADNEXAL MASS ON STIR \n\n1. Fat of mature cystic teratoma\n2. Hemorrhagic ovarian cyst\n3. Endometrioma\n$\\diamond$ Use selective fat-suppressed T1WI to identify fat!\n\n## Low-intensity Adnexal Lesion on T2WI\n\nA. Blood products\n\n1. Endometrioma\n2. Hemorrhagic cyst\n3. Hematosalpinx\n4. Cystic adenomyosis\nB. Smooth muscle\n5. Uterine leiomyoma\nC. Fibrous tissue\n6. Ovarian fibroma\n7. Theca cell tumor of ovary\n8. Cystadenofibroma\n9. Ovarian fibromatosis\n10. Pelvic aggressive fibromatosis\nD. Mixed cellularity\n11. Brenner tumor\n12. Struma ovarii\n13. Krukenberg tumor\n\n## T2-isointense Pelvic Mass Relative to Muscle\n\nA. Uterine origin\n\n1. Cystic adenomyosis: $\\uparrow$ T1WI\n2. Leiomyoma: enhancing\nB. Adnexal origin\n(a) $\\uparrow$ T1WI without enhancement\n3. Endometrioma\n4. Hematosalpinx",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 357,
            "markdown": "| Classification of Surface Epithelial Neoplasms by Cell Type |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Frequency | Benign | Borderline (4-14\\%) | Malignant |\n| $50 \\%$ | Serous cystadenoma | Serous borderline tumor resembling ciliated columnar cells of fallopian tube | Serous cystadenocarcinoma |\n| $15-30 \\%$ | Endometrioid cystadenoma | Endometrioid borderline tumor resembling endometrial adenocarcinoma | Endometrioid adenocarcinoma |\n| $15 \\%$ | Mucinous cystadenoma | Mucinous borderline tumor resembling endocervical canal epithelium | Mucinous adenocarcinoma |\n| $5 \\%$ | Benign clear cell tumor | Borderline clear cell tumor mesonephroid tumor | Clear cell adenocarcinoma |\n| $2.5 \\%$ | Transitional cell (Brenner) tumor | Brenner tumor of borderline malignancy | Transitional cell carcinoma (non- <br> Brenner type) |\n| Clinical Features |  |  |  |\n| Age |  | young woman | $6^{\\text {th }}-7^{\\text {th }}$ decade |\n| Solid component | minimal amount | moderate amount | marked amount |\n| Papillary projections | none / minimal (13\\%) | none / minimal (13\\%) | abundant ( $67 \\%$ ), in $38 \\%$ with domineering solid component |\n| Extraovarian tumor implants |  | noninvasive | invasive |\n| + retro-peritoneal Lnn. |  | $21 \\%$ |  |\n| + Doppler blood flow |  | $90 \\%$ | $92 \\%$ |\n| $\\uparrow$ CA-125 |  | $90 \\%$ | high |\n\n(b) $\\downarrow$ T1WI with enhancement\n\n1. Fibroma\n2. Fibrothecoma\n3. Cystadenofibroma\n4. Struma ovarii\n\n# T2-Hyperintense Adnexal Mass Brighter than Muscle \n\n(a) $\\uparrow$ T1WI\n> without enhancement\n\n1. Hemorrhagic cyst\n> with enhancement\n2. Malignant transformation of endometrioma\n(b) $\\downarrow$ T1WI\n> without enhancement\n3. Mucinous cystic neoplasm\n> with enhancement\n4. Krukenberg tumor\n\n## Adnexal Mass with Restricted Diffusion\n\n1. Malignancy\n2. Benign hemorrhagic ovarian cyst\n3. Endometrioma\n4. Benign mature cystic teratoma\n\n## Adnexal Mass in Pregnancy\n\nPrevalence: $0.5-1.2 \\%$\nA. RESOLVING BY 14-16 WEEKS EGA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 358,
            "markdown": "1. Corpus luteum cyst\n2. Theca lutein cyst\nB. PERSISTENT ADNEXAL MASS\n3. Benign correctly diagnosed by US: $95 \\%$ of dermoids, $80 \\%$ of endometriomas, $71 \\%$ of simple cysts\n4. Malignant $(0.1-0.8 \\%)$\n\n# Ovarian Tumor \n\n- abdominal discomfort, vomiting, flatulence, dyspnea\n- acute pain from torsion / hemorrhage; menstrual irregularity\n- chronic pain $\\leftarrow$ slowly enlarging mass, impaction, adhesions\n\nRadiologic guidelines:\n$\\diamond$ Imaging features of ovarian neoplasms virtually never allow a specific diagnosis. Regardless of further differentiation patients always undergo surgery!\nSigns suggestive of benignancy:\n$\\checkmark$ unilocularity of cyst\n$\\checkmark$ thin wall $<3 \\mathrm{~mm}$\n$\\checkmark$ minimal septations\n$\\checkmark$ absence of papillary projection\nSigns suggestive of malignancy:\n$\\checkmark$ solid nonfatty nonfibrous tissue (most POWERFUL PREDICTOR of malignancy!)\n$\\checkmark$ many solid-tissue elements in a complex lesion\n$\\checkmark$ wall thickness $>3 \\mathrm{~mm}$\n$\\checkmark$ inner wall irregularities / papillary projections\n$\\checkmark$ thick septations $>3 \\mathrm{~mm}$\n$\\checkmark$ increased echogenicity within a cyst\nAge: $13 \\%$ of neoplasms malignant in premenopause; $45 \\%$ of neoplasms malignant in postmenopause\nCx: (1) Torsion (in $10-20 \\%$ )\n(2) Rupture (rare)\n(3) Infection\n\nTerminology:\nprefix \"cyst-\": cystic component present\nsuffix \"fibroma\": $>50 \\%$ fibrous component\n\"tumor of low malignant potential\": borderline malignant\nClassification:\n$\\diamond 75 \\%$ of ovarian neoplasms are benign\n$\\diamond 21 \\%$ of ovarian neoplasms are malignant\n$\\diamond 4 \\%$ of ovarian neoplasms are borderline malignant\nThe proportion of malignant tumors increases with age:\n$<20$ years of age $4 \\%$\n$>50$ years of age $40 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 359,
            "markdown": "# Tumor of Surface Epithelium (60-70\\%) \n\n$=$ EPITHELIAL OVARIAN TUMOR\nOrigin: arising from precursors from outside the ovary = surface epithelium / mesothelium\nFrequency: $60 \\%$ of all ovarian tumors; $85 \\%$ of all ovarian malignancies; $50 \\%$ occur $>$ 65 years of age\nAge peak: $6^{\\text {th }}-7^{\\text {th }}$ decade; rare before puberty\n$\\checkmark$ primarily uni- / multilocular cystic mass\n$\\checkmark \\uparrow$ amounts of solid tissue (mural nodules, vascular solid component) correlate with likelihood of malignancy\n$\\checkmark$ papillary projections in benign tumor (13\\%) / borderline tumor (67\\%) / malignant neoplasm ( $38 \\%$ )\n$\\checkmark$ propensity for early peritoneal + lymphatic spread:\n$\\checkmark$ ascites\n$\\checkmark$ peritoneal studding\n$\\checkmark$ omental cake\n$\\checkmark$ perihepatic diaphragmatic implants\n$\\checkmark$ retroperitoneal lymphadenopathy\n\n## Germ Cell Tumor (20-25\\%)\n\n$\\diamond 40 \\%$ of germ cell tumors are malignant\nAge: commonly in young women\n(a) BENIGN ( $95 \\%$ )\n\n1. Dermoid cyst $=$ mature cystic teratoma\n$=$ the only benign variety\n(b) MALIGNANT (5\\%)\n$=$ ovarian malignant germ cell tumor (OMGCT\nTypes: dysgerminoma ( $1.9 \\%$ ), immature teratoma ( $1.3 \\%$ ), endodermal sinus / yolk sac tumor ( $1.0 \\%$ ), malignant mixed germ cell tumor ( $0.7 \\%$ ), embryonal carcinoma $(0.1 \\%)$, choriocarcinoma $(0.1 \\%)$, malignant struma ovarii tumor\n\nFat within a solid ovarian tumor is characteristic of a teratoma $=$ mature teratoma $\\pm$ malignant degeneration / immature teratoma / mixed GCT with immature elements\n\n## Sex Cord-Stromal Tumor (5-8\\%)\n\nusually has more than one cell type + arises from two groups of cells:\n> primitive sex cord cells, which form from the coelomic epithelium (= primordial peritoneum) and differentiate into granulosa cells + Sertoli cells\n> stromal cells (fibroblasts, theca cells, Leydig cells) derive from the mesonephros mesenchyma of the genital ridge\nAge: broad range of ages\n\n- most present at stage I with good prognosis\n- absent tumor markers\n$\\diamond$ Often manifest with tumor-mediated hormonal effects\n$\\sqrt{ }$ NO papillary projections\n$\\sqrt{ }$ lack of fat + calcifications",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 360,
            "markdown": "| Malignant Ovarian Epithelial versus Germ Cell Tumor |  |  |\n| :--: | :--: | :--: |\n| Characteristic | Epithelial Tumor | Germ Cell Tumor |\n| Prevalence | much more common | less common |\n| Highest incidence | $>65$ years of age | $15-19$ years of age |\n| Age affected | older woman | girl / young woman |\n| Race affected | more in whites | more in blacks + Asians |\n| Bilaterality | $\\begin{aligned} & \\text { serous (58\\%), mucinous } \\\\ & (21 \\%), \\text { clear cell (13\\%), } \\\\ & \\text { endometrioid (27\\%) } \\end{aligned}$ | $4 \\%$ (usually unilateral) |\n| Tumor marker | CA-125 | $\\alpha$-fetoprotein $+\\beta$-hCG |\n| Endocrine signs | None | isosexual precocity, carcinoid syndrome |\n| 5-year survival rate | $44 \\%$ (depending on stage) | dysgerminoma (100\\%), other malignant GCT (85\\%) |\n\n> hyperestrogenic tumors: granulosa cell tumor, thecoma, stromal luteoma\n> virilizing tumors: Sertoli-Leydig cell tumor, steroid cell tumor (Sertoli cell tumor, Leydig cell tumor)\nSize versus risk of malignancy: $<5 \\mathrm{~cm}$ in $3 \\%$\n$5-10 \\mathrm{~cm}$ in $10 \\%$\n$>10 \\mathrm{~cm}$ in $65 \\%$\nA. GRANULOSA-STROMAL CELL TUMOR\n\n1. Juvenile granulosa cell tumor multicystic\n2. Adult granulosa cell tumor solid\n3. Thecoma solid\n4. Fibroma solid\n5. Fibrosarcoma\n6. Sclerosing stromal tumor\nB. SERTOLI-STROMAL CELL TUMOR\n7. Sertoli-Leydig tumor solid\n8. Sertoli cell = arrhenoblastoma solid\n9. Leydig cell\nC. STEROID CELL TUMOR = LIPID CELL TUMOR\n10. Stromal luteoma\n11. Leydig cell tumor $=$ hilus cell tumor\n12. Steroid cell tumor, not otherwise specified\nD. OTHER\n13. Gynandroblastoma\n14. Sex cord tumor with annular tubules associated with Peutz-Jeghers syndrome ( $30 \\%$ of all tumors with annular tubules)\n15. Sclerosing stromal tumor\n\nParaneoplastic Syndrome of Ovarian Tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 361,
            "markdown": "Cause: autoantibodies, circulating immune complexes\nA. NERVOUS SYSTEM DISORDERS\n\n1. Cerebellar degeneration\n2. Polyneuritis\nB. CONNECTIVE TISSUE DISORDERS\n3. Dermatomyositis\nC. HEMATOLOGIC DISORDERS\n4. Hemolytic anemia\n5. Disseminated intravascular coagulation\nD. CUTANEOUS DISORDERS\n6. Acanthosis\nE. NEPHROTIC SYNDROME\n\nSecondary Ovarian Tumor (5-15\\%)\nMetastases from: pelvic organs, upper GI tract, breast, bronchus, reticuloendothelial tumors, leukemia\n\n# Solid Ovarian Tumor \n\n1. Ovarian fibroma\n2. Theca cell tumor of ovary\n3. Granulosa cell tumor\n4. Sertoli-Leydig cell tumor\n5. Brenner tumor\n6. Sarcoma\n7. Dysgerminoma\n8. Yolk sac tumor of ovary\n9. Teratoma of ovary\n10. Metastasis\n11. Endometrioma\n12. Massive ovarian edema\n13. Leiomyoma\n\n## Functioning Ovarian Tumor\n\n$\\diamond 2 / 3$ of gonadal stromal tumors produce steroids\n$\\diamond$ The most common functioning ovarian tumor is the sex cord-stromal tumor ( $=8 \\%$ of ovarian neoplasms)\n\n## Ovarian Tumor with Hyperandrogenism\n\n- male-pattern baldness, loss of female body contour\n- hirsutism, elevated serum testosterone\n- $\\pm$ elevated serum dehydroepiandrosterone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 362,
            "markdown": "| Causes of Hyperandrogenism and Hyperestrogenism |  |  |\n| :--: | :--: | :--: |\n| Cause | Hyperandrogenism | Hyperestrogenism |\n| Ovarian Disorder |  |  |\n| Sex cord-stromal tumor |  |  |\n| Sertoli stromal tumor |  |  |\n| Sertoli-Leydig cell tumor | $+$ | $(+)$ |\n| Steroid cell tumor |  |  |\n| Leydig cell tumor | $+$ | $(+)$ |\n| Stromal luteoma | $+$ | $+$ |\n| Steroid cell tumor NOS | $+$ | $(+)$ |\n| Granulosa stromal tumor |  |  |\n| Granulosa cell tumor | $(+)$ | $+$ |\n| Thecoma | $(+)$ | $+$ |\n| Sclerosing stromal tumor | - | $+$ |\n| Sex cord tumor with annular tubules | - | $+$ |\n| Gynandroblastoma | $+$ | - |\n| Germ cell tumor |  |  |\n| Carcinoid (monodermal teratoma) | $+$ | - |\n| Gonadoblastoma |  |  |\n| Surface epithelial tumor |  |  |\n| Serous tumor | - | $+$ |\n| Mucinous tumor | - | $+$ |\n| Endometrioid tumor | - | $+$ |\n| Brenner tumor | $+$ | $+$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 363,
            "markdown": "| Secondary (metastatic) tumor | + | + |\n| :--: | :--: | :--: |\n| Tumorlike lesion |  |  |\n| Polycystic ovary syndrome | + | - |\n| Stromal hyperplasia | + | - |\n| Stromal hyperthecosis | + | - |\n| Hyperreactio luteinalis | + | - |\n| Pregnant luteoma | + | - |\n| Pituitary Disorder |  |  |\n| Cushing disease | + | - |\n| Adrenal Disorder |  |  |\n| Cushing syndrome | + | - |\n| Adult-onset congenital adrenal hyperplasia | + | - |\n| Hyperfunction of adrenal gland | + | - |\n| Drugs |  |  |\n| Testosterone | + | - |\n| Danazol | + | - |\n| Anabolic steroids | + | - |\n| Synthetic progestins | + | - |\n| Estrogen | - | + |\n| Tamoxifen | - | + |\n| Other Disorder |  |  |\n| Idiopathic hirsutism | + | - |\n\n# A. SOLID $\\pm$ CYSTIC \n\n1. Sertoli-Leydig cell tumor\nB. SOLID\n2. Leydig cell tumor\nuncommon: metastasis, teratoma, choriocarcinoma, Sertoli cell tumor\n\n## OVARIAN TUMOR WITH HYPERESTROGENISM\n\n- sexual precocity in premenarchal girls\n- irregular excessive uterine bleeding\nA. CYSTIC\n\n1. Granulosa cell tumor\n2. Mucinous cystadenoma\nB. SOLID\n3. Thecoma\nuncommon: stromal luteoma, choriocarcinoma, teratoma, Brenner tumor\n\n## Other Functioning Ovarian Tumors\n\n- increased hCG levels: choriocarcinoma\n- hyperthyroidism: struma ovarii\n- carcinoid syndrome: carcinoid tumor\n- Cushing syndrome: steroid cell tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 364,
            "markdown": "- hypoglycemia: fibroma, dysgerminoma, carcinoid\n\n\n# FALLOPIAN TUBE \n\n## Fallopian Tube Disease outside Pregnancy\n\n1. Pelvic inflammatory disease\n2. Atypical tubal infection: tuberculosis, actinomycosis\n3. Torsion of fallopian tube\n4. Endometriosis\n5. Primary fallopian tube tumor\n> hydatid cyst of Morgagni\n> leiomyoma\n> fallopian tube cancer\n\n## Proximal Fallopian Tube Obstruction\n\n1. Extensive fibrosis / salpingitis isthmica nodosa ( $40 \\%$ )\n2. Amorphous debris / minimal adhesions ( $40 \\%$ )\n3. Tubal spasm $(20 \\%)$\n\n## UTERUS\n\n## Prepubertal Vaginal Bleeding\n\n1. Vaginal foreign body\n\nPrevalence: in $18 \\%$ of children with vaginal bleeding + discharge; in $50 \\%$ of children with vaginal bleeding + no discharge\n2. Vaginal rhabdomyosarcoma\n3. Precocious puberty\n4. Hemangioma\n5. Vascular malformation\n\n## Postmenopausal Uterine Bleeding\n\n1. Endometrial atrophy (in $60-75 \\%$ )\n\n- thin atrophic endometrium prone to superficial ulceration\n$\\sqrt{ }$ in $75 \\%$ endometrial thickness $<4-5 \\mathrm{~mm}$\n$\\diamond$ Patient may forego endometrial biopsy!\n$\\sqrt{ }$ in $25 \\%$ endometrial thickness of $6-15 \\mathrm{~mm}$\n\n2. Endometrial hyperplasia\n3. Endometrial polyp\n4. Submucosal fibroid\n$\\sqrt{ }$ hypoechoic mass with an overlying normal echogenic endometrium\n$\\sqrt{ } \\pm$ acoustic attenuation\n$\\sqrt{ } \\pm$ prolapse into endometrial cavity\n$R x:$ can be removed at hysteroscopy if $>50 \\%$ of mass projects into endometrial cavity\n5. Adenomyoma\n$\\sqrt{ }$ indistinguishable from submucosal fibroid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 365,
            "markdown": "6. Endometrial carcinoma (in $7-20 \\%$ )\n7. Estrogen withdrawal\n\nOptimal time of imaging:\nimmediately after cessation of bleeding when endometrium is presumed to be thinnest\n$R x$ : any focal / generalized thickness $>5 \\mathrm{~mm}$ at transvaginal US requires further investigation (sonohysterography, guided biopsy, hysteroscopy)\n\n# Postpartum Hemorrhage (PPH) \n\n$=$ blood loss sufficient to cause symptoms of hypovolemia\n\n- tachycardia, hypotension, oliguria\n$=$ blood loss $>500 \\mathrm{~mL}$ after vaginal birth $/>1,000 \\mathrm{~mL}$ after cesarean delivery\nPhysiology: bleeding decreases over $1^{\\text {st }}$ postpartum week\nIncidence: $3.3 \\%$ in developed countries\nClassification:\n(a) Primary PPH = early postpartum hemorrhage $>500 \\mathrm{~mL}$ within 24 hours in $4-6 \\%$ of all deliveries\nCause: uterine atony ( $75 \\%-90 \\%$ ), laceration of lower genital tract, bladder flap hematoma, uterine rupture, acute uterine inversion\n(b) Secondary PPH = late postpartum hemorrhage between 24 hours and 6 weeks in 1$2 \\%$ of all deliveries\nCause: endometritis, retained products\n$D D x$ : endometritis, uterine dehiscence / perforation, subinvolution of placental implantation site\nIncreased risk: maternal age $>35$ years, primipara, previous C-section, previous postpartum hemorrhage, prolonged labor, multiple pregnancy, fibroids, placental abruption, placenta previa / accreta, instrument delivery, prophylactic uterorelaxant drug therapy\nmnemonic: 4 Ts Tonus, Tissue, Trauma, Thrombin\n\n1. Uterine atony $\\left(75-90 \\%\\right.$ of $\\left.1^{\\circ} \\mathrm{PPH}\\right)$\n$=$ generalized ineffective contraction of uterine corpus with bleeding at placental site\nRisk factors: uterine overdistension (multiple pregnancy, macrosomia, polyhydramnios), labor related factors (prolonged labor, precipitate labor, induction of labor, forceps delivery, prolonged use of oxytocin, use of uterorelaxant drug)\n\n- hemorrhage in immediate postpartum period\n- pliable uncontracted uterus\n$\\sqrt{ }$ normal uterus\n$D D x$ : normal postpartum findings\n$\\sqrt{ }$ small amount of fluid / blood in uterine cavity\n$\\sqrt{ }$ intrauterine gas (up to 3 weeks post partum)\n$\\sqrt{ }$ prominent intramural + parametrial vessels\n$\\sqrt{ }$ focal thinning of myometrial wall (after C-section) + small hematoma / seroma\n$R x$ : medical Rx; internal uterine balloon tamponade; selective embolization of uterine arteries (gelatin sponge particles); uterine compression sutures; vascular ligation\n\n2. Retained products of conception (most frequent cause of secondary PPH)\n3. Lower genital tract trauma ( $2-4 \\%$ of all PPH)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 366,
            "markdown": "$\\sqrt{ }$ paravaginal hematoma (coronal reconstruction!)\nRisk factors: primipara, macrosomia, multiple pregnancy, prolonged dilatation, vulvovaginal varices, preclampsia, coagulation disorder, instrumental vaginal delivery\nBleeding source: episiotomy (cervical, vulvar, perineal tear), vaginal laceration\n(a) infralevator extension: spread to vulva, perineum, ischiorectal fossa\n\n- diagnosis by inspection + vaginal bleeding\n$R x:$ transvaginal drainage\n(b) supralevator extension: upward spread through broad ligament + retroperitoneal space\n- NO obvious vaginal bleeding $\\rightarrow$ delay in diagnosis\n- abdominal pain, hypovolemic shock\n$\\checkmark$ bladder flap hematoma\n$=$ fluid-attenuation collection in extraperitoneal space between posterior bladder wall + anterior wall of lower uterine segment\nbladder flap $=$ dissection of urinary bladder from lower uterine segment during cesarean section to allow spontaneous descent of bladder\n\n4. Coagulation disorder (acquired / congenital)\n\n# Diffusely Thickened Irregular Endometrium \n\nNormal endometrial thickness:\nSensitivity for detection of endometrial abnormalities: $80 \\%$ for transvaginal US; $30 \\%$ for endometrial biopsy\nTime of sonohysterography: day 4, 5, or 6 of menstrual cycle\n\n1. Endometrial hyperplasia\n\nAge: peri- / postmenopausal women\nCause: prolonged endogenous / exogenous unopposed estrogen stimulation\n$\\checkmark$ focal / diffuse endometrial thickening $>5-6 \\mathrm{~mm}$\n$\\checkmark$ formation of polyps of up to 5 cm\nTypes:\n(a) glandular-cystic hyperplasia (most common)\n\nHisto: dilated glands lined by tall columnar / cuboidal epithelium\n$\\checkmark$ small cysts within evenly echogenic endometrium\nPrognosis: NO premalignant condition\n(b) adenomatous hyperplasia\n$\\checkmark$ endometrium with irregular hypoechoic areas\nPrognosis: precursor of endometrial cancer\n2. Secretory endometrium\n$\\diamond$ Improve timing of the examination!\n3. Endometrial cancer\n4. Endometritis\n5. Tamoxifen-related endometrial changes\n$=$ nonsteroidal antiestrogen in breast acts as a weak estrogen agonist $\\rightarrow$ proliferative effects on endometrium\nIncreased prevalence of: endometrial hyperplasia, polyps, carcinoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 367,
            "markdown": "$\\diamond 50 \\%$ of women treated with tamoxifen will develop endometrial abnormalities within $6-36$ months\nHisto:\n(a) endometrial thickness increased to 10.4 mm ; 4.2 mm in control subjects\n(b) polyps ( $36 \\%$ ); $10 \\%$ in control subjects\n(c) atrophic changes ( $28 \\%$ ); $87 \\%$ in control subjects\n\n- hemorrhage (requires further evaluation)\n$\\checkmark$ endometrial thickening $>5-9 \\mathrm{~mm}$ :\n$\\checkmark$ endometrial hyperplasia\n$\\checkmark$ endometrial polyp\n$\\checkmark$ subendometrial cystic changes (= glandular distension within a polyp / reactivated adenomyosis within inner myometrium)\nMR:\n$\\checkmark$ endometrial-myometrial interface $\\leftarrow$ endometrial atrophy / proliferative changes:\n$\\checkmark$ homogeneously hyperintense on T2WI\n$\\checkmark$ signal void + enhancement on T1WI\n$\\checkmark$ polyps:\n$\\checkmark$ heterogeneous intensity on T2WI\n$\\checkmark$ latticelike enhancement traversing endometrial canal on T1WI\n\n\n# Focally Thickened Endometrium \n\n1. Endometrial polyp\n$=$ focal hyperplasia of stratum basale; in $20 \\%$ multiple\nAge: mainly $30-60$ years\nHisto: projections of endometrial glands + stroma into uterine cavity\n(a) hyperplastic polyp resembling endometrial hyperplasia\n(b) functional polyp resembling surrounding endometrium (least frequent)\n(c) atrophic polyp\n\nFrequently associated with: tamoxifen therapy\nUS:\n$\\checkmark$ sessile broad-based / pedunculated well-defined smooth hyperechoic homogeneous intracavitary mass ( $79 \\%$ ) / of variable echogenicity (best seen on sonohysterography):\n$\\checkmark$ cystic spaces (in $59 \\%$ ) $\\leftarrow$ enlarged dilated glands filled with proteinaceous fluid\n$\\checkmark$ heterogeneous texture $\\leftarrow$ suggestive of infarction, inflammation, hemorrhage\n$\\checkmark$ vessel visualized within stalk on color Doppler\nMalignant transformation: in $0.4-3.7 \\%$\n2. Primary carcinoma of the endometrium\n\nRisk factors: exposure to unopposed estrogen, obesity, nulliparity, hypertension, diabetes\nLocation: predominantly in uterine fundus; $24 \\%$ in isthmic portion)\n$\\diamond 10 \\%$ cancer rate with endometrial thickness of $6-15 \\mathrm{~mm}$\n$\\diamond 50 \\%$ cancer rate with endometrial thickness of $>15 \\mathrm{~mm}$\n$\\checkmark$ irregular heterogeneous endometrium $>5 \\mathrm{~mm}$ in thickness\n$\\checkmark$ focal / diffuse endometrial thickening (mean thickness of 18.2 mm )\n$\\checkmark$ irregular poorly defined endometrial-myometrial interface",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 368,
            "markdown": "$\\sqrt{ }$ increased echogenicity in myometrium (= invasive endometrial cancer)\n$\\sqrt{ }$ Doppler waveforms with resistive index $<0.7$ suggest malignancy\n3. Metastatic carcinoma: ovary, cervix, fallopian tube, leukemia\n4. Hydatidiform mole\n$\\sqrt{ }$ echogenic mass with irregular sonolucent areas\n5. Incomplete abortion\n6. Submucosal leiomyoma\n$\\sqrt{ }$ mass hypo- / hyperechoic relative to myometrium\n$\\sqrt{ }$ wide attachment to myometrium\n$\\sqrt{ }$ intracavitary margin outlined by echogenic rim of endometrium\n$\\sqrt{ } \\pm$ acoustic attenuation\n$R x:$ hysteroscopic removal if $>50 \\%$ of mass projects into endometrial cavity\n7. Focal adenomyoma\n$\\sqrt{ }$ hypoechoic mass with an overlying echogenic endometrium\n$D D x$ : indistinguishable from submucosal fibroid\n8. Intrauterine synechiae\n$\\sqrt{ }$ echogenic bands extending from one endometrial surface to the other\n$D D x$ : adherent blood clots\n\n# Fluid Collection within Endometrial Canal \n\nTypes: blood, mucus, purulent material\nA. PREMENOPAUSAL\n\n1. Infection: endometritis, pyometrium\n2. Congenital obstructive lesion: imperforate hymen, vaginal septum, vaginal / cervical atresia\n3. Acquired obstructive lesion: cervical stenosis (following instrumentation / cone biopsy / radiation), cervical carcinoma\n4. Spontaneous hematometra in bleeding disorders\n5. Pregnancy: intrauterine, ectopic, incomplete abortion\n6. Endometrial cancer\n7. Endometrial polyp, submucosal fibroid\n8. Functional: during menstruation\nB. POSTMENOPAUSAL\n9. Endometrial / cervical cancer\n10. Cervical stenosis\n11. Normal if amount small\n\n## Endometrial Cysts\n\n1. Endometrial cystic atrophy\n\nHisto: cystically dilated atrophic glands lined by single layer of flattened / low cuboidal epithelium\n$\\sqrt{ }$ very thin endometrium of $<4-5 \\mathrm{~mm}$\n2. Endometrial cystic hyperplasia\n\n## Diffuse Uterine Enlargement",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 369,
            "markdown": "1. Diffuse leiomyomatosis\n2. Adenomyosis\n3. Endometrial carcinoma ( $15 \\%$ )\n\n# Uterine Mass \n\nA. BENIGN\n\n1. Uterine fibroids ( $99 \\%$ )\n2. Pyometra\n3. Hemato- / hydrocolpos\n4. Transient uterine contraction: during pregnancy\n5. Bicornuate uterus\n6. Adenomyosis\n7. Intrauterine pregnancy\n8. Lipoleiomyoma ( $<50$ cases in world literature)\nB. MALIGNANT\n9. Cervical carcinoma\n10. Endometrial carcinoma\n11. Leiomyosarcoma\n12. Invasive trophoblastic disease\n\n## CERVIX\n\n## Congenital Cervical Anomaly\n\n1. Septate uterus ( $34-55 \\%$ )\n2. Duplication of cervix: uterus didelphys, septate uterus, bicornuate uterus\n$\\sqrt{ } 2$ endocervical canals usually divided by thicker plane of tissue than with a cervical septum\n3. Cervical agenesis $=$ blind-ending vagina often with complete absence of uterus / rudimentary uterine tissue\n$\\sqrt{ }$ evaluate for concurrent renal anomalies $(30-50 \\%)$\n\n## Cervical Mass\n\n1. Fibroid\n2. Cervical carcinoma\n3. Endocervical polyp\n4. Nabothian cyst\n5. Cervical leiomyoma\n6. Endometriosis\n\nUse of transducer pressure may show lesion mobility if a lesion is in the endocervical canal (pedunculated intracavitary myoma / polyp). Lesions arising from the cervical stroma will remain fixed in position with transducer pressure.\n\n## Cervical Stenosis\n\n$=$ obliteration + obstruction of endocervical canal\n$=$ inability to insert a $2.5-\\mathrm{mm}$ wide dilator",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 370,
            "markdown": "# A. CONGENITAL \n\n1. Transverse vaginal septum in uterus didelphys\n2. Congenital absence of cervix\nB. ACQUIRED\n3. Cervical carcinoma: postmenopausal\n4. Endometrial cancer: premenopausal\n5. Benign masses: polyp, fibroid\n6. $\\mathrm{S} / \\mathrm{P}$ radiation treatment\n7. S/P surgery, endocervical curettage, cone biopsy\n\n- obstruction to menstrual flow $\\rightarrow$ amenorrhea, dysmenorrhea\n$\\checkmark$ distension of endometrial cavity by secretions + blood products\n$\\checkmark$ narrowing of endocervical canal $<5 \\mathrm{~mm}$ by HSG preventing insertion of HSG catheter\n$C x$ : reflux endometriosis\n\n\n## VAGINA\n\n## Vaginal Cyst\n\n1. Gartner duct cyst (above pubic symphysis)\n2. Bartholin gland cyst (below pubic symphysis)\n3. Skene duct cyst\n4. MÃ¼llerian / paramesonephric duct cyst\n$=$ aberrant embryologic remnant of paramesonephric duct\nHisto: mucinous pseudostratified columnar epithelium\nLocation: anterolateral wall of vagina near cervix\n5. Epithelial inclusion cyst\n$=$ arise from urogenital sinus\nHisto: lined by transitional epithelium containing thick caseous material\n6. Epidermal / vaginal inclusion cyst\n\nCause: prior trauma / surgery\nHisto: stratified squamous epithelium\nLocation: posterior / lateral wall of vagina\n\n## Vaginal Fistula\n\n1. Enterovaginal fistula:\n(a) rectovaginal: incomplete healing of perineal laceration $\\leftarrow$ obstetric trauma, radiation therapy\n(b) anovaginal: inflammatory bowel disease ( $10 \\%$ of patients with Crohn disease)\n(c) colovaginal: diverticulitis\n2. Vesicovaginal fistula: hysterectomy, radiation therapy\n3. Ureterovaginal fistula: vaginal hysterectomy\n\n## Vaginal \\& Paravaginal Neoplasm\n\nA. PRIMARY benign\n\n1. Cavernous hemangioma of vulva\n2. Pedunculated submucosal leiomyoma prolapsed into vagina",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 371,
            "markdown": "B. Primary malignant\n\nFrequency: 1-2\\% of all gynecologic malignancies; 20\\% of all vaginal malignancies\n\n| Cystic Lesions of Female Lower Genitourinary Tract |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Lesion |  | Location | relative <br> to pubic <br> symphysis |\n| Skene duct cyst | urethral <br> orifice | anterior vaginal <br> introitus | inferior |\n| Bartholin cyst | vaginal <br> introitus | medial to labia <br> minora | inferior |\n| Gartner duct cyst | upper vagina | anterolateral wall | superior |\n| Urethral <br> diverticulum | midurethra | posterolateral <br> margin | superior |\n\n1. Vaginal carcinoma\n(a) squamous cell carcinoma ( $90 \\%$ )\n\nAssociated with: human papilloma virus\n(b) adenocarcinoma $(9 \\%)$\n2. Melanoma (3\\%)\n3. Sarcoma (1\\%): rhabdomyosarcoma\n4. Adenoid cystic carcinoma of Bartholin gland\nC. SECONDARY MALIGNANT\n\nFrequency: $80 \\%$ of all vaginal malignancies\n$\\leftarrow$ direct extension from bladder, rectum, cervix, uterus\n\n# HYSTEROSALPINGOGRAPHY \n\n## Fundic Depression on HSG\n\nA. with normal outer contour\n\n1. Septate uterus\n2. Arcuate uterus\nB. with abnormal outer contour\n3. Bicornuate uterus\n4. Fundal myoma\n\n## Filling Defect on HSG\n\n1. Synechia\n2. Endometrial polyp\n3. Submucosal myoma\n4. Uterine folds = parallel to long axis of uterus\n5. Air bubbles\n\n## Abnormal Uterine Contour on HSG\n\n1. Submucosal myoma\n2. Adenomyosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 372,
            "markdown": "3. Trauma: cesarean section, myomectomy\n\n# GAS IN GENITAL TRACT \n\nA. UTERUS\n\n1. Endometritis\n2. Superinfection of leiomyoma: more common in submucosal leiomyoma (insufficient blood supply)\n3. Bacterial metabolism of necrotic neoplastic tissue\n4. Fistula to GI tract: uterine cancer\n5. Pyometra $\\leftarrow$ obstruction by cervical cancer\n6. Gas gangrene $\\leftarrow$ clostridial infection from septic abortion\nB. OVARY\n7. Superinfected ovarian neoplasm\nC. VAGINA\n8. Vaginitis emphysematosa\n$=$ nonbacterial self-limiting process mostly occurring during pregnancy characterized by numerous gas-filled spaces in submucosa of vagina + exocervix",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 373,
            "markdown": "# ANATOMY AND PHYSIOLOGY OF THE FEMALE REPRO DUCTIVE SYSTEM \n\n## HUMAN CHORIONIC GONADOTROPIN\n\n$=\\mathrm{hCG}=$ glycoprotein elaborated by placental trophoblastic cells beginning the $8^{\\text {th }}$ day after conception\n\n## Immunologic Pregnancy Test\n\n$=$ indirect agglutination test for hCG in urine; cross-reaction with other hormones / medications possible\n\n- becomes positive at 5 weeks MA\n\nAdvantages: readily available, easily + rapidly performed\nDisadvantages: frequently false-positive + false-negative results\nSensitivity:\n(a) slide: $400-15,000 \\mathrm{mIU} / \\mathrm{mL}$ (2-minute test time)\n(b) test tube: $1,000-3,000 \\mathrm{mIU} / \\mathrm{mL}$ (2-hour test time)\n\n## Radioimmunoassay (RIA) Pregnancy Test\n\n$=$ measures beta subunit of hCG in serum with a sensitivity as low as $1-2 \\mathrm{mIU} / \\mathrm{mL}$\n$\\diamond$ Serum $\\beta$-hCG becomes positive at 3-4 weeks MA / 7-10 days following conception!\nStandards:\n(1) Second International Standard (SIS)\n(2) International Reference Preparation (IRP)\n(3) Third International Standard (TIS)\n\n$$\n\\begin{aligned}\n1 \\mathrm{mIU} / \\mathrm{mL}(\\text { SIS }) & =2 \\mathrm{mIU} / \\mathrm{mL}(\\mathrm{IRP})=2 \\mathrm{mIU} / \\mathrm{mL}(\\text { TIS }) \\\\\n1 \\mathrm{ng} / \\mathrm{mL} & =5-6 \\mathrm{mIU} / \\mathrm{mL}(\\text { SIS }) \\\\\n& =10-12 \\mathrm{mIU} / \\mathrm{mL}(\\text { IRP or TIS })\n\\end{aligned}\n$$\n\n$\\diamond$ Variations of lab values of up to $50 \\%$ can occur among different laboratories!\n$\\diamond 6-15 \\%$ between-run precision!\nAdvantages: specific for hCG, sensitive\n$\\diamond$ Highly specific + sensitive for pregnancy\nDisadvantages: requires specialized lab and 3-24 hours for completion\nSensitivity:\n(a) qualitative: $25-30 \\mathrm{mIU} / \\mathrm{mL}$ (3-hour test time)\n(b) quantitative: $3-4 \\mathrm{mIU} / \\mathrm{mL}$ (24-hour test time)\n\nRise:\n$>66 \\%$ increase of initial $\\beta$-hCG level over 48 hours in $86 \\%$ of NORMAL pregnancies\n$<66 \\%$ increase of initial $\\beta$-hCG level over 48 hours in $87 \\%$ of ECTOPIC pregnancies\n$\\diamond \\beta$-hCG levels double every 2 days during first 60 days of a NORMAL pregnancy!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 374,
            "markdown": "| \"1-7-11 Rule\" |  |  |\n| :--: | :--: | :--: |\n| $\\beta-h C G$ (IRP) | US Landmarks | Gestational Age |\n| $1,000 \\mathrm{mIU} / \\mathrm{mL}$ | gestational sac | 32 d (4.5 weeks) |\n| $7,200 \\mathrm{mIU} / \\mathrm{mL}$ | yolk sac | 36 d (5.0 weeks) |\n| $10,800 \\mathrm{mIU} / \\mathrm{mL}$ | embryo + heart motion | 40 d (6.0 weeks) |\n\n# FOLLICLE-STIMULATING HORMONE (FSH) \n\nAction: influence on (1) number of follicles, (2) development of ovarian cysts, (3) size of ovaries\nPhysiology: rises abruptly at birth $\\leftarrow$ decrease in estrogen + progesterone after loss of placenta; falls to low levels after 3 months of age; remains low until puberty\n\n## ANATOMY OF GESTATION\n\n## Choriodecidua\n\n## Chorion\n\n[chorion, Greek = skin, leather]\n$=$ trophoblast + fetal mesenchyme with villous stems protruding into decidua; provides nutrition for developing embryo\n(a) chorion frondosum = part adjacent to decidua basalis, forms primordial placenta [frondosus, Latin = foliage]\n(b) chorion laeve $=$ smooth portion of chorion with atrophied villi\n(c) \"chorionic plate\" = amnionic membrane covering the chorionic plate of the placenta\n\n## Decidua\n\n(a) decidua basalis = between chorion frondosum + myometrium\n(b) decidua capsularis = portion protruding into uterine cavity\n(c) decidua parietalis = decidua vera = portion lining the uterine cavity elsewhere\n![img-19.jpeg](img-19.jpeg)",
            "images": [
                {
                    "id": "img-19.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1392,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1944,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 375,
            "markdown": "# Gestational Sac (GS) \n\nOrigin: arises from blastocyst, which implants into secretory endometrium 6-9 days after ovulation ( $=20-23$ days of MA), surrounded by echogenic trophoblast\n$\\diamond$ GS measures 0.1 mm at time of implantation\n$\\sqrt{ }$ \"intradecidual\" sign (earliest sign: $48 \\%$ sensitive, $66 \\%$ specific, $45 \\%$ accurate at $<5$ weeks GA) = eccentrically located fluid collection corresponding to gestational sac completely embedded within an echogenic decidua adjacent to a thin echogenic line (= collapsed uterine cavity) = highly suggestive for IUP\nA nonspecific fluid collection with a smooth spherical / oval contour represents an IUP until proven otherwise!\n$\\sqrt{ }$ \"double (decidual) sac\" sign (DDS) [most useful $>5$ weeks GA with a mean sac diameter of $10 \\mathrm{~mm} / 40$ days GA] $=2$ concentric hyperechoic rings surrounding a portion of the gestational sac + bulging into uterine cavity (delineated by a thin crescent of endometrial fluid) $=$ definitive IUP\n(a) outer echogenic ring (= decidua parietalis)\n(b) inner echogenic ring (= decidua capsularis)\n$\\sqrt{ }$ GS surrounded by endometrial thickening $>12 \\mathrm{~mm}$\n$\\sqrt{ }$ continuous hyperechoic inner rim $>2 \\mathrm{~mm}$ thick\n$\\sqrt{ }$ GS of spherical / ovoid shape without angulations\n$\\sqrt{ }$ interposed hypoechoic line (apposed endometrial walls)\n$\\sqrt{ }$ DDS present with a mean sac diameter of $10 \\mathrm{~mm}(=40$ days GA)\n$\\diamond$ A \"double decidual sac\" sign correlates with the presence of a pregnancy in $98 \\%$ !\n$\\diamond$ Absence of these 2 signs (in 35\\%) does not exclude an IUP\n\n## Gestational Sac Size\n\n$=$ average of $2-3$ diameters (craniocaudad, AP, TRV) of rounded intrauterine anechoic (fluid) space within sac walls\n$\\diamond$ Used for dating between 6 and 12 weeks MA (identified as early as 4.5-5.0 weeks MA on transabdominal scan)\nEGA $[$ in wk $]=$ (GS $[$ in mm $]+25.43) \\div 7.02$\nAccuracy: $\\pm 7$ days\nGrowth rate of mean sac diameter (MSD):\n1.13 (range $0.71-1.75$ ) mm per day (often variable)\n\nLinear growth: 10 mm by $5^{\\text {th }}$ week MA\n60 mm by $12^{\\text {th }}$ week MA\nfills chorionic cavity by $11^{\\text {th }}-12^{\\text {th }}$ week MA\nAn MSD cutoff of 25 mm without an embryo is a criterion for definitive pregnancy failure; An MSD range of $16-24 \\mathrm{~mm}$ without an embryo is an indicator of suspicion of pregnancy failure.\n\n## Visualization of Gestational Sac\n\nEarliest visualization: mean sac diameter of $2-3 \\mathrm{~mm}$\nA. GS VISUALIZATION VERSUS $\\beta$-hCG LEVEL (2nd International Standard):\n(a) on transabdominal scan:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 376,
            "markdown": "in $100 \\%$ with $\\beta$-hCG levels of $>1,800 \\mathrm{IU} / \\mathrm{L}$\n(b) on transvaginal scan:\nin $20 \\%$ with $\\beta$-hCG levels of $<500 \\mathrm{IU} / \\mathrm{L}$\nin $80 \\%$ with $\\beta$-hCG levels of $500-1,000 \\mathrm{IU} / \\mathrm{L}$\nin $100 \\%$ with $\\beta$-hCG levels of $>1,000 \\mathrm{IU} / \\mathrm{L}$\nB. GS VISUALIZATION VERSUS MENSTRUAL AGE\n$5.0 \\pm 1$ weeks $=10 \\mathrm{~mm}$\n$5.5 \\pm 1$ weeks $=13 \\mathrm{~mm}$\n$6.0 \\pm 1$ weeks $=17 \\mathrm{~mm}$\n$6.5 \\pm 1$ weeks $=20 \\mathrm{~mm}$\nC. GS VISUALIZATION VERSUS EMBRYO\n\n# Secondary Yolk Sac \n\n$=$ rounded sonolucent structure (outside amniotic cavity) within chorionic sac (= extracoelomic cavity) connected to umbilicus via a narrow stalk; formed by proliferation of endodermal cells; part of yolk sac is incorporated into fetal gut; the rest persists as sac connected to fetus by vitelline duct\nFunction:\n(a) transfer of nutrients from trophoblast to embryo prior to functioning placental circulation\n(b) early formation of blood vessels + blood precursors on sac wall\n(c) formation of primitive gut\n(d) source of primordial germ cells\n\nTime of formation: at around 28 days MA\nMean size: 1.0 mm by 4.7 weeks MA; 2.0 mm by 5.6 weeks MA; 3.0 mm by 7.1 weeks MA; $4.0(2.2-5.3) \\mathrm{mm}$ by 10 weeks MA; disappears around 12 weeks MA\n![img-20.jpeg](img-20.jpeg)\n$\\diamond$ First visible structure within gestational sac $=$ confirms IUP\n$\\sqrt{ }$ eccentrically located within gestational sac (inside chorionic cavity)\nDefinite visualization on transvaginal scan:\n$\\sqrt{ }$ at 5.5 weeks MA",
            "images": [
                {
                    "id": "img-20.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 1302,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1792,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 377,
            "markdown": "$\\sqrt{ }$ inside GS with a mean sac diameter of $\\geq 8 \\mathrm{~mm}$\nDefinite visualization on transabdominal scan:\n$\\sqrt{ }$ at 7 weeks MA\n$\\sqrt{ }$ inside GS with a mean diameter of $\\geq 20 \\mathrm{~mm}$\n\n# Embryo \n\nDevelopmental stages:\nPreembryonic period: $2^{\\text {nd }}-4^{\\text {th }}$ week MA\nTrilaminar embryonic disk: during $5^{\\text {th }}$ week MA\nEmbryonic period: $6^{\\text {th }}-10^{\\text {th }}$ week MA\nPhysiologic umbilical herniation: $8^{\\text {th }}-12^{\\text {th }}$ week MA\nFetal period: early $11^{\\text {th }}$ week MA\nAverage growth rate:\n0.7 mm per day / 1.5 mm every 2 days\n$\\sqrt{ }$ curvilinear growth from 7 mm at 6.3 weeks $\\mathrm{MA} \\rightarrow$ to 50 mm at 12.0 weeks MA\nEarliest visualization (on endovaginal scan):\nat 5.4 weeks MA at CRL of 1.2 mm\n$\\sqrt{ }$ eccentrically located at periphery of yolk sac (inside amniotic cavity)\n$\\diamond$ Most accurate measurement of GA in $1^{\\text {st }}$ trimester!\nVISUALIZATION OF EMBRYO VERSUS GS\n(a) on transabdominal scan\n$100 \\%$ visualization if gestational sac $\\geq 27 \\mathrm{~mm}$\n(b) on transvaginal scan\n$100 \\%$ visualization if gestational sac $\\geq 12 \\mathrm{~mm}$\n$\\diamond$ Transvaginal scan not necessary if on transabdominal scan gestational sac $>27 \\mathrm{~mm}$ without evidence of embryo!\nFailed pregnancy: nonvisualization of embryo with mean gestational sac size of $\\geq 18 \\mathrm{~mm}$\n\n## Cardiac Activity of Embryo\n\n$\\diamond$ Heart begins to contract at a CRL of $1.5-3.0 \\mathrm{~mm}=22$ days GA $=36$ days MA\n$\\sqrt{ }$ absence of cardiac activity in embryos $<4 \\mathrm{~mm}$ may be normal\nDefinite visualization on endovaginal scan:\n(a) at 46 days GA\n(b) at mean sac diameter of 16 mm\n(c) with CRL $\\geq 5 \\mathrm{~mm}=6.2$ weeks\n\nA 7-mm CRL is necessary to yield a specificity and positive predictive value of $\\mathbf{1 0 0 \\%} \\boldsymbol{\\rightarrow}$ decreasing false-positive diagnosis associated with a $5-\\mathrm{mm}$ CRL cutoff.\nDefinite visualization on transabdominal scan:\n(a) at 55 days GA\n(b) mean sac diameter of 25 mm\n\nHeart rate:\nat 5-6 weeks GA 101 bpm\nat 8-9 weeks GA 143 bpm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 378,
            "markdown": "# Gastrulation ( $2^{\\text {nd }}-4^{\\text {th }}$ week GA) \n\n[gaster, Latin = stomach; -ula, Latin = diminutive suffix]\n$=$ transformation of bilaminar disk into trilaminar embryo\nStages:\n> bilaminar embryo develops an epiblast (= layer facing amniotic cavity) + hypoblast (= layer facing yolk sac)\n> disk forms a mesoderm \"sandwich\" bordered above by ectoderm + below by endoderm\n> at both ends where embryonic ectoderm and endoderm meet are cranially the oropharyngeal membrane ( $=$ future mouth) + caudally the cloacal membrane ( $=$ future urogenital and anal orifices)\n> craniocaudal + lateral folding converts the flat trilaminar embryonic disk into a gut tube within a body tube\n> lateral edges of somatic mesoderm move ventrally toward each other creating a coelomic space ( $=$ future peritoneal cavity) that separates gut from body tube (GI tract from primary abdominal wall)\n> myoblasts migrate into primary abdominal wall forming muscles and connective tissue\n> the cloaca (= common chamber at caudal end) forms as precursor to the intestinal + urinary + genital tracts\n> a ventral diverticulum (= allantois) projects from the cloaca into the connecting stalk (= body stalk) attaching the embryo to the chorionic mesoderm\n\n## Amnionic Membrane\n\n$=$ curvilinear echogenic line within chorionic sac; fills chorionic cavity by 11-12 weeks MA\n$\\leftarrow$ onset of fetal urine production at about 10 weeks\nFusion:\n> fuses with chorionic membrane at 14-16 weeks MA to form the chorionic plate\n> incomplete fusion with chorion frequent\n(DDx: subchorionic hemorrhage, twin abortion, coexistent with limb-body wall complex)\n\n## Umbilical Cord\n\nFunction: communication between placenta and fetus allowing exchange of gas and nutrients Embryology:\n> cord forms between $7^{\\text {th }}-8^{\\text {th }}$ week post conception with contributions from body stalk, omphalomesenteric or vitelline duct, yolk sac, allantois\n> junction of the amnion with ventral surface of embryo forms umbilicus\n> allantoic vessels establish continuity with placental villi and form the vessels of the umbilical cord\n> allantois / urachus develops as $2^{\\text {nd }}$ outpouching from primitive gut $12-16$ weeks GA and projects into connecting stalk\n> physiologic midgut herniation into base of umbilical cord at $\\sim 7-12$ weeks (returns by end of $11^{\\text {th }}$ week GA)\n> cord grows until end of $2^{\\text {nd }}$ trimester: average diameter of 17 mm , length of $50-60 \\mathrm{~cm}$ Anatomy:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 379,
            "markdown": "> 2 umbilical arteries (= branches of the 2 internal iliac arteries) + 2 umbilical veins by 6 weeks GA\nFunction: deoxygenated blood from fetus to placenta\n> one umbilical vein (remains after regression of right umbilical vein by 8 weeks GA ) $\\rightarrow$ connects to left portal vein $\\rightarrow$ fissure for ligamentum venosum after birth\nFunction: oxygenated blood from placenta to fetus\n> covered with unique compressible matrix of mucopolysaccharide-rich substance $=$ Wharton jelly\n> covered by amnion\n> spiraling of cord with $0-40$ helical turns ( $\\mathrm{L}>\\mathrm{R}$ ) by 9 weeks\n$\\diamond$ coiling adds strength + resists compression of vessels\n$\\diamond$ normal cord length + coiling requires adequate fluid space and fetal activity\nCord thickness: $1-2 \\mathrm{~cm}$ in diameter\n(a) \"lean\" umbilical cord = cross-sectional area of cord measuring below $10^{\\text {th }}$ percentile for GA\nAssociated with: increased prevalence of fetal IUGR, oligohydramnios, fetal distress during delivery\n(b) \"fat\" umbilical cord\n\nAssociated with: mothers with diabetes, fetus with aneuploidy\nUmbilical coiling index (UCI):\n$=$ number of cord spirals completed per cm of cord length\n(a) hypocoiled cord ( $\\mathrm{UCI} \\leq 0.29 /<10^{\\text {th }}$ percentile)\n\nAssociated with:\nincreased rate of IUGR, fetal demise, intrapartum fetal heart rate decelerations, fetal distress at delivery, karyotype abnormalities, higher rate of abnormal cord insertion\n(b) hypercoiled cord ( $\\mathrm{UCI} \\geq 0.6 />90^{\\text {th }}$ percentile)\n\nAssociated with:\nincreased rate of fetal IUGR, intrapartum fetal cardiac decelerations, vascular thrombosis, cord stenosis\n\n# PLACENTA \n\n[plakuos, Greek = flat cake]\n(a) fetal portion\n\n1. Villi of chorion frondosum\ncontain arterial plexuses supplied by umbilical artery and protrude into intervillous space bathing in maternal blood\n(b) maternal portion\n2. Decidua placentalis: lines intervillous space\n\n## Imaging of Normal Placenta\n\nCT:\n@ $1^{\\text {st }}$ trimester\n$\\sqrt{ }$ placenta indistinguishable from myometrium\n@ $2^{\\text {nd }}$ trimester",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 380,
            "markdown": "$\\checkmark$ hyperattenuating relative to subjacent myometrium following enhancement\n$\\checkmark$ rounded hypoattenuating foci surrounded by enhancing placenta $=$ placental cotyledons\n@ $3^{\\text {rd }}$ trimester\n$\\checkmark$ increased heterogeneity of normal placenta and visualization of venous lakes\n\n# Variant Morphology of Placenta \n\nA. Additional lobes\n\n1. Succenturiate lobe of placenta\n$=$ ACCESSORY LOBE\n$=$ single / multiple separate additional lobe(s) separate from but connected to main placenta by fetal blood vessels within membrane\nPrevalence: $0.14-3.00 \\%$\nCause: placental villi atrophy in area of inadequate blood supply $\\rightarrow$ proliferate in two opposite directions (trophotropism) with fetal vessels remaining at the site of villous atrophy\nCx: (1) Retention of accessory lobe in utero $\\rightarrow$ postpartum hemorrhage\n(2) Placenta previa (= implantation over cervical os) $\\rightarrow$ intrapartum hemorrhage\n(3) Vasa previa (= connecting succenturiate vessels traversing internal os) may rupture $\\rightarrow$ fetal blood loss\n2. Bilobed placenta\n$=2$ placentas of relative same size connected by a thin bridge of placental tissue Risk: none\n\n## B. Placenta extrachorialis\n\n$=$ chorionic plate smaller than basal plate; ie, the transition of membranous to villous chorion occurs at a distance from the placental edge that is smaller than the basal plate radius\n\n1. Circummarginate placenta\n\nFrequency: up to $20 \\%$ of placentas\nRisk: no clinical significance\n$\\checkmark$ fetal membranes form a flat ring at site of attachment to chorionic plate\n$\\checkmark$ placental margin not deformed\n2. Circumvallate placenta\n$=$ attachment of fetal membranes form a folded thickened ring with underlying fibrin + often hemorrhage\nPrevalence: $1-2 \\%$ of pregnancies\nRisk: premature labor, threatened abortion, increased perinatal mortality, abruption, marginal hemorrhage\n\n## C. Placenta membranacea\n\n$=$ thin membranous placenta circumferentially occupying the entire periphery of chorion + presence of well-vascularized placental villi in the peripheral membranes $\\leftarrow$ failure of regression\nCause: ? endometritis, endometrial hyperplasia, extensive vascularization of decidua",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 381,
            "markdown": "capsularis, previous endometrial damage by curettage\nRisk: repeated vaginal bleeding extending into $2^{\\text {nd }}$ trimester; abortion at $20-30$ weeks; postpartum hemorrhage\n$\\sqrt{ }$ thickened outline over whole gestational sac $(0.2-3.0 \\mathrm{~cm})$\n$\\sqrt{ }$ may show additional distinct disk of placenta\n\n# Placental Grading \n\n$=$ grading according to echo appearance of basal zone, chorionic plate, placental substance\n![img-21.jpeg](img-21.jpeg)",
            "images": [
                {
                    "id": "img-21.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 534,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1097,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 382,
            "markdown": "![img-22.jpeg](img-22.jpeg)\n$\\diamond$ Premature placental calcifications are associated with cigarette smoking, hypertension, IUGR!\n$\\diamond$ Not considered useful because placental grading is imprecise for fetal dating or for fetal lung maturity!\nGRADE 0\n$\\checkmark$ homogeneous placenta + straight line of chorionic plate\nTime: $<30$ weeks MA\nGRADE 1\n$\\checkmark$ undulated chorionic plate + scattered bright placental echoes\nTime: seen at any time during pregnancy; in $40 \\%$ at term\n$\\diamond$ in $68 \\% \\mathrm{~L} / \\mathrm{S}$ (lecithin-sphingomyelin) ratio $>2.0$\nGRADE 2\n$\\checkmark$ linear bright echoes parallel to basal plate\n$\\checkmark$ confluent stippled echoes within placenta $\\pm$ indentations of chorionic plate\nTime: rarely seen in gestations $<32$ weeks MA and in $40 \\%$ at term\n$\\diamond$ in $87 \\% \\mathrm{~L} / \\mathrm{S}$ ratio $>2.0$\nGRADE 3\n$\\checkmark$ calcified intercotyledonary septa, often surrounding sonolucent center",
            "images": [
                {
                    "id": "img-22.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1223,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 383,
            "markdown": "Time: rarely seen in gestations $<34$ weeks MA;\nin $15-20 \\%$ at term\n$\\diamond$ in $100 \\% \\mathrm{~L} / \\mathrm{S}$ ratio $>2.0$ (= strongly correlated with lung maturity)\n\n# Premature Placental Senescence \n\n$=$ grade 3 placenta seen in gestation $<34$ weeks MA\n$\\diamond$ In $50 \\%$ suggestive of maternal hypertension / IUGR\n\n## Uteroplacental Circulation\n\nBy 20 weeks MA trophoblast invades maternal vessels and transforms spiral arteries into distended tortuous vessels $=$ uteroplacental arteries\nPhysiology: maintains fetal pulmonary, hepatic, renal function by exchange of gas, metabolites, nutrients and indirect vascular interaction of fetal with maternal blood\nHisto:\n(a) in decidual segments of spiral arteries: proliferating trophoblast from anchoring villi invades lumen of spiral arteries + partially replaces endothelium\n(b) in myometrial segments of spiral arteries: disintegration of smooth muscle elements $\\rightarrow$ loss of elastic lamina $\\rightarrow$ easily distensible vascular system of low resistance\n\n## Uterine Blood Volume Flow\n\n$>50 \\mathrm{~mL} / \\mathrm{min}$ shortly after conception\n$>500-900 \\mathrm{~mL} / \\mathrm{min}$ by term\nIntervillous blood flow: $140 \\pm 53 \\mathrm{~mL} / \\mathrm{min}$ (by 133Xe washout)\n\n## Umbilical Artery Doppler\n\nVariables affecting Doppler measurements:\nsite of Doppler (close to placenta preferred), fetal heart rate, fetal breathing, drugs (eg, ritodrine hydrochloride decreases S/D ratio)\n$\\sqrt{ }$ degree of diastolic flow increases as gestation progresses\n$>$ high-resistance flow $\\quad @<20$ weeks\n$>\\mathrm{S} / \\mathrm{D}$ ratio between 3.3 and $4.3 \\quad @ \\geq 20$ weeks\n$>\\mathrm{S} / \\mathrm{D}$ ratio between 1.7 and $2.4 \\quad @$ term\n$\\sqrt{ }$ highly turbulent flow\n\n## IUGR Lesions\n\n$=$ narrowing of vascular lumen through\n(a) thrombosis of decidual segments of uteroplacental aa.\n(b) failure of development of myometrial segments of uteroplacental arteries\n\n## FETAL MENSURATION\n\n$\\diamond$ US is more reliable than LMP / physical examination!\n\n## Ultrasound Milestones\n\n$\\sqrt{ }$ gestational sac w/o embryo or yolk sac $=5.0$ weeks\n$\\sqrt{ }$ gestational sac + yolk sac w/o embryo $=5.5$ weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 384,
            "markdown": "$\\sqrt{ }$ heartbeat $\\pm$ embryo $<5 \\mathrm{~mm}=6.0$ weeks\nAccuracy: $\\pm 0.5$ week\n\n# Fetal Age \n\n$=$ GESTATIONAL AGE (GA) = \"MENSTRUAL AGE\"(MA)\n$=$ age of pregnancy based on woman's regular last menstrual period (LMP) projecting the estimated date of confinement (EDC) at 40 weeks\n$\\diamond$ Note the inaccurate clinical usage of \"gestational age,\" which strictly speaking refers to the true (histologic) age of the pregnancy counting from the day of conception, whereas \"menstrual age\" refers to the (clinical) age of the pregnancy accounting for the $\\sim+2$ weeks discrepancy!\n$\\diamond$ On subsequent US scans GA = GA assigned at $1^{\\text {st }}$ ultrasound + number of intervening weeks!\n\n| Timeline of Normal Early Pregnancy |  |\n| :--: | :--: |\n| Time Period [weeks] | Developmental Milestone |\n| 0 | last menstrual period |\n| 2 | conception |\n| $4.5-5.0$ | gestational sac appears |\n| $5.0-5.5$ | yolk sac appears |\n| 6.0 | embryo appears, cardiac pulsation $>100 \\mathrm{bpm}$ |\n| $6.5-7.0$ | amniotic membrane appears, cardiac <br> pulsation $>120 \\mathrm{bpm}$ |\n| $7-8$ | spine develops |\n| 8 | head curvature separated from body, 4 limb <br> buds appear |\n| $8.0-8.5$ | intrinsic motion of embryo occurs |\n| $8-10$ | rhombencephalon develops |\n\n\n| Accuracy of Biometry ( $95 \\%$ confidence range) |  |  |\n| :--: | :--: | :--: |\n| Stage | Based on | Accuracy [weeks] |\n| 1st trimester |  |  |\n| $5-6$ weeks | US milestones | $\\pm 0.5$ |\n| $6-13$ weeks | CRL | $\\pm 0.7$ |\n| 2nd trimester |  |  |\n| $14-20$ weeks | cBPD / HC | $\\pm 1.2$ |\n|  | BPD / FL | $\\pm 1.4$ |\n| $20-26$ weeks | cBPD / HC | $\\pm 1.9$ |\n|  | BPD / FL | $\\pm 2.1-2.5$ |\n| 3rd trimester |  |  |\n| $26-32$ weeks | cBPD / HC / FL | $\\pm 3.1-3.4$ |\n|  | FL | $\\pm 3.1$ |\n| $32-42$ weeks | cBPD / HC / FL | $\\pm 3.5-3.8$ |\n|  | FL | $\\pm 3.5$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 385,
            "markdown": "ACCURACY OF CLINICAL ASSESSMENT:\nmenstrual history $\\pm 2-3$ weeks\n$1^{\\text {st }}$-trimester exam $\\pm 2$ weeks\nfandal height $\\pm 4$ weeks\n\n# Early Embryonic Size \n\n$=$ length of embryo $<25 \\mathrm{~mm}$ on transvaginal scan performed at $<11$ weeks MA\nGestational age (days) $=$ embryonic size $(\\mathrm{mm})+42$\nAccuracy: $\\pm 3$ days\n\n## Crown-Rump Length (CRL)\n\n$=$ length of fetus; useful up to 12 weeks MA (usually identified by 7 weeks MA on transabdominal scan)\nRule of thumb: MA (in weeks) $=$ CRL (in cm$)+6$\nAccuracy: $\\pm 5-7$ days\n\n## Biparietal Diameter (BPD)\n\n$=$ measured from leading edge to leading edge of calvarial table at widest transaxial plane of skull = level of thalami + cavum septi pellucidi + sylvian fissures with middle cerebral arteries\n$\\diamond$ Excellent means of estimating GA in $2^{\\text {nd }}$ trimester $>12$ weeks MA\nAccuracy: 2 mm for \"between occasion error\"\n$\\diamond$ Most accurate for dating if combined with HC, AC, FL provided body ratios are normal!\n$\\diamond$ Less reliable for dating in $3^{\\text {rd }}$ trimester because of increasing biologic variability!\n\n## Discordant Estimated Date of Confinement (EDC) by LMP and BPD\n\n1. Methodological error in measurement\n(a) wrong axial section\n(b) cranial compression (multiple gestation, breech presentation, oligohydramnios, dolichocephaly)\n2. Erroneous LMP\nother measurements (AC, FL) correlate with BPD\n3. Abnormal head growth\n(a) BPD $<$ AC: microcephaly, fetal macrosomia\n(b) BPD $>$ AC: intracranial abnormality, asymmetric IUGR\n\n## Cephalic Index (CI)\n\n$=\\mathrm{BPD} / \\mathrm{OFD}$; measurements of BPD and occipitofrontal diameter (OFD) both from outer to outer edge of calvarium\n$\\diamond$ Confirms appropriate use of BPD if ratio is between 0.70 and $0.86(2 \\mathrm{SD})$\n\n## Corrected BPD (cBPD)\n\n$=\\mathrm{BPD}$ and OFD are used to adjust for variations in head shape\n\n$$\n\\mathrm{cBPD}=\\sqrt{\\mathrm{BPD} \\times \\mathrm{OFD}} \\div 1.26\n$$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 386,
            "markdown": "# Head Circumference (HC) \n\nUsed if ratio of BPD/OFD outside $0.70-0.86$\n\n$$\n\\begin{aligned}\n\\mathrm{HC} & =([\\mathrm{BPD}+\\mathrm{OFD}] / 2) \\times \\pi \\\\\n& =([\\mathrm{BPD}+\\mathrm{OFD}] \\times 1.62) \\times 3.1417\n\\end{aligned}\n$$\n\nAccuracy: slightly less than for BPD\nHC too large: hydrocephalus, hydranencephalus, intracranial hemorrhage, short limb dystrophies, tumor\nHC too small: anencephaly, cerebral infarction, synostosis, microcephaly vera\n\n## Abdominal Circumference (AC)\n\n$=$ measured at level of vascular junction of umbilical vein with left portal vein (\"hockeystick\" appearance) where it is equidistant from the lateral walls in a plane perpendicular to long axis of fetus; measured from outer edge to outer edge of soft tissues\n$\\diamond$ Allows evaluation of head-to-body disproportion\n$\\diamond$ Better predictor of fetal weight than BPD\nAC too large: GI tract obstructions, obstructive uropathy, ascites, hepatosplenomegaly, congenital nephrosis, abdominal tumor\nAC too small: diaphragmatic hernia, omphalocele, gastroschisis, renal agenesis\n\n## Femur Length (FL)\n\n$=$ measurement of ossified femoral diaphysis\nError: \"flare\" at distal end included in measurement (= reflection from cartilaginous condyle)\n\n## Thoracic Circumference (TC)\n\n$=$ measured in axial plane of chest, which includes four-chamber view of heart without inclusion of SQ tissue\n$\\diamond$ Linear growth between 16 and 40 weeks similar to AC\nUseful age-independent parameter: $\\mathrm{TC} \\div \\mathrm{AC}>0.80$\n\n## Estimated Fetal Weight (EFW)\n\nbased on measurements of head size (BPD / HC), abdominal size (AD / AC), and femur length (FL)\nAccuracy:\n\n| body part used | $95 \\%$ confidence range |\n| :--: | :--: |\n| abdomen | $\\pm 22 \\%$ |\n| head + abdomen | $\\pm 17-20 \\%$ |\n| head + abdomen + femur | $\\pm 15 \\%$ |\n\n## Appearance of Epiphyseal Bone Centers\n\nin $95 \\%$ of all cases\n> distal femoral epiphysis (DFE): $>33$ weeks GA\n> distal femoral epiphysis (DFE) $>5 \\mathrm{~mm}:>35$ weeks\n> proximal tibial epiphysis (PTE): $>35$ weeks GA\n> proximal humeral epiphysis (PHE): $>38$ weeks GA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 387,
            "markdown": "# CNS Ventricles \n\nwidth of $3^{\\text {rd }}$ ventricle: $<3.5 \\mathrm{~mm}$ (any gestational age)\n\n## Diameter of Cisterna Magna\n\nmeasured from inner margin of occiput to vermis cerebelli: $2-10 \\mathrm{~mm}$\n\n## ASSESSMENT OF FETAL WELL-BEING\n\n## Amniotic Fluid Index\n\n$=$ sum of vertical depths of largest clear amniotic fluid pockets in the 4 uterine quadrants measured in mm\nMethod: patient supine, uterus viewed as 4 equal quadrants, transducer perpendicular to plane of floor + aligned longitudinally with patient's spine\nVariation: $3.1 \\%$ intraobserver, $6.7 \\%$ interobserver\nResult:\n> 95th percentile: 185 mm at 16 weeks GA, rising to 280 mm at 35 weeks, declining to 190 mm at 42 weeks\n> 5th percentile: 80 mm at 16 weeks GA, rising to 100 mm at 23 weeks, declining to 70 mm at 42 weeks\n\n## Biophysical Profile (Platt and Manning) = BPP\n\n$=$ in utero Apgar score $=$ assessment of fetal well-being\nGestational age at entry: 25 weeks MA\nObservation period: 30 (occasionally 60) min; ordinarily $<8 \\mathrm{~min}$ needed; in $2 \\%$ full 30 min required\nA. ACUTE BIOPHYSICAL VARIABLES\n$\\diamond$ Subject to rhythmic variation coincident with sleep-wake cycle!\n\n1. Fetal breathing movement (FBM):\n$\\sqrt{ } \\geq 1$ episode of chest + abdominal wall movement for at least 30 seconds (time is arbitrary to avoid confusion with general body movements / maternal respiration) stimulated by: glucose, catecholamine, caffeine, prostaglandin synthetase inhibitor suppressed by: barbiturates, benzodiazepine, labor, hypoxia, asphyxia, prostaglandin E2\n2. Fetal body movement:\n$\\sqrt{ } \\geq 3$ discrete movements of limbs / trunk\nInfluenced by: glucose, gestational age, time of day, maternal drugs, intrinsic rhythm, labor\n3. Fetal tone\nupper + lower limbs usually fully flexed with head on chest; least sensitive test parameter\n$\\sqrt{ } \\geq 1$ episode of opening + closing of hand / extension + flexion of limb\nB. CHRONIC FETAL CONDITION\n4. Amniotic fluid volume\n$\\sqrt{ }$ at least one pocket $\\geq 2 \\mathrm{~cm}$ in vertical diameter in two perpendicular planes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 388,
            "markdown": "$\\diamond$ Avoid inclusion of loops of cord!\n\n# BPP Score \n\nfor each test: 2 points if normal; 0 points if abnormal\nFalse-negative rate: $0.7 \\div 1,000$\n$\\diamond$ The probability of fetal death within a week of a BPP score of $8 / 8$ is $1 \\div 1,000$ !\n\n## Stress Tests\n\n## Nonstress Test (NST)\n\n$\\diamond$ Test needed in less than $5 \\%$ of cases!\n$\\sqrt{ }$ reactive fetal heart rate tracing (normal) = at least 4 fetal heart accelerations ( $>15 \\mathrm{bpm}$ over baseline lasting $>15$ seconds) in a 20 -minute period subsequent to fetal movement $>34$ weeks GA\n$\\sqrt{ }$ nonreactive (abnormal) fetal heart rate tracing = absence of acceleration in a continuous 40 -min observation period\nN.B.: no heart accelerations in immaturity, during sleep cycle, with maternal sedative use\n\nAccuracy: false-negative rate of $3.2 \\div 1,000$ (if done weekly) or $1.6 \\div 1,000$ (if done biweekly); $50 \\%$ false-positive rate for neonatal morbidity $+80 \\%$ for neonatal mortality\n\n|  | Results of Biophysical Profile Score <br> (including NST for a maximum of 10 points) |  |  |\n| :--: | :--: | :--: | :--: |\n| Score | Fluid | Interpretation | Perinatal <br> Mortality |\n| 10 |  | asphyxia rare | $0.0 \\%$ |\n| 8 | normal | asphyxia rare | $<0.1 \\%$ |\n| 8 | abnormal | chronic compromise | $8.9 \\%$ |\n| 6 | normal | equivocal | variable |\n| 6 | abnormal | asphyxia probable | $8.9 \\%$ |\n| 4 |  | asphyxia highly probable | $9.1 \\%$ |\n| 2 |  | asphyxia almost certain | $12.5 \\%$ |\n| 0 |  | asphyxia certain | $60.0 \\%$ |\n\n## Contraction Stress Test (CST)\n\n$=$ external monitoring after injection of oxytocin / maternal breast stimulation\n$\\sqrt{ }>3$ uterine contractions in 10 -minute period\nAccuracy: false-negative rate of $0.4 \\div 1000 ; 50 \\%$ false-positive rate\n\n## INVASIVE FETAL ASSESSMENT\n\n## Amniocentesis\n\nIndications:\n(1) Inadequate sonographic fetal anatomic survey $\\leftarrow$ fetal position / maternal body habitus\n(2) Equivocal sonographic findings: eg, abnormal posterior fossa but spinal defect not seen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 389,
            "markdown": "(3) Experienced sonographer not available\n(4) Nonlethal anomaly detected on level I sonogram for which karyotype testing is appropriate\nRisk: fetal loss rate generally quoted as $1 \\div 200(0.5 \\%)$\nA. FETAL RISK\n\n1. Spontaneous abortion ( $0.3-1.5 \\%)$\n2. Amniotic fluid leak\n3. Chorioamnionitis\n4. Fetal injury: skin dimple, limb gangrene, porencephalic cyst, hemothorax, spleen laceration, orthopedic abnormality, amniotic band syndrome\nB. MATERNAL RISK (rare)\n5. Bowel perforation\n6. Hemorrhage\n7. Isoimmunization\n\n# Diagnostic Amniocentesis \n\n1. Genetic studies: karyotype, DNA analysis, biochemical assay\n\nTiming: early (11-15 weeks), late (15-18 weeks)\n2. Neural tube defect: $\\alpha$-fetoprotein, acetylcholinesterase\n3. Isoimmunization: $\\Delta$-OD 450\n4. Fetal lung maturity\n5. Intraamniotic infection\n6. Confirmation of ruptured membranes\n\nAdvantage over CVS:\n\n1. Error rate $(<1 \\%$ versus $2 \\%)$\n2. Culture failure rate $(0.6 \\%$ versus $2.2 \\%)$\n3. Fetal loss rate $(0.6-0.8 \\%$ less $)$\n\n## Therapeutic Amniocentesis\n\n1. Polyhydramnios\n2. Twin-twin transfusion syndrome\n\nTechnique:\n$\\checkmark$ avoid fetus, placenta, umbilical cord, uterine contraction, fibroid, large uterine vessel\n$\\checkmark$ use continuous ultrasound guidance\n$\\checkmark$ inject $2-5 \\mathrm{~mL}$ of indigo carmine dye in first sac of twin (colorless fluid assures that second sac has been entered)\n\n## Chorionic Villus Sampling (CVS)\n\n= aspiration of cells from chorion frondosum for genetic studies (karyotype, DNA analysis, biochemical assay)\n$\\diamond$ Transabdominal CVS for rapid karyotyping in $2^{\\text {nd }}+3^{\\text {rd }}$ trimester = placental biopsy\nAdvantage: $>2$ weeks earlier results compared with amniocentesis\nTiming: $9-11$ weeks\nApproach:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 390,
            "markdown": "(a) transcervical route $=$ catheter introduced through cervix into chorion frondosum, easier for posterior placenta; contamination by cervical flora possible\n$\\diamond$ CONTRAINDICATED in cervical infections!\n(b) transabdominal route $=20-22$-gauge needle inserted through anterior abdominal wall; easier for anterior / fundal placenta; sterile technique\nChromosome analysis:\n(a) direct preparation $=$ analysis of cytotrophoblasts (may have different karyotype than fetus) $\\rightarrow$ analysis can be performed immediately\n(b) villus culture $=$ cells from central mesenchymal core (same karyotype as fetus) $\\rightarrow$ cultured for several days before analysis\nErrors $(2 \\%)$ :\n\n1. Mosaicism $=$ cell line forming cytotrophoblast may develop abnormal karyotype while fetal cell line is normal\n2. Maternal contamination $=$ cells from maternal decidua may overgrow mesenchymal core cells\nRisks:\n3. Spontaneous abortion $(1 \\%)$\n4. Perforation of amniotic sac\n5. Infection\n6. Teratogenesis: limb reduction defect\n\n# Cordocentesis \n\n$=$ PERCUTANEOUS UMBILICAL BLOOD SAMPLING (PUBS)\nA. DIAGNOSTIC CORDOCENTESIS\n\n1. Hematocrit\n2. Karyotype\n3. Immunodeficiency: chronic granulomatous disease, severe combined immunodeficiency\n4. Coagulopathy: von Willebrand syndrome, factor deficiency\n5. Platelet disorder: alloimmune / idiopathic thrombocytopenic purpura\n6. Hemoglobinopathy: sickle cell anemia, thalassemia\n7. Infection: toxoplasmosis, rubella, parvovirus, varicella, cytomegalovirus\n8. Hypoxia / acidosis\nB. THERAPEUTIC CORDOCENTESIS\n9. Intravascular fetal transfusion (fresh rh-negative CMV-negative leukodepleted irradiated packed cells compatible with mother infused at $10-15 \\mathrm{~mL} / \\mathrm{min}$ )\n10. Direct delivery of medication to fetus\n\nCx: 1. Chorioamnionitis\n2. Rupture of membranes\n3. Umbilical cord hematoma\n4. Umbilical cord thrombosis\n5. Bleeding from insertion site\n6. Fetal bradycardia\n\n## MULTIPLE GESTATIONS",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 391,
            "markdown": "Prevalence: $1.2 \\%$ of all births; in 5-50\\% clinically undiagnosed at term\nOccurrence (Hellin rule):\ntwins in $1 \\div 85$ pregnancies $\\left(=85^{1}\\right)$\ntriplets in $1 \\div 7,225$ pregnancies $\\left(=85^{2}\\right)$\nquadruplets in $1 \\div 614,125$ pregnancies $\\left(=85^{3}\\right)$\nquintuplets in $1 \\div 52,200,625$ pregnancies $\\left(=85^{4}\\right)$\n\n- uterus large for dates\n- may have $\\uparrow$ hCG, HPL (human placental lactogen), AFP levels\n\nPerinatal morbidity \\& mortality compared with singletons:\ntwins: up to 5-fold increase\ntriplets: up to 18 -fold increase\n\n# Twin Pregnancy \n\nZygote $=$ fertilized egg\nPrevalence: in up to $2.5 \\%$ of all pregnancies\n\n## Monozygotic Twins ( $1 / 2$ )\n\n$=$ identical TWINS\n$=$ division of a single fertilized ovum fertilized by one sperm during earliest stages of embryogenesis (chorion differentiates 4 days and amnion 8 days after fertilization)\nPrevalence: 1:250 birth (constant around the world)\nPredisposing factors: (1) Advanced maternal age\n(2) In vitro fertilization\n$\\sqrt{ }$ same sex + identical genotype\nCx: (1) perinatal mortality 2.5 times greater than for dizygotic twins\n(2) Fetal anomalies 3-7 times higher than in dizygotic twins / singletons (often only affecting one twin): anencephaly, hydrocephalus, holoprosencephaly, cloacal exstrophy, VATER syndrome, sirenomelia, sacrococcygeal teratoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 392,
            "markdown": "![img-23.jpeg](img-23.jpeg)\n\n| Embryologic Events in Monozygotic Twinning |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Days after Fertilization | Embryologic Event | Cleavage results in |  |\n|  |  | Chorion | Amnion |\n| $1-2$ | cell divisions $\\rightarrow$ morula | di- | di- |\n| $3-4$ | chorionic differentiation |  |  |\n| 6 | blastocyst implants in endometrium | mono- | di- |\n| 8 | amnionic differentiation | mono- | mono- |\n| $>13$ | division of embryonic disk | mono- | mono- |\n|  |  | but con | oined |\n\n# DICHORIONIC DIAMNIOTIC TWINS (30\\%) \n\n$=$ separation at two-cell stage ( $=$ blastomere) $\\sim 60$ hours $/<4$ days after fertilization\n$\\sqrt{ } 2$ separate fused / unfused placentas\n$\\sqrt{ }$ membrane $>2 \\mathrm{~mm} \\leftarrow 2$ separate chorionic sacs +2 separate amniotic sacs ( $92 \\%$ accurate for dichorionic diamniotic twins)\n$\\sqrt{ }$ \"twin peak\" sign = triangular projection of placental tissue insinuated between layers of intertwin membrane\n\n## MONOCHORIONIC DIAMNIOTIC TWINS (69-80\\%)\n\n$=$ separation in blastocyst stage between $4^{\\text {th }}$ and $7^{\\text {th }}$ day after fertilization (chorion already developed and separated from embryo)\n$\\sqrt{ } 2$ separate amniotic sacs in single chorionic sac",
            "images": [
                {
                    "id": "img-23.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 187,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1012,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 393,
            "markdown": "$\\diamond$ Common monochorionic placenta has vascular communications in 100\\%!\nCx: (1) Twin-twin transfusion syndrome\n(2) Twin embolization syndrome\n(3) Acardiac parabiotic twin\n\n# MONOCHORIONIC MONOAMNIOTIC THINS (1\\%) \n\n$=$ division of embryonic disk between $8^{\\text {th }}$ and $12^{\\text {th }}$ day after fertilization (amniotic cavity already developed)\n$\\checkmark$ common amniotic + chorionic sac without separating membrane\n$\\checkmark$ entanglement of cords $=$ the only definitive positive sonographic sign of monoamnionicity\nCx: double perinatal mortality up to $45 \\%$\n(1) Entangled umbilical cord $(70 \\%)$\n(2) True knot of cord\n(3) Conjoined twins: umbilical cord with $>3$ vessels, shared fetal organs, continuous fetal skin contour\nPrognosis: $40 \\%$ survival rate\n\n## Dizygotic Twins ( $5 / 4$ )\n\n$=$ FRATERNAL TWINS\n(a) fertilization of 2 ova by 2 separate spermatozoa during 2 simultaneous ovulations (occurring either in both ovaries or in one ovary)\n(b) superfetation $=$ fertilization of 2 ova by 2 separate spermatozoa during 2 subsequent ovulations (? frequency)\n(c) superfecundation $=2$ ova fertilized by 2 different fathers (very rare)\n\nPrevalence: $1 \\div 80$ to $1 \\div 90$ births\nPredisposing factors:\n(1) Advanced maternal age (increased up to age 35 ): $\\downarrow$ gonadal-hypothalamic feedback $+\\uparrow$ FSH levels\n(2) Ovulation-inducing agents (multiple pregnancies in 6-17\\% with clomiphene, in 18$53 \\%$ with Pergonal ${ }^{\\circledR}$ )\n(3) Maternal history of twinning ( 3 times as frequent compared with normal population)\n(4) Increased parity\n(5) Maternal obesity\n(6) Race with inherited predisposition for multiple ovulations (Blacks $>$ Whites $>$ Asians)\n$\\checkmark$ different phenotypes; same / opposite sex\n$\\checkmark$ always dichorionic diamniotic\n\n## Growth Rates of Twins\n\n$\\diamond$ Twins should be scanned every 3-4 weeks $>26-28$ weeks GA!\nA. Below $30-32$ weeks GA\n$\\checkmark$ normal individual twins grow at same rate as singletons\n$\\checkmark$ BPD growth rates similar to singleton fetuses\nB. Beyond $30-32$ weeks GA\n$\\checkmark$ combined weight gain of both twins equals that of a singleton pregnancy (AC of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 394,
            "markdown": "twins $<$ AC of singleton)\n$\\diamond$ Weight of twin fetus falls below that of singleton when combined weight of twins $>$ $4,000 \\mathrm{~g}$ !\n$\\checkmark$ BPD + HC growth may / may not be affected (controversial)\n$\\checkmark$ FL not affected\n\n# Discordant Growth \n\n$=$ weight difference at birth $>25 \\%$\nCause: (1) Twin-twin transfusion syndrome\n(2) IUGR of one fetus\n$\\checkmark$ BPD difference $>5 \\mathrm{~mm}$ (discordant growth in $20-30 \\%$ )\n$\\checkmark$ discordant HC increases probability of IUGR\n$\\checkmark$ AC is single most sensitive parameter for IUGR\n$\\checkmark$ EFW is the most sensitive set of combined parameters for IUGR\n$\\checkmark>15 \\%$ S/D ratio difference of umbilical artery Doppler waveforms between twins\n\n## Amnionicity \\& Chorionicity\n\nRules:\n$\\diamond$ Only monozygotic twins can give rise to monochorionic monoamniotic pregnancies!\n$\\diamond$ All monoamniotic twins must also be monochorionic!\n$\\diamond$ All dizygotic twins must be dichorionic and diamniotic!\n$\\diamond 77 \\%$ of all twin pregnancies are dichorionic\n$>67 \\%$ of all dizygotics ( $2 / 3$ of all twins)\n$>10 \\%$ of all monozygotics ( $1 / 3$ of all twins)\n\n1. GESTATIONAL SACS ( $<10$ weeks MA)\n\nAccuracy: $100 \\%$ in $1^{\\text {st }}$ trimester, $80-90 \\%$ in $2^{\\text {nd }}$ trimester\n$\\checkmark 2$ gestational sacs, each with a live fetus, indicates dichorionic twinning\n$\\checkmark$ single gestational sac with 2 live fetuses indicates monochorionic twins\n$\\checkmark$ single extraembryonic coelom indicates monochorionic twins\n2. YOLK SAC\n$\\checkmark$ number of yolk sacs $=$ number of amnions\n3. FETAL GENDER\n$\\checkmark$ different genders (in $25 \\%$ of twin pregnancies) must be dizygotic twins and thus dichorionic!\n(DDx: testicular feminization demonstrates female external genitalia with a 46,XY karyotype)\n$\\checkmark$ identical sex twins with a monochorionic placenta must be monozygotic\n$\\checkmark$ identical sex twins with a dichorionic placenta require further analysis to determine zygosity\n4. PLACENTAL SITES\n$\\checkmark 2$ placentas (in $45 \\%$ of twin pregnancies) indicate dichorionic diamniotic pregnancy\n$\\checkmark 1$ placenta indicates\n(a) monochorionic pregnancy OR\n(b) dichorionic pregnancy with fused placenta (occurs in $50 \\%$ of dichorionic twin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 395,
            "markdown": "# pregnancies) \n\n5. CHORIONIC PEAK\n$\\sqrt{ }$ \"twin peak\" sign in late $1^{\\text {st }}$ and early $2^{\\text {nd }}$ trimester ( $=$ triangular projection of placental tissue extending beyond chorionic surface of placenta + insinuated between layers of intertwin membrane + wider at chorionic surface with tapering to a point some distance inward from surface) indicates dichorionic pregnancy\n6. MEMBRANE\n$\\sqrt{ }$ separating membrane confirms diamniotic pregnancy, but does not distinguish between mono- or dichorionic pregnancy\n$\\sqrt{ }$ dichorionic membrane ( 2 layers of chorion +2 layers of amnion) is thicker ( $>2 \\mathrm{~mm}$ ) than monochorionic membrane ( 2 layers of amnion $<1 \\mathrm{~mm}$ ): $88-92 \\%$ accuracy in $1^{\\text {st }}$ trimester, $39-83 \\%$ accuracy in $2^{\\mathrm{nd}}+3^{\\mathrm{rd}}$ trimester\n$\\diamond$ All membranes appear to be thin in $3^{\\text {rd }}$ trimester!\n$\\sqrt{ }$ absence of membrane suggests a monoamniotic monochorionic twin pregnancy\n$\\diamond$ Nonvisualization of membrane is not sufficient evidence of monoamnionicity due to technical factors!\n7. CORD\n$\\sqrt{ }$ entanglement of cords is the only definitive positive sonographic sign of monoamnionicity\n$\\sqrt{ }$ simultaneous recording of fetal arterial signals at nonsynchronous rates within wide Doppler gate\n8. AMNIOGRAPHY\n$\\sqrt{ }$ detection of imbibed intestinal contrast in both twins by CT following single sac contrast injection proves monoamniotic monochorionic twin pregnancy\n\n## Risks of Multiple Gestations\n\n1. Placental abruption 3-fold\n2. Anemia 2.5 -fold\n3. Hypertension 2.5 -fold\n4. Congenital anomaly $2-3$-fold\n5. Preterm delivery 12 -fold\n6. Perinatal mortality $4-6$-fold\n$\\diamond$ Risk increases with number of fetuses, monozygosity, monochorionicity\n\n## Risk for IUGR in Multiple Gestations\n\nmonochorionic-monoamniotic $>$ monochorionic-diamniotic $>$ dichorionic-diamniotic\n\n## Risk for Perinatal Mortality in Multiple Gestations\n\n$1 \\%$ for singletons, $9 \\%$ for diamniotic dichorionic twins, $26 \\%$ for diamniotic monochorionic twins, $50 \\%$ for monoamniotic monochorionic twins\nPrognosis:\n(1) Perinatal mortality 5-10 times that of singleton pregnancy ( $91-124 \\div 1,000$ births)\n$9 \\%$ for dichorionic diamniotic twins\n$26 \\%$ for monochorionic diamniotic twins",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 396,
            "markdown": "$>50 \\%$ for monochorionic monoamniotic twins\n(a) preterm delivery with birth weight $<2,500 \\mathrm{~g}$\n(b) IUGR ( $25-32 \\% ; 2^{\\text {nd }}$ most common cause of perinatal mortality + morbidity)\n(c) amniotic fluid infection $(60 \\%)$\n(d) premature rupture of membranes ( $11 \\%$ )\n(e) twin-twin transfusion syndrome ( $8 \\%$ )\n(f) large placental infarct $(8 \\%)$\n(g) placenta previa\n(h) abruptio placentae\n(i) preeclampsia\n(j) cord accidents\n(k) malpresentations\n(1) velamentous cord insertion (7-fold increase compared with singleton pregnancy)\n(2) Fetal death in utero: $0.5-6.8 \\% ; 3$ times as often in monochorionic than in dichorionic gestations\n$\\diamond 50 \\%$ of twin gestations seen at 10 weeks GA will be singletons at birth!\n(3) Increased risk of congenital anomalies: $23 \\div 1,000$ births $=$ twice as frequent as in singletons; 3-7 times more frequent in mono- than in dizygotic twins\n\n# UTERUS \n\n## Uterine Size\n\n$\\diamond$ Overfilling of urinary bladder can modify uterine shape!\nA. PREPUBERTAL UTERUS\n(a) neonate\n$\\checkmark$ uterine size:\n) length of 2.3-4.6 (mean, 3.4) cm\n) fundal width of $0.8-2.1$ (mean, 1.2) cm\n> cervical width of $0.8-2.2$ (mean, 1.4) cm\n$\\diamond$ becomes smaller by $4^{\\text {th }}$ month of life $(2.6-3.0 \\mathrm{~cm})$\n$\\checkmark$ uterine shape:\n> spade-shaped uterus (58\\%) with cervix often twice as thick as fundus\n> tube-shaped uterus ( $32 \\%$ ) with cervical + fundal AP measurements identical\n) adult pear-shaped uterus ( $10 \\%$ ) with fundus wider than cervix\n\n| Uterine Size and Shape |  |  |  |\n| :-- | --: | --: | --: |\n| Stage | Uterine Length <br> $[\\mathrm{cm}]$ | Fundal Width <br> $[\\mathrm{cm}]$ | Uterine Body-to- <br> Cervix Ratio |\n| Neonatal | 3.5 | 1.2 | $2 \\div 1$ |\n| Pediatric | $1-3$ | $0.4-1.0$ | $1 \\div 1$ |\n| Prepubertal | $3-4.5$ | $0.8-2.1$ | $1-1.5 \\div 1$ |\n| Pubertal | $5-8$ | $1.6-3.0$ | $1.5-2 \\div 1$ |\n| Reproductive | $8-9$ | $3-5$ | $2 \\div 1$ |\n| Postmenopausal | $3.5-7.5$ | $1.2-1.8$ | $1-1.5 \\div 1$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 397,
            "markdown": "$\\checkmark$ endometrium:\n$\\sqrt{ }$ thin echogenic endometrium $\\pm$ surrounding hypoechoic halo\n$\\checkmark$ endometrial fluid (in $23 \\%$ ) $\\leftarrow$ maternal hormonal stimulation\n$\\diamond$ Best time to evaluate uterus in child with ambiguous genitalia is first few months of life!\n(b) infant\n\nAge: infancy to 7 years of age\n$\\checkmark$ uterine size:\n) length of $2.5-4.5$ (mean, 3.3) cm\n) fundal width of $0.4-1.0 \\mathrm{~cm}$\n) cervical width of $0.6-1.0 \\mathrm{~cm}$\n$\\checkmark$ cervix occupies $2 / 3$ of uterine length\n$\\checkmark$ thin echogenic line of endometrium visible in $50 \\%$\n(c) prepuberty\n$\\checkmark$ uterine size:\n$>$ mean length of 4.3 cm\n$>$ fundal width of $0.8-2.1$ (mean, 1.2) cm\n$>$ cervical width of $0.8-2.2$ (mean, 1.4) cm\n$\\checkmark$ usually tubular configuration with fundocervical ratio of $1 \\div 1$\nB. PUBERTY\n$\\checkmark$ pear-shaped uterus with thick and round body\n$\\checkmark$ uterine body-to-cervix ratio $1.5 \\div 1$\nC. POSTPUBERTAL UTERUS\n> nulliparous: $5-8 \\mathrm{~cm}(\\mathrm{~L}) ; 3 \\mathrm{~cm}(\\mathrm{AP}) ; 1.6-3.0 \\mathrm{~cm}$ (TRV)\n> multiparous: $6-11 \\mathrm{~cm}(\\mathrm{~L}) ; 3-4 \\mathrm{~cm}(\\mathrm{AP}) ; 3-5 \\mathrm{~cm}$ (TRV)\n$\\checkmark$ fundocervical ratio of $2 \\div 1$ to $3 \\div 1$\n$\\checkmark$ mean uterine volume of $90 \\mathrm{~cm}^{3}$\nD. POSTMENOPAUSAL UTERUS\n\n- most rapid decline in size within first 10 years\n$>65$ years: $3.5-7.5 \\mathrm{~cm}(\\mathrm{~L}) ; 1.2-3.3 \\mathrm{~cm}(\\mathrm{AP}) ; 1.2-1.8 \\mathrm{~cm}$ (TRV)\n$\\checkmark$ fundocervical ratio of $2 \\div 1$ to $1 \\div 1$\n$\\checkmark$ calcified uterine arcuate vessels, especially with diabetes / vascular disease / hypertension / hypercalcemia\n\n\n# Uterine Position \n\nFlexion $=$ angle of long axis of uterine body to that of cervix\nVersion $=$ angle of long axis of cervix to long axis of vagina\nmnemonic: V for Vagina and Version!\nAnteversion + anteflexion $=$ most common position\nCave: Retroversion can be mistaken for a pelvic mass!\n\n## Trilaminar Uterine Zonal Anatomy (on T2WI)\n\n$\\diamond$ Premenarchal uterus has indistinct zonal anatomy\n$\\diamond$ Thickness of zones depends on menstrual cycle + hormonal medication!\n\n1. ENDOMETRIUM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 398,
            "markdown": "$\\sqrt{ }$ high signal intensity $\\leftarrow$ mucin-rich endometrial glands\n2. JUNCTIONAL ZONE $=$ INNER MYOMETRIUM\n\nMean thickness: $<12 \\mathrm{~mm}$\nHisto: compact smooth muscle fibers with 3-fold increase in number + size of nuclei compared with outer myometrium\n$\\sqrt{ }$ low SI (= compact smooth muscle with lower water content); seen in $40-60 \\%$, may not be visible in premenarchal + postmenopausal women\n3. OUTER MYOMETRIUM\n\nHisto: $65-70 \\%$ smooth muscle\n$\\sqrt{ }$ intermediate SI (= less compact muscle with greater water content + blood vessels); $\\rightarrow$ increases during secretory phase\n4. OUTER SURFACE OF UTERUS\n$\\sqrt{ }$ thin low-signal intensity line\n\n# Uterine Enhancement Pattern \n\n1. Myometrium\ndemarcates level of internal cervical os\n2. Inner mucosal + outer stromal layers of cervix\n$\\sqrt{ }$ hypoattenuating on CECT\n3. Inner stromal layer of cervix\n\n## Cervix\n\n$=$ lower cylindrical portion of uterus\nSize: $\\quad 2.5-3.0 \\mathrm{~cm}(\\mathrm{~L}) \\times 2.5 \\mathrm{~cm}(\\mathrm{~W})$\nStroma: primarily collagenous tissue + smooth muscle (15\\%)\nPortions:\n(1) Supravaginal upper portion $=$ endocervix\n\n- not palpable / visible by pelvic exam\n(2) Lower portion protruding into vagina $=$ ectocervix encircled by vagina (higher posteriorly and laterally) forming fornices ( $=$ vaginal recesses)\n- palpable during pelvic exam + visible with speculum\n\nUS:\n$\\sqrt{ }$ ovoid / round on short-axis (coronal endovaginal) view\n$\\sqrt{ }$ cylindrical on long-axis (sagittal)\n$\\sqrt{ }$ little / NO vascularity on color Doppler\n\n## Ectocervix\n\nHisto: mucosa composed of stratified squamous epithelium similar to vaginal epithelium\nTransformation zone $=$ squamocolumnar junction\n$=$ region where glandular tissue (columnar epithelium) is replaced by squamous epithelium\nLocation: (a) on ectocervix in $94 \\%$ of women $<25$ years (b) on ectocervix in $2 \\%$ of women $>65$ years\n$\\sqrt{ }$ not discernible at imaging\nN.B.: most cervical cancers arise in transformation zone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 399,
            "markdown": "# Endocervical Canal \n\n8 mm wide fusiform canal connecting uterus with vagina, tapering at both ends into\n(a) external cervical os $=$ opening into vaginal canal\n(b) internal cervical os $=$ opening into uterine cavity\n\nSize of internal cervical os: $10 \\mathrm{~mm}(\\mathrm{~L}) \\times 1-12 \\mathrm{~mm}(\\mathrm{~W})$\nHisto: endocervical mucosa\n> characterized by villi lined with a single layer of mucus-secreting columnar epithelial cells + separated by crypts (= endocervical glands) extending 3-10 mm deep into stroma of cervix\n> arranged into longitudinal ridges with interdigitating branching folds (plicae palmatae of arbor vitae = irregular branched mucosal pattern of cervical canal\n$\\sqrt{ }$ best visualized on HSG\nUS:\n$\\sqrt{ }$ endocervical canal $=$ echogenic line (best on SAG view) delineating interface between anterior + posterior mucosa\n$\\sqrt{ }$ thin central an- / hypoechoic region $\\leftarrow$ fluid / mucus during periovulatory period\nMR: (see below)\n\n## Cervical Isthmus\n\n$=$ junction of supravaginal cervix and uterine body\n$\\sqrt{ }$ slight external tapering of outer contour of uterus\n$\\sqrt{ }$ slight internal narrowing forming internal cervical os\n\n## Cervical Zones (on T2WI = best soft-tissue contrast)\n\n$=$ distinctive trilaminar appearance\n(1) Central stripe of high signal intensity\n\nHisto: secretions in endocervical canal + cervical mucosa + plicae palmatae\n$\\sqrt{ } 3-8 \\mathrm{~mm}$ hyperintense layer of mucosa + secretions\n(2) Middle layer of low SI continuous with junctional zone\n\nHisto: inner zone of fibromuscular stroma with percentage of nuclear area 2.5 times greater than in outer zone\n$\\sqrt{ } 3-8 \\mathrm{~mm}$ hypointense layer of inner cervical stroma\n(3) Outer layer of intermediate signal intensity\n\nHisto: outer zone of fibromuscular stroma with greater number of fibroblasts + smooth muscle cells and less vascularized connective tissue\n$\\sqrt{ } 2-8 \\mathrm{~mm}$ intermediate-SI layer of outer cervical stroma\n(4) Outermost thin low-intensity serosal layer continuous with uterine serosa\n\n## Postpartum Uterus\n\nPuerperium $=$ period 6-8 weeks after delivery\n[ puer $=$ Latin, boy + parere, Latin $=$ to bear; puerpera $=$ a woman in childbed]\n\n- after childbirth weight of uterus $=1 \\mathrm{~kg}$ decreasing by $50 \\%$ during following $24-48$ hours\n$\\sqrt{ }$ length of uterus: $>20.0 \\mathrm{~cm}$ after birth\n$>11.2 \\mathrm{~cm}$ at 3 weeks\n$>8.7 \\mathrm{~cm}$ at 6 weeks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 400,
            "markdown": "$\\diamond$ Timing of uterine involution\n> prolonged in multiparous women\n> foreshortened in preterm delivery\n> not affected by birth weight / breast feeding\n$\\checkmark$ heterogeneous myometrium of higher echogenicity compared to nongravid uterus\n$\\checkmark$ increased diffuse / focal myometrial vascularity at site of placental insertion\n\n# Endometrium by US \n\nMeasurements refer to\n> AP diameter of both apposed endometrial layers (= bilayer thickness) excluding intrauterine fluid\nthe level of the uterine fundus\n> midline long-axis image of uterus\n$\\diamond$ Measurements increase by $1-2 \\mathrm{~mm}$ in patients with large body habitus\n$\\diamond$ If there is a discrepancy between concomitant endometrial + ovarian findings bleeding is usually associated with anovulatory cycles\n\n1. MENSTRUAL PHASE (usually days 1-4)\n\nThickness: 1-5 (mean, 4.6) mm\n$\\checkmark$ interrupted thin echogenic line of central interface\n2. PROLIFERATIVE PHASE (days 5-13)\n\nThickness: $6-12 \\mathrm{~mm}$\n$\\checkmark$ bright echogenic central line (= apposed borders of endometrial canal)\n$\\checkmark$ thickened mildly echogenic endometrium compared with myometrium $\\leftarrow$ development of glands, blood vessels, stroma\n3. LATE PROLIFERATIVE + OVULATORY PHASE (days 13-16)\n\nThickness: mean of 12.4 mm on the day of luteinizing hormone surge\n$\\checkmark$ \"triple ring\" sign = multilayered endometrium:\n$\\checkmark$ echogenic basal layer\n$\\checkmark$ hypoechoic inner functional layer\n$\\checkmark$ thin echogenic median layer arising from the central interface\n$\\checkmark$ concomitant with mature preovulatory follicle\n$\\checkmark$ disappears within 12-48 hours after ovulation\n4. PERIOVULATORY PHASE (days 8-20)\n$=$ uncertain days defined relative to day of ovulation\nN.B.: day of luteinizing hormone surge extremely variable $=$ ovulation occurs between day 8 and 20 of menstrual cycle\n5. SECRETORY PHASE (days 16-28)\n\nThickness: $7-12-16 \\mathrm{~mm}$\n$\\checkmark$ bright central line\n$\\checkmark$ markedly echogenic thick endometrium of more homogeneous echotexture $\\leftarrow$ stromal edema + distended glands filled with mucus + glycogen:\n$\\checkmark \\pm$ posterior acoustic enhancement\n$\\checkmark$ maximum thickness during midsecretory phase\n$\\checkmark$ concomitant with a corpus luteum\n$\\checkmark$ thin hypoechoic halo of inner myometrial zone",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 401,
            "markdown": "# 6. HORMONAL CONTRACEPTIVES \n\n$\\sqrt{ }$ endometrium thin throughout menstrual cycle\n\n## Postmenopausal Endometrium\n\nMenopause $=$ permanent cessation of menstruation with an intact uterus\n[men, ancient Greek = month + pausis, Greek = cessation]\nDefinition: amenorrhea for 12 months\nOnset: 51-53 (range, 40-60) years (Western countries)\nAffected by: smoking, race, ethnicity, body mass index\nPerimenopause $=$ menstrual cycles of variable lengths + volume with frequent skipping of cycles\nA. NO HORMONAL REPLACEMENT THERAPY\n$\\sqrt{ }$ bilayer thickness of usually $1-2 \\mathrm{~mm}$ (max. 5 mm ) with a homogeneous echogenic endometrium $=99 \\%$ NPV for endometrial cancer\nHisto: consistently associated with atrophic inactive endometrium\nB. WITH HORMONE REPLACEMENT THERAPY\n(a) cyclic estrogen + progestin therapy\n$\\checkmark$ endometrial thickness may increase to 8 mm :\n$\\checkmark$ thickest prior to progestin exposure\n$\\checkmark$ thinnest after progestin phase (imaging should be done at beginning / end of a treatment cycle)\n![img-24.jpeg](img-24.jpeg)\n(b) continuous estrogen + progesterone regimen\n$\\checkmark$ normal endometrial thickness\nHisto: endometrial atrophy\n(c) unopposed estrogen therapy usually prescribed for posthysterectomy patients Associated with: increased risk of endometrial hyperplasia / carcinoma\n(d) tamoxifen (= estrogenic effect on uterus) usually prescribed for breast cancer patients\n$\\checkmark$ endometrial thickness $>8 \\mathrm{~mm}$ in $50 \\%$ (notably beyond 3 years of therapy)\n$\\checkmark$ endometrial thickness may increase to 15 mm\nRx: biopsy / D\\&C recommended (?) if endometrial thickness $>8 \\mathrm{~mm}$\n\n## Normal Postpartum Endometrium",
            "images": [
                {
                    "id": "img-24.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1051,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1493,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 402,
            "markdown": "$\\checkmark$ endometrial cavity $<20 \\mathrm{~mm}$ in diameter:\n$\\checkmark$ small echogenic foci of retained membranes / remaining superficial decidua / clot / debris\n> normal in up to $24 \\%$ in first few days post partum\n> normal in up to $50 \\%$ at 1 week post partum\n> normal in up to $6 \\%$ at 3 weeks post partum\n$\\checkmark$ intrauterine air (as late as 3 weeks after vaginal / cesarean delivery)\n$\\checkmark$ cavity wall:\n$\\checkmark$ smooth well-defined border\n$\\checkmark$ irregular heterogeneous lining\n$\\checkmark$ endometrial stripe thickness decreases with uterine involution\n$\\checkmark$ endometrium restored by 3-6 weeks post partum\n\n# Pelvic Spaces \n\n1. Rectouterine pouch $=$ cul-de-sac\n\nAnterior boundary: broad ligaments + uterus\n$\\diamond$ Most dependent portion of pelvis in women!\n2. Rectovesical recess\n$\\diamond$ Most dependent portion of pelvis in men!\n3. Vesicouterine recess\n4. Inguinal fossa\nlocated between lateral + medial umbilical folds\n\n## Pelvic Ligaments\n\n1. Broad ligament\n\nHisto: double fold of peritoneum covering anterior + posterior surfaces of uterus\nOrigin: uterine peritoneum\nLocation: lateral uterine margin to pelvic sidewall incompletely dividing true pelvis into anterior + posterior compartments\nAttachment: pelvic sidewall\n> medial superior free edge (= point where peritoneal layers are continuous): encloses fallopian tube\n> lateral superior free edge: suspensory ligament of ovary\n> lower margin: cardinal ligament\nContents (= parametrium):\nextraperitoneal connective tissue, smooth muscle, fat, fallopian tube, round ligament, ovarian ligament, uterine + ovarian blood vessels, nerves, lymphatics, mesonephric remnants\n$\\checkmark$ usually not seen on CT, unless surrounded by ascites\n2. Round ligament\n$=$ anterior suspensory ligament of uterus\nHisto: band of fibromuscular tissue + lymphatic channels\nOrigin: anterolateral uterine fundus, just below + anterior to ovarian ligament",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 403,
            "markdown": "![img-25.jpeg](img-25.jpeg)\n\nAttachment: through internal inguinal canal (lateral to deep inferior epigastric vessels) to labia majora\n3. Cardinal ligament $=$ transverse cervical ligament $=$ Mackenrodt ligament\n\nOrigin: cervix + upper vagina\nAttachment: fascia of obturator internus muscle\nRelationship:\n> uterine artery runs along its superior aspect\n> forms the base of the broad ligament\n\n# 4. Uterosacral ligament \n\nOrigin: posterolateral cervix + vagina\nAttachment: anterior body of sacrum at S2 / S3\n5. Ovarian ligament $=$ utero-ovarian lig. $=$ round ligament of the ovary\n$=$ round fibromuscular band just inferior + posterior to fallopian tube + round ligament enclosed between 2 layers of broad ligament\nOrigin: medial aspect of ovary\nAttachment: uterine cornu\nContents: ovarian branches of uterine artery + vein\n$\\sqrt{ }$ short narrow soft-tissue band between uterus and ovary on CT\n6. Suspensory ligament of ovary $=$ infundibulopelvic lig.\n$=$ peritoneal fold ( $=$ superolateral part of broad ligament) suspending ovary from posterolateral pelvic wall\nOrigin: anterolateral tubal end of ovary\nAttachment: connective tissue covering psoas muscle\nContents: ovarian artery + veins ( $=$ major component due to gradual arterial atrophy); lymphatics\nLength: up to $4-5 \\mathrm{~cm}$\n$\\diamond$ Good anatomic landmark to localize ovary!\n$\\sqrt{ }$ extends from ovary in direction of iliac vessels on CT\n7. Lateral umbilical fold / ligament\n$=$ reflection of peritoneum over deep inferior epigastric vessels\n8. Medial umbilical fold / ligament",
            "images": [
                {
                    "id": "img-25.jpeg",
                    "top_left_x": 430,
                    "top_left_y": 189,
                    "bottom_right_x": 1264,
                    "bottom_right_y": 734,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 404,
            "markdown": "$=$ reflection of peritoneum over obliterated umbilical arteries\n9. Median umbilical ligament\n$=$ reflection of peritoneum over obliterated urachus\nOrigin: dome of urinary bladder\nAttachment: umbilicus\n\n# FALLOPIAN TUBE \n\n[Gabriele Falloppio aka Fallopius (1523-1562), chair of anatomy at University of Padua]\nLocation: superior aspect of broad ligament\nLength: $10-12 \\mathrm{~cm}$\nSegments:\n(1) Interstitial / intramural / cornual portion\n$=$ short segment that traverses muscular wall of the uterus\n(2) Isthmic portion\n$=$ long narrow segment between interstitial + ampullary end\nDiameter: up to 4 mm\n(3) Ampullary portion\n$=$ widened region near ovary accounting for $>50 \\%$ of the entire tubal length\nDiameter: up to 8 mm\n(4) Infundibular portion\n$=$ most lateral funnel-shaped segment\nDiameter: up to 10 mm\nFree edge: 25 fingerlike projections / fimbriae\nWall:\n(a) mucosa: folds form fingerlike projections (= plicae) $\\rightarrow$ plicae coalesce at infundibulum contiguous with fimbriae\n(b) muscularis\n(c) serosa\n$\\sqrt{ }$ usually not visualized unless abnormal / surrounded by fluid\n\n## OVARY\n\nOrigin: thickening of mesothelial layer of peritoneum $\\rightarrow$ gonadal ridge $\\rightarrow$ primitive gonad; part of mesonephros remains connected to genital ridge $=$ mesovarium\nFixation: gubernaculum connects ovary to uterine fundus = ovarian ligament; part of gubernaculum between uterus and labia $=$ round ligament that is accompanied by peritoneum analogous to processus vaginalis of testis (= canal of Nuck)\nThe ovary is fairly mobile with attachments to\nanterior pelvic wall by broad ligament\nuterine body by uteroovarian ligament\nfallopian tube by tuboovarian ligament\nlateral pelvic wall by infundibulopelvic ligament\nOvarian descent: inhibited by gubernaculum $\\rightarrow$ NO further than level of uterine fundus N.B.: failure of gubernaculum to contract $\\rightarrow$ ovary may descend through inguinal canal into labium majus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 405,
            "markdown": "Mesovarium: short double-layered peritoneal fold extending posteriorly from broad ligament attaching anteriorly to ovary; contains ovarian blood vessels ( $=$ anastomotic branches of ovarian + uterine arteries and venous plexus)\n$\\diamond$ Lax supporting ligaments + shallow fetal and infantile pelvis make fetal ovary more susceptible to torsion than postpubertal ovary!\nEmbryology of ovary:\n(a) coelomic (surface) epithelium (gonadal cortex) migrates from near the allantois and invaginates into\n(b) mesenchymal substance of central part = medulla of ovary (= primary sex cords) and incorporates primordial germ cells that develop into primordial follicles\n(c) germinal epithelium eventually loses connection with central mass; an additional layer develops between medulla and cortex $=$ tunica albuginea\nOocytogenesis:\n> cells from dorsal endoderm of yolk sac migrate along hindgut to gonadal ridge (primordial germ cells) which multiply by mitosis\n> after reaching gonadal ridge they are named oogonia (= diploid stem cells of ovary)\n> oogonia become fully surrounded by a layer of connective tissue (= pre-granulosa cells of primary oocyte)\n> primary oocyte formation completed by end of $3^{\\text {rd }}$ trimester\n> most primary oocytes degenerate + only a small portion of primary oocytes undergo ovulation after onset of puberty\nHisto:\nA. Stromal cells\n> form cortex, medulla, hilus\n> surround all developing follicles\n> cell surface has estrogen-, progesterone-, testosterone-binding sites\n> major source of androgens in postmenopause\nB. Cells derived from stroma cells\n\n1. Fibroblasts\n2. Luteinizing stromal cells containing lipid\n3. Hilus cells\nmorphologically similar to Leydig cells in testis;\ncontain intracellular crystalline structures (= crystals of Reinke)\n4. Theca cells\n> surround granulosa cells\n> produce estradiol under control of FSH\n> stimulated by LH after ovulation into theca-lutein cells, which develop lipid-laden cytoplasm involved in steroidogenesis\nC. Cells derived from sex cords\n5. Granulosa cells\n> surround each primordial oocyte\n> form lining of developing follicle\n> granulosa cell layer contains small cystic cavities lined by basal lamina (=CallExner bodies)\n> produce estradiol under control of FSH",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 406,
            "markdown": "> stimulated by LH after ovulation into granulosa-lutein cells, which develop lipidladen cytoplasm involved in steroidogenesis\n2. Sertoli cells\nnot seen in normal ovary\n\n# Ovarian Size \n\nOvarian volume $=$ length $x$ height $x$ width $\\times 0.523$\nfetus: $>28$ weeks GA\n$<3$ months: $1.06-3.56 \\mathrm{~cm}^{3}$\n$4-12$ months: up to $2.71 \\mathrm{~cm}^{3}$\n1 year: $1.05 \\pm 0.7$ (S.D.) $\\mathrm{cm}^{3}$\n$2-6$ years: $\\leq 1.0 \\pm 0.4$ (S.D.) $\\mathrm{cm}^{3}$\n$6-10$ years: $1.2-2.3 \\mathrm{~cm}^{3}$\n$11-12$ years: $2-4 \\mathrm{~cm}^{3}$\nafter puberty: $2.5-5 \\mathrm{~cm}(\\mathrm{~L}), 0.6-1.5 \\mathrm{~cm}(\\mathrm{H}), 1.5-3 \\mathrm{~cm}(\\mathrm{~W})=8$ (range $2.5-20) \\mathrm{cm}^{3}$\npremenopausal: $<6 \\mathrm{~cm}^{3}$\npostmenopausal: $<2.5 \\mathrm{~cm}^{3}$\n$<30$ years: mean volume of $6.6 \\mathrm{~cm}^{3}$\n30-39 years: mean volume of $6.1 \\mathrm{~cm}^{3}$\n$40-49$ years: mean volume of $4.8 \\mathrm{~cm}^{3}$\n$50-59$ years: mean volume of $2.6 \\mathrm{~cm}^{3}$\n$\\diamond$ An ovary $>20 \\mathrm{~cm}^{3}$ is enlarged!\n$\\diamond$ An ovary between 15 and $20 \\mathrm{~cm}^{3}$ requires follow-up!\n$\\diamond$ An ovarian volume $>4 \\mathrm{~cm}^{3}+>6$ follicles in girls $<7$ years suggests premature sexual development!\n\n## Ovarian Morphology\n\nneonate:\n$\\checkmark$ follicles occasionally fail to involute + undergo growth\n$<8$ years:\n$\\checkmark$ solid ovoid structures with homogeneous / finely heterogeneous texture\n$\\checkmark$ up to $68-80 \\%$ of ovaries contain cystic follicles (in $95 \\%<9 \\mathrm{~mm}$, in $5 \\%>9 \\mathrm{~mm}$ ) premenopausal:\n$\\checkmark$ changes in size, morphology, blood flow with menstrual cycle\n\n| Ovarian Volume and Appearance |  |  |\n| :-- | :--: | :-- |\n| Stage | Ovarian Volume <br> $\\left[\\mathrm{cm}^{3}\\right]$ | Ovarian Appearance |\n| Neonatal | $1.0-3.5$ | follicles + cysts common |\n| Pediatric | $0.5-1.5$ | $<6$ follicles; cysts uncommon |\n| Prepubertal | $1.0-4.0$ | follicles + cysts common |\n| Pubertal | $2.0-6.0$ | follicles + cysts common |\n| Reproductive | $4.0-16.0$ | follicles + cysts common |\n| Postmenopausal | $1.2-5.8$ | follicles + cysts in 15-20\\% |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 407,
            "markdown": "# Visualization of Ovaries by US \n\n(a) after menopause (average onset at age 50):\n$<5$ years after menopause: in $78 \\%$\n$>10$ years after menopause: in $64 \\%$\n, both ovaries: in $85 \\%$\n, one ovary: in $60 \\%$\n(b) following hysterectomy: in $43 \\%$\n\n## Location of Ovaries\n\nInfluenced by: > size of uterus + ovary\n, distension of bladder + rectosigmoid\n, presence of pelvic mass\n(a) in neonates: located above level of true pelvis (visualized by transabdominal US)\n(b) older child: located adjacent to uterus deep within pelvis\n\nLocation: ovarian fossa (= fossa of Waldeyer) bounded posteriorly by ureter + internal iliac artery, superiorly by external iliac vein, anteriorly by obliterated umbilical artery\n(c) during $1^{\\text {st }}$ pregnancy: pulled into abdomen by enlarging uterus + stretched broad ligament\n(d) after $1^{\\text {st }}$ pregnancy: greater ovarian mobility $\\leftarrow$ enlarged redundant broad ligament\n\nPotential locations: > adnexal region lateral to uterus\n> posterior cul-de-sac\n> superior / posterior to uterine fundus\n$\\diamond$ In retroverted uterus ovaries may be ventral / lateral to uterus\n\n## Ovarian Blood Supply\n\n$=$ dual arterial supply\n\n## Ovarian ARTERY\n\nOrigin: abdominal aorta slightly below renal artery\nCourse: (a) descends caudally + laterally ventral to psoas major muscle\n(b) crosses over external / common iliac vessels\n(c) passes through suspensory ligament of ovary near pelvic brim\n(d) descends inferiorly + medially between 2 layers of broad lig. near mesovarian border\nTerminus: multiple branches within ovarian hilum\n\n## Adnexal Branch of Uterine Artery\n\n## Ovarian Vein\n\n$\\diamond$ Tracking the ovarian vein caudally is most helpful to identify ovary!\nOrigin: pampiniform plexus in mesovarium that merges to form one vein\nCourse: alongside ovarian artery\nTerminus: left ovarian vein $\\rightarrow$ left renal vein; right ovarian vein $\\rightarrow$ inferior vena cava below level of renal vessel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 408,
            "markdown": "# RELATIONSHIP OF OVARIAN VESSELS TO URETER \n\n@ lower renal pole medial to ureter\n@ middle to lower lumbar region crossover\n@ lower abdomen + pelvis lateral to ureter\n$\\sqrt{ }$ location of ureter relative to a pelvic mass can be a most helpful hint to the ovarian origin on CT\n\n## Ovarian Doppler Signals\n\nA. NONFUNCTIONING OVARY\n$\\sqrt{ }$ high-impedance waveform\nB. FUNCTIONING OVARY\n> days $1-6$ :\n$\\sqrt{ }$ high-impedance waveform with RI close to 1.0\n> days $7-22=$ midfollicular to midluteal phase\n$=$ developing dominant follicle + ovulation + corpus luteal phase:\n$\\sqrt{ }$ continuous diastolic flow with RI close to 0.5\n> days $23-28=$ late luteal phase:\n$\\sqrt{ }$ high-impedance waveform with RI close to 1.0\n\n## Ovarian Cycle\n\n1. FOLLICULAR PHASE = days 1-14 (of a 28-day cycle)\n\n- a number of immature primordial follicles begin to mature in response to FSH\n$\\sqrt{ }$ multiple small cysts:\n(a) unstimulated follicles are $<2 \\mathrm{~mm}$ in size\n(b) stimulated follicles grow $>2 \\mathrm{~mm}$ in size\n$\\sqrt{ } 2-3$ follicles in each ovary of day 4 enlarge subsequently to $\\sim 10 \\mathrm{~mm}$\n- 2-3 follicles capture the most FSH and aromatize the most estradiol from their granulosa cells\n$\\sqrt{ }$ follicles may be seen by 5-7 days\n$\\sqrt{ }$ single more ascendant / dominant / graafian follicle appears by day $8-10-12$ (see below):\n$\\sqrt{ }$ progressively increasing diastolic flow on the side of maturing follicle\n\n2. OVULATORY PHASE = day 14\n\n- \"Mittelschmerz\" = pain just prior to ovulation (pressure of graafian follicle distending ovarian capsule)\n$\\sqrt{ }$ sudden decrease in follicular size over minutes / hours (= rupture of mature graafian follicle with extrusion of oocyte)\n$\\sqrt{ }$ fluid in cul-de-sac detectable in up to $40 \\%$\n\n3. LUTEAL PHASE $=$ days $15-28$\n$=$ remnant dominant follicle transforms into corpus luteum hemorrhagicum\n$\\sqrt{ }$ irregular cyst with scalloped margins\n$\\diamond$ All corpora lutea evolve over days and change size and texture constantly\n$\\diamond$ All corpora lutea contain hemorrhage: $\\rightarrow$ uncontrolled bleeding into center frequently at time of ovulation + on day 8 when regression begins\n$\\sqrt{ }$ round / ovoid bulging protrusion on one side of ovary = corpus luteum of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 409,
            "markdown": "menstruation:\n$\\sqrt{ }$ mean diameter of $10-25 \\mathrm{~mm}$ (typically $<3 \\mathrm{~cm}$ )\n$\\checkmark$ hyperechoic $1-4-\\mathrm{mm}$ thick wall\n$\\checkmark$ hyperechoic central blood clot gradually transforming into weblike fibrin net\n$\\checkmark$ color Doppler US:\n$\\checkmark$ corpus luteum surrounded by circumferential wreath-like color flow = \"ring of fire\"\n$\\checkmark$ blood flow in main arteriole supplying the corpus luteum is $\\sim 100 \\mathrm{~cm} / \\mathrm{sec}$\n$\\checkmark$ arterial flow differences between active + inactive ovary:\n$\\checkmark$ inactive (nondominant) ovary: steady high-resistance pattern of ovarian arterial flow\n$\\checkmark$ active (dominant) ovary: low-resistance arterial pattern with its nadir in early luteal phase\n$\\checkmark$ involution + atrophy of corpus luteum on about $24^{\\text {th }}$ day of cycle $=$ corpus luteum atreticum\nPrognosis: large painful corpora lutea resolve in a week\n\n# Postmenopausal Ovary \n\n$\\checkmark$ less echogenic, fewer follicles than normal\n$\\checkmark$ small atrophic organ with mean size of $1.2-5.8 \\mathrm{~cm}^{3}$\n$\\diamond$ Ovarian volume $>8 \\mathrm{~cm}^{3}$ is abnormal!\n$\\checkmark$ may contain simple cyst up to 3 cm (in 15\\%)\n$R x$ : serial follow-up to document spontaneous regression\n$\\checkmark$ may contain simple cyst $<1 \\mathrm{~cm}$ (in $21 \\%$ )\n$R x$ : no follow-up necessary\n$\\checkmark$ peripheral $1-3 \\mathrm{~mm}$ punctate echogenic foci without associated soft-tissue mass\nCause: (a) dystrophic calcifications in atretic follicles\n(b) dystrophic calcifications in surface epithelial inclusion cysts\n(c) tiny cystic spaces with reverberation artifacts\n\n## Graafian Follicle\n\n[Reinier de Graaf (1641-1673), Dutch physician and anatomist]\n$=$ DOMINANT FOLLICLE\nTime of onset: day 8-10-12 of 28-day menstrual cycle\nSize of mature graafian follicle: 17-29 mm\n\n- rapidly rising estradiol production triggers the hypothalamic arcuate nucleus to increase GnRH secretion $\\rightarrow$ prompts anterior pituitary to disgorge the stored LH over 24 hr\n- LH binds to ovarian receptors $\\rightarrow$ releases cAMP from granulosa cells $\\rightarrow$ halting granulosa cell mitosis + increasing peptidase, collagenase, growth factor, angiotensin, prostaglandin as the cause for follicular rupture + conversion to corpus luteum\n$\\checkmark>14 \\mathrm{~mm}$ in diameter:\n$\\checkmark$ growth rate $2-3 \\mathrm{~mm} /$ day until the last preovulatory 24 hours followed by a sudden increase in diameter\n$\\checkmark$ subsequent enlargement to 21 (range 17-24) mm by day 14\n$\\checkmark$ cumulus oophorus $=1-\\mathrm{mm}$ mural echogenic focus projecting into antrum of follicle +",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 410,
            "markdown": "containing oocyte, followed by ovulation within next 36 hours\n$\\checkmark 2$ dominant follicles may develop in $5-11 \\%$ of cycles BUT NOT within same ovary\n\n# Signs of Ovulation \n\n$\\checkmark$ development of solid echoes within graafian follicle\n$\\checkmark$ decrease in diameter / sudden collapse of dominant follicle $28-35$ hours after LH peak\n$\\checkmark$ \"ring\" structure within uterine fundus\n$\\checkmark$ free fluid appearing in pouch of Douglas\n\n## Signs of Ovulatory Failure\n\n$\\checkmark$ development of internal echoes prior to 18 mm size\n$\\checkmark$ continuous cystic enlargement up to $30-40 \\mathrm{~mm}$\n\n## Hormonal Status\n\nThelarche $=$ onset and progress of breast development\nMean age: 8 years\nAdrenarche $=$ onset and progress of pubic (pubarche) + axillary hair development\nMean age: 9.8 years\nMenarche $=$ first episode of vaginal bleeding originating from the uterus\nMean age: 12.7 years in USA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 411,
            "markdown": "# RADIOLOGY CONSIDERATIONS FOR MOTHER \\& FETUS \\& NEONATE \n\n## CONTRAST MEDIA DURING PREGNANCY\n\nNo well-controlled studies available on the use of oral / IV iodinated / IV gadolinium contrast material!\n\n## Oral Contrast Material\n\n$\\diamond$ Not considered a threat to pregnant patients due to intraluminal administration + excretion!\n$\\diamond$ Intraluminal barium can act as internal shielding\n\n## IV lodinated Contrast Medium\n\n$=$ FDA category B drug: NO fetal risk in animal reproduction studies\n$\\diamond$ Considered generally inert + safe in pregnancy!\nPhysiology: IV iodinated contrast material crosses placenta + enters the fetus\nRisk: depression of fetal thyroid function $\\leftarrow$ uptake of free iodine; NO mutagenic / teratogenic effects of lower-osmolality contrast media (in lab animals)\nRecommendation: evaluate thyroid function of newborn in first few days of life (already standard practice in U.S. for all newborns)\n\n## IV Gadolinium-based Contrast Medium\n\nPhysiology: IV gadolinium-based contrast material crosses placenta + enters the fetus\nRisk: toxic effects of high doses in lab animals (doses $2-7 \\mathrm{x}$ higher than used in humans); NO direct toxic effects of gadolinium in humans\nTheoretical risk: gadolinium chelates may accumulate in amniotic fluid $\\rightarrow$ dissociate over time $\\rightarrow$ release toxic free gadolinium ions (of no known clinical significance)\nRecommendation: well documented thoughtful risk-benefit analysis based on potential benefit outweighing theoretical risks\n\n## FETAL EXPOSURE TO RADIATION\n\nCounseling for necessary exposure to radiation while pregnant:\n\n- Have written policy for screening + management of pregnant women:\n> last menstrual period (LMP $>14$ days): reliable, regular?\n> checking of b-hCG level needed?\n> imaging protocol adjustment possible?\n- Expeditious consultation with medical physicist to evaluate required fetal dose and associated risk\n- Discussion of risk with parents to make informed decision",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 412,
            "markdown": "| Potential Radiation Effects on Fetus by Gestational Age |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Gestational Period Gestational Age (wk) |  | Effects <br> (theoretical risk for < 100 mGy unlikely) | Estimated Threshold Dose (mGy) |\n| Before implantation | $0-2$ | All (death of embryo) or None | $50-100$ |\n|  | $3-4$ | Spontaneous abortion possible |  |\n| Organogenesis | $2-8$ | Congenital anomalies: skeleton, eyes, genitals | 200 |\n|  |  | Growth retardation | $200-250$ |\n| Fetal Period | $8-15$ | Severe mental retardation | $60-310$ |\n|  |  | Intellectual deficit | 25 IQ point loss per Gray |\n|  |  | Microcephaly | 200 |\n|  | $16-25$ | Severe mental retardation (low risk) | $250-280$ |\n|  | $18-27$ | IQ deficit not detectable at diagnostic doses |  |\n|  | $>27$ | None applicable to diagnostic medicine |  |\n\n> for most diagnostic procedures the risk of congenital anomalies, miscarriage, birth defects, or mental retardation is negligible\n> the risk of childhood cancer and leukemia is real but small compared to other spontaneous risks\n> available imaging options should be described\n> consequences of delaying / refusing imaging must be explained\nMR: inform patient that there are no known risks to the fetus. However, MR's safety has not been proved and cannot be guaranteed\n\n- Calculation of precise dose delivered to fetus with consideration of gestational age, maternal body habitus and acquisition parameters\n> not performed after head scan (insignificant scatter radiation to fetus)\n> not performed during first 2 weeks of pregnancy (all-or-nothing response)\n- Thermoluminescent dosimeter (TLD) on skin of patient to determine surface dose if medical physicist not on staff:\n> fetal dose estimate $=1 / 3$ of entrance dose of average patient\n> if estimated dose $>50 \\mathrm{mGy}$ a consulting physicist is needed for detailed dosimetry report\n- Modify CT scans to use the lowest dose possible: $\\downarrow$ z-axis coverage, $\\uparrow$ pitch, $\\downarrow$ tube potential (kilovolt peak), $\\downarrow$ tube current-time product (milliampere-second)\n\n\n# Effect of lonizing Radiation on Fetus \n\n$=$ biologic effect of ionizing radiation on physical and chemical processes result in\n(1) cell death OR\n(2) morphologic effects (via alteration of nuclear DNA) $\\rightarrow$ genetic mutation (teratogenesis) / carcinogenesis\n\n## Deterministic Effects\n\n$=$ NONSTOCHASTIC EFFECT $=$ THRESHOLD EFFECT\n[ terminus, Latin = end, limit; determinare, Latin = setting limits]\n$=$ dose threshold before damage occurs to a number of cells (= multicellular damage) caused by radiation at high doses\nEffect: malformation, growth + mental retardation, death\nRisk: increasing with increasing dose",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 413,
            "markdown": "Dose threshold: 100 mGy to fetus (dependent on time of exposure to gestation)\n\n- $3 \\%$ chance of cancer (leukemia, breast, thyroid, brain)\n- $6 \\%$ chance of mental retardation\n- $15 \\%$ chance of microcephaly\n- loss of 30 IQ points per 100 mGy\n$\\diamond$ NO risk to embryo / fetus from any diagnostic procedure!\nVulnerable stage: $8^{\\text {th }}-15^{\\text {th }}$ (range, $2^{\\text {nd }}-20^{\\text {th }}$ ) week GA\nRecommendation: assess for pregnancy termination at 150 mGy exposure to fetus\n\n\n# Stochastic Effects \n\n[ stokhastikos, Greek = capable of guessing, conjecture]\n= damage to a single cell with exposure to any amount of ionizing radiation increasing with radiation dose\nEffect: carcinogenesis, other germ cell mutation\nDose threshold: none\nIncremental risk of cancer:\nfetal dose up to 1 mGy: $\\quad<1 \\div 10,000$\nfetal dose of $20-50 \\mathrm{mGy}: \\quad<1 \\div 250$\n(general population without radiation: $\\quad 1 \\div 500$ )\n\n## Effect of Diagnostic Imaging on Fetus\n\nNatural background radiation: 1 mGy to fetus during pregnancy\n$\\diamond$ Most radiologic studies use ionizing radiation of $<0.05 \\mathrm{~Gy}(50 \\mathrm{mGy})$ resulting in a negligible risk compared to natural risks of pregnancy\nNatural risks of pregnancy:\n$>15 \\%$ risk of spontaneous abortion\n$>4 \\%$ risk of prematurity\n$>4 \\%$ risk of growth retardation\n$>3 \\%$ risk of spontaneous birth defect\n$>1 \\%$ risk of mental retardation\nA fetal radiation dose of 50 mGy increases the overall lifetime risk for cancer by $2 \\%$ !\nFetal radiation doses of $<50 \\mathrm{mGy}$ are not associated with increased fetal malformation or fetal loss throughout pregnancy!\nA fetal radiation dose of $<100 \\mathrm{mGy}$ also should not be considered a reason to terminate pregnancy.\n\n## CT during Pregnancy\n\n(a) head / cervical spine / extremities: little concern during any trimester of pregnancy\n(b) Chest = low-dose examination when fetus is excluded from primary beam\n(c) renal stones, appendicitis, pulmonary emboli: no fetal neurologic deficits\n(d) appendicitis: may double risk for childhood cancer\n$\\diamond$ US and MR should be considered whenever possible!\nDuring pregnancy CT is the first-line imaging modality for trauma and suspected pulmonary emboli. Trauma is the leading cause of nonobstetric maternal mortality worldwide.\nIn developing countries, venous thromboembolism is the leading cause of maternal mortality.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 414,
            "markdown": "# MR during Pregnancy \n\nConcern: heating effects of RF pulses and acoustic noise\n$\\diamond$ No known harmful effects to date at $\\leq 1.5 \\mathrm{~T}$\nMR imaging can be used in pregnant patients regardless of gestational age (1) when the information gained is likely to alter treatment, (2) when it cannot be obtained through other nonionizing means, and (3) when MR imaging cannot be delayed until completion of the pregnancy.\nRecommendation: written informed consent to document patient's understanding of risk-benefit ratio + any alternative diagnostic options\n\n## US during Pregnancy\n\n$\\diamond$ No documented adverse effects on fetus from US",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 415,
            "markdown": "| Estimated Radiation Doses to Fetus |  |\n| :--: | :--: |\n| Type of Exam | Fetal Dose (mGy) |\n| Annual background radiation | $1.1-2.5$ |\n| High Dose (10-50 mGy) |  |\n| Abdominal CT | $1.3-35$ |\n| Pelvic CT | $10-50$ |\n| CT abdomen \\& pelvis | 25 |\n| CT angio of aorta | 34 |\n| PET/CT | $10-50$ |\n| Moderate Dose (0.1-10.0 mGy) |  |\n| Radiography |  |\n| Abdomen (AP) 21-cm patient thickness | 1.0 |\n| Abdomen (AP) 33-cm patient thickness | 3.0 |\n| L spine (2 views) | $1.0-10$ |\n| IVP | $5-10$ |\n| DC barium enema | $1.0-2.0$ |\n| CT |  |\n| Head \\& neck CT | $0-10$ |\n| Chest CT / angio CT of chest | $0.01-0.66$ |\n| CT pelvimetry (single section) | $<1$ |\n| CT of coronaries | 0.1 |\n| NucMed |  |\n| Perfusion scintigram (low dose) | $0.1-0.5$ |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ bone scintigram | $4-5$ |\n| Pulmonary DSA | 0.5 |\n| Low Dose ( $<0.1 \\mathrm{mGy}$ ) |  |\n| C-spine (2 views) | $<0.001$ |\n| Extremity radiography | $<0.001$ |\n| Mammography (2 views) | $0.001-0.010$ |\n| T-spine | 0.003 |\n| CXR (2 views) | $0.0005-0.0100$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 416,
            "markdown": "| Estimated Radiation Doses to Fetus from a Single Acquisition with a 64-Row CT Scanner |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n|  |  | CT Protocol |  | Imaging Parameters |  |\n| Type of CT <br> Exam | Fetal Dose (mGy) | Section <br> Thickness (mm) | Noise <br> Index | Tube CurrentTime Product (mAs) | Pitch |\n| Chest | 0.02 | 2.5 | 30 | 80 | 1.375 |\n| Pulmonary angio | 0.02 | 1.25 | 30 | 88 | 0.984 |\n|  | $\\begin{gathered} 0.24-0.66 \\text { in anthropomorphic phantom with } 16 \\text {-row } \\\\ \\text { CT } \\end{gathered}$ |  |  |  |  |\n| Abdomen | 1.3 | 2.5 | 36 | 110 | 1.375 |\n| Urinary tract | 11 | 2.5 | 36 | 110 | 1.375 |\n|  | 4-12 in anthropomorphic phantom with 16-row CT |  |  |  |  |\n| Pelvis | 13 | 2.5 | 36 | 130 | 1.375 |\n| Abdomen \\& Pelvis | 13 | 2.5 | 36 | 130 | 1.375 |\n|  | 15-40 in anthropomorphic phantom with 16-row CT |  |  |  |  |\n| Angio | 13 | 2.5 | 30 | 130 | 1.375 |\n\nUpper exposure limit: $720 \\mathrm{~mW} / \\mathrm{cm}^{2}$ for spatial-peak temporal average intensity Doppler US: can produce high intensities\n$\\diamond$ Keep exposure time + acoustic output at lowest level possible\n\n# Clinical Scenarios \n\n## Abdominal Pain in Pregnancy\n\nImaging sequence: US $\\rightarrow$ low-dose CECT / MR (if US nondiagnostic)\n\n## Acute Appendicitis in Pregnancy\n\n$\\diamond$ Most common nonobstetric emergency requiring surgery during pregnancy!\nAssociated with: premature labor, fetal morbidity + mortality, high rate of perforation\n\n- limited use of clinical signs in pregnancy\n\nImaging sequence: US with graded compression $\\rightarrow$ MR / CECT (if US nondiagnostic)\n> Graded Compression US: 66-100\\% sensitive, 95-96\\%specific\n> MR: $100 \\%$ sensitive, $94 \\%$ specific, $94 \\%$ accurate, PPV of $1.4 \\%$, NPV of $100 \\%$\n> CT: $92 \\%$ sensitive, $99 \\%$ specific, NPV of $99 \\%$\nAssociated cancer risk: $1 \\div 500$ fetuses exposed to 30 mGy\n\n## Pulmonary Embolism in Pregnancy\n\nPrevalence: $0.5-3.0 \\div 1,000$ pregnancies\nRisk of DVT: $5 \\times$ increase compared to nonpregnant state $\\leftarrow \\uparrow$ venous stasis + hypercoagulability\nMortality: up to $15 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 417,
            "markdown": "- progressive $\\uparrow$ in D-dimer levels during normal pregnancy Imaging sequence: PA chest $\\rightarrow$ Doppler US $\\rightarrow$ CT angio chest OR V/Q scan (if allergic to iodine)\n> Compression US\nÂ» for thigh veins: $95 \\%$ sensitive, $98 \\%$ specific\nÂ» for iliac veins: low sensitivity\nN.B.: $10 \\%$ of patients have PE angiographically\n> CT angiography: $81-91 \\%$ sensitive, $93-97 \\%$ specific\n> High-probability V/Q scan: $41 \\%$ sensitive\nBenefit of CT (with abdominal shielding):\nÂ» radiation exposure comparable to V/Q scan\nÂ» allows identification of other causes of chest pain (pulmonary edema, pneumonia, pleural effusion)\n\n\n# Trauma in Pregnancy \n\n$\\diamond$ Leading nonobstetric cause of maternal death!\nPrevalence: 6-7\\% of pregnant women (MVA)\nFetal mortality: $3-38 \\%$ after blunt trauma $\\leftarrow$ placental abruption or maternal death / shock\n(a) low-level trauma: US\n(b) serious trauma: tailored CT of head, chest, abdomen, pelvis; MR for neural axis; angio for extravasation\n$\\diamond$ Concerns about fetal radiation exposure should neither deter nor delay radiologic evaluation!\n(c) uterine / fetal injury: US $\\pm$ CT / MR\n\n## Urolithiasis in Pregnancy\n\n$\\diamond$ Most common painful nonobstetric condition for hospitalization in pregnant patients!\n\n- admitting diagnosis in $28 \\%$ incorrect\n\nPrevalence: $0.4-5.0 \\div 1,000$ pregnancies\nPrognosis: $70-80 \\%$ of ureteral calculi pass spontaneously\nCx: pyelonephritis, premature labor induced by renal colic\nImaging sequence: US $\\rightarrow$ low-dose NECT (if US nondiagnostic)\n$>$ US: $34-95 \\%$ sensitive\n$>$ MR urography\n> low-dose CT: $>95 \\%$ sensitive, $>98 \\%$ specific\n\n## NEONATAL EXPOSURE TO IV CONTRAST MEDIA\n\n$\\diamond$ Interruption of breast feeding is NOT recommended! (not even for 24-48 hours)!\n> breast feeding is recommended as the only source of feeding for full-term healthy infants during first 6 months of life (WHO)\n> should be continued during first 2 years / longer if desired\n> temporary cessation can lead to complete weaning\nIt is not necessary to stop breast-feeding. Some mothers may prefer to express and discard breast milk for 12-24 hours after they are given contrast agents.",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 418,
            "markdown": "# Pharmacokinetics: \n\nnonionized and water-soluble iodinated + Gd-based contrast media have high molecular weight $\\rightarrow$ minimal binding to breast milk $\\rightarrow$ low concentration of injected dose in breast milk $(0.01 \\%$ for gadopentetate and $0.5 \\%$ for iohexol $) \\rightarrow$ contrast in milk peaks at 5 hours; undetectable after 12 hours\nOnly a small percentage of iodinated or Gd-based contrast material is excreted in breast milk and absorbed by the infant. There have been no reported cases of direct toxicity, allergic sensitivity, or reaction to these agents.\nIngested Dose: $0.2 \\%$ of maximum dose allowed for urography\n\n## IV CONTRAST MATERIAL IN PEDIATRICS\n\nConventional dose: $1 \\mathrm{~mL}+$ pound up to 150 mL\nMaximum dose: $280-300 \\mathrm{mg} \\mathrm{I} / \\mathrm{mL}$\nRecommended Pediatric Dose for Urography:\nfor babies $<6.5 \\mathrm{~kg}: 900 \\mathrm{mg} \\mathrm{I} / \\mathrm{kg}$ body weight\nfor babies $>7.0 \\mathrm{~kg}: 600 \\mathrm{mg} \\mathrm{I} / \\mathrm{kg}$ body weight",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 419,
            "markdown": "# OBSTETRIC AND GYNECOLOGIC DISORDERS \n\n## ABORTION\n\n$=$ loss of products of conception $<20$ weeks of MA (definitions may vary)\nA. INDUCED ABORTION\n(a) medical / therapeutic abortion\n(b) nonmedical abortion\nB. SPONTANEOUS ABORTION\n\n## Spontaneous Abortion\n\n$=$ FAILED PREGNANCY $=$ PREGNANCY LOSS $=$ MISCARRIAGE\nFrequency:\n$>50 \\%$ of all fertilized ova (estimate)\n$31-43 \\%$ of all implantations (estimate)\n$10-25 \\%$ of clinically diagnosed pregnancies\n$2-4 \\%$ with normal cardiac activity\n> decreases with increasing gestational age\nTime of loss: $<8-10$ weeks MA; majority before $7^{\\text {th }}$ week MA\nEtiology (usually due to abnormal karyotype):\nautosomal trisomy ( $52 \\%$ ), triploidy ( $20 \\%$ ), monosomy ( $15 \\%$ )\n$\\diamond$ Spontaneous pregnancy loss at $<8$ weeks gestation occurs in $10-17 \\%$ of embryos with cardiac activity!\n\n## Signs of Abnormal Pregnancy\n\n$\\sqrt{ }$ thin decidual reaction of $<2 \\mathrm{~mm}$\n$\\sqrt{ }$ abnormally shaped sac\n$\\sqrt{ }$ gestational sac low in uterus\n\n## Impending / Inevitable Abortion\n\n$=$ ABORTION IN PROGRESS\n$=$ gestational sac with embryo having become detached from implantation site $\\rightarrow$ spontaneous abortion within next few hours\n\n- Clinical triad: (1) bleeding $>7$ days, (2) persistent painful uterine contractions, (3) rupture of membranes\n- cervix moderately effaced / dilated $>3 \\mathrm{~cm}$\n$\\sqrt{ }$ sac located low within uterus (DDx: cervical ectopic with closed internal os)\n$\\sqrt{ }$ progressive migration of sac toward / into cervical canal (on rescanning a short time later)\n$\\sqrt{ }$ dilated cervix\n$\\sqrt{ }$ sac surrounded by anechoic zone of blood\n\n\n## Threatened Abortion\n\n$=1^{\\text {st }}$ trimester bleeding (after period of implantation bleed at 3-4 weeks MA) with a live",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 420,
            "markdown": "embryo\nFrequency: $20-25 \\%$ of all pregnancies\n\n- Clinical triad: (1) mild bleeding, (2) cramping, (3) closed cervix\n\n\n# NONVIABILITY DIAGNOSIS WITH CERTAINTY \n\non transvaginal ultrasound\n@ Cardiac activity:\n$\\sqrt{ }$ no cardiac activity with a CRL $\\geq 5 \\mathrm{~mm}$\n$\\sqrt{ }$ no cardiac activity with certain GA $\\geq 6.5$ weeks\n$\\sqrt{ }$ no cardiac activity with a GS diameter $>16 \\mathrm{~mm}$\n@ Yolk sac:\n$\\sqrt{ }$ no yolk sac with a GS diameter $\\geq 20 \\mathrm{~mm}$\n$\\sqrt{ }$ embryo visualized without demonstrable yolk sac\n$\\sqrt{ }$ yolk sac diameter $>5.6 \\mathrm{~mm}$ at $<10$ weeks MA\n@ GS contents:\n$\\sqrt{ }$ fibrinous strands / residual embryonic debris (in 25\\%)\n\n## NONVIABILITY DIAGNOSIS WITH HIGH PROBABILITY\n\non transvaginal ultrasound\n@ Ultrasound milestones not met as expected:\n$\\sqrt{ } \\geq 5.0$ weeks gestational sac first identifiable\n$\\sqrt{ } \\geq 5.5$ weeks yolk sac first identifiable\n$\\sqrt{ } \\geq 6.0$ weeks embryo and FHM first identifiable\n@ Yolk sac:\n$\\sqrt{ }$ no yolk sac with GS of 6-9 mm\n$\\sqrt{ }$ distorted sac configuration\n@ Choriodecidua\n$\\sqrt{ }$ thinning of choriodecidual reaction with hypoechoic clefts\n@ Cardiac activity:\n$\\sqrt{ }$ no cardiac activity with GS of $\\geq 9 \\mathrm{~mm}$\n$\\sqrt{ }$ slow embryonic heart rate (=bradycardia):\n\n| $\\leq 6.2$ Weeks | $\\leq 7.0$ Weeks | Mortality Rate |\n| :-- | :-- | :--: |\n| $>100 \\mathrm{bpm}$ | $>120 \\mathrm{bpm}$ | $11 \\%$ |\n| $90-99 \\mathrm{bpm}$ | $110-119 \\mathrm{bpm}$ | $32 \\%$ |\n| $80-89 \\mathrm{bpm}$ | $100-109 \\mathrm{bpm}$ | $64 \\%$ |\n| $<80 \\mathrm{bpm}$ | $<100 \\mathrm{bpm}$ | $100 \\%$ |\n\nPredictors of poor outcome:\n@ Bradycardia\n$\\sqrt{ }<85 \\mathrm{bpm}$ during 5-8 weeks EGA\n@ Small sac size = \"first-trimester oligohydramnios\"\n[mismomer: amnionic cavity is not diminished in size but rather the chorionic cavity]\n= MSD (mean sac diameter) - CRL $\\leq 5 \\mathrm{~mm}$ (with a live embryo at 5.5-9.0 weeks)\nPrognosis: miscarriage in $94 \\%$\n@ Abnormal yolk sac",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 421,
            "markdown": "$\\sqrt{ }$ failure to visualize yolk sac at 5.5 weeks $\\mathrm{MA}=$ mean diameter of $\\mathrm{GS} \\geq 8 \\mathrm{~mm}$\n$\\sqrt{ }$ yolk sac size $>5 \\mathrm{~mm}$\n$\\sqrt{ }$ calcification / debris within yolk sac\n$\\sqrt{ }$ double appearance of yolk sac\n@ Abnormal amnion\n$\\sqrt{ }$ mean diameter of amniotic cavity $>$ CRL\n@ Subchorionic hemorrhage\nFrequency: in up to $18 \\%$ of pregnancies during first half of pregnancy\nN.B.: significance controversial\n\nPrognosis: $50 \\%$ develop normally; $15-39 \\%$ blighted ovum, $4 \\%$ mole, $4-13 \\%$ ectopic pregnancy, $0-15 \\%$ incomplete abortion, $17-57 \\%$ missed abortion\n\n# Complete Abortion \n\n- absence of transvaginal bleeding, cervix closed\n- abrupt decline of serum $\\beta$-hCG\n$\\sqrt{ }$ IUP no longer visualized although documented previously\n$\\sqrt{ }$ thin regular endometrium ( $<10-15 \\mathrm{~mm}$ ) with apposed surfaces\n$\\sqrt{ }$ absence of central / eccentric fluid-filled sac\n$D D x$ : nongravid state, very early IUP, ectopic pregnancy\n$R x$ : dilatation \\& curettage may be avoided if IUP was documented previously\n\n\n## Incomplete Abortion\n\n$=$ RETAINED PRODUCTS OF CONCEPTION (RPOC)\n$=$ portion of chorionic villi (placental tissue) / trophoblastic tissue (fetal tissue) remaining within uterus after spontaneous abortion (= miscarriage) / planned termination / preterm or term delivery\n$=$ most frequent cause of secondary postpartum hemorrhage $\\left(2^{\\circ} \\mathrm{PPH}\\right)$\nIncidence: $\\quad$ 1st trimester: $40 \\%$\n$>2^{\\text {nd }}$ trimester $17 \\%$\n$>3^{\\text {rd }}$ trimester: $3 \\%$\n\n- incomplete placenta at delivery, patulous cervix\n- continued (occasionally massive) genital bleeding (may occur months / years after last abortion / delivery)\n- normal / low levels of $\\beta$-hCG\n\nUS:\n$\\sqrt{ }$ fetal parts / embryo / echogenic mass within uterine cavity (MOST ACCURATE SIGNS)\n$\\sqrt{ }$ irregular / angulated small gestational sac containing amorphous echogenic material\n$\\sqrt{ }$ ragged disrupted choriodecidual reaction\n$\\sqrt{ }$ subchorionic fluid $\\pm$ hemorrhage\n$\\sqrt{ }$ intracavitary heterogeneously echogenic mass separate from endometrium\n$\\sqrt{ }>8-10-13 \\mathrm{~mm}$ thickened endometrial echo complex\n$\\diamond$ Measurement of endometrial thickness alone is a poor test for diagnosing an incomplete miscarriage!\n$\\sqrt{ }$ calcification of retained products (late finding)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 422,
            "markdown": "| Incomplete Miscarriage versus Endometrial Thickness on US |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Endometrial <br> Thickness | Sensitivity | Specificity | PPV | NPV |\n| $>5 \\mathrm{~mm}$ | 0.94 | 0.05 | 0.85 | 0.13 |\n| $>8 \\mathrm{~mm}$ | 0.87 | 0.21 | 0.86 | 0.22 |\n| $>12 \\mathrm{~mm}$ | 0.75 | 0.37 | 0.87 | 0.80 |\n| $>15 \\mathrm{~mm}$ | 0.56 | 0.53 | 0.87 | 0.17 |\n| $>25 \\mathrm{~mm}$ | 0.10 | 0.32 | 0.88 | 0.33 |\n| Sawyer E, Ofuasia E, Ofili-Yebovi D et al.: The value of measuring endometrial thickness and volume on transvaginal ultrasound scan for the diagnosis of incomplete miscarriage. <br> Ultrasound Obstet Gynecol 2007; 29:205-209 |  |  |  |  |\n\n# Doppler US (x 2 improvement in diagnosis): \n\n$\\sqrt{ } \\pm$ increased vascularity in endometrial echo complex / intracavitary mass (compared to myometrium)\n$\\sqrt{ }$ flow velocity $>21 \\mathrm{~cm} / \\mathrm{sec}$ (supplying residual trophoblastic tissue)\n$\\sqrt{ } \\pm$ low-resistance internal blood flow often at endometrial-myometrial interface\nPitfalls: uterine AVM (involves myometrium only), endometrial polyp, submucosal fibroid\nMR:\n$\\sqrt{ }$ partially / delayed enhancing heterogeneous mass on T1WI + T2WI (DDx: gestational trophoblastic disease)\n$D x$ : presence of chorionic villi in curettage exhibiting variable vascularity\n$C x$ : endometritis, myometritis, peritonitis, septic shock, diffuse intravascular coagulation (with retention $>1$ month)\n$R x$ : expectant management, uterotonic medication (prostaglandin E1 analogs), suction D\\&C after IV oxytocin, hysteroscopic removal\n$D D x$ : intraluminal blood clot, mole, blighted ovum, embryonic demise, intrauterine fetal death\n\n## Placental Polyp\n\n$=$ intrauterine polypoid mass formed by a retained fragment of placental tissue after an abortion / term pregnancy\nPredilection: placenta accreta\nMR:\n$\\sqrt{ }$ hyperintense polypoid mass on T2WI\n$D D x$ : arteriovenous malformation, trophoblastic disease, endometrial polyp, submucosal myoma\n\n## Subinvolution of Placental Implantation Site\n\n$=$ exceptionally rare postpartum condition characterized by failure of uterine vessels to involute following delivery\nRisk factors: atony, multiparity, cesarean section, uterine prolapse, uterine fibroids, endometritis, coagulopathy, RPOC\n$\\sqrt{ }$ unusually large postpartum uterus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 423,
            "markdown": "$\\sqrt{ }$ dilated myometrial vessels\n\n# Missed Abortion \n\n$=$ dead conceptus within uterine cavity for $\\geq 8$ weeks occurring prior to 28 weeks MA Time of diagnosis: not before 13 weeks MA\n\n- brownish vaginal discharge, closed firm cervix\n$\\sqrt{ }$ no cardiac activity in a well-defined embryo with CRL $>9 \\mathrm{~mm}$ (on abdominal scan) / CRL $>5 \\mathrm{~mm}$ (on TV scan)\n$\\sqrt{ }$ gestation not in correspondence with menstrual age\n$\\sqrt{ }$ sac $>25 \\mathrm{~mm}$ in diameter without an embryo\n(DDx: anembryonic pregnancy)\n$\\sqrt{ }$ sac $>20 \\mathrm{~mm}$ without yolk sac\n$\\sqrt{ }$ crenated irregular / distorted angular sac configuration\n$\\sqrt{ }$ stringlike debris within gestational sac (in $25 \\%$ )\n$\\sqrt{ }$ discontinuous / irregular / thin ( 2 mm ) choriodecidual reaction\n$\\sqrt{ }$ no double decidual sac\n$\\sqrt{ }$ low sac position\n$\\sqrt{ }$ subchorionic collection\n$C x$ : coagulopathy $\\leftarrow$ low plasma fibrinogen (after 4 weeks in $2^{\\text {nd }}$ trimester pregnancy)\n$R x$ : suction $\\mathrm{D} \\& \\mathrm{C}$ (in $1^{\\text {st }}$ trimester); prostaglandin E suppositories (in $2^{\\text {nd }}$ trimester)\n$D D x$ : blighted ovum\n\n\n## ACARDIA\n\n$=$ ACARDIAC MONSTER $=$ TWIN REVERSED ARTERIAL PERFUSION SEQUENCE (TRAP)\n$=$ rare developmental anomaly of monochorionic twinning in which one twin develops without a functioning heart\nPrevalence: $1 \\div 30,000-35,000$ births; in $1 \\%$ of monozygotic twins\nPathophysiology:\nnormal twin perfuses acardiac twin through artery-to-artery + vein-to-vein anastomoses in shared placenta $\\rightarrow$ reversed circulation alters hemodynamic forces $\\rightarrow$ abnormal cardiac morphogenesis\nSpectrum:\n(1) Holoacardia $=$ no heart at all\n(2) Pseudoacardia $=$ rudimentary cardiac tissue\n$\\sqrt{ }$ proximity of the 2 cord insertions on placental surface linked by an arterioarterial anastomosis\n$\\sqrt{ }$ reversed arterial flow in cord toward acardiac twin\n$\\sqrt{ }$ fused placentas\n$\\sqrt{ }$ polyhydramnios\nA. PUMP TWIN\n\nRisk: increased for fetal demise + preterm labor\n$\\sqrt{ }$ morphologically normal\n$\\sqrt{ }$ cardiac overload signs: hydrops, IUGR, hypertrophy of right ventricle, increased cardiothoracic ratio, hepatosplenomegaly, ascites\nB. PERFUSED TWIN $=$ ACARDIAC TWIN",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 424,
            "markdown": "Pathophysiology: vascular anastomosis sustains life of acardiac monster Associated with: monochorial placenta (= same gender); wide range of abnormalities $\\sqrt{ }$ absent / rudimentary heart (\"acardius\")\n$\\sqrt{ }$ tiny / absent cranium (acephalus)\n$\\sqrt{ }$ small upper torso $\\pm$ absent / deformed upper extremities\n$\\sqrt{ }$ marked integumentary edema + cystic hygroma\nPrognosis: mortality of $100 \\%$ for perfused twin, $50 \\%$ for pump twin (increased with increased size of acardiac twin)\n$R x$ : laser ablation of umbilical cord to acardiac twin (up to 20-22 weeks)\n\n# ADENOMYOSIS \n\n$=$ ENDOMETRIOSIS INTERNA (term no longer used)\n$=$ focal / diffuse benign invasion of myometrium by endometrium (heterotopic \"endometrial islands\") inciting reactive myometrial (smooth muscle) hyperplasia\nCause: ? uterine trauma (parturition, myomectomy, curettage), chronic endometritis, hyperestrogenemia\nPrevalence: $5-70 \\%$ of hysterectomy specimens\nHormonal dependency:\nectopic endometrial glands of adenomyosis ( $=$ generally of basalis type of endometrium) do NOT respond to cyclic ovarian hormones (largely nonfunctioning $\\leftarrow$ resistance to hormonal stimulation unlike endometriosis); some degree of proliferative + secretory changes occur during menstrual cycle; tamoxifen (= nonsteroidal antiestrogen) increases incidence of adenomyosis in postmenopausal women\nPath: endometrial glands deeper than $1 / 4$ of thickness of junctional zone $=2-3 \\mathrm{~mm}$ below endometrial-myometrial junction\nHisto: endometrial glands + stroma within myometrium surrounded by smooth muscle hyperplasia\nAge: multiparous premenopausal women $>30$ years during menstrual life (later reproductive years)\nAssociated with: endometriosis (in 36-40\\%)\nTypes: diffuse form / focal (localized circumscribed) form\n\n- asymptomatic in $5-70 \\%$; pelvic pain, menorrhagia, dysmenorrhea (abates after menopause)\n$\\sqrt{ }$ globular uterine enlargement\nHSG:\n$\\sqrt{ }$ multiple small linear / saccular diverticula extending into myometrium\n$\\sqrt{ }$ uterine cavity may be enlarged / distorted\n$\\sqrt{ }$ irregular masslike filling defect in uterine fundus in focal adenomyosis\nUS ( $53-89 \\%$ sensitive, $67-98 \\%$ specific, $68-86 \\%$ accurate):\n$\\sqrt{ }$ poorly marginated hypoechoic heterogeneous areas within myometrium + myometrial cysts\n$\\sqrt{ }$ globular / asymmetrically enlarged uterus\nMR ( $78-93 \\%$ sensitive, $66-93 \\%$ specific, $85-90 \\%$ accurate):\n$\\sqrt{ }$ diffuse / focal thickening of junctional zone forming an ill-defined area of low SI $\\pm$ embedded bright foci on T2WI\nCx: infertility",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 425,
            "markdown": "$R x$ : conservative medical treatment (analgesics + minimally effective menstrual suppression Rx with danazol / GnRH agonist); surgical treatment (endometrial ablation, laparoscopy, lesion excision; alternatively uterine artery embolization; hysterectomy (the only definitive cure for debilitating adenomyosis)\n\n# Cystic Adenomyosis \n\n$=$ very rare well-circumscribed cystic myometrial lesion of hemorrhage in different stages of organization (in $40 \\%$ of diffuse adenomyosis, in $100 \\%$ of focal adenomyosis)\nPath: extensive menstrual bleeding into ectopic endometrium $\\leftarrow$ unusual response to cyclical ovarian hormones\nLocation: uterine origin confirmed by (a) myometrial splaying around lesion, (b) \"bridging vessel\" sign (c) separate distinct identification of ovaries\n$\\sqrt{ }$ \"Swiss cheese\" appearance of myometrium on US\n$\\checkmark$ miniature uterus:\n$\\checkmark$ fluid content of high SI $\\leftarrow$ hemorrhage at different stages of organization similar to endometriotic cyst\n$\\checkmark$ surrounding wall of inner zone of low SI on T1WI (= junctional zone)\n$\\checkmark$ relatively bright outer myometrium\n$D D x$ : (1) Leiomyoma with hemorrhagic degeneration\n(2) Hematometra\n\n## Diffuse Adenomyosis (67\\%)\n\nIn $90 \\%$ associated with: pelvic endometriosis (in women $<36$ years of age)\n\n- infertility $\\leftarrow$ impaired uterine contractility for directed sperm transport\n\nUS:\n$\\checkmark$ smooth uterine enlargement (DDx: diffuse leiomyomatosis)\n$\\checkmark$ asymmetric thickening of anterior and posterior myometrial walls\n$\\checkmark$ diffuse heterogeneous myometrial echotexture (in 75\\%):\n$\\checkmark$ nodular / linear areas of increased myometrial echogenicity (= heterotopic endometrial tissue)\n$\\checkmark$ area of decreased myometrial echogenicity (= smooth muscle hyperplasia)\n$\\checkmark$ HIGHLY SPECIFIC $<5 \\mathrm{~mm}$ small subendometrial cysts (in $50 \\%$ ) $\\leftarrow$ dilated cystic glands / hemorrhagic foci\n$\\checkmark$ widening of junctional zone $>12 \\mathrm{~mm}$ on T2WI\n$\\checkmark$ poor definition of endomyometrial junctional zone (= endometrial tissue extending into myometrium)\n$\\checkmark$ pseudowidening of endometrium $\\leftarrow$ increased myometrial echogenicity\n$\\checkmark$ lack of uterine contour abnormality / mass effect\nMR:\n$\\checkmark$ enlargement of the uterus\n$\\checkmark$ widening of junctional zone (= inner myometrium) $\\geq 12 \\mathrm{~mm}$ hypointense on T2WI, T2weighted SE images, contrast-enhanced T1WI $\\leftarrow$ hyperplasia of smooth muscle\n$\\checkmark$ bright foci on T2WI $(50 \\%) \\leftarrow$ islands of ectopic endometrial tissue + cystic dilatation of glands:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 426,
            "markdown": "$\\sqrt{ }$ pseudowidening of endometrium (= indistinct foci of endometrial invasion of myometrium)\n$\\sqrt{ }$ myometrial cysts + nodules, linear striations\n$\\sqrt{ }$ foci of high SI on T1WI $\\leftarrow$ hemorrhage within ectopic endometrial tissue\n$\\sqrt{ }$ variable degrees of enhancement always less than adjacent myometrium\n$D D x$ : (1) Marked physiologic thickening of junctional zone during menstruation (esp. cycle days $1+2$ )\n$\\diamond$ Avoid imaging during menstrual phase\n(2) Myometrial contraction (ill-defined hypointense area on T2WI in up to $75 \\%$, transient nature, distortion of endometrial lining)\n(3) Muscular hypertrophy (hypoechoic inner myometrium, diffuse junctional zone thickening)\n(4) Endometrial carcinoma (error in staging if adenomyosis coexists)\n\n# Focal Adenomyosis (33\\%) \n\n$=$ \"ADENOMYOMA\"\n$\\sqrt{ }$ polypoid mass (= polypoid adenomyoma / adenomyomatous polyp) protruding into uterine cavity (less commonly in myometrial / subserosal location)\nUS:\n$\\sqrt{ }$ focal echogenic myometrial mass of $2-7 \\mathrm{~cm}$ in diameter:\n$\\sqrt{ }$ mass of oval / elongated shape with ill-defined margins\n$\\sqrt{ }$ contiguity with junctional zone\n$\\sqrt{ }$ penetrating vascular pattern\nMR:\n$\\sqrt{ }$ oval myometrial mass with indistinct margins of primarily low SI on all sequences $\\leftarrow$ surrounding reactive dense smooth muscle hypertrophy\n$\\sqrt{ }$ widening of the junctional zone from 8 mm up to 12 mm\n$\\sqrt{ }$ focal thickening of junctional zone $>12 \\mathrm{~mm}$\n$\\sqrt{ }$ linear / round foci of high SI on T1WI within mass $\\leftarrow$ T1 shortening effect of methemoglobin in hemorrhagic foci\n$\\sqrt{ }$ spotty signal voids on GRE $\\leftarrow$ T2*-shortening effect of hemosiderin in old hemorrhagic foci\n$\\sqrt{ }$ foci of central high-intensity spots / linear striations on T2WI (= dilated endometrial glands in secretory phase / endometrial cyst, hemorrhagic focus) in $50 \\%$\n$\\sqrt{ }$ low to intermediate SI on DWI $\\leftarrow$ benign neoplastic nature\n$R x$ : polypectomy / myomectomy\n$D D x$ :\n(1) Fibroid = leiomyoma (round hypoechoic mass anywhere in myometrium, well-defined margins, separate from junctional zone, calcifications, edge shadowing, whorled appearance, draping pattern of dilated vessels in periphery of mass, low SI on T1WI + T2WI, no small foci of high SI on T2WI)\n(2) Adenomatoid tumor of uterus\n= rare benign mesothelial tumor difficult to distinguish from leiomyoma / adenomyoma\n(3) Metastatic myometrial involvement by cancer of breast, stomach, malignant lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 427,
            "markdown": "(4) Low-grade endometrial stromal sarcoma (rare, young woman, extensive myometrial invasion)\n\n# AMNIOTIC BAND SYNDROME \n\n$=$ CONGENITAL CONSTRICTION BAND SEQUENCE $=$ EARLY AMNION RUPTURE SYNDROME\n$=$ \"slash defects\" in nonanatomic distribution\nPathogenesis:\n(a) early amniotic rupture exposing the fetus to the injurious environment of constrictive\nfibrous mesodermic bands that emanate from the chorionic side of the amnion\n(b) vascular disruption events\n\nPrevalence: $0.5-1.0 \\div 10,000$ live births\n$\\sqrt{ }$ very thin sheet / band attached to fetus:\n$\\sqrt{ }$ fine linear echoes that extend from fetal defect to uterine wall but are difficult to see\n$\\sqrt{ }$ membrane that flaps with fetal movement\n$\\sqrt{ }$ restriction of fetal motion $\\leftarrow$ entrapment of fetal parts by bands\nAssociated with fetal deformities in $77 \\%$ :\n\n1. Limb defects (multiple + characteristically asymmetric)\n$\\sqrt{ }$ simple grooves / constriction rings of limbs / digits\n$\\sqrt{ }$ amputation of limbs / digits\n$\\sqrt{ }$ distal syndactyly\n$\\sqrt{ }$ clubbed feet $(30 \\%)$\n$\\sqrt{ }$ gibbus deformity of spine\n2. Craniofacial defects\n$=$ asymmetric nonanatomic defects of skull + brain\n$\\sqrt{ }$ pterygium, facial cleft\n$\\sqrt{ }$ anencephaly\n$\\sqrt{ }$ asymmetric lateral encephalocele\n$\\sqrt{ }$ facial clefting of lip / palate\n$\\sqrt{ }$ asymmetric microphthalmia\n$\\sqrt{ }$ incomplete / absent cranial calcification\n$\\sqrt{ } \\pm$ attachment of head to uterine wall\n3. Visceral defects\n$\\sqrt{ }$ thoracoschisis\n$\\sqrt{ }$ abdominoschisis $\\pm$ exteriorization of liver\n$\\sqrt{ }$ normal umbilical cord\nDDx of abdominoschisis due to bands from body stalk anomaly depends on demonstration of a normal umbilical cord.\n$\\sqrt{ }$ abdominal contents floating in amniotic fluid without clear visualization of encasing membrane\n$D D x$ : (1) Chorioamnionic separation $\\leftarrow$ subchorionic hemorrhage\n(2) Intrauterine synechiae\n(3) Adams-Oliver syndrome (aplasia cutis, limb defects), scalp and skull defects at vertex associated with often asymmetric transverse limb defects",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 428,
            "markdown": "(4) Body stalk anomaly\n\n# ANEMBRYONIC PREGNANCY \n\n$=$ BLIGHTED OVUM\n$=$ abnormal intrauterine pregnancy with developmental arrest prior to formation of embryo; may occur as a blighted twin\nCause: early arrest of embryonic development related to chromosomal abnormality\n\n- $\\pm$ vaginal bleeding\n$\\checkmark$ empty gestational sac ( $>6.5$ weeks MA)\n$\\checkmark$ yolk sac identified without embryo:\n$\\checkmark$ vanishing (passed) yolk sac on serial scans\n$\\checkmark$ gestational sac small / appropriate / large for dates:\n$\\checkmark$ decrease in gestational sac (GS) size\n$\\checkmark$ GS fails to grow by $>0.6 \\mathrm{~mm} /$ day on serial scans\n$\\checkmark$ irregular weakly echogenic decidual reaction of $<2 \\mathrm{~mm}$\n$\\checkmark$ distorted sac shape\n(a) by transabdominal scan:\n\nGS usually not visualized before 5.0-5.5 weeks MA; yolk sac forms at 4 weeks MA when\nGS is 3 mm ; embryo usually visualized by 6 weeks MA\n$\\checkmark$ GS size $\\geq 10 \\mathrm{~mm}$ of mean diameter without DDS\n$\\checkmark$ GS size $\\geq 20 \\mathrm{~mm}$ of mean diameter without yolk sac\n$\\checkmark$ GS size $\\geq 25 \\mathrm{~mm}$ of mean diameter without embryo\n(b) by transvaginal scan\nnormal intradecidual GS routinely detected at $4-5$ weeks with a mean sac diameter of 5 mm\n$\\checkmark$ GS size $\\geq 8 \\mathrm{~mm}$ of mean diameter without yolk sac\n$\\checkmark$ GS size $\\geq 16 \\mathrm{~mm}$ of mean diameter without cardiac activity\n$C x$ : first trimester bleeding\n\n## ARTERIOVENOUS MALFORMATION OF UTERUS\n\n$=$ UTERINE ARTERIOVENOUS FISTULA = UTERINE CIRSOID ANEURYSM\nAssociated with: dilatation \\& curettage, endometrial carcinoma, gestational trophoblastic disease\n\n- genital bleeding, often requiring blood transfusions\n\nMR:\n$\\checkmark$ tortuous tubular signal voids in myometrium / parametrium / protruding into endometrial cavity on T1WI + T2WI\n$\\checkmark$ vascular lake with sluggish flow hyperintense on T2WI\n$\\checkmark$ intensely enhancing lesion isointense to vessels on contrast-enhanced dynamic subtraction MR\n\n## ASHERMAN SYNDROME\n\n[Joseph G. Asherman (1889-?), Czech-Israeli gynecologist in Tel Aviv]\n$=$ association of multiple intrauterine synechiae ( $=$ adhesions consisting of fibrous tissue or smooth muscle) with menstrual dysfunction + infertility",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 429,
            "markdown": "Cause: sequelae of endometrial trauma (vigorous instrumentation during dilatation \\& curettage) usually during postpartum or postabortion period / severe endometritis\nPath: scars / bands of fibrous tissue (synechiae) connect opposing sides of the endometrium by crossing the endometrial cavity; scars cause the endometrial cavity to contract resulting in an irregular surface\n\n- hypomenorrhea / amenorrhea; habitual abortion / sterility\n\nHSG:\n$\\checkmark$ solitary / multiple filling defects\n$\\checkmark$ bands of tissue traversing endometrial cavity\n$\\checkmark$ irregular surface contour of uterine cavity\n$\\checkmark$ small uterine cavity partially / near completely obliterated (DDx: DES exposure)\nSonohysterography:\n$\\checkmark$ echogenic bands bridging the uterine cavity\n$\\diamond$ Thick fibrotic bands may prevent complete uterine distension\nMR:\n$\\checkmark$ small thin irregular endometrial cavity\n\n# BARTHOLIN GLAND CYST \n\n[Caspar Bartholin the Younger (1655-1738), Danish anatomist and physician]\n$=$ retention cyst\nOrigin: derived from urogenital sinus, female homologue of male (bulbourethral) Cowper glands\nCause: chronic inflammation / infection of gland $\\rightarrow$ ductal obstruction from purulent material / thick mucus\nHisto: lined by mucinous transitional cell / columnar epithelium\nLocation: posterolateral inferior $1 / 3$ of vaginal introitus medial to labia minora at / below level of pubic symphysis\nSize: $1-4 \\mathrm{~cm}$\n$\\checkmark$ unilocular cyst hyperintense on T2WI\n$\\checkmark$ variable T1 hyperintensity depending on proteinaceous / mucinous contents\n$R x$ : administration of silver nitrate; marsupialization; surgical excision\n\n## BECKWITH-WIEDEMANN SYNDROME\n\n[John Bruce Beckwith (1933-?), pediatric pathologist at Children's Orthopedic Hospital in Seattle, WA]\n[Hans Rudolf Wiedemann (1915-2006), chair of pediatrics at the University of Kiel, Germany]\n= EMG SYNDROME (Exomphalos = omphalocele, Macroglossia, Gigantism)\n$=$ common autosomal dominant overgrowth syndrome with reduced penetrance + variable expressivity related to short arm of chromosome 11; sporadic in $85 \\%$\nPrevalence: $1 \\div 13,700$ to $1 \\div 14,300$ live births; $\\mathrm{M} \\div \\mathrm{F}=1 \\div 1$\n$4 \\%$ risk for developing embryonal tumors:\nnephro-, hepato-, pancreatoblastoma, rhabdomyosarcoma\n\n- neonatal polycythemia\n$\\checkmark$ advanced bone age",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 430,
            "markdown": "# Constellation: \n\n(1) Hemihypertrophy $13-33 \\%$\n(2) Hyperplastic visceromegaly: $57 \\%$\nkidney, liver (hepatomegaly), spleen, pancreas, clitoris, penis, ovaries, uterus, bladder\n(3) Abdominal wall defects\n(a) Omphalocele $76 \\%$\n(b) Umbilical hernia $49 \\%$\n(c) Diastasis recti $33 \\%$\n(4) Macroglossia $98 \\%$\n(5) Facial nevus flammeus $63 \\%$\n(6) Ear lobe creases and pits $66 \\%$\n(7) Prominent eyes with intraorbital creases\n(8) Infraorbital hypoplasia $81 \\%$\n(9) Gastrointestinal malrotation $83 \\%$\n(10) Pancreatic islet hyperplasia $\\rightarrow$ hyperglycemia\n(11) Cardiac anomalies\n(12) Natal / postnatal gigantism $77 \\%$\n@ Adrenal gland\nHisto: adrenocortical hyperplasia, hyperplastic adrenal medulla, cystic adrenal cortex, bilateral adrenal cytomegaly (= enlargement of fetal cortical cells)\n@ Kidney\nHisto: disordered lobar arrangement, medullary dysplasia\n$\\checkmark$ nephromegaly\n$\\checkmark$ increased cortical echogenicity $\\leftarrow$ glomeruloneogenesis\n$\\checkmark$ accentuation of corticomedullary definition\n$\\checkmark$ medullary sponge kidney\n$\\checkmark$ pyelocalyceal diverticula\nOB-US:\n$\\checkmark$ LGA fetus with growth along $95^{\\text {th }}$ percentile\n$\\checkmark$ polyhydramnios $(51 \\%)$\n$\\checkmark$ thickened placenta\n$\\checkmark$ long umbilical cord\nCx: (1) Development of malignant tumors (in 4\\%)\n(2) Neonatal hypoglycemia ( $50-61 \\%$ )\n\n## BRENNER TUMOR\n\n[Fritz Brenner (1877-1969), German physician and pathologist practicing in German South West Africa and Johannesburg]\n$=$ almost always benign uncommon epithelial-stromal ovarian tumor\nFrequency: $1.5-2.5 \\%$\nHisto: transitional epithelial cells (similar to urothelium) within prominent fibrous connective tissue stroma\nAssociated with: mucinous cystadenoma / other epithelial tumor in 20-30\\%\nPeak age: $40-70$ years",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 431,
            "markdown": "- may have estrogenic activity\n\nSize: most $1-2 \\mathrm{~cm}$ (up to 30 cm ) in diameter; bilateral in 5-7\\%\n$\\sqrt{ } \\pm$ extensive calcifications\nUS:\n$\\sqrt{ }$ usually hypoechoic solid homogeneous tumor with well-defined back wall\nMR:\n$\\sqrt{ }$ markedly hypointense tumor component on T2WI (fibrous component + calcifications)\n$\\sqrt{ }$ moderate enhancement (DDx: hypovascular fibrothecoma)\n\n# CERVICAL CARCINOMA \n\n$\\diamond$ Most common gynecologic malignancy in developing countries; $3^{\\text {rd }}$ most common gynecologic malignancy (after endometrial + ovarian cancer) in USA; $6^{\\text {th }}$ most common cause of death from cancer in women\nHighest prevalence: Central + South America $>$ South Central Asia $>$ parts of Africa\nIncidence: $12 \\div 100,000$ women annually; 12,990 new cases $+4,120$ deaths in USA (2016)\nPeak age: $45-55$ years\nHisto: squamous cell carcinoma ( $80-95 \\%$ ) arising low in endocervical canal, adenocarcinoma $(5-20 \\%)$ arising from endocervical columnar epithelium, clear cell adeno-carcinoma (unusual) in women exposed to DES in utero\nRisk factors: lower socioeconomic standing, Black race, early marriage, multiparity, early age at first intercourse, multiple sexual partners, cigarette smoking, immunosuppressed state, use of oral contraceptives, human papilloma virus infection (HPV serotypes $16,18,31,33,56 \\rightarrow>80 \\%$ of all invasive cervical carcinomas)\nSignificance of tumor size:\n$>4 \\mathrm{~cm}$ : nodal metastases ( $80 \\%$ ), local recurrence ( $40 \\%$ ), distant metastases ( $28 \\%$ )\n$<4 \\mathrm{~cm}$ : nodal metastases ( $16 \\%$ ), local recurrence ( $5 \\%$ ), distant metastases ( $0 \\%$ )\nSpread:\n(a) direct extension to lower uterine segment + vagina + paracervical space along uterosacral and broad ligaments\n(b) lymphatic: paracervical $>$ parametrial $>$ hypogastric + obturator $>$ external iliac $>$ common iliac + presacral $>$ para-aortic nodes\n(c) hematogenous: lung, liver, bone\n\n- leukorrhea $\\pm$ abnormal vaginal bleeding $(<30 \\%)$\n- intermenstrual / postcoital bleeding / metrorrhagia\n\nClinical staging: limited accuracy of $66 \\%$ stage I (78\\%), stage III (25\\%)\nLocation:\narises almost exclusively from transformation zone (= squamo- columnar junction)\n(a) on cervix (in young woman)\n(b) in endocervical canal (older woman)\nwith protrusion into vagina / invasion of lower myometrium\nTumors tend to be exophytic in younger patients + endophytic in older patients $\\leftarrow$ variable location of transformation zone with advancing age\nUS:\n(a) Primary tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 432,
            "markdown": "$\\sqrt{ }$ small tumor isoechoic to mucosa difficult to detect\n$\\sqrt{ }$ altered echotexture + distortion of normal cervical morphology + lack of compressibility with increasing size\n$\\sqrt{ }$ color Doppler US may facilitate visualization and delineation of tumor $\\leftarrow$ hypervascular tumor (in 95\\%)\nCT:\n(a) Primary tumor\n\n| Staging of Cervical Cancer (2009) |  |  |\n| :--: | :--: | :--: |\n| FÃ©dÃ©ration Internationale de GynÃ©cologie et d'ObstÃ©trique (FIGO) |  |  |\n| FIGO | Description | Nodal |\n| Stage |  | Metastases |\n| 0 | Carcinoma in situ (before invasion) | $0.3 \\%$ |\n| I | Confined to cervix |  |\n| IA | preclinical microscopic invasion |  |\n| IA1 | microinvasion of stroma ( $\\leq 3 \\mathrm{~mm}$ deep and $\\leq 7 \\mathrm{~mm}$ wide) | $0.3 \\%$ |\n| IA2 | tumor $>3 \\mathrm{~mm}$ and $\\leq 5 \\mathrm{~mm}$ deep and $\\leq 7 \\mathrm{~mm}$ horizontal spread | $14 \\%$ |\n| IB | tumor larger than IA | $16 \\%$ |\n| IB-1 | clinically visible lesion $\\leq 4 \\mathrm{~cm}$ |  |\n| IB-2 | clinically visible lesion $>4 \\mathrm{~cm}$ |  |\n| II | Extension beyond cervix but not to pelvic wall / lower $1 / 3$ of vagina |  |\n| IIA | no parametrial invasion | $33 \\%$ |\n| IIA1 | clinically visible lesion $\\leq 4 \\mathrm{~cm}$ in diameter |  |\n| IIA2 | clinically visible $>4 \\mathrm{~cm}$ in diameter |  |\n| IIB | parametrial invasion excepting pelvic sidewall | $37 \\%$ |\n| III | Extension to pelvic wall or lower $1 / 3$ of vagina or hydronephrotic / nonfunctioning kidney |  |\n| IIIA | invasion of lower $1 / 3$ of vagina |  |\n| IIIB | pelvic side wall invasion + hydronephrosis |  |\n| IV | Located outside true pelvis or invasion of bladder or rectal mucosa | $55 \\%$ |\n| IVA | invasion of bladder / rectal mucosa |  |\n| IVB | spread to distant organs (paraaortic / inguinal nodes, intraperitoneal metastasis) |  |\n\n$\\sqrt{ }$ growth pattern: exophytic, infiltrating, endocervical\n$\\sqrt{ }$ bulky enlargement of cervix $>3.5 \\mathrm{~cm}$ (DDx: cervical fibroid)\n$\\sqrt{ }$ iso- (50\\%) / hypoattenuating after IV contrast $\\leftarrow$ necrosis, ulceration, reduced vascularity\n$\\sqrt{ }$ gas within tumor (necrosis / prior biopsy)\n$\\sqrt{ }$ fluid-filled uterus (blood, serous fluid, pus) $\\leftarrow$ obstruction\n$\\sqrt{ }$ hypoattenuating lesion of myometrium / with vaginal distension\n(a) Parametrial spread ( $30-58 \\%$ accuracy):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 433,
            "markdown": "$\\checkmark$ parametrial soft-tissue mass\n$\\checkmark$ ureteral encasement\n$\\checkmark$ thickening of ureterosacral ligaments\n$\\checkmark>4$-mm soft-tissue strands of increased attenuation extending from cervix into parametria, cardinal / sacrouterine ligaments\n$\\checkmark$ obliteration of fat planes\n$\\checkmark$ ill-defined irregular cervical margins\n$\\checkmark$ eccentric parametrial enlargement\n$D D x$ : parametrial inflammation $\\leftarrow$ instrumentation, ulceration, infection, prior pelvic surgery, endometriosis\n@ Pelvic side wall disease\n$\\checkmark$ tumor $<3 \\mathrm{~mm}$ from side wall\n$\\checkmark$ enlarged piriform / obturator internus muscles\n$\\checkmark$ encasement of iliac vessels\n$\\checkmark$ destruction of pelvic bones\n@ Pelvic visceral disease ( $60 \\%$ PPV)\n$\\checkmark$ loss of perivesical / perirectal fat plane\n$\\checkmark$ asymmetric nodular thickening of bladder / rectal wall\n$\\checkmark$ intraluminal mass\n$\\checkmark$ air in bladder $\\leftarrow$ fistula\n@ Lymphatic spread ( $65-77-80 \\%$ accuracy)\n$\\checkmark$ nodes $>1 \\mathrm{~cm}$ in diameter ( $>7 \\mathrm{~mm}$ for internal iliac nodes, $>9 \\mathrm{~mm}$ for common iliac nodes, $>10 \\mathrm{~mm}$ for external iliac nodes) with $44 \\%$ sensitivity\n$\\checkmark$ lymph node necrosis ( $100 \\%$ PPV)\n$D D x$ : adenopathy from secondary tumor infection\nMR (76-78-91\\% accuracy for staging, 82-94\\% accuracy for parametrial involvement):\n@ Primary tumor\n$\\checkmark$ focal bulge / mass in cervix:\n$\\checkmark$ mass isointense on T1WI\n$\\checkmark$ hyperintense on T2WI compared with fibrous stroma (DDx: postbiopsy changes, inflammation, nabothian cysts)\n$\\checkmark$ size of tumor accurately depicted (on T2WI rarely overestimated due to inflammation / edema)\n$\\checkmark$ Tumor diameter and probability of recurrence + metastases are related; tumor diameter $>4 \\mathrm{~cm}$ (stage IB2) means no surgical treatment\n$\\checkmark$ early contrast enhancement on fat-saturated T1WI\n$\\checkmark$ blurring + widening of junctional zone (retained secretions in uterine cavity) $\\leftarrow$ obstruction of cervical os\n$\\checkmark$ disruption of hypointense vaginal wall by hyperintense thickening on T2WI\n$\\checkmark$ disruption of hypointense cervical fibrous stromal ring on T2WI by nodular / irregular tumor SI\n@ Parametrial invasion (best seen on T1WI):\n$\\checkmark$ low-intensity spiculated areas of soft tissue radiating from periphery of cervical mass\n$\\checkmark$ irregular lateral margins of cervix = linear stranding around cervical mass\n$\\checkmark$ thickening of uterosacral ligament",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 434,
            "markdown": "@ Pelvic sidewall invasion\n$\\checkmark$ tumor involves obturator internus, piriform, levator ani m.\n$\\checkmark$ dilatation of ureter + hydronephrosis\n@ Pelvic visceral disease\n$\\checkmark$ disruption of hypointense walls of bladder / rectum (DDx: hyperintense thickening of bladder wall on T2WI $\\leftarrow$ bullous edema)\n@ Lymphatic spread\n$\\checkmark$ lymphadenopathy $>10 \\mathrm{~mm}$, hyperintense compared with muscle / blood vessels on T2WI\nPET/CT:\nIndication: staging, restaging, evaluation of response to therapy\nPitfalls:\n(1) Cyclical endometrial uptake during ovulatory + menstrual phases\n(2) Attenuation correction artifact with metallic prosthetic implants, IUD, surgical clips\n(3) Physiologic ovarian uptake in premenopausal women by corpus luteum\n(4) Uptake by uterine leiomyoma\n(5) Uptake by postsurgical healing, radiation fibrosis, infection\n\nPrognosis: depending on tumor stage + volume of primary mass + histologic grade + lymph node metastases; in $30 \\%$ recurrent / persistent disease (usually within 2 years)\n5-year survival rate: tumor diameter $\\leq 1 \\mathrm{~cm} \\quad 84 \\%$\ntumor diameter $>4 \\mathrm{~cm} \\quad 67 \\%$\nstage IIB $65 \\%$\nstage III $40 \\%$\nstage IVA $<20 \\%$\nCx: stenosis + obstruction of cervical canal $\\rightarrow$ hydrometra, hematometra, pyometra\nRx: (1) Surgery for stages $<$ IIA / tumor $<4 \\mathrm{~cm}$\n(2) Radiation therapy $\\pm$ chemotherapy for stages $>$ IIB\n\nPrevention: human papillomavirus vaccine\n$D D x$ : (1) Endometrial polyp / adenocarcinoma (centered in endometrial cavity protruding into endocervical canal)\n(2) Prolapsed submucosal fibroid (more hypointense on T2WI)\n\n# Recurrent Cervical Carcinoma \n\n$=$ local tumor growth / development of distant metastasis $\\geq 6$ months after complete regression\n@ Pelvic recurrence\nPrevalence: varies with stage, histologic type, adequacy of therapy, host response; $11 \\%$ in stage IB\nSite: cervix, uterus, vagina / vaginal cuff, parametria, ovaries, bladder, ureters, rectum, anterior abdominal wall, pelvic side wall\n\n- lower extremity swelling $\\leftarrow$ lymphatic obstruction\n- pain $\\leftarrow$ nerve compression, ureteral obstruction\n$\\checkmark$ hydrometra $\\leftarrow$ obstruction by preserved cervix",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 435,
            "markdown": "$\\sqrt{ }$ rectovaginal fistula\n$\\sqrt{ }$ hydronephrosis ( $70 \\%$ by autopsy)\n$\\sqrt{ }$ vesicovaginal fistula\n$\\sqrt{ }$ pelvic side wall mass\n$D D x:$ radiation fibrosis ( $82 \\%$ MR accuracy)\n@ Nodal recurrence\n$\\diamond$ Prognosis worsens as nodal involvement progresses!\n(a) primary: paracervical, parametrial, internal + external iliac, obturator nodes (= medial group of the external iliac nodes)\nFrequency: in $75 \\%$ of adenocarcinoma, in $61 \\%$ of squamous cell carcinoma (autopsy)\n(b) secondary: sacral, common iliac, inguinal, paraaortic nodes Frequency: in $62 \\%$ of adenocarcinoma, in $30 \\%$ of squamous cell carcinoma (autopsy)\n@ Solid abdominal organ recurrence\nLocation: liver (33\\%) > adrenal gland (15\\%) > spleen, pancreas, kidney\n@ Peritoneal recurrence\n\n1. Peritoneal carcinomatosis (5-27\\% by autopsy)\n2. Tumor deposits in mesentery + omentum\n\n- Sister Joseph nodule $=$ umbilical metastasis developing from anterior peritoneal surface\n@ GI tract recurrence\nLocation: rectosigmoid junction (17\\%), colon, small bowel\n$\\sqrt{ }$ fistula formation\n$\\sqrt{ }$ focal bowel wall thickening + tethering\n$\\sqrt{ }$ intestinal obstruction ( $12 \\%$ by autopsy)\nPrognosis: immediate cause of death in $7 \\%$\n@ Chest recurrence\n\n1. Lung metastases ( $33-38 \\%$ by autopsy)\n2. Pleural metastases associated with hydrothorax\n3. Pericardial metastasis\n4. Lymphangitic carcinomatosis $(<5 \\%)$\n5. Mediastinal / hilar adenopathy + pleural lesions / effusion\n@ Osseous recurrence\nPrevalence: $15-29 \\%$ by autopsy\nLocation: vertebra $>$ pelvis $>$ rib $>$ extremity\nMechanism: direct extension from paraaortic nodes (most common) / lymphatic / hematogenous spread\n@ Skin + subcutaneous tissue recurrence (in up to $10 \\%$ )\n\n# CHORIOAMNIONIC SEPARATION \n\n(a) normally seen $<16$ weeks MA\n\nCause: incomplete fusion of amniotic membrane with chorionic plate\n(b) abnormal $>17$ weeks MA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 436,
            "markdown": "Cause: hemorrhage / amniocentesis (10\\%)\n$\\sqrt{ }$ membrane extends over fetal surface + stops at origin of umbilical cord\n$\\sqrt{ }$ elevated membrane thinner than chorionic membrane\n$C x$ : rupture of amniotic membrane $\\rightarrow$ may lead to amniotic band syndrome\n$D D x$ : amniotic band syndrome, uterine synechia, fibrin strand after amniocentesis, cystic hygroma (moves with embryo)\n\n# CHORIOANGIOMA \n\n$=$ benign vascular malformation of proliferating capillaries (= hamartoma) without malignant potential\nPrevalence: $0.5-1.0 \\%$ of pregnancies; $>5 \\mathrm{~cm}$ in $1 \\div 3,500$ to $1 \\div 16,000$ births\n$\\diamond$ Most common tumor of the placenta\nHisto: angiomatous (capillary), cellular, degenerative subtypes\nLocation: usually near the umbilical cord insertion site supplied by fetal circulation\n\n- elevated maternal serum $\\alpha$-fetoprotein level (rare)\n\nUS:\n$\\sqrt{ }$ well-circumscribed hypo- / hyperechoic rounded intraplacental mass protruding from the fetal surface of the placenta into amniotic cavity\n$\\sqrt{ }$ contains anechoic cystic areas ( $=$ vessels)\n$\\sqrt{ }$ arterial signal on Doppler ultrasound in angiomatous chorioangioma\nMR:\n$\\sqrt{ }$ placental mass with high T2 SI (similar to hemangioma)\n$\\sqrt{ }$ heterogeneous $\\mathrm{SI} \\leftarrow$ acute infarction + degenerative changes\nPrognosis: regression after infarction\nMaternal Cx: preterm labor, toxemia, placental abruption, preeclampsia, hemorrhage\nFetal Cx (30-50\\%):\npolyhydramnios (in $1 / 2$ ), fetal hydrops, fetal hemolytic anemia, fetal thrombocytopenia, cardiomegaly, IUGR, congenital anomalies, fetal demise (with large / multiple lesion)\n$R x$ : expectant management with serial US imaging (6-8 week intervals for small tumors, 1-2 week intervals for large tumors); serial fetal transfusion, fetoscopic laser coagulation, chemosclerosis with absolute alcohol, endoscopic surgical devascularization\n$D D x$ : partial hydatidiform mole, placental hematoma, teratoma, metastasis, leiomyoma\n\n## CHORIOCARCINOMA\n\n$=$ remarkably aggressive\nFrequency: $<1 \\%$\n\n## Primary Ovarian Choriocarcinoma\n\n$=$ NONGESTATIONAL CHORIOCARCINOMA\nPrevalence: extremely rare; 50 cases in world literature\nAge: $\\quad<20$ years\nAssociated with: germ cell tumor / epithelial neoplasm\n\n- $\\uparrow$ serum hCG ( $100 \\%$ sensitive, $100 \\%$ specific)\n- isosexual precocity ( $50 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 437,
            "markdown": "$\\sqrt{ }$ usually unilateral\n$\\sqrt{ }$ vascular predominantly solid tumor with areas of hemorrhage + necrosis + cyst formation\nPrognosis: $90 \\% 5$-year survival in spite of typically late diagnosis at advanced stage\n$D D x$ : ectopic pregnancy (frequently mistaken diagnosis!), metastasis to ovary from gestational choriocarcinoma (reproductive age)\n\n# Gestational Ovarian Choriocarcinoma \n\nCause: metastasis from uterine choriocarcinoma (frequently bilateral ovarian masses); arising from ectopic ovarian pregnancy (extremely rare)\nAge: reproductive age\n\n## Gestational Uterine Choriocarcinoma\n\nPrevalence: 5\\% of gestational trophoblastic diseases\nAge: child-bearing age\nHisto: biphasic pattern including syncytiotrophoblastic + cytotrophoblastic proliferation without villous structures; extensive necrosis + hemorrhage; early + extensive vascular invasion\nPreceded by: mnemonic: MEAN\nMole (hydatidiform) in $50.0 \\%$\nEctopic pregnancy in $2.5 \\%$\nAbortion, spontaneous in $25.0 \\%$\nNormal pregnancy in $22.5 \\%$\n\n- continued elevation of hCG after expulsion of molar / normal pregnancy (25\\%); continued vaginal bleeding\nUS:\n$\\sqrt{ }$ mass enlarging the uterus\n$\\sqrt{ }$ mixed hyperechoic pattern (hemorrhage, necrosis)\nCT (useful for staging):\n$\\sqrt{ }$ heterogeneous predominantly hypoattenuating intrauterine tissue\n$\\sqrt{ }$ detection of distant metastases\nMR:\n$\\sqrt{ }$ heterogeneous hyperintense mass on T2WI\n$\\sqrt{ }$ focal signal voids (= vessels) on T1WI + T2WI\n$\\sqrt{ }$ disruption of hypointense myometrium (= local invasion)\n$\\sqrt{ }$ marked enhancement $\\leftarrow$ high vascularity\n$\\sqrt{ }$ enhancing parametrial tissue (= local spread)\nMetastases:\n(a) hematogenous (usually): lung, kidney ( $10-50 \\%$ ), brain\n$\\sqrt{ }$ radiodense pulmonary masses with hazy borders $\\leftarrow$ hemorrhage + necrosis\n$\\sqrt{ }$ hyperechoic hepatic foci\n(b) lymphatic: pelvic lymph nodes\n(c) direct extension (occasionally): vagina\n\nPrognosis: $85 \\%$ cure rate (even with metastases); fatal with spread to kidneys + brain\nRx: (1) Chemotherapy: methotrexate, actinomycin $\\mathrm{D} \\pm$ cyclophosphamide\n(2) Hysterectomy (if at risk for uterine rupture)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 438,
            "markdown": "$D D x:$ mnemonic: THE CLIP\nTrue mole\nHydropic degeneration of placenta\nEndometrial proliferation\nCoexistent mole and fetus\nLeiomyoma (degenerated)\nIncomplete abortion\nProducts of conception (retained)\n\n# CLEAR CELL NEOPLASM OF OVARY \n\n$=$ MESONEPHROID TUMOR\n$=$ almost always invasive carcinoma\nFrequency: $2-5-10 \\%$ of all ovarian cancers\nHisto: clear cells (cuboidal cells with clear cytoplasm) + hobnail cells (columnar cells with large nuclei projecting into the lumina of glandular elements); identical to clear cell carcinoma of endometrium, cervix, vagina, kidney; $\\sim 100 \\%$ malignant\nNot associated with: in utero DES exposure (like lesions of the vagina + cervix)\n\n- $75 \\%$ of patients present with stage I disease\n$\\checkmark$ frequently unilocular cyst + mural nodule(s)\nPrognosis: $50 \\% 5$-year survival rate (better than for other ovarian cancers)\n\n\n## CLOACAL EXSTROPHY\n\n$=$ exstrophy of all structures forming cloaca (rectum, bladder, lower GU tract) similar to bladder exstrophy\nPrevalence: $1 \\div 200,000-400,000$ live births; $\\mathrm{M}<\\mathrm{F}$\nCause: ? premature rupture of cloacal membrane; ? abnormal overdevelopment of lower cloaca preventing mesenchymal tissue migration: ? abnormal fusion of genital tubercle below cloacal membrane; ? abnormal caudal position of body stalk; ? failure of mesenchymal ingrowth\nAssociated abnormalities: OEIS\n(a) lumbosacral (common): vertebral column / spinal cord abnormalities, tethered cord, lipomeningocele, lipomyelocystocele\n(b) genitourinary (in up to $60 \\%$ ): hydronephrosis, renal developmental variants, abnormal genitalia, oligohydramnios $\\leftarrow$ renal obstruction\n$\\cdot$absent anal dimple $\\leftarrow$ anal atresia\n$\\checkmark$ low abdominal wall defect\n$\\checkmark$ absence of visible bladder\n$\\checkmark$ omphalocele (initial observation) as craniad part of large complex anterior wall defect extending inferiorly to pubis\n$\\checkmark$ \"elephant trunk\" = bowel herniation between everted bladder halves\n\n## CONJOINED TWINS\n\n$=$ incomplete division of embryonic cell mass in monozygotic twins occurring at 13-16 days but before the $3^{\\text {rd }}$ week of GA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 439,
            "markdown": "Prevalence: $1 \\div 50,000$ to $1 \\div 200,000$ deliveries; $1 \\div 14,000$ to $1 \\div 25,000$ in Southeast Asia + Africa; $1 \\div 600$ twin births; $\\mathrm{M}+\\mathrm{F}=1 \\div 3$\nOB-US (diagnosed as early as 12 weeks GA):\n$\\sqrt{ }$ single placenta without separating amniotic membrane (monochorionic, monoamniotic = HALLMARK OF MONOZYGOTIC TWINNING)\n$\\sqrt{ }$ inseparable fetal bodies + skin contours:\n$\\sqrt{ }$ fetuses commonly face each other\n$\\sqrt{ }$ both fetal heads persistently at same level\n$\\sqrt{ }$ no change in relative position of fetuses\n$\\sqrt{ }$ bibreech (more common) / bicephalic presentation (cephalic-breech presentation is most common presentation for omphalopagus)\n$\\sqrt{ }$ backward flexion of cervical spine (in anterior fusion)\n$\\sqrt{ }$ single cardiac motion (if heart shared)\n$\\sqrt{ }$ polyhydramnios (in almost $50 \\%$ )\n$\\sqrt{ }$ single umbilical cord with $>3$ vessels\n$\\sqrt{ }$ fewer limbs than expected\nAssociated malformations:\n$\\sqrt{ }$ omphalocele\n$\\sqrt{ }$ congenital heart disease (high frequency in all types of conjoined twinning)\nPrognosis: $40-60 \\%$ stillborn; $35 \\%$ die within 24 hours of life\n\n# Craniopagus \n\n$=$ united at any part of the skull except face / foramen magnum (usually vertical / parietal in $>$ $60 \\%)$\n$\\sqrt{ }$ shared cranium, meninges, dural venous sinuses (brains commonly remain separate $\\pm$ connecting bridge of neural tissue)\n\n## Ischiopagus\n\n$=$ united from umbilicus to large conjoined pelvis: face to face / end to end\nTypes: tetrapus (4 legs), tripus (3 legs), bipus (2 legs)\n$\\sqrt{ }$ usually two sacra $\\pm$ single symphysis pubis\n$\\sqrt{ }$ varying degrees of renal fusion + ectopia\n$\\sqrt{ }$ one / two urinary bladders\n$\\sqrt{ }$ single external urethral orifice (usually)\n$\\sqrt{ }$ shared sex organs (frequently born as females)\n$\\sqrt{ }$ lower GI tract usually shared with anal atresia + colovesical fistulas\n$\\sqrt{ }$ large pelvic vessel connecting both aortas\n\n## Omphalopagus\n\n$=$ joined ventrally in umbilical region, often with inclusion of lower thorax\n$\\sqrt{ }$ liver fusion $(80 \\%)$\n$\\sqrt{ }$ shared terminal ileum (joined Meckel diverticulum) + proximal colon (33\\%)\n\n## Parapagus\n\n$=$ side-to-side position with ventrolateral fusion sharing umbilicus, abdomen, pelvis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 440,
            "markdown": "Types: dithoracic (= separate thoraces), dicephalic (= separate heads)\n$\\checkmark$ conjoined pelvis with single symphysis pubis\n$\\checkmark$ one / two sacra\n$\\checkmark$ multiple other anomalies\n\n# Pygopagus \n\n[pegos, Greek = fixed, pegged]\n$=$ united dorsally sharing sacrococcygeal + perineal region\n$\\checkmark$ fusion of sacral vertebrae (spinal cords usually separate)\n$\\checkmark$ single anus $\\pm$ single rectum\n$\\checkmark$ single urinary bladder + urethra ( $15 \\%$ )\n\n| Conjoined Twins <br> classified according to most prominent site of connection |  |\n| :--: | :--: |\n| Superior Conjunction |  |\n| Dipygus ( $<1 \\%$ ) | single head, thorax, abdomen <br> + two pelves and four legs |\n| Syncephalus ( $<1 \\%$ ) | facial fusion $\\pm$ thoracic fusion |\n| Craniopagus (2\\%) | joined between homologous portions of cranial vault |\n| Middle Conjunction |  |\n| Thoracopagus (40\\%) | between thoracic walls; conjoined hearts ( $75 \\%$ ) |\n| Omphalopagus (33\\%) | joined between umbilicus + xiphoid |\n| Xiphopagus | joined at xiphoid |\n| Rachipagus | joined at any level of spinal column above sacrum |\n| Thoracoomphalopagus |  |\n| Inferior Conjunction |  |\n| Diprosopus ( $<1 \\%$ ) | two faces + one head and body |\n| Dicephalus ( $<1 \\%$ ) | two heads + one body |\n| Ischiopagus (6\\%) | joined by inferior sacrum and coccyx |\n| Pygopagus (19\\%) | joined by posterolateral sacrum and coccyx |\n| Incomplete Duplication (10\\%) | duplication of only one part of body |\n| The more fused twins are usually joined laterally, whereas the more separate twins are joined anteriorly, posteriorly, cranially, and caudally! |  |\n\n## Thoracopagus\n\n$=$ united from upper thorax to umbilicus\n$\\checkmark$ common sternum, diaphragm, upper abdominal wall\n$\\checkmark$ common pericardial sac $(90 \\%)+$ some degree of cardiac fusion\n$\\checkmark$ fusion of liver (invariably):\n$\\checkmark$ shared biliary system (in $25 \\%$ )\n$\\checkmark \\pm$ absent / anomalous hepatic venous drainage\n$\\checkmark$ common small intestine (in $50 \\%$ ): joined at duodenum + separated at distal ileum",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 441,
            "markdown": "Prognosis: cardiac fusion precludes successful surgical separation in $75 \\%$\n\n# CORD PROLAPSE \n\n$=$ prolapse / descent of cord into endocervical canal after rupture\nPrevalence: $0.5 \\%$ at delivery, $2-3 \\%$ prenatally\nPredisposing factors:\nlow birth weight, breech presentation, nonvertex fetal lie, polyhydramnios, cephalopelvic disproportion, multiparity, abnormal placentation, increased length of umbilical cord, velamentous cord insertion, spontaneous rupture of membranes\n\n- prolonged fetal bradycardia\n- severe and repetitive fetal heart rate decelerations\n\nMay be associated with: fetal hypoxia, perinatal death, fetal neurologic sequelae\nCx: cord compression with high perinatal mortality\nN.B.: MEDICAL EMERGENCY! Alert obstetrician immediately!\n\nOB management:\n(1) Patient immediately placed into Trendelenburg / knee-elbow position in radiology department (!)\n(2) Cesarean section for term infants\n(3) Expectant management for preterm infants\n\nDDx: Cord / funic presentation (= normal looping of umbilical cord between fetal presenting part and cervix)\n\n## DERMOID\n\n$=$ DERMOID CYST $=$ MATURE CYSTIC TERATOMA\n$=$ congenital benign slow-growing germ cell tumor containing mature tissues from all 3 germ cell layers with predominance of ectodermal component\nFrequency: $96 \\%$ of germ-cell tumors; 5-11-25\\% of all ovarian neoplasms; $20 \\%$ of ovarian tumors in adults; $50-80 \\%$ of pediatric ovarian tumors\n$\\diamond$ Most common ovarian neoplasm!\nOrigin: self-fertilization of a single germ cell after the first meiotic division (= random error in meiosis)\nPath: unilocular thin-walled cyst lined by an opaque gray-white wrinkled epidermis from which hair shafts protrude; lumen of cyst filled with sebaceous secretions mixed with hair strands\nHisto: composed primarily of mature ectodermal components (skin, hair follicles, sebaceous glands, teeth, desquamated epithelium); cartilage; bone; muscle; bronchus; fat; salivary gland; neuronal tissue; pancreas; retina; may contain struma ovarii, carcinoid tumor $\\diamond 15 \\%$ of mature cystic teratomas may not show a fat component on imaging!\nMean age: 36 years (range, 4 months to 74 years); age peak $20-40$ years; in $80 \\%$ during reproductive life; $\\mathrm{M}>\\mathrm{F}$\n\n- relatively soft pelvic mass $\\left({ }^{2} / 3\\right)$ difficult to palpate\n- pelvic pressure / pain $\\leftarrow$ torsion / hemorrhage\n- paraneoplastic syndrome (rare): autoimmune hemolytic anemia refractory to conventional therapy, virilization, hyperestrogenism; asymptomatic (mostly)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 442,
            "markdown": "Location: ovaries and testes (common); also anywhere along path of germ cell migration during embryogenesis, usually along midline of body; \"misplaced\" in head and neck, mediastinum, abdomen, omentum, retroperitoneum, abdominal viscera, sacrococcygeal region; bilateral in $8-15-25 \\%$\nMean diameter: $7-10 \\mathrm{~cm}$\n$\\sqrt{ }$ well-defined thin-walled heterogeneous mass $=$ mixture of solid and cystic components (appearance dependent on composition)\n$\\sqrt{ }$ fat, fat-fluid level, calcium within the same lesion is considered PATHOGNOMONIC (albeit present in only a minority of cases)\n$\\sqrt{ }$ cystic mass with macroscopic fat $(93 \\%)$ :\n$\\sqrt{ }$ fat-fluid / hair-fluid level\n$\\sqrt{ }$ \"dermoid plug\" = Rokitansky nodule $=10-65 \\mathrm{~mm}$ oval / round mural solid tissue protuberance / tubercle / nipple (mamilla) projecting into cyst lumen; often containing hair, calcific, dental, adipose or sebaceous components\n$\\sqrt{ }$ calcification $(56 \\%)$\nPlain film (diagnostic in 40\\%):\n$\\sqrt{ }$ tooth / bone\n$\\sqrt{ }$ fat density (SPECIFIC)\nUS ( $77-87 \\%$ sensitive):\n$\\sqrt{ }$ variable presentation (see table):\n$\\sqrt{ }$ complex mass containing echogenic components ( $66 \\%$ )\n$\\sqrt{ }$ predominantly solid mass ( $10-31 \\%$ )\n$\\sqrt{ }$ well-defined purely cystic mass ( $9-15 \\%$ )\n$\\sqrt{ }$ thin capsule + NO septa\n$\\sqrt{ }$ mixture of sebum + hair strands:\n$\\sqrt{ }$ clump of hair $=$ hyperechoic focus with multiple tissue interfaces that absorbs + reflects sound $\\rightarrow$ gradual \"dirty\" acoustic shadowing\n$\\sqrt{ }$ sebum (liquefied at body temperature) = background of anechoic fluid with variable internal echoes\n$\\sqrt{ }$ \"tip of the iceberg\" sign $\\rightarrow$ hair ball floating in sebum in $25-44 \\%$ (DDx: stool-filled rectosigmoid)\n\n| Sonographic Features of Dermoids |  |  |\n| :-- | :--: | :--: |\n| Feature | Incidence [\\%] | PPV [\\%] |\n| $\\sqrt{ }$ shadowing echogenic focus | s | 96 |\n| $\\sqrt{ }$ hyperechoic lines and dots | 61 | 98 |\n| $\\sqrt{ }$ regional / diffuse bright echoes | 58 | 98 |\n| $\\sqrt{ }$ fluid-fluid level | 8 | 60 |\n| $\\sqrt{ }$ cyst with wall nodularity | 53 |  |\n| $\\sqrt{ }$ solid mass without cystic features | 42 |  |\n\n$\\sqrt{ }$ dermoid mesh = bright undulating hyperechoic fine lines and dots = hair dispersing into surrounding fluid (DDx: fibrous strands in hemorrhagic cyst)\n$\\sqrt{ }$ hyperechoic focus with acoustic shadowing $\\leftarrow$ calcification (in $86 \\% ; 96 \\%$ PPV)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 443,
            "markdown": "$\\sqrt{ }$ NO central vascularity on color Doppler\nCT:\n$\\sqrt{ }$ round well-circumscribed thin-walled uni- or multilocular cystic mass with solid components of fat floating in interface between two water-density components ( $93 \\%$ )\n$\\sqrt{ }$ Rokitansky nodule $=$ dermoid plug ( $81 \\%$ ) of adipose tissue; usually single, may be multiple\n$\\sqrt{ }$ sebum-rich fat-fluid level in cyst cavity ( $12 \\%$ )\n$\\sqrt{ }$ globular calcifications (tooth) / rim of calcification (56\\%)\n$\\sqrt{ }$ Hounsfield unit values of -20 to $-140 \\leftarrow$ fat within dermoid cyst (highly suggestive of Dx) MR:\n$\\sqrt{ }$ cyst with fluid-fluid level:\n$\\sqrt{ }$ hyperintense lipid-laden nondependent cyst fluid (above fluid of low SI) on T1WI + of intermediate intensity on T2WI\n$\\sqrt{ }$ hyperintense mass ( $=$ fat + serous fluid both with high SI) on T2WI\n$\\sqrt{ }$ chemical shift artifact of bright / dark bands (along frequency-encoding gradient)\n$\\sqrt{ }$ signal drop at chemical-selective fat-saturated T1WI in $97 \\%$ (mandatory sequence!)\n$\\sqrt{ }$ chemical shift imaging for identification of microscopic fat:\n$\\sqrt{ }$ in-phase GRE image:\n$\\sqrt{ }$ dependent fluid hypointense compared with muscle\n$\\sqrt{ }$ nondependent fluid slightly hypointense compared with surrounding fat\n$\\sqrt{ }$ opposed-phase GRE image:\n$\\sqrt{ }$ dependent fluid still hypointense compared with muscle\n$\\sqrt{ }$ slightly hypointense compared with surrounding fat\n$\\sqrt{ }$ thin black outline at interface between water and fat $\\leftarrow$ phase cancellation of water + lipid in same voxel\n$D x:$ fat + calcification are PATHOGNOMONIC\n$C x$ : (1) Malignant degeneration in $1-2 \\%$ (usually within dermoid plug of tumors $>10 \\mathrm{~cm}$ in diameter in postmenopausal women) into squamous cell carcinoma (most common)\n(2) Torsion $(4-16 \\%)$\n(3) Rupture with chemical peritonitis (1-4\\%)\n(4) Hydronephrosis\n\nRx: surgery (to avoid torsion / rupture)\n$D D x$ : tuboovarian abscess, acute hemorrhagic cyst, atypical endometrioma, bowel gas\n\n# Rupture of Ovarian Cystic Teratoma \n\nCause: torsion, infarction, trauma, infection, malignant change, prolonged pressure during labor, idiopathic\n\n- acute abdomen (due to severe chemical peritonitis) $\\rightarrow$ shock\n$\\sqrt{ }$ discontinuity of tumor wall + ascites\n$\\sqrt{ }$ distorted / flattened shape of tumor\n$\\sqrt{ }$ spilled sebaceous material / hair ball on T1WI + fat-suppressed T1WI (DDx to fluid)\n$\\sqrt{ }$ calcifications outside confines of cyst\n$\\sqrt{ }$ thickened peritoneum / intraperitoneal adhesions on contrast-enhanced fat-suppressed T1WI\n$C x$ : chronic recurrent leakage $\\rightarrow$ chronic granulomatous peritonitis (= gliomatosis) $\\rightarrow$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 444,
            "markdown": "peritoneal adhesions $\\rightarrow$ bowel obstruction\n$D D x$ : tubercular peritonitis, carcinomatosis\n\n# DIETHYLSTILBESTROL (DES) EXPOSURE \n\n$=$ first reported transplacental carcinogen\n@ Vagina: adenosis, septa, ridges, clear-cell adenocarcinoma ( $1 \\div 1,000$ females exposed in utero to DES, by age 35 )\n@ Cervix: hypoplasia, stenosis, mucosal displacement, pseudopolyps, hooded / \"cockscomb\" appearance\n@ Uterus: hypoplasia, bands, contour irregularity, \"T- shaped\" uterus\n@ Tubes: deformity, irregularity, obstruction\n\n## ECLAMPSIA\n\n$=$ coma $\\pm$ pre-, intra-, or postpartum convulsions not related to a coincidental neurologic disorder in a preeclamptic patient\nPathophysiology:\nA. VASOSPASM THEORY\noverregulation of cerebral vasoconstrictive response to acute + severe hypertension $\\rightarrow$ progresses to vasospasm; prolonged vasospasm $\\rightarrow$ local ischemia, increased brain capillary permeability, disruption of blood-brain barrier, arteriolar necrosis $\\rightarrow$ cerebral edema + hemorrhage\nB. FORCED-DILATATION THEORY\nwith severe arterial hypertension upper limit of cerebral autoregulation is reached $\\rightarrow$ cerebral vasodilatation starts disrupting blood-brain barrier $\\rightarrow$ cerebral edema\nTime of onset: $2^{\\text {nd }}$ half of pregnancy in primigravida; $<20^{\\text {th }}$ week GA with trophoblastic disease\n\n- severe throbbing frontal headache; seizures (usually tonic-clonic)\n- retinal / cortical blindness: scotomata, amaurosis, blurred vision\n- hyperreflexia, hemi- / quadriparesis, confusion, coma\n\nCT (positive in up to $50 \\%$ ):\n$\\sqrt{ }$ bilateral rather symmetric white matter hypodensities without contrast enhancement\n$\\sqrt{ } \\pm$ cerebral edema $\\rightarrow$ compression of lateral ventricles\n$\\sqrt{ }$ usually transient + completely reversible cerebral-cortical + basal ganglia hypodensities (= reversible ischemic lesions)\n$\\sqrt{ }$ cerebral infarction in prolonged ischemia\n$\\sqrt{ }$ intracerebral hemorrhage (major cause of mortality in 10-60\\%)\nMR:\n$\\sqrt{ }$ transiently increased T2-SI in cerebral cortex + subcortical white matter frequently in watershed areas of posterior hemispheres\n\n## ECTOPIA CORDIS\n\n$=$ fusion defect of anterior thoracic wall / sternum / septum transversum prior to $9^{\\text {th }}$ week of gestation\nA. THORACIC TYPE $(60 \\%)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 445,
            "markdown": "$=$ heart outside thoracic cavity protruding through defect in sternum\nB. ABDOMINAL TYPE ( $30 \\%$ )\n$=$ heart protruding into abdomen through gap in diaphragm\nC. THORACOABDOMINAL TYPE (7\\%)\n$=$ in pentalogy of Cantrell\nD. CERVICALTYPE (3\\%)\n$=$ displacement of heart into cervical region\nAssociated with:\n(1) Facial deformities\n(2) Skeletal deformities\n(3) Ventral wall defects\n(4) CNS malformations: meningocele, encephalocele\n(5) Intracardiac anomalies: tetralogy of Fallot, TGA\n(6) Amniotic band syndrome\n\nPrognosis: stillbirth / death within first hour / death within first days of life in most case\n\n# ECTOPIC PREGNANCY \n\n$=$ implantation of blastocyst outside the endometrial cavity\nIncidence: $2 \\%$ of all pregnancies in USA (1992); higher for in vitro fertilization; 73,700 cases in USA (1986)\nRisk of recurrence: $10-15 \\%$\nCause: delayed transit of fertilized zygote (formed on day 14 MA ) secondary to\n(a) abnormal angulation of oviduct\n(b) adhesions or scarring from inflammation\n(c) slowed tubal transit from ciliary abnormalities\n\nRisk factors:\n(1) Previous tubal surgery: tubal ligation / tuboplasty\n(2) Previous PID (30-50\\%): esp. Chlamydia\n(3) Assisted reproductive technology (ART): in vitro fertilization / gamete intrafallopian tube transfer (GIFT)\n(4) Endometriosis\n(5) Previous ectopic pregnancy (prevalence up to $1.1 \\%, 10$-fold increase in risk, $25 \\%$ chance of recurrence)\n(6) Current use of IUD\n(7) Advanced maternal age $>40$ years\n(8) In utero exposure to diethylstilbestrol\n(9) Documented tubal anomaly: salpingitis, prior surgery\n\nTime of manifestation: usually by $7^{\\text {th }}$ week of MA\n\n- asymptomatic (50\\%); cervical motion tenderness\n- CLASSIC CLINICAL TRIAD (<50\\%):\n- abnormal vaginal bleeding ( $75-86 \\%$ )\n- mild pelvic pain ( $97 \\%$ ): pain decreases with tubal rupture!\n- palpable adnexal mass (23-41\\%)\n- 5-9 week history of secondary amenorrhea (61\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 446,
            "markdown": "- positive urinary pregnancy test $(50 \\%)$\n- progesterone level $<25 \\mathrm{mg} / \\mathrm{mL}$\n- $\\beta$-hCG does not rise $>66 \\%$ within 48 hours (lower levels + slower rise and decline compared with IUP)\n$\\diamond$ Most ectopic pregnancies do not exhibit a $\\beta$-hCG of $>6,500 \\mathrm{mIU} / \\mathrm{mL}$ (1 $1^{\\text {st }}$ IRP) prior to symptomatology!\n$\\diamond$ A $\\beta$-hCG level above the discriminatory zone with absence of IUP suggests ectopic pregnancy!\n\nDiscriminatory zone of $\\boldsymbol{\\beta}$-hCG (at which a normal IUP should be visualized):\n> by endovaginal scan: $\\geq 2,000-3,000 \\mathrm{mIU} / \\mathrm{mL}$ (IRP) $\\geq 2000 \\mathrm{mIU} / \\mathrm{mL}$ (TIS)\n> by transabdominal scan: $\\geq 6,500 \\mathrm{mIU} / \\mathrm{mL}$ (IRP)\nCaveats: technical quality of exam, multiple gestations, distortion of uterine cavity (leiomyoma), lab error, assay variation\nDx: diagnostic laparoscopy ( $3-4 \\%$ false negative, $5 \\%$ FP)\nLocation: bilateral $(0.1 \\%)$\nÂ» $95 \\%$ 1. Tubal\n$Â»<5 \\%$ 2. Interstitial\n3. Cervical\n4. Cesarean scar in anterior lower uterine segment\n5. Ovarian\n6. Intraabdominal (peritoneal cavity)\n![img-26.jpeg](img-26.jpeg)",
            "images": [
                {
                    "id": "img-26.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 1078,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1738,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 447,
            "markdown": "| Probability of Ectopic Pregnancy <br> without IUP or clinical symptoms of an ectopic pregnancy |  |\n| :-- | :--: |\n| $\\checkmark$ normal scan / simple cyst in adnexa | $5 \\%$ |\n| $\\checkmark$ complex adnexal mass | $92 \\%$ |\n| $\\checkmark$ tubal ring | $95 \\%$ |\n| $\\checkmark$ live embryo outside uterus | $100 \\%$ |\n\nÂ» even less common\n7. Intramural\n8. Heterotopic\n9. Ectopic twin pregnancy\n\nSpectrum:\nType 1: unruptured live ectopic + heartbeat\nType 2: early embryonic demise without rupture / embryonic structures / heartbeat\nType 3: ruptured ectopic with blood in pelvis\nType 4: no sonographic signs of ectopic\nPrognosis: leading cause of $1^{\\text {st }}$ trimester maternal death\nTransvaginal US (6-20\\% false-negative rate):\n$\\diamond$ Detected 1 week sooner than by transabdominal US!\n@ Uterus\n$\\checkmark$ absence of intrauterine pregnancy (beyond 6 weeks MA / with $\\beta$-hCG level $>1,000$ $\\mathrm{mIU} / \\mathrm{mL}[2^{\\text {nd }}$ IRP $])$\n$\\diamond$ If pregnancy not documented as intrauterine, the patient must be considered at risk!\n$\\diamond$ No IUP by endovaginal (transvesical) US means ectopic pregnancy in $67 \\%(45 \\%)$\n$\\checkmark$ normal endometrium\n$\\checkmark$ thickening of endometrium:\n$\\checkmark$ trilaminar endometrium\n$\\checkmark$ hyperechoic endometrial thickening $(50 \\%) \\leftarrow$ hormonal stimulation from ectopic pregnancy\n$\\checkmark$ sloughing of endometrium $=$ decidual cast $(21 \\%)$\n![img-27.jpeg](img-27.jpeg)",
            "images": [
                {
                    "id": "img-27.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1425,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1940,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 448,
            "markdown": "$\\sqrt{ }$ decidual endometrium lacks low-impedance blood flow\n$\\sqrt{ }$ decidual cyst $=$ thin-walled $1-5-\\mathrm{mm}$ cyst at junction of endometrium and myometrium $(14 \\%)$; may be seen in normal pregnancy\n$\\sqrt{ }$ pseudogestational sac $(10-20 \\%)=$ thick single parietal decidual layer surrounding a centrally located anechoic fluid collection in uterine cavity $\\leftarrow$ bleeding (DDx: true gestational sac)\n\n# Tubal Ectopic Pregnancy (95\\%) \n\nLocation:\n(1) Ampullary ectopic ( $75-80 \\%$ )\n(2) Isthmic ectopic ( $10-12-15 \\%)$\n(3) Fimbrial / infundibular ectopic (5-11\\%)\n\nTransvaginal US:\n@ Adnexa\n$\\diamond$ Up to $35 \\%$ of ectopic pregnancies may not display any adnexal abnormality!\n$\\checkmark$ adnexal mass separate from ovary:\n$\\checkmark$ echogenic \"tubal mass\" (89-100\\%)\n$\\checkmark$ extrauterine gestational sac WITHOUT live embryo / yolk sac (35\\%)\n$\\checkmark$ yolk sac\n$\\checkmark$ embryonic heartbeat $(6-28 \\%)=$ PATHOGNOMONIC\n$\\checkmark$ \"tubal ring\" = extrauterine hypoechoic saclike structure (20-65\\%) 1-3 cm in diameter surrounded by a $2-4-\\mathrm{mm}$ concentric echogenic ring\n$\\checkmark$ varying flow pattern depending on viability\n$\\checkmark$ corpus luteum within ovary in $>50 \\%$ on side of ectopic pregnancy (DDx: ectopic pregnancy)\n@ Cul-de-sac\n$\\checkmark$ clotted blood free in peritoneal cavity / hematosalpinx (36\\%)\n$\\checkmark$ free fluid ( $40-83 \\%$ ): echogenic / particulate fluid (= hemoperitoneum) with a $93 \\%$ positive predictive value for an ectopic pregnancy\n$D D x$ : anechoic fluid in $10-27 \\%$ of IUP\n@ Abdominal cavity\n$\\checkmark$ echogenic fluid in posterior subhepatic space (Morison pouch) = ruptured ectopic probable\nDoppler-US (low diagnostic impact):\n$\\checkmark$ \"ring-of-fire\" sign = high-velocity low-impedance flow in hyperechoic rim of extrauterine gestation in $54 \\%$ (up to 4 kHz shift with 3 MHz transducer, Pourcelot index of $0.38 \\pm 0.2$, RI between 0.18 and 0.58 ) [DDx: normal maturing follicle / corpus luteal cyst within ovary]\n$\\checkmark$ absence of peritrophoblastic flow after 36 days ( $<0.8 \\mathrm{kHz}$ shift with 3 MHz transducer or $<1.3 \\mathrm{kHz}$ shift with 5 MHz transducer)\n$D D x$ of low-impedance flow:\ncorpus luteum cyst, tuboovarian abscess, fibroid\nMR:\n$\\checkmark$ hematosalpinx:\n$\\checkmark$ slightly hyperintense relative to urine on fat-suppressed T1WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 449,
            "markdown": "$\\sqrt{ }$ low signal intensity on T2WI\n$\\sqrt{ }$ hemoperitoneum:\n$\\sqrt{ }$ iso- (acute) to hyperintense (subacute) free fluid with SI greater than that of urine on T1WI\n$\\checkmark$ heterogeneous appearance on T2WI\n$\\checkmark$ heterogeneous paraovarian adnexal mass of mixed SI on fat-suppressed T1WI + T2WI\n$\\checkmark$ extravasation of contrast material (= bleeding site) on contrast-enhanced dynamic subtraction MR\nPrognosis:\n(1) $3.8 \\div 10,000$ mortality rate ( $4 \\%$ of all maternal deaths)\n$\\diamond$ Leading cause of death during $1^{\\text {st }}$ trimester with a mortality rate of $9-14 \\%$ !\n(2) Infertility (in $40 \\%$ )\n\nDx: (1) Laparoscopy (almost $100 \\%$ accurate)\n(2) Culdocentesis: aspiration of nonclotting blood with a hematocrit $>15=$ high probability for ectopic\n$C x$ : tubal rupture $(10-15 \\%)$\nRx: (1) Surgery\n(2) Methotrexate ( $>90 \\%$ success rate)\n\nContraindications to methotrexate therapy:\n(1) $\\beta$-hCG level of $>5000 \\mathrm{IU} / \\mathrm{L}$\n(2) Documented fetal cardiac activity on US\n(3) Ectopic mass of $\\geq 3.5 \\mathrm{~cm}$\n(4) Hemodynamic instability\n(5) Unreliable patient who may not comply with serial $\\beta$-hCG testing\n\nComplications of methotrexate therapy:\n(1) Selflimiting posttreatment pain\n(2) Treatment failure: severe pain, hemodynamic instability, tubal rupture, hemoperitoneum\n(3) Increase in size of gestational mass (in up to $56 \\%$ ) up to 8 cm in diameter\n(4) Slow resolution of ectopic (up to 108 days)\n\nDDx: (1) Hemorrhagic corpus luteum / hematoma\n(2) Adnexal mass: hydrosalpinx, endometrioma, ovarian cyst\n(3) Fluid-containing small bowel loop\n(4) Eccentrically placed GS in bicornuate / retroflexed / fibroid uterus\n\n# Interstitial Ectopic Pregnancy (2-4\\%) \n\n$=$ ectopic pregnancy in an eccentric location relative to endometrium + close to uterine serosa\nLocation: implantation of blastocyst in upper lateral aspect of uterus BUT outside the endometrial cavity in intramyometrial portion of fallopian tube\nInterstitial segment of fallopian tube:\n$\\sqrt{ }$ thin echogenic line that extends from lateral aspect of uterine cavity through myometrium to uterine serosa (best evaluated in TRV plane)\n$\\diamond$ Often late rupture $\\leftarrow$ greater myometrial distensibility compared with other parts of tube!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 450,
            "markdown": "$\\diamond$ High likelihood of catastrophic hemorrhage from intramyometrial arcuate vasculature supplied by both ovarian + uterine arteries!\nIncreased risk: previous ipsilateral salpingectomy, in-vitro fertilization (IVF)\n\n- Baart de la Faille sign = broad-based palpable mass extending outward from uterine angle\n- Ruge-Simon syndrome = fundus displaced to contralateral side with rotation of uterus + elevation of affected cornu\n$\\checkmark$ \"interstitial line\" sign = thin echogenic line extending from endometrium directly up to center of ectopic pregnancy (= endometrial canal / interstitial portion of fallopian tube) in $92 \\%(80 \\%$ sensitive, $98 \\%$ specific)\n$\\checkmark$ eccentric heterogeneous mass in cornual region ( $66 \\%$ ):\n$\\checkmark$ eccentrically placed gestational sac ( $25 \\%$ )\n$\\checkmark$ \"bulging sign\" = CHARACTERISTIC bulging of uterine contour\n$\\checkmark$ \"myometrial mantle sign\" = ectopic pregnancy surrounded by myometrium on all sides:\n$\\checkmark$ myometrium between sac and uterine cavity\n$\\checkmark$ thinning of myometrial mantle to $<5 \\mathrm{~mm}(33 \\%)$ with enlargement of pregnancy\n![img-28.jpeg](img-28.jpeg)\n$\\checkmark$ large vascular channels + peritrophoblastic blood flow\n$\\checkmark$ absence of \"double decidual\" sign\n$\\checkmark$ empty endometrial cavity\nMR:\n$\\checkmark$ intact junctional zone between uterine cavity + mass\n$C x$ : rupture of an interstitial pregnancy $\\rightarrow$ profuse bleed from erosion of uterine arteries + veins due to close proximity of gestational sac to intramyometrial arcuate vasculature (pregnancy may survive up to 12 weeks GA)\nMaternal mortality: up to $2.5 \\% ; 15 \\mathrm{x}$ that of other tubal ectopic pregnancies\n$D D x$ : eccentrically located normal pregnancy $\\leftarrow$ distortion from uterine fibroids / myometrial contraction; cornual pregnancy; angular pregnancy ; hydatidiform mole; degenerating uterine fibroid",
            "images": [
                {
                    "id": "img-28.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 825,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1458,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 451,
            "markdown": "# Ovarian Ectopic Pregnancy (3\\%) \n\n$=$ ovum fertilized + retained within ovary\nIncreased risk: presence of intrauterine device, assisted reproductive technology, endometriosis, pelvic inflammatory disease\n\n- adnexal mass moves with ovary (DDx: corpus luteum cyst)\n$\\checkmark$ gestational sac / atypical cyst with thick hyperechoic ring inside ovary / inseparable from ovary\n$\\checkmark$ empty endometrial cavity + normal fallopian tubes\n$\\checkmark$ \"ring of fire\" sign = peritrophoblastic flow on color Doppler (DDx: corpus luteum cyst)\n$\\checkmark$ interval growth + gradually recognizable GS contents\n$D D x$ : corpus luteum cyst (progressive involution and increasing crenulation of its margins)\nPerform serial measurements of $\\beta$-hCG serum levels and follow-up US in 2-3 days in any suspected intraovarian ectopic of a clinically stable patient.\n\n\n## Abdominal Ectopic Pregnancy (0.9-1.4\\%)\n\n$=$ implantation within peritoneal cavity excluding tubal + ovarian + intraligamentous locations\nPathophysiology: nutrient supply via omentum + abdominal organs (bowel, liver, spleen, urinary bladder)\nFrequency: $1 \\div 6,000$ ectopic pregnancies\nIncreased risk: assisted reproduction\nClassification:\n(1) primary (rare) = fertilization of ovum within abdominal cavity\n(2) secondary (common) = ruptured tubal / ovarian pregnancy with extrusion into peritoneal cavity\n$\\diamond>25 \\%$ may be missed sonographically!\n\n- bloating, abdominal pain (fetal movement / peritoneal irritation $\\leftarrow$ adhesions); bleeding, hypotension, shock\n$\\checkmark$ absence of GS in endometrium / cervix / tube / ovary\n$\\checkmark$ intraperitoneal GS with surrounding echogenic margin\n$\\checkmark$ placenta outside confines of uterine cavity\n$\\checkmark$ peritrophoblastic flow on color Doppler\n$\\checkmark$ uterus compressed with visible endometrial cavity line\n$\\checkmark$ absence of uterine wall between gestation + bladder / abdominal wall\n$\\checkmark$ anhydramnios\n$\\checkmark$ free echogenic fluid (= hemoperitoneum)\nMortality: up to $20 \\% \\leftarrow$ hemorrhage; 7.7 x that of other ectopic pregnancies\n$C x$ : bowel obstruction / perforation; erosion of pregnancy through abdominal wall; massive blood loss $\\leftarrow$ incomplete / complete placental separation\n\n\n## Lithopedion\n\n$=$ \"stone child\" = very rare obstetric complication consisting of a dehydrated + calcified demised fetus in an extrauterine pregnancy existing for $>3$ months without infection Types:\n(1) Lithokelyphosis $=$ fetal membranes calcified",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 452,
            "markdown": "(2) Lithokelyphopedion $=$ fetus + membranes calcified\n(3) True lithopedion $=$ only fetus calcified\n\nMaternal age at discovery: 23-100 years of age; within 4-20 years of fetal demise\nLocation: most common in adnexa\n$\\sqrt{ }$ large densely calcified mass in lower abdomen / upper pelvis\n$\\sqrt{ }$ CT scan reveals fetal skeleton\n$D D x$ : uterine fibroid, calcified ovarian malignancy / cyst, sarcoma\n\n# Cervical Ectopic Pregnancy (< 1\\%) \n\n$=$ implantation of blastocyst within the endocervical canal and subsequently fibrous wall of cervix\nRisk factors: IUD; in-vitro fertilization; repeated endometrial curettage; Asherman syndrome\n\n- vaginal bleeding, vague abdominal pain\n$\\sqrt{ }$ uterus shape: hourglass-like / figure of $8 \\leftarrow$ ballooned cervix\n$\\sqrt{ }$ cardiac activity inferior to internal os\n$\\sqrt{ }$ absent \"sliding\" sign (= nonadherent gestational sac can be manipulated by gentle pressure with transvaginal transducer)\n$\\sqrt{ } \\pm$ peritrophoblastic flow around ectopic gestational sac\n$D x$ : embryonic heartbeat in a gestational sac within the endocervical canal caudad to cervical internal os\n\n| DDx of Cervical Ectopic versus Abortion in Progress |  |\n| :--: | :--: |\n| Cervical Ectopic | Abortion in Progress |\n| implantation of GS in cervix | GS not attached |\n| round gestational sac | irregular deformed GS |\n| surrounding echogenic ring | no echogenic margins |\n| peritrophoblastic color flow | no peritrophoblastic color flow |\n| hourglass / figure-of-8 uterus | globular uterus |\n| closed internal cervical os | open internal cervical os |\n| negative sliding sign | positive sliding sign |\n| fetal heartbeat inferior to cervical os | absent fetal cardiac activity |\n| well-formed yolk sac / fetal pole | poor visualization of fetal parts |\n| no blood products in endometrium | blood products in endometrium |\n| interval growth / rise in hCG | NO interval growth / rise in hCG |\n\nA misdiagnosis of a cervical ectopic pregnancy as abortion in progress can be deleterious because a $\\mathrm{D} \\& \\mathrm{C}$ can cause massive life-threatening hemorrhage secondary to trophoblastic invasion of the cervix.\n$D D x$ : low-lying gestational sac with abortion in progress\n\n## Cesarean Scar Ectopic Pregnancy (< 1\\%)\n\n$=$ implantation within a scar of a prior cesarean section in the anterior lower uterine segment\nPath: blastocyst surrounded by myometrium + fibrous tissue",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 453,
            "markdown": "- vaginal bleeding between 5 weeks and 16 weeks\n\nA high degree of suspicion for cesarean scar pregnancy is necessary because up to $40 \\%$ of patients will not present with specific clinical symptoms.\n$\\checkmark$ gestational sac in anterior lower uterine segment\n$\\checkmark$ thinned / absent anterior myometrium between sac and bladder (best assessed in SAG plane)\n$\\checkmark$ empty uterus + empty cervical canal\n$\\checkmark$ gestational sac with echogenic margins + peritrophoblastic flow at scar site\n$\\checkmark$ enlarging sac $\\rightarrow$ exerts increasing mass effect on bladder\n$C x$ : uterine rupture with catastrophic hemorrhage\n\n# Cornual Ectopic Pregnancy (< 1\\%) \n\n= implantation of blastocyst within one horn (= cornua) of a bicornuate / septate uterus\n$\\checkmark$ eccentric position of gestational sac $>1 \\mathrm{~cm}$ from lateral wall of endometrial cavity\n$\\checkmark<5 \\mathrm{~mm}$ thin rim of myometrium (identical to interstitial ectopic pregnancy)\n$C x$ : rupture with catastrophic hemorrhage\n\n## Heterotopic Pregnancy\n\n$=$ simultaneous occurrence of intra- + extrauterine pregnancy\nPrevalence: $1 \\div 21,000-30,000$ pregnancies; $1-3 \\%$ in patients undergoing ovulation induction + in-vitro fertilization\n\n- persistent adnexal pain + abnormal $\\beta$-hCG levels after abortion of intrauterine pregnancy\n$\\diamond$ An IUP should not preclude a complete pelvic ultrasound evaluation, although depiction of an IUP virtually excludes the diagnosis of an ectopic pregnancy!\n$\\checkmark$ enlarged uterus with visible intrauterine GS\n$\\checkmark$ concurrent heterogeneous extrauterine GS\n$\\checkmark$ free echogenic fluid (= hemoperitoneum) after termination of intrauterine pregnancy\n$\\checkmark$ enlarged ovaries from ovarian hyperstimulation\n$R x$ : laparoscopic removal of extrauterine embryo\nMortality: delayed diagnosis of missed ectopic pregnancy $\\rightarrow$ catastrophic hemoperitoneum + hypovolemic shock\n\n\n## Intramural Ectopic Pregnancy (< 1\\%)\n\n= gestational sac completely surrounded by myometrium\nIncreased risk: adenomyosis, in vitro fertilization, defective trophoblastic activity, previous uterine trauma (D\\&C, myomectomy)\n\n- abdominal pain, vaginal bleeding, positive pregnancy test\n$\\checkmark$ nonvisualization of GS in endometrium / tubes\n$\\checkmark$ peritrophoblastic flow at color Doppler\n$C x$ : uterine rupture\n$R x$ : hysterectomy\n\n\n## Angular Pregnancy\n\n= implantation within lateral angle of uterus medial to uterotubal junction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 454,
            "markdown": "Prognosis: high rate of spontaneous abortion, uterine rupture, (23\\%), placenta accreta $\\sqrt{ }$ completely surrounded by myometrium $\\pm$ focal thinning\n$\\sqrt{ } \\pm$ placental invasion of myometrium (placenta accreta)\n$\\sqrt{ } \\pm$ intramural hemorrhage\n$\\sqrt{ } \\pm$ myometrial discontinuity\n\n# EMBRYONIC DEMISE \n\nFrequency: $20-71 \\%$ loss rate of one twin $<10$ weeks\n\n## Early Embryonic Demise / Failing Pregnancy\n\n- $\\beta$-hCG level $<2-3$ standard deviations below the mean for given MA / GS size / CRL\n$\\sqrt{ }$ on endovaginal scan:\nA. DEFINITE DEMISE\n$\\sqrt{ }$ absence of cardiac activity with CRL of $\\geq 5 \\mathrm{~mm} / \\geq 6.5$ weeks GA (repeat scan in 3 days for confirmation)\nB. PROBABLY FAILING PREGNANCY\n$\\sqrt{ }$ mean sac diameter of $\\geq 16 \\mathrm{~mm}$ without embryo\n$\\sqrt{ }$ mean sac size of $\\geq 8 \\mathrm{~mm}$ without yolk sac (repeat scan in 3 days for confirmation)\n$\\sqrt{ }>1,000 \\mathrm{mIU} / \\mathrm{mL}\\left(1^{\\text {st }} \\mathrm{IRP}\\right)$ without gestational sac\n$\\sqrt{ }>7,200 \\mathrm{mIU} / \\mathrm{mL}\\left(1^{\\text {st }} \\mathrm{IRP}\\right)$ without yolk sac\n$\\sqrt{ }>10,800 \\mathrm{mIU} / \\mathrm{mL}\\left(1^{\\text {st }} \\mathrm{IRP}\\right)$ without embryo\nC. MODERATELY HIGH RISK OF DEMISE\n$\\sqrt{ }$ bradycardia of $80-90 \\mathrm{bpm}$\n$\\sqrt{ }$ large subchorionic hematoma lifting much of placenta\n$\\sqrt{ }$ yolk sac $>6 \\mathrm{~mm} /$ abnormal shape\nD. HIGH RISK OF SUBSEQUENT DEMISE\n$\\sqrt{ }$ severe bradycardia $<80 \\mathrm{bpm}$\n$\\sqrt{ }$ small mean gestational sac size\n$\\checkmark$ Difference between mean sac size and CRL of $<5 \\mathrm{~mm}$ is predictive of miscarriage in $94 \\%$ !\n$\\sqrt{ }$ mean gestational sac size too small for good clinical dates\n$\\sqrt{ }$ gestational sac growth $\\leq 0.7 \\mathrm{~mm} /$ day (normal growth rate of daily 1.13 mm determines appropriate time interval for follow-up scan, ie, when sac is expected to be 27 mm )\n$\\sqrt{ }$ sac position in lower uterine segment / cervix\n$\\sqrt{ }$ stringlike / granular debris / fluid-fluid level within gestational sac $\\leftarrow$ intrasac bleeding\n\n## Late Embryonic Demise\n\n$\\sqrt{ }$ on endovaginal scan:\n$\\sqrt{ }$ wrinkled collapsing amniotic membrane\n$\\sqrt{ }$ irregular distorted shape of gestational sac\n(DDx: compression by bladder, myoma, contraction)\n$\\sqrt{ }$ absence of double decidual sac = thin weakly hyperechoic / irregular choriodecidual reaction of $<2 \\mathrm{~mm}$\n\n## ENDOMETRIAL CANCER",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 455,
            "markdown": "Most common invasive gynecologic malignancy in industrialized countries; $4^{\\text {th }}$ most prevalent female cancer in USA women\nIncidence: 60,050 new cases with 10,470 deaths annually (2016)\nHisto: adenocarcinoma ( $90-95 \\%$ ), sarcoma ( $1-3 \\%$ )\nPeak age: 55-62 years; $74 \\%>$ age 50\nRisk factors: nulliparity, late menopause, exposure to unopposed estrogen therapy, polycystic ovaries, obesity, hypertension, diabetes mellitus\nHisto:\n(a) endometrioid carcinoma ( $75 \\%$ of all cancers)\n(b) serous, mucinous, clear cell carcinoma (less common): similar to ovarian counterpart\n(c) squamous (rare): associated with cervical stenosis, pyometra, chronic inflammation\n(d) mixed mesodermal tumor: contains elements of epithelial + mesenchymal differentiation\n\n| 2009 FIGO Staging for Endometrial Carcinoma |  |\n| :--: | :--: |\n| FIGO Stage | Description |\n| 0 | In situ |\n| I | Tumor confined to uterus |\n| IA | $<50 \\%$ invasion of myometrium |\n| IB | $\\geq 50 \\%$ of myometrium |\n| II | Cervical stromal invasion |\n| IIIA | Invasion of serosa / adnexa / peritoneal metastases |\n| IIIB | Vaginal / parametrial involvement |\n| IIIC1 | Pelvic lymph node involvement |\n| IIIC2 | Paraaortic lymph node involvement |\n| IV | Extension to pelvic wall, lower $1 / 3$ of vagina, hydronephrotic / nonfunctioning kidney |\n| IVA | Invasion of bladder / bowel mucosa |\n| IVB | Distant metastases (lung, brain, bone) including metastases to pelvic / paraaortic lymph nodes intraabdominal / inguinal lymph nodes |\n| (5) Clinical staging with dilatation \\& curettage inaccurate in up to $51 \\%$ ! |  |\n\nLymph node metastases: $3 \\%$ with superficial invasion; $40 \\%$ with deep invasion\n\n- postmenopausal bleeding without hormonal therapy\n\nLocation: predominantly in uterine fundus; $24 \\%$ in isthmic portion\nUS:\n$\\sqrt{ }$ normal-sized / enlarged uterus\n$\\sqrt{ }$ focal / diffuse endometrial thickening (mean anteroposterior bilayer thickness of 18.2 mm )\n$\\diamond$ Any endometrial thickness $>5 \\mathrm{~mm}$ is suspicious ( $100 \\%$ negative predictive value, not very specific):\n$\\diamond 10 \\%$ cancer rate with endometrial thickness of $6-15 \\mathrm{~mm}$\n$\\diamond 50 \\%$ cancer rate with endometrial thickness of $>15 \\mathrm{~mm}$\n$\\sqrt{ }$ irregular heterogeneous echogenic texture with hypoechoic areas ( $=$ signs of invasive endometrial cancer):\n$\\sqrt{ }$ irregular poorly defined endometrial-myometrial interface",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 456,
            "markdown": "$\\sqrt{ }$ increased echogenicity in myometrium\n$\\sqrt{ }$ intrauterine fluid collection (DDx: cervical stenosis)\nTransvaginal US:\n$\\sqrt{ }$ apparent distension of endometrial lumen with extrinsic thinning of the myometrium (= polypoid tumor)\n$\\sqrt{ }$ Doppler pulsatility index of $<1.5$ or resistive index $<0.7$ suggests malignancy (DDx: endometritis, benign endometrial polyp)\n$\\sqrt{ }$ areas of venous flow (DDx: endometrial hyperplasia)\nMR ( $82-92 \\%$ accuracy for staging, $74-87 \\%$ accuracy for depth of invasion):\n$\\sqrt{ }$ endometrial cancer has a slightly lower SI than endometrium but higher SI than myometrium on T2WI\n$\\sqrt{ }$ endometrial thickness abnormal if $>3 \\mathrm{~mm}$ (postmenopausal woman) / $>10 \\mathrm{~mm}$ (under estrogen replacement)\n$D D x$ : blood clot, uterine secretions, adenomatous hyperplasia, submucosal leiomyoma\n$\\sqrt{ }$ disruption / absence of junctional zone $\\leftarrow$ myometrial invasion\n$\\sqrt{ }$ hyperintense areas penetrating into myometrium (= deep muscle invasion; 74-87\\% accuracy with CEMR / DWI)\n\n# ENDOCERVICAL POLYP \n\n$=$ most common benign cervical growth\nIncidence: up to $4 \\%$\nAge: multiparous women in their 30s and 40s\nHisto: connective-tissue stalk with focal hyperplasia of glandular columnar epithelium $\\pm$ squamous metaplasia (frequent)\nTypes: adenomatous (mostly), cystic, fibrous, vascular, inflammatory, fibromyomatous\nOften associated with: endometrial hyperplasia $\\leftarrow$ ? link to estrogen exposure\n\n- common cause of intermenstrual bleeding\n- metrorrhagia, menorrhagia, postmenopausal bleeding, contact bleeding, vaginal discharge\n$\\sqrt{ }$ typically slightly hyperechoic polyp compared with normal mucosa\n$\\sqrt{ }$ may undergo cystic change $\\rightarrow$ confusion with nabothian cyst\n$\\sqrt{ }$ may be mobile at dynamic imaging with transducer pressure\n$\\sqrt{ } \\pm$ vascular stalk arising from endocervical mucosa (Doppler US)\nVisualization of the origin of the endocervical polyp is critical to differentiate it from a lesion arising in the uterine body with extension into the endocervical canal (eg, prolapsed intracavitary leiomyoma / endometrial polyp).\n$R x$ : management of prolapsed lesions tends to be more complicated $\\leftarrow$ more extensive blood supply\n$\\sqrt{ }$ coexisting endometrial polyp (in $25 \\%$ )\n$C x$ : malignancy / dysplasia (in $0.2-1.5 \\%$ )\n\n\n## ENDOMETRIOID CARCINOMA OF OVARY\n\nFrequency: $8-15 \\%$ of all ovarian cancers; $2^{\\text {nd }}$ most common malignant ovarian neoplasm (after serous adenocarcinoma)\nAssociated with: hyperplasia / carcinoma of the uterine endometrium in 20-33\\%\nPath: malignant mixed mesodermal tumor $=$ carcinoma-sarcoma is grouped with endometrioid",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 457,
            "markdown": "cancer\nHisto: tubular glandular pattern with a pseudostratified epithelium resembling endometrial adenocarcinoma / metastatic colon carcinoma; $\\sim 100 \\%$ malignant\n$\\sqrt{ }$ solid / complex ( $=$ cystic + solid) tumor\n$\\sqrt{ }$ bilateral in $15 \\%$ of stage I cases\nPrognosis: better than serous / mucinous carcinomas\n\n# ENDOMETRIOSIS \n\n$=$ ENDOMETRIOSIS EXTERNA\n$=$ encysted functional endometrial epithelium + stroma in an ectopic site outside myometrium\nN.B.: internal endometriosis within myometrium = adenomyosis\n\nPrevalence: $5-10 \\%$ of menstruating women; in $5 \\%$ of post-menopausal women on estrogen replacement therapy\nEtiology:\n(1) Metastatic / implantation theory\n$=$ \"shedding\" of endometrial cells during retrograde menstruation via fallopian tubes onto peritoneum\n$\\diamond$ Up to $90 \\%$ of women have bloody peritoneal fluid during perimenstrual period\n$\\diamond$ Obstructive mÃ¼llerian duct anomalies are the most common cause in girls $<17$ years of age\n(2) Dissemination theory = vascular + lymphatic spread\n(3) Direct theory = intraoperative implantation (uterine surgery, amniocentesis, needle biopsy)\n(4) Coelomic metaplasia theory = conversion of peritoneal epithelium into functioning endometrial tissue\n(5) Induction theory = combination of metastatic + metaplastic theory\n\nMean age: $25-29$ years\nHisto: endometrial glands, stroma, rare smooth muscle fibers; secretory changes during $2^{\\text {nd }}$ half of menstrual cycle; stromal decidualization during pregnancy\n\n- infertility:\n$\\diamond 20-50 \\%$ of infertile women have endometriosis\n$\\diamond 30-50 \\%$ of women with endometriosis are infertile\nCause: involvement of tubes + ovaries $\\rightarrow$ peritubal adhesions $\\rightarrow$ anatomic distortion, impaired tubal mobility to capture ovum, tubal destruction / occlusion\n- pelvic pain:\n- cyclic pelvic pain: estrogen-sensitive ectopic endometrial implants proliferate and bleed synchronously with uterine endometrium\n$\\diamond 24-33 \\%$ of women with pelvic pain have endometriosis: NO correlation between amount of pelvic pain + extent of disease\n- dysmenorrhea, perimenstrual diarrhea, dyspareunia\n- sacral back ache with menses, rectal discomfort\n- chronic pelvic pain $\\leftarrow$ peritoneal adhesions\n$\\diamond$ Endometriosis is found in $90 \\%$ of women with chronic pelvic pain!\n- abnormal menstrual bleeding",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 458,
            "markdown": "- fixed pelvic organs during bimanual exam\n- localized tenderness along uterosacral ligaments + cul-de-sac + adnexa; thickened nodular ligaments + rectovaginal masses\nLocation:\n(1) Ovaries (20-40\\%): cysts with hemorrhagic content\n(2) Ligaments: uterosacral ligament; round ligament ( $=$ painful inguinal mass in the canal of Nuck, $\\mathrm{R}>\\mathrm{L}$ )\n(3) Rectouterine pouch $=$ pouch of Douglas $=$ posterior cul-de-sac); anterior rectosigmoid\n(4) Vesicouterine pouch $=$ posterior wall of urinary bladder $=$ anterior cul-de-sac\n(5) Uterine serosal surface / wall: posterior $>$ anterior\n(6) Fallopian tube (6\\%): (sub)serosal / mucosal\n(7) Bladder dome\n(8) Cesarean section / other abdominal surgical scars $(<1 \\%)$\n\nDepth:\n\n1. Deeply infiltrating endometriosis $=>5 \\mathrm{~mm}$ from peritoneal surface\n\nAssociated with: fibrosis + muscular hyperplasia\nMorphologic types:\n\n1. Diffuse endometriosis\n2. Discrete pelvic mass $=$ endometrioma (in up to $10 \\%$ )\n\nDx: laparoscopy / surgery $\\leftarrow$ limitations of imaging\nRx: (1) Expectant with NSAID\n(2) Hormonal therapy (for pelvic pain / dyspareunia) to create a state of pseudopregnancy / pseudo-menopause / chronic anovulation: danocrine (Danazol ${ }^{\\circledR}$ ), GnRH agonist (Lupron ${ }^{\\circledR}$ ), oral contraceptive pills\n(3) Surgery (for infertility / intractable pain): implant recurrence in $28 \\%$ by 18 months + in $40 \\%$ by 9 years; adhesion recurrence in $40-50 \\%$\n\n# Diffuse Endometriosis \n\nPath: punctate small foci / stellate patches of $<2 \\mathrm{~cm}$ initiating inflammatory response $\\rightarrow$ organizing hemorrhage, fibrosis, adhesions\nUS (low sensitivity):\n$\\sqrt{ }$ in $70 \\%$ normal $=$ often no detectable abnormality (when lesions small + scattered)\nMR ( $71 \\%$ sensitive, $82 \\%$ specific):\n$\\sqrt{ }$ frequently hyperintense multiple cysts bilaterally with thick walls on T1WI\n$\\sqrt{ }$ foci of elevated signal intensity on T1WI (only $13 \\%$ sensitive) $\\leftarrow$ peritoneal implants\n$\\sqrt{ }$ hypointense masses on T2WI\n$\\sqrt{ }$ loss of interface between lesion + adjacent organs\n$\\sqrt{ }$ hydrosalpinx hyperintense on T1WI $\\leftarrow$ blood products as luminal content\n\n## Endometrioma\n\n$=$ the only form of endometriosis that is readily imaged\nPath: endometriotic cyst in ovary containing thick dark degenerated blood products $=$ \"chocolate cyst\" $\\leftarrow$ repeated cyclic hemorrhage, in up to $50 \\%$ bilateral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 459,
            "markdown": "over time: iron overload, high concentration of protein, increased viscosity\nHisto: obliterated mostly endometrial gland lining; initially thin wall that becomes fibrotic + thickened with irregular external border\n$\\diamond$ Multiplicity favors the diagnosis of endometrioma\nUS ( $83 \\%$ sensitive, $89 \\%$ specific for endometrioma):\n$\\sqrt{ }$ unilocular endometrioma $=$ nonspecific cyst of usually $2-5 \\mathrm{~cm}$ (up to 20 cm ) in diameter:\nLocation: within ovary, often bilateral\n$\\sqrt{ }$ variable appearance of cyst cavity:\n$\\sqrt{ }$ diffuse homogeneous internal low-level echoes / ground-glass appearance (in 95\\%) $\\leftarrow$ hemorrhagic debris\n$\\sqrt{ }$ fine reticular appearance $\\leftarrow$ interdigitating septations without blood flow\n$\\sqrt{ } \\pm$ fluid-fluid / fluid-debris level $\\leftarrow$ layering of debris\n$\\sqrt{ } \\pm$ echogenic material floating in dependent portion of cyst cavity $\\leftarrow$ fresh blood clot\n$\\sqrt{ } \\pm$ triangular / curvilinear soft-tissue component / often attached to cyst wall $\\leftarrow$ retracting blood clot\n$\\sqrt{ }$ anechoic cyst (rare)\n$\\sqrt{ }$ posterior acoustic enhancement\n$\\sqrt{ }$ echogenic wall nodularity / irregularity (in 20-35\\%) $\\leftarrow$ cholesterol deposits\n$\\sqrt{ }$ blood flow in thick septations $\\leftarrow$ revascularization of chronic hematoma\n$\\sqrt{ }$ multilocular endometrioma $=$ multiple separate cysts:\n$\\sqrt{ }$ thin / thick septations between loculi\n$\\sqrt{ }$ hematosalpinx (in 28\\%)\n$\\sqrt{ }$ change in size + appearance on 6-week follow-up\n$D D x$ :\n(1) Hemorrhagic ovarian cyst (acute symptoms, more complex cyst with clot retraction, thin fibrin stranding, resolution in 4-6 weeks)\n(2) Dermoid cyst (calcification, fat-fluid level, hyperechoic areas)\n(3) Cystic neoplasm\n(4) Tuboovarian abscess\n\nCT:\n$\\sqrt{ }$ solid and cystic heterogeneous masses (varied findings)\n$\\sqrt{ }$ irregular margins\nMR ( $91-96 \\%$ accurate, $90-92 \\%$ sensitive, $91-98 \\%$ specific with fat suppression):\n$\\sqrt{ }$ typically homogeneously hyperintense \"light bulb\" SI of cyst(s) on T1WI similar to fat\n$\\leftarrow$ intra- and extracellular methemoglobin shortens T1 of fluids:\n$\\sqrt{ }$ hyperintensity on fat-suppressed T1WI (effectively excludes fat in a dermoid)\n$\\sqrt{ } \\pm$ \"T2 shading\" sign = faint / complete loss of signal of entire cyst (lower than that of simple cyst fluid) / in dependent fluid-debris layer on T2WI $\\leftarrow$ high concentration of cross-linked proteins of high viscosity + iron $\\leftarrow$ recurrent hemorrhage (usually mixed with areas of high SI) in cyst that exhibits high SI on T1WI\n$D D x$ : hemorrhagic functional ovarian cyst (solitary, thin-walled, SI lower on T1WI + higher on T2WI); mature cystic teratoma\n\nThe presence of blood is more conclusively established on the basis of the MRI appearance ( $>90 \\%$ specific)!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 460,
            "markdown": "$\\checkmark$ atypically hypointense on all pulse sequences in $27 \\%$\n$\\checkmark$ restricted diffusion\n$\\checkmark$ multilocularity + multiplicity\n$\\diamond$ CEMR NOT needed to evaluate for endometriosis\n$\\checkmark$ ancillary insensitive findings:\n$\\checkmark$ hypointense peripheral ring $\\leftarrow$ hemosiderin staining of thick fibrous wall in chronic lesion (DDx: PID)\n$\\checkmark$ adhesion to surrounding organs $=$ bowel tethering and sharp angulations\n$\\checkmark$ peritoneal implants\n$\\checkmark \\pm$ obliteration of posterior cul-de-sac\nCx: (1) Adhesions (after rupture of endometrioma)\n\n- fixed pelvic organs (during bimanual US)\n$\\checkmark$ obscuration of organ interfaces\n$\\checkmark$ posterior displacement of uterus (retroverted uterus) and ovaries\n$\\checkmark$ angulation of bowel loops\n$\\checkmark$ elevation of posterior vaginal fornix\n$\\checkmark$ loculated fluid collection\n$\\checkmark$ dilated fallopian tube: hydrosalpinx (in up to $30 \\%$ );\nhydrosalpinx+hematosalpinx $=6 \\div 4$\n$\\diamond$ Suggestive of endometriosis if hydrosalpinx exhibits T1-hyperintensity!\n(2) Malignant transformation to ovarian cancer (1-2.5\\%)\n\nHisto: endometrioid ca. $>$ clear cell carcinoma\n\n- in women $>45$ years of age\n$\\checkmark$ typically for endometriomas $>9 \\mathrm{~cm}$\n$\\checkmark$ enhancing mural nodules\n$D D x$ : hemorrhagic functional cyst (most often solitary, brighter than endometrioma on T2WI, generally no shading), mature cystic teratoma, pelvic inflammatory disease, cystic ovarian neoplasm, pedunculated myoma\n\n\n# Ruptured Ovarian Endometrioma \n\n$=$ uncommon acute complication\n\n- acute abdomen $\\leftarrow$ chemical peritonitis\n$\\checkmark$ distorted shape of endometrioma\n$\\checkmark$ thinned irregular wall component $=$ rupture site\n$\\checkmark$ markedly hyperintense fluid in free intraperitoneal space on fat-suppressed T1WI\nRx: EMERGENCY SURGERY\n\n\n## Atypical Sites of Endometrial Implantation\n\n@ GI tract $(12-37 \\%)$\n\n- catamenial diarrhea, constipation\n- rectal pain / hematochezia [ khezein, Greek = defecate]\n\nPath: initially serosal endometriotic deposits $\\rightarrow$ that erode into bowel wall $\\rightarrow$ hypertrophy + fibrosis of muscularis propria\nLocation: inferior margin of sigmoid colon + anterior wall of rectosigmoid (72\\%) >",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 461,
            "markdown": "rectovaginal septum $(14 \\%)>$ ileum $(7 \\%)$ usually within 10 cm of ileocecal valve $>$ jejunum $>$ cecum $(4 \\%)>$ appendix ( $3 \\%$, almost always associated with ovarian endometriosis); occasionally multiple\n$\\sqrt{ }$ single extramucosal mass with crenulated / spiculated mucosal pattern (DDx: drop metastasis)\n$\\sqrt{ }$ polypoid intraluminal mass / annular constricting lesion (rare appearance)\n$C x$ : adhesion, bowel stricture, GI obstruction\n$D D x$ : invasive malignancy (in deeply penetrating lesion)\n@ GU tract $(3-20-37 \\%)$\n\n- dysuria, urgency, frequency, cyclical hematuria\n- urinary obstruction, flank pain\n\nPath: initially serosal endometriotic deposits that may infiltrate into bladder / ureteral wall\n$\\sqrt{ }$ mass projecting into bladder lumen typically at dome of bladder posteriorly (DDx: bladder cancer)\n$\\sqrt{ }$ smooth / tapered / angulated short to medium-length ureteral stricture near inferior aspect of sacroiliac joint\n@ Chest\n= THORACIC ENDOMETRIOSIS SYNDROME\n\n- pleuritic chest pain, cyclic hemoptysis\n\nCause: microembolization (via lymphatics or vascular channels), peritoneal-pleural migration (through diaphragmatic defects)\nTime of onset: 5 years after pelvic endometriosis\n\n- presenting symptoms:\n- pneumothorax ( $73 \\%$ ), hemothorax ( $14 \\%$ )\n- hemoptysis ( $7 \\%$ ), lung nodules ( $6 \\%$ )\n$\\sqrt{ }$ almost exclusively right-sided pleural lesions\n$\\sqrt{ }$ bilateral lung nodules\n$\\sqrt{ }$ catamenial pneumothorax\n$\\sqrt{ }$ pleural effusion\n@ Cutaneous Tissue\n- palpable mass $\\pm$ catamenial bleeding\n- focal pain / tenderness associated with menses\n\nLocation: laparotomy scar, cervical biopsy / electrocautery, episiotomy scar, umbilicus\n$\\sqrt{ }$ well-defined hypoechoic / cystic / solid mass\n$\\sqrt{ }$ hyperechoic border / tissue stranding $\\leftarrow$ inflammatory reaction\n$D D x$ : abscess, hematoma, hernia, sebaceous cyst, lipoma, hemangioma, malignant tumor\n@ CNS\n\n- cyclic headaches, seizures\n$\\sqrt{ }$ subarachnoid hemorrhage\n\n\n# FACIAL CLEFTING \n\nPrevalence: $0.5 \\div 1,000$ in blacks; $1 \\div 1,000$ live births in white population; $1.5 \\div 1,000$ in Asians; $3.6 \\div 1,000$ in American Indians; $13 \\%$ of all congenital anomalies; $2^{\\text {nd }}$ most common",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 462,
            "markdown": "congenital malformation; most common craniofacial malformation Normal embryology:\n$1^{\\text {st }}$ branchial arch develops into maxillary + mandibular prominences; by $5^{\\text {th }}$ week the stomadeum is surrounded by 5 prominences: frontal-nasal, paired maxillary, paired mandibular prominences; nasal pits are formed by invagination of nasal placodes on each side of frontal-nasal prominence; the 2 maxillary prominences grow medially to fuse with the 2 medial nasal prominences forming the upper lip; the lateral nasal prominences form the nasal alae\nRisk of recurrence: $4 \\%$ with one affected sibling, $17 \\%$ with one affected sibling + parent\nCleft lip $\\pm$ palate and isolated cleft palate are distinct entities with different implications for underlying genetic syndromes, associated anomalies, and prognosis.\n\n# Median Facial Cleft \n\n$=$ failure of fusion of the 2 medial nasal prominences\nPrevalence: rare\n![img-29.jpeg](img-29.jpeg)\n\n## Cause:\n\n1. Median cleft face syndrome $=$ frontonasal dysplasia $\\sqrt{ }$ brain anomalies rare\n2. Holoprosencephaly\n3. Majewski syndrome (short rib, polydactyly, median cleft)\n\n## Lateral Facial Cleft",
            "images": [
                {
                    "id": "img-29.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 831,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1678,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 463,
            "markdown": "# Cleft Lip (25\\%) \n\nCause: lack of fusion of maxillary prominence with medial nasal prominence (= intermaxillary segment) around $7^{\\text {th }}$ week MA\nAssociated with: anomalies in 20\\% (most frequently clubfoot); NO chromosomal anomalies\nSite: isolated in $8 \\%$, bilateral in $20 \\%$\n$\\sqrt{ }$ linear echo-poor region extending from one side of fetal upper lip into nostril\nPrognosis: excellent\n\n## Cleft Lip \\& Palate (50\\%)\n\nCause: incomplete fusion of lip + primary palate with secondary palate\nAssociated with: 72 abnormalities in $56-80 \\%$ : most frequently polydactyly; chromosomal anomalies in $20-33 \\%$\nLocation: $\\mathrm{L}>\\mathrm{R}$\nSite: unilateral in $23 \\%$, bilateral in $30 \\%$\n$\\sqrt{ }$ linear defect extending through alveolar ridge + hard palate reaching the floor of the nasal cavity / orbit (often deeper + longer cleft than in isolated cleft lip)\n$\\sqrt{ }$ paranasal echogenic mass inferior to nose ( $=$ premaxillary protrusion of soft tissue + alveolar process + dental structures) in bilateral cleft lip + palate\n\n## Cleft Palate (25\\%)\n\n$=$ lack of fusion of mesenchymal masses of lateral palatine processes around $8^{\\text {th }}-9^{\\text {th }}$ weeks MA\nAssociated with: anomalies in 50\\% (most frequently clubfoot + polydactyly)\nStickler syndrome $=$ ocular abnormalities, maxillary hypoplasia, isolated cleft palate\n$\\sqrt{ }$ often missed on prenatal sonograms\n$\\sqrt{ }$ small fetal stomach + polyhydramnios $\\leftarrow$ impaired fetal swallowing",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 464,
            "markdown": "| FIGO and TNM Staging of Fallopian Tube Cancer (1993) |  |  |\n| :--: | :--: | :--: |\n| FIGO | TNM | Description |\n| I | T1 | Limited to fallopian tube |\n| IA | T1a | limited to one fallopian tube without serosa |\n| IB | T1b | limited to both fallopian tubes without serosa |\n| IC | T1c | + extension onto / through serosa <br> + positive peritoneal lavage / ascites |\n| II | T2 | Limited to pelvis |\n| IIA | T2a | involvement of one / both fallopian tubes |\n| IIB | T2b | extension to other pelvic structures |\n| IIC | T2c | + positive peritoneal lavage / ascites |\n| III | T3 | Peritoneal implants outside pelvis |\n| IIIA | T3a | microscopic abdominal peritoneal seeding |\n| IIIB | T3b | $\\leq 2 \\mathrm{~cm}$ implants of abdominal peritoneum |\n| IIIC | T3c | $>2 \\mathrm{~cm}$ implants of abdominal peritoneum |\n|  | N1 | Regional lymph node metastasis |\n| IV | M1 | Distant metastasis |\n| $\\odot 50-70-75 \\%$ of patients have stage III / IV disease at time of diagnosis! |  |  |\n\n# FALLOPIAN TUBE CANCER \n\n$=$ PRIMARY FALLOPIAN TUBE CARCINOMA\nPrevalence: $3.72 \\div 1,000,000$ women (likely underestimated); $0.9-17 \\%$ of prophylactic salpingo-oophorectomies\nAge: $6^{\\text {th }}-7^{\\text {th }}$ decade\nPath: tumor produces large amount of serous secretions $\\rightarrow$ painful distension of fallopian tube $\\rightarrow$ palpable pelvic mass $\\rightarrow$ passage of fluid from either end of patent tube $\\rightarrow$ shrinkage of pelvic mass\nHisto: papillary serous carcinoma (most common)\n\n- often insidious nonspecific presentation\n- hydrops tubae profluens [profluo, Latin = discharging]\n$=$ intermittent discharge of clear / bloody fluid $\\leftarrow$ spontaneous / caused by pressure, followed by shrinkage of adnexal mass\n- Latzko triad (in 15\\%):\n(1) intermittent profuse serosanguinous vaginal discharge\n(2) colicky lower abdominal pain relieved by discharge\n(3) adnexal mass\n\nGrowth pattern: nodular, papillary, infiltrative, masslike\nLocation: ampulla of tube; bilateral in $20 \\%$\n$\\sqrt{ }$ fluid-filled tubular adnexal structure containing nodular / papillary solid components\n$\\checkmark$ multilocular cystic mass with spoke-wheel appearance\n$\\checkmark$ contrast enhancement of solid component\n$\\checkmark$ intrauterine fluid collection, peritumoral ascites\n$\\checkmark$ low vascular impedance ( $=$ resistive index of $0.29-0.40$ ) in solid component on Doppler",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 465,
            "markdown": "ultrasound\n$\\sqrt{ }$ increased adnexal metabolic activity on PET\n$D x$ : at least one of following histologic criteria\n(1) tumor arises from endosalpinx\n(2) tumor resembles epithelium of mucosa\n(3) demonstrable transition from benign to malignant\n(4) normal ovaries or endometrium / foci of metastasis\n\n# FETAL AKINESIA DEFORMATION SEQUENCE (FADS) \n\nCause: neurogenic diseases, myogenic anomalies, restrictive dermopathies\nLocation: generalized + symmetric; lower > upper limbs\n$\\sqrt{ }$ abnormal limb position, craniofacial deformation\n$\\sqrt{ }$ growth restriction, polyhydramnios\n$\\sqrt{ }$ abnormally short umbilical cord\n$D x$ : fixed abnormal position (flexion deformities, multiple camptodactylies) in association with restricted fetal movements / complete akinesia\n$D D x$ : trisomy 18\nPrognosis: usually lethal $\\leftarrow$ lung hypoplasia\n\n## FETAL CARDIAC DYSRHYTHMIAS\n\nNormal heart rate: $120-160 \\mathrm{bpm}$\n\n## Premature Atrial Contractions\n\n$=\\mathrm{PAC}=$ most common benign rhythm abnormality\n$\\sqrt{ }$ transient tachycardia\n$\\sqrt{ }$ transient bradycardia $\\leftarrow$ atrial bigeminy if every other beat is nonconducted\n$C x$ : supraventricular tachycardia (unusual)\n$R x$ : discontinue smoking, alcohol, caffeine\nFollow-up: biweekly auscultation until arrhythmia resolves\n\n## Supraventricular Tachyarrhythmia\n\nPrevalence: $1 \\div 25,000$; most frequent tachyarrhythmia in children\nEtiology: viral infection, hypoplasia of sinoatrial tract\nPathogenesis:\n(1) Automaticity = irritable ectopic focus discharges at high frequency\n(2) Reentry = electric pulse reentering atria + inciting new discharges\n\nTypes:\n\n1. Supraventricular tachyarrhythmia (SVT)\n(a) paroxysmal supraventricular tachycardia\n(b) paroxysmal atrial tachycardia\n$\\sqrt{ }$ atrial rate of $180-300 \\mathrm{bpm}$\n$\\sqrt{ }$ ventricular response of $1 \\div 1$\n2. Atrial flutter\n$\\sqrt{ }$ atrial rate of $300-460 \\mathrm{bpm}$\n$\\sqrt{ }$ ventricular rate of $60-200 \\mathrm{bpm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 466,
            "markdown": "3. Atrial fibrillation\n$\\sqrt{ }$ atrial rate of $400-700 \\mathrm{bpm}$\n$\\sqrt{ }$ ventricular rate of $120-200 \\mathrm{bpm}$\nHemodynamics: fast ventricular rate results in suboptimal filling of heart chambers $\\rightarrow$ decreased cardiac output, overload of RA, CHF\nAssociated with:\n(1) cardiac anomalies (5-10\\%): ASD, congenital mitral valve disease, cardiac tumors, WPW syndrome, cardiomyopathy\n(2) thyrotoxicosis\n\nOB-US:\n$\\sqrt{ }$ M-mode echocardiography with simultaneous visualization of atrial + ventricular contractions $\\rightarrow$ allows inference of atrioventricular activation sequence\n$C x$ : congestive heart failure + nonimmune hydrops\n$R x$ : intrauterine pharmacologic cardioversion (digoxin, verapamil, propranolol, procainamide, quinidine)\n\n# Atrioventricular Block \n\nPrevalence: $1 \\div 20,000$ live births; in $4-9 \\%$ of all infants with CHD\nEtiology: (1) Immaturity of conduction system\n(2) Absent connection to AV node\n(3) Abnormal anatomic position of AV node\n\nAssociated with:\n(1) Cardiac structural anomalies (45-50\\%): corrected transposition, univentricular heart, cardiac tumor, cardiomyopathy\n(2) Maternal connective tissue disease: lupus erythematosus\n\nTypes:\n\n1. First-degree heart block $=$ simple conduction delay\n$\\sqrt{ }$ normal heart rate + rhythm (not reportedly diagnosed in utero)\n2. Second-degree heart block\n(a) Mobitz type I\n$=$ progressive prolongation of PR interval $\\rightarrow$ finally leading to the block of one atrial impulse (Luciani-Wenckebach phenomenon)\n$\\sqrt{ }$ a few atrial contractions $\\rightarrow$ NOT followed by a ventricular contraction\n(b) Mobitz type II\n$=$ intermittent conduction with a ventricular rate as a submultiple of the atrial rate (eg, $2 \\div 1 / 3 \\div 1$ block)\n$\\sqrt{ }$ atrial contraction NOT followed by a ventricular contraction in a constant relationship\n3. Third-degree heart block $=$ complete heart block\n$=$ complete dissociation of atria + ventricles\n$\\sqrt{ }$ slow atrial + ventricular contractions independent from each other\n$C x$ : decreased cardiac output + CHF\n\n## FETAL DEATH IN UTERO",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 467,
            "markdown": "$=$ INTRAUTERINE DEMISE\n$=$ fetal death during $2^{\\text {nd }}+3^{\\text {rd }}$ trimesters\nSpecific signs:\n$\\sqrt{ }$ absent cardiac / somatic motion\nNonspecific signs seen not before 48 hours after death:\n$\\sqrt{ }$ same / decreased BPD measurement compared to prior exam\n$\\sqrt{ }$ development of dolichocephaly\n$\\sqrt{ }$ \"Spalding\" sign = overlapping fetal skull bones\n$\\sqrt{ }$ distorted fetus without recognizable structures\n$\\sqrt{ }$ skin edema (epidermolysis) = fetal maceration\n$\\sqrt{ }$ increased amount of echoes in amniotic fluid (= fetal tissue fragments)\n$\\sqrt{ }$ gas in fetal vascular system\n\n# \"Vanishing Twin\" \n\n$=$ disappearance of one twin in utero $\\leftarrow$ complete resorption / anembryonic pregnancy\nPrevalence: $21 \\%$ (range, 13-78\\%) before 14 weeks GA\nTime: $<13$ weeks MA\n$\\sqrt{ }$ NO sonographic evidence of twin pregnancy later in pregnancy\n\n## \"Fetus Papyraceus\"\n\n$=$ compression + mummification of fetus\nTime: in $2^{\\text {nd }}$ trimester\nPath: resorption of fluid resulting in paperlike fetal body + compression into adjacent membranes\n$\\sqrt{ }$ compressed mummified fetus plastered against uterine wall\nRisk to surviving twin:\nA. Dichorionic gestation (minimal risk)\n(1) Premature labor\n(2) Obstruction of labor by macerated fetus\nB. Monochorionic gestation\n\nDIC $\\leftarrow$ release of thromboplastin from degenerating fetus\n(a) into maternal circulation\n(b) into twin fetus through shared circulation (= twin embolization syndrome)\n\n## FETAL HYDROPS\n\n## Nonimmune Hydrops\n\n$=$ excess of total body water $\\rightarrow$ extracellular accumulation of fluid in tissues + serous cavities without antibodies against RBC\nPrevalence: $1 \\div 1,500$ to $1 \\div 4,000$ deliveries\nCause:\n\n1. Cardiac anomalies ( $40 \\%$ ):\n(a) structural heart disease ( $25 \\%$ ): AV septal defect, hypoplastic left heart, rhabdomyoma\n(b) tachyarrhythmia ( $15 \\%$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 468,
            "markdown": "2. Hematologic causes: thalassemia, hemolysis, fetal blood loss\n3. Idiopathic $(25-44 \\%)$\n4. Twin-twin transfusion $(20 \\%)$\n5. Chromosomal abnormalities (6\\%): Turner syndrome\n6. Skeletal dysplasias: achondroplasia, achondrogenesis, osteogenesis imperfecta, thanatophoric dwarfism, asphyxiating thoracic dysplasia\n7. Renal disease (4\\%): congenital nephrotic syndrome\n8. Infections: toxoplasmosis, CMV, syphilis, Coxsackie virus, parvovirus\n9. Cervical tumors: teratoma\n10. Chest masses: cystic adenomatoid malformation, extralobar sequestration, mediastinal tumor, rhabdomyoma of heart, diaphragmatic hernia\n11. Abdominal masses: neuroblastoma, hemangioendothelioma of liver\n12. Placental tumors: chorioangioma\n\nPrognosis: $46 \\%$ death in utero; $17 \\%$ neonatal death\n\n# Immune Hydrops \n\n$=$ ERYTHROBLASTOSIS FETALIS\n$=$ lysis of fetal RBCs by maternal IgG antibodies\nPrevalence: $35 \\div 10,000$ live births at risk\nPathophysiology:\nrh-negative women ( $=$ no D antigen) may become isoimmunized ( $=$ alloimmunization) if exposed to paternally derived fetal Rh-positive blood inherited from the father ( $=\\mathrm{D}$ allotype present); maternal IgM antibodies develop initially, later IgG antibodies with ability to cross placenta ( $=$ transplacental passage)\nCause of isoimmunization:\nfetomaternal hemorrhage during pregnancy / delivery / spontaneous or elective abortion if fetus is D-positive; fetus has a $50 \\%$ chance of being rh-negative as $56 \\%$ of Rh D-positive fathers are heterozygous for D antigen\nAt risk:\nCaucasians (15\\%), Blacks (6\\%), Orientals (1\\%); absence of D antigen originates in Basques\nDetermination of extent of disease by:\n(1) Optical density shift at 450 nm (= delta OD 450) reflects amount of bilirubin in amniotic fluid; reasonably reliable only $>25$ weeks MA; unreliable in alloimmunization due to Kell antibodies\n(2) Percutaneous umbilical cord sampling (PUBS) with direct determination of Hct and Hb\n\n- hemolysis + anemia\n$\\checkmark$ anasarca ( $=$ skin edema $)$\n$\\checkmark$ fetal ascites in $2^{\\text {nd }}$ trimester (present in only $66 \\%$ ) $\\rightarrow$ indicates severe anemia with Hct $<$ $15 \\%, \\mathrm{Hb}<4 \\mathrm{~g} / \\mathrm{dL}$\n$\\checkmark$ pleural effusion\n$\\checkmark$ increased diameter of umbilical vein\n$\\checkmark$ subcutaneous edema (skin thickness $>5 \\mathrm{~mm}$ )\n$\\checkmark$ polyhydramnios ( $75 \\%$ )\n$\\checkmark$ placentomegaly $>6 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 469,
            "markdown": "$\\sqrt{ }$ pericardial effusion\n$\\sqrt{ }$ hepatosplenomegaly\n$\\sqrt{ }$ increased blood flow in middle cerebral artery $\\leftarrow$ increased cardiac output + decline in blood viscosity\nProphylaxis:\nRh immune globulin (RhoGAM ${ }^{\\circledR}=$ antibody against D antigen) given at 28 weeks to all rhnegative women $\\rightarrow$ blocks antigen sites on Rh-positive cells in maternal circulation $\\rightarrow$ prevents initiation of maternal antibody production\nOB management:\nregular monitoring from 18 weeks on when maternal anti-D concentration exceeds $4 \\mathrm{IU} / \\mathrm{mL}$ $\\rightarrow$ severe anemia unlikely if maternal antibodies $<15 \\mathrm{IU} / \\mathrm{mL}$\nPrognosis: (if untreated) in $45-50 \\%$ mild anemia, in $25-30 \\%$ moderate anemia (with neonatal problems only), in $20-25 \\%$ hydrops (death in utero / neonatally)\n$R x$ : umbilical vein transfusion during PUBS (necessary in only $10 \\%$ before 34 weeks GA)\n\n# FETUS IN FETO \n\n$=$ one monozygotic twin encompasses body of other twin\nLocation: mostly retroperitoneum\n$\\sqrt{ }$ well-circumscribed complex mass with internal calcifications + mixed fluid and solid components\n$\\sqrt{ }$ vertebral bodies within mass (DIAGNOSTIC)\n$D D x$ : teratoma\n\n## FETAL TRAUMA\n\nPrevalence: $7 \\%$ of pregnant patients sustain accidental injury (greatest frequency during 3rd trimester); $0.3-0.4 \\%$ are admitted to a hospital\nCause: motor vehicle accident (66\\%), physical abuse (10\\%)\nType of injury to pregnancy:\n\n1. Uterine rupture $(0.6 \\%)$\n2. Complete (6-66\\%) / incomplete (30-80\\%) placental separation\n\nUS:\n$\\sqrt{ }$ evaluate fetal motion, breathing, heart rate, placenta\n$\\diamond$ The major cause of fetal death is maternal death!\n\n## GARTNER DUCT CYST\n\n$=$ secretory retention cyst of remnant mesonephric duct\nFrequency: $1-2 \\%$\nOrigin: remnant of vaginal portion of mesonephric / wolffian duct $\\leftarrow$ incomplete involution with gradual enlargement $\\leftarrow$ persistent glandular secretion\nHisto: lined by nonmucinous flat cuboidal / low columnar epithelium\nMay be associated with: complex renal + urogenital malformations\n(1) Herlyn-Werner-Wunderlich syndrome $=$ ipsilateral renal agenesis + ipsilateral blind vagina\n(2) Ectopic ureteral insertion into Gartner duct cyst",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 470,
            "markdown": "- usually asymptomatic\n\nLocation: anterolateral aspect of proximal third of vaginal wall above level of most inferior aspect of pubic symphysis extending into ischiorectal fossa\nSize: usually $<2 \\mathrm{~cm}$\n$\\sqrt{ }$ well-defined round lesion with fluid contents:\n$\\sqrt{ }$ T2-hyperintense + T1-hypointense fluid\n$\\sqrt{ }$ hemorrhagic / proteinaceous contents hypointense on T2WI + hyperintense on T1WI\n$\\sqrt{ }$ may contain septa\n$\\sqrt{ }$ large cyst may displace ureter upward / protrude through introitus\n$C x$ : dyspareunia; interference with vaginal delivery\n$R x$ : cyst aspiration; tetracycline sclerotherapy; surgical excision\n$D D x$ : urethral diverticulum (urethral displacement)\n\n# GASTROSCHISIS \n\n= paramedian full-thickness abdominal fusion defect usually on right side of umbilical cord; may involve thorax; nonrotated bowel lacking secondary fixation to dorsal abdominal wall\nPrevalence: $4 \\div 10,000$ live births (in 2005), sporadic\nCause: deficient mesenchyme during lateral body wall folding\nformer theory: abnormal involution of right umbilical vein / premature interruption of right omphalomesenteric artery with ischemic damage to abdominal wall\nRisk factor: young maternal age (teenage mother $\\div$ mother aged $>25$ years $=7 \\div 1$ ); more common in non-Hispanic white mothers; NO sex predilection\nAge of occurrence: 37 days ( 5 weeks) of embryonic life\nAge of detection: as early as 12 weeks GA; difficult $<20$ weeks GA $\\leftarrow$ small size of defect $(1-3 \\mathrm{~cm})$ and lack of bowel dilatation\nAssociated anomalies (5-14\\%):\nintestinal atresia / stenosis ( $25 \\%$; small size of opening $\\rightarrow$ compression / torsion of vessels; ectopia cordis (rare)\n\n- MS-AFP $\\geq 2.5$ MoM in $77-100 \\%$\n$\\sqrt{ }$ exteriorized bowel $=$ thick-walled edematous freely floating loops outside fetal abdomen $\\leftarrow$ inflammation + direct trauma $\\leftarrow$ lack of peritoneal covering\n$\\sqrt{ }$ dilated intra- / extraperitoneal bowel $\\leftarrow$ intestinal atresia\n$\\sqrt{ }$ gastric fundus pulled toward defect\n$\\sqrt{ }<2-5 \\mathrm{~cm}$ paraumbilical defect, usually on right side of cord insertion\n$\\sqrt{ }$ normal insertion of umbilical cord\n$\\sqrt{ }$ no fetal ascites\n$\\sqrt{ }$ polyhydramnios may be present\n$\\sqrt{ }$ liver / spleen may herniate infrequently\n$\\sqrt{ }$ malrotation / nonrotation of bowel\nCx before birth:\n(1) Bowel obstruction\n(2) Peritonitis (exposure of bowel to fetal urine / meconium)\n(3) Perforation $\\leftarrow$ peritonitis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 471,
            "markdown": "(4) Fetal growth restriction (38-77\\%) $\\leftarrow$ nutritional loss from exposed bowel\n\nCx after birth:\nmalrotation, jejunal / ileal atresia (18\\%), bowel necrosis, necrotizing enterocolitis, hyperalimentation hepatitis, prolonged intestinal motility dysfunction, chronic short-gut syndrome\nMortality rate: $17 \\%$\nSurvival rate: $91-94 \\%$ after surgical treatment (during $1^{\\text {st }}$ day of life, not influenced by mode of delivery); death from premature delivery / sepsis / bowel ischemia\n\n# GESTATIONAL TROPHOBLASTIC DISEASE \n\n$=$ group of disorders characterized by abnormal proliferation of trophoblastic tissue with invasive tendency originating from the developing blastocyst\nCause: aberrant fertilization\nComponents of trophoblast:\n\n1. Cytotrophoblast $=$ stem cell with high mitotic activity\n2. Syncytiotrophoblast $=$ synthesis of $\\beta$-hCG\n3. Intermediate trophoblast $=$ responsible for endometrial invasion + implantation\n\n- $1^{\\text {st }}$ trimester bleeding; increased levels of $\\beta$-hCG\n- rapid uterine enlargement / excessive size for EGA\n- hyperemesis gravidarum / preeclampsia (in $2^{\\text {nd }}$ trimester)\n\nFrequency: $<1 \\%$ of all gynecologic malignancies\nAssociated with: molar pregnancy (most), post abortion, ectopic pregnancy, term pregnancy\nSpectrum:\n\n1. Benign hydatidiform mole $(80-90 \\%)$\n2. Invasive mole $(5-8-10 \\%)$\n3. Choriocarcinoma (1-2-5\\%)\n4. Placental site trophoblastic tumor (rare)\n\nCytogenesis:\n$=$ fertilization of one egg by two sperm $=$ chromosomes completely / predominantly of paternal origin\n\n1. Diploid karyotype\n> $46, \\mathrm{XX}=$ from fertilization of ovum by two $23, \\mathrm{X}$ sperm after loss of maternal haploid chromosomes\n> $46, \\mathrm{XY}=$ from fertilization of a chromosomally empty ovum by two different sperm:\n\n- complete hydatidiform mole (almost 100\\%), invasive mole (almost 100\\%), choriocarcinoma ( $50 \\%$ )\n\n2. Triploid karyotype (69,XXX; 69 XXY; 69,XYY)\n$=$ fertilization of a normal ovum ( $23, \\mathrm{X}$ ) by two different sperm thus containing $2 / 3$ paternal chromosomes\n\n- occurs in partial hydatidiform mole\n\nAt risk: maternal age $>35$ years and $<20$ years, previous molar gestation, previous spontaneous abortions\n\n## GRANULOSA CELL TUMOR",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 472,
            "markdown": "$\\diamond$ Most common hormone-active estrogenic tumor of ovary\n$\\diamond$ Most common malignant sex cord-stromal tumor (70\\%)\nFrequency: $2-3 \\%$ of all ovarian neoplasms\nOrigin: from cells surrounding developing follicles\nAge: puberty (5\\%), reproductive age (45\\%), postmenopausal (50\\%)\nPath:\n(a) large encapsulated smooth / lobulated multicystic mass with thick irregular septa + solid components; multiple blood-filled cysts $\\leftarrow$ hemorrhage / cystic degeneration with increase in tumor size\n(b) unilocular cyst (rare) apt to manifest with virilization\n\n- abdominal pain (acute hemorrhage into tumor / rupture into peritoneal cavity); palpable adnexal mass\nLocation: unilateral in 95\\%; bilateral in 2-5\\%\nSize: average size of 12.5 cm (up to 40 cm ) in diameter\nUS:\n$\\sqrt{ }$ large complex multilocular cystic mass with fluid / blood (most frequently) + solid components:\n$\\sqrt{ }$ thick irregular septations but NO intracystic papillary projections\n$\\sqrt{ }$ solid component isoechoic to myometrium with Doppler flow\n$\\checkmark$ predominantly solid small heterogeneous hypoechoic mass simulating fibroid (uncommon)\n$\\checkmark$ calcifications (rare)\nCT:\n$\\checkmark$ iso- to hyperattenuating enhancing solid component\n$\\checkmark$ hyperattenuating hemorrhage within cystic component\nMR:\n$\\checkmark$ intermediate SI of solid component + multiple cystic spaces on T2WI = \"spongelike\" appearance\n$\\checkmark$ hyperintense on T1WI $\\leftarrow$ hemorrhage within tumor cysts\n$\\checkmark$ enhancement of solid component\n$\\checkmark$ ascites\nEstrogenic effects:\n$\\checkmark$ uterine enlargement\n$\\checkmark$ endometrial thickening / hemorrhage\n$\\checkmark$ endometrial polyps / hyperplasia (80\\%) / carcinoma (10\\%)\nN.B.: Androgenic effect with virilization extremely rare\n\nPattern of dissemination (extraovarian spread uncommon):\n$\\checkmark$ local extension\n$\\checkmark$ peritoneum-based metastases similar to epithelial neoplasm (rare)\n$\\checkmark$ cystic liver metastases\nPrognosis: low malignant potential; late recurrence following surgery after $>3$ decades\nRx: uni- / bilateral salpingo-oophorectomy $\\pm$ postoperative chemotherapy\n$D D x$ : serous / mucinous ovarian tumor (intracystic papillary projections); metastasis\n\n# Adult Granulosa Cell Tumor (95\\%) \n\n$\\diamond$ Most common estrogenic ovarian tumor!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 473,
            "markdown": "(rarely produces androgen)\nFrequency: $95 \\%$ of all GCT; 5-10\\% of solid ovarian tumors\nAge: in middle-aged peri- and postmenopausal (50\\%) women; peak prevalence at 50-55 years\nHisto: macrofollicular (multiple cysts resembling follicles), microfollicular (with CallExner bodies), insular, trabecular, cylindromatous, watered silk, diffuse type; frequently accompanied by theca cells + fibroblasts\n\n- irregular menstruation cycles, menorrhagia $\\leftarrow$ endometrial hyperplasia; postmenopausal bleeding; amenorrhea\n- $90 \\%$ present at stage I (confined to ovary)\nCx: (1) Malignant transformation (5-25\\%)\n(2) Low-grade endometrial carcinoma (3-25\\%)\n(3) Recurrence $\\rightarrow$ raised serum aromatase + estradiol levels\n\nRecurrence: common even decades after resection with slow growth\n\n# Juvenile Granulosa Cell Tumor (5\\%) \n\nFrequency: $5 \\%$ of all GCT; $90 \\%$ of GCT in patients $<30$ years old\nMean age: 13 years; $80 \\%$ of GCT occur in first 2 decades; only in $3 \\%$ in women $>30$ years of age\nPath: solid component of granulosa + theca cells; follicles lined by granulosa cells staining positive for $\\alpha$-inhibin\nHisto: larger cells with hyperchromatic nuclei + lack of characteristic nuclear groves (compared with adult GCT); NO Call-Exner bodies\nAssociated with: Ollier disease, Maffucci syndrome\n\n- hyperestrogenism (in $80 \\%$ ):\n$\\diamond 10 \\%$ of all cases of precocious precocity\n- isosexual pseudoprecocity in $70 \\% \\leftarrow$ estrogen effect without ovulation / production of progesterone\n- premature breast development; low gonadotropin levels\n- pubic-axillary hair formation\n- clear vaginal discharge $\\leftarrow$ stimulated endocervical glands\n- atypical irregular uterine bleeding\n- accelerated somatic + skeletal development\n\nCx: malignant degeneration (rare)\nPrognosis: $80-93 \\%$ cure rate after surgery\n$\\diamond$ Juvenile tumors have a better prognosis (most diagnosed in stage I) but tend to recur after a shorter interval than adult tumors\n$\\diamond$ Increased risk of endometrial + breast cancer\nRecurrence: unusual after simple resection for stage Ia / Ib tumors; as late as 25 years after treatment\n\n- serum inhibin $\\rightarrow$ useful marker to monitor\n\nDDx: malignant germ cell tumors (yolk sac tumor, embryonal ca.), cystic teratoma, thecoma (hyperestrogenism in $50 \\%$, postmenopausal in $80 \\%$ ), Sertoli-Leydig cell tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 474,
            "markdown": "# HELLP SYNDROME \n\n$=$ Hemolysis, Elevated Liver enzymes, Low Platelets\n$\\diamond$ Most common cause of severe liver disease in pregnancy!\nPrevalence: $4-12 \\%$ of patients with severe preeclampsia / eclampsia; higher in White women $(24 \\%)$, with delayed diagnosis of preeclampsia / delayed delivery ( $57 \\%$ ), in multiparous patients ( $14 \\%$ )\nTime of onset: before / immediately after birth (usually within 48 hours after delivery)\nHisto: portal areas surrounded by deposited fibrin + hemorrhage + hepatocellular necrosis\n\n- nonspecific epigastric / RUQ pain ( $90 \\%$ )\n- nausea + vomiting ( $45 \\%$ ), occasionally jaundice\n- headache ( $50 \\%$ ); demonstrable edema ( $55 \\%$ )\n- abnormal liver function tests, low platelet count\n$\\checkmark$ hepatomegaly\n$\\checkmark$ fatty infiltration of liver (peak at $35^{\\text {th }}$ week)\n$\\checkmark$ intraparenchymal hemorrhage of liver $\\leftarrow$ subcapsular hematoma / rupture into peritoneal cavity\n$\\checkmark$ hepatic edema $\\leftarrow$ early ischemia $\\leftarrow$ necrosis\n$\\checkmark$ ascites + pleural effusions\n$\\checkmark$ subcapsular hematoma of kidney\n$\\checkmark$ vitreous hemorrhage\nCx: (1) Perinatal mortality (8-60\\%)\n(2) Maternal death (3-24\\%) $\\leftarrow$ hepatic necrosis, hemorrhagic liver infarction, liver rupture, DIC, abruptio placentae, acute renal failure, sepsis\n\n\n## HYDATIDIFORM MOLE\n\n$=$ MOLAR PREGNANCY\n[hydatisia, Greek = a drop of water; mola, Latin = false conception]\nFrequency: $1 \\div 1,200$ to $1 \\div 2,000$ pregnancies; $<5 \\%$ of abortions\nPrognosis: noninvasive in $85 \\%$, locally invasive in $13 \\%$, metastasizing in $2 \\%$\nComplete / Classic Mole (common)\n$=$ pregnancy failure $\\leftarrow$ implantation of nonviable fertilized egg\nCause: fertilization of an \"empty egg\" (= ovum with no active chromosomal material after loss of its maternal haploid chromosome)\n(a) by single $23, \\mathrm{X}$ sperm (in $90 \\%$ ) $\\rightarrow$ followed by sperm mitosis to form $46, \\mathrm{XX}$ chromosome set\n(b) by two different sperms of $23, \\mathrm{X}$ and $23, \\mathrm{Y}$ (in $10 \\%$ ) $\\rightarrow$ to form $46, \\mathrm{XY}$ chromosome set\n$\\diamond 46, \\mathrm{YY}$ diploid karyotype is not observed!\nPath: complex multicystic mass = \"cluster of grapes\"\nHisto: generalized hydropic swelling of all chorionic villi with prominent acellular space centrally; pronounced tropho- blastic proliferation of syncytio- and cytotrophoblast\n\n- severe eclampsia prior to 24 weeks\n- uterus too large for dates (in 50\\%); $1^{\\text {st }}$ trimester bleeding",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 475,
            "markdown": "- marked elevation of $\\beta$-hCG with hyperemesis\n- passing of grapelike vesicles per vagina\n- hyperthyroidism $\\leftarrow$ thyroid-stimulating properties of $\\beta$-hCG\n- anemia $\\leftarrow$ plasma volume expansion + vaginal bleeding\n\nUS:\n$\\sqrt{ }$ hyperechoic to moderately echogenic central uterine mass interspersed with punctate hypoechoic areas\n$\\sqrt{ }$ numerous discrete cystic spaces (= hydropic villi) within a central area of heterogeneous echotexture $=$ \"snowstorm\"\n$\\sqrt{ }$ no identifiable fetal tissue\n$\\sqrt{ }$ increased vascularity with low-resistance waveforms in spiral arteries of uterus\n$\\sqrt{ }$ in $25 \\%$ atypical appearance:\n$\\sqrt{ }$ large hyperechoic areas (= blood clot) + areas of cystic degeneration resembling incomplete abortion\n$\\sqrt{ }$ single large central fluid collection with hyperechoic rim mimicking an anembryonic gestation / abortion\n$\\sqrt{ }$ no fetal parts / no chorionic membrane\n$\\sqrt{ }$ bilateral theca lutein cysts $(18-37-50 \\%) \\rightarrow$ may take 4 months to regress after evacuation of a molar pregnancy $\\leftarrow$ hyperstimulation of ovaries by excessive $\\beta$-hCG production\n$\\sqrt{ } \\pm$ ascites\nMR:\n$\\sqrt{ }$ predominantly hypointense heterogeneous mass distending uterine cavity on T1WI\n$\\sqrt{ }$ hyperintense mass on T2WI\n$\\sqrt{ } \\pm$ focal areas of hemorrhage + cystic spaces\n$\\sqrt{ }$ avid enhancement\n$\\sqrt{ }$ hypointense myometrium (without invasion)\nPrognosis: in $80-85 \\%$ benign, in $15-20 \\%$ invasive mole / choriocarcinoma\n$R x$ : dilatation + suction curettage (curative in $85 \\%$ )\n$D D x$ : (1) Hydropic degeneration of the placenta (associated with incomplete / missed abortions)\n(2) Degenerated uterine leiomyoma\n(3) Incomplete abortion $=$ retained products with hemorrhage\n(4) Choriocarcinoma\n(5) Loculated abruptio placentae\n(6) Hydropic changes of the placenta\n\n# Complete Mole with Coexistent Fetus (1-2\\%) \n\n$=$ molar degeneration of one conceptus of a dizygotic twin pregnancy with same risk of malignant degeneration as in classic mole\n\n- vaginal bleeding in $2^{\\text {nd }}$ trimester; uterus large for dates\n- abnormally elevated serum $\\beta$-hCG\n- amniocentesis with normal diploid karyotype excludes diagnosis of partial mole\n$\\sqrt{ }$ normal gestation with placenta + separate typical echogenic material of a hydatidiform",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 476,
            "markdown": "mole\n$\\sqrt{ }$ ovarian theca lutein cysts\nPrognosis: fetal survival unlikely $\\leftarrow$ maternal complications from coexistent mole\n\n# Invasive Mole \n\n$=$ CHORIOADENOMA DESTRUENS\n$=$ locally invasive nonmetastasizing neoplasm\nHisto: excessive trophoblastic proliferation with presence of villous structure + invasion of myometrium\nPreexisting condition: complete / partial hydatidiform mole\n\n- history of previous molar gestation / missed abortion (75\\%)\n- continued uterine bleeding\n- persistently elevated $\\beta$-hCG levels $\\leftarrow$ failure of $\\beta$-hCG to return to undetectable levels after treatment of a complete hydatidiform mole\nSpread: lung, vagina\n$\\checkmark$ hyperechoic tissue with punctate lucencies\n$\\checkmark$ irregular focal hyperechoic region within myometrium\n$\\checkmark$ bilateral theca lutein cysts, $4-8 \\mathrm{~cm}$ in size\n$\\checkmark$ myometrial invasion occasionally demonstrable\n$R s$ : chemotherapy, hysterectomy (if at risk for uterine perforation)\n$D D x$ : choriocarcinoma (same imaging features)\n\n\n## Partial Hydatidiform Mole\n\n$=$ areas of molar change alternating with normal villi + nonviable fetus with significant congenital anomalies\nCause: fertilization of an egg by two sperm $\\rightarrow$ triploid genotype of $69, \\mathrm{XXY}(66 \\%)$ or $69, \\mathrm{XXX}(33 \\%)$\nHisto: moderate focal proliferations of syncytiotrophoblast; normal villi interspersed with hydropic villi\n\n- early onset of preeclampsia\n$\\checkmark$ nearly always coexistent fetus with severe abnormalities + IUGR\n$\\checkmark$ placenta with numerous cystic spaces\n$\\checkmark$ oligohydramnios\nPrognosis:\n(1) frequently spontaneous abortion (unrecognized as mole for lack of karyotyping of the abortus)\n(2) no survival of triploid fetus\n(3) $3 \\%$ risk of persistent gestational trophoblastic neoplasia\n\n\n## HYDRO- / HEMATOMETROCOLPOS\n\n$=$ accumulation of sterile fluid (hydro-) / blood (hemato-) / pus (pyo-) within uterus (-metria) + vagina (-colpos);\n(a) premenarcheally $=$ secretions + mucus\n(b) postmenarcheally $=$ blood\n\nPrevalence: $1 \\div 16,000$ female births",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 477,
            "markdown": "- asymptomatic; vague pelvic discomfort\n- pain during defecation / urination\n$\\sqrt{ }$ smooth symmetric enlargement resulting in pear-shaped uterus $\\pm$ distended vagina\n$\\sqrt{ }$ varying amounts of low-level internal echoes centrally within uterus continuous with vaginal canal\n$\\checkmark$ hematosalpinx $\\pm$ endometriosis\nOB-US:\n$\\sqrt{ }$ cystic / midlevel echogenic retrovesical mass $\\leftarrow$ mucous secretions $\\leftarrow$ stimulation by maternal estrogens during fetal life\n$\\checkmark$ cystic mass $\\pm$ fluid-debris level (= distended vagina)\n$\\checkmark$ bladder often not identified (compressed by distended vagina)\nMR:\n$\\checkmark$ endometrial cavity + upper part of vagina distended by blood products:\n$\\checkmark$ fluid of hyperintense SI on T1WI\n$\\checkmark$ less hyperintense than urine on T2WI\n$D D x$ : ovarian cyst, duplication cyst, meconium cyst, mesenteric cyst, rectovesical fistula, anterior meningocele, cystic tumor, trophoblastic disease, degenerating leiomyoma / leiomyosarcoma\n$C x$ : endometritis, myometritis, parametritis (= pelvic lymphangitis), pelvic abscess, septic pelvic thrombophlebitis, urinary tract infection\n\n\n# Acquired Hydro- / Hematometra \n\nCause: neoplastic obstruction of endocervical canal / vagina; postpartum infection; attempted abortion; cervical stenosis after radiotherapy; postsurgical scarring (eg, dilatation \\& curettage, traumatic delivery); senile contraction\n\n## Congenital Hematometra / Hematometrocolpos\n\nAge: puberty\nCause:\n(a) persistent urogenital sinus = single exit chamber for bladder + vagina; separate orifice for anus; caused by virilization of female fetus / intersex anomaly / arrest of normal vaginal development\nFrequently associated with: ambiguous genitalia Age: newborn period\n(b) cloacal malformation = single perineal orifice for bladder + vagina + rectum; caused by early embryologic arrest\nFrequently associated with: duplicated genital tract Age: newborn period\n(c) imperforate hymen, transverse vaginal septum, segmental vaginal atresia, imperforate cervix, blind horn of bicornuate uterus, Mayer-Rokitansky-KÃ¼ster-Hauser syndrome (= agenesis of uterus + vagina with active uterine anlage)\n$\\diamond$ Hematometrocolpos / hematocolpos $\\leftarrow$ imperforate hymen / transverse vaginal septum\n$\\diamond$ Hematometra $\\leftarrow$ cervical dysgenesis + vaginal agenesis / Mayer-Rokitansky-KÃ¼sterHauser syndrome / obstructed uterine horn\n\n- primary amenorrhea = \"delayed menarche\"",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 478,
            "markdown": "- cyclical abdominal pain; interlabial mass\n\nMay be associated with:\nimperforate anus, hydronephrosis, renal agenesis / dysplasia, polycystic kidneys, duplication of vagina + uterus, sacral hypoplasia, esophageal atresia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 479,
            "markdown": "# INCOMPETENT CERVIX \n\n= gaping cervix usually develops during $2^{\\text {nd }}$ trimester / early $3^{\\text {rd }}$ trimester\nPredisposed: cervical trauma (D \\& C, cauterization), DES exposure in utero with cervical hypoplasia, estrogen medication\n\n- physical examination tends to underestimate the true length of the cervix\n$\\diamond$ Appearance of cervix may change during course of sonographic examination!\nCause: uterine contraction / manual pressure on fundus / patient erect (stress test of cervix) / degree of bladder distention\n\n| Normal Cervical Length |  |  |\n| :-- | :--: | :--: |\n|  | Transabdominal | Transvaginal |\n| $1^{\\text {st }}$ trimester $(<14 \\mathrm{wks})$ | $53 \\pm 17 \\mathrm{~mm}$ | $40 \\pm 8 \\mathrm{~mm}$ |\n| $2^{\\text {nd }}$ trimester $(14-28 \\mathrm{wks})$ | $44 \\pm 14 \\mathrm{~mm}$ | $42 \\pm 10 \\mathrm{~mm}$ |\n| $3^{\\text {rd }}$ trimester $(\\geq 28 \\mathrm{wks})$ | $40 \\pm 10 \\mathrm{~mm}$ | $32 \\pm 12 \\mathrm{~mm}$ |\n| $\\diamond$ Distended bladder improves visualization but increases cervical length |  |  |\n| on transabdominal US! |  |  |\n| $\\diamond$ Difference between nulli- and multiparous women $10 \\%$ ! |  |  |\n\n$\\sqrt{ }$ dilatation of cervical canal beginning at internal os + extending toward external os:\n$\\sqrt{ }$ beaking / funneling of cervical canal\n$\\sqrt{ }$ bulging of membranes through external os $\\leftarrow$ amniotic fluid within dilated endocervical canal\n$\\sqrt{ }$ visualization of fetal parts within dilated endocervical canal\n$\\sqrt{ }$ shortening of cervix to $<25 \\mathrm{~mm}$\nPrognosis: $14^{\\text {th }}-18^{\\text {th }}$ week best time for Rx prior to significant cervical dilatation\n\n## CONTRACEPTIVE DEVICES\n\n## Intrauterine Devices (IUD) approved in USA\n\n- retrieval string protrudes $2-3 \\mathrm{~cm}$ from external cervical os\n$\\sqrt{ }$ double echogenic line with plastic IUD\n$\\sqrt{ }$ reverberation echoes with metal IUD\n\n1. Mirena ${ }^{\\circledR}$\n\nFunction: barium-impregnated T-shaped polyethylene frame with collar of a synthetic progesterone (levonorgestrel); discharges a small amount of the drug for up to 5 years $\\rightarrow$ thickens cervical mucus + thins uterine lining\n2. ParaGard ${ }^{\\circledR}$\n\nFunction: polyethylene frame wound with copper wire slowly releasing spermicidal copper ions for up to 10 years\n3. $1^{\\text {st }}$ generation devices:\n(a) Lippes loop\n$\\sqrt{ } 4-5$ echogenic dots on SAG view\n$\\sqrt{ }$ horizontal line / dot on TRV view\n(b) Saf-T-coil",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 480,
            "markdown": "$\\sqrt{ }$ echogenic solid line on SAG view\n$\\sqrt{ }$ series of echoes / dot on TRV view\n(c) Copper 7 / Copper T / Progestasert ${ }^{\\circledR}$\n$\\sqrt{ }$ dot in fundus + solid line in corpus on SAG view\n$\\sqrt{ }$ solid line in fundus + dot in corpus on TRV view\n(d) Dalkon shield (pulled from market in 1974)\n\nCx: PID, sepsis, 17 deaths\n$C x$ :\n(1) Pelvic inflammatory disease (2-3-fold risk compared with that of non-IUD users) in 35\\%; actinomycosis with IUD in place for $>6$ years\n(2) Perforation $(0.1 \\%)$ into / through myometrium during placement\n(3) Migration by tracking into surgical scar\n\n# \"Lost IUD\" \n\n$=$ locator device missing; string not visible / not palpated\nCause: 1. Migration (displacement) / detachment of string\n2. Expulsion of IUD\n4. Uterine perforation of IUD\n$\\diamond$ Abdominopelvic radiograph is indicated if IUD not identified by US!\n\n## EXPULSION OF IUD\n\nFrequency: $10 \\%$\nRisk factors: insertion early in menstrual cycle / immediate postpartum period, nulliparity, menorrhagia, severe uterine distortion\nLocation: cervix, vagina\n\n## DISPLACEMENT OF IUD\n\n$=$ improper position within uterine cavity\nFrequency: $25 \\%$\n\n## Perforation of IUD\n\nFrequency: up to $1 \\div 1,000$ cases\nRisk factors: lactation, birth within past 6 months, uterine abnormality, clinician inexperience\n$\\sqrt{ }$ embedment in endometrium / myometrium (18\\%)\n$\\sqrt{ }$ migration into peritoneal cavity $\\rightarrow$ freely floating / encased in adhesions / adherent to bowel or omentum\n\n## IUD \\& Pregnancy\n\nPrevalence: $2 \\div 100$ women annually\n$\\sqrt{ }$ IUD may not be visualized after $1^{\\text {st }}$ trimester $\\rightarrow$ as uterus grows IUD is drawn into cavity\n$\\sqrt{ } \\pm$ ectopic pregnancy\nPrognosis: high risk of spontaneous ( $40-50 \\%$ ) / septic abortion, premature labor, chorioamnionitis, low birth weight\n$R x$ : early removal of IUD during $1^{\\text {st }}$ trimester using IUD hook / alligator forceps unless removal of IUD could disrupt pregnancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 481,
            "markdown": "# Tubal Occlusion Devices \n\n> external occlusion by minilaparotomy:\n(a) hinged clips\n\n1. Filshie ${ }^{\\circledR}$ Clip\n$C x: \\quad 0.51 \\%$ failure rate at 1 year; dislodgement; migration\n2. Hulka ${ }^{\\circledR}$ Clip\n$C x: \\quad 3.56 \\%$ failure rate at 10 year\n(b) rings / loops\n\nFalope ring, Yoon ring, Lay loop\n![img-30.jpeg](img-30.jpeg)\n> internal occlusion:\n$\\diamond$ Occlusion must be verified 3 months after placement with adequate HSG pressure of $150-200 \\mathrm{mmHg}$ !\n(1) Essure ${ }^{\\circledR}$ Permanent Birth Control System\ninner coil: stainless steel + polyethylene terephthalate fibers; tubal end with ball; uterine end with connected rectangle\nouter coil: radiographically invisible nitinol (= alloy of titanium + nickel): uterine end with isolated rectangle; tubal end with square\nHSG: $\\sqrt{ }$ peripheral tubal end of inner coil (arrow $\\uparrow$ in drawing) within fallopian tube $\\sqrt{ }<50 \\%$ of inner coil within uterine cavity\n$\\sqrt{ }$ central tubal end of inner coil (arrow $\\uparrow$ in drawing) extends $<30 \\mathrm{~mm}$ into tube from contrast-filled cornu\n$C x:$\n(1) Tubal patency after 3 months (3\\%) $\\rightarrow$ follow-up in another 3 months\n(2) Expulsion into uterine cavity $(0.6-3 \\%)$\n(3) Partial / complete extrusion into peritoneal cavity (1-2\\%) $\\pm$ adhesions with small bowel obstruction\n(1) Adiana ${ }^{\\circledR}$ Permanent Contraception System\n$=$ nonabsorbable nonradiopaque silicone elastomer matrix inserted into fallopian tube after focal radiofrequency thermocoagulation\n$H S G: \\quad \\sqrt{ }$ tubal opacification of $<10 \\mathrm{~mm}$\n$C x$ : Tubal patency after 3 months ( $8.8 \\%$ ) $\\rightarrow$ follow up in another 3 months (4.3-5.6\\%)",
            "images": [
                {
                    "id": "img-30.jpeg",
                    "top_left_x": 374,
                    "top_left_y": 585,
                    "bottom_right_x": 1334,
                    "bottom_right_y": 1045,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 482,
            "markdown": "# INTRAUTERINE GROWTH RESTRICTION \n\n$=$ FETAL GROWTH RETARDATION\n$=$ perinate with a weight at / below the $10^{\\text {th }}$ percentile for gestational age occurring as a result of a pathologic process inhibiting expression of normal intrinsic growth potential\nfor twin pregnancy: discordant weight $>25 \\%$\n\n- Fetal weight at / below $10^{\\text {th }}$ percentile for age will classify $7 \\%$ of normal fetuses as growth retarded!\nPrevalence: $3-7 \\%$ of all deliveries; in 12-47\\% of all twin pregnancies; in $25 \\%$ of fetuses following birth of a growth-retarded sibling / stillborn\n- fundal height as screening test ( $37-60 \\%$ true positive, $40-55 \\%$ false negative; $26-60 \\%$ false positive)\n- IUGR is primarily an ultrasound diagnosis!\n\nSequence of events in fetal hypoxia:\nnonreactive CST $>$ absence of fetal breathing $>$ nonreactive NST $>$ diminished fetal\nmovements $>$ absence of fetal movements $>$ absence of fetal tone\nEtiology:\nA. UTEROPLACENTAL INSUFFICIENCY ( $80 \\%$ )\n$=$ injury during period of cell hypertrophy $\\rightarrow$ decreased cell size with features of intrauterine starvation + protective cardiac output redistribution reflex\n![img-31.jpeg](img-31.jpeg)\n\n- absence of body fat; diminished liver and muscle glycogen\n\n1. Maternal causes:\n$\\sqrt{ }$ asymmetric IUGR / symmetric IUGR (in severe cases)\n(a) deficient supply of nutrients:\ncyanotic heart disease, severe anemia (in 10-25\\% of sickle cell anemia), maternal starvation, life in high altitudes, drugs (anticonvulsants, methotrexate,",
            "images": [
                {
                    "id": "img-31.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 1009,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1718,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 483,
            "markdown": "warfarin), alcohol abuse (dose related), illicit drugs (up to $50 \\%$ with heroine addiction, $30 \\%$ with cocaine abuse), uterine anomaly, multiple gestation (in 15 $20 \\%)$\n(b) maternal vascular disease resulting in inadequate placental perfusion: nicotine-induced release of catecholamines, preconceptual diabetes, preeclampsia, chronic renal disease, collagen vascular disease (SLE)\n(c) maternal demographics:\nmaternal age (adolescence / advanced), nulliparous mother, small short habitus, racial influence (Asians)\n2. Primary placental causes:\nextensive placental infarctions, chronic partial separation (abruption), partial mole, Breus mole, chorioangioma, placenta previa, low implantation, placental metastases (breast, melanoma), placentitis (luetic, malaria)\nHisto: reduction in placental villous surface area + in number of capillary vessels $\\checkmark$ asymmetric growth failure\nB. PRIMARY FETAL CAUSES ( $20 \\%$ )\n$=$ injury during the period of cell hyperplasia ( $=$ embryogenesis) producing profound reduction in cell number across all cell lines\n$\\checkmark$ symmetric IUGR (globally decreased intrinsic growth)\n$\\checkmark$ normal / increased amniotic fluid volume\n\n1. Chromosomal abnormalities (in $2-6 \\%$ ): triploidy, tetraploidy, trisomy $13+18+21$, aneuploidy (Turner syndrome), partial deletion (4p, 5p [cri-du-chat], 13q), partial trisomy ( $4 \\mathrm{p}, 18 \\mathrm{p}, 10 \\mathrm{q}, 18 \\mathrm{q}$ ), unbalanced translocation (chromosomes $4+15$ ), balanced translocation (chromosomes $5+11$ )\n2. Structural anomalies: CHD, genitourinary anomalies, CNS anomalies, dwarfism\n3. Viral infection: rubella (in $40-60 \\%$ ), CMV, varicella (in $40 \\%$ )\n$\\diamond$ All fetuses with IUGR need to have a detailed and often repeated search for structural anomalies!\n\n# Diagnostic Ultrasound Methods in IUGR: \n\n$\\diamond$ An accurate fix on fetal age dictates the accuracy of diagnosis of IUGR (early US exam, clinical dates, early physical exam, pregnancy test)!\n$\\diamond$ Every effort needs to be made to determine the underlying cause for growth failure as it effects management + perinatal morbidity and mortality!\n\n1. Fetal morphometric indices\n\nThe 3 key parameters for diagnosing IUGR are\n(1) Low estimated fetal weight (EFW),\n(2) Low amniotic fluid volume (AFV),\n(3) Maternal hypertension (HBP)!\n(a) intrafetal proportions\n$\\sqrt{ }$ elevated $\\mathrm{HC} \\div \\mathrm{AC}$ ratio for dysmature IUGR (overall $36 \\%$ sensitive, $90 \\%$ specific, $67 \\%$ PPV, $72 \\%$ NPV; $93 \\%$ sensitive in fetus $>28$ weeks MA with severe dysmature IUGR)\n$\\diamond$ Early-onset dysmature IUGR not detectable!\n$\\diamond$ May not be used in anomalous fetuses!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 484,
            "markdown": "(b) rate of growth $=$ growth velocity\n$\\sqrt{ }$ HC, AC, FL measurements allow DDx between erroneous dates + normal small fetus + fetus with intrinsic abnormality\n$\\sqrt{ }$ plot growth curves\n$\\diamond$ Minimum time interval of 2 weeks necessary!\n2. Amniotic fluid volume\n$\\diamond$ Screening for decreased amniotic fluid is of value in the fetus with dysmature IUGR $(60-84 \\%$ sensitive, $79-100 \\%$ accurate $)!$\n$\\sqrt{ }$ normal amniotic fluid does not exclude IUGR\n$\\sqrt{ }$ oligohydramnios means dysmature IUGR in a fetus with normal GU tract until proven otherwise (DDx: trisomy $13+18$ )\n3. Fetal morphologic assessment + fat distribution\n$\\sqrt{ }$ diminished thigh circumference\n$\\sqrt{ }$ absent paraspinal fat pad (posterior neck)\n$\\sqrt{ }$ reduced / absent malar fat pads\n$\\sqrt{ }$ disproportionately small liver size\n$\\sqrt{ }$ increased small bowel echogenicity $\\leftarrow$ absent omental fat\n4. Placental assessment\n$\\sqrt{ }$ increased placental calcium deposition\n5. Biophysical profile\nAccuracy: false-negative fetal death rate of 0.645 per 1000 fetuses within 1 week of the last normal BPP; $33 \\%$ sensitive, $17 \\%$ positive predictive value\n6. Invasive fetal testing: fetal blood analysis for karyotyping, hypoxemia, hyper-capnia, acidemia, hypoglycemia, hypertriglyceridemia\n7. Nonstress test (NST)\n8. Contraction stress test (CST)\n\n| Sonographic Criteria for IUGR |  |  |\n| :-- | --: | --: |\n| Sonographic Finding | PPV [\\%] | NPV [\\%] |\n| Advanced placental grade | 16 | 94 |\n| Elevated FL $\\div$ AC ratio | $18-20$ | $92-93$ |\n| Abnormal UA waveform | $17-37$ |  |\n| Low total intrauterine volume | $21-24$ | $92-97$ |\n| Small BPD | $21-44$ | $92-98$ |\n| Slow BPD growth rate | 35 | 97 |\n| Low EFW | 45 | 99 |\n| Oligohydramnios | 55 | 92 |\n| Elevated HC $\\div$ AC ratio | 62 | 98 |\n\n# Diagnostic Doppler Methods in IUGR: \n\nA. PLACENTAL PERFUSION\n\n1. Umbilical artery velocimetry (UA)\n$\\diamond$ Not useful with unknown dates / for screening!\n$\\diamond$ Better predictor of adverse perinatal outcome than MCA or RA pulsatility index",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 485,
            "markdown": "Pathophysiology: fewer terminal villi $\\leftarrow$ develop-mental defect / villous infarction\n$\\sqrt{ }$ elevated systolic+diastolic ratio (S/D ratio $>3.0$ beyond $30-34$ weeks GA) $\\leftarrow$ increase in vascular resistance within placental circulation\n$\\sqrt{ }$ absent diastolic flow $\\leftarrow$ villous obliteration $>50 \\%$ ( $50-90 \\%$ mortality rate)\n$\\sqrt{ }$ reverse diastolic flow $\\leftarrow$ villous obliteration $>50 \\%$ (= impending fetal collapse)\nNote: S/D ratio increases with sampling site closer to fetus + increasing fetal heart rate; $\\downarrow$ of S/D ratio with advancing gestational age; S/D ratio may decrease in lateral recumbent position\n2. Uterine artery waveform\n\nMethod: sample volume at point of overlap of uterine artery with external iliac artery\n$\\sqrt{ } \\mathrm{S} / \\mathrm{D}$ ratio $>2.6$ after 26 weeks GA\n$\\sqrt{ }$ persistence of early diastolic notch\nPathophysiology: lack of trophoblastic invasion of spiral arteries\nRules:\n> Trophoblastic invasion may not occur until 20-22 weeks GA in some patients\n> An abnormal waveform at 24 weeks GA will never become normal\n> A normal waveform will never revert to a high resistive waveform\n> Both / one uterine artery may be abnormal\nB. FETAL CIRCULATION\n\nPathophysiology: preferential shunting of blood to brain (\"brain sparing\") + myocardium in response to hypoxemia\n\n1. Fetal middle cerebral artery (MCA)\n$\\diamond$ Significant correlation between hypoxemia at cordocentesis and MCA pulsatility index\n$\\checkmark$ If the MCA pulsatility index is normal the fetus is unlikely to have a major adverse outcome\nMethod: sample volume in MCA of near field 1 cm distal to its origin\n$\\sqrt{ } \\downarrow$ in S/D ratio to 2.5 to 3.0 (normal is about 6.0 )\n2. Renal artery waveform (RA)\n\nMethod: sample volume in proximal renal artery on coronal image that visualizes entire renal a.\n$\\sqrt{ }$ increase of pulsatility index\n3. Fetal aortic flow volume (no proven usefulness)\n$\\sqrt{ }$ decrease in blood flow to $<185-246 \\mathrm{~mL} / \\mathrm{kg} / \\mathrm{min}$\n$C x$ : increased risk for perinatal asphyxia, meconium aspiration, electrolyte imbalance from metabolic acidosis, polycythemia\nNeonatal $C x$ : pulmonary hemorrhage + vasoconstriction, persistent fetal circulation, intracranial hemorrhage, bowel ischemia, necrotizing enterocolitis, acute renal failure\nPrognosis: 6-8-fold risk increase for intrapartum + neonatal death\n$\\diamond 20 \\%$ of all stillborn fetuses are growth retarded!\nDDx of fetus small for gestational age (SGA):\nDefinition: fetus measures less than expected for GA age but grows normally throughout pregnancy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 486,
            "markdown": "(1) Small normal fetus ( $80-85 \\%$ )\n(2) Small abnormal fetus $(5-10 \\%)$\n(3) Dysmature fetus $(10-15 \\%)$\n\n# Pure Symmetric IUGR \n\n$=$ DECREASED-CELL-NUMBER IUGR = EARLY-INSULT IUGR = LOW-PROFILE IUGR\n$=$ proportionate reduction of all fetal measurements due to\n(a) intrinsic alteration in growth potential (usually due to chromosomal abnormalities)\n(b) severe nutritional deprivation overwhelming protective brain-sparing mechanism occurring $<26$ weeks MA and persisting until delivery\n$\\sqrt{ }$ proportionate decrease in HC and AC with maintenance of normal $\\mathrm{HC} \\div \\mathrm{AC}$ ratios\n$\\sqrt{ }$ estimated fetal weight $<10^{\\text {th }}$ percentile for age by middle of $2^{\\text {nd }}$ trimester\n\n## Mixed IUGR\n\n$=$ onset of IUGR during period of mixed hyperplasia / hypertrophy with near normal inherent fetal growth potential but decreased size + impaired function of placenta\n$\\sqrt{ }$ impaired fetal growth $\\pm$ asymmetry\n$\\sqrt{ }$ abnormal Doppler umbilical artery flow velocity $\\leftarrow$ increased placental vascular resistance\n$\\sqrt{ }$ progressive oligohydramnios\n\n## Asymmetric IUGR\n\n$=$ DECREASED-CELL-SIZE IUGR\n$=$ LATE-ONSET IUGR = LATE-FLATTENING IUGR (75\\%)\n$=$ disproportionate reduction of fetal measurements $\\leftarrow$ uteroplacental insufficiency with preferential shunting of blood to fetal brain occurring after 26 weeks GA\n$\\diamond$ IUGR usually not detectable before 32-34 weeks GA (time of maximal fetal growth)!\nEffective time for screening: 34 weeks MA\nRoutine surveillance: every 4 weeks from 26 weeks MA on\n$\\sqrt{ }$ AC $>2$ SD below the mean for age $=$ highly suspicious; $\\mathrm{AC}>3 \\mathrm{SD}$ below mean for age $=$ DIAGNOSTIC\n$\\diamond$ The abdominal circumference is the single most effective fetal parameter for the detection of asymmetric IUGR!\n$\\sqrt{ }$ high $\\mathrm{HC} \\div \\mathrm{AC}$ and $\\mathrm{FL} \\div \\mathrm{AC}$ ratios (head size + femur length less affected)\n$\\sqrt{ }$ fetal weight percentile useful for follow-up\n$\\sqrt{ }$ accelerated placental maturity\n$\\sqrt{ }$ decreased amniotic fluid volume\n$\\sqrt{ }$ elevated umbilical artery S/D ratio\n$\\diamond \\mathrm{FL} \\div \\mathrm{AC}$ ratio + umbilical artery $\\mathrm{S} / \\mathrm{D}$ ratio are the only effective techniques to screen for IUGR on a single exam with late prenatal care in $3^{\\text {rd }}$ trimester!\n\n## KRUKENBERG TUMOR\n\n$=$ metastatic ovarian adenocarcinoma most commonly originating in GI tract\nOrigin: stomach $>$ breast $>$ colon $>$ appendix $>$ pancreas $>$ biliary primary; ? colon+stomach $=$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 487,
            "markdown": "$2 \\div 1$\n$\\diamond 2 \\%$ of females with gastric cancer develop Krukenberg tumor\n$\\diamond$ Krukenberg tumors antedate the discovery of the primary lesion in up to $20 \\%$ !\nAge: any age, most common in $5^{\\text {th }}-6^{\\text {th }}$ decade\n$\\checkmark$ solid mass + intratumoral cysts; in $60-80 \\%$ bilateral\n$\\checkmark$ hypo- / hyperechoic mass $\\pm$ cystic degeneration\nMR:\n$\\checkmark$ variable hypointensity on T2WI $\\leftarrow$ mucin-filled signet-ring cells + abundant collagen formation\n$\\checkmark$ moderate to marked enhancement of solid components\n\n# LIMB-BODY WALL COMPLEX \n\n$=$ BODY STALK ANOMALY\n$=$ characterized by attachment of visceral organs to placenta with short / absent umbilical cord Prevalence: $0.12 \\div 10,000$ live and still births\nCause: ? abnormal lateral body folding; ? severe form of amniotic band syndrome; ? early vascular disruption; ? embryonic dysplasia due to malformation of ectodermal placodes\nA. EXTERNAL DEFECTS\n\n1. Ventral wall anomaly\n$\\checkmark$ large eccentric defect\nLocation: $\\mathrm{L} \\div \\mathrm{R}=3 \\div 1$ (DDx: gastroschisis)\n2. Craniofacial defects: anencephaly, cephalocele, facial cleft\n3. Limb anomalies: clubfoot, absent limbs\n4. Spinal defects: dysraphism, scoliosis\nB. INTERNAL DEFECTS (in 95\\%)\n5. Cardiac defects\n6. Diaphragmatic absence\n7. Bowel atresia\n8. Renal abnormalities: agenesis, hydronephrosis, dysplasia\n\nUS (confusing appearance):\n$\\checkmark$ fetus usually in a fixed position\n$\\checkmark$ cord insertion site not identifiable\n$\\checkmark$ NO free-floating loops of cord\n$\\checkmark$ severe kyphoscoliosis (frequent)\n$\\checkmark \\pm$ oligohydramnios $\\rightarrow$ MRI\n$\\checkmark$ complete evisceration of abdominal contents with adherence to placental surface\n$\\checkmark$ persistence of extraembryonic coelom ( $=$ separation of amnion + chorion)\nPrognosis: invariably fatal shortly after birth\n\n## MACROSOMIA\n\n$=$ FETAL GROWTH ACCELERATION\n$=$ fetus large for gestational age (LGA) with EFW $>90^{\\text {th }}$ percentile for age $/>4,000 \\mathrm{~g}$ at term\n$\\checkmark \\mathrm{AC}>3 \\mathrm{SD}$ above the mean for age (most reliable + largest measurement)\n$\\checkmark$ estimated fetal weight (EFW) including fetal head, abdomen, femur length $>90^{\\text {th }}$ percentile ( $\\pm$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 488,
            "markdown": "$15 \\%$ accuracy)\n$\\sqrt{ }$ low $\\mathrm{FL}+\\mathrm{AC}$ ratio\n$\\sqrt{ }$ low $\\mathrm{HC}+\\mathrm{AC}$ ratio\n$\\sqrt{ }$ enlarged thigh circumference\n$\\sqrt{ }$ low $\\mathrm{FL}+$ thigh circumference ratio\n$\\sqrt{ }$ greater than expected interval growth\n$\\sqrt{ }$ polyhydramnios\nRisk: shoulder dystocia, prolonged labor, meconium aspiration\n\n# MASSIVE OVARIAN EDEMA \n\n$=$ tumorlike condition with marked enlargement of one / both (occasionally) ovaries $\\leftarrow$ accumulation of edema fluid in stroma\nPrevalence: rare; common in young woman during ovulation induction / pregnancy\nLocation: right $>$ left ovary\nAge: 6-33 (average 21) years\nCause:\n(1) partial / intermittent torsion $\\rightarrow$ obstruction to ovarian lymphatic + venous drainage\n(2) ovarian stromal proliferation with enlargement of ovary susceptible to torsion\n\nHisto: edematous ovarian stroma + extensive fibromatosis surrounding primordial follicles, luteinized cells\n\n- acute / intermittent lower abdominal pain for months\n- masculinization (in chronic phase)\n$\\sqrt{ }$ solid / multicystic adnexal mass\n$\\sqrt{ }$ ovarian diameter of 5-40 (mean 11.5) cm\n$R x:$ oophorectomy / salpingo-oophorectomy / wedge resection with ovarian suspension\n\n\n## MEIGS SYNDROME\n\n[Joe Vincent Meigs, 1892-1963, obstetrician and gynecologist at Harvard University and Massachusetts General Hospital]\n$=$ characterized by\n(1) Ascites (in $15-40 \\%$ of tumors $>10 \\mathrm{~cm}$ ):\n(2) Pleural effusion (rare)\n(3) Benign ovarian tumor: fibroma / fibrothecoma ( $91 \\%$ ), granulosa cell tumor (5\\%), Brenner tumor $(2 \\%)]$\n\n## Pseudo-Meigs syndrome\n\n(4) Mature teratoma / leiomyoma / cystadenoma / ovarian malignancy\n\nPathogenesis: ? vasoendothelial and fibroblast growth factors + cytokines; pressure of tumor on lymph vessels\n\n- CA-125 may be elevated\n$\\diamond$ Ascites + pleural effusion resolve after removal of tumor\n\n\n## MUCINOUS OVARIAN TUMOR\n\nFrequency: $20 \\%$ of all ovarian tumors; $2^{\\text {nd }}$ most common benign epithelial neoplasm of ovary (after serous ovarian neoplasm)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 489,
            "markdown": "Histo: single layer of nonciliated tall columnar epithelium with clear cytoplasm of high mucin content (similar to endocervix + intestinal epithelium)\nAge: middle adult life, rare before puberty + after menopause\nCx: (1) Rupture may lead to pseudomyxoma peritonei\n(2) Torsion\n\nDDx: serous ovarian tumor (smaller, unilocular)\n\n# Mucinous Cystadenoma (80\\%) \n\nPrevalence: $20 \\%$ of all benign ovarian neoplasms\nAge: $\\quad 3^{\\text {rd }}-5^{\\text {th }}$ decade of life\n$\\sqrt{ }$ multilocular cyst with numerous thin septa\n$\\sqrt{ }$ cysts frequently have high protein content:\n$\\sqrt{ }$ low-level echoes in cysts\n$\\checkmark$ high attenuation on CT\n$\\checkmark$ hyperintense on T1WI\n$\\checkmark$ usually unilateral, bilateral in $5 \\%$\n\n## Borderline Malignant Mucinous Cystadenoma (10\\%)\n\n## Mucinous Cystadenocarcinoma (10\\%)\n\nHisto: mucoid material in cysts, sometimes accompanied by hemorrhagic / cellular debris; difficult to differentiate from benign variety + metastasis from intestinal primary\n$\\checkmark$ multilocular with numerous smooth thin-walled cysts\n$\\checkmark$ solid tissue areas: thick septa + other soft-tissue elements within septated cyst\n$\\checkmark$ usually unilateral; bilateral in $5-10 \\%$ of stage I cases\n$\\checkmark$ capsular infiltration with loss of definition + fixation\nCT:\n$\\checkmark$ multiseptated tumor of low attenuation\n$\\checkmark$ high-attenuation proteinaceous material (20-30 HU) in some loculi\nMR:\n$\\checkmark$ variable signal intensity in different loculi $\\leftarrow$ proteinaceous / mucinous content, hemorrhage\n\n## NABOTHIAN CYST\n\n$=$ most common benign masslike lesion of cervix\nIncidence: in women during reproductive years\nCause: mucus-retention / epithelial-inclusion cyst $\\leftarrow$ obstruction of endocervical gland by proliferating squamous epithelium $\\leftarrow$ chronic cervicitis / after childbirth\nSize: $<1 \\mathrm{~cm}$ (majority); may enlarge to become symptomatic\n$\\checkmark$ simple anechoic cyst without vascularity (incidentally detected at imaging)\n$\\checkmark$ may increase in echogenicity $\\leftarrow$ proteinaceous / hemorrhagic content\n$\\checkmark$ \"tunnel cluster\" (in up to $8 \\%$ ) = multicystic dilatation of endocervical glands mimicking adenoma malignum\nRx: none (unless symptomatic)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 490,
            "markdown": "$D D x$ : adenoma malignum = minimal deviation adenocarcinoma (solid components, marked hypervascularity)\n\n# NUCHAL CORD \n\n$=$ umbilical cord encircling fetal neck: single loop $(96 \\%)>2$ loops $(2-3 \\%)>3$ or more loops $(<1 \\%)$\nPrevalence: $5-29 \\%$ of pregnancies; increases with fetal age; frequently transient\nAssociated with: increased cord length, small fetus, vertex presentation, polyhydramnios\n\n- generally not of clinical significance: no difference in 5-min Apgar score, no increase in infant mortality\n$\\checkmark$ umbilical cord loop $>360^{\\circ}$ around fetal neck\n$\\checkmark$ two adjacent cross sections of cord on longitudinal view of neck (diagnosis facilitated by color Doppler flow)\n$\\checkmark$ \"divot\" sign = indentation of skin by nuchal cord suggests tight loop\n$\\sqrt{ }$ NO effect on fetal MCA + umbilical artery flow velocimetry\nCx: (1) Fetal distress: fetal bradycardia + intrapartum deceleration + depressed 1-min Apgar score\n(2) Umbilical artery acidemia\n(3) Passage of meconium\n(4) Fetal demise\n\nOB management:\n\n1. Assess fetal well-being (biophysical profile biweekly, NST, fetal growth)\n2. Vaginal delivery permissible if without evidence of fetal compromise\n3. Intervention only for signs of fetal distress\n\n## OMPHALOCELE\n\n$=$ herniation of abdominal viscera through an enlarged umbilical ring into base of umbilical cord during $3^{\\text {rd }}-4^{\\text {th }}$ week of GA\nPrevalence: $1 \\div 4,000-5,500$ pregnancies; $2-3 \\div 10,000$ live births\nCause:\n(a) migration failure of lateral mesodermal body folds: $\\checkmark$ omphalocele contains liver\n(b) persistence of primitive body stalk beyond $12^{\\text {th }}$ week MA\n\nAge: earliest detection at 12 weeks menstrual age; diagnosis $<11-12$ weeks' gestation should be made with caution\n\nNormal physiologic herniation should be $<1 \\mathrm{~cm}$ into cord and never involve the liver. At 14 weeks follow-up bowel should have returned into abdominal cavity.\nHigh incidence of ASSOCIATED ANOMALIES (45-88\\%):\n\n1. Chromosomal (10-25-58\\%): trisomy 13, 18, 21; Turner syndrome ( $13 \\%$ with liver in omphalocele, $77 \\%$ with bowel in omphalocele)\n2. Genitourinary $(40 \\%)$\nmnemonic: OEIS complex (= aide-mÃ©moire acronym)\nOmphalocele",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 491,
            "markdown": "# Exstrophy of bladder \n\nImperforate anus\nSpinal defect\n3. Cardiac (16-30-47\\%): VSD; ASD; tetralogy of Fallot; ectopia cordis in pentalogy of Cantrell; DORV\n4. Neural tube defects (4-39\\%): holoprosencephaly; encephalocele; cerebellar hypoplasia\n5. IUGR $(20 \\%)$\n6. Beckwith-Wiedemann syndrome (5-10\\%)\n7. Gl tract:\nintestinal atresia (vascular compromise); malrotation; abnormal fixation of liver; esophageal atresia; facial cleft; diaphragmatic hernia\n8. Limb-body wall deficiency; cystic hygroma\n\n- MS-AFP $\\geq 2.5$ in $40-70 \\%$\n\nSac contents: primarily bowel, liver, other viscera (variable)\n$\\sqrt{ }$ herniation of abdominal viscera at base of umbilical cord:\nliver $(27 \\%) \\pm$ stomach $\\pm$ bowel\n$\\sqrt{ }$ midline central defect at base of umbilical cord insertion:\n$\\sqrt{ }$ defect over entire ventral abdominal wall of variable size (mean, $2.5-5 \\mathrm{~cm}$ )\n$\\sqrt{ }$ widened cord where it joins the skin of the abdomen\n$\\sqrt{ }$ covering amnioperitoneal membrane:\n$\\sqrt{ }$ inner layer $=$ peritoneum; outer layer $=$ amnion\n$\\sqrt{ }$ cord inserts at apex of defect on covering membrane, NOT directly on abdominal wall\n$\\sqrt{ }$ hypoechoic loose mesenchymal tissue (= Wharton jelly) between layers of membrane\n$\\sqrt{ }$ ascites within herniated sac (common)\n$\\sqrt{ }$ polyhydramnios (occasionally oligohydramnios)\nmnemonic: OMPHALOCele\nOther anomalies (common)\nMembrane surrounding viscera\nPerfectly midline\nHeart anomalies\nAscites\nLiver commonly herniated\nO for \"zero\" bowel complications\nChromosomal abnormalities (common)\nCx: (1) Infection, inanition\n(2) Immaturity ( $23 \\%$ )\n(3) Rupture of hernia sac (in up to $15 \\%$ )\n(4) Intestinal obstruction\n\nMortality rate: $10 \\%$ mortality if isolated abnormality; $80 \\%$ with one / more concurrent malformations; $\\sim 100 \\%$ with chromosomal + cardiovascular abnormalities\n$D D x$ : (1) Congenital umbilical hernia (covered by intact skin and subcutaneous tissue)\n(2) Gastroschisis (usually right-sided defect)\n(3) Limb-body wall complex (usually left-sided defect)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 492,
            "markdown": "# Pseudo-omphalocele \n\n(1) Deformation of fetal abdomen by pressure with transducer coupled with an oblique scan orientation may give the appearance of an omphalocele\n$\\sqrt{ }$ obtuse angle between pseudomass + fetal abdominal wall\n(2) Physiologic herniation of midgut into umbilical cord between $8^{\\text {th }}$ and $12^{\\text {th }}$ week of gestation\n$\\sqrt{ }$ herniated sac never contains liver\n$\\sqrt{ }$ herniated sac usually $<7 \\mathrm{~mm}$\n$\\sqrt{ }$ disappears by $12^{\\text {th }}$ week GA\n\n## OMPHALOMESENTERIC DUCT CYST\n\nEtiology: persistence + dilatation of an omphalomesenteric / vitelline duct segment $\\rightarrow$ joining embryonic midgut and primary yolk sac $\\rightarrow$ which is formed during the $3^{\\text {rd }}$ week and $\\rightarrow$ closed by the $16^{\\text {th }}$ week of gestation\nHisto: cyst lined by columnar mucin-secreting GI epithelium\n$\\mathrm{M} \\div \\mathrm{F}=3 \\div 5$\nLocation: usually in close proximity to fetus\n$\\sqrt{ }$ umbilical cord cyst up to 6 cm in diameter\n$\\sqrt{ }$ beneath amniotic surface of cord (= eccentric)\n$C x$ : (1) Compression of umbilical vessels by expanding cyst\n(2) Erosion of umbilical vein from acid-producing gastric mucosal lining\n\nDDx: allantoic cyst, umbilical cord hematoma\n\n## OVARIAN CANCER\n\n$=7^{\\text {th }}$ leading cause of cancer in women ( $4 \\%$ of all cancers among women); $2^{\\text {nd }}$ most common gynecologic malignancy; $5^{\\text {th }}$ leading cause of cancer deaths in USA women after lung, breast, colon, pancreas (leading cause of cancer deaths of all female cancers); accounts for $50 \\%$ of cancer deaths of female genital tract ( $67 \\%$ of patients present with advanced stage III disease)\n$\\diamond 1 \\div 75$ women will develop ovarian cancer (lifetime risk)\n$\\diamond 1 \\div 100$ women will die of ovarian cancer\nIncidence: $50 \\div 100,000$ women annually ( $33 \\div 100,000$ women $>$ age 50 annually); in USA 22,280 new cases $+14,240$ deaths (2016)\nEtiology: ovarian surface epithelium proliferates temporarily to repair defect after rupture of ovum, which may result in an \"inclusion body\" / \"cystoma\"; an error in DNA replication within inclusion body may occur resulting in inactivation / loss of a tumor-suppressor gene\n\n## Epidemiology:\n\n(1) sporadic: \"ovulation hypothesis\" = risk of ovarian cancer is a direct function of the number of ovulatory cycles during a woman's life span\n(2) hereditary $(1-5 \\%)=$ defined as ovarian cancer occurring in at least two $1^{\\text {st }}$-degree relatives\n$\\diamond 50 \\%$ lifetime probability to develop ovarian cancer\n(a) breast cancer-ovarian cancer syndrome\n(b) ovarian cancer only syndrome",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 493,
            "markdown": "(c) Lynch type II cancer family syndrome\n$=$ inheritance of nonpolyposis colorectal cancer, endometrial cancer and (rarer) ovarian cancer\nIncreased risk:\nnulliparity, early menarche, late menopause, Caucasian race, higher socioeconomic group, positive family history for ovarian cancer (risk factor of 3 with one close relative, risk factor of 30 with two close relatives affected with ovarian cancer), history of breast cancer (risk factor of 2) / early colorectal cancer (risk factor of 3.5)\nDecreased risk = protective effect:\nmultiparity, use of oral contraceptives, breast-feeding\nAge: increasing with age; peaking at $55-59$ years ( $80 \\%$ of cases in women $>50$ years)\nSpread:\n(1) direct extension through subperitoneal space (sigmoid mesocolon on left, cecum + distal ileum on right), uterus, fallopian tubes, broad ligament\n(2) intraperitoneal implantation $=$ exfoliation of tumor cells from ovarian capsule into peritoneal space (often microscopic):\nwith frequent seeding to:\n> posterior cul-de-sac in pouch of Douglas\n> infundibulopelvic ligaments\n> omentum\n> superior aspect of sigmoid\n> right paracolic gutter\n> termination of small bowel mesentery\n> undersurface of right hemidiaphragm\nwith less frequent seeding to:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 494,
            "markdown": "| FIGO and TNM Staging of Ovarian Cancer (2010) |  |  |\n| :--: | :--: | :--: |\n| FIGO | TNM | based on staging laparotomy |\n| I | T1 | Limited to ovary |\n| IA | T1a | limited to one ovary |\n| IB | T1b | limited to both ovaries |\n| IC | T1c | + positive peritoneal lavage / ascites |\n| II | T2 | Limited to pelvis |\n| IIA | T2a | involvement of uterus / fallopian tubes |\n| IIB | T2b | extension to other pelvic tissues |\n| IIC | T2c | + positive peritoneal lavage / ascites |\n| III | T3 $\\pm \\mathrm{Nl}$ | Limited to abdomen = intraabdominal extension outside pelvis / retroperitoneal or inguinal nodes / extension to small bowel / omentum |\n| IIIA | T3a | microscopic abdominal peritoneal seeding |\n| IIIB | T3b | $\\leq 2 \\mathrm{~cm}$ implants of abdominal peritoneum |\n| IIIC | T3c $\\pm \\mathrm{Nl}$ | $>2 \\mathrm{~cm}$ implants of abdominal peritoneum |\n| IV | M1 | Hematogenous disease (liver parenchyma) / spread beyond abdomen / positive Lnn |\n| $\\diamond 50-70-75 \\%$ of patients have stage III / IV disease at time of diagnosis! |  |  |\n\n) Morison pouch\n> liver surface\n> porta hepatis\n> intrahepatic fissure\n(3) lymphatic spread\n> craniad parallel to gonadal veins in infundibulopelvic ligament terminating at level of renal vessels\n> laterally through broad ligament terminating at pelvic side wall: external iliac, obturator, hypogastric chains\nSize: short-axis diameter of $>1 \\mathrm{~cm}$ (in $88 \\%$ positive for ovarian cancer)\n$\\sqrt{ }$ hydronephrosis ( $2^{\\text {nd }}$ most common form of tumor-related morbidity after bowel obstruction)\n$\\sqrt{ }$ thoracic adenopathy: paracardiac lymph nodes $>5 \\mathrm{~mm}$ in $28 \\%$ of stage II/III disease; mediastinal lymphadeno-pathy ( $29 \\%$ at autopsy)\n(4) hematogenous dissemination ( $\\%$ at autopsy):\nliver ( $45-48 \\%$ ), lung ( $34-39 \\%$ ), adrenal gland ( $15-21 \\%$ ), pancreas ( $11-21 \\%$ ), spleen ( $15-20 \\%$ ), bone ( $11 \\%$ ), kidney ( $7-10 \\%$ ), skin ( $5 \\%$ ), brain ( $3-6 \\%$ )\n$\\sqrt{ }$ malignant pleural effusion (pleural metastases in $28-60 \\%$, lung parenchymal metastases in $7 \\%$, pericardial metastases in $5 \\%$ )\nStaging laparotomy:\n$=$ abdominal hysterectomy + bilateral salpingo-oophorectomy + omentectomy + random peritoneal biopsy + lymph node biopsy\nLimitations of imaging:\n$\\diamond$ Microscopic peritoneal disease not detectable!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 495,
            "markdown": "# Benefit of imaging: \n\n$\\diamond$ Second-look surgery can be avoided if there is evidence for residual / recurrent tumor!\nCave: NO biopsy in the absence of peritoneal disease as it may cause spillage and upstaging of the cancer!\n\n- often \"silent\" without obvious signs / symptoms\n- occasional pelvic-abdominal pain\n- constipation, urinary frequency; early satiety; ascites\n- paraneoplastic hypercalcemia\n- Human epididymal protein 4 (HE4)\n\nAccuracy: $89 \\%$ sensitive, $92 \\%$ specific during premenopause\n\n- CA-125 level (= cancer-associated marker = high-molecular-weight glycoprotein) $>35 \\mathrm{kU} / \\mathrm{L}$ :\n\nAccuracy: (a) premenopausal ( $83 \\%$ sensitive, $60 \\%$ specific)\n(b) postmenopausal ( $94 \\%$ sensitive, $82 \\%$ specific)\n\nLevels: $>35(>65) \\mathrm{kU} / \\mathrm{L}$ in $29-50(21) \\%$ of stage I disease\n$\\diamond \\uparrow$ CA-125 levels in $80 \\%$ of ovarian cancers ( $60 \\%$ of mucinous $+20 \\%$ of nonmucinous tumors) and in $40 \\%$ of patients with advanced intraabdominal nonovarian malignancy!\n$\\diamond \\uparrow$ CA-125 levels in $30 \\%$ of benign processes (in $1 \\%$ of healthy individuals, fibroid, firsttrimester pregnancy, menstruation, endometriosis, PID, benign ovarian tumors, liver cirrhosis, pancreatitis)!\nUS:\n$\\diamond$ Screening finds adnexal cysts in $1-15 \\%$ of postmenopausal women; only $3 \\%$ of ovarian cysts $<5 \\mathrm{~cm}$ are malignant!\n@ Morphologic tumor criteria ( $85-97 \\%$ sensitive, $56-95 \\%$ specific, $99 \\%$ NPV):\n$\\sqrt{ }$ thick irregular walls and thick septations\n(DDx: endometrioma, abscess, peritoneal cyst, cystadenofibroma, mucinous cystadenoma)\n$\\checkmark$ papillary projections $\\geq 3 \\mathrm{~mm}$ : in $67 \\%$ [38\\%] \\{9\\%\\} of borderline [malignant] \\{benign\\} neoplasm\n$\\checkmark$ solid / moderately echogenic loculi\n$\\checkmark$ postmenopausal ovarian volume $>9 \\mathrm{~cm}^{3}$\n@ Doppler tumor criteria ( $50-100 \\%$ sensitive, $46-100 \\%$ specific, $49 \\%$ PPV; more sensitive + specific in postmenopausal women):\n$\\checkmark$ presence of color flow (in $93 \\%$ of malignant $+35 \\%$ of benign tumors) usually within thick wall, septa, papillary projections, solid inhomogeneous areas\n$\\checkmark$ low-resistance Doppler waveform $\\leftarrow$ lack of muscular layer of arterial wall + presence of arteriovenous shunts in neoplasm: RI $<0.40$, PI $<1.0$ (37-47\\% PPV)\nFalse positive: physiologic alteration of ovarian blood flow during menstrual cycle, benign tumor, acute inflammatory disease, endometriosis\n@ Metastatic disease\n$\\checkmark$ omental / peritoneal masses (\"omental cake\")\n$\\checkmark$ pseudomyxoma peritonei (with tumor rupture)\n$\\checkmark$ liver metastases\n$\\checkmark$ ascites\nCT ( $70-90 \\%$ preoperative staging accuracy):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 496,
            "markdown": "@ Primary tumor:\n$\\sqrt{ }$ lesion diameter $>4 \\mathrm{~cm}$\n$\\sqrt{ }$ enhancing papillary projections\n$\\sqrt{ }$ septa and walls $>3 \\mathrm{~mm}$ thick\n$\\sqrt{ }$ partially solid, partially cystic mass\n$\\sqrt{ }$ lobulated solid mass\n$\\sqrt{ }$ tumor vessels on contrast-enhanced images\n@ Local extension:\n$\\sqrt{ }$ localized distortion of uterine contour\n$\\sqrt{ }$ irregular interface between tumor and myometrium\n$\\sqrt{ }$ loss of tissue plane between tumor and wall of sigmoid colon / bladder\n$\\sqrt{ }$ encasement of sigmoid colon\n$\\sqrt{ }$ tumor distance from pelvic side wall $<3 \\mathrm{~mm}$\n$\\sqrt{ }$ iliac vessels surrounded / displaced by tumor\n@ Secondary findings:\n$\\sqrt{ }$ ascites:\n$\\sqrt{ }$ often lesser sac ascites with displacement of fundus and posterior wall of stomach anteriorly (DDx to benign ascites) + gastrosplenic ligament laterally\n$\\sqrt{ }$ loculated ascites $\\leftarrow$ adhesions\n$\\sqrt{ }>10-\\mathrm{mm}$ nodular / plaquelike peritoneal implants:\n$\\sqrt{ }$ indentation of hepatic / splenic surface\n$\\sqrt{ } \\pm$ calcifications\n$\\sqrt{ }$ lymphadenopathy, may be calcified\n$\\sqrt{ }$ omental implants:\n$\\sqrt{ }$ small nodules / strands of hyperdense soft tissue $\\rightarrow$ increased attenuation of omental fat / marked omental thickening (\"omental cake\")\n$\\sqrt{ }$ fat plane obscured between anterior abdominal wall + intestinal wall\n$\\sqrt{ }$ mesenteric deposits:\n$\\sqrt{ }$ round / irregular ill-defined masses / stellate lesions of small bowel mesentery\n$\\sqrt{ }$ tethering of small bowel loops\n$\\sqrt{ }$ invasion ofbowel:\n$\\sqrt{ }$ bowel obstruction (most common form of ovarian-cancer associated morbidity)\n$\\sqrt{ }$ nodular / plaquelike lesions along / projecting from peritoneal surfaces\n$\\sqrt{ }$ bowel wall thickening\n$\\sqrt{ }$ pseudomyxoma peritonei\nMR:\n$\\diamond$ Useful for lesions that are indeterminate by US (with $89 \\%$ highest accuracy of all modalities)\n$\\sqrt{ }$ papillary projections from wall / septum of a cystic lesion\n$\\sqrt{ }$ mass with solid + cystic components\n$\\sqrt{ }$ necrosis within a solid lesion\n$\\sqrt{ }$ multiple $>3 \\mathrm{~mm}$ thick septations; irregular septum / wall\n$\\sqrt{ }$ large size $>6 \\mathrm{~cm}$\n$\\sqrt{ }$ bilateral adnexal lesions\n$\\sqrt{ }$ ascites; peritoneal disease; lymphadenopathy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 497,
            "markdown": "$\\sqrt{ }$ strong early enhancement with high wash-in rate $>9.5 \\mathrm{~L} / \\mathrm{s}$\n$\\diamond$ Note clearly benign features:\n$\\checkmark$ high SI on T1WI = fat / blood\n$\\checkmark$ subsequent loss of SI on fat-suppressed T1WI = blood\n$\\checkmark$ low SI on T2WI = fibrous tissue / hemosiderin\n$\\checkmark$ lack of enhancement\nPET: $\\sqrt{ }$ ovarian carcinoma is FDG avid requiring a size of $6-10 \\mathrm{~mm}$ of spatial resolution\n$D D x$ : endometrioma, benign cystic teratoma, inflammatory mass (PID), physiologic change\n$\\checkmark$ may be useful for staging and recurrence\nBE:\n$\\checkmark$ serosal spiculation / tethering\n$\\checkmark$ annular constriction / complete obstruction\n$R x$ :\nstage I: total abdominal hysterectomy (TAH) + bilateral salpingo-oophorectomy (BSO) $\\pm$ melphalan / intraperitoneal Phosphorus-32\nstage $>$ I: TAH-BSO + surgical cytoreduction (debulking) +6 cycles of chemotherapy (cyclophosphamide + cisplatin)\nPrognosis (without change in past 60 years):\n$46 \\%$ overall 5-year survival rate, $10-25 \\%$ for stage IV, $37 \\%$ for stage III, $50 \\%$ for stage II, $80-90 \\%$ for stage I\n$D D x$ : tuboovarian abscess, dermoid cyst, endometrioma\n\n# OVARIAN CYST \n\nDefinition: any ovarian cyst $>2.5 \\mathrm{~cm}$\n$\\diamond$ Fetal ovarian cysts $>4 \\mathrm{~cm}$ may be at risk of in utero torsion!\n\n## Dominant Follicle\n\nCause: physiologic (estrogen sensitive)\n\n- pelvic pain from\n(a) stretching of ovarian capsule\n(b) ovulation (Mittelschmerz) triggered by surge in LH\n(c) cyst rupture / hemorrhage\n\nNumber: 1 or 2 dominant follicles\n$\\checkmark$ follicular enlargement at a rate of 2 mm per day during first half of menstrual cycle $\\leftarrow$ under influence of FSH\n$\\checkmark 18-25 \\mathrm{~mm}$ Graafian follicle at time of ovulation\n$\\checkmark$ conversion into corpus luteum after ovulation\n$D D x$ : nonovulatory follicle ( $<10 \\mathrm{~mm}$ ); ovarian cyst\n$C x$ : ovarian torsion\n\n## Functional / Retention Cyst\n\n$\\diamond$ Functional cysts are commonly unilateral!\nCause:\n(a) failure of involution of follicle / corpus luteum with changes in the menstrual cycle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 498,
            "markdown": "(b) excessive hormonal stimulation of follicles preventing normal follicular regression (eg, theca-lutein cysts)\nPrognosis: spontaneous regression is common but unpredictable; typically resolve within 2 menstrual cycles (less likely if cyst $>5 \\mathrm{~cm}$ )\n$C x$ : torsion\nRx: (1) Hormonal manipulation\n(2) Surgery $\\rightarrow$ absolutely indicated if cyst enlarges\n(3) Percutaneous aspiration (if chance of malignancy is nil as in infants)\n\nDDx: cystic teratoma, simple benign epithelial neoplasm, endometrioma in resolution, paraovarian cyst, quiescent hydrosalpinx\n\n# Follicular Cyst (from preovulatory follicle) \n\n## Cause:\n\n(a) unruptured Graafian follicle from failure to ovulate\n(b) Graafian follicle with failure to regress / involute\n(c) ruptured Graafian follicle that sealed immediately (after continued stimulation)\n\n- pain $\\leftarrow$ rapid cystic enlargement / rupture / hemorrhage\n- may elaborate estrogen (extremely common)\n- sign of anovulatory cycle\n\nPredisposed: patients during puberty + menopause; status post salpingectomy\nSize: usually $3-8 \\mathrm{~cm}$; occasionally up to 10 cm (if cyst remains hormonally sensitive); up to 25 cm (under influence of placental gonadotropin in pregnancy)\n$\\checkmark$ thin-walled unilocular cyst\n$\\checkmark$ located within ovary $\\rightarrow$ compressing adjacent ovarian follicle-containing parenchyma\n$\\checkmark$ usually multiple / may be single\nUS:\n$\\checkmark$ contains anechoic fluid $\\rightarrow$ posterior through-transmission\n$\\checkmark \\pm$ minimal mobile low-level internal echoes\nCT:\n$\\checkmark$ well-defined round simple fluid collection\n$\\checkmark$ thin nonenhancing wall\n$\\checkmark$ internal attenuation of $<15 \\mathrm{HU}$\nPrognosis: usually resolves after 1-2 menstrual cycles (follow-up best performed on days $5-10$ of subsequent menstrual cycle)\n$D D x$ : cystadenoma (larger, persistent, in older woman)\n\n## Corpus Luteum Cyst (from postovulatory follicle)\n\n$=$ hemorrhage into mature corpus luteum\nPhysiology: grows under the influence of LH; granulosa cells undergo marked neoangiogenesis $\\rightarrow$ frequently causing hemorrhage\nTypes:\n\n1. Corpus luteum of menstruation\n$=$ formed after rupture of follicle + increasing in size until $22^{\\text {nd }}$ day of menstrual cycle\nSize: usually $>12-17 \\mathrm{~mm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 499,
            "markdown": "- elaborates progesterone $\\rightarrow$ release into maternal circulation $\\rightarrow$ delayed menstruation / persistent bleeding\nPrognosis: resolves within 1-2 menstrual cycles\n\n2. Corpus luteum of pregnancy\n$=$ maintained by circulating $\\beta$-hCG during pregnancy with similar effect as LH\n\n- may be temporarily painful\n\nSize: usually $30-40 \\mathrm{~mm}$, may grow up to 15 cm in diameter\n$\\diamond$ Excessively large cyst with thin wall suggests poor function $\\leftarrow$ low progesterone level\n$\\checkmark$ reaches maximum size after $8-10$ weeks\n$\\checkmark$ occurs on same side as ectopic in $85 \\%$\nPrognosis:\nnormally resolved by 12-16 weeks (as placenta becomes dominant source of progesterone); occasionally persists past $1^{\\text {st }}$ trimester with failure to involute\nUS:\n$\\checkmark$ increased peripheral vascularity with high diastolic flow component\n$\\checkmark$ irregular thick-walled usually unilateral cyst\n$\\checkmark$ echogenic (= organized clot) / isoechoic with low-level internal echoes (= hemorrhage) / sonolucent (= serum)\n$\\checkmark$ posterior through-transmission\nCT:\n$\\checkmark$ unilocular cyst with thick crenulated enhancing wall\n$\\checkmark$ intracystic blood products with high attenuation\n$\\checkmark$ fluid surrounding adnexa (after rupture)\n$C x$ :\n(1) Enlarging hemorrhagic corpus luteum with\n> severe pelvic adhesions preventing ovulation of luteinized follicles\n> NSAIDs which may cause luteinized unruptured follicle syndrome\n> excessive anticoagulation\n> endometriosis\n(2) Rupture with intraperitoneal life-threatening hemorrhage at ovulation\n$D D x$ : endometrioma, ovarian tumor, organized clot in any enclosed space\n\n# Corpus Albicans Cyst \n\n$=$ from corpus luteum following regression of luteal tissue; no hormone production\n\n## Theca Lutein Cyst\n\n$=$ multiple bilateral corpus luteum cysts $\\leftarrow$ ovarian hyperstimulation $\\leftarrow$ abnormally high levels of $\\beta$-hCG\nCause: (a) multiple gestations (twins)\n(b) gestational trophoblastic disease (in $40 \\%$ )\n(c) fetal hydrops\n(d) pharmacologic stimulation of ovaries with $\\beta$-hCG\n(e) normal pregnancy (uncommon)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 500,
            "markdown": "- elaborates estrogen\n$\\sqrt{ }$ multiloculated cysts, often bilateral\n$\\sqrt{ }$ ovaries several cm in size\n$\\sqrt{ }$ involution within a few months after source of gonadotropin removed\n\n\n# Surface Epithelial Inclusion Cyst \n\ncommon in postmenopausal women\nAge: any; in newborns (influence of maternal estrogen)\nPrevalence: $3-5-17 \\%$ in postmenopausal women\n\n- usually asymptomatic\n- acute unilateral pelvic pain $\\leftarrow$ hemorrhage / pressure\n$\\sqrt{ }$ up to $8-10 \\mathrm{~cm}$ in diameter\n\n\n## Imaging Classification of Ovarian Cysts\n\n## Simple Ovarian Cyst\n\nLocation: uni- > bilateral; intra-abdominal > intrapelvic\nSize: $<20 \\mathrm{~mm}$ in diameter $=$ maturing $/$ physiologic follicle\n$\\sqrt{ }$ round smooth cyst + thin sharply defined wall of $<3 \\mathrm{~mm}$\n$\\sqrt{ }$ unilocular $=\\mathrm{NO}$ internal septations / mural nodules\nN.B.: may occasionally contain single avascular septation\n$\\sqrt{ }$ contents anechoic\n$\\sqrt{ }$ posterior acoustic enhancement\n$\\sqrt{ }$ \"daughter cyst\" = small round anechoic structure within a cyst is PATHOGNOMONIC for an ovarian cyst $(82 \\%)$\n$\\sqrt{ }$ Doppler flow in cyst wall (detected in 19-61\\%) with a pulsatility index of $>1.0 / \\mathrm{RI}>$ 0.4 (unreliable!)\n$\\sqrt{ }$ isointense to urine on T1WI + T2WI\n$D D x:$ serous cystadenoma\n\n| Management of Premenopausal Asymptomatic Adnexal Cyst (Society of Radiologists in Ultrasound, 2010) |  |  |\n| :--: | :--: | :--: |\n| Cyst Size [cm] | Cyst Content | Recommendation |\n| $\\leq 3$ | simple / hemorrhagic | no follow-up; may be omitted from report |\n| $3-5$ | simple / hemorrhagic | no follow-up; mention in report |\n| $>5$ and $\\leq 7$ | simple | sonographic follow-up annually |\n|  | hemorrhagic | follow-up in 6-12 weeks to ensure resolution |\n| $>7$ | simple | MR imaging / surgery |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 501,
            "markdown": "| Postmenopausal (> 5 years) Asymptomatic Adnexal Cyst <br> (Society of Radiologists in Ultrasound, 2010) |  |  |\n| :--: | :--: | :--: |\n| Cyst Size [cm] Cyst Content |  | Recommendation |\n| $\\leq 1$ | simple | no follow-up; may be omitted <br> from report |\n| $>1$ and $\\leq 7$ | simple | sonographic follow-up annually |\n| $>7$ | simple | MR imaging / CA-125 / surgery |\n| Risk of Malignancy Index (RMI) |  |  |\n| Score |  | Description |\n| U-score | Number of malignant features at ultrasound: <br> multilocular cyst, solid component, bilateral, <br> metastases, ascites |  |\n| 0 | no features of malignancy |  |\n| 1 | one feature of malignancy |  |\n| 3 | $\\geq 2$ features of malignancy |  |\n| M score | Patient's menopausal status: no menstruation $>1$ <br> year $/>50$ years old with hysterectomy |  |\n| 1 | premenopausal |  |\n| 3 | postmenopausal |  |\n| RMI | RMI = U x M x CA-125 level |  |\n| $>200$ | high risk ( $84-85 \\%$ sensitive, $77-97 \\%$ specific); <br> staging CT + referral to gynecologic oncology |  |\n| $25-200$ | intermediate risk; MRI for further characterization |  |\n| $<25$ | low risk; clinical reevaluation |  |\n\n# Complex / Complicated Ovarian Cyst \n\n$=$ does not satisfy criteria for hemorrhagic cyst / endometrioma\nCause: ovarian torsion\n$\\sqrt{ }$ thick-walled cyst of heterogeneous echogenicity\n$\\sqrt{ }$ multiple septations, mobile internal echoes, solid appearance, fluid-fluid level\n$\\sqrt{ }$ internal septations / mural nodules / internal echoes\n$\\sqrt{ } \\pm$ polyhydramnios, ascites $\\leftarrow$ transudate / cyst rupture\nCx: obstruction of bowel / kidneys\n\n## Hemorrhagic Ovarian Cyst\n\n$=$ functional cyst (follicular cyst / corpus luteum) that developed internal hemorrhage $\\rightarrow$ resolves partially / completely over time\n$\\diamond$ Common cause of RLQ pain $\\leftarrow$ rupture into peritoneal cavity\nPath: functional cyst + corpus luteum cyst\nUS:\n$\\sqrt{ }$ hematocrit level in acute bleed\n$\\sqrt{ }$ \"ground-glass\" pattern = diffuse low-level echoes\n$\\sqrt{ }$ whirled / spongy pattern of mixed echogenicity\n$\\sqrt{ }$ \"fishnet weave\" pattern = fine interdigitating septations / lacelike reticular pattern for",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 502,
            "markdown": "first 24 hours (SPECIFIC)\n$\\sqrt{ }$ gelatinous echogenic mass (= retracting clot) jiggling during transducer ballottement with triangular / curvilinear echogenic regions at cyst wall\n$\\sqrt{ }$ fluid-debris level\n$\\sqrt{ }$ NO color Doppler signals inside cyst\n$\\sqrt{ }$ posterior through-transmission\nCT:\n$\\sqrt{ }$ unilocular cyst with an attenuation of $25-100 \\mathrm{HU}$\n$\\sqrt{ }$ fluid-fluid level + hemoperitoneum (after cyst rupture)\nMR:\n$\\sqrt{ }$ SI varies depending on age of hemorrhage:\n$\\sqrt{ }$ intermediate SI on T1WI + low SI on T2WI $\\leftarrow$ deoxyhemoglobin of subacute hemorrhage\n$\\sqrt{ }$ increased SI on T1WI + decreased SI on T2WI $\\leftarrow$ intracellular methemoglobin\n$\\sqrt{ }$ hematocrit effect of layering blood products\n$\\sqrt{ }$ intermediate to high intensity on fat-suppressed T1WI\n$\\sqrt{ }$ hyperintense / intermediate intensity with distinct central area of hypointensity on T2WI\n$\\sqrt{ }$ heterogeneous mild signal loss with NO shading on T2WI\n$\\sqrt{ }$ pelvic peritoneal fluid of elevated T1 signal $\\leftarrow$ hemorrhage\n$D D x$ : endometrioma (\"light bulb\" T1-hyperintensity, T2 shading, stable over time)\n$C x$ : rupture into intraperitoneal space\n\n# Ovarian Cyst concerning for Neoplasm \n\n$\\sqrt{ }$ irregular solid / multilocular cystic mass\n$\\sqrt{ }$ solid component / papillary projections on cyst wall\n$\\sqrt{ }$ absence of thin septations\n$\\sqrt{ }$ presence of thick septations $>3 \\mathrm{~mm}$\n$\\sqrt{ }$ central vascularity with high flow in echogenic component / septation / focal wall thickening\n$\\sqrt{ }$ low resistance flow $(\\mathrm{RI}<0.5, \\mathrm{PI} \\leq 1.0)$\n$\\sqrt{ }$ ascites\n$\\sqrt{ }$ omental / peritoneal nodules\n\n## Management of Asymptomatic Adnexal Cyst\n\nA. NEONATAL\n$\\sqrt{ }$ change in position between exams suggests pedunculated lesion $\\rightarrow$ potential for torsion\n$\\sqrt{ }$ fluid-debris level / low-level echoes / retracting clot suggest torsion\nB. PREMENOPAUSAL\n\nRisk of malignancy: $<1 \\%$ for simple cyst $<5 \\mathrm{~cm}, 0.8 \\%$ for lesion $>7.5 \\mathrm{~cm}$\n$\\diamond$ Adnexal cysts up to 10 cm are highly likely benign (in $84 \\%$ serous cystadenoma)!\n$\\diamond$ Hemorrhage WITHOUT a vascular soft-tissue component is a reliable indicator of a benign lesions\nN.B.: All follow-up scans should take place in the immediate postmenstrual period (= early proliferative phase), when follicular cysts should not be present!",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 503,
            "markdown": "C. POSTMENOPAUSAL ( $<5$ years after LMP)\n$=$ ovulation + hemorrhagic cysts may occasionally occur\nRisk of malignancy: $1.6 \\%$ for simple cyst $<5 \\mathrm{~cm}$\n$R x:$ follow-up in 6-12 weeks to ensure resolution\nC. POSTMENOPAUSAL ( $>5$ years after LMP)\n\nRisk of malignancy: $1.0-9.6 \\%$\n$\\diamond$ A hemorrhagic cyst in an anovulatory woman is likely neoplastic! $18 \\%$ of complex cysts are malignant!\n\n# OVARIAN FIBROMA \n\nFrequency: $3-4 \\%$ of all ovarian tumors; bilateral in $<10 \\%$\n$\\diamond$ Most common of the sex cord-stromal tumors!\nAge: $4^{\\text {th }}-6^{\\text {th }}$ decade\nPath: solid firm white mass\nHisto: pure mesenchymal tumor consisting of intersecting whorled bundles of spindle-shaped fibroblasts + collagen; varying degrees of edema often separate cells\n\n- usually asymptomatic (pure fibromas are not estrogenic, admixture of theca cells causes estrogenic effect)\n- Meigs syndrome (in only 1\\%)\n- elevated carcinogenic antigen levels\n\nAssociated with: basal cell nevus (Gorlin) syndrome in commonly bilateral calcified fibromas\n$\\diamond$ Fibromas occur in $17 \\%$ of patients with basal cell nevus syndrome\nLocation: unilateral (common); bilateral in 4-8\\%\n$\\sqrt{ } \\pm$ cystic degeneration and edema in larger lesions\n$\\sqrt{ }$ calcification + hemorrhage $(<10 \\%)$\nUS:\n$\\sqrt{ }$ solid hypoechoic mass with marked sound attenuation\n$\\sqrt{ }$ occasionally hyperechoic / with increased through-transmission\nMR:\n$\\sqrt{ }$ well-circumscribed mass with nonspecific hypo- to isointensity on T1WI\n$\\sqrt{ }$ low-SI mass on T2WI less than or equal to myometrium $\\leftarrow$ abundant collagen content (FAIRLY DIAGNOSTIC)\n$\\sqrt{ }$ scattered high-signal-intensity areas on T2WI (= edema / cystic degeneration)\n$\\sqrt{ }$ delayed mild enhancement with gadolinium\nCT:\n$\\sqrt{ }$ well-defined solid homogeneous / slightly heterogeneous mildly hypoattenuating mass\n$\\sqrt{ }$ poor delayed contrast enhancement\n$R x$ : may be managed conservatively; rarely recurs after excision\n$D D x$ : fibrothecoma; pedunculated uterine leiomyoma; Brenner tumor; adenofibroma; malignant ovarian neoplasm\n\n## OVARIAN FIBROMATOSIS\n\n$=$ rare benign condition causing tumorlike enlargement of ovaries related to massive ovarian edema",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 504,
            "markdown": "Cause: ?\nAverage age: 25 years\n\n- pelvic pain, menstrual abnormalities, occasional virilization\n\nHisto: proliferation of collagen-producing spindle cells surrounding normal ovarian structures with collagenous thickening of superficial cortex; partial preservation of normal ovarian structures within the fibrous mass, which allows differentiation of ovarian fibromatosis from similar conditions.\n$\\checkmark$ nonspecific enlargement of ovaries\n$\\checkmark$ at least partial preservation of ovarian anatomy\nUS:\n$\\checkmark$ enlarged heterogeneously echogenic ovary with areas of acoustic shadowing\n$\\checkmark$ low flow at Doppler imaging\nMR:\n$\\checkmark$ hypointense areas on T1WI + T2WI\n$\\checkmark$ \"black garland\" on T2WI $\\leftarrow$ fibrous tissue encasing peripheral aspect of ovary\n$D D x$ : (1) Pelvic aggressive fibromatosis (desmoid) involving ovary\n(2) Brenner tumor (calcifications)\n(3) Ovarian sex-cord stromal tumors: fibroma, fibrothecoma\n(4) Krukenberg tumor (bilateral, avid enhancement)\n\n# OVARIAN HYPERSTIMULATION SYNDROME \n\n$=$ potentially life-threatening iatrogenic complication of ovulation induction / ovarian stimulation\nIncidence: (a) Clomid ${ }^{\\circledR}$ : mild in $13 \\%$, moderate in $8 \\%$\n(b) Pergonal ${ }^{\\circledR}$ : mild in $20-33 \\%$, moderate in $3-6 \\%$, severe in $0.1-2 \\%$\n\n## Etiology:\n\n(1) Induced by hCG therapy with human menopausal gonado-tropin (Pergonal ${ }^{\\circledR}$ ), occasionally with clomiphene (Clomid ${ }^{\\circledR}$ )\n(2) Hydatidiform mole\n(3) Chorioepithelioma\n(4) Multiple pregnancies\n\nPath: enlarged ovaries with multiple follicular + theca lutein cysts, edematous stroma\nPathophysiology:\nsecretion of ovarian vasoactive angiogenic substances $\\rightarrow$ increased capillary permeability $\\rightarrow$ fluid shift out of intravascular space $\\rightarrow$ ascites $\\rightarrow$ hemoconcentration\n\n- abdominal pain $(100 \\%)+$ distension $(100 \\%)$\n- nausea ( $100 \\%$ ), vomiting ( $36 \\%$ ), acute abdomen ( $17 \\%$ )\n- dyspnea ( $16 \\%$ ), thrombophlebitis ( $11 \\%$ ), fainting ( $11 \\%$ )\n- marked hemoconcentration, blurred vision (5\\%)\n- anasarca (5\\%), hydrothorax, enhanced fertility\n$\\checkmark$ \"spoke-wheel\" appearance of ovaries = bilateral symmetrically enlarged ovaries $>5 \\mathrm{~cm}$ in longest dimension containing large geometrically packed follicles:\n$\\checkmark$ cysts separated by thin septa",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 505,
            "markdown": "| Modified Golan Classification of Hyperstimulation Syndrome |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Category | Grade | Ovarian size [cm] | Signs and symptoms |\n| Mild | I | $<6$ | Abdominal distension |\n| (65\\%) |  |  |  |\n|  | II |  | + nausea, vomiting, diarrhea |\n| Moderate | III | $6-12$ | + ascites at US; weight gain |\n| Severe | IV | $>12$ | Clinical ascites / pleural effusion |\n|  | V |  | + hypovolemia, hemoconcentration, hypercoagulability, renal failure, hepatic dysfunction, thromboembolism, shock |\n\n$\\sqrt{ }$ cysts usually anechoic, unless complicated by hemorrhage\n$\\sqrt{ }$ resolution on follow-up\n$\\sqrt{ }$ ovarian cyst $>10 \\mathrm{~cm}(100 \\%)$ : usually disappears after 20-40 days; may persist for 12-16 weeks during pregnancy\n$\\sqrt{ }$ ascites (33\\%)\n$\\sqrt{ }$ pleural effusion (5\\%)\n$\\sqrt{ }$ hydroureter (11\\%)\nMR:\n$\\sqrt{ }$ cysts with increased SI on T1WI (common) $\\leftarrow$ hemorrhage\n$\\sqrt{ } \\uparrow$ SI of ovarian stroma on T2WI $\\leftarrow$ edema\nCx of volume depletion:\n(1) Hypovolemia + hemoconcentration\n(2) Oliguria, electrolyte imbalance, azotemia\n(3) Death from intraabdominal hemorrhage / thromboembolic event\n\nOther Cx:\n(1) Ovarian torsion (7\\%)\n(2) Ectopic pregnancy (in $2.1-8.6 \\%$ )\n\n# OVARIAN MALIGNANT GERM CELL TUMOR \n\n= OMGCT = heterogeneous group of tumors sharing the primitive germ cell of the embryonic gonad as a common origin\nIncidence: $2.6 \\%$ of all malignant ovarian neoplasms\n$\\diamond 60-75 \\%$ of ovarian cancers seen in $1^{\\text {st }}-2^{\\text {nd }}$ decade\nAge-adjusted incidence: $0.34-0.41 \\div 100,000$ women-years\nTypes and Incidence of each OMGCT:\n\n1. Dysgerminoma $37 \\%$\n2. Immature teratoma $36 \\%$\n3. Yolk sac tumor $15 \\%$\n4. Choriocarcinoma $3 \\%$\n5. Malignant mixed germ cell tumor $<1 \\%$\n6. Embryonal carcinoma $<1 \\%$\n7. Malignant degeneration of mature cystic teratoma $3 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 506,
            "markdown": "Mean age: highest incidence at age 14 (range, 15-19) years\n\n- abdominal distension / pain (in 87\\%) of 2-4 weeks duration\n- pelvic pain $\\leftarrow$ torsion / hemorrhage / tumor rupture\n- vaginal bleeding, fever, large mass at presentation (in 85\\%)\n- elevated a-fetoprotein $\\leftarrow$ component of yolk sac tumor: $60 \\%$ in immature teratoma; $100 \\%$ in endodermal sinus tumor:\n- elevated $\\beta$-hCG $\\leftarrow$ component of choriocarcinoma: $30 \\%$ of endodermal sinus tumors\n$\\triangleq \\alpha$-fetoprotein $/ \\beta$-hCG are virtually diagnostic of OMGCTs\nSpread: most commonly lymphatic\nAverage size: 15 cm in diameter\n$\\checkmark$ unilateral, rarely bilateral\n$\\checkmark$ calcifications $(40 \\%)$\n$\\checkmark$ homogeneously solid (3\\%), predominantly solid (85\\%), predominantly cystic (12\\%)\n\n\n# Dysgerminoma (37\\%) \n\n$=$ malignant germ cell tumor of ovary homologous to testicular seminoma\n$\\diamond$ Second most common ovarian germ cell tumor\n$\\diamond$ Most common ovarian malignant germ cell tumor (OMGCT)\nFrequency: $1-2 \\%$ of all primary ovarian neoplasms; $35 \\%$ of all ovarian malignant germ cell tumors\nAge-adjusted incidence: $0.109 \\div 100,000$ women-years\nPath: solid well encapsulated lobulated tumor $\\pm$ coagulative necrosis / hemorrhage\nHisto: uniform population of round cells with clear to eosinophilic cytoplasm + central large round / flattened nucleus resembling primordial germ cells in well-defined nests, separated by fibrous strands, infiltrated by T lymphocytes; numerous mitoses\nPeak age: $2^{\\text {nd }}-3^{\\text {rd }}$ decade (range, 7 months -70 years)\n\n- pain, bloating, menstrual disorder\n- often nonspecific elevation of serum lactic dehydrogenase + alkaline phosphatase\n- typically NO elevation of a-fetoprotein / b-hCG\n\nCave: elevation of a-fetoprotein / b-hCG in $5 \\% \\leftarrow$ presence of multinucleated syncytiotrophoblastic giant cells\nLocation: usually unilateral; bilateral in 7-10\\%\nMean diameter: 15 cm\n$\\checkmark$ multilobulated well-defined solid mass divided by fibrovascular enhancing septa\n$\\checkmark \\pm$ areas of hemorrhage and necrosis\n$\\checkmark$ speckled pattern of calcifications (rare)\nMR:\n$\\checkmark$ mass of low signal intensity relative to muscle on T1WI\n$\\checkmark$ isointense / slightly hyperintense mass on T2WI\n$\\checkmark$ hypo- / isointense septa on T2WI with contrast enhancement on T1WI\nUS:\n$\\checkmark$ heterogeneous hyperechoic solid mass\n$\\checkmark$ prominent arterial color Doppler flow within septa\n$R x$ : highly radiosensitive",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 507,
            "markdown": "$D D x$ : fibrothecoma (predominantly low SI on T2WI), Brenner tumor (extensive low SI on T2WI), granulosa cell tumor (associated with uterine enlargement, most common estrogenic ovarian tumor), epithelial ovarian carcinoma, metastasis\n\n# Embryonal Carcinoma of Ovary (< 1\\%) \n\nLaterality: unilateral\nPath: predominantly solid mass with cystic spaces containing mucoid material, smooth outer surface, extensive areas of hemorrhage + necrosis\nHisto: solid sheets + nests of large primitive cells in pseudo- glandular pattern + occasional papillae; large crowded pleomorphic vesicular nuclei with prominent nucleoli\nAverage size: 17 cm\n\n## Immature Teratoma of Ovary (36\\%)\n\n$=$ EMBRYONAL TERATOMA $=$ MALIGNANT TERATOMA\n$=$ SOLID TERATOMA\nFrequency: $1.3 \\%$ of all ovarian malignancies; $36 \\%$ ( $=2 \\mathrm{nd}$ most common) of all malignant germ cell tumors\nPath: predominantly solid encapsulated mass $\\pm$ small cysts; frequently with areas of necrosis + hemorrhage; $\\pm$ fat + hair + sebaceous material\nHisto: immature embryonic tissue derived from the 3 germ cell layers; grades $0-3$ reflect amount of immature neuroectodermal tissue\nMay be associated with: gliomatosis peritonei = multiple peritoneal implants of mature glial tissue; dermoid cyst in up to $26 \\%$\nPeak age: $15-19$ years\n\n- $\\uparrow$ AFP levels (50\\%); no elevation of serum hCG levels\n\nLaterality: dermoid cyst in contralateral ovary in $10 \\%$\nMean tumor size: $12-25 \\mathrm{~cm}$ in diameter\n$\\checkmark$ predominantly solid tumor with numerous cysts of varying size + intratumoral fat\n$\\checkmark$ scattered small calcifications $\\leftarrow$ invariable association with mature teratoma\nUS:\n$\\checkmark$ heterogeneous solid mass + scattered small calcifications\n$\\checkmark$ areas of increased echogenicity = larger fat components\nCT / MR:\n$\\checkmark$ predominantly solid mass + fatty elements\n$\\checkmark$ numerous cysts of variable sizes\n$\\checkmark$ coarse irregular calcifications\nMR:\n$\\checkmark$ wide variety of signal intensities on T2WI\n$\\checkmark \\pm$ fatty fluid within cystic compartments\nPrognosis: responsible for $30 \\%$ of deaths from ovarian cancer in women $<20$ years\n\n## Growing Teratoma Syndrome\n\n$=$ enlarging teratoma of mature elements arising during / after chemotherapy for treatment of a nonseminomatous germ cell tumor in male / female patients with normal serum $\\alpha$ fetoprotein and b-hCG levels",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 508,
            "markdown": "Mechanism: (a) ? chemotherapeutic retroconversion = induction of somatic maturation in malignant cells by chemotherapy\n(b) selective destruction of immature elements by chemotherapy, which leaves behind resistant mature elements\n\n# Malignant Mixed Germ Cell Tumor (< 1\\%) \n\n$=$ composed of $>1$ germ cell element (mainly dysgerminoma, teratoma, and yolk sac tumor)\n$\\sqrt{ }$ solid mass + areas of cystic change $\\leftarrow$ hemorrhage / necrosis / cystic lesion with solid components\n\n## Nongestational Choriocarcinoma (3\\%)\n\nFrequency: with 2.1-3.4\\% among rarest of all OMGCTs\nHisto: plexiform arrangement of syncytiotrophoblast cells with mononucleated (mostly cytotrophoblast) cells around foci of hemorrhage\nUS:\n$\\sqrt{ }$ well-defined adnexal mass of mixed echogenicity\n$\\sqrt{ }$ NO uterine / ectopic pregnancy\nCT:\n$\\sqrt{ }$ enhancing highly vascular solid mass\nMR:\n$\\sqrt{ }$ abnormal large signal voids on T2WI $\\leftarrow$ vascular structures + small cystic cavities\n$\\sqrt{ }$ high-signal-intensity foci in solid portions on T1WI $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ substantial uptake of contrast material in solid portions $\\leftarrow$ highly vascularized tumor\n$D D x$ : gestational choriocarcinoma (concomitant / proximate gestation, no other germ cell tumor component)\n\n## Polyembryoma\n\n$=$ usually component of mixed OMGCT (immature teratoma + yolk sac tumor), extremely rare\nHisto: small embryo-like bodies with central \"germ disks\" composed of embryonal carcinoma epithelia and 2 cavities (dorsal cavity resembling amniotic cavity + ventral cavity resembling yolk sac cavity); embryoid bodies lie in an edematous to myxoid stroma with prominent blood vessels\nMean age: 24.5 (range, 3-44) years\n\n- $\\pm$ elevation of a-fetoprotein + b-hCG\n$\\sqrt{ }$ large unilateral mass\n\n\n## Yolk Sac Tumor of Ovary (15\\%)\n\n$=$ ENDODERMAL SINUS TUMOR OF OVARY\nFrequency: $1 \\%$ of all ovarian malignancies; $15 \\%$ ( $=3^{\\text {rd }}$ most common) of all malignant germ cell tumor\nPath: large encapsulated mass with admixed solid + cystic components $\\leftarrow$ up to $2-\\mathrm{cm}$ large cysts +hemorrhage + necrosis; capsular tears in $27 \\% \\leftarrow$ rapid growth\nHisto: resembles endodermal sinuses of primitive yolk sac\n(a) papillary pattern (most common): contains glomerular structures with central vessel + peripheral sleeve of embryonic epithelial cells (= Schiller-Duval bodies)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 509,
            "markdown": "(b) others: solid, reticular, endodermal sinus, alveolar -glandular, polyvesicular vitelline, myxomatous, microcystic, macrocystic papillary, hepatoid\n> periodic acid-Schiff reaction\n$>\\alpha$-fetoprotein-positive hyaline globules\nAge: $\\quad 2^{\\text {nd }}-3^{\\text {rd }}$ decade; rare in women $>40$ years\nMay be associated with: teratoma, dermoid cyst, chorioca.\n\n- frequently abdominal enlargement + pain $\\leftarrow$ rapid growth\n- elevated serum AFP (common)\n\nLaterality: bilateral in $<5 \\%$; contralateral ovary with dermoid cyst in $10 \\%$\nMean size: 15 cm in diameter\n$\\sqrt{ }$ unilateral smoothly contoured enhancing mixed solid + cystic mass\n$\\sqrt{ }$ \"bright dot\" sign = enhancing foci in wall / solid component of tumor (common) $\\leftarrow$ dilated vessels\n$\\checkmark$ cystic areas $\\leftarrow$ epithelial-lined cysts / cysts of coexisting mature teratoma / hemorrhage / necrosis\n$\\checkmark$ capsular tears\nUS:\n$\\checkmark$ predominantly heterogeneous echogenic solid tumor\n$\\checkmark$ cystic spaces divided by septa\nMR:\n$\\checkmark$ foci of high signal intensity on T1WI $\\leftarrow$ hemorrhage\n$R x$ : surgery + combination chemotherapy\nPrognosis: poor\n\n# OVARIAN VEIN THROMBOSIS \n\nEtiology:\n(1) Bacterial seeding from puerperal endometritis with secondary thrombosis (pregnancy + puerperium are hypercoagulable states) $=$ puerperal ovarian vein thrombophlebitis\n(2) Pelvic inflammatory disease\n(3) Gynecologic surgery\n(4) Malignant tumors\n(5) Chemotherapy\n\nPrevalence: $1 \\div 600-1 \\div 2,000$ deliveries\n\n- presents on $2^{\\text {nd }} / 3^{\\text {rd }}$ postpartum day\n- lower abdominal / flank pain (>90\\%)\n- palpable ropelike tender abdominal mass ( $50 \\%$ )\n- fever + chills if diagnosis delayed\n\nLocation: right [left] \\{both\\} ovarian veins in $80 \\%[6 \\%]\\{14 \\%\\}$\nCT:\n$\\checkmark$ tubular structure in location of ovarian vein with low-density center + peripheral enhancement\nCx: IVC thrombosis; pulmonary embolism (25\\%); septicemia; metastatic abscess formation Mortality: $5 \\%$\n$R x$ : IV antibiotics + heparin; ligation of involved vessel at most proximal point of thrombosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 510,
            "markdown": "after failure to improve after 3-5 days\n$D D x$ : appendicitis, broad-ligament phlegmon / hematoma, torsion of ovarian cyst, urolithiasis, pyelonephritis, degenerated pedunculated leiomyoma, pelvic cellulitis, pelvic / abdominal abscess\n\n# PARAOVARIAN CYST \n\n$=$ vestigial remnant of wolffian duct in mesovarium\nFrequency: $10-20 \\%$ of all adnexal masses\nMean age: $3^{\\text {rd }}-4^{\\text {th }}$ decade\nEmbryology: wolffian body (= mesonephros) consists of\n(a) mesonephric duct (= wolffian duct)\n$\\rightarrow$ degenerates in female into vestigial structures of epithelial-lined cysts (= canals / ducts of Gartner)\nLocation: at lateral edge of uterus and vagina extending from broad ligament to vestibule of vagina\n(b) mesonephric tubules\n$\\rightarrow$ in female degenerate into vestigial structures of\n\n1. EpoÃ¶phoron (at lateral part of fallopian tube)\n2. ParoÃ¶phoron (at medial part of fallopian tube)\n\nLocation: between the tube and hilum of the ovary within the 2 peritoneal layers of broad ligament\nSize: mean diameter of $8 \\mathrm{~cm} \\rightarrow$ up to 18 cm\n\n- usually incidental\n- symptomatic due to large size ( $>5 \\mathrm{~cm}$ ) / torsion\n\n1. Gartner duct cyst:\ninclusion cyst lateral to vagina + uterine wall\n2. ParoÃ¶phoron: [oion, Greek $=$ egg + pherein, Greek $=$ bearing $]$\nmedial location between tube + hilum of ovary\n3. EpoÃ¶phoron:\nlateral location between tube + hilum of ovary\n4. Hydatid Cyst of Morgagni ( $=$ appendices vesiculosae $=$ fimbrial cyst): most lateral + outer end of Gartner duct within longest fimbria of fallopian tube\n$\\sqrt{ } \\geq 1$ vesicle(s) attached to fringes of tube + filled with clear serous fluid\n$\\sqrt{ }$ thin-walled unilocular cyst separate from ovary WITHOUT change over time\n$\\sqrt{ }$ may indent ovary mimicking exophytic ovarian cyst\nN.B.: separable by pressure exerted by transvaginal transducer\n$\\sqrt{ }$ may arise out of pelvis (if pedunculated + mobile)\n$\\sqrt{ } \\pm$ low-level internal echoes $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ occasionally multiple; rarely bilateral\nCx: torsion (2-16\\%), hemorrhage, rupture, infection, neoplastic transformation (3\\%)\n$D D x$ : ovarian cyst (functional, cystic teratoma, benign epithelial neoplasm), peritoneal inclusion cyst, hydrosalpinx\n\n## PARAOVARIAN CYSTADENOMA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 511,
            "markdown": "May be associated with: Von Hippel-Lindau disease\nLocation: typically unilateral\n$\\sqrt{ }$ simple cyst\n$\\sqrt{ }$ one / more small nodules along a smooth inner wall ( $86 \\%$ )\n$\\sqrt{ } \\pm$ septations\n$C x$ : malignant degeneration in $2-3 \\%$\n$D D x$ : (1) Hydrosalpinx (tubular shape, folds / short echogenic lines protruding into lumen)\n(2) Peritoneal inclusion cyst (surrounding much of the ovary, history of surgery / PID)\n(3) Cystic neoplasm of fallopian tube (more solid components)\n(4) Paraovarian cyst with blood clot (resolution of clot on follow-up sonogram)\n(5) Exophytic complex ovarian mass\n\n# PELVIC CONGESTION SYNDROME \n\n$=$ chronic ( $>6$ months) noncyclical pelvic pain associated with pelvic venous distension + valvular ovarian vein insufficiency\nPrevalence: ovarian varices in $10 \\%$ in general population\n$\\diamond$ Closely related to frequency of ovarian varices; $60 \\%$ may develop pelvic congestion syndrome\nPathophysiology:\nvenous obstruction $\\leftarrow$ retroaortic left renal vein, compression of left renal vein by SMA $=$ nutcracker phenomenon; right common iliac vein compression; valvular incompetence; portal hypertension; acquired vena cava syndrome\nRisk factors: hereditary factors, hormonal influence, pelvic surgery, retroverted uterus, history of varicose veins, multiple pregnancies\n\n- uni- / bilateral chronic dull deep pelvic ache, pressure, heaviness often associated with movement / posture / activities that increase abdominal pressure\n- dyspareunia ( $71 \\%$ ), dysmenorrhea ( $66 \\%$ ), postcoital ache ( $65 \\%$ )\n- rectal discomfort, urinary frequency\n- varicose veins in vulva, buttocks, legs\n- ovarian point tenderness ( $94 \\%$ sensitive, $77 \\%$ specific)\n\nUS:\n$\\sqrt{ }$ multiple tortuous pelvic veins $>4-6 \\mathrm{~mm}$ in diameter around uterus + ovaries\n$\\sqrt{ }$ slow ( $\\leq 3 \\mathrm{~cm} / \\mathrm{s}$ ) / reversed (caudal) flow\n$\\sqrt{ }$ dilated arcuate vein in myometrium\n$\\sqrt{ }$ polycystic changes of ovaries\nCT / MR:\n$\\sqrt{ }$ dilated tortuous enhancing tubular structures\nLocation: around uterus, ovary, broad ligament, pelvic sidewall, paravaginal plexus\nAngio (standard nearly replaced by US, CT, MRI):\nTechnique: selective catheterization of ovarian veins, transuterine injection of contrast material, direct injection into vulval varices\n$\\sqrt{ }$ ovarian vein diameter $>10 \\mathrm{~mm}$\n$\\sqrt{ }$ retrograde flow in ovarian / pelvic veins\n$\\sqrt{ }$ tortuous collateral pelvic venous pathways",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 512,
            "markdown": "$\\sqrt{ }$ delayed / stagnant clearance of injected contrast from veins\n$R x$ : hormone analogues (medroxyprogestrone, GnRH analog goserelin) + analgesics; laparoscopic transperitoneal ligation of ovarian veins; hysterectomy $\\pm$ salpingooophorectomy; percutaneous coil embolization of the gonadal vein ( $70-85 \\%$ successful)\n$D D x$ : asymptomatic pelvic varicosities\n\n# Ovarian Vein Syndrome \n\n$=$ obstructive uropathy $\\leftarrow$ ureteral compression at pelvic brim by dilated / aberrant / thrombosed ovarian vein\nAnatomy: ovarian vein crosses ureter obliquely in retroperitoneum at L3\nSite: $\\quad \\mathrm{R} \\div \\mathrm{L}=95 \\div 5$\nTime of onset: during (2nd-3rd trimester) / after pregnancy\nIVP:\n$\\sqrt{ }$ oblique extrinsic impression on ureter:\n$\\sqrt{ }$ proximal hydroureteronephrosis + normal pelvic ureter\n$\\sqrt{ }$ medial deviation of obstructed segment (with retrocaval ureter) = characteristic reverse J configuration\nCT / coronal MR urography:\n$\\sqrt{ }$ concurrent evaluation of cause of compression, implicated vessel + proximal dilatation\n$C x$ : spontaneous rupture with life-threatening hemorrhage (rare)\n\n## PELVIC INFLAMMATORY DISEASE (PID)\n\n= acute clinical syndrome usually associated with ascending spread of microorganisms\n(\"canalicular spread\") from vagina / cervix to uterus, fallopian tubes, and adjacent pelvic structures; not related to surgery / pregnancy\nFrequency: $24 \\%$ of visits to emergency department for gynecologic pain; $10 \\%$ of women in reproductive age ( $17 \\%$ in Blacks); 106,000 outpatient visits and 60,000 hospitalizations annually in USA (2015)\nRisk factors: early age at sexual debut, multiple sexual partners, high coital frequency, history of sexually transmitted disease, douching\nPredisposed: formerly married $>$ married $>$ never married; intrauterine contraceptive device (1.5-4-fold increase in risk)\nEtiology: (a) bilateral: venereal disease, IUD, S/P abortion\n(b) unilateral (= nongynecologic): rupture of appendix, diverticulum, S/P pelvic surgery\nOrganism:\n(1) Chlamydia trachomatis + Neisseria gonorrhoeae ( $>50 \\%$ with high prevalence of coinfection) $\\rightarrow$ damage protective barrier of endocervical canal $\\rightarrow$ spread to tubes (30$50 \\%$ ) producing fibrosis + adhesions\n(2) Aerobes: Streptococcus, Escherichia coli, H. influenzae\n(3) Anaerobes: Bacteroides, Peptostreptococcus, Peptococcus\n(4) Mycobacterium tuberculosis (hematogenous)\n(5) Actinomycosis in IUD users\n$=$ chronic suppurative infection characterized by multiple abscesses, abundant granulation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 513,
            "markdown": "tissue, fibrosis\n(6) Herpesvirus hominis type 2, Mycoplasma\n$\\diamond$ Polymicrobial infection in $30-40 \\%$\nMay be associated with: Fitz-Hugh-Curtis syndrome (see below)\n\n- usually bilateral dull aching lower abdominal pain 7-10 days after menstruation $\\leftarrow$ peritoneal irritation\n- adnexal + cervical motion tenderness:\n- \"chandelier\" sign = patient reaching for the chandelier $\\leftarrow$ intense pain during pelvic examination\n- purulent vaginal discharge / uterine bleeding\n- dysuria, dyspareunia, nausea, vomiting\n- fever, leukocytosis, $\\uparrow$ ESR; $\\uparrow$ serum C-reactive protein\n\nUS:\n$\\checkmark$ No findings\n$\\checkmark$ thickened tubular adnexal structures $\\pm$ central fluid\n$\\checkmark$ increased adnexal volume\n$\\checkmark$ periadnexal inflammatory hyperemia\n$\\checkmark$ loss of normal tissue planes + ill-defined uterus:\n$\\checkmark$ echogenic periovarian fat\n$\\checkmark \\pm$ free fluid\nCT:\n$\\checkmark$ nonspecific stranding of parapelvic fat\n$\\checkmark$ thickening of uterosacral ligaments\nMR:\n$\\checkmark$ ill-defined hyperintense parametrial area on fat-suppressed T2WI + intense enhancement on contrast-enhanced fat-suppressed MR (= extent of inflammation)\n$D x:$ clinically, laparoscopically\n$\\diamond$ Imaging employed only to differentiate between medical + surgical condition and if\n(a) symptoms nonspecific\n(b) expected response to treatment absent\n(c) complication suspected (eg, abscess)\n(d) percutaneous treatment a possible option\n\nCx: (1) Infertility: $8 \\%[20 \\%]\\{40 \\%\\}$ after single [2] $\\{\\geq 3\\}$ episodes of PID $\\leftarrow$ tubal occlusion (in $25 \\%$ )\n(2) Tubo-ovarian abscess\n(3) Ectopic pregnancy ( 6 x as frequent)\n(4) Chronic pelvic pain $\\leftarrow$ pelvic adhesions",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 514,
            "markdown": "| Sexually Transmitted Diseases (STD) |  |  |  |\n| :-- | --: | :-- | :-- |\n| Chlamydia | $33 \\%$ | Human papilloma virus <br> (warts) | $6.0 \\%$ |\n| Trichomoniasis | $25 \\%$ | Genital herpes simplex | $4.0 \\%$ |\n| Nonspecific urethritis | $10 \\%$ | Hepatitis B virus | $1.2 \\%$ |\n| Gonorrhea | $9 \\%$ | Syphilis | $1.0 \\%$ |\n| Mucopurulent cervicitis | $8 \\%$ | HIV | $0.3 \\%$ |\n\n# Cervicitis \n\n$=$ generic term describing cervical inflammation\nCause: (a) noninfectious: trauma, pelvic irradiation, chemical irritation, malignancy\n(b) infectious: Trichomonas vaginalis, Candida albicans, herpes simplex virus (esp. type 2), Neisseria gonorrhoeae, Chlamydia trachomatis\n\n- purulent / mucopurulent cervical + vaginal discharge\n- pelvic pressure / discomfort\n\nUS:\n$\\sqrt{ }$ diffusely heterogeneous echotexture of cervical mucosa and stroma\n$\\sqrt{ }$ nonspecific markedly increased vascularity without mass\n\n## Endometritis\n\n$\\checkmark$ endometrial prominence\n$\\checkmark$ small amount of fluid within uterine lumen\n$\\checkmark$ gas reflection within uterine cavity (most specific)\n$\\checkmark$ pain over uterus\n\n## Postpartum Endometritis\n\nFrequency: $2-3 \\%$ of vaginal deliveries; in up to $85 \\%$ of cesarean sections\nAssociated with: prolonged labor, premature rupture of membranes, retained clots, retained products of conception\n\n- fever (most common cause of postpartum fever)\n$\\checkmark$ normal ultrasound\n$\\checkmark$ thickened heterogeneous endometrium\n$\\checkmark$ intracavitary fluid\n$\\checkmark$ intrauterine air\n\n\n## Fitz-Hugh-Curtis Syndrome\n\n$=$ GONORRHEAL PERIHEPATITIS\n[Thomas Fitz-Hugh, Jr (1894-1963), American physician; Arthur Hale Curtis (1881-1955) American gynecologist]\n$=$ inflammation of peritoneal capsule of liver $\\leftarrow$ peritoneal spread of infection via right paracolic gutter\nFrequency: up to $15 \\%$ in women with PID\n\n- right upper quadrant pain $\\leftarrow$ ascending pelvic infection\n\nPath: inflammation of liver capsule / diaphragm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 515,
            "markdown": "Organism: chlamydia+gonorrhea $=5 \\div 1$\nUS:\n$\\sqrt{ }$ perihepatic and pericholecystic ascites $\\pm$ loculations\nLocation: anterior to liver (original description), hepatorenal fossa (= Morison space), gallbladder (mimicking acute cholecystitis)\n$\\sqrt{ } \\pm$ peritoneal septations (= \"violin string\" adhesions extending from anterior surface of liver to peritoneum)\nCT:\n$\\sqrt{ }$ thickening + intense enhancement of anterior liver capsule and gallbladder wall $\\pm$ loculations\n$\\sqrt{ }$ periportal edema\n$\\sqrt{ } \\pm$ transient subcapsular + periportal hepatic perfusion abnormalities\n\n# Salpingitis \n\n- often beginning during / immediately after menstruation $\\leftarrow$ mucus barrier of cervix less effective\nMR:\n$\\sqrt{ }$ thickened wall of dilated fallopian tube + tubal contents of low signal intensity on T2WI\n$\\sqrt{ }$ debris / hemorrhage in fluid component most conspicuously hypointense to urine on heavily T2WI\n$C x:$ tubo-ovaritis $=$ salpingo-oophoritis $=$ tubal fimbriae adhere to ovary\n\n\n## Salpingitis Isthmica Nodosa\n\nEtiology: unknown; commonly associated with pelvic inflammatory disease, infertility, ectopic pregnancy\nLocation: uni- / bilateral\n\n- nodular thickening of isthmic portion of tube\n$\\sqrt{ }$ irregularity + multiple $2-3 \\mathrm{~mm}$ diverticula / obstruction of isthmic portion of fallopian tube on HSG\n\n\n## Fallopian Tube Cyst\n\nCause: pelvic inflammatory disease, endometriosis, adhesions, microtubal surgery, total abdominal hysterectomy without salpingo-oophorectomy, ectopic pregnancy, tumor (rare)\nPrevalence: in 8\\% of women with PID / endometriosis\nLocation: between uterus + adnexa; often bilateral\nSite of obstruction: ampullary / infundibular portion of tube\n$\\sqrt{ }$ undulating / folded tubular structure in extraovarian location filled with sterile fluid / debris / pus\n$\\sqrt{ }$ \"kissing ovary\" sign = adhesions pull ovaries and tubes toward the midline\n$\\sqrt{ }$ serpentine C- or S-shaped complex cystic solid adnexal mass $\\leftarrow$ encasement of ovary by fallopian tube\n$\\diamond$ Find ipsilateral ovary!\n$C x:$ tubal torsion\n$D D x$ : dilated uterine / ovarian vein, TOA, cystic ovarian neoplasm, endometrioma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 516,
            "markdown": "developing follicle, fluid-filled small bowel (peristalsis)\n\n# Hydrosalpinx $=$ Chronic PID \n\n$=$ accumulation of continued secretion of tubal epithelium (sterile fluid) into lumen of a fallopian tube obstructed at two sites\n$\\diamond$ A simple hydrosalpinx is not accompanied by pelvic inflammation!\nCause:\n\n1. Adhesions from prior episodes of PID\n2. Tubal ligation\n3. Hysterectomy without salpingo-oophorectomy\n4. Endometriosis\n5. Tubal malignancy\n\n- asymptomatic / recurrent lower abdominal pain, infertility\n\nUS (sensitivity of $34 \\%$ ):\n$\\sqrt{ }$ thin- / thick-walled C- / S-shaped tubular / corkscrew-like structure separate from ovaries\n$\\sqrt{ }$ \"waist\" sign = indentations of its opposing walls\n$\\sqrt{ }$ incomplete septation $\\leftarrow$ infolding of tube on itself\n$\\sqrt{ }$ PATHOGNOMONIC longitudinal folds:\n$\\sqrt{ }$ \"cogwheel\" sign = short linear / small round projections of mucosal folds protruding into lumen of fluid-filled tube similar to spokes of a cogwheel on shortaxis images\n$\\sqrt{ }$ \"beads-on-a-string\" sign = flat nodular submucosal folds in chronic dilatation MR:\n$\\sqrt{ }$ T2-hyperintense + T1-hypointense dilated fallopian tube interposed between ovary and uterus\n$\\sqrt{ }$ high-SI of fluid on T1WI $\\leftarrow$ proteinaceous fluid (DDx: hemorrhage)\n$\\sqrt{ }$ incomplete longitudinal folds = partially effaced mucosal / submucosal plicae (SPECIFIC)\nHSG:\n$\\sqrt{ }$ absence of peritoneal spill\n$\\sqrt{ }$ dilated ampullary portion of tube (visualization of mucosal folds confirm intratubal contrast accumulation) (DDx: contrast collection adjacent to tubes $\\leftarrow$ peritubal adhesions)\nN.B.: prescribe postprocedural antibiotic prophylaxis (eg, doxycycline) to prevent procedure-related infection!\n$D D x$ : tortuous pelvic veins (blood flow at Doppler imaging), dilated fluid-filled bowel (lack of peristalsis), cystic ovarian neoplasm\n\n## Pyosalpinx\n\n$=$ infection + superimposed obstruction of fallopian tube\n\n- acute pelvic pain, fever, leukocytosis\n- cervical motion tenderness\n\nPath: fallopian tube filled with pus\nLocation: more likely bilateral than hydrosalpinx",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 517,
            "markdown": "$\\sqrt{ }$ enhancing thickened wall and septa of fallopian tube\n$\\sqrt{ }$ thickened uterosacral ligaments\n$\\sqrt{ }$ edema of presacral fat\n$\\sqrt{ }$ small-bowel ileus\nMR:\n$\\sqrt{ }$ T2-hyperintense cystic tubule\n$\\sqrt{ }$ T1-variointense depending on protein content of fluid\n$\\sqrt{ }$ pelvic fat stranding\nPrognosis: pus undergoing proteolysis transforming a pyosalpinx into a hydrosalpinx\n\n# Hematosalpinx \n\n$=$ fallopian tube filled with blood\nCause: pelvic endometriosis, tubal ectopic pregnancy, pelvic inflammatory disease, adnexal torsion, malignancy, trauma\n$\\diamond$ A hematosalpinx is an invitation to search for endometrial deposits + endometriomas!\n$\\sqrt{ }$ tubular / corkscrew-shaped structure centered in fallopian tube\n$\\sqrt{ }$ \"waist\" sign = tubular cystic structure with a folded configuration\n$\\sqrt{ }$ tubal contents of homogeneous low-level echoes on US\n$\\sqrt{ }$ tubal contents of high attenuation on CT\n$\\sqrt{ }$ tubal contents of low signal on T2WI with small round projections in a tubular shape (MOST SPECIFIC)\n$\\sqrt{ }$ tubal contents of high signal on T1WI fat-suppressed image\n\n## Tubo-ovarian abscess (TOA)\n\n$=$ inflammatory mass encompassing ovary + fallopian tube\nCause: sexually transmitted disease, IUD (20\\%), diverticulitis, appendicitis, pelvic surgery, gynecologic malignancy\nOrganism: anaerobic bacteria become dominant, Actinomyces israelii associated with IUD\nLocation: usually in posterior cul-de-sac extending bilaterally\n$\\sqrt{ }$ multilocular complex mass often with debris, septations, irregular thick wall:\n$\\sqrt{ } \\pm$ fluid-debris level\n$\\sqrt{ }$ intense contrast enhancement of abscess wall\n$\\sqrt{ }$ nonspecific free pelvic fluid\n$\\sqrt{ }$ anterior displacement of broad ligament $\\leftarrow$ posterior position of mesovarium (DDx from other pelvic abscess)\nUS:\n$\\sqrt{ }$ surrounding edema / inflammation = increased echogenicity of pelvic fat\nCT:\n$\\sqrt{ }$ pelvic fat stranding\n$\\sqrt{ }$ thickening + enhancement of peritoneum and uterine ligg.\n$\\sqrt{ }$ gas is SPECIFIC but rare\nMR:\n$\\sqrt{ }$ T1WI:\n$\\sqrt{ }$ abscess usually hypointense $\\pm$ mildly hyperintense areas $\\leftarrow$ hemorrhagic $/$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 518,
            "markdown": "proteinaceous material\n$\\sqrt{ }$ hyperintense rim along inner abscess wall $\\leftarrow$ granulation tissue and hemorrhage\n$\\sqrt{ }$ T2WI:\n$\\checkmark$ heterogeneous hyperintense mass with septa of low SI\n$\\checkmark$ meshlike hypointense linear stranding in adjacent pelvic fat $\\leftarrow$ adhesions + fibrosis\n$\\checkmark$ hyperintense edema of parametrial fat\nCEMR:\n$\\checkmark$ enhancement of septa + thick abscess wall\n$\\checkmark$ enhancement of surrounding inflammatory stranding\nCx: (1) rupture $\\rightarrow$ life-threatening peritonitis $\\rightarrow$ intraperitoneal abscess\n(2) secondary involvement of adjacent structures (eg, ileus, hydroureteronephrosis)\n\nDDx: endometrioma, ovarian tumor, infected cyst, abscess from other sources (eg, Crohn disease, appendicitis)\n\n# PENA-SHOKEIR PHENOTYPE \n\n= autosomal recessive syndrome ( $45 \\%$ sporadic, $55 \\%$ familial) characterized by fetal akinesia\nCause: decreased / absent fetal motion $\\leftarrow$ abnormalities of fetal muscle / nerves / connective tissue (\"fetal akinesia deformation sequence\")\nTime of first detection: 16-18 weeks MA\n@ Spine: scoliosis, kyphosis, lordosis\n@ Thorax: pulmonary hypoplasia, cardiac anomalies\n@ Kidney: renal dysplasia\n@ Limbs: limited movement, knee + hip ankylosis (arthrogryposis), abnormal shape + position, demineralization, camptodactyly, clubfeet\n$\\checkmark$ craniofacial anomalies\n$\\checkmark$ polyhydramnios\n$\\checkmark$ IUGR\n$\\checkmark$ short umbilical cord\nPrognosis: still birth\n$D D x$ : multiple pterygium syndrome, Neu-Laxova syndrome, restrictive dermopathy, Larsen syndrome, trisomies $13+18$\n\n## PENTALOGY OF CANTRELL\n\n$=$ sporadic very rare abnormality\nPrevalence: $5.5 \\div 1,000,000$ live births; $\\mathrm{M} \\div \\mathrm{F}=2.7 \\div 1$\nCause: failure of fusion of lateral thoracic folds + transverse diaphragmatic septum with variable extension inferiorly during days $14-18$ of embryonic life\n\n1. Omphalocele $(63 \\%)=$ defect of supraumbilical abdominal wall and sternum\n2. Ectopia cordis\n3. Deficiency of anterior diaphragm $\\rightarrow$ herniation of intraabdominal organs into thoracic cavity is rare\n4. Deficiency of diaphragmatic pericardium\n5. Congenital cardiovascular malformation: atrioventricular septal defect (50\\%), VSD (18\\%), tetralogy of Fallot (11\\%), left ventricular diverticulum, Ebstein malformation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 519,
            "markdown": "Associated with:\n(a) chromosomal anomalies: trisomies 13, 18, Turner syndrome\n(b) facial defects: cleft lip or palate\n(c) CNS anomalies: exencephaly, encephalocele, spina bifida, hydrocephalus\n(d) musculoskeletal anomalies: clubfoot, absent radius\n$\\sqrt{ }$ exteriorization of heart\nPrognosis: death within a few days after birth\n\n# PERLMAN SYNDROME \n\n$=$ rare fetal overgrowth disorder characterized by visceromegaly, renal lesions, distinctive facial features, high neonatal mortality\nCause: ? autosomal recessive with reported abnormalities of chromosome 11\n\n- generalized muscle hypotonia, pancreatic islet cell hyperplasia\n- hypertrophy of islets of Langerhans\n$\\checkmark$ cystic hygroma\n$\\checkmark$ fetal macrosomia\n$\\checkmark$ macrocephaly\n$\\checkmark$ agenesis of corpus callosum\n$\\checkmark$ choroid plexus cyst\n$\\checkmark$ nephromegaly + hydronephrosis\n$\\checkmark$ hepatomegaly\n$\\checkmark$ cryptorchidism\n$\\checkmark$ polyhydramnios\nPrognosis: death within first few days of life\n\n\n## PLACENTAL ABRUPTION\n\n$=$ PLACENTAL HEMORRHAGE\n$=$ premature separation of placenta from myometrium $\\leftarrow$ maternal hemorrhage into decidua basalis after $20^{\\text {th }}$ week EGA\nFrequency: $0.5-1.3 \\%$ of gestations\nRisk factors: mnemonic: VASCULAR\nVascular disease + hypertension\nAbruption (previous history)\nSmoking\nCocaine\nUnknown: idiopathic\nLeiomyoma\nAnomaly: fetal malformation\nReckless driving: trauma\nAssociated with: intraplacental infarction / hematoma\n\n- vaginal bleeding ( $80 \\%$ ): bright red (acute), brownish red (chronic); abdominal pain (50\\%)\n- consumptive coagulopathy $=$ DIC ( $30 \\%$ ); uterine rigidity ( $15 \\%$ )\n\nUS:\n\n* A normal ultrasound ( $50 \\%$ ) does NOT rule out abruption if",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 520,
            "markdown": "(a) separation occurs WITHOUT hematoma\n(b) hematoma is isoechoic to placenta\n\nEchogenicity of hemorrhage:\n$\\sqrt{ }$ hyperechoic / isoechoic hematoma (initially difficult to distinguish from placenta):\n$\\sqrt{ }$ abnormally thick + heterogeneous placenta (if blood isoechoic)\n$\\sqrt{ }$ hypoechoic / complex collection between uterine wall + placenta in $50 \\%$ within 1 week\n$\\leftarrow$ hematoma / placental infarction\n$\\sqrt{ }$ anechoic collection within 2 weeks\nNECT:\n$\\diamond$ NECT \\& CECT are $43-100 \\%$ sensitive \\& $80-98 \\%$ specific.\n$\\sqrt{ }$ lenticular high-attenuating collection $=$ retroplacental hematoma\n$\\sqrt{ }$ high-attenuation blood products in dependent portions of the amniotic sac\nCECT:\n$\\sqrt{ }$ nonenhancing placenta\n$\\sqrt{ }$ contiguous retroplacental area of decreased enhancement forming acute angles with myometrium $=$ retroplacental hematoma\n$\\sqrt{ }$ areas of contrast extravasation in infarcted placenta (occasionally)\nFalsely positives:\n(1) Myometrial contraction $=$ bulging areas hypoattenuating relative to placenta forming obtuse angles with adjacentx myometrium\n(2) Venous lake $=$ pooled maternal blood on maternal side of the placenta\n(3) Chorionic villous plate indentations\n(4) Small wedge-shaped placental infarcts of no clinical significance\n(5) Small subchorionic hemorrhages + preplacental hemorrhages of no clinical significance\nMR (modality of choice):\n$\\sqrt{ }$ increased intrauterine T1 signal at site of bleeding\nPrognosis:\n(1) Only large hematomas (occupying $>30-40 \\%$ of the maternal surface) result in fetal hypoxia\n(2) Abruptions with contained hematoma have worse prognosis\n(3) Responsible for up to $15-25 \\%$ of all perinatal deaths\n(4) Normal term deliveries in $27 \\%$ with hematomas that were detected $>20$ weeks GA\n(5) Normal delivery in $80 \\%$ of intrauterine hematomas detected $<20$ weeks GA\n\nCx: (1) Perinatal mortality ( $20-60 \\%$ )\n(2) Fetal distress / demise ( $15-27 \\%$ of all perinatal deaths)\n(3) Premature labor + premature delivery (23-52\\%) (3-fold increase)\n(4) Threatened abortion during first 20 weeks\n(5) Infant small-for-gestational age (6-7\\%)\n\nDDx: (1) Normal draining basal veins\n(2) Normal uterine tissue\n(3) Retroplacental myoma\n(4) Focal contraction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 521,
            "markdown": "(5) Chorioangioma\n(6) Coexistent mole\n\n# Retroplacental Hemorrhage (16\\%) \n\n$=$ ABRUPTIO PLACENTAE\n$=$ accumulation of blood beneath placenta separating placenta from myometrium\nPathophysiology: hypertension + vascular disease $\\rightarrow$ rupture of spiral arteries $\\rightarrow$ highpressure bleed (hemorrhage may dissect into placenta / myometrium)\nFrequency: $4.5 \\% ; 16 \\%$ of all placental abruptions\n\n- external bleeding\n$\\sqrt{ }$ thickened heterogeneous appearing placenta (hematoma of similar echogenicity as placenta)\n$\\sqrt{ }$ becomes anechoic in $1-2$ weeks\n$\\sqrt{ }$ rounded placental margins + intraplacental sonolucencies\nPrognosis: clinically significant if $30-40 \\%$ of maternal surface of placenta involved\nCx: (1) Precipitous delivery\n(2) Coagulopathy\n(3) Fetal demise ( $15-25 \\%$ of all perinatal deaths)\n\nRisk for fetal demise with hematomas $>60 \\mathrm{~mL}: 6 \\%$ before [29\\% after] 20 weeks GA\n![img-32.jpeg](img-32.jpeg)\n\nPlacental Hematomas (in anterior placenta)\n\n| Signal Intensities of Intrauterine Hematoma |  |  |  |  |\n| :-- | :-- | :-- | :-- | :-- |\n| Stage | T1WI | T2WI | DWI | Hemoglobin (Hb) |\n| Hyperacute | $\\leftrightarrow$ to $\\downarrow$ | $\\uparrow$ | $\\uparrow$ to $\\downarrow$ | intracell oxyHb |\n| Acute | $\\leftrightarrow$ to $\\downarrow$ | $\\downarrow$ | $\\downarrow$ | intracell deoxyHb |\n| Early subacute | $\\uparrow$ | $\\downarrow$ | $\\downarrow$ | intracell metHb |\n| Late subacute | $\\uparrow$ | $\\uparrow$ | $\\uparrow$ | extracell metHb |\n| Chronic | $\\downarrow$ | $\\downarrow$ | $\\leftrightarrow$ to $\\downarrow$ | intracell hemosiderin |\n\n$D D x$ : myometrial contraction, fibroid, subplacental venous network\n\n## Subchorionic Hemorrhage (79\\%)\n\n$=$ MARGINAL PLACENTAL HEMORRHAGE",
            "images": [
                {
                    "id": "img-32.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1007,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1423,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 522,
            "markdown": "$=$ SUBMEMBRANOUS PLACENTAL HEMORRHAGE\n$=$ separation of chorionic membrane from decidua with accumulation of blood in subchorionic space\nN.B.: placental membranes are more easily stripped from myometrium than from placenta\n\nPathophysiology: low-pressure bleed $\\leftarrow$ tears of marginal veins; associated with cigarette smoking\nFrequency: $79 \\%$ of all placental abruptions; in $91 \\%$ before 20 weeks MA\n\n- may lead to vaginal hemorrhage after dissection through decidua ( $=18 \\%$ of all causes of $1^{\\text {st }}$-trimester bleeding)\n$\\checkmark$ placental margin detached from adjacent myometrium ( $60 \\%$ ):\n$\\checkmark$ separation / rounding of placental margin\n$\\checkmark$ elevation of chorioamnionic membrane\n(DDx: incomplete chorioamnionic fusion during $2^{\\text {nd }}$ trimester, blighted twin)\n$\\checkmark$ hematoma contiguous with placental margin $(100 \\%)=$ marginal hematoma\n$\\checkmark$ predominant hemorrhage often separate from placenta, even on opposite side of placenta\nPrognosis: worsens with (1) increased maternal age, (2) earlier gestational age, (3) size of hematoma ( $>60 \\mathrm{~mL}$ ); $9 \\%$ overall miscarriage rate; risk of fetal demise doubles once hematoma reaches $2 / 7$ of circumference of chorion\n\n\n# Preplacental Hemorrhage \n\n$=$ BREUS MOLE $=$ SUBCHORIAL HEMORRHAGE $=$ MASSIVE SUBCHORIAL THROMBOSIS\n$=$ variant of placental abruption with progressive slow intracotyledonary bleeding\nFrequency: in $4 \\%$ of all placental abruptions\nEtiology: massive pooling + stasis $\\leftarrow$ extensive venous obstruction\nTime of onset: 18 weeks MA\n$\\checkmark$ total loss of normal placental architecture\n$\\checkmark$ gelatinous character of placenta elicited by fetal movement / abdominal jostling\n$\\checkmark$ hematoma bulging into amniotic fluid\n$\\checkmark$ severe symmetric IUGR\nRisk for fetal demise: $67 \\%$ overall; $100 \\%$ for hematomas $>60 \\mathrm{~mL}$\n$D D x$ : subamniotic hematoma\n\n## Intraplacental Hemorrhage\n\n$=$ massive retroplacental hematoma dissecting into placenta; related to placental infarcts\n$\\checkmark$ focal mass of varying echogenicity within placenta\n\n## Intraamniotic hematoma\n\n$\\checkmark$ internal echoes in amniotic fluid\n\n## PLACENTA ACCRETA\n\n$=$ defect in normal decidua basalis from prior trauma allows abnormal adherence + penetration of chorionic villi to / into myometrium\nPrevalence: $1 \\div 2,500-7,000$ deliveries related to increase in uterine surgery; in $5 \\%$ of placenta previa patients\nRisk of placenta accreta versus cesarean section:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 523,
            "markdown": "in $10 \\%$ of placenta previa; in $24 \\%$ of placenta previa +1 cesarean section; in $48 \\%$ of placenta previa +2 cesarean sections; in $67 \\%$ of placenta previa +4 cesarean sections Predisposed: areas of uterine scarring with deficient decidua: previous dilatation + curettage, endometritis, submucosal leiomyoma, Asherman syndrome, manual removal of placenta, adenomyosis, increasing parity\nAssociated with: placenta previa (in 20\\%)\nTypes:\n\n1. Placenta accreta ( $76 \\%$ )\n$=$ chorionic villi in direct contact with myometrium\n2. Placenta increta ( $18 \\%$ )\n$=$ villi invade myometrium\n3. Placenta percreta ( $6 \\%$ )\n$=$ villi penetrate through uterine serosa\nUS ( $77-93 \\%$ sensitive, $71-96 \\%$ specific):\n$\\checkmark$ loss of normal retroplacental clear space\n$\\checkmark$ thinning to $<1 \\mathrm{~mm}$ / absence of hypoechoic myometrial zone between placenta + echodense uterine serosa / posterior bladder wall (normally, retroplacental hypoechoic zone of decidua + myometrium + dilated periuterine venous channels measures 9.5 mm thick $>18$ weeks GA)\n$\\checkmark$ thinning / irregularity / focal disruption of linear hyperechoic boundary echo (= uterine serosa-bladder wall interface)\n$\\checkmark$ focal masslike elevations / extensions of echogenic placental tissue beyond uterine serosa\n$\\checkmark>6$ irregular intraplacental lacunae ( $=$ poorly marginated irregular vascular spaces with turbulent flow) $\\rightarrow$ highest positive predictive value\nMR ( $80-88 \\%$ sensitive, $65-100 \\%$ specific):\n$\\checkmark$ heterogeneous hyperintense placenta on T2WI\n$\\checkmark$ dark intraplacental bands (= lacunae) on T2WI\n$\\checkmark$ interruption of junctional zone\n$\\checkmark$ focal thinning of hypointense myometrium\n$\\checkmark$ abnormal uterine bulging\nCx: (1) Life-threatening hemorrhage in $3^{\\text {rd }}$ stage of labor necessitating emergent hysterectomy\n(2) Maternal death\n(3) Retention of placental tissue\n(4) Persistent postpartum bleeding\n\nRx: (1) Hysterectomy\n(2) Conservative measures: curettage, oversewing of placental bed, ligation of uterine arteries\n\n# PLACENTA PREVIA \n\n$=$ abnormally low implantation of ovum with the placenta covering all / part of internal cervical os $>15$ weeks GA\nFrequency: $0.5 \\%$ of all deliveries; $3-5 \\%$ of all pregnancies complicated by $3^{\\text {rd }}$ trimester bleeding (of these $7-11 \\%$ are due to placenta previa); in $0.26 \\%$ with unscarred",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 524,
            "markdown": "uterus\nRisk for placenta previa versus cesarean section:\n$0.65 \\%$ after 1 section, $1.8 \\%$ after 2 sections, $3 \\%$ after 3 sections, $10 \\%$ after 4 sections\nCause: defective decidual vascularization in areas of endometrial scarring $\\rightarrow$ compensatory placental thinning $\\rightarrow$ placenta occupies a greater surface of the uterus with increased probability for encroachment upon internal os\nPredisposed:\n(1) Previous uterine incision: cesarean section, myomectomy\n(2) Older woman\n(3) Multiparous woman\n\n- painless vaginal bleeding in $93 \\%$ : usually $3^{\\text {rd }}$ trimester / as early as 20 weeks\n\nTypes on clinical examination:\n\n1. Normal placental implantation $=$ lower placental edge $>2 \\mathrm{~cm}$ away from margin of internal os\n2. Complete / total previa $(1 / 5)=$ complete covering of internal os\n3. Central previa $=$ placenta implanted directly over internal os\n4. Partial previa $=$ internal os partially but not fully covered by placenta\n5. Marginal previa $=$ placenta extends to edge of internal os\n6. Low-lying placenta $=$ low placental edge within 2 cm of internal os without covering it; palpable by examining finger\n![img-33.jpeg](img-33.jpeg)\n\nUS - False Positives (5-7\\%):\n\n1. Placental \"migration\" / rotation\n$=$ differential growth rates between lower uterine segment + placenta\n$\\diamond 63-93 \\%$ will have normal implantation at term!\n> conversion to normal position: anterior wall > posterior wall of uterus\n> NO conversion if placenta attaches to both posterior + anterior walls\n2. Overfilled urinary bladder\nbladder-induced compression leads to apposition of the lower anterior + posterior uterine walls simulating a placenta previa $\\rightarrow$ cervical length $>3.5-4 \\mathrm{~cm}$\n3. Focal myometrial contraction in the region of the lower uterine segment $\\rightarrow$ myometrial thickness $>1.5 \\mathrm{~cm}$\nmnemonic: ABCD and F\nAbruption (may mimic placenta previa)\nBladder (must be empty)\nContraction (may have to wait $15-20 \\mathrm{~min}$ )\nDates (be wary in $1^{\\text {st }}$ half of pregnancy)",
            "images": [
                {
                    "id": "img-33.jpeg",
                    "top_left_x": 372,
                    "top_left_y": 1029,
                    "bottom_right_x": 1322,
                    "bottom_right_y": 1309,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 525,
            "markdown": "# Fibroid \n\nUS - False Negatives (2\\%):\n\n1. Obscuring fetal head\n$\\rightarrow$ remedied by Trendelenburg position / gentle upward traction on fetal head\n2. Lateral position of placenta previa\n$\\rightarrow$ remedied by obtaining oblique scans\n3. Blood in region of internal os: mistaken for amniotic fluid MR:\n$\\sqrt{ }$ abnormal position of placenta infringing on cervical os\n$C x$ : secondary to premature detachment of placenta from lower uterine segment\n(1) Maternal hemorrhage (blood from intervillous space)\n(2) Premature delivery\n(3) IUGR\n(4) Perinatal death (5\\%)\n\nRx: precludes vaginal delivery + pelvic examination\n\n## PLACENTAL SITE TROPHOBLASTIC DISEASE\n\n$=$ very rare neoplasm (? type of choriocarcinoma)\nPath: microscopic tumor / diffuse nodular replacement of myometrium\nHisto: proliferation of predominantly intermediate trophoblasts but no syncytio- or cytotrophoblasts\n\n- abnormal bleeding / amenorrhea\n- low $\\beta$-hCG levels $\\leftarrow$ lack of syncytiotrophoblastic proliferation\n$\\sqrt{ }$ cystic / solid lesions $\\pm$ central component\n$\\sqrt{ }$ myometrium usually invaded\nPrognosis: benign / highly malignant course\nRx: hysterectomy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 526,
            "markdown": "# POSTMATURITY SYNDROME \n\n$=$ inability of aging placenta to support demands of fetus\nPrevalence: in $15 \\%$ of all postterm gravidas\n\n- meconium-stained amniotic fluid\n$\\checkmark$ grade 3 placenta (in $85 \\%$ ), grade 2 (in $15 \\%$ ), grade 1 (in $0 \\%$ )\n$\\checkmark$ decreased subcutaneous fat + wrinkling of skin\n$\\checkmark$ long fingernails\n$\\checkmark$ decreased vernix\n$C x$ : meconium aspiration, perinatal asphyxia, thermal instability\n\n\n## Postterm Fetus\n\n$=$ fetus undelivered by $42^{\\text {nd }}$ week MA\nPrevalence: $7-12 \\%$ of all pregnancies\nRisk of perinatal mortality: 2-fold at 43 weeks MA; 4-6-fold at 44 weeks MA\n\n## PREECLAMPSIA\n\n$=$ TOXEMIA OF PREGNANCY $=$ EPH GESTOSIS\nPrevalence: $5 \\%$ of pregnancies, typically during $3^{\\text {rd }}$ trimester\n\n- Clinical triad: [EPH = Edema, Proteinuria, Hypertension]\n(1) Peripheral edema + weight gain\n(2) Proteinuria\n(3) Pregnancy-induced / -aggravated hypertension\n\nHisto: blunted invasion of vasa media of spiral arterioles + focal vasculitis + atheromatous degeneration + fibrin deposits in intima of maternal placental arterioles\n$\\checkmark$ heavy calcium deposition (in areas of placental degeneration)\n$\\checkmark$ IUGR ( $6 \\%$ with late-onset preeclampsia, $18 \\%$ with early-onset preeclampsia)\nCx:\n@ CNS: convulsive eclampsia, stroke\n@ Liver: hematoma, infarction\n@ Kidney: glomerular endotheliosis $=$ variant of thrombotic microangiopathy $\\rightarrow$ decreased GFR\n\n## Eclampsia\n\n- convulsions + coma\n\n\n## PREMATURE RUPTURE OF MEMBRANES\n\n$=$ spontaneous rupture of chorioamnionic membranes before the onset of labor\nTypes:\n(a) Preterm premature rupture of membranes (PPROM) $<37$ weeks GA\n(b) Term premature rupture of membranes (TPROM) $>37$ weeks GA\n\nPrevalence: overall $2.1-17.1 \\%$; PPROM $0.9-4.4 \\%$;\nin $29 \\%$ of all preterm deliveries;\nin $18 \\%$ of all term deliveries",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 527,
            "markdown": "Risk of recurrence: $21 \\%$ of women with PPROM\nCause: ? infection of membranes\n$\\sqrt{ }$ decrease in the amount of amniotic fluid\nCT:\n$\\checkmark$ products of conception low-lying / in cervix\n$\\checkmark$ blood in cervix / vagina $\\leftarrow$ signs of impending / ongoing spontaneous abortion\nCx:\n(a) TPROM:\n$>24$ hours may result in intrapartum fever\n$>72$ hours may result in chorioamnionitis + still-birth\n(b) PPROM: respiratory distress syndrome ( $9-43 \\%$ ), neonatal sepsis ( $2-19 \\%$ )\n\n# SCLEROSING STROMAL TUMOR OF OVARY \n\n$=$ benign sex cord-stromal tumor\nAge: $<30$ years\n\n- irregular menses\n\nHisto: pseudolobular pattern = cellular areas separated by edema + collagenous hypocellular tissue\n$\\checkmark$ hypointense nodules set against hyperintense stroma on T2WI\n$\\checkmark$ peripheral enhancement with centripetal progression\n\n## SECKEL SYNDROME\n\n$=$ BIRD-HEADED DWARFISM\n$=$ rare autosomal recessive disorder (44 cases)\n\n- proportionate postnatal short stature\n- characteristic stance: slight flexion of hips and knees\n- mental retardation, simian crease, cryptorchidism\n@ Skull\n$\\checkmark$ severe microcephaly\n$\\checkmark$ receding forehead, large beaked nose, micrognathia\n@ Skeleton\n$\\checkmark$ dislocation of radial head + hypoplasia of proximal end of radius\n$\\checkmark$ absence of phalangeal epiphysis\n$\\checkmark$ clinodactyly of $5^{\\text {th }}$ digit\n$\\checkmark$ gap between $1^{\\text {st }}$ and $2^{\\text {nd }}$ toe\n$\\checkmark$ hip dislocation\n$\\checkmark$ hypoplasia of proximal fibula\n$\\checkmark$ absence of patella\n$\\checkmark 11$ pairs of ribs\nOB-US:\n$\\checkmark$ severe IUGR\n$\\checkmark$ oligohydramnios\n$\\checkmark$ decreased bone length: femur, tibia, fibula\n$\\checkmark$ decreased $\\mathrm{AC}, \\mathrm{HC}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 528,
            "markdown": "# SEROUS OVARIAN TUMOR \n\n$\\diamond$ Most common neoplasm in benign + malignant category\nFrequency: $30 \\%$ of all ovarian tumors $60-80 \\%$ of all malignant ovarian neoplasms\nPath: areas of solid tissue components + hemorrhage and necrosis (more common in malignant tumors)\nHisto: lined by tall columnar epithelial cells (as in fallopian tubes), filled with serous fluid, psammoma bodies ( $=$ microscopic calcifications in up to $30 \\%$ of malignant tumors)\nAge: $20-50$ years (malignant variety later)\n\n## Serous Cystadenoma (60\\%)\n\n$\\diamond$ Second most common benign tumor of the ovary (after dermoid cyst); $20 \\%$ of all benign ovarian neoplasms\n$\\checkmark$ usually unilocular (occasionally multilocular) thin-walled cyst up to 20 cm in diameter\n$\\checkmark$ only small amount of solid tissue: occasional septum / mural nodule (papillary projections in $9 \\%$ )\n$\\checkmark$ bilateral in $7-20-30 \\%$\n\n## Cystadenofibroma\n\n$=$ variant of serous cystadenoma, rarely malignant\nPrevalence: nearly $50 \\%$ of all benign ovarian cystic serous tumors; bilateral in $6 \\%$\nMean age: 31 (range, 15-65) years\n\n- may produce estrogen excess\n$\\checkmark$ small multilocular cystic tumor\n$\\checkmark$ clusters of short rounded papillary processes\nMR:\n$\\checkmark$ multiloculated cystic mass\n$\\checkmark$ solid fibrous component:\n$\\checkmark$ low SI on T2WI\n$\\checkmark$ mild enhancement on T1WI\n\n\n## Borderline Malignant Serous Cystadenoma (15\\%)\n\nHisto: identical to peritoneal serous micropapillomatosis\n$\\checkmark$ papillary projections within cyst (in 67\\%)\n\n## Serous Cystadenocarcinoma (25\\%)\n\n$=$ SEROUS PAPILLARY CARCINOMA OF OVARY\nPrevalence: $60-80 \\%$ of all ovarian carcinomas\nOrigin: peritoneal mesothelial cells with mÃ¼llerian differentiation / nests of ovarian tissue remnants within peritoneum\nAge: postmenopausal woman\nHisto: identical to primary peritoneal serous papillary ca.\n$\\checkmark$ multilocular cyst with large amount of solid tissue: papillomatous excrescences within cyst (= papillary serous carcinoma) in $38 \\%$\n$\\checkmark$ may have calcifications\n$\\checkmark$ bilateral in $50-70 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 529,
            "markdown": "$\\sqrt{ }$ loss of capsular definition + tumor fixation\n$\\sqrt{ }$ ascites $\\leftarrow$ peritoneal surface implantation\n$\\sqrt{ }$ lymph node enlargement: periaortic, mediastinal, supra- clavicular\nCT:\n$\\sqrt{ }$ psammomatous calcifications $(12 \\%)$\n\n# SERTOLI-STROMAL CELL TUMOR OF OVARY \n\n$=$ ANDROBLASTOMA $=$ ARRHENOBLASTOMA\nOrigin: from hilar cells of ovary\nPrevalence: $<0.5 \\%$\nAge: any age; most common in $2^{\\text {nd }}-3^{\\text {rd }}$ decade\nHisto: components of Sertoli cells, Leydig cells, fibroblasts; tissues are so varied that it is frequently confused with other tumors\nClassification:\n(1) Sertoli cell tumor (4\\%) - usually nonfunctioning\n(2) Leydig cell tumor\n(3) Sertoli-Leydig cell tumor\n\n- androgenic\n$\\checkmark$ hypoechoic mass simulating fibroid\n$\\checkmark$ may have cystic / hemorrhagic degeneration\n\n\n## Sertoli-Leydig Cell Tumor\n\n$\\diamond$ Most common virilizing tumor of ovary!\nFrequency: $0.5 \\%$ of all ovarian neoplasms\nMean age: 25 (range, 15-66) years; $75 \\%$ occur in patients $<30$ years of age\nPath: solid $\\pm$ cystic areas; hemorrhage is rare\nHisto: well differentiated / intermediately differentiated / poorly differentiated / retiform (4 subtypes)\n\n- nonfunctioning (50\\%); abdominal mass $\\pm$ pain\n- virilization (30\\%): amenorrhea, male secondary sexual characteristics\n$\\diamond$ Virilizing tumor often small and difficult to detect!\n- estrogenic (20\\%); no hormonal manifestations (50\\%)\n\nLocation: unilateral in $98 \\%$\n$\\checkmark$ small mass often difficult to visualize by US / CT\n$\\checkmark$ maximally $5-27 \\mathrm{~cm}$ in diameter\n$\\checkmark$ solid mass $\\pm$ cystic components $\\leftarrow$ hemorrhage and necrosis\n$\\checkmark$ well-defined hypoechoic mass + (rarely) intratumoral cysts\n$\\checkmark$ calcifications are unusual\n$\\checkmark$ contrast enhancement\nMR:\n$\\checkmark$ predominantly low SI (= fibroblasts) + scattered areas of high SI on T2WI\n$C x$ : malignant transformation in $10-18 \\%$\nPrognosis: good when detected at stage I (in 92\\%)\nRecurrence: soon after initial diagnosis (in 20\\%)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 530,
            "markdown": "$D D x$ : granulosa cell tumor (spongelike multicystic with areas of hemorrhage)\n\n# SINGLE UMBILICAL ARTERY \n\n$=$ TWO-VESSEL CORD\nEtiology:\n(1) Primary agenesis of one umbilical artery (usually first appears in $5^{\\text {th }}$ menstrual week)\n(2) Secondary atrophy / atresia of one umbilical artery\n(3) Persistence of original single allantoic artery of body stalk\n\nPrevalence: $0.2-1 \\%$ of singleton births; $5 \\%$ in dizygotic twins; $2.5 \\%$ in abortuses; increased incidence in trisomy D / E, diabetic mothers, White patients, spontaneous abortions\nAssociated with:\n(a) congenital anomalies $(21-33 \\%)$ :\n\n1. CHD (most frequent): VSD, conotruncal anomalies\n2. GU: hydronephrosis, dysplastic kidney\n3. Abdomen: ventral wall defect, diaphragmatic hernia\n4. Esophageal atresia, cystic hygroma, cleft lip\n5. CNS: hydrocephalus, holoprosencephaly, spina bifida\n6. Polydactyly, syndactyly\n(b) IUGR \\& small for gestational age\n(c) premature delivery\n(d) perinatal mortality ( $20 \\%$ ): stillbirth ( $66 \\%$ )\n(e) marginal ( $18 \\%$ ) / velamentous ( $9 \\%$ ) cord insertion\n(f) chromosomal anomalies ( $10-67 \\%$ ): trisomy 18 (in $40 \\%$ ) > trisomy $13>$ Turner syndrome $>$ triploidy\n$\\diamond$ Detailed anatomic survey \\& close follow-up evaluation of fetal growth strongly recommended!\nMaternal risk factors:\nadvanced maternal age, white ethnicity, multiparity ( $3-7 \\mathrm{x}$ higher than for singleton pregnancy), smoking, diabetes, hypertension, preeclampsia, maternal drug use, epilepsy\nSite: left artery slightly more often absent than right\n$\\checkmark$ axial view of cord shows 2 vessels\n$\\checkmark$ single umbilical artery nearly as large as umbilical vein $\\rightarrow$ umbilical vein-to-umbilical artery ratio $<2$\n$\\checkmark$ incurvation of distal aorta toward common iliac artery on the side of patent umbilical artery\n$\\checkmark$ ipsilateral hypoplastic / absent common iliac artery in fetus\n$\\checkmark$ color flow imaging permits earlier ( $15-16$ weeks) + more confident diagnosis\nPrognosis:\n(1) 4 -fold increase in perinatal mortality ( $14 \\%$ ) with concurrent major abnormality\n(2) Isolated single umbilical artery does not affect clinical outcome\n\nDDx:\n(1) Normal variant $=2$ arteries at fetal end may fuse near placental end into single umbilical artery (umbilical arteries normally unite with allantoic artery near placental insertion)\n(2) Arterial convergence of 2 into 1 umbilical artery",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 531,
            "markdown": "# STEIN-LEVENTHAL SYNDROME \n\n$=$ POLYCYSTIC OVARY SYNDROME\n[Irving Freiler Stein (1887-1976), American gynecologist in Chicago]\n[Michael Leo Leventhal (1901-1971), American gynecologist in Chicago]\n$=$ functional NOT imaging diagnosis\nPrevalence: $2.5-8 \\%$ of women in reproductive age; affects $4-5$ million women in USA\nEtiology: deficient aromatase activity (= catalyst for conversion of androgen into estrogen) $\\rightarrow$ androgen excess (= hyperandrogenism); exaggerated pulsatile release of LH stimulates continued ovarian androgen secretion at the expense of estradiol; reduction of local estrogen impairs FSH activity $\\rightarrow$ accumulation of small- and medium-sized atretic follicles without final maturation into graafian follicles ( $=$ incomplete ovulatory cycles)\nPath: pearly white ovaries with multiple cysts below the capsule $\\rightarrow$ lined by a hyperplastic theca interna layer showing pronounced luteinization; granulosa cells are absent / degenerating; corpora lutea are absent\nAge: late $2^{\\text {nd }}$ decade\nAssociated with: Cushing syndrome, basophilic pituitary adenoma, postpill amenorrhea, virilizing ovarian / adrenal tumor\n\n- OB/GYN symptoms:\n- $\\Downarrow$ fertility / sterility\n- recurrent spontaneous abortion\n- secondary amenorrhea (most common cause)\n$\\diamond$ Women with PCOS are frequently ovulatory!\n- menstrual irregularities / oligomenorrhea\n- metabolic symptoms:\n- obesity ( $30-70 \\%$ ) with body mass index $\\geq 30 \\mathrm{~kg} / \\mathrm{m} 2$\n- periodic abdominal discomfort\n- glucose intolerance $(16 \\%)+$ type 2 diabetes mellitus $(10 \\%)$\n- dyslipidemia ( $\\uparrow$ triglycerides, $\\uparrow$ LDL (low-density lipoproteins), $\\uparrow$ VLDL (very-low-density lipoproteins), $\\downarrow$ HDL (high-density lipoproteins)\n- cardiovascular symptoms:\n- hypertension; coronary + carotid atherosclerosis\n- myocardial infarct + cerebrovascular accidents\n- cephalic symptoms:\n- cystic acne; cephalic hair loss\n- mild facial / severe generalized hirsutism ( $70 \\%$ in USA)\n- laboratory findings:\n- $\\uparrow \\mathrm{LH}$ levels without LH surge with $\\leftrightarrow / \\downarrow \\mathrm{FSH}=\\uparrow \\mathrm{LH} / \\mathrm{FSH}$ ratio $\\leftarrow$ preferential production of androgen\nLH: regulates synthesis of androgens from cholesterol in ovarian theca cells\nFSH: regulates aromatase activity of granulosa cells $=$ how much estrogen is synthesized from androgenic precursors\n- elevated androstenedione / testosterone levels\n- elevated estrone / estradiol",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 532,
            "markdown": "$\\sqrt{ }$ at least one enlarged ovary $>10 \\mathrm{~cm}^{3}$\n$\\sqrt{ }$ normal ovarian size (in $30 \\%$ ), polycystic ovaries have a volume of $6-30 \\mathrm{~cm}^{3}$\n$\\sqrt{ }$ excessive number of developing follicles:\n$\\sqrt{ }$ multiple ( $>12$ ) follicles of $2-9 \\mathrm{~mm}$ in subcapsular location\n$\\diamond 20-30 \\%$ of normal young women may have ovaries of a similar appearance!\n$C x$ : endometrial cancer $<40$ years of age $\\leftarrow$ unopposed chronic estrogen stimulation\n$D D x$ : ovaries in congenital adrenal hyperplasia, normal ovaries\nRx: (1) Ovulation induction with clomiphene (Clomid ${ }^{\\circledR}$ ) / menotropins (Pergonal ${ }^{\\circledR}$ )\n(2) Wedge resection (transient effect only)\n\n# STEROID CELL TUMOR \n\n$=$ LIPID / LIPOID CELL TUMOR\n$=$ characterized by cells resembling typical steroid hormone-secreting cells (lutein cells, Leydig cells, adrenocortical cells)\nFrequency: $\\quad 0.1-0.2 \\%$ of all ovarian tumors\nAge: wide range of ages; usually $5^{\\text {th }}-6^{\\text {th }}$ decade\nTypes: (1) Stromal luteoma ( $60 \\%$ estrogenic, $12 \\%$ androgenic)\n(2) Leydig / hilus cell tumor ( $75 \\%$ androgenic)\n(3) Steroid tumor not otherwise specified\n\nPath: usually $<3 \\mathrm{~cm}$ yellow nodule with rich vascularity; rarely cystic\nHisto: abundant clear cytoplasm + varying amounts of lipid resembling adrenocortical cells\n\n- virilizing (majority): amenorrhea, hirsutism\n- Cushing syndrome (rare)\n$\\sqrt{ }$ unilateral $<3 \\mathrm{~cm}$ small solid tumor\n$\\sqrt{ }$ cystic change / necrosis (rare)\nCT:\n$\\sqrt{ }$ areas of low attenuation (= abundant lipid content)\nMR:\n$\\sqrt{ }$ NO high-signal intensity on T1WI $\\leftarrow$ lipid content obscured by fibrous stroma\n$\\sqrt{ }$ various signal intensities on T2WI\n$\\sqrt{ }$ intense contrast enhancement $\\leftarrow$ high tumor vascularity\nPrognosis: clinically malignant (33\\%)\n\n\n## STRUMA OVARII\n\n$=$ rare highly specialized form of ovarian teratoma\nTerminology: (a) pure form = tumor composed entirely of thyroid tissue\n(b) impure form = component of mature cystic teratoma occupying $>50 \\%$ of its volume\nPrevalence: $\\quad 0.30-0.65 \\%$ of ovarian tumors; $5-20 \\%$ of all mature cystic ovarian teratomas\nAge: premenopausal women\nPath: unilateral; often $<10 \\mathrm{~cm}$ in size\nHisto: mature thyroid tissue of variably sized acini filled with colloid: lined by single layer of columnar / flattened epithelium",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 533,
            "markdown": "- asymptomatic / pelvic mass\n- hyperthyroidism / thyrotoxicosis (5\\%)\n- pseudo-Meigs syndrome = abdominal ascites / hydrothorax\n$\\sqrt{ }$ multilocular cystic mass with smooth margins + large cystic spaces $=$ dilated thyroid follicles filled with thyroglobulin and thyroid hormones\nUS:\n$\\sqrt{ }$ nonspecific solid + cystic tumor\n$\\sqrt{ }$ characteristic struma pearls $=$ well circumscribed round vascularized echogenic solid areas with smooth contour\nCT:\n$\\sqrt{ }$ high-attenuation loculi $=$ iodinated thyroid hormone and calcifications\n$\\sqrt{ }$ intense enhancement\n$\\sqrt{ } \\pm$ loculi of fat attenuation $=$ sebaceous material\nMR:\n$\\sqrt{ }$ multilobulated complex mass with thick septa + multiple cysts of variable SI + enhancing solid components\n$\\sqrt{ }$ cystic spaces with marked hypointensity on T2WI + intermediate intensity on T1WI (= thick gelatinous colloid)\n$\\sqrt{ }$ T1-hyperintense locules $\\leftarrow$ hemorrhage\n$\\sqrt{ }$ SI drop-off with surrounding chemical shift artifact on opposed-phase T1WI $\\leftarrow$ microscopic fat\n$\\sqrt{ }$ strong enhancement of solid component / thickened septa / cyst walls\nPrognosis: benign in $95 \\%$\nCx: malignancy (in 5-10\\%)\n$D x:$ usually by pathologic analysis\n$D D x$ : mature cystic teratoma without fatty tissue, cystadenoma, cystadenocarcinoma, endometriosis, tuboovarian abscess, metastatic tumor\n\n\n# TERATOMA OF OVARY \n\n$=$ immature derivatives of all 3 germ cell layers\nPrevalence: most common germ cell neoplasm; $20 \\%$ of adult $+50 \\%$ of pediatric ovarian tumors\nTypes: (1) Mature cystic teratoma\n(2) Immature teratoma\n(3) Monodermal teratoma\n(4) Combination tumor $=$ intermixed varying histologic components without definite interface\n(5) Collision tumor $=$ two adjacent histologically distinct tumors without histologic admixture at interface\nAge: usually childhood / adolescence\n$\\sqrt{ }$ variably from purely cystic to mainly solid masses\nUS:\n$\\sqrt{ }$ cystic / complex mass (most frequently)\n$\\sqrt{ }$ usually large solid mass with internal echoes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 534,
            "markdown": "Dx: identification of intratumoral fat on US, CT, MR imaging\nCx: 1. Torsion $(16 \\%)$\n2. Ruptured teratoma $(1-4 \\%)$\n$\\checkmark$ discontinuity of tumor wall\n$\\checkmark$ fatty implants within peritoneal cavity\n$\\checkmark$ chronic granulomatous peritonitis:\n$\\checkmark$ ascites, hazy omental infiltration\n$\\checkmark$ inflammatory omental mass\n3. Malignant transformation $(1-2 \\%)$\n4. Infection $(1 \\%)$\n5. Autoimmune hemolytic anemia $(<1 \\%)$\n\n# Malignant Transformation of Ovarian Teratoma \n\nPrevalence: $1-2 \\%$ of ovarian teratomas; $1 \\%$ of all ovarian malignancies\nPath: squamous cell carcinoma arising from squamous lining of the cyst (in 80\\%); adenocarcinoma\nAge: $\\quad>45$ years\n\n- serum squamous carcinoma antigen level $>2 \\mathrm{ng} / \\mathrm{mL}$\n- elevated CA-125 level $>35 \\mathrm{U} / \\mathrm{mL}$ (in 67\\%)\n- elevated CA 19-9 level $>37 \\mathrm{U} / \\mathrm{mL}$ (in $75 \\%$ )\n\nLocation: in any of 3 germ cell layers\nCommon site: Rokitansky nodule\nSize of tumor: $>10 \\mathrm{~cm}$\n$\\checkmark$ transmural growth of Rokitansky nodule\n$\\checkmark$ contrast enhancement of Rokitansky nodule\nCT / MR:\n$\\checkmark$ invasive growth of large irregularly marginated soft-tissue component through tumor wall\n$\\checkmark$ irregular soft-tissue components within tumor\n$\\checkmark$ obtuse angle between soft tissue and inner cyst wall\n$\\checkmark$ enhancing soft-tissue component\n\n## Malignant Carcinoid of Ovary\n\n$=$ rare neoplasm of monodermal teratoma with differentiation toward argentaffin cells\nPrevalence: 0.5 of all carcinoid tumors; $0.1 \\%$ of all malignant ovarian tumors\nPath: usually component of mature cystic teratoma\nHisto: insular (= composed of islet cells); trabecular; mucinous (= composed of goblet cells); stromal; mixed (= combination of the 4 pure types)\n\n- carcinoid syndrome ( $1 / 2$ ) in the absence of metastases $\\leftarrow \\mathrm{NO}$ inactivation of serotonin $\\leftarrow$ tumor drains directly into systemic circulation bypassing the liver\nLaterality: unilateral\nSize of tumor: up to 20 cm\n$\\checkmark$ multilocular cystic mass with soft-tissue component\n$\\checkmark$ solid enhancing component may appear as sponge-like mass\n$\\checkmark$ low SI on T2WI + intermediate SI on T1WI",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 535,
            "markdown": "# THECA CELL TUMOR OF OVARY \n\n$=$ THECOMA $=$ FIBROSED THECOMA $=$ FIBROTHECOMA\n$=$ benign sex cord-stromal tumor similar to fibroma\nPath: solid mass, occasionally with cystic changes\nHisto: spectrum of tumors with varying amounts of theca cells (= swollen lipid-rich stromal cells with estrogenic activity) + fibroblasts\nFrequency: $\\quad 0.5-1 \\%$ of all ovarian neoplasms; $50 \\%$ of all gonadal-stromal tumors\nMean age: 59 years; $>30$ years ( $30 \\%$ ); postmenopausal ( $>80 \\%$ )\n\n- estrogenic activity with uterine bleeding ( $60 \\%$ )\n\nMay be associated with: endometrial hyperplasia; endometrial carcinoma ( $>20 \\%$ )\nLaterality: unilateral\nUS:\n$\\sqrt{ }$ echogenic mass with sound attenuation / well-defined hypoechoic mass / anechoic lesion with sound through-transmission\n$\\sqrt{ }$ endometrial thickening\nMR:\n$\\sqrt{ }$ hypointense ovarian mass on T2WI $\\leftarrow$ fibrotic component\n$\\sqrt{ }$ high SI on T2WI for components with little / no fibrosis $\\leftarrow$ edema / cystic degeneration of larger masses\n$\\sqrt{ }$ low signal intensity on T1WI\n$\\sqrt{ }$ variable degree of contrast enhancement governed by amount of nonenhancing fibrous tissue\n$\\sqrt{ }$ widening of endometrial stripe ( $=$ thickened endometrium)\n$\\sqrt{ }$ endometrial polyps\nPrognosis: almost always benign with low malignant potential\n\n## Luteinized Thecoma\n\n$=$ rare subtype of fibrothecoma containing steroid type cells\n\n- hormonal activity: estrogenic ( $50 \\%$ ), nonfunctioning ( $39 \\%$ ), androgenic ( $11 \\%$ )\n\nAge: younger\n\n## TORSION OF FALLOPIAN TUBE\n\nFrequency: $1 \\div 1.5$ million women (exceedingly rare)\nAge: adolescent girls + women of reproductive age\nRisk factors: long / congested mesosalpinx, prior tubal ligation, hydatid cyst of Morgagni, hydrosalpinx, PID, hypermotility of fallopian tube, trauma\nLocation: $\\mathrm{R}>>\\mathrm{L} \\leftarrow$ fixation by sigmoid colon\nMechanism: adnexal venous + lymphatic obstruction $\\rightarrow$ enlargement of fimbrial end as lead point\n\n- acute onset of crampy / constant dull lower abdominal pain\n- nausea, vomiting, peritoneal signs\n\nUS:\n$\\sqrt{ }$ fusiform tubal dilatation with tapered ends\n$\\sqrt{ }$ thickened echogenic wall $\\pm$ internal debris\n$\\sqrt{ }$ central solid component (= edematous mesosalpinx) surrounded by dilated tube",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 536,
            "markdown": "CT:\n$\\sqrt{ }$ dilated fluid-filled structure separate from ovary:\n$\\checkmark$ tubular shape with tapered ends ( $=$ \"beak\" sign)\n$\\checkmark$ twisted configuration of dilated tubular cystic mass\n$\\checkmark$ intraluminal attenuation $>50 \\mathrm{HU}$ (= hemorrhage)\n$\\checkmark$ thick enhancing fallopian tube wall\n$\\checkmark$ free fluid + peritubal fat stranding\n$\\checkmark$ thickening + enhancement of broad ligaments\n$\\checkmark$ focal reactive ileus\n\n# TORSION OF OVARY \n\n$=$ OVARIAN TORSION\n$=$ twisting of ovary on its axis around suspensory ligament\nAdnexal torsion: torsion of ovary / fallopian tube / both (67\\%)\nPredisposing condition:\n(1) Enlarged ovary (in $50-81 \\%$ ):\n(a) physiologic: large hemorrhagic cyst, paraovarian cyst, multicystic ovary from hyperstimulation, abscess\n(b) neoplastic: benign mature cystic teratoma (= \"dermoid\"), serous cystadenoma, malignancy\n$\\diamond$ Benign mature cystic teratoma is the most common neoplasm causing torsion!\n$\\diamond$ Ovarian torsion is rare with ovarian cysts $<5 \\mathrm{~cm}$\n(2) Hypermobility of normal adnexa $\\leftarrow$ markedly mobile fallopian tube, excessively long mesosalpinx, elongated pelvic ligaments, fallopian tube spasm, strenuous exercise, abrupt changes in intraabdominal pressure\n$\\diamond$ Most frequent in prepubertal girls + during 1st trimester of pregnancy At risk: 1st trimester of pregnancy (8-16 weeks EGA) responsible for $14 \\%$ of all ovarian torsions\n$\\diamond$ Uncommon after PID / endometriosis / malignant neoplasm $\\leftarrow$ immobile ovaries $\\leftarrow$ presence of adhesions\nPrevalence: $2.7 \\%$ of gynecologic emergencies\nAssociated with: ipsilateral ovarian lesion (in 50-81\\%)\nPath: hemorrhagic necrosis\nPathophysiology:\n(a) early stage of partial torsion: arteries with thick muscular walls are less collapsible so that circulatory stasis affects initially lymphatics + veins $\\rightarrow$ massive ovarian edema + distention of peripheral follicles $\\rightarrow$ diffuse ovarian enlargement + capsular stretch\n(b) later stage of progressive complete torsion: arterial obstruction (= arterial stasis + thrombosis) $\\rightarrow$ ovarian ischemia / necrosis / hemorrhagic infarction $\\rightarrow$ severe peritonitis $\\rightarrow$ systemic inflammation + death\nAge: any; usually affects women of reproductive age (17-20\\% during pregnancy) in first 3 decades of life; may occur prenatally\n$\\diamond$ Torsion of a normal ovary is unusual and more common in adolescents!\n\n- gradual / sudden onset of severe lower abdominal / pelvic pain:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 537,
            "markdown": "- sharp localized right / left lower abdominal pain + tenderness with peritoneal signs\n- intermittent pain / resolving pain\n- waves of nausea, vomiting, pyrexia; palpable mass in $50 \\%$\n\nLocation: $\\mathrm{R} \\div \\mathrm{L}=3 \\div 2$ (? protective effect of sigmoid mesentery); frequently one ovary with corresponding fallopian tube\nUS ( $87 \\%$ PPV, $93 \\%$ specific):\n$\\sqrt{ }$ enlarged ovary $>4 \\mathrm{~cm}$ in diameter ( 28 x normal size):\n$\\checkmark$ ovarian stromal heterogeneity with solid + cystic components $\\leftarrow$ hemorrhage and edema\n$\\checkmark$ good sound transmission $\\leftarrow$ vascular engorgement and stromal edema\n$\\checkmark \\pm$ coexistent complex (cystic / solid) pelvoabdominal/adnexal mass\n$\\checkmark$ \"string of pearls\" = multiple peripherally aligned displaced follicles measuring $8-25 \\mathrm{~mm}$ in diameter $(64-74 \\%) \\leftarrow$ transudation of fluid into nonovulatory follicles\n$\\checkmark$ small amount of free fluid in cul-de-sac (in up to $87 \\%$ ):\n$\\checkmark$ clear ascites ( $70 \\%$ ) / hemorrhagic ascites ( $10 \\%$ )\n$\\checkmark \\pm$ local tenderness of ovary at transvaginal US\n$\\checkmark$ \"whirlpool\" sign = ellipsoid / tubular mass abutting ovarian mass = twisted vascular pedicle $(88 \\%)$\nColor Doppler:\n$\\checkmark$ engorgement of blood vessels on side of torsion\n$\\checkmark$ \"corkscrew\" appearance = twisted circular / coiled arterial + venous vessels within vascular pedicle\n$\\checkmark$ diminished / absent venous flow (in $93 \\%$ ) $\\leftarrow$ early collapse of compliant venous walls\n$\\checkmark$ absent / high-resistance arterial Doppler waveforms (in $73 \\%$ ) = SPECIFIC but NOT SENSITIVE\n$\\checkmark$ Normal arterial waveforms do NOT rule out torsion! Some color Doppler flow in up to $60 \\%$ of surgically proved cases $\\leftarrow$ dual blood supply by ovarian + uterine arteries / symptoms secondary to venous thrombosis\nUtility: Nonviable ovary shows NO central venous flow! Viable twisted ovary shows central venous flow!\nCT:\n$\\checkmark$ unilateral ovarian enlargement ( $100 \\%$ ) with cortical follicles\n$\\checkmark$ displacement of torsed ovary toward pelvic midline / contralateral side + superior to fundus\n$\\checkmark$ deviation of uterus toward side of torsed ovary ( $36 \\%$ )\n$\\checkmark$ amorphous targetlike / tubular mass ( $84 \\%$ ) between adnexal mass + uterus $\\leftarrow$ tubal thickening $>10 \\mathrm{~mm}$\nN.B.: the diameter of the normal tube measures up to 4 mm at isthmic, 8 mm at ampullary, 10 mm at infundibular portion\n$\\checkmark$ cystic ovarian mass with smooth wall thickening ( $76 \\%$ ) converging on a thickened fallopian tube:\n$\\checkmark$ eccentric $>10 \\mathrm{~mm} \\leftarrow$ suggests hemorrhagic infarction\n$\\checkmark$ attenuation $>50 \\mathrm{HU}$ on NECT = hemorrhagic infarction\n$\\checkmark$ small uniform peripheral hypoattenuating cysts surrounding an edematous ovarian stroma\n$\\checkmark$ obliteration of fat planes / fat stranding around torsed ovary",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 538,
            "markdown": "$\\sqrt{ }$ twisted vascular ovarian pedicle (PATHOGNOMONIC)\n$\\sqrt{ }$ enlarged veins\n$\\sqrt{ }$ lack of enhancement of solid component (= infarction)\n$\\sqrt{ }$ hematoma / gas within torsed mass\n$\\sqrt{ }$ ascites\nMR:\n@ ovary:\n$\\sqrt{ }$ imaging findings vary with stage:\n$\\sqrt{ }$ initially ovarian enlargement with diffuse high SI on T2WI $\\leftarrow$ stromal edema $=$ frequently viable ovary\n$\\sqrt{ }$ variable SI $\\leftarrow$ hemorrhage + necrosis\n$\\sqrt{ } \\downarrow$ SI on T1WI and T2WI $\\leftarrow$ hemorrhagic infarction\n$\\sqrt{ }$ high SI on fat-suppressed T1WI $\\leftarrow$ blood products\n$\\sqrt{ }$ smooth thickening of cyst wall / mural nodule\n$\\sqrt{ }$ no enhancement of solid component on contrast-enhanced dynamic subtraction MR = chronic stage\n$\\sqrt{ }$ enlarged follicles along periphery of ovary\n$\\sqrt{ }$ twisted vascular pedicle\n$\\sqrt{ }$ beaked protrusion at periphery of torsed ovary $\\leftarrow$ engorged blood vessels\n$\\sqrt{ }$ obliteration of fat planes\n@ tube:\n$\\sqrt{ }$ tubal thickening (SAG image improves detection)\n$\\sqrt{ }$ increased tubal SI on T2WI $\\leftarrow$ edema\n$\\sqrt{ }$ hemorrhage into thickened tube\n@ uterus:\n$\\sqrt{ }$ deviation of uterus to side of torsion\n$\\sqrt{ }$ pelvic ascites / hemoperitoneum\nPrognosis:\n(1) Spontaneous detorsion is common (history of prior similar episodes = intermittent torsion)\n(2) Infection of torsed ovary with local peritonitis $\\pm$ bowel obstruction\n\nCx: infarction, necrosis, infection, peritonitis\n$R x$ : immediate surgery (most ovaries NOT salvageable)\n$D D x$ : (1) Hemorrhagic ovarian cyst (fishnet appearance, retracting blood clot, fluid-fluid / fluid-debris level\n(2) Serous cystadenoma (large unilocular thin-walled cystic lesions $\\pm$ thin septations / papillary projection)\n(3) Ovarian hyperstimulation syndrome (bilaterally enlarged ovaries due to multiple distended peripherally located corpora lutea cysts)\n\n# TRIPLOIDY \n\n$=69$ chromosomes ( $=3$ haploid sets of 23 chromosomes)\nPrevalence: $1 \\%$ of conceptions; $0.04 \\%$ of 20-week fetuses\nNO obvious pattern!\n$\\sqrt{ }$ early severe asymmetric IUGR (MOST PROMINENT FEATURE); cephalocorporal disproportion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 539,
            "markdown": "$\\sqrt{ }$ oligohydramnios\n$\\sqrt{ }$ large hydropic placenta with scattered vesicular spaces (partial hydatidiform mole)\n$\\sqrt{ }$ congenital heart disease: ASD, VSD\n$\\sqrt{ }$ brain anomalies: hydrocephalus, holoprosencephaly, neural tube defect\n$\\sqrt{ }$ cleft lip / palate\n$\\sqrt{ }$ syndactyly of fingers\n$\\sqrt{ }$ omphalocele\n$\\sqrt{ }$ renal abnormalities\nPrognosis: most ending in spontaneous abortion\n\n# TRISOMY 13 \n\n$=$ PATAU SYNDROME\nCause: nondisjunction of chromosome 13 during meiosis\nPrevalence: $1 \\div 5,000$ live births\n@ OB: severe IUGR, hydramnios\n@ CNS: alobar holoprosencephaly, posterior encephalocele, neural tube defect\n@ Face: midline labial cleft, proboscis, hypotelorism, cyclopia, anophthalmia\n@ Skeleton: postaxial polydactyly, rocker-bottom foot\n@ Heart: (CHD in 90\\%) VSD, echogenic chordae tendineae, hypoplastic ventricle, tetralogy of Fallot, transposition\n@ Kidney: polycystic kidney, horseshoe kidney\n@ GI: omphalocele (occasionally)\nPrognosis: few infants live more than a few days / hours; death by 3 months of age\n$D D x$ : Meckel-Gruber syndrome\n\n## TRISOMY 18\n\n$=$ EDWARDS SYNDROME\nPrevalence: $1 \\div 3,000-5,000$ live births\n\n- triple-marker screening test:\n(1) $\\downarrow$ maternal alpha-fetoprotein\n(2) $\\downarrow \\mathrm{hCG}$ (DDx: increased in Down syndrome)\n(3) $\\downarrow$ estriol\n$\\sqrt{ }$ no anomalies ( $14 \\%$ ) on initial $2^{\\text {nd }}$-trimester sonogram only $\\leftarrow$ incomplete / early gestational age\n@ OB: severe symmetric IUGR ( $28 \\%<24$ weeks MA), single umbilical artery ( $30 \\%$ ), polyhydramnios (occasionally)\n@ Face: micrognathia, hypotelorism, facial cleft ( $10-40 \\%$ )\n@ Head: strawberry-shaped head ( $50 \\%$ ), cystic hygroma\n@ CNS: holoprosencephaly, choroid plexus cyst ( $30-51-75 \\%$ ), cerebellum $\\leq 10^{\\text {th }}$ percentile with prominent cisterna magna ( $45 \\%$ ), myelomeningocele\n@ Hand: clenched hand with overlapping of index finger ( $33 \\%$, HIGHLY CHARACTERISTIC), abnormal wrist position (27\\%)\n@ Arm: shortened radial ray, clubbed forearm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 540,
            "markdown": "@ Foot: clubbed foot, rocker-bottom foot\n@ Heart: CHD in 90\\%: VSD (82\\%), ASD (8\\%), complete AV canal, DORV\n@ GI: diaphragmatic hernia, omphalocele ( $30-40 \\%$ ), tracheoesophageal fistula\n@ Kidney: polycystic kidney, horseshoe kidney, UPJ obstruction\nPrognosis: usually delivered by emergency cesarean section $\\leftarrow$ IUGR + fetal distress, if not detected prenatally; death by 1 year of age\n\n# TWIN EMBOLIZATION SYNDROME \n\n$=$ rare complication of monochorionic pregnancy following the death of one twin whose blood pressure falls to zero\nPathophysiology:\n\n1. Acute reversal of transfusion to co-twin at time of intra-uterine demise of one twin with ischemic changes in survivor\n2. Embolization (= transfer of thromboplastin-enriched blood / detritus) from the dead to the living twin through vascular anastomoses in placenta\n\n- DIC (disseminated intravascular coagulation)\n\nEmbolized organs: CNS (72\\%), GI tract (19\\%), kidneys (15\\%), lungs\n$\\sqrt{ }$ ventriculomegaly, cortical atrophy, porencephalic cyst, cystic encephalomalacia within 2 weeks of death of co-twin\nMorbidity / mortality: $17 \\%$\n\n## TWIN-TWIN TRANSFUSION SYNDROME\n\n$=$ FETOFETAL TRANSFUSION SYNDROME $=$ MONOVULAR TWIN TRANSFUSION $=$ INTRAUTERINE PARABIOTIC SYNDROME\n$=$ complication of monozygotic twinning with one placenta or one fused placenta of mono- / dizygotic twins\nPrevalence: $5-18 \\%$ of twin pregnancies; $5-15 \\%$ of monozygotic multiple pregnancies; $15-30 \\%$ of monochorionic twin gestations\nCause: unbalanced intrauterine shunting of blood through shared placental vessels\nTime of onset: $2^{\\text {nd }}$ trimester with discordant amniotic fluid volumes\nPath: large communication between arterial circulation of one twin + venous circulation of the other twin through arteriovenous shunt ( $=$ common villous district) deep within placenta\n$\\sqrt{ }$ discrepant amniotic fluid volume $(75 \\%)$\n$\\sqrt{ }$ discordant BPD by $>5 \\mathrm{~mm}(57 \\%)$\n$\\sqrt{ }$ discordant estimated fetal weight $>25 \\%(67-100 \\%)$\nA. DONOR TWIN\n$=$ twin that transfuses the recipient twin + remains itself underperfused residing in an oligo/ anhydramniotic sac\n\n- anemia + hypovolemia\n- high output cardiac failure + hydrops (rare)\n$\\sqrt{ }$ oligohydramnios $(75-80 \\%)$\n$\\sqrt{ }$ \"stuck twin\" $\\leftarrow$ severe oligohydramnios $(60 \\%) \\leftarrow$ oliguria\n$\\sqrt{ }$ amnion invisible $\\leftarrow$ close contact with fetal parts\n$\\sqrt{ }$ fetus fixed relative to the uterine wall $\\rightarrow$ without change during shift in maternal position",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 541,
            "markdown": "$\\sqrt{ }$ diminished / absent active fetal motion\n$\\sqrt{ }$ absence of intermingling of fetal parts between twins\n$\\sqrt{ }$ IUGR (= intrauterine growth restriction, common) diagnosed by discordant EFW of $>$ $25 \\%$\n$\\sqrt{ }$ morphologically normal\nPrognosis: fetal death in utero\nB. RECIPIENT TWIN\n\n- polycythemia (higher hemoglobin)\n- plethora $=$ hypervolemia (volume overload)\n$\\sqrt{ }$ polyhydramnios ( $70-75 \\%$ ) $\\leftarrow$ increased fetal urination\n$\\sqrt{ }$ fetal hydrops ( $10-25 \\%$ ): pericardial + pleural effusions, ascites, skin thickening\n$\\sqrt{ }$ organomegaly\n$\\sqrt{ }$ fetus papyraceus $=$ macerated dead fetus\n$\\sqrt{ }$ velamentous cord insertion ( $64 \\%$ )\nPrognosis: $80-100 \\%$ perinatal mortality if presenting $<28$ weeks MA and left untreated\nCx: amniorrhexis, preterm labor\nRx: elective termination, volume-reduction amniocentesis of polyhydramniotic sac (decreases mortality rate to $34 \\%$ ), selective feticide, laser ablation of vascular anastomoses\n$D D x:$ IUGR of one dizygotic twin (two separate placentas, two different sexes)\n\n\n# UTERINE ANOMALIES \n\n$=$ MÃLLERIAN DUCT ANOMALIES\n$=$ anomalies of fusion of paramesonephric duct (= MÃLLERIAN DUCT) completed by 18th week of fetal life\nPrevalence: $0.1-3 \\%$\n$\\diamond$ Uterine anomalies are found in $9 \\%$ of women with infertility / repeated spontaneous abortions!\n$\\diamond 25 \\%$ of women with uterine abnormalities have fertility problems\nAssociated with: urinary tract anomalies in $20-50 \\%$; possibly increased familial occurrence of limb reduction\nEmbryology:\n(a) mÃ¼llerian ducts develop at 5-6 weeks GA from coelomic epithelium and form uterovaginal canal by lateral fusion at $7-9$ weeks GA\n(b) by 8 weeks the uterovaginal canal reaches the urogenital sinus at the mÃ¼llerian tubercle while a vaginal plate develops distally resulting in vertical fusion (upper $2 / 7$ to $4 / 5$ of vagina are of mÃ¼llerian duct origin, lower $1 / 3$ or $1 / 5$ of vagina originate from urogenital sinus)\nRisk: spontaneous abortion, prematurity, IUGR, abnormal fetal lie, dystocia\nClassification:\n[classes in parenthesis refer to the classification of the American Fertility Society]\nA. ARRESTED MÃLLERIAN DUCT DEVELOPMENT\n\n1. bilateral: Uterovaginal agenesis / hypoplasia (class I)\n$\\mathrm{I}-\\mathrm{A}=$ Vaginal $\\quad \\mathrm{I}-\\mathrm{D}=$ Tubal\n$\\mathrm{I}-\\mathrm{B}=$ Cervical $\\mathrm{I}-\\mathrm{E}=$ Combination",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 542,
            "markdown": "I-C $=$ Fundal\nPrevalence: $1 \\div 5,000 ; 5-10 \\%$ of uterine anomalies\nOften associated with: vaginal agenesis / hypoplasia\nAge of detection: menarche\n\n- primary amenorrhea\n- normal secondary sex characteristics\n$\\sqrt{ }$ small / absent uterus with small endometrial canal\n$\\sqrt{ } \\pm$ endometrial layer\n$\\sqrt{ }$ poor zonal differentiation + abnormal T2-hypointense myometrium\n\n2. unilateral: Unicornuate uterus $=$ Uterus unicornis unicollis (class II)\n\nII-A $=$ Communicating II-D $=$ No cavity\nII-B = Noncommunicating II-E = No horn\n$=$ failure of one mÃ¼llerian duct to elongate / reach the urogenital sinus during $9^{\\text {th }}$ week of gestation\n(a) with contralateral rudimentary horn\n> cavitary = functioning endometrial tissue (\"functional rudimentary horn\")\nÂ» communicating with contralateral cavity (10\\%)\nÂ» noncommunicating ( $22 \\%$ )\n> noncavitary $(33 \\%)=$ no endometrial tissue\n> noncavitary with endometrial strip ( $32 \\%$ )\n(b) without rudimentary horn\n\nFrequency: 3-6-20\\% of uterine anomalies\nMay be associated with: ipsilateral renal agenesis\n\n- infertility in 5-20\\%\n$\\sqrt{ }$ reduced uterine volume\n$\\sqrt{ }$ asymmetric ellipsoidal uterine configuration located in lateral aspect of pelvis\n$\\sqrt{ }$ solitary fusiform \"banana-shaped\" uterine cavity with lateral deviation within pelvis terminating in a single fallopian tube on HSG\n$\\sqrt{ }$ nonfunctional rudimentary horn of low SI on T2WI with loss of normal zonal anatomy\n$\\sqrt{ }$ large high-signal-intensity cavity on T1WI + T2WI in functional rudimentary horn (= hematometra)\n$C x$ : endometriosis $\\leftarrow$ cryptomenorrhea within endometrium-containing rudimentary horn; ectopic pregnancy $\\leftarrow$ transperitoneal sperm migration; abnormal fetal lie, IUGR; preterm delivery\n\n# 3. Mayer-Rokitansky-KÃ¼ster-Hauser syndrome \n\n(1) vaginal agenesis / hypoplasia of proximal + middle segments\n(2) intact normal ovaries + fallopian tubes\n(3) variable anomalies of uterus (agenesis / hypoplasia, uni- or bicornuate)\n(4) variable anomalies of urinary tract (renal agenesis, pelvic kidney in $40-50 \\%$ ) + skeletal system $(12 \\%)$\nmnemonic: MURCS complex\nMÃ¼llerian duct aplasia\nRenal aplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 543,
            "markdown": "Cervicothoracic Somite dysplasia\nFrequency: $1 \\div 4,000-1 \\div 5,000$\nCause: lack of mÃ¼llerian development\n\n- normal external genitalia; amenorrhea\n- shallow distal vaginal pouch (derived from urogenital sinus)\n- cyclic pelvic pain in $6-10 \\% \\leftarrow$ functioning endometrium within rudimentary uterine tissue\n$\\diamond 2^{\\text {nd }}$ most common cause of primary infertility\n$R x$ : neovaginoplasty\nB. TOTAL / PARTIAL FAILURE OF MÃLLERIAN DUCT FUSION = duplication defects $=$ disorders of lateral fusion ( $75 \\%$ of uterine anomalies)\n\n1. Uterus didelphys (class III)\n$=$ failure of fusion of paramesonephric ducts at 9 weeks of gestation $\\rightarrow$ complete duplication with 2 vaginas +2 cervices +2 uterine horns\nFrequency: $11 \\%$ of uterine anomalies\nMay be associated with: renal agenesis\n\n- usually asymptomatic; frequently first diagnosed during routine obstetric sonography\n$\\sqrt{ }$ two widely spaced uterine corpora with normal zonal anatomy and volume, each with a single fallopian tube\n$\\sqrt{ }$ separate widely divergent uterine horns\n$\\sqrt{ }$ large fundal cleft\n$\\sqrt{ }$ cervical duplication\n$\\sqrt{ }$ longitudinal vaginal septum (in 75\\%)\n$\\sqrt{ }$ unilateral hemivaginal septum:\n$\\sqrt{ }$ obstructing transverse vaginal septum between upper $1 / 3$ and lower $2 / 3$ of vagina connecting to longitudinal septum (commonly with ipsilateral renal agenesis)\n$\\sqrt{ }$ opacification of single deviated horn on HSG\n$D D x$ : bicornuate bicollis uterus (communication between uterine horns maintained)\n$C x$ : unilateral hydro- / hematocolpos (if transverse vaginal septum present) with reflux endometriosis\n$R x$ : metroplasty is rarely performed\n\n2. Bicornuate uterus $=$ uterus bicornis (class IV)\n\nIV-A $=$ Complete IV-B $=$ Partial\n$=$ lack of fusion of corpus\n(a) bicornis bicollis = complete division down to external os\n(b) bicornis unicollis = division down to internal os\n\nFrequency: $10 \\%$ of all uterine anomalies\n$\\sqrt{ }$ external uterine fundal contour (MR):\n$\\sqrt{ }$ concave heart-shaped surface depression $>1-2 \\mathrm{~cm}$ deep\n$\\sqrt{ }$ large fundal cleft\n$\\sqrt{ }$ separation of uterine horns\n$\\sqrt{ }$ intercornual angle of $>75-105^{\\circ}$ (demonstrated on luteal-phase US in conjunction with HSG)\n$\\sqrt{ }$ intercornual distance (= distance between maximum lateral extent of hyperintense",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 544,
            "markdown": "endometrium on transaxial image $)>4 \\mathrm{~cm}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 545,
            "markdown": "![img-34.jpeg](img-34.jpeg)\n$\\checkmark$ divider between cornua comprised of myometrium / fibrous tissue / both\n$\\checkmark$ fusiform shape of each uterine horn with lateral convex margins\n$\\checkmark$ discrepancy in size of the 2 uterine horns\n$\\checkmark$ elongation + widening of cervical canal + isthmus\nLaparoscopy: typical external fundal indentation\n$C x$ : repeated spontaneous abortions in $30 \\%$ (frequently in $2^{\\text {nd }}-3^{\\text {rd }}$ trimester), premature rupture of membranes, premature labor (20\\%), SGA infant, persistent malpresentations (transverse lie)\n$D D x$ : septate uterus (convex external contour)\n$\\diamond$ HSG is unreliable to distinguish bicornuate from septate uterus!",
            "images": [
                {
                    "id": "img-34.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1526,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 546,
            "markdown": "$\\diamond 3$-dimensional US is $90-92 \\%$ accurate!\n$\\diamond$ MR is nearly $100 \\%$ accurate!\n$R x$ : transabdominal surgery to fuse uterine horns (abdominal / open metroplasty)\nC. NONRESORPTION OF SAGITTAL UTERINE SEPTUM\n\n1. Septate uterus (class V)\n$\\mathrm{V}-\\mathrm{A}=$ Complete $\\mathrm{V}-\\mathrm{B}=$ Partial\n$=$ failure of resorption of septum by $12^{\\text {th }}$ week EGA\n$\\diamond$ Most common anomaly ( $55 \\%$ ) associated with reproductive failure in 26-65-94\\% unrelated to length of septum\nPath: septum may be composed of fibrous tissue (low SI), myometrium (intermediate SI), or both\n\n- generally asymptomatic $\\pm$ unilateral obstruction, dysmenorrhea, normal menses, endometriosis\n$\\sqrt{ }$ convex / flat / minimally indented $(\\leq 1 \\mathrm{~cm})$ external fundal contour\n$\\sqrt{ }$ intercornual angle of $\\leq 75^{\\circ}$ (MR more accurate than HSG with its projectional problems)\n$\\sqrt{ }$ duplication of uterine horns on HSG (DDx to bicornuate uterus unreliable)\n$\\sqrt{ }$ distal portion of septum hypoechoic to myometrium / of low SI on T2WI (= fibrous tissue)\nTypes:\n(a) Uterus septus\n$=$ complete septum extending to internal os\n$\\sqrt{ }$ endometrial canals completely separated by tissue isoechoic to myometrium extending into endocervical canal\n(b) Uterus subseptus\n$=$ partial septum involving endometrial canal\n$C x: \\quad 90 \\%$ abortion rate (poor septal vascularity)\n$R x$ : hysteroscopic metroplasty (= excision of septum)\n\n2. Uterus arcuatus (class VI)\n$=$ nearly completely resorbed uterovaginal septum\n$\\diamond$ Most common anomaly unassociated with reproductive failure $=$ normal variant\n$\\sqrt{ }$ NO division of uterine horns\n$\\sqrt{ }$ normal fundal contour\n$\\sqrt{ }$ smooth indentation of fundal endometrial canal\n$\\sqrt{ }$ increased transverse diameter of uterine cavity\n$\\sqrt{ }$ single uterine canal with saddle-shaped fundus on HSG\nD. INADEQUATE HORMONAL STIMULATION DURING FETAL DEVELOPMENT\n$=$ DES (= diethylstilbestrol)-related abnormalities (class VII)\n\n- synthetic hormone used until 1971 to prevent miscarriage; rarely seen today\n- may cause abnormal uterine morphology (with decreased fertility)\n- increased risk of vaginal clear cell carcinoma\n\n1. Uterine hypoplasia\nassociated with DES exposure in utero\n$\\sqrt{ }$ mean uterine volume $=50 \\mathrm{~cm}^{3}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 547,
            "markdown": "# 2. T-shaped uterus \n\nPrevalence: $15 \\%$ of women exposed to DES in utero\n$\\checkmark$ low uterine volume\n$\\checkmark$ uterine fundus thinner than cervix\n$\\checkmark$ greater width than depth of corpus + fundus over cervix\n$\\checkmark$ T-shaped lumen on hysterosalpingogram\nE. VAGINAL SEPTUM ANOMALY\n\n1. Transverse vaginal septum\n$=$ failure of vertical fusion between vaginal plate (from urogenital sinus) + mÃ¼llerian ducts around $5^{\\text {th }}$ month of gestation\nPath: fibrous membrane of connective tissue with vascular + muscular components\n\n- NO transillumination (DDx to imperforate hymen)\n\nLocation: upper vagina ( $46 \\%$ ), mid-vagina ( $40 \\%$ ), lower vagina ( $14 \\%$ )\n$\\checkmark$ hematocolpos (balloon sonocolpography)\n$\\checkmark$ thickness measurement of septum is needed\n$D D x$ : congenital absence of cervix versus high septum (identification of cervix is crucial)\n2. Longitudinal vaginal septum\n\nCause: (a) failure of fusion of lateral mÃ¼llerian ducts resulting in duplication of uterus, cervix (uterus didelphys), vagina\n(b) incomplete resorption of vaginal septum\n\n- difficulties with sexual intercourse / vaginal delivery\n$\\checkmark$ low-signal-intensity septum distinct from surrounding high-signal-intensity of vaginal mucosa + secretions on T2WI\n\n3. Imperforate hymen\n$=$ failure at very end of vaginal recanalization process\nPrevalence: $0.1 \\%$; usually isolated finding; most common anomaly of female genital tract\n\n- primary amenorrhea + cyclic pelvic pain\n- $\\pm$ bulging introitus in infancy (from vaginal mucus)\n- positive transillumination of bluish membrane\n\nLocation: junction between urogenital sinus + sinovaginal bulb\n$\\checkmark$ distended vagina bulging at introitus $\\leftarrow$ hydro- / hematocolpos\n$\\checkmark$ hematocolpos with high-SI on T1WI + T2WI $\\leftarrow$ subacute bleeding episodes\n\n## UTERINE LEIOMYOMA\n\n$=$ FIBROID $=$ MYOMA\n$=$ benign overgrowth of smooth muscle + connective tissue\n$\\diamond$ Most common gynecologic neoplasm! Commonest cause for uterine enlargement after pregnancy!\nPrevalence: in 20-25\\% of White women; in 50\\% of Black women; Black+White women $=3 \\div 1$ to $9 \\div 1 ; 0.3-2.6 \\%$ during pregnancy; account for $30 \\%$ of all hysterectomies in USA\nPath: whorl-like trabeculated mesenchymal tumor surrounded by pseudocapsule; may outgrow its blood supply resulting in:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 548,
            "markdown": "(a) hyaline degeneration / fibrosis ( $>60 \\%$ )\n$=$ homogeneous eosinophilic bands / plaques of proteinaceous material in extracellular space\n(b) myxoid degeneration $(50 \\%)$\n$=$ gelatinous intratumoral foci of hyaluronic acid-rich mucopolysaccharides\n(c) red / hemorrhagic / carneous degeneration ( $10 \\%$ )\n$=$ massive hemorrhagic infarction $\\leftarrow$ venous thrombosis / rupture of intratumoral arteries; often during pregnancy / during use of oral contraceptives\n\n- painful\n(d) cystic degeneration $(4 \\%)$\n$=$ extreme sequelae of edema\n(e) calcification $(4 \\%)$\n$=$ dense amorphous calcifications of hyalinized tissue\nSpecific types:\n(1) Lipoleiomyoma $(0.8 \\%)$\n(2) Myxoid leiomyoma $=$ rare soft translucent mass $\\leftarrow$ abundant myxoid material between smooth muscle cells, may be clinically malignant\n(3) Intravenous leiomyomatosis $=$ wormlike masses growing within pelvic veins\n(4) Benign metastasizing leiomyoma\n(5) Diffuse leiomyomatosis $=$ development of innumerable small leiomyomas $\\sqrt{ }$ symmetric enlargement of uterus\n(6) Peritoneal disseminated leiomyomatosis\n- frequently associated with pregnancy\n$\\checkmark$ multiple nodules on peritoneal surface\nHisto: monoclonal proliferation of smooth muscle cells (NOT myometrial hyperplasia) separated by variable amounts of fibrous connective tissue\nHormonal dependency:\n$\\diamond$ Higher estrogen+progesterone receptor ratio than in normal myometrium!\n(1) Growth during pregnancy in $15-32 \\%$ by a mean volume of $12 \\pm 6 \\%$ within the $1^{\\text {st }}$ trimester (NOT during remainder of pregnancy)\n$\\diamond$ The larger the myoma, the greater the likelihood of growth\n(2) Growth under estrogen therapy\n(3) Shrinkage in puerperium + after menopause\n\nAge: usually $>30$ years; rare in girls $<18$ years + in postmenopausal women\n\n- asymptomatic in $70-75 \\%$; palpable abdominopelvic mass\n- pelvic pressure:\n- urinary frequency $\\leftarrow$ compression of bladder\n- constipation $\\leftarrow$ impingement on rectosigmoid\n- pain (in up to $30 \\%$ ) $\\leftarrow$ acute hemorrhagic infarction and necrosis, torsion of pedunculated subserosal fibroid, prolapse of pedunculated submucosal fibroid, compression of adjacent structures\n- dysmenorrhea $=$ colicky pelvic pain with menstruation\n- abnormal uterine bleeding:\n- menorrhagia / hypermenorrhea $=$ heavy + prolonged menstrual flow",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 549,
            "markdown": "- metrorrhagia $=$ uterine bleeding outside time of menstruation\n- infertility + early spontaneous fetal loss $\\leftarrow$ interference with embryo transfer + implantation in submucosal / intracavitary leiomyoma\nLocation: mostly in fundus + corpus; cervix (3-8\\%); fallopian tube; broad ligament; ovary\nClassification by location in uterus:\n\n1. Intramural fibroid (95\\%)\n$=$ within confines of uterine outline\n\n- asymptomatic (mostly)\n- occasionally menorrhagia $\\leftarrow$ interference with normal uterine contractility\n- occasionally infertility $\\leftarrow$ compression of interstitial portion of fallopian tube / distortion of endometrial cavity\n\n2. Subserosal / exophytic / pedunculated fibroid\n\n- usually asymptomatic; pain from infarction $\\leftarrow$ torsion\n$\\sqrt{ }$ \"bridging vascular\" sign = multiple feeding vessels arising from the uterine arteries + bridging the interface between uterus and any $>3 \\mathrm{~cm}$ juxtauterine leiomyoma\n(a) intraligamentous fibroid (lateral growth between folds of broad ligament)\n- simulates ovarian mass\n- occasionally infertility $\\leftarrow$ compression of isthmic / ampullary portion of fallopian tube\n$C x$ : hydroureteronephrosis $\\leftarrow$ compression of ureter\n(b) parasitic fibroid = subserosal fibroid, which has become detached $\\leftarrow$ circulatory occlusion of vessels in pedicle; revitalized through omental / mesenteric blood supply $\\sqrt{ }$ may grow after hysterectomy\n\n3. Submucosal fibroid (4-5-18\\%)\n$=$ projecting into endometrial canal\n$\\diamond$ Most frequent symptomatic type of fibroid:\n\n- dysmenorrhea, menorrhagia, infertility\n- increased prevalence of early abortion\n\nCx: hemorrhage, ulceration\n(a) fibroid polyp $(2.5 \\%)=$ partial / complete extrusion of pedunculated submucosal fibroid into cervical canal / vagina\nCystic, fatty, and calcific degeneration within a leiomyoma may lead to a heterogeneous imaging appearance internally, but a smooth outer contour, preserved mucosa, and negative Pap test are important features for differentiation from cervical carcinoma.\n$\\checkmark$ uterine enlargement\n$\\checkmark$ lobulated / nodular distortion of uterine outline (subserosal leiomyoma) + indentation of urinary bladder\n$\\checkmark$ distortion / obliteration of the contour of the uterine cavity (submucosal leiomyoma)\n$\\checkmark$ intramural soft-tissue mass (most frequent), usually multiple, solitary in $2 \\%$\n$\\checkmark$ speckled / ringlike / popcorn calcification\nHSG:\n$\\checkmark$ mass effect on endometrial cavity\n$\\checkmark$ lack of tubal opacification with cornual leiomyoma\nUS ( $60 \\%$ sensitivity, $99 \\%$ specificity, $87 \\%$ accuracy):",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 550,
            "markdown": "- point tenderness elicited with probe pushing on fibroid\n$\\checkmark$ hypoechoic solid concentric mass $(<33 \\%) \\leftarrow$ prevailing muscle component\n$\\checkmark$ echogenic attenuating mass $\\leftarrow$ prevailing dense fibrosis\n$\\checkmark$ sharp discrete refractory shadows (from borders between fibrous tissue and smooth muscle, margins of leiomyoma with normal myometrium, edges of whorls, bundles of smooth muscle)\n$\\checkmark$ anechoic features $\\leftarrow$ internal degeneration: atrophic, hyaline, cystic, myxomatous, lipomatous, calcareous, carneous, necrobiotic, hemorrhagic, proteolytic degeneration\n$\\checkmark$ acoustic shadowing ( $=$ calcifications)\n$\\diamond$ Presence of a prominent artery by color Doppler suggests potential for growth during pregnancy\nCT:\n$\\checkmark$ hypo- / iso- (usually) / hyperdense mass\n$\\checkmark$ deformed uterine contour\n$\\checkmark$ calcifications (common)\n@ Degenerated leiomyoma\n$\\checkmark$ central region of low attenuation\n$\\checkmark$ heterogeneous enhancement\nMR (86-92\\% sensitive, $100 \\%$ specific, $97 \\%$ accurate; most accurate + desirable for planning myomectomy):\nN.B.: subserosal, intramural and submucosal classification enabled by uterine zonal anatomy\n$\\checkmark$ hyperintense rim on T2WI in $33 \\%$ (= pseudocapsule of dilated lymphatics / veins / edema)\n$\\checkmark$ enhancement pattern (usually later than for myometrium): $65 \\%$ hypointense, $23 \\%$ isointense, $12 \\%$ hyperintense to myometrium\n@ Nondegenerated leiomyoma\n$\\checkmark$ well-circumscribed mass of:\n$\\checkmark$ homogeneously low SI on T2WI compared with myometrium (for leiomyoma with variable amounts of collagen)\n$\\checkmark$ low to intermediate SI on T1WI = isointense to surrounding uterus\n$\\checkmark$ slightly higher SI + contrast enhancement on T2WI (for cellular leiomyoma with little / no collagen)\n@ Degenerated leiomyoma\n- localized pain + tenderness + fever + leukocytosis lasting for a few days\n- enlargement of the uterus during pregnancy may interfere with blood supply to fibroids\n$\\checkmark$ low SI on T2WI $\\leftarrow$ hyaline / calcific degeneration)\n$\\checkmark$ low SI on T2WI + variable SI on T1WI $\\leftarrow$ hyaline / coagulative necrosis\n$\\checkmark$ high SI on T2WI $\\leftarrow$ cystic degeneration without enhancement of cystic areas\n$\\checkmark$ very high SI on T2WI $\\leftarrow$ myxoid degeneration with minimal enhancement\n$\\checkmark$ variable SI on T2WI $\\leftarrow$ red degeneration\n$\\checkmark$ peripheral / diffuse high SI on T1WI $\\leftarrow$ proteinaceous content of blood\nHysterosalpingography ( $9 \\%$ sensitive, $97 \\%$ specific, $76 \\%$ accurate)\n$C x$ :\n(1) Infertility in $35 \\%$\n(a) narrowing of isthmic portion of tube",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 551,
            "markdown": "(b) impingement on endometrium interfering with implantation; infertility rates highest for submucosal leiomyomas\n(2) Complications during pregnancy\n$\\diamond$ Significantly increased for myomas $>6 \\mathrm{~cm}$ in size / multiple in number / myomas $>200$ $\\mathrm{cm}^{3}$ and when fibroid is retroplacental\n(a) increased frequency of spontaneous abortions\n(b) increased frequency of ectopic pregnancies\n(c) increased frequency of IUGR\n(d) preterm labor in $7 \\%+$ premature rupture of membranes\n(e) placental abruption\n(f) uterine dyskinesia, uterine inertia during labor\n(g) dystocia, obstruction of birth canal during vaginal delivery (if near internal os)\n(h) abnormal presentation\n(i) postpartum hemorrhage\n(j) retained products of conception\n(3) Hydroureteronephrosis\n(4) Leg edema $\\leftarrow$ compression of pelvic vessels\n(5) Sarcomatous transformation (in $<0.1 \\%$ )\n$R x$ : (1) Hysterectomy for pain, menorrhagia, visceral compression (after childbearing completed)\n(2) Myomectomy for $2^{\\text {nd }}$ trimester fetal loss / anemia due to hypermenorrhea / pelvic pain\n$\\diamond$ Submucosal leiomyomas may be treated with hysteroscopic myomectomy\n(3) Uterine artery embolization for symptomatic fibroids\n\nDDx of necrotic leiomyoma:\n(1) Ovarian mass: ovarian cyst, hemorrhagic cyst, endometrioma, cystic dermoid, cystadenoma, malignancy\n(2) Ectopic interstitial pregnancy\n(3) Intrauterine gestational sac\n(4) Intrauterine fluid collection\n(5) Hydatidiform mole\n(6) Myometrial contraction (lasting for 15-30 minutes)\n(7) Cervical tumor\n(8) Hematoma of broad ligament\n\nDDx of pedunculated subserosal leiomyoma:\n(1) Ovary: use transvaginal US / MR to identify follicles!\n\nDDx of leiomyoma by MR:\n(1) Adenomyosis\n(2) Solid adnexal mass: Brenner tumor, fibroma\n(3) Focal myometrial contraction (transient)\n(4) Uterine leiomyosarcoma\n\n# Uterine Lipoleiomyoma (0.8\\%) \n\n= uncommon benign uterine neoplasm with substantial amount of fat due to fatty",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 552,
            "markdown": "metamorphosis\nCause: fatty metamorphosis of smooth muscle cells\nHisto: smooth muscle + fat + connective tissue\nAssociated with: leiomyomas\nLocation: corpus; predominantly intramurally, endophytic or exophytic\nUS:\n$\\sqrt{ }$ well-defined hyperechoic mass surrounded by hypoechoic ring of myometrium\nCT:\n$\\sqrt{ }$ predominantly fatty mass + areas of nonfat soft-tissue density tissue arising from uterus MR:\n$\\checkmark$ hyperintense fat on T1WI + T2WI with chemical shift artifact\n\n# Benign Metastasizing Leiomyoma \n\n$=$ smooth muscle tumors in lung, lymph nodes, abdomen\nPrevalence: $<60$ cases\nClassification:\n(1) Benign metastasizing leiomyoma\n\nOrigin: uterus in mature women; progression with estrogen + regression with progesterone\n\n- benign uterine leiomyoma removed many years earlier\n$R x$ : hysterectomy, bilateral oophorectomy, long-term hormone therapy; good prognosis\n(2) Metastatic leiomyoma\n\nOrigin: extrauterine primary in men + children (? slow-growing sarcoma)\n$R x$ : surgical resection with mixed success\n(3) Multiple fibroleiomyomatous hamartomas\n\nOrigin: lung; totally benign behavior\nSpread: lymph nodes outside of pelvis, peritoneal surface, venous channels, lung, heart\n\n- asymptomatic in most cases, fever, mild nonproductive cough\n\nHisto: well-differentiated benign-appearing smooth muscle cells\n$\\checkmark$ multiple pulmonary nodules\n$\\checkmark$ miliary pattern\n$\\checkmark$ pedunculated pulmonary leiomyoma with cyst formation\n$\\checkmark$ giant cyst\n\n## UTERINE LEIOMYOSARCOMA\n\nPrevalence: $0.67 \\div 100,000 ; 25 \\%$ of all uterine sarcomas\nCause: (a) de novo growth independent of leiomyoma!\n(b) sarcomatous transformation of preexisting leiomyoma (in $<1 \\%$ of leiomyomas)\n\nHisto: infiltrative margins, nuclear atypia, increased mitotic figures\n\n- rapidly enlarging uterus $(<3 \\%)$\n$\\checkmark$ mass with irregular margin\n$\\checkmark$ rapid change in size + appearance\n$\\checkmark$ extensive degeneration\n$\\checkmark$ loss of well-defined outer capsule",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 553,
            "markdown": "$D x:$ often first established by pathologist\n\n# UTERINE RUPTURE IN PREGNANCY \n\n$=$ disruption of all layers surrounding the fetus (membranes, decidua, myometrium, serosa)\nPrevalence: $3-5 \\%$ for classic cesarean sections; $1-2 \\%$ for lower segment operations; $1 \\%$ of pregnant trauma patients\nClassification:\n\n1. Spontaneous rupture during labor\n2. Traumatic rupture during delivery\n3. Rupture $\\leftarrow$ myometrial scars / disease\n4. Rupture during blunt trauma\n\nPredisposed: previous uterine surgery, previously excessively long / difficult labor\n\n- pain, shock, absent fetal heart tones\n\nLocation:\n(a) corpus with rupture before onset of labor\n(b) lower uterine segment during labor, $\\mathrm{L}>\\mathrm{R}$\n$\\sqrt{ }$ full-thickness defect of uterine wall\n$\\sqrt{ }$ extrusion of fetus into the abdomen\n$\\sqrt{ }$ hemoperitoneum\n$C x$ : hypofibrinogenemia (triggered by excessive blood loss, trauma, amniotic fluid embolism)\nMortality: $2-20 \\%$ maternal mortality; $10-25 \\%$ fetal mortality\n$D D x$ : Uterine dehiscence $=$ rupture of only myometrium\n\n## UTERINE TRAUMA DURING PREGNANCY\n\nPrevalence: $6-7 \\%$\nCause: motor vehicle accident (70\\%), physical abuse (10\\%)\nDuring pregnancy at increased risk for:\n) serious abdominal injury $\\leftarrow$ enlarged spleen, displacement of spleen and liver closer to rib cage\n> complex multiple intestinal injuries $\\leftarrow$ bowel displacement superiorly\n> bladder injury $\\leftarrow$ compression of bladder\n> collecting-system injury $\\leftarrow$ hydronephrosis of pregnancy\n> pelvic hemorrhage $\\leftarrow$ engorged ovarian + pelvic veins\n\n1. Placental abruption\ncomplete $(6-66 \\%)$ / incomplete $(30-80 \\%)$\n\n- more common $>16$ weeks of gestation\n\nPrognosis: $67-75 \\%$ rate of fetal mortality\n2. Uterine rupture $(0.6 \\%)$\n\nPrognosis: nearly $100 \\%$ fetal mortality; up to $10 \\%$ maternal mortality\n3. Premature rupture of membranes\n4. Fetal injury: eg, cerebral injury\n5. Fetal death\n\nThe major cause of fetal death is maternal death!\nUS: evaluate fetal motion, breathing, heart rate, placenta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 554,
            "markdown": "Essentially all diagnostic ionizing imaging examinations for evaluation of traumatic injury are well below 50 mGy and NOT associated with an increased risk of fetal anomalies or fetal loss throughout pregnancy!\n\n# VAGINAL AGENESIS \n\n$\\diamond 2^{\\text {nd }}$ most common cause of primary amenorrhea\nPrevalence: $1 \\div 4,000-5,000$ women\n\n- cyclic abdominal pain\n\nMay be associated with:\n(1) Uterine + partial tubal agenesis ( $90 \\%$ )\n(2) Unilateral renal agenesis / ectopia (34\\%)\n(3) Skeletal malformations (12\\%)\n(4) McKusick-Kaufman syndrome (hydrometrocolpos + polydactyly + heart defects)\n(5) Ellis-van Creveld syndrome\n\n## VASA PREVIA\n\n= presence of abnormal fetal vessels within amniotic membranes that are unsupported by Wharton jelly / placental tissue and cross internal cervical os / lower uterine segment in advance of fetal parts\nPrevalence: $0.04 \\%$\nAt risk: $2^{\\text {nd }}$-trimester low-lying placenta / placenta previa, velamentous cord insertion, succenturiate placenta, in vitro fertilization, and multiple gestation\nCause:\n(a) cord vessels of velamentous (membranous) cord insertion from low-lying placenta connecting to main body of placenta\n(b) vessels connecting portions of a bilobed placenta\n(c) vessels connecting succenturiate lobe to main portion of placenta\n$\\checkmark$ Doppler ultrasound demonstrates flow within aberrant vessels overlying the internal os\n$C x$ : (1) tear of fetal vessels after rupture of membranes / due to direct injury during labor $\\rightarrow$ fetal exsanguination\n(2) Cord compression by presenting part during labor\n(3) Cord prolapse\n\nRx: cesarean delivery\nPrognosis: $50-100 \\%$ fetal mortality; fetal survival rate improves from $44 \\%$ to $97 \\%$ if recognized\n$D D x$ : prominent maternal sinus vessels at edge of marginal previa (= marginal sinus previa)\n\n## VELAMENTOUS CORD INSERTION\n\n$=$ umbilical cord insertion into membranes outside placental margin $=$ attachment of cord to chorion laeve\nPrevalence: $0.09-1.8 \\%$, more frequent in multiple gestations\n\n- low Apgar scores\n- abnormal intrapartum fetal heart rate patterns",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 555,
            "markdown": "$\\sqrt{ }$ segments of umbilical cord course between amnion + chorion unprotected by Wharton jelly / placenta\n$\\sqrt{ }$ splayed umbilical vessels at periphery of placenta\nAssociated with:\n(a) multiple gestation, uterine anomaly, IUD\n(b) congenital anomalies (in 5.9-8.5\\%):\nasymmetric head shape, spina bifida, esophageal atresia, obstructive uropathy, VSD, cleft palate\nCx: (1) IUGR\n(2) Preterm labor\n(3) Placental abruption\n\nRisk: (1) Cord compression\n(2) Rupture of cord with traction during delivery\n(3) Vasa previa\n(4) Neonatal demise",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 556,
            "markdown": "# GENERAL RADIOLOGY \n\n## NUCLEAR MEDICINE\n\n| Table of Dose, Energy, Half-Life, Radiation Dose |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Organ | Pharmaceutical | Dose | $k e V$ | $T_{\\text {in }}$ phys | $T_{\\text {in }}$ bio |\n| Brain | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-$ pertechnetate | $\\begin{aligned} & 10-30 \\\\ & \\mathrm{mCi} \\end{aligned}$ | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA | 10 mCi | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ -glucoheptonate | 10 mCi | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-Ceretec ${ }^{\\circledR}$ | 20 mCi | 140 | 6 hr |  |\n|  | ${ }^{123}$ I Spectamine ${ }^{\\circledR}$ | $\\begin{gathered} 3-6 \\\\ \\mathrm{mCi} \\end{gathered}$ | 159 | 13.6 hr |  |\n| CSF | ${ }^{111}$ In-DTPA | $500 \\mu \\mathrm{Ci}$ | 173,247 | 2.8 d |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA | 1 mCi | 140 | 6 hr |  |\n| Cardiac | ${ }^{201} \\mathrm{Tl}$ | $1-2 \\mathrm{mCi}$ | $\\begin{gathered} 72, \\\\ 135,167 \\end{gathered}$ | 73 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ pyrophosphate | 15 mCi | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ -pertechnetate | $\\begin{gathered} 15-25 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled RBCs | $\\begin{gathered} 10-20 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi | 25 mCi | 140 | 6 hr |  |\n| Liver | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-teboroxime | 30 mCi | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid | $3-5 \\mathrm{mCi}$ | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DISIDA | $4-5 \\mathrm{mCi}$ | 140 | 6 hr |  |\n| Lung | ${ }^{127} \\mathrm{Xe}$ | $\\begin{gathered} 5-10 \\\\ \\mathrm{mCi} \\end{gathered}$ | $\\begin{gathered} 172, \\\\ 203, \\\\ 375 \\end{gathered}$ | 36.4 d | 13 sec |\n|  | ${ }^{153} \\mathrm{Xe}$ | $\\begin{gathered} 10-20 \\\\ \\mathrm{mCi} \\end{gathered}$ | 81,161 | 5.3 d | 20 sec |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 557,
            "markdown": "|  | ${ }^{81 \\mathrm{~m}} \\mathrm{Kr}$ | 20 mCi | $\\begin{gathered} 176 \\\\ 188,190 \\end{gathered}$ | 13 sec |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Kidney | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAA}$ aerosol | 3 mCi | 140 | 6 hr | 8 hr |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA | $\\begin{gathered} 15-20 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n|  | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA | $2-5 \\mathrm{mCi}$ | 140 | 6 hr |  |\n|  | 99 mTc -glucoheptonate | $\\begin{gathered} 15-20 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n|  | 99 mTc -mercaptoacetyltriglycine | 10 mCi | 140 | 6 hr |  |\n|  | 131I-Hippuran | $250 \\mu \\mathrm{Ci}$ | $365^{*}$ | 8 d | 18 min |\n| Thyroid | 123I-Hippuran | 1 mCi | 159 | 13.2 hr |  |\n|  | 99 mTc pertechnetate | $\\begin{gathered} 5-10 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n|  | 123I | $\\begin{gathered} 50-200 \\\\ \\mu \\mathrm{Ci} \\end{gathered}$ | 159 | 13.2 hr |  |\n|  | 125I | $\\begin{gathered} 30-100 \\\\ \\mu \\mathrm{Ci} \\end{gathered}$ | 27,35 | 60 d |  |\n|  | 131I | $\\begin{gathered} 30-100 \\\\ \\mu \\mathrm{Ci} \\end{gathered}$ | $365^{*}$ | 8 d |  |\n| Testes | 99 mTc pertechnetate | 10 mCi | 140 | 6 hr |  |\n| Gastric mucosa | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-$ pertechnetate | $\\begin{gathered} 50 \\mu \\mathrm{Ci} \\\\ / \\mathrm{kg} \\end{gathered}$ | 140 | 6 hr |  |\n| Gallium | ${ }^{67} \\mathrm{Ga}$-citrate | $3-5 \\mathrm{mCi}$ | $\\begin{gathered} 93 \\\\ 184 \\\\ 296 \\\\ 388 \\end{gathered}$ | 3.3 d |  |\n| WBC | ${ }^{111}$ In-oxine | $550 \\mu \\mathrm{Ci}$ | 173, 247 | 2.8 d |  |\n|  | $9^{\\text {9m }}$ Tc-Ceretec | $\\begin{gathered} 10-20 \\\\ \\mathrm{mCi} \\end{gathered}$ | 140 | 6 hr |  |\n| mnemonic: | * = as many days as in a year |  |  |  |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 558,
            "markdown": "| Radiation Dose to Critical Organs |  |  |\n| :--: | :--: | :--: |\n| Radiopharmaceutical | Critical Organ | $\\mathrm{rad} / \\mathrm{mCi}$ |\n| ${ }^{131} \\mathrm{I}$ | Thyroid | 1,000 |\n| ${ }^{125} \\mathrm{I}$ | Thyroid | 900 |\n| ${ }^{111}$ In-oxine WBC | Spleen | 26 |\n| ${ }^{125} \\mathrm{I}$ | Thyroid | 15 |\n| ${ }^{111}$ In-DTPA | Spinal cord | 12 |\n| ${ }^{203} \\mathrm{Tl}$ | Kidney | 1.5 |\n| ${ }^{67}$ Ga-citrate | Colon | 1.0 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc-MAA}$ | Lung | 0.4 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-albumin microspheres | Lung | 0.4 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DISIDA | Large bowel | 0.39 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid | Liver | 0.33 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate | Intestine | 0.3 |\n|  | Thyroid | 0.15 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-glucoheptonate | Kidney | 0.2 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate (+ perchlorate) | Colon | 0.2 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pyrophosphate | Bladder | 0.13 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-phosphate | Bladder | 0.13 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ DTPA | Bladder | 0.12 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-tagged RBCs | Spleen | 0.11 |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-albumin | Blood | 0.015 |\n| ${ }^{133} \\mathrm{Xe}$ | Trachea |  |\n\n# Pediatric Dose \n\nActual doses for pediatric patients may vary in different institutions based on empirical data. As rough guidelines use:\n\n1. Clark's rule (body weight):\n\nDose $_{\\text {Ped }}=$ Body weight [in lbs] / $150 x$ Dose $_{\\text {Adult }}$\n2. Young's rule (child up to age 12):\n\nDose $_{\\text {Ped }}=$ Age of child / (Age of child + 12) $x$ Dose $_{\\text {Adult }}$\n3. Surface area:\n\nDose $_{\\text {Ped }}=$ (weight [in kg] $0.7 / 11$ ) $/ 1.73 \\times$ Dose $_{\\text {Adult }}$\n\n## Lactating Patients\n\n1. Nursing mothers must be counseled about the need to interrupt / discontinue breast feeding\n2. Pumped milk may be refrigerated and used after the radioactivity has decayed\n\nComplete cessation of breast feeding:\n${ }^{67} \\mathrm{Ga}$-citrate\n${ }^{131}$ I-sodium iodide therapy\nInterruption of breast feeding for 12 hours:\n${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-macroaggregated albumin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 559,
            "markdown": "99mTc-labeled RBCs (in vivo labeling)\n${ }^{111}$ In-labeled WBCs\nInterruption of breast feeding for 24 hours:\n99 mTc - pertechnetate\n123 I -metaiodobenzylguanidine\n99 mTc -labeled WBCs\nInterruption of breast feeding for 168 hours:\n210 Tl -chloride\n\n# QUALITY CONTROL OF RADIOPHARMACEUTICALS \n\n$\\diamond$ Quality control logs should be kept for 3 years!\n\n## Production of Radionuclides\n\n## Reactor-produced Radionuclides\n\n$\\diamond$ Not carrier free $=$ contamination with other forms\nÂ» Thermal neutrons captured by stable nuclides\nÂ» Used to produce standard generators\n(1) ${ }^{99} \\mathrm{Mo} /{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ generator\n(parent) (daughter)\n${ }^{99} \\mathrm{Mo} \\rightarrow{ }^{99 \\mathrm{~m}} \\mathrm{Tc} \\rightarrow{ }^{99} \\mathrm{Tc} \\rightarrow{ }^{99} \\mathrm{Ru}$\n67 hours 6 hours $2.1 \\times 105$ years stable\nglass column filled with aluminum $\\left(\\mathrm{Al}_{2} \\mathrm{O}_{3}\\right)$; parent and daughter isotopes are firmly absorbed onto aluminum at top of column; daughter isotope can be separated / eluted by passing isotonic oxidant-free NaCl through the column\n(2) ${ }^{81 \\mathrm{~m}} \\mathrm{Kr}$ generator\n(parent) (daughter)\n${ }^{81} \\mathrm{Rb} \\rightarrow{ }^{81 \\mathrm{~m}} \\mathrm{Kr} \\rightarrow{ }^{81} \\mathrm{Kr}$\n4.7 hours 13 seconds stable\n\n## Accelerator / Cyclotron-produced Radionuclides\n\n$\\diamond$ Generally carrier-free product\n\n- collision of charged particles (protons, deuterons, helium, alpha particles) with target nuclide\n- used to produce ${ }^{67} \\mathrm{Ga},{ }^{123} \\mathrm{I},{ }^{201} \\mathrm{Tl}$\n\n\n## Fission-produced Radionuclides\n\n$\\diamond$ Carrier-free product\n\n- splitting of a heavy nucleus into smaller nuclei\n- used to produce ${ }^{131} \\mathrm{I},{ }^{99} \\mathrm{Mo}$\n\n\n## Radionuclide Impurity\n\n$=$ amount $(\\mu \\mathrm{Ci})$ of radiocontaminant per amount $(\\mu \\mathrm{Ci} / \\mathrm{mCi})$ of desired radionuclide\n\n## ${ }^{99}$ Mo Breakthrough Test\n\nTest frequency: with every elution",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 560,
            "markdown": "(a) NRC allowable contamination of $1 \\div 1,000$\n$=1 \\mu \\mathrm{Ci}{ }^{99} \\mathrm{Mo}$ per 1 mCi of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$\n(b) USP limit of $0.15 \\mu \\mathrm{Ci}{ }^{99} \\mathrm{Mo}$ per $1 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$\n(c) $<5 \\mu \\mathrm{Ci}{ }^{99} \\mathrm{Mo}$ per administered dose (NRC dropped this requirement, but nonagreement states may still require this)\n(d) chemical evaluation: ${ }^{99}$ Mo contaminated eluate forms colored complexes with phenylhydrazine (for reactor product generators)\n\n- measured in dose calibrator with lead shielding of vial (filters 140 keV but permits 740 and 780 keV of ${ }^{99}$ Mo to pass through)\nEffect of impurity: increased radiation dose, poor image quality\n\n\n# Radiochemical Impurity \n\nTest frequency: with every elution\nPrecise registration of different compounds of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$, eg,\n> hydrolyzed reduced technetium (HR Tc) a radiocolloid $\\left[\\mathrm{TcO}(\\mathrm{OH}) 2 \\cdot \\mathrm{H}_{2} \\mathrm{O}\\right]$\nLimit: $<2 \\%$ (presently no legal limit)\n> free pertechnetate $\\left[\\mathrm{TcO}^{4}\\right]^{-1}$\n\n- can be monitored by paper chromatography\n\nEffect of impurity with hydrolyzed reduced Tc:\nRES uptake, poor image quality, increased radiation dose\n\n## Chemical Impurity\n\nChemicals from elution process are restricted in their amount (NRC limit):\n${ }^{99 \\mathrm{~m}} \\mathrm{Tc}: \\quad<10 \\mu \\mathrm{~g} \\mathrm{Al}^{3+}$ per 1 mL eluate if radionuclide from fission generator; $<20 \\mu \\mathrm{~g} \\mathrm{Al}^{3+}$ per 1 mL eluate if radionuclide from thermal activation generator\n\n## Aluminum Ion Breakthrough Test:\n\nTest frequency: with every elution\n\n- one drop of generator eluate placed on one end of special test paper containing aluminum reagent\n- equal-sized drop of a standard solution of $\\mathrm{Al}^{3+}(10 \\mathrm{ppm})$ is placed on other end of strip\n- if color at center of drop eluate is lighter than that of standard solution, the eluate has passed the colorimetric test\nEffect of impurity: degradation of image quality\n\n\n## Radiopharmaceutical Sterility and Pyrogenicity\n\n## USP XX Test\n\nMonitor rectal temperature of 3 suitable rabbits after injection of material via ear vein Acceptable results: no rabbit shows a rise of $>0.6^{\\circ} \\mathrm{C}$; total rise for all three rabbits $<$ $1.4^{\\circ} \\mathrm{C}$\n\n## Limulus Amoebocyte Lysate Test (LAL)\n\n$\\diamond$ Highly specific for Gram-negative bacterial endotoxins, sensitivity 10 x greater than USP XX test\nAmoebocyte $=$ primitive blood cell of horseshoe crab (Limulus polyphebus); lysate",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 561,
            "markdown": "| Positive result: | formed by hydrolysis of amoebocyte in the presence of minute amounts of endotoxin LAL forms an opaque gel; response to other pyrogens (particulate contaminations, chemicals) doubtful |\n| :--: | :--: |\n\n# QUALITY CONTROL OF CALIBRATORS \n\n| Quality Control for Dose Calibrators |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Test | When | Limit | Test Isotopes |\n| Constancy | daily,* | $< \\pm 5 \\%$ | ${ }^{137} \\mathrm{Cs}$ |\n| Channel check | daily,* | $< \\pm 5 \\%$ | ${ }^{137} \\mathrm{Cs}$ |\n| Linearity | quarterly,* | $< \\pm 5 \\%$ | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ |\n| Accuracy | annually,* | $< \\pm 5 \\%$ | ${ }^{137} \\mathrm{Cs},{ }^{57} \\mathrm{Co},{ }^{133} \\mathrm{Ba}$ |\n| Geometry | * | $< \\pm 1.6 \\%$ | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ |\n| * = after install / repair |  |  |  |\n\n## Dose Calibrator\n\n$=$ gas ionization chamber $\\rightarrow$ transforms photon flux into current with digital readout\nDisadvantages:\n(1) open top geometry\n(2) nonlinearity between photon energy and measured current (corrected with a calibration factor)\n\n## Constancy = Precision\n\n$=$ reproducibility over time\nTest frequency: daily\nMethod: measurement of a long-lived source, usually 137Cs standard\nEvaluation: measurement must fall within $\\pm 5 \\%$ of the calculated activity\n\n## Linearity\n\n$=$ accurate measurement over large range of activity levels\nTest frequency: 4 x per year\nMethod: 1 mCi source activity is measured every 4 hours for $10 /$ more measurements (down to $10-100 \\mu \\mathrm{Ci}$ )\nEvaluation: measurements must fall within $\\pm 5 \\%$ of the calculated physical decay curve\n\n## Accuracy\n\nTest frequency: annually\nMethod: measurements of three different activity standards whose amount is certified by the National Bureau of Standards (NBS); standard values are decayed mathematically to calibrator date\n${ }^{99 \\mathrm{~m}} \\mathrm{Tc}: 140 \\mathrm{keV}$, half-life of 6.01 hr\n${ }^{57} \\mathrm{Co}: 123 \\mathrm{keV}$, half-life of 270 d\n${ }^{133} \\mathrm{Ba}: 356 \\mathrm{keV}$, half-life of 10.5 yr",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 562,
            "markdown": "${ }^{137} \\mathrm{Cs}: 662 \\mathrm{keV}$, half-life of 30.1 yr\nEvaluation: measurements must fall within expected range\n\n# Geometry \n\n= to ensure that measurement is not dependent upon location of tracer within ionization chamber (usually done by manufacturer)\nTest frequency: at installation / after factory repair / recalibration\nMethod: 0.5 mL of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ (activity 25 mCi ) is measured in a $3-\\mathrm{mL}$ syringe; syringe contents are then diluted with water to $1.0 \\mathrm{~mL}, 1.5 \\mathrm{~mL}$, and 2.0 mL and each level remeasured; test is repeated with a $10-\\mathrm{mL}$ glass vial\n\n## QUALITY CONTROL FOR SCINTILLATION CAMERA\n\n| Quality Control for Gamma Cameras |  |  |\n| :-- | :--: | :--: |\n| Test | When | Test Result |\n| Peaking | daily | ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ and ${ }^{57} \\mathrm{Co}$ |\n| Energy resolution | daily | $<14 \\%$ at FWHM |\n| Extrinsic field uniformity | daily | $<5 \\%$ RMS variation |\n| Bar phantom | weekly | visual assessment |\n| Field uniformity | monthly | visual assessment |\n| Center of rotation | monthly | visual assessment |\n| Jaczak phantom | quarterly | visual assessment |\n\n## Peaking\n\n$=$ ensures that window of pulse height selector is correctly set to desired photopeak\n(a) for ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ source: between 137 and 143 keV\n(b) for ${ }^{57} \\mathrm{Co}$ source: between 117 and 123 keV\n\nFrequency of quality control: daily\n\n## Field Uniformity\n\n$=$ ability of camera to reproduce a uniform radioactive distribution $=$ variability of observed count density with a homogeneous flux\n(a) Integral uniformity $\\quad=$ maximum deviation\n(b) Differential uniformity $=$ maximum rate of change over a specified distance ( 5 pixels)\n\nCauses for nonuniformity:\n(1) High kilovoltage drift of photomultiplier tubes\n(2) Physical damage to collimator\n(3) Improper photopeak setting\n(4) Contamination\n\nFrequency of quality control: daily\nEvaluation:\n(1) Compare uncorrected with corrected images. Note acquisition time!\n(2) Store correction flood\n(3) Rerecord image with corrected flood + check for uniformity",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 563,
            "markdown": "(4) Variation in image should be $<5 \\%$ RMS\n\n# Intrinsic Field Uniformity Test \n\n(without collimator)\n\n1. Remove collimator + replace with lead ring (to eliminate edge packing)\n2. Place a point source at a distance of at least 5 crystal diameters from detector (4-5 feet for small, $7-9$ feet for large crystals)\n3. Point source contains $200-400 \\mu \\mathrm{Ci}$ of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ for minimal personnel exposure (avoid contamination of crystal)\n4. Set count rate below limit of instrument ( $<30,000$ counts)\n5. Adjust the pulse height selector to normal window settings by centering at 140 keV with a window of $15 \\%$ (for ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ studies only)\n6. Use the same photographic device\n7. Acquire 1.25 million counts for a 10 \" field of view, 2.5 million counts for a 15 \" field of view\n8. Register counts, time, CRT intensity, analyzer settings, initials of controller\n\n## Extrinsic Field Uniformity Test\n\n(with collimator on)\n\n1. Collimator is kept in place\n$\\diamond$ Only 1 of 2,000 gamma rays that reach the collimator are transmitted to the sodium iodide crystal!\n2. Sheet source / flood of $2-10 \\mathrm{mCi}$ activity is placed on collimator\n(a) fillable floods: mix thoroughly, avoid air bubbles, check for flat surface\n(b) nonfillable: commercially available ${ }^{57} \\mathrm{Co}$ source\n3. Other steps as described above\n\n## Spatial Resolution / Linearity\n\n## A. SPATIAL RESOLUTION\n\n$=$ parameter of scintillation camera that characterizes its ability to accurately determine the original location of a gamma ray on an $\\mathrm{X}, \\mathrm{Y}$ plane; measured in both X and Y directions; expressed as full width at half maximum (FWHM) of the line spread function in mm\n(a) intrinsic spatial resolution\n(b) system spatial resolution\nB. INTRINSIC SPATIAL LINEARITY\n$=$ parameter of a scintillation camera that characterizes the amount of positional distortion caused by the camera with respect to incident gamma events entering the detector\n(a) differential linearity = standard deviation of line spread function peak separation (in mm )\n(b) absolute linearity = maximum amount of spatial displacement (in mm )\n\nFrequency of quality control: every week\nMethod:\n\n1. Mask detector to collimated field of view (lead ring)\n2. Lead phantom is attached to front of crystal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 564,
            "markdown": "(a) Four-quadrant bar pattern ( 3 pictures each after $90^{\\circ}$ rotation to test entire crystal)\n(b) Parallel-line equal-spacing (PLES) bar pattern [2 pictures]\n$\\diamond$ Change bar direction angles weekly\n(c) Smith orthogonal hole test pattern (OHP) [one picture only]\n(d) Hine-Duley phantom [2 pictures]\n3. Set symmetric analyzer window to width normally used\n4. Place a point source $(1-3 \\mathrm{mCi})$ at a fixed distance of at least 5 crystal diameters from detector on central axis (remove all sources from immediate area so that background count rate is low)\n5. Acquire 1.25 million counts for a small field, 2.5 million counts for a large field on the same media used for clinical studies\n6. Record counts, time, CRT intensity, analyzer setting, initials of controller\n(All new cameras are equipped with a spatial distortion correction circuit)\nEvaluation:\nvisual assessment of (1) Spatial resolution over entire field (2) Linearity\n\n# Intrinsic Energy Resolution \n\n$=$ ability to distinguish between primary gamma events and scattered events; performed without collimator; expressed as ratio of photopeak FWHM to photopeak energy (in \\%)\nLimit: $11 \\%$ for SPECT, $14 \\%$ for some planar cameras\nFrequency of quality control: daily (may be weekly for some cameras)\n\n## CRT-output / Photographic Device\n\n(1) Check for dirt, scratches, burnt spots on CRT face plates\n(2) Adjust gray scale + contrast settings to suit film\n\n## SPECT QUALITY CONTROL\n\n$=$ SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY\n$=$ gamma cameras rotating about a pallet supporting the patient obtain $60-120$ views over $180^{\\circ}$ / $360^{\\circ}$ rotation with typically a field of view of $40-50 \\mathrm{~cm}$ across the patient and $30-40 \\mathrm{~cm}$ in axial direction\nSpatial resolution: $\\sim 8 \\mathrm{~mm}$ for high-count study\n\n## SPECT Uniformity\n\n1. $64 \\times 64$ word matrix $=30$ million count flood with collimator, orientation and magnification same as patient study\n2. ${ }^{57} \\mathrm{Co}$ sheet source with $<1 \\%$ uniformity variance is necessary\n3. $128 \\times 128$ word matrix $=120$ million count flood with collimator, orientation, magnification same as patient study\nFrequency of quality control: weekly\n\n## Center of Rotation (COR)\n\n1. ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-filled line source $(5-8 \\mathrm{mCi})$ positioned $3-5 \\mathrm{~cm}$ off the center of rotation while keeping scanning palette out of field of view\n2. Direction of rotation to be the same as in patient study",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 565,
            "markdown": "3. Number of steps ( 32,64 , or 128 ) to be the same as in patient study\n4. Time per step such that at least 100 K counts are acquired\n5. COR must be done with same collimator, orientation, and magnification as patient study\n\nFrequency of quality control: weekly\n\n# Jaczak Phantom SPECT Study \n\ntests multiple camera systems with a final image\n\n- phantom contains multiple objects of various sizes (hot and cold rods and cold balls)\n- final reconstructed image is visually assessed\n\n\n## SPECT Sources of Artifacts\n\n1. Scanning palette in field of view\n2. Collimator shifting + rotation on camera face\n3. Noncircular orbit of camera head\n4. PMT failure\n5. PMT uncoupling\n6. Cracked crystal\n7. Improper peaking of camera\n\n## SOURCES OF ARTIFACTS\n\nA. Attenuator between source and detector\n\nMaterials: cable, lead marker, solder dropped into collimator during repair, belt buckle / watch / key on patient, defective collimator\n(a) at time of correction flood procedure:\n$\\checkmark$ hot spot\n(b) after correction flood procedure:\n$\\checkmark$ cold spot\nB. Cracked crystal\n$\\checkmark$ white band with hot edges\nC. PMT failure + loss of optical coupling between PMT + crystal\n$\\checkmark$ cold defect\nD. Problems during film exposure + processing\n\n1. Double exposed film\n2. Light leak in multiformat camera\n3. Water lines from film processing\n4. Frozen shutter:\n$\\checkmark$ part of film cut off\n5. Variations in film processing\nE. Improper window setting\n6. Photopeak window set too high:\n$\\checkmark$ hot tubes\n7. Photopeak window set too low:\n$\\checkmark$ cold tubes\nF. Administration of wrong isotope\n$\\checkmark$ atypically imaged organs",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 566,
            "markdown": "G. Excessive amounts of free ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate\n$\\sqrt{ }$ too much uptake in choroid plexus, salivary glands, thyroid, stomach\nH. Faulty Injection Technique\neg, inadvertently labeled blood clot in syringe leading to iatrogenic pulmonary emboli\nI. Contamination with radiotracer\non patient's skin, stretcher, collimator, crystal\nJ. CRT problems\n\n1. Burnt spot on CRT phosphor\n2. Dirty / scratched CRT face plates\n\n# POSITRON EMISSION TOMOGRAPHY \n\n$=\\mathrm{PET}=$ technique that permits noninvasive in vivo examination of metabolism, blood flow, electrical activity, neurochemistry\nConcept: measurement of distribution of a biocompound as a function of time after radiolabeling and injection into patient\nLabeling: PET compounds are radiolabeled with positron-emitting radionuclides\nPhysics:\n${ }^{18} \\mathrm{~F}=$ positron-emitting $(\\beta+)$ radionuclide $\\rightarrow$ positron matter-antimatter annihilation reaction with an electron $(\\beta-) \\rightarrow$ formation of annihilation photons ( 511 keV each) emitted in exactly opposite directions\nDetection of positron annihilation photons:\nsimultaneous arrival of dual photons at detectors (bismuth germanate-68) on opposite sides of the patient (= electronic collimation through coincidence circuitry)\nN.B.: lead collimators not necessary ( $=$ advantages in resolution + sensitivity over SPECT); spatial reconstruction similar to transmission CT\n\n## Radionuclide Production in PET\n\nin nuclide generator / particle accelerator (positive / negative ion cyclotron; linear accelerator)\nExpected amount of radionuclide: $500-2,000 \\mathrm{mCi}$\nGenerator characteristics:\nbeam energy (radionuclide production rate increases monotonically with beam energy), beam current (production rate directly proportional to beam current), accelerated particle, shielding requirement, size, cost\n\n## Radiopharmaceutical Production in PET\n\n(1) Initialize accelerator, setup\n(2) Irradiation\n(3) Synthesis\n(4) Sterility test, compounding\n\n## Sensitivity of PET\n\n$=$ fraction of radioactive decays within the patient that are detected by the scanner as true events (measured in counts per sec per microcurie per milliliter)\n$\\diamond 30-100$ times more sensitive than SPECT $\\leftarrow$ electronic collimation as opposed to lead",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 567,
            "markdown": "collimation!\n\n# Resolution of PET \n\n$=$ resolving power $=$ smallest side-by-side objects that can be distinguished as separate objects in images with an infinite number of counts (measured in mm ); determined by\n> distance a positron travels before annihilation occurs (usually $0.5-2 \\mathrm{~mm}$ depending on energy)\n> angle variation from $180^{\\circ}\\left( \\pm 5^{\\circ}=0.5 \\mathrm{~mm}\\right)$\n> physical size of detector $(1-3 \\mathrm{~mm})$\n$\\diamond$ Typical spatial resolution: $4-7 \\mathrm{~mm}$ (reconstructed spatial resolution $=5-6 \\mathrm{~mm}$ full width at half maximum in phantom measurements)\n$\\diamond$ In clinical practice spatial resolution is about 10 mm\nDetection dependent on:\n(1) Tumor size\n(2) FDG activity\n(3) Tumor-to-background ratio\n(4) Effect of motion\n$\\diamond$ A smaller than 1 cm lesion can be detected when conditions are favorable\n\n## Radioactivity Distribution in PET\n\nPixel values proportional to radioactivity per volume\nUnit: $\\quad \\mathrm{mg}$ of glucose per minute per 100 g tissue\nImaging time: $1-10 \\mathrm{~min}$\n\n| Common Radiopharmaceuticals in Positron Emission Tomography |  |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: | :--: |\n| Isotope |  | Use | Half-life (min) | Average Positron Energy (keV) | Typical Reaction | Yield at 10 MeV ( $\\mathrm{mCi} / \\mu \\mathrm{A}$ EOSB) |\n| Rubidium | ${ }^{85} \\mathrm{Rb}$ |  | 1.23 | 1,409 | $\\mathrm{Sr} / \\mathrm{Rb}$ generator | - |\n| Fluorine | ${ }^{18} \\mathrm{~F}$ | glucose metabolism | 110.00 | 242 | ${ }^{16} \\mathrm{O}(\\mathrm{p}, \\mathrm{n})^{18} \\mathrm{~F}$ | 120 |\n| Oxygen | ${ }^{15} \\mathrm{O}$ | $\\mathrm{O}_{2}, \\mathrm{H}_{2} \\mathrm{O}, \\mathrm{CO}_{2}, \\mathrm{CO}$ | 2.1 | 735 | ${ }^{15} \\mathrm{~N}(\\mathrm{p}, \\mathrm{n})^{15} \\mathrm{O}$ | 70 |\n| Nitrogen | ${ }^{13} \\mathrm{~N}$ | perfusion of $\\mathrm{NH}_{3}$ | 10.00 | 491 | ${ }^{13} \\mathrm{C}(\\mathrm{p}, \\mathrm{n})^{15} \\mathrm{~N}$ | 110 |\n| Carbon | ${ }^{13} \\mathrm{C}$ | carbon metabolism | 20.3 | 385 | ${ }^{14} \\mathrm{~N}(\\mathrm{p}, \\alpha)^{13} \\mathrm{C}$ | 85 |\n| $\\mathrm{p}=$ proton injected; $\\mathrm{n}=$ neutron ejected; $=$ alpha particle; EOSB = end of saturated bombardment (infinitely long irradiation at which time the numbers of radionuclides produced equals the number of radionuclides that are decaying) per microampere of beam current (= number of particles per sec emerging from accelerator and impinging on target material) |  |  |  |  |  |  |\n\n## Organ-specific Concentration\n\n(a) heart, brain: contain little glucose-6-phosphatase $\\rightarrow$ resulting in high concentrations of ${ }^{18} \\mathrm{~F}$-fluorodeoxyglucose\n> metabolic rate of glucose is proportional to phosphorylation rate of FDG\n(b) liver: abundance of glucose-6-phosphatase + low levels of hexokinase resulting in rapid clearing of FDG\n(c) urine: $50 \\%$ of injected activity excreted unmetabolized in urine\n(c) neoplasm: enhanced glycolysis with increased activity of hexokinase + other enzymes\n\n## FDG Distribution\n\nIntense accumulation in: brain, myocardium, intrarenal collecting system + ureter + bladder",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 568,
            "markdown": "Moderate accumulation in: liver, spleen, bone marrow, renal cortex, mediastinal blood pool\nSites of variable physiologic uptake:\n@ Brown (baby) fat\n$=$ highly specialized heat producing tissue in response to cold exposure / ingestion of food ( $=$ nonshivering / diet-induced thermogenesis)\nHisto: increased vascularity + high density of mitochondria $\\rightarrow$ generation of heat Location:\nsuboccipital cervical and supraclavicular region; paraspinal region of neck and chest; intercostal spaces at costovertebral junction; lipomatous hypertrophy of the interatrial septum, axilla; retrocrural; mediastinum adjacent to thoracic vessels; perinephric fat\n$\\diamond$ Keep uptake room warm; use warm blankets\n@ Brain \\& spinal cord intense uptake in cerebral > cerebellar cortex, basal ganglia, thalamus; moderate uptake in cervical + upper thoracic spine\n$\\diamond$ Often used as a reference for semiquantification\n@ Bone marrow usually mild uptake with homogeneous distribution; moderate to intense uptake after chemotherapy + treatment with GCsF (granulocyte colonystimulating factor) + in anemic patients\n@ Nasopharynx Waldeyer ring (negative correlation between age and uptake intensity); sublingual glands (mucous gland with inverted V-shaped uptake at floor of mouth)\n@ Thyroid gland moderate / intense uptake in $1 / 3$ of euthyroid patients; consistent with chronic thyroiditis, Graves disease\n@ Thymus mild to moderate intensity; rebound hyperplasia + increased uptake for 3 months to 1 year\n@ Digestive tract\nCause: metabolically active smooth muscle + mucosa, swallowed secretions, microbial uptake\n> esophagus: more intense at GE junction\n> stomach: SUV usually $<3.8$, may be as high as 5.6\n> small bowel: isolated foci with $\\mathrm{SUV}<4$\n> colon: right colon may have an SUV as high as 10 (lymphatic cells); moderate to intense uptake in rectum\n$\\diamond$ Enemas do not reduce uptake!\n@ Liver hepatocytes have a higher concentration of phosphatase enzymes $\\rightarrow$ resulting in dephosphorylation of FDG-6-phosphate + a faster FDG washout\n$\\diamond$ Delayed imaging for indeterminate liver lesion\n@ Spleen diffuse uptake as physiologic reaction to extrasplenic infection, granulocyte colony-stimulating factor therapy, anemia (extramedullary hematopoiesis)\n@ Skeletal muscle Major energy sources: fat and glucose (at rest $9 \\div 1$, at low exercise $6 \\div 4$, at high exercise $1 \\div 9$ );\n> Diabetics take medication, have morning meal within 4 hours prior to imaging\n$\\diamond$ No muscle effort for 24 hours before PET imaging\n$\\diamond$ No chewing gum / tobacco, reading, talking during uptake phase\nLocation: extraocular muscles; paravertebral muscles in neck + thorax (stress-",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 569,
            "markdown": "induced, patient anxiety); intrinsic laryngeal muscles (speech); diaphragm (hyperventilation, forced respiration)\n@ Myocardium free fatty acids are predominant metabolic substrate ( $50-70 \\%$ ); insulin $\\rightarrow$ increases glucose transporters (GLUT-1 + GLUT-2) $\\rightarrow$ glucose utilization increases after carbohydrate (glucose, lactate) intake\n$\\diamond$ Fasting ( $\\geq 4$ hours since last meal) switches to predominantly fatty acid metabolism:\n> fall of plasma insulin levels $\\rightarrow \\uparrow$ in lipolysis in peripheral tissue $+\\uparrow$ fatty acid levels in plasma\n> decrease of glucose transport into myocytes\n@ Genitourinary tract pooling in upper pole calix, dilated redundant ureter, bladder diverticulum, endometrial uptake, testes (young patients)\n$\\diamond$ Catheterization of bladder to reduce activity + filling with 200 mL of saline just before pelvic imaging\nSites of benign pathologic uptake:\n@ Healing bone (for months)\n@ Lymph nodes active granulomatous disease (TB, sarcoidosis), infection, recent instrumentation\n@ Joints degenerative / inflammatory joint disease (often in sternoclavicular + acromioclavicular + shoulder joints), tendinopathy, enthesopathy, bursitis\n@ Infection / inflammation leukocytic infiltration in abscess, pneumonia, sinusitis, granulomatous infection, talc pleurodesis, acute pancreatitis, healing by secondary intention, wound repair, resorption of necrotic debris, hematoma, fistula\n\n| Effect of Blood Glucose Level on FDG-Uptake |  |\n| :--: | :--: |\n| Blood Glucose Level [mg/dL] | Maximum SUV Uptake in Brain |\n| $<80$ | $13,3 \\pm 3.7$ |\n| $80-110$ | $12.1 \\pm 3.2$ |\n| $110-150$ | $9.8 \\pm 2.4$ |\n| $150-200$ | $7.8 \\pm 3.1$ |\n| $>200$ | $4.8 \\pm 1.8$ |\n\nFocal areas of abnormally increased FDG uptake are suspicious for malignant disease secondary to metabolic alterations that precede morphologic changes.\n\n# PET Imaging in Oncology \n\n$\\mathrm{FDG}=$ glucose analogue tracer 2-[18fluorine]-fluoro-2-deoxy-D-glucose\nPathophysiology:\nserum glucose competes with FDG for entry into tumor cells $\\rightarrow$ FDG becomes\nphosphorylated by hexokinase (malignant cells have increased hexokinase activity $\\rightarrow$ high rate of glycolysis) $\\rightarrow$ FDG-6-phosphate does NOT enter glycolysis pathway $\\rightarrow{ }^{18} \\mathrm{FDG}$ trapped intracellularly\nPreparation:\n(1) fasting for $6(-18)$ hours\n(2) in diabetics blood glucose level $<200 \\mathrm{mg} / \\mathrm{dL}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 570,
            "markdown": "Reason: FDG tumor uptake is diminished by a competitively elevated serum glucose level\n\nFDG PET scanning should be delayed for 8-12 weeks after surgery / radiation therapy to reduce FDG-avid postsurgical changes / radiation effects that can interfere with scan interpretation!\nDose: $\\quad 15$ (range, $13.5-16.5) \\mathrm{mCi}$\nPhysical half-life: 110 min\nImaging time: 45-60-70 min after administration (trade-off between decreasing background activity and declining counting statistics)\nDistortion correction in whole-body imaging:\nattenuation correction can be achieved with a transmission scan before / after emission image acquisition at each corresponding bed position\n\n# Standardized Uptake Value (SUV): \n\n$=$ target-to-background measure to allow comparison within and between different patients and diseases normalized to body mass\n$\\mathrm{SUV}=\\mathrm{A}_{\\text {mea }}[\\mathrm{mCi} / \\mathrm{mL}] /\\left(\\mathrm{A}_{\\text {inj }}[\\mathrm{mCi}] / \\mathrm{W}[\\mathrm{kg}]\\right)$\n\n| $\\mathrm{A}_{\\text {mea }}$ | $=$ decay-corrected regional radiotracer <br> concentration in volume of interest |\n| :-- | :-- |\n| $\\mathrm{A}_{\\text {inj }}$ | $=$ injected radiotracer activity |\n| W | $=$ body weight in kilograms |\n\nN.B.: SUV calculations may alternatively be based on body surface area / lean body mass (corrected for body fat as it elevates SUV spuriously)\n\nTypical values:\nsoft tissue 0.8\nblood pool (at 1 hour) 1.5-2.0\nliver 2.5\nrenal cortex 3.5\nmalignant neoplasm $2-20$\nnon-small cell lung cancer 8.2\nbreast cancer 3.2\nPET - visual assessment: $98 \\%$ sensitive, $69 \\%$ specific\nPET - SUV measurement: $92 \\%$ sensitive, $90 \\%$ specific",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 571,
            "markdown": "| FDG Uptake in Benign Tumors / Tumorlike Conditions |  |\n| :--: | :--: |\n| Neck |  |\n| Thyroid adenoma | Hyperplastic thyroid nodule |\n| Pleomorphic adenoma | Warthin tumor |\n| Abdomen |  |\n| Adrenal hyperplasia | Adrenal adenoma |\n| Pheochromocytoma | Myelolipoma |\n| Bone |  |\n| Fibrous dysplasia | Giant cell tumor |\n| Paget disease | Nonossifying fibroma |\n| Eosinophilic granuloma | Aneurysmal bone cyst |\n| Enchondroma | Myositis ossificans |\n| Low FDG Uptake in Malignant Tumors |  |\n| Bronchoalveolar cell ca. | Carcinoid |\n| Marginal zone lymphoma (eg, MALToma) | Low-grade HCC |\n| Low-grade sarcoma | Chondrosarcoma |\n| Renal cell carcinoma | Necrotic tumor |\n| Sclerotic bone metastasis | Mucinous tumor |\n\n# Response Evaluation in PET Imaging \n\n(1) Reproduce the same time delay between injection and imaging as used at baseline imaging\n(2) Consider partial volume effect in small residual tumor = risk of underestimation of SUV values\n(3) Time delay after last chemotherapy use might influence response assessment\n\n## HYBRID PET/CT IMAGING\n\n$=$ combination of high-resolution PET scanner + CT scanner allows acquisition of 3dimensional images\nIndications:\n\n1. Lung cancer\n2. Breast cancer\n3. Colon cancer recurrence\n4. Head and neck cancer\n5. Brain tumor\n\n## Lymphoma\n\n$=$ histologically heterogeneous group of cancers derived from cells of immune system\nPrevalence: $5 \\%$ of all cancers in USA\nPrognosis: $6.0 \\div 100,000(=20,150)$ deaths annually in 2013\n$\\sqrt{ }$ enlargement of lymph nodes / secondary lymphoid tissues\n$\\sqrt{ }$ may arise from almost any organ $=$ extranodal lymphoma\nFactors in FDG uptake:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 572,
            "markdown": "histologic features (Hodgkin disease versus NHL)\n> grade (indolent versus aggressive NHL)\n\n| PET/CT Artifacts |  |\n| :--: | :--: |\n| Misregistration $=$ located to inappropriate anatomic structure |  |\n| Respiration | Patient motion |\n| Bowel motility | Bladder distention |\n| Attenuation-correction Artifact $=$ artificial activity increase |  |\n| Metallic objects | Vertebroplasty cement |\n| Contrast media |  |\n\n> viable tumor cell fraction\n> tumor cell proliferation\n> upregulation of glucose metabolism\n> salvage pathways and tumor-specific pathways\n> local perfusion $\\rightarrow$ substrate delivery to the cancer cell\n> presence of hypoxia\n\n# Extranodal Lymphoma \n\nPrevalence: $1 / 3$ of all lymphomas\nLocation: skin, stomach, small intestine (most common)\n(a) primary extranodal lymphoma = early stage I (65\\%), stage II (74\\%) disease\n(b) secondary extranodal lymphoma $=$ sign of more advanced stage III or IV disease\n\n## Malignant Lymphoma / NHL\n\nMalignancy grade:\n$\\sqrt{ }$ uptake lower for indolent compared to aggressive lymphoma (SUV > 10 likely to have aggressive disease)\n$\\checkmark$ aggressive transformation ( $=$ change from low-grade to high-grade lymphoma) in 5$10 \\%$; requires repeat biopsy\nStaging: PET/CT tends to upstage tumors\n$\\checkmark$ splenic $>$ hepatic uptake indicates splenic involvement\n$\\checkmark$ heterogeneous scattered uptake in bone marrow involvement\nPitfalls:\n(a) gastric + cerebral lymphoma difficult to detect $\\leftarrow$ physiologic accumulation\n(b) increased uptake after treatment with granulocyte colony-stimulating factor (GCSF)\n(c) uptake in brown fat of mediastinum\n(d) uptake in Lnn with sarcoid involvement\n(e) physiologic colonic uptake may be mistaken for lymphoma\n(f) small-volume lesions may be undetectable\n\nResponse to Rx:\n(1) Early response assessment after one cycle of chemotherapy has high prognostic value\n(2) Residual abnormal FDG uptake after therapy suggests poor prognosis!\n\n## Hodgkin Lymphoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 573,
            "markdown": "$97 \\%$ of disease sites identified by FDG PET\n$\\diamond$ Lesion contiguity is CHARACTERISTIC!\n\n# IMMUNOSCINTIGRAPHY \n\n$=$ imaging with monoclonal antibodies ( $[=$ homogeneous antibody population directed against a single antigen [eg, cancer cell]) and labeled with a radiotracer\nHybridoma technique:\nantibody-producing B lymphocytes are extracted from the spleen of mice that were immunized with a specific type of cancer cell; B lymphocytes are fused with immortal myeloma cells (= hybridoma)\nAgents:\n${ }^{111}$ Indium-satumomab pendetide $={ }^{111} \\mathrm{In}-\\mathrm{CYT}-103$ (OncoScint ${ }^{\\mathrm{TM}} \\mathrm{CR} / \\mathrm{OV}$ ) = murine monoclonal antibody product derived by site-specific radiolabeling of the antibody B27.3GYK-DTPA conjugate with ${ }^{111} \\mathrm{In}$\nUse: detection + staging of colorectal + ovarian cancers\nDose: 1 mg of antibody radiolabeled with 5 mCi of ${ }^{111}$ In injected IV\nBiodistribution: liver, spleen, bone marrow, salivary glands, male genitalia, blood pool, kidneys, bladder\nImaging: 2 sets of images $2-5$ days post injection +48 hours apart\n\n## LYMPHANGIOSCINTIGRAPHY\n\n## Lymphangioscintigraphy Technique\n\n${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-albumin solution injected intradermally to raise a wheal in $1^{\\text {st }}$ interdigital web space of both feet / hands\nDose: $\\quad 500 \\mu \\mathrm{Ci}(18.5 \\mathrm{MBq}) ; 92-98 \\%$ of albumin are tightly bound to ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$\nVolume: $\\quad 0.05 \\mathrm{~mL} ;>98 \\%$ of albumin macromolecules (molecular weight of 60 kDa ) enter lymphatic vessels\nImaging: at $1 \\mathrm{~min}, 10-40 \\mathrm{~min}$ and $3-5 \\mathrm{hr}$ with parallel-hole collimator passing over patient\n\n## Transport Index Score (TIS)\n\n$=$ semiquantitative measurement of objective + subjective criteria of peripheral lymphatic radiotracer transport\nTIS $=\\mathrm{K}+\\mathrm{D}+0.04 \\cdot \\mathrm{~T}+\\mathrm{N}+\\mathrm{V}$\n$\\mathrm{K}=$ transport kinetics $=$ degree of transport delay\n$\\mathrm{D}=$ radionuclide distribution pattern $=$ degree of dermal backflow\n$\\mathrm{T}=$ timing of radionuclide appearance in regional lymph nodes (in minutes normalized for 200 min as maximal delay)\n$\\mathrm{N}=$ demonstration + intensity of lymph nodes\n$\\mathrm{V}=$ demonstration + intensity of lymphatic collectors\n\n## BRAIN SCINTIGRAPHY\n\nBlood-Brain Barrier (BBB) Agents",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 574,
            "markdown": "$=$ old-style agents require a disruption of blood-brain barrier to diffuse into brain\nA. 99 mTc -glucoheptonate\n$15-20 \\mathrm{mCi}$ bolus injection in $<2 \\mathrm{~mL}$ saline; 30 flow images of 2 -second duration; static image of 1 million counts after 4 hours; delayed image after 24 hours (higher target-tobackground ratio than DTPA)\nB. 99 mTc DTPA\nC. 201Thallium: best predictor for tumor burden\n\n# Brain Perfusion Agents \n\n$=$ lipophilic agents rapidly crossing blood-brain barrier with accumulation in brain\nApplications: any disease in- / decreasing regional perfusion\n\n1. Brain death (most common)\n2. Refractory seizure disorder\n3. Dementia\npotentially: stroke, receptor imaging, activation studies, tumor recurrence\n\n## 99m Tc HMPAO\n\n$=$ hexamethylpropylene amine oxime $=$ exametazime\nProduct: Ceretec ${ }^{\\circledR}$\nDose: $10-30 \\mathrm{mCi}$\nImaging: as early as 15 min post injection\nPharmacokinetics: lipophilic radiopharmaceutical distributes across a functioning blood-brain barrier proportional to cerebral blood flow; no redistribution\nIndication: acute cerebral infarct imaging before evidence of CT / MR pathology; positive findings within 1 hour of event\n\n## 99m Tc-ECD\n\n$=$ ethyl cysteinate dimer $=$ bicisate\nProduct: NEUROLITE ${ }^{\\circledR}$\nDose: $10-30 \\mathrm{mCi}$\nImaging: $30-60 \\mathrm{~min}$ post injection\n\n## ${ }^{123}$ I-Iofetamine\n\n$=\\mathrm{N}$-isopropyl-p[123I]iodoamphetamine iodine $=123 \\mathrm{I}-\\mathrm{IMP}$\nProduct: Spectamine ${ }^{\\circledR}$\nPharmacokinetics:\ninitially distributes proportional to regional cerebral blood flow with increased flow to basal ganglia and cerebellum; homogeneous uptake in gray matter; $\\downarrow$ activity in white matter; redistribution over time\n$\\sqrt{ }$ activity in an area of initial deficit on reimaging (after 4 hours) implies improved prognosis\n\n## Increased Perfusion in Radionuclide Angiography\n\n1. Primary / metastatic brain tumor\n2. AVM, large aneurysm, tumor shunting",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 575,
            "markdown": "3. Luxury perfusion after infarction\n4. Infection: eg, herpes simplex encephalitis\n5. Extracranial lesions: bone metastasis, fibrous dysplasia, Paget disease, eosinophilic granuloma, fractures, burr holes, craniotomy defects\n\n# Decreased Perfusion in Radionuclide Angiography \n\n1. Arterial stenosis\n2. Alzheimer disease:\n$\\sqrt{ }$ bilateral temporoparietal hypoperfusion\n3. Most tumors\n4. Hemorrhage\n5. Subdural hematoma\n\n## Indications for Radionuclide Angiography of Brain\n\n## Seizures\n\nAbnormal cerebral radionuclide angiography within 1 week of seizure activity even without underlying organic lesion\nEtiology:\n(1) $35 \\%$ cerebral tumors: meningioma in $34 \\%$, metastases in $17 \\%$\n(2) Cerebrovascular disease (more common in $>50$ years of age)\n(3) Trauma, inflammation, CNS effects of systemic disease\n$\\sqrt{ }$ transient hyperperfusion of involved hemisphere\n\n## Seizure Focus Imaging\n\nfor localizing intractable seizures\n$\\checkmark$ focal hypoperfusion during interictal injection of tracer (less sensitive)\n$\\checkmark$ focal hyperperfusion during ictal injection of tracer (better detection)\n\n## Brain Tumor\n\nEtiology:\n$\\checkmark$ good correlation between hyperperfusion and enlarged supplying vessels:\n(1) Meningioma (increased activity in $60-80 \\%$ );\n(2) Metastases (increased activity in 11-23\\%);\n(3) Vascular metastases: thyroid, renal cell, melanoma, anaplastic tumors from lung / breast\n\n## Arterial Stenosis\n\n$\\diamond$ Radionuclide angiography of limited value!\n$\\checkmark$ asymmetric decreased perfusion in acute / chronic cerebrovascular disease:\n(1) Complete occlusion / $>80 \\%$ stenosis of ICA:\n$53-80 \\%$ sensitivity\n(2) $50-80 \\%$ stenosis of ICA: $50 \\%$ sensitivity\n(3) $<50 \\%$ stenosis of ICA: $10 \\%$ sensitivity\n\nProblematic lesions:\n(1) Bilaterally similar degree of stenosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 576,
            "markdown": "(2) Occlusion of MCA + unilateral ACA\n(3) Vertebrobasilar occlusive disease ( $20 \\%$ sensitivity)\n\n# Stroke \n\n$\\sqrt{ }$ \"flip-flop\" phenomenon ( $=\\Downarrow$ perfusion in arterial phase, equalization of activity in capillary phase, $\\uparrow$ activity in venous phase) $\\leftarrow$ late arrival of blood via collaterals and slow washout\n\n## PET IN BRAIN IMAGING\n\nA. REGIONAL CEREBRAL BLOOD FLOW\n(a) breathing of carbon monoxide (11C and 15O), which concentrates in RBCs\n(b) 133Xe inhalation / injection into ICA / IV injection after dissolution in saline: volume distribution within cerebral water space; no correction for recirculation necessary because all Xe is exhaled during lung passage, but correction for scalp + calvarial activity is required\n$\\sqrt{ }$ washout rate of gray matter $\\div$ white matter $=4-5 \\div 1$\nB. GLUCOSE METABOLISM\nfor measurements of metabolic rate + mapping of functional activity\n(a) 11C glucose: rapid uptake, metabolization, and excretion by brain\n(b) ${ }^{18} \\mathrm{~F}$-fluorodeoxyglucose (FDG): diffuses across blood-brain barrier + competes with glucose for phosphorylation by hexokinase $\\rightarrow$ traps FDG-6-phosphate within mitochondria; FDG-6-phosphate cannot enter most metabolic pathways (eg, glycolysis, storage as glycogen) and accumulates proportional to intracellular glycolytic activity; FDG-6-phosphate is dephosphorylated slowly by glucose-6-phosphatase and then escapes cell\nIndications:\n\n1. Focal epilepsy prior to seizure surgery\n$\\sqrt{ }$ interictal $\\Downarrow$ uptake of FDG of $>20 \\%$ at seizure focus ( $70 \\%$ sensitivity, $90 \\%$ for temporal lobe hypometabolism)\n$\\sqrt{ }$ hypermetabolism within 30 minutes of seizure\n$\\sqrt{ }$ measurement of opiate receptor density with 11C-labeled carfentanil (= high-affinity opium agonist) uptake by $\\mu$ receptors (found in thalamus, striatum, periaqueductal gray matter, amygdala), which mediate analgesia and respiratory depression\n2. Alzheimer disease\n\nPrevalence: 5.4 million persons in USA in 2016\n\n- clinical diagnosis false positive in $35 \\% \\leftarrow$ challenging diagnosis in earlier milder forms of the disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 577,
            "markdown": "![img-35.jpeg](img-35.jpeg)\n\nHisto: amyloid plaques + neurofibrillary angles (autopsy)\n$\\sqrt{ }$ bilateral temporoparietal hypoperfusion + hypometabolism $\\rightarrow$ decreased FDG uptake $(92-100 \\%$ sensitive $)$\n$\\sqrt{ }$ sparing of sensory and motor cortex + basal ganglia + thalamus\n$\\sqrt{ }$ atrophy of entire brain with predilection for hippocampus\n$D D x$ : frontal lobe dementia, primary progressive aphasia without dementia, normalpressure hydrocephalus, multi-infarct dementia\n3. Parkinson disease\n$=$ deficient presynaptic terminals with normal postsynaptic dopaminergic receptors\n\n- clinical diagnosis in $50-70 \\%$ accurate\n$D D x$ : drug-induced chorea, Huntington disease, tardive dyskinesia, progressive supranuclear palsy, Shy-Drager syndrome, striatonigral degeneration, alcoholrelated cerebellar dysfunction, olivopontocerebellar atrophy\n\n4. Huntington disease, senile chorea\n$\\sqrt{ }$ hypometabolism of basal ganglia\n5. Schizophrenia\n$\\sqrt{ }$ abnormally reduced glucose activity in frontal lobes\n$\\sqrt{ }$ dopamine receptors in caudate / putamen elevated to 3 x that of normal levels\n6. Stroke, cerebral vasospasm\n$\\sqrt{ }$ disassociated oxygen metabolism + brain blood flow\n\n# PET in Brain Tumor \n\nIndications:\n(1) Tumor grading + estimation of prognosis",
            "images": [
                {
                    "id": "img-35.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1337,
                    "bottom_right_y": 990,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 578,
            "markdown": "$\\diamond$ Apparently low-grade gliomas without contrast enhancement by CT/MR are malignant in $30 \\%$\n(2) Localization of optimal biopsy site\n$\\diamond$ The most malignant area shows maximum of uptake\n\n| Grading and Prognosis for Gliomas |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Grade | Uptake Ratio | Pathology | Median <br> Survival |\n| 0 | no uptake | in $86 \\%$ |  |\n| 1 | tumor $\\leq$ normal white matter | grade I/II | 2.3 years |\n| 2 | tumor $>$ white matter and <br> $<$ normal cortex | in $94 \\%$ <br> grade III / IV | 11 months |\n| 3 | tumor $\\geq$ normal cortex |  |  |\n\n# Unproven: \n\n(3) Detection of recurrence versus radionecrosis\n$\\diamond$ Plagued by low specificity of $22 \\%$ (cut-off greater than WM) and $56 \\%$ (cut-off greater than cortex)\n(4) Assessment of response to therapy\n$\\diamond$ SUV increases within weeks following radiation / chemotherapy $\\leftarrow \\uparrow$ in metabolically active inflamma- tory elements + energy consumption for apoptosis\n(5) Defining target volume for radiotherapy (?)\n\nAssessment: $35-50 \\mathrm{~min}$ post injection\n>SUV\n> tumor-to-white matter ratio (T/WM): 1.5\n> tumor-to-cortex ratio (T/C): $>0.6$\n$\\diamond$ Activity in tumor + reference area steadily increases with time after injection\n\n## RADIONUCLIDE CISTERNOGRAPHY\n\nIndications:\n\n1. Suspected normal pressure hydrocephalus\n2. Occult CSF rhinorrhea / otorrhea\n3. Suspected ventricular shunt malfunction\n\n4 Porencephalic cyst, leptomeningeal cyst, posterior fossa cyst\nTechnique:\n\n1. Measurement of spinal subarachnoid pressure\n2. Sample of CSF for analysis\n3. Subarachnoid injection of radiotracer\n\nNormal study (completed within 48 hours):\nsymmetric activity sequentially from basal cisterns $\\rightarrow$ up the sylvian fissures + anterior commissure $\\rightarrow$ eventual ascent over cortices with parasagittal concentration\n$\\sqrt{ }$ image lumbar region immediately after injection to ensure subarachnoid injection\n$\\sqrt{ }$ activity in basal cistern by $2-4$ hours\n$\\sqrt{ }$ activity at vertex by $24-48$ hours\n$\\sqrt{ }$ no / minimal lateral ventricular activity (may be transient in older patients)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 579,
            "markdown": "# Agents: \n\n1. ${ }^{111}$ Indium-DTPA\n\nPhysical half-life: 2.8 days\nGamma photons: $173 \\mathrm{keV}(90 \\%), 247 \\mathrm{keV}(94 \\%)$ detected with dual pulse height analyzer\nDose: $250-500 \\mu \\mathrm{Ci}$\nRadiation dose: $9 \\mathrm{rad} / 500 \\mu \\mathrm{Ci}$ for brain + spinal cord (in normal patients)\nImaging: at 10 -minute intervals / 500,000 counts up to $4-6$ hours; repeat scans at 24,48 , 72 hours\n2. ${ }^{99 \\mathrm{~m}}$ Technetium-DTPA\n\nNot entirely suitable for imaging up to $48-72$ hours; DTPA tends to have faster flow rate than CSF; used for shunt evaluation + CSF leak study since leak increases CSF flow\nDose: $4-10 \\mathrm{mCi}$\nRadiation dose: 4 rad for brain + spinal cord\n3. 131 Iodine-serum albumin (RISA)\nprototype agent; beta emitter\nPhysical half-life: 8 days; high radiation dose of $7.1 \\mathrm{rad} / 100 \\mu \\mathrm{Ci}$; no longer used secondary to pyrogenic reactions\n4. 169 Ytterbium-DTPA\n\nPhysical half-life: 32 days\nGamma decay: $63 \\mathrm{keV}, 177 \\mathrm{keV}(17 \\%$ ); $198 \\mathrm{keV}(25 \\%$ ); 308 keV ; dual pulse height analyzer set for $177+198 \\mathrm{keV}$\nDose: $500 \\mu \\mathrm{Ci}$\nRadiation dose: $9 \\mathrm{rad} / 500 \\mathrm{mCi}$ for brain + spinal cord (in normal patients)\n\n## CSF Leak Study\n\nPurpose: localization of origin of CSF leak in patient with CSF rhinorrhea / otorrhea Causes of dural fistula:\n(a) traumatic: in $30 \\%$ of basilar skull fractures\n(b) nontraumatic: brain, pituitary and skull tumors; skull infections; congenital defects\n\nLocation of dural fistula:\ncribriform plate $>$ ethmoid cells $>$ frontal sinus\nMethod:\nÂ» Weigh cotton pledgets\nÂ» Pledgets placed by ENT surgeon in the anterior and posterior turbinates bilaterally\nÂ» Radiopharmaceutical injected intrathecally via lumbar puncture; immediate postinjection view of lumbar region to ensure intrathecal placement\n$\\diamond$ Contraindicated in active meningitis / elevated intracranial pressure!\nÂ» Pledgets removed and weighed 4-6 hours after lumbar injection\nÂ» Pledget activity counted + indexed to weight\nÂ» Results compared with $0.5-\\mathrm{mL}$ serum specimens drawn at the time of pledget removal\nÂ» Pledget to serum count ratio of $>1.5=$ evidence of CSF leak\nÂ» With active leak patient should be placed in various positions with various maneuvers to accentuate leak\nDisadvantage: low sensitivity + high FN in intermittent leak",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 580,
            "markdown": "# THYROID SCINTIGRAPHY \n\n## Indications:\n\n(1) Classification of hyperthyroidism\n(2) Evaluation of solitary / dominant nodule\n(3) Detection and staging of postoperative thyroid cancer\n(4) Evaluation of upper mediastinal mass\n(5) Evaluation of neonatal hypothyroidism\n(6) Evaluation of developmental anomalies\nA. SUPPRESSION SCAN\n$=$ to define autonomy of a nodule\n$\\sqrt{ }$ suppression of a hot nodule following T3 / T4 administration is proof that autonomy does not exist\nB. STIMULATION SCAN\n$=$ to demonstrate thyroid tissue suppression by hyperfunctioning nodule\n$\\sqrt{ }$ administration of TSH documents functioning thyroid tissue (rarely done)\nC. PERCHLORATE WASHOUT TEST\n$=$ to demonstrate organification defect\n$\\sqrt{ }$ repeat measurement of radioiodine uptake following oral potassium perchlorate shows lower values if organification defect present\n$\\diamond$ Best interpreted by direct comparison with sonography!\n\n## 99mTc-Pertechnetate in Thyroid Imaging ( $\\left.{ }^{99 \\mathrm{mTcO}_{4}-}\\right)$\n\nPhysical half-life (for gamma emission): 6.03 hours\nBiologic half-life: 1 day ( $94 \\%$ decays to ${ }^{99} \\mathrm{Tc}$ in 24 hours)\nDecay: by photon emission of 140 keV\nQuality control:\n(1) $<0.1 \\%{ }^{99} \\mathrm{Mo}\\left(=1 \\mu \\mathrm{Ci} / \\mathrm{mCi}\\right)$, maximum of ${ }^{99} \\mathrm{Mo}$ at $5 \\mu \\mathrm{Ci}$\n(2) $<0.5 \\mathrm{mg}$ aluminum $/ 10 \\mathrm{mCi}{ }^{99 \\mathrm{mTc}}$\n(3) $<0.01 \\%$ radionuclide impurities\n\nAdministration: oral / IV\nDose: $\\quad 3-5 \\mathrm{mCi}$ administered IV 20 min prior to imaging ( $100-300 \\mathrm{mrad} / \\mathrm{mCi}$ )\nPharmacokinetics:\nUptake by: thyroid, salivary glands, gastric mucosa, choroid plexus\nExcretion: mostly in feces, some in urine\nUptake in thyroid: $0.5-3.7 \\%$ at 20 minutes (time of maximum uptake); assessment of trapping function only; NO organification; may be almost completely discharged by perchlorate\nImaging:\n(a) Collimator: usually with pinhole collimator for image magnification ( $5-\\mathrm{mm}$ hole)\n(b) Distance: selected so that organ makes up $2 / 3$ of field of view; significant distortion of organ periphery occurs if detector too close\n(c) Counts: $200,000-300,000$ counts are usually acquired within 5 min after a dose of 5 $10 \\mathrm{mCi} \\mathrm{of}{ }^{99 \\mathrm{mTc}}$-pertechnetate\n(d) Image must include markers for scale + anatomic landmarks + palpatory findings",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 581,
            "markdown": "Advantages:\n(1) Low cost\n(2) Reduced radiation exposure\n(3) Greater photon flux than iodine $=$ detectability of small thyroid lesions $(>8 \\mathrm{~mm})$ is improved\n(4) Excellent physical characteristics\n\n# Disadvantages: \n\n(1) High neck background (target-to-background ratio less favorable than with iodine)\n(2) Lesions with pertechnetate-iodine discordance\n( $=$ hot on ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate + cold on radio-iodine) are very rare + due to ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-avid cancer\n(3) Poor for substernal evaluation\n\n## 123lodine\n\n$\\diamond$ Agent of choice for thyroid imaging!\nProduction: in accelerator; contamination with ${ }^{124} \\mathrm{I}$ dependent on source ( ${ }^{122} \\mathrm{Te}$ in $\\sim 5 \\%$, $123 \\mathrm{Xe}$ in $\\sim 0.5 \\%$ ); contamination with ${ }^{125} \\mathrm{I}$ increases with time elapsed after production\nPhysical half-life: 13.3 hours\nDecay: by electron capture with photon emission at $159 \\mathrm{keV}(83 \\%$ abundance) + x-ray of 28 $\\mathrm{keV}(87 \\%$ abundance)\nDose: $\\quad 200-400 \\mu \\mathrm{Ci}$ orally 24 hours prior to imaging (radiation dose of $7.5 \\mathrm{mrad} / \\mu \\mathrm{Ci}$ )\nUptake: iodine readily absorbed from GI tract ( $10-30 \\%$ by 24 hours), distributed primarily in extracellular fluid spaces; trapped + organified by thyroid gland; trapped by stomach + salivary glands\nExcretion: via kidneys in $35-75 \\%$ during first 24 hours + GI tract\nAdvantages:\n(1) Low-radiation exposure\n(2) Excellent physical characteristics\n(3) Uptake + scan with one agent (organified)\n\nDisadvantages compared with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate:\n(1) More expensive\n(2) Less available with short shelf-life\n(3) More time-consuming\n(4) Radionuclide impurities\n(5) Higher dose to thyroid (but less to whole body)\n\n## 131lodine\n\nIndication: thyroid uptake study, thyroid imaging, treatment of hyperthyroidism, treatment of functioning thyroid cancer, imaging of functioning metastases\nProduction: by fission decay\nPhysical half-life: 8.05 days (allows storing for long periods)\nDecay: principal gamma energy of $364 \\mathrm{keV}(82 \\%$ abundance) + significant beta decay fraction of a mean energy of $192 \\mathrm{keV}(92 \\%$ abundance)\nDose: $\\quad 30-50 \\mu \\mathrm{Ci}(1.2 \\mathrm{rad} / \\mu \\mathrm{Ci}=50 \\mathrm{rad}$ for thyroid $)$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 582,
            "markdown": "Radiation dose: ( $90 \\%$ from beta decay, $10 \\%$ from gamma radiation) $0.6 \\mathrm{mrad} / \\mathrm{mCi}$ for whole body; $1.2 \\mathrm{mrad} / \\mu \\mathrm{Ci}$ for thyroid (critical organ)\nPharmacokinetics: identical to ${ }^{123} \\mathrm{I}$\n\n| Thyroid Agents |  |  |  |\n| :--: | :--: | :--: | :--: |\n|  | ${ }^{131} I$ | ${ }^{123} I$ | ${ }^{99 \\mathrm{~m}} T_{C}$ |\n| Physical half-life | 8 d | 13 hr | 6 hr |\n| Main photopeak | 364 keV | 159 keV | 140 keV |\n| Usual dose | $50-100 \\mu \\mathrm{Ci}$ | $100-300 \\mu \\mathrm{Ci}$ | $2-10 \\mathrm{mCi}$ |\n| Absorbed dose | $50-100 \\mathrm{rad}$ | $2-5 \\mathrm{rad}$ | $0.2-1.8 \\mathrm{rad}$ |\n| Administration | PO | PO | IV |\n| Interval to image | 24 hr | 6 hr | 20 min |\n\nAdvantages:\n(1) Low cost\n(2) Ectopic tissue search\n(3) Uptake and scan at same time\n\nDisadvantages:\n(1) Too energetic for gamma camera, well suited for rectilinear scanner with limited resolution\n(2) High radiation exposure ( $\\leftarrow$ beta decay) $\\rightarrow$ PROHIBITS USE FOR DIAGNOSTIC PURPOSES\n(3) Ectopic thyroid tissue just as well detectable with ${ }^{123} \\mathrm{I}$ or ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate\n\n# ${ }^{131}$ Iodine SPECT/CT \n\nAdvantage: precise localization of foci of radioactivity to anatomic structures (incremental value over planar imaging in $40 \\%$ )\nIndication: distinction of benign mimics from true metastatic disease\n\n## PHYSIOLOGIC ${ }^{131}$ IODINE ACTIVITY\n\nNIS $=$ sodium $(\\mathbf{N}) /$ iodide $(\\mathbf{I})$ symporter $(\\mathbf{S})$ transports 2 sodium cations $\\left(\\mathrm{Na}^{+}\\right)$for each iodide anion ( $\\mathrm{I}^{-}$) into the cell\nA. Thyroidal tissue\n\n1. after total thyroidectomy: thyroglossal duct, thyroid bed remnant\n2. Ectopic thyroid: lingual thyroid, lateral aberrant thyroid, intracardiac thyroid (struma cordis), ovarian thyroid (struma ovarii)\nB. Orthotopic / ectopic extrathyroidal tissue with NIS expression\n3. Extrathyroidal tissue with NIS expression: salivary gland (parotid, submandibular), choroid plexus, lacrimal gland, nasal mucosa, thymus, breast, gastric mucosa, colon\n$\\diamond$ Breast feeding must be terminated after administration of ${ }^{131} \\mathrm{I}$.\n4. Ectopic extrathyroidal tissue with NIS expression: Barrett esophagus, Meckel diverticulum, GI duplication cyst, supernumerary breast tissue\nC. Physiologic\n5. Intravascular space: cardiac blood pool, carotid ectasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 583,
            "markdown": "2. Hepatic metabolism: diffuse hepatic activity $\\leftarrow{ }^{131}$ I-labeled thyroxine $\\leftarrow$ produced by carcinoma metabolized in liver\n3. Secretions of saliva, sweat, tears, nose: oropharynx, esophagus, Zenker diverticulum, poorly dissolved ${ }^{131}$ I capsule, chewing gum / tobacco, external contamination\n4. GI and GU excretion: colon, bladder\nD. Benign disease\n5. Cyst with passive diffusion: lactational duct, renal, ovarian, pleuropericardial, bronchogenic\n6. Inflammation: lung, pericardium, joint, sinus, wound healing, etc.\n7. Third spacing: pericardial effusion, pleural effusion, ascites, scrotal hydrocele\nE. Neoplasm: meningioma, non-small cell lung carcinoma, teratoma, salivary gland + ovarian + gastric adenocarcinoma\nF. Contamination: urine, feces, drooling\n\n# Iodine Fluorescence Imaging \n\nTechnique: collimated beam of 60 keV gamma photons from an 241 Am source is directed at thyroid, which results in production of K -characteristic x-rays of 28.5 keV ; x-rays are detected by semiconductor detector\nAdvantages:\n(1) No interference with flooded iodine pool / thyroid meds\n(2) Measures total iodine content\n(3) Low radiation exposure ( 15 mrad ) acceptable for children + pregnant women\n\nDisadvantage: dedicated equipment necessary\n\n## PARATHYROID SCINTIGRAPHY\n\nfor the evaluation of primary hyperparathyroidism after other causes for hypercalcemia have been excluded\n\n## [Technetium-thallium Subtraction Imaging]\n\n*** superceded by ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MIBI at most centers ***\n$=$ DUAL ISOTOPE SCINTIGRAPHY\nSensitivity: $72-92 \\%$ (depending on size, smallest adenoma was 60 mg )\nSpecificity: $43 \\%$ (benign thyroid adenomas, focal goitrous changes, Hashimoto thyroiditis, parathyroid ca., cancer metastatic to neck, lymphoma, sarcoidosis, lymph nodes also concentrate thallium)\nMethod:\nÂ» IV injection of $1-3.5 \\mathrm{mCi}{ }^{201} \\mathrm{Tl}$ chloride; images recorded for 15 minutes with $2-\\mathrm{mm}$ pinhole collimator\n$\\sqrt{ }$ concentrates in normal thyroid + enlarged parathyroid glands (extraction proportional to regional blood flow + tissue cellularity)\nÂ» IV injection of $1-10 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate; images recorded at 1-min intervals for 20 min\n$\\sqrt{ }$ pertechnetate concentrates only in thyroid\nÂ» Computerized subtraction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 584,
            "markdown": "$\\sqrt{ }$ focal / multifocal excess ${ }^{201} \\mathrm{Tl}$\nLimitations:\n(1) Unfavorable dosimetry + poor quality images of ${ }^{201} \\mathrm{Tl}$ (up to $3.5 \\mathrm{mCi}, 80 \\mathrm{keV}$ photons)\n(2) Prolonged patient immobilization (motion artifact)\n(3) Processing artifacts (eg, over- / undersubtraction)\n(4) Poor ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ thyroid uptake from interfering medications / recent iodinated contrast media\n(5) Parathyroid pathology may be mimicked by coexisting thyroid disease (eg, nonfunctioning adenoma, multinodular goiter)\nIndication: localization of one / more parathyroid adenomas (hyperplasia not visualized), may be more sensitive than CT / MR in detection of ectopic mediastinal parathyroid tissue and in postoperative context\n\n# 99mTechnetium-Sestamibi ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MIBI) \n\nIndication: recurrent hypercalcemia following previous parathyroid surgery\nSensitivity: $79-100 \\%$ (smallest adenoma weighed 150 mg ); $79 \\%$ for early pinhole, $85 \\%$ for late pinhole, $86 \\%$ for subtraction, $83 \\%$ for SPECT imaging\n$\\diamond$ adversely affected by multigland disease\n$\\diamond$ For unknown reasons even large tumors ( 2 g ) may not accumulate sufficient MIBI for detection!\n\n## Pharmacokinetics:\n\nafter IV injection lipophilic cationic molecules of MIBI distribute according to blood flow $\\rightarrow$ cross cell membrane by passive diffusion $\\rightarrow$ concentrate intracellularly in region of mitochondria proportional to regional blood flow and cellular metabolic activity (eg, in myocardium and mitochondria-rich oxyphil cells of parathyroid gland); MIBI washes out of thyroid quickly, but is retained in abnormal parathyroids $\\rightarrow$ need for dual-phase study\nPhysiologic distribution:\n(1) Parotid gland\n(2) Submandibular salivary glands (uptake in oral cavity)\n(3) Thyroid gland\n(4) Heart\n(5) Liver\n(6) Bone marrow: mild generalized uptake\n(7) Thymus: mild uptake in young individuals\n(8) Brown fat\n( ) NO uptake in normal parathyroid glands\n\nAdvantages (over thallium):\nA. Physical properties:\n> optimal gamma emission ( 140 keV )\n> abundant photons (high dose of 20 mCi )\n> favorable dosimetry\n> high parathyroid-to-thyroid ratio\n> unaffected by medications / iodinated contrast\nB. Technical features:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 585,
            "markdown": "> single readily available radiopharmaceutical\n> simple protocol of early + delayed images\n> no prolonged patient immobilization\n> no subtraction study / computer processing\n> SPECT / multiple projections possible\nC. Scan interpretation\n> sharp images\n> clear visualization of abnormal parathyroid glands\n> ectopic sites surveyed\n> improved detection sensitivity\n\n# Method: \n\nÂ» IV injection of $20-30 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MIBI\nÂ» $1^{\\text {st }}$ set of images: $10-15-30$ minutes after injection\nÂ» $2^{\\text {nd }}$ set of images: at $1.5-3-4$ hours post injection\nÂ» Adjunctive dual phase imaging with\n(a) optional dual-isotope thyroid-selective agent ( $\\left.{ }^{123} \\mathrm{I},{ }^{99 \\mathrm{~m}} \\mathrm{Tc}\\right)$ for computer-aided subtractions\nDisadvantages:\n(1) Necessity of 2 radionuclide injections\n(2) Requires cooperative + immobile patient identically positioned for 2 studies\n(3) Increased likelihood of artifacts\n(b) single isotope early - and delayed phase technique $\\leftarrow{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ sestamibi washes out more rapidly from thyroid gland than from hyperfunctioning parathyroid glands\nÂ» Image acquisition: of cervicothoracic region from submandibular glands to basal $1 / 3$ of heart\n(1) 2-D planar imaging: anterior, anterior oblique, lateral views with large-field-ofview camera equipped with low-energy high-resolution parallel-hole collimator acquiring 5 minutes/view for $1^{\\text {st }}$ set of images and 10 minutes/view for $2^{\\text {nd }}$ set of images\n(2) 3-D SPECT imaging with improved contrast resolution ( $\\uparrow$ target to background)\n(a) software program\n(b) hybrid SPECT/CT imaging system with anatomic information from CT\n\nAdvantage: more precise anatomic localization of ectopic mediastinal parathyroid adenomas\nFalse positive scintigraphic findings:\n\n1. Solitary thyroid adenoma\n2. Nodule in multinodular goiter\n3. Tumor: breast, lung, head \\& neck carcinoma, bronchial carcinoid\n4. Metastasis to lymph node and bone\n\nDelayed wash-out in neck region:\n\n1. Differentiated thyroid malignancy\n2. Primary thyroid lymphoma\n3. Lymph node metastasis from papillary thyroid ca.\n4. Reactive lymph node\n5. Remnant thymus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 586,
            "markdown": "6. PTH-secreting paraganglioma\n7. Enlarged submandibular gland\n\nFalse negative scintigraphic findings:\n\n1. Double parathyroid adenomas\n2. Four-gland hyperplasia\n$\\diamond$ Small gland less likely detected than large gland!\n\n# LUNG SCINTIGRAPHY \n\n## Perfusion Agents\n\n## ${ }^{99 m}$ Tc-Macroaggregated Albumin (MAA)\n\nPreparation:\nheat-denatured +pH -adjusted human serum albumin (HSA); added stannous chloride $\\rightarrow$ precipitates albumin into tin- containing macroaggregates; lyophilization prolongs stability; added ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate is reduced by SnCl 2 and tagged onto the MAA particles\nQuality control (USP guidelines):\n(1) $90 \\%$ of particles should have a diameter of $10-90 \\mu \\mathrm{~m}$\n(2) No particle should exceed $150 \\mu \\mathrm{~m}$\n(3) Should $\\geq 90 \\%$ pure $\\leftarrow$ ascending chromatography\n(4) ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MAA batch should be used $<8 \\mathrm{hr}$ post preparation\n(5) Preparation should not be backflushed with blood into syringe $\\rightarrow$ \"hot spots\" in lung images\nPhysical half-life: 6 hr\nBiologic half-life: 6 hr\nDose: $\\sim 2-4-6 \\mathrm{mCi}+0.14 \\mu \\mathrm{~g} / \\mathrm{kg}$ albumin corresponding to $>60,000$ particles (200,000700,000 particles recommended for even spatial distribution + good image quality) N.B.: $\\downarrow$ number of particles to $50,000-80,000$ in\n(a) critically ill patients with severe COPD, on mechanical ventilator support, documented pulmonary arterial hypertension, significant left-to-right cardiac shunts $\\rightarrow$ NO reduction in tagged activity!\n(b) children up to age 5 need reduction in number of particles + tagged activity!\nÂ» IV injection in supine position to give an even distribution between base + apex of lung (ventral to posterior gradient persists)\nÂ» imaging in upright position to allow maximum expansion of lung, especially at lung bases\nRadiation dose $(\\mathrm{rad} / \\mathrm{mCi}): \\quad 0.013$ for whole body, 0.25 for lung (critical organ), 0.01 for gonads\nPhysiology:\n$90 \\%$ of MAA particles act as microemboli $\\rightarrow$ trapped in an estimated 600 million pulmonary arterioles small enough to trap the particles on 1st pass; physiologically insignificant effect $\\rightarrow$ only 500,000 particles are injected per study; $0.22 \\%(2 \\div 1,000)$ of capillaries become occluded; protein is lysed within 6-8 hours and taken up by RES; particles $<1 \\mu \\mathrm{~m}$ are phagocytized by RES in liver + spleen",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 587,
            "markdown": "Imaging: Large-field-of-view scintillation camera + parallel-hole low-energy collimator with identical recording times for corresponding views\nViews:\n$>$ anterior, posterior\n> posterior oblique (LPO, RPO): additional information in $50 \\% \\leftarrow$ segmental delineation of basal segments and $\\leftarrow$ separation of both lungs\n> anterior oblique (LAO, RAO): oblique views reduce equivocal findings from $30 \\%$ to $15 \\%$\n> lateral: \"shine through\" from contralateral lung\nCounts: $750,000-1,000,000$ counts for each image\n\n# 99mTc-Human Albumin Microspheres (HAM) \n\nParticle size: $20-30 \\mu \\mathrm{~m}$\nBiologic half-life: 8 hours\n\n## Ventilation agents\n\n${ }^{133} \\mathrm{Xe},{ }^{127} \\mathrm{Xe},{ }^{125} \\mathrm{Xe},{ }^{81 \\mathrm{~m}} \\mathrm{Kr},{ }^{13} \\mathrm{~N},{ }^{1}{ }_{5} \\mathrm{O}_{2},{ }^{11} \\mathrm{CO}_{2},{ }^{11} \\mathrm{CO}$, radioactive aerosol ( ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{DTPA},{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ PYP, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled ultrafine dry dispersion of carbon \"soot\")\n\n## 133Xenon\n\nFission product of 235 U\nDecay: to stable 133Cs under emission of beta particle ( 374 keV ), gamma ray ( 81 keV ), x-ray ( 31 keV ); beta-component responsible for high radiation dose of 1 rad to lung)\nPhysical half-life: 5.24 days\nBiologic half-life: $2-3 \\mathrm{~min}$\nPhysical properties: highly soluble in oil + grease, absorbed by plastic syringe\nAdministration: injection into mouth piece of a disposable breathing unit at the beginning of a maximal inspiration\nDose: $15-20 \\mathrm{mCi}$\nTechnique:\nVentilation study preferably done before perfusion scan to avoid interference with higher-energy ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ (Compton scatter from ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ into lower 133Xe photopeak); [may be feasible after perfusion scan if dose of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MAA is kept below $2 \\mathrm{mCi}+$ concentration of 133 Xe is above $10 \\mathrm{mCi} / \\mathrm{L}$ of air and if 133 Xe acquisition times for washing, equilibrium, washout images are kept to about 30 sec ]\n$\\diamond$ Posterior imaging routine, ideally in upright position\nPhase $1=$ single-breath image:\n$=$ inhalation of $10-20 \\mathrm{mCi} 133 \\mathrm{Xe}$ to vital capacity with breath-holding over $10-30$ seconds ( $65 \\%$ sensitivity for abnormalities)\n$\\sqrt{ }$ cold spot is abnormal\nPhase $2=$ equilibrium phase:\n$=$ tidal breathing $=$ closed-loop rebreathing of $133 \\mathrm{Xe}+$ oxygen for $3-5$ minutes for tracer to enter poorly ventilated areas; also functions as internal control for air leaks",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 588,
            "markdown": "Â» posterior oblique + posterior images are obtained to improve correlation with perfusion scan\n$\\checkmark$ activity distribution corresponds to aerated lung\nPhase $3=$ washout phase:\n$=$ clearance phase after readjusting intake valves of spirometer permits patient to inhale ambient air and to exhale 133 Xe into shielded charcoal trap\nÂ» washout phase should last $>5$ minutes\nÂ» images taken at $30-60$-second intervals for $>5 \\mathrm{~min}$\n$\\checkmark$ rapid clearance within 90 seconds yields slight normal retention in upper zones\n$\\checkmark$ tracer retention (hot spot) at 3 minutes reveals areas of air-trapping\n$\\checkmark$ poor image quality secondary to significant scatter\n$\\checkmark$ abnormal scan:\n(a) COPD / acute obstructive disease:\n$\\checkmark$ delayed wash-in (during initial 30 seconds of tidal breathing)\n$\\checkmark$ tracer accumulation on equilibrium views $\\leftarrow$ partial obstruction with collateral air drift + diffusion into affected area via bloodstream\n$\\checkmark$ delayed washout $=$ retention $>3$ minutes $\\leftarrow$ air trapping\n$\\checkmark$ tracer retention in regions not seen on initial single-breath view $\\leftarrow$ collateral airdrift into abnormal lung zones\n(b) consolidated lung disease\n$\\checkmark$ no tracer uptake throughout imaging sequence\n\n# 127Xenon \n\ncyclotron-produced with high cost\nPhysical half-life: 36.4 days\nPhoton energies: $172 \\mathrm{keV}(22 \\%), 203 \\mathrm{keV}(65 \\%)$\nAdvantages:\n(1) High photon energy allows ventilation study following perfusion study\n(2) Decreased radiation dose ( 0.3 rad)\n(3) Storage capability because of long physical half-life\n\n## ${ }^{81 m}$ Krypton\n\ninsoluble inert gas; eluted from 81 Rb generator (half-life of 4.7 hr ); decays to 81 Kr by isomeric transition\nPhysical half-life: 13 sec\nBiologic half-life: $<1 \\mathrm{~min}$\nPrincipal photon energy: $190 \\mathrm{keV}(65 \\%$ abundance)\nAdvantages:\n(1) Higher photon energy than ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ so that ventilation scan can be performed following perfusion study\n(2) Each ventilation scan can be matched to perfusion scan without moving patient\n(3) Can be used in patients on respirator (no contamination due to short half-life)\n(4) Low radiation dose (during continuous inhalation for 6-8 views 100 mrad are delivered)\nDisadvantages:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 589,
            "markdown": "(1) High cost\n(2) Limited availability (generator good only for one day, so weekend availability may not be possible\n(3) No washout images possible $\\leftarrow$ short half-life\n(4) Decreased resolution $\\leftarrow$ septal penetration with low-energy collimators\n$\\checkmark$ lack of activity = abnormal area (tracer activity is proportional to regional distribution of tidal volume\n\n# 99m Tc-DTPA Aerosol \n\n$=99 \\mathrm{mTc}$-diethylenetriaminepentaacetic radioaerosol\n$=$ UltraVent ${ }^{\\circledR}$\nBiological half-life: 55 min\nAdministration: delivery through a nebulizer during inspiration\nDose: $30-50 \\mathrm{mCi}$ in $2-3 \\mathrm{~mL}$ of saline added to nebulizer unit and connected to wall oxygen at a flow rate of $8-10 \\mathrm{~L} / \\mathrm{min}$\nPhysiology:\nradioaerosols are small particles that become impacted in central airways, sediment in more distal airways, experience random contact with alveolar walls during diffusion in alveoli; cross respiratory epithelium with rapid removal by bloodstream\n$\\diamond$ Less physiologic indicator of ventilation + subject to nebulization technique\n$\\diamond$ Erect position preferable for basilar perfusion defects (dependent lung region receives more ventilation + radiotracer)\nTechnique:\nÂ» breathing from nebulizer for 3-5 minutes\nÂ» images recorded in multiple projections, each for 100,000 counts\n$\\diamond$ Aerosol applied ideally before perfusion; however postperfusion aerosol imaging is possible to assess for \"fill-in\" of aerosol in region of perfusion defect\n$\\diamond$ The count rate of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MAA activity must be $>4$ times the count rate of the ventilation activity!\n$\\checkmark$ abnormal scan:\n(a) COPD\n$\\checkmark$ decreased activity in peripheral lung (slow and turbulent airflow prevents a normal amount of aerosol to reach the involved lung)\n$\\checkmark$ central airway deposition (aerosol sticks to trachea + bronchial walls)\n(b) consolidated lung disease\n$\\checkmark$ absent tracer\n99m Tc-labeled Ultrafine Carbon Particles (Technegas)\npreferred in pulmonary obstructive disease\n\n## Carbon Dioxide Tracer\n\n${ }^{15} \\mathrm{O}$-labeled carbon dioxide\nPhysical half-life: 2 min (requires on-site cyclotron)\nPhysiology: inhalation of carbon dioxide; rapid diffusion across alveolar-capillary membrane; clearance from lung within sec",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 590,
            "markdown": "$\\sqrt{ }$ cold spot $\\leftarrow$ failure of tracer entry into airway = airway disease\n$\\sqrt{ }$ hot spot $\\leftarrow$ delayed / absent tracer clearance $=$ perfusion defect $(87 \\%$ sensitive, $92 \\%$ specific)\nIndications:\n\n1. Emboli can be detected in preexisting cardiopulmonary disease\n2. Equivocal / indeterminate V/Q studies\n\n# Positron Emission Tomography for Lung Tumor \n\nDose: $\\quad 10 \\mathrm{mCi}$ FDG\nTechnique:\nÂ» patient fasts for 4 hours\n$\\diamond \\uparrow$ serum glucose may cause a decrease in FDG uptake!\n$\\diamond$ Blood glucose level of diabetic should be $<200 \\mathrm{mg} / \\mathrm{dL}$\nÂ» imaging 30-45-60 minutes after IV injection in 30-45 image planes ( 15 cm axial field of view; resolution of 5 mm )\nÂ» calculation of maximum standardized uptake ratio (SUV) in region of interest\n$\\diamond$ SUV $>2.5$ indicates malignant disease\nIndications:\n(1) Evaluation of solitary pulmonary nodule\n(2) Staging (PET-CT better than any other technique)\n(3) Recurrent disease\n\n## HEART SCINTIGRAPHY\n\n## Cardiac Imaging Choices\n\n1. PLANAR imaging\n2. SPECT imaging\n3. QUANTITATIVE analysis\n$=$ circumferential profiles $=$ plotting of average counts along equally spaced radii emanating from center of LV makes interpretation more objective + reproducible\n\n## Planar Imaging\n\n$\\sqrt{ }$ tracer defect may be visible on only one image projection\n$\\sqrt{ } 15-20 \\%$ regional tracer intensity variation is normal\n\n## Left Ventricular Anatomy and Projections\n\nA. AP\n$\\sqrt{ }$ displays anterolateral wall, apex, inferior wall\n$\\sqrt{ }$ decreased activity at apex of $\\mathrm{LV} \\leftarrow$ thinning in $50 \\%$\nB. LEFT LATERAL\n$\\sqrt{ }$ displays inferior + anterior wall\nC. LAO $40^{\\circ} /$ LAO $70^{\\circ}$\n$\\diamond$ Most often used projection; for all exercise studies\n$\\sqrt{ }$ displays interventricular septum, posterior wall, inferior wall\n$\\sqrt{ }$ best projection to separate right + left ventricles",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 591,
            "markdown": "$\\sqrt{ }$ best projection to evaluate septal + posterior LV wall motion\nD. RAO $45^{\\circ}$\n$\\sqrt{ }$ displays anterior + inferior ventricular wall\n$\\sqrt{ }$ useful during $1^{\\text {st }}$-pass studies with temporal separation of ventricles\nE. LPO $45^{\\circ}$ (rarely used)\n$10^{\\circ}$ caudal tilt minimizes LA contamination of LV region\n$\\sqrt{ }$ displays anterior + inferior ventricular wall\n$\\sqrt{ }$ preferred over RAO $45^{\\circ}$ because LV is closer to camera\nF. Angled LAO (slant-hole collimator / caudal tilt)\n$\\sqrt{ }$ separates ventricular from atrial activity\n$\\sqrt{ }$ highlights apical dyskinesis\n\n# Location of Perfusion Defects on Planar Images \n\n(1) Right coronary artery (RCA) best seen on left LAT / AP projections\n$\\sqrt{ }$ inferior + posteroseptal segments\n(2) Circumflex branch of left coronary artery (LCX) best seen on LAO projection\n$\\sqrt{ }$ posterolateral segment\n(3) Anterior descending branch of left coronary artery (LAD)\n$\\sqrt{ }$ anteroseptal, anterior, anterolateral segments\nN.B.: decreased activity in apical + posterior segments is not reliably correlated with disease of any vessel!\n\n## SPECT Myocardial Perfusion Imaging (MPI)\n\nimproves object contrast by removing overlying tissues; cinematic display of wall motion; EF calculation\n$\\sqrt{ }$ tracer defect should be visible on more than one image set\n$\\sqrt{ }$ up to $30 \\%$ regional tracer intensity reduction compared with peak activity is normal\n(a) Standard SPECT $180^{\\circ}$ acquisition extending from $45^{\\circ} \\mathrm{RAO}$ to $45^{\\circ} \\mathrm{LPO}$ for single-head camera\n(b) ECG-gated SPECT\n$\\sqrt{ }$ viable although hypoperfused myocardium may demonstrate systolic contraction + wall thickening\n$\\sqrt{ }$ geometric EF calculation based on ROIs drawn on end-systolic + end-diastolic frames (different from blood pool scans)\n\n## Display of SPECT Images\n\nSPECT $=$ single photon emission tomography\n\n- stress study $=$ top row\n- resting study $=$ second row\n\n1. Short-axis views (SA): apex $\\rightarrow$ base\n2. Horizontal long axis (HLA): inferior $\\rightarrow$ superior (anterior)\n3. Vertical long axis (VLA): septum $\\rightarrow$ lateral\n\n## Rotating (Cine) Planar Images\n\n$=$ rotating (cine loop) of stress + rest planar images for a review of unprocessed raw data to recognize artifacts",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 592,
            "markdown": "# Analysis of Tomographic Slices \n\n## Quality control:\n\n1. Assess count statistics: poor, fair, good, excellent\n$\\rightarrow$ peak pixel activity in LV myocardium should exceed 100 counts for ${ }^{201} \\mathrm{Tl}$ and 200 counts for ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$\n2. Review raw data sets in cinematic display to determine if any artifact is present due to\n(a) patient movement\n(b) respiratory motion\n(c) extracardiac uptake (eg, lymphoma, breast cancer)\n3. Review sinogram of cardiac (horizontal) motion for extracardiac uptake (eg, in lungs or esophagus) and motion-related artifact\nCavity Size:\n> cavity-to-wall thickness ratio\n> poststress images with larger cavity than rest images = stress -induced transient ischemic dilatation (TID) $>1.22 \\leftarrow$ stress-induced subendocardial ischemia indicative of severe and extensive multivessel coronary artery disease + high risk for a hard cardiac event\n> dilatation on rest + stress images indicates LV dysfunction / volume overload\n\n## ECG-gated SPECT\n\ndisplayed as individual tomographic slices / 3-D cine loop ( 8 frames per cardiac cycle); spatial + temporal changes in tracer activity reflect regional myocardial wall motion + thickening\nEvaluation for:\n> global function\n$\\sqrt{ }$ LV ejection fraction normal $/\\geq 60 \\%$\n$\\sqrt{ }$ end-diastolic + end-systolic LV volumes\nnormal EDV: $95 \\pm 27 \\mathrm{~mL}(\\mathrm{M}), 64 \\pm 19 \\mathrm{~mL}(\\mathrm{~F})$\nnormal ESV: $41 \\pm 17 \\mathrm{~mL}(\\mathrm{M}), 22 \\pm 12 \\mathrm{~mL}(\\mathrm{~F})$\n> endocardial surface\n> motion of endocardial + epicardial surfaces\n> myocardial thickening (brightening)\n> regional LV wall motion abnormalities graphically depicted as 3-D plot\n$0=$ normal\n$1=$ mildly hypokinetic\n$2=$ moderately hypokinetic\n$3=$ severely hypokinetic\n$4=$ akinetic\n$5=$ dyskinetic\n> RV size + perfusion + wall motion\nCalculated automated algorithm (QPS, Cedars-Sinai):\n(a) Myocardial contour of endo- and epicardial surfaces overlying end-diastolic + endsystolic frames displayed on 3 short-axis images (apical, midventricular, basal) on midcavity horizontal and midcavity vertical long-axis image",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 593,
            "markdown": "(b) Quantitative polar plots measuring regional myocardial perfusion at end diastole and end systole (in \\%), motion (in 10 mm ), and wall thickening (in \\%)\n(c) Three-dimensional display of endocardial (solid) and epicardial (grid) LV surfaces\n(d) Endocardial time-volume curve during R-R interval, endsystolic and end- diastolic volumes, and LVEF",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 594,
            "markdown": "![img-36.jpeg](img-36.jpeg)",
            "images": [
                {
                    "id": "img-36.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 191,
                    "bottom_right_x": 1127,
                    "bottom_right_y": 2006,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 595,
            "markdown": "# Interpretation: \n\n$\\sqrt{ }$ reversible defect (perfusion defect on stress + no defect on rest images) = myocardial ischemia\n$\\sqrt{ }$ nonreversible (fixed) defect from stress to rest $\\rightarrow$\n(a) myocardial infarct\n(b) attenuation artifact if associated with normal regional wall thickening / wall motion\nValue of review of gated SPECT images:\n> reduction in number of borderline interpretations\n> increase in \"definitely normal\" from $74 \\%$ to $93 \\%$\nTechnique:\nÂ» patient supine with arms raised above head\nÂ» nylon belt wrapped snugly around abdomen to minimize respiratory motion\n\n1. Low-dose ( $0.2-0.4-\\mathrm{mSv}$ ) end-tidal expiratory breath-hold CT to obtain an attenuation map\n2. ECG-gated SPECT with a frame rate of $8-16$ per cardiac cycle with forwardbackward gating to allow rejection of premature and postpremature heartbeats by using an acceptance window of $20-30 \\% \\mathrm{R}-\\mathrm{R}$ variation\nÂ» symmetric $15 \\%$ energy window centered at $140 \\mathrm{keV}=$ photopeak energy of 99 mTc sestamibi\nÂ» low-energy high-resolution parallel hole collimators\nÂ» acquisition parameters include $90^{\\circ}$ rotation (with use of two camera heads) + noncircular orbit with step-and-shoot acquisitions\n3. Reconstruction of SPECT images (for $128 \\times 128$ matrix)\n(a) without attenuation by filtered back projection method\n(b) with attenuation correction by iterative ordered subset expectation maximum algorithm and filtering\n(c) careful coregistration of myocardial perfusion imaging data set with CT attenuation map\n(d) display in traditional cardiac planes + as polar maps normalized to myocardial region with highest counts\n(e) compare normalized map with database of normalized polar maps from subjects with verified normal left ventricular perfusion\n\n## Ejection Fraction\n\nEjection fraction (EF) = stroke volume (SV) divided by end-diastolic volume (EDV)\nstroke volume $=$ end-diastolic volume (EDV) minus end-systolic volume (ESV)\n\n$$\n\\begin{aligned}\n& \\text { EF }=\\text { [EDV }- \\text { ESV }] /[\\text { EDV }] \\\\\n& =[\\text { EDcounts }- \\text { EScounts }] /[\\text { EDcounts }- \\text { BKGcounts }]\n\\end{aligned}\n$$\n\nsensitive indicator of left ventricular function\n@) Left ventricle\n> calculated on shallow LAO view\nNormal value $50-65 \\%$ ( $5 \\%$ variation)\nDefinitely abnormal $<50 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 596,
            "markdown": "Hypertrophic myocardium $>65 \\%$\n$\\diamond$ Peak exercise LVEF is an independent predictor of coronary artery disease\n@ Right ventricle\nmean normal value $>45 \\%$\n(RV ejection fraction is smaller than for LV because RV has greater EDV than LV but the same stroke volume)\nVariability of $E F$ :\nLVEF is not a fixed number for any patient but varies with: heart rate, blood pressure, level of circulating catecholamines, patient position, medications\nAccuracy in detection of coronary artery disease:\n(a) Exercise EF: $87 \\%$ sensitive; $92 \\%$ specific\n(b) Exercise ECG: $60 \\%$ sensitive; $81 \\%$ specific\n\n# Interpretation: \n\n$\\diamond$ Ventricular function at rest is insensitive to CAD!\n(1) at rest\n$\\sqrt{ }$ EF may be decreased in CAD\n$D D x$ : cardiomyopathy, valvular disease\n$\\sqrt{ }$ correlates well with clinical severity + regional distribution of myocardial infarction\n(2) during exercise\n$\\sqrt{ }$ reduced (hypokinetic) / absent (akinetic) / paradoxical (dyskinetic) wall motion indicate varying degrees of CAD / myocardial infarction\n$\\sqrt{ }$ focal akinetic / dyskinetic area = aneurysm\n$\\sqrt{ }$ paradoxical septal motion (= septal movement to right in systole) may reflect septal infarction, left bundle branch block, S/P bypass surgery\nShortcoming:\npoor study in patients with atrial fibrillation because of inability to achieve adequate cardiac gating (exercise MUGA can yield more sensitive assessment of coronary artery disease)\nFalse-positive with (a) inadequate exercise\n(b) recent ingestion of meal\n![img-37.jpeg](img-37.jpeg)\n\n## Blood Pool Agents\n\n## 99m Tc-DTPA / 99m Tc-Sulfur Colloid\n\npreferred for cardiac first-pass studies as they allow multiple studies with little residual from any preceding study",
            "images": [
                {
                    "id": "img-37.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 1425,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1782,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 597,
            "markdown": "# ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled Autologous RBCs \n\n$=$ agent of choice because of good heart-to-lung ratio\n(1) IN VIVO LABELING\nÂ» IV injection of reducing agent stannous pyrophosphate ( 1 vial PYP diluted with 2 mL sterile saline $=15 \\mathrm{mg}$ sodium pyrophosphate containing 3.4 mg anhydrous stannous chloride)\nÂ» $15-20-30 \\mathrm{~min}$ later injection of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate ( +7 ), which binds to \"pretinned\" RBCs (reduction to ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}[+4]$ )\n$\\diamond$ Least time-consuming + easiest method!\n$\\diamond$ Worst labeling efficiency ( $30 \\%$ not tagged to RBCs + excreted in urine)!\n(2) IN VIVTRO LABELING\n$=$ MODIFIED IN VIVO METHOD\n$\\diamond$ Preferred over in vivo because of high labeling efficiency within syringe, which reduces exposure to plasma constituents + creates little free pertechnetate!\nÂ» IV injection of 1 mg stannous pyrophosphate\nÂ» 10 min later $2-5-10 \\mathrm{~mL}$ of blood are drawn into a heparinized syringe\nÂ» $10-20-\\mathrm{min}$ incubation period with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate\nÂ» reinjection of preparation in 3-way stopcock technique\nN.B.: poor tagging in\n(a) heparinized patient\n(b) injection through IV line (adherence to wall)\n(c) syringe flushed with dextrose instead of saline\n(3) IN VITRO LABELING\n$\\diamond$ Most reliable labeling method!\nÂ» 50 mL drawn blood incubated with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ reduced by stannous ion; RBCs washed and reinjected\nN.B.: Labeling kit (with chelating + oxidizing substances) allows excellent in vitro labeling with only 3 mL of blood and $15-\\mathrm{min}$ incubation period!\nDose: $15-20-30 \\mathrm{mCi}$ (larger dose required for stress MUGA + obese patients); for children: $200 \\mu \\mathrm{Ci} / \\mathrm{kg}$; minimum dose of $2-3 \\mathrm{mCi}$\nRadiation dose: 1.5 rad for heart, 1.0 rad for blood, 0.4 rad for whole body\n\n## ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-HSA\n\n$\\mathrm{HSA}=$ human serum albumin\nIndication: drug interference with RBC labeling (eg, heparinized patient)\nPhysiology:\n(a) albumin slowly equilibrates in extracellular space\n(b) poorer heart-to-lung ratio than with labeled RBCs\n\n## Ventricular Function\n\n## First-pass Ventriculography\n\n$=$ FIRST-PASS RADIONUCLIDE ANGIOGRAPHY $=$ FIRST TRANSIT\n$=$ recording of initial transit time of an intravenously administered tight ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ bolus through heart + lungs; limited number of cardiac cycles available for interpretation;",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 598,
            "markdown": "additional projections / serial studies require additional bolus injection\nAccuracy: good correlation with contrast ventriculography\nAgents: pertechnetate, pyrophosphate, albumin, DTPA, sulfur colloid (almost any ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ labeled compound except lung scanning particles), ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled autologous RBCs\nIndications:\n(1) Only 15 seconds of patient cooperation required\n(2) Calculation of cardiac output + ejection fraction (RBCs)\n(3) Subsequent first-pass studies within 15-20 minutes of initial study possible (DTPA)\n(4) Separate assessment of individual cardiac chambers in RAO projection (temporal separation without overlying atria, pulmonary artery, aortic outflow tract), eg, for right ventricular EF and intracardiac shunts\nMinimal dose: 10 mCi\nTechnique:\nÂ» cannulation of antecubital / external jugular vein with $\\geq 20$ ga needle attached to 3way stopcock and two syringes:\nÂ» syringe 1 contains $\\leq 1 \\mathrm{~mL}$ of radiotracer\nÂ»syringe 2 contains a saline flush ( $10-20 \\mathrm{~mL}$ )\nÂ» injection of radiotracer $\\rightarrow$ followed by a strong flush of saline\nGating:\nimproved images obtained by selection of time interval corresponding only to RV passage of bolus averaged over several (3-5) individual beats; gating may be done intrinsically or with ECG guidance\nImaging: region of interest (ROI) over RV silhouette in RAO projection; background activity taken over horseshoe-shaped ventricular wall; counts in ROI displayed as function of time; 25 frames/second for $20-30$ seconds\nQuality Control:\n(a) Bolus Adequacy:\n> good $=$ FWHM of time activity curve $<1$ second\n> adequate $=$ FWHM of $1-1.5$ seconds\n> delayed $=$ FWHM of $>1.5$ seconds\n> split $=$ more than one discrete peak\nProblem: delayed bolus may cause oversubtraction of background resulting in spurious $\\uparrow$ in LVEF, $\\downarrow$ in LV volume, overestimation of regional wall motion\n(b) Count Statistics\n$>4000-5000 \\mathrm{cps}$ (counts per second) of LV end-diastolic counts in the representative cycle\n(c) Tracer Transit Time\nvisual examination of bolus transiting the central circulation\n(d) Beat Selection\nonly beats with end-diastolic counts of $\\geq 70 \\%$ of peak end-diastolic counts\n(e) Background Selection\na frame close to the beginning of the LV phase\nNormal passage of bolus: SVC, RA, RV, lungs, LA, LV, aorta",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 599,
            "markdown": "R-to-L shunt: tracer appears in left side of heart before passage through lungs Evaluation of:\n\n1. Obstruction in SVC region\n2. Reflux from RA into IVC / jugular vein\n3. Stenosis in pulmonary outflow tract\n4. R-L shunt\n5. Contractility of RV\n6. Sequential beating of RA and RV\n7. Ejection fraction of RV and LV\n\nCardiac Rhythm \\& Conduction:\nRegional wall motion + LVEF may be effected by:\n(1) Frequent premature ventricular contractions (PVCs)\n(2) Ventricular bigeminy\n(3) Very irregular atrial fibrillation\n(4) Pacemaker rhythm: from apex $\\rightarrow$ to base\n(5) Left bundle branch block (LBBB)\n$\\sqrt{ }$ infero- / anteroapical wall motion abnormalities\nN.B.: paradoxical septal motion not detectable in RAO projection\n\n# Equilibrium Images \n\n= \"blood pool\" radionuclide cardioangiography\nAgents: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-labeled autologous RBCs (most commonly) / human serum albumin\nImaging: after thorough mixing of radiotracer throughout vascular space\nÂ» acquisition of images during selected portions of cardiac cycle triggered by R-wave; each image is composed of $>200,000$ counts ( $2-10$ minutes) obtained over $500-1,000$ beats after equilibrium has been reached; high-quality images can be obtained in different projections\nÂ» gated acquisition from 16-32 equal subdivisions of the R-R cycle (electronic bins) allows display of synchronized cinematic images (assembled to composite single-image sequence) of an \"average\" cardiac cycle\n$\\sqrt{ }$ may be displayed as time activity curves reflecting changes in ventricular counts throughout R-R interval\n> measured functional indices: preejection period (PEP), left ventricular ejection time (LVET), left ventricular fast filling time (LVFT1), left ventricular slow filling time (LVFT2), PEP/LVET ratio, rate of ejection + filling of LV\nÂ» at rest: count density of 200-250 counts/pixel requires generally $7-10$ minutes acquisition time for $200,000-250,000$ counts/frame\nÂ» during exercise: $100,000-150,000$ counts/frame requires an acquisition time of 2 minutes\nEvaluation of:\n\n1. LV ejection fraction\n2. Regional wall motion\n3. Valvular regurgitation\n\nInterpretation:\n\n1. Heart failure: decreased EF, prolongation of PEP, shortening of LVET, decreased rate",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 600,
            "markdown": "of ejection\n2. Hypertensive heart: normal systolic indices, normal EF, prolonged LVFT1\n3. Hypothyroidism: prolonged PEP, normal EF\n4. Aortic stenosis: mild reduction of EF, prolonged LV emptying time, decreased rate of ejection, normal rate of filling\n$\\sqrt{ }$ area of decreased periventricular uptake secondary to\n(a) pleural effusion $>100 \\mathrm{~mL}$\n(b) ventricular hypertrophy\n\n# Gated Blood Pool Imaging \n\n$=$ MULTIPLE GATED ACQUISITION (MUGA)\n$=$ gated equilibrium images depict average cardiac contraction by summation over several minutes\nRecording of:\n(1) Ejection fraction (EF) of left ventricle before + after exercise ( $>6$ million counts, 32 frames)\n(2) Regional wall motion of ventricular chambers ( $>4.5$ million counts, 24 frames)\n(a) at rest: myocardial infarction, aneurysm, contusion\n(b) during exercise: ischemic dyskinesia (detectable in 63\\%)\n(3) Regurgitant index\n\nProjection:\n(a) septal view (usually LAO $45^{\\circ}$ ) best for EF; often requires some cephalad tilting of detector head\n(b) two additional views for evaluation of wall motion (usually anterior + left lateral views)\nImaging:\nphysiologic trigger provided by R-R interval of ECG (\"bad beat\" rejection program\ndesirable); R-R interval divided into typically about 20 frames; several hundred cardiac\ncontractions are summed (depending on count density) for each planar projection\n(a) gated images obtained for 5 minutes\n(b) 2-min image acquisition time for each stage of exercise\n\nPROs: (1) Higher information density than 1st-pass method\n(2) Assessment of pharmacologic effect possible\n(3) \"Bad beat\" rejection possible\n\nCONs: (1) Significant background activity\n(2) Inability to monitor individual chambers in other than LAO $45^{\\circ}$ projection\n(3) Plane of AV valve difficult to identify\n\nRadiation dose: 1.5 rad for heart; 1.0 rad for blood; 0.4 rad for whole body\nQualitative evaluation:\n(1) Chamber size\n(2) Wall thickness\n(3) Regional wall motion\n\n## Myocardial Perfusion Imaging Agents",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 601,
            "markdown": "Most commonly used: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ sestamibi $+{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ tetrofosmin\nPreparation: Â» NPO for 4 hours before perfusion imaging\nÂ» NO caffeine for $12-24$ hours before exam\nAt discretion of referring physician:\nÂ» withhold consumption of $\\beta$ - and calcium channel blockers for 24 hours before imaging\nÂ» long-acting nitrates should be withheld the day of the exam\n\n# 43Potassium \n\nNot suitable for clinical use because of its high energy\n\n## ${ }^{201}$ Thallium-chloride\n\n$=$ cation produced in cyclotron from stable ${ }^{203} \\mathrm{Tl}$\n$=$ image agent of choice to assess myocardial viability\nCyclotron: by $(\\mathrm{p}, 3 \\mathrm{n})$ reaction to radioactive 201 Pb (half-life of 9.4 hours) $\\rightarrow$ decays by electron capture to ${ }^{201} \\mathrm{Tl}$\nDecay: by electron capture to ${ }^{201} \\mathrm{Hg}$\nEnergy spectrum: $69-83 \\mathrm{keV}$ of $\\mathrm{Hg}-\\mathrm{K}$ x-rays ( $98 \\%$ abundance); $135 \\mathrm{keV}(2 \\%)+167 \\mathrm{keV}$ ( $8 \\%$ abundance) gamma photons\nPhysical half-life: 74 hours\nBiologic half-life: $10 \\pm 2.5$ days\nDose: low dose of $3-4 \\mathrm{mCi}$ (the larger dose for SPECT) because of long half-life and slow body clearance\nRadiation dose:\n3 rad for kidneys (critical organ) $(=1.2 \\mathrm{rad} / \\mathrm{mCi}) ; 1.2 \\mathrm{rad}$ for gonads $(=0.6 \\mathrm{rad} / \\mathrm{mCi})$;\n0.7 rad for heart + marrow $(=0.34 \\mathrm{rad} / \\mathrm{mCi}) ; 0.5 \\mathrm{rad}$ for whole body $(=0.24 \\mathrm{rad} / \\mathrm{mCi})$\n\nQuality control: should contain $<0.25 \\% 203 \\mathrm{~Pb} ;<0.5 \\%{ }^{202} \\mathrm{Tl}(439 \\mathrm{keV})$\nIndications:\n\n1. Acute myocardial infarction\n2. Coronary artery disease\nÂ» particularly useful over ECG in:\n(a) conduction disturbances: eg, bundle branch block, preexitation syndrome\n(b) previous infarction\n(c) under drug influence: eg, digitalis\n(d) left ventricular hypertrophy\n(e) hyperventilation\n(f) ST depression without symptoms\n(g) if stress ECG impossible to obtain\n\nThallium uptake \\& distribution:\n> intracellular uptake via $\\mathrm{Na} / \\mathrm{K}$-ATPase (analogue to ionic potassium), but less readily released from cells than $\\mathrm{K}+$\n> distribution is proportional to regional blood flow\n> uptake depends on\n(1) quality of regional perfusion\n(2) viable cells with integrity of $\\mathrm{Na} / \\mathrm{K}$ pump\n@ Blood pool $<5 \\%$ remain in blood pool 15 minutes post injection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 602,
            "markdown": "@ Myocardial uptake depends on\n(a) myocardial perfusion\n(b) myocardial mass\n(c) myocardial cellular integrity\n$\\diamond$ First-pass extraction efficiency is $88 \\%$ !\nREMEMBER: $90 \\%$ in 90 seconds!\n$>4 \\%$ of total dose localizes in myocardium at rest (myocardial blood flow $=4 \\%$ of cardiac output)\n> peak myocardial activity occurs at 5-15 minutes after injection\n> uptake can be increased to $8-10 \\%$ with dipyridamole stress\n> clearance from myocardium is proportional to regional perfusion + begins within a few min after injection (\"wash out\"); zones of initially higher uptake wash out more rapidly than areas of low uptake (= \"redistribution\")\n@ Skeletal muscle + splanchnicus: first-pass extraction efficiency is $65 \\%$\n> accumulate $40 \\%$ of injected dose\n$>4-6$ hour fast + exercise $\\rightarrow \\downarrow$ flow to splanchnicus and $\\uparrow$ cardiac uptake\n@ Lung: $10 \\%$ of total dose localizes in lung\n> augmented pulmonary extraction with LV dysfunc-tion, bronchogenic carcinoma, lymphoma of lung\n$\\sqrt{ }<5 \\%$ activity over lung is normal\n$\\sqrt{ } \\downarrow$ heart-to-lung ratio with triple-vessel disease\n@ Kidney: accumulates $4 \\%$ of injected dose\n> excretion of $4-8 \\%$ within 24 hours\n@ Thyroid:\n$\\sqrt{ }$ increased uptake $>1 \\%$ in Graves disease + thyroid ca.\n@ Brain:\n$\\sqrt{ }$ uptake only if blood-brain barrier disrupted\nTechnique:\nA. Single dose method\nÂ» 3 mCi injected at peak exercise for exercise image immediately + rest image 3 hours later\nB. Split dose method\nÂ» 2 mCi injected for exercise image\nÂ» 1 mCi reinjected at rest after 3 hours with rest image taken 30 minutes later\nC. Booster reinjection technique\nÂ» reinjection of thallium followed by imaging after 18-24-72 hours $\\uparrow$ blood concentration of isotope\n= late reversibility provides evidence of regional myocardial ischemia + viability not appreciated even on very delayed ( $24-72$ hour) redistribution images; predicts scintigraphic improvement post intervention\nReasoning: $50 \\%$ of irreversible persistent defects improve significantly after booster reinjection\nImaging:\n\n1. EXERCISE IMAGE = DISTRIBUTION IMAGE\n$=$ stress thallium image",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 603,
            "markdown": "$=$ map of regional perfusion obtained within minutes after injection at peak exercise; initial distribution proportional to myocardial blood flow + arterial concentration of radioisotope + muscle mass; $300,000-400,000$ counts / view ( $\\sim 5-8$ minutes sampling time), should be completed by 30 minutes\n2. REDISTRIBUTION IMAGE\n$=$ equilibrium between tracer uptake and efflux dependent on blood flow + mass of viable tissue + concentration gradient\n$=$ map of hypoperfused ischemic but viable myocardium obtained at rest after 2-34 -6 hours; washout half-life from normal myocardium is 54 min\n3. DELAYED IMAGE (optional)\n$=$ viability study at 24 hours\n\n# Interpretation: \n\n$\\sqrt{ }$ \"apical thinning\" = less myocardial mass of cardiac apex as a normal finding\n$\\checkmark$ normally diminished tracer uptake at basal portions of ventricle (near plane of mitral valve) $\\leftarrow$ more fibrous tissue + less muscle mass\n$\\checkmark$ variation in tracer intensity by $15-20 \\%$ between regions on planar images may be normal $\\leftarrow$ soft-tissue attenuation artifacts from subdiaphragmatic abdominal contents or breast tissue\n\n| Interpretation of Stress Thallium Images |  |  |\n| :--: | :--: | :--: |\n| Immediate Image | Delayed Image | Diagnosis |\n| normal | normal | normal |\n| defect | fill-in | exertional ischemia |\n| defect | persistent | myocardial scar |\n| defect | partial fill-in | scar + ischemia / <br> persistent ischemia |\n\n1. Initial phase $=$ first-pass extraction\n$\\checkmark$ temporary defect accentuated by exercise\n$\\checkmark$ defect $>15 \\%$ of ventricular surface suggests $>50 \\%$ stenosis of coronary artery\n$\\checkmark$ right heart well seen during stress test, tachycardia, volume / pressure overload\n$\\checkmark$ dilated heart cavity on stress images (but not on rest images) $\\leftarrow$ exercise-induced LV dysfunction\n2. Redistribution phase (on 2-4-hour images)\n$\\checkmark$ washout in normal areas\n$\\checkmark$ slow continued accumulation of tracer for areas of greatly $\\Downarrow$ perfusion\n$\\checkmark \\uparrow$ uptake in viable ischemic zones (\"redistribution\")\n$\\checkmark$ permanent defect = nonviable myocardium as in myocardial infarction / fibrosis\n$\\checkmark \\uparrow$ lung activity (ie, $>50 \\%$ of myocardial count) indicative of\n(a) left ventricular failure $\\leftarrow$ severe LCA disease / myocardial infarction\n(b) pulmonary venous hypertension $\\leftarrow$ cardiomyopathy / mitral valve disease\n$\\checkmark$ right heart faintly visualized during rest ( $15 \\%$ of perfusion to right side); $\\uparrow$ activity in RV $\\leftarrow$\n(a) $\\uparrow$ in ventricular systolic pressure\n(b) $\\uparrow$ in mean pulmonary artery pressure",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 604,
            "markdown": "(c) $\\uparrow$ in total pulmonary vascular resistance\n\nSensitivity: overall $82-84 \\%$ for stress ${ }^{201} \\mathrm{Tl}(60-62 \\%$ for exercise ECG)\n(a) increased with:\n(1) Severity of stenosis ( $86 \\%+67 \\%$ sensitive with stenosis $>75 \\%+<75 \\%$ )\n(2) Greater number of involved arteries\n(3) Stenosis of left main $>$ LAD $>$ RCA $>$ LCX\n(4) Prior infarction\n(5) High work load during exercise testing in patients with single-vessel disease\n(b) decreased with:\n(1) Presence of collaterals\n(2) Beta blockers\n(3) Time delay for poststress images\n\nSpecificity: overall $91-94 \\%$ for stress ${ }^{201} \\mathrm{Tl}(81-83 \\%$ for exercise ECG)\nFalse-positive thallium test (37-58\\%):\nA. Infiltrating myocardial disease\n\n1. Sarcoidosis\n2. Amyloidosis\nB. Cardiac dysfunction\n3. Cardiomyopathy\n4. IHSS\n5. Valvular aortic stenosis\n6. Mitral valve prolapse (rare)\nC. Decreased cardiac perfusion other than myocardial infarction\n7. Cardiac contusion\n8. Myocardial fibrosis\n9. Coronary artery spasm: severe unstable angina may cause defect after stress + on redistribution images, but will be normal at rest!\nD. Normal variant\n10. Apical myocardial thinning\n11. Attenuation by diaphragm, breast, implant, pacemaker\nmnemonic: I'M SIC\nIdiopathic hypertrophic subaortic stenosis\nMyocardial infarct without coronary artery disease\nScarring, Spasm, Sarcoidosis\nInfiltrative / metastatic lesion\nCardiomyopathy\nFalse-negative thallium test:\n12. Under influence of beta-blocker: eg, propranolol\n13. \"Balanced ischemia\" = symmetric 3-vessel disease\n14. Insignificant obstruction\n15. Inadequate stress\n16. Failure to perform delayed imaging\n17. Poor technique\nmnemonic: 3NMRS COR\n3-vessel disease (rare)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 605,
            "markdown": "Noncritical stenosis\nMedications interfering\nRight coronary lesion (isolated)\nSubmaximal exercise\nCollateral (coronary) blood vessels\nOverestimation of stenosis on angiography\nRedistribution (early / delayed)\nAdvantages compared with ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ compounds:\n(1) Higher total accumulation in myocardium\n(2) Provides redistribution information\n\nDisadvantages:\n(1) Low energy x-rays result in poor resolution $\\rightarrow$ improved with SPECT\n(2) Dose is limited by its long half-life\n(3) Half-value thickness of 3 cm results in less avid appearing myocardium: inferior wall (deeper part of myocardium) / anterolateral wall (overlain by breast)\n(4) Imaging must be completed by 45 minutes post injection or redistribution occurs\n\n# ${ }^{99 \\mathrm{~m}}$ Tc-MIBI (Sestamibi) \n\n$=$ cationic lipophilic isonitrile complex, which binds to myocyte intramitochondrial proteins\nPharmacokinetics:\n> relatively rapid clearance from circulation ( $40 \\%$ first- pass extraction) $\\leftarrow$ passive diffusion across cell membranes\n> high myocardial accumulation ( $4 \\%$ ) with nonlinear uptake proportional to regional perfusion (fall-off in extraction at higher rates of flow)\n> slow washout with long retention time in myocardium and little recirculation\n> significant hepatic + gallbladder activity\nExcretion: through biliary tree (give milk after injection and before imaging to decrease GB activity)\nDose: $25-30 \\mathrm{mCi}$ (Cardiolite ${ }^{\\circledR}$ )\nImaging: optimum images 1 hour after injection (may be imaged up until 3 hours)\nTechnique: separate injections for stress and rest studies because of slow washout\nA. 1-DAY PROTOCOL (rest-stress protocol)\n\nImproved detection of reversibility compared with stress-rest protocol\nÂ» inject $5-8 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi\nÂ» take rest images $60-90 \\mathrm{~min}$ after injection\nÂ» wait $0-4$ hours\nÂ» stress patient followed by injection with $15-25 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi at peak stress ( $\\uparrow$ myocardial blood flow means $\\uparrow$ myocardial uptake)\nÂ» image 30-60 minutes later (optimum imaging time of stress-induced defects)\nB. 2-DAY PROTOCOL (impractical stress-rest protocol):\nÂ» stress images on $1^{\\text {st }}$ day: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi given at peak stress; imaging after $30-60-$ minute delay $\\rightarrow$ to allow some clearing of liver activity\nÂ» repeat on $2^{\\text {nd }}$ day ONLY if stress views abnormal\nC. DUAL TRACER STRATEGY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 606,
            "markdown": "Â» ${ }^{201} \\mathrm{Tl}$ for initial injection\nÂ» ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sestamibi as $2^{\\mathrm{nd}}$ injection immediately afterwards $\\rightarrow$ its higher energy photons are unaffected by residual ${ }^{201} \\mathrm{Tl}$\nAdvantages over thallium:\n(1) Low radiation dose $\\leftarrow$ shorter half-life allowing larger doses with less patient radiation\n(2) Excellent imaging characteristics due to\n(a) improved photon flux $\\rightarrow$ faster imaging + ability for cardiac gating\n(b) higher photon energy $\\rightarrow$ less attenuation artifact from breast tissue / diaphragm + less scatter\n(3) NO redistribution\n(4) Temporal separation of injection and imaging allows injection during acute myocardial infarct when patient may not be stable for imaging; after stabilization + intervention (angioplasty / urokinase) imaging can demonstrate the pre-intervention defect\n(5) Low cost\n(6) Easy availability\n(7) Flexible scheduling\n(8) Increased patient throughput\n\nDisadvantage: less well suited to assess viability\n\n# ${ }^{99 \\mathrm{~m}}$ Tc-Teboroxime \n\n$=$ neutral boronic acid oxime complex\nPharmacokinetics:\n> very rapid clearance time from circulation $\\leftarrow$ rapid uptake by myocardium $=$ high extraction efficiency\n> distribution proportional to cardiac blood flow EVEN at high blood flow levels (sestamibi + thallium plateau at high levels of flow)\n> biexponential washout from myocardium + little recirculation\n> high background from lung + liver (cleared earlier and more rapidly from the liver)\nDose: $25-30 \\mathrm{mCi}$ (CardioTec ${ }^{\\circledR}$ )\nImaging: must begin immediately post injection $\\leftarrow$ rapid washout; rest image can immediately follow stress image\n\n## ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-Tetrofosmin\n\n$=$ diphosphine complex (Myoview ${ }^{\\mathrm{TM}}$ )\nRelated compounds: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{Q} 12$ (furifosmin), Q3\nPharmacokinetics:\n> lower first-pass extraction + accumulation than thallium\n> slow myocardial washout\n> rapid background clearance\n> quicker liver excretion than sestamibi\n\n## Positron Emission Tomography\n\nPerfusion agents: ${ }^{13} \\mathrm{~N}$-ammonia, ${ }^{15} \\mathrm{O}$ water, ${ }^{82} \\mathrm{Rb}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 607,
            "markdown": "Metabolic agents: ${ }^{18}$ Fluorine-deoxyglucose $=$ FDG (glycolysis), ${ }^{11}$ carbon-palmitate (beta-oxidation), ${ }^{11}$ carbon-acetate (tricarboxylic acid cycle)\n\n# Myocardial Metabolic PET \n\nPathophysiology: in myocardial ischemia glycolysis (utilization of glucose) increases while mitochondrial $\\beta$-oxidation of fatty acids decreases!\nSensitivity: $>95 \\%$\nTechnique:\nÂ» give oral glucose load\nÂ» inject 10 mCi FDG\nÂ» image after 30 min\nVariation: simultaneous injection of perfusion tracer\nInterpretation:\n$\\sqrt{ }$ mismatched defect (= decreased perfusion but enhanced metabolism indicated by FDG uptake) indicates $\\rightarrow$ viable (but dysfunctional) myocardium salvageable by revascularization procedure\n$\\sqrt{ }$ matched defect (= flow + FDG accumulation both decreased) $\\rightarrow$ nonviable myocardium\n$\\diamond 80-90 \\%$ of matching defects do NOT improve after bypass\n$\\sqrt{ }$ 11C-acetate superior to FDG (accurately reflects overall oxidation metabolism $\\leftarrow$ not influenced by myocardial substrate utilization)\nComparison with thallium:\naccuracy for fixed lesions similar; higher for reversible ischemia\n\n## Myocardial Perfusion PET\n\nAbility to detect obstructive CAD in $>1$ coronary artery with $>50 \\%$ stenosis:\n$83 \\%-100 \\%$ sensitive, $73 \\%-100 \\%$ specific, $80 \\%-100 \\%$ PPV, $36 \\%-100 \\%$ NPV, $84 \\%$ $98 \\%$ accurate\nAdvantages of PET over SPECT:\n\n1. Improved accuracy $\\leftarrow$ increased specificity + marginally improved sensitivity\n2. Capacity to quantify left ventricular function at rest + during peak stress and coronary flow reserve\n3. Better definition of extent of anatomic CAD\n4. Lower radiation dose than SPECT\n5. Integration of PET + CT for anatomic extent of CAD\n\n## Stress test\n\nRationale:\n$\\diamond$ Rest-injected images can separate viable from nonviable myocardium + detect very severe ischemia (with stenosis of $>90-95 \\%$ ), but cannot detect most coronary artery disease (CAD)!\nExercise increases myocardial work and oxygen requirement: at peak exercise blood flow may rise 5-fold from baseline through coronary artery dilatation + increase in heart rate; exercise will unveil CAD-related regional hypoperfusion relative to normal regions, if coronary artery stenosis $>50 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 608,
            "markdown": "# Physical / Physiologic / Exercise Stress Test \n\n$\\diamond$ Exercise in erect position (peak heart rate lower if supine) on treadmill or bicycle; isometric handgrip exercise raises blood pressure less (but adequate for evaluation)\n$\\diamond$ Starting point of workload selected according to preliminary exercise results (at an average of 200 kilowatt pounds)\nBruce treadmill protocol:\nÂ» grade of exercise incrementally increased by inclination + belt speed (200 kilowatt pounds)\nÂ» graded exercise in 3-min stages of increasing workload\nÂ» endpoints for discontinuing exercise:\n(1) attainment of $85 \\%$ of predicted maximal heart rate $=220-$ age in years\n(2) Inability to continue $\\leftarrow$ fatigue, dyspnea, leg cramps, dizziness, chest pain\n(3) Severe angina / hypotension\n(4) Severe ECG ischemic changes / arrhythmia\n(5) Fall in $\\mathrm{BP}>10 \\mathrm{mmHg}$ below previous stage\n(6) Ventricular tachycardia\n(7) Run of 3 successive premature ventricular beats\n$\\diamond$ Cardiologist with crash cart should be available!\nProblems with exercise imaging:\n(1) Sensitivity to detect ischemic lesions decreases with suboptimal exercise (in particular for older population)\n(2) Higher false-positive tests in women (artifacts from overlying breast tissue)\n(3) Propranolol (beta blocker) interferes with stress test, should be discontinued 24-48 hr prior to testing\n\n## Pharmacologic Stress Test\n\nAdvantages:\n(1) Reproducibility\n(2) Independent from patient motivation\n(3) Freedom from patient infirmities: eg, severe peripheral vascular disease, arthritis, pain\nVasoactive drugs:\nA. Primary coronary vasodilators\n\nAction: binding to $\\mathrm{A}_{2}$ receptors affects the intracellular cyclic AMP, GMP, and calcium levels $\\rightarrow$ coronary hyperemia\nN.B.: Discontinue use of caffeine, tea, chocolate, cola drinks for 24 hours prior to test\n$\\diamond$ Cannot be used in patients on theophylline!\n(1) IV infusion of $140 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ dipyridamole ( $=$ Persantine ${ }^{\\circledR}$ ) $\\rightarrow 3-5$-fold increase in coronary artery blood flow\nTotal dose: $\\quad 0.84 \\mathrm{mg} / \\mathrm{kg}$\nDrug action: 30 minutes\nSide effects: flushing, nausea, bronchospasm (reversible with aminophylline) Â» dipyridamole injection over 4 min",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 609,
            "markdown": "Â» wait 10 min for maximum effect\nÂ» inject radiotracer\n$\\diamond$ Prolonged supervision after test necessary!\n(2) IV infusion of $140 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ adenosine ( $=$ Adenocard $^{\\circledR}$, Adenoscan $\\left.{ }^{\\circledR}\\right)$\n\n| Radiopharmaceuticals for Myocardial Perfusion PET |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Radiotracer | Physical Half-Life | Availability | Advantage | Disadvantage |\n| Rubidium $82\\left({ }^{( }\\right.$ Rb) | 76 sec | Strontium 82 <br> $\\left({ }^{(2)} \\mathrm{Sr}\\right){ }^{(0)} \\mathrm{Rb}$ generator | simplicity of use <br> high extraction simplifies <br> quantitation | relatively poor resolution requires cyclotron, heterogeneous uptake |\n| Nitrogen $13\\left({ }^{( }\\right.$ N) ammonia | 10 min | Cyclotron |  |  |\n| Copper $62\\left({ }^{( }\\right.$ Cu)-pyruvaldehyde-bis (N4methylthiosemicarbazone (PTMS) | 10 min | ${ }^{62} \\mathrm{Zu}{ }^{62} \\mathrm{Cu}$ generator | rapid blood pool clearance, long myocardial retention | short parent isotope half-life |\n| Oxygen $15\\left({ }^{( }\\right.$ O)-water | 2 min | Cyclotron | diffusible with high extraction | requires cyclotron, not suitable for clinical imaging |\n| Fluorine $18\\left({ }^{( }\\right.$ F) flurpiridaz | 110 min | Cyclotron | long half-life allows exercise studies | higher radiation dose for same-day stress-rest studies |\n\nDrug action: 2-3 minutes (half life of 15 seconds)\nSide effects: flushing, nausea, transient AV block, bronchospasm\nDrug reversal: theophylline\nÂ» continuous IV infusion for 3 minutes\nÂ» radiotracer injection\nÂ» continue infusion for additional 3 minutes\n$\\diamond$ Supervision after test not needed\nContraindication: significant pulmonary disease requiring use of inhalers\n(3) IV injection of 0.4 mg Regadenoson (Lexiscan ${ }^{\\circledR}$ ) followed by saline flush $=$ highly specific adenosine A2A receptor agonist acting as coronary vasodilator with very low affinity for $\\mathrm{A} 1(\\rightarrow \\mathrm{AV}$ node block), $\\mathrm{A} 2 \\mathrm{~B}(\\rightarrow$ severe peripheral vasodilation and hypotension), A3 ( $\\rightarrow$ bronchoconstriction)\nAdvantages: weight-unadjusted single bolus dose, fast onset + short duration of action, fewer side effects than adenosine\nÂ» radiotracer injection $10-20 \\mathrm{sec}$ after saline flush\nÂ» 150 mg of IV aminophylline $>3-4$ minutes after radiotracer injection\nÂ» complete limited exercise protocol tailored to patient's physical ability\nB. Chronotropic inotropes\n\nDrug action: $\\beta-1$ agonist $\\rightarrow \\uparrow$ myocardial contractility + work $=\\uparrow$ oxygen demand\nCandidates: patients with COPD, asthma, allergy to vasodilators, patients on theophylline preparations\n(1) IV infusion of $5 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ dobutamine for 5 minutes, increased in steps of 5 $\\mu \\mathrm{g} / \\mathrm{kg}$ every 5 minutes to a maximum infusion rate of $30-40 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ titrated to patient's response\nÂ» radiotracer injected at onset of significant symptoms / ECG changes / achievement of maximal rate of infusion or heart rate\nÂ» infusion maintained for an additional 2 minutes with dose adjusted to patient's condition\n(2) IV infusion of arbutamine with its own computerized delivery system titrating",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 610,
            "markdown": "dose rate automatically\nContraindication: severe hypertension, atrial flutter / fibrillation\nPrecautions:\n\n1. Monitoring devices: electrocardiographic and blood pressure monitors\n2. Emergency resuscitation equipment: defibrillator\n3. Emergency cart: drugs + pharmacologic antidotes (epinephrine, $\\beta$-blocker, atropine, bronchodilator, antiarrhythmic medication)\nApplied to:\n4. THALLIUM IMAGING (redistribution images after stress test):\nÂ» injection of $1.5-2 \\mathrm{mCi}$ of ${ }^{201} \\mathrm{Tl}$ during peak exercise, continuation of exercise for additional 60 seconds before imaging commences\nClues for stress images:\n$\\sqrt{ }$ RV myocardium well visualized\n$\\checkmark$ little pulmonary background activity\n$\\checkmark$ little activity in liver, stomach, spleen\n$\\checkmark$ distribution more uniform after stress than during rest\n$\\diamond$ Degree of liver uptake useful as direct measure of level of exercise!\nSources of technical errors:\nmnemonic: ABCDE PS\nAttenuation from overlying breast / diaphragm\nBackground oversubtraction\nCamera field nonuniformity\nDrugs, Delayed (excessively) imaging, Dose infiltration\nEating / Exercising between stress + delayed images\nPositioning variation between stress + delayed images\nSubmaximal exercise\n5. GATED BLOOD POOL IMAGING (response of EF)\n$\\sqrt{ } \\uparrow$ in ejection fraction from $63-93 \\%$ in normals\n$\\sqrt{ } \\uparrow$ in ventricular wall motion (anterolateral $>$ posterolateral $>$ septal)\n6. MR MYOCARDIAL PERFUSION IMAGING\n\n# Infarct-avid Imaging \n\n$=$ hot spot imaging\nAgent: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pyrophosphate (standard), 203Hg chlormerodrin, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-tetracycline, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ glucoheptonate, ${ }^{18} \\mathrm{~F}$-sodium fluoride, ${ }^{111}$ Indium-antimyosin (murine monoclonal antibodies to myosin), ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-antimyosin Fab fragment\n\n## ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-Pyrophosphate\n\nPathophysiology in MYOCARDIAL INFARCTION:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 611,
            "markdown": "| Pharmacologic Stress Agents |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Stress Agent | Dose | Administration | Mechanism of Action | Contraindication, Side Effects |\n| Dobutamine | $40 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ <br> (max) | infusion | direct $\\mathrm{B}_{1}+\\mathrm{B}_{2}$ receptor stimulation with doserelated increase in heart rate + blood pressure + myocardial contractility | Systemic hypertension Complex arrhythmia HOCM Uncontrolled CHF |\n| Atropine | $0.25-\\mathrm{mg}$ fractions typical (max 2 mg ) | fractional injections | nonselective muscarinic acetylcholinergic antagonist | Narrow-angle glaucoma <br> Myasthenia gravis <br> Obstructive uropathy |\n| Adenosine <br> (Adenocard ${ }^{\\circledR}$, Adenoscan ${ }^{\\circledR}$ ) | $140 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{min}$ | $4-6 \\mathrm{~min}$ infusion | Activation of $\\mathrm{A}_{1}, \\mathrm{~A}_{2 B}$ and $\\mathrm{A}_{3}$ receptors <br> Activation of $\\mathrm{A}_{2 A}$ receptors <br> Half-life $=10 \\mathrm{sec}$ | $2^{\\text {nd }} / 3^{\\text {rd }}$-degree AV block <br> Systolic BP $<90 \\mathrm{mmHg}$ <br> Active airway disease <br> Hypersensitivity |\n| Regadenoson (LexiscanÂ®) | 0.4 mg | single injection | $\\mathrm{A}_{2 A}$ receptor agonist inducing direct coronary arteriolar vasodilatation <br> Weak affinity $\\mathrm{fr} \\mathrm{A}_{2 \\mathrm{~B}}+\\mathrm{A}_{3}$ receptors <br> Initial phase half-life $=2-4$ min followed by elimination phase of $2-4 \\mathrm{~h}$ | Similar but reduced side effects as adenosine ( $\\rightarrow$ suitable for patients with mild reactive airway + obstructive lung disease) |\n\npyrophosphate is taken up by myocardial necrosis through complexation with calcium deposits $>10-12$ hours post infarction\n) requires presence of residual collateral blood flow\n$>30-40 \\%$ maximum accumulation in hypoxic cells with a $60-70 \\%$ reduction in blood flow (greater levels of occlusion reduce uptake)\nUptake post infarction:\n> earliest uptake by 6-12-24 hours;\n> peak uptake by $48-72$ hours;\npersistent uptake seen up to 5-7 days with return to normal by 10-14 days\nSensitivity: $90 \\%$ for transmural infarction, $40-50 \\%$ for subendocardial (nontransmural) infarction\nSpecificity: as low as $64 \\%$\nDose: $15-20 \\mathrm{mCi}$ IV (minimal count requirement of 500,000/view)\nImaging: at $3-6 \\mathrm{hr}$ ( $60 \\%$ absorbed by skeleton within 3 hr )\nIndications:\n\n1. Lost enzyme pattern = patient admitted $24-48 \\mathrm{hr}$ after infarction\n2. Equivocal ECG + atypical angina:\n(a) left ventricular bundle branch block\n(b) left ventricular hypertrophy\n(c) impossibility to perform stress test\n(d) patient on digitalis\n3. ST depression without symptoms\n4. Equivocal enzyme pattern + equivocal symptoms\n5. S/P cardiac surgery (perioperative infarction in $10 \\%$, enzymes routinely elevated, ECG always abnormal), requires preoperative baseline study as $40 \\%$ are preoperatively abnormal\n6. For detection of right ventricular infarction\n\nNOT HELPFUL:\n\n1. In differentiating multiple- from single-vessel disease\n2. Typical angina",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 612,
            "markdown": "3. Normal ECG stress test + no symptoms\n\nScan interpretation:\n[Grade $2+$ and above are positive]\nGrade 0 no activity\nGrade $1+$ faint uptake\nGrade $2+$ slightly less than sternum, equal to ribs\nGrade $3+$ equal to sternum\nGrade $4+$ greater than sternum\n$\\sqrt{ }$ \"doughnut\" pattern = central cold defect (necrosis in large infarct) usually in cases of large anterior + anterolateral wall infarctions\n$\\sqrt{ }$ uptake in inferior wall extending behind sternum (anterior projection) suggests RV infarction\n$\\diamond$ SPECT imaging improves sensitivity ( $\\leftarrow$ eliminates rib overlap)\n$\\checkmark$ diffuse uptake can be seen in angina, cardiomyopathy, subendocardial infarct, pericarditis and normal blood pool (normal blood pool can be eliminated with delayed imaging)\nFALSE POSITIVES ( $10 \\%$ ):\nA. Cardiac causes:\n\n1. Recent injury: myocardial contusion, resuscitation, cardioversion, radiation injury, Adriamycin ${ }^{\\circledR}$ cardiotoxicity, myocarditis, acute pericarditis\n2. Previous injury: left ventricular aneurysm, mural thrombus, unstable angina, previous infarct with persistent uptake\n3. Calcified heart valves / calcified coronary arteries (rare) / chronic pericarditis\n4. Cardiomyopathy: eg, amyloidosis\nB. Extracardiac causes:\n5. Soft-tissue uptake: breast tumor / inflammation, chest wall injury, paddle burns from cardioversion, surgical drain, lung tumor\n6. Osseous: calcified costal cartilage (most common), lesions in rib / sternum\n7. Increased blood pool activity secondary to renal dysfunction / poor labeling technique (improvement on delayed images)\nmnemonic: SCUBA\nSubendocardial infarction (extensive)\nCardiomyopathy / myocarditis\nUnstable angina\nBlood pool activity\nAmyloidosis\nFALSE NEGATIVES (5\\%)\nMyocardial metastasis\nPERSISTENTLY POSITIVE SCAN (> 2 weeks)\n$=$ ongoing myocardial necrosis indicating poor prognosis, may continue on to cardiac aneurysm, repeat infarction, cardiac death\n> in $77 \\%$ of persistent / unstable angina pectoris\n> in $41 \\%$ of compensated congestive heart failure\n> in $51 \\%$ of ECG evidence of ventricular dyssynergy",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 613,
            "markdown": "Prognosis: the larger the area, the worse the mortality + morbidity\n99m Tc-Antimyosin Fab Fragments\n![img-38.jpeg](img-38.jpeg)\n$=$ specific marker for myocyte damage\n$=$ Fab fragments of an antibody raised against water-insoluble heavy chains of cardiac myosin exposed due to necrosis\nSensitivity: $95 \\%$\n$\\sqrt{ }$ uptake ONLY in acute infarct with decreasing intensity as the infarct heals\n\n# Nonavid Infarct Imaging \n\n$=$ COLD SPOT IMAGING\n$=$ myocardial perfusion study for acute myocardial infarct\nAgent: ${ }^{201} \\mathrm{Tl}$ (at rest)\nSensitivity after onset of symptoms:\n$96 \\%$ within 6-12 hours, $79 \\%$ after 48 hours, $59 \\%$ in remote infarction; sensitivity for\nSPECT (seven pinhole tomography) $94 \\%>$ planar scintigraphy $75 \\%$\n$\\sqrt{ }$ fixed permanent defect in acute infarction\n$\\sqrt{ }$ fixed permanent defect at rest + on stress thallium + redistribution images in old infarction\n$\\sqrt{ }$ \"cold defect\" at rest may represent transient ischemia in unstable angina\nN.B.: ${ }^{201} \\mathrm{Tl}$ cannot distinguish between recent + remote infarction!\n\n## Intracardiac Shunts\n\nBlood-pool agents administered by peripheral IV injection:\n99mTc-pertechnetate, DTPA, sulfur colloid, macroaggregated albumin, labeled RBCs Method:\n$\\mathrm{C} 2+\\mathrm{C} 1$-method measures hemodynamic significance of a shunt; raw data obtained from pulmonary activity curve (gamma variate method, $\\mathrm{Qp}+\\mathrm{Qs}$ ratio $=$ two-area ratio method, count method); accuracy depends on the shape of the input bolus (single peak of $<2$ second duration); measuring C1, C2, T1, T2\nA. Normal\n\nC2+C1 is $<32 \\%$\nB. L-R shunt\n\nIndication: ASD, VSD, AV canal, aortopulmonic window, rupture of sinus of Valsalva aneurysm",
            "images": [
                {
                    "id": "img-38.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 327,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 712,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 614,
            "markdown": "$\\sqrt{ }$ C2 $\\div \\mathrm{C} 1>35 \\%$ (area $\\mathrm{A}=$ primary pulmonary circulation; area $\\mathrm{B}=\\mathrm{L}-\\mathrm{R}$ shunt; area $(\\mathrm{A}-$ B) $=$ systemic circulation; $\\mathrm{QP} \\div \\mathrm{QS}=$ area $\\mathrm{A} /$ area $(\\mathrm{A}-\\mathrm{B})>1.2$\nC. R-L shunt\n\nIndication: Tetralogy of Fallot, transposition, truncus, Ebstein anomaly\n$\\sqrt{ }$ early arrival of tracer in left side of heart + aorta (first-pass method) prior to arrival of activity from lungs to LV\n$\\sqrt{ }$ quantification possible only by registration of sum of activity of trapped macroaggregate / microspheres in brain + kidneys\nCauses of abnormal nonshunt-related activity:\n(1) Radiopharmaceutical breakdown\n$\\sqrt{ }$ free pertechnetate activity in salivary glands, gastric mucosa, thyroid, kidney\n(2) Hepatic cirrhosis abnormal pulmonary vascular channels bypassing the lung (in 10$70 \\%)$\n(3) Pulmonary AVM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 615,
            "markdown": "# BILIARY SCINTIGRAPHY \n\n## Application:\n\n1. Acute cholecystitis\n2. Congenital biliary atresia\n3. Evaluation of bile leak\n4. Choledochal cyst\n5. Biliary-enteric fistula\n6. Chronic GB dysfunction\n\n## 99mTc-IDA analogs = HIDA agents\n\n$=99 \\mathrm{mTc}$-acetanilide iminodiacetic acid analogs (IDA)\nDependent on the substance's lipophility, there is a trade-off between renal excretion + hepatic uptake (BIDA is the most lipophilic, HIDA the least lipophilic)\n\n1. HIDA (2,6-dimethyl derivative): $[\\mathrm{H}=$ hepatic $]$ bilirubin threshold of $<18 \\mathrm{mg} / \\mathrm{dL} ; 15 \\%$ renal excretion\n2. BIDA (parabutyl derivative): bilirubin threshold of $<20 \\mathrm{mg} / \\mathrm{dL}$\n3. PIPIDA (paraisopropyl derivative): $2 \\%$ renal excretion\n4. DIDA (diethyl derivative)\nmost often used:\n5. DISIDA (diisopropyl derivative) $=$ Disida $^{\\circledR}$, Disofenin ${ }^{\\circledR}$, Hepatolite ${ }^{\\circledR}$ : bilirubin threshold of $<30 \\mathrm{mg} / \\mathrm{dL}$\n6. TMB-IDA (m-bromotrimethyl IDA) $=$ Mebrofenin ${ }^{\\circledR}$, Choletec ${ }^{\\circledR}: \\mathrm{T} 1 / 2$ uptake is $6 \\mathrm{~min}, \\mathrm{~T} 1 / 2$ excretion is 14 min in normals; bilirubin levels may be as high as $30 \\mathrm{mg} / \\mathrm{dL}$\nQuality control: the final compound should contain\n$>90-100 \\% 99 \\mathrm{mTc}-\\mathrm{IDA}$\n$>10 \\% 99 \\mathrm{mTc}$-tin colloid\n$>10 \\% 99 \\mathrm{mTc}$-sodium pertechnetate\nPharmacokinetics:\n@ Bloodstream\ntracer binds predominantly to albumin $\\rightarrow$ decreasing renal excretion (renal excretion seen in most normals); dissociation of albumin $+99 \\mathrm{mTc}$-IDA takes place in space of Disse\n@ Liver\npeak liver activity $5-15$ minutes post injection\n$=$ hepatic phase; $85 \\%$ extracted by hepatocytes tracer enters anion pathway of bilirubin\n$\\diamond$ Delayed liver uptake implies hepatocyte dysfunction / CHF (less likely)\n$\\diamond$ Look for liver lesions on early images\n@ Bile\nsecretion by hepatocytes without conjugation; $\\mathrm{CBD}+$ cystic duct visualized within 10-\n30 min (not always visualized in normals); GB visualized by $20-60 \\mathrm{~min}$\n$\\diamond$ Activity in right paracolic gutter / intraperitoneal space implies postoperative bile leak\n@ Bowel\nexcretion into duodenum by 30 minutes; bowel visualized within 1 hour; no",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 616,
            "markdown": "enterohepatic recirculation\nDose: $\\quad 2-8 \\mathrm{mCi}$ for adults\nRadiation dose: 2 rad for upper large bowel; 0.55 rad for gallbladder; $3 \\mathrm{rad} / \\mathrm{mCi}$ for small bowel; $0.01 \\mathrm{rad} / \\mathrm{mCi}$ for whole body\nPatient preparation:\nÂ» Fasting for at least (2-)4 hours to avoid a contracted gallbladder (because endogenous cholecystokinin contracts gallbladder)\nÂ» Injection of $0.02 \\mu \\mathrm{~g} / \\mathrm{kg}$ Kinevac ${ }^{\\circledR}$ over $>3$ minutes to empty gallbladder about 30 minutes before tracer injection in patients on prolonged fasting (fasting $>24$ hours causes an overdistended GB)\nÂ» Narcotics (opiates) + sedatives $\\rightarrow$ increase tone of sphincter of Oddi and have to be stopped $6-12$ hours before exam\nEquipment:\nLarge field-of-view scintillation camera fitted with LEAP collimator; spectrometer set at 140 keV with $20 \\%$ window\nComputer software for deconvolutional analysis allows determination of percent of hepatic arterial and of portal venous blood flow to liver (helpful in assessment of liver transplants)\nImaging: at 5-10-minute intervals for 60 min ; if gallbladder not visualized for at least up to 4 hrs; RLAT, RAO, LAO projections to confirm gallbladder position\n$\\diamond$ Look for enterogastric reflux as a cause of biliary gastritis!\nIV morphine sulfate ( $0.04 \\mathrm{mg} / \\mathrm{kg}$ or up to 3 mg ):\ncontracts sphincter of Oddi + raises intrabiliary pressure $\\rightarrow$ retrograde filling of gallbladder\nEffect: maximum 5 minutes post injection $\\rightarrow$ shortens study time in cases of nonvisualization of gallbladder $\\rightarrow$ increases accuracy from $88 \\%$ to $98 \\%$ and specificity from $83 \\%$ to $100 \\%$\nÂ» redose patient with a small amount of radiotracer\nÂ» inject morphine at 45-60 minutes if tracer in bowel\nÂ» image for 45 minutes after injection\nNormals: (excludes diagnosis of acute cholecystitis)\n$\\checkmark$ gallbladder appearance within 60 minutes\n$\\checkmark$ gallbladder visualization within 30 minutes in $90 \\%$\n$\\checkmark$ small bowel activity within $90 \\mathrm{~min}(80 \\%$ within 60 min$)$\n\n# LIVER SCINTIGRAPHY \n\n## 99mTechnetium Sulfur Colloid\n\n$=$ LIVER-SPLEEN SCAN\nIndications: liver, spleen, bone marrow, acute rejection in renal transplant, lower GI bleeding, gastric emptying\nPhysiology: small colloid particles are phagocytized by reticuloendothelial system (RES); $90 \\%$ of RES function lies within liver + spleen, $10 \\%$ primarily within bone marrow\nPreparation:",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 617,
            "markdown": "99mTc-pertechnetate and sodium trisulfate are heated in a water bath $\\left(95 \\pm 5^{\\circ} \\mathrm{C}\\right)$ for $10 \\pm 2$ minutes; sulfur atoms aggregate to form a \"colloid\" (average particle size $0.1-1 \\mu \\mathrm{~m}$ with a range of $0.001-1 \\mu \\mathrm{~m}$; true colloid has a particle size of $0.001-0.5 \\mu \\mathrm{~m}$ ); gelatin is added to prevent further growth of particles\nQuality control:\n(a) $>92 \\%$ remain at origin of ascending chromatography\n(b) upper limit for particle size is $1 \\mu \\mathrm{~m}$\n, Usual cause for poor preparation is excessive / prolonged heating or a $\\mathrm{pH}>7$\n, Preparation should not be used $>6$ hours (agglomeration of particles with aging)\nDose: usually $3-6 \\mathrm{mCi}$ ( 8 mCi for SPECT)\nRadiation dose: $0.3 \\mathrm{rad} / \\mathrm{mCi}$ for liver (critical organ); $0.02 \\mathrm{rad} / \\mathrm{mCi}$ for whole body; 0.025 $\\mathrm{rad} / \\mathrm{mCi}$ for bone marrow\nImaging: $15-30$ min post IV injection\nPharmacokinetics: accumulation in liver ( $85 \\%$ ), spleen ( $10 \\%$ ), bone marrow ( $5 \\%$ ); lung localization is rare (presumably secondary to circulating endotoxins + macrophage infiltration)\nA. RETICULOENDOTHELIAL LOCALIZATION\n$\\sqrt{ }$ colloid shift away from liver in diffuse hepatic dysfunction / decreased hepatic perfusion\n$\\sqrt{ } \\uparrow$ bone marrow activity in hemolytic anemia\n$\\sqrt{ } \\uparrow$ splenic activity in hypersplenism of splenomegaly / cancer / systemic illness\nB. BONE MARROW LOCALIZATION\n\nHematopoietic system extends into long bones in children; recedes to axial skeleton, femora, and humeri with age\n$\\diamond$ Bone marrow distribution cannot be used to determine sites of erythropoiesis!\nC. ABSCESS LOCALIZATION Sulfur colloid phagocytized by PMNs + monocytes Labeling:\n(a) in vivo: small labeling yield\n(b) in vitro: $40 \\%$ labeling efficiency, but difficult + time-consuming preparation\n\n# SPLENIC SCINTIGRAPHY \n\n1. ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid: $3-5 \\mathrm{mCi}$\n2. ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-heat-denatured erythrocytes\n\nIndication:\n(1) Splenic trauma\n(2) Accessory + ectopic spleen\n\nTechnique to make heat-denatured erythrocytes:\nÂ» 20-30 minutes after injection of pyrophosphate IV 15-20 mL of blood are drawn\nÂ» drawn blood is incubated with 2 mCi of pertechnetate $\\rightarrow$ heated to $49.5^{\\circ} \\mathrm{C}$ for 35 minutes and $\\rightarrow$ reinjected\n$\\diamond$ Fragmentation of RBCs from overheating increases hepatic uptake!\nImaging: 20 minutes post injection\n\n## GASTROINTESTINAL SCINTIGRAPHY",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 618,
            "markdown": "# Radionuclide Esophagram \n\nPreparation: 4-12 hours fasting; imaging in supine / erect position\nDose: $\\quad 250-500 \\mu \\mathrm{Ci}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid in 10 mL of water taken through straw\nImaging: when swallowing begins\nNormal transit time: 15 seconds with 3 distinct sequential peaks progressing aborally\nProlonged transit time:\nachalasia, progressive systemic sclerosis, diffuse esophageal spasm, nonspecific motor disorders, \"nutcracker\" esophagus, Zenker diverticulum, esophageal stricture + obstruction\nDifficult interpretation in: hiatal hernia, GE reflux, Nissen fundoplication\n\n## Levine / Denver Shunt Patency\n\nTechnique: sterile injection of $0.5-1 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAA} /$ sulfur colloid via paracentesis Imaging: over abdomen (or chest) to detect uptake in liver (or lung) $\\rightarrow$ confirms patency\n\n## RENAL SCINTIGRAPHY\n\n## Renal Agents\n\n1. Agents for renal function: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA, ${ }^{131} \\mathrm{I}$-Hippuran\n2. Renal cortical agent: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA\n3. Renal combination agent: ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-glucoheptonate\n\n## ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA\n\n$={ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-diethylenetriamine pentaacetic acid\n$=$ agent of choice for assessment of\n(1) Perfusion\n(2) Glomerular filtration = relative GFR\n(3) Obstructive uropathy\n(4) Vesicoureteral reflux\n\nPharmacokinetics:\nglomerular agent excreted exclusively by glomerular filtration (similar to inulin) without reabsorption / tubular excretion / metabolism; chelating agent in $5-10 \\%$ bound to plasma protein; extracted with $20 \\%$ efficiency on each pass through kidney ( $=$ filtration fraction)\n$\\diamond$ May be used only in patients with normal / mildly impaired renal function!\nTime-activity behavior:\n> abdominal aorta ( $15-20$ seconds)\n> kidneys + spleen (17-24 seconds); liver appears later because of portal venous supply\n> renal cortical activity ( $2-4 \\mathrm{~min}$ ): mean transit time of $3.0 \\pm 0.5 \\mathrm{~min}$; static images of cortex taken at $3-5 \\mathrm{~min}$\n> renal pelvic activity ( $3-5 \\mathrm{~min}$ ): peak at 10 minutes; asymmetric clearance of renal pelvis in $50 \\%$; accelerated by furosemide\nBiologic half-life: 20 minutes\nDose: $10-20 \\mathrm{mCi}$\nRadiation dose: $0.85 \\mathrm{rad} / \\mathrm{mCi}$ for renal cortex; $0.6 \\mathrm{rad} / \\mathrm{mCi}$ for kidney; $0.5 \\mathrm{rad} / \\mathrm{mCi}$ for bladder; $0.15 \\mathrm{rad} / \\mathrm{mCi}$ for gonads; $0.15 \\mathrm{rad} / \\mathrm{mCi}$ for whole body",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 619,
            "markdown": "Adjunct: Lasix administration (20-40 mg IV) 20 minutes into exam allows assessment of renal pelvic clearance with accuracy equal to Whitaker test (DDx of obstructed from dilated but nonobstructed pelvicalyceal system)\n\n# [99m Tc-Glucoheptonate] \n\n$\\diamond 99 \\mathrm{~m} T \\mathrm{C}-\\mathrm{GHA}$ is largely replaced by ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$\nPharmacokinetics:\nrapid plasma clearance + urinary excretion with excellent definition of pelvicalyceal\nsystem during $1^{\\text {st }}$ hour; extracted by\n(a) glomerular filtration and\n(b) tubular excretion ( $30-45 \\%$ within $1^{\\text {st }}$ hour); $5-15 \\%$ of dose accumulates in tubular cells by 1 hour, $15-25 \\%$ by 3 hours; cortical accumulation remains for 24 hours\nImaging:\n(a) collecting system within first 30 minutes\n(b) renal parenchyma after 1-2 hours (interfering activity in collecting system)\n\nBiologic half-life: 2 hours\nDose: 15 (range $10-20$ ) mCi\nRadiation dose: $0.17 \\mathrm{rad} / \\mathrm{mCi}$ for kidney; $0.008 \\mathrm{rad} / \\mathrm{mCi}$ for whole body; $0.015 \\mathrm{rad} / \\mathrm{mCi}$ for gonads\n\n## ${ }^{99 m}$ Tc-DMSA\n\n$=99 \\mathrm{~mTc}$-dimercaptosuccinic acid\n$=$ suitable for imaging of functioning cortical mass: pseudotumor versus lesion\nPharmacokinetics:\nhigh protein-binding + slow plasma clearance; $4 \\%$ extracted per renal passage; $4-8 \\%$\nglomerular filtration within 1 hour and $30 \\%$ by 14 hours; $50 \\%$ of dose accumulates in proximal + distal renal tubular cells by 3 hours (= cortical agent)\nImaging: after 1-3-24 hours (optimal at 34 hours); $\\uparrow$ sensitivity to structural defects with SPECT\nBiologic half-life: $>30$ hours\nDose: $5-10 \\mathrm{mCi}$\nRadiation dose: $0.014 \\mathrm{rad} / \\mathrm{mCi}$ for gonads; $0.015 \\mathrm{rad} / \\mathrm{mCi}$ for whole body\n\n## [131I-OIH]\n\nlargely replaced by ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$\n$=131$ I-orthoiodohippurate (Hippuran ${ }^{\\circledR}$ )\n$=$ good for evaluation of renal tubular function / effective renal plasma flow; agent with highest extraction ratio without binding to renal parenchyma; visualizes kidney even in severe renal failure\nPharmacokinetics:\n$80 \\%$ secreted by proximal tubules; $20 \\%$ filtered by glomeruli; maximal renal concentration within 5 minutes; normal transit time of $2-3$ minutes; $\\sim 2 \\%$ free iodine $\\diamond$ Lugol's solution is administered to protect thyroid!\nImaging: in 15-60-second intervals for 20 minutes; renal uptake determined from images obtained by $1-2$ minutes (patient in supine position $\\rightarrow$ equidistance of kidneys",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 620,
            "markdown": "to camera)\nBiologic half-life: 10 minutes (with normal renal function)\nDose: 200 (range $150-300$ ) $\\mu \\mathrm{Ci}$\nRadiation dose: $\\quad 0.06 \\mathrm{rad} / 200 \\mu \\mathrm{Ci}$ for bladder; $0.02 \\mathrm{rad} / 200 \\mu \\mathrm{Ci}$ for kidney; 0.02 $\\mathrm{rad} / 200 \\mu \\mathrm{Ci}$ for whole body; $0.02 \\mathrm{rad} / 200 \\mu \\mathrm{Ci}$ for gonads\n\n# 99m Tc-Mertiatide $=99 \\mathrm{~m}$ Tc-Mercaptoacetyltriglycine $\\left(\\mathrm{MAG}_{3}\\right)$ \n\n$=$ renal plasma flow agent similar to OIH but with imaging benefits of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ label (improved dosimetry)\nPharmacokinetics:\ntubular agent $\\rightarrow$ cleared primarily by active secretion in proximal tubules + only minimal glomerular filtration; clearance is less than Hippuran; surrogate measure for effective renal plasma flow\nDose: 10 mCi\nEvaluation: true renal plasma flow = MAG3 flow (obtained off renogram curve) multiplied by a constant (varies between 1.4 and 1.8 )\n\n## Enalaprilat (VasotecÂ®)-enhanced Renography\n\nTechnique:\n\n| Renal Scintigraphic Agents |  |  |  |\n| :--: | :--: | :--: | :--: |\n| Agent | Dose | Pharmacokinetics | Imaging Characteristics |\n| MORPHOLOGIC AGENTS |  |  |  |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-GHA | 5 mCi | proximal tubular uptake <br> + glomerular filtration | collecting system visualized on delayed images |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DMSA | $2-5 \\mathrm{mCi}$ | proximal + distal tubular uptake | limited availability, relatively high radiation dose, collecting system not visualized on delayed images |\n| FUNCTIONAL AGENTS |  |  |  |\n| ${ }^{131} \\mathrm{I}$-OIH | $200-400 \\mu \\mathrm{Ci}$ | $80 \\%$ secreted, $20 \\%$ filtered | routinely used for ERPF measurement, analog of $\\mathrm{PAH}_{2}$ highest renal extraction fraction, poor image detail, high radiation dose, requires high-energy collimator |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA | $10-15 \\mathrm{mCi}$ | nearly $100 \\%$ filtered | GFR calculation, delayed time-to-peak with slow clearance |\n| ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$ | $2-10 \\mathrm{mCi}$ | $99 \\%$ secreted | ERPF estimate, good cortical detail, high target-to background ratio |\n\n\" Blood pressure check $\\rightarrow$ to prevent testing excessively hypertensive patients\nÂ» Discontinue captopril / lisinopril 3 days before study\nÂ» Discontinue enalaprilat\nÂ» Stop any other antihypertensive medications overnight (except for $\\beta$-blockers)\nÂ» Fasting: liquids acceptable\nÂ» Bladder catheterization to monitor urinary output\nÂ» $1 / 2$ normal saline IV drip at $75 \\mathrm{~mL} /$ hour at a dose of 10 mL fluid $/ \\mathrm{kg}$ body weight $\\rightarrow$ to ensure adequate hydration\nÂ» Furosemide ( $=$ Lasix $\\left.{ }^{\\circledR}\\right)$ IV\n20 mg if serum creatinine $<1.5 \\mathrm{mg} / \\mathrm{dL}$\n40 mg if serum creatinine $>1.5 \\mathrm{mg} / \\mathrm{dL}$\n60 mg if serum creatinine $>3.0 \\mathrm{mg} / \\mathrm{dL}$\n(not to exceed $1.0 \\mathrm{mg} / \\mathrm{kg}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 621,
            "markdown": "Â» $2.5-5 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$ IV for baseline study\n(a) flow phase with $1 \\mathrm{sec} /$ frame for 60 frames\n(b) tracer kinetic (dynamic) phase with $15 \\mathrm{sec} /$ frame for 120 frames\nÂ» Rehydration with $1 / 2$ normal saline keeping a $250-300 \\mathrm{~mL}$ negative fluid balance\nÂ» Postvoid image (or Foley catheter with PVR)\nÂ» $0.04 \\mathrm{mg} / \\mathrm{kg}$ enalaprilat IV (up to a maximum of 2.5 mg ) infused over $5 \\mathrm{~min}+$ blood pressure and heart rate checks q 5 minutes\nÂ» Repeat furosemide (= Lasix ${ }^{\\circledR}$ ) IV\nÂ» $5-7.5 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$ IV [or $10 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$ IV single post-enalaprilat study for patients already on ACEI therapy]\nÂ» Image acquisition:\n$>1-3$ seconds / frame for first 60 seconds\n$>10-30$ seconds / frame thereafter\n> image display at 1-3-minute intervals\n$>$ total acquisition time of $20-30$ minutes\nÂ» whole-kidney ROI (better count statistics) / cortical ROI (for unusual retention in renal pelvis)\n2-day protocol:\n> ACEI renography on day 1\n> if test abnormal patient has to return on day 2 for a baseline study to maximize specificity\n\n# Captopril (Capoten ${ }^{\\circledR}$ )-enhanced Renography \n\nDose: $\\quad 1 \\mathrm{mg} / \\mathrm{kg}$ PO for pediatric patient; 25 or 50 mg PO for adult patient (crush tablets + dissolve in 200 mL of water)\nTechnique:\nÂ» no solids for 4 hours prior to study\nÂ» moderate hydration with 7 mL water / kg BW ingested $30-60$ minutes before study\nÂ» radiopharmaceutical injected 60 minutes after ingestion of captopril\nÂ» at the same time 20 mg furosemide IV $\\rightarrow$ to wash out radiopharmaceutical from distal nephron + calices + pelvis $\\rightarrow$ improving detection of cortical retention\n\n## Differential Renal Function\n\nAgents:\n(1) 99 m Tc-DTPA: measurements prior to excretion within first $1-3$ minutes; images taken at 1.5 -second intervals for 30 seconds followed by serial images for next 30 minutes\n(2) 131I-Hippuran: measurements prior to excretion within first 1-2 minutes\n\nEvaluation: generation of time-activity curves\n$\\checkmark$ upslope (= accretion phase)\n$\\checkmark$ peak activity (maximum uptake phase)\n$\\checkmark$ downslope (excretion phase)\n$\\checkmark$ increased hepatic + soft-tissue uptake with impaired renal function\n$\\checkmark$ measurements usually not significantly affected with differences in renal depth\n$\\checkmark$ measurements are accurate in renal obstruction if obtained within 1-3 minutes\n$\\checkmark$ prediction about functional recovery not possible following surgical relief of obstruction",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 622,
            "markdown": "# Diuretic Renal Scintigraphy \n\nIndication: differentiation of obstructed from nonobstructed chronically dilated collecting system $\\pm$ ureter in patients with history of surgery / obstruction\nAgents: tubular agent ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ mertiatide (eg, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}-\\mathrm{MAG}_{3}$ ); glomerular agent ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ pentetic acid (ie, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA)\nTime activity curve of urinary tract obstruction:\n(a) moderate obstruction\n$\\sqrt{ } \\downarrow$ radiotracer activity (= perfusion) in affected kidney during angiographic phase\n$\\sqrt{ }$ delayed cortical concentration (= delayed uptake) before administration of diuretic\n$\\sqrt{ }$ delayed clearance of activity after administration of diuretic with half-time $>20$ minutes\n(b) high-grade obstruction:\n$\\sqrt{ }$ failed clearance of radiotracer from kidney\n$\\sqrt{ }$ no excretion of tracer into renal collecting system\nFalse positives:\nattenuated effectiveness of furosemide, reservoir effect in severe dilatation of nonobstructed collecting system, poor hydration, high filling pressure of bladder\n\n## Radionuclide Cystogram\n\nUse: evaluation of bladder volume at reflux, volume of refluxed urine, residual urine volume, ureteral reflux drainage time\nTechnique:\n(a) indirect: IV injection of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-DTPA\n(b) direct: instillation of $0.5-1 \\mathrm{mCi}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate-saline mixture into bladder (more sensitive for reflux during filling phase, which occurs in $20 \\%$ )\nImaging:\nposterior upright views throughout filling and voiding phases; review on cinematic loop helpful; residual bladder volume can be calculated\nAdvantage:\nlower radiation dose to gonads than fluoroscopic contrast cystography ( 5 mrad )!\n\n## ADRENOCORTICAL SCINTIGRAPHY\n\n1. NP-59\n2. Selenium-75 6- $\\beta$-selenomethylnorcholesterol (Scintadrin ${ }^{\\circledR}$ )\n\n## Iodocholesterol\n\nAgent: ${ }^{131} \\mathrm{I}-6-\\beta$-iodomethyl-19-norcholesterol (NP-59); no FDA approval (available as investigational new drug)\nIndications: adrenocortical imaging\n(1) ACTH-independent Cushing syndrome: adenoma, cortical nodular hyperplasia\n(2) Adrenocortical carcinoma\n$\\sqrt{ }$ spectrum from nonfunctioning to functioning\n(3) Primary aldosteronism: adenoma, bilateral adrenal hyperplasia $\\rightarrow$ improved scintigraphic discrimination requires dexamethasone suppression before + during imaging",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 623,
            "markdown": "(4) Hyperandrogenism: adrenal adenoma, zona reticularis hyperplasia, polycystic ovary disease, ovarian stromal hyperplasia, androgen-secreting ovarian neoplasm\n(5) Incidentaloma ( $=$ adrenal mass)\n$\\sqrt{ }$ localization to side of CT-depicted adrenal mass (= concordant uptake) suggests hyperfunctioning adenoma\n$\\sqrt{ }$ markedly diminished / absent uptake (= discordant uptake) or symmetric uptake (= nonlateralization) suggests space-occupying mass (eg, cyst) / malignant adrenal mass\nPharmacokinetics:\nNP-59 is incorporated into low-density lipoproteins (LDL) $\\rightarrow$ circulates to adrenal cortex $\\rightarrow$ absorbed from LDL complex by low-density lipoprotein receptors $\\rightarrow$ esterified in adrenal cortex; adrenocortical uptake affected by adrenocortical secretagogues (corticotropin, angiotensin II); enterohepatic excretion may obscure adrenals (prior laxative administration beneficial)\nDose: $\\quad 1 \\mathrm{mCi}(37 \\mathrm{MBq})$ with slow IV injection\nRadiation dose: $26 \\mathrm{rad} / \\mathrm{mCi}$ for adrenals, $8.0 \\mathrm{rad} / \\mathrm{mCi}$ for ovaries, $2.4 \\mathrm{rad} / \\mathrm{mCi}$ for liver, 2.3 $\\mathrm{rad} / \\mathrm{mCi}$ for testes, $1.2 \\mathrm{rad} / \\mathrm{mCi}$ for whole body\nMethod: Lugol solution administered orally ( 50 mg of iodine per day) for $4-5$ days starting the day before injection $\\rightarrow$ to block thyroid uptake of free iodine; mild laxative $\\rightarrow$ to decrease bowel activity\nImaging:\n(a) 5-7-days interval between injection + imaging\n(b) 3-5-days interval between injection + imaging in case of dexamethasone suppression ( 1 mg four times daily for 7 days prior to and throughout $4-5$ days of postinjection imaging interval)\n\n# SCINTIGRAPHY OF NEUROENDOCRINE TUMORS \n\nOrigin: embryonic neural crest tissue forming neuroendocrine cells + neuroendocrine tumors\nLocation: hypothalamus, pituitary gland, thyroid gland, adrenal medulla, GI tract\nFunction: neuroendocrine cells synthesize amines from precursor molecules $\\rightarrow$ decarboxylate amines $\\rightarrow$ polypeptides ( $=$ neurotransmitters + hormones); former name: APUD (amine precursor uptake and decarboxylose) cells + APUDomas\nRadiopharmaceuticals:\nsimilar in molecular structure to hormones that tumor synthesizes / incorporates into metabolic + cellular processes\n\n## Somatostatin Analogs\n\n$=14$-amino acid peptide that inhibits peptide + hormone synthesis by neuroendocrine cells (\"antigrowth hormone\") in the anterior pituitary (ACTH, prolactin, TSH) and in pancreas + GI tract (insulin, glucagon, gastrin, VIP, secretin, motilin, cholecystokinin)\nBiologic half-life: 2-4 minutes (molecule disrupted by various plasma enzymes in circulation)\n\n## Octreotide $=$ Sandostatin $^{\\circledR}$\n\n$=8$-amino acid analog of somatostatin\nPlasma half-life: 2 hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 624,
            "markdown": "# 111InDIUM-PentetREOtide $=$ OctREOSCAN ${ }^{\\circledR}$ \n\nIndication: pituitary tumor, gastrinoma, paraganglioma, carcinoid, neuroblastoma, small cell lung cancer, pheochromocytoma\nPhysical half-life: 68 hours\nEmission: 171 and 245 keV\nChelating agent: diethylenetriaminepentaacetic acid\nSensitive to: somatostatin receptor subtypes 2 ( $80 \\%$ of enteropancreatic neuroendocrine tumors) and 5\nDistribution: kidneys, spleen, gallbladder, liver, urinary bladder, intestines, thyroid, pituitary gland\nDose: $3-5-6 \\mathrm{mCi}$\nPreparation: oral laxative (in patient without diarrhea); cessation of octreotide therapy 72 hours before administration\nAdvantage: superior to MIBG\nImaging protocol:\nÂ» SPECT of area of interest after 4 hours (to avoid superimposed physiologic biliary excretion into small + large bowel)\nÂ» delayed SPECT imaging at 18-24 hours\nÂ» planar whole-body imaging\n\n## Guanethidine Analogs\n\nIndications:\ncatecholamine-producing adrenal medullary tumor (intrarenal pheochromocytoma + extraadrenal paraganglioma) and chromaffin cell tumor ( C cells of thyroid, melanocytes of skin, chromaffin cells of adrenal medulla, pancreatic cells, Kulchitsky cells)\n(1) Pheochromocytoma ( $80-90 \\%$ sensitive, $>90 \\%$ specific) tumors as small as 0.2 g have been detected\n(2) Neuroblastoma, carcinoid, medullary thyroid carcinoma, nonfunctioning retroperitoneal neuroendocrine tumor, middle mediastinal paraganglioma, adrenal metastasis of choriocarcinoma, Merkel (skin) tumor\nPharmacokinetics:\nactive transport into cell membrane (= type I uptake mechanism) of sympathomedullary system, which have neurosecretory granules capable of accumulating MIBG; not metabolized to any appreciable extent\nNormal activity is seen in liver, spleen, bladder, salivary glands, myocardium, lungs; $85 \\%$ of injected dose is excreted unchanged by kidneys\nPreparation:\n(1) Lugol solution administered orally ( 50 mg of iodine per day) for $4-5$ days starting the day before injection $\\rightarrow$ to block thyroid uptake of free iodine\n(2) To avoid false-negative scan $\\rightarrow$ cessation of sympatho- mimetics, reserpine, calcium channel blockers, tricyclic antidepressants, labetalol for 3-4 days before administration\n\n## 1311-METAOODOBENZYLGUANIDINE (MIBG)\n\nSensitivity: $77-100 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 625,
            "markdown": "Emission: 159 keV (for ${ }^{123} \\mathrm{I}$ ); 364 keV (for ${ }^{131} \\mathrm{I}$ )\nDose: $0.5-1.0 \\mathrm{mCi}$\nRadiation dose: $35 \\mathrm{rad} / \\mathrm{mCi}$ for adrenal medulla, $1.0 \\mathrm{rad} / \\mathrm{mCi}$ for ovaries, $0.4 \\mathrm{rad} / \\mathrm{mCi}$ for liver, $0.22 \\mathrm{rad} / \\mathrm{mCi}$ for whole body\nImaging: planar static whole body imaging at 48-72 hours (target-to-background ratio improved at 72 hours) of thorax, abdomen, pelvis with 100,000 counts / 20 minutes per image at each location $\\pm$ SPECT\n\n# 123]-MetaiodobenzyLguAnidine (MIBG) \n\nagent of choice $\\leftarrow$ higher quality images + lower radiation burden + quicker results, allows SPECT imaging\nDose: $5-10 \\mathrm{mCi}$\nRadiation dose: $2.76 \\mathrm{rad} / \\mathrm{mCi}$ for adrenals, $0.07 \\mathrm{rad} / \\mathrm{mCi}$ for ovaries, $0.05 \\mathrm{rad} / \\mathrm{mCi}$ for liver, $0.02 \\mathrm{rad} / \\mathrm{mCi}$ for whole body\nImaging: at 6 hours and 24 hours\n\n## Glucose Analogs\n\n## 2-(18FLUORINE)FLUORO-2-DEOXY-D-GLUCOSE (FDG)\n\nUptake: accumulation in cells of rapidly growing tumor $\\leftarrow$ accelerated glucose metabolism (phosphorylation to FDG-6-phosphatase)\nFDG-positive: aggressive neuroendocrine tumor\nFDG-negative: slow tumor growth in $50 \\%$ of neuroendocrine tumors\n\n## BONE AGENTS\n\nA. POLYPHOSPHATES $=$ LINEAR PHOSPHATES $=$ CONDENSED PHOSPHATES\n\nFirst agents described; contain up to 46 phosphate residues; simplest form contains 2 phosphates $=$ pyrophosphate (PYP)\nB. DIPHOSPHONATES Organic analogs of pyrophosphate characterized by P-C-P bond; chemically more stable; not susceptible to hydrolysis in vivo; most widely used agents:\n\n1. Ethylene hydroxydiphosphonate (EHDP)\n= ethane-1-hydroxy-1,1-diphosphonate\n2. Methyl diphosphonate (MDP)\n\nSynonym: Methylene diphosphonate / Medronate\nC. Imidodiphosphonates (IDP) Characterized by P-N-P bond\n\n## Physiologic Uptake of Bone Agents\n\n(a) rapid distribution into ECF ( $78 \\%$ of injected dose with biologic half-life of 2.4 minutes) directly related to blood flow + vascularity; blood clearance rate determines ECF (= background) activity (at 4 hours $1 \\%$ for diphosphonates, $5 \\%$ for pyrophosphate / polyphosphate secondary to greater degree of protein binding)\n(b) chemisorbs on hydroxyapatite crystals in bone + in calcium crystals in mitochondria; MDP concentration at 3 hours is directly proportional to calcium contents of tissues ( $14-24 \\%$ calcium in bone, $0.005 \\%$ calcium in muscle); $50-60 \\%$ ( $58 \\%$ for MDP, $48 \\%$ for EHDP, $47 \\%$ for PYP) are localized in bone by $\\sim 3$ hours depending on blood flow + osteoblastic activity; $2-10 \\%$ of the dose are present within soft tissues; myocardial uptake depends on",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 626,
            "markdown": "at least some revascularization of infarcted muscle\n\n# Excretion of Bone Agents \n\nvia urinary tract by 6 hours in $68 \\%$ of MDP / EHDP, in $50 \\%$ of PYP, in $46 \\%$ of polyphosphates\n$\\diamond$ Forcing fluids + frequent voiding reduces radiation dose to bladder!\n\n## Indications for Bone Imaging\n\n1. Imaging of bone, myocardial / cerebral infarct, ectopic calcifications, some tumors (neuroblastoma)\n2. Rx for Paget disease, myositis ossificans progressiva, calcinosis universalis $\\rightarrow$ inhibits formation + dissolution of hydroxyapatite crystals\n\n## Pediatric Indications for Bone Scan\n\nA. Back pain\n\n1. Diskitis\n2. Pars interarticularis defect: SPECT imaging adds sensitivity\n3. Osteoid osteoma: can be used intraoperatively to ensure removal of nidus\n4. Sacroiliac infection\nB. Nonaccidental trauma\n\nPediatric Dose Formula: $0.25 \\mathrm{mCi} / \\mathrm{kg}{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-medronate; (minimum dose of 1 mCi )\nor dose range: $[($ age +1$) /($ age +7$) ] \\times[$ lowest adult range]\n\n## Imaging with Bone Agents\n\n@ Bone: $2-3$ hours post injection\n$\\diamond$ Fractures may not show positive uptake until 3-10 days depending on age of patient\n@ Myocardium: $90-120 \\mathrm{~min}$ post injection\n$\\diamond$ Ideal imaging time is $1-3$ days post infarction\nUsual dose: $20 \\mathrm{mCi}(740 \\mathrm{MBq})$\nRadiation dose: $0.13 \\mathrm{rad} / \\mathrm{mCi}$ for bladder (critical organ), $0.04 \\mathrm{rad} / \\mathrm{mCi}$ for bone, 0.01 $\\mathrm{rad} / \\mathrm{mCi}$ for whole body\nLabeling: Tc (VII) is eluted as a pertechnetate ion; chemical reduction with Sn (II) chloride; chelated into a complex of ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ (IV)-tin-phosphate\nQuality Control:\n(1) $<10 \\%{ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-tin colloid / free ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-pertechnetate (a good preparation is $95 \\%$ bound)\n(2) Agent should not be used prior to 30 min after preparation\n(3) Avoid injection of air in preparation of multidose vials (oxidation results in poor Tc bond)\n(4) Kit life is $4-5$ hours after preparation\n\n## Three-Phase Bone Scanning\n\nover area of interest\n\n1. Rapid sequence flow study $(2-5 \\mathrm{sec} /$ frame $)=$ early arterial flow $=1 \\mathrm{st}$ phase\n2. Immediate postflow images ( 1 million counts for central body +0.5 million counts for extremities) $=$ blood pool $=$ tissue phase $=2^{\\mathrm{nd}}$ phase\n3. Delayed images ( $0.5-1.0$ million counts) between $3-4$ hours following injection $=3^{\\mathrm{rd}}$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 627,
            "markdown": "# BONE MARROW AGENTS \n\nfor assessment of hematopoiesis / phagocytosis by RES\n\n1. ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-sulfur colloid ( $10 \\%$ uptake in bone marrow)\n2. ${ }^{111}$ In chloride\n3. ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MMAA\n$=$ mini-microaggregated albumin colloid for liver, spleen, hematopoietic marrow\nParticle size: $30-100 \\mu \\mathrm{~m}$\nDose: 10 mCi\nMarrow dose: 0.55 rad\nMarrow accumulation at 1 hour:\n6 x higher than for sulfur colloid\n3 x higher than for antimony-sulfur colloid\n\n## Indications for Bone Marrow Imaging:\n\nA. EXPANSION of hematopoietically active bone marrow\n\n1. Hematologic disorders to reveal presence of peripheral expansion of functional marrow\nB. FOCAL DEFECT from displacement by infiltrating disease\n2. Marrow replacement disorders: eg, Gaucher disease\n3. Bone infarction: eg, sickle cell anemia (DDx from osteomyelitis)\n4. Avascular necrosis in children\n\nIndications for Non-organ-specific Whole Body Imaging\n\n1. Tumor\n\nAgents: ${ }^{67} \\mathrm{Ga}$ citrate, ${ }^{131} \\mathrm{I}$ MIBG,\n${ }^{111}$ In pentetreotide (OctreoScan ${ }^{\\mathrm{TM}}$ ),\n${ }^{111}$ In antiprostate antibody (ProstaScint ${ }^{\\circledR}$ ),\n${ }^{111}$ In OncoScint ${ }^{\\mathrm{TM}}$,\n${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ anti-CEA antibody (CEA-Scan ${ }^{\\circledR}$ ),\n${ }^{18} \\mathrm{~F}$ deoxyglucose\n2. Inflammation / infection\n\nAgents: ${ }^{67} \\mathrm{Ga}$ citrate, ${ }^{111}$ In oxime labeled WBC, ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$ HMPAO labeled WBC\n\n## AGENTS FOR INFLAMMATION\n\n## ${ }^{67}$ Ga-citrate Scintigraphy\n\noverall $58-100 \\%$ sensitivity; $75-100 \\%$ specificity (lower for abdominal inflammation because of problematic abdominal activity)\nIndication: ${ }^{67} \\mathrm{Ga}$ mostly limited to\n(a) chest: interstitial pneumonia, opportunistic infection, sarcoidosis, drug toxicity\n(b) bone: osteomyelitis\n\nPathophysiology:\nleakage of protein-bound ${ }^{67} \\mathrm{Ga}$ into extracellular space $\\leftarrow$ hyperemia + increased",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 628,
            "markdown": "capillary permeability; ${ }^{67} \\mathrm{Ga}$ is preferentially bound to nonviable PMNs + macrophages\n\n1. Leukocyte incorporation (rich in lactiferous)\n2. Bacterial uptake (iron-chelating siderophores)\n3. Inflammatory tissue stimulates lactoferrin production\n\n# Gallium in Chronic Abdominal Inflammation \n\n$67 \\%$ sensitivity, $64 \\%$ specificity, $13 \\%$ false-negative rate, $5 \\%$ false-positive rate\nDose: 5 mCi\nImaging: routine at 48-72 hours (after clearance of high background activity); optional at 6-24 hours (prior to renal + gastrointestinal excretion); delayed images as needed\n$\\checkmark$ diffuse uptake in peritonitis\n$\\checkmark$ localized uptake in acute pyogenic abscess, phlegmon, acute cholecystitis, acute pancreatitis, acute gastritis, diverticulitis, inflammatory bowel disease, surgical wound, pyelonephritis, perinephric abscess\n\n## Labeled Leukocyte Scintigraphy\n\n$=$ primary imaging method for inflammation / infection\nIndication:\n(1) Fever of unknown origin / bacteremia\n(2) Abdominal infection/abscess\n(3) Osteomyelitis\n(4) Inflammatory bowel disease\n(5) Vascular graft infection\n\nPreparation (3-hour time):\nÂ» $30-40 \\mathrm{~mL}$ of whole blood drawn into syringe containing an anticoagulant\nÂ»syringe stands in upright position for $1-2 \\mathrm{hr}$ with addition of hydroxyethyl starch (for sedimentation of RBCs)\nÂ» under centrifugation leukocytes form a pellet at bottom of tube (allows separation of leukocytes from platelets)\nRequirements:\n\n1. WBC count $>2,000 / \\mathrm{mm} 3$\n2. Neutrophil-mediated inflammatory process\n\nBiodistribution: closely parallels hematopoietically active marrow\nPhysiologic uptake:\n@ Granulation wounds = healing by secondary intention (eg, ostomies, skin graft)\n$\\diamond$ Leukocytes do NOT accumulate in normally healing wounds\n@ Lung\n$\\checkmark$ physiologic diffuse lung uptake up to 4 hours\n$\\diamond$ Lung uptake $>24$ hours due to pneumonia / ARDS\n$\\checkmark$ physiologic diffuse lung uptake in severely septic patient $\\leftarrow$ cytokine release at site of infection + subsequent activation of pulmonary vascular endothelium\n\n## III In-labeled WBC\n\n$=111$ In-oxime-labeled autologous leukocytes with $80 \\%$ sensitivity; $97 \\%$ specificity, $91 \\%$",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 629,
            "markdown": "accuracy (superior to ${ }^{67} \\mathrm{Ga}$ citrate); no activity in intestinal contents / urine\nIndication:\noccult sepsis (postoperative fever), acute pyogenic infection, abdominal + renal abscess, inflammatory bowel disease, nonpulmonary infection with HIV positivity, prosthetic graft infection (bone / cardiovascular graft), acute + chronic + complicated bone / joint infection\nTechnique:\nchelating agents (oxime $=8$-hydroxyquinoline / tropolone) used for labeling of leukocytes; lipophilic oxime-indium complex penetrates cell membrane of white cells; intracellular proteins scavenge the indium from oxime; oxime diffuses out from cell; requires 2 hr of preparation time\nRecovery rate: $30 \\%$ at 1-4 hours after injection\nLimitations: 19 gauge IV access, leukopenia, impaired chemotaxis, abnormal WBCs, children\nDose: 0.5 mCi\nHalf-life: 67 hours\nUseful photopeaks: $173 \\mathrm{keV}(89 \\%), 247 \\mathrm{keV}(94 \\%)$\nRadiation dose:\n$13-18 \\mathrm{rad} / \\mathrm{mCi}$ for spleen; $3.8 \\mathrm{rad} / \\mathrm{mCi}$ for liver; $0.65 \\mathrm{rad} / \\mathrm{mCi}$ for red marrow; 0.45 $\\mathrm{rad} / \\mathrm{mCi}$ for whole body; $0.29 \\mathrm{rad} / \\mathrm{mCi}$ for testes; $0.14 \\mathrm{rad} / \\mathrm{mCi}$ for ovaries (compared with ${ }^{67} \\mathrm{Ga}$ higher dose to spleen, but lower dose to all other organs)\nBiodistribution: spleen, liver, bone marrow; blood clearance halftime of 6-7 hours; NO bowel activity\nImaging:\nbest at 18-24 hours following injection of cell preparation; optional at 2-6 hours (eg, in inflammatory bowel disease); delayed images as needed; bone marrow uptake provides useful landmarks\n\n- SPECT imaging $>>$ standard planar imaging\n$\\sqrt{ }$ focal activity greater than in spleen is typical for abscess (comparison based on liver, spleen, bone marrow activity)\n$\\checkmark$ activity equal to liver (significant inflammatory focus)\n$\\checkmark$ abdominal activity is always abnormal (eg, pseudomembranous / ischemic colitis, inflammatory bowel disease, GI bleeding)\n\nFalse positives:\n@ Chest: CHF, RDS, embolized cells, cystic fibrosis, vascular access lines, dialysis catheter\n@ Abdomen: accessory spleen, colonic accumulation, renal transplant rejection, active GI hemorrhage, vasculitis, ischemic bowel disease, following CPR, uremia, postradiation therapy, Wegener granulomatosis, ALL, lumbar puncture\n@ Miscellaneous: IM injection, histiocytic lymphoma, cerebral infarction, arthritis, skeletal metastases, thrombophlebitis, hematoma, hip prosthesis, cecal carcinoma, postsurgical pseudoaneurysm, necrotic tumors that harvest WBCs\nFalse negatives:\nchronic infection, aortofemoral graft, LUQ abscess, infected pelvic hematoma,",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 630,
            "markdown": "splenic abscess, hepatic abscess (occasionally)\n\n# Disadvantages: \n\n2-day procedure, low-quality images especially of extremities\nAdvantages:\nno activity in normal GI / GU tract (preferred in postoperative patient + vascular grafts); simultaneous WBC + sulfur colloid bone marrow scan possible\n\n## 99mTc-HMPAO Labeled WBC\n\nOptimal use: osteomyelitis in extremities\nBiodistribution: bone marrow, little soft tissue, spleen $>$ liver, renal + bladder activity\nExcretion: in bile + urine\nAdvantages over ${ }^{111}$ In WBC imaging:\n(a) improved photon flux with lower dose\n(b) earlier imaging (same day)\n\n## Disadvantages:\n\n(1) Biliary excretion leads to bowel activity, which may obscure abdominal / graft abscess if not imaged early\n(2) Heart and blood pool activity\n(3) Nonspecific accumulation in lung may obscure lung disease\n\nTechnique:\nchelating agents (exametazime oxime) used for labeling of leukocytes; ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-Ceretec binds with autologous WBCs and is reinjected\nDose: up to 10 mCi\nImaging:\n30 min (optimum for use in abdomen), $60 \\mathrm{~min}, 3-4$ hours, $4-8$ hours (optimum outside abdomen); 24 hr (optional)\nFalse positives:\nmay be due to unusual marrow distribution, correlation with bone marrow (sulfur colloid) scan may be necessary\n\n## 67GA-CITRATE\n\n${ }^{67} \\mathrm{Ga}$ acts as an analogue of ferric ion; used as gallium citrate (water-soluble form)\nProduction: bombardment of zinc targets $(67 \\mathrm{Zn}, 68 \\mathrm{Zn})$ with protons (cyclotron); virtually carrier-free after separation process\nDecay: by electron capture to ground state of 67 Zn\nEnergy levels:\n(a) used: $93 \\mathrm{keV}(38 \\%), 184 \\mathrm{keV}(24 \\%), 296 \\mathrm{keV}(16 \\%), 388 \\mathrm{keV}(8 \\%)$\n(b) unused: $91 \\mathrm{keV}(2 \\%), 206 \\mathrm{keV}(2 \\%)$\n\nPhysical half-life: 3.3 days ( $=78$ hours)\nBiologic half-life: $2-3$ weeks\nAdult dose: $3-6 \\mathrm{mCi}$ or $50 \\mu \\mathrm{Ci} / \\mathrm{kg}$\nRadiation dose:\n$0.3 \\mathrm{rad} / \\mathrm{mCi}$ for whole body; $0.9 \\mathrm{rad} / \\mathrm{mCi}$ for distal colon (= critical organ); $0.58 \\mathrm{rad} / \\mathrm{mCi}$ for red marrow; $0.56 \\mathrm{rad} / \\mathrm{mCi}$ for proximal colon; $0.46 \\mathrm{rad} / \\mathrm{mCi}$ for liver; $0.41 \\mathrm{rad} / \\mathrm{mCi}$ for",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 631,
            "markdown": "kidney; $0.24 \\mathrm{rad} / \\mathrm{mCi}$ for gonads\n\n# Binding Sites of ${ }^{67} \\mathrm{Ga}$-citrate \n\nPhysiology:\n${ }^{67} \\mathrm{Ga}$ is bound to iron-binding sites of various proteins (strongest bond with transferrin in plasma, lactoferrin in tissue); multiexponential + slow plasma disappearance; competitive iron administration (Fe-citrate) enhances target-to-background ratio by increasing ${ }^{67} \\mathrm{Ga}$ excretion\nA. Fluid spaces\n\n1. Transferrin, haptoglobin, albumin, globulins in blood serum ( $90 \\%$ )\n2. Interstitial fluid space (increased capillary permeability and hyperemia in inflammation + tumor)\n3. Lactoferrin in tissue\nB. Cellular binding\n4. Viable PMNs incorporate $10 \\%$ of ${ }^{67} \\mathrm{Ga}$ (bound to lactoferrin in intracytoplasmic granules)\n5. Nonviable PMNs + their protein exudate (iron-binding proteins are deposited at sites of inflammation; these remove iron from the extracellular space; iron is no longer available for bacterial growth)\n6. Lymphocytes have lactoferrin-binding surface receptors\n7. Phagocytic macrophages engulf protein-iron complexes\n8. Bacteria + fungi (siderophores $=$ lysosomes $=$ low-molecular-weight chelates produced by bacteria) have iron-transporting protein mechanism\n9. Tumor cell-associated transferrin receptor + transportation into cells (lymphocytes bind ${ }^{67} \\mathrm{Ga}$ less avidly than PMNs; RBCs do NOT bind ${ }^{67} \\mathrm{Ga}$ )\nmnemonic: LFT'S\nLactoferrin (WBCs)\nFerritin\nTransferrin\nSiderophores (bacteria)\n\n## Uptake of ${ }^{67} \\mathrm{Ga}$-citrate\n\nat 24 hr : most intense in RES, liver, spleen (4\\%), bone marrow (lumbar spine, sacroiliac joints), bowel wall (chiefly colonic activity on delayed images), renal cortex, nasal mucosa, lacrimal + salivary glands, blood pool (20\\%), lung ( $<3 \\%=$ equivalent to background activity), breasts\nat 72 hr : $75 \\%$ of dose remains in body its activity equally distributed among soft tissue (orbit, nasal mucosa, large bowel), liver, bone or bone marrow (occiput); kidney activity no longer detectable; lacrimal + salivary glands may still be prominent\n\n## Excretion of ${ }^{67} \\mathrm{Ga}$ - citrate\n\n(a) via urinary tract ( $10-25 \\%$ within 24 hours) no activity in kidneys + urinary bladder after 24 hours\n(b) via GI tract ( $10-20 \\%$ ) hepatobiliary pathway + colonic mucosal excretion",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 632,
            "markdown": "$\\diamond$ Enemas + laxatives promote clearing of bowel activity!\n$\\diamond$ Bowel cleansing not optimal as gallium lies also within colonic wall\n(c) via various body fluids eg, human milk (mandates to stop nursing for 2 weeks)\n\n# Imaging of ${ }^{67} \\mathrm{Ga}$-citrate \n\nusually [6, 24], 48-72 hours (up to 7 days)\n$\\diamond$ Best target-to-background ratio generally at 72 hours\n$\\diamond$ Optimal target-to-background ratio at 6-24 hours for abscess\n$\\diamond$ Optimal target-to-background ratio at $24-48$ hours for tumor\n\n- 500,000 count spot views / whole body\n- SPECT useful\n\n\n## Degrading Factors of Gallium Imaging\n\n$\\sqrt{ }$ lesions $<2 \\mathrm{~cm}$ are not detectable\n$\\sqrt{ }$ photon scatter within overlying tissues\n$\\sqrt{ }$ physiologic high activity of liver, spleen, bones, kidney, GI tract may obscure lesion\n\n## Normal Variants of Gallium Uptake\n\n1. Breasts: increased uptake under stimulus of menarche, estrogens, pregnancy, lactation, phenothiazine medication, renal failure, hypothalamic lesion\n2. Liver: suppressed uptake by chemotherapeutic agents / high levels of circulating iron / irradiation / severe acute liver disease\n3. Lung: prominent uptake after lymphangiography\n4. Spleen: increased uptake in splenomegaly\n5. Thymus: uptake in children\n6. Salivary glands: uptake within first 6 months after radiation therapy to neck (may persist for years)\n7. Epiphyseal plates in children\n8. Previous steroid therapy, chemotherapy, and radiation therapy may decrease Ga uptake\n9. Healing surgical incision\n\n## No Gallium Uptake\n\nmost benign neoplasms; hemangioma; cirrhosis; cystic disease of the breast, liver, thyroid; reactive lymphadenopathy; inactive granulomatous disease\n\n## Indications for Gallium Imaging\n\nA. Infection Gallium has been largely replaced with WBC imaging but can be used in chronic infection\n\n1. Inflamed / infarcted bowel (eg, Crohn disease)\n$D D x$ : normal bowel excretions (must be cleared by enema; bowel pathology shows persistent activity)\n2. Diffuse lung uptake sarcoidosis, diffuse infections (TB, CMV, PCP), lymphangitic metastases, pneumoconioses (asbestosis, silicosis), diffuse interstitial fibrosis (UIP), drug-induced pneumonitis (bleomycin, cyclophosphamide, busulfan), acute radiation pneumonitis, recent lymphangiographic contrast\n3. Lymph node involvement sarcoidosis, TB, MAI, Hodgkin disease",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 633,
            "markdown": "$D D x$ : NOT seen in Kaposi sarcoma, a useful distinction in AIDS patients with hilar nodes\nB. Tumor Neoplastic uptake is variable; prominent uptake is usually seen in:\n\n1. Non-Hodgkin lymphoma (especially Burkitt)\n2. Hodgkin disease\n3. Hepatoma\n4. Melanoma\n\nUseful in:\n$>$ detection of tumor recurrence\n$>$ DDx of focal cold liver lesions on $\\mathrm{Tc}-{ }^{99 \\mathrm{~m}}$ sulfur colloid scan\n\n# Gallium in Bone Imaging \n\nIncreased activity in:\n\n1. Active osteomyelitis ( $90 \\%$ sensitivity is higher than for ${ }^{99 \\mathrm{~m}} \\mathrm{Tc}$-MDP)\n2. Sarcoma\n3. Cellulitis (bone scan followed by gallium scan)\n4. Septic arthritis, rheumatoid arthritis\n5. Paget disease\n6. Metastases ( $65 \\%$ sensitivity, less than for bone agents)\n\n## Gallium in Tumor Imaging\n\nParticularly useful in evaluating extent of known tumor disease + in detection of tumor recurrence\nA. USEFUL CATEGORY\n\n1. Lymphoma\na: Hodgkin disease: $74-88 \\%$ sensitivity\nb: NHL: sensitivity varies\n> histiocytic form: $85-90 \\%$ sensitivity\n> lymphocytic well-diff.: $55-70 \\%$ sensitivity\n$95 \\%$ sensitivity for mediastinal disease,\n$80 \\%$ sensitivity for cervical + superficial lesions; poor sensitivity below diaphragm\n2. Burkitt lymphoma: almost $100 \\%$ sensitivity\n3. Rhabdomyosarcoma: $>95 \\%$ sensitivity\n4. Hepatoma: $85-95 \\%$ sensitivity\n5. Melanoma: $69-79 \\%$ sensitivity\nB. POSSIBLY USEFUL\n6. NHL: good for large + mediastinal lesions\n7. Nodal metastases from seminoma + embryonal cell carcinoma: $87 \\%$ sensitivity\n8. Non-small cell lung cancer: $85 \\%$ sensitivity for primary of any histologic type, $90 \\%$ probability for uptake in mediastinal nodes, $67 \\%$ probability for uptake in normal mediastinal nodes, $90 \\%$ probability for uptake in extrathoracic metastases\nC. NOT USEFUL head \\& neck tumors, GI tumors (especially adenocarcinomas; 35-40\\% sensitivity), breast tumor ( $52-65 \\%$ sensitivity), gynecologic tumors ( $<26 \\%$ sensitivity), pediatric tumors",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 634,
            "markdown": "# Gallium in Lung Imaging \n\n$\\diamond$ Scans obtained at 48 hours, because $50 \\%$ of normals show activity at 24 hours\nA. FOCAL UPTAKE\n\n1. Primary pulmonary malignancy ( $>90 \\%$ sensitivity)\n2. Benign disorders: granuloma, abscess, pneumonia, silicosis\nB. MULTIFOCAL / DIFFUSE UPTAKE\n(a) Infection\n3. Tuberculosis\n$\\sqrt{ }$ intense uptake in active lesions ( $97 \\%$ )\n$=$ parameter of activity\n$\\sqrt{ }$ diffuse uptake in miliary TB + rapidly progressive TB pneumonia\n4. Pneumocystis carinii\n$\\checkmark$ increased uptake at time when physical signs, symptoms, and roentgenographic changes are unimpressive\n5. Cytomegalovirus\n(b) Inflammation\n6. Sarcoidosis $70 \\%$ sensitivity for active parenchymal disease, $94 \\%$ sensitivity for hilar adenopathy\n$=$ indicator of therapeutic response to steroids\n7. Interstitial lung disease pneumoconiosis, idiopathic pulmonary fibrosis, lymphangitic carcinomatosis\n8. Exudative stage of radiation pneumonitis\n(c) Drugs\n9. Bleomycin toxicity\n10. Amiodarone\n(d) Contrast lymphangiography (in 50\\%)\nC. GALLIUM UPTAKE + NORMAL CHEST FILM\n11. Pulmonary drug toxicity\n12. Tumor infiltration\n13. Sarcoidosis\n14. Pneumocystis carinii\n\n## Panda Sign\n\n$=$ facial uptake of ${ }^{67} \\mathrm{Ga}$ in both parotid glands + both lacrimal glands + nose\n\n1. Sarcoidosis\n$\\diamond 100 \\%$ specific for sarcoidosis if lung infiltrates are present!\n2. Treated lymphoma\n3. Systemic lupus erythematosus\n4. SjÃ¶gren syndrome\n\n## Gallium in Renal Imaging\n\nAbnormal uptake on delayed images at 48-72 hours\nA. Renal tumor\n\n1. Primary renal tumor (variable uptake)\n2. Lymphoma / leukemia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 635,
            "markdown": "3. Metastases (eg, melanoma)\nB. Renal inflammation\n4. Acute pyelonephritis ( $88 \\%$ sensitivity)\n$\\sqrt{ }$ diffuse / focal uptake\n5. Lobar nephronia\n6. Renal abscess\nC. Others\n7. Collagen-vascular disease, vasculitis, Wegener granulomatosis\n8. Amyloidosis, hemochromatosis\n9. Hepatic failure\n10. Administration of antineoplastic drugs\nD. Transplant\n11. Acute / chronic rejection\n12. Acute tubular necrosis\nE. Urinary bladder\n13. Cystitis\n14. Tumor\nmnemonic: CHANT An OLD PSALM\nChemotherapy\nHemochromatosis, Hepatorenal failure\nAcute tubular necrosis, Acute lobar nephronia\nNeoplasm\nTransfusion, Tuberous sclerosis\nAbscess\nObstruction\nLymphoma\nDrugs (Fe, drugs causing ATN)\nPyelonephritis, Polyarteritis nodosa\nSarcoidosis\nAmyloidosis, Allograft\nLeukemia\nMetastasis, Myeloma\n\n# Gallium Imaging in Lymphoma \n\n$=$ chief use of gallium in tumor imaging before + after chemo- / radiation therapy:\n$\\sqrt{ }$ persisting ${ }^{67} \\mathrm{Ga}$ uptake indicates residual tumor\n$\\sqrt{ }$ reversion to normal of a previously ${ }^{67} \\mathrm{Ga}$ avid mass indicates fibrosis\n$\\sqrt{ }$ new ${ }^{67} \\mathrm{Ga}$ uptake during therapy indicates tumor progression\nA. Hodgkin disease\n$50-70 \\%$ average sensitivity dependent on size, location, technique\nB. Non-Hodgkin lymphoma\n$30 \\%$ sensitivity for lymphocytic subtype,\n$70 \\%$ sensitivity for histiocytic subtype\nSensitivity:\n$90 \\%$ for mediastinal nodes",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 636,
            "markdown": "$80 \\%$ for neck nodes\n$48 \\%$ for periaortic nodes\n$47 \\%$ for iliac nodes\n$36 \\%$ for axillary nodes\n\n# Gallium Imaging in Malignant Melanoma \n\n## Types:\n\n1. Lentigo maligna: low invasiveness, low metastatic potential\n2. Superficial spreading melanoma: intermediate prognosis\n3. Nodular melanoma: most lethal\n\nPrognosis (level of invasion versus 5-year survival):\nLevel I (in situ) $100 \\%$\nLevel II (within papillary dermis) $100 \\%$\nLevel III (extending to reticular dermis) $88 \\%$\nLevel IV (invading reticular dermis) $66 \\%$\nLevel V (subcutaneous infiltration) $15 \\%$\nGa-67:\n$>50 \\%$ sensitivity for primary + metastatic sites\nDetectability versus tumor size:\n$73 \\%$ sensitivity $>2 \\mathrm{~cm} ; 17 \\%$ sensitivity $<2 \\mathrm{~cm}$\nBone, brain, liver scintigraphy:\nshow very low yield in detecting metastases at time of preoperative assessment and are not indicated",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 637,
            "markdown": "# STATISTICS \n\n| Decision Matrix |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| GOLD STANDARD |  |  |  |  |\n|  | normal | abnormal | subtotal |  |\n| TN | FN | T- | NPV |  |\n| abnormal | FP | TP | T+ | PPV |\n| subtotal | D- | $\\mathrm{D}+$ | total | preval |\n|  | specificity | sensitivity |  | accuracy |\n\n$\\mathrm{TP}=$ test positive in diseased subjects\n$\\mathrm{FP}=$ test positive in nondiseased subjects\n$\\mathrm{FN}=$ test negative in diseased subjects\n$\\mathrm{TN}=$ test negative in nondiseased subjects\n$\\mathrm{T}+=$ abnormal test results\n$\\mathrm{T}-$ = normal test results\n$\\mathrm{D}+=$ diseased subjects\n$\\mathrm{D}-$ = nondiseased subjects\n\n## STATISTICS\n\nIncidence $=$ number of diseased people per 100,000 population annually\nPrevalence $=$ number of existing cases per 100,000 population at a target date\nFrequency $=$ number of times an event occurred; often graphically represented in histograms\nMortality $=$ number of deaths per 100,000 population annually\nFatality $=$ number of deaths per number of diseased\n\n## Sensitivity\n\n$=$ ability to detect disease\n$=$ probability of having an abnormal test given disease\n$=$ number of correct positive tests / number with disease\n$=$ true positive ratio $=\\mathrm{TP} /(\\mathrm{TP}+\\mathrm{FN})=\\mathrm{TP} / \\mathrm{D}+$\n\n- $\\mathrm{D}+$ column in decision matrix\n$\\diamond$ Independent of prevalence\n\n\n## Specificity\n\n$=$ ability to identify absence of disease\n$=$ probability of having a negative test given no disease\n$=$ number of correct negative tests / number without disease\n$=$ true negative ratio $=\\mathrm{TN} /(\\mathrm{TN}+\\mathrm{FP})=\\mathrm{TN} / \\mathrm{D}-$\n\n- D- column in decision matrix",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 638,
            "markdown": "$\\diamond$ Independent of prevalence\n\n# Accuracy \n\n$=$ number of correct results in all tests\n$=$ number of correct tests / total number of tests\n$=(\\mathrm{TP}+\\mathrm{TN}) /(\\mathrm{TP}+\\mathrm{TN}+\\mathrm{FP}+\\mathrm{FN})=(\\mathrm{TP}+\\mathrm{TN}) /$ total\n$\\diamond$ Depends much on the proportion of diseased + nondiseased subjects in studied population\n$\\diamond$ Not valuable for comparison of tests\nExample: same test accuracy of $90 \\%$ for two tests A and B\n\n## Positive Predictive Value\n\n$=$ positive test accuracy\n$=$ likelihood that a positive test result identifies disease\n$=$ number of correct positive tests / number of positive tests\n$=\\mathrm{TP} /(\\mathrm{TP}+\\mathrm{FP})=\\mathrm{TP} / \\mathrm{T}+$\n\n- $\\mathrm{T}+$ row in decision matrix\n$\\diamond$ Dependent on prevalence\n$\\diamond$ PPV $\\uparrow$ with $\\uparrow$ prevalence for given sensitivity + specificity\n$\\diamond$ PPV $\\uparrow$ with $\\uparrow$ specificity for given prevalence\n![img-39.jpeg](img-39.jpeg)\n\n## Negative Predictive Value\n\n$=$ negative test accuracy\n$=$ likelihood that a negative test result identifies absence of disease\n$=$ number of correct negative tests / number of negative tests\n$=\\mathrm{TN} /(\\mathrm{TN}+\\mathrm{FN})=\\mathrm{TN} / \\mathrm{T}-$\n\n- T- row in decision matrix",
            "images": [
                {
                    "id": "img-39.jpeg",
                    "top_left_x": 431,
                    "top_left_y": 957,
                    "bottom_right_x": 1252,
                    "bottom_right_y": 1702,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 639,
            "markdown": "$\\diamond$ Dependent on prevalence\n$\\diamond$ NPV $\\uparrow$ with $\\uparrow$ prevalence for given sensitivity + specificity\n$\\diamond$ NPV $\\uparrow$ with $\\uparrow$ sensitivity for given prevalence\n\n# False-positive Ratio \n\n$=$ proportion of nondiseased patients with abnormal test result\n\n- D- column in decision matrix\n$=\\mathrm{FP} /(\\mathrm{FP}+\\mathrm{TN})=\\mathrm{FP} / \\mathrm{D}-$\n$=1-$ specificity $=(\\mathrm{TN}+\\mathrm{FP}-\\mathrm{TN}) /(\\mathrm{TN}+\\mathrm{FP})$\nFalse-negative Ratio\n$=$ proportion of diseased patients with a normal test result\n- D+ column in decision matrix\n$=\\mathrm{FN} /(\\mathrm{TP}+\\mathrm{FN})=\\mathrm{FN} / \\mathrm{D}+$\n$=1-$ sensitivity $=(\\mathrm{TP}+\\mathrm{FN}-\\mathrm{TP}) /(\\mathrm{TP}+\\mathrm{FN})$\n\n\n## Disease Prevalence\n\n$=$ proportion of diseased subjects to total population\n$=(\\mathrm{TP}+\\mathrm{FN}) /(\\mathrm{TP}+\\mathrm{TN}+\\mathrm{FP}+\\mathrm{FN})=\\mathrm{D}+/$ total\n$\\diamond$ Sensitivity + specificity are independent of prevalence!\n$\\diamond$ Affects predictive values + accuracy of a test result\nExample:\nTest A, C, D: $90 \\%$ sensitivity $+90 \\%$ specificity\n\n## Bayes Theorem\n\n$=$ the predictive accuracy of any test outcome that is less than a perfect diagnostic test is influenced by\n(a) pretest likelihood of disease\n(b) criteria used to define a test result\n\n## Receiver Operating Characteristics (ROC)\n\n$=$ degree of discrimination between diseased + nondiseased patients using varying diagnostic criteria instead of a single value for the TP + TN fraction\n$=$ curvilinear graph generated by plotting TP ratio as a function of FP ratio for a number of different diagnostic criteria (ranging from definitely normal to definitely abnormal)\n$Y$-axis: true-positive ratio $=$ sensitivity\n$X$-axis: false-positive ratio $=1$ - specificity; reversing the values on the X -axis results in an identical \"sensitivity-specificity curve\"\nUse: variations in diagnostic criteria $\\rightarrow$ reported as a continuum of responses $\\rightarrow$ ranging from definitely abnormal to equivocal to definitely normal $\\leftarrow$ based on subjectivity + bias of individual radiologists\n$\\diamond$ A minimum of 4-5 data points of diagnostic criteria are needed!\nDifficulty: subjective evaluation of image features; subjective diagnostic interpretation; data must be ordinal ( $=$ discrete rating scale from definitely negative to definitely positive)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 640,
            "markdown": "# Interpretation: \n\n$\\diamond \\uparrow$ in sensitivity leads to $\\downarrow$ in specificity!\n$\\diamond \\uparrow$ in specificity leads to $\\downarrow$ in sensitivity!\n$\\diamond$ Most sensitive point is the point with the highest TP ratio\n$\\rightarrow$ equivalent to \"overreading\" by using less stringent diagnostic criteria (all findings read as abnormal)\n$\\diamond$ Most specific point is the point with the lowest FP ratio\n$\\rightarrow$ equivalent to \"underreading\" by using more strict diagnostic criteria (all findings read as normal)\n$\\diamond$ Does not consider disease prevalence in the population\n$\\diamond$ The ROC curve closest to the Y-axis represents the best diagnostic test\n\n| Test $\\mathrm{C}_{1}: \\quad \\mathbf{1 0 \\%}$ prevalence, $\\mathbf{9 0 \\%}$ sensitivity, $\\mathbf{9 0 \\%}$ specificity |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Decision Matrix |  |  |  |  |\n|  | normal | abnormal | subtotal |  |\n| normal | 162 | 2 | 164 | $99 \\%$ |\n| abnormal | 18 | 18 | 36 | $50 \\%$ |\n| subtotal | 180 | 20 | 200 | $10 \\%$ |\n|  | $90 \\%$ | $90 \\%$ |  | $90 \\%$ |\n| Test $\\mathrm{C}_{2}: \\quad \\mathbf{9 0 \\%}$ prevalence, $\\mathbf{9 0 \\%}$ sensitivity, $\\mathbf{9 0 \\%}$ specificity |  |  |  |  |\n| Decision Matrix |  |  |  |  |\n|  | normal | abnormal | subtotal |  |\n| normal | 18 | 18 | 36 | $50 \\%$ |\n| abnormal | 2 | 162 | 164 | $99 \\%$ |\n| subtotal | 20 | 180 | 200 | $90 \\%$ |\n|  | $90 \\%$ | $90 \\%$ |  | $90 \\%$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 641,
            "markdown": "![img-40.jpeg](img-40.jpeg)\n\n# Confidence Limit \n\n$=$ degree of certainty that the proportion calculated from a sample of a particular size lies within a specific range (binomial theorem)\n$\\diamond$ Analogous to the mean $\\pm 2 \\mathrm{SD}$\n![img-41.jpeg](img-41.jpeg)",
            "images": [
                {
                    "id": "img-40.jpeg",
                    "top_left_x": 362,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 891,
                    "image_base64": null
                },
                {
                    "id": "img-41.jpeg",
                    "top_left_x": 362,
                    "top_left_y": 1097,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1746,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 642,
            "markdown": "![img-42.jpeg](img-42.jpeg)\n\n# Clinical Epidemiology \n\n= application of epidemiologic principles + methods to problems encountered in clinical medicine with the purpose of developing + applying methods of clinical observation that will lead to valid clinical conclusions\nEpidemiology = branch of medical science dealing with incidence, distribution, determinants in control of disease within a defined population\n\n## Screening Techniques",
            "images": [
                {
                    "id": "img-42.jpeg",
                    "top_left_x": 357,
                    "top_left_y": 189,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 1632,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 643,
            "markdown": "Principle question: Can early detection influence the natural history of the disease in a positive manner?\nOutcome measure: Early detection + effective therapy should reduce morbidity + mortality $\\rightarrow \\uparrow$ survival rates (observational study)!\nBiases:\nLead time $=$ interval between disease detection at screening + the usual time of clinical manifestation; early diagnosis always appears to improve survival by at least this interval, even when treatment is ineffective\nLength time $=$ differences in growth rates of tumors:\n(a) slow-growing tumors exist for a long time before manifestation $\\rightarrow$ enhancing opportunity for detection\n(b) fast-growing tumors exist for a short time before manifestation $\\rightarrow$ less opportunity for detection at screening $=$ \"interval cancers\" $=$ clinically detected between scheduled screening exams are likely fast-growing tumors; patients with tumors detected by means of screening tests will have a better prognosis than those with interval cancers\nSelf-selection bias $=$ decision to participate in screening program usually made by patients better educated + more knowledgeable + more health-conscious; mortality rates from noncancerous causes can be expected to be lower than in general population\nSolution: randomization\nOverdiagnosis $=$ detection of lesions of questionable malignancy, eg, in situ cancers, which might never have been diagnosed without screening + have an excellent prognosis\n\n# Selection Bias \n\n1. Define target population (for whom study is intended)\n2. Define accessible population (inclusion + exclusion criteria)\n3. Devise sampling scheme (for intended sample population)\n4. Study population (= enrolled population)\n\nSample Bias $=$ intended sample does not adequately reflect the spectrum of characteristics in target population / poor choice of control group volunteers\nConsequence: overestimation of diagnostic accuracy $\\rightarrow$ test in question appears more specific\nLoss-to-Follow-up Bias $=$ subjects in cohort study lost to follow up differ from those who remain in study until study termination / endpoint\nDisease Spectrum Bias = only cases with a limited range of disease spectrum are included Consequence: overestimation of sensitivity\nReferral Bias = individual preferences (eg, distinct clinical groups use different indications for ordering a test) / local practices (eg, tertiary care center) determine which subjects are referred\nParticipation Bias = factors that affect final enrollment of the intended sample (eg, some subjects refuse to participate, certain records unavailable for review, participants inadvertently excluded)\nImage-based Selection Bias = subjects participation depends on having undergone a certain",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 644,
            "markdown": "imaging study\nStudy Examination Bias $=$ exclusion of technically limited / incomplete studies or prospective inclusion of only patients who are deemed competent to produce a technically adequate examination\nConsequence: overestimation of sensitivity + specificity by excluding uninterpretable imaging results\n\n# Observation Bias \n\n$=$ methodologic differences in which information is collected about / from study subjects Consequence: misclassification\nRecall Bias $=$ exposure information misclassified for subjects with and without disease (eg, patients with positive results and subsequent treatment will recall better and may exaggerate presentation symptoms)\nInterviewer Bias $=$ interviewer may inadvertently coach subjects\nSolution: use interviewer not involved / interested in study result\nVerification / Work-up Bias $=$ differences in the manner in which disease status is determined\nFollow-up / Medical Surveillance Bias $=$ subjects differentially undergo follow-up of disease status\nResponse Bias $=$ missing data are present nonrandomly for study subjects who are still included in analysis\nReviewer Bias $=$ person collecting / reviewing data is inappropriately blinded\nDiagnostic-Review Bias $=$ reference test results are not definite + study test results affect how final diagnosis is established\nTest-Review Bias = knowledge of diagnosis may affect test interpretation in a retrospective study if subjective study test is performed after diagnosis has been established\nSolution: adequate control group\nIncorporation Bias $=$ results of test are incorporated as evidence for final diagnosis if reference test cannot be performed\nImperfect-Standard Bias $=$ reference standard not $100 \\%$ accurate or use of surrogate reference test $\\leftarrow$ cost / ethical considerations\nReader-Order Bias = retained knowledge of results of one study influences interpretation of second study\nSolution: randomization\nMeasurement Bias $=$ discrepancy in measurements obtained with a new technique compared to the reference technique on the same subjects under same conditions\nClustering / Repeated-Measurement Bias = multiple measurements / observations obtained from the same subject\nConsequence: distortion of standard deviation\nContext Bias $=$ effect of altered disease prevalence on estimates of given parameters such as sensitivity, specificity and ROC\nPublication Bias = in metaanalysis if journals reviewed favor publication of studies with positive results\nConsequence: overly optimistic results\nConfounding $=$ in epidemiologic and observational studies additional factors / variables are",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 645,
            "markdown": "associated with exposure and disease status (eg, age, sex)\nSolution: randomization, restriction, matching, stratification\n\n# Randomized Trials \n\nDesign: two arms consisting of (a) study group and (b) control group with patients assigned to each arm on randomized basis\nEndpoint: difference in mortality rates of both groups\nPower: study must be of sufficient size + duration to detect a difference, if one exists; analogous to sensitivity of a diagnostic test\nImpact on effective size of groups:\nCompliance $=$ proportion of women allocated to screening arm of trial who undergo screening\nContamination $=$ proportion of women allocated to control group of trial who do undergo screening\n\n## Case-control Studies\n\nRetrospective inquiry, which is less expensive, takes less time, is easier to perform:\n(a) determine the number of women who died from breast cancer\n(b) chose same number of women of comparable age who have not died from breast cancer\n(c) ascertain the number of women who were screened\n(d) number of women who were not screened in both arms\n\nCalculation of odds ratio $=\\mathrm{ad} / \\mathrm{bc}$\n\n## KAPPA COEFFICIENT\n\n$=$ statistical measure of agreement between 2 observers ( $=$ interobserver concordance) for categorical items accounting for chance\n$\\mathrm{P}_{\\mathrm{o}}=$ proportion of observed agreement\n$\\mathrm{P}_{\\mathrm{c}}=$ hypothetical proportion of chance agreement\n\n$$\n\\mathrm{K}=\\frac{\\mathrm{P}_{\\mathrm{o}}-\\mathrm{P}_{\\mathrm{c}}}{1-\\mathrm{P}_{\\mathrm{c}}}\n$$\n\nPredictive value of K (Strength of Agreement):\n$<0.00$ poor\n$0.00-0.20$ slight\n$0.20-0.40$ fair\n$0.40-0.60$ moderate\n$0.60-0.80$ substantial\n$0.80-1.00$ almost perfect",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 646,
            "markdown": "# CONTRAST MEDIA, NEPHROTOXICITY, PREMEDICATION, CONTROL OF HEART RATE \n\nIonic $\\quad=$ dissociation in water\nNonionic $=$ soluble in water (hydrophilic); no dissociation in solution\nIodine-to-particle ratio:\n$=$ quotient of iodine atoms (attenuation of x rays) and number of particles (osmotoxic effect)\nratio 1.5 agents $=$ high-osmolar contrast media (HOCM)\nratio 3.0 agents $=$ low-osmolar contrast media (LOCM)\nratio 6.0 agents $=$ isotonic contrast media (IOCM)\nN.B.: Organic iodine is an essential element, so individuals cannot be allergic to it. An allergy to shellfish is not a predictor of increased risk to contrast media!\n\n## IONIC MONOMERS\n\n$=$ monoacidic salts composed of benzoic acid derivatives, with 3 hydrogen atoms replaced by iodine atoms +3 hydrogen atoms replaced by simple amide chains\nIn solution: strong organic acid completely dissociated (ionized) into negatively charged ions / anions\nConjugated cations: (1) sodium\n(2) methylglucamine (meglumine)\n(3) combination of both\n\nIodine concentration: up to $400 \\mathrm{mg} / \\mathrm{mL}$\nIodine-to-particle ratio: $3 \\div 2$ or $1.5 \\div 1$\nOsmolality: $1,400-2,100 \\mathrm{mOsm} / \\mathrm{kg}=\\mathrm{HOCM}$\n\n## IONIC DIMERS\n\nConstruction: 2 iodinated benzene rings containing 6 iodine atoms, one of which contains an ionizing carboxyl group; benzene rings are connected by a common amide side chain\nConjugation with: sodium + meglumine\nCompound: ioxaglate (the only available)\nIodine concentration: $320 \\mathrm{mg} / \\mathrm{mL}$\nIodine-to-particle ratio: $6 \\div 2$ or $3 \\div 1$\nOsmolality: $600 \\mathrm{mOsm} / \\mathrm{kg}=$ LOCM",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 647,
            "markdown": "![img-43.jpeg](img-43.jpeg)\n\n## Acetrizoate\n\nThe parent triiodinated contrast medium in $1^{\\text {st }}$ clinical use; the benzene ring is attached to a carboxyl (COO-) group at the 1-carbon position and conjugated with sodium / meglumine\n![img-44.jpeg](img-44.jpeg)\n\nDiatrizoate\nThe unsubstituted hydrogen of acetrizoate has been exchanged for another acetamido unit leading to higher biologic tolerance through higher degree of protein binding\n![img-45.jpeg](img-45.jpeg)\n\nIoxaglate (Hexabrix ${ }^{\\circledR}$ )\nSodium and meglumine are conjugated with the carboxyl group\n\n# NONIONIC MONOMERS \n\nConstruction: benzoic acid carboxyl group replaced by amide; side chains have been modified by adding 4-6 hydroxyl $(\\mathrm{OH})$ groups $\\rightarrow$ allows solubility in water\nIodine concentration: up to $350 \\mathrm{mg} / \\mathrm{mL}$\nIodine-to-particle ratio: $3 \\div 1$\nCompounds: iohexol, iopamidol, ioversol, iopental, iopromide (Ultravist ${ }^{\\circledR}$ ), iobitridol (Xenetix ${ }^{\\circledR}$ ), ioxilan (Oxilan ${ }^{\\circledR}$ )\nOsmolality: $616-796 \\mathrm{mOsm} / \\mathrm{kg}$\n\n## NONIONIC DIMERS\n\nConstruction: contain up to 12 hydroxyl groups $\\rightarrow$ eliminates ionicity, $\\uparrow$ hydrophilicity, $\\downarrow$ osmotoxicity, $\\uparrow$ iodine atoms per molecule\nCompounds: iodecol, iotrolan (Isovist ${ }^{\\circledR}$ ), iodixanol (Visipaque ${ }^{\\circledR}$ )\nIodine-to-particle ratio: $6 \\div 1$\nOsmolality: hypo- / isoosmolar",
            "images": [
                {
                    "id": "img-43.jpeg",
                    "top_left_x": 515,
                    "top_left_y": 198,
                    "bottom_right_x": 732,
                    "bottom_right_y": 477,
                    "image_base64": null
                },
                {
                    "id": "img-44.jpeg",
                    "top_left_x": 935,
                    "top_left_y": 187,
                    "bottom_right_x": 1285,
                    "bottom_right_y": 519,
                    "image_base64": null
                },
                {
                    "id": "img-45.jpeg",
                    "top_left_x": 430,
                    "top_left_y": 770,
                    "bottom_right_x": 1283,
                    "bottom_right_y": 1133,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 648,
            "markdown": "![img-46.jpeg](img-46.jpeg)\n\nMetrizamide\nThe $1^{\\text {st }}$ compound with 4 hydroxyl groups positioned at one end of the molecule on the glucosamide moiety\n![img-47.jpeg](img-47.jpeg)\n\nIohexol (Omnipaque ${ }^{\\circledR}$ )\ncontains 6 hydroxyl ( OH ) groups more evenly distributed around the molecule improving subarachnoid toxicity\n![img-48.jpeg](img-48.jpeg)\n\nIopamidol (Isovue ${ }^{\\circledR}$ )\nThis nonionic monomer contains five hydroxyl $(\\mathrm{OH})$ groups\n![img-49.jpeg](img-49.jpeg)\n\nIoversol (Optiray ${ }^{\\circledR}$ )\nThis nonionic monomer contains six hydroxyl $(\\mathrm{OH})$ groups",
            "images": [
                {
                    "id": "img-46.jpeg",
                    "top_left_x": 479,
                    "top_left_y": 189,
                    "bottom_right_x": 732,
                    "bottom_right_y": 635,
                    "image_base64": null
                },
                {
                    "id": "img-47.jpeg",
                    "top_left_x": 861,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 655,
                    "image_base64": null
                },
                {
                    "id": "img-48.jpeg",
                    "top_left_x": 552,
                    "top_left_y": 858,
                    "bottom_right_x": 1145,
                    "bottom_right_y": 1304,
                    "image_base64": null
                },
                {
                    "id": "img-49.jpeg",
                    "top_left_x": 516,
                    "top_left_y": 1414,
                    "bottom_right_x": 1198,
                    "bottom_right_y": 1892,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 649,
            "markdown": "![img-50.jpeg](img-50.jpeg)\n\nThis nonionic dimer contains twelve hydroxyl ( OH ) groups\n\n# Excretory Urography \n\nClearance: $>99 \\%$ of contrast material eliminated through kidney ( $<1 \\%$ through liver, bile, small and large intestines, sweat, tears, saliva); vicarious excretion with renal insult / failure (may be unilateral as in obstructive uropathy)\nHalftime: 1-2 hours (doubled in dialysis patients)\nConcentration: $60 \\%$ by weight\n(a) Sodium-containing HOCM\n$\\sqrt{ }$ less distension of collecting system\n(b) Meglumine-only HOCM\n$\\sqrt{ }$ improved distension of collecting system $\\leftarrow$ decreased tubular resorption of water\n(c) LOCM\n$\\sqrt{ }$ denser nephrogram + slightly denser pyelogram than $\\mathrm{HOCM} \\leftarrow$ higher tubular concentration\n\n## Angiography\n\nBurning sensation:\n(a) intense with concentration of $60-76 \\%$ HOCM\n(b) reduced with concentration of $\\leq 30 \\% \\mathrm{HOCM} / \\mathrm{LOCM}$\n$\\diamond$ Overall incidence of adverse allergic-type reactions is (for unknown reasons) much less with intraarterial than with intravenous use of contrast media!\n\n## Venography\n\n(1) Foot / calf discomfort or pressure or burning\n(a) $\\sim 24 \\%$ with $60 \\% \\mathrm{HOCM}$\n(b) $\\sim 5 \\%$ with $40 \\% \\mathrm{HOCM} / 300 \\mathrm{mg}$ iodine $/ \\mathrm{mL}$ LOCM\n$\\diamond$ The addition of $10-40 \\mathrm{mg}$ lidocaine $/ 50 \\mathrm{~mL}$ of contrast media decreases patient discomfort!\n(2) Postphlebography deep vein thrombosis\n(a) $26-48 \\%$ with $60 \\%$ HOCM",
            "images": [
                {
                    "id": "img-50.jpeg",
                    "top_left_x": 360,
                    "top_left_y": 187,
                    "bottom_right_x": 1336,
                    "bottom_right_y": 789,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 650,
            "markdown": "(b) $0-9 \\%$ with dilute HOCM / LOCM\n$\\diamond$ Infusion of $150-200 \\mathrm{~mL}$ of $5 \\%$ dextrose in water / $5 \\%$ dextrose in $0.45 \\%$ saline / heparinized saline through injection site immediately after examination reduces likelihood of DVT!\n\n| Physicochemical Properties of Commonly Used Radiographic Contrast Media |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Contrast Media | Compound | $\\mathrm{mOsm} / \\mathrm{kg} \\mathrm{H2O}$ | $\\frac{\\text { Viscosity (cps) at }}{37 \\cdot C}$ | lodine $\\mathrm{mg} / \\mathrm{mL}$ |\n| Ionic monomers |  |  |  |  |\n| UroRADIOLOGICAL |  |  |  |  |\n| Cysto-Conray ${ }^{\\circledR}$ II (Mallinckrodt) | Meglumine-iothalamate | 1,300 | 4.0 | 202 |\n| Gastrointestinal |  |  |  |  |\n| Hypaque ${ }^{\\circledR}$ Sodium Oral Solution (Nycomed Amersham) | Na diatrizoate | 1,300 | 4.0 | 249 |\n| GastrografinÂ® (Bracco) | Na-meglumine diatrizoate | 1,940 | 8.4 | 370 |\n| Intravascular |  |  |  |  |\n| Renovue ${ }^{\\circledR}$-Dip (Bracco) | Meglumine iodamide | 433 | 1.8 | 111 |\n| Conray ${ }^{\\circledR}-60$ (Mallinckrodt) | Meglumine-iothalamate | 1,400 | 4.0 | 282 |\n| RenografinÂ®60 (Bracco) | Na-meglumine diatrizoate | 1,450 | 4.0 | 292 |\n| Ionic dimers |  |  |  |  |\n| Hexabrix ${ }^{\\circledR}$ (Mallinckrodt) | Na-meglumine ioxaglate | 600 | 7.5 | 320 |\n| Nonionic monomers |  |  |  |  |\n| OxilanÂ® 300 (Cook) | ioxilan | 585 | 5.1 | 300 |\n| Ultravist ${ }^{\\circledR} 300$ (Berlex) | iopromide | 607 | 4.9 | 300 |\n| Isovue ${ }^{\\circledR} 300$ (Bracco) | iopamidol | 616 | 4.7 | 300 |\n| Optiray ${ }^{\\circledR} 300$ (Mallinckrodt) | ioversol | 651 | 5.5 | 300 |\n| Omnipaque ${ }^{\\circledR} 300$ (Nycomed Amersham) | iohexol | 672 | 6.3 | 300 |\n| Omnipaque ${ }^{\\circledR} 140$ (Nycomed Amersham) | iohexol | 322 | 1.5 | 140 |\n| Omnipaque ${ }^{\\circledR} 240$ (Nycomed Amersham) | iohexol | 520 | 3.4 | 240 |\n| Omnipaque ${ }^{\\circledR} 350$ (Nycomed Amersham) | iohexol | 844 | 10.4 | 350 |\n| Nonionic dimers |  |  |  |  |\n| IotrolÂ® 300 (Schering AG) | iotrolan | $\\sim 310$ | 9.1 | 300 |\n| VisipaqueÂ® ${ }^{\\circledR} 320$ (Nycomed Amersham) | iodixanol | 290 | 11.8 | 320 |\n| Osmolality of human serum is $290 \\mathrm{mOsm} / \\mathrm{kg}$ ! |  |  |  |  |\n| The higher the number of hydroxyl groups $\\rightarrow$ the larger the size of the molecule + the higher the viscosity + hydrophilicity; responsible for a decrease in protein- and tissue-binding properties $\\rightarrow$ making the compound biologically more inert |  |  |  |  |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 651,
            "markdown": "| Gadolinium-based Contrast Agents |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Contrast Media | Compound | Excess Ligand (\\%) | $\\begin{gathered} \\text { T1-Relaxivity Plasma } \\\\ \\text { [L/(mmol+sec)] } \\\\ \\text { at } 37 \\cdot C, 1.5 \\text { T } \\end{gathered}$ | $\\log K_{\\text {cold }} / p H$ <br> 7.4) | Excretion |\n| Linear Nonionic |  |  |  |  |  |\n| Omniscan (GE) | Gadodiamide (Gd-DTPA-BMA) | 5.0 | 4.6 | 14.9 | renal (R) |\n| Optimark ${ }^{\\text {TM }}$ (Mallinckrodt) | Gadoversetamide (Gd-DTPA-BMEA) | 10.0 | 5.2 | 15.0 | renal |\n| Linear Ionic |  |  |  |  |  |\n| MultiHance ${ }^{\\circledR}$ (Bracco) | Gadobenate (Gd-BOPTA) | 0.1 | 6.7 | 18.4 | $\\begin{aligned} & 96 \\% \\text { renal, } \\\\ & 4 \\% \\text { biliary } \\end{aligned}$ |\n| Magnevist ${ }^{\\circledR}$ (Bayer) | Gadopentetate (Gd-DTPA) | 0.1 | 4.3 | 17.9 | renal |\n| Eovist ${ }^{\\circledR}$ (Bayer) | Gadoxetate (Gd-EOB-DTPA) | 0.6 | 6.9 | 18.7 | $\\begin{aligned} & 50 \\% \\text { renal, } \\\\ & 50 \\% \\text { biliary } \\end{aligned}$ |\n| Vasovist ${ }^{\\circledR}$ (Bayer) | Gadofosveset | 0.1 | 19.0 | 18.9 | $\\begin{aligned} & 95 \\% \\text { renal, } \\\\ & 5 \\% \\text { biliary } \\end{aligned}$ |\n| Macrocyclic nonionic |  |  |  |  |  |\n| ProHance ${ }^{\\circledR}$ (Bracco) | Gadoteridol (Gd-HP-DO3A) | 0.1 | 4.4 | 17.1 | renal |\n| Macrocyclic ionic |  |  |  |  |  |\n| Dotarem ${ }^{\\circledR}$ (Guerbet) | Gadoterate (Gd-DOTA) | 0.0 | 3.6 | 18.0 | renal |\n| Gadovist ${ }^{\\circledR}$ (Bayer) | Gadobutrol (Gd-BT-DO3A) | 0.1 | 5.2 | 15.5 | renal |\n| 0 The greater the relaxivity (proportional to magnitude of magnetic moment, its tumbling frequency, its electron spin relaxation time) the smaller the dose needed to achieve a given level of enhancement |  |  |  |  |  |\n| 0 The higher the dissociation constants ( $\\log \\mathrm{K}$ ) the greater the stability of an agent |  |  |  |  |  |\n| Abbreviations: $\\quad$ BMA $=$ bis-methylamide; BMEA $=$ bis-methoxyethylamide; BOPTA $=$ benzyloxypropionictetraacetate; $\\mathrm{BT}=$ butrol; |  |  |  |  |  |\n| DOPTA $=$ tetraazacyclododecanetetraacetic acid; DOTA $=$ dodecano-tetraacetic acid; $\\mathrm{DO} 3 \\mathrm{~A}=1,4,7,10$-tetraazacyclododecane |  |  |  |  |  |\n| 1,4,7-triacetic acid; DTPA $=$ diethylenetriaminepentaacetic acid; $\\mathrm{EOB}=$ ethoxybenzyl; $\\mathrm{Gs}=$ gadolinium (free $\\mathrm{Gd}^{3+}$ is toxic); |  |  |  |  |  |\n| HP $=$ hydroxypropyl |  |  |  |  |  |\n| 0 Distribution is intra- and extravascular in all with the exception of Vasovist, which is predominantly intravascular. |  |  |  |  |  |\n| 0 Dissociation $\\mathrm{T}_{1 / 2}=>1000$ years for all macrocyclic compounds |  |  |  |  |  |\n\n# Evaluation of Intravenous Access \n\n1. Chose a catheter appropriate for injection:\n> antecubital / large forearm vein $\\geq 20$-gauge for $3 \\mathrm{~mL} / \\mathrm{sec}$\n> peripherally placed 22 -gauge for $<1.5 \\mathrm{~mL} / \\mathrm{sec}$\n2. Confirm venous return\n3. Perform a saline flush\n4. Perform a test injection with the power injector esp. for power-injector compatible central venous / peripherally inserted central catheters by observing manufacturer-recommended pressure limits\n\n## Contrast Extravasation\n\n$=$ escape of contrast material from vascular lumen + infiltration of interstitial tissue during injection\nIncidence: $<1 \\%$; no direct correlation with injection flow rate\n\n- may be asymptomatic; edema, erythema\n- swelling, tightness, tenderness, stinging, burning pain\n\nDx: (1) Palpate catheter venipuncture site during initial seconds of injection\n(2) Ask patient to report any sensation of pain / swelling at injection site\n\nSevere Cx (uncommon): compartment syndrome, skin ulceration, tissue necrosis\nRx: (1) Elevate affected extremity / site\n(2) Apply a warm / cold compress",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 652,
            "markdown": "(3) Monitor for a sufficiently long period\n(4) Discharge with instructions to watch for symptoms that indicate a need for surgical evaluation\n(5) Initiate surgical consultation for progressive pain / swelling, decreased capillary refill, paresthesia, skin ulceration / blistering\n\n# ADVERSE CONTRAST REACTIONS \n\nRisk factors:\n\n1. A history of a previous severe reaction to iodinated contrast agent increases the overall risk of a subsequent reaction by about 5 - to 6 -fold.\n2. All severe allergies and reactions (to medications and food)\n\nThere is NO specific link between shellfish allergy and allergy to contrast agents.\n3. History of asthma / bronchospasm / atopy\n4. History of cardiac / renal disease\n5. Age $>60$ years OR $<5$ years\nA. Nonidiosyncratic (= dose-related) reactions\n\nCause: direct chemotoxic / hyperosmolar effect\n\n- nausea, vomiting; cardiac arrhythmia; renal failure\n- pulmonary edema; cardiovascular collapse\nB. Idiosyncratic (= anaphylactoid) reactions\n$=$ reactions occurring unpredictably + independently of dose / concentration $=$ not a true antigen-IgE antibody-mediated reaction nor a reaction to iodine / iodide\nCause: unknown\n- hives, itching; facial / laryngeal edema\n- bronchospasm, respiratory collapse; circulatory collapse\nC. Delayed reactions\n- erythematous rashes, pruritus, fever, chills, flulike symptoms\n- joint pain, loss of appetite, taste disturbance, headache\n- fatigue, depression, abdominal pain, constipation, diarrhea\n\nSignificant underlying medical conditions\n(a) renal disease\n(b) cardiac disease\n(c) blood dyscrasias\n(d) pheochromocytoma\n(e) $\\uparrow$ symptoms with COPD plus pulmonary hypertension\n(f) $\\uparrow$ sickling in patients with sickle-cell disease\n$\\diamond$ Approximately $20-40 \\%$ of population are at increased risk for adverse reaction to contrast media!\n$\\diamond$ In patients with adverse reactions to HOCM repeated reactions will be lowered to $5 \\%$ by using LOCM\n$\\diamond$ No direct correlation / association to povidone-iodine skin cleansing solution (Betadine ${ }^{\\circledR}$ )\n\n## Assessment of Patients before Contrast Injection",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 653,
            "markdown": "A. General status\n\nAssess hemodynamic, neurologic, general nutritional, anxiety status\nB. History of significant allergies\n\n1. Prior anaphylactic response to any allergen\n2. Asthma\nC. Renal disease\n3. Renal dysfunction: obtain baseline BUN + creatinine\n4. Diabetes mellitus\n5. Multiple myeloma\n$\\diamond$ Hydrate patients and limit contrast dose!\nD. Cardiac disease\n6. Angina\n7. CHF with minimal exertion\n8. Severe aortic stenosis\n9. Primary pulmonary hypertension\n10. Severe cardiomyopathy\n$\\diamond$ Limit contrast dose!\n\n# NEPHROTOXICITY \n\n$=$ CONTRAST-INDUCED NEPHROTOXICITY (CIN)\n$=$ sudden deterioration of renal function after recent IV administration of contrast media in the absence of another nephrotoxic event\n\n## Indications for Obtaining Creatinine Levels\n\nA. IODINATED CONTRAST AGENTS\n\n| Prevalence of Adverse Contrast Reactions |  |  |\n| :--: | :--: | :--: |\n|  | High-osmolar Ionic | Low-osmolar <br> Nonionic |\n| Non-life-threatening reaction | $1-2 \\%$ | $0.2-04 \\%$ |\n| Life-threatening reaction | $0.2 \\%$ | $0.04 \\%$ |\n| Mortality | $1 \\div 100,000$ | $1 \\div 100,000$ |\n| Late reaction |  | $6 \\%$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 654,
            "markdown": "| Risk Factors and Incidence of Adverse Reactions <br> for High- and Low-Osmolality Contrast Media |  |  |\n| :--: | :--: | :--: |\n| Type of Reaction | HOCM [\\%] | LOCM [\\%] |\n| Overall incidence |  |  |\n| Australia (Palmer et al.) | 3.80 | 1.20 |\n| USA (Wolf et al.) | 4.20 | 0.70 |\n| Japan (Katayama et al.) | 12.70 | 3.10 |\n| Severe adverse reaction | 0.22 | 0.04 |\n| Severe allergies to drugs, foods, etc. | 23.40 | 6.90 |\n| Asthma | 19.70 | 7.80 |\n| Repeat reaction to contrast media | $16-44$ | $4.1-11.2$ |\n\n1. Age $>60$ years\n2. History of kidney disease as an adult, including tumor / transplant\n3. Family history of kidney failure\n4. Diabetes treated with insulin / other prescribed meds\n5. Hypertension\n6. Paraproteinemia syndromes / diseases (eg, myeloma)\n7. Current use of nephrotoxic medications (eg, chemotherapeutic agents, chronic use of NSAIDs)\nB. GADOLINIUM-BASED CONTRAST AGENTS\n8. Age $>60$ years\n9. History of kidney disease as an adult, including tumor / transplant\n10. Single kidney / kidney surgery\n11. Diabetes treated with insulin / other prescribed meds\n12. Hypertension requiring medical therapy\n\n# Nonoliguric Transient Renal Dysfunction \n\n$=$ transient decline of renal function\n\n- serum creatinine level peaks on days 3-5\n- serum creatinine returns to baseline values within 14-21 days\n- fractional excretion of sodium $<0.01$ (DISTINCTIVE CHARACTERISTIC compared with other causes)\n\n\n## Acute Renal Failure\n\n$=$ sudden + rapid deterioration of renal function\n$=$ increase in serum creatinine of $>25 \\%$ or to $>2 \\mathrm{mg} / \\mathrm{dL}$ within 2 days of receiving contrast material\nFrequency: $1-30 \\% ; 3^{\\text {rd }}$ most common cause of in-hospital renal failure after hypotension and surgery\nRisk factors:\nContrast agent-independent acute kidney injury is NOT significantly different and may be clinically indistinguishable when adjusted for patient risk factors.\n\n1. Preexisting renal insufficiency (serum creatinine $>1.5 \\mathrm{mg} / \\mathrm{dL}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 655,
            "markdown": "2. Diabetes mellitus with renal insufficiency (possibly related to dehydration / hyperuricemia)\n$\\diamond$ Ratio 3 nonionic LOCM appear to be $50 \\%$ less nephrotoxic than ratio 1.5 ionic HOCM\n$\\diamond$ Diabetics with normal renal function are not at $\\uparrow$ risk!\n3. Dehydration\n4. Cardiovascular disease\n5. Use of diuretics\n6. Advanced age $>70$ years\n7. Multiple myeloma (in dehydrated patients)\n8. Hypertension\n9. Hyperuricemia / uricosuria\n10. High dose of contrast material\n\nCAVE:\n$\\diamond$ Small decreases in renal function may greatly exacerbate the mortality caused by the underlying condition!\n$\\diamond$ Metformin (Glucophage ${ }^{\\circledR}$ ) should be discontinued for 48 hours after contrast medium administration (accumulation of metformin may result in lactic acidosis $\\rightarrow$ fatal in $50 \\%$ )!\n$\\diamond$ It is not necessary to stop metformin after gadolinium administration because gadolinium is not nephrotoxic!\n$\\diamond$ Avoid concomitant use of nephrotoxic drugs (eg, gentamicin, NSAIDs)\nProposed mechanisms:\n$>$ contrast agents are concentrated in nephrons + collecting tubules\n\n1. Vasoconstriction\n(a) $\\uparrow$ in intrarenal pressure induced by hypertonicity\n(b) intrarenal smooth muscle contraction $\\leftarrow$ hypertonic substances\n2. RBC aggregation in medullary circulation\n3. Direct tubular cell injury\n\nPotential antidotes:\nHydration ( $0.9 \\%$ saline at $100 \\mathrm{~mL} / \\mathrm{hr}$ ) 12 hours before +12 hours after angiography\n$\\diamond$ Extracellular volume expansion is the most effective + widely recommended measure!\n$\\checkmark$ immediate dense nephrogram persisting for up to 24 hours (in 75\\%)\n$\\checkmark$ gradually increasing dense nephrogram resembling bilateral acute ureteral obstruction (in $25 \\%)$ :\n$\\checkmark$ bilaterally enlarged smooth kidneys\n$\\checkmark$ poor opacification of urine-conducting structures\n$\\checkmark$ effacement of collecting system (interstitial edema)\nCx: $34 \\%$ mortality ( $0.4 \\%$ of all patients)\nRx: $0.1 \\%$ require renal replacement therapy\n\n# NEPHROGENIC SYSTEMIC FIBROSIS \n\n$=$ NEPHROGENIC FIBROSING DERMOPATHY\n$=$ rare potentially debilitating chronic fibrosing condition involving multiple organ systems",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 656,
            "markdown": "initially described in 2006 without specific imaging findings\nCause: gadolinium-based contrast agents\nPathophysiology: unclear\nRisk factors:\n(1) High dose gadolinium-based contrast agent\n> highest risk: Omniscan ${ }^{\\circledR}$, Magnevist ${ }^{\\circledR}$, OptiMARK ${ }^{\\text {TM }}$\n> medium risk: MultiHance ${ }^{\\circledR}$, Ablavar ${ }^{\\circledR}$, Eovist ${ }^{\\circledR}$\n> low risk: Gadavist ${ }^{\\circledR}$, Dotarem ${ }^{\\circledR}$, ProHance ${ }^{\\circledR}$\n(2) Acute / chronic renal failure: especially dialysis, hepatorenal syndrome, perioperative liver transplantation period, renal transplant failure\n(3) Venous thrombosis\n(4) Vascular surgery\n\nAge: any; most commonly middle-aged; $\\mathrm{M}+\\mathrm{F}=1+1$\nOrgan involvement: skin, subcutaneous tissue, lung, pleura, skeletal muscle, bone, heart, pericardium, testis, esophagus, kidney\nOnset: days to months (average time, 2-10 weeks) after administration of GBCA, up to 8 years after exposure\n@ Skin\nLocation: distal lower extremities $\\rightarrow$ (subsequent) extension to thighs $\\rightarrow$ lower abdomen $\\rightarrow$ upper extremities\n\n- patterned skin plaques, cobblestone, marked induration\n- erythematous papules coalescing into plaques of peau d'orange appearance\n- thickening of dermis developing a woody texture similar to scleromyxedema / scleroderma with sparing of face\n$C x$ : pain + decreased range of motion $\\rightarrow$ contractures and joint immobility\nHisto: thick collagen bundles $\\leftarrow$ proliferation of dermal fibroblasts + dendritic cells (CD68, factor XIIIa-positive) with variable amounts of mucin + elastic fibers\n$D D x$ : cellulitis, fasciitis, scleroderma, cutaneous lymphoma, lymphatic / venous obstruction, dermatopolymyositis\nRisk reducing strategy:\n(1) Consider CT in anuric patient\n(2) Use low-risk Gd-based contrast agent\n(3) Initiate dialysis within 2 hours of exposure + schedule several prolonged dialysis treatments for those patients who are already on dialysis\n\n\n# TREATMENT OF CONTRAST REACTIONS \n\n$\\diamond 94-100 \\%$ of severe + fatal anaphylactoid reactions occur within 20 minutes of contrast medium injection\n$\\Rightarrow$ use a plastic cannula for IV access\n$\\Rightarrow$ maintain IV access for 30 min\n$\\Rightarrow$ have emergency drugs close to the room where contrast injections are done\n$\\Rightarrow$ post a listing of available medications + their common doses in the room\n\n## Oral Steroid Premedication Protocol (see table)\n\nIndication: previous respiratory adverse contrast reaction, history of significant allergies /",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 657,
            "markdown": "severe asthma\nCaution in patients with: active tuberculosis, diabetes mellitus, peptic ulcer disease\n$\\diamond$ Antihistamines alone have not proved to be effective!\n\n# Treatment of Premedicated Patients \n\nA. Patient on $\\beta$-blocker\nif response to epinephrine inadequate\n$\\Rightarrow 1-5 \\mathrm{mg}$ glucagon IV + subsequent slow drip of 5 mg glucagon over 60 minutes\n![img-51.jpeg](img-51.jpeg)",
            "images": [
                {
                    "id": "img-51.jpeg",
                    "top_left_x": 187,
                    "top_left_y": 532,
                    "bottom_right_x": 1509,
                    "bottom_right_y": 1768,
                    "image_base64": null
                }
            ],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 658,
            "markdown": "| Treatment for Reactions to Contrast Agents in Adults |  |  |\n| :--: | :--: | :--: |\n| Reaction | Treatment | Dosage |\n| Bronchospasm |  |  |\n| Mild | $\\beta$-agonist inhaler $=$ albuterol | 2 puffs ( $=180 \\mu \\mathrm{~g}$ ); repeat up to 3 times |\n| Moderate | $\\beta$-agonist inhaler $=$ albuterol epinephrine | 2 puffs ( $=180 \\mu \\mathrm{~g}$ ); repeat up to 3 times <br> IM: $0.3 \\mathrm{mg}(0.3 \\mathrm{~mL}$ of $1 \\div 1000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg or IV: $0.3 \\mathrm{mg}(1-3 \\mathrm{~mL}$ of $1 \\div 10,000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg |\n| Severe | epinephrine | IM: $0.3 \\mathrm{mg}(0.3 \\mathrm{~mL}$ of $1 \\div 1000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg or IV: $0.3 \\mathrm{mg}(1-3 \\mathrm{~mL}$ of $1 \\div 10,000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg |\n| Laryngeal edema | Epinephrine | IM: $0.3 \\mathrm{mg}(0.3 \\mathrm{~mL}$ of $1 \\div 1000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg or IV: $0.3 \\mathrm{mg}(1-3 \\mathrm{~mL}$ of $1 \\div 10,000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg |\n| Hypotension <br> $<90 \\mathrm{mmHg},<100 \\mathrm{bpm}$ | Elevate legs $>60^{\\circ}$ | Consider $1000-\\mathrm{mL}$ bolus of $0.9 \\%$ normal saline / lactated Ringer |\n| Vasovagal reaction |  |  |\n| Mild | None | ... |\n| Moderate to severe | Atropine | IV: $0.6-1.0 \\mathrm{mg}$ slowly infused followed by saline flush $\\rightarrow$ repeat to total dose of 3 mg |\n| Anaphylactoid reaction $<90 \\mathrm{mmHg},>100 \\mathrm{bpm}$ | Epinephrine | IM: $0.3 \\mathrm{mg}(0.3 \\mathrm{~mL}$ of $1 \\div 1000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg or IV: $0.3 \\mathrm{mg}(1-3 \\mathrm{~mL}$ of $1 \\div 10,000$ dilution $) \\rightarrow$ repeat to total dose of 1 mg |\n| Hypertensive crisis | Labetalol or Nitroglycerin or Furosemide (Lasix) | IV: $20-\\mathrm{mg}$ slow in fusion over 2 min (double dose every 10 min ) sublingual tablet of 0.4 mg - repeat very $5-10 \\mathrm{~min}$ <br> IV: $20-40 \\mathrm{mg}$ slowly infused over 2 min |\n\nB. Patient on calcium channel blocker (eg, nifedipine, nicardipine)\n$\\Rightarrow$ calcium IV\nC. Excessive vasoconstriction on epinephrine IV\n$\\Rightarrow$ infusion of $0.5-10 \\mu \\mathrm{~g} / \\mathrm{kg} / \\mathrm{min}$ of reconstituted sodium nitroprusside (Nipride ${ }^{\\circledR}$ ) ( 50 mg in $500-1000 \\mathrm{~mL}$ of $5 \\%$ dextrose wrapped in metal foil during use to protect solution from light)\nD. Metformin (Glucophage ${ }^{\\circledR}$ )\n$\\Rightarrow$ Stop metformin medication at time of contrast injection + for subsequent 48 hours\n$\\Rightarrow$ Reinstate medication if renal function remains normal\n$\\diamond$ Contrast material is contraindicated if patient is in renal failure because of risk of lactic acidosis!\n\n# Useful Medications \n\n1. Alpha- and $\\beta$-adrenergic agents:\n\nAction: vasoconstriction, increased cardiac output\n\n- Epinephrine\n$\\Rightarrow 1 \\mathrm{~mL}$ glass vial of epinephrine $1: 1,000$\nAdult dose: $\\quad 0.1-0.2 \\mathrm{~mL}$ epinephrine $(1: 1,000=0.1-0.2 \\mathrm{mg}) \\mathrm{SQ}$\nPediatric dose: $0.01 \\mathrm{~mL} / \\mathrm{kg}$ up to $0.3 \\mathrm{~mL} /$ dose\n$\\Rightarrow$ repeat in $15-30$ minutes if needed\nIndications: bronchospasm, facial edema, severe urticaria, laryngospasm\n$\\Rightarrow 10-\\mathrm{mL}$ syringe of epinephrine $1 \\div 10,000$ (prepackaged)\nAdult dose: $\\quad 1-3 \\mathrm{~mL}$ epinephrine $(1 \\div 10,000)$\n$(=0.1 \\mathrm{mg})$ slowly IV\nPediatric dose: $0.1 \\mathrm{~mL} / \\mathrm{kg}$ slowly IV\n$\\Rightarrow$ repeat every $5-15$ minutes if needed\nIndications: bronchospasm / laryngospasm with peripheral vascular collapse",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 659,
            "markdown": "# Maximum dose: 1.0 mg \n\n- Dopamine (Inotropin ${ }^{\\circledR}$ )\n\nAdult dose: $2-5 \\mathrm{pg} / \\mathrm{kg} / \\mathrm{min}$ IV; rarely need to exceed $20 \\mathrm{pg} / \\mathrm{kg} / \\mathrm{min}$\nIndications: hypotension\nCx: arrhythmia, myocardial ischemia, nausea, vomiting, tremulousness, headache\n2. Atropine sulfate\n\nAdult dose: $0.6-1.0 \\mathrm{mg}$ slowly IV\nPediatric dose: $0.02 \\mathrm{mg} / \\mathrm{kg}$ slowly IV $(0.2 \\mathrm{mg} / \\mathrm{kg}$ of the $0.1 \\mathrm{mg} / \\mathrm{mL}$ solution); minimum dose of 0.1 mg (children) +1.0 mg (adolescents)\nRepeat after 5 min\nMaximum dose: $0.04 \\mathrm{mg} / \\mathrm{kg}(2-3 \\mathrm{mg})$ in adults\nIndications: bradycardia, hypotension\nCx: angina, myocardial infarction\n3. Metered-dose inhalers of $\\beta$-adrenergic bronchodilators\n\n- Metaproterenol (Alupent ${ }^{\\circledR}$ )\n- Terbutaline (Brethaire ${ }^{\\circledR}$ )\n- Albuterol (Proventil ${ }^{\\circledR}$, Ventolin ${ }^{\\circledR}$ )\n\nDose: 2 puffs every $20-30$ minutes, as needed\n4. $\\mathbf{H}_{1}$ antagonists $=$ antihistamines\n\n- Diphenhydramine (Benadryl ${ }^{\\circledR}$ )\n\nAdult dose: $25-50 \\mathrm{mg}$ PO/IM/IV\nPediatric dose: $1-2 \\mathrm{mg} / \\mathrm{kg}$ IV, up to 50 mg\n\n- Hydroxyzine (Vistaril ${ }^{\\circledR}$ )\n\nDose: $25-50 \\mathrm{mg}$ PO/IM/IV\nIndications: hives, rash, itching\nCx: hypotension, sedation\n5. $\\mathrm{H}_{2}$ receptor blockers\n\n- Cimetidine (Tagamet ${ }^{\\circledR}$ )\n\nDose: 300 mg PO / slowly IV (diluted in 10 mLD 5 W solution)\n\n- Ranitidine (Zantac ${ }^{\\circledR}$ )\n\nDose: 50 mg PO / slowly IV (diluted in 10 mLD 5 W solution)\nIndications: hypotension; bronchospasm\n6. Aminophylline\n\n- 250 mg in 250 mL of $5 \\%$ dextrose\n\nDose: $6 \\mathrm{mg} / \\mathrm{kg}$ IV in D5W over 15-20 minutes (loading dose); then $0.4-1.0 \\mathrm{mg} / \\mathrm{kg} / \\mathrm{hour}$\nIndications: bronchospasm, pulmonary edema\nCx: hypotension, cardiac arrhythmia\n7. Terbutaline\n\n- $0.25-0.50 \\mathrm{mg} \\mathrm{IM} / \\mathrm{SQ}$\n\n8. Sedatives\n\n- Midazolam (Versed ${ }^{\\circledR}$ )\n\nDose: $1-2.5 \\mathrm{mg}$ IV over 2 minutes; titrate to effect q 2 minutes; maximum 5 mg Indications: sedation\n\n- Diazepam (Valium ${ }^{\\circledR}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 660,
            "markdown": "Dose: $2-10 \\mathrm{mg}$ IM/IV q 3-4 hours; maximum 30 mg Indications: seizures\n\n- Pentobarbital (Nembutal ${ }^{\\circledR}$ )\n\nDose: $<50 \\mathrm{mg} / \\mathrm{min}$ IV; $150-200 \\mathrm{mg}$ IM\nIndications: toxic convulsions\n$C x$ : respiratory depression, apnea, laryngospasm, hypotension\n9. Pain\n\n- Fentanyl\n\nDose: $25-50 \\mathrm{mg}$ IV; short acting\n\n- Morphine\n\nDose: $1-3 \\mathrm{mg}$ IV\nIndications: pain; pulmonary edema\n\n- Demerol\n\nCx: respiratory depression\n10. Volume expander\n\n- Crystalloid solution as $0.9 \\%$ saline\n- Hydroxylethyl starch (high-molecular-weight colloid)\n\n11. Furosemide (Lasix ${ }^{\\circledR}$ )\n\nAdult dose: $20-40 \\mathrm{mg}$ IV slow push / PO\nPediatric dose: $1 \\mathrm{mg} / \\mathrm{kg} /$ dose IV up to 40 mg\nEffect: 5-15 minutes after IV; 60 min after PO\nIndications: acute pulmonary edema, CHF, hypertensive emergency\n12. Corticosteroids\n\n- Methylprednisolone (Solu-Medrol ${ }^{\\circledR}$ )\n\nDose: (a) 32 mg PO; 12 hours \\& 2 hours prior\n(b) $100-1,000 \\mathrm{mg}$ (anaphylaxis with shock)\n\n# REDUCTION OF HEART RATE FOR IMAGING \n\nPurpose: Cardiac anatomic imaging\nPharmacology: $\\downarrow$ frequency of sinus node, $\\downarrow$ spontaneous rate of depolarization of ectopic pacemakers, slowing conduction in atria + AV node, $\\uparrow$ functional refractory period of AV node\nTarget: $<60$ beats per minute\nDrugs: cardioselective ( $\\beta 1$ ) $\\beta$-blocker\n\n- Metoprolol\n\nDose: $2.5-5 \\mathrm{mg}$ IV administered over 1-2 minutes; may be repeated at 2-5-minute intervals\nMaximum dose: 30 mg\nOral bioavailability: $40 \\%$ (high interindividual differences)\nBiologic half-life: 3-4 hours\n\n- Atenolol\n\nDose: $5-10 \\mathrm{mg}$ IV\nOral bioavailability: $50 \\%$\nBiologic half-life: 5-8 hours",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 661,
            "markdown": "# - Esmolol \n\nDose: $1-2 \\mathrm{mg} / \\mathrm{kg}$ bolus / continuous titrated infusion\nBiologic half-life: 9 min\nProtocol: (1) Oral premedication 1 hour prior to scan: 100 mg Metoprolol / 100-200 mg Atenolol\n(2) IV supplement as needed: 5 mg Metoprolol at arrival to scanner; additional 25 mg each 5 minute (max 30 mg ) or $1-2 \\mathrm{mg} / \\mathrm{kg}$ body weight Esmolol\n\n## Side effects:\n\n(a) $\\beta 1$-selective intrinsic sympathomimetic activity:\n\n- hypotension, bradycardia, widening of QRS complex\n- prolonged AV conduction times\n(b) binding on noncardiac $\\beta 2$ receptors $\\rightarrow$ compensatory sympathetic reflexes $\\rightarrow$ activation of vascular $\\alpha$-adrenergic receptors:\n- peripheral vasoconstriction sparing brain\n\nContraindications (in 5-10\\%):\n\n1. (Allergic) asthma bronchiale / severe chronic obstructive pulmonary disease\n2. AV block Mobitz type II or type III\n3. Severe bradycardia of $<50 \\mathrm{bpm}$\n4. Severe hypotension of $<100 \\mathrm{mmHg}$\n5. Acute congestive heart failure\n6. Allergy to $\\beta$-blockers",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 662,
            "markdown": "# SEDATION, ANALGESIA, LOCALANESTHESIA \n\n| Classification and Effects of Levels of Sedation |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Level | Response to stimuli | Airway | Spontaneous ventilation | Cardiovascular function |\n| minimal* | normal | unaffected | unaffected | unaffected |\n| moderate | purposeful | no intervention required | adequate | usually maintained |\n| deep | purposeful after repeated / painful stimuli | intervention may be required | may be inadequate | usually maintained |\n| general anesthesia | unarousable | intervention often required | frequently inadequate | may be impaired |\n\n## SEDATION\n\n$=$ administration of medication to calm the nervous system: $\\Downarrow$ awareness; $\\Downarrow$ responsiveness to external stimuli; $\\Downarrow$ anxiety; $\\Downarrow$ spontaneous movements; may produce amnesia\nPhases of sedation protocol: 1. Preprocedural assessment\n2. Intraprocedural monitoring\n3. Postprocedural monitoring\n\n## Presedation Assessment\n\n1. Evaluate patient (within 30 days of procedure + update within 24 hours)\n(a) personal history:\n> cardiovascular: hypertension, myocardial infarction within prior 6 months, CHF, arrhythmia $\\rightarrow$ pose an increased risk\n> respiratory: asthma, COPD, other lung disease\n> gastrointestinal: GERD, peptic ulcer, nil per os (NPO) status\n> fasting status: predictor of aspiration\n$\\diamond$ In an emergent procedure administer 10 mg IV metoclopramide (Reglan ${ }^{\\circledR}$ ) +10 mg IV famotidine (Pepcid ${ }^{\\circledR}$ ) / other $\\mathrm{H}_{2}$ blocker!\n(b) medication history\n> continue cardiovascular medication\n> monitor blood sugar in diabetics\n(c) physical examination\n2. Classify physical status of patient (see table)",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 663,
            "markdown": "| Classification of Patient's Physical Status |  |\n| :--: | :--: |\n| Class | Status |\n| I normal healthy patient without systemic disease |  |\n| II | mild--moderate systemic disease (ie, controlled |\n|  | hypertension, diabetes) / elderly |\n| III | severe systemic disease (ie, limited activity but not |\n|  | incapacitating) |\n| IV | severe incapacitating systemic disease |\n| V | moribund $=$ without intervention death anticipated |\n|  | within 24 hours |\n| VI | brain dead organ donor |\n| E | emergency modifier |\n\n3. Document discussion with patient concerning risks and benefits + obtain consent\n4. Document plan for sedation\n\nDose adjustment:\n, in elderly $30-50 \\%$ dose reduction + more frequent dose intervals\n, decrease dose with impaired kidney / liver function\n, habitual users of opioids / benzodiazepines require higher doses\nConvert to monitored anesthesia (= supervision by anesthesiologist) if:\n(a) sedation cannot be administered safely (eg, Pickwickian syndrome, sleep apnea)\n(b) deep sedation is required\n5. Assure presence of appropriate personnel + equipment\n6. Identify correct patient immediately before onset of procedure\n\n# Intraprocedural Monitoring \n\n1. Respiratory rate: continuous monitoring with pulse oximetry\n2. ECG: continuous monitoring\n3. Blood pressure: every $5 \\mathrm{~min}+$ before every dose\n4. Assessment of Alertness\n5. Pain assessment: verbal descriptor, linear numeric, face-pain scale\n\n| Assessment of Alertness during Sedation |  |\n| :--: | :--: |\n| Level | Description |\n| V | ready response to name calling; normal speech |\n| IV | lethargic response to name calling; mild slowing of speech |\n| III | response to repeated name calling; slurred speech |\n| II | response only after mild prodding |\n| I | no response to mild prodding / shaking |\n\n## Postprocedural Monitoring\n\n$=$ monitoring for postprocedural complications as drugs are unopposed by anxiety and pain related to procedure $\\rightarrow$ deepening of sedation + respiratory depression\nFrequency: in 15 -minute intervals for $\\geq 30$ minutes after last dose; for $\\geq 2$ hours after use of",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 664,
            "markdown": "reversal agent\n\n# Sedatives \n\nA. Benzodiazepines\n\nAction: facilitate actions of g-aminobutyric acid (= main inhibitory neurotransmitter) in CNS; synergistic with opioids\nProperties: anxiolytic, amnestic\n\n1. Midazolam (Versed ${ }^{\\circledR}$ )\n\nAdministration: IM, IV (rapid onset of action)\nElimination half-life: 1-4 hours (short)\n2. Lorazepam (Ativan ${ }^{\\circledR}$ )\n\nAdministration: PO, IM, IV (variable peak effect)\nElimination half-life: mean of 15 hours\n3. Diazepam (Valium ${ }^{\\circledR}$ ): also anticonvulsant\n\nElimination half-life: 20-100 hours\nAdministration: PO, IM, IV (painful)\nB. Diphenhydramine (Benadryl ${ }^{\\circledR}$ )\n\nAction: blocks histamine-1 receptors (H1 blocker); anticholinergic\nContraindication: asthma, narrow-angle glaucoma, urinary retention\nSide effect: dry mouth, dizziness, sedation\n\n## Reversal Agents\n\n$=$ drugs counteracting effects of drugs used for anesthesia\nAssessment: patient difficult to arouse, cardiorespiratory depression (= oxygen desaturation, drop in blood pressure)\n\n| Adult Parenteral Dosing for Sedatives |  |  |\n| :--: | :--: | :--: |\n| Brand | Supplied | Dosing |\n| Versed ${ }^{\\text {Â® }}$ | $\\begin{gathered} 1 \\mathrm{mg} / \\mathrm{mL} \\text { or } \\\\ 5 \\mathrm{mg} / \\mathrm{mL} \\end{gathered}$ | 1-2.5 mg IV over 2 min ; titrate to effect q 2 min ; maximum 5 mg |\n| Ativan ${ }^{\\circledR}$ | $2 \\mathrm{mg} / \\mathrm{mL}$ or $4 \\mathrm{mg} / \\mathrm{mL}$ | $0.05 \\mathrm{mg} / \\mathrm{kg}$ IM 2 hrs prior; 2 mg or $0.0444 \\mathrm{mg} / \\mathrm{kg}$ IV |\n| Valium ${ }^{\\circledR}$ | $5 \\mathrm{mg} / \\mathrm{mL}$ | 2-10 mg IM/IV q 3-4 hours; maximum 30 mg |\n| Benadryl ${ }^{\\circledR}$ | $50 \\mathrm{mg} / \\mathrm{mL}$ | $10-50 \\mathrm{mg}$ IV $/ \\leq 100 \\mathrm{mg}$ IM |\n\n(1) reversing effects of opioids (reverse first)\n\n1. Naloxone (NARCAN ${ }^{\\circledR}$ )\n\nOnset: within 1-2 minutes\nDuration: 45 minutes; may be needed repeatedly\n(2) reversing effects of benzodiazepines (reverse second)\n\n1. Flumazenil (Romazicon ${ }^{\\circledR}$ )\n\nOnset: within 1-2 minutes\nDuration: 30-60 minutes; may be needed repeatedly\n\n## ANALGESIA",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 665,
            "markdown": "$=$ symptomatic relief of pain with use of pharmacologic agents\n$\\diamond$ Pain is more resistant to analgesics in an anxious patient!\nA. Opioids = drugs with opium- / morphin-like action augmented when administered with benzodiazepines\n> titrated to effect (no maximal dose)\nAction: analgesic, sedative, antitussive, antirigor properties\nSide effects: nausea, constipation, CNS depression, respiratory depression\nLong-term side effects: tolerance, addiction\n(a) natural alkaloids\n\n1. Morphine\n\nAdministration: IM, IV, suppository, PO (immediate / sustained release tablet, solution)\nDose: $1-3 \\mathrm{mg}$ IV\nIndications: pain; pulmonary edema\nElimination: metabolized to active morphine-6-glucoronide + eliminated by kidneys; releases histamine\nContraindication: renal failure, asthma, hypotension\n\n| Aldrete Postanesthesia Discharge Score |  |  |\n| :--: | :--: | :--: |\n| Variable | Parameter | Score |\n| Activity | 4 extremities | 2 |\n|  | 2 extremities | 1 |\n|  | 0 extremities | 0 |\n| Respiration | breathing deeply / coughing freely | 2 |\n|  | dyspneic / shallow breathing / tachypneic | 1 |\n|  | apneic | 0 |\n| Circulation | $\\mathrm{BP} \\pm 20 \\%$ of presedation level | 2 |\n|  | $\\mathrm{BP} \\pm 20-49 \\%$ of presedation level | 1 |\n|  | $\\mathrm{BP} \\pm 50 \\%$ of presedation level | 0 |\n| Consciousness | fully awake | 2 |\n|  | arousable on calling | 1 |\n|  | not responding | 0 |\n| Oxygen saturation | $>92 \\%$ on room air | 2 |\n|  | needs $\\mathrm{O}_{2}$ to remain $>90 \\%$ | 1 |\n|  | $<90 \\%$ with $\\mathrm{O}_{2}$ | 0 |\n\n(b) synthetic derivatives\n\n# 2. Fentanyl \n\nAdministration: transdermal, buccal, nasal spray, PO (tablet, lozenge), IM, IV\nAction: $50-100 \\mathrm{x}$ potency of morphine\nDose: $25-50 \\mathrm{mg}$ IV; short acting\nSide effect: few; stiff chest syndrome (= rigidity of skeletal muscles caused by rapid IV administration) treated with intubation + succinylcholine\n3. Meperidine (Demerol ${ }^{\\circledR}$ )",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 666,
            "markdown": "Administration: IM, IV\nAction: 0.1 x potency of morphine; antirigor property\nElimination: metabolized to CNS stimulant normeperidine $\\rightarrow$ seizure risk with high dose + renal insufficiency\nSide effect:\nitching; atropine-like (dry mouth, tachycardia, pupil dilatation); myocardial depression; interactions with nonprescription drugs (eg, Prozac ${ }^{\\circledR}$, St John's wort); coadministration of serotonin uptake inhibitor causes life-threatening serotonin syndrome (autonomic instability with hypertension, tachycardia, diaphoresis, hyperreflexia, hyperthermia, agitation)\n\n| Adult Dosing of Analgesics |  |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: | :--: |\n| Brand Name | Component | Admin | Available Dose | Recommended Dose (p.r.n.) | Max Dose |\n| Tylenol | Acetaminophen | Tablet | $325,500,650 \\mathrm{mg}$ | $500-1000 \\mathrm{mg}$ PO q $4-6 \\mathrm{hr}$ | $4000 \\mathrm{mg} / \\mathrm{d}$ |\n| Tylenol | Acetaminophen | Solution | $500 \\mathrm{mg} / 15 \\mathrm{~mL}$ | $500-1000 \\mathrm{mg}$ PO q $4-6 \\mathrm{hr}$ | $4000 \\mathrm{mg} / \\mathrm{d}$ |\n| Aspirin (extra stimulits) | ASA | Tablet | 500 mg | $1-2$ tabs PO q 4-6 hrs | $4000 \\mathrm{mg} / \\mathrm{d}$ |\n| Celebrex | Celecoxib | Tablet | $50,100,200,400 \\mathrm{mg}$ | 400 mg PO $1^{\\text {st }}$ day then 200 mg PO b.i.d. |  |\n| Dolobid | Diflunisal | Tablet | 500 mg | 1000 mg PO initially then 500 mg PO q 8-12 hr | $1500 \\mathrm{mg} / \\mathrm{d}$ |\n| Motrin IB | Ibuprofen | Tablet | 200 mg | 200 mg PO q 4-6 hr. | $1200 \\mathrm{mg} / \\mathrm{d}$ |\n| Indocin | Indomethacin | Capsule | $25,50 \\mathrm{mg}$ | $25-50 \\mathrm{mg}$ PO q 8-12 hr. | $150-200 \\mathrm{mg} / \\mathrm{d}$ |\n| Indocin | Indomethacin | Solution | $25 \\mathrm{mg} / 5 \\mathrm{~mL}$ | $25-50 \\mathrm{mg}$ PO q 8-12 hr | $150-200 \\mathrm{mg} / \\mathrm{d}$ |\n| Toradol | Ketorolac | Tablet | 10 mg | transition from IV to PO: 20 mg PO then $10 \\mathrm{mg} \\mathrm{POq} 4-6 \\mathrm{hr}$ | $40 \\mathrm{mg} / \\mathrm{d}<5 \\mathrm{~d}$ |\n| Toradol | Ketorolac | Injectable | $15,30 \\mathrm{mg} / \\mathrm{mL}$ | 30 mg IV/IM q 6 hr | $120 \\mathrm{mg} / \\mathrm{d}<5 \\mathrm{~d}$ |\n| Aleve | Naproxen | Caplet | 220 mg | 440 mg PO in $1^{\\text {st }} \\mathrm{hr}$ then $220 \\mathrm{mg} \\mathrm{POq} 8-12 \\mathrm{hr}$ | $660 \\mathrm{mg} / \\mathrm{d}$ or 440 mg in 8-12-hr period |\n| Naprosyn | Naproxen | Tablet | $250,375,500 \\mathrm{mg}$ | 500 mg initially then 250 mg PO q 6-8 hr or 500 mg q 12 hr | $1500 \\mathrm{mg} / \\mathrm{d}$ |\n| Naprosyn | Naproxen | Solution | $125 \\mathrm{mg} / 5 \\mathrm{~mL}$ | 500 mg initially then 250 mg PO q 6-8 hr or 500 mg q 12 hr | $1500 \\mathrm{mg} / \\mathrm{d}$ |\n\n\n| Drugs for Pain-controlled Analgesia in 70-kg Adult |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Name |  | Intermittent Dose | Frequency | Basal Infusion Rate |\n| Hydromorphone |  | $0.2-0.5 \\mathrm{mg}$ | $6-10 \\mathrm{~min}$ | $0.2-0.5 \\mathrm{mg} / \\mathrm{hr}$ |\n| Meperidine |  | $10-15 \\mathrm{mg}$ | $6-10 \\mathrm{~min}$ | $15-50 \\mathrm{mg} / \\mathrm{hr}$ |\n| Morphine |  | $1-2 \\mathrm{mg}$ | $6-10 \\mathrm{~min}$ | $0.5-1 \\mathrm{mg} / \\mathrm{hr}$ |\n| Fentanyl |  | $10-25 \\mu \\mathrm{~g}$ | $2-5 \\mathrm{~min}$ | $25-50 \\mu \\mathrm{~g} / \\mathrm{hr}$ |\n| Alfentanil |  | $0.01-0.03 \\mathrm{mg}$ | $1-3 \\mathrm{~min}$ | none |\n\n(c) semisynthetic derivatives\n4. Hydromorphone (Dilaudid ${ }^{\\circledR}$ )\n\nAdministration: suppository, PO (tablet, liquid), IM, IV\nAction: 4-8 x potency of morphine; antitussive\nSide effect: few\nB. Nonopioids reserved for less severe pain in outpatients, not used in a procedure, not associated with dependency\n\n# 1. Acetaminophen \n\nSide effect: liver toxicity with dose excess of 4 g per day",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 667,
            "markdown": "2. Nonsteroidal anti-inflammatory drug (NSAID)\n\nAdministration: PO; limit to maximally 2 months of Rx\nAction: more effective against inflammation\nSide effect: depression of platelet function\n(a) selective COX-2 inhibitor\n3. Celecoxib (Celebrex ${ }^{\\circledR}$ )\n\nSide effect: less GI irritation + bleeding\n(a) nonselective COX-2 inhibitor\n> acetylated carboxylic acid derivative\n4. Aspirin\n\nSide effect: GI irritation + bleeding\n> nonacetylated carboxylic acid derivative\n5. Diflunisal (Dolobid ${ }^{\\circledR}$ )\n\nSide effect: better gastric tolerance\n> acetic acid derivative\n6. Indomethacin (Indocin ${ }^{\\circledR}$ )\n\nSide effect: CNS, GI\n7. Ketorolac (Toradol ${ }^{\\circledR}$ ) excellent pain relief, parenteral administration possible, limit use to 5 days\nSide effect: renal toxicity + liver injury\n> propionic acid derivative\n8. Ibuprofen (Advil ${ }^{\\circledR}$, Motrin ${ }^{\\circledR}$ )\n\nSide effect: hypertension, fluid retention\n9. Naproxen (Aleve ${ }^{\\circledR}$, Naprosyn ${ }^{\\circledR}$ )\n\nSide effect: hypertension, fluid retention\n\n# Pain-controlled Analgesia \n\n$=$ self-administration of small doses of opioid analgesic by means of computer-controlled IV infusion\nBenefit: enhances patient satisfaction, reduction of required total dose\nIndication: solid-organ embolization in patients with good neurologic, pulmonary and renal function\nControl setting: dose delivered, lock-out interval (= time between doses), background continuous infusion\n\n## LOCAL ANESTHESIA\n\n$=$ pharmacologic blocking of pain signal reception by CNS\nAdministration: topical (cream, ointment, aerosol, lotion, jelly) / infiltrative (subcutaneous injection)\nAction: reversible binding to sodium channels $\\rightarrow$ stabilizing nerve membranes\nRisk: too large dose / intravascular injection result in Local Anesthetic Systemic Toxicity (LAST)\n> early signs: metallic taste sensation, mouth numbness, ringing in ears, lightheadedness\n> late signs: nervousness, blurred vision, tremor, seizure, cardiovascular collapse",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 668,
            "markdown": "Allergy: to preservative para-aminobenzoic acid used in all local anesthetics\nSide effect: pain with infiltration (managed with reassurance, pinching of skin, warming of anesthetic, slow injection, sedation, use of topical anesthetic prior to injection, alkalinization with $8.4 \\%$ sodium bicarbonate in $1 \\div 10$ ratio for lidocaine $+1 \\div 35$ ratio for bupivacaine)\n(a) amides (more potent + more common)\n\n1. Lidocaine (Xylocaine ${ }^{\\circledR}$ )\n2. Emla ${ }^{\\circledR}$ Cream ( $2.5 \\%$ prilocaine $+2,5 \\%$ lidocaine) applied with occlusive dressing for $\\geq 1$ hour before minor dermal procedure\n> longer acting\n3. Mepivacaine (Polocaine ${ }^{\\circledR}$ )\n4. Bupivacaine (Marcaine ${ }^{\\circledR}$, Sensorcaine ${ }^{\\circledR}$ )\n\nSide effect: more cardiotoxic\n5. Ropivacaine less toxic alternative to bupivacaine\n(b) esters\n\n1. Procaine (Novocain ${ }^{\\circledR}$ )\n2. Chloroprocaine (Nesacaine ${ }^{\\circledR}$ )\n\n| Local Anesthetics |  |  |  |  |\n| :--: | :--: | :--: | :--: | :--: |\n| Name | Concentration | Max. Dose | Max. Volume | Onset + Duration |\n| Procaine | $0.25-0.5 \\%$ | $350-600 \\mathrm{mg}$ | $140-240 \\mathrm{~mL}+70-120 \\mathrm{~mL}$ | $2-5 \\mathrm{~min}+15-60 \\mathrm{~min}$ |\n| Chloroprocaine | $1-2 \\%$ | $<800 \\mathrm{mg}$ | $80-40 \\mathrm{~mL}$ | $6-12 \\mathrm{~min}+30 \\mathrm{~min}$ |\n| Lidocaine, plain | $1-2 \\%$ | $3-5 \\mathrm{mg} / \\mathrm{kg}<300 \\mathrm{mg}$ | $30-15 \\mathrm{~mL}$ | $1-2 \\mathrm{~min}+30-60 \\mathrm{~min}$ |\n| Lidocaine + epinephrine | $\\begin{gathered} 1-2 \\% \\\\ 1 \\div 100,000 \\text { or } \\\\ 1 \\div 200,000 \\end{gathered}$ | $5-7 \\mathrm{mg} / \\mathrm{kg}<500 \\mathrm{mg}$ | $50-25 \\mathrm{~mL}$ | $1-2 \\mathrm{~min}+60-240 \\mathrm{~min}$ |\n| Bupivacaine | $0.25-0.5 \\%$ | $2.5 \\mathrm{mg} / \\mathrm{kg}<175 \\mathrm{mg}$ | $70-35 \\mathrm{~mL}$ | $5 \\mathrm{~min}+120-240 \\mathrm{~min}$ |\n| Bupivacaine + epinephrine | $\\begin{gathered} 0.25-0.5 \\% \\\\ 1 \\div 200,000 \\end{gathered}$ | $<225 \\mathrm{mg}$ | $90-45 \\mathrm{~mL}$ | $5 \\mathrm{~min}+180-360 \\mathrm{~min}$ |\n| Mepivacaine | $1 \\%$ | $<400 \\mathrm{mg}$ | 40 mL | $3-5 \\mathrm{~min}+45-90 \\mathrm{~min}$ |",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 669,
            "markdown": "# INDEX \n\n## Symbols\n\n1-2-3 sign, lung 668\n$1 / 3$ rule 370\n$1-7-11$ rule 1320\n3-chamber view 763\n4D syndrome 962\n4-chamber view 763\n\n## Abdominal\n\nadenopathy of low attenuation 1028\nair, abnormal 992\nangina 1125\naortic aneurysm 785\nblunt trauma 1052\ncalcifications 995\ncavity\nforeign objects 995\ncircumference, fetus 1325\ncocoon 1138\ncompartment syndrome 1042, 1066\ncystic mass in fetus 1308\ncyst in childhood 997\ndesmoid 1123\nectopic pregnancy 1350\nfat necrosis 1027\nfluid 996\nhernia 1100\nmass\nin infant \\& child 992\nin neonate 992\npseudotumor 1001\nrhabdomyosarcoma 1266\nsarcoidosis 665\ntrauma 1052\nvascular calcifications 996",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 670,
            "markdown": "wall\ncalcifications 996\ndefect in fetus 1307\ndesmoid 77\nfibromatosis 77\nmass 992\nAbernethy shunt 977\n\n# Aberrant \n\nhepatic artery 885\nhepatic bile duct 890\ninternal carotid artery 474\nleft pulmonary artery 781\npapilla 1168\nrenal artery 1185\nspleen 985\n\n## Abnormal\n\nair, abdomen 992\ncisterna magna 1304\nesophageal\nfolds 1004\nperistalsis 1003\nfirst trimester 1296\nfour-chamber view 1307\nintraabdominal fluid 996\nleft ventricular outflow tract 755\nlung patterns 522\nnephrogram 1165\nplacental size 1297\nsmall bowel folds 1016\ntubular function 1166\n\n## Abortion 1338\n\nAbortive calyx 1193\nAbruptio placentae 1377\n\n## Abscess\n\namebic 933\nbrain 326\nbreast 704\nBrodie 172\nepidural 253\ngranulomatous, brain 326\nkidney 1243\nliver 933\norbit 424\npancreas 970\npericholecystic 909",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 671,
            "markdown": "perinephric 1243\nperirenal 1243\npharyngeal 500\nprostate 1237\nscrotum 1268\nspleen 881\n\n# Absence of \n\ngreater sphenoid wing 216\ninnominate line 216\nnephrogram 1165\nouter end of clavicle 19\nrenal outline, plain film 1158\nseptum pellucidum 286\nspleen 882\n\n## Absent\n\nabdominal gas in neonate 998\nbow-tie sign 25, 149\ndiaphragm sign 610\nkidney sign, bone scan 2\n\n## Absidia 682\n\nAbsolute linearity, scintillation camera 1395\nAcalculous cholecystitis 909\n\n## Acanthosis\n\nglycogen, esophagus 1098\nnigrans, skin 76\n\n## Acardia 1339\n\n## Accelerated\n\nacute rejection, kidney 1254\ninterstitial pneumonia 623\n\n## Accelerating TIA 284\n\n## Accessory\n\nbile ducts 890\ncardiac bronchus 565\ndiaphragm 605\nduct of Santorini 893\nlobe, placenta 1322\nossicles, foot and ankle 56\nrenal artery 1185\nspleen 896\n\n## Accordion\n\nfolds, scleroderma 1134\nsign, colon 1020, 1062\nvertebra 123\n\n## Accuracy\n\ncalibrator 1395",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 672,
            "markdown": "statistics 1427\nAccutane ${ }^{\\circledR} 85$\nACE\ninhibitor scintigraphy 1246\ntiter in sarcoidosis 665\nAcetabular angle 82\nAcetabulum\nfracture 110\nprotrusio 22\nAcetylcholinesterase 1295\nAchalasia\ncricopharyngeal 1068\nlower esophageal sphincter 1042\npattern, esophagus 1003\nureter 1220\nAcheiria 1300\nAchilles tendon 52\nAchondrogenesis 57\nAchondroplasia 57\nhyperplastic 152\nAcidification mechanism, kidney 1188\nAcid test, esophagus 1088\nAcinar\ncell carcinoma, pancreas 958\nnodule 531\nrosettes 522\ntuberculosis 680\nAcinus 567\nAclasis\ndiaphyseal 166\ntarsoepiphyseal 91\nAcne conglobata 195\nAcoustic neuroma 390\nAcquired\nacroosteolysis 21\narachnoid cyst 331\nCMV infection of CNS 349\ncystic\ndisease of uremia 1193\nkidney disease 1193\nheart disease 741\napproach to 741\nhepatic cyst 937\nhypogammaglobulinemia 678\nimmune deficiency syndrome 574",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 673,
            "markdown": "left ventricular aneurysm 857\nlymphangiectasia, intestine 1106\nporencephaly 395\nsmall bowel obstruction in childhood 1001\nsyphilis 205\nurethral diverticulum 1285\nAcrania 326\nAcrocephalopolysyndactyly 71\nAcrocephalosyndactyly 1301\nAcromegaly 58\nAcromelia 1300\nAcromelic dwarfism 1301\nAcromicria 89\nAcromioclavicular dislocation 86\nAcromion types 36\nAcroosteolysis 21\nfamilial 58\nidiopathic 96\nAcroosteosclerosis 21\nAcropachy, thyroid 207\nACTH-independent macronodular hyperplasia 1199\nACTH-producing tumor 961\nActinomycosis 58\nAcute\nabdomen in child 987\nacalculous cholecystitis 909\nalveolar infiltrate 523\naortic syndrome 754\nasthma + pulmonary edema 517\navulsion injury 156\nbacterial epiglottitis 484\nBudd-Chiari syndrome 900\ncalcific retropharyngeal tendinitis 476\ncerebral hematoma 362\ncholecystitis 908\ncoarctation syndrome 852\ncolonic pseudoobstruction 1107\ncoronary syndrome 822\ncortical necrosis 1194\ndiffuse\nbacterial nephritis 1240\ninterstitial fibrosis 623\ndisseminated encephalomyelitis 353\neosinophilic pneumonia 614\nepididymitis 1207",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 674,
            "markdown": "epiglottitis 484\nesophagitis 1087\nexogenous lipoid pneumonia 630\nextrinsic allergic alveolitis 616\nfatty liver of pregnancy 927\nfocal bacterial nephritis 1240\ngastric atony 1009\nhemorrhagic leukoencephalitis 353\nhepatitis 940\nhydronephrosis 1212\nidiopathic scrotal edema 1176\ninterstitial\nedema, lung 526\nnephritis 1194\npneumonia 623\nischemic infarction, brain 371\nlaryngotracheobronchitis 482\nmastitis 728\nmediastinal widening 550\nmediastinitis 639\nmesenteric ischemia 1124\nnonsuppurative ascending cholangitis 904\nobstruction by ureteric calculi 1288\nobstructive cholangitis 904\nosteomyelitis 170\notitis media 495\npancreatitis 966\nparotitis 502\npericarditis 838\nportal vein thrombosis 977\npseudoobstruction, colon 1107\npulmonary\nthromboembolism 653\nin pregnancy 655\npyelonephritis 1239\nradiation hepatitis 942\nrejection\nkidney transplant 1254\nlung transplant 631\npancreas transplant 966\nrenal\nfailure 1149\ncontrast media 1434\ninfarction 1253\nvein thrombosis 1259",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 675,
            "markdown": "respiratory distress syndrome 575\nliver disease 918\nseptic meningitis 379\nsilicosis 670\nsinusitis 503\nsplenic sequestration crisis 198\nsubdural hematoma 400\nsubmandibular sialadenitis 501\nsuppurative\nascending cholangitis 904\npyelonephritis 1240\nthyroiditis 509\ntesticular torsion 1269\nthoracic aortic injury 852\ntubular necrosis\nnative kidney 1194\nrenal transplant 1254\nvasomotor nephropathy 1194\nviral spasmodic laryngitis 482\nAcutely symptomatic scrotum 1176\nAcyanotic heart disease 740\nAdamantinoma\nextremity 59\njaw 242\nAdamkiewicz artery 238\nAdams-Oliver syndrome 1341\nAdam syndrome 367\nADC Map 370\nAddison disease 1194\nAdducted thumb 209\nAdenocarcinoma\ncolon 1063\nductal, pancreas 958\nduodenum, 1013\nesophagus 1084\nlung 594\nsmall bowel 1043\nurinary bladder 1173\nAdenocard ${ }^{\\circledR} 1414$\nAdenoid cystic carcinoma\nbreast 715\nlarynx 474\nlung 588\norbit 419\nsalivary glands 474",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 676,
            "markdown": "Adenolipoma, breast 724\nAdenolymphoma 511\nAdenoma\nadrenocortical 1196\nbile duct, papillary 974\nbronchial 587\n-carcinoma sequence 1063\ngallbladder 930\nlactating 725\nliver 935\nmalignum of cervix 1133\nnephrogenic 1226\npituitary 394\npleomorphic\nlung 588\nparotis 500\nrenal 1243\nsebaceum 405\nsmall bowel 1042\nsomatotrophic, brain 394\nthyroid 506\ntubular, colon 1042\ntubulovillous, colon 1042\nvillous\ncolon 1042, 1145\nduodenum 1145\nAdenomatoid\nodontogenic tumor, jaw 242\ntumor, epididymis 1195\nAdenomatous\ngoiter 486\nhyperplasia\nliver 917\nthyroid 506\nnodule, thyroid 506\npolyp\ncolon 1025, 1042\nstomach 1092\nurethra 1180\npolyposis, familial 1089\nAdenomyoma\ngallbladder 946\nuterus 1340\nAdenomyomatosis, gallbladder 946\nAdenomyosis, uterus 1340",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 677,
            "markdown": "# Adenopathy \n\nof low-attenuation, abdomen 1028\n\n## Adenosarcoma, breast 731\n\n## AdenoscanÂ® 1414\n\nAdenosine 1414\n\n## Adenosis\n\nbreast 722\ntumor, breast 723\n\n## Adhesive atelectasis 540\n\n## Aditus ad antrum 464\n\nAdmixture lesions, heart 739\n\n## Adnexal\n\nlesion\nhigh-intensity on T1WI 1313\nlow-intensity on T1WI 1313\nlow-intensity on T2WI 1313\nmasses 1313\ntorsion 1384\n\n## Adrenal\n\nadenoma 1196\nanatomy 1189\napoplexy 1194\ncalcification 1157\ncortical\ndisease 1154\nhyperplasia 1198\ncyst 1195\ngland\nbilateral large 1154\ntrauma 1196\nhemangioma 1210\nhemorrhage 1195\nbilateral causes 1157\nunilateral causes 1157\ninsufficiency 1194\nlymphangioma 1262\nmass\nbenign 1156\ncystic 1156\nmalignant 1156\nwith small foci of fat 1156\nwith specific CT attenuation 1156\nmedullary\ndisease 1154\nparaganglioma 1230",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 678,
            "markdown": "metastases 1221\nmyelolipoma 1224\noncocytoma 1262\npseudocyst 1196\nrest 1199\nschwannoma 1268\ntuberculosis 1281\ntumor in childhood 1156\nunilateral mass 1155\nvascular anatomy 1189\nAdrenarche 1334\nAdrenocortical\nadenoma 1196\ncarcinoma 1197\nhyperfunction 1154\nhyperplasia 1198\nneoplasm, in children 1198\nrest 1199\nscintigraphy 1420\nAdrenogenital syndromes 1199\nAdrenoleukodystrophy 327\nAdrenomyeloneuropathy 327\nAdson maneuver 850\nAdult\naortic coarctation 809\ncystic nephroma 1223\nlaryngeal hemangioma 490\nosteoporosis 4\npolycystic kidney disease 1231\nrespiratory distress syndrome 575\nscurvy 196\n-type fibroadenoma 721\nvitreous 430\nAdventitial fibroplasia, arteries 816\nAdverse contrast reaction 1433\nAdynamic ileus 1002\nAerosolized pentamidine 649\nAfferent loop syndrome 1043\nAganglionic megacolon 1104\nAganglionosis, colon 1104\nAgenesis\ncochlea 495\ncorpus callosum 327\ndorsal pancreas 897\ngallbladder 889",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 679,
            "markdown": "kidney 1243\nlung 522, 682\npancreas 878\nsacrum 245\nunilateral pulmonary 682\nuterus 1386\nvagina 1391\nAgenetic porencephaly 398\nAgger nasi cells 454\nAggressive fibromatosis 77\nAging gut 1063\nAgnogenic myeloid metaplasia 156\nAgyria 375\n-pachygyria complex 375\nAICD 761\nAIDS\nCNS 328\ndementia complex 328\nintestine 1043\nkidney 1193\nlung 574\n-related\ncholangitis 905\ncomplex 575\nlymphoma, kidney 1193\nAinhum disease 60\nAir\n-block phenomenon 651\ncollection, abdomen 992\n-containing masses of neck 448\n-crescent sign, lung 538, 581, 587, 681, 682\nembolism B\nwith pulmonary edema 518\nesophagram 1004\nleaks in neonate 521\nprogression in neonatal GI tract 998\nspace pattern, lung metastases 643\ntrapping\nHRCT 531\nmediastinal shift 551\nAirspace\ncystic, HRCT 529\ndisease\ndiffuse 522\nlocalized 523",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 680,
            "markdown": "edema 810\nnodules\nHRCT 529\nwith ground-glass-opacity halo 533\nAirway\nanatomy 565\nembryology 564\nobstruction, in children 444\nAkinesis, heart 823\nAlagille syndrome 920\nAlanine aminotransferase 888\nAlar herniation 290\nAlbers-SchÃ¶nberg disease 173\nAlbuterol 1437\nAldosterone 1187\nAldosteronism, primary 1150\nAlendronate 1088\nAlexander\ndisease 328\ndysplasia 495\nAliasing 480\nAlimentary tract\ncalcifications 995\nembryology 1031\nAlkaline\n-encrusted cystitis and pyelitis 1199\nphosphatase 887\nAlkaptonuria 161\nAllantoic cyst 1299\nAllen test 777\nAllergic\nalveolitis, extrinsic 615\nangiitis 808\nbronchopulmonary aspergillosis 581\nfungal sinusitis 504\nAllis sign 82\nAlobar holoprosencephaly 365\nAlpha-1 antitrypsin deficiency 576\nAlpha-fetoprotein\nfetus 1294\nliver 888\nAlport syndrome 1211\nALPSA 87\nALT 888\nAlteration in gallbladder size 872",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 681,
            "markdown": "Altman classification 274\nAluminum\nbreakthrough test 1394\n-colored stools 896\ntoxicity 90,1149\nAlupent ${ }^{\\circledR} 1437$\nAlveolar\ncell carcinoma 590\ndisease, signs 522\nflooding edema 516\nhypersensitivity 514\ninfiltrate 523\nmacrophage pneumonia 628\nmicrolithiasis 576\npneumonia 519\nproteinosis 577\npulmonary edema 810\nsarcoidosis 668\nsilicoproteinosis 670\nAlveolitis\ndesquamative fibrosing 627\nextrinsic allergic 615\nAlzheimer disease\nbrain 328\nPET 1401\nAmastia 683, 698\nAmaurosis fugax 284\nAmazia 698\nAmbiguous genitalia 1181\nAmebiasis 1045\nAmebic\nabscess 933\nencephalitis 352\nmeningoencephalitis 353\nAmeboma 1046\nAmelia 1300\nAmeloblastic fibroma 242\nAmeloblastoma, jaw 242\nAmenorrhea 1311\nAmine precursor uptake and decarboxylation 645, 960\nAminophylline 1437\nAmiodarone\nliver 862\nlung 515\nAmmonia 600",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 682,
            "markdown": "Ammonium excretion 1188Amniocentesis 1326Amniography 1329Amnionicity 1328Amnionic membrane 1322Amniotic\nband syndrome 1341\nfluid\nembolism 577\nindex 1325\nvolume 1295\ninclusion cyst 1299\nsheet 1297\nAmosite 578\nAmpulla of Vater, anatomy 893\nAmpullary\nlesions 877\ntumor 896\nAmputation, in fetus 1303\nAmsterdam dwarfism 75\nAmstutz classification 176\nAmyand hernia 1101\nAmyloidoma\nbone 60\nstomach 1047\nAmyloidosis\nbone 60\nchronic renal failure 1149\nCNS, 287\nGI tract 1046\nGU tract 1200\nheart 781\nlung 577\nAmyotrophic lateral sclerosis 328\nAnalgesia 1439\nAnalgesic\nnephropathy 1200\nsyndrome 1200\nAnaphylactoid reaction to contrast B\nAnaplastic\nastrocytoma 335\ncarcinoma, thyroid 508\nAnatomy\nadrenal\ngland 1189",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 683,
            "markdown": "vessels 1189\naorta 775\nbrain, classification 311\nbreast 698\ncoronary arteries 767\ngonadal vessels 1190\nkidney 1184\nliver segments 884\nlung interstitium 567\npancreas 891\nprostate 1191\nrenal vessels 1185\nscrotum 1189\nuterus 1329\nAnchovy paste abscess 933\nAncient schwannoma 271\nAnderson\n-Carr-Randall theory 1286\ndisease 932\nlesion 277\nAndroblastoma 1381\nAndrogen-producing tumor 1315\nAnembryonic pregnancy 1341\nAnemia\naregenerative 678\nCooley 206\nFanconi 96\nhemolytic 125\niron deficiency 133\nMediterranean 206\nAnencephaly 329\nAneuploidy, risk 1295\nAneurysm\nabdominal aorta 785\naortic 784\natherosclerotic 786\nberry 1232, 329\nbone, malignant 177\nbrain 329\ncardiac ventricle 857\ncarotid artery 443\ncavernous sinus 330\ncoronary artery 825\ndegenerative aortic 786\nductus arteriosus 813",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 684,
            "markdown": "false\naortic 785\ncardiac 858\nfusiform 784\ngiant, brain 330\nhepatic artery 869\ninflammatory aortic 786\nleft ventricle\nacquired 857\ncongenital 857\nmultiple in brain 331\nmycotic\naorta 787\nbrain 331\npulmonary\narteriovenous 650\nartery, congenital 820\nrenal artery 1244\nrupture, abdominal aorta 785\nsaccular 785\nsinus of Valsalva 788\nsplenic artery 846\nsupraclinoid carotid 331\nsyphilitic 787\nthoracic aortic 788\ntrue\naorta 784\nheart 857\nvein of Galen 406\nAneurysmal bone cyst 60\nAngel wing sign 551\nAngiitis, primary CNS 396\nAngina, abdominal 1125\nAngioblastoma\nbone 59\ncord 262\nAngiodysplasia of colon 1047\nAngiofibroma\nfacial 405\njuvenile 474\nAngiofollicular lymph node hyperplasia 599\nAngiography\ncontrast material 1432\nradionuclide, brain 1400\nAngiolipoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 685,
            "markdown": "breast 726\nparotid 475\ntrunk, extremity 141\n\n# Angioma \n\ncapillary, brain 338\ncavernous, brain 340\nvenous, brain 351\n\n## Angiomatosis\n\nbacillary 1045\nbone 61\ncystic, bone 61\nencephalotrigeminal 399\nretinal 408\nretinocerebellar 408\n\n## Angiomatous\n\npolyp 502\nsyndromes 61\n\n## Angiomyolipoma\n\nkidney 1200\nliver 937\nAngiomyxoma, umbilical cord 1299\nAngiosarcoma 61\nbreast 732\nheart 802\nliver 937\nspleen 983\nAngiostrongylosis 897\nAngiotensin\n-converting enzyme 665\n-II 1187\nAngle of His 1088\nAngular pregnancy 1352\nAniridia, sporadic\nnephroblastomatosis 1225\nWilms tumor 1291\nAnisakiasis 1047\nAnkle\nball-in-socket mortise 205\nfracture 113\ntendons 52\nAnkylosing\nhyperostosis 85\nspondylitis 242\nAnkylosis, interphalangeal joints 16\nAnn Arbor classification 620",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 686,
            "markdown": "Annihilation reaction 1396\nAnnular pancreas 897\nAnnuloaortic ectasia 145, 788\nAnomalous\nbronchial division 564\ncoronary arteries 770\ncraniovertebral junction 219\ninnominate artery compression syndrome 781\nleft coronary artery 781\norigin of left pulmonary artery 781\npulmonary venous return 782\nAnopia 411\nAnorectal\nangle 1129\njunction 1129\nmalformation 1048\nAnoxic encephalopathy 287\nAnteaters nose 205\nAnte partum hemorrhage, placental cause 1298\nAnterior\ncerebral artery 320\ncommissure 462\ncondylar canal 235\ncruciate ligament 48\navulsion fracture 112\ntear 76\ndrawer sign 76\ninferior cerebellar artery 325\njunction line 570\nlobe, pituitary gland 312\nmediastinal mass 553\nmeningeal artery 319\nmotion of mitral valve 806\npararenal space 1186\nsacral meningocele 268\nscalloping of vertebrae 223\nshoulder dislocation 86\nspinal fixation devices 231\ntibial\nbowing 61\nveins 777\ntracking of pML 830\nAnterosuperior impingement 192\nAnthophyllite 578\nAnthracosilicosis 601",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 687,
            "markdown": "conglomerate 602\nAnthracosis 601\nAnticonvulsants\nembryopathy 1303\nMSK 90\nAntidiuretic hormone 1187\nAnti-glomerular basement membrane antibody disease 617\nAntimongoloid eye slant 208\nAntineutrophil cytoplasmic autoantibodies\nChurg-Strauss 808\npolyangiitis 828\nAntiphospholipid antibody syndrome 672\nAntitrypsin deficiency 576\nAntoni tissue 270\nAntral\nbeaking 1105\nG-cell hyperplasia 1147\nmucosal diaphragm 1049\nnarrowing 1009\nnipple sign 1105\npad sign 959, 1009\nprolapsed mucosa 1135\nweb 1049\nAntrochoanal polyp 502\nAntrum, retained gastric 1136\nAnus\nectopic 1048\nimperforate 1105\nAorta\nacute injury 852\nanatomy 775\naneurysm, leaking 787\natresia 819\natypical dissection 821\nblunt trauma 852\ncalcifications 754\ncoarctation 809\ndissection 789\ndouble arch 813\nenlarged 753\nflow volume, fetus 1364\ngraft infection 792\nimpending rupture 786\nkinking 840\nlaceration 852",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 688,
            "markdown": "Mercedes-Benz sign 790\noverriding 849\npenetrating ulcer 835\nsize in shunts 737\nthree-channel 790\ntransection 852\ntulip bulb 145\nAortic\naneurysm 784\narch\nbranching patterns 776\nchimney-shaped 840\nEdwards 755\nembryology 762\ninterruption 820\nright 844\nsyndrome 847\ncobwebs 791\ndissection 789\nhypoplasia 792\nisthmus variants 776\nnarrowing in childhood 754\nnipple 847\nregurgitation 792\nroot 775\nechocardiogram 764\nenlargement 753\nincreased dimension in fetus 1307\nrupture 793\ntraumatic 852\nspindle 776\nstenosis\nsubvalvular 794\nsupravalvular 795\nvalvular 794\nsyndrome, acute 754\nvalve\nanatomy 763\ncalcification 745\ncongenital abnormality 735\nwall thickening 753\nAorticopulmonary\nstripe 571\nwindow\nanatomy 571",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 689,
            "markdown": "mass 554\nshunt 759\nAortitis 753\ninfectious 820\nsyndrome 847\nsyphilitic 820\nAortoarteritis 847\nAortoenteric fistula 795\nAortoesophageal fistula 795\nAortopulmonary collateral 749\nAortopulmonic window 795\nApert syndrome 62\nwithout syndactyly 76\nAphthous ulcer 1024\ncolon 1020\nCrohn disease 1068\nsmall bowel 1014\nstomach 1070\nApical\ncap 549\nnotch 852\npetrositis 475\npleural cap 853\nAplasia\ncochlea 495\ndens 258\nlung 522, 1305\nmaxillary sinus 440\nradius 1302\nAplastic anemia 156\nApodia 1300\nAponeurotic fibroma, juvenile 201\nApophyseal\ninjury 105\nlesion 13\nApoplexy\nadrenal 1194\npituitary 395\nAppendagitis, epiploic 1081\nAppendicitis 1049\nAppendicolith 1049\nAppendix\nanatomy 1036\ncarcinoid 1061\ndiverticulitis 1074",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 690,
            "markdown": "double 1078\nepididymis 1190\nintussusception 1019\nprimary neoplasms 1019\ntestis 1190\ntorsion 1270\nvesiculosa 1374\n\n# Apple \n\ncore lesion\ncolon 1063\nesophagus 1083\npeel\nappearance, GI tract 1127\nsmall bowel 1026\nsauce appearance 1121\n\n## APUD cells 956\n\nAPUDoma 960, 1420\nAqueductal\nforking 331\nstenosis 331\nArachnodactyly\nbone 144\nCHD 736\nArachnoid\ncap cells 377\ncyst\nbrain 331\nsacrum 266\nspine 243\ndiverticulum 244\nloculation, spine 244\nArachnoiditis 243\nArantius nodules 764\nArcade of Riolan 1031\nArchitectural distortion, breast 696\nArcuate\ncomplex 49\navulsion fracture 112\neminence 464\nuterus 1388\nArc welder pneumoconiosis 670\nAregenerative anemia 678\nArgentaffin cells, stomach 1034\nArgentaffinoma 1058\nA-ring, esophagus 1033",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 691,
            "markdown": "Arnold\n-Chiari malformation 342\nnerve 498\nArrhenoblastoma 1381\nArrhinencephaly 365\nArrhythmogenic RV cardiomyopathy 806\nArrow-head sign\nappendix 1050\ndiverticulum 1074\nArterial\nanastomoses, brain 321\nblood gas abnormalities 569\ndisplacement, brain 291\ndissection, craniocervical 483\nhypertension 1151\nhypotension 1151\nmalformation, lung 650\nstenosis, radionuclides 1400\ntortuosity 198\nArteria lusoria 1006\nArterioportal shunt 868\nArteriosclerosis\ncarotid artery 476\nkidney 1247\nobliterans 796\nArteriosclerotic renal disease 1253\nArteriovenous\nfistula\nbone 62\nbrain 332\ncongenital 857\nnative kidney 1201\ntransplant 1256\nhemangioma 123\nmalformation 856\nbrain 333\ncolon 1047\ncord 244\nintraosseous 60\njaw 244\nkidney 1201\nuterus 1341\nArteritis\nTakayasu 847\ntemporal granulomatous 848",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 692,
            "markdown": "Artery\naberrant\nhepatic 885\nrenal 1185\nanterior\ncerebral 320\ninferior cerebellar 325\nmeningeal 319\natrioventricular node 769\naxillary 701\ncaroticotympanic 319\nchoroidal 321\ncommon carotid 319\nconus 769\ncoronary 767\nanomalies 770\nexternal carotid 319\nhepatic 885\nHeubner 320\ninternal carotid 319\nleft circumflex 767\nmiddle cerebral 320\nhyperdense sign 370\nophthalmic 319\nPercheron 321\npersistent primitive trigeminal 321\nposterior\ncerebral 320\ndescending 769\ninferior cerebellar 325\nprimitive\nacoustic (otic) 321\nhypoglossal 321\npterygoid 319\nRolandic 320\nsingle umbilical 1381\nsinoatrial node 769\nsuperior\ncerebellar 325\nmesenteric artery syndrome 846\nvertebral 325\nvidian 319\nArthritis\napproach 14\nbrucellar destructive 70",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 693,
            "markdown": "classification 14\ncollagen disease 14\ncortical erosion 16\ndistal interphalangeal joints 16\ngout, hand 16\nhand + wrist 16\ninflammatory bowel disease 14\ninterphalangeal joint of great toe 16\nLyme 143\npsoriatic 183\nrheumatoid 187\nseptic 196\nsigns 14\ntuberculous 209\nwith demineralization 15\nwithout demineralization 14\nwith periostitis 15\nArthrogryposis 62\nArthropathy\namyloid 60\ndeforming nonerosive 15\nhemophilic 126\nJaccoud 133\nneuropathic 159\nArthroplasty, hip 23\nArthrosis 162\nArthus reaction 615\nARTICLES 1067\nArtifacts\nmyocardial perfusion imaging 824\nSPECT 1396\nAryepiglottic\ncyst 444\nfold carcinoma 489\nfolds 459\nAsbestos\npseudotumor, atelectatic 580\n-related disease 578\nAsbestosis, pulmonary 579\nAscariasis 897\nAscaris-induced pancreatitis 898\nAscendant follicle 1334\nAscites 996\nchylous 997\nfetal 1309",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 694,
            "markdown": "gelatinous 1135\nhigh-density 997\nneonatal 997\nurine 997\nAseptic\nmeningitis 379\nnecrosis\nbone 63\nin renal transplant 1257\nAsherman syndrome 1341\nAsh leaf patches 405\nAskin tumor 580\nAsk-Upmark kidney 1204\nAsomia 221\nAspartate aminotransferase 888\nAspergilloma 581\nAspergillosis 580\nAspergillus clavatus 615\nAsphyxiating thoracic dysplasia 62\nAspiration 514\nbronchiolitis 583\nmeconium 639\npneumonia 583\nsolid foreign body 583\nswallow 1034\nAsplenia\nfunctional 198, 882\nsyndrome 818\nAST 888\nAsterisk sign 67\nAsteroid hyalosis 419\nAsthma 584\natopic 584\nAstler-Coller classification 1065\nAstrocytoma 334\nanaplastic 335\ncerebellar 335\njuvenile pilocytic, orbit 428\npilocytic 335\nretinal 432\nspinal cord 261\nwell-differentiated 334\nAsymbolia 159\nAsymmetric\nbreast",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 695,
            "markdown": "density 683\ntissue 696\nIUGR 1364\nseptal hypertrophy 807\nAsymmetry\nfocal, DDx 684\nglobal 695\nAsymptomatic coarctation 809\nAsynchrony, heart 823\nAtaxia-telangiectasia, CNS 336\nAtelectasis 540\ncongestive 575\nround 580\nAtelectatic asbestos pseudotumor 580\nAtheroembolic renal disease 1253\nAtheroma 477\nAtherosclerotic\naortic aneurysm 786\nulcer of aorta 835\nAthlete's heart 741\nAtlantoaxial\ndistraction 253\nrotary fixation 244\nsubluxation 220\nAtlantooccipital\nassimilation 220\ndislocation 252\njoint\nanatomy 236\naxis angle 235\nAtlas 236\nanomalies 220\nfracture 258\noccipitalization 220\nAtoll sign, lung 533\nAtony\nrenal collecting system 1167\nstomach 1009\nurinary bladder 1227\nAtopic\nasthma 584\nAtresia\naortic 819\nbronchial 588\nchoanal 480",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 696,
            "markdown": "colonic 1062\ncongenital\nbiliary 919\nintestinal 1067\nduodenal 1075\nesophageal 1066\nexternal auditory canal 485\ngastric 1008\njejunal 1110\nlarynx 1305\nof EAC 482\npulmonary artery 841\nrectum 1048\ntrachea 1305\ntricuspid valve 854\n\n# Atrial \n\nappendages\nanatomy 767\njuxtaposition 736\nleft 767\nright 766\ndiverticulum, brain 366\nfibrillation, fetus 1356\nflutter, fetus 1356\nseptal defect 796\nshunt 740\n\n## Atrioventricular\n\nblock, fetus 1356\ncanal, persistent common 814\nnode artery 769\nseptal defect 814\n\n## Atrophy\n\nbrain 289\ncerebellar 289\ncerebral 289\nhippocampus 289\npancreas 878\npostinflammatory renal 1235\npostobstructive renal 1235\nrenal, reflux 1242\nseminal vesicle 1182\nsmall bowel folds 1017\nspinal cord 231\ntestes 134\nAtropine sulfate 1437",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 697,
            "markdown": "Attic\ncholesteatoma 480\ntemporal bone 464\nAtypical\naortic dissection 821\nbacterial pneumonia 519\nbenign fibrous histiocytoma 101\ncarcinoid 645\nductal hyperplasia 723\nlipomatous tumor 142\nlobular hyperplasia, breast 723\nmeasles pneumonia 584\nmeningioma 378\nmycobacterial infection 646\nprimary pneumonia 643\nrenal cyst 1251\nsecond branchial cleft cyst 476\nteratoma, brain 357\ntuberculosis 646\nAuerbach plexus 1104\nAugmentation mammoplasty 727\nAustin Flint murmur 793\nAutoamputation, terminal tufts 1135\nAutoimmune\ninterstitial keratitis 482\npancreatitis 972\nAutone phrectomy 1281\nAutonomous adenoma, thyroid 452\nAutosomal\ndominant polycystic disease\nliver 898\ndominant polycystic kidney disease\nGU 1231\nrecessive polycystic kidney disease, GU 1233\nAutosplenectomy 198\nAvascular\nmass\nbrain 293\nkidney 1162\nnecrosis 63\ncortical infarction 64\nfemoral head 66\nhip 64\nlunate bone 65\nmedullary infarction 64",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 698,
            "markdown": "Mitchell MRI classification 64\ntarsal scaphoid 66\nvertebral body 65\n\n# Avulsion \n\nfracture 105\nanterior cruciate ligament 112\narcuate complex 112\niliotibial band 112\nposterior cruciate ligament 112\nquadriceps tendon 112\ninjury, acute 156\nrenal artery 1279\nAxial hernia 1103\nAxillary\nartery 701\nlymphadenopathy 691\nAxis\nanomalies 220\nfracture 258\nAxonal injury 351\nAzygoesophageal\nline, deviation 555\nrecess 570\nAzygos\ncontinuation of IVC 797\nvein\nenlargement 557\nnormal size 573\nAzzopardi tumor 1274\n\n## Baart de la Faille sign 1350 BAC 590 <br> Bacillary angiomatosis 1045 <br> Backflow, pyelotubular 1167 <br> Backwash ileitis 1144 <br> Bacterial <br> arthritis 14 <br> bronchopneumonia 541 <br> endocarditis 798 <br> meningitis 379 <br> nephritis <br> acute diffuse 1240",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 699,
            "markdown": "acute focal 1240\npneumonia 519\nin AIDS 575\nsinusitis 503\nBagassosis 615\nBag of\nbones, Charcot joint 159\nworms\nbrain AVM 334\nplexiform neurofibroma 273, 390\nBailey classification 475\nBaker cyst 202\nBalanced\ncoronary circulation 769\npneumoperitoneum 993\nBalkan nephropathy 1276\nBall\n-in-socket\nankle mortise 205\nepiphysis 57\n-type valve, popliteal cyst 202\nBalloon\natrial septostomy 759\nepiphysis 189\n-on-a-string sign, UPJ obstruction 1284\nBamboo spine 242\npoliomyelitis 181\nBanana\nfracture 179\n-shaped uterine cavity 1386\nsign 268,343\nBankart lesion 86\nBannayan-Riley-Ruvalcaba syndrome 1051\nBanti syndrome 898\nBantu siderosis 933\nBarber pole sign, GI tract 1128\nBardet-Biedl syndrome 1303\nBare area, liver 1038\nBaritosis 585\nBarium-133 1395\nBarlow\ndisease 195\nsyndrome 830\ntest 81\nBarotrauma 663",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 700,
            "markdown": "Barrel chest 17\nBarrett esophagus 1051\nBartholin gland cyst 1342\nBarton fracture 107\nBartter syndrome 1169\nBasal\ncell nevus syndrome 67\nencephalocele 339\nganglia 363,372\nanatomy 312\nbilateral lesions, childhood 301\ncalcification 302\nechogenic focus 303\nhematoma 363\nhypodense lesion 302\ninfarct 372\nlesions 301\nnuclei 315\nveins, placenta 1298\nBascule, cecum 1066\nBase of\nskull, foramina 234\ntongue 457\nBasilar\nimpression 220\ninvagination 220\nline 235\nmeningitis 379\nskull fracture 254\nBasiocciput hypoplasia 220\nBasion 235\n-dens interval 252\nBatson plexus 281\nBattered child syndrome 68\nBattledore placenta 1298\nBattle sign 255\nBat-wing configuration of\nlung consolidation 577\npulmonary edema 517\nventricles\nagenesis of corpus callosum 327\nChiari II 342\nBayes's theorem 1427\nBeaded\nbile ducts 906",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 701,
            "markdown": "pancreatic duct 971\nribs 168\nureter 1281\nBeak\n-shaped nose 181\nsign\nrenal cyst 1251\nsmall bowel 1001\nBean syndrome 1052\nBear paw sign 1242\nBeaten brass skull 366\nBeckwith-Wiedemann syndrome 1342\nBedside chest radiography 562\nBeemer disease 196\nBehÃ§et disease 798\nBell\npalsy 437\nBell\nand clapper deformity 1269\nBellini\nduct carcinoma 1219\nducts 1242\nBenadry ${ }^{\\circledR} 1437$\nBence-Jones protein\nabnormal nephrogram 1166\namyloidosis 60\nmultiple myeloma 154\nBends 70\nBeneficial\nASD 797\nPDA 835\nBenign\nasbestos pleurisy 579\nbone lesions, NUC 2\ncalcifications, breast 688\ncerebellar ectopia 342\nchondroblastoma 71\ncongenital Wilms tumor 1220\ncortical\ndefect 69\nrest, kidney 1163\ndisease of terminal ductal lobular unit 723\nduodenal tumors 1013\nenhancing breast lesions 693\nenlargement of subarachnoid spaces 337",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 702,
            "markdown": "extraaxial collections of infancy 337\nfetal hamartoma 1220\nfibrous\nbone lesion 10\nhistiocytoma 101\ngastric ulcer 1093\nheart tumor in adults 744\nintracranial hypertension 369\nlung tumor 536\nlymphoepithelial lesions 475\nmacrocephaly of infancy 337\nmesenchymoma 141\nmesothelioma 641\nmetastasizing leiomyoma 1390\nmixed tumor, parotis 500\nmucous membrane pemphigoid 1004\nnephrosclerosis 1253\noxyphilic adenoma 1263\nperipheral nerve sheath tumor 270\nphyllodes tumor 731\npleural mesothelioma 641\nprostatic hypertrophy 1201\nsclerosing ductal proliferation 731\nsmall bowel tumors 1018\nsubdural effusion 213\nsymmetrical lipomatosis 493\nteratoid tumor, mediastinum 675\nurethral tumor 1180\nBennett fracture 109\nBergman\nossicle 220\nsign, ureter 1277\nBergqvist triad 610\nBerry aneurysm\nCNS 329\nPCKD 1232\nrupture 330\nBertolotti syndrome 240, 213\nBerylliosis 585\nBeta-hCG\npositive without IUP 1297\nRIA 1320\nBezoar 1051\nBezold abscess 496\nBiceps",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 703,
            "markdown": "brachii\nanatomy 38\ntendon dislocation 88\nfemoris tendon 112\n-labral complex 37\nBicornuate uterus 1387\nBicuspid aortic valve 735, 799\nBifid\nclitoris 1203\ngallbladder 889\npelvis 1283\nrib 18\nureter 1283\nuvula\nApert syndrome 62\nCrouzon syndrome 76\nBig bang theory 811\nBilateral\nchest masses, fetus 1305\ndiaphragmatic elevation 559\nhilar adenopathy 556\nhyperlucent lung 542\nlarge\nadrenals 1154\nkidneys 1158\nleft-sidedness 819\nnarrowing of urinary bladder 1172\nrenal masses 1161\nright-sidedness 818\nsmall kidneys 1159\nstriopallidodentate calcinosis 355\nsuperior vena cava 755\nvagotomy, effect 1034\nBile\nduct\naberrant hepatic 890\naberrations 890\nanatomy 889\ncarcinoma 902\ncobblestone appearance 906\ncongenital cystic dilatation 876\ncystadenocarcinoma 899\ncystadenoma 899\nechogenic material within 875\nembryonal rhabdomyosarcoma 925",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 704,
            "markdown": "extrahepatic cystic dilatation 910\nfilling defect 875\ngas 873\nhamartoma, multiple 956\nmultifocal intrahepatic strictures 876\nnarrowing 875\nnormal size 889\nobstruction, incidence of infected bile 874\npapillary adenoma 974\nvariants 890\nvariants of confluence 890\nhyperattenuating 872\nleak 898\nBilharziasis 1266\nBiliary\natresia, congenital 919\ncirrhosis, primary 918\ncolic 913\ncystadenocarcinoma 899\ncystadenoma 899\n-enteric fistula 899\nmicrohamartomas 956\npancreatitis 969\npapillomatosis 974\nscintigraphy 1417\nBilirubin 888\nBilobed placenta 1323\nBimastoid line 236\nBinswanger disease 337\nBiochemical arthritis 14\nBiome chanics, spinal column 238\nBiophysical profile 1325\nBiparietal diameter 1324\nBiphosphonates 90\nBI-RADSÂ®\nbreast density 696\ncategories 697\nBirbeck granule 136\nBird\n-beak esophagus 1042\n-fancier's lung 615\n-headed dwarfism, Seckel syndrome 1380\n-like appearance, progeria 181\n-of-prey sign 1066\n-wing joint 163",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 705,
            "markdown": "Birt-Hogg-DubÃ© syndrome 1248\nBirth trauma, head 213\nBitemporal hemianopia 411\nBithalamic lesions 303\nBizarre parosteal osteochondromatous proliferation 69\nBjork-Shiley valve 760\nBlack\ndots, brain MRI 301\nepidermoid, CNS 345\nstar, breast lesion 685\nBladder\ncancer 1202\ndiverticulum 1203\nexstrophy 1203\nperforation 1174\nsquamous cell carcinoma 1203\ntransitional cell carcinoma 1203\nBlade of grass osteolysis 178\nBlake pouch cyst 337\nBlalock\n-Hanlon procedure 759\n-Taussig shunt 759\nBland\ninfarct 371\n-White-Garland syndrome 781\nBlastomere 1327\nBlastomycosis\nEuropean 606\nNorth American 585\nBleb 544\nBleeding\nfirst trimester 1296\ngastrointestinal, NUC 989\npostmenopausal uterine 1316\nprepubertal uterine 1316\nBleomycin 514\nBlighted ovum 1341\nBlind loop syndrome 1043\nBlock vertebra 221\nBlood\ncyst, orbit 425\n-filled sponge, bone 61\ngas abnormalities, lung 569\npool\nagents, NUC 1409",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 706,
            "markdown": "imaging, gated 1410\nradionuclide cardioangiography 1410\npressure, normal 762\nsupply, carpal bones 42\n\n# Blount disease 65 \n\n## Blowout\n\nbone lesion 11\nfracture, orbit 256\nlesion, posterior vertebral elements 226\n\n## Blue\n\nbloater 612\nrubber bleb nevus syndrome 1052\nvelvet 652\nBlueberry muffin syndrome 1226\nBlumensaat line 48\nBlumer shelf 1132\nBlunt\ncardiac injury 800\ntrauma\nabdomen 1052\nadrenal gland 1196\naorta 852\nesophagus 1085\nkidney 1280\ntestis 1275\nurinary bladder 1277\nBlurring, radiographic 703\nBlythe \\& Ockenden classification 1233\nBochdalek hernia 609\nBody\ncast syndrome 846\ncavity lymphoma 827\nstalk anomaly 1365\nBoeck sarcoid, lung 665\nBoerhaave syndrome 1056\nBÃ¶hler angle 55\nBolus of worms 898\nBone\nage, delayed 1\nagents, NUC 1421\nbar, epiphyseal injury 105\nbruise 7,69\ncement 24\ncenters 41\nappearance of epiphyses 1325",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 707,
            "markdown": "distal humerus 41\ncomposition 35\ncontusion 69\ncyst 200\nsolitary 200\nunicameral 200\ndensitometry 4\ndysplasia 1\nlethal 1301\nsclerosing 2\ndystrophy 1\nflap, lytic area 216\nfractures in fetus 1301\ninfarction 63\nisland\ncalvarium 405\nspongiosa 69\nlesion\napophyseal 13\nbenign, NUC 2\nblowout 11\nbubbly 10\ndiagnostic gamut 1\nepiphyseal 13\nexpansile unilocular 11\nhot, NUC 2\ninfectious bubbly 11\nintraosseous 10\nlytic on both sides of joint 11\nmixed 11\nmultiple\nlytic 11\n\\& soft-tissue tumor 12\nnonexpansile\nmultilocular 11\nunilocular 11\nosteoblastic 12\nphoton-deficient 2\npseudomalignant appearance 8\nrib 18\ntrabeculated 11\ntumorlike condition 8\nmarrow 35\nabnormalities in childhood 9\nagents, NUC 1422",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 708,
            "markdown": "edema 7\ntransplantation 587\nmass 35\nmetastases 150\nminerals 35\noverdevelopment 12\npattern of destruction 8\nscintigraphy\nbenign bone lesions 2\nimaging\nwith bone agents 1422\nwith gallium 1425\nincidental urinary tract abnormalities 1160\nindications 1422\nlong segmental diaphyseal uptake 2\nmarrow agents 1422\npediatric indications 1422\nphoton-deficient lesion 2\nprosthetic failure 24\nsoft-tissue uptake 28\nwith gallium 24\nsclerosis 2\ntrauma 13\ntumor 7\nassessment of aggressiveness 7\nbenign\nfibrous 10\nfrequency 9\nbone-forming 10\ncartilage-forming 10\nfatty tissue origin 10\nfibrous tissue forming 10\nhistiocytic origin 10\nincidence 9\nlocalized to marrow 9\nmalignant\nfrequency 9\noccurrence 9\nmatrix 10\nneural origin 10\nposition\nin longitudinal plane 8\nin transverse plane 8\nrole of radiologist 7\ntumorlike conditions 8",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 709,
            "markdown": "vascular origin 10\nvertebral body 226\nwith soft-tissue involvement 9\n-within-bone\nappearance 3\nvertebra 224\nBonnet-Dechaume-Blanc disease 334\nBonnevie-Ullrich syndrome 211\nBony outgrowths from vertebra 223\nBoomerang configuration of brain 365\nBooster reinjection technique, thallium 1411\nBoot-shaped heart 849\nBorchardt triad 1094\nBorder zone infarct 372\nBormann classification 1092\nBosniak classification 1251\nBotallo ligament\nanatomy 754\ncalcium deposition 746\nBouchard nodes 163\nBounding peripheral pulses 834\nBourneville disease 404\nBoutonniÃ¨re deformity 188\nBouveret syndrome 1090\nBovine\naortic arch 776\nxenograft, heart 760\nBowed long bones, fetus 1301\nBowel\ncontaining opaque material 995\nischemia 1123\nnecrosis 994\nnormal caliber 1035\nobstruction 998\nin children 998\nin fetus 1308\npathologic FDG uptake 992\nBowing fracture 102\nBowl of grapes sign, bone tumor 204\nBow-tie sign, cervical spine 257\nBoxers fracture 109\nBoxlike cardiomegaly 814\nBoyd vein 778\nBrachial plexus injury 245\nBrachycephaly 215",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 710,
            "markdown": "# Brachydactyly 20 \n\n## Bradycardia, fetal 1306\n\n## Brain\n\nabscess 326\nanatomic classification 311\natrophy 289\ncontusion 346\ncortical tuber 404\ncystic lesion, head ultrasound 294\ndeath 337\ndegenerative diseases 286\nedema 293\nempyema 352\nexternal tamponade 309\ngrowth 310\nhematoma 362\nherniation 289\ninfarction 369\nwatershed 372\ninfection, immunocompromised patients 373\nlesion\ncholesterol-containing 294\ndense\nand enhancing 299\nnear foramen of Monro 300\nenhancing 297\nexpanding cavernous sinus 308\nhyperdense 295\nhyperintense periventricular 301\nhypodense 293\ninnumerable small enhancing 299\nlow-attenuation in basal ganglia 302\nmesencephalic low-density 294\nmultifocal enhancing 299\nring-enhancing 298\nsuprasellar with hydrocephalus 307\nmass\nat petrous apex, dumbbell shape 440\navascular 293\ncalcified 293\ndense 296\nenhancing\nin pineal region 308\nwith supra- and intrasellar component 308\nin jugular foramen 304",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 711,
            "markdown": "intrasellar 306\nparasellar 307\nsuprasellar\nwith calcification 307\nwith low attenuation 307\nwith mixed attenuation 307\nmetastases 380\nperfusion agents 1400\nscintigraphy 1400\ntumor\nat cerebellopontine angle 305\nclassification 291\nincidence 292\nintraventricular 299\nmultifocal 293\nNUC 1400\npediatric age group 292\nposterior fossa in adult 306\npresenting at birth 292\nvascular disease 286\nvessel displacement 291\n\n# Brainstem \n\nanatomy 311\nglioma 358\npilocytic astrocytoma 336\n\n## Branch Duct IPMT 948\n\n## Branchial\n\ncleft\nanomalies 475\natypical second cyst 476\ncyst 475\ndevelopment 456-472\nfistula 476\n\n## Branham sign 123\n\nBrassy cough 482\n\n## BRCA 705\n\n## Breast\n\nabscess 704\nanatomy 698\ncalcification 687\ncancer\ncategories 704\nepidemiology 704\nevaluation 705\ninflammatory 683",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 712,
            "markdown": "in male 719\nmetastatic 706\nrole of\nmammography 707\nMRI 708\nPET/CT 709\nstereotactic biopsy 710\nultrasound 708\nscreening 706\ncomposition 699\ncyst 718\ndensity\nasymmetric 683\ndiffuse increase 683\ndevelopment\nstages 698\nvariations 683\ndisease in male 687\nedema 683\nevaluation of mass or focal asymmetry 695\nfilm reading technique 694\nhyperplasia, generalized 722\nimaging report 695\nimplant 727\nlesion\nechogenic 686\nenhancing 693\nfat-containing 685\nstellate 685\ntumor-mimicking 685\nwith atypia 684\nwith halo sign 685\nwithout atypia 683\nlobes 698\nmammographic\nimage quality 703\ntechnique 702\nmass\nmammographic evaluation 684\nsonographic evaluation 686\nwell-circumscribed 684\nmetastasis 729\npapilloma 730\nparenchymal pattern 699\nskin thickening 690",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 713,
            "markdown": "Brenner tumor 1342\nBreslow staging 1118\nBrethaire ${ }^{\\circledR} 1437$\nBreus mole 1378\nBrevicollis 264\nBridging\nleaflet 815\nliver 819\nvascular sign, pelvis 1389\nveins, brain 400\nB-ring, esophagus 1033\nBrittle bone disease 167\nBroad\nligament\nanatomy 1331\nhernia 1103\nthumb syndrome 194\nBrodie abscess 172\nBronchial\nadenoma 587\nartery, enlargement 557\natresia 588\ncirculation 568\ncuff sign 592\nfracture 586\nmucocele 542\nobstruction 558\nwall thickening 558\nBronchiectasis 588\ndistribution 559\nBronchiolar carcinoma 590\nBronchiole 567\nBronchiolitis 520, 589\naspiration 583\nHRCT 530\nobliterans 590\norganizing pneumonia 590\nsyndrome 631\nBronchioloalveolar carcinoma 590\nBronchocele 542\nBronchocentric granulomatosis 591\nBronchogenic\ncarcinoma 591\ncyst 595\nneck 447",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 714,
            "markdown": "Broncholith 559\nBroncholithiasis 559\nBronchopleural fistula 596\nBronchopneumonia 519\nBronchopulmonary\nanatomy 564\ndysplasia 596\nfistula 596\nforegut mal formation 597\nlavage 665\nsequestration 596\nBronchorrhea 590\nBronchospasm, contrast reaction Endpaper A\nBronchus 565\naccessory cardiac 565\nparacardiac 565\n-pulmonary artery ratios 749\ntracheal 564\nBronzed\ndiabetes 125\nsclerosing encephalitis 327\nBrooker classification 179\nBrown\nfat 1397\ninduration, lung 829\ntumor, skeleton 129\nBrucellosis 69\nBrunner gland\nhamartoma 1056\nhyperplasia 1056\nBrunzel sign 1269\nBrush border margins, bone 69\nBruxism 442\nBryce sign 491\nBubbles of the belly 1027\nBubbly\nbone lesion 10\nbulb sign, sprue 1139\nBucket-handle\nfracture\nbattered child 68\npelvis 111\ntear, meniscus 149\nBuckle fracture 107\nBudd-Chiari syndrome 899",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 715,
            "markdown": "Buerger disease 799\nBuffalo hump\nCushing syndrome 1206\nmediastinal lipomatosis 639\nBuford complex 41\nBulbourethral gland\nanatomy 1192\nlesions 1180\nBulging\ndisk 250\nfissure, lung 630\nBulla 544\nBullet-shaped vertebra 224\nBullous\ncystitis 1206\nedema of bladder wall 1207\nemphysema of intestine 994\nBull's-eye lesion\nbowel wall, multiple 1020\nGI tract\nmelanoma 1118\nmetastasis 1127\nliver 864\nstomach 1011\nBunch of flowers, kidney 1219\nBundles of Probst 327\nBunsen-type valve 202\nBuphthalmos 419\nBurkitt lymphoma 634, 1057\nBurnt-out\ncolon 1144\ntumor of testis 1274\nBurow vein 886\nBursa 15\ncommon locations 53\nelbow 42\nhip 43\nknee 50\nshoulder 41\nBursitis, subacromial-subdeltoid 194\nBurst fracture 257\nBuruli ulcer 646\nBuschke-Ollendorff syndrome 146, 173\nBusulfan 514\nButchart staging 642",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 716,
            "markdown": "Butler-Albright syndrome 1258\nButterfly\nfragment 102\nglioma\nGBM 357\noligodendroglioma 392\nlymphoma 375\nrash\nSLE 673\ntuberous sclerosis 405\nvertebra 221\nButton sequestrum 11\neosinophilic granuloma 137\nosteomyelitis 170\nskull 216\nButtresses of face 455\n\n# CA-125 1368 \n\nCafÃ©-au-lait spots\ncoast of California 389\ncoast of Maine 100\ntuberous sclerosis 405\nCaffey\ndisease 133\n-Kempe syndrome 68\nCaisson disease 70\nCajal cells 1096, 1108\nCake kidney 1158\nCalcaneal\nfracture 114\ninclination angle 55\npitch 55\nCalcaneonavicular coalition 205\nCalcaneus 25\nCalcific\ncochleitis 488\nlongus colli tendinitis 476\nretropharyngeal tendinitis 476\nuremic arteriolopathy 129\nCalcification\nabdominal\nvascular 996",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 717,
            "markdown": "wall 996\nadrenal 1157\nalimentary tract 995\naorta 754\nbasal ganglia 302\nbladder 1173\nbreast\ngeneral 687\npopcorn 688\ncalvarial, inadequate 215\ncardiac 745\nchicken wire 71\nchoroid plexus 295\ncoronary artery 746\ndermal, breast 688\ndiffuse peritoneal 995\ndisk 229\ndura 303\ndystrophic 29\neggshell, lymph nodes 557\nfemale genital tract 1312\nfinger tip 21\nfocal alimentary tract 995\nintraabdominal, fetus 1308\nintracranial\nfetus 1304\ngeneral 295\nphysiologic 295\nintraocular 414\nkidney 1168\nliver 866\nlobular, breast 688\nmale genital tract 1181\nmesentery 995\nmetabolic 29\nmetastatic 29\nmitral valve 746\nmultiple pulmonary 539\nmuscle, ricelike 348\nmyocardium 746\norbital 414\npancreas 878\npericardium 746\nperitoneum 1026\nperiventricular, childhood 300",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 718,
            "markdown": "pineal 295\npinna 186\npleura 550\npopcorn 556\nin histoplasmosis 619\npyelocalyceal system 1170\nretroperitoneum 1153, 1168\nrings and arcs, chondrosarcoma 73\nsign, aorta 790\nsoft-tissue 29\nspleen 882\nsuprasellar mass 307\nthyroid 450\ntram track gyrus 399\ntumoral 187\nturtle back 981\nureter 1172\nvalve leaflets 829\n\n# Calcified \n\nbrain metastases 381\nductus arteriosus 835\nintracranial mass 293\nliver metastases 952\nlung metastasis 643\nmedullary defect 69\nrenal mass 1162\nretroperitoneal mass 1153\n\n## Calcifying\n\naponeurotic fibroma 201\nepithelioma of Malherbe 28\n\n## Calcinosis 1135\n\ncircumscripta 30\ncutis 210\ngeneralized 30\ninterstitial 30\ntumoral 210\nuniversalis 30\n\n## Calciphylaxis\n\narteriolopathy 129\npenile 1230\n\n## Calcitonin\n\nmedullary thyroid cancer 508\nphysiology 36\n\n## Calcium\n\nbilirubinate stone 912",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 719,
            "markdown": "metabolism 35\npyrophosphate dihydrate deposition disease 70\nsoap, bile 954\nCalcospherites 576\nCalculus\ncommon bile duct 913\ngallbladder 913\nkidney 1286\nurinary bladder 1173\nCaliber, normal bowel 1035\nCalibrators 1394\nCallus, exuberant 13\nCalot triangle 886\nCalvaria\nanatomy 310\ninadequate calcification 215\nCalvÃ©\ndisease 137\n-KÃ¼mmel-Verneuil disease 65\n-Legg-Perthes disease 66\nCalyx\nabnormalities 1167\nabortive 1193\ndiverticulum 1239\nfunny-looking 1158\nspidery 1259\nCamalote sign, lung 923\nCameron lesion 988\nCamptodactyly 1302\nCamptomelic dysplasia 70\nCampylobacter pylori 1099\nCamurati-Engelmann disease 182\nCanal of\nCloquet 430\nKovalevski 268\nNuck 1176\nSchlemm 417\nCanavan disease 338\nCancellous osteoid osteoma 169\nCandelabra 320\nCandidiasis\nAIDS 1044\nesophagus 1087\nliver 901\nlung 598",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 720,
            "markdown": "Candle\ndrippings, brain 404\nflame osteolysis 178\nwax dripping 146\nCandy cane appearance, GI tract 1000\nCantlie line 884\nCapillary\nangioma 338\nhemangioma 817\nbone 123\nliver 939\norbit 422\nlobular hemangioma 124\nlymphangioma 492\ntelangiectasia, CNS 338\nCaplan syndrome 664\nCapotenÂ® 1419\nCapsular retraction, liver 865\nCapsuloma 1214\nCaptopril 1419\nCaput\nmedusae 975\nmembranaceum\nhypophosphatasia 132\nosteogenesis imperfecta 167\nsuccedaneum 213\nCarbamates 600\nCarbon\nblack pneumoconiosis 602\ndioxide tracer 1406\nmonoxide poisoning 302\nCarbuncle 1239\nCarcinoid\nheart disease 815\novary 1383\nsyndrome 1058\ntumor\nGI tract 1058\nlung 645\nCarcinoma\nadrenocortical 1197\ncolorectal 1062\nfallopian tube 1356\ngallbladder 930\ngastric 1091",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 721,
            "markdown": "lung 591\nrenal cell 1247\nurachal 1282\nurinary bladder 1202\nCarcinomatosis, peritoneal 1132\nCarcinomatous meningitis 381\nCarcinosarcoma, esophagus 1084\nCardiac\nactivity, embryo 1321\nanomaly, in utero detection 1306\narrest 800\ncalcifications 745\nchamber, abnormal dimensions 742\ndysrhythmia, fetus 1356\nfailure, neonate 743\nfibroma 800\nhemangioma 800\nherniation 801\ninjury 800\ninversion 739\nlipoma 801\nluxation 801\nlymphoma 827\nmalposition 739\nmetastasis 744\npacemaker 760\nparaganglioma 802\nresynchronization therapy 761\nsarcoidosis 666\nsarcoma 802\nscintigraphy 1406\nscleroderma 1134\nshock 831\nstress test 1413\ntamponade 803\nthrombus 804\ntrauma, valve dysfunction 801\ntumor 744\nveins 772\nCardinal\nligament 1332\nveins 771\nCardiolite ${ }^{\\circledR} 1412$\nCardiomegaly 741\nboxlike 814",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 722,
            "markdown": "newborn 741\nwith congestive heart failure 743\nwithout pulmonary edema 518\nwith pulmonary edema 518\n\n# Cardiomyopathy 804 \n\ncongenital 743\ncongestive 805\ndilated 805\nhypertrophic 805\nobstructive 807\nrestrictive 808\nCardiophrenic angle\nmass 555\nvarices 1086\nCardiosplenic syndromes 818\nCardioTec ${ }^{\\circledR} 1413$\nCardiothoracic ratio 741, 763\nCarman meniscus sign 1094\nCarmustine 514\nCarney\ncomplex 833\nsyndrome 833\ntriad 1113\nCaroli\ndisease 901\nsyndrome 902\nCaroticotympanic artery 319\nCarotid\nbifurcation 319\nbody tumor 498\nbulb 319\n-cavernous sinus fistula 332\nduplex ultrasound 477\nsiphon 319\nspace 464\nmass 443\nCarotid artery\naneurysm 443\ndissection 484\nduplex identification 320\nplaque 479\nstenosis 476\nCarpal\nangle 20\nbones 42",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 723,
            "markdown": "dislocation 88\ninjury 109\nligaments 43\nsign 211\ntunnel\nradiograph 42\nsyndrome 71\nCarpenter syndrome 71\nCarpentier-Edwards valve 760\nCarpet\nlesions of colon 1022\nof polyps\nfamilial adenomatous polyposis 1089\nPeutz-Jeghers syndrome 1132\nCarpus, ligaments + bones 43\nCarrot-shaped trachea 781\nCartilage\n-containing giant cell tumor 71\n-forming tumor 10\nCartilaginous node 275\nCaruncle 1180\nCase-control study 1430\nCasoni skin test 921\nCasting calcifications, breast 688\nCastleman disease 599\nCatamenial pneumothorax 600\nCataract\ncongenital 420\ntraumatic 427\nCaterpillar sign 1105\nCathartic colon 1061\nCatheter-coiling sign, ureter 1277\nCat's eye 433\nCauda equina syndrome 214\nCaudal\ndysplasia sequence 245\nregression syndrome 245\nspinal anomalies 221\nCaudate lobe, hot 900\nCaudothalamic notch 384\nCauliflower ear\ndiastrophic dysplasia 85\nrelapsing polychondritis 186\nCausalgia 185\nCaustic esophagitis 1087",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 724,
            "markdown": "# Cavernoma \n\nbrain 340\nportal vein 977\n\n## Cavernous\n\nangioma, brain 340\nhemangioma\nbone 123\nbrain 340\nliver 938\norbit 423\nurinary bladder 1173\nlymphangioma 492\nmalformation\nbrain 340\norbit 423\nsinus\nanatomy 319\naneurysm 330\nlesion 308\nsyndrome 330\nthrombosis 342\nurethra 1192\n\n## Cavitary\n\nprostatitis 1237\nsmall bowel lesions 1014\ntuberculosis 680\n\n## Cavitating\n\nlung nodule 537\nmesenteric lymph node syndrome 1140\nmetastasis, lung 643\nopportunistic infection 521\npneumonia 521\nCavoatrial tumor extension 744\nCavotricuspid isthmus 766\nCavum\nsepti pellucidi 314\nveli interpositi 314\ncyst 338\nvergae 314\nCD4 lymphocyte count 574\nCebocephaly 365\nCecal\nbascule 1066\ndiverticulitis 1074\nfilling defect 1019",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 725,
            "markdown": "ileus 1049\nvolvulus 1065\nCEC syndrome 1140\nCecum 1036\nkidney-shaped 1066\nCelery-stalk sign 194\nCeliac\naxis syndrome 828\ndisease 1141\ntrunk 1031\nCell\nnests of von Brunn 1242\nof Cajal 1096\nCellular fibroadenoma 721\nCellulitis 32\norbit 424\nskin 26\nCementoblastoma 246, 164\nCementoma 246\nCemento-osseous dysplasia 246\nCenter\n-edge angle of Wiberg 82\nof rotation, SPECT 1396\nCentipede sign, colon 1074\nCentral\nchondrosarcoma 73\ndot sign, liver 901, 1234\nfibrosarcoma 98\nhemianoptic scotoma 411\nherniation 290\nmedullary lesion, bone 8\nneurocytoma 338\nneurofibromatosis 390\nosteosarcoma 174\npontine myelinolysis 392\nprecocious puberty 1310\nscar\nhepatic lesion 866\npancreatic lesion 982\nsolitary papilloma, breast 730\nvenous\nline\nmalpositioned 562\nposition 562\npressure catheter 563",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 726,
            "markdown": "Centriacinar emphysema 611\nCentrilobular\nemphysema 611\nlung nodules 530\nCephalic index 1324\nCephalocele 338\nCephalohematoma\nbirth trauma 213\nscalp anatomy 233\nCerebellar\narteries 325\nastrocytoma 335\npilocytic 335\natrophy 289\ncystic mass 305\nectopia, benign 342\nherniation 290\npeg 342\npilocytic astrocytoma 335\nsarcoma 305\ntonsillar ectopia 342\nCerebellopontine angle tumor 305\nCerebral\namyloid angiopathy 339\napergillosis 582\naqueduct 319\natrophy 289\nblood flow, NUC 1401\ncavernous malformation 340\ncontusion 346\ndeath 337\ndegenerative disease 286\nhemiatrophy 351\nmalaria 639\nnodules, innumerable small enhancing 299\npalsy 385\nschistosomiasis 398\nveins 323\nvenous thrombosis 340\nCerebritis 342\nCerebrocostomandibular syndrome 71\nCerebrofacial arteriovenous metameric syndrome 334\nCerebrohepatorenal syndrome 410\nCerebrospinal fluid 318\nfistula 248",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 727,
            "markdown": "leak study, NUC 1402\nCeretec ${ }^{\\circledR} 1400$\nCeroid granuloma, gallbladder 910\nCeruminoma 438\nCervical\nadenitis 448\naortic arch 776\nbronchogenic cyst 447\ncarcinoma 1342\ndermoid cyst 483\ndisk herniation 251\nectopic pregnancy 1351\nincompetence 1361\nlength, normal 1361\nmass 1318\nnodes, staging for SCC of head \\& neck 487\nrib 17\nsinus 456\nspine\nfracture 256\nfusion 223\nstenosis 278\nstenosis, GYN 1319\nthymic cyst 447\ntrauma\npitfalls 257\nsigns of significance 257\nCervicitis 1375\nCervicomedullary kink 343\nCervicothoracic\nsign 550\nCervix\nanatomic zones 1330\ndilated 1297\nsign, pylorus 1105\nCesarean scar, ectopic pregnancy 1351\nCesium-137 1395\nChagas disease 1061\nChain cystography 1175\nChalasia 1061\nChalice sign 1277\nChamberlain line 235\nChampagne glass\niliac wings 57\nureter 1277",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 728,
            "markdown": "Chance\nequivalent 260\nfracture 260\nChandler disease 66\nCHAOS 602\nCharcot\njoint 159\n-Leyden crystals 584\nspine 160\ntriad, cholangitis 904\nCHARGE syndrome 439\nChauffeur fracture 107\nChemical\nimpurity 1394\nmeningitis 379\ndermoid 345\nepidermoid 345\npneumonitis 600\nChemodectoma\nchest 676\nENT 497\nChemosis 422\nCherubism 100\nChest\nbedside radiography 562\ndeformity 17\nnarrow, in fetus 1301\ntrauma 586\nwall\nfracture 110\nhamartoma 617\nlesion 560\nmass in fetus 1306\ntumor 561\nin children 561\nChiari malformation 342\nChiasmatic glioma 358\nChicago disease 585\nChicken wire calcification 71\nChief cells 1034\nChilaiditi syndrome 992\nChild abuse 68\nChildhood\nfractures 13\nosteomyelitis 171",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 729,
            "markdown": "Chimney-shaped aortic arch 840\nChinese liver fluke 919\nChlamydia trachomatis\nlymphogranuloma venereum 1114\npelvic inflammatory disease 1375\nChloroma\nbone 121\nkidney 1215\nChoanal atresia 480\nChocolate\ncyst\nENT 481\norbit 425\npelvis 1354\njoint effusion 180\nsauce abscess 933\nChokes 70\nCholangiocarcinoma 902\nCholangiohepatitis, oriental 907\nCholangiolithiasis 913\nCholangiopathy\nAIDS 905\nAIDS-related 1045\neosinophilic 925\nCholangitis 904\nacute\nnonsuppurative ascending 904\nobstructive 904\nsuppurative ascending 904\nAIDS-related 905\nchemotherapy-induced 905\nchronic\nnonsuppurative destructive 918\nobliterative 905\nfibrosing 905\noriental 907\nprimary 907\nsclerosing 905\nrecurrent pyogenic 907\nsecondary sclerosing 907\nCholecystic veins 886\nCholecystitis 908\nacalculous 909\nacute 908\nchronic 910",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 730,
            "markdown": "emphysematous 910\nlipid 946\nxanthogranulomatous 910\nCholecysto\ncolic fistula 899\nduodenal fistula 899\nkinin 1029\nlithiasis 913\nCholecystosis, hyperplastic 946\nCholedochal cyst 910\nintraduodenal 912\nCholedocho\ncele 912\nduodenal fistula 899\nlithiasis 913\nCholelithiasis 912\nCholera, pancreatic 964\nCholestasis 912\nCholesteatoma\nCNS 345\near 480\nexternal auditory canal 481\nGU tract 1204\ninflammatory 480\nCholesterol\n-containing CNS lesions 294\ncyst, ear 481\ngranuloma, ear 481\npneumonia 649\npolyp, gallbladder 947\nstone 912\nCholesterolosis 946\nChondral fracture 102\nChondroblastoma 71\nChondrocalcinosis, 15\nChondrodysplasia\nmetaphyseal 149\npunctata 72\nChondroectodermal dysplasia 72\nChondroma\njoint 203\nsoft-tissue 200\nChondromalacia patellae 73\nChondromatosis, synovial 203\nChondromyxoid fibroma 73",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 731,
            "markdown": "# Chondrosarcoma \n\nbone 73\nlarynx 489\nspine 246\nsynovial 74\n\n## Chopart fracture 114\n\n## Chorda tympani 318\n\n## Chordoma 246\n\n## Chorio\n\nadenoma destruens 1360\namnionic\nelevation 1297\nseparation 1344\nangioma 1344\ncarcinoma\ngestational 1345\nnongestational 1345, 1373\ntestis 1273\ndecidua 1320\n\n## Chorion 1320\n\n## Chorionicity 1328\n\n## Chorionic villus sampling 1326\n\n## Choristoma\n\nCNS 343\nkidney 1200\nmiddle ear 438\npancreas 924\n\n## Choroid\n\nplexus\ncalcification 295\ncyst 343\nhemorrhage, neonate 384\nneoplasm 343\npapilloma 344\npoint 325\n\n## Choroidal\n\nartery 321\ndetachment 419\nhemangioma 419\nmelanoma 431\nmetastasis 426\nosteoma 419\n\n## Christmas\n\ndisease 126\n-tree bladder 1175",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 732,
            "markdown": "# Chromaffin paraganglioma 645 \n\n## Chromo\n\ngranin 1230\nphobe renal cell carcinoma 1249\n\n## Chronic\n\nabdominal inflammation, gallium 1422\nabscess, breast 704\nalveolar infiltrate 523\naortic pseudoaneurysm 788\natrophic pyelonephritis 1242\nBudd-Chiari syndrome 900\ncalcifying pancreatitis 878\ncerebral hematoma 363\ncholecystitis 910\ncolonic pseudoobstruction 1107\ncystic mastitis 722\ndiffuse\nconfluent lung opacities 541\nfine reticulations 526\nduodenal ileus 846\neosinophilic pneumonia 614\nepididymitis 1208\nesophagitis 1087\nextrinsic allergic alveolitis 616\nfibrosing mesenteritis 1137\ngastric atony 1009\nglomerulonephritis 1204\ngranulomatous\ndisease, childhood 914\nleukemia 7\nhepatitis 941\nhydronephrosis 1213\ninfantile hyperostosis 133\ninterstitial\nlung disease simulating air-space disease 527\npneumonia 626\nintestinal pseudoobstruction syndrome 1108\nischemic infarction, brain 371\nlymphocytic thyroiditis 509\nmediastinitis 640-641\nmesenteric ischemia 1125\nmultifocal ill-defined lung opacities 541\nmyelogenous leukemia 7\nnecrotizing aspergillosis 581\nnephritis, hereditary 1211",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 733,
            "markdown": "nonsuppurative destructive cholangitis 918\nobliterative cholangitis 905\nobstructive\npancreatitis 971\npulmonary disease 611\nosteomyelitis 172\notitis media 496\npancreatitis 971\nperiaortitis 1259\npericarditis 838\nPID 1376\nportal vein thrombosis 977\nposttraumatic aortic pseudoaneurysm 854\npulmonary infiltrates in childhood 541\nradiation-induced hepatitis 942\nrecurrent\nmultifocal osteomyelitis 172\nsialadenitis 501\nrejection\nlung transplant 631\nrenal transplant 1254\nrenal\nfailure 1149\nmusculoskeletal manifestations 1149\ninfarction 1253\nvein thrombosis 1259\nsclerosing sialadenitis 481\nsimple silicosis 670\nsinusitis 503\nsubdural hematoma 401\ntesticular torsion 1270\nthromboembolism, lung 655\nvenous stasis disease 808\nChrysotile 578\nChurg-Strauss syndrome 808\nChylo\nmicrons 601\nthorax 601\nChylous ascites 997\nCicatrizing atelectasis 540\nCigarettes, pulmonary disease 514\nCigarroa formula 1205\nCimetidine 1121, 1437\nCingulate herniation 289\nCircle of Willis 320",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 734,
            "markdown": "Circulation, lung 568\nCirculatory assist devices 563\nCircum\naortic left renal vein 756\ncaval ureter 1259\nmarginate placenta 1323\nvallate placenta 1323\nCirrhosis 914\nprimary biliary 918\nCirrhotic nodule 917\nCisterna chyli 573\nCisterna magna\nabnormal 1304\ndiameter in fetus 1325\nCisternography, NUC 1401\nClark\nrule for NUC dose 1393\nstaging 1118\nClassic mole 1360\nClassification\nAltman 274\nAmstutz 176\nAnn Arbor 620\narthritis 14\nAstler-Coller 1065\nBailey 475\nBlythe \\& Ockenden, APKD 1233\nBormann 1092\nBosniak 1251\nbrain anatomy 311\nBrooker 179\nCNS anomalies 285\nCollett \\& Edwards 856\nDeBakey 790\nKimura 910\nLichtman 65\nLuke and Collins 634\nMichels 885\nMitchell 64\nOgden 113\nPapile 384\npineal gland tumors 308\npneumoconiosis 539\nprimary CNS tumors 291\nRappaport 634",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 735,
            "markdown": "Reimann 1046\nrickets 191\nRunyon 646\nSalter-Harris 105\nSchatzker 113\nsoft-tissue lesions 26\nStanford 790\nSteinberg 64\nTodani 876\nWeber 113\nWerner 422\nWiseman 608\nWolfe 699\nworking formulation 634\n\n# Claudication \n\nneurogenic 278\nof jaw 848\nClavicle\nabsence of outer end 19\ndestruction of medial end 19\npenciled distal end 19\nClaw sign, renal cyst 1251\nClay shoveler's fracture 104, 257\nClearance phase, ventilation scan 1405\nClear cell\nchondrosarcoma 74\nneoplasm of ovary 1345\nrenal cell carcinoma 1249\nsarcoma, kidney 1204\nCleft\nhand 1302\nlip 365,1355\nneural arch 221\npalate 1355\nCleidocranial dysostosis 75\nClenched hand 1302\nClinical epide miology 1429\nClinodactyly 20\nin fetus 1302\nClip injury 25\nClival line 235\nClivus\n-canal angle 235\n-torcular line 325\nCloaca",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 736,
            "markdown": "exstrophy 1345\nformation, osteomyelitis 170\nmalformation, anorectal 1049\nCloison of Bertin 1163\nClomiphene 1371, 1382\nClonorchiasis 919\nCloquet canal 430\nClosed\nexstrophy 1203\n-loop obstruction\nmidgut volvulus 1127\nsigns 1001\nClosing volume, lung 569\nClostridium difficile disease 1061\nCloverleaf\ndeformity, GI tract 1076\nskull 215\nClubfoot 25\nClubhand 1302\nCluster\nof grapes\nkidney 1223\nlung 589\nCMV\ncolitis 1044\n-induced retinitis 419\nCNS\nanomalies, classification 285\nlupus 674\nmass\nintrasellar 306\nparasellar 307\ntrauma 359\ntuberculosis 403\ntumor\nclassification 291\nincidence 292\nmetastasizing outside CNS 293\nmultifocal 293\npediatric age group 292\npresenting at birth 292\nvasculitis 288\nCoal\nmacules 601\nworker pneumoconiosis 601",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 737,
            "markdown": "Coalescent\ngranulomata 666\nmastoiditis 496\nCoarctation\nof aorta 809\nsyndrome 852\nCoarse reticulations, lung 527\nCoast of\nCalifornia, cafÃ©-au-lait spots 389\nMaine, cafÃ©-au-lait spots 100\nCoats disease 419\nCobalt-57 1395\nCobb angle 276\nCobblestone appearance\nbile ducts 906\nCrohn disease 1069\nduodenum 1057\neosinophilic gastroenteritis 1081\nesophagus 1087\nlymphoma 1115\nstomach 1070\nCobra head ureter 1283\nCobwebs of aorta 791\nCocaine 843\nCoccidioidomycosis\nbone 75\nlung 602\nCoccygeal appendage 152\nCochlea\nanatomy 467\naqueduct 468\notosclerosis 496\nCockayne syndrome 344\nCockett\nsyndrome 827\nveins 778\nCock-robin position 244\nCockscomb appearance, cervix 1348\nCodman\ntriangle 12\ntumor 71\nCoeur en sabot\npseudotruncus arteriosus 856\ntetralogy of Fallot 849\nCoffee bean sign",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 738,
            "markdown": "closed-loop obstruction 1001\nsigmoid volvulus 1066\nCogan syndrome 482\nCoiled\nspring\ngastric remnant 1010\nsign, intussusception 1108\ntube 1067\nCoin\nlesion, lung 650\n-on-edge vertebra 137\nCoke-bottle sign, orbit 422\nCold\nabscess\nbreast 704\nspine 281\nspot imaging 1416\nthyroid nodule 452\ntubes, NUC 1396\nColic\nbiliary 913\nrenal 1288\nColitis\nAIDS 1045\nCMV 1044\ncystica profunda 1062\nenterocolitis 1079\neosinophilic 1081\ngranulomatous 1070\ninfectious 1079\nischemic 1109\npseudomembranous 1061\nulcerative 1144\nCollagen vascular disease 30\npulmonary manifestations 31\nthoracic manifestations 31\nCollapsed cava sign 1052\nCollapsing cord sign 280\nCollarbutton\nlesion, chest 645\nulcers\namebiasis 1045\nulcerative colitis 1144\nCollar sign, diaphragm 610\nCollateral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 739,
            "markdown": "circulation of hand 776\nligaments of knee 48\n\n# Collecting \n\nduct carcinoma 1219\nsystem\natony 1167\neffaced 1168\nfilling defect 1167\nwidened 1167\n\n## Colles fracture 107\n\nCollett \\& Edwards classification 856\nColliculocentral point 323\nCollision tumor 1156, 1221, 1383\nColloid\ncarcinoma\nbreast 715\nGI 995\ncyst\nbrain 344\nthyroid 507\nnodule, thyroid 506\nshift, NUC 867\n\n## Coloboma 420\n\n## Colon\n\nadenocarcinoma 1063\nadenomatous polyp 1042\natresia 1062\ncarpet lesions 1022\ncutoff sign 1019\ndiverticular hemorrhage 1075\ndiverticulitis 1074\ndiverticulosis 1073\nduplication cyst 1078\nfilling defects 1021\ngas composition 871\nleadpipe appearance 1144\nmetastasis 1126\nnarrowing 1020\nobstruction 1001\npolyp, classification 1022\npseudoobstruction 1107\nsignet ring carcinoma 1064\nsmall left colon syndrome 1139\nthumbprinting 1019\ntransit time 1035",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 740,
            "markdown": "ulcers 1020\nurticaria pattern 1020\nvolvulus 1065\nwall thickness 1036\nColonic pseudoobstruction, acute 1107\nColorectal\ncarcinoid 1061\ncarcinoma 1062\nduplication 1078\nhemorrhage 988\nColpocephaly 299\nColumella 483\nColumn of Bertin, large 1163\nComb sign 1027\nCrohn disease 1069\nComedo\ncarcinoma, breast 712\nmastitis 726\nComet\nsign, lung lesion 580\n-tail\nartifact, liver and gallbladder 873\nsign, gonadal vein 1289\nComma\n-shaped\nduodenum 1076\nhilum\ninterruption of pulmonary artery 821\ntruncus arteriosus 856\nsign, liver 900\nComminuted fracture 102\nCommon\narterial trunk 856\natrioventricular canal 815\natrium 815\nbile duct\ndiverticulum 912\nlarge nonobstructed 875\nobstruction 874\nrat tail 960\nspontaneous perforation 984\nstone 913\ncarotid artery 319\nfemoral vein 778\nCommunicating",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 741,
            "markdown": "cavernous ectasia of intrahepatic bile ducts 901\nhydrocephalus 366\nsyringomyelia 280\nveins, lower extremity 778\nCommunity-acquired pneumonia 519\nCompact island 69\nCompartment syndrome\nabdominal 1042, 1066\nextremity 32\nCompensated hydrocephalus 366\nComplete\nabortion 1338\nduplication, ureter 1282\nfracture 102\nheart block, fetus 1357\nmole 1360\ntransposition of great arteries 851\nCompleted stroke 284\nComplex\nbreast cyst 718\nchest mass, fetus 1306\nmyxoma 833\novarian cyst 1370\npelvic mass 1312\nsellar cyst 306\nCompliance\nlung 569\nrandomized trial 1430\nComplicated\nbreast cyst 718\npneumoconiosis 602\nsilicosis 671\nComposition of breast 699\nCompression\ncone effect 355\nfracture of spine, acute atraumatic 261\nof trachea + displacement 853\nspinal cord 266\nConal ventricular septal defect 858\nConcentric\nhernia 1103\nleft ventricular hypertrophy 741\nConcha bullosa 455\nCondensed phosphates 1421\nCondensing osteitis, tooth 248",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 742,
            "markdown": "Conductive hearing loss 437\nCondylar\nfracture, humerus 107\nhypoplasia, skull 220\nCondyloma acuminata 1204\nCondylus tertius 220\nConed cecum 1018\nConfidence limit 1428\nConfluent hepatic fibrosis 919\nCongenital\nabsence of\npain 75\npericardium 836\npulmonary artery 841\npulmonary valve 810\nthymus 736\nadrenal hyperplasia 1199\nadrenogenital syndrome 1199\naneurysm\nCNS 329\npulmonary artery 820\natresia of EAC 482\nbiliary atresia 919\nbronchogenic cyst 595\ncardiac tumor 744\ncardiomyopathy 743\ncataract 420\ncervical anomaly 1318\ncholesteatoma\near 480\nepidermoid of brain 345\nCMV infection of CNS 349\nconstriction band sequence 1341\ncystic\nadenomatoid malformation 603\ndilatation of bile ducts 876\nlesion of neck 447\ndiaphragmatic hernia 608\nduodenal obstruction 1012\ndyshormonogenesis, thyroid 449\ndysplasia of hip 81\nesophageal stenosis 1067\nfibrosarcoma, kidney 1220\nFinnish nephrosis 1294\ngastric obstruction 1008",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 743,
            "markdown": "generalized fibromatosis 79\nheart disease 735\nincidence in newborns 735\nlong life 736\nprenatal risk factors 1306\npresenting in 1st\nfew days of life 736\nyear of life 736\nsurgical procedures 759\nsyndromes 736\nheart tumor 744\nhemangioma 818\nhemiplegia 351\nhepatic\ncyst 937\nfibrosis 920\nhydrocele 1212\nhydrocephalus 367\nhydronephrosis 1213\nhydrothorax 602\ninclusion cysts of CNS 345\ninsensitivity to pain 75\nintestinal atresia 1067\nleft ventricular aneurysm 857\nlobar\nemphysema 603\noverinflation 603\nlymphangiectasia\nintestines 1106\nlung 603\nlymphedema 826\nmegacalyces 1219\nmesoblastic nephroma 1220\nmidline nasal mass 441\nmultiple fibromatosis 79\nmuscular torticollis 485\npancreatic anomalies 877\nprimary megaureter 1220\npulmonary\nairway malformation 603\nlymphangiectasia 603\nvenolobar syndrome 605\nrenal\naneurysm 1244\nhypoplasia 1204",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 744,
            "markdown": "osteodystrophy 187\nrib anomalies 17\nrubella 194\nstippled epiphyses 72\nsubglottic stenosis 505\nsyphilis 204\ntracheobiliary fistula 890\ntracheomalacia 558\ntrue pancreatic cyst 920\ntumor 1309\nureteral abnormalities 1170\nurethral diverticulum 1285\nvesicoureteral reflux 1290\nCongenitally\ncorrected transposition 852\nshort esophagus 1103\n\n# Congestion \n\nhepatic 974\nindex, portal vein 887\nsyndrome, pelvis 1374\n\n## Congestive\n\natelectasis 575\nbrain swelling 293\ncardiomyopathy 805\nheart failure 810\nin neonate 743\nwith cardiomegaly 743\nindex, portal vein 976\nleft heart failure 810\nright heart failure, hepatic vein Doppler 810\nsplenomegaly 880\nConglomerate anthracosilicosis 602\nCongo red 60, 1046\nConidiophores 580\nConjoined\nnerve root 251\ntwins 1345\nConnatal cyst, brain 294\nConnective tissue\ndisease 30\nfibrous tumors 10\nConn syndrome 1204\nConradi-HÃ¼nermann syndrome 72\nConray ${ }^{\\circledR} 1432$\nConsolidated lung 522",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 745,
            "markdown": "# HRCT 529 \n\nConstancy, NucMed 1394\nConstitutional sclerosing bone disease 2\nConstricting lesion, small bowel 1017\nConstrictive\nbronchiolitis 590\npericarditis 837\nContained aortic rupture 786\nContamination, randomized trial 1430\nContinuous\ndiaphragm sign 551\nheart murmur 736\npositive pressure ventilation, complications 663\nContraceptive device 1361\nContraction\nesophageal 1002\nstress test 1326\nContrast\nextravasation B\nloading, CNS 362\nmedia\nacute renal failure 1434\nadverse reaction 1433\nduring pregnancy 1335\nexcretion 1188\nintravenous in pediatrics 1337\nnephrotoxicity 1434\nreflux 757\nnephropathy 1205\nradiographic 703\nreaction 1433\nwater-soluble 1431\nContrecoup 346\nContusion\nbone 69\nbrain 346\nkidney 1278\nlung 586\nmuscle 155\nmyocardium 800\nurinary bladder 1277\nConus\nartery, heart 769\nelasticus 462\neye 416",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 746,
            "markdown": "medullaris\nnormal position 240\n\n# Conventional \n\nosteosarcoma 174\nrenal cell carcinoma 1249\nConversion defect 127\nConvolutional impressions 265\nConvulsion, contrast reaction B\nCooley anemia 206\nCopper\n7, intrauterine device 1362\nT , intrauterine device 1362\nCopular point 323\nCor\npulmonale 752\ntriatriatum 811\nCoraco\nacromial\narch 37\nligament 40\nhumeral ligament 38\nCord\natrophy 231\nentanglement 1298\nepidural extramedullary lesion 230\nherniation 263\nintradural extramedullary mass 230\nintramedullary lesion 229\nlesions 230\ndelayed uptake of water-soluble contrast 231\npresentation 1346\nprolapse 1346\nsign, brain 341\ntorsion 1298\nvarix 1299\nCordocentesis 1326\nCorduroy vertebra 123\nCori disease 931\nCorkscrew appearance\nesophagus 1003\nhepatic arteries 916\nsmall bowel 1127\nureter 1281\nCorneal laceration 426\nCornelia de Lange syndrome 75",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 747,
            "markdown": "# Corner \n\nfracture 68\nsign\nPark in scurvy 196\nSalter fracture 106\nCornual ectopic pregnancy 1351\nCoronal cleft, vertebra 221\nCoronary\narcade 771\nartery\nanatomy 769\naneurysm 825\nangiograms 769\nanomalies 770\nanomalous\ncourse 771\nleft 781\ntermination 771\narteriography 770\ncalcification 746\ncollaterals 770\ndisease 822\ndominance 769\nfistula 810\ninjury 801\nterritory 769\nsinus 773\ndefect 797\nenlarged 742\nsmall 743\nvein 976\n\n## Corpus\n\nalbicans cyst 1369\ncallosum\nagenesis 327\ndysgenesis 327\ngrowth 328\nlesion 301\nlipoma 374\nring-enhancing lesion 301\nluteum cyst 1369\n\n## Corrected\n\nbiparietal diameter 1325\ntransposition 852\n\n## Corrosive",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 748,
            "markdown": "esophagitis 1087\ngastritis 1095\n\n# Cortical \n\nabrasion 76\narch, kidney 1184\narteriogram, kidney 1188\nbone\nlesion 8\nresorption 129\nbuckling, brain 378\ncontusion 346\ndefect, benign 69\ndesmoid 76\nhamartoma, CNS 404\nhyperostosis, generalized 128\ninfarction, bone 64\nlaminar necrosis 372\nnecrosis, kidney 1194\nnephrocalcinosis 1170\nnephrogram 1188\nrenal cysts 1251\nsyndromes 1164\nrim sign, renal infarct 1253\n\n## Cortico\n\nsteroids, MSK 90\ntrophic adenoma 394\ntrophinoma 961\nCosmetic breast surgery 727\nCostal osteoma 206\nCosto\nchondral junction, bulbous enlargement 19\nchondritis 606\nclavicular maneuver 850\nCotton wool skull 178\nCough fracture 110\nCoup 346\nCourvoisier phenomenon 872\nCowden disease 1068\nCowley syndrome 1147\nCowper gland\nanatomy 1192\nlesions 1180\nCoxa\nmagna 67\nplana 66",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 749,
            "markdown": "# vara 99 \n\n## Coxitis fugax 208\n\n## CPPD arthritis, hand 16\n\n## Cracked walnut appearance, Alzheimer disease 328\n\n## Cranial\n\nbruit 406\ngranulomatous arteritis 848\nmeningocele 338\nnerves 316\nnuclei 312\n\n## Cranio\n\ncervical\narterial dissection 483\ndissociation 252\nfacial\ndisjunction 255\nfibrous dysplasia 100\nplexiform neurofibroma 387\nsyndromes 216\nsynostosis 76\nlacunia 265\npagus 1346\npharyngioma 346\nschisis 339\nstenosis 214\nsynostosis 214\ntabes 190\nvertebral\nangle 235\njunction\nanatomy 235\nanomaly 219\n\n## Cranium bifidum 339\n\n## Crazy-paving pattern 533\n\nCreeping fat 1070\nCrepitus 158\nCrescendo TIA 284\nCrescent\n-in-doughnut sign 1108\nline, hip 66\nsign\nabdominal aorta 786\nhip 65\nlung 923\nCREST 1133",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 750,
            "markdown": "Cretinism 132\nCreutzfeldt-Jakob disease 347\nCricopharyngeal achalasia 1068\nCricopharyngeus muscle 1033\nCri-du-chat syndrome 76\nCHD 736\nCrista\nsupraventricularis, heart 762, 764\nterminalis, heart 766\nCritical dose, table 1393\nCrocidolite 578\nCrohn\ncolitis 1070\ndisease 1068\nCronkhite-Canada syndrome 1071\nCrossed renal ectopia 1157\nCross section\nacetabular roof 44\nbronchovascular anatomy 566\ndistal thigh 45\ngreater trochanter 44\nmid thigh 45\nminor trochanter 45\nobturator foramen 45\nproximal\nankle 46\ncalf 45\nthigh 45\nCroup 482\nCrouzon syndrome 76\nCrowded dentition 57\nCrowe sign 389\nCrow-foot sign\ngallstone 912\nlung 580\nCrown-rump length 1324\nCrucial angle of Gissane 114\nCruciate ligament\nanatomy + function 48\ninjury 76\nCruveilhier-von Baumgarten syndrome 976\nCrux, heart 767\nCryoglobulinemic vasculitis 757\nCrypto\ncoccosis 606",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 751,
            "markdown": "brain 347\npneumonia in AIDS 574\ngenic organizing pneumonia 625\nsporidiosis, in AIDS 1044\nsporidium antritis 1044\nstroma corticale 615\nCryptorchidism 1217\nCrypts of LieberkÃ¼hn 1058\nCSF\nfistula 248\nleak study, NUC 1402\nseeding of intracranial neoplasms 267\nC sign, talar dome 205\nCT\nangiogram sign, lung 523\nhalo sign\naspergillosis 581\nlung hemorrhage 536\nCubitus valgus 211\nCul-de-sac, free fluid 1312\nCullen sign 966\nCumbo sign 923\nCumulus oophorus 1334\nCupid's bow vertebra 224\nCupola sign 993\nCurled diaphragm sign 610\nCurling\nesophagus 1003\nulcer 1093\nCurrant jelly stools\nintussusception 1108\nmidgut volvulus 1127\nCurrarino\n-Silverman syndrome 17\ntriad 248, 263\nCushing\ndisease 394, 1205\nsyndrome 1205\nulcer 1093\nCutaneous leukocytoclastic angiitis 757\nCuticular overgrowth 80\nCutoff sign, colon 1019\nCuvier's duct 836\nCyanide poisoning 302\nCyanosis",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 752,
            "markdown": "decreased pulmonary blood flow 740\nincreased pulmonary blood flow 739\nCyanotic heart disease 739\nCyclophosphamide 514\nCyclopia 365\nCyclosporine nephrotoxicity 1255\nCylindrical bronchiectasis 589\nCylindroma\nlung 588\nparotis 474\nCyst\nabdominal, in childhood 997\nadrenal 1195\nallantoic 1299\namniotic inclusion 1299\narachnoid 331\naryepiglottic 444\natypical\nrenal 1251\nsecond branchial cleft 476\nBaker 202\nbranchial cleft 475\nbreast 718\nbronchogenic 595\nneck 447\ncervical thymic 447\nchocolate 1354\ncholedochal 910\ncholesterol 481\nchoroid plexus 343\nCNS lesions\nhead ultrasound 294\nCNS, with a nodule 294\ncolloid, brain 344\ncomplicated renal 1251\nconnatal, brain 294\ncorpus luteum 1369\ndecidual 1349\ndentigerous 219\ndermoid\nCNS 345\nneck 482\norbit 421\novary 1347\nduplication 1076",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 753,
            "markdown": "ejaculatory duct 1207\nendometrium 1318\nenteric 1079\nependymal 354\nepidermoid\nCNS 345\near 480\ninclusion, bone 93\nneck 482\nspleen 925\ntestis 1273\nepididymis 1179\nfallopian tube 1376\nfollicular, jaw 219\nforegut 552\nGartner duct 1358\ngastric duplication 1078\ngastrointestinal duplication 1076\nglioependymal 386\nhigh-density renal 1252\nhydatid, mediastinum 552\nimplantation 93\ninclusion in spine 263\ninterhemispheric 327\nintracranial nonneoplastic 294\nintraosseous keratin 93\njaw 218\nleptomeningeal 264\n-like pulmonary lesions 545\nliver 937\nlung 544\nmediastinum 552\nmeningeal 265\nmeniscal 147\nmesentery 1027, 1126\nmesothelial 1126\nmidline of brain 294\nmucus retention 440\nmultiple\npulmonary 544\ntiny in CNS 294\nNabothian 1365\nneurenteric 268\nneuroepithelial 386\nneuroglial 386",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 754,
            "markdown": "non-neoplastic brain 294\noil, breast 720\nomentum 1027, 1126\nomphalomesenteric 1366\norbit 413\novary 1368\npancreas 879\ntrue congenital 920\nparaovarian 1373\nparapelvic 1252\nparathyroid 447\nperiapical 218\nperiarticular 15\npericaliceal 1239\npericardial 835\nperineural sacral 266\nperipelvic 1252\nperitoneal inclusion 1131\npineal 393\nplacental 1298\npopliteal 202\nposterior fossa 305\nposttraumatic spinal cord 280\nprostate 1179\npulmonary 544\npyelogenic 1239\nradicular 218\nRathke cleft 397\nreactive, cord 280\nrenal\ncystic disease 1164\nsinus 1252\nsella 306\nseminal vesicle 1268\nsimple 200\ncortical renal 1251\nsolitary bone 200\nsubchondral 15\nsubependymal 401\nsynovial 15,202\ntailgut 1142\nTarlov 266\nteratoid, neck 482\ntestis 1178\ntheca lutein 1369",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 755,
            "markdown": "thoracic duct 676\nThornwaldt 510\nthymic 676\nthyroglossal duct 506\ntraumatic lung 587\nunicameral 200\nurachal 1282\nutricle 1289\nvagina 1319\nwithin a cyst, CNS 339\nCystadenocarcinoma\nbiliary 899\nmucinous, ovary 1365\nserous, ovary 1381\nCystadenofibroma, ovary 1381\nCystadenoma\nbile duct 899\nlymphomatosum 511\nmucinous, ovary 1365\nparaovarian 1374\nserous, ovary 1380\n\n# Cystic \n\nabdominal mass, fetus 1308\nadenoma, kidney 1223\nadenomatoid malformation 603\nadnexal mass 1313\nadrenal mass 1156\nairspaces, HRCT 529\nangiomatosis, bone 61\nareas in thyroid 451\nbrain metastases 381\nbreast disease 722\nbronchiectasis 589\nchest mass, fetus 1306\ndegeneration, BPH 1202\ndilatation, extrahepatic bile duct 910\nduct\nremnant, stone 914\nvariants of insertion 890\nfibrosis 606\nhygroma\nneck 492\norbit 425\nintracranial lesion, fetus 1304\nkidney disease, acquired 1193",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 756,
            "markdown": "liver\nlesion 864\nmetastases 954\nlymphangioma, neck 492\nmass in cerebellum 305\nmeningioma 378\nmesothelioma 1131\nnephroma 1223\npartially differentiated nephroblastoma 1223\npelvic masses 1312\nperiventricular leukomalacia 386\npneumatosis 1008\nrenal cell carcinoma 1250\nretroperitoneal mass 1152\nrheumatoid arthritis 189\nschwannoma 271\nsplenic\nlesions 881\nneoplasm 881\nteratoma, ovary 1347\ntuberculosis 210\nCysticercosis, CNS 347\nCystinuria 1287\nCystitis 1206\nAIDS 1193\nbullous 1206\ncystica 1206\nemphysematous 1206\neosinophilic 1207\ngranulomatous 1207\nhemorrhagic 1207\ninterstitial 1207\ntuberculous 1207\nCystlike soft-tissue lesions on MRI 27\nCysto\ngram, radionuclide 1419,1420\npathy, diabetic 1210\nsarcoma phyllodes 731\nCystosis, pancreatic 608\nCysts and bursae\nankle and foot 53\nelbow 42\nhip 43\nknee 50\nshoulder 41",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 757,
            "markdown": "Cytokines, pulmonary edema 517\nCytomegalic inclusion disease 286\nCytomegalovirus\nin AIDS 575\ncolitis 1044\nencephalitis 348\nesophagitis 1089\nGI infection in AIDS 1043\nCytotoxic edema 293\nCytotrophoblast 1358",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 758,
            "markdown": "Dacryo\nadenitis 420\ncystitis 420\ncystocele 420\nDactylitis 21\ntuberculous 210\nDactylolysis spontanea 60\nDagger sign, spine 242\nDalkon shield 1362\nDampening, hepatic vein Doppler 869\nDancers bone 157\nDandy-Walker\ncontinuum 350\nmalformation 349\nvariant 350\nDanger space 640\nDangling choroid plexus\nhydrocephalus 367\nmyelomeningocele 268\nDashboard injury 25\nDawson fingers 383\nDeBakey classification 790\nDecidua 1320\nDecidual\ncast 1349\ncyst 1349\nDecision matrix 1427\nDecompensated lymphangiectasia 1262\nDecompression sickness 70\nDecreased\npulmonary\nblood flow + cyanosis 740\nvascularity 749\nradiotracer uptake, thyroid 452\nvital capacity 569\nDeep\ncerebral venous thrombosis 342\nfemoral vein 778\nfibromatoses 77\npalmar arch 777\nsulcus sign 545, 546",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 759,
            "markdown": "vein thrombosis 811\nvenous system of lower extremity 777\nDefecography 1129\nDefects in porta hepatis 868\nDeferoxamine 90\nDeformity of globe contour 414\nDe Garengeot hernia 1101\nDegenerative\naortic aneurysm 786\ndisease\ncerebrum 286\ndisk 248\njoint 162\nspondylolisthesis 278\nDehiscent jugular bulb 304\nDelayed\nbone age 1\nnephrogram, unilateral 1165\npassage of gas, neonate 998\nsmall bowel transit 1017\nuptake of water-soluble contrast in cord lesion 231\nDelta\nOD 4501357\nsign, CNS 341\nDementia 284\nfrontotemporal 393\nLewy bodies 350\nPET 285\nDemerol 1437\nDemineralization\ntemporal bone 440\nDemise of\nembryo 1352\nfetus 1357\nDeMorsier syndrome 398\nDemyelinating disease 286\nDemyelination, osmotic 338\nDendritic enhancing breast lesion 693\nDens\naplasia 258\nfractures 258\nhypoplasia 258\nDense\ncerebral mass 296\nenhancing brain lesion 299",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 760,
            "markdown": "lesion near foramen of Monro 300\nlung lesion 539\nmetaphyseal bands 3\nmiddle cerebral artery sign 370\nribs 19\ntriangle sign 341\nvitreous in pediatric age group 415\nDensitometry 4\nDentate ligament 238\nDentigerous cyst 219\nDentition 241\nDenver shunt 1418\nDepressed skull fracture 254\nDepression of\nleft main-stem bronchus 853\nrenal margins 1160\nDeQuervain thyroiditis 509\nDermal\ncalcifications, breast 688\ncontrast reaction Endpaper A\nlesions of breast 690\nsinus, dorsum 253\nDermato\nfibrosarcoma protuberans 79, 732\nmyositis 80\npathic lymphadenopathy 719\nDermatomes 239\nDermoid\nCNS 345\ncyst\nneck 482\norbit 421\novary 1347\nhead and neck 482\nmediastinum 675\nnose 482\novary 1347\nplug 1347\nspine 263\nDescending necrotizing mediastinitis 639\nDesert rheumatism 75\nDES exposure 1348\nDesmofibromatosis 79\nDesmoid\nabdominal 1123",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 761,
            "markdown": "wall 77\ntumor\nbreast 719\nMSK 77\n-type fibromatosis 78\n\n# Desmoplastic \n\nfibroma 80\ninfantile ganglioglioma 356\nsmall round cell tumor 1072\n\n## Desquamated\n\nepithelial hyperplasia, breast 722\n\n## Desquamative\n\nfibrosing alveolitis 627\ninterstitial pneumonia 627\n\n## Destruction of\n\nmedial end of clavicle 19\ntemporomandibular joint 217\n\n## Destructive\n\nmonoarthritis 14\nspondyloarthropathy 1149\n\n## Deterministic effects of radiation 1335\n\nDeToni-DebrÃ©-Fanconi syndrome 190\n\n## Detrusor\n\nareflexia 1174\ninstability 1175\n-sphincter dyssynergia 1175\n\n## Developmental\n\ndysplasia of hip 81\nmediastinal cyst 552\nrenal anomalies 1157\nvascular malformation 758\nvenous anomaly, brain 351\n\n## DEXA scan 4\n\n## Dextrocardia 739\n\n## Diabetes\n\nfoot ulcer 83\ninsipidus 1150\nnephrogenic 1150\nmellitus 83\n\n## Diabetic\n\ncystopathy 1210\nfoot 83\nmastopathy 720\nmuscle disorders 84\nnephropathy 1210",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 762,
            "markdown": "Diagnostic amniocentesis 1326\nDialysis-associated\ndisorders 187\nspondyloarthropathy 277\nDiamond sign 1105\nDiaphragm\naccessory 605\nanatomy 572\nantral mucosal 1049\ndisease 1072\nembryology 572\nvariants 573\nDiaphragmatic\nelevation 559\nhernia 608\ninjury 609\nparalysis 560,610\nrupture 609\nslip 573\ntumor in children 560\nDiaphyseal\naclasis 166\ndysplasia 182\nlesion 8\nuptake, long segmental 2\nDiastasis period, heart 838\nDiastatic lambdoid suture 350\nDiastematomyelia 251\nDiastrophic dysplasia 85\nDiazepam 1437\nDicephalus 1346\nDichorionic diamniotic twin 1327\nDiencephalic syndrome 336\nDiencephalon 311\nDietary rickets 191\nDiethylstilbestrol 1388\nexposure 1348\nDietl crisis 1284\nDieulafoy\ndisease 513\nlesion 988\nDifferential\ndensity sign, heart 747\nlinearity, scintillation camera 1395\nrenal function 1160",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 763,
            "markdown": "uniformity, scintillation camera 1395\n\n# Diffuse \n\nairspace disease 522\nalveolar damage 623\naxonal injury 351\ncoarctation of aorta 809\nemphysema 612\nenlargement of pancreas 878\nesophageal\ndilatation 1003\nspasm 1072\nfat deposition, liver 927\nfine\nnodular lung disease 528\nreticulations, lung 526\ngallbladder wall thickening 872\ngiant cell tumor 180\ngoiter 486\nhepatic enlargement 861\nidiopathic skeletal hyperostosis 85\nincrease in breast density 683\nintraarticular PVNS 180\nlarge B-cell lymphoma 1116\nleiomyomatosis 1389\nliver disease 861\nlung disease, HRCT 528\nlymphangioma 603\nlymphangiomatosis 611\nmalignant mesothelioma 641\nmyelinoclastic sclerosis 351\nnecrotizing leukoencephalopathy 382\nneurofibroma 272\nosteosclerosis 2\npanbronchiolitis 647\nparenchymal lung disease 525\nperitoneal calcifications 995\npleural thickening 579\npulmonary lymphangiomatosis 611\nsclerosis, CNS 351\nsynovial lipoma 141\nthymic enlargement 557\ntoxic goiter 487\nwhite matter injury 382\nDiffusing capacity 569\nDigastric line 236",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 764,
            "markdown": "DiGeorge syndrome 736\nDigital\ninfantile fibromatosis 201\nmarkings, skull 265\nDigit, lucent lesion 20\nDiktyoma 426\nDilated\nbowel, fetus 1308\ncardiomyopathy 805\ncervix 1297\nduodenum 1013\npulmonary\nartery, idiopathic 820\ntrunk 749\nrete testis 1178\nsmall bowel + normal folds 1015\nsuperior ophthalmic vein 412\nureter 1171\nDiphenhydramine 1437\nDiphosphonates 1421\nDiplococcus pneumoniae 648\nDiploÃ« 233\nDiprosopus 1346\nDipygus 1346\nDipyridamole 1414\nDirty chest 520\nDisaccharidase deficiency 1072\nDiscoid\natelectasis 540\nchest mass 602\nmeniscus 50\nDisconnected pancreatic duct syndrome 970\nDiscordant\ndates 1324\ngrowth, twins 1328\nthyroid nodule 452\nDiscriminatory zone, beta-hCG 1348\nDisease prevalence 1427\nDisk\nballooning 224, 242\nbulge 250\ncalcification 229\ndegenerative 248\ndiskogram classification 249\nextrusion 250",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 765,
            "markdown": "herniation\ncervical spine 251\nlocation descriptor 250\nlumbar spine 251\nkidney 1158\nloss of height 228\nossification 229\nprotrusion 250\nsequestration 251\nvacuum phenomenon 228\n\n# Diskitis 251 \n\n## Disko\n\ngram classification 249\nvertebral\njunction 237\nunit 277\n\n## Dislocation 85\n\natlanto-occipital 252\nbiceps tendon 88\ncervical spine 252\nelbow 107\nhip 85\nlateral patellar 25\nlens 427\npatella 86\nshoulder 86\nsternoclavicular 86\ntestis 1275\ntransscaphoid perilunate 88\nwrist 88\n\n## Displacement of\n\ngallbladder 872\nvessels, brain 291\n\n## Dissecting aneurysm 483\n\n## Dissection\n\naorta 789\ncarotid artery 484\ncervicocephalic arteries 483\ncraniocervical arteries 483\nesophagus 1085\nvertebral artery 484\n\n## Disseminated\n\nCastleman disease 600\nhistoplasmosis 619\nlipogranulomatosis 96",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 766,
            "markdown": "# Disse space 1047 \n\n## Dissociation, atlanto-occipital 252\n\n## Distal\n\nacinar emphysema 612\nintestinal obstruction syndrome 1072\nrenal tubular acidosis 1257\nshift 291\n\n## Distraction, atlantoaxial 253\n\n## Diuretic renal scintigraphy 1420\n\n## Diverticular\n\ndisease, colon 1073\nprostatitis 1237\n\n## Diverticulitis\n\nappendix 1074\ncecum 1074\ncolon 1074\nright colon 1074\n\n## Diverticulosis\n\ncolon 1073\nileum 1105\nintramural, esophagus 1087\njejunum 1111\ntrachea 679\n\n## Diverticulum\n\narachnoid 244\ncaliceal 1239\ncolon 1073\ncommon bile duct 912\nduodenum 1075\nepiphrenic 1005\nesophagus 1005\ngallbladder 889\ngiant sigmoid 1073\nHutch 1203\ninteraorticobronchial 1005\ninterbronchial 1005\nintraluminal duodenal 1075\njejunum 1111\nKommerell 825\nMeckel 1120\nparaureteral 1203\npharyngoesophageal 1147\npulsion 1005\npyelocaliceal 1239\nroofless 4th ventricle 350",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 767,
            "markdown": "small bowel 1014\nstomach 1092\ntraction 1005\nurachus 1282\nurethra 1285\nurinary bladder 1203\nZenker 1147\nDiving ranula 501\nDizygotic twins 1328\nDodd vein 778\nDoge's cap sign 993\nDolichocephaly 214\nDominant follicle 1368\nDonor twin 1385\nDopamine 1437\nDoppler\nkidneys 1166\novary 1334\nDorello canal 315\nDorsal\nanlage, pancreas 891\ndermal sinus 253\nenteric\ncyst 278\ndiverticulum 278\nenterogenous cyst 278\nfistula 278\nsinus 278\nmeningocele 268\ntalar beak 205\nDose\ncalibrator 1394\nfor children, NUC 1393\n\n# Double \n\naortic arch 813\nappendix 1078\narch sign, lung 923\narc shadow, gallbladder 913\nbarrel\naorta 791\nesophagus 1005, 1085\nbubble sign 1308\nbulb appearance 1049\nchannels, liver 874\ndecidual sac 1320",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 768,
            "markdown": "density\nheart 829\nsign, bone scan 169\nduct sign\nampullary tumor 896\nbile ducts 877\npancreatic carcinoma 959\nexposed ribs 133\ngallbladder 889\nhalo\nconfiguration 1069\nsign 1023\n-inlet single ventricle 845\nIVC 756\nline sign, hip\navascular necrosis, hip 65\nLegg-CalvÃ©-Perthes 67\n-outlet right ventricle 813\nPCL sign 25, 149\nstripe sign, NUC 131\ntarget sign\nliver CT 934\nliver MRI 933\ntracking, colon 1020\ntrack sign, pylorus 1105\nvessel sign 819\n\n# Doughnut sign \n\naneurysmal bone cyst 61\nbone lesion 2\ngiant cell tumor 118\nhip 64\nintestines 1108\ntelangiectatic osteosarcoma 177\ntestis 1270\nDownhill varices 1086\nDown syndrome 89\nCHD 736\nDracunculiasis 996\nDrash syndrome\nnephroblastomatosis 1225\nWilms tumor 1291\nDrawer sign, anterior 76\nDressler syndrome 832\nDripping candle wax 146\nDromedary hump 1163",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 769,
            "markdown": "# Drooping \n\nlily sign, kidney\nneuroblastoma 1227\nureteral duplication 1283\nshoulder 88\n\n## Drop\n\nattack 284\nmetastases from CNS tumors 267\n\n## Drowned\n\nlung 611\nnewborn syndrome 664\n\n## Drowning 644\n\n## Drug\n\nabuse 843\n-induced\nesophagitis 1087\ngastropathy 1095\nlupus erythematosus 673\nmusculoskeletal\nanomalies 90\nembryopathy 1303\npulmonary damage 514\nnephrotoxicity, renal transplant 1255\n\n## Drum\n\nspur 465\nstick phalanges 211\n\n## Drummond artery 1031\n\nDrusen 428\nDry drowning 644\nD-transposition 851\nDual photon absorptiometry 4\nDuct\ncell adenocarcinoma, pancreas 958\nectasia, breast 720\n-penetrating sign 972\n\n## Ductal\n\nadenocarcinoma, pancreas 958\ncarcinoma in situ, breast 710\nmicrocalcifications, breast 687\nplate, bile ducts 889\nDuctectatic mucinous tumor of pancreas 947\nDuct of\nBellini 1242\nCuvier 836\nLuschka 890",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 770,
            "markdown": "Santorini 893\nWirsÃ¼ng 892\nDuctography 689\nDuctus\narteriosus\naneurysm 813\ncalcified 835\npatent 834\nphysiology 776\ndiverticulum 776\nDuhamel operation 1104\nDumbbell\nlesion, spine 223\nmass, petrous apex 440\nneurofibroma 387\nDumping syndrome 1075\nDunbar syndrome 828\nDuodenal\nadenocarcinoma 1043\nhematoma 1076\ninjury\nscoring 1053\nweb 1076\nDuodenum\natresia 1075\nbenign tumors 1013\ncancer 1013\ncarcinoid 1060\nchronic ileus 846\ndilated 1013\ndiverticulum 1075\nduplication cyst 1078\nextrinsic pressure effect 1012\nfilling defect 1012\nintraluminal diverticulum 1075\ninversum 1035\nmalignant tumors 1013\nmobile 1035\nnarrowing 1013\nobstruction 999\nsegments 1035\nthickened folds 1012\nulcer 1076\nvarices 1076\nwater-trap 1035",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 771,
            "markdown": "widened sweep 1012\n\n# Duplex ultrasound \n\ncarotid artery 477\ncarotid artery identification 320\nerrors 479\n\n## Duplication\n\ncolon 1078\ncyst 1076\ncolon 1078\nduodenum 1078\nesophagus 1077\nrectum 1078\nsmall bowel 1078\nstomach 1078\ndiaphragm 605\nforegut 1077\ngallbladder 889\nhindgut 1078\nIVC 756\nrenal 1282\nthoracoabdominal 1077\nureter 1282\n\n## Dupuytren\n\nexostosis 201\nfracture 114\n\n## Dura\n\nmater, brain 310\nspinal cord 237\n\n## Dural\n\narteriovenous fistula 333\ncalcifications 303\nectasia 223\nsinus thrombosis 340\ntail sign 304\nDuret hemorrhage 290, 360\nDutcher bodies 650\nDuverney fracture 111\n\n## Dwarfism\n\nacromelic 1301\nAmsterdam 75\ndiastrophic 85\nfetus 1300\nlate onset 1301\nlethal 1301\nmesomelic 149",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 772,
            "markdown": "metatrophic 152\nmicromelic 1301\nnonlethal 1301\nrhizomelic 1301\nDWI\nhyperintense lesions 288\nhypointense lesions 288\nin acute stroke 370\nstarfield pattern 288\nDyke-Davidoff-Mason syndrome 351\nDyschondroplasia 92\nDyschondrosteosis 91\nDysembryoplastic neuroepithelial tumor 352\nDysgenesis\ncorpus callosum 327\ngonadal 1181\nhindbrain 342\nrenal 1252\nDysgenetic multicystic kidney 1222\nDysgerminoma\nbrain 357\nmediastinum 675\novary 1372\nDyskeratosis, kidney 1215\nDyskinesis, heart 823\nDysmenorrhea 1389\nDysmorphism, lobar renal 1164\nDysmotile cilia syndrome 629\nDysmyelination, cerebrum 286\nDysostosis 1300\nDysphagia 997\nlusoria 754,825\nDysplasia\nbone\ndefinition 1\nlethal 1301\nbronchopulmonary 596\nchondroectodermal 72\ndiastrophic 85\nepiphysealis\nhemimelica 91\npunctata 72\nexternal auditory canal 484\nfibrous 98\nlymphatics 826",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 773,
            "markdown": "mesodermal 72\nmetaphyseal 150\nmetatropic 152\nmultiple epiphyseal 154\nneuroectodermal 286\nosteofibrous 167\notic capsule 495\nperiosteal 388\nprogressive diaphyseal 182\nsclerosing bone 2\nsepto-optic 398\nspondyloepiphyseal 201\nthanatophoric 206\nDysplastic\ncerebellar gangliocytoma 356\nkidney 1222\nnodule, liver 917\npulmonary valve 842\nDysraphism, spine 221\nDysrhythmia of heart, fetus 1356\nDystrophic soft-tissue calcification 29\nDystrophy\nbone 1\nSudeck 185\n\nE trisomy 208\nEagle-Barrett syndrome 1238\nEardrum 465\nEarly osteoarthritis 163\nEaton agent 644\nEbstein anomaly 813\nEccentric medullary bone lesion 8\nEchinococcosis\nbone 922\nliver 920\nlung 923\nEchinococcus\nalveolaris 923\ngranulosus 921\nlife cycle 921\nmultilocularis 923\nEchocardiogram",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 774,
            "markdown": "aortic root 764\nventricles 765\nEchocardiography, views in fetus 1307\nEchogenic\nbreast lesion 686\nfetal bowel 1308\nfocus, basal ganglia 303\nintracardiac focus 1307\nliver metastases 954\nEchogenicity\nkidney 1185\nliver, increased 862\nEchopenic liver metastases 954\nEclampsia 1348\nEclipse effect, lung 648\nEctasia\nbreast duct 720\nintrahepatic bile ducts 901\nEctocyst 921\nEctopia cordis, fetus 1348\nEctopic\nanus 1048\ncraniopharyngioma 346\ngallbladder 889\nkidney 1157\nmeningioma 378\nossification 179\npancreas 924\nparathormone production 130\nparathyroid adenoma 553\npregnancy 1348\ntestis 1218\nthymus 572\nureter 1207\ninfrasphincteric, female 1176\nureterocele 1283\nEctrodactyly 1302\nEdema\nbone marrow 7\nbrain 293\nbreast 683\nlung 515\nmesenteric 1027\nmuscle 31\norbit 424",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 775,
            "markdown": "ovary, massive 1365\nEdematous pancreatitis 969\nEdwards\naortic arch 755\nsyndrome 1385\nEffaced collecting system 1168\nEffort thrombosis 850\nEffusion\nknee joint 86\npericardial 747\npleural 546\nEgg\n-on-a-string, heart 851\n-shaped orbits 208\nEggshell calcification\nbreast 688\nlymph nodes 557\nEhlers-Danlos syndrome 91\nEisenmenger\ncomplex 814\ndefect 814\nreaction 814\nsyndrome 814\nin VSD 858\nEjaculatory duct cyst 1207\nEjection fraction\ncardiac scintigraphy 1408\ngallbladder 888\nEklund view 727\nElastofibroma dorsi 91\nElbow\nbone centers 41\ndislocation 107\nfracture 107\n-patella syndrome 158\nElephant ears, pelvis 89\nElephantiasis neuromatosa 390\nElevated\nalpha-fetoprotein 1294\ndiaphragm 559\nrenin 1151\nElfin facies, Williams syndrome 212\nEllis-van Creveld syndrome 72\nCHD 736\nEmbolic",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 776,
            "markdown": "infarction, brain 287\nlung disease 652\n\n# Embolism \n\namniotic fluid 577\nmercury 661\nparasitic 598\npulmonary 652\nseptic pulmonary 669\ntumor 661\n\n## Embryo\n\ndemise 1352\nsize 1324\nvisualization 1321\n\n## Embryology of\n\nairways 564\nalimentary tract 1031\naortic arches 762\nportal vein 885\nstapedial artery 465\nurogenital tract 1183\nvena cava 771\n\n## Embryonal\n\nadenoma, kidney 1221\ncarcinoma of ovary 1372\ncell carcinoma, testis 1272\nrhabdomyosarcoma of biliary tree 925\nsarcoma, liver 984\nteratoma, ovary 1372\n\n## Emergent gastric conditions 1007\n\nEMG syndrome 1342\nEmissary vein, skull 215\nEmperipolesis 191, 398\nEmphysema 611\ncentriacinar 611\ncentrilobular 611\ncongenital lobar 603\ngeneralized 612\ninterstitial 651\npanacinar 612\npanlobular 612\n\n## Emphysematous\n\ncholecystitis 910\ncystitis 1206\ngastritis 1095\npyelitis 1240",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 777,
            "markdown": "pyelonephritis 1241\nEmpty\ndelta sign 341\ngestational sac 1297\nsella syndrome 352\ntriangle sign, brain 341\nEmpyema\nchest 612\nCNS 352\ngallbladder 909\nnecessitatis 547\nEnalaprilat 1419\nEncapsulated fat necrosis 1078\nEncapsulating peritoneal sclerosis 1138\nEncephalitis 352\namebic 352\nEncephalo\ncele 338\nclastic porencephaly 395\nmalacia 395\nneonate 386\nmyelopathy, subacute necrotizing 374\npathia subcorticalis progressiva 337\npathy, hypertensive 287\ntrigeminal angiomatosis 399\nEnchondroma 92\nEnchondromatosis 92\nEncoche of Ranvier 165\nEndemic Burkitt lymphoma 1057\nEndobronchial\nlipoma 613\nmetastasis 643\ntuberculosis 680\ntumor 558\nEndocardial\ncushion\ndefect 814\nVSD 858\nfibroelastosis 815\nEndocarditis, bacterial 798\nEndocervical polyp 1353\nEndochondral ossification 3\nEndocrine exophthalmos 421\nEndocyst 921\nEndodermal sinus tumor",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 778,
            "markdown": "ovary 1373\ntestis 1273\nEndogenous lipid pneumonia 649\nEndoleak 788\nEndolymphatic sac tumor 497\nEndometrial\nhyperplasia 1317\npolyp 1316, 1318\nEndometrioid carcinoma, ovary 1353\nEndometrioma 1354\nEndometriosis\nexterna 1353\nGI-tract 1022\ninterna 1340\nureter 1171\nEndometritis 1375\nEndometrium\nanatomy 1330\ncancer 1352\ncysts 1318\nfluid in canal 1318\nfocally thickened 1318\nislands 1340\npostpartum 1331\nthickened irregular 1317\nEndophthalmitis 421\ninfectious 421\nsclerosing 421\nEndosteal hyperostosis 128\nEndosteoma 69\nEndovascular stent-graft, complications 788\nEnd-stage lung disease 527\nEnergy resolution, intrinsic 1396\nEngelmann-Camurati disease 182\nEnhancement\nkinetics, breast MRI 692\nleptomeningeal 298\nnormal breast 699\npachymeningeal 297\npatterns\nbrain MRI 297\nbreast MRI 692\nEnhancing\nbrain\nlesion 297",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 779,
            "markdown": "mass with supra- and intrasellar component 308\nventricular margins 299\nEnlarged vestibular aqueduct syndrome 495\nEnlargement of\naorta 753\naortic root 753\nazygos vein 557\nbronchial artery 557\nepididymis 1179\nepiglottis 444\nextraocular muscles 413\ngallbladder 872\niliopsoas compartment 1160\nlacrimal gland 415\nleft\natrium 742\nventricle 742\nlymph nodes in neck 448\npapilla of Vater 1013\nparotid gland 448\nperivascular spaces 354\npresacral space 1022\npulmonary artery 749\nright\natrium 742\nventricle 742\nsella 306\nuterus 1318\nvertebral\nbody 223\nforamen 223\nEnostosis 69\nEntamoeba histolytica 1045\nEntanglement of cord 1298\nEnteric\ncyst 1079\nhyperoxaluria 1287\nEnteritis\nradiation 1136\nregional 1068\nEnterocele 1130\nEnteroclysis categories 1000\nEnterocolitis\ninfectious 1079\ninflammatory 1079",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 780,
            "markdown": "necrotizing 1079\nYersinia 1020\n\n# Enterolith 995 \n\nEnteropathy 990\n-associated T-cell lymphoma 1117\nprotein-losing 990\nEnthesis 13\nEnthesopathy 13\nEntrapped ovarian cyst 1131\nEnuresis 1176\nEnzymatic liver tests 887\nEosinophilia-myalgia syndrome 613\nEosinophilic\ncholangiopathy 925\ncystitis 1207\ndiseases + cardiac involvement 757\ngastroenteropathy 1081\ngranuloma\nbone 137\nGI tract 1106\ngranulomatosis with polyangiitis 808\nheart disease 815\npneumonia 613\nacute 614\nchronic 614\nEpendymal cyst 354\nEpendymitis 406\ngranularis 407\nEpendymoma\nbrain 354\ncord 261\nEpicardial fat-pad 555\nEpicardium 774\nEpicondylar fracture, humerus 107\nEpidemiology 1429\nbreast cancer 704\nEpidermal inclusion cyst\nbone 93\nbreast 720\nvagina 1319\nEpidermoid\ncarcinoma\nbone 172\nlung 594\nCNS 345",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 781,
            "markdown": "cyst\near 480\nneck 482, 483\nskin 93\nspleen 925\ntestis 1273\nhead and neck 482\ninclusion cyst\norbit 421\nmediastinum 675\nspine 264\nEpidermolysis bullosa dystrophica 1004\nEpididymis 1190\ncystic lesions 1179\nenlargement with hypoechoic foci 1179\nEpididymitis 1207\nEpididymoorchitis 1208\nEpidural\nabscess 253\ncontrast injection 231\nempyema 352\nextramedullary lesion 230\nfibrosis 214\nhematoma\nbrain 354\nspine 254\nlipoma 265\nlymphoma 376\nmetastasis 266\nspace\nbrain 310\nspine 237\nEpigastric-paraumbilical venous system 886\nEpiglottic\ncarcinoma 489\nenlargement 444\nEpiglottis 459\nEpiglottitis 484\nEpignathus 506\nEpilepsy, PET 1401\nEpinephrine 1436\nEpipericardial fat necrosis 838\nEpipericarditis 838\nEpiphrenic\nbulge 1103",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 782,
            "markdown": "diverticulum 1005\n\n# Epiphyseal \n\nbone centers, appearance 1325\ndysostosis 85\ndysplasia, multiple 154\nlesion 13\novergrowth 13\nplate injury 105\nEpiphyseolysis 13\nfemoral head 93\nidiopathic 14\njuvenile 14\nEpiphysis\nballoon 189\ncerebri 315\ncongenital stippled 72\nring 224\nslipped 13\nstippled 13\nEpiphysitis, vertebra 275\nEpiploia 404\nEpiploic appendagitis 1081\nEpisodic spells 849\nEpispadia 1180\n-exstrophy complex 1203\nEpistenocardiac pericarditis 837\nEpithelial\ncyst, spleen 925\ninclusion cyst 1319\novarian cancer 1314\npolyp, colon 1042\nEpithelioid\nhemangioendothelioma, bone 122\nhemangioendothelioma, liver 925\nsarcoma 94\ntumor, GI 1096\nEpitympanum 465\nEpoÃ¶phoron 1374\nEpstein-Barr virus 1057\nEquator sign, hip 83\nEquilibrium\nimages, ventricular function 1410\nphase, V/Q scan 1405\nEquinus 25\nErb-Duchenne paresis 245",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 783,
            "markdown": "Erdheim-Chester disease 614\nErectile dysfunction 1208\nErlenmeyer flask deformity 12\nErosion, DIP joints 16\nErosive\ngastritis 1096\nosteoarthritis 163\nhand 16\nErythema migrans 962\nErythrogenic hemochromatosis 933\nEscobar syndrome 1305\nEsophageal\ncancer 1082\nleiomyomatosis 1113\nlung 598\ntrauma 1085\nEsophagitis 1087\nAIDS-related 1045\nCandida 1087\neosinophilic 1080\npill-induced 1087\nEsophagorespiratory fistula 1005\nEsophagram\nair 1004\nradionuclide 1418\nEsophagus\nabnormal\nfolds 1004\nperistalsis 1003\ncancer 1082\ncongenital atresia 1066\ncongenitally short 1103\ncontractions 1002\ndiffuse dilatation 1003\ndiverticulum 1005\ndouble-barrel 1005\nduplication cyst 1077\nextrinsic impression 1006\nfilling defect 1006\ninflammation 1004\nintramural\ndissection 1085\npseudodiverticulosis 1085\nrupture 1085\nleiomyoma 1112",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 784,
            "markdown": "long smooth narrowing 1005\nmucosal nodules 1006\nmuscular rings 1033\nperforation 1085\nplaques 1006\nring 1005\nrupture 1085\nstricture 1005\nulcer 1004\nvarices 1086\nvestibule 1033\nweb 1086\n\n# Essential \n\ncryoglobulinemic vasculitis 757\nidiopathic thrombocytopenia 7\nosteolysis 94\nEssex-Lopresti fracture 108\nEssure ${ }^{\\circledR}$ Device 1362\nEsthesio\nneuroblastoma 495\nneurocytoma 495\nneuroepithelioma 495\nEstimated fetal weight 1325\nEstrogen effect on pelvis 1310\nÃtat\ncriblÃ© 354\nlacunaire 372\nEthmocephaly 365\nEthmoid\nbulla 454\nsinus carcinoma 499\nsinuses 454\nEthylene hydroxydiphosphonate 1421\nEunuchoid constitution 134\nEuropean blastomycosis 606\nEustachian valve 766\nEvacuation proctography 1129\nEventration of diaphragm 609\nEwing sarcoma\nbone 94\nextraskeletal, 95\nfamily of tumors 95\nrib 561\nExametazime oxime 1423\nExcrescentic thickening, optic nerve 415",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 785,
            "markdown": "Excretory urography, contrast material 1432\nExencephaly 326\nExophthalmos\nendocrine 421\npulsating\ncarotid-cavernous sinus fistula 332\nneurofibromatosis 389\nExostosis 165\nmultiple hereditary 166\nsubungual 201\nExostotic chondrosarcoma 74\nExpansile lesion\nrib 18\nunilocular well-demarcated bone defect 11\nvertebra 225\nExpiratory volume, forced 569\nExstrophy\ncloacal 1345\nurinary bladder 1203\nExtensor\ncompartments, wrist 43\nmuscles, knee 48\nExternal\nauditory canal\natresia 482\ncholesteatoma 481\ndysplasia 484\nbrain tamponade 309\ncarotid artery 319\near mass 438\nfixation devices 34\nhernia 1100\nherniation, brain 290\nhydrocephalus 337\notitis, malignant 493\nExtraabdominal desmoid tumor 78\nExtraadrenal pheochromocytoma 1263\nExtraarachnoid myelography 231\nExtraaxial\nCNS lesions 304\nlow-attenuation lesion 304\ntumor 304\nExtracapsular rupture, breast implant 728\nExtracardiac rhabdomyoma 485\nExtracerebral hemorrhage, trauma 361",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 786,
            "markdown": "# Extraconal lesion 412 \n\n## Extracranial herniation 309\n\n## Extradural\n\nhematoma, brain 354\nlesions of spine 230\nExtraforaminal disk herniation 250\nExtragonadal germ cell tumor 1208\n\n## Extrahepatic\n\ncholangiocarcinoma 902\nportosystemic shunt 870, 978\nExtralobar sequestration 598\n\n## Extramedullary\n\nhematopoiesis 95\nplasmacytoma 485\n\n## Extranodal\n\nHodgkin disease 621\nmarginal zone B-Cell lymphoma 1117\nExtraocular muscle enlargement 413\nExtraosseous plasmacytoma 485\n\n## Extraperitoneal\n\nrupture of bladder 1278\nspaces 892\nExtrapleural solitary fibrous tumor 671\n\n## Extrarenal\n\naneurysm 1244\npelvis 1186\n\n## Extraskeletal\n\nchondroma 200\nchondrosarcoma 74\nEwing sarcoma, 95\nfibrosarcoma 486\nmesenchymal chondrosarcoma 74\nosseous + cartilaginous tumors 28\nosteosarcoma 174\nExtratesticular fluid collection 1178\nExtrauterine pelvic masses 1313\n\n## Extravasation\n\ncontrast material 1433\nurinary spontaneous 1167\nExtravascular leiomyosarcoma 1261\nExtraventricular hydrocephalus 366\nExtravesical infrasphincteric ectopic ureter 1176\n\n## Extrinsic\n\nallergic alveolitis 615\nasthma 584",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 787,
            "markdown": "esophageal impression 1006\nfield uniformity test 1395\npressure effect on duodenum 1012\nExtrusion, disk 250\nExuberant callus 13\nExudate 547\nExudative tuberculosis 681\nEye-of-the-tiger sign 359\n\nFabry disease 741\nFaceless kidney sign 1158\nFacet lock 257\nFacial\nangiofibroma 405\nbuttresses 455\nclefting 1355\nedema, contrast reaction Endpaper A\nnerve\nanatomy 317\nparalysis 437\nport wine stain 399\nswelling, childhood 437\nFahr disease 355\nFailed\nback surgery syndrome 213\npregnancy 1338\nFailing pregnancy 1352\nFairbank disease 154\nFalciform ligament 1039\nhernia 1102\nFallen\nfragment sign 200\nlung sign, bronchial fracture 586\nFallopian\ncanal 317\ntube 1332\ncancer 1356\ncyst 1376\nocclusion 1311\nproximal obstruction 1316\ntorsion 1383\nFalse",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 788,
            "markdown": "aneurysm\naorta 785\nheart 858\nknot, umbilical cord 1299\n-negative ratio 1427\npenumbra, perfusion CT 288\n-positive ratio 1427\nsteal 846\nvocal cords 459\n\n# Falx \n\ncerebelli 311\ncerebri 311\nfenestration 342\nincreased density 295\n\n## Familial\n\nacroosteolysis 58\nadenomatous polyposis 1089\namyloidosis 1046\ncerebrovascular ferrocalcinosis 355\nchondrocalcinosis 70\ndysautonomia 1003\nfibrous dysplasia 100\nhypophosphatemic rickets 187\nidiopathic acroosteolysis 96\nmultiple polyposis 1089\nosteochondromatosis 166\nosteoonychodysplasia 158\nxanthomatosis 1292\n\n## Famine osteomalacia 190\n\n## Fanconi\n\nanemia 96\nsyndrome 187\n\n## Farber disease 96\n\nFarmer's lung 615\nFasciae of neck 462\n\n## Fascia of\n\nGerota 1186\nZuckerkandl 1186\n\n## Fascicular sign 270\n\n## Fasciitis\n\nnecrotizing 158\nnodular 160\nossificans 157\nplantar 202\nscrotum 1209",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 789,
            "markdown": "Fascioliasis 926\nFat\n-containing\nadrenal mass 1156\nbreast lesion 685\nliver mass 864\nrenal mass 1163\nembolism 616\nsyndrome 199\nhalo sign 1024\nherniation, lung 552\nnecrosis\nabdomen 1078, 1027\nbreast 720\nretroperitoneum 1259\n-pad sign, heart 747\npads, hip 46\nring sign, mesentery 1027, 1138\n-spared area in\nliver 927\npancreas 964\n-stranding, pericecal 1019\nFatality 1427\nFatigue fracture 104\nFatty\ninfiltration\nmuscle 32\npancreas 964\nliver 926\n-meal sonography 875\nneck mass 448\npancreas 878\npelvic mass 1313\nreplacement, pancreas 964\nsoft-tissue tumor 27\nstreak, intima 477\nFDG distribution 1397\nFeeding vessel sign 670\nFeigin tumor 357\nFeline esophagus 1004\nFelty syndrome 189\nFemale\nintersex 1181\npseudohermaphroditism 1181\nFemoral",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 790,
            "markdown": "hernia 1101\ntriangle, contents 780\nvein 778\nFemoroacetabular impingement 96\nFemur length 1325\nFencers bone 157\nFenestral otosclerosis 496\nFenestration of falx 342\nFentanyl 1437\nFerguson view 240\nFerritin 363\nFerrocalcinosis, familial cerebrovascular 355\nFetal\nabdomen, cystic mass 1308\nacardia 1339\nadrenal gland, echogenic 1308\nage 1324\nakinesia deformation sequence 1356\naortic flow volume 1364\nascites 1309\nbowel, echogenic 1308\nbradycardia 1306\ncardiac\nanomalies 1306\ndysrhythmia 1356\ncirculation, persistent 838\nCNS anomalies 1303\ndeath in utero 1357\nechocardiography 1307\nexposure to radiation 1335\ngastrointestinal anomalies 1307\ngoiter 133\ngrowth\nacceleration 1365\nretardation 1362\nhamartoma, benign 1220\nhead, large 1301\nhepatomegaly 1307\nhydrops 1357\n\n+ cardiac abnormalities 1307\nhypomineralization 1301\nlobation, kidney 1164\nmensuration 1324\nmesenchymal tumor 1220\nneck anomalies 1304",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 791,
            "markdown": "ovarian cyst 1309\novergrowth disorder 1300\nperiod 1321\npyelectasis 1167\nrenal hamartoma 1220\nskeletal dysplasia 1300\nstomach, nonvisualization 1307\ntrauma 1358\ntumor 1309\nurinary tract anomalies 1309\nventriculomegaly 1304\nFetofetal transfusion syndrome 1385\nFetus\nabdominal wall defect 1307\ncardiac anomalies 1306\nchest anomalies 1305\nCNS anomalies 1303\nechogenic abdominal mass 1307\ngastrointestinal anomalies 1307\nhand anomalies 1302\nin fetu 1309\norbital anomalies 1304\npapyraceus 1357\nradiation dose 1336\nskeletal dysplasia 1300\nsmall for gestational age 1364\nurinary tract anomalies 1309\nuse of karyotyping 1295\nFibrin bodies, pleura 549\nFibrinoid leukodystrophy 328\nFibroadenolipoma, breast 724\nFibroadenoma\nbreast 721\ngiant 731\nhyalinized, breast 685\nphyllodes 731\nFibroadenomatoid mastopathy 723\nFibroadenomatosis, breast 722\nFibrochondrogenesis 97\nFibrocystic disease\nbreast 722\nlung 606\nFibrodysplasia ossificans progressiva 97\nFibroelastic\nhamartoma, heart 800",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 792,
            "markdown": "papilloma 834\nFibroelastoma, papillary, heart 834\nFibroelastosis, endocardial 815\nFibroepithelial polyp, ureter 1209\nFibrogenesis imperfecta osseum 191\nFibroid\npolyp, uterus 1389\nuterus 1388\nFibrolamellar carcinoma, liver 945\nFibrolipoma\nfilum terminale 265\nneural 141\nFibrolipomatosis, kidney 1229\nFibrolipomatous hamartoma, nerve 141\nFibroma\naponeurotic juvenile 201\ndesmoplastic 80\nheart 800\nmedullary, kidney 1259\nmolluscum 390\nnonossifying 160\nnonosteogenic 160\nossifying 162\novary 1371\nsubmucosal 1106\ntendon sheath 97\nungual 405\nFibromatoses 27\nFibromatosis\nabdominal wall 77\naggressive 77\ncolli 485\ncongenital multiple 79\ndeep 77\ndesmoid-type 78\nheart 800\ninfantile digital 201\nmesentery 1123\nmusculoaponeurotic 77\novarian 1371\npalmar 202\npenile 1230\nplantar 202\nsuperficial 201\nFibromuscular dysplasia",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 793,
            "markdown": "CNS 816\nrenal artery 1247\nFibromyxoma, kidney 1220\nFibronectin 665\nFibro-osseous pseudotumor of digits 157\nFibropolycystic liver disease 864\nFibroproductive tuberculosis 681\nFibrosarcoma\nbone 98\nextraskeletal 486\ninflammatory 1106\nvariant 101\nFibrosed the coma 1383\nFibrosing\narachnoiditis 214\ncholangitis 905\ncolonopathy 607\nmediastinitis 640\nmesenteritis 1137\nFibrosis\nbreast 723\nidiopathic pulmonary 628\nprogressive massive 602\nretroperitoneal 1259\nFibrothecoma 1383\nFibrothorax 549\nFibrous\nbone lesions, benign 10\nbreast lesion 684\nconnective tissue tumors, bone 10\ncortical defect 98\ndysplasia 98\ntemporal bone 440\nhamartoma, heart 800\nhistiocytoma\natypical benign 101\nbenign 101\nmalignant 101\nmastitis 722\nmedullary defect 160\nnodule, breast 723\nosteodystrophy 98\nosteoma 169\nplaque, intima 477\npolypoid lesion, GI tract 1106",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 794,
            "markdown": "polyp, urinary tract 1209\npseudotumor of scrotum 1209\nsoft-tissue tumors 27\ntumor of pleura 671, 200\nFibrovascular polyp, esophagus 1089\nFibroxanthoma 160, 1106\nField uniformity, scintillation camera 1395\nFifth ventricle 314\nFigure of\n3 sign\ncoarctation 809\npseudocoarctation 841\n8 configuration\ncardiac silhouette 782\npneumothoraces 546\nFiliform polyp 1022\nFilling defect\nbile ducts 875\ncecum 1019\ncollecting system 1167\ncolon 1021\nduodenum 1012\nesophagus 1006\ngallbladder 873\ngastric remnant 1010\nHSG 1319\nintraductal, breast 690\nsmall bowel 1017\nstomach 1010\nureter 1171\nFilshie ${ }^{\\circledR}$ Clip 1362\nFiltration rate, glomerulus 1187\nFilum terminale\nfibrolipoma 265\ntight 280\nFimbrial cyst 1374\nFine-needle aspiration biopsy, thyroid 451\nFinger\n-in glove appearance 582\n-in-glove sign 542\n-like mucus plugging\nbronchial atresia 588\ncystic fibrosis 606\nlucent lesion 20\nresorption of terminal tufts 21",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 795,
            "markdown": "tapered 1135\ntip calcifications 21\nFingerized hypoplastic thumb 127\nFire-eater pneumonia 630\nFirst\nbranchial\narch 456\ncleft cyst 475\n-degree heart block 1357\n-pass\nextraction, thallium 1412\nventriculography 1409\ntrimester\nabnormal sonography 1297\nbleeding 1296\nFish mouth vertebra 224\nFishnet weave pattern, ovary 1370\nFissula ante fenestrum 496\nFissure\nliver 887\nlung, bulging 630\nFistula\naortoenteric 795\naortoesophageal 795\narteriovenous, kidney 1201\nbiliary-enteric 899\nbranchial 476\nbronchopleural 596\nbronchopulmonary 596\ncarotid-cavernous sinus 332\ncholecystocolic 899\ncholecystoduodenal 899\ncholedochoduodenal 899\ncoronary artery 810\nCrohn disease 1070\nCSF 248\ndorsal enteric 278\nperianal 1071\npulmonary arteriovenous 650\ntracheobiliary congenital 890\ntracheobronchoesophageal 1005\ntracheoesophageal, congenital 1066\nvaginal 1319\nFitz-Hugh-Curtis syndrome 861, 1375\nFixation devices",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 796,
            "markdown": "bone 32\nspine 231\nFlail\nchest 110\nleaflet, definition 830\nmitral valve 817\nFlared ilium 89\nFlare phenomenon 151\nFlat-topped bladder 1267\nFleeting pulmonary opacities 523\nFleischner\nlines 654\nsign\nileocecal valve in TB 1143\nwidened pulmonary artery in PE 654\nFleurettes 433\nFlexion\ncontractures, in fetus 1303\nteardrop fracture 256\nFlexner-Wintersteiner rosettes 433\nFlip-flop\nphenomenon 1401\nsign 370\nFloating\ngallbladder 889\nosteophyte 183\nprostate 1277\nradius 108\nspleen 985\nstone, gallbladder 912\nteeth 218\neosinophilic granuloma 137\nHand-SchÃ¼ller-Christian 138\nFlocculation of barium 1139\nFloor of mouth 457\nFloppy\nmitral valve 830\nthumb sign 80\nvalve syndrome 146\nFlorid\nadenosis 723\nosseous dysplasia 246\nreactive periostitis 102\nFlow\ninversion, lung vessels 810",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 797,
            "markdown": "rates, spirometer 569\n-volume loop, lung 569\nFlowing candle wax 146\nFluffy periosteal reaction 185\nFluid\ncollection, abdomen 997\ncul-de-sac, free 1312\nendometrial canal 1318\nin small bowel 1014\nintestinal 1037\npericerebral, childhood 304\nretroperitoneum 1154\nFluorine-18 fluorodeoxyglucose 1397\nFluorosis 90\nFoam cyst, breast 718\nFocal\nalimentary tract calcifications 995\nasymmetry, breast 684\nbacterial nephritis, acute 1240\ncemento-osseous dysplasia 246\ncortical hyperplasia, kidney 1163\nepilepsy, PET 1401\nesophageal narrowing 1005\nfat deposition, liver 928\nfat-sparing, liver 927\nfibrocartilaginous dysplasia of tibia 102\nfibrosis, breast 723\nfibrous disease, breast 731\ngallbladder wall thickening 872\ngigantism 388\nhot liver lesion 867\nhydronephrosis 1213\nliver defects, NUC 867\nnodular hyperplasia 928\norchitis 1228\norganizing pneumonia 616\npancreatitis 973\npleural plaques 579\npyelonephritis 1240\npyloric hypertrophy 1105\nrenal hypertrophy 1163\nsclerosis, bone 69\nFogging phe nomenon 371\nFolded lung 580\nFolds of Kerckring 1035",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 798,
            "markdown": "Folic acid antagonists 1303\nFollicle, Graafian 1334\nFollicular\nadenoma, thyroid 507\ncarcinoma, thyroid 508\ncyst\njaw 219\novary 1369\nlymphoma 1117\nphase 1334\nFong disease 158\nFontan procedure 759\nFoot\nabnormal position 25\naccessory ossicles 56\nangles 55\ncompartments 53\ndiabetic 83\nfracture 113\nsoft-tissue masses 26\nulcer 83\nvalgus 25\nvarus 25\nFootball sign, abdomen 993\nForamen\njugulare 235\nlacerum 234\nof Luschka 349\nof Magendie 349\nmagnum 234\novale\nflap 765\nheart 765\nskull base 234\nrotundum 234\nspinosum 234\nof Winslow 1102\nForced expiratory volume 569\nForearm fracture 107\nForebrain 311\nForegut\ncyst 552\nduplication 1077\nForeign body\naspiration 583",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 799,
            "markdown": "esophagus 1085\ningestion 995, 1090\nintraocular 428\nvagina 1316\nForeign objects\nabdominal cavity 995\nForestier disease 85\nForked rib 18\nFormation of testis 1184\nFossae lacunae 215\nFossa of\nLandzert 1102\nRosenmÃ¼ller 462\nWaldeyer 1102\nFossa ovalis 767\nFour\n-chamber view 763\nabnormal 1307\n-quadrant bar pattern 1395\nFournier gangrene 1209\nFourth\nbranchial\narch 456\ncleft fistula 476\nventricle\ndiverticulum 350\nmass 300\nFox sign 966\nFracture\nankle 113\natlas 258\naxis 258\nbanana 179\nBarton 107\nBennett 109\nbiceps femoris tendon 112\nblowout 256\nbone 102\nboxer 109\nbronchus 586\nbucket handle 111\nburst 257\ncalcaneal 114\ncategories 103\ncervical spine 256",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 800,
            "markdown": "Chance 260\nChauffeur 107\nchest wall 110\nchildhood 13\nChopart 114\nclay shoveler's 104, 257\nColles 107\ncompression of vertebra 261\ncorner 68\ncough 110\ndens 258\nDupuytren 114\nDuverney 111\nelbow 107\nepiphyseal plate 105\nEssex-Lopresti 108\nfatigue 104\nfetus 1301\nfoot 113\nforearm 107\nGaleazzi 108\ngreenstick 107\ngrowing 264\nhamate 109\nhand 109\nhangman's 259\nHoldsworth 260\nHutchinson 107\ninsufficiency 103\nJefferson 258\nJones 114\nkidney 1278\nknee 112\nLe Fort\nankle 114\nskull 254\nLisfranc 115\nlunate 109\nMaisonneuve 114\nmalar 256\nMalgaigne 111\nmolar tooth 255\nMonteggia 108\nnavicular, hand 109\noccipital condyle 256",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 801,
            "markdown": "osteochondral 166\npathologic 103\npelvic 110\npenis 1230\nperoneus brevis avulsion 115\nPiedmont 108\nping-pong 355\npisiform 109\nPouteau 107\nproximal humerus 106\npyramidal 254\nreverse Colles 108\nrib 110\nRolando 110\nsacrum 261\nscaphoid 109\nscapula 110\nseatbelt 260\nSegond 112\nShepherd 115\nskull 254\nSmith 108\nsphenoid bone 255\nspine\ncompression 261\nmetastatic 261\nosteoporosis 261\nspinous process 257\nspleen 1053\nsternum 110\nStieda 157\nstress 103\nteardrop 256, 257\ntemporal bone 255\nterminology 102\ntesticle 1275\nthoracolumbar\njunction 260\nspine 259\ntibial\nplateau 113\ntubercle 113\nTillaux 114\ntime course, NUC 103\ntrachea 586",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 802,
            "markdown": "transverse process, lumbar spine 260\ntrapezium 109\ntriplane 106\ntripod 256\ntriquetral 109\nupper thoracic spine 259\nVolkmann 114\nzygomaticomaxillary 256\nFragilitas ossium 167\nFragmentation of barium 1139\nFragment-in-notch sign 149\nFrÃ¤nkel's white line 196\nFraternal twins 1328\nFrayed metaphyses 7\nFree\n-basing 551\nfragment, disk herniation 251\nFreiberg disease 65\nFrequency 1427\npelvic masses 1312\nFresh-water drowning 644\nFriedlÃ¤nder bacillus 630\nFrontal\nbossing, Parrot 205\nbullar cell 455\nrecess 454\ncells 454\nsinus 454\nFrontoethmoidal\nencephalocele 339\nrecess 454\nFrontotemporal\ndementia 393\nFrostberg inverted-3 sign\npancreatic cancer 959\npancreatitis 967\nFrostbite 115\nFrozen hemithorax 642\nFulminant fasciitis 1209\nFunctional\nasplenia 198, 882\ncolonic immaturity 1001\novarian cyst 1369\nparaganglioma 497\nresidual capacity 569",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 803,
            "markdown": "# Functioning \n\nadrenal mass 1154\novarian tumor 1315\npituitary adenoma 394\n\n## Fungal\n\nmeningitis 380\npyelonephritis 1241\nsinusitis 503\nallergic 504\ninvasive 504\n\n## Fungus\n\nball\nkidney 1224\nlung 581\ncerebri 309\n\n## Funnel\n\nchest 17\n-like cardiomegaly 814\n\n## Funny-looking calices 1158\n\n## Furosemide 1437\n\ntest 1244\nFÃ¼rstenberg test 339\n\n## Fused rib 18\n\n## Fusiform\n\naneurysm 784\nbronchiectasis 589\nthickening, optic nerve 415\n\n## Fusion\n\ncervical spine 223\nsacroiliac joint 228\n\nGadolinium arthrography, shoulder 88\nGalactocele 723\nGalactography 689\nGalactophoritis 729\nGalea aponeurotica 233\nGaleazzi\nfracture 108\nsign 82\nGallbladder\nadenoma 930\nagenesis 889",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 804,
            "markdown": "alteration in size 872\nbifid 889\nblunt trauma 1055\ncapacity 888\ncarcinoma 930\ncomet-tail artifact 873\ncongenital anomalies 889\ndisplaced 872\ndiverticulum 889\nduplication 889\nectopia 889\nejection fraction 888\nempyema 909\nenlarged 872\nfilling defect 873\nfloating 889\nfossa shadowing 872\ngangrene 909\nhydrops 872\ntransient 825\nhypoplasia 889\nmetastasis 952\nmobile intraluminal mass 873\nmultiseptated 889\nnonvisualization on US 871\nperforation 909\npolyps 873\nporcelain 975\nseptations 889\nsize 888\nsludge 912\nsmall 872\nstone 913\ntorsion 931\nwall\nthickening 872\nthickness 888\nGallium citrate\nbinding sites 1424\npharmacology 1423\nuptake 1424\nGallium imaging\nbone 1425\nindications 1424\ninflammation 1422",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 805,
            "markdown": "kidney 1425\nlung 1425\nlymphoma 1426\nmalignant melanoma 1426\nprosthetic failure 24\ntumor 1425\nGallstone 912\nileus 1090\nin neonate 913\nGamekeepers thumb 109\nGamma-glutamyl transpeptidase 887\nGamma-Gandy nodules 976\nGanciclovir 1089\nGanglio\ncytic paraganglioma 1090\ncytoma 355\nglioma\nbrain 356\nspinal cord 262\nneuroblastoma 1209\nneuroma\nretroperitoneal 1209\nspine 271\nGanglion\ncell tumor, CNS 355\nMSK 115\nof Scarpa 390\nGangrene\nFournier 1209\ngallbladder 909\nGarden spade deformity 109\nGardner syndrome 1090\nGargoylism 152\nGarland\nsign, brain 357\ntriad 668\nGarrÃ© sclerosing osteomyelitis 172\nGartner duct cyst 1358\nGas\nbiliary tree 873\ncollection, abdomen 992\n-containing gallstone 912\ngenital tract 1319\nintestinal exchange 1036\nliver 861",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 806,
            "markdown": "portal venous 871\nscrotum 1176\nstomach wall 1008\nurinary tract 1152\nvertebra 222\nGasless abdomen 967\nGasserian ganglion 316\nGastric\nantrum, retained 1136\natony 1009\natresia 1008\ncarcinoid 1059\ncarcinoma 1091\ncells 1034\ndiverticulum 1092\nduplication cyst 1078\nemptying, NUC 1007\nfilling defect 1010\nfolds, thickened 1010\nhemorrhage 988\nintramural-extramucosal lesions 1009\nleiomyosarcoma 1113\nlung 598\nmetastasis 1127\nnarrowing 1009\noutlet obstruction 999\npolyp 1092\nremnant, filling defect 1010\nstump carcinoma 1010\ntumor 1007\ncalcified 1008\nmultiple 1008\nulcer 1093\nvarices 1094\nvolvulus 1094\nGastrin 1029\nGastrinoma 962\ntriangle 962\nGastritis 1095\nAIDS-related 1045\ncorrosive 1095\nemphysematous 1095\nerosive 1096\ngiant hypertrophic 1122\ngranulomatous 1070",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 807,
            "markdown": "hemorrhagic 1096\nphlegmonous 1096\nradiation 1136\nGastrocnemius veins 777\nGastrocolic ligament 1039\nGastroduodenal mucosal prolapse 1010\nGastroenteritis 1096\neosinophilic 1081\nGastroenterogenous rickets 190\nGastroesophageal\njunction 1033\nreflux, NUC 1007\nGastrohepatic ligament 1039\nnodes 1027\nGastrointestinal\nabnormalities\nin chronic renal failure 990\nin renal transplant 990\nblunt trauma 1055\nduplication cyst 1076\nfetal anomalies 1307\nhemorrhage 987\nchild 988\ninfant 988\nintramural 988\nNUC 989\nrenal transplant 1256\nhormones 1029\nsarcoidosis 666\nscintigraphy 1418\nscleroderma 1134\nSLE 673\nstromal tumor 1096\nGastrojejunal mucosal prolapse 1010\nGastropancreatic ligament 1039\nGastroparesis diabeticorum 1009\nGastrophrenic ligament 1039\nGastroschisis 1358\nGastrosplenic ligament 1039\nGastrulation 1322\nGated blood pool imaging 1410\nGaucher disease 116\nGay bowel syndrome 1079\nGelatinous\nascites 1135",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 808,
            "markdown": "pseudocyst, brain 347\nGel bleed, breast 728\nGender 1181\nGeneralized\nangiofollicular lymph node hyperplasia 600\nbreast hyperplasia 722\ncalcinosis 30\ncortical hyperostosis 128\nemphysema 612\nhamartomatosis 79\nincreased liver echogenicity 862\ninterstitial disease 525\nlymphadenopathy syndrome 575\nlymphangiectasia 603\noligemia, lung 542\nGenetic hemochromatosis 932\nGeniculate\nganglion 317\nhemangioma 486\nGeniculum 317\nGenitalia, ambiguous 1181\nGenitourinary\ndiabetes mellitus 1210\nrhabdomyosarcoma 1265\nsarcoidosis 666\nGenu recurvatum 145\nGeodes 15\nGeographic\nbone destruction 8\nskull 138\nGeometry, calibrator 1395\nGerdy tubercle 47\nGeriatric ulcer, stomach 1093\nGerman measles 194\nGerm cell tumor\nextragonadal 1208\nmediastinum 674\nneck 505\novarian malignant 1372\novary 1315\ntestis 1272\nGerminal matrix 310\nhemorrhage 383\nGerminoma 356\nmediastinum 675",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 809,
            "markdown": "Gerota fascia 1186\nGer sign 1269\nGestational\nage 1324\nhyperplasia, breast 723\nsac\nanatomy 1320\nearliest visualization 1321\nempty 1297\nlow position 1297\nsize 1320\ntrophoblastic disease 1358\nGhon lesion 681\nGhost\ntumor, CNS 375\nvertebra 224\nGiant\naneurysm, brain 330\nbenign lymph node hyperplasia 599\nbone island 69\ncavernous hemangioma, liver 939\ncell\narteritis 848\ncarcinoma, lung 594\ngranuloma 117\ninterstitial pneumonia 617\nreaction 117\nreparative granuloma 117, 246\ntuberous sclerosis 404\ncell tumor 117\ncartilage-containing 71\ndiffuse-type 180\nsubependymal 404\ntenosynovial 181\ncolonic diverticulum 1073\nduodenal ulcer 1076\nfibroadenoma, breast 731\nhypertrophic gastritis 1122\nLambl excrescence 834\nosteoid osteoma 164\nGiardiasis 1097\nGibbus 281\nGigantism\nchildren 58\nextremity 135",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 810,
            "markdown": "focal 388\nGigantomastia 724\nGilchrist disease 585\nGissane angle 55, 114\nGIST 1096\nGI tract lymphoma classification 1115\nGlabella 483\nGLAD 87\nGland\nbulbourethral 1192\nCowper 1192\nLittrÃ© 1192\nSkene 1192\nGlasgow coma scale 360\nGlaucoma, primary 414\nGleason grading 1235\nGlenner classification 497\nGlenn shunt 759\nGlenohumeral\ndislocation 86\ninstability 192\nligaments 40\nGlenoid labrum 36\nGlioblastoma multiforme 357\nGlioependymal cyst 386\nGlioma 358\nbrainstem 358\nbutterfly 357\nchiasmatic 358\nhypothalamic 358\nnasal 494\noptic nerve 428\nspinal cord 261\nsuperficial 293\nGliomatosis\ncerebri\nGBM 358\nneurofibromatosis 387\nperitonei 1097\nGliosarcoma 357\nGlobal asymmetry 695\nGlobe\ndeformity of contour 414\nrupture 427\nGloboid cell leukodystrophy 358",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 811,
            "markdown": "Globular meningioma 377\nGlobus, epididymis 1190\nGlomangiopericytoma 486\nGlomerular filtration rate 1187\nGlomerulo\ncystic disease 1210\ncytoma 497\nnephritis, chronic 1204\nGlomus\nbody 119\njugulare 498\ntumor 486\nbone 119\nstomach 1098\ntympanicum 498\nvagale 498\nGlottic\ncarcinoma 489\nnarrowing 445\nGlottis 459\nG loved finger sign\nABPA 582\nbronchial atresia 588\ncystic fibrosis 606\nmucoid impaction 542\nGlucagon 1029\nGlucagonoma 962\nGlucophage ${ }^{\\circledR} 1434,1436$\nGlucose\nmetabolism, brain 1401\n-6-phosphatase 931\nGluten-sensitive enteropathy 1141\nGlycogen\nacanthosis 1098\n-rich cystadenoma, pancreas 981\nstorage disease, liver 931\nG nathic osteosarcoma 175\nG oblet\n-shaped pelvis 154\nsign, ureter 1277\nGoiter 486\nadenomatous 486\ndiffuse 486\ntoxic 487\nfetal 133",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 812,
            "markdown": "intrathoracic 487\niodine-deficiency 486\nmultinodular 486\ntoxic nodular 486\nGolden pneumonia 649\nGold salts 515\nGoltz-Gorlin syndrome 119\nGÃ³mez-LÃ³pez-HernÃ¡ndez syndrome 397\nGonadal\ndysgenesis 1181\nvascular anatomy 1190\nvein 1191\nGonadoblastoma, testis 1274\nGonadotropin 1320\nGonorrheal perihepatitis 1375\nGoodpasture syndrome 617\nGood syndrome 1114\nGooseneck deformity 815\nGorham-Stout disease 143\nGorlin-Goltz syndrome 68\nGosling index 779\nGossypiboma 1154\nGottron sign 80\nGouge defect 281\nGout 119\nGouty arthritis, hand 16\nGoyrand fracture 108\nGraafian follicle 1334\nGracile bones 189\nGradenigo syndrome 475\nGraft\ninfection, aortic prosthesis 792\n-versus-host disease 1098\nGram-negative pneumonia 519\nGranular\ncalcifications, breast 688\ncell myoblastoma\nGI 1099\nlung 536\ncell tumor 1099\nbreast 1099\nchest 1099\nGI Tract 1099\ninfundibulum 343\nGranulocytic sarcoma 1215",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 813,
            "markdown": "Granuloma\neosinophilic 137\ngiant cell reparative 117\ngravidarum 441\nlung 617\nmediastinum\nhistoplasmosis 619\nmidline 860\npyogenic 124\n\n# Granulomatosis \n\nbronchocentric 591\nlimited Wegener 860\nlymphomatoid 636\npulmonary mainline 652\nWegener 859\nwith polyangiitis 859\n\n## Granulomatous\n\nabscess, brain 326\namebic encephalitis 352\narteritis 848\ncolitis 1070\ncystitis 1207\ngastritis 1070\nmastitis 729\nmeningitis 379\norchitis 1228\nperitonitis 1025\nprostatitis 1179\nsinonasal disease 440\nspondylitis 222\nuveitis 421\nGranulosa cell tumor, ovary 1359\nGrape\n-like vesicles per vagina 1360\nskin cavities, lung 602\nGrashey view, shoulder 87\nGraves\ndisease, thyroid 487\nophthalmopathy 421\nGray cortex sign, bone 104\nGreat\ncardiac vein 773\nsaphenous vein 778\ntoe, arthritis of interphalangeal joint 16\nvessels, embryology 762",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 814,
            "markdown": "Greater\nomentum 1039\nsciatic foramen 47\nsphenoid wing, absent 216\nGreenstick fracture 107\nGrey-Turner sign 966\nGriffith point 1032, 1110\nGrisel syndrome 244\nGroin\nhit 843\nmass 1176\nGroove pancreatitis 973\nGround-glass\nattenuation\nCXR 532\ndefinition 529\nHRCT 529\nosteoporosis 196\npattern, ovary 1370\nGroup B streptococcus 644\nGrowing\nfracture 264\nteratoma syndrome 1272, 1373\nGrowth\nacceleration, fetus 1365\npattern, renal lesion 1162\nplate, anatomy 36\nrate, twins 1328\nrestriction, intrauterine 1362\nGrynfeltt-Lesshaft hernia 1100\nGuanethidine analogs 1421\nGuinea worm 996\nGumma 205\nGunshot injury 121\nGuyon canal\nanatomy 42\nsyndrome 211\nGymnast wrist 105\nGynecomastia 724\nGyral enhancement, brain 298\n\nHabenula 295",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 815,
            "markdown": "HAGL 87\nHair-on-end skull 215\nHairy plaque 579\nHajdu-Cheney syndrome 96\nHaller cells 454\nHallervorden-Spatz disease 359\nHalo sign\nbreast 685\nduodenal diverticulum 1076\ngallbladder 908\nlung 581\nrectum 1136\nthyroid 507\nHamartoma\nbenign fetal, kidney 1220\nbreast 724\nBrunner gland 1056\nchest wall 617\nCNS 359\nfetal renal 1220\nfibrolipomatous nerve 141\nhypothalamic 359\nleiomyomatous, kidney 1220\nlung 617\nlymphoid 599\nmesenchymal liver 951\nmultiple, bile duct 956\nrenal 1200\nspleen 983\nsubependymal 404\ntuber cinereum 359\nHamartomatosis, generalized 79\nHamartomatous polyp\ncolon 1025\nstomach 1092\nHamate fracture 109\nHamburger vertebrae 224\nHamman-Rich syndrome 623\nHammered silver skull 366\nHammocklike posterior bowing of mitral valve 831\nHamoudi tumor 982\nHampton\nhump 654\nline 1093\nHamstrings 47",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 816,
            "markdown": "Hancock valve 760\nHand\narticular disorders 16\ncollateral circulation 776\n-foot syndrome 197\nfracture 109\nmetacarpal sign 20\n-SchÃ¼ller-Christian disease 138\nHandle-bar clavicles 62\nHanging noose sign 1299\nHangman's fracture 259\nHansemann macrophages 1217\nHansen disease 139\nHard metal pneumoconiosis 618\nHarlequin orbit 388\nHarris lines 128\nHashimoto thyroiditis 509\nHasner membrane 420\nHaudek niche 1093\nHawkins sign 67\nHay fork sign 1108\nHead\ncircumference, fetus 1325\nlarge, fetus 1301\ntrauma 359\nHealing skull fracture 254\nHearing deficit 437\nHeart\nblock 1356\ncalcifications 745\nchamber, abnormal dimensions 742\ndecreased compliance 741\ndisease, acquired 741\nenlarged 741\nfailure\ncongestive 810\nneonate 743\nfetal anomalies 1306\nischemic disease 822\nmalposition 739\nmurmur, continuous 736\npressure overload 741\nrate reduction for imaging 1437\nscintigraphy 1406\ntumor 744",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 817,
            "markdown": "valve\ncalcification 745\ndysfunction, trauma 801\npositions 763\nprosthesis 760\nreplacement 563\nvegetation 798\nvolume overload 741\nHeberden nodes 163\nHeel\npad thickening 25\nultrasound, quantitative 5\nvalgus 55\nHeerfordt syndrome 669\nHeffner tumor 497\nHelicobacter pylori infection 1099\nHeliotrope rash 80\nHellmer sign 1136, 996\nHELLP syndrome 1359\nHelminthiasis 1028\nHemangioblastoma\nCNS 361\nspine 262\nHemangioendothelial sarcoma\nbone 122\nliver 937\nHemangioendothelioma\nbone 122\nepitheloid 925\ninfantile, liver 939\nHemangioepithelioma 122\nHemangioma\nadrenal gland 1210\nbone 122\nbrain 340\nbreast 725\ncapillary 817\nchoroidal 419\nclassification 817\ngeniculate 486\nGI tract 1099\nheart 800\nkidney 1211\nlaryngeal 490\nliver 938",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 818,
            "markdown": "orbit 422\nparotid gland 499\nsoft-tissue 124\nspleen 983\nsubglottic 490\nthrombocytopenia syndrome 940\numbilical cord 1299\nurinary bladder 1211\nHemangiopericytoma\nCNS 361\nmeningeal 378\norbit 423\nsoft tissues 124\nHemangiosarcoma, liver 937\nHemarthrosis 126\nHematoma\nbasal ganglia 363\nbrain 362\nbreast 725\nduodenum 1076\nepidural\nbrain 354\nspine 254\nextradural, brain 354\ninterhemispheric subdural 400\nintramural aortic 821\nmediastinal 550, 853\nretroplacental 1378\nsubcapsular renal 1170\nsubdural 400\ntestis 1275\numbilical cord 1299\nHematometrocolpos 1361\nHematopoiesis, extramedullary 95\nHematosalpinx 1376\nHematuria 1280\nHemeSelect ${ }^{\\mathrm{TM}} 1063$\nHemiatrophy, cerebral 351\nHemihypertrophy\nadrenocortical carcinoma 1197\nBeckwith-Wiedemann syndrome 1342\nhepatoblastoma 942\nWilms tumor 1291\nHemimelia 1300\nHemimyelocele 267",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 819,
            "markdown": "# Hemiplegia \n\ncongenital 351\ninfantile 351\nHemithorax, opacification 539\nHemitruncus 856\nHemivertebra 221\nHemobilia 873\nHemoccult ${ }^{\\circledR}$ test 1063\nHemochromatosis\nbone 125\ngenetic 932\nliver 932\nHemoglobin components 779\nHemolytic\nanemia 125\n-uremic syndrome 1211\nHemopericardium 747\nHemoperitoneum 987\nduring pregnancy 1296\nnontraumatic 987\ntraumatic 1052\nHemophagocytic lymphohistiocytosis 364\nHemophilia 126\nHemoptysis 513\nmassive 513\nHemoQuant ${ }^{\\circledR} 1063$\nHemorrhage\nadrenal 1157\nimaging findings 1195\nante partum, placental cause 1298\nbrain, MR appearance 363\ncolonic diverticular 1075\nfirst trimester 1296\ngastrointestinal 987\nNUC 989\nrenal transplant 1256\ngerminal matrix 383\nhypertensive 287\nintracranial 295\nintramural, GI tract 988\nintraocular 427\nlung 513\nplaque 477\npost partum 1317\npreplacental 1378",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 820,
            "markdown": "retrohyaloid 428\nretropharyngeal 501\nspontaneous\nhepatic 867\nretroperitoneal 1170\nsubarachnoid 399\nsubchorial 1378\nsubchorionic 1378\nsubdural, in newborn 400\nsubgaleal 213\nvitreous 414\n\n# Hemorrhagic \n\nadnexal lesion 1313\nbone cyst, jaw 219\nbrain metastases 381\nbreast metastasis 729\ncystitis 1207\ngastritis 1096\nhereditary telangiectasia 618\ninfarction, brain 371\nliver metastases 953\nlung\nmetastasis 643\nsyndrome 575\novarian cyst 1370\npancreatitis 969\npneumonia 513\nHemosiderin 363\nHemosiderosis 126, 933\nidiopathic pulmonary 629\n\n## Hemothorax 548\n\nHenoch-SchÃ¶nlein purpura 817\nHensen node 273\nHepar lobatum 872\nHepatic\nabscess 933\nadenoma 935\nangiomyolipoma 937\nangiosarcoma 937\nartery\nanatomy 885\naneurysm 869\nenlargement 869\nresistive index 887\nstenosis 949",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 821,
            "markdown": "thrombosis 949\ncalcifications 866\ncandidiasis 901\ncongestion, passive 974\ncyst 937\nenlargement 861\nfibrosis, congenital 920\nfissures 887\ngas 861\nhemangioma 938\nhemorrhage, spontaneous 867\nhydrothorax 919\nlipoma 948\nmass, low-density with enhancement 866\nmass with central scar 866\n-pulmonary disorders 515\nsteatosis 926\nsubcapsular steatosis 928\ntrauma 1054\nvein Doppler\ndampening 869\nwaveform 779,887\nvenoocclusive disease 940\nwedge pressure 975\n\n# Hepatitis 940 \n\nneonatal 941\nradiation-induced 942\nrecurrent pyogenic 907\n\n## Hepato\n\nbiliary triangle 891\nblastoma 942\ncellular\nadenoma 935\ncarcinoma 942\nduodenal ligament 1039\nechogenic fat 873\nlenticular degeneration 409\nmegaly 861\nAIDS 1045\nfetus 1307\nportal sclerosis 898\npulmonary syndrome 918\nsplenic tuberculosis 946\nsplenomegaly 861\n\n## Hepatoma 942",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 822,
            "markdown": "# Hereditary \n\namyloidosis 1046\nchronic nephritis 1211\nhemochromatosis 932\nhemorrhagic telangiectasia 618\nhyperoxaluria 1287\nhyperphosphatasia 126\nleptocytosis 206\nmultiple\ndiaphyseal sclerosis 127\nexostoses 166\nnonpolyposis colorectal cancer syndrome 1065\npancreatitis 966, 973\nspherocytosis 127\nHerlyn-Werner-Wunderlich syndrome 1358\nHermaphroditism 1182\nHernia 1100\nAmyand 1101\naxial 1103\nBochdalek 609\nbroad ligament 1103\nconcentric 1103\ncongenital diaphragmatic 608\nDe Garengeot 1101\ndiaphragmatic 608\nexternal 1100\nfemoral 1101\nhiatal 1103\niatrogenic 1103\ninguinal 1100\ninternal 1101\nlesser sac 1102\nLittrÃ©, 1101\nMorgagni 609\nparaduodenal 1102\nparaesophageal 1103\nparahiatal 1103\nRichter 1101\nrolling hiatal 1103\nsliding hiatal 1103\nSpigelian 1100\ntransmesenteric 1102, 1103\ntraumatic diaphragmatic 609\ntrocar site 1100\numbilicus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 823,
            "markdown": "adult 1100\nfetus 1299\n\n# Herniation \n\nbrain 289\nfree fragment 251\nheart 801\nlocation descriptor 250\nnucleus pulposus 250\npit 127\nspinal cord 263\n\n## Heroin\n\n-induced pulmonary edema 517\nIV drug abuse 843\nlung damage 515\n\n## Herpes\n\nencephalitis 353\nesophagitis 1089\ninfection in AIDS 1044\nzoster oticus 488\n\n## Hers disease 932\n\nHesselbach triangle 1100\nHeterogeneous carotid plaque 479\nHeterotaxy 739\nsyndrome 818\nHeterotopia, nasal cerebral 494\n\n## Heterotopic\n\nbone formation 179\ngastric mucosa 1120\ngray matter 364\ntuberous sclerosis 405\nisland, white matter 405\nmesenteric ossification 1104\nossification 156\npancreas 924,1103\npregnancy 1351\nHeterozygous achondroplasia 57\nHeubner artery 320\nHexabrix ${ }^{\\circledR} 1431$\nHiatal hernia 1103\nHiatus semilunaris 455\nHibernating myocardium 823\nHibernoma 127\nHide bound folds 1134\nHigh\n-altitude pulmonary edema 517",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 824,
            "markdown": "-density\nbile 872\nrenal cyst 1252\n-flow\npriapism 1235\nvascular malformation 758\n-resolution CT\nbronchiolitis 530\ndiffuse lung disease 528\n-riding third ventricle 327\nHilar\ncholangiocarcinoma 904\ncomma sign\ninterruption of pulmonary artery 821\ntruncus arteriosus 856\ndance 796\nenlargement + pleural effusion 548\nlip, kidney 1164\nmass 556\nwaterfall sign\nadmixture lesions 740\ntruncus arteriosus 856\nHildreth sign 119\nHilge nreiner line 82\nHill-Sachs defect 87\nHilum\nconvergence sign 550\noverlay sign 550\nHindbrain 311\nHindgut duplication 1078\nHine-Duley phantom 1396\nHinman syndrome 1175\nHip\narthroplasty 23\navascular necrosis 64\nbony landmarks 46\ncongenital dysplasia 81\ndislocation 85\nfat pads 46\nflexors 47\nprosthesis, pain 22\nsnapping 22\ntransient osteoporosis 207\nHippocampal atrophy 289\nHippocratic fingers 131",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 825,
            "markdown": "HippuranÂ® 1419\nHirschsprÃ¯ng disease 1104\nHirsutism 1382\nHis angle 1088\nHistiocytic lymphoma\nbrain 376\nchest 636\nHistiocytoma 1106\nfibrous 101\nHistiocytosis\npolyostotic sclerosing 614\nX 136\nHistoplasmoma 619\nHistoplasmosis\nin AIDS\nchest 574\nGI tract 1044\nlung 619\nHitchhiker's thumb\ndiastrophic dysplasia 85\nin fetus 1303\nHit the pink 843\nHIV\n-associated lymphoepithelial cysts 475\nencephalitis 328,353\nesophagitis 1089\nnephropathy 1193\nparotitis 502\nHives, contrast reaction Endpaper A\nHIV-related cholangitis 905\nHLA-B 27 histocompatibility complex 14\nHodgkin disease 620\nkidney 1216\nHofman-Rigler rule 742\nHoldsworth fracture 260\nHole-within-hole bone lesion 137\nHolman carotid slim sign 477\nHolo\nacardia 1339\nprosencephaly 364\nventricle 365\nHolt-Oram syndrome\nbone 127\nCHD 736\nHolzknecht space 554",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 826,
            "markdown": "Homans sign 811\nHomer-Wright rosettes 433\nHomocystinuria 127\nHomogeneous carotid plaque 479\nHomovanillic acid 1226\nHomozygous achondroplasia 57\nHonda sign 103\nHoneycomb\nlung\ncauses 527\ncoarse reticulations 527\nsign of chronic interstitial disease 524\nvertebra 123\nHong Kong disease 907\nHood syndrome 158\nHook-like osteophytes 125\nHormones\naffecting bones 36\nantidiuretic 1187\ngastrointestinal 1029\nthyroid 470\nHorner\nsyndrome 285, 592\n-Wright rosettes 1226\nHorseshoe\nconfiguration of brain 365\nkidney 1212\nlung 605\nHot\nbone lesions, NUC 2\ncaudate lobe 900\nliver lesion 867\nspot imaging, heart 1415\nthyroid nodule 452\ntubes, NUC 1396\nHourglass\ngallbladder 946\nphalanges 152\nstenosis, duodenum 1076\nventricle 342\nHouston valves 1144\nHowell-Jolly bodies 198, 818\nHSG\ncontour abnormality 1319\nfilling defect 1319",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 827,
            "markdown": "fundic depression 1319\nHulkaÂ® Clip 1362\nHulten variance 42\nHuman\nchorionic gonadotropin 1320\nimmunodeficiency virus 574\nHumerus fracture, proximal 106\nHump and dip sign, breast 721\nHumphrey ligament 49\nHunner ulcer 1207\nHunter disease 152\nHurler syndrome\nbone 152\nCHD 736\nHurst phenome non 1042\nHÃ¼rthle-cell adenoma 507\nHutch diverticulum 1203\nHutchinson\nfracture 107\n-Gilford syndrome 181\nsyndrome 1226\ntriad 205\nH-vertebrae 224\nHyaline\nfibroma, heart 834\nmembrane disease 662\nHyalinized fibroadenoma with fibrosis 685\nHyaloid\nartery 430\ncanal of Cloquet 430\nHyalose rositis, pleura 549\nHybridoma 1399\nHybrid PET/CT imaging, indications 1399\nHydatid\ncyst\nheart 744\nlung 552\nof Morgagni\novary 1374\ndisease\nchest 623\nCNS 922\nkidney 922\nliver 922\nlung 923",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 828,
            "markdown": "of Morgagni\ntestis 1190\nsand 921\nHydatidiform mole 1360\nHydranencephaly 365\nHydrocalicosis 1213\nHydrocalyx 1213\nHydrocarbon 600\nHydrocele 1212\nHydrocephalus 366\ncommunicating 366\ncompensated 366\ncongenital 367\nextraventricular 366\nex vacuo 289\ninfantile 367\nintraventricular 366\nnonobstructive 367\nnormal pressure 367\nobstructive 366\nposttraumatic 360\nHydrogen sulfide 600\nHydrolethalus syndrome 1302\nHydrometrocolpos 1361\nHydromyelia 280\nHydronephrosis 1212\nin pregnancy 1213\nHydrophthalmos 419\nHydropic villi 1360\nHydrops\nfetalis 1357\ngallbladder 872\ntubae profluens 1356\nHydrosalpinx 1376\nHydrostatic\npressure edema, lung 516\nreduction 1109\nHydrothorax 546\nhepatic 919\nHydroureter 1171\nHydroxyproline, increased 178\nHydroxyzine 1437\nHygroma\ncystic, neck 492\npseudo-cystic 493",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 829,
            "markdown": "subdural 401\nHymen, imperforate 1388\nHyoid arch 456\nHypaque ${ }^{\\circledR} 1432$\nHyperabduction maneuver 850\nHyperacute\ncerebral hemorrhage 362\nischemic infarction, brain 369\nrejection\nlung transplant 631\nrenal transplant 1254\nHyperaldosteronism, primary 1204\nHyperamylasemia 880\nHyperbilirubinemia, infants 874\nHypercalcemia 1150\nof infancy, idiopathic 212\nwith hypercalciuria 1170\nHypercalciuria 1169, 1287\nHypercementosis 218\nHypercoagulability 759\nHyperconvex nails 209\nHypercortisolism 1205\nHyperdense\nbrain lesion 295\nmiddle cerebral artery sign 370\nsinus secretions 440\nspleen 882\nHyperechoic\nrenal\nnodule 1163\npyramids in children 1159\nsplenic spots 882\nHypereÅasticity of skin 91\nHypereosinophilic syndrome 614\nHyperextension injury\ncervical spine 257\nknee 25\nHyperflexion injury, spine 256\nHyperfunctioning adrenocortical adenoma 1197\nHypergonadotropic hypogonadism 1311\nHyperhidrosis 185\nHyper-IgG4 disease 487\nHyperinflation\nin child 543\nin newborn 543",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 830,
            "markdown": "Hyperintense\nintracranial lesions, T1 296\nliver mass on T1 865\nmuscle 31\nperiventricular lesions, T2 301\nHyperlucent\nlung 542\nribs 19\nHypernephroma 1247\nHyperostosis\nankylosing 85\nchronic infantile 133\ncorticalis generalisata 128\ndiffuse idiopathic skeletal 85\nendosteal 128\nfrontalis interna 215\ngeneralized cortical 128\ninfantile cortical 133\nHyperoxaluria 1287\nHyperparathyroidism 128\nHyperperfusion abnormalities of liver 868\nHyperphosphatasia, hereditary 126\nHyperplasia\nadrenocortical 1198\nbenign giant lymph node 599\nBrunner gland 1056\ngeneralized, breast 722\nintimal, in TIPS 979\nlymphoid 1114\nnodular lymphoid, lung 646\nthymus 677\nHyperplastic\nachondroplasia 152\ncholecystosis 946\npolyp\ncolon 1104\nstomach 1092\nHypersegmentation, manubrium 89\nHypersensitivity\npneumonitis 615\nto organic dusts 514\nHyperstimulation, ovary 1371\nHypertelorism 1304\nHypertension\nbenign intracranial 369",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 831,
            "markdown": "contrast reaction B\nidiopathic intracranial 369\nin children 1151\nin pheochromocytoma B\nportal 975\npulmonary 750\narterial 752\nvenous 752\nrenal transplant 1257\nrenovascular 1151\nsystemic arterial 1151\n\n# Hypertensive \n\nencephalopathy 287\nhemorrhage, brain 287\nhypertrophic cardiomyopathy 807\n\n## Hyperthyroidism 450\n\n## Hypertrophic\n\ncardiomyopathy 805\ngastritis, giant 1122\nosteoarthropathy, primary 178\npulmonary osteoarthropathy 130\npyloric stenosis 1104\n\n## Hypertrophy\n\nleft ventricle, concentric 741\nprostate, benign 1201\n\n## Hyperuricosuria 1287\n\n## Hypervascular\n\ngastrointestinal metastases 1126\nliver\nmass 866\nmetastases 953\nmediastinal mass 556\npancreatic tumor 879\nsubepithelial mass, GI 1024\n\n## Hypervitaminosis\n\nA 131\nD 131\nHyphema 427\nHypodense brain lesion\nbasal ganglia 302\nmesencephalic low-density 294\nHypoechoic renal sinus 1168\nHypogammaglobulinemia, acquired 678\nHypogenetic lung 783\nsyndrome 522",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 832,
            "markdown": "Hypoglossal canal 235\nHypogonadotropic hypogonadism 1311\nHypointense\nlesion, sella 306\nliver lesion on T2 865\nT2 signal, prostate 1180\nHypokinesis, heart 823\nHypomineralization in fetus 1301\nHypoparathyroidism 131\nHypoperfusion\ncomplex 1052\ninjury, brain 368\nHypopharyngeal carcinoma 487\nHypopharynx 458\nHypophosphatasia 132\nHypophosphatemic familial rickets 187\nHypophysis cerebri 312\nHypophysitis lymphoid 375\nHypoplasia\naorta 792\nbasiocciput 220\ncongenital renal 1204\ndens 258\nfetal lung 1305\ngallbladder 889\nlung 522\nmandible 216\nmaxilla 216\nmaxillary sinus 440\noccipital condyles 220\noptic nerve 398\nradius 1302\nseminal vesicle 1182\ntubular aortic 792\nuterus 1388\nvermis 350\nzygomatic arch 208\nHypoplastic\nleft heart syndrome 819\nrib 18\nright ventricle 820\nthumb 127\nvermis 373\nHypospadia 1180\nHyposplenism 882",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 833,
            "markdown": "Hypotelorism 1304\nHypotension\narterial 1151\ncontrast reaction B\nintracranial 373\nHypothalamic\ngerminoma 356\nglioma 358\nhamartoma 359\nhypopituitarism 398\nhypothyroidism 450\nlesions 303\nosteolipoma 374\npilocytic astrocytoma 336\nHypothalamus, anatomy 311\nHypothyroidism\nclassification 450\nhypothalamic 450\nMSK 132\nHypotympanum 465\nHypovascular\nliver lesion 866\nliver metastases 953\nHypovitaminosis C 195\nHypovolemia, trauma 1052\nHypoxic-ischemic ence phalopathy 368\n\nIatrogenic hernia 1103\nIce\ncream cone 255\npick sign 972\nIdentical twins 1327\nIdiopathic\namyloidosis 1046\ndilatation of pulmonary trunk 820\neosinophilic lung disease 613\nepiphyseolysis 14\ngastric perforation 993\nhemochromatosis 932\nhydrocele 1212\nhypercalcemia of infancy 212\nhypereosinophilic syndrome 614",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 834,
            "markdown": "hypertrophic subaortic stenosis 807\nhypoparathyroidism 132\ninflammatory\naortic aneurysm 786\nsyndrome, orbit 431\ninterstitial pneumonia 623\nclassification 623\ndifferential diagnosis 622\nHRCT features 622\nintracranial hypertension 369\nintussusception 1109\nmedial aortopathy 847\nnonspecific interstitial pneumonia 624\nosteolysis 1300\nosteosclerosis, tooth 263\npulmonary\nfibrosis 628\nhemosiderosis 629\nsegmental sclerosis of vertebral body 250\nspinal cord herniation 263\nunilateral hyperlucent lung 672\nIfosfamide 190\nIgA vasculitis 817\nIgG4-related\nrenal disease 1213\nsclerosing cholangitis 905\nsclerosing disease 487\nsialadenitis 481\nthyroiditis 510\nIgnatius Loyola 899\nIleal\ncarcinoid 1060\ndiverticulosis 1105\nobstruction 999\nIleitis, backwash 1144\nIleocecal\nsyndrome 1080\nvalve\nabnormalities 1018\nanatomy 1035\nIleopectineal bursa 1176\nIleosigmoid knot 1002\nIleus 1002\nadynamic 1002\ncecal 1049",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 835,
            "markdown": "chronic duodenal 846\ngallstone 1090\nlocalized 1002\nmeconium 1121\nnonobstructive 1002\nparalytic 1002\nIliac\nhorns 158\nvein compression syndrome 827\nIliopsoas\nbursa 43\ncompartment, enlargement 1160\nIliotibial\nband avulsion fracture 112\ntract 47\nImidodiphosphonates 1421\nImmature\nlung syndrome 521\nteratoma, ovary 1372\nImmotile cilia syndrome 629\nImmune hydrops 1357\nImmunoglobulin G4-related disease 487\nImmunoscintigraphy 1399\nImpacted fracture 102\nImpaired\nrenal perfusion 1165\ntubular transit 1166\nImpedance plethysmography 812\nImpending\nabortion 1338\nrupture of aorta 786\nImperforate\nanus 1105\nhymen 1388\nImpingement syndrome, shoulder 191\nImplantable cardioverter-defibrillator 761\nImplantation cyst, bone 93\nImpotence 1208\nImpurity, radionuclides 1394\nIncarceration, GI 1100\nIncidence, statistics 1427\nIncidentaloma\nadrenal gland 1155\npituitary 395\nIncisura defect, stomach 1093",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 836,
            "markdown": "Inclusion\nbody fibromatosis 201\ncyst\nCNS 345\norbit 420\nspine 263\nIncompetent cervix 1361\nIncomplete\nabortion 1338\nbowel rotation 1119\nfracture 102\nureteral duplication 1283\nIncontinence, urinary 1175\nIncreased\ndensity of falx 295\nintracranial pressure 283\nliver\nattenuation 862\nechogenicity 862\nperiventricular echogenicity 385\npulmonary\nblood flow\nwith cyanosis 739\nwithout cyanosis 740\nvasculature 748\nrenal echogenicity\ncortex 1159\nfocal 1163\nskull thickness 215\nsplenic density 882\nthyroid uptake 452\nIncreasingly dense nephrogram 1166\nIndia ink effect 1197\nIndian file growth pattern 714\nIndinavir 1288\nIndium-111\nDTPA 1402\npentetreotide 1421\nsatumomab pendetide 1399\nWBC, 1423\nInduratio penis plastica 1230\nIndurative mastopathy 731\nInevitable abortion 1338\nInfantile\naggressive fibromatosis 79",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 837,
            "markdown": "coarctation of aorta 809\ncortical hyperostosis 133\ndigital fibromatosis 201\nfibromatosis 79\nfibromatosis, orbit 423\nhemangioendothelioma of liver 939\nhemangioma\ngeneral 817\norbit 422\nhemiplegia 351\nhepatic hemangioma 939\nhydrocele 1212\nhydrocephalus 367\nlaryngeal hemangioma 490\nmyofibromatosis 79\npancreatic carcinoma 973\npolycystic kidney disease 1233\npylorospasm 1105\nrenal tubular acidosis 1257\n\n# Infarct \n\n-avid scintigraphy 1415\nbasal ganglia 372\nbone 63\nbrain 369\ncortical bone 64\nheart 831\nkidney 1252\nlacunar 372\nlung 651\nmedullary bone 64\nmesenteric 1123\nmultiple, brain 287\nmyocardium, NUC 1415\nocclusive mesenteric 1123\nomentum 1128\nperiventricular hemorrhagic 386\nplacenta 1298\nspleen 983\ntestis 1275\nwatershed 372\n\n## Infection\n\naortic graft 792\nbrain, immunocompromised patient 373\nhip prosthesis 23\norbit 424",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 838,
            "markdown": "urinary tract 1151\n\n# Infectious \n\naortitis 820\nbubbly bone lesion 11\ncolitis 1079\nenterocolitis 1079\nmyositis 133\nspondylodiskitis 252\n\n## Inferior\n\nglenohumeral ligament 40\nmesenteric artery 1031\norbital fissure 418\nshoulder dislocation 87\n\n## Inferior vena cava\n\ndiaphragm 900\ndouble 756\ninterrupted with azygos / hemiazygos continuation 797\nleiomyosarcoma 826\nobstruction 756\nsegments 772\ntransposition 756\n\n## Infertility\n\nfemale 1311\nmale 1182\n\n## Infiltrating\n\nductal carcinoma, breast 713\nepitheliosis, breast 731\nlipoma 141\nlobular carcinoma, breast 714\n\n## Infiltration of sutures 214\n\nInfiltrative process, testis \\& epididymis 1179\n\n## Inflammation\n\nesophagus 1004\nradionuclides, 1422\n\n## Inflammatory\n\naortic aneurysm 786\nbreast cancer, 683\ncardiovascular disease 757\ncholesteatoma 480\ncyst of pelvic peritoneum 1131\nenterocolitis 1079\nfibroid polyp 1106\nfibrosarcoma 1106\nmyoblastic pseudotumor 629\nmyofibroblastic tumor 1106",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 839,
            "markdown": "orbit 431\npericarditis 838\npolyp\nesophagogastric 1087\ngallbladder 947\nstomach 1092\npseudotumor\nchest 629\nGI tract 1106\norbit 431\nurinary bladder 1214\nsuperficial soft-tissue lesion 26\nInfradiaphragmatic TAPVR 783\nInfundibular\ncyst 93\npulmonary stenosis 842\ntumor 307\nInfundibuloma 343\nInfundibulum\nostiomeatal unit 455\npituitary 313\nsign 352\nInfusothorax 547\nInguinal\narterial anatomy 780\ncanal 1040\nhernia 1100\nInhalation injury 516\nInhibin A, OB test 89\nIniencephaly 373\nInjury, coronary artery 801\nInner ear\nanatomy 467\nmasses 438\nInnervation, pelvis \\& thigh muscles 46\nInnominate\nartery compression syndrome 557\nline, absence 216\nInnumerable small enhancing cerebral nodules 299\nInotropinÂ® 1437\nInsall-Salvati index 48\nInsensitivity to pain, congenital 75\nInspiratory stridor in children 444\nInspissated bile syndrome 947\nInstability of spine 260",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 840,
            "markdown": "Instep claudication 799\nInsufficiency\nfracture 103\nmitral valve 828\nof veins, chronic 808\nInsufficient cochlear turns 495\nInsular ribbon sign 369, 371\nInsulinoma 963\nIntegral uniformity, scintillation camera 1395\nInteraorticobronchial diverticulum 1005\nInteratrial septum, anatomy 767\nInterbronchial diverticulum 1005\nIntercalary veins 886\nInterdigital neuroma 152\nInterdigitation, cerebral gyri 342\nInterfrontal sinus septal cell 455\nInterhemispheric\ncyst 327\nsubdural hematoma 400\nInterleukin 665\nInterlobular septa, lung 567\nIntermetatarsal angle 55\nIntermittent claudication 796\nInternal\nauditory canal\nanatomy 464\nenhancing lesion 440\nsmall 495\ncarotid artery\naberrant 474\nanatomy 319\ncerebral vein 323\nfixation devices 32\nhernia 1101\nsupravesical hernia 1103\nInternational Reference Preparation, beta-hCG 1320\nInterrupted periosteal reaction 12\nInterruption of\naortic arch 820\nIVC with azygos continuation 797\npulmonary artery 821\nIntersegmental laminar fusion 251\nIntersex\nfemale 1181\ntrue 1182",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 841,
            "markdown": "# Interstitial \n\nacute pneumonia 623\ncalcinosis 30\ncarcinoma 633\ncell tumors, testis 1273\nchronic pneumonia 626\ncystitis 1207\ndesquamative pneumonia 627\nectopic pregnancy 1350\nedematous pancreatitis 969\nemphysema\nlung 651\nstomach 1008\ngastric emphysema 1008\nline sign, OB 1350\nlung\nanatomy 567\ndisease 523\nchronic, simulating air-space disease 527\nclassification scheme 524\ndistribution 524\nrelated to smoking 514\nedema, acute 526\nnodules, HRCT 529\nnephritis, acute 1194\norganizing pneumonia 626\npattern, lung 524\npneumonia 520\nlymphoid 626\npulmonary edema 516, 810\nusual pneumonia 627\n\n## Interstitial cells of Cajal 1108\n\n## Intertwin\n\nmembrane 1297\ntransfusion, unbalanced 1298\n\n## Interventricular septum\n\nflattening / inversion 742\nrupture 832\n\n## Intervertebral\n\ndisk anomalies 228\nforamen, enlarged 223\nosteochondrosis 249\n\n## Intervillous thrombosis, placenta 1298\n\n## Intestinal\n\nangina 1125",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 842,
            "markdown": "atresia, congenital 1067\nfluid 1037\ngas 1036\nhypoperistalsis syndrome 1220\nlipodystrophy 1146\nlymphangiectasia 1106\nobstruction 998\nin child 999\nin neonate 998\npseudoobstruction 1002\ngeneral 1107\nsyndrome 1108\ntransit time 1037\nwall, ultrasound 1033\n\n# Intimal \n\ncalcification 754\nfibroplasia 816\nflap 852\n\n## Intraabdominal\n\ncalcifications\nadult 995\nfetus 1308\nechogenic mass, fetus 1307\nfibromatosis 78,1123\nfluid 996\n\n## Intraaortic balloon pump position 562\n\n## Intraarticular\n\nbodies 15\nlocalized nodular synovitis 181\nmass 16\nosteoid osteoma 169\n\n## Intraaxial versus extraaxial mass 304\n\nIntracapsular rupture, breast implant 728\n\n## Intracardiac\n\nechogenic focus 1307\nshunt 737\nNUC 1416\n\n## Intracerebellar hemorrhage, neonate 385\n\n## Intracerebral\n\nhematoma 362\nhemorrhage, trauma 361\n\n## Intraconal lesion 411\n\n## Intracortical\n\nhemangioma 123\nosteoid osteoma 169",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 843,
            "markdown": "osteosarcoma 175\n\n# Intracranial \n\ncalcifications 295\nfetus 1304\nhemorrhage 295\nhypotension 373\nnonneoplastic cyst 294\nphysiologic calcification 295\npneumocephalus 294\npressure, increased 283\n\n## Intracystic\n\npapillary carcinoma, breast\nin situ 713\ninvasive 716\n\n## Intradecidual sign 1320\n\n## Intraductal\n\nin situ carcinoma 710\npapillary\ncarcinoma 716\nmucinous neoplasm, pancreas 947\npapillomatosis 730\n\n## Intraduodenal choledochal cyst 912\n\n## Intradural\n\nextramedullary mass 230\nlipoma 265\nmetastasis 266\n\n## Intrahepatic\n\ncholangiocarcinoma 903\npigmented stone disease 907\n\n## Intraligamentous fibroid 1389\n\n## Intralobar sequestration 597\n\nIntraluminal duodenal diverticulum 1075\nIntramammary lymphadenopathy 691\n\n## Intramedullary\n\nchondrosarcoma 73\nfixation devices 34\nlesion, cord 229\nlipoma 265\nmetastasis 266\nosteosclerosis 133\n\n## Intramembranous ossification 3\n\n## Intramural\n\naortic hematoma 821\ndissection, esophagus 1085\ndiverticulosis, esophagus 1087",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 844,
            "markdown": "-extramucosal lesions of stomach 1009\nfibroid 1389\nhematoma, esophagus 1085\nhemorrhage, GI 988\npseudodiverticulosis, esophagus 1085\nrupture, esophagus 1085\n\n# Intramuscular \n\nlipoma 141\nmyxoma 157\n\n## Intraocular\n\ncalcifications 414\nhemorrhage 427\n\n## Intraosseous\n\narteriovenous malformation 60\nbone lesion 10\ndesmoid tumor 80\nganglion 115\nkeratin cyst 93\nlipoma 140\nmeningioma 378\nIntraperitoneal rupture of bladder 1278\nIntraplacental venous lakes 1298\nIntrapulmonary bronchogenic cyst 596\nIntrarenal aneurysm 1244\nIntrasellar mass 306\nIntraspinal enteric cyst 278\n\n## Intratesticular\n\nlipoma 1215\nmass 1177\n\n## Intrathoracic\n\ngoiter 487\nmass\nfetus 1305\nlow-attenuation 539\nstomach 1103\n\n## Intrauterine\n\ndemise 1357\ndevices 1361\nfilling defect, HSG 1311\ngrowth retardation 1362\nmembrane, in pregnancy 1297\nparabiotic syndrome 1385\n\n## Intravascular leiomyosarcoma 1261\n\n## Intravenous\n\naccess, secure 1433",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 845,
            "markdown": "contrast in pediatrics 1337\ndrug abuse 843\nleiomyomatosis 1389\n\n# Intraventricular \n\nbrain tumor 299\nhemorrhage 385\nhydrocephalus 366\nmeningioma 378\nneuroblastoma 373\nneurocytoma 373\nsupratentorial tumor 300\n\n## Intravertebral\n\ngas 228\nvacuum phenomenon 264\n\n## Intrinsic\n\nasthma 584\nenergy resolution 1396\nfield uniformity test 1395\nspatial linearity 1395\n\n## Intussusception 1108\n\nappendiceal 1019\nidiopathic 1109\njejunogastric 1010\nrectum 1131\ntransient 1109\n\n## Invagination, skull base 220\n\n## Invasive\n\nbreast cancer 713\nductal carcinoma 713\nfungal sinusitis 504\nlobular carcinoma 714\nmole 1360\npulmonary aspergillosis 581\nthymoma 679\n\n## Inversion, cardiac 739\n\n## Inverted\n\nT appearance of main stem bronchus 781\nteardrop sign 728\n3 sign, pancreas 967\numbrella defect 1143\nV sign\npharynx 482\npneumoperitoneum 993\n\n## Inverting papilloma 488\n\nInvisible main pulmonary artery 749",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 846,
            "markdown": "In vitro labeling 1409\nIn vivo labeling 1409\nIn vivtro labeling 1409\nInvolucrum 170\nInvolutional calcifications, breast 722\nIodine\n$-123$\nmetaiodobenzylguanidine 1421\nspectamine, brain imaging 1400\nthyroid 1403\n-131\nmetaiodobenzylguanidine (MIBG) 1421\northoiodohippurate 1419\nserum albumin 1402\nthyroid 1403\n-deficiency goiter 486\nfluorescence imaging 1404\nload 452\n-to-particle ratio 1431\nIodocholesterol 1420\nIonescu-Shiley valve 760\nIonic\ndimers 1431\nmonomers 1431\nIotrolÂ® 1432\nIPMN 947\nIron\naccumulation\nkidney 1160\nspleen 882\ndeficiency anemia 133\ndeposition pattern 934\nmetabolism 894\nIrregular emphysema 612\nIschemia-reperfusion injury 631\nIschemic\nbowel 1123\ncardiomyopathy 805\ncolitis 1109\nencephalopathy 368\nheart disease 822\nmesentery 1123\nnecrosis of cecum 1110\nIschiopagus 1346\nIschiorectal fossa lesions 1023",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 847,
            "markdown": "Islet cell tumor 960-964\nIsocyanates 615\nIsolated\nangiomyolipoma 1201\nmild ventriculomegaly 1304\npremature\nadrenarche 1311\nthelarche 1311\nvermian hypoplasia 373\nIsospora belli 1045\nIsovue ${ }^{\\circledR} 1431$\nIsthmic spondylolisthesis 278\nIvemark syndrome 818\nCHD 736\nIvory\nphalanx 183\nvertebra 225\nIvy sign 382\n\nJaccoud arthropathy 133\nJack stone 1288\nJacobson nerve 467, 498\nJaczak phantom 1396\nJaffÃ©-Campanacci syndrome 161\nJaffÃ©-Lichtenstein disease 100\nJail-bar ribs 156\nJakob-Creutzfeldt disease 347\nJansen disease 150\nJaundice\nin older children 875\nobstructive\nin adult 874\nin neonate 875\nJaw\nclaudication 848\ncyst 218\nosteosarcoma 175\nJefferson fracture 258\nJejunal\natresia 1110\ncarcinoid 1060\ndiverticulosis 1111",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 848,
            "markdown": "diverticulum 1111\nobstruction 999\nJejunization of\ncolon 607\nileum\namyloidosis 1047\nsprue 1139\nJejunogastric intussusception 1010\nJelly belly 1135\nJeune disease 62\nJewitt-Whitmore staging 1236\nJod-Basedow phenomenon 486\nJohanson-Blizzard syndrome 878\nJoint\natlanto-occipital 236\nchondroma 203\ndisease 14\ndisorders of hand + wrist 16\nJones fracture 114\nJoubert syndrome 374\nJ-shaped sella 306\nJudet, acetabular fracture 110\nJugular\nbulb, dehiscent 304\nforamen 235\nmass 304\nmegabulb 438\nJugulotympanic paraganglioma 498\nJumpers knee 199\nJunctional parenchymal defect, kidney 1184\nJunction line\nanterior 570\nposterior 570\nJuvenile\nangiofibroma 474\naponeurotic fibroma 201\ncapillary hemangioma 124\nepiphyseolysis 14\nfibroadenoma 721\nfibromatosis 79\nlaryngotracheal papillomatosis 490\nnephronophthisis 1218\nossifying fibroma 162\nosteoporosis 4\nPaget disease 126",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 849,
            "markdown": "papillomatosis, breast 725\npilocytic astrocytoma 335\norbit 428\npolyposis 1111\nrheumatoid arthritis 189\ntropical pancreatitis 973\nxanthogranuloma 134\nJuxta\ncortical\nbone lesion 8\nchondroma 200\nosteosarcoma 174\nductal coarctation of aorta 809\nglomerular cell tumor 1214\nposition, atrial appendages 736\n\n# Kallmann disease 1311 \n\nKaposi\n-form hemangioendothelioma 825\nsarcoma 1111\nKappa statistics 1430\nKartagener syndrome 629\nKaryotyping, fetus 1295\nKasabach-Merritt syndrome 940\nKasai procedure 920\nKatayama fever 1268\nKawasaki syndrome 825\nKayser-Fleischer ring 409\nKearns-Sayre syndrome 303\nKeloid 134\nKeratin\nball, urinary tract 1204\ncyst, testis 1273\nKeratinizing squamous metaplasia 1215\nKerato\nacanthoma 134\nconjunctivitis sicca 505\ncyst odontogenic 219\nsulfaturia 153\nKeratoma, ear 480\nKeratosis obturans 488\nKerckring, folds of 1035",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 850,
            "markdown": "Kerley lines 524\nKernohan\nnotch syndrome 290\nphenomenon 360\nKeyhole\nbladder 1234\nconfiguration, tentorium 350\nKidney\nabscess 1243\nabsent outline 1158\nacidification mechanism 1188\nbilateral\nlarge 1158\nsmall 1159\ndisc 1158\nechogenicity 1185\nimaging\ngallium 1425\nin newborn 1188\ninfarction 1252\nlocal bulge of contour 1163\nmalrotation 1158\nmarginal depression 1160\nmass 1161\navascular 1162\ncalcified 1162\nfat-containing 1163\nfluid-filled 1162\ngrowth pattern 1162\nhyperattenuating on NECT 1163\nin neonate 1161\nin older child 1161\nmultiloculated 1164\nunilateral 1162\nnonvisualization on IVP 1158\npancake 1158\npelvic 1157\npseudotumor 1163\nradionuclide imaging 1418\n-shaped cecum 1066\nsinus mass 1168\nsize 1185\nstones 1286\nsyndromes with multiple cortical cysts 1164\ntransitional cell cancer 1278",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 851,
            "markdown": "unilateral\nlarge smooth 1158\nsmall 1159\nKienbÃ¶ck disease 65\nKillian\ndehiscence 1147\n-Jamieson diverticulum 1112\nKimura classification 910\nKine vac ${ }^{\\circledR} 1029$\nKinking of aorta 840\nKirklin\nmeniscus complex 1094\nsign 1105\nKissing\ncousin sign, heart 749\nsequestra 210\nulcers 1076\nKite angle 55\nKlatskin tumor 904\nKlebsiella pneumonia 630\nKleeblattschÃ¤del 215\nKlein line 94\nKlinefelter syndrome 134\nKlippel\n-Feil syndrome\nCHD 736\ndescription 264\n-TrÃ©naunay\nsyndrome 134\n-Weber syndrome 179\nKlumpke paresis 245\nKnee\nbone contusion pattern 24\nextensors 48\nfracture 112\njoint effusion 86\nKnuckle sign, lung 654\nKoch triangle 766\nKoenen tumor 405\nKÃ¶hler disease 66\nKohn and Lambert pores 519\nKommerell diverticulum 825, 845\nKÃ¶rner septum 464\nKovale vski canal 268\nKrabbe disease 358",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 852,
            "markdown": "Krukenberg tumor 1364\nKrypton-81m 1406\nKugel collateral 770\nKulchitsky cells 587, 645\nKÃ¼mmell disease 264\nKupffer cell sarcoma 937\nKuru 347\nKussmaul sign 837\nKÃ¼ttner tumor 481\nKveim-Siltzbach test 665\nKwashiorkor 973\nKyphosis dorsalis juvenilis 275",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 853,
            "markdown": "Labeled leukocyte imaging 1422\nLabral tears, shoulder 135\nLabyrinthine aplasia 495\nLabyrinthitis 488\nLacelike trabecular pattern 667\nLaceration, lung 586\nLachman test 76\nLacrimal gland lesion 415\nLactate dehydrogenase 983\nLactating\nadenoma 725\npatients, radionuclides 1393\nLactational\nabscess 704\nmastitis 729\nLactic dehydrogenase 888\nLactogenesis 702\nLacunae of Morgagni 1192\nLacunar\ninfarction 372\nskull 265\nLadd bands 1112\nLady Windermere syndrome 647\nLaimer triangle 1147\nLamina papyracea 454\nLaminar necrosis, brain 372\nLamy-Bienenfeld disease 149\nLanger\ndisease 149\n-Saldino disease 57\nLangerhans\nbodies 136\ncell 136\ncell histiocytosis 136\nlung 651\nLanghans giant cells\nCrohn disease 1068\ntuberculosis 681\nLaplace law 786\nLarge\nairways 567",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 854,
            "markdown": "cardiac silhouette + pleural effusion 548\ncisterna magna 1304\ncolumn of Bertin 1163\nhead, fetus 1301\nnonobstructed CBD 875\nnonstenotic ulcers of small bowel 1014\nsolid adrenal mass 1156\nutricle 1179\nvestibule 495\nLarge cell\ncarcinoma, lung 594\nneuroendocrine carcinoma 646\nundifferentiated carcinoma, lung 594\nLariat sign 728\nLarva\ncurrens 1142\nmigrans, eye 421\nLaryngeal\ncarcinoma 488\nchondrosarcoma 489\ncleft 489\ncyst 489\nedema, contrast reaction Endpaper A\nhemangioma 490\nmucoepidermoid carcinoma 494\nneoplasms 444\npapillomatosis 490\npenetration 1034\nplasmacytoma 490\nsaccule 459\nLaryngitis, acute viral spasmodic 482\nLaryngo\ncele 490\nmalacia 491\ntracheobronchitis, acute 482\nLarynx, anatomy 459-472\nLasix ${ }^{\\circledR} 1437$\nLasso sign 728\nLate\nflattening IUGR 1364\n-onset dwarfism 1301\nLateral\ncollateral ligament, knee 49\ndisk herniation 251\nepicondylitis 138",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 855,
            "markdown": "facial cleft 1355\nlumbar meningocele 268\nmeningocele 388\nthoracic meningocele 268\numbilical fold 1332\nLatzko triad 1356\nLaurence-Moon-Biedl syndrome 139\nLayers of intestinal wall, ultrasound 1033\nLDH 888\nLead\n-pipe\ncolon 1144\nfracture 102\npoint, GI 1108\npoisoning 90\ntime bias 1429\nLeaking aortic aneurysm 787\nLeborgne's law 705\nLE cells 672\nLedderhose disease 202\nLe Fort fracture\nankle 114\nskull 254\nLeft\naortic arch\nwith aberrant right subclavian artery 825\natrial enlargement 742\natrium, anatomy 767\ncircumflex artery 767\ncoronary artery, anatomy 768\ndominant coronary circulation 769\nisomerism 819\nIVC 756\n-sided pleural effusion 548\nsuperior vena cava 755\n-to-right shunts 737\nupper lobe collapse 540\nventricular\nanatomy and projections, NUC 1407\naneurysm 857\nconcentric hypertrophy 741\nconfiguration 794\nenlargement 742\nfailure 752\ninflow tract obstruction 752",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 856,
            "markdown": "outflow tract\nabnormal 755\nobstruction 755\nLegg-CalvÃ©-Perthes disease 66\nLegionella pneumonia 630\nLegionnaires disease 630\nLeigh disease 374\nLeiomyoma\nbenign metastasizing 1390\nesophagus 1112\nkidney 1214\nmultiple vascular 79\nsmall bowel 1113\nurinary bladder 1173\nuterus 1388\nLeiomyomatosis, esophagus 1113\nLeiomyomatous hamartoma, kidney 1220\nLeiomyosarcoma\nheart 803\nIVC 826\nkidney 1214\nretroperitoneum 1261\nsmall bowel 1113\nstomach 1113\nuterus 1390\nLemierre syndrome 491\nLemon sign\nDDx 1304\nencephalocele 339\nmyelomeningocele 268\nLength-time bias 1429\nLens dislocation 427\ndownward 127\nupward 145\nLenticulostriate vasculopathy 303\nLentigo maligna 1426\nLeontiasis ossea 100, 215\nLEOPARD syndrome 842\nLepedic growth 590\nLeprosy 139\nLeptocytosis, hereditary 206\nLeptomeningeal\ncyst 264,331\ndisease 304\nenhancement 298",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 857,
            "markdown": "Leptomeninges 310\nLeptomeningitis 379\nLÃ©ri\ndisease 146\n-Layani-Weill syndrome 91\nLesch-Nyhan syndrome 120\nLesions involving stomach and duodenum 1011\nLesser\nomentum 1039\nsac 1038\nhernia 1102\nsaphenous vein 778\nLethal bone dysplasia 1301\nLetournel acetabular fracture 110\nLetterer-Siwe disease 138\nLeukemia\nbone 139\nchronic\ngranulomatous 7\nmyelogenous 7\nCNS 376\ncongenital 1310\nkidney 1214\ntestis 1274\nLeukemic lines, bone 139\nLeukoariaosis 337\nLeukocyte scintigraphy 1422\nLeukocytoclastic vasculitis 828\nLeukodystrophy 301\ngloboid cell 358\nmetachromatic 380\nLeukoencephalitis, acute hemorrhagic 353\nLeukoencephalopathy 301\nperiventricular 385\npostviral 353\nprogressive multifocal 397\nradiation-induced 382\nsyndrome, posterior reversible 396\nLeukokoria 415\nLeukomalacia, periventricular 385\nLeukoplakia, kidney 1215\nLeukorrhea 1343\nLevel\nII OB ultrasound 1293\nI OB ultrasound 1293",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 858,
            "markdown": "Levine shunt 1418\nLevocardia 739\nLewy bodies dementia 350\nLeydig cell\nhyperplasia, testis 1215\ntumor\novary 1382\ntestis 1273\nLhermitte-Duclos disease 356\nLichtenstein-JaffÃ© disease 100\nLichtman classification, lunatomalacia 65\nLi-Fraumeni syndrome\nadrenocortical neoplasm in children 1198\nglioblastoma multiforme 357\nLigament of\nBotallo\nanatomy 754\ncalcium deposition 746\nHumphrey 49\nWrisberg 49\nLigaments\ncarpus 43\ncruciate 48\ndefinition 1037\ngastric 1039\nglenohumeral 40\nknee 48\npelvis 1331\nperitoneal 1039\nLigamentum\nteres\nhepatic fissure 887\nnotch 993\nsign 993\nventral mesentery 1039\nvenosum 887\nLightwood syndrome\nrenal tubular acidosis 1258\nLillehei-Kaster valve 760\nLimb\n-body wall complex 1365\nreduction anomalies 1302\nin fetus 1303\nLimbus vertebrae 224\nLimited Wegener granulomatosis 860",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 859,
            "markdown": "Limping child 1\nLimulus amoebocyte lysate test 1394\nLimy bile 954\nLincoln log vertebrae 197\nLindau tumor 408\nLinear\nemphysema 612\nphosphates 1421\nLinearity\ncalibrator 1395\nlung pattern 524\nscintillation camera 1395\nLingual thyroid 491\nLinguine sign, breast 728\nLinitis plastica 1009\nLip, cleft 1355\nLipid\ncell tumor 1382\ncholecystitis 946\npneumonia, endogenous 649\nLipo\nblastic meningioma 378\nblastoma 139\nblastomatosis\nchildhood 140\ncalcinogranulomatosis 210\ndystrophy\nintestinal 1146\nmesenteric 1138\nfibroadenoma, breast 724\nfibromatosis 140\ngranuloma of mesentery 1137\ngranulomatosis, disseminated 96\nleiomyoma, uterus 1390\nmyelomeningocele 265\nnecrosis macrocystica calcificans 720\nsarcoma 141\nbreast 732\nretroperitoneal 1261\nsclerotic mesenteritis 1137\nLipoid\ngranulomatosis 614\npneumonia 630\nLipoma\narborescens 141",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 860,
            "markdown": "bone 140\nbrain 374\nbreast 726\ncorpus callosum 374\nGI tract 1113\nheart 801\ninfiltrating 141\nliver 948\nmediastinum 552\nscrotum 1215\nsoft-tissue 140\nspermatic cord 1215\nspine 265\n\n# Lipomatosis \n\nbenign symmetrical 493\nileocecal valve 1018\nmediastinum 639\nmultiple symmetric 552\npancreatic 964\npelvic 1229\nrenal sinus 1268\n\n## Lipomatous\n\nhypertrophy of interatrial septum 826, 767\ntumor 27\n\n## Lipomul 875\n\nLippes loop 1361\nLisch nodules 389\nLisfranc fracture 115\nLissencephaly 375\nLithium-induced nephrotoxicity 1215\nLitho\ngenic index 912\nkelyphopedion 1351\nkelyphosis 1351\npedion 1351\nLittle league\nelbow 105\nshoulder 105\nLittrÃ©\nglands 1192\nhernia 1101\nLiver\nabscess 933\nadenoma 935\nattenuation 887",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 861,
            "markdown": "increased 862\ncalcifications 866\ncandidiasis 901\ncapsule 887\ncirculation 868\ncirrhosis 914\ncomet-tail artifact 873\ncyst 937\ncystic lesion 864\ndiffuse\ndisease 861\nenlargement 861\nechogenicity 887\nenzymes 887\nfibrosis, congenital 920\nfissures 887\nfluke, Chinese 919\nfocal scintigraphic defects 867\nhemangioma 938\ninfantile 939\nincreased echogenicity 862\ninjury categories 1054\nlesion\nbull's-eye 864\nfocal hot 867\nmiliary 864\nmultiple 864\nwith central scar 866\n-lung disorders 515\nmass 862\nfat-containing 864\nhyperintense 865\nhypervascular 866\nin chronic liver disease 866\nin normal liver 866\nhypovascular 866\nlow-density\nin porta hepatis 868\nwith enhancement 866\nring-enhancing 866\nsolitary echogenic 864\nuptake of superparamagnetic iron oxide particles 866\nwith capsule 865\nwith echogenic rim 864\nmetastasis 952",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 862,
            "markdown": "mottled uptake 867\nnormal hemodynamic parameters 886\nperfusion, variations 868\nscintigraphy 1417\nsegments, functional anatomy 884\nsize 887\nsolitary lesion 863\n-spleen scan 1417\ntests 887\nthird inflow 886\ntransient parenchymal enhancement 868\ntransplant 948\nbiliary complications 950\nparenchymal complications 950\nvascular complications 948\ntrauma 1054\n\n# Lobar \n\ndensities + pleural effusion 548\ndysmorphism, kidney 1164\nemphysema, congenital 603\nholoprosencephaly 365\nnephronia 1240\npneumonia 519\nrenal infarction 1253\n\n## Lobstein disease 167\n\n## Lobster claw\n\nhand 1302\nsign, papillary necrosis 1228\n\n## Lobular\n\nbronchiole 567\ncalcifications, breast 688\ncapillary hemangioma 124\ncarcinoma in situ, breast 713\nmicrocalcifications, breast 687\nneoplasia, breast 684\npneumonia 519\n\n## Lobule\n\nbreast 699\nlung 567\n\n## Local\n\nanesthesia 1440\nbulge in renal contour 1163\n\n## Localized\n\nairspace disease 523\nangiofollicular lymph node hyperplasia 599",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 863,
            "markdown": "caliectasis 1167\nCastleman disease 599\ncoarctation 809\ncolonic narrowing 1021\ncystic disease, kidney 1215\nemphysema 612\nfibrous mesothelioma 641\nileus 1002\nlucent lung 543\nlymphangioma 603\nneurofibroma 272\nosteopenia 7\nosteoporosis 4\nLocked facets 257\nLoeys-Dietz syndrome 753\nLÃ¶ffler syndrome 613\nLÃ¶fgren syndrome 665\nLollipop-tree, bile ducts 920\nLong\n-acting thyroid-stimulating factor 421\nsegmental diaphyseal uptake, NUC 2\nsmooth esophageal narrowing 1005\nLongitudinal\nesophageal folds 1004\nvaginal septum 1388\nLongus colli tendinitis 476\nLoop-to-loop colon, renal ectopia 1157\nLoose intraarticular bodies 15\nLoosening, hip prosthesis 24\nLooser\nlines 182\nzones 182\nLost IUD 1362\nLove test 119\nLow\nalpha-fetoprotein 1295\n-attenuation abdominal adenopathy 1028\nback pain, childhood 213\nconus medullaris 280\n-density\nhepatic mass with enhancement 866\nmass in porta hepatis 868\nmesencephalic lesion 294\nnodes, neck 448\nretroperitoneal mass 1152",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 864,
            "markdown": "suprasellar lesion with hydrocephalus 307\n-flow priapism 1235\n-grade astrocytoma 334\n-lying placenta 1379\n-profile\nIUGR 1364\nmitral valve 805\nLower\nesophageal\nmucosal ring 1137\nnarrowing 1006\nsphincter 1033\ngastrointestinal hemorrhage 988\nlobe reticulations 528\nmoiety ureter 1283\nrespiratory tract infection 520\nLoyola, Ignatius 899\nL-transposition 852\nLucent lesion\nfinger 20\nlung 542\nLuciani-Wenckebach phenome non 1357\nLucid interval 355\nLÃ¼ckenschÃ¤del 265\nLudwig angina 491\nLuetic\naortitis 820\ndiaphysitis 204\nLuftsichel sign 540\nLuke and Collins classification 634\nLumbar\ndisk herniation 251\nmeningocele 268\nspinal stenosis 278\nLumbosacral\nplexus 47\npostsurgical syndrome 213\ntransitional vertebra 240\nLump kidney 1158\nLunate fracture 109\nLunatomalacia 65\nLung\nabnormal patterns 522\ncancer 591\nasbestos related 580",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 865,
            "markdown": "capacities 568\ncavity 544\ncirculation 568\ncompliance 569\nconsolidation 522\ncontusion 586\ncyst 544\ntraumatic 587\ndensity 541\ndevelopment 567\ndisease\nassociated with cigarette smoking 514\nCT angiogram sign 523\nend-stage 527\ninterstitial 523\nmacronodular 528\nmicronodular 528\nnodular 528\nreticulonodular 528\nwith chest wall extension 561\nedema 515\nfluke 392\nchest 647\nfunction 568\ngranuloma 617\nhamartoma 617\nimaging, gallium 1425\ninfarct 651\ninfiltrates\nchronic, in childhood 541\ndiffuse, in immunocompromised 541\ndistribution 524\nfleeting 542\nin neonate 521\ninterstitium 567\nlaceration 586\nlesion\ncystlike 545\ndense 539\nlucent 542\nmass 533\nlarge 537\nwith air bronchogram 538\nmetastasis 642\nmycotic infection 519",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 866,
            "markdown": "nodule 533\ncalcified 539\ncavitating 537\nhemorrhagic 536\nmultiple 538\nsmall 539\nPET imaging 1406\nshaggy 538\nwith pneumothorax 539\nperfusion\ndefects 660\nradionuclides 1405\nunilateral 660\nscintigraphy\nall agents 1405\ngallium 1425\nsegments\nbronchopulmonary anatomy 564\ncross-sectional anatomy 566\nV/Q scan 658\nstone 619\ntorsion 679\ntransplant 631\n\n+ pulmonary edema 518\ntumor\nbenign 536\nin childhood 536\nvolumes 568\nzones 570\nLupus\nerythematosus\ndrug-induced 673\nsystemic 672\npernio 668\nLuschka\nducts 890\nforamen 349\nLusorian artery 845\nLuteal phase 1334\nLuteinized the coma 1383\nLutembacher syndrome\natrial septal defect 797\nmitral stenosis 830\nLuxatio erecta 87\nLuxation",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 867,
            "markdown": "heart 801\n\n# Luxury perfusion \n\nbrain infarct 369\ncarotid artery stenosis 477\nsyndrome 370\nLye 1087\nLyme arthritis 143\nLymphadenitis, mesenteric 1123\nLymphadenopathy\n-associated virus 574\naxillary 691\nbreast 690\nin AIDS\nabdomen 1045\nchest 574\nregional pattern, abdomen 1027\nsyndrome, generalized 575\nLymphangiectasia\ncongenital 1106\nIntestinal 1106\nkidney 1262\nlung 603\nparapelvic 1252\nLymphangio\nleiomyomatosis 632\nmyomatosis, lung 632\nscintigraphy 1400\nLymphangioma\nadrenal gland 1262\nbreast 692\nkidney 1262\nlung 603\nmesentery 1114\nneck 492\norbit 425\nretroperitoneal 1262\nLymphangiomatosis\nbone 143\nlung 611\nLymphangitic carcinomatosis 633\nLymphatic\ndevelopment 492\ndrainage, breast 700\ndysplasia 826\nmalformation 857",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 868,
            "markdown": "Lymphedema\nperiportal 870\nprecox 827\nprimary 826\nLymph node\nbreast imaging 690\nenlarged\nin neck 448\nwith low-density center 1028\nhyperplasia\nangiofollicular 599\nbenign giant 599\nlevel in neck 473\nlow-density, neck 448\nLympho\ncele\npelvis 1216\nrenal transplant 1255\nepithelioma 306\ngranuloma venereum 1114\nhistiocytosis, hemophagocytic 364\nproliferative disease 637\nLymphoblastic NHL 636\nLymphocytic interstitial pneumonitis 626\nLymphoid\nhamartoma 599\nhyperplasia, GI tract 1114\nhypophysitis 375\ninterstitial pneumonia 626\nnodular hyperplasia 646\nLymphoma\nAIDS-related\nkidney 1193\nlung 575\nbone 143\nbrain 375\nbreast 726\nextranodal marginal zone B-Cell 1117\nfollicular 1117\ngallium scintigraphy 1426\nGI tract 1114\nclassification 1115\nheart 827\nHodgkin 620\nkidney 1216",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 869,
            "markdown": "liver 950\nlung 634\nMALT 1117\nmantle cell 1117\nmesentery 1118\nnon-Hodgkin 634\norbit 425\npancreas 951,879\nperipheral T-Cell 1117\nprimary\nbone 143\nlung 649\nretroperitoneum 1262\nspinal\ncord 265\nepidural 376\nspleen 881\nsystemic brain 376\ntestis 1274\nurinary bladder 1173\nvitreous 414\nLymphomatoid granulomatosis 636\nLymphomatous polyposis 1115\nLymphoplasmacytic sclerosing pancreatitis 972\nLymphoproliferative\nmalignancies 515\nLynch syndrome 1065\nLytic bone lesion\nin patient $<30$ years of age 11\non both sides of joint 11\nsurrounded by marked sclerosis 11\n\nMacCallum patch 746\nMackenrodt ligament 1332\nMackler triad 1056\nMacLeod syndrome 672\nMacro\nadenoma, pituitary 395\nconidia 619\ndystrophia lipomatosa 144\nglobulinemia, WaldenstrÃ¶m 1146\nglossia 1305",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 870,
            "markdown": "somia 1365\n\n# Macrocystic \n\nadenoma, pancreas 955\nlesion, pancreas 880\nMacrodantin ${ }^{\\circledR}$, lung damage 515\nMacronodular\ncirrhosis 917\nlung disease 528\nMacrophthalmia 414\nMacroscopic lesions, placenta 1298\nMadelung\ndeformity\ndyschondrosteosis 91\nTurner syndrome 211\ndisease 493\nMaffucci syndrome 93\nMagendie foramen 349\nMagic angle effect 194\nMaiden waist deformity 1260\nMain\nduct IPMT 947\npulmonary artery, invisible 749\n-stem bronchus, inverted-T appearance 781\nMainline granulomatosis 652\nMaisonneuve fracture 114\nMajewski syndrome 196\nMakar stricture 1267\nMalabsorption 991\nMaladie de Roger 858\nMalakoplakia, GU 1217\nMalar\nfracture 256\nhypoplasia 208\nMalaria 638\nMaldescended testis 1217\nMale\nbreast disease 687\ninfertility 1182\npseudohermaphroditism 1181\nTurner syndrome 161\nMalformation\ncavernous 423\ncongenital pulmonary 522\nvascular 758\nMalgaigne fracture 111",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 871,
            "markdown": "Malherbe, calcifying epithelioma 28\nMalignant\nangioblastoma 59\nbone aneurysm 177\ncalcifications, breast 688\ncarcinoid, ovary 1383\nduodenal tumors 1013\nexternal otitis 493\nfibrous\nhistiocytoma 101\nxanthoma 101\ngastric ulcer 1093\ngerm cell tumor, ovary 1372\nheart tumors 744\nlymphoma 634\nmelanoma 1118\nbrain metastasis 381\ngallium imaging 1426\nuvea 431\nmesenchymoma 984\nmesothelioma 1131\nnephrosclerosis 1253\noptic glioma of adulthood 429\notitis 438\nperipheral nerve sheath tumor 273\nphyllodes tumor 731\npleural mesothelioma 641\nsmall bowel tumors 1018\nteratoid tumor, mediastinum 675\nteratoma, ovary 1372\nthymoma 679\nMalleolar fractures 113\nMallet finger 188\nMallory-Weiss syndrome 1118\nMal perforans 83\nMalpositioned\ncentral venous line 562\nnasogastric tube 562\nseptum primum 797, 827\nSwan-Ganz line 562\ntestis 1217\ntracheal tube 562\nMalrotation\nintestinal tract 1119\nkidney 1158",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 872,
            "markdown": "MALT lymphoma 1117\nstomach 1116\nMalt worker's lung 615\nMammary\nduct ectasia 726\ndysplasia 722\nproliferative disease 722\nMammography\nevaluation of mass 684\nfilm reading 694\nimage quality 703\nreport 695\nscreening 706\ntechnique 702\nMammoplasty 727\nMandible\nhypoplasia 216\nlesions by location 217\nlingual salivary gland inclusion defect 219\nosteolysis 218\nsclerotic lesions 217\nsolid\nbenign lesions 217\nmalignant lesions 217\nvascular lesions 217\nMandibular nerve 317\nMandibulofacial dysostosis 208\nMantle cell lymphoma 1117\nMANTRELS scoring system 1049\nManubrium, hypersegmentation 89\nMaple\nbark disease 615\nsyrup urine disease 302\nMarble bone disease 173\nMarbling of pancreas 964\nMarcus Gunn pupil 383\nMarfan syndrome\nbone 144\nCHD 736\nMarginal\nartery of Drummond 1031\nsyndesmophyte 242\nMarie-Bamberger disease 130\nMarine-Lenhart syndrome 449\nMarked sclerosis surrounding osteolysis 11",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 873,
            "markdown": "Maroteaux-Lamy disease\nmucopolysaccharidosis 152\npyknodysostosis 183\nMartorell sign 799\nMartorell syndrome 847\nMassive\nfibrosis, progressive 602\nhemoptysis 513\nosteolysis 143\novarian edema 1365\npleural effusion 547\nsubchorial thrombosis 1378\nMasson bodies 590, 625\nMass within lung cavity 544\nMasticator space\nanatomy 462\nmass 442\nMastitis 728\nfibrosa cystica 722\ngranulomatous 729\nnonpuerperal 729\nobliterans 726\nplasma cell 726\npuerperal 729\nMastocytosis 1120\nMature\ncystic teratoma, ovary 1347\nteratoma, mediastinum 675\nMaxillary\nnerve anatomy 317\nsinus 454\ncarcinoma 499\nhypoplasia 216\nopacification 440\nMaxillomandibular arch 456\nMaximal midexpiratory flow rate 569\nMayer-Rokitansky-KÃ¼ster-Hauser syndrome 1386\nMay-Thurner syndrome 827\nMazabraud syndrome 99\nMazoplasia 722\nMCA dot sign 370\nMcArdle disease 932\nMcCallum patch 829\nMcConnell sign 653\nMcCune-Albright Syndrome 100",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 874,
            "markdown": "McGregor line 235\nMcKusick\ndisease 150\n-Kaufman syndrome 1391\nMcRae line 235\nMeandering pulmonary vein 749\nMeasles, atypical pneumonia 584\nMechanical intestinal obstruction 998\nMecholyl test 1061\nMeckel\ncave 315\ndiverticulum 1120\n-Gruber syndrome 1218\nMeconium\naspiration syndrome 639\nileus 1121\nequivalent 1072\npassage 998\nperitonitis 1121\nplug syndrome 1122\npseudocyst 1122\nMedial\ncalcification 754\ncollateral ligament 48\ndissection 816\nfibroplasia 816\nhyperplasia 816\ntibial stress syndrome 196\numbilical fold 1332\nMedian\narcuate ligament compression 828\ncleft lip 365\nfacial cleft 1355\numbilical ligament 1332\nMediastinal\nbronchogenic cyst 596\ncollagenosis 640\ncyst 552\nfat 552\nfibrosis 640\ngranuloma, histoplasmosis 619\nhematoma 550, 853\nlipomatosis 639\nmass 553\nin fetus 1305",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 875,
            "markdown": "low-attenuation 552\nshift 551\nin neonate 521\nteratoid tumor 674\nwidening, acute 550\nMediastinitis 639\nchronic 640\nfibrosing 640\nnecrotizing descending 639\nMediastinum\nanatomy 570\ntestis 1190\nMediterranean\nanemia 206\nlymphoma 1114\nMedronate 1421\nMedullary\ncarcinoma\nbreast 715\nkidney 1219\nthyroid 508\ncystic disease 1218\nfibroma 1259\ninfarction, bone 64\nnephrocalcinosis 1169\nnephrogram 1218\nrenal tumor 1219\nsponge kidney 1219\nMedulloblastoma 376\nMedulloepithelioma 426\nMegabulb\nduodenum 1013\njugular 438\nMegacalicosis 1219\nMegacisterna magna 377, 315\nMegacolon\naganglionic 1104\ntoxic 1142\nMegacystis-microcolon syndrome 1220\nMegaduodenum 1013\nMegaesophagus 1003\nMegalencephaly, unilateral 406\nMegalo\ncornea 145\ncystis-microcolon-intestinal-hypoperistalsis 1220",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 876,
            "markdown": "ureter 1220\nurethra 1239\nMegaureter 1171\ncongenital primary 1220\nMeglumine 1189\nMegophthalmos 419\nMeigs\n-Salmon syndrome 547\nsyndrome 1365,1371\nMeissner plexus 1104\nMelanocytoma 377\nMelanoma 1118\neye 431\nMelanosis coli 1122\nMELAS 303\nMelorheostosis 146\nMelting sign, lung 654\nMembrane\nintrauterine 1297\nof Toldt 1186\nMembranous\nbronchiole 567\nsubaortic stenosis 755\nurethra 1192\nventricular septal defect 858\nMEN 956\nMenarche 1334\nMendelson syndrome 584\nMÃ©nÃ©trier disease 1122\nMÃ©niÃ¨re disease 437\nMeningeal\nartery 325\ncarcinomatosis\nbrain 381\nspine 266\ncyst 265\nenhancement sign 371\nhemangiopericytoma 378\nMeninges\nbrain 310\nspinal cord 237\nMeningioma 377\natypical 378\ncystic 378\nDDx to schwannoma 378",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 877,
            "markdown": "ectopic 378\nen plaque 377\nglobular 377\nintraosseous 378\nintraventricular 378\nlipoblastic 378\nmulticentric 377\noptic nerve sheath 429\nperioptic 429\nsphenoid wing 378\nspine 266\nsuprasellar 379\nMeningiomatosis 390\nMeningitis 379\naseptic 379\nbasilar 379\ncarcinomatous 381\nchemical 379\ndermoid of CNS 345\nepidermoid of CNS 345\nfungal 380\ngranulomatous 379\npurulent 379\ntuberculous\nbrain 403\nspine 281, 404\nMeningocele\ndorsal 268\nlateral, neurofibromatosis 388\nlumbar 268\nsacral 268\nsimple 221\nthoracic 268\ntraumatic 268\nMeningoencephalitis, primary amebic 353\nMeningoencephalocele 338\nMeningofacial angiomatosis 399\nMeningohypophyseal trunk 319\nMeningovascular neurosyphilis 205\nMeniscal\ncyst 147\nextrusion 147\nflounce 50\nMeniscofemoral ligaments 49\nMeniscus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 878,
            "markdown": "sign, lung 923\ntear 147\nMenopause 1331\nMenorrhagia 1389\nMenstrual\nage 1324\nphase, endometrium 1330\nMensuration of fetus 1324\nMercedes-Benz sign\naorta 790\ngallstone 912\nMercury 601\nembolism 661\nMeromelia 1300\nMERRF 303\nMesencephalic low-density lesion 294\nMesencephalon 311\nMesenchymal\nchondrosarcoma 74\nfetal tumor of kidney 1220\nhamartoma, liver 951\ntumor, GI tract 1008\nMesenchymoma\nbenign 141\nchest wall 617\nMesenteric\nadenitis 1123\ncalcification 995\ncyst 1027,1126\nedema 1027\nfibromatosis 1123\ninfarction 1123\nischemia 1123\nlipodystrophy 1138\nlymphadenitis 1123\nlymphoma 1118\nmasses 1026\npanniculitis 1138\nvenous thrombosis 1125\nWeber-Christian disease 1137\nMesenteritis\nchronic fibrosing 1137\nliposclerotic 1137\nretractile 1138\nMesenteroaxial volvulus, stomach 1095",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 879,
            "markdown": "Mesentery\ndefinition 1037\nshort 1026\nsmall bowel 1038\nMesial temporal sclerosis 380\nMesoatrial shunt 979\nMesoblastic nephroma 1220\nMesocardia 739\nMesocaval shunt 979\nMesodermal dysplasia 72\nMesomelia 1300\nMesomelic dwarfism 149\nMesonephroid tumor, ovary 1345\nMesonephros 1183\nMesothelial cyst 1126\nMesothelioma\nchest 641\npericardium 836\nperitoneum 1131\nMesotympanum 465\nMesovarium 1332\nMetabolic calcification 29\nMetacarpal\nindex 144\nsign 20\nMetachromatic leukodystrophy 380\nMetachronous\ntesticular tumor 1275\ntransitional cell carcinoma 1277\nMetanephric\nadenoma 1221\nblastema 1184\nvesicles 1184\nMetanephros 1183\nMetaphyseal\nchondrodysplasia 149\ndysplasia 150\nlesion 8\nMetaphysis\ndense bands 3\nfrayed 7\ntransverse lucent lines 7\nMetaphysitis 204\nMetaplastic breast cancer 715\nMetaproterenol 1437",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 880,
            "markdown": "# Metastasis \n\nadrenal 1221\nof benign tumor to lung 643\nbone 150\nbrain 380\nbreast 729\ncolon 1126\ndrop metastasis in thecal sac 267\ngallbladder 952\nGI tract 1126\nheart 744\nkidney 1221\nliver 952\nlung 642\nneck nodes 448\norbit 426\npancreas 954\nperitoneum 1132\npleura 643\nsmall bowel 1127\nspinal canal 266\nspleen 881\nstomach 1127\ntestis 1274\nureter 1221\nvertebra 266\nvertebral compression fracture 261\nMetastasizing benign leiomyoma 1390\n\n## Metastatic\n\nbreast cancer 706\nsoft-tissue calcification 29\nMetatropic dysplasia 152\nMetencephalon 311\nMetformin 1434, 1436\nMethadone, lung damage 515\nMethanol poisoning 302\nMethimazole 133\nMethotrexate 515\nectopic pregnancy 1350\nosteopathy 90\nMethylene diphosphonate 1421\nMethylmalonic acidemia 302\nMethylprednisolone 1437\nMetopic suture, persistent\ncleidocranial dysostosis 75",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 881,
            "markdown": "trisomy E syndrome 209\nMetrorrhagia 1389\nMexican hat sign 1092\nMeyerding method 278\nMichaelis-Gutmann bodies 1217\nMichel aplasia 495\nMichels classification 885\nMickey Mouse ears\nfrontal horns 366\npelvis 89\nMicroabscesses\nliver 935\nspleen 881\nMicroadenoma, pituitary 395\nMicroangiopathy, mineralizing 382\nMicrocalcifications, breast 687\nMicrocephaly 382\nMicrocolon 1021\n-megacystis syndrome 1220\nMicroconidia 619\nMicrocystic\nadenoma, pancreas 981\nlesion, pancreas 880\npancreatic lesion 981\nMicrodactyly of big toe 97\nMicrogallbladder 607\nMicrogastria 819\nMicrognathia 216\nMicrohamartomas, liver 956\nMicrolithiasis\nalveolar 576\ntesticular 1275\nMicromelia 1300\nMicromelic dwarfism 1301\nMicronodular\ncirrhosis 917\nlung disease 528\nMicrophthalmia 414\nMicropolyspora faeni 615\nMicroscopic polyangiitis 828\nMicturition attack 1173\nMidazolam 1437\nMidbrain 311\nMidbrain syndrome, progressive 348\nMiddle",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 882,
            "markdown": "cerebral artery 320\near\nanatomy 465\nmass 438\nglenohumeral ligament 40\nmediastinal mass 554\nMidgut volvulus 1127\nMidline\ngranuloma 860\nnasal mass, congenital 441\nMigraine 301\nMigration\nneurons 310\nplacenta 1379\ntestis 1184\nMigratory\nosteoporosis, regional 207\npulmonary opacities 523\nMikulicz disease 493\nMiliary\nhepatosplenic lesions 864\nnodules 528\npulmonary tuberculosis 681\nMilk-alkali syndrome 1169\nMilkman\nfracture 186\nsyndrome 182\nMilk of calcium\nbile 954\nurinary tract cyst 1162\nMilky way, breast 694\nMilroy disease 826\nMilwaukee shoulder 163\nMineral\ncomposition, renal stones 1286\noil aspiration 630\nMineralizing\nmicroangiopathy 382\nvasculopathy 303\nMiniaturized mitral valve 805\nMinicalyx 1239\nMiracidia\nparagonimiasis 647\nschistosomiasis 981\nMirenaÂ® 1361",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 883,
            "markdown": "Mirizzi syndrome 954\nMirror image aneurysm 331\nMisery perfusion, brain 372\nMissed\nabortion 1339\ntesticular torsion 1270\nMisty mesentery sign 1027\nMitchell\nclassification 64\nMitochondrial encephalomyelopathies 302\nMitral\ninsufficiency 828\nregurgitation 828\nstenosis 829\nvalve\nanatomy 764\ncalcification 746\nof annulus 746\ncongenital abnormality 736\nflail 817\nfloppy 830\nhammocklike posterior bowing 831\nlow-profile 805\nmass 745\nminiaturized 805\nprolapse 830\nsystolic anterior motion 741, 806\nMittelschmerz 1334, 1368\nMixed\nconnective tissue disease 643\nepithelial and stromal tumor 1222\nfat-water density lesion, breast 685\ngerm cell tumor 1272\ngonadal dysgenesis 1181\nIUGR 1364\nsclerotic and lytic lesion 11\nMobile duode num 1035\nMobitz heart block 1357\nModerator band, heart 762, 765\nModic endplate changes 249\nModiolus 467\nMolar\npregnancy 1360\ntooth\nfracture 255",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 884,
            "markdown": "sign 374\nMole\nBreus 1378\ninvasive 1360\nMolluscoid pseudotumors 91\nMolybdenum-99 breakthrough test 1394\nMonad sign 581\nMondini malformation 495\nMondor disease 729\nMongolism\nbone 89\nCHD 736\nMoniliasis 1087\nMonoarthritis 14\nMonochorionic\ndiamniotic twin 1327\nmonoamniotic twin 1328\nMonoclonal antibodies 1399\nMonocular blindness 411\nMonocyte chemotactic factor 665\nMonodermal dermoid 1273\nMonorchia 1217\nMonosomy 211\nMonostotic fibrous dysplasia 101\nMonoventricle 365\nMonovular twin transfusion 1385\nMonozygotic twins 1327\nMonstrocellular sarcoma 357\nMonteggia fracture 108\nMontgomery gland 698\nMoon\nface 1206\nfacies 639\nsign, lung 923\nMorgagni\nhernia 609\nlacunae 1192\nMorison pouch 1038\nMorning stiffness 188\nMorphea 1134\nMorphine 1437\nsulfate, scintigraphy 1417\nMorquio syndrome 153\nMortality 1427\nMorton neuroma 152",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 885,
            "markdown": "Mosaic\nattenuation 531\nperfusion 590\nMosaicism 1326\nMoth-eaten\nbone destruction 8\ncalyx 1281\npattern, bone 144\nMother-in-law phe nome non 378\nMotor urge incontinence 1175\nMottled hepatic uptake 867\nMottle, radiographic 703\nMoulage sign 1139\nMounier-Kuhn syndrome 679\nMount Fuji sign 309\nMouse\nbed 166\near erosions 16\nMoyamoya\ndisease 382\nsyndrome 382\nMRI enhancement patterns, breast 692\nMucin\n-containing cyst, pancreas 880\n-hypersecreting neoplasm 947\nMucinous\ncarcinoma, breast 715\ncystadenocarcinoma, pancreas 955\ncystadenoma, pancreas 955\ncystic neoplasm, pancreas 955\nductal ectasia, pancreas 947\nnon-neoplastic cyst 955\novarian tumor 1365\nvillous adenomatosis, pancreas 947\nMucocele\nappendix 1128\nparanasal sinus 494\nMucocutaneous\nlymph node syndrome 825\npigmentation 1132\nMucoepidermoid carcinoma\nlung 588\nparotis 494\nMucoid\ndegeneration, umbilical cord 1299",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 886,
            "markdown": "impaction 542\nMucopolysaccharidoses 152\nMucopus 1167\nMucopyocele 494\nMucormycosis\nlung 682\nrhinocerebral 501\nMucosal\nesophageal tumor 1006\nganglioneurofibromatosis 389\nmass, collecting system 1168\nneuroma syndrome 957\nnodule, esophagus 1006\nprolapse syndrome 1139\nstripe sign, esophagus 1085\nMucous\nmicturition 1282\nretention cyst 494\nMucoviscidosis 606\nMucus\nplug 606\nretention cyst 440\nMUGA 1410\nMulberry\nlesion, eye 432\nstone 1288\nMulder sign 152\nMÃ¼llerian duct\nanomalies 1386\ncyst\nfemale 1319\nmale 1222\nembryology 1183\nMulticentric\nangiofollicular lymph node hyperplasia 600\nmeningioma 377\nMulticentricity 711\nMulticystic\ndysplastic kidney 1222\nmesothelioma 1131\nMultifocal\nCNS tumors 293\nenhancing brain lesions 299\nfibrosclerosis 487\nglioblastoma multiforme 358",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 887,
            "markdown": "ill-defined lung densities 541\nnephroblastomatosis 1225\nosteosarcoma 175\nsubperitoneal sclerosis 1137\n\n# Multifocality 711 \n\n## Multilocular\n\ncystic\nliver lesions 864\nnephroma 1223\nrenal tumor 1223\ninclusion cyst 1131\nrenal\ncell carcinoma 1250\ncyst 1223\n\n## Multiloculated renal mass 1164\n\n## Multinodular goiter 486\n\n## Multiple\n\naneurysms 758\nbile duct hamartoma 956\nbrain aneurysms 331\nbull's-eye lesions of bowel wall 1020\nconcentric rings, GI 1109\nendocrine neoplasia 956\nepiphyseal dysplasia 154\nexostoses, hereditary 166\nfibroxanthomas 161\nfilling defects\ncolon 1022\nsmall bowel 1017\nfocal nodular hyperplasia syndrome 929\ngastric tumors 1008\ngated acquisition, NUC 1410\ngestations\nrisks 1329\nterminology 1327\nhamartoma-neoplasia syndrome 1068\ninfarctions, brain 287\nlucent lung lesions 544\nlung nodules 538\nlymphomatous polyposis 1115\nlytic bone lesions 11\nmyeloma\nbone 154\nkidney 1224\nosteochondromas 166",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 888,
            "markdown": "osteosclerotic lesions 3\nperitoneal masses 1025\npleural densities 549\npterygium syndrome 1305\npulmonary\ncalcifications 539\ncysts 544\nrenal cortical cysts, syndromes 1164\nsclerosis 382\nsmall bowel ulcers 1014\nsplenic nodules 881\nstenotic lesions of small bowel 1017\nsymmetric lipomatosis 493, 552\nthin-walled lung cavities 544\ntiny CNS cysts 294\nvacuum phenomena 161\nvascular leiomyomas 79\nMultiseptated gallbladder 889\nMumps orchitis 1227\nMural\nnodule\nastrocytoma 335\nsupratentorial tumor 292\nstratification of intestinal tract 1023\nMURCS complex 1048, 1386\nMurphy sign\nclinical 908\nsonographic 908\nMuscle\nattachments\nshoulder 38\nthigh 47\ncontusion 155\nedema 31\nfatty infiltration 32\nhyperintensity on MRI 31\nmass 30\nstrain 32\nsubacute denervation 31\nMuscular\nrim sign, GI tract 1077\nrings, esophagus 1033\nventricular septal defect 858\nMusculoaponeurotic fibromatosis 77\nMusculoskeletal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 889,
            "markdown": "fibromatoses 27\nneurogenic tumors 231\nsarcoidosis 667\nscleroderma 1134\nSLE 673\nMusculotendinous injury 155\nMushroom\nsign 1105\nworker's lung 615\nMustache sign 993\nMustard procedure 759\nMutational dysostosis 75\nMyasthenia gravis 677\nMycetoma 581\nkidney 1224\nMycobacterium\navium infection in AIDS 1044\nin AIDS, chest 575\ntuberculosis 679\nMycoplasma pneumonia 643\nMycotic\naortic aneurysm 787\nbrain aneurysm 331\npneumonia 519\nsinusitis 503\nMyelencephalon 311\nMyelination, brain 310\nMyelinoclastic\ndiffuse sclerosis 351\ndisease 286\nMyelinolysis, osmotic 392\nMyeloblastoma, bone 121\nMyelocele 221\nMyelocystocele 267\nterminal 280\nMyelofibrosis 156\nMyelography, extraarachnoid 231\nMyeloid\ndepletion 156\nmetaplasia 7\nsarcoma 121\nMyelolipoma 1224\nMyeloma, solitary bone 155\nMyelomatosis 155\nMyelomeningocele 267",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 890,
            "markdown": "Myeloproliferative\ndisorders 7\nsyndrome 156\nMyeloschisis\ndiastematomyelia 251\nspina bifida aperta 221\nMyelosclerosis 156\nMyleranÂ®, lung damage 514\nMyocardial\nbridging 771\ncalcification 746\ncontusion 800\nfat 745\nhyperenhancement of Gd 743\ninfarct 831\nmetabolic PET 1413\nperfusion\nagents, NUC 1410\ndefect analysis 823\nPET 1413\nrupture\ninfarct 832\ntrauma 801\nuptake of FDG 743\nviability assessment 823\nMyocarditis 832\nMyocardium anatomy 774\nMyoclonus 1226\nMyoepithelial\nhamartoma 924\nsialadenitis 504\nMyofibroblastic tumor\ninflammatory 1106\nMyofibroblastoma 730\nMyofibroma 79\nMyofibromatosis, infantile 79\nMyoma, uterus 1388\nMyositis\nbrucellar 70\neye 413\ninfectious 133\nossificans\ncircumscripta 156\nparaosteoarthropathy 179\nprogressiva 97",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 891,
            "markdown": "Myotendinous strain 156\nMyxofibroma, heart 834\nMyxofibrosarcoma 158\nMyxoglobulosis 1128\nMyxoid\nextraskeletal chondrosarcoma 74\nleiomyoma 1389\nliposarcoma 142\nMyxoma\nheart 832\nintramuscular 157\nodontogenic 269\nMyxopapillary ependymoma 262\n\nN\n\nNabothian cyst 1365\nNail\nhyperconvex 209\northopedic 34\n-patella syndrome 158\nNaked\nfacet 257\ntuberosity sign 193\nNapkin-ring\nstenoses of bowel 1143\ntrachea 781\nNapole on's hat sign 278\nNarrow chest in fetus 1301\nNarrowing\nantrum 1009\nbile duct 875\ncolon 1020\nduodenum 1013\nesophagus 1005\nglottis 445\nnasopharynx 444\noropharynx 444\nrectum 1022\nretropharynx 445\nstomach 1009\nsubglottis 445\nsupraglottis 445\ntrachea 557",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 892,
            "markdown": "vallecula 445\nNasal\ncerebral heterotopia 494\ndermoid 482\nglioma 494\nseptal perforation 441\nvault masses 441\nNASCET 477\nNasogastric tube, malpositioned 562\nNasopharyngeal\ncarcinoma 499\nmass 441\nnarrowing 444\nNaumoff syndrome 196\nNavicular fracture 109\nNear drowning 644\nNeck\nair-containing masses 448\nanomalies, fetus 1304\ncongenital cystic lesion 447\nfasciae 462\nlymph node\nanatomy 472\nenlargement 448\nsolid masses 445\nteratoma 505\nNecrobiotic nodules 664\nNecrolytic erythema migrans 962\nNecrosis\navascular, bone 63\nbowel 994\npancreatic 969\nrenal allograft 1256\nNecrotic pseudocyst, bone 15\nNecrotizing\ndescending mediastinitis 639\nenterocolitis 1079\nexternal otitis 493\nfasciitis 158\npancreatitis 969\npapillitis 1228\nsarcoid granulomatosis 644\nNeedle-shaped calcification, breast 727\nNegative predictive value 1427\nNeisseria gonorrhea 1375",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 893,
            "markdown": "# Nelson \n\nsyndrome 306\nX 41\nNembutal ${ }^{\\circledR} 1437$\nNeonatal\nascites 997\ncardiac failure 743\nhepatitis 941\nintracranial hemorrhage 383\nlung disease 521\nobstructive jaundice 875\nosteomyelitis 171\npneumonia 644\npulmonary infiltrates 521\nwet lung disease 663\n\n## Nephritis\n\nacute\ndiffuse bacterial 1240\nfocal bacterial 1240\ninterstitial 1194\nhereditary chronic 1211\nradiation 1242\nsalt-losing 1258\nNephroblastoma 1291\ncystic partially differentiated 1223\n\n## Nephroblastomatosis 1225\n\nNephrocalcinosis 1169\nNephrogenic\nadenofibroma 1221\nadenoma\nbladder 1173\nurinary tract 1226\ndiabetes insipidus 1150\nrest 1225\nsystemic fibrosis 1435\n\n## Nephrogram\n\nabnormal 1165\nabsent 1165\nincreasingly dense 1166\nobstructive 1166\npersistent 1165\nincreasing 1165\nrim 1165\nsegmental 1166\nspotted 1166",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 894,
            "markdown": "striated 1165\nangiographic 1166\nsunburst 1233\nSwiss cheese 1232\nNephrographic phases 1188\nNephrolithiasis 1286, 1169\nNephroma, cystic 1223\nNephronophthisis 1218\nNephropathy\nanalgesic 1200\ncontrast 1205\ndiabetic 1210\nreflux 1242\nNephrosclerosis 1253\nNephrosis, congenital Finnish 1294\nNephrotoxicity, contrast media 1434\nNerve sheath tumor, benign 270\nNervus intermedius 317\nNesidioblastosis 957\nNeural\narch clefts 222\nfibrolipoma 141\ntube defect 1303\nNeurenteric cyst 268\nNeurilemmoma 270\nNeurinoma 270\nNeuritis, optic 429\nNeuroblastoma\nadrenal 1226\nchest wall 561\nolfactory 495\nprimary cerebral 396\nNeurocutaneous\nmelanosis 386\nsyndromes 286\nNeurocysticercosis 347\nNeurocytoma, central 338\nNeuroectodermal dysplasias 286\nNeuroendocrine\ncarcinoma 645\ntumor\nGI tract 1058\nscintigraphy 1420\ntumor of lung 645\nNeuroepithelial cyst 386",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 895,
            "markdown": "Neuroe pithelioma of retina 432\nNeurofibroma 271\nNeurofibromatosis 387\nperipheral 387\nrenal artery 1247\ntype 1387\ntype 2390\nwith bilateral acoustic neuromas 390\nNeuroforaminal widening 223\nNeurogenic\nbladder 1227\nclaudication 278\npulmonary edema 517\ntumors 231\nNeuroglial cyst 386\nNeurolite ${ }^{\\circledR} 1400$\nNeuroma 390\nacoustic 390\ninterdigital 152\nMorton 152\ntraumatic 272\ntrigeminal 391\nNeuronal migration 310\nNeuropathic\ndiabetic foot 83\nosteoarthropathy 159\nspine 160\nNeurosarcoidosis 667\nNeurosyphilis 391\nNeurotrophic joint 159\nNeurulation 310\nNeutropenic colitis 1080\nNevin staging 930\nNevoid basal cell carcinoma syndrome 67\nNevus flammeus 399\nNewborn, renal imaging 1188\nNievergelt disease 149\n90/90 rule, breast MRI 709\nNipple\nadenoma 730\n-areolar complex 698\ndischarge 689\n-like common bile duct 960\nPaget disease 717\nretraction 689",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 896,
            "markdown": "sign, antrum 1105\nNissl bodies 356\nNitroblue tetrazolium test 914\nNitrofurantoin, lung damage 515\nNitrogen-13 ammonia 1397\nNitrosourea, lung damage 514\nNocardiosis\nchest 646\nin AIDS 575\nNodular\ncompensatory hypertrophy, kidney 1164\nfasciitis 160\nGraves disease 449\nlung disease 528\nlymphoid hyperplasia 646, 1017\nmelanoma 1426\nperiorchitis 1209\nregeneration, liver 917\nregenerative hyperplasia 957\nNodularity, lung 524\nNodule\n-in-nodule, liver 917, 935\nof Arantius 764\nthyroid 451\nNoise, radiographic 703\nNonaccidental trauma 68\nNonavid infarct imaging 1416\nNoncardiogenic pulmonary edema 518\nNonchromaffin paraganglioma 497\nNoncirrhotic\nidiopathic portal hypertension 898\nportal fibrosis 898\nNonclassifiable interstitial pneumonia 624\nNoncoiled cord 1298\nNoncomedo breast cancer 712\nNoncompaction cardiomyopathy 807\nNonendemic Burkitt lymphoma 1057\nNonexpansile well-demarcated bone defect\nmultilocular 11\nunilocular 11\nNonfunctioning\nislet cell tumors 963\npituitary adenoma 395\nNongestational\nchoriocarcinoma 1345,1373",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 897,
            "markdown": "Non-Hodgkin lymphoma\nchest 634\nin AIDS 1045\nin childhood 636\nNonimmune hydrops 1357\nNoninvasive\naspergillosis 581\nbreast cancer 710\nthymoma 679\nNonionic\ndimers 1431\nmonomers 1431\nNonlethal dwarfism 1301\nNonneurogenic neurogenic bladder 1175\nNonobstructive\natelectasis 540\nhydrocephalus 367\nileus 1002\nNonocclusive mesenteric ischemia 1124\nNonopaque intraluminal mass in collecting system 1167\nNonossifying fibroma 160\nNonosteogenic fibroma 160\nNonpuerperal mastitis 729\nNonradiopaque stones 1288\nNonrotation, GI tract 1119\nNonse minomatous testicular tumor 1272\nNonseptic monoarthritis 14\nNonspecific interstitial pneumonia with fibrosis 624\nNonstress test, fetus 1325\nNonsyndromic islet cell tumor 963\nNontriadal arteries 943\nNontropical sprue 1141\nNontuberculous mycobacterial infection, lung 646\nNonvisualization of\nfetal stomach 1307\ngallbladder\nUS 871\nkidney, IVP 1158\nspleen 880\nNoonan syndrome\nbone 161\nCHD 737\nNoose sign 728\nNora lesion 69, 166\nNormal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 898,
            "markdown": "pressure hydrocephalus 367\npulmonary\nblood flow without cyanosis 740\nvascularity + normal-sized heart 748\nsmall bowel folds \\& diarrhea 1015\nNormocalcemia\nwith hypercalciuria 1169\nwith normocalciuria 1170\nNorrie disease 426\nNorth American blastomycosis 585\nNorwood procedure 759\nNosocomial pneumonia 519\nNotching\nribs 19\nureter 1168\nNotch sign, thymus 572\nNP-59 1420\nNubbin sign\nkidney 1283\ntestis 1270\nNuchal\ncord 1366\nskin thickening 1304\nNuclei of brainstem 312\nNull cell adenoma 395\nNumbering vertebral levels 240\nNumerary renal anomaly 1157\nNummular pneumonia 521\nNutcracker phe nomenon 833\n\nOat cell cancer 594\nOblique carotid line 216\nObliterative\nbronchiolitis 590\notosclerosis 496\nObscured teardrop sign 22\nObscure GI bleed 988\nObservation hip 208\nObstruction\nbronchial 558\nclosed-loop, signs 1001\ncolonic 1001",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 899,
            "markdown": "duodenal 999\nfetal bowel 1308\ngastric outlet 999\nileal 999\ninferior vena cava 756\nintestines 998\njejunal 999\nLVOT 755\nprostatic 1176\nsmall bowel\nin adulthood 1001\nin childhood 1001\nstrangulated 1000\nsuperior vena cava 756,846\n\n# Obstructive \n\natelectasis 540\ncardiomyopathy 807\nhydrocephalus 366\njaundice\nadulthood 874\nneonate 875\nnephrogram 1166\nnephropathy 1212\nuropathy 1212\n\n## Occipital\n\ncondyle fracture 256\nencephalocele 339\n\n## Occipitalization of atlas 220\n\n## Occlusive\n\nmesenteric infarction 1123\nvascular disease, brain 287\n\n## Occult\n\nintrasacral meningocele 266\nspinal dysraphism 221\nsteal syndrome 846\n\n## Ochronosis 161\n\nOctreoScan 1421\nOctreotide 1421\nOcular\ndetachments 427\nlarva migrans 421\nlesion 413\nnoncalcified 414\ntrauma 426\nOddi sphincter 893",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 900,
            "markdown": "O'Donoghue triad 25\nOdontogenic\ninfection 494\nkeratocyst 219\nmyxoma 269\nsinusitis 504\nOdontoid erosion 220\nOdontoma 269\nOdynophagia 1061\nOEIS complex 1048, 1366\nOgden classification 113\nepiphyseal plate injury 106\nOgilvie syndrome 1107\nOil cyst 720\nOleothorax 680\nOlfactory neuroblastoma 495\nOligemia, pulmonary 542\nOligodendroglioma 391\nOligodendrogliomatosis 391\nOligohydramnios 1296\nOligomeganephronia 1282\nOligomenorrhea 1312\nOlive pit sign 1105\nOllier disease 92\nOmental\ncake 1026, 1132\ncyst 1027,1126\ninfarction 1128\nmass 1026\nOmentum, anatomy 1037\nOmnipaque ${ }^{\\circledR} 1431$\nOmphalocele 1366\nOmphalomesenteric duct 1120\ncyst 1366\nOmphalopagus 1346\nOncocalyx 1276\nOncocytic adenoma, thyroid 507\nOncocytoma\nadrenal gland 1262\nkidney 1263\npituitary 395\nretroperitoneal 1262\nOncogenic rickets 190\nOnion skin periosteal reaction 12\nOnodi cell 454",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 901,
            "markdown": "# Opacification of \n\nhemithorax 539\nmaxillary sinus 440\nsinus + expansion 441\nOpaque material in bowel 995\nOpen\nbronchus sign 591\nfracture 102\n-globe injury 427\n-mouth odontoid view 235\nOpening pressure, CSF 319\nOphthalmic\nartery 319\nnerve 316\nOphthalmoplegia 411\nOpisthion 235\nOpisthorchis\nfelineus 919\nviverrini 919\nOpportunistic infection\nin AIDS 574\nlung cavity 521\nOpsoclonus 1226\nOptic\ncanal 418\ndisk pallor 327\ndrusen 428\nnerve\nanatomy 417\nenlargement 415\nexcrescentic thickening 415\nfusiform thickening 415\nglioma 428\nsheath meningioma 429\ntram-track sign 412\nneuritis 429\npathway glioma 428\nstrut 418\nOptiray ${ }^{\\circledR} 1431$\nOral\ncavity 457\nOrbit\negg-shaped 208\nfetal anomalies 1304\nmeasurements 416",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 902,
            "markdown": "Orbital\nabscess 424\ncellulitis 424\ncompartments 416\ndisorders 411\nedema 424\nhemangioma 422\ninfection 424\nlymphoma 425\nmass 412\nin adults 412\nin childhood 412\nsuperolateral quadrant 413\nmetastasis 426\npseudotumor 431\nschwannoma 430\nseptum 424\nspaces 416\ntumor\nmalignant 413\nvascular 413\nvarix 435\nOrchitis 1227\nOrganic dust hypersensitivity 514\nOrganized thrombus 811\nOrganizing\ninterstitial pneumonia 626\npneumonia, focal 616\nOrganoaxial volvulus, stomach 1095\nOrgan of Zuckerkandl 1187\nOriental\ncholangiohepatitis 907\nlung fluke, CNS 392\nOrmond disease 1259\nOrodigitofacial syndrome 161\nOrofaciodigital syndrome 161\nOropharyngeal narrowing 444\nOropharynx 458\nOrthodeoxia 650\nOrthoiodohippurate 1419\nOrthopedic fixation devices 32\nOrthotopic\nliver transplant 949\nureterocele 1283\nOrtolani test 81",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 903,
            "markdown": "Os\nacromiale 192\nincae 234\nodontoideum 220, 258\nOsgood-Schlatter disease 161\nOsler-Weber-Rendu syndrome 618\nOsmotic\ndemyelination syndrome 338\nmyelinolysis 392\nOsseous\nhemangioendothelioma 122\nhemangioma 123\nmalignant fibrous histiocytoma 102\nmetaplasia, mesentery \\& peritoneum 1104\nOssicles, accessory of foot and ankle 56\nOssicular injury, ear 256\nOssiculum terminale 258\npersistent 220\nOssification\ndisk 229\nectopic 179\nendochondral 3\nheterotopic 156\nintramembranous 3\nparavertebral 224\nsoft tissue 30\nspine 224\nOssifying\ncochleitis 488\nfibroma 162\nosteoblastoma 164\nskull 269\nrenal tumor of infancy 1228\nOsteitis\ncondensans ilii 162\ndeformans 178\nfibrosa\ncystica 129\ndisseminata 98\nOsteoarthritis 162\nearly 163\nerosive 163\nhand 16\npremature 15\nrapidly destructive 164",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 904,
            "markdown": "spine 249\nOsteoarthropathy\nhypertrophic pulmonary 130\nneuropathic 159\nprimary hypertrophic 178\nOsteoblastic bone\nlesion 12\nmetastases 150\nOsteoblastoclastoma 117\nOsteoblastoma 164\nOsteocartilaginous exostosis 165\nOsteochondral fracture, definition 102\nOsteochondritis dissecans 166\nOsteochondrodysplasia 1300, 1301\nOsteochondroma 165\nmultiple 166\nsolitary 166\nOsteochondromatosis 203\nOsteochondrosis\ndissecans 166\nintervertebral 249\nspinal 275\nvertebral 65\nOsteoclastoma\ngiant cell tumor 117\nhyperparathyroidism 129\nOsteodermopathia hypertrophicans 178\nOsteodystrophia fibrosa 98\nOsteodystrophy, renal 186\nOsteofibrous dysplasia 167\nOsteogenesis imperfecta 167\nCHD 737\nOsteogenic\nfibroma, bone 164\nsarcoma, heart 803\nOsteoid\nosteoma 168\nseams 182\nOsteolipoma, hypothalamus 374\nOsteolymphoma 143\nOsteolysis\nclavicle, medial end 19\nessential 94\nexpansile multilocular 11\nidiopathic 1300",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 905,
            "markdown": "mandible 218\nmassive 143\nmixed sclerotic + lytic 11\nmultiple 11\nnonexpansile\nmultilocular 11\nunilocular 11\non both sides of joint 11\nouter end of clavicle 19\nsacrum 228\nskull 215\ntemporomandibular joint 217\ntrabeculated 11\ntufts 21\nwith marked sclerosis 11\nwith periosteal reaction 11\nwithout periosteal reaction 11\nOsteolytic bone metastases 150\nOsteoma 169\nchoroidal 419\ncostal 206\nsoft-tissue 200\nOsteomalacia 6\nfamine 190\nrenal osteodystrophy 186\nOsteomyelitis 169\nbrucellar 70\nspine 269\ntuberculous 210\nOsteonecrosis 63\nMitchell MRI classification 64\nspontaneous, knee 67\nOsteo-onychodysostosis 158\nOsteopathia\ncondensans disseminata 173\nstriata 172\nOsteopenia 4\nrenal osteodystrophy 186\nOsteopetrosis 172\nOsteophyte\nfloating 183\nspine 224\nOsteopoikilosis 173\nOsteoporosis 4\ncircumscripta 178",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 906,
            "markdown": "partial transient 207\nposttraumatic 185\nspine 6\ntransient regional 207\nvertebral compression fracture 261\nOsteoradionecrosis 184\nOsteosarcoma\nbone 174\nheart 803\nOsteosarcomatosis 175\nOsteosclerosis\nconstitutional 2\ncortical lesion in child 3\ndiffuse 2\nintramedullary 133\nmultiple lesions 3\nsolitary 3\ntufts 21\nwidespread lesions 12\nOstiomeatal unit 455\nOstium\nprimum 765\nprimum defect 797\nsecundum 765\ndefect 797\nOtic capsule dysplasia 495\nOtitis\nmalignant 438\nexternal 493\nmedia 495\nOtomastoiditis 496\nOtosclerosis 496\nOtospongiosis 496\nOvarian\ncancer 1367\ncarcinoid 1383\ncycle 1334\ncyst 1368\nfetal 1309\nmanagement 1370\nDoppler signals 1334\ndysgenesis, CHD 737\nectopic pregnancy 1350\nfibromatosis 1371\nhyperstimulation syndrome 1371",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 907,
            "markdown": "ligament 1332\nmalignant germ cell tumor 1372\nmassive edema 1365\nmorphology 1333\nsize 1333\nsolid tumor 1315\nteratoma 1383\ntorsion 1384\ntumor 1314\nparaneoplastic syndrome 1315\nsurface epithelium 1314\nvein\nsyndrome 1374\nthrombosis 1373\nvisualization 1333\nOvary, postmenopausal 1334\nOvercirculation, pulmonary vessels 748\nOverdevelopment, bone 12\nOverdiagnosis bias 1429\nOvergrowth\nbone 12\nepiphyseal 13\nfetal 1300\nOverhanging margin 120\nOverlapping\n2nd finger 209\ndigit, in fetus 1303\nfracture 103\nindex finger 209\nOverlap syndrome 643\nOverriding\naorta 849\nfracture 103\nOveruse injury, physis 105\nOvulation\nfailure, signs 1334\nsigns 1334\nOvulatory phase 1331, 1334\nOxalosis\nbone 178\nkidney 1169, 1287\nOxime 1423\nOxycephaly 215\nOxygen toxicity 575\nOxyphilic adenoma",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 908,
            "markdown": "kidney 1263\nthyroid 507\nOyster pearl calcifications, breast 722\n\n# $\\mathbf{P}$ \n\nPacchionian granulations 215\nPachydermoperiostosis 178\nPachygyria\nholoprosencephaly 365\nlissencephaly 375\nPachymeningeal enhancement 297\nPachymeninges 310\nPachymeningitis 379\nPage kidney 1228\nPaget disease\nbone 178\njaw 218\njuvenile 126\nof the nipple 717\ntemporal bone 440\nPaget-Schroetter Syndrome 850\nPainful scoliosis 164\nPainless thyroiditis 509\nPalate, cleft 1355\nPalmar\narch\ndeep 777\nsuperficial 777\nfibromatosis 202\nPampiniform plexus 1290\nPanacinar emphysema 612\nPanbronchiolitis 647\nPancake\nbrain 365\ncerebrum 365\nkidney 1158\nvertebra 224\nPancoast\nsyndrome 560\ntumor 592\nPancreas\nagenesis 897\nannular 897",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 909,
            "markdown": "atrophy 878\nblunt trauma 1055\ncalcifications 878\ncongenital anomalies 877\ncyst 879\ndevelopment 891\ndiameters 891\ndiffuse enlargement 878\ndivisum 957\nectopic 924\nfatty replacement 878\nglycogen-rich cystadenoma 981\nheterotopic 1103\nhypervascular tumors 879\nmacrocystic adenoma 955\nmetastasis 954\nmicrocystic\nadenoma 981\nlesion 880\nmucinous cystic neoplasm 955\nneoplasm 878\nserous cystadenoma 981\nsolid and papillary neoplasm 982\ntransplant 965\ntrue congenital cyst 920\n\n# Pancreatic \n\nabscess 970\nacinar cell carcinoma 958\nagenesis 878\ncholera 964\nchoristoma 924\ncyst\nunilocular 879\nwith solid component 880\ncystosis 608\nductal adenocarcinoma 958\nendocrine tumor 960\nfluid collection 969\nislet cell tumor 960-964\nlipomatosis 964\nneuroendocrine tumor 964\nphlegmon 969\npseudocyst 965\nrest 924\nsequestration 970",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 910,
            "markdown": "Pancreaticobiliary junction variants 893\nPancreaticoduodenal\narcade 1032\nnodes 1028\nPancreatitis 966\nacute 966\nascaris-induced 898\nautoimmune 972\nbiliary 969\nchronic 971\nfocal 973\ngroove 973\ninterstitial edematous 969\nnecrotizing 969\nPancreatoblastoma 973\nPancreozymin 1029\nPanda sign, gallium imaging 1425\nPandora's pneumonitis 615\nPanlobar nephroblastomatosis 1226\nPanlobular emphysema 612\nPanner disease 67\nPanniculitis\nossificans 157\nPannus 188\nPantothenate kinase-associated neurodegeneration 359\nPapile classification 384\nPapilla of Vater, enlargement 1013\nPapillary\nadenoma, bile ducts 974\nblush, kidney 1219\ncarcinoma\nbreast 716\nthyroid 508\ncystadenoma lymphomatosum 511\ncystic neoplasm, pancreas 982\nducts of Bellini 1242\nendolymphatic sac tumor 497\nepididymal cystadenoma 1178\nfibroelastoma, heart 834\nmuscle, rupture 832\nnecrosis 1228\nrenal cell carcinoma 1250\nserous carcinoma of ovary 1381\nstenosis, bile duct 876\nPapilledema 283",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 911,
            "markdown": "Papillitis, necrotizing 1228\nPapilloma\nbreast 730\nchoroid plexus 343\ninverting 488\nPapillomatosis\nintraductal, breast 730\njuvenile, breast 725\nlaryngeal 490\npulmonary 490\ntracheobronchial 490\nParabiliary venous system 886\nParabiotic syndrome, intrauterine 1385\nParacardiac bronchus 565\nParachute mitral valve 819\nParacicatricial emphysema 612\nParadoxical\nbrain herniation 309\ndilatation, colon 1116\nenophthalmos 426\nmiddle turbinate 455\nParaduodenal hernia 1102\nParaesophageal\nhernia 1103\nvarices 1086\nParaffinoma 630\nParaganglioma\nadrenal medullary 1230\ncardiac 802\nchromaffin 645\ngangliocytic 1090\nhead \\& neck 497\njugulotympanic 498\nnonchromaffin 497\nretroperitoneal 1263\nspinal cord 269\nthoracic 676\nParaGard ${ }^{\\circledR} 1361$\nParaglottic space 459\nParagonimiasis\nbrain 392\nlung 647\nParahiatal hernia 1103\nParalaryngeal space 459\nParallel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 912,
            "markdown": "-line equal spacing 1396\ntrack sign, NUC 131\nParalysis\ndiaphragm 560, 610\nfacial nerve 437\nParalytic ileus 1002\nParamesonephric duct 1183\nParanasal\nsinus\ncarcinoma 499\nmass 440\nsinuses 454\nsinusitis 412\nParaneoplastic\nectopic ACTH production 1205\nsyndrome\nlung cancer 593\novarian tumors 1315\nthromboembolism 855\nParaosteoarthropathy 179\nParaovarian\ncyst 1373\ncystadenoma 1374\nParapagus 1346\nParapelvic\ncyst 1252\nlymphangiectasia 1252\nParapharyngeal space\nanatomy 462\nmass 442\nParaquat 600\nPararenal spaces 1186\nParasellar mass 307\nParaseptal emphysema 612\nParasitic\nembolism 598\nfibroid 1389\ninfestation 1028\nParaspinal\nline\nleft 570\nright 570\nneurofibromas 388\nParasternal\nlong-axis view 762",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 913,
            "markdown": "short-axis views 762\nParasympathetic ganglia tumors 555\nParatesticular\nlipoma 1215\nmass 1177\nrhabdomyosarcoma 1266\nParathormone 36\nParathymic syndromes 677\nParathyroid\nadenoma 499\nectopic 553\nanatomy 471\ncyst 447\nscintigraphy 452\nParatracheal\nspace, widened 554\nstripe 570\nParaureteral diverticulum 1203\nParaurethral glands 1192\nParavertebral\nmasses 227\nossification 224\nParenchymal\nband, lung 580\nbreast pattern 699\npeliosis hepatis 974\nParenti-Fraccaro disease 57\nParent-infant traumatic stress syndrome 68\nParietal\nband, heart 762\ncells 1034\nencephalocele 339\nforaminae 215\nParinaud syndrome 308\nParity nomenclature 1293\nPark corner sign 196\nParkes Weber syndrome 135, 179\nParkinson disease, PET 1401\nParoÃ¶phoron 1374\nParosteal\nbone lesion 8\nosteochondromatous proliferation, bizarre 69\nosteosarcoma 176\nParotid\ngland 469",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 914,
            "markdown": "enlargement 448\nmultiple lesions 449\nhemangioma 499\nmucoepidermoid carcinoma 494\nspace 464\n\n# Parotitis \n\nacute 502\nHIV 502\nviral 502\nParoxysmal nocturnal hemoglobinuria 1229\n\n## Parrot\n\nbeak tear 148\npseudopalsy 204\n\n## Pars\n\nflaccida cholesteatoma 480\nintermedia, pituitary 312\ntensa cholesteatoma 481\n\n## Partial\n\nagenesis, corpus callosum 328\nanomalous pulmonary venous return 783\nduplication, ureter 1283\nmole 1360\nprevia 1379\nsteal syndrome 846\ntransient osteoporosis 207\nPartially polycystic kidney 1223\nPassavant ridge 458\nPassive\natelectasis 540\nhepatic congestion 974\n\n## Patau syndrome 1385\n\nPatella\nalta 48,145\nbaja 112\nsquared 126\n\n## Patellar\n\ndislocation 86\nsleeve avulsion 199\ntendon rupture 180\n\n## Patent\n\nductus arteriosus 834\nforamen ovale 767\nurachus 1282\nPaterson-Kelly syndrome 1086\nPathergy test 798",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 915,
            "markdown": "Pathologic fracture 103\nPavlik harness 83\nPayr sign 811\nPE 652\nPearl\n-like breast calcifications 688\nnecklace gallbladder 946\nPearly\ntumor, CNS 345\nwhite ovaries 1382\nPear-shaped urinary bladder 1172\nPeau d'orange 405\nPectus\ncarinatum 17\nexcavatum 17\nindex 17,145\nPediatric dose, NUC 1393\nPedicle sclerosis 225\nPeliosis 974\nPelizaeus-Merzbacher disease 392\nPelkan spurs 196\nPellegrini-Stieda disease 157\nPelvic\ncongestion syndrome 1374, 834\nfloor\nanatomy 1037\nprolapse 1130\nrelaxation 1130\nfloor dysfunction 1129\nfracture 110\ninflammatory disease 1374\nkidney 1157\nligaments 1331\nlipomatosis 1229\nmasses\ncomplex 1312\ncystic 1312\nextrauterine 1313\nfatty 1313\nfrequency 1312\nsolid 1312\nnodes 1028\npain\nchildhood 1313\npregnancy 1293",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 916,
            "markdown": "spaces 1331\nPelvis\nelephant ears 89\ngoblet-shaped 154\ninsufficiency fracture 103\nMickey Mouse ears 89\ntrident 62\nwine-glass shape\nasphyxiating thoracic dysplasia 63\nMorquio syndrome 154\nPemphigoid, benign mucous membrane 1004\nPena-Shokeir phenotype 1377\nPencil\n-in-cup deformity 183\npoint deformity, metatarsal bone 159\nPenciled distal end of clavicle 19\nPenciling, terminal tufts 1135\nPendred syndrome 449, 499\nPendulous urethra 1192\nPenetrating\naortic ulcer 835\nrenal trauma 1280\nPenetration, laryngeal 1034\nPenicillium frequentans 615\nPenile\n-brachial index 1208\ncalciphylaxis 1230\ncarcinoma 1229\nfibromatosis 1230\nfracture 1230\ninduration, painful 1180\nsquamous papilloma 1204\nPentagastrin\nMeckel diverticulum 1121\nphysiology 1029\nPentalogy of\nCantrell 1377\nFallot 850\nPentobarbital 1437\nPenumbra 370\nfalse 288\nPepper syndrome 1226\nPeptic ulcer 1093\nPercheron artery 321\nPerchlorate washout test 1402",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 917,
            "markdown": "Percutaneous umbilical blood sampling 1326\nPerforating veins 778\nPerforation\ncommon bile duct, spontaneous 984\nesophagus 1085\ngallbladder 909\nGI tract, renal transplant 1256\nidiopathic gastric 993\nnasal septum 441\nurinary bladder 1174\nPerfused twin 1339\nPerfusion\nagents, brain 1400\nCT\nanalysis 370\nstroke 370\ndefects, lung 660\nliver 868\nPergonalÂ® 1371, 1382\nPeriadventitial hyperplasia 816\nPeriampullary\ncarcinoma 1013\ntumors 877\nPerianal fistulas 1071\nPeriaortitis, chronic 1259\nPeriapical\ncemental dysplasia 246\ncyst 218\nPeriarteritis nodosa 838\nPeriarticular\ncalcification 15\ncyst 15\nPeribronchial pneumonia 520\nPericaliceal cyst 1239\nPericardial\ncalcification 746\ncompressive syndromes 747\nconstriction 837\ncyst 835\ndefect 836\ndisease 748\neffusion 747\nfat necrosis 556\ninjury 801\nknock sound 837",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 918,
            "markdown": "mesothelioma 836\ntamponade 803\nteratoma 836\nthickening 747\ntumor 748\nPericarditis\ncause 837\nconstrictive 837\ninflammatory 838\nPericardium\nanatomy 774\nsinuses and recesses 774\nPericecal\nfat-stranding 1019\nhernia 1102\nPericerebral fluid, childhood 304\nPericholecystic abscess 909, 975\nPericranium 233\nPericyst 921\nPeridiverticulitis 1074\nPeriductal mastitis 726\nPerifocal emphysema 612\nPerigastric lymph nodes 1041\nPerihepatitis 862\nPerihilar\nbat-wing infiltrates 542\nlung disease 524\nPerihippocampal fissures 318\nPerilunate dislocation 88\nPerimedial fibroplasia, renal artery 816\nPerimembranous VSD 858\nPerimenopause 1331\nPerineal\nhernia 1100\nurethra 1192\nPerinephric\nabscess 1243\nfat stranding 1158\nPerineural sacral cyst 266\nPeriodic acid Schiff 1146\nPeriodontal disease 499\nPerioptic\nmeningioma 429\nneuritis 429\nPeriorbital cellulitis 424",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 919,
            "markdown": "Periorchitis, nodular 1209\nPeriosteal\nchondroma 200\ndysplasia 388\nfibrosarcoma 98\nganglion 116\nosteosarcoma 176\nreaction 12\nin childhood 12\nin infant 13\nPeriostitis 12\nflorid reactive 102, 157\nPeriovulatory phase, endometrium 1331\nPeripancreatic fluid collection 969\nPeripelvic\ncyst 1252\nlipomatosis 1268\nPeripheral\ncholangiocarcinoma 904\nchondrosarcoma 74\nlung disease 524\nmultiple papillomas 730\nnerve sheath tumor 270\nneurofibromatosis 387\npneumonia 519\nprecocious puberty 1310\nreverse bat-wing infiltrates 542\nT-cell lymphoma 1117\nwashout sign, liver 903\nPeriportal\ncollar 948\nhypoattenuating halo 870\ntracking 1054\nPerirenal\nabscess 1243\nspace 1186\nPerisellar vascular lesion 308\nPerisplenic nodes 1028\nPeristalsis\nesophagus 1002\nsmall bowel 1035\nPeritoneal\nbands 1112\ncalcifications 1026\ndisseminated leiomyomatosis 1389",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 920,
            "markdown": "fibrosing syndrome 1138\ninclusion cyst 1131\nlymphopneumatosis 994\nmass 1025\nmesothelioma 1131\nmetastases 1132\nspaces 1038\nPeritoneocele 1130\n\n# Peritonitis \n\nchronica fibrosa incapsulata 1138\ngranulomatous 1025\nmeconium 1121\ntuberculous 1143\nPeritonsillar abscess 500\nPeriurethral glands 1192\nPerivascular\ncloaking 967\npseudorosettes 354\nspaces, enlarged, brain 354\n\n## Periventricular\n\ncalcifications in childhood 300\ncystic PVL 385\nenhancement 299\nhemorrhagic infarction 386\nhypodensity 300\nincreased echogenicity 385\nleukoencephalopathy 385\nleukomalacia 385\nT2WI-hyperintense lesions 301\nPerivillous fibrin deposition 1298\nPerkin's line 82\nPerlman\nsyndrome\nGU 1225\nOB 1377\ntumor 1223\nPermeability edema, lung 517\nPermeative\nbone destruction 8\npattern, bone 144\nPernicious anemia\ncholelithiasis 912\nextramedullary hematopoiesis 95\ngastric\ncarcinoma 1091",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 921,
            "markdown": "polyp 1092\nlymphoid\nhyperplasia 1114\ninterstitial pneumonia 626\nneurogenic bladder 1227\n\n# Peroneal \n\nnerve\ndistal 54\nproximal 54\nveins 777\nPeroneus brevis avulsion fracture 115\nPersantine ${ }^{\\circledR} 1414$\nPersimmons 1051\nPersistence of stapedial artery 500\nPersistent\ncommon atrioventricular canal 814\ncortical lobation, kidney 1164\nembryonic infundibular recess 393\nfetal\ncirculation 838\nsyndrome 639\nvasculature 430\nhyperplastic primary vitreus 430\nincreasing nephrogram 1165\nleft SVC 755\nmetopic suture\ncleidocranial dysostosis 75\ntrisomy E syndrome 209\nnephrogram 1165\nossiculum terminale 220\nostium atrioventriculare 814\nprimitive trigeminal artery 321\npulmonary hypertension, newborn 838\nright umbilical vein 1299\ntruncus arteriosus 856\n\n## Perthes\n\ndisease 66\nlesion 87\nPes\nanserinus 48\ncavus 25\nplanus 25\nPET imaging\nbrain tumor 1401\ncardiac 1413",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 922,
            "markdown": "concept 1396\ndementia 285\ngeneral 1396\nin oncology 1398\nlung 1406\nPetiole 459\nPetit hernia 1100\nPetroclinoid ligament 295\nPetrositis, apical 475\nPetrous\napex\nanatomy 315\ndumbbell mass 440\nlesions 439\napicitis 475\npyramid, scalloping 350\nPeutz-Jeghers syndrome 1132\nPeyer patches 1143\nPeyronie disease 1230\nPfaundler-Hurler disease 152\nPfeiffer syndrome 180\nPHACES 423\nPhakoma 405\nPhakomatoses 286\nPhalangeal preponderance 211\nPhalanges, rectangular 189\nPhantom\nbone disease 143\nbreast tumor 685\ncalyx\nTCC 1276\ntuberculosis 1281\nlung tumor 548\nPharmacological stress test 1414\nPharyngeal\nabscess 500\nmucosal space 462\nspace mass 442\nPharyngoesophageal diverticulum 1147\nPhasicity 779\nPhemister triad 209\nPhenobarbital, biliary atresia 920\nPhenylketonuria 180\nPheochromocytoma\nadrenal 1230",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 923,
            "markdown": "bladder 1173\nextraadrenal 1263\nPhlebectatic peliosis hepatis 974\nPhlebolith 123\nPhlegmasia\ncerulea dolens 812\ndolens alba 812\nPhlegmonous\ngastritis 1096\npancreatitis 969\nPhocomelia 1300, 1302\nPhosphate diabetes 187\nPhosphoethanolamine 132\nPhosphorus\nmetabolism 35\npoisoning 180\nPhotochromogens 646\nPhotographic negative, pulmonary edema 614\nPhoton-deficient bone lesion 2\nPhrenic\nampulla 1033\nnerve paralysis 560\nPhrenicocolic ligament 1039\nPhrygian cap 889\nPhthisis bulbi 414\nPhycomycosis 682\nPhyllodes\nsarcoma 731\ntumor 730\nPhysaliferous cells 246\nPhyseal widening 13\nPhysical stress test 1413\nPhysiologic\nintracranial calcification 295\nradioiodine activity 1403\nPhysis, anatomy 36\nPhytobezoar 1051\nPia\narteriovenous fistula 333\nmater 238\nPick disease 393\nPicket-fence, GI\nintramural hemorrhage 989\nmesenteric ischemia 1124\nPicture",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 924,
            "markdown": "-frame vertebra 179\nframing, osteoporosis 6\nPID 1374\nPiedmont fracture 108\nPie-in-the-sky bladder 1277\nPierre Robin syndrome 180\nPigeon\nbreast 17\nbreeder's lung 615\nPiggyback IVC-aorta 819\nPigmentation, mucocutaneous 1132\nPigmented\niris hamartomas 387\nstone, disease, intrahepatic 907\nvillonodular synovitis 180\nPigment stone 912\nPigskin 405\nPill esophagitis 1087\nPilocytic astrocytoma 335\nPilomatricoma 28, 181\nPindborg tumor 500\nPineal\ncalcification 295\ncell tumors 393\ncyst 393\ngerminoma 357\ngland 315\nteratocarcinoma 393\nteratoma 401\ntumors, classification 308\nPinealoma 357\nPineoblastoma 393\nPineocytoma 394\nPing-Pong\nfracture 355\nvolume, heart 813\nPink\npuffer 612\ntetralogy 850\nPins, orthopedic 34\nPIOPED criteria 659\nPipe stem ureter 1281\nPiriform sinus\nanatomy 458\nPisiform fracture 109",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 925,
            "markdown": "Pistol-grip deformity, femur 94\nPitfalls in cervical trauma 257\nPituilith 306\nPituitary\nadenoma 394\napoplexy 395\ndiabetes insipidus 1150\ngland 312\nanatomy 312\nenlargement 306\nmacroadenoma 395\nmicroadenoma 395\nstalk 313\nthickened 306\nPivot shift\ninjury, knee 24\ntest 76\n\n# Placenta \n\nabnormal size 1297\naccreta 1379\nbiopsy 1326\ncysts 1298\ndecreased size 1297\nenlargement 1297\nextrachorialis 1323\ngrading 1323\nhemorrhage 1377\nincreta 1379\ninfarct 1298\nlow-lying 1379\nmacroscopic lesion 1298\nmembranacea 1323\nmigration 1379\npercreta 1379\npremature senescence 1323\nprevia 1379\nrotation 1379\nseptal cyst 1298\nsuccenturiate lobe 1323\ntumor 1298\nvariant morphology 1322\nvascular spaces 1298\n\n## Placental\n\nabruption 1377\npolyp 1339",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 926,
            "markdown": "site trophoblastic disease 1380\n\n# Placentomegaly 1297 \n\n## Plagiocephaly 215\n\n## Plantar\n\ncompartments\nforefoot 52\nmidfoot 52\nfasciitis 202\nfibromatosis 202\n\n## Plaque\n\nesophagus 1006\nhemorrhage 477\nulceration 477\n\n## Plasma\n\ncell\ngranuloma 629, 1106\nmastitis 726\nflow, kidney 1187\n\n## Plasmacytoma\n\nextramedullary 485\nkidney 1231\nlaryngeal 490\nsolitary of bone 155\nPlates, orthopedic 33\nPlatybasia 220\nPlatyhelminthes 1028\nPlatyspondyly 1301\ngeneralisata 222\n\n## Pleomorphic\n\nadenoma\nlung 588\norbit 430\nparotis 500\nhyalinizing angiectatic tumor 732\nxanthoastrocytoma 336\n\n## Plethysmography\n\nimpedance 812\nvenous occlusion 812\n\n## Pleura\n\nasbestos-related disease 578\n-based lung nodule 539\nempyema 612\nsolitary mass 548\n\n## Pleural\n\naspergillosis 582",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 927,
            "markdown": "calcification 550\ndensities, multiple 549\neffusion 546\nfetus 1306\nfibroma, benign 641\nhyaloserositis 549\nmetastasis 643\npeel 613\nplaques 579\npseudotumor 536\nrind\nempyema 613\ntuberculosis 682\nthickening 549\nPleuropneumonia-like organism 644\nPleuropulmonary paragonimiasis 647\nPlexiform neurofibroma 273\nPlexogenic pulmonary arteriopathy 840\nPlicae circulares 1035\nPlombage 680\nPlumbism 90\nPlummer\ndisease\ntoxic autonomous nodule 510\ntoxic nodular goiter 486\n-Vinson syndrome\nesophageal web 1086\nhypopharyngeal carcinoma 487\nPlunging 309\nranula 501\nPNET\nbrain 396\npancreas 964\nPneumatic reduction 1109\nPneumatocele 648\nPneumatocyst 648\nPneumatosis\ncystoides\ncoli 1133\nintestinalis 994\nintestinalis 994\nsphenoidale 379\nstomach 1008\nPneumobilia 873\nPneumocephalus",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 928,
            "markdown": "intracranial 294\ntension 309\nPneumococcal pneumonia 648\nPneumoconiosis 539\ncategories 539\ncoal worker's 601\ncomplicated 602\nrheumatoid 664\nwith mass 539\n\n# Pneumocystis \n\ncarinii 648\nin AIDS 574\njirovecii\nkidney infection 1193\nPneumocystography, breast 718\nPneumocystosis 648\nin AIDS 1044\nPne umomediastinum 551\nPneumonectomy chest 649\nPneumonia 519\nacute interstitial 623\nalveolar 519\nmacrophage 628\naspiration 583\natypical measles 584\nbilateral lower lobe 519\ncavitating 521\ncholesterol 649\ncommunity-acquired 519\ndesquamative interstitial 627\nextensive bilateral 519\nfire-eater 630\nfocal organizing 616\ngolden 649\nGram-negative 519\nhemorrhagic 513\ninterstitial 520, 623\nKlebsiella 630\nLegionella 630\nlipid 649\nlipoid 630\nlobar 519\nlobular 519\nlymphoid interstitial 626\nMycoplasma 643",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 929,
            "markdown": "neonatal 644\nnosocomial 519\nnummular 521\norganizing interstitial 626\nperibronchial 520\npneumococcal 648\npostobstructive 649\nprimary atypical 643\nPseudomonas 650\nrecurrent in childhood 521\nround 521\nsegmental 519\nstaphylococcal 671\nstreptococcal 672\nvaricella-zoster 682\nviral 520\n\n# Pneumonitis \n\nhypersensitivity 615\nlymphocytic interstitial 626\nPandora's 615\nradiation 662\nPneumopericardium 552, 748\nPneumoperitoneum 992\nbalanced 993\nPneumoretroperitoneum 994\nPneumosinus dilatans 378\nPneumothorax 545\nPocket shot 843\nPodagra 120\nPOEMS syndrome 155\nPoint of Sudeck 1110\nPoisoning, phosphorus 180\nPoland syndrome 649\nPoliomyelitis, bone 181\nPolka-dot sclerosis 123\nPolyangiitis, microscopic 828\nPolyarteritis nodosa 838\nPolycystic\nkidney disease 1231\nliver disease 898\nnephroblastoma 1223\novary syndrome 1382\nPolycythemia 1150\nvera 7\nPolydactyly 20",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 930,
            "markdown": "in fetus 1302\nPolyembryoma 1373\nPolyhydramnios 1295\nPolymastia 683, 698\nPolymethylmethacrylate 24\nPolymyalgia rheumatica 848\nPolymyositis 80\nPolyorchidism 1234\nPolyostotic\nfibrous dysplasia 101\nsclerosing histiocytosis 614\nPolyp\nadenomatous, colon 1042\nangiomatous, nasal 502\nantrochoanal 502\ncarpet\nfamilial adenomatous polyposis 1089\nPeutz-Jeghers 1132\ncholesterol, gallbladder 947\ncolon 1022\nendocervical 1353\nendometrium 1316\nepithelial, colon 1042\ngallbladder 873\nhyperplastic, colon 1104\ninflammatory, gallbladder 947\nplacental 1339\nstomach 1092\nPolyphosphates 1421\nPolyposis\nfamilial\nadenomatous 1089\nmultiple 1089\njuvenile 1111\nlymphomatous 1115\npostinflammatory 1133\nsinonasal 502\nsyndromes 1025\nPolysplenia syndrome 819\nPolythelia 683, 698\nPolyureteritis cystica 1242\nPompe disease 931\nPontine\nmyelinolysis 392\ntegmental cap dysplasia 395",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 931,
            "markdown": "Pontomesencephalic vein 323\nPoorly differentiated neuroendocrine tumor 963\nPopcorn calcification\nbreast 688\nchest 556\nhistoplasmosis 619\nPopliteal\nartery entrapment syndrome 839\ncyst 202\nhiatus 50\npterygium syndrome 158\nvein 778\nPoppel sign 967\nPorcelain\naorta 794\nappendix 1128\ngallbladder 975\nPorcine xenograft, heart 760\nPorencephaly 395\nPores of Kohn and Lambert 519\nPork tapeworm 347\nPorta hepatis\ndefect, NUC 868\nlow-density mass 868\nnodes 1027\nPortal\nfibrosis, noncirrhotic 898\nhypertension 975\nnoncirrhotic idiopathic 898\ntriad 888\nvein\nabnormal flow 870\ncongestion index 887\ndiameter 884\nembryology 885\ngas 871\npressure 975\npulsatility 870\nshunt 870\nstenosis 870\nthrombosis 976\nvarix 976\nvelocity 886\nPortalization, hepatic veins 869\nPortocaval shunt 978",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 932,
            "markdown": "Portoenterostomy 920\nPortopulmonary hypertension 919\nPortosystemic shunt 870, 977\ncongenital extrahepatic 920\nspontaneous 976\nsurgical 978\ntransjugular intrahepatic 979\nPort-wine nevus\nKlippel-TrÃ©naunay syndrome 134\nSturge-Weber-Dimitri 399\nPositional headache 344\nPosition, uterine 1329\nPositive predictive value 1427\nPositron emission tomography 1396\nbrain 1401\nheart 1413\nlung 1406\nPostaxial, definition 20\nPostbulbar ulceration 1014\nPostcholecystectomy syndrome 980\nPostcricoid\narea 458\ncarcinoma 487\ndefect 1133\nPostductal aortic coarctation 809\nPosterior\nankle tendons 52\ncerebral artery 320\ncommissure 462\ncruciate ligament 48\navulsion fracture 112\ninjury 77\ndescending artery 769\nethmoid air cells 454\nfossa\ncyst 305\ntumor, in adult 306\ninferior cerebellar artery 325\njunction line 570\nlobe, pituitary gland 312\nlongitudinal ligament 239\nmediastinal mass 554\npararenal space 1187\npharyngeal wall carcinoma 487\nreversible encephalopathy syndrome 396",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 933,
            "markdown": "scalloping of vertebrae 223\nshoulder dislocation 87\nspinal fixation devices 231\ntibial\nnerve 54\nveins 777\ntracheal stripe 571\nurethral valves 1234\nurethrovesical angle 1175\nvertebral elements\nblowout lesion 226\nprimary tumor 226\nwall of bronchus intermedius 571\nPosteromedial corner of knee 49\nPosthemorrhagic hydrocephalus 384\nPostinfectious encephalitis 353\nPostinflammatory\npolyp 1022\npolyposis 1133\nrenal atrophy 1235\nPostlumpectomy breast MRI 694\nPostmaturity syndrome 1380\nPostmenopausal\nendometrial thickness 1331\nosteoporosis 4\novary 1334\nuterine bleeding 1316\nPostmicturitional adrenergic attack 1173\nPostmyocardial infarction syndrome 832\nPostobstructive\npneumonia 649\npulmonary edema 517\nrenal atrophy 1235\nPostoperative\ndiskitis 252\nhematoma, breast 685\nscar, breast 685\nstomach, complications 1011\nstomal edema 999\nthoracic deformity 760\nPostpartum\nendometrium 1331\nhemorrhage 1317\nthyroiditis 509\nuterus 1330",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 934,
            "markdown": "Postphlebitic valvular incompetence 808\nPostpneumonectomy pulmonary edema 518\nPostprimary pulmonary tuberculosis 681\nPostrheumatic heart disease 840\nPostrubella syndrome\nCHD 737\nheart 842\nPostsurgical brain herniation 309\nPostterm fetus 1380\nPosttransplant lymphoproliferative disease 637\nPosttraumatic\nhydrocephalus 360\nosteoporosis 185\npulmonary insufficiency 575\nspinal cord cyst 280\nsyringomyelia 280\nPostviral leukoencephalopathy 353\nPotassium-43 1411\nPott\ndisease 281\npuffy tumor 424\nshunt 759\nPotter\nclassification 1164\nfacies 1244\nsequence 1244\nsyndrome\nbilateral renal agenesis 1244\nclassification 1164\nPouch of Rathke 312\nPourcelot index 779\nPouteau fracture 107\nPowers ratio 252\nPPD tuberculin test 680\nPreaxial, definition 20\nPrecapillary hypertension, lung 749\nPrecentral cerebellar vein 323\nPrecision 1394\nPrecocious puberty 1310\nPrediverticular disease, colon 1073\nPreductal aortic coarctation 809\nPreeclampsia 1380\nPregnancy\nacute fatty liver 927\nadnexal mass 1314",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 935,
            "markdown": "-associated breast cancer 718\nfailure 1338\nhydronephrosis 1213\nintrauterine device 1362\nloss 1338\npulmonary embolism 655\nPreiser disease 67\nPremature\nadrenarche 1311\natrial contractions, fetus 1356\nepiphyseal ossification 13\ninfant, patent ductus arteriosus 835\nlabor 1297\nosteoarthritis 15\nplacental senescence 1323\nrupture of membranes 1380\nthelarche\nbreast 683\nprecocious puberty 1311\nPrematurity with accelerated lung maturity 521\nPrenatal intracranial calcifications 1304\nPreplacental hemorrhage 1378\nPrepubertal\ntesticular mass 1177\nvaginal bleeding 1316\nPRES 396\nPresacral space, enlarged 1022\nPresbyesophagus 1133\nPreseptal cellulitis 424\nPressure edema, lung 516\nPretibial\ndimple 71\nmyxedema 487\nPrevalence 1427\nPrevascular mediastinal mass 554\nPrevertebral\nabscess 501\nspace\nanatomy 464\nmass 443\nPrhen sign 1208\nPriapism 1235\nPrimary\nacquired cholesteatoma 480\nadrenal insufficiency 1194",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 936,
            "markdown": "aldosteronism 1150\namebic meningoencephalitis 353\namenorrhea 1311\namyloidosis 1046\nangiitis of CNS 396\natypical pneumonia 643\nbenign liver tumor 862\nbiliary cirrhosis 918\ncholangitis 907\ncholesteatoma\nbrain 345\ntemporal bone 480\nCNS tumors, classification 291\ncyst of spleen 925\neffusion lymphoma 827\nesophageal peristalsis 1002\nextragonadal germ cell tumor 1208\nfallopian tube carcinoma 1356\nfamilial xanthomatosis 1292\nglaucoma 414\nhemochromatosis 932\nhyperaldosteronism 1204\nhypercoagulable state 759\nhyperoxaluria 1287\nhyperparathyroidism 129\nhypertrophic osteoarthropathy 178\nhypophosphatemia 187\nhypothyroidism 450\nliposclerosis of mesentery 1137\nlymphatic dysplasia 826\nlymphedema 826\nlymphoma\nbone 143\nbowel 1114\nCNS 376\nmalignant\nliver tumors 863\npericardial mesothelioma 836\nmegaureter, congenital 1220\nmesenteric adenitis 1123\nneoplasm of appendix 1019\norbital melanoma 431\nosteogenic sarcoma, heart 803\novarian choriocarcinoma 1345\nperistalsis 1002",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 937,
            "markdown": "pigmented nodular adrenocortical disease 1199\nprotein-losing enteropathy 1106\npulmonary\nhypertension 840\nlobule 567\nlymphangiectasia 603\nlymphoma 649\ntuberculosis 680\nretroperitoneal fibrosis 1260\nsclerosing cholangitis 905\nspinal tumors by tissue origin 226\nspongiosa 3\ntumor of posterior elements 226\nvesicoureteric reflux 1290\nvitreous 430\n\n# Primitive \n\nacoustic artery 321\nhindgut 1048\nhypoglossal artery 321\nneuroectodermal tumor 580\nCNS 396, 397\nspinal cord 273\nPrimordial cyst, tooth 219\nPrion 347\nProatlantal intersegmental artery 323\nProboscis 365\nProbst bundles 327\nProcarbazine, lung damage 515\nProcessus vaginalis 1189\nProctography 1129\nProgeria 181\nProgestasert ${ }^{\\circledR} 1362$\nPrognathism 58\nProgressing stroke 284\nProgressive\ndiaphyseal dysplasia 182\nmassive fibrosis 602\nsilicosis 671\nmidbrain syndrome 348\nmultifocal leukoencephalopathy 397\nsystemic sclerosis 1133\nProjectile vomiting 1105\nProlactin elevation 283\nProlapse of\nantral mucosa 1135",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 938,
            "markdown": "mitral valve 830\nrectum\ncystic fibrosis 607\ndefecography 1131\nright aortic valve cusp 858\nspleen 985\numbilical cord 1346\nProliferative\nbronchiolitis 625\nphase, endometrium 1330\nProminent pyramidal lobe 450\nPromontory mass 438\nPronephros 1183\nPropoxyphene, lung damage 515\nProptosis 422\nPropylthiouracil 133\nProsencephalon 311\nProstaglandin E\nmusculoskeletal anomalies 90\ntransposition of great arteries 852\nProstate\nabscess 1237\nanatomy 1191\nbenign hypertrophy 1201\ncancer 1235\ncyst 1179\nextraprostatic cyst 1179\nhypoechoic lesion 1179\nhypointense T2 signal 1180\nobstruction 1176\n-specific antigen 1235\nProstatic intraepithelial neoplasia 1235\nProstatitis 1237\nProsthesis, heart valve 760\nProsthetic\nfailure, scintigraphy 24\ngraft infection, aorta 792\nProtein-losing enteropathy 990\nProteus syndrome 182\nProtrusio acetabuli 22\nProtrusion, disk 250\nProventilÂ® 1437\nProximal\nacinar emphysema 611\nloop syndrome 1043",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 939,
            "markdown": "renal tubular acidosis 1257\nshift, brain 291\ntubular adenoma 1263\nPrune belly syndrome 1238\nPruned tree appearance\nbile ducts 906\nbronchogram 672\nhepatic vein branches 916\nPruning, pulmonary arteries 751\nPruritus, contrast reaction Endpaper A\nPrussak space 465\nPSA\ndensity 1235\nvelocity 1235\nPsammoma bodies 1312\nmeningioma 378\nthyroid 451\nPsathyrosis 167\nPseudarthrosis\n1st rib 18\nin infancy 99\nlong bones 13\nPseudoacardia 1339\nPseudoachalasia 1042\nPseudoachondroplasia 58\nPseudoaneurysm 785\nchronic aortic 788\nposttraumatic 854\nheart 858\npancreatitis 968\npulmonary artery 841\nrenal transplant 1256\nPseudoangiomatous stromal hyperplasia 731\nPseudo-blind loop syndrome 1134\nPseudocalculus, bile duct 875\nPseudocavitation, lung 590\nPseudocirrhosis 919\nPseudocoarctation\nacute thoracic aortic injury 853\naortic kinking 840\nPseudocryptorchidism 1218\nPseudocyst 970\nadrenal 1196\nbone, necrotic 15\ngelatinous, brain 347",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 940,
            "markdown": "meconium 1122\npancreas 965\nperitoneal 1131\nspleen 881\nsubarticular 15\numbilical cord 1299\nPseudocystic hygroma 493\nPseudo-Dandy-Walker-malformation 350\nPseudodiverticula, small bowel 1014\nPseudodiverticulosis, intramural esophagus 1085\nPseudoenhancement, renal cyst 1251\nPseudoe xstrophy 1203\nPseudofractures 182\nPseudogestational sac 1349\nPseudoglioma, eye 419\nPseudogout 70\nPseudogynecomastia 724\nPseudohermaphroditism 1199\nfemale 1181\nmale 1181\nPseudohyperparathyroidism 130\nPseudohypoparathyroidism 183\nPseudo-Jefferson fracture 258\nPseudokidney sign 1164\nPseudoleukemia 156\nPseudolymphoma 629, 1106\nbreast 726\nlung 646\nPseudomembrane, fetal neck 493\nPseudomembranous colitis 1061\nDDx 1020\nPseudomonas pne umonia 650\nPseudomyxoma peritonei 1135\nPseudoneuroma of median nerve 71\nPseudoobstruction\nintestinal 1107\nPseudoobstruction, intestinal 1002\nPseudo-omphalocele 1366\nPseudopalisading 357\nPseudopalsy, Parrot 204\nPseudopapilledema 428\nPseudoperiostitis 128\nPseudopneumoperitoneum 994\nPseudopolyposis 1133\nPseudopolyps, definition 1022",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 941,
            "markdown": "Pseudoporencephaly 395\nPseudo-post Billroth-I appearance 1070\nPseudoprecocious puberty 1310\nPseudopseudohypoparathyroidism 132\nPseudoretinoblastomas 434\nPseudorosettes, perivascular 354\nPseudosacculations\nchronic mesenteric ischemia 1125\nCrohn disease 1069\nscleroderma 1134\nPseudosarcoma, esophagus 1084\nPseudospondylolisthesis 278\nPseudostrictures, colon 1061\nPseudosubluxation, C-spine 221\nPseudosyrinx 280\nPseudothrombophlebitis 812\nsyndrome 202\nPseudotrabeculae 81\nPseudotruncus arteriosus 856\nPseudotumor\nabdomen 1001\natelectatic asbestos 580\ncerebri 369\nchest 629\nhemophilic 126\ninflammatory, GI tract 1106\nkidney 1163\nof infancy 485\norbit 431\npleura 536\nsinonasal 502\nsmall bowel 1015\nurinary bladder 1214\nxanthomatous 1106\nPseudo-Turner syndrome 161\nPseudoulcerations 1062\nPseudoureterocele 1283\nPseudovagina 1181\nPseudo-wall sign, intestines 994\nPseudo-Whipple disease, MAI infection 1044\nPseudowidening, joint space 128\nPseudoxanthoma elasticum 183\nhereditary hyperphosphatasia 126\ntumoral calcinosis 210\nPseudo Z-E syndrome 1147",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 942,
            "markdown": "Psoriatic arthritis 183\nhand 16\nPsychogenic water intoxication 1150\nPterygium colli 493\nPterygoid\nartery 319\ncanal 234\nPubarche 1334\nPuberty 1310\nPubic bone malde velopment 1302\nPuerperal\nmastitis 729\novarian vein thrombophlebitis 1373\nPuerperium 1330\nPuff of smoke, brain 382\nPulmonary\nagenesis 522\nunilateral 682\nalveolar proteinosis 577\naplasia 522, 1305\narterial\nhypertension 752\nmalformation 650\narteriovenous\naneurysm 650\nfistula 650\nmalformation 650\nartery\naberrant left 781\ncongenital\nabsence 841\naneurysm 820\ndecreased diameter 749\ndilatation 749\nfilling defect 749\nidiopathic dilatation 820\ninterruption 821\ninvisible 749\nnormal diameter 776\npseudoaneurysm 841\nsling 781\nstenosis 841\nartery-to-bronchus ratio 749\nasbestosis 579\natresia 841",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 943,
            "markdown": "without VSD 820\nblood flow\ndecreased + cyanosis 740\nincreased\nwith cyanosis 739\nwithout cyanosis 740\nnormal without cyanosis 740\nunequal 749\ncalcifications, multiple 539\ncapillary\nhemangiomatosis 651\nwedge pressure 516\ncirculation 568\ncongenital venolobar syndrome 605\ncontusion 586\ncyst 544\nmultiple 544\ndysmaturity 682\nedema, B\nembolic disease 652\nseptic 669\nembolism\nin pregnancy 655\nwith edema 517\nhemorrhage 513\nhemosiderosis, idiopathic 629\nhistoplasmosis 619\nhypertension 750\nin cirrhosis 919\npersistent, newborn 838\nprimary 840\nhypoplasia 522, 1305\ninfarction 651\ninfiltration with eosinophilia 613\ninterstitial emphysema 651\nlaceration 586\nLangerhans cell histiocytosis 651\nlinearity 524\nlobule\nprimary 567\nsecondary 567\nlymphangiectasia, primary 603\nmainline granulomatosis 652\nmalformation 522\nmalignant fibrous histiocytoma 102",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 944,
            "markdown": "metastases 642\nnodularity 524\nnodule 533\nenhancement 535\nPET 535\noligemia 542\npapillomatosis 490\nprimary lymphoma 649\nreimplantation response 631\n-renal syndromes 515\nscleroderma 1135\nsequestration spectrum 522\ntalcosis\ninhalational 674\nmainline 652\nthromboembolic disease 652\nthromboembolism in pregnancy 655\nvalve, congenital absence 810\nvarix 662\nvascularity 748\ndecreased 749\nincreased 748\nnormal + normal-sized heart 748\non erect chest film 749\nvein\ncalcification 750\nstenosis 749\nvariant anatomy 776\nvenoocclusive disease\nwith edema 517\nvenoocclusive disease 661\nvenous hypertension 752\nwith cyanosis 740\n\n# Pulmonic \n\nclick 842\ninsufficiency 841\nstenosis 841\nvalve, anatomy 764\n\n## Pulp stones 210\n\n## Pulsatile\n\nportal vein 870\ntinnitus 438\n\n## Pulsatility 779\n\n## Pulsating exophthalmos\n\ncarotid-cavernous sinus fistula 332",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 945,
            "markdown": "neurofibromatosis 389\nPulseless disease 847\nPulsion diverticulum 1005\nPulsus\nalternans 760\nparadoxus 803\nparvus et tardus 794\nPulverized lung 648\nPulvinar, hip joint 82\nPump\nlung 575\ntwin 1339\nPunched-out lytic bone lesion 120\nPure\nred cell aplasia 678\nXY gonadal dysgenesis 1182\nPurulent meningitis 379\nPustulotic arthrosteitis 194\nPutty kidney 1281\nPyelectasis, fetal 1167\nPyelitis, emphysematous 1240\nPyelocalyceal diverticulum 1239\nPyelogenic cyst 1239\nPyelonephritis 1239\nacute 1239\nsuppurative 1240\nchronic atrophic 1242\nemphysematous 1241\nxanthogranulomatous 1241\nPyelotubular backflow 1167\nPyelotumoral backflow 1248\nPyeloureteritis cystica 1242\nPygopagus 1346\nPyknodysostosis 183\nPyle disease 150\nPylephlebitis 980\nPylethrombosis 976\nPyloric\nstenosis 1104\nteat 1105\nPylorospasm, infantile 1105\nPylorus 1034\nPyocephalus 406\nPyogenic\nabscess",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 946,
            "markdown": "brain 326\nliver 934\ngranuloma 124\nrenal abscess 1243\nspondylodiskitis 252\nPyomyositis 133\nPyonephrosis 1242\nPyosalpinx 1376\nPyramidal\nfracture 254\nthyroid lobe, prominent 450\nPyriform sinus carcinoma 487\nPyrophosphate 1421\n\nQuadriceps tendon avulsion fracture 112\nQuadrilateral\nretinoblastoma 433\nspace syndrome 184\nQuad test 89\nQuality control, SPECT 1396\nQuantitative\ncomputed tomography 5\ndigital radiography 4\nheel ultrasound 5\nQuartz 670",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 947,
            "markdown": "# Rabbit ears, lung 591 \n\n## Raccoon eyes 255\n\nRacemose neurocysticercosis 348\nRachischisis of atlas 220\nRachitic rosary 190\nRadial\nartery harvest 777\nscar, breast 731\n\n## Radiation\n\ndose 1393\nto fetus 1336\nfetal exposure 1335\nhepatitis 942\n-induced\nbreast cancer 708\nsarcoma 185\nleukoencephalopathy 382\nthyroid cancer 507\ninjury 184\nGI tract 1136\nrectum 1136\nnephritis 1242\npneumonitis 662\nRadicular cyst 218\nRadiochemical impurity 1394\nRadiographic\ncontrast 703\nmottle 703\nRadiography, bedside chest 562\nRadioiodine\nphysiologic activity 1403\ntherapy for hyperthyroidism 450\ntracer 1403\n\n## Radiolucent\n\ncrescent line 66\nliver sign 927\n\n## Radionuclide\n\nangiography, CNS 1400\ncisternography 1401\ncystogram 1420\nesophagram 1418",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 948,
            "markdown": "impurity 1394\nproduction 1394\ntable 1393\nRadionuclide angiography 337\nRadiopharmaceuticals, quality control 1394\nRadioulnar index 42\nRadius\naplasia 1302\nhypoplasia 1302\nRaider triangle 553\nRailroad track calcification, heart 835\nRamsay-Hunt syndrome 488\nRam's horn sign 1070\nRandomized trials 1429\nRang classification 106\nRanitidine 1437\nRanke complex 681\nRanula 500\nRapidly destructive articular disease 164\nRappaport classification 634\nRashkind procedure 759\nRasmussen aneurysm 680\nRastelli procedure 760\nRat\nbite erosion 120\ntail\ncommon bile duct 960\nesophagus 1042\nRathke\ncleft cyst 397\npouch 312\nRatio of\ncaudate to right hepatic lobe 915\npulmonary artery-to-bronchus 749\nRaynaud\ndisease 842\nphenomenon 843\nsyndrome 842\nReabsorption of sodium 1188\nReactivation tuberculosis 681\nReactive\nairway disease 584\narthritis 185\ncyst, cord 280\nRebound thymic hyperplasia 677",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 949,
            "markdown": "Recanalized thrombus 811\nReceiver operating characteristics 1427\nRecipient twin 1386\nRECIST 953\nRecklinghausen, von 387\nReconversion, bone marrow 35, 126\nRecreational drug abuse 843\nRecrudescent tuberculosis 681\nRectal\natresia 1048\ncancer 1065\nduplication cyst 1078\nintussusception 1131\nnarrowing 1022\nprolapse\ncystic fibrosis 607\ndefecography 1131\nradiation injury 1136\nulcer, solitary 1139\nRectangular phalanges 189\nRectocele 1130\nRectovesical septum 1048\nRectum 1036\nRecurrent\ndislocations 91\nfleeting infiltrates 542\nlaryngeal nerve 470\npneumonia in childhood 521\npneumothorax\nLangerhans cell histiocytosis 652\nlymphangiomyomatosis 633\npyogenic\ncholangitis 907\nhepatitis 907\nrespiratory papillomatosis 490\nRed cell hyperplasia 9\nRedistribution\nimage 1411\nphase, thallium 1412\nReduction\nheart rate for imaging 1437\nmammoplasty 728\nReed-Sternberg cell 620\nReexpansion pulmonary edema 518\nReflex sympathetic dystrophy 185",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 950,
            "markdown": "# Reflux \n\natrophy 1242\ncontrast material 757\nesophagitis 1088\ngastroesophageal, NUC 1007\nnephropathy 1242\nureteroureteral 1283\nvesicoureteric 1290\n\n## Refractory asthma 588\n\n## Regenerative\n\ngastric polyp 1092\nnodular hyperplasia 957\nnodules in liver cirrhosis 917\n\n## Regional\n\ncerebral blood flow, PET 1401\nenteritis 1068\nmigratory osteoporosis 207\noligemia, lung 542\nosteoporosis, transient 207\nRegressed germ cell tumor of testis 1274\n\n## Regurgitation\n\naortic 792\nmitral valve 828\npulmonary valve 841\nReid lobule 567\nReilly bodies 153\nReimann classification 1046\nReimplantation response, lung 631\nReinhardt syndrome 149\nReiter syndrome 185\nRejection\nlung transplant 631\nrenal transplant 1254\nRelapsing polychondritis 185\nRemote cerebellar hemorrhage 309\n\n## Renal\n\nabscess 1243\nacidification mechanism 1188\nadenocarcinoma 1247\nadenoma 1243\nagenesis 1243\nagents, NUC 1418\nallograft necrosis 1256\nanatomy 1184\nanomalies, developmental 1157",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 951,
            "markdown": "apergillosis 582\narteriosclerosis 1247\nartery\naneurysm 1244\nfibromuscular dysplasia 1247\npedicle injury 1279\nstenosis\nnative kidney 1244\nrenal transplant 1255\nthrombosis, transplant 1255\natrophy\npostinflammatory 1235\npostobstructive 1235\nreflux 1242\ncalcification 1168\ncalcified mass 1162\ncell carcinoma 1247\ncolic 1288\ncontour, local bulge 1163\ncortex, increased echogenicity 1159\ncyst 1251\ncystic disease 1164\ndevelopmental anomalies 1157\nDoppler 1166\nduplication 1282\ndysgenesis 1252\nechogenicity\nfocally increased 1163\nnormal 1185\nfailure 1149\ncontrast-induced 1205\nGI abnormalities 990\nfracture 1278\nfunction, differential 1160\nfusion 1158\nhalo sign 967\nhamartoma 1200\nfetal 1220\nhemangioma 1211\nhyperechoic nodule 1163\nhypoplasia, congenital 1204\nimaging\ngallium 1425\nin newborn 1188\ninfarction 1252",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 952,
            "markdown": "leiomyoma 1214\nleiomyosarcoma 1214\nmalrotation 1158\nmass 1161\ncalcified 1162\ngrowth pattern 1162\nmedical disease 1159\nmetastases 1221\nosteodystrophy 186\nperfusion, impaired 1165\nplasma flow 1187\npseudotumor 1163\npyramids, hyperechoic in children 1159\nradionuclides 1418\nsarcoma 1253\nscintigraphy 1418\ncold defect 1160\ngallium 1425\nscleroderma 1135\nsinus\ncyst 1252\nhypoechoic 1168\nmass 1168\nsize 1185\nSLE 673\ntransitional cell carcinoma 1276\ntransplant 1253\nGI abnormalities 990\ntrauma 1278\ntubular acidosis\ncongenital bone disease 187\nkidney 1257\nunderdevelopment 1157\nvascular anatomy 1185\nvein\nanatomy 1185\ncircumaortic 756\nentrapment syndrome 833\nretroaortic 756\nstenosis, transplant 1256\nthrombosis 1258\nthrombosis, transplant 1256\nRendu-Osler-Weber syndrome 618\nReniculus 1184\nRenin",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 953,
            "markdown": "-aldosterone mechanism 1187\nelevation 1151\nReninoma 1214\nRen lobatus 1184\nRenomedullary interstitial cell tumor 1259\nRenovascular hypertension 1151\nReperfusion\nedema, lung transplant 631\npulmonary edema 518\nReplacement lipomatosis 1269\nResidual\ncapacity, functional 569\ncyst, jaw 219\nvolume 569\nResistance index 779\nResorption of terminal tufts 21\nResorptive atelectasis 540\nRespirator lung\nadult 575\nneonate 596\nRespiratory\nbronchiole 567\nbronchiolitis-interstitial disease 625\ndistress\ncontrast reaction Endpaper A\nsyndrome, newborn 662\npapillomatosis, recurrent 490\nRestrictive cardiomyopathy 808\nRetained\nfetal lung fluid 663\ngastric antrum 1136\nproducts of conception 1338\nRete\nmirabile 323\ntestis, dilated 1178\nRetention\ncyst\nprostate 1202\nsinuses 440\npolyp\ncolon 1071\nstomach 1092\nReticulations\nchronic diffuse 526\ncoarse, lung 527",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 954,
            "markdown": "diffuse fine 526\nlung 524\nwith hilar adenopathy 527\nwith pleural effusion 527\nReticulogranular densities in neonate 521\nReticulonodular lung disease 528\nReticulum cell sarcoma, bone 143\nRetinal\nangiomatosis 408\nastrocytic hamartoma 432\nastrocytoma 432\ndetachment 432\ntraumatic 427\ndysplasia 426\ntelangiectasia 419\nRetinoblastoma 432\nRetinocerebellar angiomatosis 408\nRetinocytoma 434\nRetinoids 90\nRetinoma 434\nRetinopathy of prematurity 434\nRetractile\nmesenteritis 1138\ntestis 1218\nRetraction, liver capsule 865\nRetroalar herniation 290\nRetroaortic left renal vein 756\nRetroatrial sign 782\nRetrocardiac space of Holzknecht 554\nRetrocaval ureter 1259\nRetrocrural\nneoplasm 560\nnodes 1027\nspace, anatomy 573\nRetrofenestral otosclerosis 496\nRetrogastric space, widened 1008\nRetrohyaloid hemorrhage 428\nRetrolental fibroplasia 434\nRetroperitoneal\ncalcification 1168\ncompartments 1186\nfat necrosis 1259\nfibrosis 1259\nfluid 1154\nhemorrhage, spontaneous 1170",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 955,
            "markdown": "leiomyosarcoma 1261\nliposarcoma 1261\nlymphangioma 1262\nlymphoma 1262\nmass\ncystic 1152\nlow-density 1152\nprimary 1152\nvascular 1153\nnodes 1028\noncocytoma 1262\nparaganglioma 1263\nteratoma 1263\ntumor 1153\nxanthogranuloma 1137\nRetroperitoneum, definition 1186\nRetropharyngeal\nabscess 501\nhemorrhage 501\nnarrowing 445\nspace 463\nmass 443\ntendinitis 476\nRetroplacental hematoma 1378\nRetropneumoperitoneum 994\nRetrorectal cystic hamartoma 1142\nRetrotracheal triangle 553\nRetzius space 1282\nReversal sign 287, 368\nReversed\nColles fracture 108\nfigure 3 sign, esophagus 1006\nhalo sign, lung 533\nHill-Sachs defect 87\nrim sign, cortical necrosis 1194\nrotation, GI tract 1120\nS sign\nesophagus 1006\nof Golden 592\n3 sign, heart 809\nReversible\nbronchiectasis 589\nischemic neurologic deficit 284\nposterior leukoencephalopathy syndrome 396\nRex-Cantlie line 884",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 956,
            "markdown": "Reye\nsyndrome 397\ntumor 201\nReynold sign 197\nRhabdoid tumor, kidney 1264\nRhabdomyolysis 30\nRhabdomyoma\nextracardiac 485\nheart 844\nRhabdomyosarcoma 1264\nabdominal 1266\nbiliary tree 925\nbladder-prostate 1266\nchest wall 561\nfemale genital tract 1266\ngenitourinary 1265\nhead \\& neck 1265\nheart 803\norbit 1265\nRheumatic spondylodiskitis 277\nRheumatoid\narthritis 16,187\njuvenile 189\nlung 664\npneumoconiosis syndrome 664\nvasculitis 189\nRhinocerebral mucormycosis 501\nRhizomelia 1300\nRhizomelic\nbrachymelia 63\ndwarfism 1301\nRhizopus 682\nRhoGAMÂ® 1358\nRhombencephalon 311\nRhombencephalosynapsis 397\nRib\nbeaded 168\nbifid 18\ncervical 17\ncongenital anomalies 17\ndense 19\ndouble-exposed 133\nEwing sarcoma 95\nexpansile lesion 18\nforked 18",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 957,
            "markdown": "fracture 110\nfusion 18\nhyperlucent 19\nhypoplastic 18\njail bar 156\nlesion 18\nnotching\ninferior margin 18\nsuperior margin 19\nshort 18\nslender 19\nwide 19\nRibbing disease 127\nRibbon\nbowel 1017\nribs 19\n\n# Rice \n\nbodies 15\n-like muscle calcifications 348\n\n## Rich focus 403\n\nRichter\nhernia 1101\nsyndrome 980\n\n## Rickets 190\n\nin renal osteodystrophy 186\n\n## Rider's bone 157\n\n## Riedel thyroiditis 510\n\n## Right\n\naortic arch 844\n\n+ aberrant\nleft brachiocephalic artery 845\nleft subclavian artery 845\n+ isolated left subclavian 845\n+ mirror image branching 845\natrial enlargement 742\natrium, anatomy 765\ncardiophrenic angle mass 555\ncoronary artery, anatomy 768\ndominant coronary circulation 769\nisomerism 818\nlower quadrant pain 987\nparatracheal stripe 570\nposterior hepatic notch sign 915\n-sided pleural effusion 548\nventricular",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 958,
            "markdown": "enlargement 742\ninfarction 832\nRigler\nsign 993\ntriad 1090\nRiley-Day disease 1003\nRim\n-enhancing breast lesion 693\n-lymphoma 375\nnephrogram 1165\nsign\nbiliary scintigraphy 873\ngallbladder 908\nIVP 1213\nRIND\nimage findings 372\nterminology 284\nRing\n-enhancing\nbrain lesion 298\nliver mass 866\nepiphysis 224\nesophageal 1005\nlesion, brain 298\nsign, liver 944\nRings and arcs calcification\nchondrosarcoma 73\nenchondroma 92\nRiolan arcade 1031\nRobinow syndrome 149\nRocker-bottom foot 25\nRodent facies 206\nRod, orthopedic 34\nRokitansky\n-Aschoff sinus 946\nlobe 598\n-Mayer-KÃ¼ster-Hauser syndrome 1386\nnodule 1347\nRolandic artery 320\nRolando fracture 110\nRolling\ngait 57\nhiatal hernia 1103\nRomanus lesion 277\nRoos test 850",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 959,
            "markdown": "Root of tongue 457\nRosai-Dorfman disease 397, 191\nRosary\nbeading\nbone scintigraphy 2\nesophagus 1003\nsign, gallbladder 946\nRosenmÃ¼ller fossa 462\nRotary\nfixation, atlantoaxial 244\nsubluxation of scaphoid 88\nRotation, placenta 1379\nRotator\ncuff\nlesions 191\nmuscles 36\ntear 192\ninterval 40\nRouleaux formation 154\nRound\natelectasis 580\ncell tumors, bone 10\nligament 1331\npneumonia 521\nshift 291\nRounded atelectasis 540\nRoundworm 408\nRouviÃ¨re node 443\nRubella 194\nRubeola 584\nRubinstein-Taybi syndrome 194\nRudick red flags 383\nRudimentary rib 18\nRuge-Simon syndrome 1350\nRugger-jersey spine 224\nRule of\n3 's\nsmall bowel anatomy 1035\nhydrostatic reduction 1109\n1/3's, carcinoid 1059\n10 's, pheochromocytoma 1231\n2's, Meckel diverticulum 1120\nRunyon classification 646\nRupture\naortic aneurysm",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 960,
            "markdown": "acute 785\nimpending 786\nberry aneurysm 330\nbreast prosthesis 728\ndiaphragm 609\nesophagus\nintramural 1085\ntransmural 1085\nglobe 427\ninterventricular septum 832\nmyocardium\ninfarct 832\ntrauma 801\novarian endometrioma 1354\npapillary muscle 832\npregnant uterus 1391\nspleen, spontaneous 882\ntendon 32\nteratoma 1383\ntestis 1276\nurinary bladder 1278\nuterine membranes, premature 1380\nRUQ pain 861\nRusty sputum 648\nRuvalcaba-Myhre-Smith syndrome 1051\n\n# Saber \n\n-shin tibia 205\n-sheath trachea 611\n\n## Saccular\n\naneurysm 785\nbronchiectasis 589\n\n## Sack-of-marbles appearance 482\n\n## Sacral\n\nagenesis 245\narachnoid cyst 266\ncanal tumor 228\ndestructive lesion 228\nfracture 261\nmeningocele 268\nneoplasms 228\nosteolysis 228",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 961,
            "markdown": "Sacrococcygeal\nchordoma 247\nteratoma 273\nSacroiliac joint\nanatomy 240\nfusion 228\nwidening 228\nSacroiliitis 227\nSaddle\nlesion, colon 1064\nnose 205\nperistalsis, ureter 1283\n-shaped uterine fundus 1388\nSaddlebag sign 993\nSaf-T-coil 1362\nSail\n-like tricuspid valve 814\nsign, chest 572\nSalad-oil sign 728\nSaldino-Noonan syndrome 196\nSalicylate, lung damage 515\nSalivary gland\nbilateral enlargement 449\ninflammatory disease 448\nmultiple small hypoechoic areas 448\nneoplasm 449\nSalpingitis 1375\nSalter-Harris classification 105\nSalt-losing nephritis 1258\nSandal-gap deformity 89\nSandlike lucencies, small bowel 1017\nSandwich\nconfiguration, adenopathy 1115\nsign 1108, 1118\nvertebrae 224\nSanfilippo disease 152\nSantorinicele 957\nSantorini duct 893\nSaphenous vein\ngreat 778\nsmall 778\nSAPHO syndrome 194\nSaponification 970\nSappey vein 886\nSaprophytic aspergillosis 581",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 962,
            "markdown": "# Sarcoidosis 665 \n\nalveolar 668\n\n## Sarcoma\n\nbotryoides\nENT 1264\nGU 1266\nbreast 731\nby age 9\ncardiac 802\ncerebellar 305\nclear cell, kidney 1204\nembryonal, liver 984\nEwing 94\ngranulocytic 1215\nhemangioendothelial 121\nKaposi 1111\nkidney 1253\nmonstrocellular 357\nradiation-induced 185\nreticulum cell 143\nsclerosing osteogenic 175\nsynovial 203\nundifferentiated, liver 984\n\n## Saucerization 200\n\n## Sausage digit\n\npsoriasis 183\nscleroderma 1135\n\n## Saw tooth\n\nsign, colon 1073\nureter 1281\n\n## Scalenus\n\nanticus syndrome 850\nminimus muscle 850\n\n## Scalloping of\n\npetrous pyramid 350\nvertebrae 223\n\n## Scalp, anatomy 233\n\n## Scaphocephaly 214\n\n## Scaphoid\n\nabdomen 608\nanatomy 42\nfracture, hand 109\nosteonecrosis 67\n\n## Scapholunate dissociation 88\n\n## Scapula fracture 110",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 963,
            "markdown": "Scapulothoracic syndrome 852\nScar\ncarcinoma 592\ntumor of liver 866\nScarpa ganglion 390\nSchatzker classification 113\nSchatzki ring 1137\nScheibe dysplasia 495\nScheie disease 152\nScheuermann disease 275\nSchilder disease 351\nSchiller-Duval bodies 1373\nSchimmelbusch disease 722\nSchistosomiasis\ncardiopulmonary 598\nCNS 398\nGU tract 1266\nliver 981\nSchizencephaly 398\nSchlemm canal 417\nSchmid disease 149\nSchmincke tumor 306\nSchmorl node 275\nSchneiderian papilloma 488\nSchumacher criteria 383\nSchwann cell 270\nSchwannoma 270\nadrenal gland 1268\nancient 271\norbit 430\nstomach 1137\ntrigeminal 391\nSchwartze sign 496\nSciatica 251\nSciatic foramen 47\nScimitar\nsacrum 268\nsyndrome 605,783\nvein 605\nScintigraphy\nadrenal 1420\nbrain 1400\nfracture, time course 103\nGI tract 1418\nheart 1406",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 964,
            "markdown": "liver 1417\nlung 1405\nneuroendocrine tumors 1420\nparathyroid 1404\nsplenic 1418\nScintillation camera 1395\nScirrhous carcinoma, breast 685\nScleral\nband / buckle 414\nplaques 414\nSclerodactyly 1135\nScleroderma 1133\narthritis, hand 16\nSclerosing\nadenosis, breast 722\nbone dysplasia 2\ncholangitis 905\nduct hyperplasia 731\nendophthalmitis 421\nlabyrinthitis 488\nlipogranuloma, scrotum 1177\nlipogranulomatosis 1137\nlobular hyperplasia 723\nmediastinitis 640\nmesenteritis 1137\nosteomyelitis of GarrÃ© 172\nosteosarcoma 175\nperitonitis 1138\nretroperitoneal granuloma 1259\nsialadenitis, chronic 481\nstromal tumor, ovary 1380\nSclerosis\nbone 2\nchronic subperitoneal 1137\ndiffuse, CNS 351\nhepatoportal 898\ntemporal bone 440\nSclerosteosis 195\nSclerotic\nbone island 69\ncalvarial patches 405\npedicle 225\ntooth mass 217\nScoliosis 275\npainful 164",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 965,
            "markdown": "# Scotochromogens 646 \n\nScotoma, central hemianoptic 411\nScottie dog appearance 279\nScreening\nbreast cancer 706\nmammography 707\nScrews, orthopedic 32\nScrofula 510\nScrotal\ncalculi 1177\nedema\nacute idiopathic 1176\npearls 1177\nsac 1189\ntrauma 1275\nScrotolith 1270\nScrotum\nabscess 1268\nacutely symptomatic 1176\nanatomy 1189\narterial supply 1191\ngas 1176\nmass 1177\nwall thickening 1176\nScurvy 195\nScutum 465\nSea\n-gull joint 163\n-water drowning 644\nSeatbelt\nfracture 260\ninjury 260\nSebaceous cyst 93\nbreast 733\nSeckel syndrome 1380\nSecond\nbranchial\narch 456\ncleft cyst 475\n-degree heart block 1357\nInternational Standard, beta-hCG 1320\nSecondary\nacquired cholesteatoma 481\namenorrhea 1312\namyloidosis 1046",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 966,
            "markdown": "arachnoid cyst 331\ncholesteatoma 480\nchondromatosis 203\ndrowning 644\nhemochromatosis 933\nhydrocele 1212\nhyperoxaluria 1287\nhyperparathyroidism 130\nhypertension 1151\nhypothyroidism 450\nlymphatic dysplasia 826\nlymphedema 827\nlymphoma\nbone 144\nbrain 376\nosteosarcoma 177\nperistalsis 1003\npulmonary lobule 567\npulmonary lymphangiectasia 603\nretroperitoneal fibrosis 1260\nsclerosing cholangitis 907\nspongiosa 3\ntumoral calcinosis 187\nSecretin 1030\nstimulation test 1030\nSecretory\ndisease, breast 685\nhyperplasia,. breast 723\nphase, endometrium 1331\nSedation 1438\nSedimentation sign 210\nSeesaw peristalsis, ureter 1283\nSegmental\nanalysis of CHD 737\ndefect, lung scan 657\nfracture 102\nliver anatomy 883\nlobar lung densities 541\npneumonia 519\nportal hypertension 976\nrenal cystic disease 1215\nSegmentation\nanomalies of vertebra 221\nbarium 1139\nSegond fracture 112",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 967,
            "markdown": "Seizure\ncontrast reaction B\nfocus imaging 1400\nSelf-selection bias 1429\nSella\nabnormalities 306\ncomplex cyst 306\ndestruction 306\nempty sella syndrome 352\nenlargement 306\nhypointense lesion 306\nJ-shaped 306\nSemicircular canals 468\nSemiinvasive aspergillosis 581\nSemilobar holoprosencephaly 365\nSeminal vesicle\natrophy 1182\ncyst 1268\nhypoplasia 1182\nSeminoma\nmediastinum 675\ntestis 1272\nSenile\namyloidosis 1046\nosteoporosis 4\nSensitive bladder 1175\nSensitivity 1427\nSensorineural hearing loss 437\nSensory urgency 1175\nSentinel\nclot 1053\nloop 1002\nnode of RouviÃ¨re 443\nSeparation of bowel loops 1014\nSeptal\natrial defect 796\nband, heart 762\nbounce 837\ncyst, placenta 1298\nlines 524\nnotch 852\nperforation, nose 441\nventricular defect 858\nSeptate uterus 1388\nSeptations, gallbladder 889",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 968,
            "markdown": "Septic arthritis 196 meningitis 379\npulmonary emboli 669\nSeptooptic dysplasia 398\nSeptum\nof Bertin 1163\nof orbit 424\npellucidum 313\nabsence 286\nprimum 765\nsecundum 765\ntransversum defect 609\nSequestration\nbronchopulmonary 596\ndisk 251\npancreatic 970\nSequestrum, button 137\nSequoiosis 615\nSeroma, breast 733\nSeronegative spondyloarthritis 276\nSerous\ncystadenoma\novary 1380\npancreas 981\novarian tumor 1380\npapillary carcinoma of ovary 1381\nSerpentine high-flow vascular channels 759\nSerpent sign 923\nSerrated beak sign 1001\nSertoli\ncell tumor, testis 1274\n-Leydig cell tumor, ovary 1381\n-stromal cell tumor, ovary 1381\nSestamibi 1412\nSex\ncord-stromal tumor\novary 1315\ntestis 1273\ndefinition 1181\ndevelopment 1184\nSexually transmitted disease 1375\nShading sign 1354\nShaggy\nesophagus 1087",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 969,
            "markdown": "heart border\nasbestosis 579\nUIP 627\nlung nodule 538\nShagreen rough skin patches 405\nSharpness, radiographic 703\nShattered\nkidney 1279\nspleen 1053\nShawl rash 80\nShearing injury, white matter 351\nSheehan syndrome 395\nShellfish allergy 1431\nShentons line 82\nShepherd fracture 115\nShepherd's crook deformity 99\nShibuol 1051\nShin\nsoreness 196\nsplints 196\nShiny corners vertebra 242, 277\nShish kebab esophagus 1003\nShock\nbowel\nabdominal trauma 1052\nmesenteric ischemia 1124\nlung 575\nnephrogram 1052\nShone syndrome 819\nShort\naxis view 763\nrib 18\n-polydactyly syndrome 196\nShotgun sign 874\nShoulder\ndislocation 86\n-hand syndrome 185\nimpingement 191\ninstability 19\njoint anatomy 36\nlabral tears 135\nMilwaukee 163\nmuscles, anatomy 38\nrotator cuff lesions 191\nsign, hypertrophic pyloric stenosis 1105",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 970,
            "markdown": "Shrapnell membrane 465\nShrinking breast 714\nShrunken bladder 1281\nShunt\naortic size 737\nevaluation 737\nintracardiac, NUC 1416\npatency 1418\nportal vein 870\nportosystemic 977\nventriculoperitoneal, complications 407\nwith normal left atrium 737\nShwachman-Diamond syndrome 981\nSialadenitis 501\nchronic\nrecurrent 501\nsclerosing 481\nmyoepithelial 504\nSialolithiasis 502\nSialosis 502\nSicca syndrome 504\nSickle\ncell\nanemia 197\ndisease 196\ntrait 199\n-Thal disease 199\nSiderosilicosis 670\nSiderosis 670\nSiderotic nodule 917\nSigmoid\nmesocolon hernia 1103\nvolvulus 1066\nSigmoidocele 1130\nSignet ring\ncarcinoma, colon 1064\nsign\nkidney 1229\nlung 559\nSign of the Camalote, lung 923\nSilent thyroiditis 509\nSilhouette sign 550\nSilicone\nimplant 727\nleaching 728",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 971,
            "markdown": "spread, breast 728\nSiliconoma 728\nSilicoproteinosis 670\nSilicosiderosis 670\nSilicosis 670\nSilicotuberculosis 671\nSilo-filler's disease 527\nSilver\n-colored stools 896\n-fork deformity 108\nSimian crease 89\nSimon focus 680\nSimple\nbone cyst 200\nbone cyst, jaw 219\nbreast cyst 718\ncoal worker's pneumoconiosis 601\nfracture 102\nmeningocele 221\novarian cyst 1370\npulmonary eosinophilia 613\nrenal cortical cyst 1251\nureterocele 1283\nSimpson's white line 1202\nSincipital cephalocele 339\nSinding-Larsen-Johansson disease 199\nSingle\n-breath image, NUC 1405\n-cavity cochlea 495\ncolonic filling defect 1021\noutlet of heart 856\nphoton absorptiometry 4\numbilical artery 1381\nventricle 845\ndouble inlet 845\nSingular canal 315\nSinoatrial node\nanatomy 766\nartery 769\nSinonasal\nglomus tumor 486\ngranulomatous disease 440\npolyposis 502\npseudotumor 502\n-type hemangiopericytoma 486",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 972,
            "markdown": "# Sinus \n\naplasia 440\nhyperdense secretions 440\nhypoplasia 440\nlipomatosis 1268\nof Valsalva aneurysm 788\nopacification + expansion 441\nparanasal 454\npericranii 277\nthrombosis 340\nvenosus defect 784\nvenosus, heart 766\n\n## Sinusitis 502\n\nSinusoidal obstruction syndrome 982\nSipple disease 957\nSirenomelia 245\nSister Joseph nodule, 1027\nSistrunk procedure 506\nSitus 737\nambiguus 739\nindeterminatus 739\ninversus 738\nsolitus 738\nSitzmarks test 1035\nSixth ventricle 314\nSjÃ¶gren syndrome 504\nSkeletal dysplasia in fetus 1300\nSkene\nduct cyst 1269\nglands 1192\nSkiers thumb 109\nSkin\nlesions, breast 690\nthickening, breast 690\nSkip\naganglionosis 1104\nlesions 1068\nSkull\nabnormalities 214\nbase\nlines on lateral view 235\ntumors 216\nfractures 254\nhair-on-end 215\ninadequate calcification 215",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 973,
            "markdown": "increased thickness 215\nosteolysis 215\nthinned 215\nSlanting, tibiotalar joint 25\nSLAP lesion, shoulder 136\nSLE 672\nSlender ribs 19\nSlice of sausage pattern, breast 725\nSliding hiatal hernia 1103\nSlim sign, carotid artery 477\nSlipped\ncapital femoral epiphysis 93\nepiphysis 13\nSlit ventricle syndrome 407\nSlow\n-flow vascular malformation 846\nstroke 284\nSludge, gallbladder 912\nSly disease 152\nSmall\nairways 567\nbladder capacity 1172\nbowel\nabnormal folds 1016\nadenoma 1042\nbenign tumors 1018\ncast 1098\ncavitary lesions 1014\nconstricting lesion 1017\ndelayed transit 1017\ndilatation + normal folds 1015\ndilated dry 991\ndilated wet 991\ndisease location 1014\ndiverticula 1014\nduplication cyst 1078\nfeces sign 1000\nfilling defects 1017\nfluid 1014\nfold\nanatomy 1035\natrophy 1017\nhemorrhage 988\nleiomyoma 1113\nleiomyosarcoma 1113",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 974,
            "markdown": "malignant tumors 1018\nmesentery 1038\nmultiple\nfilling defects 1017\nstenotic lesions 1017\nulcers 1014\nnodularity + malabsorption 991\nnormal folds\n\n+ diarrhea 1015\n+ fluid 991\n+ wet 991\nobstruction 999\nperistalsis 1035\nribbonlike 1017\nsandlike lucencies 1017\nseparation of loops 1014\nsolitary filling defect 1017\ntethered folds 1016\nthickened\nirregular folds $\\pm$ dilatation 1016\nnodular irregular folds 991\nsmooth folds $\\pm$ dilatation 1016\nstraight folds 991\ntumor 1017\nulcer 1014\nvolvulus 1138\ncell\nosteosarcoma 177\nundifferentiated carcinoma, lung 594\ncisterna magna 1304\nfor gestational age fetus 1364\ngallbladder 872\ninternal auditory canal 495\nleft colon syndrome 1139\nnoncleaved NHL 636\npulmonary nodules 539\nsaphenous vein 778\nspleen 880\nunilateral adrenal tumor 1156\nvertebral body 222\nSmallpox 199\nSmith\nfracture 108\northogonal hole test 1396\nSmith-Lemli-Opitz syndrome 1302",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 975,
            "markdown": "Smoking-related interstitial lung disease 514\nSmooth\nbrain 375\nesophageal narrowing 1005\nSmudged papillae 1281\nSnake-head sign, barium 1000\nSnapping hip syndrome 22\nSnowman configuration, cardiac silhouette 782\nSnowstorm pattern, breast 728\nSnuff box 109\nSoap-bubble appearance\nabdomen of neonate 995\nbone 118\nmeconium ileus 1121\nSoave procedure 1104\nSodium reabsorption 1188\nSoft-tissue\ncalcification 29\nchondroma 200\nganglion 115\nhemangioendothelioma 122\nhemangioma 124\nlesion, inflammatory 26\nlipoma 140\nmalignant fibrous histiocytoma 101\nmass\ncategories 26\nfoot + ankle 26\nsuperficial 26\nossification 30\nosteoma 200\nradionuclide uptake on bone scan 28\nrim sign, ureter 1289\ntumor\nbenign fibrous 27\ncartilaginous 28\nfat-containing 27\nmalignant 27\nmost frequent benign 27\nosseous 28\nSoleal muscle veins 777\nSoleus syndrome 196\nSolid\nand cystic tumor, pancreas 982\nand papillary carcinoma, pancreas 982",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 976,
            "markdown": "chest mass, fetus 1306\ncircumscribed carcinoma, breast 715\novarian tumor 1315\npelvic mass 1312\nperiosteal reaction 12\n-pseudopapillary tumor, pancreas 982\nrenal mass 1162\nsplenic lesions 881\nthymic lesion 553\n\n# Solitary \n\nbone cyst\nextremity 200\ntooth 219\nechogenic liver mass 864\nfibrous tumor 671, 200\nfilling defect, small bowel 1017\nleft IVC 756\nliver lesion 863\nmetastatic lung nodule 643\nmyeloma, bone 155\nosteochondroma 166\nosteosclerotic lesion 3\nplasmacytoma of bone 155\npleural mass 548\npulmonary nodule\ndefinition 533\ngrowth rate 535\nmanagement 535\nmorphologic evaluation 533\nrectal ulcer syndrome 1139\nSolu-Medrol ${ }^{\\circledR} 1437$\nSomatostatin 1030\nanalogs 1421\nreceptor scintigraphy 961\nSomatostatinoma 964\nSomatotrophic adenoma 394\nSoto syndrome 58\nSources of artifacts\nNUC 1396\nSpace of Retzius 1282\nSpadelike hand 58\nSpalding sign 1357\nSpasmus nutans 428\nSpastic bladder 1227\nSpatial resolution, scintigram 1395",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 977,
            "markdown": "# Specificity 1427 \n\nSpeckling, V/Q scan 633\nSPECT\nmyocardial perfusion imaging 1407\nquality control 1396\nSpectamine ${ }^{\\circledR} 1400$\nSpermatic cord\nanatomy 1190\nlipoma 1215\ntorsion 1269\nSpermatocele 1178\nSperm granuloma 1177\nSpheno\nethmoidal encephalocele 339\nmaxillary encephalocele 339\noccipital chordoma 247\norbital encephalocele 339\npharyngeal encephalocele 339\nSphenoid\nbone fracture 255\nherniation 290\nsinus 455\nwing\nabsent 216\nmeningioma 378\nSphenoidal encephalocele 339\nSpherocytosis, hereditary 127\nSpheroids 91\nSphincter\nof Oddi 893\nweakness incontinence 1175\nSpider cell, rhabdomyoma 844\nSpiderlike\ncalices 1259\npelvocaliceal system 1269\nSpidery calices 1259\nSpigelian hernia 1100\nSpina\nbifida 221\nventosa 210\nSpinal\nchordoma 248\ncolumn 238\ncord\natrophy 231",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 978,
            "markdown": "compression 266\nglioma 261\nherniation 263\nlesions 229\ndelayed uptake of water-soluble contrast 231\ndysraphism 221\nepidural lymphoma 376\nfixation devices 231\nfusion, assessment of bridging 232\ninstability 260\ninstrumentation, complications 232\nosteochondrosis 275\nschistosomiasis 398\nstenosis 277\ntumors by tissue origin 226\n\n# Spindle cell \n\ncarcinoma, esophagus 1084\ntumor, GI 1096\n\n## Spine 238\n\nbiomechanics 238\ncervical fusion 223\ndislocation 252\ndrop metastases from CNS tumors 267\nendplate changes 249\nosteoporosis 6\nparavertebral ossification 224\nplasma cell myeloma 154\nvacuum phenomenon 228\nSpinnaker-sail sign 551\nSpinogle noid notch 36\nSpinous process fracture 257\n\n## Spleen\n\naccessory 896\nattenuation 894\ncalcification 882\ncystic\nlesion 881\nneoplasm 881\nembryology 894\nepidermoid cyst 925\nfalse cyst 881\nhamartoma 983\nhistology 894\nhyperechoic spots 882\nincreased density 882",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 979,
            "markdown": "infarction 983\niron accumulation 882\nlarge 880\nlesion 881\nmetastasis 881\nmicroabscesses 881\nnonvisualization 880\nscintigraphy 1418\nsequestration crisis 198\nsignal intensity 894\nsize 894\nsmall 880\nsolid lesion 881\nspontaneous rupture 882\nweight 894\n\n# Splenic \n\nabscess 881\nangiosarcoma 983\nartery aneurysm 846\nbump 1163\nhamartoma 983\nhemangioma 983\ninjury\ncategories 1053\ntorsion 985\ntrauma 1053\nSplenogonadal fusion 896\nSplenoma 983\nSplenomegaly 880\nin AIDS 1045\nSplenorenal ligament 1039\nSplenosis\nabdomen 983\nthoracic 676\nSplit\natlas 220\nbrain 398\ncord 251\ncranium 339\ndose method, thallium 1411\n-fat sign 270\nhand 1302\nnotochord syndrome 278\npleura sign 547, 613\nSpoke-wheel",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 980,
            "markdown": "pattern, liver 929\nrenal mass 1263\nsign, small bowel 1138\n\n# Spondylitis \n\nankylosing 242\nRomanus lesion 277\ntuberculous 281\n\n## Spondylo\n\narthritis, seronegative 276\narthropathy 276\ndestructive 1149\ndialysis-associated 277\ndiskitis\npyogenic 252\nrheumatic 277\nepiphyseal dysplasia 201\nlisthesis 278\ntraumatic 259\nlysis 279\n\n## Spondylosis\n\ncervical spine 279\ndeformans 249, 223\nSpongiform leukodystrophy 338\nSpongiosa\nprimary 3\nsecondary 3\n\n## Spontaneous\n\nabortion 1338\ncarotid dissection 483\nhemoperitoneum 987\nhepatic hemorrhage 867\nosteonecrosis, knee 67\nperforation of common bile duct 984\npneumomediastinum 551\npneumothorax 546\nretroperitoneal hemorrhage 1170\nsplenic rupture 882\nurinary extravasation 1167\n\n## Spoon-shaped nails 72\n\nSporadic\naniridia\nnephroblastomatosis 1225\nWilms tumor 1291\nBurkitt lymphoma 1057\nSprengel deformity 201",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 981,
            "markdown": "in Klippel-Feil syndrome 264\nSpring onion ureter 1283\nSprue 1139\nSquamous cell carcinoma\nesophagus 1084\nhead and neck\nPET 442\nhead \\& neck\nstaging of cervical nodes 487\nkidney 1270\nlung 594\nurinary bladder 1203\nSquared\npatella 126\nvertebral bodies 89\nSquare shift, brain 291\nSquashed carpi 190\nSquatting position 849\nSqueeze sign 1113\nS sign of Golden 592\nStacked-coin appearance 989\nStafne cyst 219\nStaghorn calculus 1288\nStandardized uptake value 1398\nStanford classification 790\nStapedial\nartery\nembryology 465\npersistence 500\nnerve anatomy 318\notosclerosis 496\nStaphylococcal pneumonia 671\nStaphyloma 435\nStaples, orthopedic 34\nStarfish scar, lung 651\nStarr-Edwards valve 760\nStarry sky pattern 940\nStatins, MSK 90\nStatistics 1427\nStauffer syndrome 1248\nSteatosis, liver 926\nSteeple sign, pharynx 482\nSteinberg\nclassification 64\nsign 144",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 982,
            "markdown": "Stein-Leventhal syndrome 1382\nStellate\nbreast lesion 685\ncentral scar, pancreas 982\nStener lesion 110\nStenogyria 342\nStenosis\naortic valve 793\naqueduct 331\ncarotid artery 476\nhepatic artery 949\nmitral valve 829\nmultiple small bowel 1017\npapilla of Vater 876\npulmonary valve 841\nrenal\nartery 1244\nvein, transplant 1256\nspine 277\nsubglottic 505\nStensen duct 501\nStepladder\nappearance, C-spine 188\nsign\nbreast 728\nGI tract 1000\nStercoral ulceration 1134\nSterile\nosteomyelitis 172\npyuria 1281\nSterilized metastasis 643\nSternal fracture 110\nSternoclavicular\ndislocation 86\nhyperostosis 194\nSternocleidomastoid tumor of infancy 485\nSteroid\ncell tumors 1382\npremedication 1435\nStewart-Treves syndrome 61\nStieda fracture 157\nStierlin sign 1143\nStiff\nlung syndrome 575\n-man syndrome 1003",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 983,
            "markdown": "Still disease 190\nStimulation scan, thyroid 1402\nStippled epiphyses 13\ncongenital 72\nStipple sign, TCC 1276\nSt. Jude valve 760\nStochastic effects of radiation 1336\nStomach\nanatomy 1034\nantral narrowing 1009\natony 1009\nbull's-eye lesions 1011\ncalcified tumor 1008\nextrinsic impression 1010\nglomus tumor 1098\nintraluminal mass 1010\nintramural-extramucosal lesion 1009\nintrathoracic 1103\nintrinsic wall lesion 1010\nlesion involving stomach \\& duodenum 1011\nnarrowing 1009\nnonvisualization in fetus 1307\npolyp 1092\n\n+ small bowel, thickened folds 1016\nthickened folds 1010\ntumor 1007\nulcer 1093\nvarices 1094\nStomal edema 999\nStone\nbile duct 913\nbiliary 912\nchild 1351\ncholesterol 912\ncystic duct remnant 914\nfecal 995\nfloating 912\ngas-containing 912\nkidney 1286\npigment 912\nurinary bladder 1173\nStorage disease, glycogen 931\nStraight\nanterior vertebral border 223\nback syndrome 830",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 984,
            "markdown": "cord 1298\n\n# Strain \n\nmuscle 32\nmyotendinous 156\nStrangulated obstruction 1000\nStrangulation 1100\nStrangury 1266\nStratification of intestinal tract 1023\nStrawberry\ngallbladder 946\nnevus 124\n-shaped head 1385\nStreptococcal pneumonia 672\nStreptococcus\ngroup A B-hemolytic 672\ngroup B 644\nStress\nfracture 103\nincontinence 1175\ninjury 103\ntest\nfetus 1325\nheart 1413\nthallium image 1411\nStretch sign 1000\nStriated\nangiographic nephrogram 1166\ncerebellum sign 356\nnephrogram 1165\nStricture\nesophagus 1005\nextrahepatic bile ducts 875\nintrahepatic bile ducts 876\nureter 1171\nurethra 1180\nString\n-of-beads sign\nabdomen 1000\nexcessive fluid in small bowel 1015\nkidney 1247\nrenal artery 816\nsmall bowel 1015\n-of-pearls sign\nkidney 1247\nlung 589",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 985,
            "markdown": "pancreas 971\nsign\ncarotid dissection 484\nCrohn disease 1069\nhypertrophic pyloric stenosis 1105\nosteosarcoma 176\nStriopallidodentate calcinosis 355\nStripe sign, lung scintigraphy 657\nStroke\nbrain infarction 369\nclinical 283\nvolume, heart 1408\n\n# Stromal \n\nluteoma 1382\ntumors, testis 1273\nStrongyloides hyperinfection syndrome 1142\nStrongyloidiasis 1141\nStruma ovarii 1382\nStruvite 1288\nStuart index 779\nStuck twin 1385\nSturge-Weber-Dimitri syndrome 399\nStylohyoid ligament calcification 76\nSubacromial\npain syndrome 191\n-subdeltoid bursitis 194\n\n## Subacute\n\ncerebral hematoma 362\nencephalitis 328\nextrinsic allergic alveolitis 616\ngranulomatous thyroiditis 509\ninterstitial pneumonia 624\nischemic infarction, brain 371\nlymphocytic thyroiditis 509\nmuscle denervation 31\nnecrotizing encephalomyelopathy 374\nrenal vein thrombosis 1259\nsubdural hematoma 401\ntesticular torsion 1270\nthyroiditis 510\nSubadventitial hyperplasia 816\nSubaortic stenosis 794\nSubarachnoid\nhemorrhage 399\nspace",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 986,
            "markdown": "brain 310\nspine 238\nSubarcuate canal 315\nSubarticular\nlesion 13\npseudocyst 15\nSubcapsular hematoma, kidney 1170\nSubcarinal space lesion 554\nSubchondral\nbone resorption 128\ncyst 15\nfracture 65\nSubchorial hemorrhage 1378\nSubchorionic\nfibrin deposition 1298\nhemorrhage 1378\nSubclavian steal syndrome 846\nSubcoracoid shoulder dislocation 86\nSubcortical\narteriosclerotic encephalopathy 337\nhamartoma, CNS 404\nSubcutaneous nodules 189\nSubdural\ncontrast injection 231\neffusion, benign 213\nempyema 352\nfluid collection 304\nhematoma 400\nhemorrhage, newborn 400\nhygroma 309, 401\nspace 310\nSubependymal\ncyst 401\ngiant cell tumor 404\nhamartoma 404\noligodendroglioma 391\nSubependymoma, spinal cord 262\nSubepithelial\nlesion\ncolon 1021\ntumor\nesophagus 1006\nSuberosis 615\nSubfalcine herniation 289\nSubgaleal",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 987,
            "markdown": "hemorrhage 213\nhygroma 309\nspace 233\nSubglottic\ncarcinoma 489\nhemangioma 490\ninverted V sign 482\nnarrowing 445\nstenosis 505\nSubglottis 462\nSubhepatic space 1038\nSubinfundibular pulmonary ste nosis 842\nSublabral foramen 41\nSublingual\ngland 469\nsalivary glands 457\nspace 457\nSubluxation, atlantoaxial 220\nSubmandibular\ngland 469\nsialadenitis 501\nspace 464\nSubmucosal\ndissection, esophagus 1085\nfibroid 1389\nfibroma 1106\nSubperiosteal\nabrasion 76\nbone resorption 128\norbital abscess 424\nosteoid osteoma 169\nSubpial space 311\nSubpleural pulmonary arcades 579\nSubpulmonic effusion 548\nSubsegmental\natelectasis + pleural effusion 548\ndefect, lung scan 657\nSubserosal fibroid 1389\nSubungual\nexostosis 201\nglomus tumor 119\nkeratoacanthoma 134\ntumors 21\nSubvalvular\naortic stenosis 794",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 988,
            "markdown": "pulmonary stenosis 842\nSuccenturiate lobe, placenta 1322\nSucquet-Hoyer canal 119\nSudanophilic leukodystrophy 392\nSudden cardiac death 759\nSudeck\ndystrophy 185\npoint 1110\nSulcal brain development 310\nSulcus terminalis, heart 766\nSulfur granules 59\nSunburst\ngyral pattern 327\nnephrogram 1233\nperiosteal reaction 12\nvascularity, brain 378\nSuperfecundation 1328\nSuperfemale syndrome 134\nSuperfetation 1328\nSuperficial\nfibromatoses 201\ngliomas 293\npalmar arch 777\nspreading\ncarcinoma\nesophagus 1083\nstomach 1091\nmelanoma 1426\nvenous system of lower extremity 778\nSuperior\ncerebellar artery 325\nglenohumeral ligament 40\nmesenteric artery 1031\nsyndrome 846\nophthalmic vein\ndilated 412\nthrombosis 435\norbital fissure\nanatomy 418\nwidened 216\nsagittal sinus thrombosis 340\nshoulder dislocation 88\nsublabral recess 38\nsulcus tumor 592\nvena cava",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 989,
            "markdown": "bilateral 755\ncongenital anomalies 772\norigin 771\nsyndrome 846\nSupernormal artery, brain 287\nSupernumerary\nkidney 1270\nparathyroid glands 472\nSuperparamagnetic iron oxide particles 866\nSuperscan 1\nSuppression scan, thyroid 1402\nSuppurative acute pyelonephritis 1240\nSuprabullar cell 455\nSupraclinoid carotid aneurysm 331\nSupracondylar fracture 107\nSupracristal ventricular septal defect 858\nSupradiaphragmatic TAPVR 782\nSupraglottic\ncarcinoma 489\nnarrowing 445\nSupraglottis 459\nSupraglottitis 484\nSupraorbital ethmoid cell 455\nSuprascapular\nnerve 36\nnotch 36\nSuprasellar\ngerminoma 356\nlow-density lesion with hydrocephalus 307\nmass 307\nmeningioma 379\nSupraspinatus tendinosis 194\nSupratentorial\nintraventricular tumors 300\nmidline tumors 292\ntumor with mural nodule 292\nSupravalvular\naortic stenosis 795\npulmonary stenosis 842\nSupraventricular\ncrest, heart 762\ntachyarrhythmia 1356\nSupravesical hernia 1103\nSurface\narea rule, NUC dose 1393",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 990,
            "markdown": "osteosarcoma 175\nSurfactant 568\ndeficiency disorder 662\nSurfer's ear 438\nSurgical procedure\ncongenital heart disease 759\nDuhamel 1104\nmesoatrial shunt 979\nmesocaval shunt 979\nportocaval shunt 978\nportosystemic shunts 978\nSoave 1104\nstomach 1011\nSwenson pull-through 1104\nWarren shunt 979\nSusac syndrome 383\nSuspensory ligament\nliver 1039\novary 1332\nSutures 233\ninfiltration 214\nwide 214\nSUV 1398\nSwallowing function 1033\nSwan-Ganz line, malpositioned 562\nSwan neck deformity 188\nSwenson pull-through procedure 1104\nSwimming pool granuloma 646\nSwiss cheese\nair bronchogram 580\ndisease, breast 725\nmyometrium 1340\nnephrogram 1232\nsign, liver 874\nSwollen brain hemispheres 293\nSwyer-James syndrome 672\nSylvian triangle 291\nSymmetric\nhypertrophy, heart 807\nIUGR 1364\nperiosteal reaction in adulthood 12\nSympathetic ganglia tumors 555\nSympathoblastoma 497\nSympathogonia 498\nSymphysis pubis, widened 228",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 991,
            "markdown": "# Symptomatic \n\ncoarctation of aorta 809\nvascular rings 754\nSyncephalus 1346\nSynchronous testicular tumor 1275\nSyncytiotrophoblast 1358\nSyndactyly 20\nin fetus 1303\nSyndesmophyte\nmarginal, ankylosing spondylitis 242\nspine 224\nSyndromes with\ncongenital heart disease 736\nmultiple cortical renal cysts 1164\nSynechia\nuterus 1341\nvulvae 1176\nSynovial\nchondrosarcoma 74\ncyst 202\nperiarticular 15\nsubchondral 15\ndisease, decreased signal intensity 15\nhemangioma 124\nherniation pit 127\nlipoma, diffuse 141\nosteochondromatosis 203\nrecesses, location 53\nsarcoma 203\nSynovioma 203\nSynovitis\nbrucellar 70\npigmented villonodular 180\nSyphilis\naortic aneurysm 787\naortitis 820\nbone 204\nSyringobulbia 294\nSyringohydromyelia 279\nSyringomyelia 280\nSyrinx 279\nSystemic\nlupus erythematosus 672\narthritis, hand 16\nlymphoma, brain 376",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 992,
            "markdown": "nodular panniculitis 1137\nsclerosis 1133\nSystolic anterior motion of mitral valve\nDDx 741\nhypertrophic cardiomyopathy 806\n\nT1-hyperintense intracranial lesions 296\nT2-hyperintense periventricular brain lesions 301\nT2 shading 1354\nTable of\ndose, energy, half-life 1393\nradiation dose 1393\nTaeniasis 348\nTaenia solium 347\nTagamet ${ }^{\\circledR} 1437$\nTailgut cyst 269, 1142\nTail sign, lung 591\nTakayasu arteritis 847\nTalar beak\ndorsal 205\nventral 25\nTalcosis, lung\ninhalational 674\nmainline 652\nTalipes 25\nequinovarus 25\nTalocalcaneal angle 55\nTalus, vertical 25\nTalwin 843\nTamm-Horsfall protein 1224\nabnormal nephrogram 1166\nTamoxifen 1317\nTamponade\nexternal brain 309\nheart 803\nTanner stages 698\nTapered fingers 1135\nTapeworm 347\nTarget\nlesion, lung 619\nsign\nappendicitis 1049,1050",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 993,
            "markdown": "CMV colitis 1044\ncommon bile duct 914\nCrohn disease 1069, 1070\nerosive gastritis 1096\ngiant aneurysm, brain 330\nhypertrophic pyloric stenosis 1105\nintussusception 1108\nliver 901\nmalignant melanoma 1118\nmural stratification, GI tract 1023\nneurofibroma 270\npseudomembranous colitis 1062\nrectum 1136\ntuberculoma, brain 403\nTargetoid growth, breast 714\nTarlov cyst 266\nTarsal\ncoalition 205\ntunnel syndrome 205\nTarsoepiphyseal aclasis 91\nTAR syndrome 207\nTaussig-Bing heart 813\nTaxoid derivatives 515\nT-cell lymphoma, peripheral 1116\nTeacup\ncalcifications, breast 722\n-like breast calcifications 688\n\n# Teardrop \n\nappearance, duodenum 1076\nfracture 257\npelvic anatomy 22\nventriculomegaly 327\nwidth, pelvis 22\nTeboroxime 1413\nTechnegas 1406\nTechnetium-99m\nacetanilide iminodiacetic acid 1417\nantimyosin Fab fragments 1416\ndiethylenetriamine pentaacetic acid 1418\ndimercaptosuccinic acid 1418\nDMSA 1418\nDTPA 1418\naerosol 1406\nECD 1400\nglucoheptonate 1418",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 994,
            "markdown": "heat-denatured erythrocytes 1418\nHMPAO 1400\nhuman\nalbumin microspheres 1405\nserum albumin 1409\nIDA analogs 1417\n-labeled autologous RBCs\nblood pool agents 1409\nintestinal bleeding 989\nmacroaggregated albumin 1405\nmercaptoacetyltriglycine 1419\nmertiatide 1419\nmini-microaggregated albumin colloid 1422\npertechnetate\nGI bleed 990\nthyroid 1402\npyrophosphate 1415\nsestamibi, parathyroid 1404\nsulfur colloid\nGI bleed 990\nliver 1417\n-thallium subtraction imaging 1404\nTectal be aking 343\nTegmental cap 395\nTegmen tympani 464\nTelangiectasia\ncapillary, brain 338\nhereditary hemorrhagic 618\nretinal 419\nTelangiectatic\nfocal nodular hyperplasia 929\nosteosarcoma 177\nTelencephalon 311\nTelephone handle bone 207\nTelltale triangle sign 993\nTemporal\nbone\nanatomy 464-472\ndemineralization 440\nfracture 255\ngranulomatous arteritis 848\nTemporomandibular joint\nanatomy 464\ndestruction 217\nTendon rupture 32",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 995,
            "markdown": "# Tennis elbow 138 \n\n## Tenosynovial giant cell tumor 181\n\n## Tension\n\npneumocephalus 309\npneumomediastinum 552\npneumopericardium 552, 748\npneumothorax 545\n\n## Teratocarcinoma\n\nmediastinum 675\npineal gland 393\n\n## Teratoid\n\ncyst, neck 482\ntumor, mediastinum 674\n\n## Teratoma\n\nCNS 401\nmediastinum 674\nneck 505\norbit 412\novary 1383\npericardial 836\npineal 401\nretroperitoneum 1263\nsacrococcygeal 273\nspine 280\ntestis 1273\n\n## Terbutaline 1437\n\n## Terminal\n\nbronchiole 567\nductal lobular unit 699\nmyelocystocele 280\ntufts\nautoamputation 1135\nresorption 21\nureterectasis 1220\n\n## Terry-Thomas sign 88\n\n## Tertiary\n\nesophageal contractions 1003\nhyperparathyroidism 130\nhypothyroidism 450\nsyphilis 205\n\n## Testicular\n\nanatomy 1190\nappendage, torsion 1176, 1270\natrophy 134\nblood flow 1176",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 996,
            "markdown": "cancer 1270\ncystic lesions 1178\ndislocation 1275\nfeminization 1181\nfracture 1275\nhematoma 1275\ninfarction 1275\nmetastases 1274\nmicrolithiasis 1275\nrupture 1276\ntorsion 1269\ntrauma 1176, 1275\nTetany 131\nTethered\ncord 280\nfolds, small bowel 1016\nTetralogy of Fallot 849\nTetrofosmin 1413\nTeutschlÃ¤nder disease 210\nTextiloma 1154\nThalassemia 206\nThalidomide 1303\nThallium-201\nchloride 1411\nuptake and distribution 1411\nThanatophoric dysplasia 206\nThebesian valve 766\nTheca\ncell tumor, ovary 1383\nlutein cyst 1369\nThecoma 1383\nThelarche 698\nisolated premature 1311\npremature 683\nTherapeutic\namniocentesis 1326\ncordocentesis 1326\nThermoactinomyces vulgaris 615\nThermophilic actinomycetes 615\nThickened\nbladder wall 1172\ncentral cavity complex, pregnancy 1297\nduodenal wall 1014\nfolds\nduodenum 1012",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 997,
            "markdown": "irregular $\\pm$ dilatation, small bowel 1016\nsmooth $\\pm$ dilatation, small bowel 1016\nstomach 1010\nstomach + small bowel 1016\ngallbladder wall 872\nheel pad 25\nirregular endometrium 1317\npituitary stalk 306\nThigh muscles, anatomy 47\nThimble bladder 1281\nThin skull 215\nThird\nbranchial\narch 456\ncleft cyst 476\n-degree heart block 1357\nhepatic inflow 868\ninflow to liver 886\nInternational Standard, beta-hCG 1320\nventricle\nhigh-riding 327\nmass 300\n\n# Thoracic \n\naortic\naneurysm 788\ninjury, acute 852\ncircumference, fetus 1325\ndeformity 17\npostoperative 760\ndisk herniation 251\nduct\ncyst 676\nroute 573\nendometriosis syndrome 1355\ninlet lesions 553\nmeningocele 268\noutlet syndrome 850\nparaganglioma 676\npulsion diverticulum 1005\nsarcoidosis 668\nSLE 673\nspine, anatomy 239\nsplenosis 676\n\n## Thoraco\n\nabdominal duplication 1077",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 998,
            "markdown": "lumbar spine\nfracture 259\ntransitional vertebra 240\nomphalopagus 1346\npagus 1346\nstomy tube position 562\nThorium dioxide 984\nThorny radiations, bone 69\nThorotrastosis 984\nThread and streaks sign\nportal vein thrombosis 977\ntumor thrombus, HCC 945\nThreatened abortion 1338\nThree\n-chamber view 763\n-channel aorta 790\n-phase bone scanning 1422\nThrombangiitis obliterans 799\nThrombocytopenia-absent radius syndrome 207\nThromboembolism\nlung 652\nparaneoplastic 855\nThrombophilia 759\nThrombosis\ndeep vein 811\nhepatic artery 949\nintervillous, placenta 1298\nmesenteric vein 1125\novarian vein 1373\nportal vein 976\nrenal vein\nnative kidney 1258\ntransplant 1256\nsuperior ophthalmic vein 435\nTIPS 979\nvenous\nbrain 351\nsinus, CNS 340\nThrombus\ncardiac 804\norganized 811\nrecanalized 811\nThrush 1087\nThumb\nadducted 209",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        },
        {
            "index": 999,
            "markdown": "fingerized hypoplastic 127\nfloppy-thumb sign 80\ngamekeepers 109\nhitchhikers 85\nhypoplastic 127\nskier's 109\ntriphalangeal 127\nThumbprinting 1062\nacute mesenteric ischemia 1124\ncolon 1019\nintramural hemorrhage 989\nmidgut volvulus 1127\nnecrotizing enterocolitis 1079\npseudomembranous colitis 1062\nretractile mesenteritis 1137\nulcerative colitis 1144\nThymic\ncarcinoma 679\ncyst 676\nepithelial tumors 677\nsail sign 551\nThymolipoma 677\nThymoma 677\nThymus\nanatomy 571\ndiffuse enlargement 557\nectopic 572\nembryogenesis 571\nhyperplasia 677\nmass 557\nneoplasia 557\nsolid lesion 553\nweight 571\nThyroglossal\nduct 471\ncyst 506\nThyroid\nacropachy 207\nadenoma 506\ncalcifications 450\ncarcinoma 507\nanaplastic 508\nfollicular 508\nmedullary 508\npapillary 508",
            "images": [],
            "dimensions": {
                "dpi": 200,
                "height": 2200,
                "width": 1700
            }
        }
    ],
    "model": "mistral-ocr-2503-completion",
    "usage_info": {
        "pages_processed": 1000,
        "doc_size_bytes": 7735656
    }
}